PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Abe, H; Kamimura, K; Kawai, H; Kamimura, H; Domori, K; Kobayashi, Y; Nomoto, M; Aoyagi, Y				Abe, Hiroyuki; Kamimura, Kenya; Kawai, Hirokazu; Kamimura, Hiroteru; Domori, Koji; Kobayashi, Yuji; Nomoto, Minoru; Aoyagi, Yutaka			Diagnostic imaging of hepatic lymphoma	CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY			English	Review							NON-HODGKINS-LYMPHOMA; OF-THE-LITERATURE; B-CELL LYMPHOMA; GD-EOB-DTPA; INTRAVASCULAR LYMPHOMA; EXTRANODAL LYMPHOMA; CLINICAL-EVALUATION; LIVER; CT; CHEMOTHERAPY	Hepatic lymphoma is a rare disease with poor prognosis because of delayed diagnosis. The disease comprises primary, metastatic, and intravascular hepatic lymphomas. The pathological characteristics of lymphomas differ contributing to difficulty in early diagnosis. Early diagnosis and appropriate treatment result in improved prognosis; therefore, diagnostic radiology and its development with various contrast agents are critical for improving disease outcomes. Herein, we review hepatic lymphomas and summarize the results of imaging studies in correlation with pathological characteristics. The information provided will help physicians in early diagnosis and thereby improving prognosis. (C) 2014 Published by Elsevier Masson SAS.	[Abe, Hiroyuki; Kamimura, Kenya; Kawai, Hirokazu; Kamimura, Hiroteru; Domori, Koji; Kobayashi, Yuji; Nomoto, Minoru; Aoyagi, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Niigata 9518510, Japan	Kamimura, K (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Chuo Ku, 1-757 Asahimachi Dori, Niigata, Niigata 9518510, Japan.	kenya-k@med.niigata-u.ac.jp					Abe H, 2014, INTERNAL MED, V53, P587, DOI 10.2169/internalmedicine.53.1812; Ahmed S, 2013, ABDOM IMAGING, V38, P763, DOI 10.1007/s00261-012-9934-y; Ferreri AJM, 2004, BRIT J HAEMATOL, V127, P173, DOI 10.1111/j.1365-2141.2004.05177.x; Zelenetz AD, 2011, J NATL COMPR CANC NE, V9, P484; DIGIUSEPPE JA, 1994, J CLIN ONCOL, V12, P2573; Noronha V, 2005, CRIT REV ONCOL HEMAT, V53, P199, DOI 10.1016/j.critrevonc.2004.10.010; HAMM B, 1995, RADIOLOGY, V195, P785; Civardi G, 2002, EUR J CANCER, V38, P2382, DOI 10.1016/S0959-8049(02)00481-1; Reimer P, 1996, RADIOLOGY, V199, P177; Tan Y, 2013, ABDOM IMAGING, V38, P511, DOI 10.1007/s00261-012-9918-y; Iacobelli J, 2012, AM J DERMATOPATH, V34, pE133, DOI 10.1097/DAD.0b013e31824fec43; DOMIZIO P, 1989, HEMATOL ONCOL, V7, P195, DOI 10.1002/hon.2900070303; Lettieri CJ, 2003, AM J GASTROENTEROL, V98, P1641, DOI 10.1016/S0002-9270(03)00365-4; Bronowicki JP, 2003, HEPATOLOGY, V37, P781, DOI 10.1053/jhep.2003.50121; Maher MM, 2001, CLIN RADIOL, V56, P295, DOI 10.1053/crad.2000.0649; FREEMAN C, 1972, CANCER, V29, P252, DOI 10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#; Cultrera JL, 2012, CANCER CONTROL, V19, P204; AOZASA K, 1993, LEUKEMIA LYMPHOMA, V10, P353, DOI 10.3109/10428199309148560; Appelbaum L, 2005, ISRAEL MED ASSOC J, V7, P19; Avlonitis VS, 1999, EUR J SURG, V165, P725; Badawy ME, 2013, EGYPT J RADIOL NUCL, V44, P453; BAGLEY CM, 1973, CANCER, V31, P840, DOI 10.1002/1097-0142(197304)31:4<840::AID-CNCR2820310412>3.0.CO;2-W; CACCAMO D, 1986, ARCH PATHOL LAB MED, V110, P553; Cameron AM, 2005, TRANSPLANTATION, V80, P993, DOI 10.1097/01.TP.0000173999.09381.95; CASTELLANI R, 1977, CANCER, V40, P2322, DOI 10.1002/1097-0142(197711)40:5<2322::AID-CNCR2820400547>3.0.CO;2-9; Chim CS, 2001, LEUKEMIA LYMPHOMA, V40, P667, DOI 10.3109/10428190109097665; Colavolpe C, 2014, HEMATOL ONC IN PRESS; D'souza Maria M, 2013, Indian J Radiol Imaging, V23, P354, DOI 10.4103/0971-3026.125626; Eichenauer DA, 2011, ANN ONCOL S, V22, pvi55; Emile JF, 2001, ANN ONCOL, V12, P1005, DOI 10.1023/A:1011131930409; Ferreri AJM, 2004, ANN ONCOL, V15, P1215, DOI 10.1093/annonc/mdh274; Gatter KC, 2001, WHO CLASSIFICATION T, P177; Gebauer N, 2014, AM J DERMATOPATH, V36, pE100, DOI 10.1097/DAD.0000000000000003; Haider Fyeza S, 2008, J Med Case Rep, V2, P279, DOI 10.1186/1752-1947-2-279; Kaneko K, 2011, ANN NUCL MED, V25, P303, DOI 10.1007/s12149-010-0460-0; Kheyri Z, 2013, MIDDLE E J DIG DIS, V5, P168; Lei KIK, 1998, LEUKEMIA LYMPHOMA, V29, P293, DOI 10.3109/10428199809068566; Ma YJ, 2011, HEPAT MON, V11, P203; Malnick S, 2008, J CLIN GASTROENTEROL, V42, P69; Masood A, 2009, CURR ONCOL, V16, P74; Matano S, 1998, AM J GASTROENTEROL, V93, P2301; Metser U, 2004, AM J ROENTGENOL, V182, P1579; Miyashita K, 2011, INTERNAL MED, V50, P617, DOI 10.2169/internalmedicine.50.4686; Oto A, 2005, RADIOL CLIN N AM, V43, P827, DOI 10.1016/j.rcl.2005.05.002; Rizzi EB, 2001, J CLIN ULTRASOUND, V29, P125; RYAN J, 1988, CANCER, V61, P370, DOI 10.1002/1097-0142(19880115)61:2<370::AID-CNCR2820610228>3.0.CO;2-I; Salmon JS, 2006, CLIN LYMPHOMA MYELOM, V6, P273, DOI 10.3816/CLM.2006.n.001; Seshadri N, 2010, CANCER IMAGING, V10, P194, DOI 10.1102/1470-7330.2010.0028; Swerdlow SH, 2008, WHO CLASSIFICATION T, V2; Zech Christoph J, 2007, Magn Reson Med Sci, V6, P43, DOI 10.2463/mrms.6.43	50	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	2210-7401	2210-741X		CLIN RES HEPATOL GAS	Clin. Res. Hepatol. Gastroenterol.	SEP	2015	39	4					435	442		10.1016/j.clinre.2014.11.001		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ9HE	WOS:000360923500009		
J	Choijookhuu, N; Hino, S; Oo, PS; Batmunkh, B; Mohmand, NA; Kyaw, MTH; Hishikawa, Y				Choijookhuu, Narantsog; Hino, Shin-ichiro; Oo, Phyu Synn; Batmunkh, Baatarsuren; Mohmand, Noor Ali; Kyaw, Myat Tin Htwe; Hishikawa, Yoshitaka			Ontogenetic changes in the expression of estrogen receptor beta in mouse duodenal epithelium	CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY			English	Article							PEPTIC-ULCER; ALPHA; CANCER; COLON; MICE; RAT; IDENTIFICATION; PROLIFERATION; LOCALIZATION; SECRETION	Estrogen is considered to be involved in duodenal function; however, the details of its receptor expression are largely unknown. The purpose of this study was to determine the expression and localization of estrogen receptors (ERs) in mouse duodenum. Male and female C57BL/6J mouse intestinal tissues were used to investigate the expression of ER alpha and ER beta by RT-PCR, western blotting, immunohistochemistry, and Southwestern histochemistry. ER beta, but not ER alpha, was expressed in proximal duodenal epithelium, but not in jejunum and ileum. The expression of ER beta mRNA and protein were confirmed by RT-PCR and western blotting, respectively. At postnatal day 20, the transit period of suckling to weaning, the distribution of ER beta-positive cells was changed in the crypt-villus axis, and cytoplasm/nuclear staining changed to only nuclear staining. Moreover, Southwestern histochemistry was used to detect estrogen response element (ERE)-binding proteins, and their expression pattern was highly similar to that of ER beta. These results suggested that ER beta is the predominant ER type in mouse small intestine, and the highly similar co-localization of ERE-binding proteins reveals that ER beta is functionally active in mouse duodenum. The ER beta expression changes during postnatal development indicate that ER beta may be involved in the differentiation of duodenal epithelium. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Choijookhuu, Narantsog; Hino, Shin-ichiro; Oo, Phyu Synn; Batmunkh, Baatarsuren; Mohmand, Noor Ali; Kyaw, Myat Tin Htwe; Hishikawa, Yoshitaka] Miyazaki Univ, Div Histochem & Cell Biol, Dept Anat, Fac Med, Miyazaki 8891692, Japan	Hishikawa, Y (reprint author), Miyazaki Univ, Div Histochem & Cell Biol, Dept Anat, Fac Med, 5200 Kihara, Miyazaki 8891692, Japan.	yhishi@med.miyazaki-u.ac.jp			Japan Society for the Promotion of Science [21590216, 24590255, 23790340]	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 21590216 and No. 24590255 to Y. Hishikawa and No. 23790340 to S.-I. Hino).	AGUWA CN, 1984, EUR J PHARMACOL, V104, P79, DOI 10.1016/0014-2999(84)90371-6; ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775; Harris Heather A, 2007, Mol Endocrinol, V21, P1, DOI 10.1210/me.2005-0459; Ulziibat S, 2006, HUM REPROD, V21, P2281, DOI 10.1093/humrep/del176; Moolman JA, 2006, CARDIOVASC RES, V69, P777, DOI 10.1016/j.cardiores.2006.01.001; Shukuwa K, 2006, HISTOCHEM CELL BIOL, V126, P111, DOI 10.1007/s00418-005-0141-6; VESSEY MP, 1992, CONTRACEPTION, V46, P349, DOI 10.1016/0010-7824(92)90097-D; Imai Y, 2010, MOL ENDOCRINOL, V24, P877, DOI 10.1210/me.2009-0238; Castiglione F, 2008, DIAGN MOL PATHOL, V17, P231, DOI 10.1097/PDM.0b013e3181656d67; Tuo BG, 2011, EUR J PHARMACOL, V651, P159, DOI 10.1016/j.ejphar.2010.10.070; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Wang H, 2000, BIOL REPROD, V63, P1331, DOI 10.1095/biolreprod63.5.1331; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P2959, DOI 10.1073/pnas.0511271103; Solomon NS, 2001, PEDIATR RES, V49, P782, DOI 10.1203/00006450-200106000-00012; Martineti V, 2005, ENDOCR-RELAT CANCER, V12, P455, DOI 10.1677/erc.1.00861; Choijookhuu N, 2012, HISTOCHEM CELL BIOL, V137, P575, DOI 10.1007/s00418-012-0935-2; El Marzouk S, 2008, J STEROID BIOCHEM, V110, P186, DOI 10.1016/j.jsbmb.2008.03.034; Giroux V, 2008, INT J CANCER, V123, P303, DOI 10.1002/ijc.23532; Hishikawa Yoshitaka, 2003, Medical Electron Microscopy, V36, P67; Kawano N, 2004, HISTOCHEM CELL BIOL, V121, P399, DOI 10.1007/s00418-004-0644-6; Kitamura M, 2012, CHEM-BIOL INTERACT, V195, P95, DOI 10.1016/j.cbi.2011.11.002; KOJI T, 1994, J HISTOCHEM CYTOCHEM, V42, P1399; Koji T, 2008, HISTOCHEM CELL BIOL, V130, P917, DOI 10.1007/s00418-008-0487-7; KURATA JH, 1985, AM J PUBLIC HEALTH, V75, P625, DOI 10.2105/AJPH.75.6.625; Lam SK, 2000, BEST PRACT RES CL GA, V14, P41, DOI 10.1053/bega.1999.0058; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Muncan V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1463; Norbury R, 2003, EXP GERONTOL, V38, P109, DOI 10.1016/S0531-5565(02)00166-3; ROSENSTOCK SJ, 1995, GUT, V36, P819, DOI 10.1136/gut.36.6.819; Sar M, 1999, ENDOCRINOLOGY, V140, P963, DOI 10.1210/en.140.2.963; Shih CD, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-60; Shimozawa N, 2007, AM J PHYSIOL-GASTR L, V292, pG615, DOI 10.1152/ajpgi.00117.2006; Shirendeb U, 2009, ACTA HISTOCHEM CYTOC, V42, P181, DOI 10.1267/ahc.09030; Smith A, 2008, ENDOCRINOLOGY, V149, P4554, DOI 10.1210/en.2007-1597; SONNENBERG A, 1987, DIGEST DIS SCI, V32, P1, DOI 10.1007/BF01296680; Tuo B, 1954, GASTROENTEROLOGY, V141, P854	38	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	2210-7401	2210-741X		CLIN RES HEPATOL GAS	Clin. Res. Hepatol. Gastroenterol.	SEP	2015	39	4					499	507		10.1016/j.clinre.2015.01.004		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ9HE	WOS:000360923500017		
J	Tanaka, K; Robson, S; Kobayashi, H; Takasaki, M; Nakano, M; Totsuka, A				Tanaka, Katsufumi; Robson, Seiya; Kobayashi, Haruki; Takasaki, Midori; Nakano, Masami; Totsuka, Atsushi			Simultaneous observations of microgap flow behavior and microstructure of electro-rheological nano-suspensions based on titanium dioxide nano-particles	COLLOID AND POLYMER SCIENCE			English	Article						Electro-rheology; Nano-particles; Steric hindrance; Simultaneous observations; Flow behavior; Microstructure; Microgap; Shear thinning	EXCHANGE RESIN PARTICLES; EXTERNAL ELECTRIC-FIELDS; FLUID; RHEOLOGY; TIO2; GAP	Electro-rheological (ER) nano-suspensions based on titanium dioxide nano-particles with particle diameter around 400 nm and a chemically modified silicone oil with a viscosity of 0.04 PaI double dagger s were prepared. Microgap flow behavior in the absence of an external electric field and the ER responses were investigated in relation to the microstructure observed in the quiescent state. The effects of the continuous phase of suspending oil and particle volume fraction were reported for the nano-suspensions. For the modified silicone oil-based nano-suspensions of 8.8 and 12 vol %, no plateau stresses were observed, whereas a plateau stress around 5 Pa was found only for the nano-suspension of 20 vol %. On the other hand, the ER effect of the modified silicone oil-based nano-suspension of 20 vol % was comparable to that of the silicone oil-based nano-suspension of 12 vol %. Simultaneous optical observations with the ER effect were also performed for the nano-suspension of 20 vol %. The effects of shear rate and time on the shear stress and flow behavior in the presence (or absence) of the dc electric field were reported, showing unexpected reduction of the ER effect and the shear thinning-like behavior with flow instability at higher shear rates. Possible factors for improving the ER effect were discussed in the present paper.	[Tanaka, Katsufumi; Robson, Seiya; Kobayashi, Haruki; Takasaki, Midori] Kyoto Inst Technol, Dept Macromol Sci & Engn, Kyoto 6068585, Japan; [Nakano, Masami; Totsuka, Atsushi] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808577, Japan	Tanaka, K (reprint author), Kyoto Inst Technol, Dept Macromol Sci & Engn, Kyoto 6068585, Japan.	ktanaka@kit.ac.jp			Cooperative Research Program of the Institute of Fluid Science, Tohoku University	This work was partially supported by the Cooperative Research Program of the Institute of Fluid Science, Tohoku University.	TAO R, 1991, PHYS REV LETT, V67, P398, DOI 10.1103/PhysRevLett.67.398; Wen WJ, 2003, NAT MATER, V2, P727, DOI 10.1038/nmat993; BLOCK H, 1988, J PHYS D APPL PHYS, V21, P1661, DOI 10.1088/0022-3727/21/12/001; KLINGENBERG DJ, 1989, J CHEM PHYS, V91, P7888, DOI 10.1063/1.457256; Kim SG, 2007, POLYMER, V48, P6622, DOI 10.1016/j.polymer.2007.09.013; Henley S, 1999, J RHEOL, V43, P1323, DOI 10.1122/1.551024; WINSLOW WM, 1949, J APPL PHYS, V20, P1137, DOI 10.1063/1.1698285; Parthasarathy M, 1996, MAT SCI ENG R, V17, P57, DOI 10.1016/0927-796X(96)00191-X; Tanaka K, 2004, SENSOR ACTUAT A-PHYS, V112, P376, DOI 10.1016/j.sna.2004.02.009; Furusho J, 1999, INT J MOD PHYS B, V13, P2151, DOI 10.1142/S0217979299002253; HOSSEINISIANAKI A, 1992, INT J MOD PHYS B, V6, P2667, DOI 10.1142/S0217979292001365; Israelachvili JN, 1985, INTERMOLECULAR SURFA; KLINGENBERG DJ, 1990, LANGMUIR, V6, P15, DOI 10.1021/la00091a003; MARSHALL L, 1989, J CHEM SOC FARAD T 1, V85, P2785, DOI 10.1039/f19898502785; Misono Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061412; Nakano M, 1999, INT J MOD PHYS B, V13, P2168, DOI 10.1142/S0217979299002277; Nakano M, 2009, JPN J MULTIPHASE FLO, V23, P135; Nakano M, 1998, P 6 INT C ER FLUIDS; Nakano M, 2005, JSME INT J B-FLUID T, V48, P494, DOI 10.1299/jsmeb.48.494; Nakano M, 2006, P MECH ENG C 2006 JA, V2, P25; NEGITA K, 1995, PHYS REV E, V52, P1934, DOI 10.1103/PhysRevE.52.1934; Oehme F, 1964, CHEM ZTG, V88, P657; PARKER RA, 1961, PHYS REV, V124, P1719, DOI 10.1103/PhysRev.124.1719; SEE H, 1991, J PHYS SOC JPN, V60, P2778, DOI 10.1143/JPSJ.60.2778; Takimoto J, 1992, P 3 INT C ER FLUIDS, P53; Tanaka K, 2013, COLLOID POLYM SCI, V291, P1279, DOI 10.1007/s00396-012-2849-x; Tanaka K, 2007, COLLOID POLYM SCI, V285, P1201, DOI 10.1007/s00396-007-1673-1; Tanaka K, 2001, INT J MOD PHYS B, V15, P930, DOI 10.1142/S0217979201005453; Tanaka K, 2013, P 12 INT S FLUID CON; TANAKA K, 1995, PHYS REV E, V52, pR3325; Tanaka K, 2001, J SOC RHEOL JPN, V29, P105; Tanaka K, 2011, COLLOID POLYM SCI, V289, P855, DOI 10.1007/s00396-011-2396-x; Tanaka K, 2009, POLYM J, V41, P1019, DOI 10.1295/polymj.PJ2009106R; Tanaka K, 2010, NIHON REOROJI GAKK, V38, P93; Tanaka K, 2002, INT J MOD PHYS B, V16, P2683, DOI 10.1142/S0217979202012840; Tanaka K, 2009, NIHON REOROJI GAKK, V37, P17; Verwey EJW, 1999, THEORY STABILITY L 3; Weast R. C., 1984, CRC HDB CHEM PHYS; Yin JB, 2001, J PHYS D APPL PHYS, V34, P2063, DOI 10.1088/0022-3727/34/13/317	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	SEP	2015	293	9					2531	2541		10.1007/s00396-015-3638-0		11	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CQ8KW	WOS:000360857700010		
J	Fukuhara, L; Kosugi, K; Yamamoto, Y; Jinnai, H; Nishioka, H; Ishii, H; Fukuda, M; Kawahara, S				Fukuhara, Lina; Kosugi, Kenichiro; Yamamoto, Yoshimasa; Jinnai, Hiroshi; Nishioka, Hideo; Ishii, Hiroyuki; Fukuda, Masao; Kawahara, Seiichi			Frozen non-equilibrium structure for anisotropically deformed natural rubber with nanomatrix structure observed by 3D FIB-SEM and electron tomography	COLLOID AND POLYMER SCIENCE			English	Article						Natural rubber; Nanomatrix structure; Non-equilibrium structure; FIB-SEM; Electron tomography	OZONOLYSIS-GPC METHOD; GRAFT-COPOLYMERIZATION; BLOCK-COPOLYMER; GRAIN-BOUNDARY; NANO-MATRIX; 1,2 UNITS; PROTEINS; STYRENE; UREA	Effect of frozen non-equilibrium structure for anisotropically deformed natural rubber with the nanomatrix structure on mechanical properties was investigated with respect to morphology analysis through 3D observation. Natural rubber with the nanomatrix structure was prepared by graft copolymerization of styrene onto natural rubber particles in latex stage followed by coagulation of the resulting latex. The morphology was observed by electron tomography and focused ion beam-scanning electron microscopy (FIB-SEM). The nanomatrix structure in isotropic state was precisely analyzed by electron tomography and synchrotron scattering technique. The nanomatrix structure was found to consist of natural rubber particles and polystyrene nanoparticles. The frequency-independent loss tangent at plateau region was attributed to the discontinuous nanomatrix structure. After annealing at 403 K and 7 MPa, the nanomatrix became continuous, which resulted in the increases in stress at strain of one and storage modulus as well as increase in loss tangent.	[Fukuhara, Lina; Yamamoto, Yoshimasa; Ishii, Hiroyuki] Tokyo Natl Coll Technol, Dept Chem Sci & Engn, Hachioji, Tokyo 1930997, Japan; [Kosugi, Kenichiro; Fukuda, Masao; Kawahara, Seiichi] Nagaoka Univ Technol, Fac Engn, Nagaoka, Niigata 9402188, Japan; [Jinnai, Hiroshi] Tohoku Univ, IMRAM, Sendai, Miyagi 9808577, Japan; [Nishioka, Hideo] JEOL Ltd, Akishima, Tokyo 1968556, Japan	Kawahara, S (reprint author), Nagaoka Univ Technol, Fac Engn, Nagaoka, Niigata 9402188, Japan.	kawahara@mst.nagaokaut.ac.jp	Jinnai, Hiroshi/F-8456-2014		Japan Society for the Promotion of Science [26620176, 25288098]; JST-JICA SATREPS; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24310092]	This work was supported in part by a Grant-in-Aid (26620176) for Challenging Exploratory Research and Grant-in-Aid (25288098) for Scientific Research (B) from Japan Society for the Promotion of Science and JST-JICA SATREPS. H.J. gratefully acknowledges the financial support received through a Grant-in-Aid (24310092) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Pukkate N, 2007, EUR POLYM J, V43, P3208, DOI 10.1016/j.eurpolymj.2007.04.037; Jinnai H, 2006, MACROMOLECULES, V39, P5815, DOI 10.1021/ma0600153; Kawahara S, 2003, POLYMER, V44, P4527, DOI 10.1016/S0032-3861(03)00415-4; Kawahara S, 2004, POLYM ADVAN TECHNOL, V15, P181, DOI 10.1002/pat.465; Wilkins GMH, 2009, LANGMUIR, V25, P8951, DOI 10.1021/la9004196; Fukuhara L, 2015, POLYMER, V57, P143, DOI 10.1016/j.polymer.2014.11.020; HYTTEL P, 1986, ACTA ANAT, V125, P27; Jinnai H, 2007, MACROMOLECULES, V40, P6758, DOI 10.1021/ma071102d; Jinnai H, 2006, MACROMOL SYMP, V245, P170, DOI 10.1002/masy.200651324; Kakuta K, 1999, MACROMOLECULES, V32, P5994, DOI 10.1021/ma9816416; Kawahara S, 2014, POLYMER, V55, P5024, DOI 10.1016/j.polymer.2014.07.026; Kawahara S, 2008, MACROMOLECULES, V41, P4510, DOI 10.1021/ma7028538; Klinklai W, 2004, J APPL POLYM SCI, V93, P555, DOI 10.1002/app.20463; Kosugi K, 2012, COLLOID POLYM SCI, V290, P1457, DOI 10.1007/s00396-012-2703-1; Michler GH, 2001, J MACROMOL SCI PHYS, VB40, P277, DOI 10.1081/MB-100106158; Pukkate N, 2008, COLLOID POLYM SCI, V286, P411, DOI 10.1007/s00396-007-1787-5; Staniewicz L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07389; TANAKA Y, 1993, MACROMOLECULES, V26, P5253, DOI 10.1021/ma00071a042; Tuampoemsab S, 2007, KGK-KAUT GUMMI KUNST, V60, P678; Tunnicliffe LB, 2012, J MICROSC-OXFORD, V246, P77, DOI 10.1111/j.1365-2818.2011.03589.x; YAMANAKA J, 1994, MAT SCI ENG A-STRUCT, V179, P401, DOI 10.1016/0921-5093(94)90235-6; Yusof NH, 2015, COLLOID POL IN PRESS	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	SEP	2015	293	9					2555	2563		10.1007/s00396-015-3631-7		9	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CQ8KW	WOS:000360857700012		
J	Zaragoza-Contreras, EA; Hernandez-Escobar, CA; Vega-Rios, A; Flores-Gallardo, SG; Kobayashi, T				Zaragoza-Contreras, E. Armando; Hernandez-Escobar, Claudia A.; Vega-Rios, Alejandro; Flores-Gallardo, Sergio G.; Kobayashi, Takaomi			Diaminium salt as reactive amphiphile for the synthesis of poly(m-phenylenediamine) and paraffin microencapsulation	COLLOID AND POLYMER SCIENCE			English	Article						Microencapsulation; Paraffin; Phenylenediamine; Polyphenylenediamine; Reactive surfactant	POLY-O-PHENYLENEDIAMINE; PHASE-CHANGE MATERIALS; THERMAL-ENERGY STORAGE; POLYANILINE NANOSTRUCTURES; INTERFACIAL POLYMERIZATION; OXIDATIVE POLYMERIZATION; EMULSION POLYMERIZATION; EFFECTIVE ADSORPTION; ORGANIC COUNTERIONS; MICELLAR PARAMETERS	Poly(m-phenylenediamine) (PmPDA) was synthesized via an oxidative polymerization using benzene-1,3-diaminium dodecyl sulfate (P2) as the monomer. P2 is a new concept of reactive surfactant because, unlike conventional polymerizable surfactants where the polymerizable group is a carbon-carbon double bond, therein, the polymer chain propagates through the diaminium group. Polymerization in aqueous micellar solution, chloroform/water interface, and xylene/water emulsion allowed successful synthesis of PmPDA. Infrared and UV-vis spectroscopy revealed that PmPDA share chemical structure, based on phenazine with open segments, rich in quinoid rings (pernigraniline-like), and partially doped, regardless of the method of synthesis. Conversely, electron microscopy exhibited important effect on morphology (nanofibers, pot-like, and globular nanoparticles) as a function of polymerization method and temperature. Additionally, cyclic voltammetry indicated electroactivity in all products, showing reduced/semi-oxidized and semi-oxidized/oxidized redox transitions with differences concerning synthesis method and temperature. A paraffin/PmPDA core-shell composite was obtained by emulsion polymerization method taking advantage of P2 amphiphilic properties. Electron microscopy evidenced microencapsulation, whereas thermal properties (melting temperature, melting enthalpy, thermal stability, and viscosity as function of temperature) suggested promising properties for the design of form-stable phase change materials.	[Zaragoza-Contreras, E. Armando; Kobayashi, Takaomi] Nagaoka Univ Technol, Dept Mat Sci, Nagaoka, Niigata 6402188, Japan; [Zaragoza-Contreras, E. Armando; Hernandez-Escobar, Claudia A.; Vega-Rios, Alejandro; Flores-Gallardo, Sergio G.] Ctr Invest Mat Avanzados, Engn & Mat Chem Dept, Chihuahua, Chih, Mexico	Zaragoza-Contreras, EA (reprint author), Nagaoka Univ Technol, Dept Mat Sci, 1603-1 Kamitomioka, Nagaoka, Niigata 6402188, Japan.	armando.zaragoza@cimav.edu.mx					ANACKER EW, 1981, J PHYS CHEM-US, V85, P2463, DOI 10.1021/j150617a011; Stejskal J, 2010, PROG POLYM SCI, V35, P1420, DOI 10.1016/j.progpolymsci.2010.07.006; Tian JQ, 2011, CATAL SCI TECHNOL, V1, P1393, DOI 10.1039/c1cy00212k; Li D, 2007, J MATER CHEM, V17, P2279, DOI 10.1039/b700699c; Zhang ZM, 2002, MACROMOLECULES, V35, P5937, DOI 10.1021/ma020199v; Permpool T, 2014, POLYM INT, V63, P2076, DOI 10.1002/pi.4745; Li JB, 2008, POLYM INT, V57, P337, DOI 10.1002/pi.2353; Ariffin AA, 2012, INT J ELECTROCHEM SC, V7, P10154; Abdolahi A, 2012, MATERIALS, V5, P1487, DOI 10.3390/ma5081487; Kenisarin MM, 2012, RENEW SUST ENERG REV, V16, P1999, DOI 10.1016/j.rser.2012.01.015; Laslau C, 2010, PROG POLYM SCI, V35, P1403, DOI 10.1016/j.progpolymsci.2010.08.002; Zhang YW, 2011, CHEM COMMUN, V47, P3927, DOI 10.1039/c1cc10402k; Zeng JL, 2008, J THERM ANAL CALORIM, V91, P443, DOI 10.1007/s10973-007-8545-2; Stejskal J, 2006, POLYMER, V47, P8253, DOI 10.1016/j.polymer.2006.10.007; Stejskal J, 2008, MACROMOLECULES, V41, P3530, DOI 10.1021/ma702601q; Wang MR, 2013, ELECTROCHIM ACTA, V91, P144, DOI 10.1016/j.electacta.2012.12.087; Liao F, 2014, SYNTHETIC MET, V189, P126, DOI 10.1016/j.synthmet.2014.01.008; Wei ZX, 2002, LANGMUIR, V18, P917, DOI 10.1021/la0155799; Buwalda RT, 2000, LANGMUIR, V16, P6780, DOI 10.1021/la000164t; Sestrem RH, 2010, EUR POLYM J, V46, P484, DOI 10.1016/j.eurpolymj.2009.12.007; Dominguez A, 1997, J CHEM EDUC, V74, P1227; Zeng JL, 2014, APPL ENERG, V115, P603, DOI 10.1016/j.apenergy.2013.10.061; Li BX, 2013, CHEM ENG J, V215, P819, DOI 10.1016/j.cej.2012.11.077; Zhang YW, 2011, LANGMUIR, V27, P2170, DOI 10.1021/la105092f; Hassan PA, 2002, LANGMUIR, V18, P2543, DOI 10.1021/la011435i; Li D, 2006, J AM CHEM SOC, V128, P968, DOI 10.1021/ja056609n; Zhou DM, 2010, J APPL ELECTROCHEM, V40, P1997, DOI 10.1007/s10800-010-0179-6; Tyagi VV, 2011, RENEW SUST ENERG REV, V15, P1373, DOI 10.1016/j.rser.2010.10.006; Konyushenko EN, 2006, POLYM INT, V55, P31, DOI 10.1002/pi.1899; Li XG, 2001, J POLYM SCI POL CHEM, V39, P3989, DOI 10.1002/pola.10041; Huang MR, 2005, POLYM INT, V54, P70, DOI 10.1002/pi.1618; Wang Z, 2014, ANAL CHEM, V86, P7719, DOI 10.1021/ac5016563; Huang MR, 2006, CHEM-EUR J, V12, P4341, DOI 10.1002/chem.200501070; Liu P, 2009, CRIT REV SOLID STATE, V34, P75, DOI 10.1080/10408430902875968; Zhou CQ, 2008, J PHYS CHEM B, V112, P5014, DOI 10.1021/jp711356w; Archana S, 2014, RES J CHEM SCI, V4, P60; Bachofer SJ, 1996, LANGMUIR, V12, P1744, DOI 10.1021/la950612a; Bijma K, 1998, J COLLOID INTERF SCI, V205, P245, DOI 10.1006/jcis.1998.5687; CHAN HSO, 1991, EUR POLYM J, V27, P1303, DOI 10.1016/0014-3057(91)90069-Z; Dan LI, 2009, ACCOUNTS CHEM RES, V42, P135; GAMBOA C, 1989, J PHYS CHEM-US, V93, P5540, DOI 10.1021/j100351a043; Guo T, 2012, J MAT SCI RES, V1, P25; Guyot A, 2004, ADV COLLOID INTERFAC, V108, P3, DOI 10.1016/j.cis.2003.10.009; GUYOT A, 1994, ADV POLYM SCI, V111, P43; Hao QL, 2009, MATER LETT, V63, P334, DOI 10.1016/j.matlet.2008.10.041; Hartmann PC, 2005, J COLLOID INTERF SCI, V284, P289, DOI 10.1016/j.jcis.2004.10.009; Huang JX, 2003, J AM CHEM SOC, V125, P314, DOI 10.1021/ja028371y; Huang MR, 2001, POLYM DEGRAD STABIL, V71, P31; Ichinohe D, 1998, MACROMOL CHEM PHYSIC, V199, P1241, DOI 10.1002/(SICI)1521-3935(19980601)199:6<1241::AID-MACP1241>3.0.CO;2-Z; Jeevananda T, 2008, MATER LETT, V62, P3995, DOI 10.1016/j.matlet.2008.05.041; Jiang KP, 2014, J MATER CHEM A, V2, P19208, DOI 10.1039/c4ta04269g; Kunleda H, 1976, J PHYS CHEM-US, V80, P2468; Lakouraj Moslem Mansour, 2014, Advances in Polymer Technology, V33, DOI 10.1002/adv.21385; Li J, 2003, ANAL BIOANAL CHEM, V376, P902, DOI 10.1007/s00216-003-1989-8; Li XG, 2001, J APPL POLYM SCI, V81, P3107, DOI 10.1002/app.1762; Li XG, 2003, POLYMER, V44, P5579, DOI 10.1016/S0032-3861(03)00584-6; Lin XQ, 1996, ELECTROCHIM ACTA, V41, P2019, DOI 10.1016/0013-4686(96)00007-2; Parsa A, 2008, POLYMER, V49, P3702, DOI 10.1016/j.polymer.2008.06.044; Sang PL, 2013, T NONFERR METAL SOC, V23, P243, DOI 10.1016/S1003-6326(13)62452-8; Shishov MA, 2011, GLASS PHYS CHEM+, V37, P106, DOI 10.1134/S1087659611010135; Sulimenko T, 2001, J COLLOID INTERF SCI, V236, P328, DOI 10.1006/jcis.2000.7415; Tran HD, 2006, CHEM COMMUN, P3915, DOI 10.1039/b605928g; UNDERWOOD AL, 1984, J PHYS CHEM-US, V88, P2390, DOI 10.1021/j150655a042; Vega-Rios A, 2013, SYNTHETIC MET, V167, P64, DOI 10.1016/j.synthmet.2013.02.009; Vega-Rios A, 2013, SYNTHETIC MET, V184, P52, DOI 10.1016/j.synthmet.2013.09.014; Wang JJ, 2008, ADV FUNCT MATER, V18, P1105, DOI 10.1002/adfm.200700583; Wang L, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1294; Wang ZF, 2012, J NANOMATER, DOI 10.1155/2012/682802; Wright KA, 1939, J AM CHEM SOC, V61, P549, DOI 10.1021/ja01872a003; Wu LL, 1996, J ELECTROANAL CHEM, V417, P53, DOI 10.1016/S0022-0728(96)04759-6; Yong Y, 2004, CHEM RES CHINESE U, V20, P240; Zaragoza-Contreras EA, 2012, J COLLOID INTERF SCI, V377, P231, DOI 10.1016/j.jcis.2012.03.047; Zeng JL, 2008, J THERM ANAL CALORIM, V91, P455, DOI 10.1007/s10973-007-8495-8; Zhang LY, 2011, LANGMUIR, V27, P13729, DOI 10.1021/la203162y; Zhang YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020569; Zeng JL, 2013, SOL ENERG MAT SOL C, V114, P136, DOI 10.1016/j.solmat.2013.03.006; Zhu F-R, 2013, J THERM ANAL CALORIM, V115, P1133	77	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	SEP	2015	293	9					2635	2645		10.1007/s00396-015-3667-8		11	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CQ8KW	WOS:000360857700021		
J	Horinaka, J; Tanaka, M; Takigawa, T				Horinaka, Jun-ichi; Tanaka, Maki; Takigawa, Toshikazu			Rheological properties of ionic liquid solutions of xanthan	COLLOID AND POLYMER SCIENCE			English	Article						Rheology; Molecular weight between entanglements; Ionic liquid; Xanthan; Concentrated solution	VISCOELASTIC PROPERTIES; CONCENTRATED-SOLUTIONS; MOLECULAR-WEIGHT; POLYSACCHARIDE; POLYMERS; HELIX; GUM	Dynamic viscoelasticity and steady shear flow of ionic liquid solutions of xanthan were examined. Concentrated solutions of xanthan were prepared using 1-butyl-3-methylimidazolium acetate as the solvent. The solutions exhibited the viscoelastic behavior typical of polymer solutions with the entanglement coupling. The absolute value of the complex viscosity and the steady shear viscosity agreed quite well, namely the Cox-Merz rule held, when the terminal flow behavior was observed in the dynamic viscoelasticity and the zero-shear viscosity was able to be determined. The molecular weight between entanglements for xanthan in the molten state was estimated to be 1.7 x 10(4), being significantly greater than that for cellulose.	[Horinaka, Jun-ichi; Tanaka, Maki; Takigawa, Toshikazu] Kyoto Univ, Dept Chem Mat, Grad Sch Engn, Kyoto 6158510, Japan	Horinaka, J (reprint author), Kyoto Univ, Dept Chem Mat, Grad Sch Engn, Kyoto 6158510, Japan.	horinaka.junichi.5c@kyoto-u.ac.jp					SANTORE MM, 1990, CARBOHYD POLYM, V12, P329, DOI 10.1016/0144-8617(90)90074-3; LIM T, 1984, J RHEOL, V28, P367, DOI 10.1122/1.549757; COX WP, 1958, J POLYM SCI, V28, P619, DOI 10.1002/pol.1958.1202811812; FETTERS LJ, 1994, MACROMOLECULES, V27, P4639, DOI 10.1021/ma00095a001; El Seoud OA, 2007, BIOMACROMOLECULES, V8, P2629, DOI 10.1021/bm070062i; JANSSON PE, 1975, CARBOHYD RES, V45, P275, DOI 10.1016/S0008-6215(00)85885-1; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; Izawa H, 2009, J MATER CHEM, V19, P6969, DOI 10.1039/b916864h; HOLZWARTH G, 1977, SCIENCE, V197, P757, DOI 10.1126/science.887918; Izawa H, 2010, J MATER CHEM, V20, P5235, DOI 10.1039/c0jm00595a; BESIO GJ, 1987, J APPL POLYM SCI, V33, P825, DOI 10.1002/app.1987.070330312; de Gennes P. G., 1979, SCALING CONCEPTS POL; Doi M, 1986, THEORY POLYM DYNAMIC; Ferry JD, 1980, VISCOELASTIC PROPERT; Horinaka J, 2012, COLLOID POLYM SCI, V290, P1793, DOI 10.1007/s00396-012-2728-5; Horinaka J, 2009, CARBOHYD POLYM, V78, P576, DOI 10.1016/j.carbpol.2009.05.033; Horinaka J, 2013, J APPL POLYM SCI, V130, P2439, DOI 10.1002/app.39459; Horinaka J, 2012, J APPL POLYM SCI, V123, P3023, DOI 10.1002/app.34972; Horinaka J, 2015, CELLULOSE, V22, P2305, DOI 10.1007/s10570-015-0670-7; Horinaka J, 2011, J POLYM SCI POL PHYS, V49, P961, DOI 10.1002/polb.22262; MASUDA T, 1972, POLYM J, V3, P315, DOI 10.1295/polymj.3.315; ROCHEFORT WE, 1987, J RHEOL, V31, P337, DOI 10.1122/1.549953; Moorhouse R, 1977, ACS SYM SER, V45, P90; NEMOTO N, 1972, MACROMOLECULES, V5, P641, DOI 10.1021/ma60029a021; Onogi S., 1970, MACROMOLECULES, V3, P109, DOI 10.1021/ma60014a001; SATO T, 1984, POLYM J, V16, P341, DOI 10.1295/polymj.16.341; TAKADA Y, 1991, MACROMOLECULES, V24, P6215, DOI 10.1021/ma00023a024; WHITCOMB PJ, 1978, J RHEOL, V22, P493, DOI 10.1122/1.549485	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	SEP	2015	293	9					2709	2712		10.1007/s00396-015-3718-1		4	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CQ8KW	WOS:000360857700029		
J	Suwa, K; Sato, K; Anzai, J				Suwa, K.; Sato, Katsuhiko; Anzai, J.			Preparation of multilayer films consisting of glucose oxidase and poly(amidoamine) dendrimer and their stability	COLLOID AND POLYMER SCIENCE			English	Article						Phenylboronic acid; Dendrimer; Multilayer film; Glucose oxidase	BY-LAYER FILMS; CONTROLLED-RELEASE; HYDROGEN-PEROXIDE; THIN-FILMS; PHENYLBORONIC ACID; INSULIN; ASSEMBLIES; CAPSULES; MICROCAPSULES; COMPLEXATION	Multilayer films comprising of glucose oxidase (GOx) and phenylboronic acid-modified poly(amidoamine) dendrimer (PBA-PAMAM) were prepared and their pH- and glucose-induced decomposition was studied. Multilayered GOx/PBA-PAMAM films were prepared through boronate ester linkages between PBA-PAMAM and carbohydrate chains of GOx. In contrast, preparation of multilayer film was unsuccessful when unmodified PAMAM was used in lieu of PBA-PAMAM, confirming an essential role of PBA residues in constructing multilayer films. The ten-layered (GOx/PBA-PAMAM)(10) film was stable in aqueous solutions of pH 8.5, whereas the multilayer film decomposed in neutral and acidic media as a result of cleavage of the boronate ester bond. The pH threshold for the film decomposition was pH 7.0-8.0. In addition, the (GOx/PBA-PAMAM)(10) film decomposed in glucose solutions owing to the oxidative scission of carbon-boron bond of PBA-PAMAM by enzymatically produced hydrogen peroxide. Thus, the potential use of the (GOx/PBA-PAMAM)(10) film for the development of pH- and glucose-sensitive devices is suggested.	[Suwa, K.; Sato, Katsuhiko; Anzai, J.] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Anzai, J (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	junanzai@mail.pharm.tohoku.ac.jp					Egawa Y, 2011, MAT SCI ENG C-MATER, V31, P1257, DOI 10.1016/j.msec.2011.05.007; Watahiki R, 2014, J MATER CHEM B, V2, P5809, DOI 10.1039/c4tb00676c; Lux CD, 2012, J AM CHEM SOC, V134, P15758, DOI 10.1021/ja303372u; Chen XY, 2011, BIOMATERIALS, V32, P1759, DOI 10.1016/j.biomaterials.2010.11.002; Dam HH, 2013, LANGMUIR, V29, P7203, DOI 10.1021/la304580x; Crouzier T, 2010, CURR OPIN COLLOID IN, V15, P417, DOI 10.1016/j.cocis.2010.05.007; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Yan J, 2004, TETRAHEDRON, V60, P11205, DOI 10.1016/j.tet.2004.08.051; Yoshida K, 2014, MAT SCI ENG C-MATER, V34, P384, DOI 10.1016/j.msec.2013.09.045; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; Zhang X, 2012, J MATER CHEM, V22, P16299, DOI 10.1039/c2jm33413e; Song J, 2013, EUR POLYM J, V49, P2477, DOI 10.1016/j.eurpolymj.2013.01.029; Qi W, 2009, BIOMATERIALS, V30, P2799, DOI 10.1016/j.biomaterials.2009.01.027; Ding ZB, 2009, SOFT MATTER, V5, P2302, DOI 10.1039/b901910c; Luo J, 2012, BIOMATERIALS, V33, P8733, DOI 10.1016/j.biomaterials.2012.08.041; Sato K, 2013, MOLECULES, V18, P8440, DOI 10.3390/molecules18078440; Sato K, 2012, ANAL SCI, V28, P929; De Geest BG, 2006, LANGMUIR, V22, P5070, DOI 10.1021/la053368o; Suzuki I, 2002, CHEM COMMUN, P164, DOI 10.1039/b108771c; Liang X, 2012, CHEM MATER, V24, P3707, DOI 10.1021/cm301657q; Levy T, 2008, ADV FUNCT MATER, V18, P1586, DOI 10.1002/adfm.200701291; Yoshida K, 2010, J MATER CHEM, V20, P1546, DOI 10.1039/b918226h; Sato K, 2014, LANGMUIR, V30, P9247, DOI 10.1021/la501750s; Lo LC, 2003, CHEM COMMUN, P2728, DOI 10.1039/b309393j; Du XX, 2015, COLLOID POLYM SCI, V293, P2129, DOI 10.1007/s00396-015-3625-5; Jiang GH, 2015, COLLOID POLYM SCI, V293, P209, DOI 10.1007/s00396-014-3394-6; Lojou E, 2006, BIOELECTROCHEMISTRY, V69, P237, DOI 10.1016/j.bioelechem.2006.03.028; Manna U, 2010, ACS APPL MATER INTER, V2, P1521, DOI 10.1021/am100139j; Picheth GF, 2014, COLLOID POLYM SCI, V292, P97, DOI 10.1007/s00396-013-3048-0; Suwa K, 2015, COLLOID POLYM SCI, V293, P1043, DOI 10.1007/s00396-014-3490-7; Tomita S, 2008, J COLLOID INTERF SCI, V326, P35, DOI 10.1016/j.jcis.2008.06.054; WILSON R, 1992, BIOSENS BIOELECTRON, V7, P165, DOI 10.1016/0956-5663(92)87013-F; Zhang X., 2011, BIOMACROMOLECULES, V13, P92	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	SEP	2015	293	9					2713	2718		10.1007/s00396-015-3722-5		6	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CQ8KW	WOS:000360857700030		
J	Tanaka-Ishii, K; Aihara, S				Tanaka-Ishii, Kumiko; Aihara, Shunsuke			Computational Constancy Measures of Texts-Yule's K and Renyi's Entropy	COMPUTATIONAL LINGUISTICS			English	Article							SYMBOL SEQUENCES; INFORMATION; FREQUENCIES	This article presents a mathematical and empirical verification of computational constancy measures for natural language text. A constancy measure characterizes a given text by having an invariant value for any size larger than a certain amount. The study of such measures has a 70-year history dating back to Yule's K, with the original intended application of author identification. We examine various measures proposed since Yule and reconsider reports made so far, thus overviewing the study of constancy measures. We then explain how K is essentially equivalent to an approximation of the second-order Renyi entropy, thus indicating its signification within language science. We then empirically examine constancy measure candidates within this new, broader context. The approximated higher-order entropy exhibits stable convergence across different languages and kinds of text. We also show, however, that it cannot identify authors, contrary to Yule's intention. Lastly, we apply K to two unknown scripts, the Voynich manuscript and Rongorongo, and show how the results support previous hypotheses about these scripts.	[Tanaka-Ishii, Kumiko] Kyushu Univ, Fukuoka, Fukuoka, Japan; [Tanaka-Ishii, Kumiko] JST PRESTO, Kawaguchi, Saitama 3320012, Japan; [Aihara, Shunsuke] Gunosy Inc, Minato Ku, Tokyo, Japan	Tanaka-Ishii, K (reprint author), Kyushu Univ, 744 Motooka Nishiku, Fukuoka, Fukuoka, Japan.	kumiko@ait.kyushu-u.ac.jp			JST's PRESTO program	This research was supported by JST's PRESTO program.	Schurmann T, 1996, CHAOS, V6, P414; SHIELDS PC, 1992, ANN PROBAB, V20, P403, DOI 10.1214/aop/1176989934; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stamatatos E, 2000, COMPUT LINGUIST, V26, P471, DOI 10.1162/089120100750105920; Teh YW, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P985; GRASSBERGER P, 1989, IEEE T INFORM THEORY, V35, P669, DOI 10.1109/18.30993; SICHEL HS, 1975, J AM STAT ASSOC, V70, P542, DOI 10.2307/2285930; SHANNON CE, 1948, AT&T TECH J, V27, P623; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Barthel T., 2013, RONGORONGO E ISLAND; Bell T. C., 1990, TEXT COMPRESSION; Bromiley P. A., 2010, SHANNON ENTROPY RENY; Brunet E, 1978, VOCABULAIRE J GIRAUD; COVER TM, 1978, IEEE T INFORM THEORY, V24, P413, DOI 10.1109/TIT.1978.1055912; Cover T. M., 2006, ELEMENTS INFORM THEO; Daniels Peter T., 1996, WORLDS WRITING SYSTE; Debowski L., 2014, RELAXED HILBERG CONJ; Debowski L, 2009, STAT PROBABIL LETT, V79, P1260, DOI 10.1016/j.spl.2009.01.016; Debowski L., 2013, METHODS APPL QUANTIT, P143; Dugast D., 1979, VOCABULAIRE STYLISTI; Farach M., 1995, P 6 ANN ACM SIAM S D, V95, P48; Genzel D., 2002, ANN M ASS ACL PHIL P, P199; Golcher F., 2007, RECENT ADV NATURAL L; Guiraud H., 1954, CHARACTERES STAT VOC; Gusfield D., 1997, ALGORITHMS STRINGS S; Herdan G, 1964, QUANTITATIVE LINGUIS; HILBERG W, 1990, FREQUENZ, V44, P243; Honore A, 1979, ASS LIT LINGUISTIC C, V7, P172; Kimura D., 2014, J NATURAL LANGUAGE P, V21, P877; Kimura D., 2011, J NATURAL LANGUAGE P, V18, P119; Kitchens B. P., 1998, SYMBOLIC DYNAMICS; Brown P. F., 1992, Computational Linguistics, V18; Levy R., 2007, ANN C NEUR INF PROC, P1; Maas H. D., 1972, Z LITERATURWISSENSCH, V8, P73; Mandelbrot B., 1953, COMMUN THEORY, P486; Manning C.D., 1999, FDN STAT NATURAL LAN; Montemurro MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066344; Orliac Catherine, 2005, Archaeology in Oceania, V40, P115; Orlov J., 1983, B ACAD SCI GEORGIA, V110, P269; Pozdniakov K., 2007, FORUM ANTHR CULTURE, V3, P3; Reddy S., 2011, ACL WORKSH LANG TECH; Reny A., 1960, P 4 BERK S MATH STAT, P547; Renyi A., 1970, FDN PROBABILITY; Stein B., 2010, LANG RESOUR EVAL, V45, P63; Tuldava J., 1977, SMIL Q J LINGUISTIC, V4, P28; Tweedie FJ, 1998, COMPUT HUMANITIES, V32, P323, DOI 10.1023/A:1001749303137; Yule G. U., 1944, STAT STUDY LIT VOCAB; Zipf G. K., 1965, HUMAN BEHAV PRINCIPL	48	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0891-2017	1530-9312		COMPUT LINGUIST	Comput. Linguist.	SEP	2015	41	3					481	502		10.1162/COLI_a_00228		22	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Linguistics; Language & Linguistics	Computer Science; Linguistics	CR0WQ	WOS:000361044700004		
J	He, Y; Hazarika, H; Yasufuku, N; Han, Z				He, Yi; Hazarika, Hemanta; Yasufuku, Noriyuki; Han, Zheng			Evaluating the effect of slope angle on the distribution of the soil-pile pressure acting on stabilizing piles in sandy slopes	COMPUTERS AND GEOTECHNICS			English	Article						Stabilizing piles; Sandy slope; Soil arching; Slope angle; Limit equilibrium method	DESIGN	In the past, the response of stabilizing piles subjected to lateral soil movement or lateral force loading has been analysed assuming that the piles are embedded in horizontal semi-infinite soil grounds. In this study, a limit equilibrium method analysing the lateral force (soil-pile pressure per unit thickness) on stabilizing piles embedded in semi-infinite slopes is presented. In addition, the soil arching effects between two neighbouring stabilizing piles are analysed, and the lateral active stress in the rear of the piles is obtained. Furthermore, the squeezing effect between two piles proposed by Ito and Matsui is combined with the lateral active stress in the slope to evaluate the distribution of the soil-pile pressure per unit length of the stabilizing piles in sandy slopes. A numerical simulation using FLAC(3D) is used to evaluate the proposed approach. The simulation shows that the proposed model could reasonably predict the shape of the distribution of the soil-pile pressure acting on the stabilizing piles, while some discrepancy exists between the numerical results and predicted values. Furthermore, the prediction of the proposed model is also evaluated through comparison to the experimental data from the published literature. Parametric analysis is carried out to investigate the influence of the slope angle on the distribution of the soil-pile pressure. The shape of the distribution of the soil-pile pressure acting on the piles is shown to vary with the angle of the slope, while the magnitude of the soil-pile pressure remains in the same order. (C) 2015 Elsevier Ltd. All rights reserved.	[He, Yi; Hazarika, Hemanta; Yasufuku, Noriyuki; Han, Zheng] Kyushu Univ, Dept Civil & Struct Engn, Fukuoka 8190395, Japan	Han, Z (reprint author), Kyushu Univ, Nishi Ku, West 2-1108,744 Motooka, Fukuoka 8190395, Japan.	hankzzz@163.com					Liang R, 2002, SOILS FOUND, V42, P83; LEE CY, 1995, COMPUT GEOTECH, V17, P1, DOI 10.1016/0266-352X(95)91300-S; Wei WB, 2009, COMPUT GEOTECH, V36, P1176, DOI 10.1016/j.compgeo.2009.05.004; Griffiths DV, 1999, GEOTECHNIQUE, V49, P387; Ashour M, 1998, J GEOTECH GEOENVIRON, V124, P303, DOI 10.1061/(ASCE)1090-0241(1998)124:4(303); Won J, 2005, COMPUT GEOTECH, V32, P304, DOI 10.1016/j.compgeo.2005.02.006; Kourkoulis R, 2011, J GEOTECH GEOENVIRON, V137, P663, DOI 10.1061/(ASCE)GT.1943-5606.0000479; ZIENKIEWICZ OC, 1975, GEOTECHNIQUE, V25, P671; Ausilio E, 2001, COMPUT GEOTECH, V28, P591, DOI 10.1016/S0266-352X(01)00013-1; Paik KH, 2003, GEOTECHNIQUE, V53, P643; Lirer S, 2012, ENG GEOL, V149, P70, DOI 10.1016/j.enggeo.2012.08.002; Ashour M, 2004, J GEOTECH GEOENVIRON, V130, P580, DOI 10.1061/(ASCE)1090-0241(2004)130:6(580); Galli A, 2013, CAN GEOTECH J, V50, P41, DOI 10.1139/cgj-2012-0104; Hassiotis S, 1997, J GEOTECH GEOENVIRON, V123, P314, DOI 10.1061/(ASCE)1090-0241(1997)123:4(314); POULOS HG, 1995, CAN GEOTECH J, V32, P808, DOI 10.1139/t95-078; Ashour M, 2012, COMPUT GEOTECH, V39, P85, DOI 10.1016/j.compgeo.2011.09.001; Ashour M, 2000, J GEOTECH GEOENVIRON, V126, P420, DOI 10.1061/(ASCE)1090-0241(2000)126:5(420); Chen LT, 1997, SOILS FOUND, V37, P1; De Beer E., 1977, P 9 INT C SOIL MECH; Durrani JK, 2006, 4 INT FLAC S NUM MOD, P231; Guo W, 2006, FDN ANAL DESIGN, P174; Ito T, 1981, SOILS FOUND, V21, P21; Ito T, 1982, SOILS FOUND, V22, P1; Li XP, 2010, J GEOTECH GEOENVIRON, V136, P880, DOI 10.1061/(ASCE)GT.1943-5606.0000296; Martin GR, 2005, COMPUT STRUCT, V83, P588, DOI 10.1016/j.compstruc.2004.11.006; Norris G., 1986, P 3 INT C NUM METH O, P361; Ugai K, 1995, SOILS FOUND, V35, P1, DOI DOI 10.3208/SANDF.35.4_1; Viggiani C., 1981, P 10 INT C SOIL MECH, V3, P555; Wang WL, 1974, J GEOTECH GEOENVIRON, P61	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0266-352X	1873-7633		COMPUT GEOTECH	Comput. Geotech.	SEP	2015	69						153	165		10.1016/j.compgeo.2015.05.006		13	Computer Science, Interdisciplinary Applications; Engineering, Geological; Geosciences, Multidisciplinary	Computer Science; Engineering; Geology	CR1GW	WOS:000361073900014		
J	Hussien, MN; Karray, M; Tobita, T; Iai, S				Hussien, Mahmoud N.; Karray, Mourad; Tobita, Tetsuo; Iai, Susumu			Kinematic and inertial forces in pile foundations under seismic loading	COMPUTERS AND GEOTECHNICS			English	Article						Soil-pile-structure interaction; Finite element; Kinematic; Inertial; Bending moment	SOIL-STRUCTURE INTERACTION; RISE BUILDINGS; SINGLE PILES; LAYERED SOIL; EXCITATION	Under seismic excitation, a pile undergoes stresses stemming from both the vibration of the surrounding soil (kinematic interaction) and that of the superstructure (inertial interaction). The relative contributions of kinematic and inertial interaction on the magnitude of seismic forces induced in pile foundations are investigated by means of nonlinear two-dimensional (2D) finite element (FE) analyses. The interaction between the pile and the surrounding soil in three-dimensional (3D) type was idealized in the 2D analysis using soil-pile interaction springs with hysteretic nonlinear load displacement relationships. Parametric analyses are carried out, focusing on normalized seismic forces in the piles as affected by typical characteristics of structures and piles as well as ground nonlinearity. The results of the study provide a new interpretation of the interplay between pile kinematic and inertial seismic forces. The numerical results showed that for relatively short/stiff piles or where structure's natural frequency is lower than that of the ground, the kinematic interaction can be the prime contributor to the seismic forces in the pile provided that the excitation frequency is not close to the natural frequency of the coupled soil-pile-struc ture system, f(SSI). In a frequency band approaching f(SSI), the inertial interaction generally prevails imposing large bending moments at or near the pile head. The results showed also that maximum kinematic seismic force does not always occur at the fundamental frequency of the deposit. For certain relative soil-pile stiffness and excitation amplitudes, the largest peak of the lcinematic seismic forces in piles can be occurring at the second mode. (C) 2015 Elsevier Ltd. All rights reserved.	[Hussien, Mahmoud N.] Assiut Univ, Fac Engn, Dept Civil Engn, Assiut, Egypt; [Hussien, Mahmoud N.; Karray, Mourad] Univ Sherbrooke, Fac Engn, Dept Civil Engn, Sherbrooke, PQ J1K 2R1, Canada; [Tobita, Tetsuo; Iai, Susumu] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan	Hussien, MN (reprint author), Assiut Univ, Fac Engn, Dept Civil Engn, Assiut, Egypt.	mahmoudnasser2002@aun.edu.eg; Mourad.Karray.Benhassen@USherbrooke.ca; tobita.tetsuo.8e@kyoto-u.ac.jp; iai.susumu.6x@kyoto-u.ac.jp					Guin J, 1998, J STRUCT ENG-ASCE, V124, P434, DOI 10.1061/(ASCE)0733-9445(1998)124:4(434); Dutta SC, 2004, SOIL DYN EARTHQ ENG, V24, P893, DOI 10.1016/j.soildyn.2004.07.001; Hokmabadi AS, 2014, COMPUT GEOTECH, V55, P172, DOI 10.1016/j.compgeo.2013.08.011; Di Laora R, 2013, SOIL DYN EARTHQ ENG, V46, P52, DOI 10.1016/j.soildyn.2012.12.007; Anoyatis G, 2013, SOIL DYN EARTHQ ENG, V44, P183, DOI 10.1016/j.soildyn.2012.09.011; MAMOON SM, 1990, EARTHQUAKE ENG STRUC, V19, P597, DOI 10.1002/eqe.4290190410; [Anonymous], 2009, P750 FEMA BUILD SEIS; Rovithis EN, 2009, SOIL DYN EARTHQ ENG, V29, P1005, DOI 10.1016/j.soildyn.2008.11.005; Curras CJ, 2001, J GEOTECH GEOENVIRON, V127, P585, DOI 10.1061/(ASCE)1090-0241(2001)127:7(585); Dezi F, 2010, SOIL DYN EARTHQ ENG, V30, P679, DOI 10.1016/j.soildyn.2010.02.009; Di Laora R, 2013, EARTHQ ENG STRUCT D, V42, P319, DOI 10.1002/eqe.2201; DOBRY R, 1982, J GEOTECH ENG-ASCE, V108, P439; DOBRY R, 1976, B SEISMOL SOC AM, V66, P1293; Eurocode8 (EC8), 2003, 4PREN19985 EC8 COMM; Fan K, 1991, J GEOTECHNICAL ENG, V117, P557; Gazetas G, 1984, SOIL DYN EARTHQ ENG, V3, P82; Hadjian AH, 1992, ASCE SPECIAL PUBLICA, V34, P1; Hussien MN, 2011, P 8 INT C URB EARTHQ, P495; Hussien MN, 2013, P 66 CAN GEOT C GEOM; Hussien MN, 2011, THESIS KYOTO U KYOTO; Hussien MN, 2010, CAN GEOTECH J, V47, P1234, DOI 10.1139/T10-026; Hussien Mahmoud N., 2012, Geomechanics & Geoengineering: An International Journal, V7, DOI 10.1080/17486025.2011.598571; Iai S., 1990, REPORT PORT HARBOUR, V29, P57; Ishihara K, 1985, P 5 INT C NUM METH G, V1, P373; KAVVADAS M, 1993, GEOTECHNIQUE, V43, P207; Kaynia AM, 1996, J ENG MECH-ASCE, V122, P46, DOI 10.1061/(ASCE)0733-9399(1996)122:1(46); lai S, 2010, INT WORKSH SOIL FDN, P101; lai S, 1992, SOILS FOUND, V32, P1; Makris N, 1997, SOIL DYN EARTHQ ENG, V16, P113, DOI 10.1016/S0267-7261(96)00037-1; Maravas A, 2007, P 4 INT C EARTHQ GEO; Maravas A, 2014, SOIL DYN EARTHQ ENG, V61-62, P29, DOI 10.1016/j.soildyn.2014.01.016; Markis N., 1992, EARTHQ ENG STRUCT D, V21, P145; Masayuki H, 1991, P 2 INT C REC ADV GE, V3, P2079; Mason HB, 2013, SOIL DYN EARTHQ ENG, V48, P162, DOI 10.1016/j.soildyn.2013.01.014; MATTHEES W, 1982, NUCL ENG DES, V73, P343, DOI 10.1016/0029-5493(82)90011-5; Mendoza M, 1985, BEHAV BUILDING FDN M, P66; Meymand P.J., 1998, THESIS U CALIFORNIA; Mizuno H, 1984, P 8 WORLD C EARTHQ E, V3, P649; Mizuno H, 1996, P 11 WORLD C EARTHQ; Mylonakis G. E., 1997, EARTHQ ENG STRUCT D, V27, P337; Nikolaou S, 2001, GEOTECHNIQUE, V51, P425, DOI 10.1680/geot.51.5.425.39973; Ozutsumi O, 2001, P 4 INT C REC ADV GE; Ozutsumi O, 2003, THESIS KYOTO U KYOTO; Pender M, 1993, B NZ NATL SOC EARTHQ, V26, P49; Prakash Kumar S, 2004, GEOTECHNICAL GEOLOGI, V22, P375, DOI 10.1023/B:GEGE.0000025041.00879.5b; Roesset J. M., 1973, J STRUCT DIV ASCE, V99, P399; Roesset JM, 1980, ASCE SPEC C CIV ENG; Seed HB, 1978, NUCL ENG DES, V46, P346; Tokimatsu K, 2004, P 13 WORLD C EARTHQ; Towhata I, 1985, P 5 INT C NUM METH G, V1, P523; Veletsos A. S., 1974, EARTHQ ENG STRUCT D, V3, P121, DOI DOI 10.1002/EQE.4290030203; Waas G, 1984, P 8 WORLD C EARTHQ E, V5; Wilson DW, 1998, THESIS U CALIFORNIA; WOLF JP, 1981, NUCL ENG DES, V65, P329, DOI 10.1016/0029-5493(81)90098-4; Zienkiewicz OC, 1988, ADV COMPUTATIONAL NO, P109	55	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0266-352X	1873-7633		COMPUT GEOTECH	Comput. Geotech.	SEP	2015	69						166	181		10.1016/j.compgeo.2015.05.011		16	Computer Science, Interdisciplinary Applications; Engineering, Geological; Geosciences, Multidisciplinary	Computer Science; Engineering; Geology	CR1GW	WOS:000361073900015		
J	Wen, XZ; Zhou, FY; Fukuwa, NB; Zhu, HP				Wen, Xuezhang; Zhou, Fangyuan; Fukuwa, Nobuo; Zhu, Hongping			A simplified method for impedance and foundation input motion of a foundation supported by pile groups and its application	COMPUTERS AND GEOTECHNICS			English	Article						Impedance; Foundation input motion; Neighboring piles; Single equivalent pile; Soil-structure interaction	FINITE-ELEMENT-ANALYSIS; DYNAMIC BEHAVIOR; ELASTIC ANALYSIS; SOIL	A simplified method is developed to analyze the impedance and foundation input motion of foundations supported by pile groups. In the proposed method, neighboring piles are replaced by a single equivalent pile. This replacement process reduces the number of degrees of freedom as well as the required computer memory and calculation time. To validate the simplified method, the impedance and foundation input motion of a raft foundation and an embedded foundation supported by pile groups with rigid and pin-jointed conditions between the pile head and foundation are calculated using both a simplified method and a rigorous numerical method. The results show that the proposed simplified method for the impedance and foundation input motion analysis of a foundation with a large number of piles yields sufficient accuracy. The simplified method is also applied to estimate the dynamic response of an isolated structure with a foundation supported by 2203 cement-soil piles with consideration of the soil-structure interaction. The results show that the dynamic response of the structure can be precisely simulated using the simplified method. (C) 2015 Elsevier Ltd. All rights reserved.	[Wen, Xuezhang] Hunan Univ, Coll Civil Engn, Changsha 410082, Hunan, Peoples R China; [Zhou, Fangyuan; Zhu, Hongping] Huazhong Univ Sci & Technol, Sch Civil Engn & Mech, Wuhan 430074, Hubei, Peoples R China; [Fukuwa, Nobuo] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan	Zhou, FY (reprint author), Huazhong Univ Sci & Technol, Sch Civil Engn & Mech, Wuhan 430074, Hubei, Peoples R China.	wenxuezhang@sohu.com; fangyuanzhou@hust.edu.cn; fukuwa@sharaku.nuac.nagoya-u.ac.jp; zhuhongping630@hotmail.com			National Natural Science Foundation of China [51308243]; National Basic Research Program (973) of China [2011CB013800]	The authors gratefully acknowledge financial support provided by the National Natural Science Foundation of China (Grant No. 51308243) and the National Basic Research Program (973) of China (Grant No. 2011CB013800).	Almelda VS, 2007, ADV ENG SOFTW, V38, P835, DOI [10.1016/j.advengsoft.2006.08.034, 10.1016/j.adveiigsoft.2006.08.034]; MAMOON SM, 1990, J ENG MECH-ASCE, V116, P2237, DOI 10.1061/(ASCE)0733-9399(1990)116:10(2237); GAZETAS G, 1991, J GEOTECH ENG-ASCE, V117, P1531, DOI 10.1061/(ASCE)0733-9410(1991)117:10(1531); Xu KJ, 2000, INT J NUMER ANAL MET, V24, P1109, DOI 10.1002/1096-9853(20001225)24:15<1109::AID-NAG72>3.0.CO;2-N; Sheng DC, 2005, COMPUT GEOTECH, V32, P17, DOI 10.1016/j.compgeo.2004.10.004; OTTAVIANI M, 1975, GEOTECHNIQUE, V25, P159; DOBRY R, 1988, GEOTECHNIQUE, V38, P557; Architectural Institute of Japan, 1996, INTR DYN SOIL STRUCT; Asega H, 1999, J STRUCT CONSTRUCT E, P45; BUTTERFI.R, 1971, GEOTECHNIQUE, V21, P43; DAVIES TG, 1985, J GEOTECH ENG-ASCE, V111, P1365; GAZETAS G, 1991, EARTHQUAKE ENG STRUC, V20, P115, DOI 10.1002/eqe.4290200203; Hull S, 1985, THESIS MIT; Hull S, 1984, P 5 ASCE EMD SPEC C, P201; Kausel E, 1981, R8113 MIT DEP CIV EN; Kaynia A. M., 1982, P 2 INT C NUM METH O; Kaynia A. M., 1991, SOIL DYN EARTHQ ENG, V10, P386, DOI 10.1016/0267-7261(91)90053-3; Kaynia AM, 1982, R8303 MIT; KAYNIA AM, 1992, EARTHQUAKE ENG STRUC, V21, P303, DOI 10.1002/eqe.4290210403; Lysmer J, 1981, UCBGT8102 U CAL; MAKRIS N, 1992, EARTHQUAKE ENG STRUC, V21, P145, DOI 10.1002/eqe.4290210204; Mandolini A, 1997, GEOTECHNIQUE, V47, P791; MIURA K, 1994, EARTHQUAKE ENG STRUC, V23, P183, DOI 10.1002/eqe.4290230206; NOGAMI T, 1985, EARTHQUAKE ENG STRUC, V13, P321, DOI 10.1002/eqe.4290130306; Nozoe H, 1999, J STRUCT CONSTRUCT E, P49; Poulos H. G., 1980, PILE FDN ANAL DESIGN; Shimizu N, 1977, T AIJ, V253, P31; Varun, 2009, SOIL DYN EARTHQ ENG, V29, P268, DOI 10.1016/j.soildyn.2008.02.001; Varun, 2013, SOIL DYN EARTHQ ENG, V47, P92, DOI 10.1016/j.soildyn.2012.03.008; Varun, 2012, SOIL DYN EARTHQ ENG, V32, P56, DOI 10.1016/j.soildyn.2011.08.004; Waas G., 1972, S7114 U CAL	31	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0266-352X	1873-7633		COMPUT GEOTECH	Comput. Geotech.	SEP	2015	69						301	319		10.1016/j.compgeo.2015.06.004		19	Computer Science, Interdisciplinary Applications; Engineering, Geological; Geosciences, Multidisciplinary	Computer Science; Engineering; Geology	CR1GW	WOS:000361073900026		
J	Schoiber, J; Tippelt, G; Redhammer, GJ; Yada, C; Dolotko, O; Berger, RJF; Husing, N				Schoiber, Juergen; Tippelt, Gerold; Redhammer, Guenther J.; Yada, Chihiro; Dolotko, Oleksandr; Berger, Raphael J. F.; Huesing, Nicola			Defect and Surface Area Control in Hydrothermally Synthesized LiMn0.8Fe0.2PO4 Using a Phosphate Based Structure Directing Agent	CRYSTAL GROWTH & DESIGN			English	Article							RECHARGEABLE LITHIUM BATTERIES; LIMPO4 M; LIFEPO4; OLIVINES; DIFFRACTION; TRIPHYLITE; LIMNPO4; FE; NI	As confirmed by ion coupled plasma-optical emission spectroscopy and powder X-ray diffraction, stoichiometrically pure samples of olivine type LiFe0.2Mn0.8PO4 04 in the presence of a phosphoric acid ester based structure directing agent have been prepared. A Rietveld analysis of X-ray and n(0) diffraction data suggests that the solids are largely free of defect occupation of Fe at the lithium sites. This is confirmed by Fe-57-Mossbauer spectroscopic investigations. The use of the structure directing surfactant results in significantly higher specific surface areas (SSA) and smaller particle sizes as compared to samples prepared without using a surfactant.	[Schoiber, Juergen; Tippelt, Gerold; Redhammer, Guenther J.; Berger, Raphael J. F.; Huesing, Nicola] Paris Lodron Univ Salzburg, Mat Sci & Phys, A-5020 Salzburg, Austria; [Yada, Chihiro] Toyota Motor Co Ltd, Higashifuji Tech Ctr, Battery Res Div, Susono, Shizuoka 4101193, Japan; [Dolotko, Oleksandr] MLZ Forsch Sreaktor Munchen FRM II, D-85747 Garching, Germany	Berger, RJF (reprint author), Paris Lodron Univ Salzburg, Mat Sci & Phys, A-5020 Salzburg, Austria.	Raphael.Berger@sbg.ac.at	Redhammer, Guenther/J-9069-2012; Huesing, Nicola/E-7296-2011	Redhammer, Guenther/0000-0003-0996-3930; Huesing, Nicola/0000-0003-2274-9779			Park Y, 2012, CRYSTENGCOMM, V14, P4612, DOI 10.1039/c2ce25159k; Fisher CAJ, 2008, CHEM MATER, V20, P5907, DOI 10.1021/cm801262x; Yamada A, 2001, J ELECTROCHEM SOC, V148, pA224, DOI 10.1149/1.1348257; Chen JJ, 2006, ELECTROCHEM COMMUN, V8, P855, DOI 10.1016/j.elecom.2006.03.021; Losey A, 2004, CAN MINERAL, V42, P1105, DOI 10.2113/gscanmin.42.4.1105; Garcia-Moreno O, 2001, CHEM MATER, V13, P1570, DOI 10.1021/cm000596p; Chung SY, 2002, NAT MATER, V1, P123, DOI 10.1038/nmat732; STRELTSOV VA, 1993, ACTA CRYSTALLOGR B, V49, P147, DOI 10.1107/S0108768192004701; Adams S, 2010, J SOLID STATE ELECTR, V14, P1787, DOI 10.1007/s10008-010-1012-1; Chen JJ, 2008, SOLID STATE IONICS, V178, P1676, DOI 10.1016/j.ssi.2007.10.015; Koleva V, 2010, MATER CHEM PHYS, V121, P370, DOI 10.1016/j.matchemphys.2010.01.043; Chung SY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.195501; Jensen KMO, 2013, CHEM MATER, V25, P2282, DOI 10.1021/cm4008393; Gardiner GR, 2010, CHEM MATER, V22, P1242, DOI 10.1021/cm902720z; Saha A, 1996, J BIOL INORG CHEM, V1, P231, DOI 10.1007/s007750050048; Chung SY, 2012, NANO LETT, V12, P3068, DOI 10.1021/nl300909h; Gibot P, 2008, NAT MATER, V7, P741, DOI 10.1038/nmat2245; Perea A, 2012, RSC ADV, V2, P9517, DOI 10.1039/c2ra20949g; Fang HS, 2008, ELECTROCHEM COMMUN, V10, P1071, DOI 10.1016/j.elecom.2008.05.010; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Yoshida J, 2013, J POWER SOURCES, V226, P122, DOI 10.1016/j.jpowsour.2012.09.081; Whittingham MS, 2005, J MATER CHEM, V15, P3362, DOI 10.1039/b501961c; Bridges CA, 2013, J SOLID STATE CHEM, V205, P197, DOI 10.1016/j.jssc.2013.07.011; Hoelzel M, 2012, NUCL INSTRUM METH A, V667, P32, DOI 10.1016/j.nima.2011.11.070; RODRIGUEZCARVAJAL J, 1993, PHYSICA B, V192, P55, DOI 10.1016/0921-4526(93)90108-I; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551	26	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	SEP	2015	15	9					4213	4218		10.1021/acs.cgd.5b00324		6	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CQ8OI	WOS:000360867300006		
J	Cong, SR; Sugahara, T; Wei, TT; Jiu, JT; Hirose, Y; Nagao, S; Suganuma, K				Cong, Shuren; Sugahara, Tohru; Wei, Tingting; Jiu, Jinting; Hirose, Yukiko; Nagao, Shijo; Suganuma, Katsuaki			Growth and Extension of One-Step Sol-Gel Derived Molybdenum Trioxide Nanorods via Controlling Citric Acid Decomposition Rate	CRYSTAL GROWTH & DESIGN			English	Article							LITHIUM-ION BATTERIES; FIELD-EMISSION PROPERTIES; CORE-SHELL NANORODS; HIGH-CAPACITY; HYDROTHERMAL SYNTHESIS; NANOWIRE ARRAYS; ANODE MATERIALS; MOO3 NANOWIRES; THIN-FILMS; ALPHA-MOO3	A simple sol gel solution route for the synthesis of a-phase molybdenum trioxide (alpha-MoO3) nanorods is investigated in terms of growth mechanism with controlling the citric acid decomposition rate. The single-phase and single-crystal nanorod arrays of MoO3 grown in random directions from a silica glass substrate had mean diameters and lengths of 10 and 500 nm, respectively, as determined through chemical analysis. The citric acid plays a critical role for the nanorods growth process from investigating the relative molar ratio of molybdate and citric acid in the precursor. Moreover, the dissociation timing of the citric acid, which was controlled by the other two synthesis parameters, i.e., sintering time and solvents, also greatly influences growth and phase transition of the MoO3 nanorods, which was analyzed by scanning electron microscopy (SEM) and X-ray diffraction (XRD). The synthesis parameters were optimized to design the length and density of the nanorod arrays. The longest nanorods can be obtained up to 600 nm using a dimethylacetamide solvent, a molar ratio of Mo:citric acid = 0.5:1.5, and sintering at 673 K for 15 min in an ambient atmosphere. Findings of the present study describe that the factors of the nanorods' growth and phase changing are deeply correlated with disassemble steps of the Mo metal citric acid complex in the sol gel precursor solution, which may contribute to applying the material development in several electronic devices using MoO3 nanostructures.	[Cong, Shuren] Osaka Univ, Dept Adapt Machine Syst, Grad Sch Engn, Ibaraki, Osaka 5670047, Japan; [Cong, Shuren] Kunming Inst Phys, Infrared Detector Ctr, Kunming 650223, Peoples R China; [Sugahara, Tohru; Jiu, Jinting; Hirose, Yukiko; Nagao, Shijo; Suganuma, Katsuaki] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Wei, Tingting] Kunming Univ Sci & Technol, Fac Sci, Kunming 650093, Peoples R China	Sugahara, T (reprint author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	sugahara@sanken.osaka-u.ac.jp			 [25810140]	This work was supported by a Grant-in-Aid for Young Scientists (B) Grant (25810140). The authors are thankful to the Comprehensive Analysis Center of Osaka University for use of TEM and XRD and to Mr. Ishibasi for assistance with TEM.	Lou XW, 2002, CHEM MATER, V14, P4781, DOI 10.1021/cm0206237; Zhou L, 2011, ACS APPL MATER INTER, V3, P4853, DOI 10.1021/am201351z; Comini E, 2005, CHEM PHYS LETT, V407, P368, DOI 10.1016/j.cplett.2005.03.116; Sugahara T, 2014, J AM CERAM SOC, V97, P3238, DOI 10.1111/jace.13116; Chernova NA, 2009, J MATER CHEM, V19, P2526, DOI 10.1039/b819629j; Zhou J, 2003, ADV MATER, V15, P1835, DOI 10.1002/adma.200305528; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Wang ZY, 2010, CHEM COMMUN, V46, P6906, DOI 10.1039/c0cc01174f; Epifani M, 2004, CHEM MATER, V16, P5495, DOI 10.1021/cm048997i; Liu YD, 2013, CHEM SOC REV, V42, P2610, DOI 10.1039/c2cs35369e; Meduri P, 2012, NANO LETT, V12, P1784, DOI 10.1021/nl203649p; Ibrahem MA, 2014, NANOSCALE, V6, P5484, DOI 10.1039/c4nr00692e; Chen JS, 2010, J PHYS CHEM C, V114, P8675, DOI 10.1021/jp1017482; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Qiu JJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/15/155603; Dong W, 1998, J MATER CHEM, V8, P665, DOI 10.1039/a706537j; Li WY, 2006, J PHYS CHEM B, V110, P119, DOI 10.1021/jp0553784; Zhou J, 2003, APPL PHYS LETT, V83, P2653, DOI 10.1063/1.1613992; Brezesinski T, 2010, NAT MATER, V9, P146, DOI [10.1038/nmat2612, 10.1038/NMAT2612]; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Wang Q, 2014, ELECTROCHIM ACTA, V146, P411, DOI 10.1016/j.electacta.2014.09.020; Qi LM, 2010, COORDIN CHEM REV, V254, P1054, DOI 10.1016/j.ccr.2010.02.005; Chu WG, 2007, J MATER RES, V22, P1609, DOI 10.1557/JMR.2007.0217; Fang L, 2007, J PHYS CHEM C, V111, P2401, DOI 10.1021/jp065791r; Xu CK, 2010, J PHYS CHEM C, V114, P125, DOI 10.1021/jp9085415; Wang ZY, 2012, J PHYS CHEM C, V116, P12508, DOI 10.1021/jp304216z; Liang RL, 2011, CHEM COMMUN, V47, P10305, DOI 10.1039/c1cc14030b; Zheng L, 2010, J MATER CHEM, V20, P7135, DOI 10.1039/c0jm00744g; Stoyanova A, 2009, J OPTOELECTRON ADV M, V11, P1127; Di WH, 2008, J PHYS CHEM C, V112, P18815, DOI 10.1021/jp807527y; Shi L, 2012, CATAL SCI TECHNOL, V2, P2569, DOI 10.1039/c2cy20423a; CARCIA PF, 1987, THIN SOLID FILMS, V155, P53, DOI 10.1016/0040-6090(87)90452-4; Chen XH, 2009, J PHYS CHEM C, V113, P21582, DOI 10.1021/jp908155m; Cho IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2729; Choopun S., 2004, JPN J APPL PHYS, V43, pL91; Dinh N. N., 2013, MAT SCI APPL, V4, P275; Foon K. L., 2014, CERAM INT, V40, P753; Hu JT, 1999, ACCOUNTS CHEM RES, V32, P435, DOI 10.1021/ar9700365; Kim HD, 2014, SCI REP-UK, V4, DOI 10.1038/srep04614; Kurtoglu ME, 2011, J MATER CHEM, V21, P7931, DOI 10.1039/c1jm10752f; Liu C., 2011, APPL PHYS LETT, V99; Navas I, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/17/175305; SEGAWA K, 1984, B CHEM SOC JPN, V57, P2721, DOI 10.1246/bcsj.57.2721; Shakir I, 2010, CHEM COMMUN, V46, P4324, DOI 10.1039/c000003e; Taurino A. N., 2006, APPL PHYS LETT, V88; Wang LQ, 2012, EUR J INORG CHEM, P5831, DOI 10.1002/ejic.201200519; Wang Q, 2015, J MATER CHEM A, V3, P5083, DOI 10.1039/c5ta00127g; Wang Q, 2014, CHEM-ASIAN J, V9, P3299, DOI 10.1002/asia.201402809; Wei XM, 2003, J PHYS CHEM B, V107, P2619, DOI 10.1021/jp0274177; Wen W, 2013, RSC ADV, V3, P12052, DOI 10.1039/c3ra41735b	51	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	SEP	2015	15	9					4536	4542		10.1021/acs.cgd.5b00790		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CQ8OI	WOS:000360867300041		
J	Tokuhisa, T; Kawasaki, M; Kisailus, D; Yuda, M; Matsunaga, T; Arakaki, A				Tokuhisa, Takahito; Kawasaki, Masashi; Kisailus, David; Yuda, Masamichi; Matsunaga, Tadashi; Arakaki, Atsushi			Crystal Growth of Aspirin Using a Temperature-Controlled Microfluidic Device	CRYSTAL GROWTH & DESIGN			English	Article							PHARMACEUTICAL PARENT COMPOUNDS; ON-A-CHIP; POLARIZING MICROSCOPE; MICROCAVITY ARRAY; FORCE MICROSCOPY; ENHANCEMENT; DISSOLUTION; GRADIENT; PLANES; DRUGS	Identifying the most appropriate polymorph of active pharmaceutical ingredients is one of the important steps in drug development, since their bioactivities are largely dependent on their solid forms. However, the sample preparation for the characterization of crystal forms is time-consuming and requires large quantities of sample. Here, we introduce a microfluidic device-based method to prepare a sub-millimeter-sized single aspirin crystal from a small quantity of material. For the crystal preparation, a device equipped with a solution flow system and temperature controller was placed under the microscope. To use the device, concentration temperature phase diagrams were generated, and regions where dominant nucleation or crystal growth with specific directions were clearly determined. By observing time-dependent changes of crystal number and size with solution temperature, a pathway to grow a single crystal of aspirin was determined and applied to prepare a submillimeter-sized crystal from 250 mu g of aspirin. The obtained crystal was sufficiently large for single-crystal X-ray diffraction analysis, which usually requires 10 mg to 1 g of material per crystallization experiment. Thus, this method can be adapted as an efficient approach to uncovering the crystallization process to obtain required crystal forms with minimal sample consumption.	[Tokuhisa, Takahito; Matsunaga, Tadashi; Arakaki, Atsushi] Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Kawasaki, Masashi; Yuda, Masamichi] Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Dept Drug Discovery, Tsukuba, Ibaraki 3058585, Japan; [Kisailus, David] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA	Arakaki, A (reprint author), Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	arakakia@cc.tuat.ac.jp	Arakaki, Atsushi/B-9984-2013	Arakaki, Atsushi/0000-0001-6692-9398			Mark D, 2010, CHEM SOC REV, V39, P1153, DOI 10.1039/b820557b; Chen J, 2011, CRYST GROWTH DES, V11, P887, DOI 10.1021/cg101556s; Matsunaga T, 2008, ANAL CHEM, V80, P5139, DOI 10.1021/ac800352j; Srinivasan V, 2004, LAB CHIP, V4, P310, DOI 10.1039/b403341h; Hosokawa M, 2010, ANAL CHEM, V82, P6629, DOI 10.1021/ac101222x; Goyal S, 2012, CRYST GROWTH DES, V12, P6023, DOI 10.1021/cg3011212; Lee AY, 2011, ANNU REV CHEM BIOMOL, V2, P259, DOI 10.1146/annurev-chembioeng-061010-114224; Danesh A, 2000, ANAL CHEM, V72, P3419, DOI 10.1021/ac991498u; Othman A, 2007, J PHARM SCI-US, V96, P1380, DOI 10.1002/jps.20940; Merlin A, 2012, SOFT MATTER, V8, P3526, DOI 10.1039/c2sm07149e; Aubrey-Medendorp C, 2008, J PHARM SCI-US, V97, P1361, DOI 10.1002/jps.21055; Veesler S, 2003, ORG PROCESS RES DEV, V7, P983, DOI 10.1021/op034089f; tenWolde PR, 1997, SCIENCE, V277, P1975; Hosokawa M, 2011, ANAL CHEM, V83, P3648, DOI 10.1021/ac2000225; Danesh A, 2001, PHARMACEUT RES, V18, P299, DOI 10.1023/A:1011046728622; Lee K, 2009, LAB CHIP, V9, P709, DOI 10.1039/b813582g; Arakaki A, 2010, BIOTECHNOL BIOENG, V106, P311, DOI 10.1002/bit.22663; Desrosiers P. J., 2004, MOD DRUG DISCOV, P40; Goyal S, 2013, LAB CHIP, V13, P1708, DOI 10.1039/c3lc41271g; Hammond RB, 2007, J PHARM SCI-US, V96, P1967, DOI 10.1002/jps.20869; Heng JYY, 2007, J PHARM SCI-US, V96, P2134, DOI 10.1002/jps.20841; Muresan-Pop M, 2014, J PHARM SCI-US, V103, P3594, DOI 10.1002/jps.24151; WATANABE A, 1982, CHEM PHARM BULL, V30, P2958; WATANABE A, 1980, CHEM PHARM BULL, V28, P372; Wyttenbach N., 2008, HDB PHARM SALTS, P203; Yin HB, 2009, ANAL CHEM, V81, P473, DOI 10.1021/ac801980b	26	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	SEP	2015	15	9					4549	4555		10.1021/acs.cgd.5b00805		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CQ8OI	WOS:000360867300043		
J	Hojamberdiev, M; Yubuta, K; Vequizo, JJM; Yamakata, A; Oishi, S; Domen, K; Teshima, K				Hojamberdiev, Mirabbos; Yubuta, Kunio; Vequizo, Junie Jhon M.; Yamakata, Akira; Oishi, Shuji; Domen, Kazunari; Teshima, Katsuya			NH3-Assisted Flux Growth of Cube-like BaTaO2N Submicron Crystals in a Completely Ionized Nonaqueous High-Temperature Solution and Their Water Splitting Activity	CRYSTAL GROWTH & DESIGN			English	Article							PHOTOGENERATED CHARGE-CARRIERS; VISIBLE-LIGHT IRRADIATION; PEROVSKITE-TYPE STRUCTURE; DIELECTRIC-PROPERTIES; SINGLE-CRYSTALLINE; LATIO2N CRYSTALS; PHOTOCATALYSTS; OXIDATION; OXIDE; SR	As the 600 nm-class photocatalyst, BaTaO2N is one of the promising candidates of the perovskite-type oxynitride family for photocatalytic water splitting under visible light. The oxynitrides are routinely synthesized by nitriding corresponding oxide precursors under a high-temperature NH3 atmosphere, causing an increase in the defect density and a decrease in photocatalytic activity. To improve the photo catalytic activity by reducing the defect density and improving the crystallinity, we here demonstrate an NH3-assisted KCl flux growth approach for the direct synthesis of BaTaO2N crystals. The effects of various fluxes, solute concentration, and reaction time and temperature on the phase evolution and morphology transformation of the BaTaO2N crystals were systematically investigated. By changing the solute concentration from 10 to 50 mol %, it was found that phase-pure BaTaO2N crystals could only be grown with the solute concentrations of >= 10 mol % using the KCl flux, and the solute concentration of 10 mol % was solely favorable to directly grow cube-like BaTaO2N crystals with an average size of about 125 nm and exposed {100} and {110} faces at 950 degrees C for 10 h. The time- and temperature-dependent experiments were also performed to postulate the direct growth mechanisms of cube-like BaTaO2N submicron crystals. The BaTaO2N crystals modified with Pt and CoOx nanopartides showed a reasonable H-2 and O-2 evolution, respectively, due to a lower defect density and higher crystallinity achieved by an NH3-assisted KCl flux method.	[Hojamberdiev, Mirabbos; Oishi, Shuji; Teshima, Katsuya] Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, Nagano 3808553, Japan; [Teshima, Katsuya] Shinshu Univ, Ctr Energy & Environm Sci, Nagano 3808553, Japan; [Yubuta, Kunio] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Vequizo, Junie Jhon M.; Yamakata, Akira] Toyota Technol Inst, Grad Sch Engn, Tempa Ku, Nagoya, Aichi 4688511, Japan; [Domen, Kazunari] Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Teshima, K (reprint author), Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, 4-17-1 Wakasato, Nagano 3808553, Japan.	teshima@shinshu-u.ac.jp			Japan Technological Research Association of Artificial Photosynthetic Chemical Process (ARPChem)	This research was supported in part by the Japan Technological Research Association of Artificial Photosynthetic Chemical Process (ARPChem). The authors thank Drs. Takashi Hisatomi and Qian Wang of the University of Tokyo, Japan, for the H<INF>2</INF> and O<INF>2</INF> evolution experiments.	Rahinov I, 2003, APPL PHYS B-LASERS O, V77, P541, DOI 10.1007/s00340-003-1267-7; Maeda K, 2007, J PHYS CHEM C, V111, P7851, DOI 10.1021/jp070911w; Matsukawa M, 2014, NANO LETT, V14, P1038, DOI 10.1021/nl404688h; Uehara M, 1999, NATURE, V399, P560; Page K, 2007, CHEM MATER, V19, P4037, DOI 10.1021/cm0709673; Tessier F, 2005, CHEM MATER, V17, P3570, DOI 10.1021/cm050402b; Maegli AE, 2014, J PHYS CHEM C, V118, P16344, DOI 10.1021/jp4084162; Wolff H, 2008, J COMPUT CHEM, V29, P2260, DOI 10.1002/jcc.20895; Kim YI, 2004, CHEM MATER, V16, P1267, DOI 10.1021/cm034756j; Ebbinghaus SG, 2009, PROG SOLID STATE CH, V37, P173, DOI 10.1016/j.progsolidstchem.2009.11.003; Fang CM, 2003, J PHYS CHEM SOLIDS, V64, P281, DOI 10.1016/S0022-3697(02)00296-2; Kasahara A, 2002, J PHYS CHEM A, V106, P6750, DOI 10.1021/jp025961+; Maegli AE, 2012, J MATER CHEM, V22, P17906, DOI 10.1039/c2jm32718j; Kim YI, 2011, J CERAM SOC JPN, V119, P371, DOI 10.2109/jcersj2.119.371; He T, 2001, NATURE, V411, P54, DOI 10.1038/35075014; Kim YI, 2007, CHEM MATER, V19, P618, DOI 10.1021/cm062480k; Higashi M, 2013, J AM CHEM SOC, V135, P10238, DOI 10.1021/ja404030x; Kozuka H, 2012, J MATER CHEM, V22, P20217, DOI 10.1039/c2jm34613c; Hashimoto S, 1999, J EUR CERAM SOC, V19, P335, DOI 10.1016/S0955-2219(98)00202-7; Higashi M, 2008, CHEM PHYS LETT, V452, P120, DOI 10.1016/j.cplett.2007.12.021; Madaro F, 2011, CRYSTENGCOMM, V13, P1304, DOI 10.1039/c0ce00413h; Yamakata A, 2015, J PHYS CHEM C, V119, P1880, DOI 10.1021/jp510647b; Maeda K, 2014, J CATAL, V310, P67, DOI 10.1016/j.jcat.2012.12.003; Takata T, 2011, CRYST GROWTH DES, V11, P33, DOI 10.1021/cg901025e; Homes CC, 2001, SCIENCE, V293, P673, DOI 10.1126/science.1061655; Maeda K, 2013, ANGEW CHEM INT EDIT, V52, P6488, DOI 10.1002/anie.201301357; Zhang FX, 2012, J AM CHEM SOC, V134, P8348, DOI 10.1021/ja301726c; Kawashima K, 2015, CRYST GROWTH DES, V15, P333, DOI 10.1021/cg501397x; Ravel B, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.184121; Balaz S, 2013, CHEM MATER, V25, P3337, DOI 10.1021/cm401815w; Ida S, 2014, J PHYS CHEM LETT, V5, P2533, DOI 10.1021/jz5010957; Withers RL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2890052; Ma SSK, 2012, J AM CHEM SOC, V134, P19993, DOI 10.1021/ja3095747; Hafez AM, 2014, PHYS CHEM CHEM PHYS, V16, P18418, DOI 10.1039/c4cp02088j; HELLWIG A, 1994, J MATER SCI, V29, P4686, DOI 10.1007/BF00356510; Watanabe T, 2011, CHEM LETT, V40, P1101, DOI 10.1246/cl.2011.1101; Hojamberdiev M, 2015, INORG CHEM, V54, P3237, DOI 10.1021/ic502862t; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; PORS F, 1988, MATER RES BULL, V23, P1447, DOI 10.1016/0025-5408(88)90270-X; Kato H, 2013, CATAL SCI TECHNOL, V3, P1733, DOI 10.1039/c3cy00014a; Yamakata A, 2014, J PHYS CHEM C, V118, P23897, DOI 10.1021/jp508233z; Odochian L, 2011, KINET CATAL+, V52, P480, DOI 10.1134/S0023158411040112; Kawashirna K, 2015, J PHYS CHEM C, V119, P15896, DOI 10.1021/acs.jpcc.5b03718; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Marchand R., 1986, J PHYS C SOLID STATE, V47, pC1; Yamakata A, 2015, J PHOTOCH PHOTOBIO A, V313, P168, DOI 10.1016/j.jphotochem.2015.05.016	46	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	SEP	2015	15	9					4663	4671		10.1021/acs.cgd.5b00927		9	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CQ8OI	WOS:000360867300055		
J	Maiwa, K; Nakamura, H; Kimura, H				Maiwa, Koji; Nakamura, Hiroaki; Kimura, Hideo			The Effect of Growth Kinetics on the Formation of Peritectic Microstructures in a Sr(NO3)(2)-H2O System	CRYSTAL GROWTH & DESIGN			English	Article							IN-SITU OBSERVATION; AQUEOUS-SOLUTION; PHASE SELECTION; CRYSTALS; CRYSTALLIZATION; SOLIDIFICATION; TRANSFORMATION; NUCLEATION; INTERFACE; MECHANISM	We evaluated the growth and dissolution behavior of the primary a phase, Sr(NO3)(2), and peritectic beta phase, Sr(NO3)(2)center dot 4H(2)O, coexisting in aqueous solutions above or below the peritectic temperature (T-p) in situ. Above T-p, when the two phases simultaneously grew in close proximity, the metastable beta phase began to partially dissolve where it approached the alpha phase, although the remaining portion of the beta phase was still growing. Overall, the growing alpha phase could not approach the dissolving face of the beta phase; thus, a peritectic microstructure with the alpha phase enclosing the beta phase was not formed. Conversely, below T-p, regardless of whether the metastable alpha phase was growing or dissolving, the stable beta phase engulfed the alpha phase, resulting in a peritectic microstructure with the beta phase enveloping the alpha phase. This demonstrated that it is necessary for the stable phase to dominate the metastable phase in growth kinetics for bringing about a peritectic microstructure consisting of the metastable phase in the core and the stable phase in the periphery.	[Maiwa, Koji; Nakamura, Hiroaki; Kimura, Hideo] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Maiwa, K (reprint author), Natl Inst Mat Sci, Sengen 1-2-1, Tsukuba, Ibaraki 3050047, Japan.	MAIWA.Koji@nims.go.jp			Japan Society for the Promotion of Science (JSPS) [KAKENHI 6510072]	K.M. is grateful to the late Prof. I. Sunagawa for his constant advice and encouragement. This work was partly supported by a Grant-in-Aid for Scientific Research (KAKENHI 6510072) from the Japan Society for the Promotion of Science (JSPS).	Boettinger WJ, 2000, ACTA MATER, V48, P43, DOI 10.1016/S1359-6454(99)00287-6; Milke R, 2001, CONTRIB MINERAL PETR, V142, P15; Griesser S, 2014, ACTA MATER, V67, P335, DOI 10.1016/j.actamat.2013.12.018; Shaw CSJ, 2008, CONTRIB MINERAL PETR, V155, P199, DOI 10.1007/s00410-007-0237-1; Yasuda H, 2012, IOP CONF SER-MAT SCI, V27, DOI 10.1088/1757-899X/27/1/012084; CHERNOV AA, 1989, CONTEMP PHYS, V30, P251, DOI 10.1080/00107518908225517; Nagashio K, 2000, ACTA MATER, V48, P3049, DOI 10.1016/S1359-6454(00)00132-4; Aswal DK, 1999, J CRYST GROWTH, V197, P379, DOI 10.1016/S0022-0248(98)00888-4; Barker N. J. W., 1974, Metal Science, V8; FREDRIKSSON H, 1982, MET SCI, V16, P283; Griesser S, 2014, ACTA MATER, V81, P111, DOI 10.1016/j.actamat.2014.08.020; Lebrun N, 2003, CAN J PHYS, V81, P61, DOI 10.1139/P02-116; Ludwig A, 2009, T INDIAN I METALS, V62, P433; Maiwa K, 2003, J CRYST GROWTH, V255, P386, DOI 10.1016/S0022-0248(03)01307-1; MAIWA K, 1990, J CRYST GROWTH, V102, P43, DOI 10.1016/0022-0248(90)90887-Q; Maiwa K, 2003, J CRYST GROWTH, V255, P379, DOI 10.1016/S0022-0248(03)01306-X; Maiwa K, 2006, J CRYST GROWTH, V289, P303, DOI 10.1016/j.jcrysgro.2005.10.110; McDonald NJ, 2005, J MATER SCI, V40, P2411, DOI 10.1007/s10853-005-1967-y; McDonald NJ, 2003, METALL MATER TRANS A, V34A, P1931, DOI 10.1007/s11661-003-0158-1; Mogeritsch JP, 2012, IOP CONF SER-MAT SCI, V27, DOI 10.1088/1757-899X/27/1/012028; Nagashio K, 1999, J CRYST GROWTH, V200, P118, DOI 10.1016/S0022-0248(98)01258-5; Nishimura Y, 1996, J CRYST GROWTH, V158, P255, DOI 10.1016/0022-0248(95)00436-X; Shibata H, 2000, METALL MATER TRANS B, V31, P981, DOI 10.1007/s11663-000-0074-3; Sieverts A., 1933, ANORG ALLG CHEM, V212, P233; STJOHN DH, 1990, ACTA METALL MATER, V38, P631, DOI 10.1016/0956-7151(90)90218-6; St John DH, 1987, ACTA METALL MATER, V35, P171, DOI 10.1016/0001-6160(87)90226-4; Strohmenger J, 2004, MAT SCI ENG A-STRUCT, V375, P561, DOI 10.1016/j.msea.2003.10.191; Terborg R, 1997, J MATER RES, V12, P2002, DOI 10.1557/JMR.1997.0269; Yasuda H, 1996, J CRYST GROWTH, V158, P128, DOI 10.1016/0022-0248(95)00420-3	29	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	SEP	2015	15	9					4672	4675		10.1021/acs.cgd.5b00951		4	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CQ8OI	WOS:000360867300056		
J	Shin, DM; Hwang, YH; Ko, JH; Kojima, S				Shin, Dong-Myeong; Hwang, Yoon-Hwae; Ko, Jae-Hyeon; Kojima, Seiji			Relaxation behaviors of enantiomorphic S-ibuprofen as revealed by dielectric and photon correlation spectroscopies	CURRENT APPLIED PHYSICS			English	Article						S-ibuprofen; Pharmaceutical; Glass transition; Dielectric spectroscopy; Photon correlation spectroscopy	BRILLOUIN LIGHT-SCATTERING; SUPERCOOLED LIQUID; RACEMIC IBUPROFEN; PHASE-II; GLASSY; DYNAMICS; DIFFRACTION; ASPIRIN; STATES; TIME	Relaxation behaviors of enantiomorphic S-ibuprofen were investigated in its amorphous state by using dielectric and photon correlation spectroscopies. The dielectric relaxation processes of the S-ibuprofen were nearly identical to those of the racemic RS-ibuprofen. The relaxation parameters and the dielectric strengths of the alpha-process and the D-process for the S-ibuprofen were very similar to those for the RS-ibuprofen. These results indicate that the stereochemistry of ibuprofen molecules do not have any substantial effect on molecular motions in the amorphous state of ibuprofen. The relaxation times of the main relaxation process probed by using the photon correlation spectroscopy were consistent with those of the dielectric alpha-process. The fragility of the S-ibuprofen was 76, which was nearly the same to that determined based on the thermal relaxation times and smaller than that of the racemic compound. (C) 2015 Elsevier B.V. All rights reserved.	[Shin, Dong-Myeong; Hwang, Yoon-Hwae] Pusan Natl Univ, Dept Nanoenergy Engn, Miryang 627706, South Korea; [Shin, Dong-Myeong; Hwang, Yoon-Hwae] Pusan Natl Univ, Plus Nanoconvergence Technol Div BK21, Miryang 627706, South Korea; [Ko, Jae-Hyeon] Hallym Univ, Dept Phys, Chunchon 200702, Gangwondo, South Korea; [Kojima, Seiji] Univ Tsukuba, Grad Sch Pure & Appl Phys, Tsukuba, Ibaraki 3058573, Japan	Hwang, YH (reprint author), Pusan Natl Univ, Dept Nanoenergy Engn, Miryang 627706, South Korea.	yhwang@pusan.ac.kr; hwangko@hallym.ac.kr		Shin, Dong-Myeong/0000-0002-5402-9947	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2006582, 2012R1A1B3001357]; Defense Research Laboratory Program of the Defence Acquisition Program Administration; Agency for Defense Development of Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A2006582 and 2012R1A1B3001357) and by the Defense Research Laboratory Program of the Defence Acquisition Program Administration and the Agency for Defense Development of Republic of Korea.	Derollez P, 2010, ACTA CRYSTALLOGR B, V66, P76, DOI 10.1107/S0108768109047363; Bras AR, 2008, J PHYS CHEM B, V112, P11087, DOI 10.1021/jp8040428; Kaminski K, 2009, CARBOHYD RES, V344, P2547, DOI 10.1016/j.carres.2009.10.001; Johari GP, 2001, J CHEM PHYS, V114, P4634, DOI 10.1063/1.1346635; Yamaguchi M, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1857080; Adrjanowicz K, 2010, J PHYS CHEM B, V114, P6579, DOI 10.1021/jp910009b; Hancock BC, 1997, J PHARM SCI, V86, P1, DOI 10.1021/js9601896; Kim TH, 2014, CURR APPL PHYS, V14, P965, DOI 10.1016/j.cap.2014.05.001; Affouard F, 2010, J PHYS CHEM B, V114, P11397, DOI 10.1021/jp1046358; Shankland N, 1997, ACTA CRYSTALLOGR C, V53, P951, DOI 10.1107/S0108270197003193; Fragiadakis D, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3374820; Hedoux A, 2011, INT J PHARMACEUT, V421, P45, DOI 10.1016/j.ijpharm.2011.09.015; ALVAREZ F, 1991, PHYS REV B, V44, P7306, DOI 10.1103/PhysRevB.44.7306; Johari GP, 2007, J PHARM SCI-US, V96, P1159, DOI 10.1002/jps.20921; Ngai KL, 2003, J PHYS-CONDENS MAT, V15, pS1107, DOI 10.1088/0953-8984/15/11/332; Hwang YH, 1999, J PHYS-CONDENS MAT, V11, P1453, DOI 10.1088/0953-8984/11/6/009; Johari GP, 2000, PHYS CHEM CHEM PHYS, V2, P5479, DOI 10.1039/b007086f; Kim TH, 2013, AIP CONF PROC, V1518, P316, DOI 10.1063/1.4794590; Ko JH, 2011, CHEM PHYS LETT, V515, P221, DOI 10.1016/j.cplett.2011.09.024; Kwon HJ, 2013, CHEM PHYS LETT, V556, P117, DOI 10.1016/j.cplett.2012.11.072; McConnell J.F., 1974, CRYST STRUCT COMMUN, V3, P73; Newnham R. E., 2005, PROPERTIES MAT ANISO; Xu F, 2005, ACTA PHYS-CHIM SIN, V21, P1, DOI 10.3866/PKU.WHXB20050101	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1739	1878-1675		CURR APPL PHYS	Curr. Appl. Phys.	SEP	2015	15	9					958	963		10.1016/j.cap.2015.05.012		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CQ9EM	WOS:000360914900002		
J	Kang, DW; Chowdhury, A; Sichanugrist, P; Abe, Y; Konishi, H; Tsuda, Y; Shinagawa, T; Tokioka, H; Fuchigami, H; Konagai, M				Kang, Dong-Won; Chowdhury, Amartya; Sichanugrist, Porponth; Abe, Yusuke; Konishi, Hirofumi; Tsuda, Yuki; Shinagawa, Tomohiro; Tokioka, Hidetada; Fuchigami, Hiroyuki; Konagai, Makoto			Highly transparent Zn1-xMgxO/ITO multilayer for window of thin film solar cells	CURRENT APPLIED PHYSICS			English	Article						Zn1-xMgxO; ITO; Transparent conductive oxide; Silicon; Solar cell	PULSED-LASER DEPOSITION; EFFICIENCY; TCO	Texture-etched Zn1-xMgxO films were fabricated and applied as front transparent electrodes for superstrate type thin film solar cells. The Zn0.65Mg0.35O film (x = 0.35) showed optical transparency better than commercially available Asahi VU and double-textured ZnO (WT-ZnO) substrates. To provide pertinent conductivity, ITO film was coated on the texture-etched Zn0.65Mg0.35O. By employing the Zn0.65Mg0.35O/ITO substrate instead of the SnO2, we demonstrated an enhancement of quantum efficiency for amorphous silicon thin film solar cell devices, resulted in efficiency improvement from 8.92 to 9.56%. We also examined effectiveness of the Zn0.65Mg0.35O/ITO substrate for the microcrystalline silicon solar cells which delivered an efficiency of 9.73% with proper anti-reflection coating. Our experimental results suggest that the Zn0.65Mg0.35O/ITO multilayer front contact can be beneficial for reinforcing performances of silicon-based thin film solar cell devices. (C) 2015 Elsevier B.V. All rights reserved.	[Kang, Dong-Won] Cheongju Univ, Dept Solar & Energy Engn, Cheongju 363764, South Korea; [Chowdhury, Amartya; Sichanugrist, Porponth; Abe, Yusuke; Konagai, Makoto] Tokyo Inst Technol, Dept Phys Elect, Tokyo 1528552, Japan; [Konishi, Hirofumi; Tsuda, Yuki; Shinagawa, Tomohiro; Tokioka, Hidetada; Fuchigami, Hiroyuki] Mitsubishi Electr Corp, Adv R&D Ctr, Amagasaki, Hyogo 6618661, Japan; [Konagai, Makoto] Tokyo City Univ, Adv Res Lab, Setagaya Ku, Tokyo 1580082, Japan	Kang, DW (reprint author), Cheongju Univ, Dept Solar & Energy Engn, Cheongju 363764, South Korea.	kang@cju.ac.kr			New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade, and Industry, Japan (METI)	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade, and Industry, Japan (METI).	Abe Y, 2014, IEEE J PHOTOVOLT, V4, P1374, DOI 10.1109/JPHOTOV.2014.2358085; Kim S, 2013, SOL ENERG MAT SOL C, V119, P214, DOI 10.1016/j.solmat.2013.07.011; Kaushal A, 2011, J ALLOY COMPD, V509, P200, DOI 10.1016/j.jallcom.2010.09.077; Fujibayashi T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2200741; Kang DW, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NB10; Muller J, 2004, SOL ENERGY, V77, P917, DOI 10.1016/j.solener.2004.03.015; Minemoto T, 2000, THIN SOLID FILMS, V372, P173, DOI 10.1016/S0040-6090(00)01009-9; Kang DW, 2011, SOL ENERG MAT SOL C, V95, P138, DOI 10.1016/j.solmat.2010.04.068; Matsui T, 2013, PROG PHOTOVOLTAICS, V21, P1363, DOI 10.1002/pip.2300; Wang NF, 2012, OPT EXPRESS, V20, P7445, DOI 10.1364/OE.20.007445; Fernandez S, 2011, SOL ENERG MAT SOL C, V95, P2281, DOI 10.1016/j.solmat.2011.03.042; Schuttauf JW, 2015, SOL ENERG MAT SOL C, V133, P163, DOI 10.1016/j.solmat.2014.11.006; Hongsingthong A, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.051102; Hironiwa D, 2015, CURR APPL PHYS, V15, P383, DOI 10.1016/j.cap.2015.01.011; Cohen DJ, 2004, J APPL PHYS, V96, P459, DOI 10.1063/1.1760239; Gu XQ, 2008, SOL ENERG MAT SOL C, V92, P343, DOI 10.1016/j.solmat.2007.09.012; Hu YH, 2015, CURR APPL PHYS, V15, P423, DOI 10.1016/j.cap.2015.01.015; Kim S, 2014, CAN J PHYS, V92, P917, DOI 10.1139/cjp-2013-0620; Konishi H., 2014, 6 WORLD C PHOT EN CO, P214; Lu JG, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2424308; Maejima K, 2010, THIN SOLID FILMS, V518, P2949, DOI 10.1016/j.tsf.2009.09.196; Si FT, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4892890	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1739	1878-1675		CURR APPL PHYS	Curr. Appl. Phys.	SEP	2015	15	9					1022	1026		10.1016/j.cap.2015.05.017		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CQ9EM	WOS:000360914900012		
J	Urakawa, H; Hasegawa, Y; Tsukushi, S; Seki, T; Kozawa, E; Ishiguro, N; Nishida, Y				Urakawa, Hiroshi; Hasegawa, Yukiharu; Tsukushi, Satoshi; Seki, Taisuke; Kozawa, Eiji; Ishiguro, Naoki; Nishida, Yoshihiro			Subchondral Fracture of the Femoral Head in a High School Badminton Player: A Case Report	CURRENT SPORTS MEDICINE REPORTS			English	Review							INSUFFICIENCY FRACTURE; ROTATIONAL OSTEOTOMY; YOUNG-ADULTS; OSTEONECROSIS; TRANSPLANTATION		[Urakawa, Hiroshi; Tsukushi, Satoshi; Seki, Taisuke; Kozawa, Eiji; Ishiguro, Naoki; Nishida, Yoshihiro] Nagoya Univ, Grad Sch, Dept Orthopaed Surg, Nagoya, Aichi 4668550, Japan; [Urakawa, Hiroshi; Tsukushi, Satoshi; Seki, Taisuke; Kozawa, Eiji; Ishiguro, Naoki; Nishida, Yoshihiro] Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Hasegawa, Yukiharu] Nagoya Univ, Grad Sch Med, Dept Hip & Knee Reconstruct Surg, Showa Ku, Nagoya, Aichi 4668550, Japan	Urakawa, H (reprint author), Nagoya Univ, Grad Sch, Dept Orthopaed Surg, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	urakawa@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24791533]	One or more of the authors (H.U.) has received research funding from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid 24791533 for Scientific Research (C)).	Yamamoto T, 1999, ARTHRITIS RHEUM, V42, P2719, DOI 10.1002/1529-0131(199912)42:12<2719::AID-ANR31>3.0.CO;2-X; Yamamoto T, 2010, CLIN ORTHOP RELAT R, V468, P3181, DOI 10.1007/s11999-010-1364-y; Ramappa AJ, 2000, J BONE JOINT SURG AM, V82A, P1140; Sugioka Y, 2008, CLIN ORTHOP RELAT R, V466, P1104, DOI 10.1007/s11999-008-0192-9; Sugano N, 1999, J BONE JOINT SURG BR, V81B, P590, DOI 10.1302/0301-620X.81B4.9393; Davies M, 2004, EUR RADIOL, V14, P201, DOI 10.1007/s00330-003-1998-1; Ikemura S, 2005, ARTHRITIS RHEUM, V52, P1293, DOI 10.1002/art.20994; Ikemura S, 2010, AM J ROENTGENOL, V195, pW63, DOI 10.2214/AJR.09.3271; Iwasaki K, 2011, CLIN IMAG, V35, P208, DOI 10.1016/j.clinimag.2010.05.005; Iwasaki K, 2009, SKELETAL RADIOL, V38, P925, DOI 10.1007/s00256-009-0706-x; Kim JW, 2007, CLIN ORTHOP RELAT R, P196, DOI 10.1097/BLO.Ob013e3181577212; Song WS, 2004, J BONE JOINT SURG AM, V86A, P1917	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1537-890X	1537-8918		CURR SPORT MED REP	Curr. Sport. Med. Rep.	SEP-OCT	2015	14	5					386	388		10.1249/JSR.0000000000000189		3	Sport Sciences	Sport Sciences	CR1TS	WOS:000361108600013		
J	Hamada, Y; Bando, T; Nakamura, T; Ishimaru, Y; Mito, T; Noji, S; Tomioka, K; Ohuchi, H				Hamada, Yoshimasa; Bando, Tetsuya; Nakamura, Taro; Ishimaru, Yoshiyasu; Mito, Taro; Noji, Sumihare; Tomioka, Kenji; Ohuchi, Hideyo			Leg regeneration is epigenetically regulated by histone H3K27 methylation in the cricket Gryllus bimaculatus	DEVELOPMENT			English	Article						Regeneration; Epigenetics; Histone H3K27; Gryllus bimaculatus; Polycomb	DROSOPHILA IMAGINAL DISCS; DACHSOUS/FAT SIGNALING PATHWAY; PROXIMODISTAL AXIS; EXPRESSION PATTERNS; TISSUE REGENERATION; LIMB REGENERATION; RNA INTERFERENCE; URODELE LIMB; DISTAL-LESS; STEM-CELL	Hemimetabolous insects such as the cricket Gryllus bimaculatus regenerate lost tissue parts using blastemal cells, a population of dedifferentiated proliferating cells. The expression of several factors that control epigenetic modification is upregulated in the blastema compared with differentiated tissue, suggesting that epigenetic changes in gene expression might control the differentiation status of blastema cells during regeneration. To clarify the molecular basis of epigenetic regulation during regeneration, we focused on the function of the Gryllus Enhancer of zeste [Gb'E(z)] and Ubiquitously transcribed tetratricopeptide repeat gene on the X chromosome (Gb'Utx) homologues, which regulate methylation and demethylation of histone H3 lysine 27 (H3K27), respectively. Methylated histone H3K27 in the regenerating leg was diminished by Gb'E(z)(RNAi) and was increased by Gb'Utx(RNAi). Regenerated Gb'E(z)(RNAi) cricket legs exhibited extra leg segment formation between the tibia and tarsus, and regenerated Gb'Utx(RNAi) cricket legs showed leg joint formation defects in the tarsus. In the Gb'E(z)(RNAi) regenerating leg, the Gb'dac expression domain expanded in the tarsus. By contrast, in the Gb'Utx(RNAi) regenerating leg, Gb'Egfr expression in the middle of the tarsus was diminished. These results suggest that regulation of the histone H3K27 methylation state is involved in the repatterning process during leg regeneration among cricket species via the epigenetic regulation of leg patterning gene expression.	[Hamada, Yoshimasa; Tomioka, Kenji] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama, Okayama 7008558, Japan; [Bando, Tetsuya; Ohuchi, Hideyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Okayama 7008558, Japan; [Nakamura, Taro; Ishimaru, Yoshiyasu; Mito, Taro; Noji, Sumihare] Univ Tokushima, Grad Sch, Inst Sci & Technol, Dept Life Syst, Tokushima 7708506, Japan	Bando, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	tbando@cc.okayama-u.ac.jp; hohuchi@okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23710217, 25830133, 22370080, 22124003]	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan [#23710217 and #25830133 to T.B.; and #22370080 and #22124003 to S.N.]. Y.H. is a Japan Society for the Promotion of Science (JSPS) Research Fellow.	Agata K, 2012, DEV GROWTH DIFFER, V54, P143, DOI 10.1111/j.1440-169X.2011.01323.x; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Nakamura T, 2008, DEV BIOL, V319, P46, DOI 10.1016/j.ydbio.2008.04.002; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Takayama K, 2014, GENE EXPR PATTERNS, V14, P105, DOI 10.1016/j.gep.2014.01.005; Tamura K, 2010, DEV GROWTH DIFFER, V52, P89, DOI 10.1111/j.1440-169X.2009.01144.x; Ding XL, 2014, STEM CELLS DEV, V23, P931, DOI 10.1089/scd.2013.0267; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637; Kojima T, 2004, DEV GROWTH DIFFER, V46, P115; Nakamura T, 2007, DEV GROWTH DIFFER, V49, P79, DOI 10.1111/j.1440-169x.2007.00915.x; Yakushiji N, 2007, DEV BIOL, V312, P171, DOI 10.1016/j.ydbio.2007.09.022; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI [10.1038/nbt.1684, 10.1038/nbt1684]; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Stewart S, 2009, P NATL ACAD SCI USA, V106, P19889, DOI 10.1073/pnas.0904132106; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; Katsuyama T, 2011, FEBS LETT, V585, P1617, DOI 10.1016/j.febslet.2011.05.010; Herz HM, 2010, MOL CELL BIOL, V30, P2485, DOI 10.1128/MCB.01633-09; Repiso A, 2011, DEV GROWTH DIFFER, V53, P177, DOI 10.1111/j.1440-169X.2010.01247.x; Mito T, 2002, MECH DEVELOP, V114, P27, DOI 10.1016/S0925-4773(02)00052-7; Bando T, 2009, DEVELOPMENT, V136, P2235, DOI 10.1242/dev.035204; Yakushiji N, 2009, SEMIN CELL DEV BIOL, V20, P565, DOI 10.1016/j.semcdb.2008.12.007; Bando T, 2013, DEVELOPMENT, V140, P959, DOI 10.1242/dev.084590; Bando T, 2011, DEV DYNAM, V240, P1440, DOI 10.1002/dvdy.22647; Barrero MJ, 2011, EMBO REP, V12, P208, DOI 10.1038/embor.2011.10; Handberg-Thorsager M, 2008, FRONT BIOSCI-LANDMRK, V13, P6374, DOI 10.2741/3160; Hirose K., 2014, EPIGENETICS, V8, P899; Hubert A., 2014, EPIGENETICS, V8, P79; Inoue Y, 2002, MECH DEVELOP, V113, P141, DOI 10.1016/S0925-4773(02)00017-5; Ishimaru Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08387; Konstantinides N, 2014, SCIENCE, V343, P788, DOI 10.1126/science.1243529; Matsuoka Y, 2015, BIOL OPEN, V4, P702, DOI 10.1242/bio.201411064; McCusker CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077064; Torres CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060020; Nakamura T, 2008, CELL MOL LIFE SCI, V65, P64, DOI 10.1007/s00018-007-7432-0; Niwa N, 2013, DEV BIOL, V381, P460, DOI 10.1016/j.ydbio.2013.04.010; Noji S., 2008, COLD SPRING HARB PRO, V2008, P331; Robb SMC, 2014, CURR TOP DEV BIOL, V108, P71, DOI 10.1016/B978-0-12-391498-9.00004-8; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Sun GP, 2014, CURR TOP DEV BIOL, V108, P95, DOI 10.1016/B978-0-12-391498-9.00003-6; Tajiri R, 2011, DEVELOPMENT, V138, P4621, DOI 10.1242/dev.067330; Tamaki S, 2013, PHYSIOL ENTOMOL, V38, P163, DOI 10.1111/phen.12015; TRUBY PR, 1985, J EMBRYOL EXP MORPH, V85, P177; Tweedell KS, 2010, THESCIENTIFICWORLDJO, V10, P954, DOI 10.1100/tsw.2010.115; Uryu O, 2013, J INSECT PHYSIOL, V59, P494, DOI 10.1016/j.jinsphys.2013.02.009	49	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	SEP	2015	142	17					2916	+		10.1242/dev.122598		17	Developmental Biology	Developmental Biology	CQ7DO	WOS:000360763300007		
J	Mise, K; Hoshino, J; Ueno, T; Hazue, R; Sumida, K; Hiramatsu, R; Hasegawa, E; Yamanouchi, M; Hayami, N; Suwabe, T; Sawa, N; Fujii, T; Hara, S; Ohashi, K; Takaichi, K; Ubara, Y				Mise, Koki; Hoshino, Junichi; Ueno, Toshiharu; Hazue, Ryo; Sumida, Keiichi; Hiramatsu, Rikako; Hasegawa, Eiko; Yamanouchi, Masayuki; Hayami, Noriko; Suwabe, Tatsuya; Sawa, Naoki; Fujii, Takeshi; Hara, Shigeko; Ohashi, Kenichi; Takaichi, Kenmei; Ubara, Yoshifumi			Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy	DIABETES-METABOLISM RESEARCH AND REVIEWS			English	Article						diabetic nephropathy; eGFR decline; integrated discrimination improvement analysis; net reclassification improvement analysis; receiver operating characteristic analysis; renal pathology	GLOMERULAR-FILTRATION-RATE; RENAL PROGNOSIS; RECLASSIFICATION; DISEASE; BIOPSY; ALBUMINURIA; PROGRESSION; MELLITUS; RISK	BackgroundThe effect of clinical and pathological parameters on the estimated glomerular filtration rate (eGFR) decline has not been investigated in patients with type 2 diabetes and overt proteinuric biopsy-proven diabetic nephropathy. MethodsAmong 198 patients with type 2 diabetes who underwent renal biopsy and were confirmed to have pure diabetic nephropathy according to the recent classification, 128 patients with overt proteinuria were enrolled. Receiver operating characteristic, net reclassification improvement (NRI) and integrated discrimination improvement (IDI) analyses were performed using models adjusted for various clinical and pathological covariates to determine the best predictors of rapid eGFR decline [defined as >14.9%/year (median eGFR decline)]. ResultsA model that incorporated proteinuria showed the largest area under the curve (AUC) among clinical models, which suggested that proteinuria was the best clinical predictor. Although a model incorporating interstitial fibrosis and tubular atrophy (IFTA) score did not display a significantly larger AUC than the model with proteinuria (0.843 vs 0.812, respectively, p=0.47), a model with both IFTA score and proteinuria had a significantly larger AUC than the model with proteinuria alone (0.875 vs 0.812, respectively, p=0.014). Similarly, the addition of IFTA score resulted in a significantly greater net reclassification improvement and integrated discrimination improvement than the model with proteinuria alone [NRI: 0.78 (95% CI: 0.43-1.13; p<0.001), IDI: 0.13 (95% CI: 0.07-0.19; p<0.001)]. ConclusionsOur results suggest that not only proteinuria but also tubulointerstitial lesions should be assessed to predict rapid eGFR decline in patients with type 2 diabetes who have overt proteinuria and biopsy-proven diabetic nephropathy. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Mise, Koki; Hoshino, Junichi; Ueno, Toshiharu; Hazue, Ryo; Sumida, Keiichi; Hiramatsu, Rikako; Hasegawa, Eiko; Yamanouchi, Masayuki; Hayami, Noriko; Suwabe, Tatsuya; Sawa, Naoki; Hara, Shigeko; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Fujii, Takeshi; Ohashi, Kenichi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Hara, Shigeko; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo, Japan; [Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan	Mise, K (reprint author), Toranomon Hosp Kajigaya, Nephrol Ctr, Takatu Ku, 1-3-1 Kajigaya, Tokyo, Kanagawa 2130015, Japan.	kokims-frz@umin.ac.jp			Okinaka Memorial Institute for Medical Research	This work was supported by a grant from Okinaka Memorial Institute for Medical Research. We are grateful to Drs Shogi Kawatsu (The Institute for Adult Diseases, Asahi Life Foundation), Ayako Hakura, Masafumi Yokota, Yukio Maruyama, Tomio Onuma and Ai Terai for providing data and for treatment after renal biopsy. We are also grateful to Drs Satoshi Hamanoue, Takashi Iijima and Koichi Kikuchi for their helpful comments and managing patients.	Wada T, 2012, CLIN EXP NEPHROL, V16, P96, DOI 10.1007/s10157-011-0508-z; Atkins RC, 2005, AM J KIDNEY DIS, V45, P281, DOI 10.1053/j.ajkd.2004.10.019; Zoppini G, 2012, CLIN J AM SOC NEPHRO, V7, P401, DOI 10.2215/CJN.07650711; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Pavkov ME, 2012, CLIN J AM SOC NEPHRO, V7, P78, DOI 10.2215/CJN.07610711; Zhang LW, 2012, DIABETES RES CLIN PR, V96, P286, DOI 10.1016/j.diabres.2011.12.006; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Pencina Michael J, 2011, Stat Med, V30, P11, DOI 10.1002/sim.4085; Sharma SG, 2013, CLIN J AM SOC NEPHRO, V8, P1718, DOI 10.2215/CJN.02510213; Lorenzo V, 2010, NEPHROL DIAL TRANSPL, V25, P835, DOI 10.1093/ndt/gfp475; Keane WF, 2003, KIDNEY INT, V63, P1499, DOI 10.1046/j.1523-1755.2003.00885.x; Shimizu M, 2013, DIABETES CARE, V36, P3655, DOI 10.2337/dc13-0298; White KE, 2000, J AM SOC NEPHROL, V11, P1667; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; KDOQI, 2007, Am J Kidney Dis, V49, pS12; Mise K, 2014, NEPHROL DIAL TRANSPL, V29, P109, DOI 10.1093/ndt/gft349; Mise K, 2015, DIABETIC MED, V32, P546, DOI 10.1111/dme.12633; Mishra RK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000907; Okada T, 2012, NEPHROLOGY, V17, P68, DOI 10.1111/j.1440-1797.2011.01525.x; Yokoyama H, 2011, NEPHROL DIAL TRANSPL, V26, P2924, DOI 10.1093/ndt/gfq774; Yokoyama H, 2009, CLIN J AM SOC NEPHRO, V4, P1432, DOI 10.2215/CJN.06511208	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-7560			DIABETES-METAB RES	Diabetes-Metab. Res. Rev.	SEP	2015	31	6					572	581		10.1002/dmrr.2633		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CR2UD	WOS:000361185200004		
J	Yokoyama, H; Araki, S; Kawai, K; Hirao, K; Oishi, M; Sugimoto, K; Sone, H; Maegawa, H; Kashiwagi, A				Yokoyama, H.; Araki, S.; Kawai, K.; Hirao, K.; Oishi, M.; Sugimoto, K.; Sone, H.; Maegawa, H.; Kashiwagi, A.		Japan Diabet Clinical Data Managem	Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36)	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Pioglitazone; cardiovascular disease; mortality; type 2 diabetes; coronary heart disease; stroke; observational cohort	RANDOMIZED CONTROLLED-TRIAL; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; MACROVASCULAR EVENTS; MELLITUS; RISK; ADIPONECTIN; GLUCOSE; SAFETY	Aims: The protective association of pioglitazone with cardiovascular events and death was investigated over 6-years in large-scale type 2 diabetic subjects without established cardiovascular disease in a primary care setting. Methods: A six-year observational cohort study including 2864 subjects with type 2 diabetes without established cardiovascular disease was performed. The primary endpoint was a composite of first occurrence of cardiovascular disease or death. The effect of pioglitazone use at a baseline year with a Cox proportional hazard model and the time-dependent use in each one-year examination interval with a pooled logistic regression model were analyzed. Results: Baseline use of pioglitazone (n = 493) did not show a statistically protective effect on the primary endpoint (n = 175), although it tended to reduce the risk (adjusted hazard ratio 0.67 [95% CI: 0.43-1.05]). However, pooled logistic regression analysis indicated a significant protective association of pioglitazone with the primary endpoint (0.58 [0.38 to 0.87] and cardiovascular disease (0.54 [0.33-0.88]), independent of concurrent levels of blood glucose, blood pressure, lipids, albuminuria, and renal function. In particular, this protective association was observed in those with diabetic nephropathy regardless of the daily dose of pioglitazone. Among a total of 898 subjects who took pioglitazone during the period, 43% experienced a discontinuation at least once; however, serious adverse effects were rare. Conclusions: This observational study indicated a protective association of pioglitazone with cardiovascular disease and death in type 2 diabetic subjects without established vascular disease, particularly those with nephropathy. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Yokoyama, H.] Jiyugaoka Med Clin, Internal Med, Obihiro, Hokkaido, Japan; [Araki, S.; Maegawa, H.; Kashiwagi, A.] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Kawai, K.] Kawai Clin, Tsukuba, Ibaraki, Japan; [Hirao, K.] HEC Sci Clin, Yokohama, Kanagawa, Japan; [Oishi, M.] Oishi Clin, Kyoto, Japan; [Sugimoto, K.] Sugimoto Clin, Kitakyushu, Japan; [Sone, H.] Niigata Univ, Dept Internal Med, Fac Med, Niigata 95021, Japan	Yokoyama, H (reprint author), Jiyugaoka Med Clin, Internal Med, Obihiro, Hokkaido, Japan.	hiroki@m2.octv.ne.jp			Japan Diabetes Society	The JDDM cohort is supported by research programme grant funding from the Japan Diabetes Society.	Schulze MB, 2005, DIABETES, V54, P534; Pfutzner A, 2005, J AM COLL CARDIOL, V45, P1925, DOI 10.1016/j.jacc.2005.03.041; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Yokoyama H, 2011, DIABETIC MED, V28, P1221, DOI 10.1111/j.1464-5491.2011.03347.x; Barseghian A, 2011, J AM COLL CARDIOL, V57, P761, DOI 10.1016/j.jacc.2010.11.011; Subramanian V, 2010, CIRC RES, V107, P953, DOI 10.1161/CIRCRESAHA.110.219089; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Schernthaner G, 2013, DIABETES CARE, V36, pS155, DOI 10.2337/dcS13-2031; Derosa G, 2010, DRUGS, V70, P1945, DOI 10.2165/11538100-000000000-00000; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Kung J, 2012, EXPERT OPIN DRUG SAF, V11, P565, DOI 10.1517/14740338.2012.691963; Yokoyama H, 2006, STROKE, V37, P2420, DOI 10.1161/01.STR.0000236632.58323.cd; Ogasawara D, 2009, CIRC J, V73, P343; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Aso Y, 2009, DIABETES RES CLIN PR, V85, P147, DOI 10.1016/j.diabres.2009.05.015; Azoulay L, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3645; Betteridge DJ, 2005, DIABETOLOGIA, V48, P2477, DOI 10.1007/s00125-005-0034-1; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; DeFronzo RA, 2013, DIABETES CARE, V36, pS127, DOI 10.2337/dcS13-2011; Derosa G, 2009, DIABETES OBES METAB, V11; Erdmann E, 2014, DIABETES OBES METAB, V16, P63, DOI 10.1111/dom.12180; Gutierrez AD, 2012, ATHEROSCLEROSIS, V223, P204, DOI 10.1016/j.atherosclerosis.2012.04.016; Kaku K, 2009, CURR MED RES OPIN, V25, P2925, DOI 10.1185/03007990903328124; Kasliwal R, 2008, DRUG SAFETY, V31, P839, DOI 10.2165/00002018-200831100-00003; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Perez A, 2009, CURR MED RES OPIN, V25, P2915, DOI 10.1185/03007990903350011; Permana PA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1076, DOI 10.1152/ajpendo.91013.2008; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829; STEHOUWER CDA, 1992, LANCET, V340, P319, DOI 10.1016/0140-6736(92)91401-S; Tsuchiya K, 2009, ENDOCR J, V56, P691, DOI 10.1507/endocrj.K08E-308; Tzoulaki I, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4731; Yokoyama H, 2012, DIABETOLOGIA, V55, P1911, DOI 10.1007/s00125-012-2536-y; Yokoyama J, 2007, HEART VESSELS, V22, P146, DOI 10.1007/s00380-006-0951-z; Yoshii H, 2014, J ATHEROSCLER THROMB, V21, P563	40	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	SEP	2015	109	3					485	492		10.1016/j.diabres.2015.06.005		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ9BP	WOS:000360906200013		
J	Roughead, EE; Chan, EW; Choi, NK; Kimura, M; Kimura, T; Kubota, K; Lai, ECC; Man, KKC; Nguyen, TA; Ooba, N; Park, BJ; Sato, T; Shin, JY; Wang, TT; Griffiths, J; Wong, ICK; Yang, YHK; Pratt, NL				Roughead, Elizabeth E.; Chan, Esther W.; Choi, Nam-Kyong; Kimura, Michio; Kimura, Tomomi; Kubota, Kiyoshi; Lai, Edward Chia-Cheng; Man, Kenneth K. C.; Tuan Anh Nguyen; Ooba, Nobuhiro; Park, Byung-Joo; Sato, Tsugumichi; Shin, Ju-Young; Wang, TongTong; Griffiths, Jenna; Wong, Ian C. K.; Yang, Yea-Huei Kao; Pratt, Nicole L.			Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries	DRUG SAFETY			English	Article							SEQUENCE SYMMETRY ANALYSIS; TYPE-2 DIABETES-MELLITUS; PRO12ALA POLYMORPHISM; PPAR-GAMMA; IN-VITRO; PIOGLITAZONE; METAANALYSIS; ROSIGLITAZONE; CYP2C8; INDIVIDUALS	Introduction The prevalence of polymorphisms among the metabolising enzymes and pharmacodynamic receptors relevant for the thiazolidinediones differs by ethnic group, a factor that may modify risk of adverse drug events. ObjectiveThe aim of the study was to determine if the risk of oedema or heart failure associated with the thiazolidinediones varies in populations in Australia, Canada, Hong Kong, Japan, Korea and Taiwan. Methods Sequence symmetry analyses were undertaken to investigate the risk of peripheral oedema, as measured by incident furosemide dispensing, and risk of hospitalisations for heart failure. Results were pooled, with Australia and Canada representing predominantly Caucasian population and all other countries contributing to Asian population estimates. Results Pooled estimates of risk for furosemide initiation in the Caucasian populations were significantly increased for pioglitazone [adjusted sequence ratio (ASR) 1.47; 95 % confidence interval (CI) 1.14-1.91] and rosiglitazone (ASR 1.65; 95 % CI 1.58-1.72), while in the Asian populations, the pooled risk estimates were lower (ASR 1.11; 95 % CI 0.93-1.32 and ASR 1.21; 95 % CI 1.01-1.45 for pioglitazone and rosiglitazone, respectively). Results for hospitalisation for heart failure showed a similar trend, with elevated risk in the Australian data (ASR 1.88; 95 % CI 1.01-3.5 and ASR 1.25; 95 % CI 0.76-2.05 for pioglitazone and rosiglitazone, respectively), while no increased risk was found in the pooled results for the Asian populations. Conclusion The risk of both oedema and heart failure with thiazolidinediones was higher in predominantly Caucasian countries than in the Asian countries assessed. Assessment of adverse events by ethnicity may support safer medicine use.	[Roughead, Elizabeth E.; Tuan Anh Nguyen; Pratt, Nicole L.] Univ S Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Qual Use Med & Pharm Res Ctr, Adelaide, SA 5001, Australia; [Chan, Esther W.; Man, Kenneth K. C.; Wong, Ian C. K.] Univ Hong Kong, Dept Pharmacol & Pharm, Ctr Safe Med Practice & Res, Pokfulam, Hong Kong, Peoples R China; [Choi, Nam-Kyong] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Med Res Collaborating Ctr, Seoul, South Korea; [Kimura, Michio; Kimura, Tomomi] Hamamatsu Univ, Sch Med, Dept Med Informat, Shizuoka, Japan; [Kubota, Kiyoshi; Ooba, Nobuhiro; Sato, Tsugumichi] Univ Tokyo, Grad Sch Med, Dept Pharmacoepidemiol, Tokyo, Japan; [Lai, Edward Chia-Cheng; Yang, Yea-Huei Kao] Natl Cheng Kung Univ, Hlth Outcome Res Ctr, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Park, Byung-Joo] Seoul Natl Univ, Coll Med, Dept Preventat Med, Seoul, South Korea; [Park, Byung-Joo; Shin, Ju-Young] Korea Inst Drug Safety & Risk Management, Seoul, South Korea; [Wang, TongTong; Griffiths, Jenna] Hlth Canada, Hlth Prod & Food Branch, Marketed Hlth Prod Directorate, Ottawa, ON K1A 0L2, Canada	Nguyen, TA (reprint author), Univ S Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Qual Use Med & Pharm Res Ctr, Adelaide, SA 5001, Australia.	Tuan.Nguyen@unisa.edu.au		Choi, Nam-Kyong/0000-0003-1153-9928	Australian Government National Health and Medical Research Council Centre of Research Excellence in Post-Marketing Surveillance of Medicines and Medical Devices Grant [GNT1040938]	The preparation of this manuscript was funded by an Australian Government National Health and Medical Research Council Centre of Research Excellence in Post-Marketing Surveillance of Medicines and Medical Devices Grant (GNT1040938), and the work was independent of the funding source.	Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Kirchheiner J, 2005, CLIN PHARMACOKINET, V44, P1209, DOI 10.2165/00003088-200544120-00002; Tonjes A, 2006, DIABETES CARE, V29, P2489, DOI 10.2337/dc06-0513; Chen X, 2012, CHINESE MED J-PEKING, V125, P4301, DOI 10.3760/cma.j.issn.0366-6999.2012.23.025; Garcia-Martin E, 2006, MOL DIAGN THER, V10, P29; Tornio A, 2008, DRUG METAB DISPOS, V36, P73, DOI 10.1124/dmd.107.018010; Man M, 2010, J CLIN PHARMACOL, V50, P929, DOI 10.1177/0091270009355161; Tsiropoulos I, 2009, PHARMACOEPIDEM DR S, V18, P483, DOI 10.1002/pds.1736; Mannucci E, 2010, INT J CARDIOL, V143, P135, DOI 10.1016/j.ijcard.2009.01.064; Baldwin SJ, 1999, BRIT J CLIN PHARMACO, V48, P424; Hallas J, 1996, EPIDEMIOLOGY, V7, P478, DOI 10.1097/00001648-199609000-00004; [Anonymous], 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000259.PUB2; Yeo CW, 2011, DRUG METAB DISPOS, V39, P711, DOI 10.1124/dmd.110.035899; Pratt N, 2013, PHARMACOEPIDEM DR S, V22, P915, DOI 10.1002/pds.3440; Kung J, 2012, EXPERT OPIN DRUG SAF, V11, P565, DOI 10.1517/14740338.2012.691963; Andersen M, 2013, PHARMACOEPIDEM DR S, V22, P700, DOI 10.1002/pds.3439; Frederiksen L, 2002, J CLIN ENDOCR METAB, V87, P3989, DOI 10.1210/jc.87.8.3989; Gouda HN, 2010, AM J EPIDEMIOL, V171, P645, DOI 10.1093/aje/kwp450; Hernandez AV, 2011, AM J CARDIOVASC DRUG, V11, P115, DOI 10.2165/11587580-000000000-00000; Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1136/BMJ.D5928; Jaakkola T, 2006, BASIC CLIN PHARMACOL, V99, P44, DOI 10.1111/j.1742-7843.2006.pto_437.x; Li Z, 2008, DIABETES OBES METAB, V10, P794, DOI 10.1111/j.1463-1326.2008.00905.x; Loke YK, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1309; Martis S, 2013, PHARMACOGENOMICS J, V13, P369, DOI 10.1038/tpj.2012.10; Mori H, 2001, DIABETES, V50, P891, DOI 10.2337/diabetes.50.4.891; Pratt NL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-66; Sun H, 2008, BRIT J CLIN PHARMACO, V65, P917, DOI 10.1111/j.1365-2125.2008.03145.x; Wahab IA, 2013, PHARMACOEPIDEM DR S, V2, P140, DOI [10.4172/2167-1052.1000140, DOI 10.4172/2167-1052.1000140]; Wahab IA, 2014, DRUG SAFETY, V37, P53, DOI 10.1007/s40264-013-0124-9; Wahab IA, 2013, PHARMACOEPIDEM DR S, V22, P496, DOI 10.1002/pds.3417; WHO collaborating centre for drug statistics methodology, 2011, ATC STRUCT PRINC; World Health Organization, 2002, INTERNATIONAL STATIS; Zhou K, 2010, DIABETOLOGIA, V53, pS133	33	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.	SEP	2015	38	9					823	831		10.1007/s40264-015-0318-4		9	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	CQ9ME	WOS:000360938200007		
J	Ogawa, Y; Ono, Y				Ogawa, Yoshitomo; Ono, Yoshiyasu			Partial Replacement of Protective Tariffs by Production Subsidies and Welfare	ECONOMIC RECORD			English	Article							DOMESTIC DISTORTIONS; OPTIMUM SUBSIDY; TRADE; TERMS; COUNTRY	Using a two-country framework, this paper examines the welfare effect of partially replacing a tariff with a production subsidy. It considers some plausible situations for industry protection, including where the initial tariff is higher than the optimal tariff, where a certain output of the protected commodity must be maintained, and where domestic production of the sector yields some externalities. In these cases it is shown that the partial replacement benefits the country. Properties of the optimal replacement are also explored.	[Ogawa, Yoshitomo] Kinki Univ, Fac Econ, Higashiosaka, Osaka 5778502, Japan; [Ono, Yoshiyasu] Osaka Univ, Inst Social & Econ Res, Ibaraki, Osaka, Japan	Ogawa, Y (reprint author), Kinki Univ, Fac Econ, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	ogawa@eco.kindai.ac.jp					Syropoulos C, 2002, REV ECON STUD, V69, P707, DOI 10.1111/1467-937X.t01-1-00028; MARKUSEN JR, 1975, J INT ECON, V5, P15, DOI 10.1016/0022-1996(75)90025-2; BHAGWATI J, 1969, J POLIT ECON, V77, P1005, DOI 10.1086/259587; Bhagwati J. N., 1971, TRADE BALANCE PAYMEN, P69; BHAGWATI J, 1963, J POLIT ECON, V71, P44, DOI 10.1086/258733; BOND EW, 1990, INT ECON REV, V31, P103, DOI 10.2307/2526631; CORDEN WM, 1957, ECONOMICA, V24, P235, DOI 10.2307/2551696; Graaff JD, 1949, REV ECON STUD, V17, P47; HATTA T, 1977, REV ECON STUD, V44, P1, DOI 10.2307/2296969; Johnson HG, 1951, REV ECON STUD, V19, P28, DOI 10.2307/2296268; Kaldor N, 1940, ECONOMICA-NEW SER, V7, P377, DOI 10.2307/2550231; KEMP MC, 1967, ECON REC, V43, P395, DOI 10.1111/j.1475-4932.1967.tb00074.x; KENNAN J, 1988, INT ECON REV, V29, P81, DOI 10.2307/2526808; Lahiri S, 1999, CAN J ECON, V32, P55, DOI 10.2307/136395; LAHIRI S, 1989, ECON REC, V65, P27, DOI 10.1111/j.1475-4932.1989.tb00675.x; NEARY JP, 1995, INT ECON REV, V36, P531, DOI 10.2307/2527359; OECD, 2010, AGR POL OECD COUNTR; Ogawa Y, 2007, ECON THEOR, V33, P271, DOI 10.1007/s00199-006-0143-1; Ogawa Y, 2012, ECON THEOR, V51, P139, DOI 10.1007/s00199-010-0599-x; Syropoulos C, 2002, ECON J, V112, P625, DOI 10.1111/1468-0297.00733	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-0249	1475-4932		ECON REC	Econ. Rec.	SEP	2015	91	294					300	308		10.1111/1475-4932.12192		9	Economics	Business & Economics	CR0TZ	WOS:000361037400002		
J	Cato, S; Matsumura, T				Cato, Susumu; Matsumura, Toshihiro			Optimal Privatisation and Trade Policies with Endogenous Market Structure	ECONOMIC RECORD			English	Article							FOREIGN DIRECT-INVESTMENT; MIXED DUOPOLY APPROACH; FREE ENTRY; STRATEGIC PRIVATIZATION; IMPERFECT COMPETITION; OLIGOPOLY; FIRMS; TAXATION; ENTERPRISES; PENETRATION	This study investigates the short-run and long-run relationships of trade and privatisation policies. In both the short run and the long run, the optimal degree of privatisation is increasing in the import tariff rate. The optimal tariff rate is strictly positive in the short run but can be non-positive in the long run. Thus, the long-run analysis yields contrasting implications on trade policy in mixed oligopolies.	[Cato, Susumu; Matsumura, Toshihiro] Univ Tokyo, Inst Social Sci, Bunkyo Ku, Tokyo 1130033, Japan	Cato, S (reprint author), Univ Tokyo, Inst Social Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	susumu.cato@gmail.com	Matsumura, Toshihiro/F-3997-2010	Matsumura, Toshihiro/0000-0003-0572-6516	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Murata Science Foundation [26870477, 15k03347]	We thank Jeffrey Sheen and two anonymous referees of this journal for their constructive comments. This paper was financially supported by a Grant-in-Aid for Young Scientists (B) and Basic Research (C) from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology and from the Murata Science Foundation (Grant number: 26870477 and 15k03347).	Han L, 2008, FINANZARCHIV, V64, P352, DOI 10.1628/001522108X374179; Cato S, 2012, J INST THEOR ECON, V168, P444; Davidson C, 2007, INT J IND ORGAN, V25, P157, DOI 10.1016/j.ijindorg.2006.03.003; Matsumura T, 2004, ECONOMICA, V71, P671, DOI 10.1111/j.0013-0427.2004.00394.x; Pal D, 1998, SOUTHERN ECON J, V65, P264, DOI 10.2307/1060667; Matsumura T, 2005, J ECON, V84, P27, DOI 10.1007/s00712-004-0098-z; Anderson SP, 1997, EUR ECON REV, V41, P1635, DOI 10.1016/S0014-2921(97)00086-X; Wang LFS, 2013, ECON MODEL, V30, P729, DOI 10.1016/j.econmod.2012.11.007; Lahiri S, 1998, ECON J, V108, P444, DOI 10.1111/1468-0297.00297; Ogawa H, 2007, AUST ECON PAP, V46, P191, DOI 10.1111/j.1467-8454.2007.00313.x; Ino H, 2010, J ECON, V101, P213, DOI 10.1007/s00712-010-0153-0; Fujiwara K, 2007, J ECON, V92, P51, DOI 10.1007/s00712-007-0267-1; Matsumura T, 2010, MANCH SCH, V78, P609, DOI 10.1111/j.1467-9957.2009.02147.x; Ino H, 2012, INT ECON REV, V53, P1323, DOI 10.1111/j.1468-2354.2012.00722.x; Cato S, 2013, FINANZARCHIV, V69, P215, DOI 10.1628/001522113X666944; Mukherjee A, 2009, EUR ECON REV, V53, P775, DOI 10.1016/j.euroecorev.2009.02.004; BRANDER JA, 1985, J INT ECON, V18, P83, DOI 10.1016/0022-1996(85)90006-6; VENABLES AJ, 1987, ECON J, V97, P700, DOI 10.2307/2232931; Wang LFS, 2010, J ECON, V100, P33, DOI 10.1007/s00712-010-0117-4; Barcena-Ruiz JC, 2005, REV DEV ECON, V9, P502, DOI 10.1111/j.1467-9361.2005.00290.x; Barcena-Ruiz Juan Carlos, 2005, EUROPEAN J POLITICAL, V21, P247, DOI 10.1016/j.ejpoleco.2004.02.008; BESLEY T, 1989, J PUBLIC ECON, V40, P359, DOI 10.1016/0047-2727(89)90048-0; Brandao A, 2007, J ECON, V92, P263, DOI 10.1007/s00712-007-0286-y; Chang W. W., 2005, J INT TRADE ECON DEV, V14, P19, DOI 10.1080/0963819042000333234; Chao C. C., 2006, REV INT ECON, V14, P87, DOI 10.1111/j.1467-9396.2006.00562.x; Corneo Giacomo, 1994, ANN EC STAT, V33, P73; De Santis RA, 2004, J INT ECON, V64, P545, DOI 10.1016/j.jinteco.2003.08.008; Etro F., 2014, SCANDINAVIA IN PRESS, DOI [10.1111/sjoe.12084, DOI 10.1111/SJOE.12084]; Etro F, 2011, INT ECON REV, V52, P63, DOI 10.1111/j.1468-2354.2010.00619.x; Etro F, 2014, ECON REC, V90, P282, DOI 10.1111/1475-4932.12108; Etro F., 2007, COMPETITION INNOVATI; Fjell K, 1996, CAN J ECON, V29, P737, DOI 10.2307/136260; Ghosh A, 2012, J PUBLIC ECON THEORY, V14, P441, DOI 10.1111/j.1467-9779.2012.01546.x; Han L., 2007, E073 NAG U EC RES CT; HORSTMANN IJ, 1986, J INT ECON, V20, P225, DOI 10.1016/0022-1996(86)90020-6; LAHIRI S, 1995, INT ECON REV, V36, P609, DOI 10.2307/2527363; Lin MH, 2012, J ECON, V107, P71, DOI 10.1007/s00712-011-0254-4; Long N. V., 2009, CANADIAN J EC, V42, P590; Marjit S, 2008, REV INT ECON, V16, P1010, DOI 10.1111/j.1467-9396.2008.00764.x; Matsumura T, 2013, CAN J ECON, V46, P526, DOI 10.1111/caje.12022; Matsumura T, 1998, J PUBLIC ECON, V70, P473, DOI 10.1016/S0047-2727(98)00051-6; Matsumura T, 2009, J ECON, V98, P203, DOI 10.1007/s00712-009-0091-x; MERRILL WC, 1966, Q J ECON, V80, P400, DOI 10.2307/1880727; Pigou A.C., 1920, EC WELFARE; Saha B., 2013, J PUBLIC EC IN PRESS; SERTEL MR, 1988, J ECON, V48, P111, DOI 10.1007/BF01234606; Wen M, 2001, ECON REC, V77, P283, DOI 10.1111/1475-4932.t01-1-00023	47	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-0249	1475-4932		ECON REC	Econ. Rec.	SEP	2015	91	294					309	323		10.1111/1475-4932.12189		15	Economics	Business & Economics	CR0TZ	WOS:000361037400003		
J	Isobe, T; Sato, K; Joon-Woo, K; Tanabe, S; Suzuki, G; Nakayama, K				Isobe, Tomohiko; Sato, Kentaro; Joon-Woo, Kim; Tanabe, Shinsuke; Suzuki, Go; Nakayama, Kei			Determination of natural and synthetic glucocorticoids in effluent of sewage treatment plants using ultrahigh performance liquid chromatography-tandem mass spectrometry	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Glucocorticoids; Cortisol; Dexamethasone; Betamethasone; Betamethasone valerate; Prednisolone; Effluent of sewage treatment plant; LC-MS/MS	RIVER WATERS	A sensitive and comprehensive analytical method for glucocorticoids (GCs) in water samples was developed and applied to effluent of sewage treatment plants (STPs). In the present study, totally 10 natural and synthetic GCs, including cortisol, betamethasone valerate, clobetasol propionate, clobetasone butyrate, difluprednate, betamethasone, dexamethasone, betamethasone dipropionate, methylprednisolone, and prednisolone, were targeted. Analytes were extracted and concentrated using an OASIS HLB solid phase extraction cartridge. Chromatographic separation and quantification were achieved using an ultrahigh performance liquid chromatograph coupled with a tandem mass spectrometer (UHPLC-MS/MS). Method detection limits were 0.05 to 0.89 ng/L, which were 1-2 orders of magnitude more sensitive than in the previous reports. Cortisol was detected in more than half of (27 out of 50) analyzed effluent samples at concentrations in the range of ND-1.36 ng/L, indicating continuous discharge of natural GC via STP effluent. On the other hand, dexamethasone + betamethasone, prednisolone, betamethasone valerate, and clobetasol propionate were detected in 25, 8, 20, and 9 samples among 50 effluent samples, respectively, suggesting not extreme but significant administration of synthetic GCs.	[Isobe, Tomohiko] Natl Inst Environm Studies, Ctr Environm Hlth Sci, Tsukuba, Ibaraki 3058506, Japan; [Isobe, Tomohiko; Sato, Kentaro; Tanabe, Shinsuke; Nakayama, Kei] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan; [Joon-Woo, Kim] Natl Inst Environm Res, Monitoring & Anal Div, Seamangeum Reg Environm Off, Sejong Si, South Korea; [Suzuki, Go] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki 3058506, Japan	Isobe, T (reprint author), Natl Inst Environm Studies, Ctr Environm Hlth Sci, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	isobe.tomohiko@nies.go.jp	Nakayama, Kei/F-3269-2015; Tanabe, Shinsuke/G-6950-2013; 	Nakayama, Kei/0000-0002-0247-757X; Kim, Joon-Woo/0000-0001-6417-864X	Ministry of the Environment of Japan [5ZRFc-1201]; Japanese Ministry of Education, Science, Sports, Culture and Technology (MEXT) [25257403, 25241013, 25281008]; Japan Society for the Promotion of Science (JSPS)	Financial support was provided by grant under the framework of the EXTEND2010 and Environment Research and Technology Development Fund (5ZRFc-1201) from the Ministry of the Environment of Japan and Grants-in-Aid for Scientific Research (A: 25257403, A: 25241013, B: 25281008, Challenging Exploratory Research: 24651010) of the Japanese Ministry of Education, Science, Sports, Culture and Technology (MEXT) and Japan Society for the Promotion of Science (JSPS).	Isobe T, 2007, MAR POLLUT BULL, V54, P1139, DOI 10.1016/j.marpolbul.2007.04.017; Tomy GT, 2005, RAPID COMMUN MASS SP, V19, P2819, DOI 10.1002/rcm.2129; Kugathas S, 2013, ENVIRON SCI TECHNOL, V47, P9487, DOI 10.1021/es4019332; Schriks M, 2010, ENVIRON SCI TECHNOL, V44, P4766, DOI 10.1021/es100013x; Kugathas S, 2011, ENVIRON SCI TECHNOL, V45, P2377, DOI 10.1021/es104105e; Liu S, 2012, J ENVIRON MONITOR, V14, P482, DOI 10.1039/c1em10783f; Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y; Chang H, 2007, ENVIRON SCI TECHNOL, V41, P3462, DOI 10.1021/es062746o; LaLone CA, 2012, ENVIRON TOXICOL CHEM, V31, P611, DOI 10.1002/etc.1729; Herrero P, 2012, J CHROMATOGR A, V1224, P19, DOI 10.1016/j.chroma.2011.12.054; Health Policy Bureau MoH, 2012, ANN REP STAT PROD PH; Kitaichi Y, 2010, J HEALTH SCI, V56, P547, DOI 10.1248/jhs.56.547; Nakayama K, 2014, MAR POLLUT BULL, V85, P370, DOI 10.1016/j.marpolbul.2014.01.042; Public Works Research Institute, 2011, FY2010 ANN REP WAST	14	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	SEP	2015	22	18					14127	14135		10.1007/s11356-015-4626-0		9	Environmental Sciences	Environmental Sciences & Ecology	CQ8GI	WOS:000360844200046		
J	Fukushi, K; Fukiage, T				Fukushi, Keisuke; Fukiage, Tomo			Prediction of Intrinsic Cesium Desorption from Na-Smectite in Mixed Cation Solutions	ENVIRONMENTAL SCIENCE & TECHNOLOGY			English	Article							CLAY-MINERALS; IONIC-STRENGTH; MONTMORILLONITE; DIFFUSION; CS; ADSORPTION; EXCHANGE; SORPTION; SIZE; BENTONITE	Quantitative understanding of the stability of sorbed radionuclides in smectite is necessary to assess the performance of engineering barriers used for nuclear waste disposal. Our previous study demonstrated that the spatial organization of the smectite platelets triggered by the divalent cations led to the apparent fixation of intrinsic Cs in smectite, because some Cs is retained inside the formed tactoids. Natural water is usually a mixture of Na+ and divalent cations (Ca2+ and Mg2+). This study therefore investigated the desorption behavior of intrinsic Cs in Na-smecite in mixed Na+-divalent cation solutions under widely various cation concentrations using batch experiments, grain size measurements, and cation exchange modeling (CEM). Results show that increased Na+ concentrations facilitate Cs desorption because Na+ serves as the dispersion agent. A linear relation was obtained between the logarithm of the Na+ fraction and the accessible Cs fraction in smectite. That relation enables the prediction of accessible Cs fraction as a function of solution cationic compositions. The corrected CEM considering the effects of the spatial organization suggests that the stability of intrinsic Cs in the smectite is governed by the Na+ concentration, and suggests that it is almost independent of the concentrations of divalent cations in natural water.	[Fukushi, Keisuke] Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan; [Fukiage, Tomo] Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kanazawa, Ishikawa 9201192, Japan	Fukushi, K (reprint author), Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan.	fukushi@staff.kanazawa-u.ac.jp			Japan Society for the Promotion of Science [25110506]	We greatly appreciate K. Asahi and T. Ushiyama for experimental support and S. Arai and A Tamura for support during the use of ICP-MS. Discussions with Y. Aoi, H. Ito, T. Kashiwabara, T. Kozaki, H. Sakai, and Y. Tachi are also greatly appreciated. The manuscript benefited from comments from the Associate Editor and three anonymous reviewers. Financial support was provided to K.F. by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 25110506).	Longerich HP, 1996, J ANAL ATOM SPECTROM, V11, P899, DOI 10.1039/ja9961100899; Bourg IC, 2010, ENVIRON SCI TECHNOL, V44, P2085, DOI 10.1021/es903645a; OHNUKI T, 1994, RADIOCHIM ACTA, V66-7, P327; Segad M, 2010, LANGMUIR, V26, P5782, DOI 10.1021/la9036293; Segad M, 2012, J PHYS CHEM C, V116, P25425, DOI 10.1021/jp3094929; GAINES GL, 1953, J CHEM PHYS, V21, P714, DOI 10.1063/1.1698996; Bostick BC, 2002, ENVIRON SCI TECHNOL, V36, P2670, DOI 10.1021/es0156892; Iwatsuki T, 2015, ENVIRON EARTH SCI, V74, P3041, DOI 10.1007/s12665-015-4337-3; JARVIS KE, 1993, CHEM GEOL, V106, P251, DOI 10.1016/0009-2541(93)90030-M; Gates WP, 2009, ELEMENTS, V5, P105, DOI 10.2113/gselements.5.2.105; Beuselinck L, 1998, CATENA, V32, P193, DOI 10.1016/S0341-8162(98)00051-4; Gaucher EC, 2006, WASTE MANAGE, V26, P776, DOI 10.1016/j.wasman.2006.01.027; VERBURG K, 1994, CLAY CLAY MINER, V42, P207, DOI 10.1346/CCMN.1994.0420211; SCHRAMM LL, 1982, CLAY CLAY MINER, V30, P40, DOI 10.1346/CCMN.1982.0300105; Staunton S, 1997, CLAY CLAY MINER, V45, P251, DOI 10.1346/CCMN.1997.0450213; Whitley HD, 2004, J CHEM PHYS, V120, P5387, DOI 10.1063/1.1648013; Kim Y, 1996, GEOCHIM COSMOCHIM AC, V60, P1041, DOI 10.1016/0016-7037(95)00452-1; Appelo C.A.J., 2005, GEOCHEMISTRY GROUNDW; Bethke C. M., 1998, GEOCHEMISTS WORKBENC; Bourg IC, 2008, APPL GEOCHEM, V23, P3635, DOI 10.1016/j.apgeochem.2008.09.004; Carabante I, 2009, COLLOID SURFACE A, V346, P106, DOI 10.1016/j.colsurfa.2009.05.032; Chen Z, 2014, CHEM GEOL, V387, P47, DOI 10.1016/j.chemgeo.2014.08.008; Coppin F, 2003, GEOCHIM COSMOCHIM AC, V67, P2515, DOI 10.1016/S0016-7037(03)00078-4; Drever J.I., 1997, GEOCHEMISTRY NATURAL; Fukushi K, 2014, ENVIRON SCI TECHNOL, V48, P10743, DOI 10.1021/es502758s; Iijima K, 2010, APPL CLAY SCI, V49, P262; Kozaki T, 2010, PHYS CHEM EARTH, V35, P254, DOI 10.1016/j.pce.2010.04.006; Kozaki T, 1999, ENG GEOL, V54, P223, DOI 10.1016/S0013-7952(99)00077-0; Liu XD, 2008, GEOCHIM COSMOCHIM AC, V72, P1837, DOI 10.1016/j.gca.2008.01.028; Missana T, 2014, GEOCHIM COSMOCHIM AC, V128, P266, DOI 10.1016/j.gca.2013.10.007; Nakano M, 2003, APPL CLAY SCI, V23, P15, DOI 10.1016/S0169-1317(03)00082-6; Pais L., 1997, HDB TRACE ELEMENTS; SHOMER I, 1978, CLAY CLAY MINER, V26, P135, DOI 10.1346/CCMN.1978.0260208; Tachi Y, 2014, GEOCHIM COSMOCHIM AC, V132, P75, DOI 10.1016/j.gca.2014.02.004; Tertre E, 2015, GEOCHIM COSMOCHIM AC, V149, P251, DOI 10.1016/j.gca.2014.10.011; Tournassat C, 2011, J COLLOID INTERF SCI, V364, P443, DOI 10.1016/j.jcis.2011.07.039; WANNER H, 1996, ANAL BIOANAL CHEM, V354, P763, DOI 10.1007/s0021663540763; Yoshida N, 2012, ELEMENTS, V8, P201, DOI 10.2113/gselements.8.3.201; Yui M, 2004, GEOCHEM J, V38, P33	39	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0013-936X	1520-5851		ENVIRON SCI TECHNOL	Environ. Sci. Technol.	SEP 1	2015	49	17					10398	10405		10.1021/acs.est.5b01884		8	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CQ7HM	WOS:000360773600016		
J	Letu, H; Hara, M; Tana, G; Bao, YH; Nishio, F				Letu, Husi; Hara, Masanao; Tana, Gegen; Bao, Yuhai; Nishio, Fumihiko			Generating the Nighttime Light of the Human Settlements by Identifying Periodic Components from DMSP/OLS Satellite Imagery	ENVIRONMENTAL SCIENCE & TECHNOLOGY			English	Article							OPERATIONAL LINESCAN SYSTEM; SPATIAL-ANALYSIS; ELECTRIC-POWER; CO2 EMISSIONS; POPULATION; CONSUMPTION; POLLUTION; DYNAMICS	Nighttime lights of the human settlements (hereafter, "stable lights") are seen as a valuable proxy of social economic activity and greenhouse gas emissions at the subnational level. In this study, we propose an improved method to generate the stable lights from Defense Meteorological Satellite Program/Operational Linescan System (DMSP/OLS) daily nighttime light data for 1999. The study area includes Japan, China, India, and other 10 countries in East Asia. A noise reduction filter (NRF) was employed to generate a stable light from DMSP/OLS time-series daily nighttime light data. It was found that noise from amplitude of the 1-year periodic component is included in the stable light. To remove the amplitude of the 1-year periodic component noise included in the stable light, the NRF method was improved to extract the periodic component. Then, new stable light was generated by removing the amplitude of the 1-year periodic component using the improved NRF method. The resulting stable light was evaluated by comparing it with the conventional nighttime stable light provided by the National Oceanic and Atmosphere Administration/National Geophysical Data Center (NOAA/NGDC). It is indicated that DNs of the NOAA stable light image are lower than those of the new stable light image. This might be attributable to the influence of attenuation effects from thin warm water clouds. However, due to overglow effect of the thin cloud, light area in new stable light is larger than NOAA. stable light. Furthermore, the cumulative digital numbers (CDNs) and number of light area pixels (NLAP) of the generated stable light and NOAA/NGDC stable light were applied to estimate socioeconomic variables of population, electric power consumption, gross domestic product, and CO2 emissions from fossil fuel consumption. It is shown that the correlations of the population and CO2FF with new stable light data are higher than those in NOAA stable light data; correlations of the EPC and GDP with NOAA stable light data are higher those in the new stable light data.	[Letu, Husi] Tokai Univ, Res & Informat Cen, Shibuya Ku, Tokyo 1510063, Japan; [Hara, Masanao] VisionTech Inc, VTI Res Inst, Tsukuba, Ibaraki 3050045, Japan; [Tana, Gegen; Nishio, Fumihiko] Chiba Univ, Ctr Environm Remote Sensing CEReS, Inage Ku, Chiba 2638522, Japan; [Letu, Husi; Bao, Yuhai; Nishio, Fumihiko] Inner Mongolia Normal Univ, Remote Sensing & GIS Key Lab, Hohhot 010022, Peoples R China	Letu, H (reprint author), Tokai Univ, Res & Informat Cen, Shibuya Ku, 2-28-4 Tomigawa, Tokyo 1510063, Japan.	husiletuw@hotmail.com			National Natural Science Foundation of China [61261030]	The authors thank the Satellite Image Database System (SIDaB) of the Ministry of Agriculture, Forestry and Fisheries Agriculture Information Resources System (AGROPEDIA) of Japan and National Oceanic and Atmosphere Administration/National Geophysical Data Center (NOAA/NGDC) for providing DMSP/OLS daily nighttime light data and stable light product. This study was supported by National Natural Science Foundation of China (61261030).	Amaral S., 2005, COMPUTERS ENV URBAN, V29, P179, DOI DOI 10.1016/J.COMPENVURBSYS.2003.09.004; Chalkias C, 2006, J ENVIRON MANAGE, V79, P57, DOI 10.1016/j.jenvman.2005.05.015; Huang QX, 2015, LANDSCAPE URBAN PLAN, V137, P138, DOI 10.1016/j.landurbplan.2015.01.004; Ghosh T, 2010, ENERGIES, V3, P1895, DOI 10.3390/en3121895; Elvidge CD, 2001, ISPRS J PHOTOGRAMM, V56, P81, DOI 10.1016/S0924-2716(01)00040-5; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/Bams-83-11-1631, 10.1175/BAMS-83-11-1631]; Kuechly HU, 2012, REMOTE SENS ENVIRON, V126, P39, DOI 10.1016/j.rse.2012.08.008; Small C, 2011, REMOTE SENS ENVIRON, V115, P269, DOI 10.1016/j.rse.2010.08.021; Zhao N, 2011, ECOL ECON, V70, P921, DOI 10.1016/j.ecolecon.2010.12.023; Oda T, 2011, ATMOS CHEM PHYS, V11, P543, DOI 10.5194/acp-11-543-2011; Raupach MR, 2010, ENERG POLICY, V38, P4756, DOI 10.1016/j.enpol.2009.08.021; Doll CNH, 2010, ENERG POLICY, V38, P5661, DOI 10.1016/j.enpol.2010.05.014; Letu H, 2010, INT J REMOTE SENS, V31, P4443, DOI 10.1080/01431160903277464; Elvidge CD, 1997, PHOTOGRAMM ENG REM S, V63, P727; Elvidge CD, 1997, INT J REMOTE SENS, V18, P1373, DOI 10.1080/014311697218485; Baugh K., 2010, P 30 AS PAC ADV NETW, P114; Briggs DJ, 2007, REMOTE SENS ENVIRON, V108, P451, DOI 10.1016/j.rse.2006.11.020; Doll CNH, 2000, AMBIO, V29, P157, DOI 10.1639/0044-7447(2000)029[0157:NTIAAT]2.0.CO;2; Ghosh T., 2010, OPEN GEOGRAPHY J, V3, P147, DOI DOI 10.2174/1874923201003010147; Ghosh T., 2010, THESIS CTR ENV SOCIA; Hara M., 2010, INT J REMOTE SENS EA, V1, P31; Hara M., 2003, JAPAN SOC PHOTOGRAMM, V42, P48; Letu H, 2014, ENVIRON SCI TECH LET, V1, P259, DOI 10.1021/ez500093s; Levin N, 2014, REMOTE SENS ENVIRON, V149, P1, DOI 10.1016/j.rse.2014.03.019; Small C, 2005, REMOTE SENS ENVIRON, V96, P277, DOI 10.1016/j.rse.2005.02.002; Sutton P, 2001, INT J REMOTE SENS, V22, P3061, DOI 10.1080/01431160010007015; Sutton PC, 2010, REMOTE SENS DIGIT IM, V10, P329, DOI 10.1007/978-1-4020-4385-7_17; Zhang QL, 2011, REMOTE SENS ENVIRON, V115, P2320, DOI 10.1016/j.rse.2011.04.032	28	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0013-936X	1520-5851		ENVIRON SCI TECHNOL	Environ. Sci. Technol.	SEP 1	2015	49	17					10503	10509		10.1021/acs.est.5b02471		7	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CQ7HM	WOS:000360773600028		
J	Imatoh, T; Kamimura, S; Miyazaki, M				Imatoh, T.; Kamimura, S.; Miyazaki, M.			Coffee but not green tea consumption is associated with prevalence and severity of hepatic steatosis: the impact on leptin level	EUROPEAN JOURNAL OF CLINICAL NUTRITION			English	Article							FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; INFLAMMATION; MICE; CAFFEINE; DRINKING; STEATOHEPATITIS; ACCUMULATION; METAANALYSIS; EXPRESSION	BACKGROUND/OBJECTIVES: Most of the studies that have investigated the association between coffee consumption and hepatic steatosis have been experimental and small-scale clinical studies. As a result, epidemiological studies are scarce. To clear the association, we conducted a cross-sectional study and investigated the effects of coffee consumption with those of green tea consumption. SUBJECTS/METHODS: We analyzed 1024 Japanese male workers. The diagnosis of hepatic steatosis was based on ultrasonography. We divided coffee and green tea consumption into the following three categories: non-drinker; 1-2 cups/day and >= 3 cups/day. To investigate the association between hepatic steatosis and coffee or green tea consumption, we calculated the odds ratio (OR) and adjusted the means of leptin levels on each severity of hepatic steatosis. RESULTS: A total of 265 of our subjects (25.9%) were diagnosed with hepatic steatosis. The ORs of the group of subjects who drank >3 cups of coffee/day was significantly lower compared with that of the noncoffee drinker group (OR 0.59, 95% confidence intervals 0.38-0.90, P = 0.03). Although there was a significant difference between coffee consumption and leptin level only in the asymptomatic group, we found a decreasing trend in the asymptomatic and moderate-severe hepatic steatosis group. We did not find the same relationships in green tea consumption. CONCLUSIONS: Although we did not find an association between hepatic steatosis and green tea consumption, coffee may have beneficial effects on hepatic steatosis. In addition, we produced one possible hypothesis that coffee consumption negatively associates with leptin levels in hepatic steatosis.	[Imatoh, T.] Fukuoka Univ, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka 81401, Japan; [Kamimura, S.] Tenjin Clin, Div Prevent Med, Dept Internal Med, Fukuoka, Japan; [Miyazaki, M.] Saitama City Inst Hlth Sci & Res, Saitama, Japan	Imatoh, T (reprint author), Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	imatoh@nihs.go.jp			Clinical Research Promotion Foundation	This work was supported by Grant of The Clinical Research Promotion Foundation (2010, 2014). We thank public health nurse Yuko Shibata for her invaluable help.	Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; Omagari K, 2002, J GASTROEN HEPATOL, V17, P1098, DOI 10.1046/j.1440-1746.2002.02846.x; Bravi F, 2013, CLIN GASTROENTEROL H, V11, P1413, DOI 10.1016/j.cgh.2013.04.039; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Salomone F, 2014, TRANSL RES, V163, P593, DOI 10.1016/j.trsl.2013.12.001; Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731; Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8; Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010; IMAI K, 1995, BRIT MED J, V310, P693; Bravi F, 2007, HEPATOLOGY, V46, P430, DOI 10.1002/hep.21708; Katayama M, 2014, CLIN NUTR, V33, P302, DOI 10.1016/j.clnu.2013.05.006; Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x; Jin X, 2008, LIVER INT, V28, P990, DOI 10.1111/j.1478-3231.2008.01776.x; Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88; Das S, 2013, TOXICOL APPL PHARM, V269, P297, DOI 10.1016/j.taap.2013.02.003; Gutierrez-Grobe Y, 2012, ANN HEPATOL, V11, P350; Imatoh T, 2011, EUR J NUTR, V50, P279, DOI 10.1007/s00394-010-0136-5; Bae Ki-Cheor, 2013, Diabetes Metab J, V37, P196, DOI 10.4093/dmj.2013.37.3.196; Bhardwaj P, 2013, CHIN J NAT MEDICINES, V11, P345, DOI [10.1016/S1875-5364(13)60051-5, 10.3724/SP.J.1009.2013.00345]; Cornelis MC, 2007, CURR OPIN CLIN NUTR, V10, P745; Moraes A. dos S., 2013, Hormone and Metabolic Research, V45, P605; Fiorini RN, 2005, LIVER TRANSPLANT, V11, P298, DOI 10.1002/lt.20348; Imamura Y, 2013, J GASTROENTEROL, V49, P1406; Meli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066570; Russell VL, 2014, LSMEANS LEAST SQUARE; Tsochatzis EA, 2009, MEDIAT INFLAMM, DOI 10.1155/2009/831670; Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6; Yuan JM, 2011, PHARMACOL RES, V64, P123, DOI 10.1016/j.phrs.2011.03.002	30	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0954-3007	1476-5640		EUR J CLIN NUTR	Eur. J. Clin. Nutr.	SEP	2015	69	9					1023	1027		10.1038/ejcn.2015.23		5	Nutrition & Dietetics	Nutrition & Dietetics	CQ7SX	WOS:000360805600005		
J	Liu, Y; Liao, JY; Zhao, M; Wu, HJ; Yung, SS; Chan, TM; Yoshimura, A; Lu, QJ				Liu, Yu; Liao, Jieyue; Zhao, Ming; Wu, Haijing; Yung, Susan; Chan, Tak Mao; Yoshimura, Akihiko; Lu, Qianjin			Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						Histone modification; IL-17; Systemic lupus erythematosus; T cells; TLR2	SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; BLOOD MONONUCLEAR-CELLS; DISEASE-ACTIVITY; TNF-ALPHA; EPIGENETICS; AUTOIMMUNITY; PATHOGENESIS; INDUCTION; ACTIVATION	The innate immune system has been shown to play an important pathologic role in systemic lupus erythematosus (SLE). TLR2, a PRR, recognizes exogenous PAMPs, and endogenous damage-associated molecular patterns and has been implicated in the initiation and maintenance of the perpetuated inflammatory reactions in autoimmune diseases. Here, we report increased expression of TLR2 in CD4(+) and CD8(+) T cells, CD19(+) B cells, and CD14(+) monocytes from SLE patients. Conventional treatment, such as hydroxychloroquine and corticosteroids, showed no effect on TLR2 expression in CD4(+) T cells from SLE patients. In vitro stimulation of TLR2 in CD4(+) T cells from SLE patients increased CD40L and CD70 expression, as well as secretion of IL-6, IL-17A, IL-17F, and TNF-alpha, while Foxp3 transcription decreased. This effect was reversed by TLR2 siRNA. Moreover, TLR2 activation upregulated H3K4 tri-methylation and H4 acetylation levels while downregulated H3K9 tri-methylation level in the IL-17A promoter region. In addition, it also increased H4 acetylation levels and decreased H3K9 tri-methylation levels in the IL-17F promoter region. In summary, our findings demonstrate that increased expression of TLR2 contributes to immune reactivity and promotes IL-17A and IL-17F expression through histone modifications in SLE.	[Liu, Yu; Liao, Jieyue; Zhao, Ming; Wu, Haijing; Lu, Qianjin] Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Hunan Key Lab Med Epigen, Changsha 410011, Hunan, Peoples R China; [Yung, Susan; Chan, Tak Mao] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Nephrol, Hong Kong, Hong Kong, Peoples R China; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	Lu, QJ (reprint author), Cent S Univ, Xiangya Hosp 2, Dept Dermatol, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.	qianlu5860@gmail.com			National Natural Science Foundation of China [81210308042, 81220108017, 30972745]; National Basic Research Program of China [2009CB825605]; Science-Technology Commission of Hunan Province [2011FJ2007, 2011TP4019-7, 2012WK3046, 2012TT2015]; Fundamental Research Funds for the Central Universities; National Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China	This work was supported by the National Natural Science Foundation of China (No. 81210308042, No. 81220108017 and No. 30972745), the National Basic Research Program of China (973 Plan) (2009CB825605), the programs of Science-Technology Commission of Hunan Province (2011FJ2007, 2011TP4019-7, 2012WK3046 and 2012TT2015), the Fundamental Research Funds for the Central Universities, and the National Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China. Principal recipient of the funding listed above is Prof. Qianjin Lu. We would like to thank the systemic lupus erythematosus patients from Second Xiangya hospital for donating blood samples. We are grateful to the healthy-control volunteers. We also appreciate the support and assistance of the Dermatology team at Second Xiangya hospital.	Smith PP, 2010, AUTOIMMUN REV, V10, P43, DOI 10.1016/j.autrev.2010.08.016; Yap DYH, 2013, NEPHROLOGY, V18, P243, DOI 10.1111/nep.12047; Lartigue A, 2009, J IMMUNOL, V183, P6207, DOI 10.4049/jimmunol.0803219; Richardson B, 2007, NAT CLIN PRACT RHEUM, V3, P521, DOI 10.1038/ncprheum0573; Doria A, 2008, AUTOIMMUN REV, V8, P24, DOI 10.1016/j.autrev.2008.07.019; Wen ZK, 2013, J IMMUNOL, V190, P5411, DOI 10.4049/jimmunol.1203301; Postal M, 2011, CYTOKINE, V56, P537, DOI 10.1016/j.cyto.2011.08.026; Reba SM, 2014, EUR J IMMUNOL, V44, P1410, DOI 10.1002/eji.201344100; Teixeira-Coelho M, 2014, EUR J IMMUNOL, V44, P856, DOI 10.1002/eji.201343734; Li J, 2013, PHARMACOL THERAPEUT, V138, P441, DOI 10.1016/j.pharmthera.2013.03.003; Liu Y, 2013, CLIN REV ALLERG IMMU, V45, P314, DOI 10.1007/s12016-013-8398-3; Deng Y, 2014, CURR OPIN RHEUMATOL, V26, P482, DOI 10.1097/BOR.0000000000000086; Nyirenda MH, 2011, J IMMUNOL, V187, P2278, DOI 10.4049/jimmunol.1003715; Li YP, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/206298; Zhang YQ, 2013, J AUTOIMMUN, V41, P92, DOI 10.1016/j.jaut.2013.01.005; O'Reilly S, 2014, CLIN SCI, V126, P329, DOI 10.1042/CS20130367; Lu QJ, 2013, J AUTOIMMUN, V41, P1, DOI 10.1016/j.jaut.2013.01.010; Balada E, 2014, CLIN EXP RHEUMATOL, V32, P113; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; van der Vlugt LEPM, 2014, METHODS MOL BIOL, V1190, P127, DOI 10.1007/978-1-4939-1161-5_10; Hedrich CM, 2014, AUTOIMMUNITY, V47, P234, DOI 10.3109/08916934.2013.801462; Kirchner M, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-9; Kow NY, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/245928; Liu Y, 2014, CLIN REV ALLERG IMMU, V47, P136, DOI 10.1007/s12016-013-8402-y; McBride A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003397; Mesquita D, 2014, BRAZ J MED BIOL RES, V47, P662, DOI 10.1590/1414-431X20143483; Mittag D, 2013, EUR J IMMUNOL, V43, P723, DOI 10.1002/eji.201242747; Rao V, 2014, CURR OPIN RHEUMATOL, V26, P510, DOI 10.1097/BOR.0000000000000085; Selmi C, 2012, J AUTOIMMUN, V39, P272, DOI 10.1016/j.jaut.2012.05.007; Su DL, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/347141; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thwaites R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00001; Tsao JT, 2012, CLIN EXP MED, V12, P153, DOI 10.1007/s10238-011-0161-6; Wong CK, 2010, CLIN EXP IMMUNOL, V159, P11, DOI 10.1111/j.1365-2249.2009.04036.x; Zhao M, 2013, J AUTOIMMUN, V41, P152, DOI 10.1016/j.jaut.2013.01.004; Zhao M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3214	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	SEP	2015	45	9					2683	2693		10.1002/eji.201445219		11	Immunology	Immunology	CQ9GK	WOS:000360921200023		
J	Reddel, HK; Bateman, ED; Becker, A; Boulet, LP; Cruz, AA; Drazen, JM; Haahtela, T; Hurd, SS; Inoue, H; de Jongste, JC; Lemanske, RF; Levy, ML; O'Byrne, PM; Paggiaro, P; Pedersen, SE; Pizzichini, E; Soto-Quiroz, M; Szefler, SJ; Wong, GWK; FitzGerald, JM				Reddel, Helen K.; Bateman, Eric D.; Becker, Allan; Boulet, Louis-Philippe; Cruz, Alvaro A.; Drazen, Jeffrey M.; Haahtela, Tari; Hurd, Suzanne S.; Inoue, Hiromasa; de Jongste, Johan C.; Lemanske, Robert F., Jr.; Levy, Mark L.; O'Byrne, Paul M.; Paggiaro, Pierluigi; Pedersen, Soren E.; Pizzichini, Emilio; Soto-Quiroz, Manuel; Szefler, Stanley J.; Wong, Gary W. K.; FitzGerald, J. Mark			A summary of the new GINA strategy: a roadmap to asthma control	EUROPEAN RESPIRATORY JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; EXHALED NITRIC-OXIDE; 1ST 6 YEARS; PRESCHOOL-CHILDREN; INHALED CORTICOSTEROIDS; PERSISTENT ASTHMA; DOUBLE-BLIND; SEVERE EXACERBATIONS; CLUSTER-ANALYSIS	Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA report was published in 2014, and updated in 2015, reflecting an evolving understanding of heterogeneous airways disease, a broader evidence base, increasing interest in targeted treatment, and evidence about effective implementation approaches. During development of the report, the clinical utility of recommendations and strategies for their practical implementation were considered in parallel with the scientific evidence. This article provides a summary of key changes in the GINA report, and their rationale. The changes include a revised asthma definition; tools for assessing symptom control and risk factors for adverse outcomes; expanded indications for inhaled corticosteroid therapy; a framework for targeted treatment based on phenotype, modifiable risk factors, patient preference, and practical issues; optimisation of medication effectiveness by addressing inhaler technique and adherence; revised recommendations about written asthma action plans; diagnosis and initial treatment of the asthma-chronic obstructive pulmonary disease overlap syndrome; diagnosis in wheezing pre-school children; and updated strategies for adaptation and implementation of GINA recommendations.	[Reddel, Helen K.] Univ Sydney, Woolcock Inst Med Res, Glebe, NSW 2037, Australia; [Bateman, Eric D.] Univ Cape Town, Lung Inst, ZA-7925 Cape Town, South Africa; [Becker, Allan] Univ Manitoba, Winnipeg, MB, Canada; [Boulet, Louis-Philippe] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Cruz, Alvaro A.] Univ Fed Bahia, Salvador, BA, Brazil; [Drazen, Jeffrey M.] Harvard Univ, Sch Med, Boston, MA USA; [Haahtela, Tari] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Hurd, Suzanne S.] Global Initiat Asthma, Vancouver, WA USA; [Inoue, Hiromasa] Kagoshima Univ, Kagoshima 890, Japan; [de Jongste, Johan C.] Erasmus Univ, Med Ctr, Dept Pediat, Rotterdam, Netherlands; [Lemanske, Robert F., Jr.] Univ Wisconsin, Madison, WI USA; [O'Byrne, Paul M.] St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON, Canada; [O'Byrne, Paul M.] McMaster Univ, Hamilton, ON, Canada; [Paggiaro, Pierluigi] Univ Pisa, Pisa, Italy; [Pedersen, Soren E.] Univ Southern Denmark, Kolding Hosp, Pediat Res Unit, Kolding, Denmark; [Pizzichini, Emilio] Univ Fed Santa Catarina, NUPAIVA Asthma Res Ctr, Florianopolis, SC, Brazil; [Soto-Quiroz, Manuel] Univ Costa Rica, Natl Childrens Hosp, San Jose, Costa Rica; [Szefler, Stanley J.] Childrens Hosp Colorado, Aurora, CO USA; [Wong, Gary W. K.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Pediat, Hong Kong, Hong Kong, Peoples R China; [FitzGerald, J. Mark] Univ British Columbia, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada	Reddel, HK (reprint author), Univ Sydney, Woolcock Inst Med Res, 431 Glebe Point Rd, Glebe, NSW 2037, Australia.	helen.reddel@sydney.edu.au	Pizzichini, Emilio/L-2252-2014	Pizzichini, Emilio/0000-0001-7046-9996	Almirall; Boehringer Ingelheim; Boston Scientific; CIPLA; Chiesi; Clement Clarke; GlaxoSmithKline; Merck Sharp and Dohme; Novartis; Takeda	During the period in which the GINA 2014 report was being prepared (2012-2013), the work of GINA was partly supported by unrestricted educational grants from the following companies: Almirall, Boehringer Ingelheim, Boston Scientific, CIPLA, Chiesi, Clement Clarke, GlaxoSmithKline, Merck Sharp and Dohme, Novartis and Takeda. Since 2014, the work of GINA has been supported only by income generated from the sale of its report, resources and related materials. Members of the GINA Committees serve in a voluntary capacity, and are solely responsible for the statements and recommendations in the GINA report and resources. Statements of interest for members of the GINA Science Committee and Board of Directors are published on the GINA website (www.ginasthma.org).	Jenkins CR, 2005, EUR RESPIR J, V26, P36, DOI 10.1183/090319836.05.00144704; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Foster JM, 2012, INTERN MED J, V42, pE136, DOI 10.1111/j.1445-5994.2011.02541.x; Harrison TW, 2004, LANCET, V363, P271, DOI 10.1016/S0140-6736(03)15384-6; Patel M, 2013, LANCET RESP MED, V1, P32, DOI 10.1016/S2213-2600(13)70007-9; Andersen H, 2013, CLIN RESPIR J, V7, P342, DOI 10.1111/crj.12013; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Sly PD, 2008, LANCET, V372, P1100, DOI 10.1016/S0140-6736(08)61451-8; Borrelli B, 2007, J ALLERGY CLIN IMMUN, V120, P1023, DOI 10.1016/j.jaci.2007.08.017; Papi A, 2013, LANCET RESP MED, V1, P23, DOI 10.1016/S2213-2600(13)70012-2; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI [10.1164/rccm.200711-1754OC, 10.1164/rccm.200711-17540C]; Singer F, 2013, ALLERGY, V68, P531, DOI 10.1111/all.12127; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Herland K, 2005, RESP MED, V99, P11, DOI 10.1016/j.rmed.2004.03.026; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Osborne ML, 2007, CHEST, V132, P1151, DOI 10.1378/chest.05-3084; Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; Perrin K, 2011, THORAX, V66, P937, DOI 10.1136/thx.2010.155259; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; van der Heijden HHACM, 2014, PEDIATR PULM, V49, P291, DOI 10.1002/ppul.22796; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Savenije OEM, 2012, J ALLERGY CLIN IMMUN, V130, P325, DOI 10.1016/j.jaci.2012.05.007; Oborne J, 2009, AM J RESP CRIT CARE, V180, P598, DOI 10.1164/rccm.200904-0616OC; Rodrigo GJ, 2003, CHEST, V124, P1312, DOI 10.1378/chest.124.4.1312; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Boulet LP, 2012, EUR RESPIR J, V39, P1220, DOI 10.1183/09031936.00184511; Robertson CF, 2007, AM J RESP CRIT CARE, V175, P323, DOI 10.1164/rccm.200510-1546OC; Kauppi P, 2011, J ASTHMA, V48, P279, DOI 10.3109/02770903.2011.555576; O'Byrne PM, 2013, CHEST, V143, P511, DOI 10.1378/chest.12-0412; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408; Williams LK, 2011, J ALLERGY CLIN IMMUN, V128, P1185, DOI 10.1016/j.jaci.2011.09.011; Lai CKW, 2009, THORAX, V64, P476, DOI 10.1136/thx.2008.106609; Wilson SR, 2010, AM J RESP CRIT CARE, V181, P566, DOI 10.1164/rccm.200906-0907OC; Schultz A, 2010, ACTA PAEDIATR, V99, P56, DOI 10.1111/j.1651-2227.2009.01508.x; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Zeiger RS, 2011, NEW ENGL J MED, V365, P1990, DOI 10.1056/NEJMoa1104647; Melani AS, 2011, RESP MED, V105, P930, DOI 10.1016/j.rmed.2011.01.005; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Wisnivesky JP, 2008, ANN ALLERG ASTHMA IM, V101, P264, DOI 10.1016/S1081-1206(10)60491-7; GEELHOED GC, 1994, ANN EMERG MED, V23, P1236, DOI 10.1016/S0196-0644(94)70347-7; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Basheti IA, 2007, J ALLERGY CLIN IMMUN, V119, P1537, DOI 10.1016/j.jaci.2007.02.037; Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880; Marsh SE, 2008, THORAX, V63, P761, DOI 10.1136/thx.2007.089193; Miller MK, 2007, RESP MED, V101, P481, DOI 10.1016/j.rmed.2006.07.005; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403; Baiardini I, 2009, CURR OPIN ALLERGY CL, V9, P228, DOI 10.1097/ACI.0b013e32832b4651; Armour CL, 2013, J ASTHMA, V50, P302, DOI 10.3109/02770903.2012.754463; Bel EH, 2011, THORAX, V66, P910, DOI 10.1136/thx.2010.153643; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Plaza V, 1998, RESPIRATION, V65, P195, DOI 10.1159/000029259; Lucas AEM, 2008, FAM PRACT, V25, P86, DOI 10.1093/fampra/cmn006; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Brand PLP, 2014, EUR RESPIR J, V43, P1172, DOI 10.1183/09031936.00199913; Fuhlbrigge AL, 2001, J ALLERGY CLIN IMMUN, V107, P61, DOI 10.1067/mai.2001.111590; Basheti IA, 2011, RESP CARE, V56, P1916, DOI 10.4187/respcare.01205; Papi A, 2009, ALLERGY, V64, P1463, DOI 10.1111/j.1398-9995.2009.02134.x; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Boulet LP, 2012, CLIN CHEST MED, V33, P405, DOI 10.1016/j.ccm.2012.06.002; Bateman Eric D, 2010, J Allergy Clin Immunol, V125, P600, DOI 10.1016/j.jaci.2009.11.033; Blaiss MS, 2012, ALLERGY ASTHMA PROC, V33, P47, DOI 10.2500/aap.2011.32.3520; Boulet LP, 2009, RESP MED, V103, P1554, DOI 10.1016/j.rmed.2009.02.015; Canonica GW, 2004, PULM PHARMACOL THER, V17, P239, DOI 10.1016/j.pupt.2004.04.006; Cates CJ, 2014, COCHRANE DB SYST REV, V2; Demoly P, 2009, Eur Respir Rev, V18, P105, DOI 10.1183/09059180.00001209; English René G, 2006, BMC Pulm Med, V6, P22, DOI 10.1186/1471-2466-6-22; Fink James B, 2005, Respir Care, V50, P1360; FitzGerald JM, 2014, CHEST, V146, P10, DOI 10.1378/chest.13-2817; FitzGerald JM, 2004, THORAX, V59, P550, DOI 10.1136/thx.2003.014936; Fuhlbrigge A, 2009, ALLERGY ASTHMA PROC, V30, P529, DOI 10.2500/aap.2009.30.3276; Gibson PG, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001117, DOI 10.1002/14651858.CD001117]; Gibson Peter G, 2004, Prim Care Respir J, V13, P17, DOI 10.1016/j.pcrj.2003.12.001; Global Initiative for Asthma, 2006, GLOB STRAT ASTHM MAN; Global Initiative for Asthma, 2014, GLOB STRAT ASTHM MAN; Global Initiative for Asthma, 1995, NIH PUBLICATION, V96-3659C; GOLD, 2015, GLOB STRAT DIAGN MAN; Gold LS, 2014, RESP MED, V108, P271, DOI 10.1016/j.rmed.2013.12.004; Haughney John, 2004, Prim Care Respir J, V13, P28, DOI 10.1016/j.pcrj.2003.11.007; Jansen J, 2012, PRIM CARE RESP J, V21, P94, DOI 10.4104/pcrj.2012.00004; Janson S, 1998, J ASTHMA, V35, P427, DOI 10.3109/02770909809048951; Karner C, 2013, COCHRANE DB SYST REV, V4; Lozano R, 2013, LANCET, V380, P2095, DOI [10.1016/S0140-6736(12)61728-0, DOI 10.1016/S0140-6736(12)61728-0]; Marklund B, 1999, FAM PRACT, V16, P112, DOI 10.1093/fampra/16.2.112; Montnemery P, 2002, FAM PRACT, V19, P365, DOI 10.1093/fampra/19.4.365; Moore V, 2011, EUR RESP J S55, V38, pP4941; Nannini LJ, 2013, COCHRANE DB SYST REV, V8; Partridge MR, 2003, EUR RESPIR J, V21, p23S, DOI 10.1183/09031936.0.00054503; Powell C, 2013, LANCET RESP MED, V1, P301, DOI 10.1016/S2213-2600(13)70037-7; Levy Mark L, 2006, Prim Care Respir J, V15, P20, DOI 10.1016/j.pcrj.2005.10.004; Quon BS, 2010, COCHRANE DB SYST REV, V10; Reddel Helen K, 2008, Prim Care Respir J, V17, P39, DOI 10.3132/pcrj.2008.00014; Rice-McDonald G, 2005, INTERN MED J, V35, P693, DOI 10.1111/j.1445-5994.2005.00972.x; Roberts NJ, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-37; Roche N, 2013, LANCET RESP MED, V1, pE29, DOI 10.1016/S2213-2600(13)70199-1; Rosas-Salazar C, 2012, J ALLERGY CLIN IMMUN, V129, P935, DOI 10.1016/j.jaci.2012.01.040; Rowe BH, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000195.PUB2; Royal College of Physicians, 2014, WHY ASTHM STILL KILL; Spahn J, 2009, J ALLERGY CLIN IMMUN, V124, P1197, DOI 10.1016/j.jaci.2009.08.042; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; van Schayck C P, 2004, Prim Care Respir J, V13, P218, DOI 10.1016/j.pcrj.2004.07.001; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P403	108	5	5	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	SEP	2015	46	3					622	639		10.1183/13993003.00853-2015		18	Respiratory System	Respiratory System	CQ6BM	WOS:000360689400013		
J	Kirby, M; Ohtani, K; Lisbona, RML; Lee, AMD; Zhang, W; Lane, P; Varfolomeva, N; Hui, L; Ionescu, D; Coxson, HO; MacAulay, C; FitzGerald, JM; Lam, S				Kirby, Miranda; Ohtani, Keishi; Lopez Lisbona, Rosa Maria; Lee, Anthony M. D.; Zhang, Wei; Lane, Pierre; Varfolomeva, Nina; Hui, Linda; Ionescu, Diana; Coxson, Harvey O.; MacAulay, Calum; FitzGerald, J. Mark; Lam, Stephen			Bronchial thermoplasty in asthma: 2-year follow-up using optical coherence tomography	EUROPEAN RESPIRATORY JOURNAL			English	Letter							COMPUTED-TOMOGRAPHY; LESIONS; SAFETY		[Kirby, Miranda; Coxson, Harvey O.] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada; [Kirby, Miranda; Coxson, Harvey O.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Ohtani, Keishi] Tokyo Med Univ, Dept Surg, Tokyo 1608402, Japan; [Ohtani, Keishi; Lopez Lisbona, Rosa Maria; Lee, Anthony M. D.; Zhang, Wei; Lane, Pierre; MacAulay, Calum; Lam, Stephen] British Columbia Canc Res Ctr, Integrat Oncol Dept, Imaging Unit, Vancouver, BC V5Z 1L3, Canada; [Lopez Lisbona, Rosa Maria] Bellvitge Univ Hosp, Dept Respirol, Barcelona, Spain; [Zhang, Wei] Peking Univ, Hosp 1, Dept Resp & Crit Care Med, Beijing 100871, Peoples R China; [Varfolomeva, Nina; Hui, Linda; FitzGerald, J. Mark; Lam, Stephen] Univ British Columbia, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada; [Varfolomeva, Nina; Hui, Linda; FitzGerald, J. Mark; Lam, Stephen] Vancouver Gen Hosp, Vancouver, BC, Canada; [Ionescu, Diana] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC V5Z 4E6, Canada; [Ionescu, Diana] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Lam, S (reprint author), British Columbia Canc Res Ctr, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	slam2@bccancer.bc.ca					Williamson JP, 2011, AM J RESP CRIT CARE, V183, P612, DOI 10.1164/rccm.201002-0178OC; Tsuboi M, 2005, LUNG CANCER-J IASLC, V49, P387, DOI 10.1016/j.lungcan.2005.04.007; Cox G, 2006, AM J RESP CRIT CARE, V173, P965, DOI 10.1164/rccm.200507-1162OC; Wechsler ME, 2013, J ALLERGY CLIN IMMUN, V132, P1295, DOI 10.1016/j.jaci.2013.08.009; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; Whiteman SC, 2006, CLIN CANCER RES, V12, P813, DOI 10.1158/1078-0432.CCR-05-0245; Coxson Harvey O, 2009, Proc Am Thorac Soc, V6, P439, DOI 10.1513/pats.200904-015AW; Nakano Y, 2005, AM J RESP CRIT CARE, V171, P142, DOI 10.1164/rccm.200407-874OC; Lam S, 2008, CLIN CANCER RES, V14, P2006, DOI 10.1158/1078-0432.CCR-07-4418; Kauczor HU, 1997, JMRI-J MAGN RESON IM, V7, P538, DOI 10.1002/jmri.1880070314; Hariri LP, 2013, CHEST, V143, P64, DOI 10.1378/chest.11-2797; Coxson HO, 2008, AM J RESP CRIT CARE, V177, P1201, DOI 10.1164/rccm.200712-1776OC; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2014, THORAX, V69, pi1; Lee AMD, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.050501	15	0	0	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	SEP	2015	46	3					859	862		10.1183/09031936.00016815		5	Respiratory System	Respiratory System	CQ6BM	WOS:000360689400038		
J	Korkmaz, S; Atmanli, A; Li, SL; Radovits, T; Hegedus, P; Barnucz, E; Hirschberg, K; Loganathan, S; Yoshikawa, Y; Yasui, H; Karck, M; Szabo, G				Korkmaz, Sevil; Atmanli, Ayhan; Li, Shiliang; Radovits, Tamas; Hegedus, Peter; Barnucz, Eniko; Hirschberg, Kristof; Loganathan, Sivakkanan; Yoshikawa, Yutaka; Yasui, Hiroyuki; Karck, Matthias; Szabo, Gabor			Superiority of zinc complex of acetylsalicylic acid to acetylsalicylic acid in preventing postischemic myocardial dysfunction	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						Myocardial ischemia; acetylsalicylic acid; zinc complex of acetylsalicylic acid; cardiac function; isoproterenol; antioxidant	CARDIAC TROPONIN-T; OLD MALE RATS; INFARCTION; ISOPROTERENOL; HEART; INJURY; INHIBITION; ISCHEMIA; PROTECTS; ASPIRIN	The pathophysiology of ischemic myocardial injury involves cellular events, reactive oxygen species, and an inflammatory reaction cascade. The zinc complex of acetylsalicylic acid (Zn(ASA)(2))has been found to possess higher anti-inflammatory and lower ulcerogenic activities than acetylsalicylic acid (ASA). Herein, we studied the effects of both ASA and Zn(ASA)(2) against acute myocardial ischemia. Rats were pretreated with ASA (75 mg/kg) or Zn(ASA)(2) (100 mg/kg) orally for five consecutive days. Isoproterenol (85 mg/kg, subcutaneously [s.c.]) was applied to produce myocardial infarction. After 17-22 h, animals were anesthetized with sodium pentobarbital (60 mg/kg, intraperitoneally [i.p.]) and both electrical and mechanical parameters of cardiac function were evaluated in vivo. Myocardial histological and gene expression analyses were performed. In isoproterenol-treated rats, Zn(ASA)(2) treatment normalized significantly impaired left-ventricular contractility index (E-max 2.6 +/- 0.7mmHg/mu L vs. 4.6 +/- 0.5 mmHg/mu L, P<0.05), increased stroke volume (30 +/- 3 mu L vs. 50 +/- 6 mu L, P<0.05), decreased systemic vascular resistance (7.2 +/- 0.7 mmHg/min/mL vs. 4.2 +/- 0.5 mmHg/min/mL, P < 0.05) and reduced inflammatory infiltrate into the myocardial tissues. ECG revealed a restoration of elevated ST-segment (0.21 +/- 0.03mV vs. 0.09 +/- 0.02 mV, P < 0.05) and prolonged QT-interval (79.2 +/- 3.2ms vs. 69.5 +/- 2.5 ms, P < 0.05) by Zn(ASA)(2). ASA treatment did not result in an improvement of these parameters. Additionally, Zn(ASA) 2 significantly increased the mRNA-expression of superoxide dismutase 1 (+73 +/- 15%), glutathione peroxidase 4 (+44 +/- 12%), and transforming growth factor (TGF)-beta(1) (+102 +/- 22%). In conclusion, our data demonstrate that oral administration of zinc and ASA in the form of bis(aspirinato)zinc(II) complex is superior to ASA in preventing electrical, mechanical, and histological changes after acute myocardial ischemia. The induction of antioxidant enzymes and the anti-inflammatory cytokine TGF-beta(1) may play a pivotal role in the mechanism of action of Zn(ASA)(2).	[Korkmaz, Sevil; Atmanli, Ayhan; Li, Shiliang; Hegedus, Peter; Barnucz, Eniko; Hirschberg, Kristof; Loganathan, Sivakkanan; Karck, Matthias; Szabo, Gabor] Heidelberg Univ, Dept Cardiac Surg, D-69120 Heidelberg, Germany; [Radovits, Tamas; Hegedus, Peter; Barnucz, Eniko] Semmelweis Univ, Ctr Heart, H-1122 Budapest, Hungary; [Yoshikawa, Yutaka; Yasui, Hiroyuki] Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Kyoto 6078414, Japan	Korkmaz, S (reprint author), Heidelberg Univ, Dept Cardiac Surg, D-69120 Heidelberg, Germany.	korkmaz@uni-heidelberg.de			Land Baden-Wurttemberg, Germany; Medical Faculty of the University of Heidelberg, Germany; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	This study was supported by the Land Baden-Wurttemberg, Germany, by the Medical Faculty of the University of Heidelberg, Germany (to Dr S Korkmaz and Dr K Hirschberg), and by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to Dr T Radovits). The expert technical assistance of Karin Sonnenberg, Patricia Kraft, Lutz Hoffmann and Nadine Weiberg is gratefully acknowledged. We thank Alice Lehner for her help in histological studies.	Ahn YK, 1999, JPN HEART J, V40, P79; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; Frantz S, 2008, BASIC RES CARDIOL, V103, P485, DOI 10.1007/s00395-008-0739-7; Zhou R, 2008, EUR J PHARMACOL, V586, P244, DOI 10.1016/j.ejphar.2008.02.057; RAVKILDE J, 1995, J AM COLL CARDIOL, V25, P574, DOI 10.1016/0735-1097(94)00430-X; Kmecova J, 2010, EUR J PHARMACOL, V641, P187, DOI 10.1016/j.ejphar.2010.05.038; Wang TA, 2010, EUR J PHARMACOL, V636, P121, DOI 10.1016/j.ejphar.2010.03.035; Ott I, 2009, ANGEW CHEM INT EDIT, V48, P1160, DOI 10.1002/anie.200803347; Korkmaz S, 2009, CIRCULATION, V120, P677, DOI 10.1161/CIRCULATIONAHA.109.870774; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; CHAGOYA DSV, 1997, CAN J PHYSL PHARM, V75, P1300; Chohan ZH, 2002, J ENZYM INHIB MED CH, V17, P87, DOI 10.1080/14756360290030734; CHVAPIL M, 1977, J MOL CELL CARDIOL, V9, P151, DOI 10.1016/0022-2828(77)90046-3; HAFT JI, 1972, CIRCULATION, V46, P698; KARMAZYN M, 1981, J PHARMACOL EXP THER, V218, P764; Karthick M, 2006, J PHARM PHARMACOL, V58, P701, DOI 10.1211/jpp.58.5.0016; KRAIKITPANITCH S, 1976, AM HEART J, V92, P615, DOI 10.1016/S0002-8703(76)80081-6; Luscher MS, 1997, CIRCULATION, V96, P2578; MARTYNYUK R A, 1975, Byulleten' Eksperimental'noi Biologii i Meditsiny, V79, P31; POWELL SR, 1994, AM J PHYSIOL, V266, pH2497; Powell S.R, 2000, J NUTR, V130, P1447; Radovits T, 2008, REJUV RES, V11, P945, DOI 10.1089/rej.2008.0762; Rajadurai M, 2007, TOXICOLOGY, V230, P178, DOI 10.1016/j.tox.2006.11.053; Sahna E, 2008, CLIN EXP HYPERTENS, V30, P673, DOI 10.1080/10641960802251966; Shih CJ, 2013, INFLAMMATION, V36, P616, DOI 10.1007/s10753-012-9583-x; Sides GD, 2002, DIS MARKERS, V18, P57; SINGLA AK, 1994, INT J PHARM, V108, P173, DOI 10.1016/0378-5173(94)90126-0; Suga H, 2003, CLIN EXP PHARMACOL P, V30, P580, DOI 10.1046/j.1440-1681.2003.03879.x; Troskot B, 1997, BIOMETALS, V10, P325, DOI 10.1023/A:1018332618512; WEXLER BC, 1978, AM HEART J, V96, P70, DOI 10.1016/0002-8703(78)90128-X; WEXLER BC, 1974, AM HEART J, V88, P343, DOI 10.1016/0002-8703(74)90470-0; Whellan David J, 2005, Cardiol Rev, V13, P231, DOI 10.1097/01.crd.0000135765.60824.2f	33	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1535-3702	1535-3699		EXP BIOL MED	Exp. Biol. Med.	SEP	2015	240	9					1247	1255		10.1177/1535370215570184		9	Medicine, Research & Experimental	Research & Experimental Medicine	CR1AI	WOS:000361054600014		
J	Yokoi, N; Sonomura, Y; Kato, H; Komuro, A; Kinoshita, S				Yokoi, N.; Sonomura, Y.; Kato, H.; Komuro, A.; Kinoshita, S.			Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjogren's syndrome	EYE			English	Article							CONJUNCTIVAL EPITHELIUM; SODIUM HYALURONATE; RECEPTOR AGONISTS; BARRIER FUNCTION; FLUID SECRETION; GENE-EXPRESSION; CORNEAL; MENISCUS; SURFACE; INS365	Purpose To investigate the long-term results of 3% diquafosol ophthalmic solution as an alternative therapy to existing ophthalmic solutions, including topical immunosuppression, for the treatment of dry eye in patients with Sjogren's syndrome. Methods This study involved 14 female dry-eye patients (mean age: 62.4 years) with Sjogren's syndrome who insufficiently responded to their current therapy. In all patients, 3% diquafosol ophthalmic solution was administered six times daily for 12 months in substitution for artificial tears and sodium hyaluronate ophthalmic solution. Their use of corticosteroid eye drops remained unchanged from that prior to the treatment with diquafosol sodium. The subjective symptoms assessed, and ocular signs including tear meniscus radius and the tear film breakup time, and ocular-surface epithelial damage score were examined at 1, 2, 3, 4, 5, 6, 9, and 12 months after initiating treatment. Results Among the subjective symptoms, significant improvement was obtained in dryness at 2 months post treatment, in eye fatigue at 1, 2, 3, 4, and 12 months post treatment, and in pain at 1, 2, 6, and 12 months post treatment. Difficulty in opening the eye, foreign body sensation, and redness were also significantly ameliorated at various time-points. The tear meniscus radius and the tear film breakup time were significantly improved throughout the observation period, and the corneal epithelial staining scores were significantly decreased at 3 months post treatment. Conclusions In dry-eye patients with Sjogren's syndrome, treatment with 3% diquafosol ophthalmic solution improved both symptoms and signs, and that effectiveness was maintained for 12 months.	[Yokoi, N.; Sonomura, Y.; Kato, H.; Komuro, A.; Kinoshita, S.] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto 6020841, Japan	Yokoi, N (reprint author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6020841, Japan.	nyokoi@koto.kpu-m.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	We thank Mr John Bush (Senior Editor, Kyoto Prefectural University of Medicine) for reviewing the manuscript. This study was supported in part by Grants-in-Aid for scientific research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Ishibashi T, 2003, J GLAUCOMA, V12, P486, DOI 10.1097/00061198-200312000-00008; Yokoi N, 1997, BRIT J OPHTHALMOL, V81, P533, DOI 10.1136/bjo.81.7.533; Arita R, 2013, BRIT J OPHTHALMOL, V97, P725, DOI 10.1136/bjophthalmol-2012-302668; Yokoi N, 2004, EXP EYE RES, V78, P399, DOI 10.1016/j.exer.2003.09.020; TODA I, 1993, ACTA OPHTHALMOL, V71, P347; Caffery B, 2010, INVEST OPHTH VIS SCI, V51, P2381, DOI 10.1167/iovs.09-4188; Koh S, 2003, AM J OPHTHALMOL, V136, P513, DOI 10.1016/S0002-9394(03)00317-9; Kawasaki S, 2003, EXP EYE RES, V77, P17, DOI 10.1016/S0014-4835(03)00087-3; Li YS, 2001, AM J PHYSIOL-CELL PH, V281, pC595; TODA I, 1995, OPHTHALMOLOGY, V102, P302; Pflugfelder SC, 1997, OPHTHALMOLOGY, V104, P223; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Koh S, 2013, JPN J OPHTHALMOL, V57, P440, DOI 10.1007/s10384-013-0251-y; Fujihara T, 2002, J OCUL PHARMACOL TH, V18, P363, DOI 10.1089/10807680260218524; Shimazaki-Den S, 2013, CORNEA, V32, P1120, DOI 10.1097/ICO.0b013e3182930b1d; Yokoi N, 2014, AM J OPHTHALMOL, V157, P85, DOI 10.1016/j.ajo.2013.09.009; FOX RI, 1986, ARTHRITIS RHEUM, V29, P577, DOI 10.1002/art.1780290501; Fujihara T, 2001, INVEST OPHTH VIS SCI, V42, P96; Murakami T, 2004, OPHTHAL RES, V36, P89, DOI 10.1159/000076887; Oguz H, 2000, CORNEA, V19, P497, DOI 10.1097/00003226-200007000-00019; Toda I, 2014, AM J OPHTHALMOL, V157, P616, DOI 10.1016/j.ajo.2013.11.017; Takamura E, 2012, BRIT J OPHTHALMOL, V96, P1310, DOI 10.1136/bjophthalmol-2011-301448; [Anonymous], 2007, OCUL SURF, V52, P75; Argueso P, 2002, INVEST OPHTH VIS SCI, V43, P1004; Nakamura M, 2012, ADV THER, V29, P579, DOI 10.1007/s12325-012-0033-9; Yokoi N, 2000, CORNEA, V19, pS37, DOI 10.1097/00003226-200005001-00008; Matsumoto Y, 2012, OPHTHALMOLOGY, V119, P1954, DOI 10.1016/j.ophtha.2012.04.010; Hirai N, 2006, EXP EYE RES, V82, P371, DOI 10.1016/j.exer.2005.07.009; Hirotani Yumi, 2003, Nippon Ganka Gakkai Zasshi, V107, P719; Jones DT, 1998, ADV EXP MED BIOL, V438, P533; Lemp Michael A., 1995, CLAO Journal, V21, P221; Masuda Q, 2013, J EYE, V30, P249; Murakami T, 2002, OPHTHALMIC RES, V34, P371, DOI 10.1159/000067042; PFLUGFELDER SC, 1990, OPHTHALMOLOGY, V97, P985; Shimazaki J., 2007, J EYE, V24, P181; SHIMMURA S, 1995, BRIT J OPHTHALMOL, V79, P1007, DOI 10.1136/bjo.79.11.1007; Stern Michael E, 2004, Ocul Surf, V2, P124; TAKAMURA E, 1994, ADV EXP MED BIOL, V350, P535; Takaoka-Shichijo Y, 2011, J EYE, V28, P261; Takaoka-Shichijo Y., 2011, J EYE, V28, P425; Takeshita T., 2013, JPN J CLIN OPHTHAL, V67, P327; TSUBOTA K, 1994, CORNEA, V13, P202, DOI 10.1097/00003226-199405000-00002; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Yamaguchi M, 2014, ADV THER, V31, P1169, DOI 10.1007/s12325-014-0162-4; Yamaguchi M, 2012, J EYE, V29, P527; Yerxa BR, 2002, ADV EXP MED BIOL, V506, P261; Yokoi N, 2013, DRY EYE SYNDROME BAS, P96, DOI DOI 10.2217/EBO.12.340; Yokoi N, 2004, ARCH OPHTHALMOL-CHIC, V122, P1265, DOI 10.1001/archopht.122.9.1265	48	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-222X	1476-5454		EYE	Eye	SEP	2015	29	9					1204	1212		10.1038/eye.2015.125		9	Ophthalmology	Ophthalmology	CR0XD	WOS:000361046000013		
J	Cho, HK; Kojima, S; Inoue, T; Fukushima, A; Kee, C; Tanihara, H				Cho, H-K; Kojima, S.; Inoue, T.; Fukushima, A.; Kee, C.; Tanihara, H.			Effect of laser suture lysis on filtration openings: a prospective three-dimensional anterior segment optical coherence tomography study	EYE			English	Article							FILTERING BLEBS; TRABECULECTOMY BLEBS; SURGERY	Purpose To investigate the effects of laser suture lysis (LSL) on filtration openings after trabeculectomy. Methods Prospective study analyzing the changes in the location and width of filtration openings, fluid cavity height, total bleb height, bleb wall thickness, and bleb wall intensity before and after LSL using threedimensional anterior segment optical coherence tomography (3D AS-OCT). Results Fourteen patients had clear scleral flap image analysis. As five patients underwent LSL twice and two patients underwent LSL thrice, 23 comparison studies were possible. After LSL the intraocular pressure (IOP) decreased (P= 0.0015) from 20.5 +/- 5.3 to 14.9 +/- 6.4 mm Hg, and the fluid cavity height increased significantly from 0.2 +/- 0.2 mm to 0.3 +/- 0.1 mm (P = 0.0094). Other bleb parameters were not significantly different when comparing before and after LSL. When the IOP reduction ratio was 425% following LSL, the width of the filtration openings on the LSL side, the total bleb height, and the fluid cavity height increased (P = 0.0273, 0.0342, and 0.0024, respectively). In multiple regression analysis the changes in fluid cavity height, the wall thickness, the wall intensity, and the width of the filtration opening were positively associated with the IOP reduction rate (P = 0.0428, 0.0226, 0.0420, and 0.0356, respectively). Conclusions 3D AS-OCT allowed a detailed examination of the internal morphology of filtration blebs and openings before and after LSL. The changes in the internal morphology were closely associated with the success of LSL to decrease IOP.	[Cho, H-K; Kojima, S.; Inoue, T.; Fukushima, A.; Tanihara, H.] Kumamoto Univ, Dept Ophthalmol, Fac Life Sci, Kumamoto 8608556, Japan; [Cho, H-K; Kee, C.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Inoue, T (reprint author), Kumamoto Univ, Dept Ophthalmol, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	noel@da2.so-net.ne.jp					Kojima S, 2015, JAMA OPHTHALMOL, V133, P148, DOI 10.1001/jamaophthalmol.2014.4489; Kawana K, 2009, OPHTHALMOLOGY, V116, P848, DOI 10.1016/j.ophtha.2008.11.019; Singh M, 2007, OPHTHALMOLOGY, V114, P47, DOI 10.1016/j.ophtha.2006.05.078; Wells AP, 2004, J GLAUCOMA, V13, P454, DOI 10.1097/00061198-200412000-00005; PAVLIN CJ, 1992, AM J OPHTHALMOL, V113, P381; Inoue T, 2012, INVEST OPHTH VIS SCI, V53, P8288, DOI 10.1167/iovs.12-10941; Cantor LB, 2003, J GLAUCOMA, V12, P266, DOI 10.1097/00061198-200306000-00015; CAIRNS JE, 1968, AM J OPHTHALMOL, V66, P673; Singh M, 2007, AM J OPHTHALMOL, V143, P873, DOI 10.1016/j.ajo.2006.12.001; Miura M, 2008, J GLAUCOMA, V17, P193, DOI 10.1097/IJG.0b013e31815a34cd; Kojima S, 2014, J GLAUCOMA, V23, P312, DOI 10.1097/IJG.0b013e3182741ee6; Leung CKS, 2007, BRIT J OPHTHALMOL, V91, P340, DOI 10.1136/bjo.2006.100321; Nakashima KI, 2015, GRAEF ARCH CLIN EXP, V253, P439, DOI 10.1007/s00417-014-2872-3; Picht G, 1998, Curr Opin Ophthalmol, V9, P2, DOI 10.1097/00055735-199804000-00002; Sng CCA, 2012, J GLAUCOMA, V21, P313, DOI 10.1097/IJG.0b013e31820e2d23; VESTI E, 1993, OPHTHALMIC SURG LAS, V24, P249	16	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-222X	1476-5454		EYE	Eye	SEP	2015	29	9					1220	1225		10.1038/eye.2015.129		6	Ophthalmology	Ophthalmology	CR0XD	WOS:000361046000015		
J	Hotta, F; Eguchi, H; Imai, S; Miyamoto, T; Mitamura-Aizawa, S; Mitamura, Y				Hotta, Fumika; Eguchi, Hiroshi; Imai, Shoji; Miyamoto, Tatsuro; Mitamura-Aizawa, Sayaka; Mitamura, Yoshinori			Scanning Electron Microscopy Findings With Energy-Dispersive X-ray Investigations of Cosmetically Tinted Contact Lenses	EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE			English	Article							MICROBIAL KERATITIS	Objective: To investigate the surfaces and principal elements of the colorants of cosmetically tinted contact lenses (Cos-CLs). Methods: We analyzed the surfaces and principal elements of the colorants of five commercially available Cos-CLs using scanning electron microscopy with energy-dispersive x-ray analysis. Results: In two Cos-CLs, the anterior and posterior surfaces were smooth, and colorants were found inside the lens. One lens showed colorants located to a depth of 8 to 14 mu m from the anterior side of the lens. In the other lens, colorants were found in the most superficial layer on the posterior surface, although a coated layer was observed. The colorants in the other three lenses were deposited on either lens surface. Although a print pattern was uniform in embedded type lenses, uneven patterns were apparent in dot-matrix design lenses. Colorants used in all lenses contained chlorine, iron, and titanium. In the magnified scanning electron microscopy images of a certain lens, chlorine is exuded and spread. Conclusions: Cosmetically tinted contact lenses have a wide variety of lens surfaces and colorants. Colorants may be deposited on the lens surface and consist of an element that has tissue toxicity.	[Hotta, Fumika; Eguchi, Hiroshi; Miyamoto, Tatsuro; Mitamura-Aizawa, Sayaka; Mitamura, Yoshinori] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Ophthalmol, Tokushima 7708503, Japan; [Imai, Shoji] Univ Tokushima, Inst Socioarts & Sci, Div Chem, Tokushima 7708503, Japan	Eguchi, H (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Ophthalmol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	hiroegu0113@gmail.com			Seed Co., Ltd.	F. Hotta, H. Eguchi, T. Miyamoto, S. Mitamura-Aizawa, and Y. Mitamura received a grant from Seed Co., Ltd. S. Imai has no conflicts of interest to disclose.	Eaton JW, 2002, FREE RADICAL BIO MED, V32, P833, DOI 10.1016/S0891-5849(02)00772-4; Keay L, 2006, INVEST OPHTH VIS SCI, V47, P4302, DOI 10.1167/iovs.06-0564; Dart JKG, 2008, OPHTHALMOLOGY, V115, P1647, DOI 10.1016/j.ophtha.2008.05.003; Begley C G, 1991, J Am Optom Assoc, V62, P208; Chana KY, 2014, CONTACT LENS ANTERIO, V37, P267, DOI 10.1016/j.clae.2013.12.002; Choi HW, 2008, CORNEA, V27, P252, DOI 10.1097/ICO.0b013e31815bcd9c; Giraldez MJ, 2010, OPTOMETRY VISION SCI, V87, pE426, DOI 10.1097/OPX.0b013e3181da8656; Latkovic Stefan, 1997, CLAO Journal, V23, P185; Lorenz KO, 2014, CLIN EXP OPTOM, V97, P411, DOI 10.1111/cxo.12148; Ray M, 2013, EYE CONTACT LENS, V39, P192, DOI 10.1097/ICL.0b013e3182448881; Ren David H., 1999, CLAO Journal, V25, P80; Santos Lívia, 2007, Cont Lens Anterior Eye, V30, P183, DOI 10.1016/j.clae.2006.12.007; Sauer A, 2011, ACTA OPHTHALMOL, V89, P439; Singh S, 2012, CORNEA, V31, P777, DOI 10.1097/ICO.0b013e31823cbe9c; Solomon O. David, 1994, CLAO Journal, V20, P109; Spiteri N, 2012, CASE REP OPHTHALMOL, V2012; Steinemann Thomas L, 2003, Eye Contact Lens, V29, P196, DOI 10.1097/00140068-200310000-00002; Steinemann Thomas L, 2005, Eye Contact Lens, V31, P194, DOI 10.1097/01.icl.0000175654.79591.03; Yang Z, 2008, ACTA METALL SIN, V21, P313, DOI DOI 10.1016/S1006-7191(08)60054-X	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1542-2321	1542-233X		EYE CONTACT LENS	Eye Contact Lens-Sci. Clin. Pra.	SEP	2015	41	5					291	296		10.1097/ICL.0000000000000122		6	Ophthalmology	Ophthalmology	CQ9WK	WOS:000360965700009		
J	Nagahara, Y; Koh, S; Maeda, N; Nishida, K; Watanabe, H				Nagahara, Yukiko; Koh, Shizuka; Maeda, Naoyuki; Nishida, Kohji; Watanabe, Hitoshi			Prominent Decrease of Tear Meniscus Height With Contact Lens Wear and Efficacy of Eye Drop Instillation	EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE			English	Article							DIQUAFOSOL OPHTHALMIC SOLUTION; OPTICAL COHERENCE TOMOGRAPHY; TFOS INTERNATIONAL WORKSHOP; IN-SITU KERATOMILEUSIS; DEFICIENT DRY EYE; SODIUM HYALURONATE; DISCOMFORT REPORT; FLUID SECRETION; FILM; TETRASODIUM	Objective: To investigate the change in tear meniscus height (TMH) before and after wearing soft contact lenses (CLs) of different water contents (WCs) and the influence of eye drop instillation on TMH during CL wear. Methods: Tear meniscus heights were measured using anterior segment optical coherence tomography in 20 normal subjects wearing a high-WC CL (WC, 69%) in 1 eye and a low-WC CL (WC, 24%) in the other. Tear meniscus height change after eye drop instillation with 3% diquafosol ophthalmic solution or saline with CL wear was evaluated at 5, 15, 30, and 60 min after instillation. Results: A significant decrease in TMH was observed after lens insertions of both CLs. Tear meniscus height was significantly decreased with high-WC CL wear compared with that with low-WC CL wear. With high-WC CL wear, TMH increased significantly (P<0.001) at 5 min after the instillation of 3% diquafosol ophthalmic solution compared with the baseline values and then returned to the pre-instillation level. No significant TMH changes were found with the instillation of either eye drop (diquafosol or saline) with low-WC CL wear. Conclusions: Tear meniscus height decreased with CL wear, especially with high-WC CL wear. Significant increases in TMH were observed at 5 min after the instillation of diquafosol ophthalmic solution with high-WC CL wear. The increases in TMH after diquafosol instillation tended to be greater than those after saline instillation at least for 30 min with both high-WC and low-WC CLs.	[Nagahara, Yukiko; Koh, Shizuka; Maeda, Naoyuki; Nishida, Kohji; Watanabe, Hitoshi] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan; [Watanabe, Hitoshi] Kansai Rosai Hosp, Dept Ophthalmol, Amagasaki, Hyogo, Japan	Watanabe, H (reprint author), Osaka Univ, Grad Sch Med, Dept Ophthalmol, Room E7,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	wat@kanrou.net					Mori Y, 2014, CORNEA, V33, P659, DOI 10.1097/ICO.0000000000000136; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; HOLLY FJ, 1985, T OPHTHAL SOC UK, V104, P374; Ohtomo K, 2014, INVEST OPHTH VIS SCI, V55, P2057, DOI 10.1167/iovs.13-12692; Li YS, 2001, AM J PHYSIOL-CELL PH, V281, pC595; Kaido M, 2013, J OCUL PHARMACOL TH, V29, P595, DOI 10.1089/jop.2012.0246; Spurr-Michaud S, 2007, EXP EYE RES, V84, P939, DOI 10.1016/j.exer.2007.01.018; Kamiya K, 2012, EYE, V26, P1363, DOI 10.1038/eye.2012.166; Jumblatt JE, 1998, EXP EYE RES, V67, P341, DOI 10.1006/exer.1998.0520; Guillon M, 2008, EYE CONTACT LENS, V34, P326, DOI 10.1097/ICL.0b013e31818c5d00; Palakuru JR, 2007, INVEST OPHTH VIS SCI, V48, P3032, DOI 10.1167/iovs.06-1507; Nichols JJ, 2006, INVEST OPHTH VIS SCI, V47, P1319, DOI 10.1167/iovs.05-1392; Koh S, 2013, JPN J OPHTHALMOL, V57, P440, DOI 10.1007/s10384-013-0251-y; Craig JP, 2013, INVEST OPHTH VIS SCI, V54, P123, DOI 10.1167/iovs.13-13235; Shimazaki-Den S, 2013, CORNEA, V32, P1120, DOI 10.1097/ICO.0b013e3182930b1d; EFRON N, 1986, AM J OPTOM PHYS OPT, V63, P819; Yokoi N, 2014, AM J OPHTHALMOL, V157, P85, DOI 10.1016/j.ajo.2013.09.009; Murakami T, 2004, OPHTHAL RES, V36, P89, DOI 10.1159/000076887; Toda I, 2014, AM J OPHTHALMOL, V157, P616, DOI 10.1016/j.ajo.2013.11.017; Takamura E, 2012, BRIT J OPHTHALMOL, V96, P1310, DOI 10.1136/bjophthalmol-2011-301448; Jones L, 2013, INVEST OPHTH VIS SCI, V54, P37, DOI 10.1167/iovs.13-13215; Lemp MA, 2007, OCUL SURF, V5, P75; Fukuda R, 2013, AM J OPHTHALMOL, V155, P620, DOI 10.1016/j.ajo.2012.11.009; Matsumoto Y, 2012, OPHTHALMOLOGY, V119, P1954, DOI 10.1016/j.ophtha.2012.04.010; CEDARSTAFF TH, 1983, AM J OPTOM PHYS OPT, V60, P167; Chen Q, 2011, INVEST OPHTH VIS SCI, V52, P2175, DOI 10.1167/iovs.10-5780; Chen Q, 2009, INVEST OPHTH VIS SCI, V50, P3159, DOI 10.1167/iovs.08-2794; Glasson M J, 2006, Cont Lens Anterior Eye, V29, P41, DOI 10.1016/j.clae.2005.12.006; Koh S, 2014, ACTA OPHTHALMOL, V92, pe671, DOI 10.1111/aos.12443; Le QH, 2009, CORNEA, V28, P851, DOI 10.1097/ICO.0b013e318197ec24; LOWTHER GE, 1968, AMER J OPT ARCH AM A, V45, P587; MARTIN DK, 1995, J BIOMED MATER RES, V29, P857, DOI 10.1002/jbm.820290711; McConville Patrick, 2001, CLAO Journal, V27, P186; Palakuru JR, 2008, AM J OPHTHALMOL, V146, P920, DOI 10.1016/j.ajo.2008.06.020; POLSE KA, 1978, INVEST OPHTH VIS SCI, V17, P1202; Thai LC, 2004, OPTOMETRY VISION SCI, V81, P194, DOI 10.1097/00006324-200403000-00012; Tomlinson A, 1982, J BR CONTACT LENS AS, V5, P141, DOI 10.1016/S0141-7037(82)80012-8; Wang JH, 2009, INVEST OPHTH VIS SCI, V50, P1106, DOI 10.1167/iovs.08-2458; Watanabe Hitoshi, 2002, Cornea, V21, pS17, DOI 10.1097/00003226-200203001-00005; Young G, 1996, OPTOMETRY VISION SCI, V73, P247, DOI 10.1097/00006324-199604000-00006	40	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1542-2321	1542-233X		EYE CONTACT LENS	Eye Contact Lens-Sci. Clin. Pra.	SEP	2015	41	5					318	322		10.1097/ICL.0000000000000134		5	Ophthalmology	Ophthalmology	CQ9WK	WOS:000360965700014		
J	Watanabe, K; Sasaki, K; Saito, T; Ogawa, G				Watanabe, Kyuji; Sasaki, Kei; Saito, Toshihiko; Ogawa, Gen			Scenario analysis of the effects of the Great East Japan Earthquake on the chum salmon population-enhancement system	FISHERIES SCIENCE			English	Article						Catastrophe; Chum salmon; Exploitation rate; Great East Japan Earthquake; Hatchery; Iwate Prefecture; Simulation; Survival rate	ONCORHYNCHUS-KETA; MANAGEMENT; COAST; SIZE; SEA	The Great East Japan Earthquake may have resulted in increased mortality of artificially propagated chum salmon fry (2010 year class) from Iwate Prefecture (CSI), both in the hatchery and after release. Individuals from the 2010 year class will return in 2014-2015. To evaluate the potential for future issues associated with the effects of the earthquake, we simulated CSI population dynamics using a model that incorporated stratified earthquake-influenced survival rates lambda (l) (l = 0.00-1.00 at intervals of 0.25) under various scenarios. Under laissez-faire scenarios (median exploitation rate E (Med)) under low post-release survival rate S (Low) and all lambda (l) , the median number of hatchery-released fry did not reach the target H (*) in 2014 and 2015. The probability P (j,t) of not meeting the targets was 0.56-1.00 (2014) and 0.79-1.00 (2015). Meanwhile, with simulation of a low exploitation rate, S (Low), and a higher lambda (l) (0.50), the P (j,t) in 2014 and 2015 was 0.00-0.17 and 0.21-0.72, respectively. Under S (Med) and S (High), reached H (*) at lambda (l) (> 0.50) regardless of E (l) , and the cumulative catch varied primarily with S (l) . Our results suggest that simulations can provide a method of predicting potential issues and can offer insight into strategies to minimize future problems.	[Watanabe, Kyuji; Saito, Toshihiko] Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Toyohira Ku, Sapporo, Hokkaido 0620922, Japan; [Ogawa, Gen] Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Miyako 0270097, Japan; [Ogawa, Gen] Iwate Fisheries Technol Ctr, Kamaishi, Iwate 0260001, Japan	Watanabe, K (reprint author), Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Toyohira Ku, 2-2 Nakanoshima, Sapporo, Hokkaido 0620922, Japan.	watanabk@fra.affrc.go.jp					Adbul-Aziz OI, 2010, CAN J FISH AQUAT SCI, V68, P1660; HEALEY MC, 1982, CAN J FISH AQUAT SCI, V39, P952, DOI 10.1139/f82-130; Saito T, 2009, FISH RES, V95, P14, DOI 10.1016/j.fishres.2008.07.004; Francis RICC, 1997, CAN J FISH AQUAT SCI, V54, P1699, DOI 10.1139/cjfas-54-8-1699; Saito T, 2011, FISH OCEANOGR, V20, P278, DOI 10.1111/j.1365-2419.2011.00583.x; Fukuwaka M, 2010, MAR ECOL PROG SER, V403, P219, DOI 10.3354/meps08461; HARADA Y, 1992, NIPPON SUISAN GAKK, V58, P1833; INOUE Y, 1987, NIPPON SUISAN GAKK, V53, P695; Irvine JR, 2012, NPAFC DOC, V1422, P1; ISHIDA K, 1991, Bulletin of the Japanese Society of Fisheries Oceanography, V55, P105; IWATA M, 1984, CAN J FISH AQUAT SCI, V41, P744; Iwate-ken Sake-masu zoshoku kyoukai, 2010, ANN REPORT; Kaeriyama M, 2014, BIOL INTERACTIONS WI, P223; Kishi MJ, 2010, DEEP-SEA RES PT II, V57, P1257, DOI 10.1016/j.dsr2.2009.12.013; Kitada S, 2014, FISHERIES SCI, V80, P237, DOI 10.1007/s12562-013-0692-8; Miyakoshi Y, 2012, ENVIRON BIOL FISH, V94, P197, DOI 10.1007/s10641-011-9872-5; Morita K, 2013, NIPPON SUISAN GAKK, V79, P206; National Salmon Resources Center, 1989, SALM DAT BAS; Ogawa G, 2012, NIPPON SUISAN GAKK, V78, P1040; Pope J., 1972, INT COMM NW ATL FISH, V9, P65; Prefecture Iwate, 1973, DAT REL SALM IW PREF; UENO Y, 1991, NIPPON SUISAN GAKK, V57, P1445; UENO Y, 1992, CAN J FISH AQUAT SCI, V49, P2307; Watanabe K, 2011, CAN J FISH AQUAT SCI, V68, P458, DOI 10.1139/F10-161	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					803	814		10.1007/s12562-015-0896-1		12	Fisheries	Fisheries	CQ9FP	WOS:000360918500001		
J	Yamamoto, T; Maruta, H; Suzuki, T; Kitanishi, S				Yamamoto, Toshiaki; Maruta, Hatsuna; Suzuki, Tatsuya; Kitanishi, Shigeru			Sperm traits dependent on body size in masu salmon Oncorhynchus masou	FISHERIES SCIENCE			English	Article						Masu salmon; Size-dependent; Sperm concentration; Sperm longevity; Sperm swimming speed	MATURE MALE PARR; ALTERNATIVE REPRODUCTIVE TACTICS; SECONDARY SEXUAL CHARACTERS; ATLANTIC SALMON; COMPETITION GAMES; SOCKEYE-SALMON; MATING TACTICS; LAKE TOYA; SALAR L; FERTILIZATION	Most comparative studies on the sperm traits (sperm concentration, swimming speed, and longevity) of salmonid fish involve males with alternative life histories (anadromous versus resident forms) that exhibit different reproductive strategies. However, males exhibit a dominance hierarchy within the same life history, in which smaller males have a tendency to be lower rank. This phenomenon prompted us to compare the sperm traits of large anadromous and small resident males in masu salmon Oncorhynchus masou, and to identify the size-dependent sperm traits within these two life history groups. We detected a significant difference in sperm concentration between the two groups, with resident males having higher sperm concentrations than anadromous males. For resident males, we detected a significantly negative correlation between body size and sperm swimming speed, i.e., faster sperm speed was associated with smaller body size. These findings support earlier data and suggest that smaller or younger males utilize more energy to produce high concentration and high speed sperms.	[Yamamoto, Toshiaki; Maruta, Hatsuna; Suzuki, Tatsuya] Nippon Vet & Life Sci Univ, Dept Vet Nursing & Technol, Musashino, Tokyo 1808602, Japan; [Kitanishi, Shigeru] Gifu Univ, Fac Reg Studies, Gifu 5011193, Japan	Yamamoto, T (reprint author), Nippon Vet & Life Sci Univ, Dept Vet Nursing & Technol, Musashino, Tokyo 1808602, Japan.	tyamamoto@nvlu.ac.jp			JSPS [TY25430196]; River Fund in charge of The Foundation of River and Watershed Environment Management (FOREM), Japan	We thank M. Komiya, A. Ohya, H. Omiya and C. Uehara for their help in the field. This research was supported in part by JSPS Grants-in-Aid for Scientific Research TY25430196 and the River Fund in charge of The Foundation of River and Watershed Environment Management (FOREM), Japan (S.K.).	Andersson M., 1994, SEXUAL SELECTION; Neff BD, 2003, BEHAV ECOL, V14, P634, DOI 10.1093/beheco/arg032; Fleming IA, 1996, REV FISH BIOL FISHER, V6, P379, DOI 10.1007/BF00164323; Watanabe M, 2008, CAN J ZOOL, V86, P1121, DOI 10.1139/Z08-093; MAEKAWA K, 1983, JPN J ICHTHYOL, V30, P227; Gage MJG, 1995, PHILOS T ROY SOC B, V350, P391, DOI 10.1098/rstb.1995.0173; Foote CJ, 1997, CAN J FISH AQUAT SCI, V54, P1785, DOI 10.1139/cjfas-54-8-1785; Koseki Y, 2000, BEHAV ECOL SOCIOBIOL, V48, P211, DOI 10.1007/s002650000231; Pitcher TE, 2009, J FISH BIOL, V74, P1450, DOI 10.1111/j.1095-8649.2009.02210.x; Thomaz D, 1997, P ROY SOC B-BIOL SCI, V264, P219; Rudolfsen G, 2006, P ROY SOC B-BIOL SCI, V273, P325, DOI 10.1098/rspb.2005.3305; Vladic TV, 2001, P ROY SOC B-BIOL SCI, V268, P2375, DOI 10.1098/rspb.2001.1768; Rudolfsen G, 2008, AQUAC RES, V39, P212, DOI 10.1111/j.1365-2109.2007.01863.x; Ishijima S, 2002, MOL REPROD DEV, V61, P376, DOI 10.1002/mrd.10017; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; JONSSON N, 1991, J FISH BIOL, V39, P739, DOI 10.1111/j.1095-8649.1991.tb04403.x; Janhunen M, 2009, BIOL J LINN SOC, V98, P794; MYERS RA, 1987, J FISH BIOL, V31, P143, DOI 10.1111/j.1095-8649.1987.tb05220.x; JARVI T, 1990, ETHOLOGY, V84, P123; Ball MA, 1996, J THEOR BIOL, V180, P141, DOI 10.1006/jtbi.1996.0090; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Hoysak DJ, 2001, J FISH BIOL, V58, P1286, DOI 10.1006/jfbi.2000.1536; BABA SA, 1985, CELL MOTIL CYTOSKEL, V5, P475; Esteve M, 2011, ECOL FRESHW FISH, V20, P492, DOI 10.1111/j.1600-0633.2010.00455.x; Fleming Ian A., 2004, P264; Gasparini C, 2010, J EVOLUTION BIOL, V23, P124, DOI 10.1111/j.1420-9101.2009.01889.x; Hendry A. P., 2004, EVOLUTION ILLUMINATE; Kato F., 1991, P447; Kortet R, 2004, BIOL J LINN SOC, V81, P111, DOI 10.1111/j.1095-8312.2004.00275.x; Koseki Y, 2002, CAN J FISH AQUAT SCI, V59, P1717, DOI 10.1139/F02-143; Ohta H, 2000, NIPPON SUISAN GAKK, V66, P88; Quinn T.P., 2005, BEHAV ECOLOGY PACIFI; STOSS J, 1981, AQUACULTURE, V22, P97, DOI 10.1016/0044-8486(81)90136-8; Tamate T, 2000, EURASIAN J FOR RES, V1, P39; Watanabe M, 2010, J FISH BIOL, V77, P162, DOI 10.1111/j.1095-8649.2010.02667.x; Yamamoto T, 2000, ICHTHYOL RES, V47, P407, DOI 10.1007/BF02674271; Yamamoto T, 2002, J FRESHWATER ECOL, V17, P275, DOI 10.1080/02705060.2002.9663896	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					815	820		10.1007/s12562-015-0899-y		6	Fisheries	Fisheries	CQ9FP	WOS:000360918500002		
J	Tomano, S; Sanchez, G; Ueno, K; Ueta, Y; Ohara, K; Umino, T				Tomano, Satoshi; Sanchez, Gustavo; Ueno, Kanako; Ueta, Yukio; Ohara, Kenichi; Umino, Tetsuya			Microsatellite DNA variation of oval squid Sepioteuthis sp 2 reveals a single fishery stock on the coastline of mainland Japan	FISHERIES SCIENCE			English	Article						Genetic diversity; Microsatellite loci; Oval squid; Sepioteuthis sp 2; Population structure	POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; COMPUTER-PROGRAM; LOLIGINID SQUID; LESSONIANA; AGGREGATIONS; CEPHALOPODA; MARKERS	The level of genetic diversity and population differentiation of oval squid Shiro-ika Sepioteuthis sp. 2 around mainland Japan were examined using highly polymorphic DNA markers. Ten microsatellite loci showed relatively low genetic diversity (average observed heterozygosity H (O) = 0.68, overall mean number of alleles N (A) = 10.0) as compared with other squid, which may be explained by a recent history of population expansion. Populations from 12 sites along the coastline of Japan were genetically homogeneous, as measured by F (ST) values (global F (ST): -0.0006; pairwise F (ST): from -0.0046 to 0.0083), R (ST) values (global R (ST): 0.0025; pairwise R (ST): from -0.0076 to 0.03), a neighbor-joining (NJ) tree based on Cavalli-Sforza and Edwards chord distance, Bayesian clustering or analyses of three geographical groups (Sea of Japan, Seto Inland Sea, and Pacific Ocean; F (CT) = -0.0005), and should be considered as a single fishery stock. Allele frequencies also showed a high degree of similarity across different years in the samples taken from Hiroshima. Factors influencing this homogeneity include genetic exchange without barriers preventing gene flow, larval dispersal, and active adult migration of Sepioteuthis sp. 2.	[Tomano, Satoshi; Sanchez, Gustavo; Ueno, Kanako; Umino, Tetsuya] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 7398528, Japan; [Ueta, Yukio] Tokushima Agr Forestry & Fisheries Technol Suppor, Naruto, Tokushima 7710361, Japan; [Ohara, Kenichi] Gifu Prefectural Res Inst Freshwater Fish & Aquat, Gero, Gifu 5092592, Japan	Umino, T (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 7398528, Japan.	umino@hiroshima-u.ac.jp			Ministry of Education, Culture, Sport, Science, and Technology of Japan [26292106]; Japan Society for Promotion of Science (JSPS)	We gratefully acknowledge the assistance of people who helped with collecting specimens, Dr. Shiro Itoi (College of Bioresource Sciences, Nihon University), Mr. Atsushi Urabe (Kochi Prefectural Freshwater Fisheries Experimental Station), Dr. Akira Okamoto (Nagasaki Prefectural Government), Mr. Hiroyuki Hatanaka (Fukui Prefectural Fisheries Experimental Station), Ms. Shigemi Tsuda (Ishikawa Prefectural Fisheries Research Center), Mr. Kingo Tsumoto (Mie Prefectural Government), Mr. Kazuhiko Wada (Kagoshima Prefectural Government), and Mr. Makoto Watanabe (Miyazaki Prefectural Government). We would like to thank Dr. Tomoe Hikosaka for her cooperation and assistance in sequencing using the ABI 3130xl sequencer at the Gene Science Division, Natural Science Centre for Basic Research and Development, Hiroshima University. We also appreciate the cooperation of the executive committee of the squid fishing competition in Sukumo, Kochi Prefecture, and Breeden Co., Ltd., for kindly collecting specimens. This research was supported partly by Grants-in-Aid for Scientific Research (No. 26292106 for T.U.) from the Ministry of Education, Culture, Sport, Science, and Technology of Japan. This work was also supported by grants for a Research Fellowship from the Japan Society for Promotion of Science (JSPS) for Young Scientists to S.T.	RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.2307/2409177; Garoia F, 2004, HEREDITY, V93, P166, DOI 10.1038/sj.hdy.6800489; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Shaw PW, 2004, MAR BIOL, V144, P961, DOI 10.1007/s00227-003-1260-z; Pritchard JK, 2000, GENETICS, V155, P945; Shaw PW, 1999, MOL ECOL, V8, P407, DOI 10.1046/j.1365-294X.1999.00588.x; Shigeno S, 2001, J COMP NEUROL, V437, P449, DOI 10.1002/cne.1295; Shaw PW, 2010, MAR ECOL PROG SER, V408, P117, DOI 10.3354/meps08593; Sugimoto C, 2012, FISHERIES SCI, V78, P287, DOI 10.1007/s12562-011-0464-2; Hardy OJ, 2003, GENETICS, V163, P1467; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Aoki M, 2008, PAC SCI, V62, P403, DOI 10.2984/1534-6188(2008)62[403:LGDOOS]2.0.CO;2; CAVALLIS.LL, 1967, AM J HUM GENET, V19, P233; Cornuet LM, 1996, GENETICS, V144, P2001; Dotsu K, 1981, ECOLOGY FISHERIES OV, P457; Imai H, 2012, ANAL GENETIC VARIATI, P151; Ito K, 2006, NIPPON SUISAN GAKK, V72, P905, DOI 10.2331/suisan.72.905; Izuka Takashi, 1994, Venus the Japanese Journal of Malacology, V53, P217; Izuka T, 1996, AM MALACOL BULL, V12, P129; Jereb P, 2010, FAO SPECIES CATALOGU, V2; Kanamaru H, 2007, B SAGA GENKAI FISH R, V4, P51; Nabhitabhata J, 2014, CULTURE CEPHALOPOD, P315; Okutani T, 1984, SAIBAI GIKEN, V13, P69; Segawa Susumu, 1993, P513; SEGAWA S, 1987, Journal of the Tokyo University of Fisheries, V74, P67; Segawa S, 1993, JPN J MALACOL VENUS, V52, P195; Tomano S, 2013, INT J MOL SCI, V14, P19971, DOI 10.3390/ijms141019971; Ueta Y, 1995, B JPN SOC FISH OCEAN, V4, P409; Yokogawa K, 2000, JPN J MALACOL VENUS, V59, P45	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					839	847		10.1007/s12562-015-0905-4		9	Fisheries	Fisheries	CQ9FP	WOS:000360918500005		
J	Ashida, H; Horie, M				Ashida, Hiroshi; Horie, Masahiro			Reproductive condition, spawning season, batch fecundity and spawning fraction of skipjack tuna Katsuwonus pelamis caught around Amami-Oshima, Kagoshima, Japan	FISHERIES SCIENCE			English	Article						Atresia; Postovulatory follicles; Spawning interval; Temperate zone	CENTRAL PACIFIC-OCEAN; WESTERN INDIAN-OCEAN; THUNNUS-ALBACARES; YELLOWFIN TUNA; ATLANTIC COD; FREQUENCY; CYCLES; FISHES; INDEX	To illustrate the spawning characteristics of skipjack tuna Katsuwonus pelamis in the Northwestern Pacific Ocean, we examined seasonal changes in the histological condition of gonads, spawning fraction, and batch fecundity (BF) of skipjack tuna caught around Amami-Oshima in the northern Nansei Islands, Japan, from May 2011 to July 2013. Females classified as "mature" appeared from June to October, and mature males were present from April to November. Spawning began in June when the sea surface temperature (SST) exceeded 24 A degrees C and peaked in August. Although the SST was still above 24 A degrees C, spawning ended in September when the SST started decreasing continuously. The minimum size (fork length, FL) at first maturity was 40.5 cm for females and 37.6 cm for males. The BF (mean +/- A SD) and relative batch fecundity (RBF) were estimated at 93,700 +/- A 21,800 oocytes and 56.8 +/- A 14.3 oocytes/g, respectively. The total spawning fraction (spawning intervals) during the spawning season was estimated at 0.53 (1.88 days). These results indicate that the spawning activity of skipjack tuna around Amami-Oshima changes seasonally depending on SST.	[Ashida, Hiroshi] Fisheries Res Agcy, Natl Res Inst Far Seas Fisheries, Shizuoka, Shimizu 4248633, Japan; [Horie, Masahiro] Kagoshima Prefectural Fisheries Technol & Dev Ctr, Kagoshima, Ibusuki 8910315, Japan	Ashida, H (reprint author), Fisheries Res Agcy, Natl Res Inst Far Seas Fisheries, Shizuoka, Shimizu 4248633, Japan.	hashida@affrc.go.jp			Japan Fisheries Agency	We thank the staff of the Setouchi Fisheries Cooperative Association and the Kagoshima Prefectural Fisheries Technology and Development Center for their cooperation in fish measurement and sampling. We also thank T. Tanabe (Seikai National Fisheries Research Institute) and H. Okamoto (National Research Institute of Far Seas Fisheries) for valuable comments about our manuscript. This research was made possible by a grant from the Japan Fisheries Agency.	Marteinsdottir G, 2002, MAR ECOL PROG SER, V235, P235, DOI 10.3354/meps235235; Wright PJ, 2009, FISH FISH, V10, P283, DOI 10.1111/j.1467-2979.2008.00322.x; Stequert B, 2001, AQUAT LIVING RESOUR, V14, P313, DOI 10.1016/S0990-7440(01)01126-3; Margulies D, 2007, FISH B-NOAA, V105, P249; Yoneda M, 2005, J FISH BIOL, V67, P1225, DOI 10.1111/j.1095-8649.2005.00819.x; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; HUNTER JR, 1986, FISH B-NOAA, V84, P895; Schaefer KM, 1996, FISH B-NOAA, V94, P98; Ashida H, 2010, FISHERIES SCI, V76, P785, DOI 10.1007/s12562-010-0282-y; Ashida H, 2007, NIPPON SUISAN GAKK, V73, P437, DOI 10.2331/suisan.73.437; Ashida H, 2008, NIPPON SUISAN GAKK, V74, P802, DOI 10.2331/suisan.74.802; Ashida H, 2013, NIPPON SUISAN GAKK, V79, P226; Brawn-Peterson NJ, 2011, MAR COAST FISH, V3, P52; CAYRE P, 1986, MAR BIOL, V90, P345, DOI 10.1007/BF00428558; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; Grande M, 2012, J SEA RES, V73, P117, DOI 10.1016/j.seares.2012.06.008; GRIER HJ, 1981, AM ZOOL, V21, P345; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P67; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P79; Itano D.G., 2000, JIMAR CONTRIBUTION; Kurita Yutaka, 2010, Bulletin of the Japanese Society of Fisheries Oceanography, V74, P4; Lambert Yvan, 2003, Journal of Northwest Atlantic Fishery Science, V33, P115, DOI 10.2960/J.v33.a7; Matsumoto WM, 1984, NOAA TECH REP NMFS C, V451, P1; Matsuyama Michiya, 2010, Bulletin of the Japanese Society of Fisheries Oceanography, V74, P66; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Naganuma A, 1979, B TOHOKU REG FISH R, V40, P1; NIKAIDO H, 1991, B NAT RES I FAR SEAS, V28, P47; Nishikawa Y., 1985, FAR SEAS FISH RES LA, V12, P1; Okamoto S, 2013, B JPN SOC FISH ONEAN, V77, P155; Russell L.D., 1993, SERTOLI CELL, P703; Schaefer MB, 1956, INTERAM TROP TUNA CO, V1, P283; Shimizu Akio, 2010, Bulletin of the Japanese Society of Fisheries Oceanography, V74, P58; Stequert B, 1996, AQUAT LIVING RESOUR, V9, P235, DOI 10.1051/alr:1996027; Tanabe T, 2003, SKJ8 SCTB16, P1; Tashiro K, 1989, B MIYAZAKI PRE FISH, V5, P1; Tsuruta Y, 1992, B NAT RES I FISH ENG, V13, P129; UEYANAGI S, 1969, Bulletin Far Seas Fisheries Research Laboratory (Shimizu), V2, P177; WCPFC, 2013, TUN FISH YB 2012; Wild A, 1994, P 1 FAO EXP CONS INT, P1; Yabe H, 1954, GEN VIEW FISHERY SCI, P182; Yasui M, 1985, B SHIZUOKA PREF FISH, V20, P1; Yoneda M, 2014, MAR BIOL, V160, P2733; Yoneda M, 2013, B JPN SOC FISH OCEAN, V77, P59; Yoshida H. O., 1966, Fishery Bulletin United States, V65, P479	44	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					861	869		10.1007/s12562-015-0909-0		9	Fisheries	Fisheries	CQ9FP	WOS:000360918500007		
J	Mori, T; Miyata, N; Aoyama, J; Niizuma, Y; Sato, K				Mori, Tomohiko; Miyata, Naoyuki; Aoyama, Jun; Niizuma, Yasuaki; Sato, Katsufumi			Estimation of metabolic rate from activity measured by recorders deployed on Japanese sea bass Lateolabrax japonicus	FISHERIES SCIENCE			English	Article						Biologging; Oxygen consumption; Tail beat frequency; Body beat frequency; Activity; Japanese sea bass; Energy expenditure rate	TAIL BEAT FREQUENCY; OXYGEN-CONSUMPTION; SWIMMING SPEED; ENERGY-EXPENDITURE; ACCELERATION DATA; SOCKEYE SALMON; TELEOST FISH; DATA-LOGGER; BIOENERGETICS; TEMPERATURE	Understanding the energy expenditure of top predators is important because a collapse in them could trigger trophic cascades through ecosystems. One such top predator, Japanese sea bass Lateolabrax japonicus, helps to balance the structure of the coastal marine ecosystem through predation. In this study, accelerometry was applied to the Japanese sea bass to estimate its energy expenditure under natural conditions. We attached accelerometers to five wild fish and measured metabolic rates such as the oxygen consumption rate (, mg O-2 kg(-1) min(-1)) using a swim tunnel. Body beat frequency (BBF) was measured using the accelerometer. The BBF was correlated with the tail beat frequency (TBF) by analyzing video recordings. was related to swimming speed (U), TBF, and BBF. We estimated the standard (45.9 kJ kg(-1) day(-1)) and active (124.0 kJ kg(-1) day(-1)) metabolic rates when fish were not swimming and when they were swimming at the optimum swimming speed, respectively. The energy required to compensate for the above metabolic rates are between 83.3 and 275.6 kJ kg(-1) day(-1) using an assimilation efficiency of 0.7 and assuming that the growth rate is zero. These costs were comparable to consuming one or two prey fish per day (e.g., Japanese sardine: mean total length 155 +/- A SD 6 mm).	[Mori, Tomohiko; Miyata, Naoyuki; Aoyama, Jun; Sato, Katsufumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Niizuma, Yasuaki] Meijo Univ, Fac Agr, Lab Environm Zool, Tenpaku Ku, Nagoya, Aichi 4688502, Japan	Mori, T (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778564, Japan.	isana-137@aori.u-tokyo.ac.jp			Ocean Policy Research Foundation, Bio-logging Science; The University of Tokyo; Japan Science Society; Japan Society for the Promotion of Science [24241001, 25660152]	We sincerely thank G. Van den Thillart for providing the Atmosphere and Ocean Research Institute, The University of Tokyo with the swim tunnel. We thank K. Mizushima, T. Niizawa, and M. Kaku for collecting fish, and especially thank T. Takatsu and H. Shinomiya for shipping. We also thank R. Manabe for his support during the laboratory work. We are grateful for the comments of A. A. Robson, which greatly improved the manuscript. This study was supported by the Ocean Policy Research Foundation, Bio-logging Science, The University of Tokyo, and the Japan Science Society (to TM) as well as the Japan Society for the Promotion of Science (24241001 and 25660152 to KS). We are grateful for the comments of three anonymous referees which greatly improved the manuscript.	Secor DH, 1998, FISHERIES SCI, V64, P740; Gleiss AC, 2010, J EXP MAR BIOL ECOL, V385, P85, DOI 10.1016/j.jembe.2010.01.012; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1111/j.1095-8649.1998.tb00986.x; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Kawabe R, 2003, FISHERIES SCI, V69, P959, DOI 10.1046/j.1444-2906.2003.00713.x; Clark TD, 2010, J COMP PHYSIOL B, V180, P673, DOI 10.1007/s00360-009-0442-5; NEY JJ, 1993, T AM FISH SOC, V122, P736, DOI 10.1577/1548-8659(1993)122<0736:BMTGPO>2.3.CO;2; Palstra A, 2008, COMP BIOCHEM PHYS A, V151, P37, DOI 10.1016/j.cbpa.2008.05.011; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183; Fuji T, 2011, J FISH BIOL, V78, P2010, DOI 10.1111/j.1095-8649.2011.02990.x; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Murchie KJ, 2011, J EXP MAR BIOL ECOL, V396, P147, DOI 10.1016/j.jembe.2010.10.019; Steinhausen MF, 2005, MAR BIOL, V148, P197, DOI 10.1007/s00227-005-0055-9; van den Thillart G, 2004, J FISH BIOL, V65, P312, DOI 10.1111/j.1095.8649.2004.00447.x; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Wright S, 2014, MAR ECOL PROG SER, V496, P19, DOI 10.3354/meps10528; ELLIOTT JM, 1975, OECOLOGIA, V19, P195, DOI 10.1007/BF00345305; ELLIOTT JM, 1976, J ANIM ECOL, V45, P923, DOI 10.2307/3590; Beamish F. W. H, 1978, FISH PHYSIOL, P101, DOI DOI 10.1016/S1546-5098(08)60164-8; BEAMISH F W H, 1970, Canadian Journal of Zoology, V48, P1221, DOI 10.1139/z70-211; BEAMISH FWH, 1974, J FISH RES BOARD CAN, V31, P1763; BOISCLAIR D, 1989, CAN J FISH AQUAT SCI, V46, P1859, DOI 10.1139/f89-234; BRETT JR, 1965, J FISH RES BOARD CAN, V22, P1491; Fujita S, 1988, JPN J ICHTHYOL, V35, P5; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Hatanaka M, 1962, NIPPON SUISAN GAKK, V28, P949; Hatanaka M, 1962, NIPPON SUISAN GAKK, V28, P851; Hatanaka M, 1962, NIPPON SUISAN GAKK, V28, P857; Kato M, 2004, B CHIBA PREF FISH RE, V3, P17; Lindsey C C, 1978, FISH PHYSIOL, V7, P1, DOI DOI 10.1016/S1546-5098(08)60163-6; Lowe CG, 2002, J EXP MAR BIOL ECOL, V278, P141, DOI 10.1016/S0022-0981(02)00331-3; Miyahara K, 1995, HYOGO SUISHI KENPO, V32, P1; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Tanaka H, 2001, J EXP BIOL, V204, P3895; Tanaka M, 2002, TEMPERATE BASS BIODI; Tytler P, 1985, FISH ENERGETICS NEW; Videler J. J., 1993, FISH SWIMMING; Watanabe T, 1965, NIPPON SUISAN GAKK, V31, P585; Yasuda T, 2012, FISHERIES SCI, V78, P229, DOI 10.1007/s12562-011-0446-4	43	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					871	882		10.1007/s12562-015-0910-7		12	Fisheries	Fisheries	CQ9FP	WOS:000360918500008		
J	Li, Z; Yamamoto, J; Sakurai, Y				Li, Zhe; Yamamoto, Jun; Sakurai, Yasunori			Vertical position, specific gravity and swimming ability of Pacific cod Gadus macrocephalus yolk-sac larvae reared at four temperatures	FISHERIES SCIENCE			English	Article						Pacific cod; Yolk-sac larvae; Various temperatures; Vertical position; Specific gravity; Vertical movement rate	JUVENILE ATLANTIC COD; LIFE-HISTORY STAGES; DEPENDENT GROWTH; FISH LARVAE; BODY-SIZE; MORHUA; SURVIVAL; PERFORMANCE; BUOYANCY; SPEED	Vertical position and movement rate were measured in the yolk-sac larvae of the Pacific cod Gadus macrocephalus at different rearing temperatures (3, 5, 7, and 9 A degrees C) and an identical temperature of 5 A degrees C in experimental columns during the initial 3 days post-hatch (dph). Larval specific gravity was also measured through sinking velocities. Yolk-sac larvae swam upward and initially (0 dph) remained in the upper section of the experimental column through intermittent upward swimming, and gradually moved to near-neutral buoyancy at 3 dph at corresponding rearing temperatures. Rearing temperature significantly affected the swimming ability: at 0 dph, vertical movement rates measured at 5 A degrees C were low in the yolk-sac larvae reared at warm temperatures. However, no such difference was observed at 3 dph. The difference in vertical movement rate may have resulted from the temperature-mediated body sizes (standard length) and yolk-sac sizes (yolk-sac volume) at hatching. Specific gravity did not change for the varying temperatures during the initial 3 days, but decreased as ontogeny progressed. Therefore, we suggest that Pacific cod yolk-sac larvae achieve a demersal-pelagic habitat transition through upward swimming and increasing buoyancy.	[Li, Zhe; Sakurai, Yasunori] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Yamamoto, Jun] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Hakodate, Hokkaido 0418611, Japan	Sakurai, Y (reprint author), Hokkaido Univ, Grad Sch Fisheries Sci, 3-1-1 Minato, Hakodate, Hokkaido 0418611, Japan.	sakurai@fish.hokudai.ac.jp					ALDERDIC.DF, 1971, J FISH RES BOARD CAN, V28, P883; von Herbing IH, 2002, J FISH BIOL, V61, P865, DOI 10.1006/jfbi.2002.2118; NEILSON JD, 1986, MAR ECOL PROG SER, V32, P229, DOI 10.3354/meps032229; MILLERO FJ, 1981, DEEP-SEA RES, V28, P625, DOI 10.1016/0198-0149(81)90122-9; BATTY RS, 1992, J EXP BIOL, V170, P187; Peck MA, 2006, ENVIRON BIOL FISH, V75, P419, DOI 10.1007/s10641-006-0031-3; Saborido-Rey F, 2003, J PLANKTON RES, V25, P291, DOI 10.1093/plankt/25.3.291; vonHerbing IH, 1996, MAR BIOL, V124, P593, DOI 10.1007/BF00351041; Takatsu T, 2002, FISH OCEANOGR, V11, P90, DOI 10.1046/j.1365-2419.2002.00193.x; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Hurst TP, 2009, FISH OCEANOGR, V18, P301, DOI 10.1111/j.1365-2419.2009.00512.x; Shepherd TD, 2000, MAR BIOL, V137, P737, DOI 10.1007/s002270000340; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; Sakurai Y, 2007, DEEP-SEA RES PT II, V54, P2526, DOI 10.1016/j.dsr2.2007.02.007; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Bian X, 2014, J FISH BIOL, V84, P85, DOI 10.1111/jfb.12257; BOEHLERT GW, 1985, FISH B-NOAA, V83, P611; Otterlei E, 1999, CAN J FISH AQUAT SCI, V56, P2099, DOI 10.1139/cjfas-56-11-2099; Beveridge OS, 2010, J EXP BIOL, V213, P4223, DOI 10.1242/jeb.045435; Bian X, 2014, J FISH BIOL, V84, P403, DOI 10.1111/jfb.12292; Childs MR, 1996, T AM FISH SOC, V125, P940, DOI 10.1577/1548-8659(1996)125<0940:TEOSPO>2.3.CO;2; DAVIS MW, 1994, ENVIRON BIOL FISH, V39, P313, DOI 10.1007/BF00005132; DOVING KB, 1994, MAR BIOL, V120, P351, DOI 10.1007/BF00680208; Folkvord A, 2005, CAN J FISH AQUAT SCI, V62, P1037, DOI 10.1139/F05-008; FORRESTER CR, 1964, J FISH RES BOARD CAN, V21, P9; Gronkjaer P, 1997, MAR ECOL PROG SER, V154, P91, DOI 10.3354/meps154091; Houde E.D., 1987, AM FISH SOC S, V2, P17; Laurel BJ, 2008, J PLANKTON RES, V30, P1051, DOI 10.1093/plankt/fbn057; Laurel BJ, 2010, MAR BIOL, V157, P1713, DOI 10.1007/s00227-010-1445-1; Laurel B.J., 2007, Journal of Experimental Marine Biology and Ecology, V351, P42, DOI 10.1016/j.jembe.2007.06.005; LITVAK MK, 1992, MAR ECOL PROG SER, V81, P13, DOI 10.3354/meps081013; METHVEN DA, 1991, CAN J ZOOL, V69, P2161, DOI 10.1139/z91-302; Sakurai Y, 1996, FISHERIES SCI, V62, P222; WEBB PW, 1986, T AM FISH SOC, V115, P115, DOI 10.1577/1548-8659(1986)115<115:FLMOEL>2.0.CO;2; YIN MC, 1987, J EXP MAR BIOL ECOL, V107, P279, DOI 10.1016/0022-0981(87)90044-X	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					883	889		10.1007/s12562-015-0911-6		7	Fisheries	Fisheries	CQ9FP	WOS:000360918500009		
J	Kim, YS; Delgado, DI; Cano, I; Sawada, Y				Kim, Yang-Su; Delgado, Darys Isabel; Cano, Amado; Sawada, Yoshifumi			Effect of temperature and salinity on hatching and larval survival of yellowfin tuna Thunnus albacares	FISHERIES SCIENCE			English	Article						Yellowfin tuna; Hatching rate; Normal larval rate; Survival activity index; Temperature; Salinity; Interaction	SWIM BLADDER INFLATION; GROWTH; EGGS; TOLERANCE; PATTERNS; SCHLEGEL; TEMMINCK; FISH	Effects of temperature and salinity on hatching rate and normal larval rate at hatching, and survival of fasting larvae after hatching (survival activity index; SAI) were investigated using spontaneously spawned eggs of captive yellowfin tuna (Thunnus albacares, YFT). Within the range of experimental temperatures, 23-35 A degrees C, at 32 psu salinity, hatching and normal larval rates and SAI were highest at 23 and 26 A degrees C. In the experiment exploring the most suitable salinity within the range 23-38 psu, 35 and 38 psu gave the highest hatching rate and normal larval rate; however, SAI was highest at 26 psu. The results of multi-factor experiments in each temperature (23, 26, and 29 A degrees C) with each salinity (32, 35, and 38 psu) indicated interactive effects of temperature and salinity on the three indices and within the experimental ranges gave an optimal combination of 23 A degrees C and 38 psu for YFT hatching and survival.	[Kim, Yang-Su; Sawada, Yoshifumi] Kinki Univ, Fisheries Labs, Oshima Branch, Wakayama 6493633, Japan; [Delgado, Darys Isabel] Aquat Resources Author Panama, Panama City, Panama; [Cano, Amado] Aquat Resources Author Panama, Achotines Lab, Los Tablas, Los Santos Prov, Panama	Kim, YS (reprint author), Kinki Univ, Fisheries Labs, Oshima Branch, Wakayama 6493633, Japan.	yskim0535@gmail.com			Science and Technology Research Partnership for Sustainable Development (SATREPS) program of the Japan Science and Technology Agency; Japan International Cooperation Agency	The authors would like to thank the staff of the Achotines Laboratory of the IATTC and the staff of the Japan International Cooperation Agency Panama Office for their cordial support throughout the experiment. This study was supported by the Science and Technology Research Partnership for Sustainable Development (SATREPS) program of the Japan Science and Technology Agency and the Japan International Cooperation Agency.	Margulies D, 2007, FISH B-NOAA, V105, P249; Haddy JA, 2000, AQUACULTURE, V188, P115, DOI 10.1016/S0044-8486(00)00326-4; Sawada Y, 2005, AQUAC RES, V36, P413, DOI 10.1111/j.1365-2109.2005.01222.x; Wexler JB, 2011, J EXP MAR BIOL ECOL, V404, P63, DOI 10.1016/j.jembe.2011.05.002; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Gracia-Lopez V, 2004, AQUACULTURE, V237, P485, DOI 10.1016/j.aquaculture.2004.04.018; Fielder DS, 2005, AQUACULTURE, V250, P201, DOI 10.1016/j.aquaculture.2005.04.045; Boeuf G, 2001, COMP BIOCHEM PHYS C, V130, P411, DOI 10.1016/S1532-0456(01)00268-X; HOLLIDAY FG, 1967, J MAR BIOL ASSOC UK, V47, P39; Song LM, 2008, FISH OCEANOGR, V17, P239, DOI 10.1111/j.1365-2419.2008.00476.x; Boyce DG, 2008, MAR ECOL PROG SER, V355, P267, DOI 10.3354/meps07237; Battaglene SC, 1995, THESIS U TASMANIA LA; BATTAGLENE SC, 1993, PROG FISH CULT, V55, P35, DOI 10.1577/1548-8640(1993)055<0035:EOSAAO>2.3.CO;2; Bergan P, 1960, NYTT MAG ZOOL, V9, P37; Blaxter J., 1988, FISH PHYSIOL, V11A; Blaxter JHS., 1969, FISH PHYSIOL, P178; BOEHLERT GW, 1994, MAR ECOL PROG SER, V107, P1, DOI 10.3354/meps107001; Cho K.-D., 1987, Bulletin of the Korean Fisheries Society, V20, P360; Guillen A, 2014, AQUACULTURE SCI, V62, P319; Harada T, 1980, MEM FAC AGR KINKI U, V13, P29; Hart RP, 1995, AQUACULTURE, V136, P221, DOI DOI 10.1016/0044-8486(95)01061-0; Holliday F. G. T., 1969, P293; Hopkins S.R., 1975, P301; Howell BR, 1998, BIOL FARMED FISH, P27; Itano DG, 2000, REPROD BIOL YELLOWFI; Kashiwagi M., 1990, Suisan Zoshoku, V38, P7; Kimura S, 2004, NIPPON SUISAN GAKK, V70, P175, DOI 10.2331/suisan.70.175; Kinne O., 1963, Oceanography and Marine Biology, V1, P301; Kinoshita H., 1989, Suisan Zoshoku, V37, P15; LANG KL, 1994, ENVIRON BIOL FISH, V39, P259, DOI 10.1007/BF00005128; LEE CS, 1981, J FISH BIOL, V19, P179, DOI 10.1111/j.1095-8649.1981.tb05822.x; Miyashita Shigeru, 2000, Suisan Zoshoku, V48, P199; Mushiake K., 1993, AQUAC SCI, V41, P339; Mushiake Keiichi, 1993, Suisan Zoshoku, V41, P155; OOZEKI Y, 1985, B JPN SOC SCI FISH, V51, P557; Ostrowski AD, 2011, AQUACULTURE, V314, P193, DOI 10.1016/j.aquaculture.2011.02.010; Partridge GJ, 2011, AQUACULTURE, V318, P471, DOI 10.1016/j.aquaculture.2011.05.039; Richards FJ, 1971, FISH B, V69, P555; Rombough PJ, 1996, SOC EXPT BIOL SEMINA, V61, P177; Schaefer KM, 1998, B INTERAMERICAN TROP, V21, P201; Shimma H., 1981, B NATL RES I AQUACUL, V2, P11; Suzuki Z, 1994, FAO FISH TECH PAP, V336, P108; Wang YJ, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-289; Wexler JB, 2007, FISH B-NOAA, V105, P1; YOUNG PS, 1993, AQUACULTURE, V112, P363, DOI 10.1016/0044-8486(93)90396-G	45	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					891	897		10.1007/s12562-015-0901-8		7	Fisheries	Fisheries	CQ9FP	WOS:000360918500010		
J	Jirapongpairoj, W; Kobayashi, K; Fukuda, Y; Takano, T; Sakai, T; Matsuyama, T; Nakayasu, C; Nozaki, R; Hirono, I; Kondo, H				Jirapongpairoj, Walissara; Kobayashi, Keigo; Fukuda, Yutaka; Takano, Tomokazu; Sakai, Takamitsu; Matsuyama, Tomomasa; Nakayasu, Chihaya; Nozaki, Reiko; Hirono, Ikuo; Kondo, Hidehiro			Development of consensus qPCR primers to detect cytokine genes in three amberjack species: Seriola quinqueradiata, S-lalandi and S-dumerili	FISHERIES SCIENCE			English	Article						Cytokine; Amberjacks; Consensus primer; qPCR	TROUT ONCORHYNCHUS-MYKISS; TUMOR-NECROSIS-FACTOR; POLYMERASE-CHAIN-REACTION; RED-SEA BREAM; REAL-TIME PCR; EXPRESSION ANALYSIS; MOLECULAR-CLONING; RAINBOW-TROUT; INTERLEUKIN-8 GENE; ADAPTIVE IMMUNITY	Partial sequences of cytokine genes IFN gamma, IL-1 beta, IL-8, IL-10, and TNF alpha were identified from next-generation sequencing data for three amberjack species: Seriola quinqueradiata, S. lalandi and S. dumerili. The cytokine genes had more than 90 % nucleotide identity among the three species. Quantitative PCR (qPCR) primers were designed from the consensus sequences to detect cytokine genes. The specificities of consensus qPCR primers were investigated in the head kidney of three amberjack species treated with formalin-killed cells (FKC) of Vibrio anguillarum and polyinosinic-polycytidylic acid [poly(I:C)] at 3 h post injection (hpi) using qPCR. The primers detected up-regulation of certain cytokine genes after FKC of V. anguillarum and poly(I:C) stimulation in all species examined. Consequently, the primers are suitable for studying and detecting cytokine genes after vaccination and pathogen infection in these three amberjack species.	[Jirapongpairoj, Walissara; Kobayashi, Keigo; Nozaki, Reiko; Hirono, Ikuo; Kondo, Hidehiro] Tokyo Univ Marine Sci & Technol, Grad Sch, Lab Genome Sci, Minato Ku, Tokyo 1088477, Japan; [Fukuda, Yutaka] Oita Prefectural Agr Forestry & Fisheries Res Ctr, Fisheries Res Div, Oita 8792602, Japan; [Takano, Tomokazu; Matsuyama, Tomomasa] Fisheries Res Agcy, Natl Res Inst Aquaculture, Minamiise, Mie 5160193, Japan; [Sakai, Takamitsu] Fisheries Res Agcy, Tamaki Lab, Natl Res Inst Aquaculture, Tamaki, Mie 5190423, Japan; [Nakayasu, Chihaya] Fisheries Res Agcy, Natl Res Inst Aquaculture, Yokohama, Kanagawa, Japan	Kondo, H (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch, Lab Genome Sci, Minato Ku, Konan 4-5-7, Tokyo 1088477, Japan.	h-kondo@kaiyodai.ac.jp			science and technology research promotion program for agriculture, forestry, fisheries and food industry	This work was supported by the science and technology research promotion program for agriculture, forestry, fisheries and food industry.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Savan R, 2003, EUR J BIOCHEM, V270, P4647, DOI 10.1046/j.1432-1033.2003.03854.x; Rauta PR, 2012, IMMUNOL LETT, V148, P23, DOI 10.1016/j.imlet.2012.08.003; Laing KJ, 2001, EUR J BIOCHEM, V268, P1315, DOI 10.1046/j.1432-1327.2001.01996.x; Furnes C, 2009, FISH SHELLFISH IMMUN, V26, P285, DOI 10.1016/j.fsi.2008.12.002; Deepak SA, 2007, CURR GENOMICS, V8, P234; Zou J, 2002, DEV COMP IMMUNOL, V26, P161, DOI 10.1016/S0145-305X(01)00058-1; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Darawiroj D, 2008, FISH SHELLFISH IMMUN, V24, P260, DOI 10.1016/j.fsi.2007.07.011; Benetti DD, 2005, AM FISH S S, V46, P491; Laube I, 2010, FOOD CHEM, V118, P979, DOI 10.1016/j.foodchem.2008.09.063; Seppola M, 2008, MOL IMMUNOL, V45, P887, DOI 10.1016/j.molimm.2007.08.003; Li S, 2014, VET IMMUNOL IMMUNOP, V157, P182, DOI 10.1016/j.vetimm.2013.11.006; Li C, 2013, FISH SHELLFISH IMMUN, V34, P799, DOI 10.1016/j.fsi.2012.12.019; RESNICK RM, 1990, J NATL CANCER I, V82, P1477, DOI 10.1093/jnci/82.18.1477; Garcia-Castillo J, 2002, IMMUNOGENETICS, V54, P200, DOI 10.1007/s00251-002-0451-y; Wang TH, 2013, FISH SHELLFISH IMMUN, V35, P1703, DOI 10.1016/j.fsi.2013.08.030; Ordas MC, 2007, MOL IMMUNOL, V44, P389, DOI 10.1016/j.molimm.2006.02.028; Sangrador-Vegas A, 2002, CYTOKINE, V17, P66, DOI 10.1006/cyto.2001.0991; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Zhang J, 2013, VET IMMUNOL IMMUNOP, V152, P303, DOI 10.1016/j.vetimm.2012.12.018; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; Zou J, 1999, CYTOKINE, V11, P552, DOI 10.1006/cyto.1998.0470; Chabalgoity JA, 2007, CYTOKINE GROWTH F R, V18, P195, DOI 10.1016/j.cytogfr.2007.01.016; Zhu LY, 2013, DEV COMP IMMUNOL, V39, P39, DOI 10.1016/j.dci.2012.04.001; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Scapigliati G, 2001, FISH SHELLFISH IMMUN, V11, P711, DOI 10.1006/fsim.2001.0347; Zhang YB, 2012, DEV COMP IMMUNOL, V38, P193, DOI 10.1016/j.dci.2012.06.003; Buonocore F, 2007, AQUACULTURE, V270, P512, DOI 10.1016/j.aquaculture.2007.05.040; CZARNIECKI CW, 1993, ANTIVIR RES, V22, P223, DOI 10.1016/0166-3542(93)90035-H; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Harms CA, 2000, FISH SHELLFISH IMMUN, V10, P61, DOI 10.1006/fsim.1999.0230; Hirono I, 2000, J IMMUNOL, V165, P4423; Inoue Y, 2005, FISH SHELLFISH IMMUN, V18, P335, DOI 10.1016/j.fsi.2004.08.004; Kadowaki T, 2009, FISH SHELLFISH IMMUN, V27, P585, DOI 10.1016/j.fsi.2008.12.006; Kariya T, 1968, FISH PATHOL, V3, P16; Kawahara E, 1986, FISH PATHOL, V1, P39; Kimura M, 1971, FISH PATHOL, V6, P8; Kono T, 2002, AQUAC RES, V33, P291, DOI 10.1046/j.1355-557x.2002.00673.x; KUDO T, 1988, INT J SYST BACTERIOL, V38, P173; Matsuoka S, 1996, FISH PATHOL, V31, P233; Milev-Milovanovic I, 2006, IMMUNOGENETICS, V58, P70, DOI 10.1007/s00251-006-0081-x; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Nakada M, 2008, FAO FISHERIES TECHNI, V508, P199; Nakajima K, 1998, FISH PATHOL, V33, P143; Nakajima N, 2012, FISH PATHOL, V47, P12; Reyes-Cerpa S, 2012, FISH SHELLFISH IMMUN, V32, P291, DOI 10.1016/j.fsi.2011.11.018; Sato H, 2000, BIOSCI BIOTECH BIOCH, V64, P1494, DOI 10.1271/bbb.64.1494; Savan R, 2004, FISH SHELLFISH IMMUN, V17, P87, DOI 10.1016/j.fsi.2003.11.001; Savan R, 2006, COMP BIOCHEM PHYS D, V1, P89, DOI 10.1016/j.cbd.2005.08.005; Sebastian RC, 2012, NEW ADV CONTRIBUTION, P3; Svec D, 2015, BIOMOL DETECT QUANTI, V3, P9; Wei H, 2013, MOL IMMUNOL, V53, P313, DOI 10.1016/j.molimm.2012.08.021; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-356; Zhang DC, 2005, J BIOCHEM MOL BIOL, V38, P571	58	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					907	914		10.1007/s12562-015-0913-4		8	Fisheries	Fisheries	CQ9FP	WOS:000360918500012		
J	Akino, M; Aso, S; Kimura, M				Akino, Masaki; Aso, Shingo; Kimura, Minoru			Effectiveness of biological filter media derived from sea urchin skeletons	FISHERIES SCIENCE			English	Article						Biological filter media; Food-processing waste; Nitrification; Sea urchin; Skeletal material	WASTE	This paper describes a study of the use of sea urchin skeletons, a waste product of food-processing, as a biological filter medium. We obtained skeletal materials (tests, spines, and teeth) from the northern sea urchin Strongylocentrotus nudus by alkali treatment and evaluated their performance as biological filter media in an aquarium experiment. The nitrification performance was investigated in an aquarium using these skeletal materials. The results showed that the tests and spines particularly provided high ammonia oxidation performance. In addition, sea urchin skeletal materials kept the pH of the aquarium water constant at 7-8. Therefore, we conclude that the structure and components of sea urchin make them suitable for use as biological filter media.	[Akino, Masaki; Aso, Shingo; Kimura, Minoru] Hokkaido Res Org, Kushiro Fisheries Res Inst, Proc & Utilizat Div, Kushiro, Hokkaido 0850027, Japan	Akino, M (reprint author), Hokkaido Res Org, Kushiro Fisheries Res Inst, Proc & Utilizat Div, 4-25 Nakahama Cho, Kushiro, Hokkaido 0850027, Japan.	akino-masaki@hro.or.jp					APHA AWWA WEF, 1999, STANDARD METHODS EXA; Department of Fisheries and Forestry Hokkaido Government, 2015, HOKK SUIS GENS; Garau G, 2012, J ENVIRON MANAGE, V109, P12, DOI 10.1016/j.jenvman.2012.05.001; Gilbert P U P A, 2011, Prog Mol Subcell Biol, V52, P199, DOI 10.1007/978-3-642-21230-7_7; Hirayama K., 1970, Bull. Jap. Soc. scient. Fish., V36, P26; Japanese Industrial Standards Committee, 2008, K0102 JIS JAP STAND; Kikuchi K, 1998, NIPPON SUISAN GAKK, V64, P227; KIKUCHI K, 1994, FISHERIES SCI, V60, P133; LaVigne M, 2013, BIOGEOSCIENCES, V10, P3465, DOI 10.5194/bg-10-3465-2013; Magdans U, 2004, EUR J MINERAL, V16, P261, DOI 10.1127/0935-1221/2004/0016-0261; Mori Tatsunari, 2011, Scientific Reports of Hokkaido Fisheries Research Institutes, V80, P33; Raup D. M., 1966, P379; Seki K, 2007, J HOKKAIDO FOREST PR, V21, P8; Smith A. B., 1980, SPEC PAP PALAEONTOL, V25, P1; Yoshida N, 2011, NIPPON SUISAN GAKK, V77, P94, DOI 10.2331/suisan.77.94	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					923	927		10.1007/s12562-015-0900-9		5	Fisheries	Fisheries	CQ9FP	WOS:000360918500014		
J	Sutani, A; Ueno, M; Nakagawa, S; Sawayama, S				Sutani, Akitoshi; Ueno, Masahiro; Nakagawa, Satoshi; Sawayama, Shigeki			Melon aroma-producing yeast isolated from coastal marine sediment in Maizuru Bay, Japan	FISHERIES SCIENCE			English	Article						Marine fungi; Melon-aroma; Yeast; Coastal sediment; Phylogenetic analysis	GEOTRICHUM-CANDIDUM; SACCHAROMYCES-CEREVISIAE; NATURAL-PRODUCTS; CHEESE; FUNGI; TECHNOLOGY; EXPRESSION; STRAIN; GROWTH	Researches on marine fungi and fungi isolated from marine environments are not active compared with those on terrestrial fungi. The aim of this study was isolation of novel and industrially applicable fungi derived from marine environments. In this study, 16 fungus-like strains, MS1-MS16, were isolated from coastal marine sediment in Maizuru Bay, Japan, under aerobic culture conditions. Phylogenetic analysis of 18S rRNA gene sequences indicated that 10 isolates belonged to Ascomycota, five isolates belonged to Sordariomycetes, two were Dothideomycetes, and three were Saccharomycetes. Liquid and agar potato dextrose cultures of strains MS1 and MS2 isolated from the coastal sediment released a melon-like aroma. Gas chromatography analysis suggested that strains MS1 and MS2 produce four major chemicals associated with a melon aroma, cis-3-hexen-1-ol, cis-6-nonenal, 3,6-nonadien-1-ol, and trans,cis-2,6-nonadienal. The sequence analyses of the 26S rRNA domains 1/2 (D1/D2) and internal transcribed spacer regions indicated that strains MS1 and MS2 were phylogenetically identified as Geotrichum candidum, a well-known yeast used as a cheese starter. These results suggest the future isolations of novel and functional fungi from marine environments.	[Sutani, Akitoshi; Nakagawa, Satoshi; Sawayama, Shigeki] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Marine Environm Microbiol, Kyoto 6068502, Japan; [Ueno, Masahiro] Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Kyoto 6250086, Japan	Sawayama, S (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Marine Environm Microbiol, Kyoto 6068502, Japan.	sawayama@kais.kyoto-u.ac.jp			Institute for Fermentation, Osaka	We are grateful to Dr. K.W. Suzuki, Mr. S. Akiyama, and Mr. K. Watanabe (Kyoto University) for technical assistance in sediment sampling, and Dr. M. Morikawa (S & A Lab) for technical assistance in GC analysis. This work was financially supported by the Institute for Fermentation, Osaka.	DOMBEK KM, 1987, APPL ENVIRON MICROB, V53, P1286; Marin P, 2014, INT DAIRY J, V36, P89, DOI 10.1016/j.idairyj.2014.01.012; Kataoka S, 2013, ARCH DERMATOL RES, V305, P683, DOI 10.1007/s00403-013-1359-0; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Etschmann MMW, 2008, APPL MICROBIOL BIOT, V80, P579, DOI 10.1007/s00253-008-1573-4; Lepelletier F, 2014, PROTIST, V165, P230, DOI 10.1016/j.protis.2014.02.004; Chen Y, 2011, DIAGN MICR INFEC DIS, V70, P492, DOI 10.1016/j.diagmicrobio.2010.04.005; Allwood JW, 2014, PHYTOCHEMISTRY, V99, P61, DOI 10.1016/j.phytochem.2013.12.010; Lignou S, 2014, FOOD CHEM, V148, P218, DOI 10.1016/j.foodchem.2013.10.045; Boutrou R, 2005, INT J FOOD MICROBIOL, V102, P1, DOI [10.1016/j.ijfoodmicro.2004.12.028, 10.1016/j.ijfloodmicro.2004.12.028]; Lessard MH, 2012, APPL ENVIRON MICROB, V78, P1813, DOI 10.1128/AEM.06645-11; Passarini MRZ, 2013, ARCH MICROBIOL, V195, P99, DOI 10.1007/s00203-012-0854-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Alper I, 2011, FUNGAL BIOL-UK, V115, P1259, DOI 10.1016/j.funbio.2011.09.002; Kubicek CP, 2013, J BIOTECHNOL, V163, P133, DOI 10.1016/j.jbiotec.2012.05.020; Blunt JW, 2014, NAT PROD REP, V31, P160, DOI 10.1039/c3np70117d; BYRNE PJ, 1975, T BRIT MYCOL SOC, V65, P185; Chen XW, 2014, MAR DRUGS, V12, P3116, DOI 10.3390/md12063116; Damasceno SM, 2008, PROCESS BIOCHEM, V39, P411; Ebler SE, 2009, J AGR FOOD CHEM, V57, P8098; Fredimoses M, 2014, MAR DRUGS, V12, P3190, DOI 10.3390/md12063190; Gammacurta M, 2014, J AGR FOOD CHEM, V62, P5378, DOI 10.1021/jf500707e; Henriquez M, 2013, WORLD J MICROB BIOT, V30, P65; Hong GS, 2004, STUD MYCOL, V50, P489; Kagkli DM, 2006, APPL MICROBIOL BIOT, V73, P434, DOI 10.1007/s00253-006-0461-z; Kiuru P, 2014, PLANTA MED, V80, P1234, DOI 10.1055/s-0034-1383001; Leclercq-Perlat MN, 2012, J DAIRY SCI, V95, P4666, DOI 10.3168/jds.2012-5368; Li L, 2014, AMB EXPRESS, V30, P60; Masuma Rokuro, 2001, Mycoscience, V42, P455, DOI 10.1007/BF02464342; Mdaini N, 2006, APPL BIOCHEM BIOTECH, V128, P127; Missous G, 2012, CRYOLETTERS, V33, P289; Thornton CR, 2010, INT J FOOD MICROBIOL, V143, P166, DOI 10.1016/j.ijfoodmicro.2010.08.012; Yalcin HT, 2014, J BASIC MICROB, V54, pS85, DOI 10.1002/jobm.201300029	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					929	936		10.1007/s12562-015-0912-5		8	Fisheries	Fisheries	CQ9FP	WOS:000360918500015		
J	Moe, NKT; Wilaipun, P; Yonezuka, K; Ishida, W; Yano, H; Terahara, T; Imada, C; Kamio, M; Kobayashi, T				Moe, Nant Kay Thwe; Wilaipun, Pongtep; Yonezuka, Kenta; Ishida, Wakana; Yano, Hirona; Terahara, Takeshi; Imada, Chiaki; Kamio, Michiya; Kobayashi, Takeshi			Isolation and characterization of malachite green-removing yeast from a traditional fermented fishery product	FISHERIES SCIENCE			English	Article						Degradation; Liquid chromatography-tandem mass spectrometry (LC-MS/MS); Malachite green; Proton nuclear magnetic resonance spectroscopy (H-1-NMR); Yeast	LEUCOMALACHITE GREEN; DECOLORIZATION; BIODEGRADATION; DETOXIFICATION; BIOREACTOR; INFECTION; EFFLUENT; NOV	The screening of malachite green (MG)-degrading microorganisms was carried out using various sources, namely, fish farms and a traditional fermented fishery product in Myanmar and Thailand. The enrichment culture method was performed using MG-containing broth media, and colonies that showed the decolorization of MG on plate media were isolated as MG-degrading candidates. From the results of the sequencing of the D1/D2 domain of the 26S rRNA gene, strain M3, a representative strain of MG-degrading candidates was identified as a halotolerant yeast, Debaryomyces nepalensis. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis indicated that during the incubation of this strain, the MG concentration gradually decreased and eventually reached undetectable levels. Conversely, the concentration of leucomalachite green (LMG) increased, and the final amount of LMG in the broth culture was estimated to be approximately 40 % of the initial MG amount. In addition, results of proton nuclear magnetic resonance spectroscopy (H-1-NMR) analysis also showed that MG and the tautomer of MG or other aromatic decomposition products of MG were not detected as a major component at the end of incubation. These results suggest that strain M3 removed MG and changed approximately 40 % to LMG and 60 % to some metabolites other than LMG.	[Moe, Nant Kay Thwe; Ishida, Wakana; Yano, Hirona; Terahara, Takeshi; Imada, Chiaki; Kamio, Michiya; Kobayashi, Takeshi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo, Japan; [Moe, Nant Kay Thwe] Minist Livestock Fisheries & Rural Dev, Dept Fisheries, Yangon, Myanmar; [Wilaipun, Pongtep] Kasetsart Univ, Fac Fisheries, Dept Fishery Prod, Bangkok, Thailand; [Yonezuka, Kenta] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 94021, Japan	Kobayashi, T (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo, Japan.	takeshik@kaiyodai.ac.jp	Kamio, Michiya/O-1923-2014	Kamio, Michiya/0000-0003-3505-1978	Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/JICA, SATREPS); Japanese Government (Monbukagakusho) Scholarship program	This research was supported in part by the Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/JICA, SATREPS). This research was also supported by the Japanese Government (Monbukagakusho) Scholarship program.	Srivastava S, 2004, AQUAT TOXICOL, V66, P319, DOI 10.1016/j.aquatox.2003.09.008; Ali H, 2010, WATER AIR SOIL POLL, V213, P251, DOI 10.1007/s11270-010-0382-4; Gummadi SN, 2008, BIORESOURCE TECHNOL, V99, P874, DOI 10.1016/j.biortech.2007.01.022; Thwe SM, 2011, FISHERIES SCI, V77, P279, DOI 10.1007/s12562-011-0328-9; Mezzatesta ML, 2012, FUTURE MICROBIOL, V7, P887, DOI [10.2217/fmb.12.61, 10.2217/FMB.12.61]; Elomari M, 1997, INT J SYST BACTERIOL, V47, P846; Nicholson JK, 1999, XENOBIOTICA, V29, P1181; Du LN, 2011, ECOTOXICOLOGY, V20, P438, DOI 10.1007/s10646-011-0595-3; Parshetti G, 2006, ACTA CHIM SLOV, V53, P492; Denton M, 1998, CLIN MICROBIOL REV, V11, P57; Yao J, 1999, ANTON LEEUW INT J G, V75, P345, DOI 10.1023/A:1002082303615; Jasinska A, 2012, INT BIODETER BIODEGR, V73, P33, DOI 10.1016/j.ibiod.2012.06.025; Simmler C, 2014, CURR OPIN BIOTECH, V25, P51, DOI 10.1016/j.copbio.2013.08.004; ALDERMAN DJ, 1985, J FISH DIS, V8, P289, DOI 10.1111/j.1365-2761.1985.tb00945.x; Bittar F, 2008, EMERG INFECT DIS, V14, P993, DOI 10.3201/eid1406.071355; Crews P, 2010, ORGANIC STRUCTURE AN; Culp SJ, 1999, CHEM-BIOL INTERACT, V122, P153, DOI 10.1016/S0009-2797(99)00119-2; Du LN, 2013, INT BIODETER BIODEGR, V78, P108, DOI 10.1016/j.ibiod.2012.12.011; Egues I, 2013, RENEW ENERG, V60, P553, DOI 10.1016/j.renene.2013.06.006; Han TX, 2008, INT J SYST EVOL MICR, V58, P1693, DOI 10.1099/ijs.0.65568-0; Hardoim PR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-164; Henderson AL, 1997, APPL ENVIRON MICROB, V63, P4099; Kalyani DC, 2012, CLEAN TECHNOL ENVIR, V14, P989, DOI 10.1007/s10098-012-0473-6; Kamio M, 2015, J EXP MAR BIOL ECOL, V463, P115, DOI 10.1016/j.jembe.2014.11.008; Kamio M, 2014, J EXP BIOL, V217, P1286, DOI 10.1242/jeb.099051; Kumdam H., 2013, AMB EXPRESS, V3, P1; Li LT, 2009, BIODEGRADATION, V20, P769, DOI 10.1007/s10532-009-9265-z; Lv GY, 2013, BIORESOURCE TECHNOL, V144, P275, DOI 10.1016/j.biortech.2013.07.003; McMurry J, 2011, ORGANIC CHEM, P456; Miura M, 2005, FISH PATHOL, V40, P81; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V47, P345, DOI 10.1016/S0167-7012(01)00344-X; Sharma DK, 2004, WORLD J MICROB BIOT, V20, P431, DOI 10.1023/B:WIBI.0000033073.28111.67; Shedbalkar U, 2011, BIOTECHNOL BIOPROC E, V16, P196, DOI 10.1007/s12257-010-0069-0; Singh A, 2012, ECOL ENG, V47, P291, DOI 10.1016/j.ecoleng.2012.07.001; Wu J, 2011, BIODEGRADATION, V22, P897, DOI 10.1007/s10532-010-9447-8; Youssef AS, 2008, BIOTECHNOLOGY, V7, P213	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					937	945		10.1007/s12562-015-0879-2		9	Fisheries	Fisheries	CQ9FP	WOS:000360918500016		
J	Sato, T; Ohgami, S; Kaneniwa, M				Sato, Taku; Ohgami, Shin-ichi; Kaneniwa, Masaki			Seasonal variations in free amino acids, nucleotide-related compounds, and fatty acids and meat yield of the coconut crab Birgus latro	FISHERIES SCIENCE			English	Article						Birgus latro; Free amino acid; Nucleotide-related compound; Fatty acid; Taste activity value; Equivalent umami concentration	BIOCHEMICAL-COMPOSITION; SOUTHERN JAPAN; HATOMA ISLAND; EGG EXTRUSION; TASTE; PREVENTION; SPERM; SIZE; HEPATOPANCREAS; REPRODUCTION	This study analyzed seasonal variations in meat yield and compositions of free amino acids (FAA), nucleotide-related compounds (NRC), and fatty acids in muscle and hepatopancreas of the coconut crab Birgus latro of Okinawa, southwest Japan. A conspicuous increase in total meat yield was observed during September to November, prior to molting in the winter dry season. Although both total FAA and NRC content in muscle and hepatopancreas did not vary significantly by seasons, the taste activity value of methionine in muscle was larger than 1 only during September to November. Seasonal variations in equivalent umami concentration (EUC) were greater in muscle than in the hepatopancreas, with the EUC of muscles highest in September to November. Although fatty acid compositions of muscle and hepatopancreas did not change significantly seasonally, amounts of total fatty acids, saturated fatty acids, and monounsaturated fatty acids in muscle and hepatopancreas, and amount of n-3 polyunsaturated fatty acids in the hepatopancreas, were significantly greater in September to November. These results indicate the best season to eat coconut crab is September to November. These findings may contribute to a premium value for this resource and promote resource conservation of this species.	[Sato, Taku] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa 9070451, Japan; [Ohgami, Shin-ichi] Fisheries Res Agcy, Nishi Ku, Yokohama, Kanagawa 2206115, Japan; [Kaneniwa, Masaki] Natl Res Inst Fisheries Sci, Res Ctr Biochem & Food Technol, Yokohama, Kanagawa 2368648, Japan	Sato, T (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Res Ctr Marine Invertebrates, Onomichi, Hiroshima 7220061, Japan.	takusato@affrc.go.jp; ohgami@fra.affrc.go.jp; mskknnw@affrc.go.jp			Department of Fisheries of Ishigaki City government	This work financed by Department of Fisheries of Ishigaki City government was possible thanks to the generous hospitality and cooperation of the residents of Hatoma Island. We thank anonymous reviewers and members of the Research Center for Subtropical Fisheries, Seikai National Fisheries Research Institute, for their helpful comments and discussion. We also thank staffs of Japan Food Research Laboratories who helped us in nutritional analyses.	Cherif S, 2008, FOOD CHEM, V111, P930, DOI 10.1016/j.foodchem.2008.05.007; KATO H, 1989, ACS SYM SER, V388, P158; Fuke S, 1996, TRENDS FOOD SCI TECH, V7, P407, DOI 10.1016/S0924-2244(96)10042-X; Sato T, 2008, FISHERIES SCI, V74, P1277, DOI 10.1111/j.1444-2906.2008.01652.x; KING I, 1990, J AM DIET ASSOC, V90, P677; Chen DW, 2007, FOOD CHEM, V104, P1200, DOI 10.1016/j.foodchem.2007.01.042; DYERBERG J, 1986, NUTR REV, V44, P125; Harper CR, 2005, AM J CARDIOL, V96, P1521, DOI 10.1016/j.amjcard.2005.07.071; Larkin SL, 1999, AM J AGR ECON, V81, P29, DOI 10.2307/1244448; Garcia F, 2002, LIPIDS, V37, P581, DOI 10.1007/s11745-002-0936-9; Sato T, 2013, AQUAT BIOL, V19, P143, DOI 10.3354/ab00517; Barrento S, 2009, J AGR FOOD CHEM, V57, P10814, DOI 10.1021/jf9025597; Brown I.W., 1991, ACIAR MONOGRAPH, V8, P1; Buckup L, 2008, COMP BIOCHEM PHYS A, V149, P59, DOI 10.1016/j.cbpa.2007.10.008; Chang E.S., 1983, P263; FAO/WHO, 1994, 57 FAOWHO, P168; Fletcher WJ, 1993, NEARSHORE MARINE RES, P643; Fletcher WJ, 1990, J EXP MAR BIOL ECOL, V27, P245; Innis SM, 2000, DEV NEUROSCI-BASEL, V22, P474, DOI 10.1159/000017478; JECKEL WH, 1991, COMP BIOCHEM PHYS B, V98, P261, DOI 10.1016/0305-0491(91)90176-E; KOMATA Y, 1990, Food Reviews International, V6, P457; KONOSU S, 1978, B JPN SOC SCI FISH, V44, P505; Mello LGS, 2005, ICES J MAR SCI, V62, P1006, DOI 10.1016/j.icesjms.2005.03.008; Ridley M, 1983, EXPLANATION ORGANIC, P272; Roynette CE, 2004, CLIN NUTR, V23, P139, DOI 10.1016/j.clnu.2003.07.005; Sato T, 2010, AQUAT BIOL, V10, P23, DOI 10.3354/ab00263; Sato T, 2010, MAR ECOL PROG SER, V402, P171, DOI 10.3354/meps08369; Sato T, 2010, J CRUSTACEAN BIOL, V30, P624, DOI 10.1651/10-3279.1; Sato Taku, 2012, Aqua-Bioscience Monographs, V5, P67; Sato Taku, 2009, Marine Biodiversity Records, V2, pe37, DOI 10.1017/S1755267209000426; Sato T, 2008, J CRUSTACEAN BIOL, V28, P663, DOI 10.1651/07-2966.1; Sato T, 2015, FISHERIES SCI, V81, P569, DOI 10.1007/s12562-015-0861-z; Sato Taku, 2013, Plankton & Benthos Research, V8, P49; Sato T, 2011, AQUAT BIOL, V13, P11, DOI 10.3354/ab00350; Sato T, 2009, FISHERIES SCI, V75, P641, DOI 10.1007/s12562-009-0093-1; Shirai T, 1996, FISHERIES SCI, V62, P283; Smith P, 1998, 988 ABARE; Smith RL, 1984, SPERM COMPETITION EV; Styrishave B, 2000, MAR BIOL, V137, P415, DOI 10.1007/s002270000345; Woll AK, 2006, AQUAC RES, V37, P1487, DOI 10.1111/j.1365-2109.2006.01587.x; Wu XG, 2010, J FOOD COMPOS ANAL, V23, P154, DOI 10.1016/j.jfca.2009.08.007; YAMAGUCH.S, 1971, J FOOD SCI, V36, P846, DOI 10.1111/j.1365-2621.1971.tb15541.x	42	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					959	970		10.1007/s12562-015-0908-1		12	Fisheries	Fisheries	CQ9FP	WOS:000360918500018		
J	Chaikaew, S; Tepkasikul, P; Young, GM; Osako, K; Benjakul, S; Visessanguan, W				Chaikaew, Siriporn; Tepkasikul, Preenapha; Young, Glenn M.; Osako, Kazufumi; Benjakul, Soottawat; Visessanguan, Wonnop			Fixed-bed degradation of histamine in fish sauce by immobilized whole cells of Natrinema gari BCC 24369	FISHERIES SCIENCE			English	Article						Immobilization; Fixed-bed bioreactor; Histamine; Natrinema gari BCC 24369; Fish sauce; Storage	BIOGENIC-AMINE FORMATION; FERMENTED SAUSAGES; SKIPJACK TUNA; DEHYDROGENASE; PRODUCTS; COLOR; MICROORGANISMS; BIOSORPTION; BACTERIA; PELAMIS	Fish sauce often contains histamine at high levels, which may cause its rejection for export and is also associated with the food poisoning. Therefore, this study aimed to apply the ability of immobilized whole cells of Natrinema gari BCC 24369 to degrade histamine in fish sauce. Under static condition, the optimum conditions for histamine degradation in fish sauce were using 10 % immobilized cells of Nnm. gari BCC 24369 for fish sauce (pH 6.5) in the presence of 10 mg/100 ml of riboflavin for 2 h, in which the immobilized cells exhibited a maximum histamine removal efficiency of 24 +/- A 1 %. The operation of immobilized cells in a fixed-bed bioreactor was more efficient than static batch operation for histamine removal. At the optimal feeding flow rate of 0.5 ml/min, a significant amount of histamine in fish sauce (51 +/- A 3 %) was removed as the result of histamine-degrading activity of the cells. After treatment with immobilized cells, not only was histamine effectively removed, but color darkening was also reduced. Additionally, no detrimental effects on the unique quality of fish sauce were observed during 6 months of storage.	[Chaikaew, Siriporn; Benjakul, Soottawat] Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai 90112, Songkhla, Thailand; [Tepkasikul, Preenapha; Visessanguan, Wonnop] Natl Ctr Genet Engn & Biotechnol, Pathum Thani 12120, Thailand; [Young, Glenn M.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Osako, Kazufumi] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, Tokyo 1088477, Japan	Visessanguan, W (reprint author), Natl Ctr Genet Engn & Biotechnol, 113 Thailand Sci Pk,Pahonyothin Rd, Pathum Thani 12120, Thailand.	wonnop@biotec.or.th			Thailand Research Fund (TRF) under the Royal Golden Jubilee Ph.D. Program [PHD/0291/2550]; Prince of Songkla University; National Center for Genetic Engineering and Biotechnology (BIOTEC)	The authors would like to thank the Thailand Research Fund (TRF) for financial support under the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0291/2550), and Prince of Songkla University for an operating grant under the graduate study program to Siriporn Chaikaew. Acknowledgments are also due to the TRF Distinguished Research Professor Grant to Soottawat Benjakul and the National Center for Genetic Engineering and Biotechnology (BIOTEC) for providing research funding, laboratory equipment and facilities.	Dapkevicius MLNE, 2000, INT J FOOD MICROBIOL, V57, P107, DOI 10.1016/S0168-1605(00)00238-5; Saratale GD, 2011, INT BIODETER BIODEGR, V65, P494, DOI 10.1016/j.ibiod.2011.01.012; Bakke M, 2005, J BIOTECHNOL, V119, P260, DOI 10.1016/j.jbiotec.2005.04.005; Martuscelli M, 2000, LETT APPL MICROBIOL, V31, P228, DOI 10.1046/j.1365-2672.2000.00796.x; EEROLA S, 1993, J AOAC INT, V76, P575; Zaman MZ, 2014, FOOD CONTROL, V40, P58, DOI 10.1016/j.foodcont.2013.11.031; Wu J, 2008, CHEM ENG J, V138, P128, DOI 10.1016/j.cej.2007.05.051; Klomklao S, 2006, FOOD CHEM, V98, P440, DOI 10.1016/j.foodchem.2005.06.013; Sekiguchi Y, 2004, J BIOSCI BIOENG, V97, P104, DOI 10.1016/S1389-1723(04)70176-0; Tapingkae W, 2010, FOOD CHEM, V120, P842, DOI 10.1016/j.foodchem.2009.11.025; Nasar-Abbas SM, 2008, POSTHARVEST BIOL TEC, V47, P113, DOI 10.1016/j.postharvbio.2007.06.007; Wrolstad RE, 2005, TRENDS FOOD SCI TECH, V16, P423, DOI 10.1016/j.tifs.2005.03.019; Tapingkae W, 2010, ENZYME MICROB TECH, V46, P92, DOI 10.1016/j.enzmictec.2009.10.011; Hughes MC, 2002, MEAT SCI, V62, P205, DOI 10.1016/S0309-1740(01)00248-0; Gram L, 1996, INT J FOOD MICROBIOL, V33, P121, DOI 10.1016/0168-1605(96)01134-8; Kwak EJ, 2004, AMINO ACIDS, V27, P85, DOI 10.1007/s00726-004-0067-7; Pathare PB, 2013, FOOD BIOPROCESS TECH, V6, P36, DOI 10.1007/s11947-012-0867-9; Leuschner RG, 1998, INT J FOOD MICROBIOL, V39, P1, DOI 10.1016/S0168-1605(97)00109-8; Lopetcharat K, 2001, FOOD REV INT, V17, P65, DOI 10.1081/FRI-100000515; Yoshida Y, 1998, FOOD REV INT, V14, P213; Zaman MZ, 2010, CZECH J FOOD SCI, V28, P440; AOAC, 2005, OFF METH AN AOAC INT; ARNOLD SH, 1980, B JPN SOC SCI FISH, V46, P991; Bagai R, 1997, APPL BIOCHEM BIOTECH, V62, P213, DOI 10.1007/BF02787997; Chen BY, 2014, BIORESOURCE TECHNOL, V160, P175, DOI 10.1016/j.biortech.2014.02.006; Codex Alimentarius, 2012, 32 SESS COD COMM FIS; HunterLab, 1995, INSIGHT COLOR, V5, P1; Jones N, 1961, P FLAVOR CHEMISTRY S, P61; Kawashima K, 1996, FISHERIES SCI, V62, P293; Lee YC, 2015, J FOOD DRUG ANAL, V23, P836, DOI 10.1016/j.jfda.2015.02.003; Lee YS, 1997, J JPN SOC FOOD SCI, V34, P313; Liu PZ, 1989, FOOD SCI, V4, P37; Mahyudin NA, 2011, INT FOOD RES J, V18, P867; Perez-Villareal B, 1992, QUALITY ASSURANCE FI, P7; Riitonen T, 2013, ADV CHEM ENG, V42, P1, DOI 10.1016/B978-0-12-386505-2.00001-8; Riquelme N, 2015, FOOD CHEM, V175, P478, DOI 10.1016/j.foodchem.2014.12.008; Shahidi F, 1994, SEAFOOD PROTEINS, P171; Siddiqui JA, 2000, FEMS MICROBIOL LETT, V189, P183, DOI 10.1016/S0378-1097(00)00277-9; Smriga M, 2010, J FOOD COMPOS ANAL, V23, P442, DOI 10.1016/j.jfca.2010.03.005; Steel R.G., 1980, PRINCIPLES PROCEDURE; Thongthai C., 2005, ASIAN FUNCTIONAL FOO, P215; TISI Thai Industrial Standard, 1983, LOC FISH SAUC STAND; Zhou DW, 2014, ACTA CRYSTALLOGR F, V70, P942, DOI 10.1107/S2053230X14011327; Zhu Y, 2007, BIOPROCESSING FOR VALUE-ADDED PRODUCTS FROM RENEWABLE RESOURCES: NEW TECHNOLOGIES AND APPLICATIONS, P373, DOI 10.1016/B978-044452114-9/50015-3	44	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					971	981		10.1007/s12562-015-0915-2		11	Fisheries	Fisheries	CQ9FP	WOS:000360918500019		
J	Miyata, T; Wakamatsu, H				Miyata, Tsutom; Wakamatsu, Hiroki			Irrational reputational damage on wakame seaweed in Sanriku district after the Fukushima nuclear disaster: revealed preference by auction experiment	FISHERIES SCIENCE			English	Article						Counterpropaganda; Irrational reputational damage; Purchase decision; Radioactive contamination; Seafood; Information treatment		This study investigated the Japanese consumer's willingness to pay for wakame seaweed produced along the Sanriku coastal area located north of Fukushima, which suffered irrational reputational damage owing to concerns about radioactive contamination of seafood after the 2011 disaster at the Fukushima Daiichi nuclear power plant. An auction experiment was conducted with and without information treatment on both literal and visual information on radioactive contamination for the purpose of reducing irrational reputational damage. The results show no statistically significant premium on willingness to pay for wakame when the information on radioactive contamination was provided. However, an information effect is revealed in terms of the change in purchasing decision, from no-purchase to purchase. Hence, counterpropaganda against the irrational reputational damage of radioactive contamination is effective not for price but for purchasing decisions. The information turned out to be ineffective for consumer preference possibly because a basis price under consumer preference blocks effective promotion.	[Miyata, Tsutom; Wakamatsu, Hiroki] Fisheries Res Agcy Japan, Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan	Miyata, T (reprint author), Fisheries Res Agcy Japan, Natl Res Inst Fisheries Sci, Kanazawa Ku, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.	tmiyata@affrc.go.jp; hwakamatsu@affrc.go.jp			Agriculture, Forestry and Fisheries Council as part of the "Development research of sustainable production system in fisheries and aquacultures" project	This study is funded mainly by the Agriculture, Forestry and Fisheries Council as part of the "Development research of sustainable production system in fisheries and aquacultures" project. The Federation of Iwate Fisheries Association provided us with useful information and permission to use labels. The Iwate Prefecture Fisheries Technology Center cooperated with us to make Table 1, as well as products for the auction. We are grateful for the cooperation of these organizations.	Fox JA, 2002, J RISK UNCERTAINTY, V24, P75, DOI 10.1023/A:1013229427237; Wada T, 2013, J ENVIRON RADIOACTIV, V124, P246, DOI 10.1016/j.jenvrad.2013.05.008; Bachev H., 2014, International Journal of Food and Agricultural Economics, V2, P95; Bachev H, 2013, 49462 MPRA; Frank B, 2014, J CONTING CRISIS MAN, V22, P197, DOI 10.1111/1468-5973.12058; Koyama R, 2014, SYOUGAKU RONSYU, V82, P15; Krishna V., 2009, AUCTION THEORY; List JA, 1999, AM J AGR ECON, V81, P942, DOI 10.2307/1244336; Miyata T, 2008, J REG FISH, V48, P1; National Federation of Fisheries Cooperative Associations, 2014, ZENG JOH, P2; Peterson HH, 2014, AGR APPL EC ASS 2014; Lusk JL, 2007, QUANT METH APPL ECON, P1, DOI 10.1017/CBO9780511611261; Sugita M, 2013, ENV HLTH PREV MED, V68, P207; Tateno S., 2013, J SCI COMMUNICATION, V12, P1; Uchida H, 2013, AUST J AGR RESOUR EC, V58, P263; Ujiie K., 2012, J FOOD SYSTEM RES, V19, P142; VICKREY W, 1961, J FINANC, V16, P8, DOI 10.2307/2977633	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	SEP	2015	81	5					995	1002		10.1007/s12562-015-0903-6		8	Fisheries	Fisheries	CQ9FP	WOS:000360918500021		
J	Xie, XL; Gi, M; Fujioka, M; Doi, K; Yamano, S; Tachibana, H; Fang, H; Kakehashi, A; Wanibuchi, H				Xie, Xiao-Li; Gi, Min; Fujioka, Masaki; Doi, Kenichiro; Yamano, Shotaro; Tachibana, Hirokazu; Fang, He; Kakehashi, Anna; Wanibuchi, Hideki			Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Ethanol-extracted propolis; Urinary bladder carcinogenesis; Mutagenicity; Urinary precipitate	L-ISOLEUCINE; L-LEUCINE; SODIUM SACCHARIN; GREEN PROPOLIS; RED PROPOLIS; CYCLIN D1; IN-VITRO; L-LYSINE; CANCER; EXPRESSION	Ethanol-extracted propolis (EEP) is used for medical, dietetic and cosmetic purposes. In this study, the effects of EEP on urinary bladder carcinogenesis, its underlying mechanism and in vivo genotoxicity were investigated. In experiment 1, rats were treated with N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) for 2 or 4 weeks followed by dietary administration of 0.125, 0.25, 0.5 or 1% EEP for 4 or 32 weeks, respectively. At week 6, the mRNA levels of top2a, cyclin D1 and survivin were significantly elevated in the 0.5 and 1% EEP groups. At week 36, the incidence and multiplicity of urothelial carcinomas and total tumors were markedly elevated in all EEP groups. In experiment 2, rats were fed basal diet or the 1% EEP diet for 13 weeks without carcinogen initiation. Increases in urinary precipitate, cell proliferation and incidence of simple hyperplasia were observed in the 1% EEP group. In experiment 3, dietary administration of 2.5% EEP to gpt delta rats for 13 weeks did not induce any obvious mutagenicity in the urinary bladder urothelium. Taken together, EEP enhanced BBN-initiated rat urinary bladder carcinogenesis in a non-genotoxic manner through increasing formation of urinary precipitate, enhancing cell proliferation and inhibiting apoptosis during the early stages of carcinogenesis. (C) 2015 Elsevier Ltd. All rights reserved.	[Xie, Xiao-Li] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Toxicol, Guangzhou 510515, Guangdong, Peoples R China; [Xie, Xiao-Li; Gi, Min; Fujioka, Masaki; Doi, Kenichiro; Yamano, Shotaro; Tachibana, Hirokazu; Fang, He; Kakehashi, Anna; Wanibuchi, Hideki] Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, Osaka 5458585, Japan	Wanibuchi, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, Asahi Machi 1-4-3, Osaka 5458585, Japan.	wani@med.osaka-cu.ac.jp			Ministry of Health, Labor and Welfare of Japan [H21-SHYOKUHIN-YIPAN-011, H24-SHYOKUHIN-YIPAN-013]; API Co. Ltd., Gifu, Japan [J102621010, J112621005]	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan (H21-SHYOKUHIN-YIPAN-011 and H24-SHYOKUHIN-YIPAN-013), and Osaka City University Contract Research Funding from API Co. Ltd., Gifu, Japan J102621010 and J112621005).	Righi AA, 2011, J SCI FOOD AGR, V91, P2363, DOI 10.1002/jsfa.4468; Valente MJ, 2011, FOOD CHEM TOXICOL, V49, P86, DOI 10.1016/j.fct.2010.10.001; Xie XL, 2013, FOOD CHEM TOXICOL, V59, P137, DOI 10.1016/j.fct.2013.05.044; Sulaiman GM, 2012, FOOD CHEM TOXICOL, V50, P1632, DOI 10.1016/j.fct.2012.01.022; Siqueira ABS, 2009, LETT APPL MICROBIOL, V48, P90, DOI 10.1111/j.1472-765X.2008.02494.x; Kurek-Gorecka A, 2014, MOLECULES, V19, P78, DOI 10.3390/molecules19010078; Takayama S, 1998, J NATL CANCER I, V90, P19, DOI 10.1093/jnci/90.1.19; Coumar MS, 2013, CANCER TREAT REV, V39, P802, DOI 10.1016/j.ctrv.2013.02.002; Simon R, 2003, INT J CANCER, V107, P764, DOI 10.1002/ijc.11477; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Boorman G.A., 1990, PATHOLOGY FISHER RAT; COHEN SM, 1990, SCANNING MICROSCOPY, V4, P135; Cohen SM, 2000, CARCINOGENESIS, V21, P783, DOI 10.1093/carcin/21.4.783; Dornelas CA, 2012, ACTA CIR BRAS, V27, P185, DOI 10.1590/S0102-86502012000200015; Dornelas CA, 2012, ACTA CIR BRAS, V27, P529, DOI 10.1590/S0102-86502012000800003; Frazier Kendall S, 2012, Toxicol Pathol, V40, p14S, DOI 10.1177/0192623312438736; Kawabe M, 2000, NUTR CANCER, V37, P179, DOI 10.1207/S15327914NC372_10; Kim E.J., 2010, UROLOGY, V75; Kimoto N, 1999, CANCER LETT, V147, P221, DOI 10.1016/S0304-3835(99)00305-5; Kopparapu PK, 2013, ANTICANCER RES, V33, P5235; Koren R, 2003, BJU INT, V91, P489, DOI 10.1046/j.1464-410X.2003.04118.x; Lee CCR, 1997, CANCER, V79, P780, DOI 10.1002/(SICI)1097-0142(19970215)79:4<780::AID-CNCR15>3.0.CO;2-W; Linden M, 2013, BJU INT, V112, P407, DOI 10.1111/j.1464-410X.2012.11653.x; Martin DT, 2014, MOL CANCER THER, V13, P71, DOI 10.1158/1535-7163.MCT-13-0502; Nakopoulou L, 2001, J CLIN PATHOL, V54, P309, DOI 10.1136/jcp.54.4.309; NISHIO Y, 1986, SCIENCE, V231, P843, DOI 10.1126/science.3945812; SHIOYA S, 1994, FOOD CHEM TOXICOL, V32, P165, DOI 10.1016/0278-6915(94)90179-1; Xie XL, 2012, MUTAT RES-GEN TOX EN, V748, P29, DOI 10.1016/j.mrgentox.2012.06.005; Xie XL, 2012, FOOD CHEM TOXICOL, V50, P3934, DOI 10.1016/j.fct.2012.07.063	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	SEP	2015	83						193	200		10.1016/j.fct.2015.06.007		8	Food Science & Technology; Toxicology	Food Science & Technology; Toxicology	CR1IQ	WOS:000361078800023		
J	Maeda, J; Inoue, K; Ichimura, R; Takahashi, M; Kodama, Y; Saito, N; Yoshida, M				Maeda, Jun; Inoue, Kaoru; Ichimura, Ryohei; Takahashi, Miwa; Kodama, Yukio; Saito, Naoaki; Yoshida, Midori			Essential role of constitutive androstane receptor in Ginkgo biloba extract induced liver hypertrophy and hepatocarcinogenesis	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Ginkgo biloba extract (GBE); Liver hypertrophy; Hepatocarcinogenesis; Constitutive androstane receptor (CAR)	TUMOR PROMOTION; GENE-EXPRESSION; BETA-CATENIN; MICE; CAR; DRUGS; METABOLISM; ACTIVATION; INDUCTION; RELEVANCE	Ginkgo biloba extract (GBE) is commonly used as a herbal supplement. The National Toxicology Program (NTP) study of GBE reported clear evidence of hepatocarcinogenicity in mice. To clarify the mode of action (MOA) for hepatocarcinogenesis by GBE, we investigated the involvement of the constitutive androstane receptor (CAR) in hepatocarcinogenesis induced by GBE using CAR-knockout (CARKO) and wild type (WT) mice. We used the same lot of GBE that was used for the NTP study. In 1-week GBE dietary treatment, hepatocellular DNA replication was increased in WT mice but not in CARKO mice. In 4-or 13-week treatment, greater hepatic Cyp2b10 induction and hepatocellular hypertrophy were observed in WT mice, whereas these effects of GBE were much smaller in CARKO mice. In a two-stage hepatocarcinogenesis model initiated by diethylnitrosamine, 27-week treatment with GBE resulted in an increase of eosinophilic altered foci and adenomas in WT mice. By contrast, foci and adenomas were clearly less evident in CARKO mice. These results indicate that GBE-induced hepatocarcinogenesis is mainly CAR-mediated. Since CAR-mediated MOA for hepatocarcinogenesis in rodents is considered to be qualitatively implausible for humans, our findings would be helpful to evaluate the carcinogenic characterization of GBE to humans. (C) 2015 Elsevier Ltd. All rights reserved.	[Maeda, Jun; Inoue, Kaoru; Ichimura, Ryohei; Takahashi, Miwa; Yoshida, Midori] Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo 1588501, Japan; [Maeda, Jun; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kodama, Yukio] Natl Inst Hlth Sci, Div Toxicol, Setagaya Ku, Tokyo 1588501, Japan	Yoshida, M (reprint author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Kamiyoga 1-18-1, Tokyo 1588501, Japan.	midoriy@nihs.go.jp			Ministry of Health, Labor, and Welfare, Japan	This work was partially supported by a grant from the Ministry of Health, Labor, and Welfare, Japan.	Gurley BJ, 2002, CLIN PHARMACOL THER, V72, P276, DOI 10.1067/mcp.2002.126913; Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931.7940.2004; Grosse Y, 2013, LANCET ONCOL, V14, P807, DOI 10.1016/S1470-2045(13)70329-2; Kressmann S, 2002, J PHARM PHARMACOL, V54, P661, DOI 10.1211/0022357021778970; Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112; Sakamoto Y, 2013, TOXICOL PATHOL, V41, P1078, DOI 10.1177/0192623313482055; Tamura K, 2013, TOXICOL LETT, V221, P47, DOI 10.1016/j.toxlet.2013.05.011; Chan PC, 2007, J ENVIRON SCI HEAL C, V25, P211, DOI 10.1080/10590500701569414; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Guo L, 2010, OMICS, V14, P75, DOI 10.1089/omi.2009.0115; Aydinlik H, 2001, ONCOGENE, V20, P7812, DOI 10.1038/sj.onc.1204982; CURRAN PG, 1991, ENDOCR REV, V12, P135; Whysner J, 1996, PHARMACOL THERAPEUT, V71, P153, DOI 10.1016/0163-7258(96)00067-8; Zadoyan G, 2012, EUR J CLIN PHARMACOL, V68, P553, DOI 10.1007/s00228-011-1174-5; Calvisi DF, 2001, CANCER RES, V61, P2085; Wei P, 2000, NATURE, V407, P920; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Cohen SM, 2010, TOXICOL PATHOL, V38, P487, DOI 10.1177/0192623310363813; DIWAN BA, 1986, CARCINOGENESIS, V7, P215, DOI 10.1093/carcin/7.2.215; Elcombe CR, 2014, CRIT REV TOXICOL, V44, P64, DOI 10.3109/10408444.2013.835786; Garcia-Alvarez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092265; Goldsworthy TL, 2002, TOXICOL PATHOL, V30, P97; Heinonen T, 2015, TOXICOLOGY, V327, P95, DOI 10.1016/j.tox.2014.10.013; Helium B.H., 2007, BASIC CLIN PHARMACOL, V100, P23; Hoenerhoff M. J., 2012, TOXICOL PATHOL, V41, P826; IARC, 2001, IARC MON EV CARC RIS, V79, P161; Lamminpaa A, 2002, EUR J CLIN PHARMACOL, V58, P137, DOI 10.1007/s00228-002-0429-6; Maeda J, 2014, TOXICOL SCI, V140, P298, DOI 10.1093/toxsci/kfu090; NTP, 2013, NATL TOXICOL PROGRAM, V578, P1; Rajaraman G, 2009, CAN J PHYSIOL PHARM, V87, P674, DOI [10.1139/y09-061, 10.1139/Y09-061]; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S; Umegaki K, 2002, JPN J PHARMACOL, V90, P345, DOI 10.1254/jjp.90.345; Umegaki K, 2007, J PHARM PHARMACOL, V59, P871, DOI 10.1211/jpp.59.6.0014; Vecchia Carlo, 2014, EUR J CANCER PREV, V23, P1; Yoshinari K, 2010, BIOCHEM PHARMACOL, V79, P261, DOI 10.1016/j.bcp.2009.08.008	37	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	SEP	2015	83						201	209		10.1016/j.fct.2015.06.010		9	Food Science & Technology; Toxicology	Food Science & Technology; Toxicology	CR1IQ	WOS:000361078800024		
J	Ikema, S; Takumi, S; Maeda, Y; Kurimoto, T; Bohda, S; Chigwechokha, PK; Sugiyama, Y; Shiozaki, K; Furukawa, T; Komatsu, M				Ikema, Satoshi; Takumi, Shota; Maeda, Yuta; Kurimoto, Takashi; Bohda, Shinya; Chigwechokha, Petros Kingstone; Sugiyama, Yasumasa; Shiozaki, Kazuhiro; Furukawa, Tatsuhiko; Komatsu, Masaharu			Okadaic acid is taken-up into the cells mediated by human hepatocytes transporter OATP1B3	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Hepatotoxicity; Microcystin-LR; OATP1B1; OATP1B3; Okadaic acid	MICROCYSTIN-LR; HUMAN LIVER; CYCLE PROGRESSION; HEPATIC-UPTAKE; CACO-2 CELLS; TOXIN; MICE; CYTOTOXICITY; PHOSPHATASES; INVOLVEMENT	Okadaic acid is known as a diarrheal shellfish poison. It is thought that there is no specific target organ for okadaic acid after it has been absorbed into the body. However, the details of its pharmacokinetics are still unknown. In this study, we demonstrated that okadaic acid was more toxic to the hepatocyte-specific uptake transporter OATP1B1- or OATP1B3-expressing cells than control vector-transfected cells. In addition, PP2A activity, which is a target molecule of okadaic acid, was more potently inhibited by okadaic acid in OATP1B1- or OATP1B3-expressing cells compared with control vector-transfected cells. The cytotoxicity of okadaic acid in OATP1B1- or OATP1B3-expressing cells was attenuated by known substrates of OATP1B1- and OATP1B3, but not in control vector-transfected cells. Furthermore, after uptake inhibition study using OATP1B3-expressing cells, Dixon plot showed that okadaic acid inhibited the uptake of hepatotoxin microcystin-LR, which is a substrate for OATP1B1 and OATP1B3, in a competitive manner.. These results strongly suggested that okadaic acid is a substrate for OATP1B3 and probably for OATP1B1, and could be involved in unknown caused liver failure and liver cancer. Since okadaic acid possesses cytotoxicity and cell proliferative activity by virtue of its known phosphatase inhibition activity. (C) 2015 Elsevier Ltd. All rights reserved.	[Ikema, Satoshi; Takumi, Shota; Maeda, Yuta; Kurimoto, Takashi; Bohda, Shinya; Chigwechokha, Petros Kingstone; Sugiyama, Yasumasa; Shiozaki, Kazuhiro; Komatsu, Masaharu] Kagoshima Univ, Fac Fisheries, Div Food & Chem Biol, Kagoshima 8900056, Japan; [Takumi, Shota] Jikei Univ, Sch Med, Dept Publ Hlth & Environm Med, Tokyo 1058461, Japan; [Takumi, Shota] Kagoshima Womens Coll, Dept Domest Sci, Kagoshima 8908565, Japan; [Furukawa, Tatsuhiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Kagoshima 8908544, Japan; [Furukawa, Tatsuhiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Res Adv Diag & Therapy Canc, Kagoshima 8908544, Japan	Komatsu, M (reprint author), Kagoshima Univ, Fac Fisheries, Div Food & Chem Biol, Shimoarata 4-50-20, Kagoshima 8900056, Japan.	komatsu@flsh.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24580304]	We express great appreciation to Professor Dietrich Keppler (German Cancer Research Center) for generously supplying the HEK293-OATP1B1, HEK293-OATP1B3 and MDCKII-OATP1B3 cells. This work was supported in part by Grant-in-Aid for Scientific Research (C) 24580304 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Seithel A, 2006, EUR J PHARM SCI, V28, P291, DOI 10.1016/j.ejps.2006.03.003; Komatsu M, 2013, FISHERIES SCI, V79, P313, DOI 10.1007/s12562-012-0593-2; Komatsu M, 2007, TOXICOL SCI, V97, P407, DOI 10.1093/toxsci/kfm054; Kurimchak A, 2012, GENE, V499, P1, DOI 10.1016/j.gene.2012.02.015; TAKAI A, 1992, BIOCHEM J, V284, P539; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Gehringer MM, 2004, FEBS LETT, V557, P1, DOI 10.1016/S0014-5793(03)01447-9; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Lancaster CS, 2013, MOL CANCER THER, V12, P1537, DOI 10.1158/1535-7163.MCT-12-0926; Komatsu M, 2000, CANCER RES, V60, P1312; Fujiki H, 1999, J CANCER RES CLIN, V125, P150, DOI 10.1007/s004320050257; Fischer WJ, 2005, TOXICOL APPL PHARM, V203, P257, DOI 10.1016/j.taap.2004.08.012; Monks NR, 2007, MOL CANCER THER, V6, P587, DOI 10.1158/1535-7163.MCT-06-0500; Nozawa T, 2003, J PHARM PHARMACOL, V55, P1013, DOI 10.1211/0022357021440; FUJIKI H, 1988, JPN J CANCER RES, V79, P1089; Briz O, 2006, J BIOL CHEM, V281, P30326, DOI 10.1074/jbc.M602048200; FUJIKI H, 1993, ADV CANCER RES, V61, P143; Nong Q, 2007, FREE RADICAL RES, V41, P1326, DOI 10.1080/10715760701704599; Ismair MG, 2001, GASTROENTEROLOGY, V121, P1185, DOI 10.1053/gast.2001.28704; Fehrenbach T, 2003, N-S ARCH PHARMACOL, V368, P415, DOI 10.1007/s00210-003-0814-4; Abolhassani M, 2008, INFLAMM RES, V57, P419, DOI 10.1007/s00011-007-7213-0; Cui Y, 2001, J BIOL CHEM, V276, P9626, DOI 10.1074/jbc.M004968200; Le Hegarat L, 2006, ENVIRON TOXICOL, V21, P55, DOI 10.1002/tox.20154; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Ferron PJ, 2014, MAR DRUGS, V12, P4616, DOI 10.3390/md12084616; Fessard V, 1996, MUTAT RES-ENVIR MUTA, V361, P133, DOI 10.1016/S0165-1161(96)90248-4; Holy M, 2012, TOXINS, V4, P940, DOI 10.3390/toxins4100940; Keppler D, 2014, DRUG METAB DISPOS, V42, P561, DOI 10.1124/dmd.113.055772; Konig J., 2000, AM J PHYSIOL-GASTR L, V278, P156; Letschert K., 2004, PHARMACOGENOMICS, V14, P441; Letschert K, 2005, J PHARMACOL EXP THER, V313, P549, DOI 10.1124/jpet.104.081224; Matias WG, 1999, HUM EXP TOXICOL, V18, P345, DOI 10.1191/096032799678840156; Meier-Abt F, 2004, BBA-BIOMEMBRANES, V1664, P64, DOI 10.1016/j.bbamem.2004.04.004; Messner DJ, 2001, CARCINOGENESIS, V22, P1163, DOI 10.1093/carcin/22.8.1163; Miao C., 2015, MOL CARCINO IN PRESS; MURATA KH, 1992, BIOCHEM INT, V26, P327; Nair S, 2008, PHARM RES-DORDR, V25, P387, DOI 10.1007/s11095-007-9364-7; Sun Yuchen, 2014, Clin Transl Med, V3, P37, DOI 10.1186/s40169-014-0037-y; Takano H, 2014, TOXICOLOGY, V326, P53, DOI 10.1016/j.tox.2014.10.003; Takumi S, 2015, ENVIRON TOXICOL PHAR, V39, P974, DOI 10.1016/j.etap.2015.02.021; Takumi S, 2010, ENVIRON HEALTH PERSP, V118, P1292, DOI 10.1289/ehp.1001899; YUASA H, 1994, J CANCER RES CLIN, V120, P208, DOI 10.1007/BF01372558	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	SEP	2015	83						229	236		10.1016/j.fct.2015.06.006		8	Food Science & Technology; Toxicology	Food Science & Technology; Toxicology	CR1IQ	WOS:000361078800028		
J	Hobbs, CA; Swartz, C; Maronpot, R; Davis, J; Recio, L; Koyanagi, M; Hayashi, S				Hobbs, Cheryl A.; Swartz, Carol; Maronpot, Robert; Davis, Jeffrey; Recio, Leslie; Koyanagi, Mihoko; Hayashi, Shim-mo			Genotoxicity evaluation of the flavonoid, myricitrin, and its aglycone, myricetin	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Genotoxicity; Flavoring agent; Myricitrin; Myricetin; DNA damage; Flavonoid	DAMAGE STRAND BREAKS; VITRO MICRONUCLEUS ASSAY; VIVO COMET ASSAY; IN-VITRO; DNA-DAMAGE; FLOW-CYTOMETRY; SALMONELLA-TYPHIMURIUM; MUTAGENICITY TEST; HUMAN-LYMPHOCYTES; PLANT FLAVONOIDS	Myricitrin, a flavonoid extracted from the fruit, leaves, and bark of Chinese bayberry (Myrica rubra SIEBOLD), is currently used as a flavor modifier in snack foods, dairy products, and beverages in Japan. Myricitrin is converted to myricetin by intestinal microflora; myricetin also occurs ubiquitously in plants and is consumed in fruits, vegetables, and beverages. The genotoxic potential of myricitrin and myricetin was evaluated in anticipation of worldwide marketing of food products containing myricitrin. In a bacterial reverse mutation assay, myricetin tested positive for frameshift mutations under metabolic activation conditions whereas myricitrin tested negative for mutagenic potential. Both myricitrin and myricetin induced micronuclei formation in human TK6 lymphoblastoid cells under conditions lacking metabolic activation; however, the negative response observed in the presence of metabolic activation suggests that rat liver S9 homogenate may detoxify reactive metabolites of these chemicals in mammalian cells. In 3-day combined micronucleus/Comet assays using male and female B6C3F1 mice, no induction of micronuclei was observed in peripheral blood, or conclusive evidence of damage detected in the liver, glandular stomach, or duodenum following exposure to myricitrin or myricetin. Our studies did not reveal evidence of genotoxic potential of myricitrin in vivo, supporting its safe use in food and beverages. (C) 2015 Elsevier Ltd. All rights reserved.	[Hobbs, Cheryl A.; Swartz, Carol; Davis, Jeffrey; Recio, Leslie] Integrated Lab Syst Inc, Toxicol Program, Res Triangle Pk, NC 27709 USA; [Maronpot, Robert] Maronpot Consulting LLC, Raleigh, NC 27607 USA; [Koyanagi, Mihoko; Hayashi, Shim-mo] San Ei Gen EEL Inc, Global Sci & Regulatory Affairs, Toyonaka, Osaka 5618588, Japan	Hobbs, CA (reprint author), Integrated Lab Syst Inc, POB 13501, Res Triangle Pk, NC 27709 USA.	chobbs@ils-inc.com			San-Ei Gen, F.F.I., Inc.	This work was conducted at ILS, Inc. and funded by San-Ei Gen, F.F.I., Inc., a manufacturer of myricitrin. Maronpot Consulting LLC is a consultant for ILS, Inc. and San-Ei Gen, F.F.I., Inc. ILS, Inc. was responsible for the study design, the collection, analysis, and interpretation of data, and the writing of the final study report and manuscript. The decision to submit the paper for publication was made by San-Ei Gen, F.F.I., Inc. The authors are indebted to Kim Shepard, John Winters, Amanda Green, and Colleen Lentz for technical assistance and data analysis. The authors also acknowledge the contributions of members of the Investigative Toxicology and Histology Departments at ILS, Inc., including Eileen Phillips and John Pope, who provided animal care, dosing and necropsy services, and Kaye Cummings and Jeanne deWard for quality assurance review of the data.	Rothfuss A, 2011, MUTAT RES-GEN TOX EN, V723, P108, DOI 10.1016/j.mrgentox.2010.12.005; Meotti FC, 2006, J PHARMACOL EXP THER, V316, P789, DOI 10.1124/jpet.105.092825; Bravo L, 1998, NUTR REV, V56, P317; Ong KC, 1997, GEN PHARMACOL-VASC S, V29, P121, DOI 10.1016/S0306-3623(96)00421-1; Duthie SJ, 1997, MUTAT RES-GEN TOX EN, V393, P223, DOI 10.1016/S1383-5718(97)00107-1; BROWN JP, 1979, MUTAT RES, V66, P223, DOI 10.1016/0165-1218(79)90083-1; Brendler-Schwaab S, 2005, MUTAGENESIS, V20, P245, DOI 10.1093/mutage.gei033; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Pfuhler S, 2007, TOXICOL SCI, V97, P237, DOI 10.1093/toxsci/kfm019; MACGREGOR JT, 1978, MUTAT RES, V54, P297, DOI 10.1016/0165-1161(78)90020-1; HEDDLE JA, 1973, MUTAT RES, V18, P187, DOI 10.1016/0027-5107(73)90035-3; Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011; GATEHOUSE D, 1994, MUTAT RES, V312, P217, DOI 10.1016/0165-1161(94)90037-X; SAHU SC, 1993, CANCER LETT, V70, P73, DOI 10.1016/0304-3835(93)90077-M; Bryce SM, 2007, MUTAT RES-GEN TOX EN, V630, P78, DOI 10.1016/jmrgentox.2007.02.002; Avlasevich S, 2011, MUTAGENESIS, V26, P147, DOI 10.1093/mutage/geq058; Avlasevich SL, 2006, ENVIRON MOL MUTAGEN, V47, P56, DOI 10.1002/em.20170; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; Meotti FC, 2006, BIOCHEM PHARMACOL, V72, P1707, DOI 10.1016/j.bcp.2006.08.028; HARDIGREE AA, 1978, MUTAT RES, V58, P231, DOI 10.1016/0165-1218(78)90014-9; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Kim HH, 2013, ARCH PHARM RES, V36, P1533, DOI 10.1007/s12272-013-0147-x; Hobbs CA, 2012, FOOD CHEM TOXICOL, V50, P854, DOI 10.1016/j.fct.2011.11.021; Anderson D, 1998, MUTAT RES-FUND MOL M, V402, P269, DOI 10.1016/S0027-5107(97)00306-0; Recio L, 2012, ENVIRON MOL MUTAGEN, V53, P101, DOI 10.1002/em.20694; Bryce SM, 2008, MUTAT RES-GEN TOX EN, V650, P181, DOI 10.1016/j.mrgentox.2007.11.006; CAMOIRANO A, 1994, MUTAT RES, V317, P89, DOI 10.1016/0165-1110(94)90019-1; Chen W., 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/724183; Delgado ME, 2008, EUR J NUTR, V47, P479, DOI 10.1007/s00394-008-0751-6; Domitrovic R, 2015, CHEM-BIOL INTERACT, V230, P21, DOI 10.1016/j.cbi.2015.01.030; Duthie SJ, 1997, MUTAT RES-GEN TOX EN, V390, P141, DOI 10.1016/S0165-1218(97)00010-4; Edenharder R, 2003, MUTAT RES-GEN TOX EN, V540, P1, DOI 10.1016/S1383-5718(03)00114-1; EFSA, 2010, EFSA J, V8, P1623, DOI [10.2093/j.efsa.2010.1623, DOI 10.2093/J.EFSA.2010.1623]; EFSA, 2011, EFSA J, V9, P2379, DOI DOI 10.2903/J.EFSA.2011.2379; FDA, 2000, REDB 2000 TOX PRINC; FDA, 2000, REDB 2000 GUID IND O; GRIFFITH.LA, 1972, BIOCHEM J, V130, P141; ICH, 2012, S2 R1 GUID GEN TEST; Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; JECFA, 2014, JOINT FAO WHO EXP CO; JECFA, 2014, WHO TECHN REP SER, V990; JMHLW, 1996, GUID DES FOOD ADD RE; Kirkland D, 2008, MUTAT RES-GEN TOX EN, V654, P114, DOI 10.1016/j.mrgentox.2008.05.002; MACGREGOR JT, 1980, ENVIRON MUTAGEN, V2, P509, DOI 10.1002/em.2860020408; OECD, 2014, OECD GUID TEST CHEM, P489; OECD, 2010, OECD GUID TEST CHEM, P487; OECD, 1997, OECD GUID TEST CHEM, P471; Redo L., 2010, J TOXICOL SCI, V35, P149; Sasaki YF, 2000, CRIT REV TOXICOL, V30, P629, DOI 10.1080/10408440008951123; Shimosaki S, 2011, NAT PROD RES, V25, P374, DOI 10.1080/14786411003774320; UYETA M, 1981, MUTAT RES, V88, P233, DOI 10.1016/0165-1218(81)90035-5; Witt KL, 2008, MUTAT RES-GEN TOX EN, V649, P101, DOI 10.1016/j.mrgentox.2007.08.004	54	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	SEP	2015	83						283	292		10.1016/j.fct.2015.06.016		10	Food Science & Technology; Toxicology	Food Science & Technology; Toxicology	CR1IQ	WOS:000361078800034		
J	Nakamura, A; Okuda, H; Nagaoka, T; Akiba, N; Kurosawa, K; Kuroki, K; Ichikawa, F; Torao, A; Sota, T				Nakamura, Atsushi; Okuda, Hidekazu; Nagaoka, Takashi; Akiba, Norimitsu; Kurosawa, Kenji; Kuroki, Kenro; Ichikawa, Fumihiko; Torao, Akira; Sota, Takayuki			Portable hyperspectral imager with continuous wave green laser for identification and detection of untreated latent fingerprints on walls	FORENSIC SCIENCE INTERNATIONAL			English	Article						Hyperspectral imager; CW visible laser; Fluorescence; Untreated latent fingerprints/palm prints on walls	VISIBLE ABSORPTION; IMAGING-SYSTEM; LUMINESCENCE; SURFACES; MELANOMA; TIME	Untreated latent fingerprints are known to exhibit fluorescence under UV laser excitation. Previously, the hyperspectral imager (HSI) has been primarily evaluated in terms of its potential to enhance the sensitivity of latent fingerprint detection following treatment by conventional chemical methods in the forensic science field. In this study however, the potential usability of the HSI for the visualization and detection of untreated latent fingerprints by measuring their inherent fluorescence under continuous wave (CW) visible laser excitation was examined. Its potential to undertake spectral separation of overlapped fingerprints was also evaluated. The excitation wavelength dependence of fluorescent images was examined using an untreated palm print on a steel based wall, and it was found that green laser excitation is superior to blue and yellow lasers' excitation for the production of high contrast fluorescence images. In addition, a spectral separation method for overlapped fingerprints/palm prints on a plaster wall was proposed using new images converted by the division and subtraction of two single wavelength images constructed based on measured hyperspectral data (HSD). In practical tests, the relative isolation of two overlapped fingerprints/palm prints was successful in twelve out of seventeen cases. Only one fingerprint/palm print was extracted for an additional three cases. These results revealed that the feasibility of overlapped fingerprint/palm print spectral separation depends on the difference in the temporal degeneration of each fluorescence spectrum. The present results demonstrate that a combination of a portable HSI and CW green laser has considerable potential for the identification and detection of untreated latent fingerprints/palm prints on the walls under study, while the use of HSD makes it practically possible for doubly overlapped fingerprints/palm prints to be separated spectrally. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nakamura, Atsushi; Okuda, Hidekazu; Nagaoka, Takashi; Sota, Takayuki] Waseda Univ, Waseda Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Akiba, Norimitsu; Kurosawa, Kenji; Kuroki, Kenro] Natl Res Inst Police Sci, Dept Forens Sci 2, Kashiwa, Chiba 2770882, Japan; [Ichikawa, Fumihiko; Torao, Akira] JFE Technores Corp, Chuo Ku, Chiba 2600835, Japan; [Sota, Takayuki] Waseda Univ, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo 1698555, Japan	Nakamura, A (reprint author), Waseda Univ, Waseda Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan.	anakamura@waseda.jp			"R&D Program for Implementation of Anti-Crime and Anti-Terrorism Technologies for a Safe and Secure Society" from the "Funds for Integrated Promotion of Social Reform and Research and Development"; Ministry of Education, Culture, Sports, Science, and Technology, a division of the Japanese Government	This work was supported by the "R&D Program for Implementation of Anti-Crime and Anti-Terrorism Technologies for a Safe and Secure Society" from the "Funds for Integrated Promotion of Social Reform and Research and Development" of the Ministry of Education, Culture, Sports, Science, and Technology, a division of the Japanese Government. We are grateful to K. Hibino at the National Police Agency and S. Hamano, K. Yamamoto, and Y. Hojo at Waseda University for their help in measuring latent fingerprints on walls.	Akiba N, 2007, J FORENSIC SCI, V52, P1103, DOI 10.1111/j.1556-4029.2007.00532.x; Amoros BG, 2014, SCI JUSTICE, V54, P346, DOI 10.1016/j.scijus.2014.04.006; MURDOCK RH, 1993, J FORENSIC SCI, V38, P521; Payne G, 2005, FORENSIC SCI INT, V150, P33, DOI 10.1016/j.forsciint.2004.06.036; Khoobehi B, 2004, INVEST OPHTH VIS SCI, V45, P1464, DOI 10.1167/iovs.03-1069; Vo-Dinh T, 2004, IEEE ENG MED BIOL, V23, P40; Archer NE, 2005, FORENSIC SCI INT, V154, P224, DOI 10.1016/j.forsciint.2004.09.120; Brown AG, 2009, J FORENSIC SCI, V54, P114, DOI 10.1111/j.1556-4029.2008.00902.x; Dalrymple B. E., 1977, J FORENSIC SCI, V22, P106; De Paoli D., 2010, J FORENSIC SCI, V55, P962; Dominick A.J., 2009, J FORENSIC IDENT, V59, P340; Dominick A.J., 2009, J FORENSIC IDENT, V59, P325; Exline DL, 2003, J FORENSIC SCI, V48, P1047; KRUSE FA, 1993, REMOTE SENS ENVIRON, V44, P145, DOI 10.1016/0034-4257(93)90013-N; Maynard P, 2009, AUST J FORENSIC SCI, V41, P43, DOI 10.1080/00450610802172248; Menzel E R, 2001, ScientificWorldJournal, V1, P498; Nagaoka T, 2012, SKIN RES TECHNOL, V18, P301, DOI 10.1111/j.1600-0846.2011.00571.x; Nagaoka T, 2015, SKIN RES TECHNOL, V21, P278, DOI 10.1111/srt.12188; Nagaoka T, 2013, SKIN RES TECHNOL, V19, pE290, DOI 10.1111/j.1600-0846.2012.00642.x; Song DF, 2011, FORENSIC SCI INT, V204, P97, DOI 10.1016/j.forsciint.2010.05.008; Tahtouh M., 2005, J FORENSIC SCI, V1, P1	21	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	SEP	2015	254						100	105		10.1016/j.forsciint.2015.06.031		6	Medicine, Legal	Legal Medicine	CQ9YY	WOS:000360974500019		
J	Tominaga, M; Michiue, T; Ishikawa, T; Inamori-Kawamoto, O; Oritani, S; Maeda, H				Tominaga, Mariko; Michiue, Tomomi; Ishikawa, Takaki; Inamori-Kawamoto, Osamu; Oritani, Shigeki; Maeda, Hitoshi			Evaluation of postmortem drug concentrations in cerebrospinal fluid compared with blood and pericardial fluid	FORENSIC SCIENCE INTERNATIONAL			English	Article						Forensic toxicology; Drug distribution; Cerebrospinal fluid; Pericardial fluid; Postmortem distribution; Toxicokinetics	HEART BLOOD; BONE-MARROW; PHARMACOKINETICS; PLASMA; LIDOCAINE; CAFFEINE; SERUM; ACETAMINOPHEN; PARACETAMOL; METABOLITES	In forensic toxicology, body fluids are important materials not only as alternatives to blood but also for investigation of postmortem drug redistributions and pharmaco-/toxicokinetic analysis; however, there are limited data on postmortem drug distributions in cerebrospinal fluid (CSF). The present study reviewed toxicological data of autopsy cases (n = 103), in which drugs were detected in CSF using gas chromatography/mass spectrometry (GC/MS), to investigate drug concentrations in CSF, compared with blood and pericardial fluid (PCF) concentrations. Oral/injected amphetamines (n = 23) showed similar CSF and blood/PCF concentrations with partly lower CSF concentrations (about x0.5-1.1). CSF concentrations of the venous anesthetic midazolam (n = 7) were lower with poor correlations. Oral caffeine (n = 15), acetaminophen (n = 7), chlorpheniramine (n = 6), dihydrocodeine (n = 6), and phenobarbital (n = 21) showed equivalent to lower CSF concentrations (about x0.2-1.2), compared with blood and PCF concentrations; however, CSF phenobarbital concentrations were high in a fatal intoxication case. CSF concentrations of phenothiazine derivatives (n = 29) were markedly lower (about x0.1) than blood/PCF concentrations. The distribution of the local anesthetic lidocaine used in critical medical care (n = 49) markedly varied by case. These findings suggest that CSF is useful in routine forensic toxicology as an alternative to blood as well as for investigating pharmaco-/toxicokinetics and postmortem redistributions. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Tominaga, Mariko; Michiue, Tomomi; Ishikawa, Takaki; Inamori-Kawamoto, Osamu; Oritani, Shigeki; Maeda, Hitoshi] Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Osaka 5458585, Japan; [Tominaga, Mariko; Michiue, Tomomi; Ishikawa, Takaki; Inamori-Kawamoto, Osamu; Maeda, Hitoshi] Osaka City Univ, Sch Med, MLCPI SC, Forens Autopsy Sect, Osaka 5458585, Japan; [Ishikawa, Takaki] Tottori Univ, Fac Med, Div Legal Med, Yonago, Tottori 6838503, Japan	Tominaga, M (reprint author), Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Asahi Machi 1-4-3, Osaka 5458585, Japan.	mari1216@med.osaka-cu.ac.jp					AALTONEN L, 1981, ACTA PHARMACOL TOX, V48, P364; Anderson BJ, 1998, BRIT J CLIN PHARMACO, V46, P237, DOI 10.1046/j.1365-2125.1998.00780.x; Antinori A, 2005, CLIN INFECT DIS, V41, P1787, DOI 10.1086/498310; Fleischhack G, 2005, CLIN PHARMACOKINET, V44, P1, DOI 10.2165/00003088-200544010-00001; Tominaga M, 2013, J ANAL TOXICOL, V37, P423, DOI 10.1093/jat/bkt047; JONES GR, 1987, J ANAL TOXICOL, V11, P186; Yilmaz A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-63; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Rambeck B, 2006, EPILEPSIA, V47, P681, DOI 10.1111/j.1528-1167.2006.00504.x; Banerjee P, 2014, J FORENSIC SCI, V59, P865, DOI 10.1111/1556-4029.12387; Schloegl H, 2006, FORENSIC SCI INT, V156, P213, DOI 10.1016/j.forsciint.2005.03.024; Kugelberg FC, 2007, FORENSIC SCI INT, V165, P10, DOI 10.1016/j.forsciint.2006.05.004; Kerrigan S, 2005, FORENSIC SCI INT, V153, P67, DOI 10.1016/j.forsciint.2005.04.016; Shen DD, 2004, ADV DRUG DELIVER REV, V56, P1825, DOI 10.1016/j.addr.2004.07.011; Singla NK, 2012, PAIN PRACT, V12, P523, DOI 10.1111/j.1533-2500.2012.00556.x; Schomburg R, 2011, J NEURAL TRANSM, V118, P641, DOI 10.1007/s00702-011-0613-x; BANNWARTH B, 1992, BRIT J CLIN PHARMACO, V34, P79; ARTRU AA, 1988, ANESTHESIOLOGY, V69, P541, DOI 10.1097/00000542-198810000-00014; BENOWITZ NL, 1990, ANNU REV MED, V41, P277, DOI 10.1146/annurev.me.41.020190.001425; Brinker Thomas, 2014, Fluids Barriers CNS, V11, P10, DOI 10.1186/2045-8118-11-10; CALDWELL J, 1972, BIOCHEM J, V129, P23; Contreras T.M., 2007, J ANAL TOXICOL, V31, P75; Cook DS, 2000, J CLIN PATHOL, V53, P282, DOI 10.1136/jcp.53.4.282; DRING LG, 1970, BIOCHEM J, V116, P425; DUDLEY MN, 1984, ANTIMICROB AGENTS CH, V26, P811; Engelhart DA, 2007, J ANAL TOXICOL, V31, P581; HANSSON E, 1961, ARCH INT PHARMACOD T, V131, P309; Har-Even R, 2014, J CLIN PHARMACOL, V54, P1023, DOI 10.1002/jcph.307; Iwasaki Y, 1998, FORENSIC SCI INT, V94, P111, DOI 10.1016/S0379-0738(98)00063-2; Kamiya Y, 2009, ANESTHESIOLOGY, V110, P1127, DOI 10.1097/ALN.0b013e31819daf15; Karla A.M., 1999, J ANAL TOXICOL, V23, P541; MARATHE PH, 1991, ANESTHESIOLOGY, V75, P804, DOI 10.1097/00000542-199111000-00012; Mc Namara J.O., 2001, GOODMAN GILMANS PHAR, V10th, P532; Morikawa N, 1998, ANN PHARMACOTHER, V32, P1008, DOI 10.1345/aph.17362; Moriya F, 2003, FORENSIC SCI INT, V137, P183, DOI 10.1016/S0379-0738(03)00333-5; Moriya F, 1999, Leg Med (Tokyo), V1, P86, DOI 10.1016/S1344-6223(99)80018-2; Moriya F, 2000, Leg Med (Tokyo), V2, P143, DOI 10.1016/S1344-6223(00)80014-0; Moriya F, 2014, LEGAL MED-TOKYO, V16, P178, DOI 10.1016/j.legalmed.2014.02.002; Moriya F., 2005, ALTERNATIVE SPECIMEN, V2, P9; Nagaki S, 1999, EUR J DRUG METAB PH, V24, P255; NOGUCHI TT, 1978, J FORENSIC SCI, V23, P490; PROUTY RW, 1987, J ANAL TOXICOL, V11, P191; Robert J.F., 2011, GUIDELINES INTERPRET, V9th; Saar E., 2012, 50 ANN M INT ASS FOR; Singer PP, 1997, J ANAL TOXICOL, V21, P506; SUE YJ, 1992, CLIN PHARMACOKINET, V23, P93; Sylvester PA, 1998, J CLIN PATHOL, V51, P250; Takayasu T, 1995, FORENSIC SCI INT, V76, P179, DOI 10.1016/0379-0738(95)01820-4; Tominaga M., 2013, J ANAL TOXICOL, V27, P122; van der Marel CD, 2003, EUR J CLIN PHARMACOL, V59, P297, DOI 10.1007/s00228-003-0622-2; WOLFF T, 1995, PAIN, V62, P147, DOI 10.1016/0304-3959(94)00268-J	51	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	SEP	2015	254						118	125		10.1016/j.forsciint.2015.07.005		8	Medicine, Legal	Legal Medicine	CQ9YY	WOS:000360974500021		
J	Takada, M; Chiba, S; Nagai, T; Takeshita, H; Kanno, S; Ikawa, T; Sakamoto, K; Sagi, M; Ichiba, K; Mukai, T				Takada, Meri; Chiba, Shoetsu; Nagai, Tomonori; Takeshita, Hiroshi; Kanno, Sanae; Ikawa, Toru; Sakamoto, Kana; Sagi, Morihisa; Ichiba, Kazue; Mukai, Toshiji			Inflammatory responses to neutral fat and fatty acids in multiple organs in a rat model of fat embolism syndrome	FORENSIC SCIENCE INTERNATIONAL			English	Article						Fat embolism syndrome; Inflammatory cytokine; Neutral fat; Fatty acid; Rat	ACUTE LUNG INJURY; OLEIC-ACID; NEUTROPHILS; DISEASE; MARKER	Fat embolism syndrome (FES) is a common complication of long bone fractures. FES is rare but with significant morbidity and occasional fatalities. Studies of animal models of FES are numerous; however, few studies compare inflammatory reactions in multiple organs. The present study investigated the effect of neutral fat and fatty acids, which cause changes in multiple organs and induce FES. Using rats we evaluated the ratio of lung-to-body weight and conducted histological analyses and quantitative analysis of inflammatory cytokine mRNAs in the lungs following intravenous administration of neutral fat or fatty acids. Neutral fat increased the ratio of lung-to-body weight, and neutral fat formed emboli in lung capillaries. The levels of interleukin-1 beta (IL-1 beta), IL-6 and tumor necrosis factor-alpha (TNF-alpha) in the lungs increased after injection of neutral fat and oleic acid. Analysis of the histologic changes revealed that the highest numbers of fat droplets, occluding the capillaries of the lungs, kidney, heart, and brain formed 12 h after the injection of neutral fat and fat droplets gradually diminished 48 h later. Fat droplets were not detected in any organs after the injection of oleic acid. IL-1 beta and TNF-alpha levels in the lungs were elevated 9-24 h after the injection of neutral fat, although IL-6 levels peaked at 6 h. After injection of oleic acid, peak levels of IL-1 beta, IL-6, and TNF-alpha were detected at 6 h, and IL-6 again increased in all organs and plasma at 15 h. Neutral fat, but not fatty acids, formed emboli in the capillaries of multiple organs. These findings suggest that neutral fat increased inflammatory cytokine levels by forming emboli in organ capillaries, particularly in the lungs, while oleic acid augmented inflammatory cytokine levels by stimulating endothelial cells of multiple organs. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Takada, Meri; Chiba, Shoetsu; Nagai, Tomonori; Takeshita, Hiroshi; Kanno, Sanae; Ikawa, Toru; Sakamoto, Kana; Sagi, Morihisa; Ichiba, Kazue; Mukai, Toshiji] St Marianna Univ, Sch Med, Dept Legal Med, Miyamae Ward, Kawasaki, Kanagawa 2168511, Japan	Takada, M (reprint author), St Marianna Univ, Sch Med, Dept Legal Med, Miyamae Ward, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	m2takada@marianna-u.ac.jp			St. Marianna University School of Medicine	St. Marianna University School of Medicine provided financial support for the conduct of this academic research. The funding source has no involvement in the research.	Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Nikolic S, 2012, INJURY, V43, P608, DOI 10.1016/j.injury.2010.08.027; Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365; Chen HI, 2009, CHINESE J PHYSIOL, V52, P339, DOI 10.4077/CJP.2009.AMH036; Murtaugh MP, 1996, VET IMMUNOL IMMUNOP, V54, P45, DOI 10.1016/S0165-2427(96)05698-X; Bulger EM, 1997, ARCH SURG-CHICAGO, V132, P435; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Miller P, 2011, AM J FOREN MED PATH, V32, P291, DOI 10.1097/PAF.0b013e31822a6428; SCHUSTER DP, 1994, AM J RESP CRIT CARE, V149, P245; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20020407; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Krebs J, 2008, J BONE JOINT SURG AM, V90A, P349, DOI 10.2106/JBJS.G.00058; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/01.mol.0000064055.08840.77; Wang HD, 2008, AESTHET PLAST SURG, V32, P731, DOI 10.1007/s00266-008-9183-1; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Mellor A, 2001, ANAESTHESIA, V56, P145, DOI 10.1046/j.1365-2044.2001.01724.x; BEILMAN G, 1995, LIPIDS, V30, P817, DOI 10.1007/BF02533957; Bennett T.D., 1981, AM J PHYSIOL, V240, P18; Bergmann E.B., 1873, KLIN WOCHENSCHR, V10, P385; Blankstein M, 2011, J ORTHOP TRAUMA, V25, P674, DOI 10.1097/BOT.0b013e318206ed30; Bolliger SA, 2011, INT J LEGAL MED, V125, P453, DOI 10.1007/s00414-011-0563-8; de Feiter PW, 2007, J TRAUMA, V63, P429, DOI 10.1097/01.ta.0000234728.27271.1e; Duis H.J., 1997, INJURY, V28, P77; Liu DD, 2008, J BONE JOINT SURG BR, V90B, P1517, DOI 10.1302/0301-620X.90B11.20761; McIff TE, 2011, J TRAUMA, V70, P1186, DOI 10.1097/TA.0b013e3181e50df6; McIff TE, 2010, J ORTHOP RES, V28, P191, DOI 10.1002/jor.20963; Nakata Y, 1999, J TRAUMA, V47, P111, DOI 10.1097/00005373-199907000-00024; NORMAN JG, 1995, ARCH SURG-CHICAGO, V130, P966; Paredes JCS, 2011, J SHOULDER ELB SURG, V20, pE1, DOI 10.1016/j.jse.2010.11.027; Parisi Debra M, 2002, Am J Orthop (Belle Mead NJ), V31, P507; Prakash S, 2013, CLIN ORTHOP RELAT R, V471, P2340, DOI 10.1007/s11999-013-2869-y; Putensen C, 2000, INTENS CARE MED, V26, P1411, DOI 10.1007/s001340000647; Shaikh Nissar, 2009, J Emerg Trauma Shock, V2, P29, DOI 10.4103/0974-2700.44680; Tokunaga S., 1976, J SHOWA MED ASS, V37, P39; Zenker F.A., 1861, J BRAUNSDORF DRESDEN, P20	35	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	SEP	2015	254						126	132		10.1016/j.forsciint.2015.07.011		7	Medicine, Legal	Legal Medicine	CQ9YY	WOS:000360974500022		
J	Sasao, A; Yonemitsu, K; Ohtsu, Y; Mishima, S; Nishitani, Y				Sasao, Ako; Yonemitsu, Kosei; Ohtsu, Yuki; Mishima, Satoko; Nishitani, Yoko			Quantitative determination of n-butane metabolites in three cases of butane sniffing death	FORENSIC SCIENCE INTERNATIONAL			English	Article						Volatile substance misuse; n-Butane; n-Butane metabolite; 2-Butanol; 2-Butanone	VOLATILE SUBSTANCE-ABUSE; SUDDEN-DEATH; INHALATION; PROPANE; 1,3-BUTADIENE	Butane is an addictive volatile substance like toluene. We report three forensic autopsy cases of sudden death that occurred while sniffing n-butane and isobutane from portable gas cartridges. n-Butane and isobutane were detected in all three cases. In cases 1-3, n-butane concentrations in heart blood were 54.3, 25.5, and 30.7 mu g/mL, respectively. These concentrations were considered fatal according to the previous reports. In addition, n-butane metabolites (2-butanol and 2-butanone) were detected in cases 1 and 3 but not in case 2. Blood levels of 2-butanol and 2-butanone were 6.5 and 1.8 mu g/mL, respectively, in case 1, and 6.3 and 5.6 mu g/mL, respectively, in case 3. According to the police investigation, the decedent in case 1 had misused butane gas for more than 6 months in the period leading up to death. The decedent in case 3 also had a history of chronic misuse of butane gas. There was no history of chronic misuse of butane gas by the decedent in case 2. It was suspected that he attempted suicide via inhalation of butane gas using a plastic bag, leading to a rapid death. The presence or absence of n-butane metabolites might reflect the way of butane inhalation, such as the frequency and duration. Although additional experimental and case studies are necessary to establish the forensic applications of n-butane metabolite detection, it may be a useful method to understand the decedents' pattern of butane sniffing before death. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Sasao, Ako; Yonemitsu, Kosei; Ohtsu, Yuki; Mishima, Satoko; Nishitani, Yoko] Kumamoto Univ, Fac Life Sci, Dept Forens Med, Chuo Ku, Kumamoto 8608556, Japan	Sasao, A (reprint author), Kumamoto Univ, Fac Life Sci, Dept Forens Med, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	ako@kumamoto-u.ac.jp					Ago Mihoko, 2002, Leg Med (Tokyo), V4, P113, DOI 10.1016/S1344-6223(01)00063-3; [Anonymous], 2002, ANN CAS REP DRUG TOX, P44; Sugie H, 2004, FORENSIC SCI INT, V143, P211, DOI 10.1016/j.forsciint.2004.02.038; Albertini RJ, 2001, CHEM-BIOL INTERACT, V135, P429, DOI 10.1016/S0009-2797(01)00181-8; Albertini RJ, 2007, CHEM-BIOL INTERACT, V166, P63, DOI 10.1016/j.cbi.2006.07.004; Statheropoulos M, 2007, SCI TOTAL ENVIRON, V385, P221, DOI 10.1016/j.scitotenv.2007.07.003; Bouche MPLA, 2002, J ANAL TOXICOL, V26, P35; Marsolek MR, 2010, PEDIATRICS, V125, P906, DOI 10.1542/peds.2009-2080; Jackowski C, 2005, AM J FOREN MED PATH, V26, P355, DOI 10.1097/01.paf.0000188076.54147.07; Pfeiffer H, 2006, INT J LEGAL MED, V120, P168, DOI 10.1007/s00414-005-0062-x; Butland BK, 2013, ADDICTION, V108, P385, DOI 10.1111/j.1360-0443.2012.04047.x; Chiba S., 1991, JPN J LEGAL MED, V45, P128; Ford JB, 2014, CLIN REV ALLERG IMMU, V46, P19, DOI 10.1007/s12016-013-8371-1; Fuke Chiaki, 2002, Leg Med (Tokyo), V4, P134; Graefe Adelgunde, 1999, Archiv fuer Kriminologie, V203, P27; Koreeda A, 2007, FORENSIC SCI INT, V168, P208, DOI 10.1016/j.forsciint.2006.01.006; SHEPHERD RT, 1989, HUM TOXICOL, V8, P287; TSUKAMOTO S, 1985, Journal of Toxicological Sciences, V10, P323; Walker R, 2006, J CHROMATOGR SCI, V44, P387	19	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	SEP	2015	254						180	184		10.1016/j.forsciint.2015.07.032		5	Medicine, Legal	Legal Medicine	CQ9YY	WOS:000360974500028		
J	Kuroki, S; Masuda, M; Yu, L				Kuroki, Shintaro; Masuda, Mikiya; Yu, Li			Small covers, infra-solvmanifolds and curvature	FORUM MATHEMATICUM			English	Article						Small cover; real moment-angle manifold; real Bott manifold; Ricci curvature; infra-solvmanifold; infra-nilmanifold; Coxeter group	REAL BOTT MANIFOLDS; QUASITORIC MANIFOLDS; RIGIDITY; POLYTOPES; SPACES	It is shown that a small cover (resp. real moment-angle manifold) over a simple polytope is an infra-solvmanifold if and only if it is diffeomorphic to a real Bott manifold (resp. flat torus). Moreover, we obtain several equivalent conditions for a small cover to be homeomorphic to a real Bott manifold. In addition, we study Riemannian metrics on small covers and real moment-angle manifolds with certain conditions on the Ricci or sectional curvature. We will see that these curvature conditions put very strong restrictions on the topology of the corresponding small covers and real moment- angle manifolds and the combinatorial structures of the underlying simple polytopes.	[Kuroki, Shintaro] Osaka City Univ, Adv Math Inst OCAMI, Sumiyoshi Ku, Osaka 5588585, Japan; [Kuroki, Shintaro] Univ Toronto, Dept Math, Toronto, ON M5S 2E4, Canada; [Masuda, Mikiya] Osaka City Univ, Dept Math, Sumiyoshi Ku, Osaka 5588585, Japan; [Yu, Li] Nanjing Univ, Dept Math, Nanjing 210093, Jiangsu, Peoples R China; [Yu, Li] Nanjing Univ, IMS, Nanjing 210093, Jiangsu, Peoples R China	Kuroki, S (reprint author), Osaka City Univ, Adv Math Inst OCAMI, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	kuroki@scisv.sci.osaka-cu.ac.jp; masuda@sci.osaka-cu.ac.jp; yuli@nju.edu.cn			JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation "Deepening and Evolution of Mathematics and Physics, Building of International Network Hub Based on OCAMI"; JSPS [P10018]; Natural Science Foundation of China [11001120]; PAPD (priority academic program development) of Jiangsu higher education institutions;  [22540094]	The first author is partially supported by the JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation "Deepening and Evolution of Mathematics and Physics, Building of International Network Hub Based on OCAMI". The second author is partially supported by Grant-in-Aid for Scientific Research 22540094. The third author is partially supported by JSPS (grant no. P10018) and Natural Science Foundation of China (grant no. 11001120). This work is also funded by the PAPD (priority academic program development) of Jiangsu higher education institutions.	Andreev E M, 1970, MATH USSSR SB, V10, P413, DOI 10.1070/SM1970v010n03ABEH001677; HAMILTON RS, 1986, J DIFFER GEOM, V24, P153; Wilking B, 2000, MATH ANN, V317, P195, DOI 10.1007/s002089900091; Qi DW, 2007, FUND MATH, V193, P79, DOI 10.4064/fm193-1-5; Erokhovets NY, 2008, RUSS MATH SURV+, V63, P962, DOI 10.1070/RM200v2008063n05ABEH004565; Wiemeler M, 2013, MATH Z, V273, P1063, DOI 10.1007/s00209-012-1044-6; Roeder RKW, 2007, ANN I FOURIER, V57, P825; Baues O, 2004, TOPOLOGY, V43, P903, DOI 10.1016/j.top.2003.11.002; Benson C.T., 1985, GRAD TEXTS MATH, V99; Buchstaber VM, 2007, MOSC MATH J, V7, P219; Burago D., 2001, GRAD STUD MATH, V33; Cai MZ, 2007, TOPOL APPL, V154, P2228, DOI 10.1016/j.topol.2007.02.008; Cheeger Jeff, 1971, J DIFFER GEOM, V6, P119; Choi S, 2008, ALGEBR GEOM TOPOL, V8, P2391, DOI 10.2140/agt.2008.8.2391; Choi S, 2010, OSAKA J MATH, V47, P109; Choi S., 2010, PREPRINT; Coxeter H. S. M., 1935, J LOND MATH SOC, V10, P21; Davis M., 1998, SELECTA MATH, V4, P491, DOI 10.1007/s000290050039; Davis M., 1991, DUKE MATH J, V61, P417; DAVIS M, 1978, PAC J MATH, V77, P315; Davis M., 2013, PREPRINT; Dinkelbach J, 2009, GEOM TOPOL, V13, P1129, DOI 10.2140/gt.2009.13.1129; Grom M., 1978, J DIFFER GEOM, V13, P231; Humphreys J., 1990, CAMBRIDGE STUD ADV M, V29; Jones L.E., 1990, CBMS REG C SER MATH, V75; Kamishima Y, 2009, ALGEBR GEOM TOPOL, V9, P2479, DOI 10.2140/agt.2009.9.2479; Kuroki S, 2013, P JPN ACAD A-MATH, V89, P114, DOI 10.3792/pjaa.89.114; Masuda M, 2010, P STEKLOV INST MATH, V268, P242, DOI 10.1134/S0081543810010165; Panov T.E., 2002, U LECT SER, V24; Petersen Peter, 2006, GRAD TEXTS MATH, V171; Pogorelov A.V., 1967, MAT ZAMETKI, V1, P3, DOI 10.1007/BF01221716; Preissmann A., 1943, COMMENT MATH HELV, V15, P175; Radcliffe D., 2003, ALGEBR GEOM TOPOL, V3, P1079, DOI 10.2140/agt.2003.3.1079; RUH EA, 1982, J DIFFER GEOM, V17, P1; Smith PA, 1944, P NATL ACAD SCI USA, V30, P105, DOI 10.1073/pnas.30.5.105; Tuschmann W, 1997, DIFFER GEOM APPL, V7, P251, DOI 10.1016/S0926-2245(96)00054-X; Ziegler G.M., 1998, LECT POLYTOPES, V152	37	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0933-7741	1435-5337		FORUM MATH	Forum Math.	SEP	2015	27	5					2981	3004		10.1515/forum-2013-0084		24	Mathematics, Applied; Mathematics	Mathematics	CQ8KE	WOS:000360855700016		
J	Halimi, NH; Ito, T				Halimi, Nazer H.; Ito, Tetsuya			Cones of certain isolated left orderings and chain domains	FORUM MATHEMATICUM			English	Article						Exceptional prime ideal; chain domain; isolated ordering; Mal'cev's problem	RINGS	We observe interesting interactions among isolated orderings of groups, exceptional prime segments of cones, and exceptional prime ideals of chain domains. We study the structure of certain isolated left orderings and their cones, and use this to construct a new family of chain domains with prime but not completely prime ideals.	[Halimi, Nazer H.] Univ Queensland, Sch Math & Phys, Brisbane, Qld 4072, Australia; [Ito, Tetsuya] Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan	Halimi, NH (reprint author), Univ Queensland, Sch Math & Phys, Brisbane, Qld 4072, Australia.	n.halimi@uq.edu.au; tetitoh@kurims.kyoto-u.ac.jp			JSPS Postdoctoral Fellowships	Tetsuya Ito was partially supported by JSPS Postdoctoral Fellowships for Research Abroad.	Navas A, 2010, ANN I FOURIER, V60, P1685; Brungs HH, 1998, J ALGEBRA, V210, P145, DOI 10.1006/jabr.1998.7456; Brungs HH, 1995, CAN J MATH, V47, P1148, DOI 10.4153/CJM-1995-059-3; Brungs HH, 2003, T AM MATH SOC, V355, P2733, DOI 10.1090/S0002-9947-03-03272-0; Conrad P., 1959, MICH MATH J, V6, P267; Dehornoy P, 2014, J GROUP THEORY, V17, P465, DOI 10.1515/jgt-2013-0049; Dubrovin N., 1984, MATH USSR SB, V48, P437, DOI 10.1070/SM1984v048n02ABEH002684; DUBROVIN NI, 1994, RUSS AC SC SB MATH+, V79, P231, DOI 10.1070/SM1994v079n02ABEH003498; Dubrovina TV, 2001, SB MATH+, V192, P693, DOI 10.1070/SM2001v192n05ABEH000564; Ito T., 2013, PREPRINT; Ito T, 2013, J ALGEBRA, V374, P42, DOI 10.1016/j.jalgebra.2012.10.016; Marubayashi H., 1997, K MONOGR MATH, V3; Mathiak K., 1986, LECT NOTES MATH, V1175; Navas A, 2011, J ALGEBRA, V328, P31, DOI 10.1016/j.jalgebra.2010.10.020; Sikora AS, 2004, B LOND MATH SOC, V36, P519, DOI 10.1112/S0024609303003060	15	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0933-7741	1435-5337		FORUM MATH	Forum Math.	SEP	2015	27	5					3027	3051		10.1515/forum-2013-0036		25	Mathematics, Applied; Mathematics	Mathematics	CQ8KE	WOS:000360855700019		
J	Xue, QY; Yabuta, K; Yan, JQ				Xue, Qingying; Yabuta, Kozo; Yan, Jingquan			Fractional type Marcinkiewicz integral operators on function spaces	FORUM MATHEMATICUM			English	Article						L-p boundedness; Marcinkiewicz integral; fractional integral operator; Triebel-Lizorkin spaces; Sobolev spaces	TRIEBEL-LIZORKIN SPACES; ROUGH KERNELS; BOUNDEDNESS	In this paper, we discussed about the boundedness of the fractional type Marcinkiewicz integral operators, and improved a result given by Chen, Fan and Ying in 2002. They showed that under certain conditions the fractional type Marcinkiewicz integral operators are bounded from the Triebel-Lizorkin spaces (F) over dot(pq)(alpha)(R-n) to L-p(R-n). We greatly weakened their assumptions and extended their results to a pretty much more general way.	[Xue, Qingying; Yan, Jingquan] Beijing Normal Univ, Lab Math & Complex Syst, Sch Math Sci, Minist Educ, Beijing 100875, Peoples R China; [Yabuta, Kozo] Kwansei Gakuin Univ, Math Sci Res Ctr, Sanda 6691337, Japan	Xue, QY (reprint author), Beijing Normal Univ, Lab Math & Complex Syst, Sch Math Sci, Minist Educ, Beijing 100875, Peoples R China.	qyxue@bnu.edu.cn			NSF of China [10931001]; Program for Changjiang Scholars and Innovative Research Team in University; Japan Society for the Promotion of Science [23540228];  [NCET-13-0065]	This work was partially supported by NSF of China (Grant No. 10931001), Program for Changjiang Scholars and Innovative Research Team in University and NCET-13-0065. The second-named author was partly supported by Grant-in-Aid for Scientific Research (C) Nr. 23540228, Japan Society for the Promotion of Science.	Al-Qassem Hussain M., 2006, Kyungpook Mathematical Journal, V46, P31; ALSALMAN A., 2005, J INTEGRAL EQUAT, V17, P357, DOI 10.1216/jiea/1181075348; Fan DS, 1997, P AM MATH SOC, V125, P3695, DOI 10.1090/S0002-9939-97-04111-7; DUOANDIKOETXEA J, 1986, INVENT MATH, V84, P541, DOI 10.1007/BF01388746; Chen JC, 2002, J MATH ANAL APPL, V276, P691, DOI 10.1016/S0022-247X(02)00419-5; WALSH T, 1972, STUD MATH, V44, P203; Fan DS, 1997, AM J MATH, V119, P799; Ding Y, 2002, J AUST MATH SOC, V72, P13; Sakamoto M, 1999, STUD MATH, V135, P103; Al-Salman A, 2002, MATH RES LETT, V9, P697; Zhang CJ, 2009, TAIWAN J MATH, V13, P973; Al-Qassem HM, 2009, STUD MATH, V190, P73, DOI 10.4064/sm190-1-3; BENEDEK A, 1962, P NATL ACAD SCI USA, V48, P356, DOI 10.1073/pnas.48.3.356; Ding Y, 2012, J MATH ANAL APPL, V387, P691, DOI 10.1016/j.jmaa.2011.09.020; Ding Y, 2000, HOKKAIDO MATH J, V29, P537; FEFFERMAN R, 1979, P AM MATH SOC, V74, P266, DOI 10.2307/2043145; Grafakos L, 2009, GRAD TEXTS MATH, V250, P1, DOI 10.1007/978-0-387-09434-2_6; HORMANDER L, 1960, ACTA MATH-DJURSHOLM, V104, P93, DOI 10.1007/BF02547187; Lu SZ, 2008, FRONT MATH CHINA, V3, P1, DOI 10.1007/s11464-008-0005-1; Si Zengyan, 2011, [数学研究与评论, Journal of Mathematical Research and Exposition], V31, P233; Stein E. M., 1958, T AM MATH SOC, V88, P430, DOI DOI 10.2307/1993226; Stein E. M., 1970, ANN MATH STUD, V63; STEIN EM, 1982, B AM MATH SOC, V7, P359, DOI 10.1090/S0273-0979-1982-15040-6; TAIBLESO.MH, 1970, MATH ANN, V186, P1, DOI 10.1007/BF01350636; UCHIYAMA A, 1985, STUD MATH, V81, P135; Yabuta K., 2002, KWANSEI GAKUIN U NAT, V6, P9; Zhang CJ, 2010, APPL MATH SER B, V25, P48, DOI 10.1007/s11766-010-2086-3	27	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0933-7741	1435-5337		FORUM MATH	Forum Math.	SEP	2015	27	5					3079	3109		10.1515/forum-2013-0200		31	Mathematics, Applied; Mathematics	Mathematics	CQ8KE	WOS:000360855700021		
J	Matsumoto, Y; Matsumoto, CS; Wakuda, R; Ichihara, S; Mizunami, M				Matsumoto, Yukihisa; Matsumoto, Chihiro-Sato; Wakuda, Ryo; Ichihara, Saori; Mizunami, Makoto			Roles of octopamine and dopamine in appetitive and aversive memory acquisition studied in olfactory conditioning of maxillary palpi extension response in crickets	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						classical conditioning; memory acquisition; dopamine; octopamine; appetite learning; aversive learning; Gryllus bimaculatus; insects	MUSHROOM BODY NEURONS; GRYLLUS-BIMACULATUS; REWARD; DROSOPHILA; SIGNALS; HONEYBEES; RECEPTORS	Elucidation of reinforcing mechanisms for associative learning is an important subject in neuroscience. Based on results of our previous pharmacological studies in crickets, we suggested that octopamine and dopamine mediate reward and punishment signals, respectively, in associative learning. In fruit-flies, however, it was concluded that dopamine mediates both appetitive and aversive reinforcement, which differs from our suggestion in crickets. In our previous studies, the effect of conditioning was tested at 30 min after training or later, due to limitations of our experimental procedures, and thus the possibility that octopamine and dopamine were not needed for initial acquisition of learning was not ruled out. In this study we first established a conditioning procedure to enable us to evaluate acquisition performance in crickets. Crickets extended their maxillary palpi and vigorously swung them when they perceived some odors, and we found that crickets that received pairing of an odor with water reward or sodium chloride punishment exhibited an increase or decrease in percentages of maxillary palpi extension responses to the odor. Using this procedure, we found that octopamine and dopamine receptor antagonists impair acquisition of appetitive and aversive learning, respectively. This finding suggests that neurotransmitters mediating appetitive reinforcement differ in crickets and fruit-flies.	[Matsumoto, Yukihisa; Mizunami, Makoto] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Matsumoto, Yukihisa] Tokyo Med & Dent Univ, Fac Liberal Arts, Ichikawa, Japan; [Matsumoto, Chihiro-Sato; Wakuda, Ryo; Ichihara, Saori] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan	Mizunami, M (reprint author), Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan.	mizunami@sci.hokudai.ac.jp			Ministry of Education, Science, Culture, Sports and Technology of Japan [24370030, 25440163]	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture, Sports and Technology of Japan (No.24370030 and No. 25440163).	Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kim YC, 2013, J NEUROSCI, V33, P1672, DOI 10.1523/JNEUROSCI.3042-12.2013; Simoes P, 2011, J EXP BIOL, V214, P2495, DOI 10.1242/jeb.055806; Shinmyo Y, 2006, DEVELOPMENT, V133, P4539, DOI 10.1242/dev.02646; Fiorillo CD, 2013, SCIENCE, V341, P546, DOI 10.1126/science.1238699; Takahashi T, 2009, J NEUROSCI METH, V179, P9, DOI 10.1016/j.jneumeth.2009.01.002; Matsumoto Y, 2002, J EXP BIOL, V205, P1429; Roeder T, 1998, EUR J PHARMACOL, V349, P171, DOI 10.1016/S0014-2999(98)00192-7; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Yamagata N, 2015, P NATL ACAD SCI USA, V112, P578, DOI 10.1073/pnas.1421930112; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Hammer M, 1998, LEARN MEMORY, V5, P146; Daly KC, 2000, J EXP BIOL, V203, P2025; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsumoto Y, 2014, LEARN MEMORY, V21, P272, DOI 10.1101/lm.032037.113; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Nakatani Y, 2009, NEUROBIOL LEARN MEM, V92, P370, DOI 10.1016/j.nlm.2009.05.003; Guerrieri FJ, 2011, J EXP BIOL, V214, P3300, DOI 10.1242/jeb.059170; Mizunami M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-46; KLEIN U, 1981, CELL TISSUE RES, V219, P229; Lin SW, 2014, NAT NEUROSCI, V17, P1536, DOI 10.1038/nn.3827; Matsumoto Y, 2013, NEUROBIOL LEARN MEM, V101, P103, DOI 10.1016/j.nlm.2013.01.008; Menzel Randolf, 2006, Behav Cogn Neurosci Rev, V5, P24, DOI 10.1177/1534582306289522; Mizunami M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00172; Mizunami Makoto, 2015, Zoological Letters, V1, P8, DOI 10.1186/s40851-014-0008-6; Mustard JA, 2003, MOL BRAIN RES, V113, P67, DOI 10.1016/S0169-328X(03)00091-3; Rescorla R. A., 1972, CLASSICAL CONDITION, V2, P64, DOI DOI 10.1016/J.COGPSYCH.2004.11.001; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Terao K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08929; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288	39	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	SEP 1	2015	9								230	10.3389/fnbh.7015.00230		9	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CR3JD	WOS:000361227600001		
J	Ohashi, K; Makino, TT; Arikawa, K				Ohashi, Kazuharu; Makino, Takashi T.; Arikawa, Kentaro			Floral colour change in the eyes of pollinators: testing possible constraints and correlated evolution	FUNCTIONAL ECOLOGY			English	Article						angiosperm diversification; bees; butterflies; colour contrast; flies; floral pigment; green-receptor contrast; phylogenetic comparison; phylogenetic signal; visual ecology	PHYLOGENETIC SIGNAL; INSECT POLLINATORS; FLOWER COLORS; BUMBLE-BEES; VISION; DISCRIMINATION; HONEYBEES; ULTRAVIOLET; HYMENOPTERA; SENSITIVITY	Many of the adaptive' traits in angiosperm flowers occur only in some species within a clade. One good example of such traits is floral colour change, that is the retention of old, nonreproductive, rewardless, but fully turgid flowers in an altered colour. This trait has been viewed as a plant strategy to enhance distant pollinator attraction while minimizing visits to nonreproductive flowers. Considering that the same scenario appears true for most visually oriented flower visitors, however, it is unclear why this trait does not prevail in nature. To understand such evolutionary patterns, we conducted a screening search for floral colour change in 219 angiosperm species. We quantified spectral alterations in petals or petaloid organs and translated them into colour shifts through insect eyes. Using phylogeny-based comparative methods, we further explored possibilities accounting for the infrequent occurrences of floral colour change: tendency of related species to resemble each other more than those randomly drawn from the phylogenetic tree (i.e. phylogenetic signal), constraints imposed through pigment coloration and their functions and evolutionary correlates of floral colour change. Ultraviolet-sensitive insect eyes were estimated to perceive floral colour change more often than previously noticed. We detected significant phylogenetic signal in the degree of floral colour change. The evolution of floral colour change appeared constrained by pigment chemistry, because greater changes were more likely to occur in yellow or red floral parts. Postchange colours tended to retain distant visual detectability (i.e. green-receptor contrast), while reducing attractiveness in a close range (i.e. colour contrast), indicating another constraint imposed through the functions of pigment coloration. Data also suggest a possible evolutionary association between floral colour change and bee pollination. Results indicate that floral colour change is scarce in nature because it primarily evolved to accommodate bees or comparable pollinators and because its occurrence was constrained by phylogenetic relatedness, pigment chemistry and ecological functions. An understanding of floral evolution thus requires considering different causalities for trait diversity in an integrative manner.	[Ohashi, Kazuharu; Makino, Takashi T.] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Arikawa, Kentaro] Sokendai Hayama Grad Univ Adv Studies, Lab Neuroethol, Hayama 2400115, Japan	Ohashi, K (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	kohashi@biol.tsukuba.ac.jp			JSPS [22770012, 21247009]; University of Tsukuba;  [183737]	We are grateful to K. Lunau and an anonymous reviewer for helpful comments on the manuscript; K. Takigami (Takibun Co. Ltd.) for providing tips for the spectrometer; L. Kawaguchi for data collection on W. middendorffiana; M. Suzuki for data collection on Weigela hortensis and W. coraeensis; T. Iwashina and M. Kato for allowing data collection at the Tsukuba Botanical Garden; J. Murata and the staff of the Koishikawa Botanical Garden for the permission for data collection on Firmiana simplex; M. Watanabe for lending the UV photography kit with instructions and A. Ushimaru and A. Nikkeshi for providing tips for the GLS and PGLS analyses. This work was supported by a JSPS Grant-in-Aid for Young Scientists (B) (no. 22770012) and a Research Support (B) at University of Tsukuba (2006 Research Projects, Life & Environmental Sciences) to K.O., a Grant-in-Aid for JSPS fellows to T.T.M. (no. 183737) and a JSPS Grant-in-Aid for Scientific Research (A) (no. 21247009) to K.A.	Ohashi K, 2009, ANN BOT-LONDON, V103, P1365, DOI 10.1093/aob/mcp088; [Anonymous], 2010, BIOL CONSERV, DOI DOI 10.1016/J.BIOCON.2009.12.003; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; MENZEL R, 1986, J COMP PHYSIOL A, V158, P165, DOI 10.1007/BF01338560; Vaknin H, 2005, PLANTA, V222, P19, DOI 10.1007/s00425-005-1509-5; WEISS MR, 1991, NATURE, V354, P227, DOI 10.1038/354227a0; TROJE N, 1993, Z NATURFORSCH C, V48, P96; HEINRICH B, 1976, ECOL MONOGR, V46, P105, DOI 10.2307/1942246; Vainstein A, 2001, PLANT PHYSIOL, V127, P1383, DOI 10.1104/pp.127.4.1383; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Suzuki MF, 2014, FUNCT ECOL, V28, P549, DOI 10.1111/1365-2435.12209; MATHUR G, 1978, ANN BOT-LONDON, V42, P1473; EISIKOWITCH D, 1987, BOT J LINN SOC, V95, P101, DOI 10.1111/j.1095-8339.1987.tb01991.x; Smith SD, 2010, NEW PHYTOL, V188, P354, DOI 10.1111/j.1469-8137.2010.03292.x; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Takeuchi Y, 2006, J EXP BIOL, V209, P2873, DOI 10.1242/jeb.02311; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; Yamamura K, 1999, RES POPUL ECOL, V41, P229; HEINRICH B, 1977, BEHAV ECOL SOCIOBIOL, V2, P247, DOI 10.1007/BF00299738; Arnold SEJ, 2009, ARTHROPOD-PLANT INTE, V3, P27, DOI 10.1007/s11829-009-9056-9; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; King C, 2013, METHODS ECOL EVOL, V4, P811, DOI 10.1111/2041-210X.12074; Jones CE, 1999, AM J BOT, V86, P273, DOI 10.2307/2656943; Iwashina T, 2009, J JPN SOC HORTIC SCI, V78, P485, DOI 10.2503/jjshs1.78.485; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Kinoshita M, 2014, J COMP PHYSIOL A, V200, P513, DOI 10.1007/s00359-014-0903-5; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23; OBERRATH R, 1995, FLORA, V190, P155; MENZEL R, 1993, APIDOLOGIE, V24, P157, DOI 10.1051/apido:19930301; Ollerton J, 2009, NATURWISSENSCHAFTEN, V96, P221, DOI 10.1007/s00114-008-0467-8; Ida TY, 2003, AM J BOT, V90, P1751, DOI 10.3732/ajb.90.12.1751; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; Goodwillie C, 2010, NEW PHYTOL, V185, P311, DOI 10.1111/j.1469-8137.2009.03043.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; RUTOWSKI RL, 1991, AM NAT, V138, P1121, DOI 10.1086/285273; Dyer AG, 2006, ENTOMOL GEN, V28, P257; Farzad M, 2003, PLANT SCI, V165, P1333, DOI 10.1016/j.plantsci.2003.08.001; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Kelber A, 1999, J COMP PHYSIOL A, V184, P535, DOI 10.1007/s003590050353; Barkman TJ, 2001, BIOCHEM SYST ECOL, V29, P1, DOI 10.1016/S0305-1978(00)00031-4; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Makino TT, 2007, FUNCT ECOL, V21, P854, DOI 10.1111/j.1365-2435.2007.01293.x; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Martinez-Harms J, 2012, J COMP PHYSIOL A, V198, P451, DOI 10.1007/s00359-012-0722-5; Wright GA, 2009, FUNCT ECOL, V23, P841, DOI 10.1111/j.1365-2435.2009.01627.x; WEISS MR, 1995, AM J BOT, V82, P167, DOI 10.2307/2445525; HARDIE RC, 1983, BIOPHYS STRUCT MECH, V9, P171, DOI 10.1007/BF00537814; MALLET J, 1987, J ANIM ECOL, V56, P377, DOI 10.2307/5054; Blomberg SP, 2012, SYST BIOL, V61, P382, DOI 10.1093/sysbio/syr118; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Cant ET, 2005, P ROY SOC B-BIOL SCI, V272, P785, DOI 10.1098/rspb.2004.3002; CASPER BB, 1984, EVOLUTION, V38, P128, DOI 10.2307/2408552; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 2005, PRACTICAL POLLINATIO, P157; Conner JK, 1997, INT J PLANT SCI, V158, pS108, DOI 10.1086/297511; DELPH LF, 1989, EVOLUTION, V43, P1252, DOI 10.2307/2409360; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garland Jr T., 1991, PHYLOGENETIC ANAL CO; Gori D.F., 1983, P31; Koshitaka H, 2008, P R SOC B, V275, P947, DOI 10.1098/rspb.2007.1614; Lunau K, 1996, PLANT SYST EVOL, V200, P125, DOI 10.1007/BF00984753; Oberrath R, 1999, OECOLOGIA, V121, P383, DOI 10.1007/s004420050943; Ohashi K., 2015, DRYAD DIGITAL REPOSI, DOI [http://dx.doi.org/10.5061/dryad.8fh42, DOI 10.5061/DRYAD.8FH42]; Ohashi K, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P274, DOI 10.1017/CBO9780511542268.015; Patiny S., 2012, EVOLUTION PLANT POLL; vonsHelversen O., 1972, J COMP PHYSIOL A, V80, P439; de Ibarra NH, 2009, J COMP PHYSIOL A, V195, P319, DOI 10.1007/s00359-009-0412-0; Webb C. O., 2011, PHYLOCOM SOFTWARE AN; Weiss MR, 1997, ISRAEL J PLANT SCI, V45, P185; Willmer P., 2011, POLLINATION FLORAL E; Wyszecki G., 1982, COLOR SCI CONCEPTS M	75	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-8463	1365-2435		FUNCT ECOL	Funct. Ecol.	SEP	2015	29	9					1144	1155		10.1111/1365-2435.12420		12	Ecology	Environmental Sciences & Ecology	CR3LV	WOS:000361235200005		
J	Ushio, M; Fujiki, Y; Hidaka, A; Kitayama, K				Ushio, Masayuki; Fujiki, Yasuto; Hidaka, Amane; Kitayama, Kanehiro			Linkage of root physiology and morphology as an adaptation to soil phosphorus impoverishment in tropical montane forests	FUNCTIONAL ECOLOGY			English	Article						phosphatase activity; phosphorus use efficiency; plant-soil (below-ground) interactions; root; root diameter; root surface area; soil phosphorus availability; tropical montane forest	PLANT ECONOMICS SPECTRUM; NET PRIMARY PRODUCTIVITY; RAIN-FORESTS; MOUNT-KINABALU; ALTITUDINAL GRADIENTS; NUTRIENT-AVAILABILITY; PHOSPHATASE-ACTIVITY; MICROBIAL COMMUNITY; NITROGEN LIMITATION; ACID-PHOSPHATASE	Tropical forests in Borneo maintain a high level of productivity/biomass even under phosphorus (P)-limited conditions. The P-acquisition properties of roots may be an important factor that contributes to forest productivity, but they have not been well evaluated compared with above-ground properties of plants. In this study, we analysed root acid phosphatase activity and morphological properties (surface area, diameter and tissue density of roots) of dominant tree species in three tropical montane forests on Mt. Kinabalu, Borneo, to investigate changes in root properties along a soil P availability gradient. We found at the community level that root phosphatase activity and specific root surface area (root surface area per gram root biomass) increased, and root diameter decreased, with decreasing soil P availability at the community level, and the relationship was not changed in general even if we focused on a single-tree species distributed across multiple study sites that differ in soil P availability. Root acid phosphatase was significantly positively correlated with specific root surface area, and negatively correlated with root diameter, suggesting that finer roots have higher phosphatase activities. Furthermore, we compared root acid phosphatase activity with leaf P concentration of a given tree species and found a significant negative correlation between them. The significant correlation suggested that root P-acquisition properties could influence leaf P concentration, and/or viceversa. Below-ground properties (i.e. root P-acquisition properties) might be directly/indirectly linked to above-ground properties (i.e. leaf P concentration) of a tree individual. In conclusion, the root physiological and morphological properties change along a gradient of soil P availability in the tropical montane forests. In addition, the changes in the root properties are coordinated with the changes in leaf P concentrations. The adaptive changes in the above-ground and below-ground properties along the soil P gradient could contribute to the maintenance of forest productivity in the tropical montane forest in Borneo.	[Ushio, Masayuki; Fujiki, Yasuto; Hidaka, Amane; Kitayama, Kanehiro] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Fujiki, Yasuto] Mitsubishi UFJ Res & Consulting Co Ltd, Kita Ku, Osaka 5308213, Japan; [Hidaka, Amane; Kitayama, Kanehiro] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Hidaka, Amane] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Japan Wildlife Res Ctr,Tomakomai Res Stn, Network Ctr Forest & Grassland Survey Monitoring, Tomakomai, Hokkaido 0530035, Japan	Ushio, M (reprint author), Ryukoku Univ, Fac Sci & Technol, Dept Environm Solut Technol, 1-5 Yokoya, Otsu, Shiga 5202194, Japan.	ushio-masayuki@ad.ryukoku.ac.jp; kanehiro@kais.kyoto-u.ac.jp	Ushio, Masayuki/F-8667-2010	Ushio, Masayuki/0000-0003-4831-7181	Japan Society for the Promotion of Science [23-586]; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [18255003, 22255002];  [26840145]	We thank T. Satomura for help with root image analysis, D.H. Hembry for help with an earlier draft of the manuscript and K. Okada for providing information about mycorrhizal fungi in the study sites. We also thank R. Wagai, S. Kita, N. Imai, H. Samejima, S. Shiodera, Frender Andreas bin Dounis, Mr. Ewin, K. Takahashi and G. Onoguchi for much advice and assistance with this work. M.U. was supported by the Japan Society for the Promotion of Science (23-586). This research was mainly supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT; 18255003 & 22255002) to K.K., and partly supported by Grant-in-Aid for Young Scientists (B) (26840145) to M.U. The authors have no conflict of interests to declare.	Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Ushio M, 2010, SOIL BIOL BIOCHEM, V42, P1588, DOI 10.1016/j.soilbio.2010.05.035; CREWS TE, 1995, ECOLOGY, V76, P1407, DOI 10.2307/1938144; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; CLARKSON DT, 1985, ANNU REV PLANT PHYS, V36, P77; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Craine JM, 2005, ECOLOGY, V86, P12, DOI 10.1890/04-1075; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Poorter L, 2007, AM NAT, V169, P433, DOI 10.1086/512045; Reich PB, 2014, J ECOL, V102, P275; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Powers JS, 2005, NEW PHYTOL, V165, P913, DOI 10.1111/j.1469-8137.2004.01279.x; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; Aiba S, 1999, PLANT ECOL, V140, P139, DOI 10.1023/A:1009710618040; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Saetre P, 2000, SOIL BIOL BIOCHEM, V32, P909, DOI 10.1016/S0038-0717(99)00215-1; Treseder KK, 2001, ECOLOGY, V82, P946, DOI 10.1890/0012-9658(2001)082[0946:EOSNAO]2.0.CO;2; Peltzer DA, 2010, ECOL MONOGR, V80, P509, DOI 10.1890/09-1552.1; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Phillips RP, 2013, NEW PHYTOL, V199, P41, DOI 10.1111/nph.12221; Ryser P, 1996, FUNCT ECOL, V10, P717, DOI 10.2307/2390506; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Turner BL, 2007, ECOSYSTEMS, V10, P1166, DOI 10.1007/s10021-007-9086-z; Craine JM, 2006, PLANT SOIL, V285, P171, DOI 10.1007/s11104-006-9002-x; Tjoelker MG, 2005, NEW PHYTOL, V167, P493, DOI 10.1111/j.1469-8137.2005.01428.x; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Reed SC, 2012, NEW PHYTOL, V196, P173, DOI 10.1111/j.1469-8137.2012.04249.x; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; Aoki M, 2012, ECOSYSTEMS, V15, P1194, DOI 10.1007/s10021-012-9575-6; Dickie Ian A., 2011, Smithsonian Contributions to Botany, P175; DRACUP MNH, 1984, J EXP BOT, V35, P466, DOI 10.1093/jxb/35.4.466; Hall SJ, 2004, BIOGEOCHEMISTRY, V70, P27, DOI 10.1023/B:BIOG.0000049335.68897.87; Hidaka A, 2009, J ECOL, V97, P984, DOI 10.1111/j.1365-2745.2009.01540.x; Hidaka A, 2011, J ECOL, V99, P849, DOI 10.1111/j.1365-2745.2011.01805.x; Kitayama Kanehiro, 2005, Science, V308, P633; Kitayama K, 2013, PLANT SOIL, V367, P215, DOI 10.1007/s11104-013-1624-1; Kitayama K, 2004, ECOSYSTEMS, V7, P259, DOI 10.1007/s10021-003-0229-6; Kitayama K, 1998, ECOL RES, V13, P301, DOI 10.1046/j.1440-1703.1998.00264.x; Kitayama K, 2012, PAC SCI, V66, P151, DOI 10.2984/66.2.5; Kitayama K, 2000, OECOLOGIA, V123, P342, DOI 10.1007/s004420051020; MCLACHLAN KD, 1980, AUST J AGR RES, V31, P429, DOI 10.1071/AR9800429; Paoli GD, 2005, ECOLOGY, V86, P1548, DOI 10.1890/04-1126; Powers JS, 2013, BIOTROPICA, V45, P1, DOI 10.1111/j.1744-7429.2012.00881.x; R Core Team, 2014, R LANG ENV STAT COMP; Russell AJ, 2002, NEW PHYTOL, V156, P283, DOI 10.1046/j.1469-8137.2002.00504.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Vitousek P, 2006, J ECOL, V94, P510, DOI 10.1111/j.1365-2745.2006.01119.x	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-8463	1365-2435		FUNCT ECOL	Funct. Ecol.	SEP	2015	29	9					1235	1245		10.1111/1365-2435.12424		11	Ecology	Environmental Sciences & Ecology	CR3LV	WOS:000361235200014		
J	Kumar, L; Michalczyk, A; Mckay, J; Ford, D; Kambe, T; Hudek, L; Varigios, G; Taylor, PE; Ackland, ML				Kumar, Loveleen; Michalczyk, Agnes; Mckay, Jill; Ford, Dianne; Kambe, Taiho; Hudek, Lee; Varigios, George; Taylor, Philip E.; Ackland, M. Leigh			Altered expression of two zinc transporters, SLC30A5 and SLC30A6, underlies a mammary gland disorder of reduced zinc secretion into milk	GENES AND NUTRITION			English	Article						Zinc; Zinc transporters; Mammary; Neonatal zinc deficiency; DNA methylation; Lactation	LETHAL MILK; PREMATURE-INFANT; DNA METHYLATION; GENE-EXPRESSION; PRETERM INFANT; DEFICIENCY; CELLS; MUTATION; ACRODERMATITIS; PATHWAY	Two cases of zinc deficiency in breastfed neonates were investigated where zinc levels in the mothers' milk were reduced by more than 75 % compared to normal. The objective of this study was to find the molecular basis of the maternal zinc deficiency condition. Significant reductions in mRNA expression and protein levels of the zinc transporters SLC30A5 and SLC30A6 were found in maternal tissue, suggesting a causal link to the zinc-deficient milk. Novel splice variants of the SLC30A6 transcript were detected. No modifications were found in coding regions, or in transcription binding sites of promoter regions or in 50 and 30 untranslated regions of both transporters in lymphoblasts and fibroblasts isolated from both mothers. Altered DNA methylation in SLC30A5 at two CpG sites was detected and may account for the reduced levels of SLC30A5 mRNA and protein in lymphoblasts. Reduced SLC30A6 mRNA and protein levels in lymphoblasts may be secondary to reduced SLC30A5 expression, as they function as a heterodimer in zinc transport. In conclusion, two cases of zinc deficiency are linked to low levels of the SLC30A5 and SLC30A6 zinc transporters. These two zinc transporters have not been previously associated with zinc deficiency in milk.	[Kumar, Loveleen; Michalczyk, Agnes; Hudek, Lee; Taylor, Philip E.; Ackland, M. Leigh] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Burwood, Vic 3125, Australia; [Mckay, Jill] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ford, Dianne] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Varigios, George] Royal Melbourne Hosp, Dept Dermatol, Melbourne, Vic 3050, Australia	Ackland, ML (reprint author), Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, 221 Burwood Highway, Burwood, Vic 3125, Australia.	leigha@deakin.edu.au					ACKLAND ML, 1992, J NUTR, V122, P1214; AGGETT PJ, 1980, ARCH DIS CHILD, V55, P547; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Kikuchi R, 2006, MOL PHARMACOL, V70, P887, DOI 10.1124/mol.106.025494; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Ions LJ, 2013, AGE, V35, P1835, DOI 10.1007/s11357-012-9485-8; Hong CB, 2005, CANCER RES, V65, P3617, DOI 10.1158/0008-5472.CAN-05-0048; Zschocke J, 2007, GLIA, V55, P663, DOI 10.1002/glia.20497; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Michalczyk A, 2003, HUM GENET, V113, P202, DOI 10.1007/s00439-003-0952-2; Bye A M, 1985, Pediatr Dermatol, V2, P308, DOI 10.1111/j.1525-1470.1985.tb00471.x; CONNORS TJ, 1983, ARCH DERMATOL, V119, P319, DOI 10.1001/archderm.119.4.319; Cragg MS, 2008, PLOS MED, V5, P356, DOI 10.1371/journal.pmed.0050077; Cragg RA, 2002, J BIOL CHEM, V277, P22789, DOI 10.1074/jbc.M200577200; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Glover M T, 1988, Pediatr Dermatol, V5, P10, DOI 10.1111/j.1525-1470.1988.tb00877.x; Gonen N, 2008, BIOCHEM BIOPH RES CO, V376, P787, DOI 10.1016/j.bbrc.2008.09.074; HEINEN F, 1995, EUR J PEDIATR, V154, P71, DOI 10.1007/BF01972977; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Kambe T, 2012, CURR TOP MEMBR, V69, P199, DOI 10.1016/B978-0-12-394390-3.00008-2; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; KHOSHOO V, 1992, PEDIATRICS, V89, P1094; LEE DY, 1992, J NUTR, V122, P2233; PARKER PH, 1982, AM J DIS CHILD, V136, P77; PILETZ JE, 1978, SCIENCE, V199, P181, DOI 10.1126/science.619449; SHARMA NL, 1988, INT J DERMATOL, V27, P485, DOI 10.1111/j.1365-4362.1988.tb00926.x; Stevens J, 1998, J PAEDIATR CHILD H, V34, P97, DOI 10.1046/j.1440-1754.1998.00164.x; Thornton JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023878; WEYMOUTH RD, 1982, AUST PAEDIATR J, V18, P208; White Helen E, 2006, Clin Chem, V52, P1005, DOI 10.1373/clinchem.2005.065086; WHITEHEAD RH, 1983, J NATL CANCER I, V71, P1193; ZIMMERMAN AW, 1982, PEDIATRICS, V69, P176	37	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1555-8932	1865-3499		GENES NUTR	Genes Nutr.	SEP	2015	10	5							38	10.1007/s12263-015-0487-x		16	Genetics & Heredity; Nutrition & Dietetics	Genetics & Heredity; Nutrition & Dietetics	CQ7XO	WOS:000360820100010		
J	Suzuki, SN; Ishihara, MI; Hidaka, A				Suzuki, Satoshi N.; Ishihara, Masae I.; Hidaka, Amane			Regional-scale directional changes in abundance of tree species along a temperature gradient in Japan	GLOBAL CHANGE BIOLOGY			English	Article						abundance; climate change; demography; directional change; disturbance; Japan; Monitoring Sites 1000 Project; permanent plots; succession; temperate forest	RECENT CLIMATE-CHANGE; LONG-TERM PLOTS; TROPICAL FORESTS; RANGE SHIFTS; STAND STRUCTURE; UNITED-STATES; DYNAMICS; GROWTH; REGENERATION; EQUILIBRIUM	Climate changes are assumed to shift the ranges of tree species and forest biomes. Such range shifts result from changes in abundances of tree species or functional types. Owing to global warming, the abundance of a tree species or functional type is expected to increase near the colder edge of its range and decrease near the warmer edge. This study examined directional changes in abundance and demographic parameters of forest trees along a temperature gradient, as well as a successional gradient, in Japan. Changes in the relative abundance of each of four functional types (evergreen broad-leaved, deciduous broad-leaved, evergreen temperate conifer, and evergreen boreal conifer) and the demography of each species (recruitment rate, mortality, and population growth rate) were analyzed in 39 permanent forest plots across the Japanese archipelago. Directional changes in the relative abundance of functional types were detected along the temperature gradient. Relative abundance of evergreen broad-leaved trees increased near their colder range boundaries, especially in secondary forests, coinciding with the decrease in deciduous broad-leaved trees. Similarly, relative abundance of deciduous broad-leaved trees increased near their colder range boundaries, coinciding with the decrease in boreal conifers. These functional-type-level changes were mainly due to higher recruitment rates and partly to the lower mortality of individual species at colder sites. This is the first report to show that tree species abundances in temperate forests are changing directionally along a temperature gradient, which might be due to current or past climate changes as well as recovery from past disturbances.	[Suzuki, Satoshi N.] Univ Tokyo, Grad Sch Agr & Life Sci, Univ Tokyo Chichibu Forest, Chichibu, Saitama 3680034, Japan; [Suzuki, Satoshi N.; Ishihara, Masae I.; Hidaka, Amane] Hokkaido Univ, Filed Sci Ctr Northern Biosphere, Tomakomai Res Stn,Japan Wildlife Res Ctr, Network Ctr Forest & Grassland Survey Monitoring, Tomakomai, Hokkaido 0530035, Japan; [Ishihara, Masae I.] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima 724, Japan	Suzuki, SN (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Univ Tokyo Chichibu Forest, 1-1-49 Hinoda Machi, Chichibu, Saitama 3680034, Japan.	s-suzuki@uf.a.u-tokyo.ac.jp			Environmental Research and Technology Development Fund of Ministry of Environment, Japan [S-9-3]	The data used here were provided by the Ministry of the Environment Monitoring Sites 1000 Project (TreeDataPackage2012 ver1.zip, downloaded from http://www.biodic.go.jp/moni1000/findings/data/index.html on April 22, 2014). We thank its participant organizations and their staffs for data collection and site management efforts. We are also grateful to Prof. Tsutom Hiura and Dr. Shigeru Niwa for their helpful comments and Dr. Ikuyo Saeki for her detailed comments on an earlier version of this manuscript. This study was partially funded by the Environmental Research and Technology Development Fund (S-9-3) of the Ministry of the Environment, Japan.	Iverson LR, 1998, ECOL MONOGR, V68, P465, DOI 10.1890/0012-9615(1998)068[0465:PAOTSF]2.0.CO;2; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Sheil D, 2000, J TROP ECOL, V16, P765, DOI 10.1017/S0266467400001723; SPRUGEL DG, 1991, BIOL CONSERV, V58, P1, DOI 10.1016/0006-3207(91)90041-7; Mori AS, 2011, J APPL ECOL, V48, P280, DOI 10.1111/j.1365-2664.2010.01956.x; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Morin X, 2008, J ECOL, V96, P784, DOI 10.1111/j.1365-2745.2008.01369.x; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Matias L, 2015, GLOBAL CHANGE BIOL, V21, P882, DOI 10.1111/gcb.12683; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Suzuki SN, 2013, J FOREST RES-JPN, V18, P139, DOI 10.1007/s10310-011-0331-0; Bell DM, 2014, GLOBAL ECOL BIOGEOGR, V23, P168, DOI 10.1111/geb.12109; Svenning JC, 2008, ECOGRAPHY, V31, P316, DOI 10.1111/j.0906-7590.2008.05206.x; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Phillips OL, 2002, ECOL APPL, V12, P576, DOI 10.1890/1051-0761(2002)012[0576:CIGOTF]2.0.CO;2; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; Yamaguchi S, 2008, J GLACIOL, V54, P125, DOI 10.3189/002214308784409026; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Fauset S, 2012, ECOL LETT, V15, P1120, DOI 10.1111/j.1461-0248.2012.01834.x; Laurance WF, 2004, NATURE, V428, P171, DOI 10.1038/nature02383; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Bradley RS, 1993, HOLOCENE, V3, P367, DOI [10.1177/095968369300300409, DOI 10.1177/095968369300300409]; Gansert D, 2004, FLORA, V199, P143, DOI 10.1078/0367-2530-00143; Henbo Y, 2006, ECOSCIENCE, V13, P451, DOI 10.2980/1195-6860(2006)13[451:LCDABA]2.0.CO;2; Hiroki S, 2001, VEGETATION SCI, V18, P31; Hoshino D, 2003, FOREST ECOL MANAG, V175, P141, DOI 10.1016/S0378-1127(02)00123-8; Ishihara M, 2011, ECOL RES, V26, P1007, DOI 10.1007/s11284-011-0847-y; KAMADA M, 1990, Japanese Journal of Ecology (Tokyo), V40, P137; Kira T, 1977, VEGETATION SCI ENV P, P21; Kubota Y, 2014, J BIOGEOGR, V41, P1267, DOI 10.1111/jbi.12290; Maejima I, 1983, GEOGRAPHICAL REPORTS, V18, P91; Miyawaki A, 1984, B I ENV SCI TECHNOLO, V11, P85; Nakao K, 2010, PLANT ECOL, V212, P229; Numata M, 1974, FLORA VEGETATION JAP; Ouedraogo DY, 2013, J ECOL, V101, P1459, DOI 10.1111/1365-2745.12165; Perry GLW, 2002, PROG PHYS GEOG, V26, P339, DOI 10.1191/0309133302pp341ra; Phillips OL, 2004, PHILOS T ROY SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Plummer M., 2006, R NEWS, V6, P7; R Core Team, 2014, R LANG ENV STAT COMP; Saito O, 2003, VEG SCI, V20, P83; Shidei T, 1979, VEGETATION LANDSCHAF, P93; Shimano K, 2002, FOLIA GEOBOT, V37, P275, DOI 10.1007/BF02805212; Tamate S., 1977, B GOV FOR EXP STN TO, V289, P43; Tanaka N, 2006, GLOBAL ENV RES, V10, P151; Totman C, 1998, GREEN ARCHIPELAGO FO	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-1013	1365-2486		GLOBAL CHANGE BIOL	Glob. Change Biol.	SEP	2015	21	9					3436	3444		10.1111/gcb.12911		9	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CR0HE	WOS:000360998400022		
J	Mori, H; Kobara, H; Nishiyama, N; Fujihara, S; Masaki, T				Mori, Hirohito; Kobara, Hideki; Nishiyama, Noriko; Fujihara, Shintaro; Masaki, Tsutomu			Review of Pure Endoscopic Full-Thickness Resection of the Upper Gastrointestinal Tract	GUT AND LIVER			English	Review						Minimally invasive surgical procedures; Suturing; Traction; Micro-Electrical-Mechanical Systems	ESOPHAGEAL SUBMUCOSAL DISSECTION; MECHANICAL COUNTER TRACTION; BAR SUTURING SYSTEMS; MUCOSAL RESECTION; TOTAL GASTRECTOMY; GASTRIC TUMORS; DEFECT CLOSURE; EX-VIVO; SURGERY; DEVICE	Natural-orifice transluminal endoscopic surgery (NOTES) using flexible endoscopy has attracted attention as a minimally invasive surgical method that does not cause an operative wound on the body surface. However, minimizing the number of devices involved in endoscopic, compared to laparoscopic, surgeries has remained a challenge, causing endoscopic surgeries to gradually be phased out of use. If a flexible endoscopic full-thickness suturing device and a counter-traction device were developed to expand the surgical field for gastrointestinal-tract collapse, then endoscopic full-thickness resection using NOTES, which is seen as an extension of endoscopic submucosal dissection for full-thickness excision of tumors involving the gastrointestinal-tract wall, might become an extremely minimally invasive surgical method that could be used to resect only full-thickness lesions approached by the shortest distance via the mouth. It is expected that gastroenterological endoscopists will use this surgery if device development is advanced. This extremely minimally invasive surgery would have an immeasurable impact with regard to mitigating the burden on patients and reducing healthcare costs. Development of a new surgical method using a multipurpose flexible endoscope is therefore considered a socially urgent issue.	[Mori, Hirohito; Kobara, Hideki; Nishiyama, Noriko; Fujihara, Shintaro; Masaki, Tsutomu] Kagawa Univ, Dept Gastroenterol & Neurol, Kita Ku, Miki, Kagawa 7610793, Japan	Mori, H (reprint author), Kagawa Univ, Dept Gastroenterol & Neurol, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	hiro4884@med.kagawa-u.ac.jp			Kagawa NOTES Project	The authors acknowledge the Kagawa NOTES Project for supporting this study.	von Renteln D, 2009, ENDOSCOPY, V41, P1056, DOI 10.1055/s-0029-1215241; Nahlieli O, 2001, BURNS, V27, P185, DOI 10.1016/S0305-4179(00)00081-4; Liu L, 2014, SURG ENDOSC, V28, P1342, DOI 10.1007/s00464-013-3280-1; Kantsevoy SV, 2012, GASTROINTEST ENDOSC, V75, P688, DOI 10.1016/j.gie.2011.04.031; Ye LP, 2014, SURG ENDOSC, V28, P1978, DOI 10.1007/s00464-014-3421-1; Fujishiro M, 2006, CLIN GASTROENTEROL H, V4, P688, DOI 10.1016/j.cgh.2006.03.024; Kato M, 2014, ENDOSCOPY, V46, P680, DOI 10.1055/s-0034-1365465; Abe N, 2013, DIGEST ENDOSC, V25, P64, DOI 10.1111/j.1443-1661.2012.01387.x; Ryou M, 2012, DIGEST DIS SCI, V57, P2130, DOI 10.1007/s10620-012-2126-3; Yamamoto H, 2003, ENDOSCOPY, V35, P690; Suzuki H, 2001, ENDOSCOPY, V33, P437, DOI 10.1055/s-2001-14269; Nakajima K, 2009, SURG ENDOSC, V23, P2650, DOI 10.1007/s00464-009-0474-7; Mori H, 2014, GASTROENTEROLOGY, V147, P278, DOI 10.1053/j.gastro.2014.06.030; Brigic A, 2013, BRIT J SURG, V100, P1649, DOI 10.1002/bjs.9298; von Renteln D, 2012, DIGEST DIS SCI, V57, P1298, DOI 10.1007/s10620-012-2039-1; Ikeda K, 2011, GASTROINTEST ENDOSC, V73, P117, DOI 10.1016/j.gie.2010.09.016; Aggarwal S, 2013, J LAPAROENDOSC ADV S, V23, P895, DOI 10.1089/lap.2013.0137; Mori H, 2014, GASTROINTEST ENDOSC, V79, P24, DOI 10.1016/j.gie.2013.08.031; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Memark VC, 2011, SURG ENDOSC, V25, P2186, DOI 10.1007/s00464-010-1521-0; Zhou PH, 2011, SURG ENDOSC, V25, P2926, DOI 10.1007/s00464-011-1644-y; Kalloo AN, 2004, GASTROINTEST ENDOSC, V60, P114, DOI 10.1016/S0016-5107(04)01309-4; Cal MY, 2012, ZHONGHUA WEI CHANG W, V15, P679; Chong-Wei Ke, 2013, Surg Laparosc Endosc Percutan Tech, V23, pe109, DOI 10.1097/SLE.0b013e31828e3939; Demir E, 2006, J BURN CARE RES, V27, P895, DOI 10.1097/01.BCR.0000245650.67130.5C; Elmunzer BJ, 2008, ENDOSCOPY, V40, P931, DOI 10.1055/s-2008-1077587; Grund KE, 2010, MINIM INVASIV THER, V19, P252; Hesami MA, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.12732; Lacerda Croider Franco, 2014, Arq Bras Cir Dig, V27, P71, DOI 10.1590/S0102-67202014000100017; Liu Fu-Chao, 2003, Acta Anaesthesiol Sin, V41, P93; Machado Marcel Autran Cesar, 2013, Arq Bras Cir Dig, V26, P144, DOI 10.1590/S0102-67202013000200016; Moine P, 2013, INT J ANTIMICROB AG, V41, P167, DOI 10.1016/j.ijantimicag.2012.09.017; Mori H, 2014, WORLD J GASTROENTERO, V20, P15763, DOI 10.3748/wjg.v20.i42.15763; Mori H, 2014, SURG ENDOSC, V28, P683, DOI 10.1007/s00464-013-3266-z; Mori H, 2015, SURG ENDOSC, V29, P212, DOI 10.1007/s00464-014-3642-3; Mori H, 2013, SURG ENDOSC, V27, P3028, DOI 10.1007/s00464-013-2846-2; Mori H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065377; Nakajima K, 2012, ENDOSCOPY, V44, P1139, DOI 10.1055/s-0032-1310093; Narula VK, 2009, SURG ENDOSC, V23, P1331, DOI 10.1007/s00464-008-0161-0; Nikfarjam M, 2014, WORLD J SURG, V38, P447, DOI 10.1007/s00268-013-2309-x; Petersen TI, 2013, ANTICANCER RES, V33, P3269; Seaman DL, 2006, GASTROINTEST ENDOSC, V64, P577, DOI 10.1016/j.gie.2006.05.029; Sodergren MH, 2011, DIAGN THER ENDOSC, V2011, DOI [10.1155/2011/245175, DOI 10.1155/2011/245175]; Sun G, 2013, GASTROINTEST ENDOSC, V77, P774, DOI 10.1016/j.gie.2012.12.017; von Renteln D, 2008, Endoscopy, V40 Suppl 2, pE224, DOI 10.1055/s-2008-1077458; WITTMANN DH, 1991, INFECTION, V19, pS337, DOI 10.1007/BF01715775; Yamamoto M, 2014, HEPATO-GASTROENTEROL, V61, P543, DOI 10.5754/hge13918; Yasuda K, 2014, SURG LAPARO ENDO PER, V24, pE191, DOI 10.1097/SLE.0b013e31828fa24a	48	0	0	EDITORIAL OFFICE GUT & LIVER	SEOUL	305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL, 135-839, SOUTH KOREA	1976-2283	2005-1212		GUT LIVER	Gut Liver	SEP	2015	9	5					590	600		10.5009/gnl14380		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR1MK	WOS:000361088700004		
J	Soma, H; Miyata, N; Hozawa, S; Higuchi, H; Yamagishi, Y; Nakamura, Y; Saeki, K; Kameyama, K; Masugi, Y; Yahagi, N; Kanai, T				Soma, Hiromitsu; Miyata, Naoteru; Hozawa, Shigenari; Higuchi, Hajime; Yamagishi, Yoshiyuki; Nakamura, Yuji; Saeki, Keita; Kameyama, Kaori; Masugi, Yohei; Yahagi, Naohisa; Kanai, Takanori			Ampullary Adenoma Treated by Endoscopic Double-Snare Retracting Papillectomy	GUT AND LIVER			English	Article						Argon plasma coagulation; Endoscopic papillectomy; Endosonography; Intraductal ultrasonography; Tubular adenoma	MAJOR DUODENAL PAPILLA; BENIGN-TUMORS; MANAGEMENT; VATER; COMPLICATIONS; RESECTION; EXCISION	We report herein improved methods for the safe and successful completion of endoscopic papillectomy (EP). Between January 2008 and November 2011, 12 patients underwent double-snare retracting papillectomy for the treatment of lesions of the major. duodenal papilla. The main outcomes were en bloc resection rates, pathological findings, and adverse events. All of the patients (mean age, 60.1 years; range, 38 to 80 years) were diagnosed with ampullary adenoma by endoscopic forceps biopsies prior to endoscopic snare papillectomy. En bloc resection by double-snare retracting papillectomy was successfully performed for all lesions (median size, 12.3 mm), comprising six tubular adenomas, one tubulovillous adenoma, three cases of epithelial atypia, one hamartomatous polyp, and one case of duodenitis with regenerative change. Significant hemorrhage and pancreatitis-were observed in one case after ER Adenoma recurrence occurred in three patients during follow-up (median, 28.5 months) at a mean interval of 2 months postoperatively (range, 1 to 3 months). No serious adverse events were observed. Double-snare retracting papillectomy is effective and feasible for treating lesions of the major duodenal papilla. Further treatment experience, including a single-arm phase II study, needs to be accumulated before conducting a randomized controlled study.	[Soma, Hiromitsu; Miyata, Naoteru; Hozawa, Shigenari; Higuchi, Hajime; Yamagishi, Yoshiyuki; Nakamura, Yuji; Saeki, Keita; Yahagi, Naohisa; Kanai, Takanori] Keio Univ, Dept Internal Med, Sch Med, Tokyo 1608582, Japan; [Kameyama, Kaori; Masugi, Yohei] Keio Univ, Dept Pathol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Hozawa, S (reprint author), Keio Univ, Dept Internal Med, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hozawas@a5.keio.jp					COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Zadorova Z, 2001, ENDOSCOPY, V33, P345, DOI 10.1055/s-2001-13693; BINMOELLER KF, 1993, GASTROINTEST ENDOSC, V39, P127, DOI 10.1016/S0016-5107(93)70051-6; Desilets DJ, 2001, GASTROINTEST ENDOSC, V54, P202, DOI 10.1067/mge.2001.116564; Catalano MF, 2004, GASTROINTEST ENDOSC, V59, P225, DOI 10.1016/S0016-5107(03)02366-6; Norton ID, 2002, GASTROINTEST ENDOSC, V56, P239, DOI 10.1067/mge.2002.126064; Bohnacker S, 2005, GASTROINTEST ENDOSC, V62, P551, DOI 10.1016/j.gie.2005.04.053; Matsumoto T, 2000, AM J GASTROENTEROL, V95, P1557; Aiura K, 2003, GASTROINTEST ENDOSC, V57, P743, DOI 10.1067/mge.2003.213; Boix J, 2009, SURG ENDOSC, V23, P45, DOI 10.1007/s00464-008-9866-3; Harano M, 2011, J HEPATO-BIL-PAN SCI, V18, P190, DOI 10.1007/s00534-010-0327-8; Itoi T, 2009, GASTROINTEST ENDOSC, V69, P136, DOI 10.1016/j.gie.2008.07.036; Cheng CL, 2004, GASTROINTEST ENDOSC, V60, P757, DOI 10.1016/S0016-5107(04)02029-2; Bohnacker S, 2006, ENDOSCOPY, V38, P521, DOI 10.1055/s-2006-925263; Hernandez LV, 2008, CURR OPIN GASTROEN, V24, P617, DOI 10.1097/MOG.0b013e3283088e12	15	0	0	EDITORIAL OFFICE GUT & LIVER	SEOUL	305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL, 135-839, SOUTH KOREA	1976-2283	2005-1212		GUT LIVER	Gut Liver	SEP	2015	9	5					689	692		10.5009/gnl14206		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR1MK	WOS:000361088700018		
J	Fujimoto, S; Kondo, T; Yamamoto, H; Yokoyama, N; Tarutani, Y; Takamura, K; Urabe, Y; Konno, K; Nishizaki, Y; Shinozaki, T; Kihara, Y; Daida, H; Isshiki, T; Takase, S				Fujimoto, Shinichiro; Kondo, Takeshi; Yamamoto, Hideya; Yokoyama, Naoyuki; Tarutani, Yasuhiro; Takamura, Kazuhisa; Urabe, Yoji; Konno, Kumiko; Nishizaki, Yuji; Shinozaki, Tomohiro; Kihara, Yasuki; Daida, Hiroyuki; Isshiki, Takaaki; Takase, Shinichi			Development of new risk score for pre-test probability of obstructive coronary artery disease based on coronary CT angiography	HEART AND VESSELS			English	Article						Obstructive coronary artery disease; Coronary computed tomography angiography; Pre-test probability; Duke clinical score; New score	CARDIOVASCULAR COMPUTED-TOMOGRAPHY; AMERICAN-HEART-ASSOCIATION; APPROPRIATE USE CRITERIA; TASK-FORCE; DIAGNOSTIC PERFORMANCE; MAGNETIC-RESONANCE; NUCLEAR CARDIOLOGY; COLLEGE; ECHOCARDIOGRAPHY; RADIOLOGY	Existing methods to calculate pre-test probability of obstructive coronary artery disease (CAD) have been established using selected high-risk patients who were referred to conventional coronary angiography. The purpose of this study is to develop and validate our new method for pre-test probability of obstructive CAD using patients who underwent coronary CT angiography (CTA), which could be applicable to a wider range of patient population. Using consecutive 4137 patients with suspected CAD who underwent coronary CTA at our institution, a multivariate logistic regression model including clinical factors as covariates calculated the pre-test probability (K-score) of obstructive CAD determined by coronary CTA. The K-score was compared with the Duke clinical score using the area under the curve (AUC) for the receiver-operating characteristic curve. External validation was performed by an independent sample of 319 patients. The final model included eight significant predictors: age, gender, coronary risk factor (hypertension, diabetes mellitus, dyslipidemia, smoking), history of cerebral infarction, and chest symptom. The AUC of the K-score was significantly greater than that of the Duke clinical score for both derivation (0.736 vs. 0.699) and validation (0.714 vs. 0.688) data sets. Among patients who underwent coronary CTA, newly developed K-score had better pre-test prediction ability of obstructive CAD compared to Duke clinical score in Japanese population.	[Fujimoto, Shinichiro; Kondo, Takeshi; Takamura, Kazuhisa; Takase, Shinichi] Takase Clin, Dept Cardiol, Takasaki, Gumma, Japan; [Fujimoto, Shinichiro; Nishizaki, Yuji; Daida, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cardiol, Tokyo 1138421, Japan; [Yamamoto, Hideya; Urabe, Yoji; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan; [Yokoyama, Naoyuki; Konno, Kumiko; Isshiki, Takaaki] Teikyo Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo 173, Japan; [Tarutani, Yasuhiro] Okamura Mem Hosp, Dept Cardiol, Shizuoka, Japan; [Shinozaki, Tomohiro] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan	Fujimoto, S (reprint author), Juntendo Univ, Grad Sch Med, Dept Cardiol, Tokyo 1138421, Japan.	s-fujimo@tj8.so-net.ne.jp					Hendel RC, 2009, J AM COLL CARDIOL, V53, P2201, DOI 10.1016/j.jacc.2009.02.013; Hoilund-Carlsen PF, 2007, CAN J CARDIOL, V23, P641; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; PRYOR DB, 1993, ANN INTERN MED, V118, P81; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; Genders TSS, 2011, EUR HEART J, V32, P1316, DOI 10.1093/eurheartj/ehr014; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; PRYOR DB, 1983, AM J MED, V75, P771, DOI 10.1016/0002-9343(83)90406-0; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Bayes T, 1763, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; CHAITMAN BR, 1981, CIRCULATION, V64, P360; Cheng Victor Y, 2011, Circulation, V124, P2423, DOI 10.1161/CIRCULATIONAHA.111.039255; Genders TSS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3485; [Anonymous], 2003, CIRCULATION, DOI DOI 10.1161/01.CIR.0000047041.66447.29; Hosmer DW, 2000, APPL LOGISTIC REGRES; Ito H, 2014, HEART VESSELS, V29, P743, DOI 10.1007/s00380-013-0420-4; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Ueda H, 2012, HEART VESSELS, V27, P128, DOI 10.1007/s00380-011-0128-2; Yamashina A, 2009, CIRC J S3, V73, P1019	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					563	571		10.1007/s00380-014-0515-6		9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800001		
J	Yoshimura, H; Kaikita, K; Ono, T; Iwashita, S; Nakayama, N; Sato, K; Horio, E; Tsujita, K; Kojima, S; Tayama, S; Hokimoto, S; Ogawa, H				Yoshimura, Hiromi; Kaikita, Koichi; Ono, Takamichi; Iwashita, Satomi; Nakayama, Naoki; Sato, Koji; Horio, Eiji; Tsujita, Kenichi; Kojima, Sunao; Tayama, Shinji; Hokimoto, Seiji; Ogawa, Hisao			Lack of association between peri-procedural myocardial damage and CYP2C19 gene variant in elective percutaneous coronary intervention	HEART AND VESSELS			English	Article						Angina pectoris; Coronary artery disease; Blood coagulation; Platelets; Thrombosis	ORAL ANTIPLATELET THERAPY; ST-SEGMENT ELEVATION; BARE-METAL STENTS; PLATELET REACTIVITY; DIABETES-MELLITUS; RANDOMIZED-TRIAL; CLOPIDOGREL; INFARCTION; THROMBOSIS; OUTCOMES	Peri-procedural myocardial damage (MD) is associated with increased risk of major in-hospital complications and adverse clinical events. The aim of this study was to evaluate the effects of on-clopidogrel platelet aggregation and CYP2C19-reduced-function gene variants on elective percutaneous coronary intervention (PCI)-related MD. We measured changes in serum high-sensitive troponin T (hs-TnT) levels, CYP2C19 genotype, and on-clopidogrel platelet aggregation (PA) using VerifyNow(A (R)) P2Y12 system in 91 patients who received stent implantation (stent group). The control group comprised 30 patients who did not receive PCI. Blood samples were obtained before and 24 h after PCI or coronary angiography (CAG). Patients of the stent group were divided into high and low MD groups based on the median value of hs-TnT level at 24 h after PCI. Serum hs-TnT levels were significantly higher 24 h after PCI (86.8 +/- A 121.5 pg/ml) compared with before PCI (9.4 +/- A 5.3, p < 0.001), whereas the levels were identical before and 24 h after CAG in the control group. Simple logistic regression analysis demonstrated that MD correlated with age (p = 0.014), estimated GFR (p = 0.003), hemoglobin A1c (p = 0.015), baseline serum hs-TnT (p = 0.049), and stent length (p < 0.001). Multiple logistic regression analysis identified old age, high hemoglobin A1c level, and long stent, but not CYP2C19 reduced-function allele or high on-clopidogrel PA, as independent predictors of elective PCI-related MD. The present study demonstrated no significant relation between peri-procedural MD and high on-clopidgrel PA associated with CYP2C19 reduced-function allele in patients undergoing elective PCI.	[Yoshimura, Hiromi; Kaikita, Koichi; Ono, Takamichi; Iwashita, Satomi; Nakayama, Naoki; Sato, Koji; Horio, Eiji; Tsujita, Kenichi; Kojima, Sunao; Tayama, Shinji; Hokimoto, Seiji; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Chuo Ku, Kumamoto 8608556, Japan	Kaikita, K (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	kaikitak@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [C24591062]	We are grateful to Megumi Nagahiro and Saeko Tokunaga from the Department of Cardiology, Kumamoto University, for the skillful technical assistance. This study was supported in part by Grants-in-Aid for Scientific Research C24591062 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Angiolillo DJ, 2010, J AM COLL CARDIOL, V55, P1139, DOI 10.1016/j.jacc.2009.10.043; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Alcock RF, 2010, INT J CARDIOL, V140, P66, DOI 10.1016/j.ijcard.2008.11.005; Kubota T, 1996, CLIN PHARMACOL THER, V60, P661, DOI 10.1016/S0009-9236(96)90214-3; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Aoki J, 2009, CIRCULATION, V119, P687, DOI 10.1161/CIRCULATIONAHA.108.804203; Lankeit M, 2010, EUR HEART J, V31, P1836, DOI 10.1093/eurheartj/ehq234; Prasad A, 2008, CIRC-CARDIOVASC INTE, V1, P10, DOI 10.1161/CIRCINTERVENTIONS.108.765610; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311; Heusch G, 2009, CIRCULATION, V120, P1822, DOI 10.1161/CIRCULATIONAHA.109.888784; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Chen ZM, 2005, LANCET, V366, P1607; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; Wiviott SD, 2008, CIRCULATION, V118, P1626, DOI 10.1161/CIRCULATIONAHA.108.791061; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636; Berger JS, 2009, CIRCULATION, V120, P2337, DOI 10.1161/CIRCULATIONAHA.109.866533; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Kurose K, 2012, DRUG METAB PHARMACOK, V27, P9, DOI 10.2133/dmpk.DMPK-11-RV-111; Gremmel T, 2010, J THROMB HAEMOST, V8, P37, DOI 10.1111/j.1538-7836.2009.03644.x; Dahabreh IJ, 2013, AHRQ PUBLICATION; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Michalak M, 2013, KARDIOL POL, V71, P325, DOI 10.5603/KP.2013.0059; Murakami D, 2011, J ATHEROSCLER THROMB, V18, P906; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Verdoia M, 2015, HEART VESSELS, V30, P20, DOI 10.1007/s00380-013-0449-4; Wu HY, 2012, CIRC J, V76, P2773, DOI 10.1253/circj.CJ-12-0635; Yusuf S, 2001, NEW ENGL J MED, V345, P494	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					572	579		10.1007/s00380-014-0516-5		8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800002		
J	Kawashiri, M; Sakata, K; Gamou, T; Kanaya, H; Miwa, K; Ueda, K; Higashikata, T; Mizuno, S; Michishita, I; Namura, M; Nitta, Y; Katsuda, S; Okeie, K; Hirase, H; Tada, H; Uchiyama, K; Konno, T; Hayashi, K; Ino, H; Nagase, K; Terashima, M; Yamagishi, M				Kawashiri, Masa-aki; Sakata, Kenji; Gamou, Tadatsugu; Kanaya, Honin; Miwa, Kenji; Ueda, Kosei; Higashikata, Toshinori; Mizuno, Sumio; Michishita, Ichiro; Namura, Masanobu; Nitta, Yutaka; Katsuda, Shoji; Okeie, Kazuyasu; Hirase, Hiroaki; Tada, Hayato; Uchiyama, Katsuharu; Konno, Tetsuo; Hayashi, Kenshi; Ino, Hidekazu; Nagase, Keisuke; Terashima, Mitsuyasu; Yamagishi, Masakazu			Impact of combined lipid lowering with blood pressure control on coronary plaque regression: rationale and design of MILLION study	HEART AND VESSELS			English	Article						Amlodipine; Atorvastatin; Coronary plaque volume; Intravascular ultrasonography (IVUS)	RANDOMIZED CONTROLLED-TRIAL; INTRAVASCULAR ULTRASOUND ANALYSIS; C-REACTIVE PROTEIN; STATIN THERAPY; CARDIOVASCULAR EVENTS; HYPERTENSIVE PATIENTS; ATHEROSCLEROSIS; DISEASE; ATORVASTATIN; AMLODIPINE	A line of epidemiological studies suggests that the accumulation of coronary risk factors promotes the progression of coronary atherosclerosis. Recent clinical studies showed that aggressive low-density lipoprotein (LDL) cholesterol-lowering therapy using statins could regress coronary atheroma and reduce major cardiovascular events. Additionally, therapy that controlled amlodipine-based blood pressure reduced major cardiovascular events in patients with hypertension compared with an atenolol-based regimen. An open-label randomized multicenter study is primarily planned to evaluate the changes in coronary atheroma volume using intravascular ultrasonography 18-24 months after intensive lowering of LDL-cholesterol and blood pressure compared with a standard therapy indicated by current guidelines in Japanese patients with coronary artery disease (CAD). The secondary endpoints include changes in serum lipid levels, inflammatory markers, glucose markers and blood pressure. In total, 100 subjects with CAD who are undergoing percutaneous coronary intervention will be tested. The MILLION study will provide new evidence and therapeutic standards for the prevention of CAD in Japanese patients by controlling both LDL-C levels and blood pressure.	[Kawashiri, Masa-aki; Sakata, Kenji; Gamou, Tadatsugu; Tada, Hayato; Uchiyama, Katsuharu; Konno, Tetsuo; Hayashi, Kenshi; Ino, Hidekazu; Yamagishi, Masakazu] Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa 9208641, Japan; [Kanaya, Honin; Miwa, Kenji] Ishikawa Prefectural Cent Hosp, Dept Cardiol, Kanazawa, Ishikawa, Japan; [Ueda, Kosei; Higashikata, Toshinori] Komatsu Municipal Hosp, Dept Internal Med, Komatsu, Japan; [Mizuno, Sumio] Fukui Cardiovasc Ctr, Dept Cardiol, Fukui, Japan; [Michishita, Ichiro] Yokohama Sakae Kyosai Hosp, Dept Internal Med, Yokohama, Kanagawa, Japan; [Namura, Masanobu] Kanazawa Cardiovasc Hosp, Dept Cardiol, Kanazawa, Ishikawa, Japan; [Nitta, Yutaka; Katsuda, Shoji] Toyama Red Cross Hosp, Dept Cardiol, Toyama, Japan; [Okeie, Kazuyasu] Koseiren Takaoka Hosp, Dept Cardiol, Takaoka, Toyama, Japan; [Hirase, Hiroaki] Takaoka Municipal Hosp, Dept Internal Med, Takaoka, Toyama, Japan; [Nagase, Keisuke] Kanazawa Univ, Grad Sch Med, Div Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Terashima, Mitsuyasu] Cardiovasc Imaging Ctr, Toyohashi, Aichi, Japan	Yamagishi, M (reprint author), Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	myamagi@med.kanazawa-u.ac.jp			Pfizer Ltd.	Dr. Yamagishi got a research grant from Pfizer Ltd.	Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; KANNEL WB, 1976, AM J CARDIOL, V38, P46, DOI 10.1016/0002-9149(76)90061-8; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Okazaki S, 2004, CIRCULATION, V110, P1061, DOI 10.1161/01.CIR.0000140261.58966.A4; Takayama T, 2009, CIRC J, V73, P2110; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Hiro T, 2009, J AM COLL CARDIOL, V54, P293, DOI 10.1016/j.jacc.2009.04.033; NAKAJIMA K, 1993, CLIN CHIM ACTA, V223, P53, DOI 10.1016/0009-8981(93)90062-9; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Ge CJ, 2008, HEART VESSELS, V23, P91, DOI 10.1007/s00380-007-1008-7; Kohro T, 2011, CIRC J, V75, P2062, DOI 10.1253/circj.CJ-11-0695; Kojima T, 2011, CIRC J, V75, P1071, DOI 10.1253/circj.CJ-11-0141; Nozue T, 2014, HEART VESSELS, V29, P456, DOI 10.1007/s00380-013-0387-1; Teramoto T, 2012, J ATHEROSCLER THROMB, V20, P517; The multiple risk factor intervention trial (MRFIT), 1976, JAMA, V235, P825	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					580	586		10.1007/s00380-014-0522-7		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800003		
J	Takahashi, M; Myojo, M; Watanabe, A; Kiyosue, A; Kimura, K; Ando, J; Hirata, Y; Komuro, I				Takahashi, Masao; Myojo, Masahiro; Watanabe, Aya; Kiyosue, Arihiro; Kimura, Koichi; Ando, Jiro; Hirata, Yasunobu; Komuro, Issei			Effect of purified eicosapentaenoic acid on red cell distribution width in patients with ischemic heart disease	HEART AND VESSELS			English	Article						Eicosapentaenoic acid (EPA); Red blood cell distribution width (RDW); Diabetes mellitus; High-sensitive C-reactive protein (hs-CRP); Ischemic heart disease (IHD)	C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; RISK; INFLAMMATION; ASSOCIATION; PREVENTION; GUIDELINES; DIAGNOSIS; DEATH; RATIO	A recent study showed eicosapentaenoic acid (EPA) is a promising treatment for prevention of coronary events in hypercholesterolemic patients. Meanwhile, a high red blood cell distribution width (RDW) is a known risk factor for cardiovascular events. However, few studies have addressed the association between EPA levels and RDW. We examined whether EPA administration reduced the levels of RDW in patients with ischemic heart disease (IHD). We retrospectively analyzed the data of 66 EPA-treated IHD patients, and these EPA-treated patients were compared with control IHD patients. The median follow-up period was 189 days in EPA-treated patients. All patients were not associated with anemia. In the follow-up period, the ratio of EPA levels to arachidonic acid levels (EPA/AA) was significantly increased. A significant decrease was observed in RDW at follow-up [Delta RDW (%); EPA vs. control = -0.34 +/- A 0.84 (SD) vs. 0.08 +/- A 0.86, P < 0.01]. These RDW changes were more marked in diabetic patients with high serum levels of high-sensitive C-reactive protein (hs-CRP) [Delta RDW (%); EPA vs. control = -0.53 +/- A 0.69 vs. 0.56 +/- A 0.85, P < 0.01]. There was no correlation between the amount of change in EPA/AA and RDW (R = 0.037, P = 0.32), but a significant negative correlation was observed in diabetic patients with high hs-CRP levels (N = 14, R = -0.506, P = 0.046). In conclusion, EPA has the potential to reduce RDW in IHD patients. This effect was intensified especially among diabetic patients with high hs-CRP levels. IHD patients with high RDW levels may be suitable for treatment with purified EPA.	[Takahashi, Masao; Myojo, Masahiro; Watanabe, Aya; Kiyosue, Arihiro; Kimura, Koichi; Ando, Jiro; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Hirata, Yasunobu] Tokyo Teishin Hosp, Dept Cardiovasc Med, Tokyo, Japan	Takahashi, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	masaotakahashi-gi@umin.org			Ministry of Education, Culture, Sports, Science and Technology of Japan [22590822]	This study was supported in part by Grants-in-Aid for Scientific Research(C) 22590822 to Y.H. by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Hasegawa T, 2014, HEART VESSELS, V29, P596, DOI 10.1007/s00380-013-0404-4; Ridker PM, 2001, CIRCULATION, V103, P1813; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; VONSCHACKY C, 1985, J CLIN INVEST, V76, P2446, DOI 10.1172/JCI112261; KONDO T, 1986, CLIN CARDIOL, V9, P413; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Itakura H, 2011, J ATHEROSCLER THROMB, V18, P99; Ueeda M, 2011, HEART VESSELS, V26, P145, DOI 10.1007/s00380-010-0038-8; Arima H, 2008, ARTERIOSCL THROM VAS, V28, P1385, DOI 10.1161/ATVBAHA.107.157164; James SK, 2006, AM J CARDIOL, V97, P167, DOI 10.1016/j.amjcard.2005.08.036; Cawood AL, 2010, ATHEROSCLEROSIS, V212, P252, DOI 10.1016/j.atherosclerosis.2010.05.022; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Dugdale AE, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-34; Genest J, 2009, CAN J CARDIOL, V25, P567; Grundy SM, 2001, SCIENCE, V293, P801; Hayakawa S, 2012, INTERNAL MED, V51, P1009, DOI 10.2169/internalmedicine.51.7162; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Koma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080240; Patel KV, 2013, ADV EXP MED BIOL, V765, P211, DOI 10.1007/978-1-4614-4989-8_29; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Zhang MF, 2006, METABOLISM, V55, P1590, DOI 10.1016/j.metabol.2006.07.019	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					587	594		10.1007/s00380-014-0526-3		8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800004		
J	Setoguchi, M; Hashimoto, Y; Sasaoka, T; Ashikaga, T; Isobe, M				Setoguchi, Masahiko; Hashimoto, Yuji; Sasaoka, Taro; Ashikaga, Takashi; Isobe, Mitsuaki			Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction	HEART AND VESSELS			English	Article						Inferior vena cava; Depression; Heart failure with preserved ejection fraction; Readmission	INITIATE LIFESAVING TREATMENT; HOSPITALIZED-PATIENTS; NATRIURETIC PEPTIDE; CLINICAL-OUTCOMES; ORGANIZED PROGRAM; BETA-BLOCKER; OPTIMIZE-HF; PREVALENCE; MORTALITY; DISCHARGE	Although there have been several studies regarding heart failure with preserved ejection fraction (HFpEF), investigations of the risk factors for readmission of Japanese patients with HFpEF remain scarce. Therefore, our goal was to identify the risk factors for readmission of Japanese patients with heart failure (HF), particularly those with HFpEF. We analyzed 310 patients who were hospitalized for the first time with HF. Preserved EF was defined EF a parts per thousand yen50 %, and reduced EF (rEF) was EF < 50 %. The study endpoint was readmission for HF after discharge. Medical history, vital signs, electrocardiograms, chest radiographs, blood tests and echocardiograms were compared between patients with HFpEF and with HFrEF. Among the 142 patients who had HFpEF, 43 reached the endpoint within 1 year. Multivariate analysis revealed depression (HR: 7.185), high brain natriuretic peptide (BNP) levels at discharge (HR: 1.003), and dilated inferior vena cava (HR: 1.100) as independent risk factors for readmission. In contrast, 39 of the 168 patients with HFrEF reached the endpoint. Risk factors for readmission of HFrEF patients were low sodium (HR: 0.856), high blood urea nitrogen (HR: 1.045), high BNP levels at discharge (HR: 1.003) and absence of beta-blocker prescription (HR: 0.395). In conclusion, our study suggests that the predictors of HF readmission differ between HFpEF and HFrEF patients.	[Setoguchi, Masahiko; Hashimoto, Yuji] Kameda Gen Hosp, Dept Cardiol, Kamogawa, Japan; [Setoguchi, Masahiko; Sasaoka, Taro; Ashikaga, Takashi; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138519, Japan	Setoguchi, M (reprint author), Kameda Gen Hosp, Dept Cardiol, Kamogawa, Japan.	setocvm@tmd.ac.jp; isobemi@tmd.ac.jp					Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Shiba N, 2004, CIRC J, V68, P427, DOI 10.1253/circj.68.427; Lee DS, 2011, CIRC-HEART FAIL, V4, P36, DOI 10.1161/CIRCHEARTFAILURE.110.957480; Zhou JM, 2010, EUR J HEART FAIL, V12, P181, DOI 10.1093/eurjhf/hfp193; Marechaux S, 2011, HEART VESSELS, V26, P313, DOI 10.1007/s00380-010-0057-5; Kitzman DW, 2012, J AM COLL CARDIOL, V59, P1006, DOI 10.1016/j.jacc.2011.12.011; West R, 2011, EUR J HEART FAIL, V13, P945, DOI 10.1093/eurjhf/hfr064; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Steinberg BA, 2012, CIRCULATION, V126, P65, DOI 10.1161/CIRCULATIONAHA.111.080770; Kociol RD, 2011, CIRC-HEART FAIL, V4, P628, DOI 10.1161/CIRCHEARTFAILURE.111.962290; Kallistratos MS, 2012, HEART VESSELS, V27, P46, DOI 10.1007/s00380-010-0115-z; Valle R, 2005, J CARD FAIL, V11, P498, DOI 10.1016/j.cardfail.2005.05.002; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Joynt KE, 2004, J CARD FAIL, V10, P258, DOI 10.1016/j.cardfail.2003.09.008; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Nath J, 2006, AM HEART J, V151, P730, DOI 10.1016/j.ahj.2005.04.023; O'Connor CM, 2008, AM HEART J, V156, P662, DOI [10.1016/j.ahj.2008.04.030, 10.1016/j.ahj.2008.04,030]; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Klein L, 2008, CIRC-HEART FAIL, V1, P25, DOI 10.1161/CIRCHEARTFAILURE.107.746933; Cournot M, 2008, AM HEART J, V155, P986, DOI 10.1016/j.ahj.2008.01.011; Hori M, 2005, J CARD FAIL, V11, P542, DOI 10.1016/j.cardfail.2005.04.003; Kato N, 2012, J CARDIOL, V60, P23, DOI 10.1016/j.jjcc.2012.01.010; Konishi M, 2012, J CARD FAIL, V18, P620, DOI 10.1016/j.cardfail.2012.06.415; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Tanaka Y, 2013, HEART VESSELS, V28, P179; Tsuchihashi-Makaya M, 2009, CIRC J, V73, P1893	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					595	603		10.1007/s00380-014-0532-5		9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800005		
J	Haruki, S; Minami, Y; Suzuki, A; Hagiwara, N				Haruki, Shintaro; Minami, Yuichiro; Suzuki, Atsushi; Hagiwara, Nobuhisa			Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: a comparison of flecainide and disopyramide	HEART AND VESSELS			English	Article						Antiarrhythmic agents; Hypertrophic cardiomyopathy; Obstruction	OUTFLOW TRACT OBSTRUCTION; INTRAVENOUS DISOPYRAMIDE; SUDDEN-DEATH; HEMODYNAMICS; CIBENZOLINE; IMPROVEMENT; MANAGEMENT; STENOSIS; THERAPY; RISK	It remains unclear whether flecainide, a Class I antiarrhythmic drug, improves left ventricular pressure gradient (LVPG) or symptoms in patients with obstructive hypertrophic cardiomyopathy (HCM). Our study evaluated the long-term efficacy of flecainide, compared to disopyramide, when administered orally, on LVPG and symptoms in obstructive HCM patients. Among 164 obstructive HCM patients, 15 were administered oral flecainide therapy and 33 administered oral disopyramide therapy. LVPG declined from 79.8 +/- A 36.6 to 39.2 +/- A 36.7 mmHg (p = 0.003) after flecainide therapy and from 74.5 +/- A 26.4 to 31.4 +/- A 24.8 mmHg (p < 0.001) after disopyramide therapy. The percent reduction in LVPG was -47.9 +/- A 43.2 % in patients treated with flecainide, comparable to the results for those treated with disopyramide (-57.1 +/- A 33.0 %; p = 0.425). We found no significant differences in improvement in NYHA functional class between patients treated with flecainide and those treated with disopyramide (p = 0.331). Patients treated with flecainide exhibited no significant adverse side effects, and there was no need for myectomy or alcohol septal ablation to reduce LVPG and symptoms. Improvements in LVPG and symptoms were similar in patients treated with flecainide and patients treated with disopyramide, suggesting that flecainide is a potentially useful alternative for symptomatic obstructive HCM patients, particularly those with disopyramide-induced vagolytic side effects, narrow angle glaucoma, or prostatic hyperplasia and pre-existing urination difficulties. Our data must be viewed with caution, however, in view of the small number of study patients. Flecainide therapy will require further proof of safety before it can be routinely recommended in patients with symptomatic obstructive HCM.	[Haruki, Shintaro; Minami, Yuichiro; Suzuki, Atsushi; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Shinjuku Ku, Tokyo 1628666, Japan	Minami, Y (reprint author), Tokyo Womens Med Univ, Dept Cardiol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yuichiro24@celery.ocn.ne.jp					ANDERSON DM, 1984, BRIT HEART J, V51, P523; Maron MS, 2006, CIRCULATION, V114, P2232, DOI 10.1161/CIRCULATIONAHA.106.644682; WIGLE ED, 1995, CIRCULATION, V92, P1680; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Kajimoto K, 2010, AM J CARDIOL, V106, P1307, DOI 10.1016/j.amjcard.2010.06.059; Hen Y, 2013, HEART VESSELS, V28, P742, DOI 10.1007/s00380-012-0300-3; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Hamada M, 1997, CIRCULATION, V96, P1520; McKenna WJ, 2002, HEART, V87, P169, DOI 10.1136/heart.87.2.169; BONOW RO, 1985, CIRCULATION, V72, P853; EPSTEIN AE, 1993, JAMA-J AM MED ASSOC, V270, P2451, DOI 10.1001/jama.270.20.2451; Fujita E, 2013, HEART VESSELS, V28, P785, DOI 10.1007/s00380-013-0332-3; GENTZKOW GD, 1984, AM J CARDIOL, V53, pB101, DOI 10.1016/0002-9149(84)90511-3; HARRISON DC, 1964, CIRCULATION, V29, P84; Hongo M, 1996, CARDIOLOGY, V87, P6, DOI 10.1159/000177052; Kawarai H, 2011, J CARD FAIL, V17, P459, DOI 10.1016/j.cardfail.2011.01.015; KIMBALL BP, 1993, AM HEART J, V125, P1691, DOI 10.1016/0002-8703(93)90760-7; Maron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Okayama S, 2015, HEART VESSELS, V30, P28, DOI 10.1007/s00380-013-0452-9; POLLICK C, 1982, NEW ENGL J MED, V307, P997, DOI 10.1056/NEJM198210143071607; ROSING DR, 1981, AM J CARDIOL, V48, P545, DOI 10.1016/0002-9149(81)90086-2; SHERRID M, 1988, AM J CARDIOL, V62, P1085, DOI 10.1016/0002-9149(88)90553-X; Sherrid MV, 1998, CIRCULATION, V97, P41; Sherrid MV, 2000, J AM COLL CARDIOL, V36, P1344, DOI 10.1016/S0735-1097(00)00830-5; Sherrid MV, 2005, J AM COLL CARDIOL, V45, P1251, DOI 10.1016/j.jacc.2005.01.012; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; [Anonymous], 1989, NEW ENGL J MED, V321, P406; ROSEN MR, 1991, CIRCULATION, V84, P1831; THOMPSON DS, 1980, BRIT HEART J, V44, P488	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					604	610		10.1007/s00380-014-0534-3		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800006		
J	Murakami, T; Takeda, A; Takei, K; Tateno, S; Kawasoe, Y; Niwa, K				Murakami, Tomoaki; Takeda, Atsuhito; Takei, Kohta; Tateno, Shigeru; Kawasoe, Yasutaka; Niwa, Koichiro			The cardiac blood supply-workload balance in children	HEART AND VESSELS			English	Article						Aging; Growth; Aortic function; Central hemodynamics	CARDIOVASCULAR-DISEASE; BODY HEIGHT; FOLLOW-UP; PRESSURE; PULSE; IMPACT; WOMEN; RISK	It is well known that the reflected pressure wave in small children returns earlier than that in adolescent. The reason of early return of the reflected pressure wave in infancy is their height. The short distance between heart and reflection point makes the reflected pressure wave returning to the heart earlier. In adult, the early return (during systole) of the reflected pressure wave means disadvantage to cardiac blood supply-workload balance. The purpose of this study was to clarify whether the early return of the reflected pressure wave in small children impairs the cardiac blood supply-workload balance. This study enrolled 37 small left-to-right shunt patients with normal aortic circulation below 15 years of age. The aortic pressure waveform was recorded using a pressure sensor mounted catheter, and augmentation index and subendocardial viability ratio were calculated. The age of patients was 6.1 +/- A 3.2 years. The augmentation index was 8.7 +/- A 14.3 % and the index had a negative correlation with patients' age (r = -0.6243, p < 0.0001). The subendocardial viability ratio, which means the cardiac blood supply-workload balance, was 0.92 +/- A 0.14 and the index had a positive relationship with patients' age (r = 0.6435, p < 0.0001). The cardiac blood supply-workload balance gradually improves from infancy to young adulthood. One of the causes of the unfavorable cardiac blood supply-workload balance in infancy would be the accelerated aortic pressure wave reflection due to their short height.	[Murakami, Tomoaki] Chiba Childrens Hosp, Dept Cardiol, Midori Ku, Chiba 2660007, Japan; [Murakami, Tomoaki; Takeda, Atsuhito; Takei, Kohta] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Murakami, Tomoaki; Tateno, Shigeru; Kawasoe, Yasutaka; Niwa, Koichiro] Chiba Cardiovasc Ctr, Dept Adult Congenital Heart Dis & Pediat Cardiol, Chiba, Japan; [Niwa, Koichiro] St Lukes Int Hosp, Dept Cardiol, Tokyo, Japan	Murakami, T (reprint author), Chiba Childrens Hosp, Dept Cardiol, Midori Ku, 579-1 Heta Cho, Chiba 2660007, Japan.	murat@seagreen.ocn.ne.jp					Smulyan H, 1998, J AM COLL CARDIOL, V31, P1103, DOI 10.1016/S0735-1097(98)00056-4; Murakami T, 2010, HYPERTENS RES, V33, P225, DOI 10.1038/hr.2009.218; McCarron P, 2002, AM J EPIDEMIOL, V155, P683, DOI 10.1093/aje/155.8.683; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; BUCKBERG GD, 1972, CIRC RES, V30, P67; Hayward CS, 1997, J AM COLL CARDIOL, V30, P1863, DOI 10.1016/S0735-1097(97)00378-1; KELLY R, 1989, CIRCULATION, V80, P1652; RICHEDWARDS JW, 1995, AM J EPIDEMIOL, V142, P909; MARCHAIS SJ, 1993, HYPERTENSION, V22, P876; Hoffman JIE, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000285; Forsen T, 2000, J INTERN MED, V248, P326, DOI 10.1046/j.1365-2796.2000.00747.x; Gevers M, 1996, INTENS CARE MED, V22, P242, DOI 10.1007/BF01712244; HEBERT PR, 1993, CIRCULATION, V88, P1437; Jousilahti P, 2000, AM J EPIDEMIOL, V151, P1112; OROURKE M, 1990, HYPERTENSION, V15, P339; Zannoli R, 1999, J BIOMECH, V32, P249, DOI 10.1016/S0021-9290(98)00144-4; BUCKBERG GD, 1975, J THORAC CARDIOV SUR, V70, P974; Chrysohoou C, 2013, HEART VESSELS, V28, P467, DOI 10.1007/s00380-012-0267-0; LONDON GM, 1992, J HYPERTENS, V10, pS93; Nichols W W, 2001, J Cardiovasc Pharmacol Ther, V6, P5, DOI 10.1177/107424840100600102; SHIEH K-Y, 1989, Australian and New Zealand Journal of Medicine, V19, P555; Shiraishi J, 2013, HEART VESSELS, V28, P434, DOI 10.1007/s00380-012-0277-y	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					626	631		10.1007/s00380-014-0537-0		6	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800009		
J	Sugiura, T; Yamanaka, S; Takeuchi, H; Morimoto, N; Kamioka, M; Matsumura, Y				Sugiura, Tetsuro; Yamanaka, Shigeo; Takeuchi, Hiroaki; Morimoto, Norihito; Kamioka, Mikio; Matsumura, Yoshihisa			Autoimmunity and pulmonary hypertension in patients with Graves' disease	HEART AND VESSELS			English	Article						Pulmonary hypertension; Hyperthyroidism; Echocardiography; Autoimmunity	THYROID-DISEASE; DOPPLER-ECHOCARDIOGRAPHY; TRICUSPID REGURGITATION; NONINVASIVE ESTIMATION; ARTERY PRESSURE; HYPERTHYROIDISM; CATHETERIZATION; HORMONE; HEART; TRAB	A link between hyperthyroidism and pulmonary hypertension has been reported, but the underlying mechanisms of these two conditions have not been clearly identified. The aim of this study was to determine the clinical correlates of pulmonary hypertension in patients with Graves' disease. Among 50 consecutive patients with Graves' disease referred for echocardiography, 18 patients (36 %) had pulmonary hypertension measured by continuous-wave Doppler echocardiography (pulmonary artery systolic pressure > 35 mmHg). The patients with pulmonary hypertension had significantly higher pulmonary vascular resistance (PVR), cardiac output and thyroid-stimulating hormone receptor antibody (TRAb) compared to those without (p < 0.001, p = 0.028 and p < 0.001, respectively). Pulmonary artery systolic pressure had a good correlation with TRAb (r = 0.74, p < 0.001), but was not related to free T4 (r = 0.12, p = 0.419) and free T3 (r = 0.22, p = 0.126). To determine the important variables present in patients with Graves' disease that may be related to pulmonary artery systolic pressure, 4 variables (PVR, cardiac output, TRAb and free T3) were used in the multivariate analysis. In addition to PVR (standard regression coefficient = 0.831, p < 0.001) and cardiac output (standard regression coefficient = 0.592, p < 0.001), TRAb (standard regression coefficient = 0.178, p < 0.001) emerged as a significant variable related to pulmonary artery systolic pressure. Thus, in addition to the effect of thyroid hormone on the cardiovascular system, autoimmune-mediated pulmonary vascular remodeling may play a role in Graves' disease-linked elevated pulmonary artery systolic pressure.	[Sugiura, Tetsuro; Yamanaka, Shigeo; Takeuchi, Hiroaki; Morimoto, Norihito; Kamioka, Mikio; Matsumura, Yoshihisa] Kochi Med Sch, Dept Lab Med, Nankoku, Kochi 7838505, Japan	Matsumura, Y (reprint author), Kochi Med Sch, Dept Lab Med, Kohasu Oko Cho, Nankoku, Kochi 7838505, Japan.	matsumur@kochi-u.ac.jp					Amano H, 2013, HEART VESSELS, V28, P505, DOI 10.1007/s00380-012-0272-3; HYMAN AL, 1986, AM J PHYSIOL, V250, P1109; Marvisi M, 2006, EUR J INTERN MED, V17, P267, DOI 10.1016/j.ejim.2005.11.023; Lindqvist P, 2011, EUR J ECHOCARDIOGR, V12, P961, DOI 10.1093/ejechocard/jer222; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Chemla D, 2004, CHEST, V126, P1313, DOI 10.1378/chest.126.4.1313; Napoli R, 2001, CIRCULATION, V104, P3076, DOI 10.1161/hc5001.100621; Siu CW, 2007, J CLIN ENDOCR METAB, V92, P1736, DOI 10.1210/jc.2006-1877; Stephen B, 1999, CHEST, V116, P73, DOI 10.1378/chest.116.1.73; CURRIE PJ, 1985, J AM COLL CARDIOL, V6, P750; HENRY WL, 1980, CIRCULATION, V62, P1054; Arroliga AC, 2000, CHEST, V118, P1224, DOI 10.1378/chest.118.4.1224; Chu JW, 2002, CHEST, V122, P1668, DOI 10.1378/chest.122.5.1668; Danzi S, 2003, CURR HYPERTENS REP, V5, P513, DOI 10.1007/s11906-003-0060-7; Grunig E, 2000, CIRCULATION, V102, P1145; Kamijo K, 2010, ENDOCR J, V57, P895; Kim BH, 2013, HEART VESSELS, V28, P524, DOI 10.1007/s00380-012-0304-z; Klein Irwin, 1996, P607; Massart C, 2009, CLIN CHIM ACTA, V407, P62, DOI 10.1016/j.cca.2009.06.033; McGoon M, 2004, CHEST, V126, p14s; Merce J, 2005, AM J MED, V118, P126, DOI 10.1016/j.amjmed.2004.08.018; Nakchbandi IA, 1999, CHEST, V116, P1483, DOI 10.1378/chest.116.5.1483; Nicolls MR, 2005, EUR RESPIR J, V26, P1110, DOI 10.1183/09031936.05.00045705; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707; YOCK PG, 1984, CIRCULATION, V70, P657	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					642	646		10.1007/s00380-014-0518-3		5	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800011		
J	Otsuka, Y; Murata, T; Kono, M; Imoto, H; Koyama, T; Nakamura, K; Kadama, S; Noguchi, H; Saito, T				Otsuka, Yoritaka; Murata, Takashi; Kono, Michiaki; Imoto, Hiroki; Koyama, Taku; Nakamura, Keita; Kadama, Sunao; Noguchi, Hiroo; Saito, Taro			Black hole restenosis after drug-eluting stent implantation for in-stent restenosis: potential mechanism and optimal strategy	HEART AND VESSELS			English	Article						Restenosis; Drug-eluting stent; Percutaneous coronary intervention	PACLITAXEL-COATED BALLOON; J-CYPHER REGISTRY; INTRAVASCULAR ULTRASOUND; SIROLIMUS; THROMBOSIS; REVASCULARIZATION; HYPERSENSITIVITY; ANGIOPLASTY; CATHETER; INSIGHTS	In-stent restenosis (ISR) has long remained as the major limitation of coronary stenting. The use of drug-eluting stent (DES) reduces the risk of repeat revascularization without an increase of death and myocardial infarction, compared to the standard bare metal stents. DES has also demonstrated markedly to reduce ISR for complex lesions. However, ISR after DES implantation still occurs and optimal treatment for ISR after DES has not been established. Herein, we report 3 cases with black hole restenosis confirmed by intravascular ultrasound at the site of overlapped DES and discuss potential mechanism and optimal strategy for this phenomenon.	[Otsuka, Yoritaka; Murata, Takashi; Kono, Michiaki; Imoto, Hiroki; Koyama, Taku; Nakamura, Keita; Kadama, Sunao; Noguchi, Hiroo; Saito, Taro] Fukuoka Wajiro Hosp, Dept Cardiol, Higashi Ku, Fukuoka 8110213, Japan	Otsuka, Y (reprint author), Fukuoka Wajiro Hosp, Dept Cardiol, Higashi Ku, 2-2-75 Wajirogaoka, Fukuoka 8110213, Japan.	yotsuka@f-wajirohp.jp					Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Farb A, 2004, CIRCULATION, V110, P940, DOI 10.1161/01.CIR.0000139337.56084.30; Carter AJ, 2004, CARDIOVASC RES, V63, P617, DOI 10.1016/j.cardiores.2004.04.029; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; Habara S, 2013, AM HEART J, V166, P527, DOI 10.1016/j.ahj.2013.07.002; Otsuka Y, 2012, HEART VESSELS, V27, P110, DOI 10.1007/s00380-011-0145-1; Abe M, 2010, CIRCULATION, V122, P42, DOI 10.1161/CIRCULATIONAHA.109.905802; Nakano M, 2013, EUR HEART J, V34, P3304, DOI 10.1093/eurheartj/eht241; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Farooq V, 2011, CIRC-CARDIOVASC INTE, V4, P195, DOI 10.1161/CIRCINTERVENTIONS.110.959882; Costa MA, 2006, AM J CARDIOL, V97, P203, DOI 10.1016/j.amjcard.2005.07.136; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Dorr O, 2015, HEART VESSELS, V30, P265, DOI 10.1007/s00380-013-0464-5; Goto K, 2009, CIRC J, V73, P1969; Habara S, 2011, JACC-CARDIOVASC INTE, V4, P149, DOI 10.1016/j.jcin.2010.10.012; Koshy SKG, 2008, J INVASIVE CARDIOL, V20, P560; Kurita T, 2012, EUROINTERVENTION, V7, P1480, DOI 10.4244/EIJV7I12A232; Landmesser U, 2012, EUROINTERVENTION, V7, P1367, DOI 10.4244/EIJV7I12A215; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Oikawa Y, 2010, EUROINTERVENTION, V6, P380, DOI 10.4244/EIJV6I3A63; Vicente JAL, 2012, EUROINTERVENTION, V7, P1479, DOI 10.4244/EIJV7I12A231	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					682	686		10.1007/s00380-014-0528-1		5	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800016		
J	Toyota, N; Miyazaki, A; Sakaguchi, H; Shimizu, W; Ohuchi, H				Toyota, Naoki; Miyazaki, Aya; Sakaguchi, Heima; Shimizu, Wataru; Ohuchi, Hideo			A high-risk patient with long-QT syndrome with no response to cardioselective beta-blockers	HEART AND VESSELS			English	Article						Long-QT syndrome; High-risk patient; Beta-blocker; Nonselective beta-blocker; Beta-1 selective blocker	THERAPY; EFFICACY; MANAGEMENT; PHENOTYPE; FAILURES	We present a case of a high-risk 19-year-old female with long-QT syndrome (LQTS) with compound mutations. She had a history of aborted cardiac arrest and syncope and had received treatment with propranolol for 15 years. However, because she developed adult-onset asthma we tried to switch propranolol, a nonselective beta-blocker, to beta-1-cardioselective agents, bisoprolol and metoprolol. These resulted in both a markedly prolonged corrected QT interval and the development of LQTS-associated arrhythmias. Eventually, propranolol was reinitiated at a higher dose with the addition of verapamil, and she has had no further cardiac or asthmatic events for 5 years.	[Toyota, Naoki; Miyazaki, Aya; Sakaguchi, Heima; Ohuchi, Hideo] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Osaka, Japan; [Toyota, Naoki] Otsu Red Cross Hosp, Dept Pediat, Otsu, Shiga 5208511, Japan; [Shimizu, Wataru] Natl Cerebral & Cardiovasc Ctr, Div Arrhythmias & Electrophysiol, Dept Cardiovasc Med, Osaka, Japan	Toyota, N (reprint author), Otsu Red Cross Hosp, Dept Pediat, 1-1-35 Nagara, Otsu, Shiga 5208511, Japan.	n-toyota@otsu.jrc.or.jp			Ministry of Health, Labour and Welfare, Japan [H24-033]	Dr. W Shimizu was supported, in part, by the Research Grant for Cardiovascular Diseases (H24-033) from the Ministry of Health, Labour and Welfare, Japan.	Moss AJ, 2000, CIRCULATION, V101, P616; Nakashima K, 2013, HEART VESSELS, V28, P126, DOI 10.1007/s00380-012-0235-8; Chockalingam P, 2012, J AM COLL CARDIOL, V60, P2092, DOI 10.1016/j.jacc.2012.07.046; Jons C, 2010, J AM COLL CARDIOL, V55, P783, DOI 10.1016/j.jacc.2009.11.042; Itoh H, 2010, HEART RHYTHM, V7, P1411, DOI 10.1016/j.hrthm.2010.06.013; Goldenberg I, 2008, CIRCULATION, V117, P2184, DOI 10.1161/CIRCULATIONAHA.107.701243; Goldenberg I, 2010, J CARDIOVASC ELECTR, V21, P893, DOI 10.1111/j.1540-8167.2010.01737.x; Vincent GM, 2009, CIRCULATION, V119, P215, DOI 10.1161/CIRCULATIONAHA.108.772533; Schwartz PJ, 2001, CIRCULATION, V103, P89; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P2291, DOI 10.1016/j.jacc.2008.02.068; Bankston JR, 2010, J MOL CELL CARDIOL, V48, P246, DOI 10.1016/j.yjmcc.2009.05.012; Aygul N, 2009, CARDIOLOGY, V112, P168, DOI 10.1159/000147950; Bando S, 2014, HEART VESSELS, V29, P554, DOI 10.1007/s00380-013-0406-2; Chatrath R, 2004, PEDIATR CARDIOL, V25, P459, DOI 10.1007/s00246-003-0567-3; DUFF HJ, 1986, J AM COLL CARDIOL, V8, P959; Extramiana F, 2013, ANN NONINVAS ELECTRO, V18, P399, DOI 10.1111/anec.12048; Viitasalo M, 2006, J AM COLL CARDIOL, V48, P747, DOI 10.1016/j.jacc.2006.04.084; Villain E, 2004, EUR HEART J, V25, P1405, DOI 10.1016/j.ehj.2004.06.016	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					687	691		10.1007/s00380-014-0530-7		5	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800017		
J	Suzuki, J; Imai, Y; Aoki, M; Fujita, D; Aoyama, N; Tada, Y; Akazawa, H; Izumi, Y; Isobe, M; Komuro, I; Nagai, R; Hirata, Y				Suzuki, Jun-ichi; Imai, Yasushi; Aoki, Mieko; Fujita, Daishi; Aoyama, Norio; Tada, Yuko; Akazawa, Hiroshi; Izumi, Yuichi; Isobe, Mitsuaki; Komuro, Issei; Nagai, Ryozo; Hirata, Yasunobu			High incidence and severity of periodontitis in patients with Marfan syndrome in Japan	HEART AND VESSELS			English	Article						Marfan syndrome; Cardiovascular complications; Periodontitis	MOUSE MODEL; DISORDER; CELLS	Marfan syndrome (MFS) is a systemic connective tissue disorder caused by mutations in the extracellular matrix protein fibrillin-1. While it is known that patients with MFS are at high risk of dental disorders and cardiovascular diseases, little information has been provided to date. To clarify the prevalence of periodontitis in patients with MFS, their oral condition and cardiovascular complications were evaluated. The subjects were patients with MFS (n = 40) who attended the University of Tokyo hospital; age- and gender-matched healthy individuals (n = 14) constituted a control group. Cardiovascular complications and full-mouth clinical measurements, including number of teeth, probing of pocket depth (PD), bleeding on probing (BOP), and community periodontal index (CPI) were recorded. MFS patients had more frequent cardiovascular complications (95 %) compared with the controls (0 %). MFS patients had periodontitis (CPI 3 and 4) more frequently (87.5 %) than the age- and gender-matched control subjects (35.7 %). Furthermore, MFS patients had significantly more severe periodontitis (CPI 2.90 +/- 0.12 vs 1.64 +/- 0.32) and fewer remaining teeth (26.7 +/- 0.4 vs 28.4 +/- 0.4) compared with the controls. However, PD and BOP were comparable between MFS patients and the control group. A high incidence of periodontitis and cardiovascular complications was observed in Japanese MFS patients.	[Suzuki, Jun-ichi; Tada, Yuko; Akazawa, Hiroshi] Univ Tokyo, Dept Adv Clin Sci & Therapeut, Bunkyo Ku, Tokyo 1138655, Japan; [Imai, Yasushi; Aoki, Mieko; Fujita, Daishi; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Aoyama, Norio; Izumi, Yuichi] Tokyo Med & Dent Univ, Sect Periodontol, Dept Hard Tissue Engn, Tokyo, Japan; [Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan; [Nagai, Ryozo] Jichi Med Univ, Shimotsuke, Japan; [Hirata, Yasunobu] Tokyo Teishin Hosp, Tokyo, Japan	Suzuki, J (reprint author), Univ Tokyo, Dept Adv Clin Sci & Therapeut, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	junichisuzuki-circ@umin.ac.jp			Medical Survey and Research Foundation; Mitsui Life Insurance Research Foundation; Mitsui Sumitomo Marine Welfare Research Foundation; Geriatric Dental Research Foundation; Human Health Future Research Foundation; St Luke's Hospital Research Foundation; Japanese Ministry of Health, Labor, and Welfare	This study was supported by grants from the Medical Survey and Research Foundation, Mitsui Life Insurance Research Foundation, Mitsui Sumitomo Marine Welfare Research Foundation, Geriatric Dental Research Foundation, Human Health Future Research Foundation, St Luke's Hospital Research Foundation, and Health Labor Science's Research Grants from the Japanese Ministry of Health, Labor, and Welfare.	Suda N, 2013, INFECT IMMUN, V81, P182, DOI 10.1128/IAI.00886-12; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Yamamoto Y, 2012, HEART VESSELS, V27, P624, DOI 10.1007/s00380-011-0214-5; Ganburged G, 2010, CELL TISSUE RES, V341, P381, DOI 10.1007/s00441-010-1021-5; De Coster PJA, 2002, ORAL SURG ORAL MED O, V93, P564, DOI 10.1067/moe.2002.121430; Saito M, 2011, J BIOL CHEM, V286, P38602, DOI 10.1074/jbc.M111.243451; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; Suda N, 2009, J EXP ZOOL PART B, V312B, P503, DOI 10.1002/jez.b.21278; Frydman M, 2008, ISR MED ASSOC J, V10, P175; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Shiga M, 2008, CELL TISSUE RES, V331, P461, DOI 10.1007/s00441-007-0528-x; Aoyama N, 2011, J PERIODONTAL RES, V46, P176, DOI 10.1111/j.1600-0765.2010.01326.x; Gonzales EA, 2009, J AM ACAD NURSE PRAC, V21, P663, DOI 10.1111/j.1745-7599.2009.00461.x; Ikonomidis JS, 2006, CIRCULATION, V114, pI365, DOI 10.1161/CIRCULATIONAHA.105.000810; Judge DP, 2008, ANNU REV MED, V59, P43, DOI 10.1146/annurev.med.59.103106.103801; Takata M, 2014, HEART VESSELS, V29, P478, DOI 10.1007/s00380-013-0393-3	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					692	695		10.1007/s00380-013-0434-y		4	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800018		
J	Fujiwara, T; Yoshida, M; Nakamura, T; Sakakura, K; Wada, H; Arao, K; Katayama, T; Funayama, H; Sugawara, Y; Mitsuhashi, T; Kakei, M; Momomura, S; Ako, J				Fujiwara, Takayuki; Yoshida, Masashi; Nakamura, Tomohiro; Sakakura, Kenichi; Wada, Hiroshi; Arao, Kenshiro; Katayama, Takuji; Funayama, Hiroshi; Sugawara, Yoshitaka; Mitsuhashi, Takeshi; Kakei, Masafumi; Momomura, Shin-ichi; Ako, Junya			Dipeptidyl peptidase-4 inhibitors are associated with improved left ventricular diastolic function after acute myocardial infarction in diabetic patients	HEART AND VESSELS			English	Article						Dipeptidyl peptidase-4 inhibitor; Diastolic function; Diabetes mellitus; Acute myocardial infarction	PEPTIDE-1 RECEPTOR; PATHWAYS; OUTCOMES; SYSTEM; MICE	Dipeptidyl peptidase-4 (DPP4) is an integral membrane glycoprotein that modulates the pathological state of diabetes mellitus (DM), and DPP4 inhibitors are a new class of anti-type-2 DM drugs. Recent preclinical studies have associated DPP4 inhibition with improved myocardial systolic and diastolic function. Based on preclinical findings, we investigated associations between the administration of DPP4 inhibitors and cardiac function after acute myocardial infarction (AMI) in a clinical setting. We enrolled 34 patients with diabetes who were treated for acute myocardial infarction at our hospital between January 2010 and December 2012. We retrospectively compared changes in cardiac parameters determined by trans-thoracic echocardiography between patients treated with (DPP4-I group; n = 13) or without (non-DPP4-I group; n = 21) a DPP4 inhibitor during follow-up. The values of E/e' and of e'/a' significantly decreased and increased, respectively, in the DPP4-I, compared with the non-DPP4-I group (-2.53 +/- A 5.53 vs. 2.58 +/- A 5.68, p = 0.038 and 0.08 +/- A 0.23 vs. -0.12 +/- A 0.21, p = 0.036, respectively). We concluded that DPP4 inhibitors could improve E/e' and e'/a' in patients with DM and AMI and thus might be effective for treating left ventricular diastolic failure.	[Fujiwara, Takayuki; Nakamura, Tomohiro; Sakakura, Kenichi; Wada, Hiroshi; Arao, Kenshiro; Katayama, Takuji; Funayama, Hiroshi; Sugawara, Yoshitaka; Mitsuhashi, Takeshi; Momomura, Shin-ichi] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Med, Saitama, Saitama 3308503, Japan; [Yoshida, Masashi; Kakei, Masafumi] Jichi Med Univ, Saitama Med Ctr, Dept Endocrinol & Metab, Saitama, Saitama 3308503, Japan; [Ako, Junya] Kitasato Univ, Dept Cardiovasc Med, Sagamihara, Kanagawa 2520375, Japan	Momomura, S (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Med, 1-847 Amanuma, Saitama, Saitama 3308503, Japan.	momoshin@omiya.jichi.ac.jp					Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.01.06.db05-0803; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Takahashi M, 2010, CIRC J, V74, P418, DOI 10.1253/circj.CJ-09-1021; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Connelly KA, 2013, CARDIOVASC THER, V31, P259, DOI 10.1111/1755-5922.12005; Zhang DS, 2010, AM J PHYSIOL-HEART C, V299, pH1339, DOI 10.1152/ajpheart.00592.2010	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	SEP	2015	30	5					696	701		10.1007/s00380-014-0509-4		6	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1GB	WOS:000361071800019		
J	Kodama, Y; Abe, K; Hosokawa, K; Ohtani, K; Nagao, M; Hirooka, Y; Sunagawa, K				Kodama, Yoshihiko; Abe, Kohtaro; Hosokawa, Kazuya; Ohtani, Kisho; Nagao, Michinobu; Hirooka, Yoshitaka; Sunagawa, Kenji			Reversal of diffuse patchy pattern in lung perfusion scan in a case of severe pulmonary arterial hypertension	HEART & LUNG			English	Article						Diffuse patchy pattern; Pulmonary arterial hypertension; Upfront combination therapy	THERAPY	A diffuse patchy pattern in the perfusion scan of the lung is a hallmark of severe pulmonary arterial hypertension (PAH). However, the mechanisms of this unique pattern remain uncertain. We here present the case of a 19-year-old woman with severe PAH who demonstrated reversal of the diffuse patchy pattern with improvement of pulmonary blood flow within a month after upfront triple combination therapy. Our case is a first report showing reversibility of diffuse patchy pattern by a short-term treatment in severe PAH. These findings suggest the possibility that the mechanisms underlying the diffuse patchy pattern may involve reversible vasoconstriction in addition to remodeling of small pulmonary arteries. (c) 2015 Elsevier Inc. All rights reserved.	[Kodama, Yoshihiko; Hosokawa, Kazuya; Ohtani, Kisho; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med, Dept Cardiovasc Med, Fukuoka 8128582, Japan; [Abe, Kohtaro; Hirooka, Yoshitaka] Kyushu Univ, Grad Sch Med, Dept Adv Cardiovasc Regulat & Therapeut, Higashi Ku, Fukuoka 8128582, Japan; [Nagao, Michinobu] Kyushu Univ, Grad Sch Med, Dept Mol Imaging & Diag, Fukuoka 8128582, Japan	Abe, K (reprint author), Kyushu Univ, Grad Sch Med, Dept Adv Cardiovasc Regulat & Therapeut, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	koabe@cardiol.med.kyushu-u.ac.jp					Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Pogoriler JE, 2012, HISTOPATHOLOGY, V61, P597, DOI 10.1111/j.1365-2559.2012.04246.x; FISHMAN AJ, 1983, CHEST, V84, P679, DOI 10.1378/chest.84.6.679; HEATH D, 1958, CIRCULATION, V18, P533; Sitbon O, 2014, EUR RESPIR J, V43, P1691, DOI 10.1183/09031936.00116313; Fukuchi K, 2002, J NUCL MED, V43, P757	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0147-9563	1527-3288		HEART LUNG	Heart Lung	SEP-OCT	2015	44	5					451	452		10.1016/j.hrtlng.2015.06.005		2	Cardiac & Cardiovascular Systems; Nursing; Respiratory System	Cardiovascular System & Cardiology; Nursing; Respiratory System	CR0OD	WOS:000361017100014		
J	Cuka, S; Ng, J; Seino, K; Waddington, SN; Kurian, MA; Rahim, AA				Cuka, Sam; Ng, Joanne; Seino, Ken-ichiro; Waddington, Simon N.; Kurian, Manju A.; Rahim, Ahad A.			Novel therapeutic strategies in NBIA: A gene therapy approach for PLA2G6-associated	HUMAN GENE THERAPY			English	Meeting Abstract	Annual Conference of the British-Society-for-Gene-and-Cell-Therapy	JUN 09-11, 2015	Glasgow, SCOTLAND	British Soc Gene & Cell Therapy					[Cuka, Sam] UCL, Sch Pharm, London, England; [Ng, Joanne; Waddington, Simon N.] UCL, Inst Womens Hlth, London, England; [Seino, Ken-ichiro] Natl Inst Neurosci, Div Bioregulat Res, Tokyo, Japan; [Kurian, Manju A.] UCL, Inst Child Hlth, London, England								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	SEP 1	2015	26	9				PO14	A15	A15				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CQ9WT	WOS:000360966600044		
J	Paul-Smith, M; Gelinas, JF; Pytel, K; Chan, M; Meng, CX; Cammack, L; Pringle, I; Inoue, M; Hasegawa, M; Hyde, S; Gill, D; Alton, E; Griesenbach, U				Paul-Smith, Michael; Gelinas, Jean-Francois; Pytel, Kamila; Chan, Mario; Meng, Cuixiang; Cammack, Lidia; Pringle, Ian; Inoue, Makoto; Hasegawa, Mamoru; Hyde, Stephen; Gill, Deborah; Alton, Eric; Griesenbach, Uta			Therapeutic levels of alpha-1-antitrypsin following gene therapy with F/HN pseudotyped simian immunodeficiency virus	HUMAN GENE THERAPY			English	Meeting Abstract	Annual Conference of the British-Society-for-Gene-and-Cell-Therapy	JUN 09-11, 2015	Glasgow, SCOTLAND	British Soc Gene & Cell Therapy					[Paul-Smith, Michael; Pytel, Kamila; Chan, Mario; Meng, Cuixiang; Cammack, Lidia; Alton, Eric; Griesenbach, Uta] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Gelinas, Jean-Francois; Pringle, Ian; Hyde, Stephen; Gill, Deborah] Univ Oxford, John Radcliffe Hosp, NDCLS, Gene Med Res Grp, Oxford OX3 9DU, England; [Paul-Smith, Michael; Gelinas, Jean-Francois; Pytel, Kamila; Chan, Mario; Meng, Cuixiang; Cammack, Lidia; Pringle, Ian; Hyde, Stephen; Gill, Deborah; Alton, Eric; Griesenbach, Uta] UK Cyst Fibrosis Gene Therapy Consortium, Oxford, England; [Inoue, Makoto; Hasegawa, Mamoru] DNAVEC, Tsukuba, Ibaraki, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	SEP 1	2015	26	9				PO05	A12	A12				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CQ9WT	WOS:000360966600035		
J	Pytel, KM; Smith, MP; McIntosh, J; Chan, M; Meng, CX; Pringle, I; Davies, L; Inoue, M; Hasegawa, M; Hyde, SC; Gill, DR; Nathwani, AC; Alton, E; Griesenbach, U				Pytel, Kamila M.; Smith, Michael Paul; McIntosh, Jenny; Chan, Mario; Meng, Cuixiang; Pringle, Ian; Davies, Lee; Inoue, Makoto; Hasegawa, Mamoru; Hyde, Stephen C.; Gill, Deborah R.; Nathwani, Amit C.; Alton, Eric; Griesenbach, Uta			Production of FVIII in the lungs	HUMAN GENE THERAPY			English	Meeting Abstract	Annual Conference of the British-Society-for-Gene-and-Cell-Therapy	JUN 09-11, 2015	Glasgow, SCOTLAND	British Soc Gene & Cell Therapy					[Pytel, Kamila M.; Smith, Michael Paul; Chan, Mario; Meng, Cuixiang; Alton, Eric; Griesenbach, Uta] Univ London Imperial Coll Sci Technol & Med, Dept Gene Therapy, London, England; [McIntosh, Jenny; Nathwani, Amit C.] UCL, Inst Canc, Dept Haematol, London, England; [Pringle, Ian; Davies, Lee; Hyde, Stephen C.; Gill, Deborah R.] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Pytel, Kamila M.; Smith, Michael Paul; Chan, Mario; Meng, Cuixiang; Pringle, Ian; Davies, Lee; Hyde, Stephen C.; Alton, Eric; Griesenbach, Uta] UK Cyst Fibrosis Gene Therapy Consortium, Edinburgh, Midlothian, Scotland; [Inoue, Makoto; Hasegawa, Mamoru] DNAVEC, Tsukuba, Ibaraki, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	SEP 1	2015	26	9				FB01	A7	A7				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CQ9WT	WOS:000360966600023		
J	Tomita, T; Kaneda, A; Nakagami, T; Kaneko, S; Yasui-Furukori, N				Tomita, Tetsu; Kaneda, Ayako; Nakagami, Taku; Kaneko, Sunao; Yasui-Furukori, Norio			Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder	HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL			English	Article						Temperament and Character Inventory; major depressive disorder; harm avoidance	ANXIETY DISORDERS; PERSONALITY; PREDICT; MODEL; TIME	Previous studies have reported changes in the dimensions of the Temperament and Character Inventory (TCI) after patients with major depressive disorder are treated. We aimed to investigate the changes in the TCI dimensions after paroxetine treatment in patients with major depressive disorder. Forty-eight patients were enrolled in this study and were treated with 10-40mg/day of paroxetine for 6weeks. The TCI was completed twice, at weeks 0 and 6. We used the Montgomery-Asberg Depression Rating Scale (MADRS) to evaluate patients. The participants were divided into three groups (responders, non-responders, and early responders) based on treatment response. The scores of each dimension of the TCI were compared before and after treatment using repeated-measures two-way analyses of variance. In the responders group (n=24), no TCI dimension scores changed significantly during treatment, but the interaction between sex and MADRS score change was significantly associated with the results. In the non-responders group (n=15), the self-directedness score increased significantly during the treatment period (p=0.000), and the change in MADRS score significantly affected the results. In the early responders group (n=9), no TCI dimension scores changed significantly during treatment. The results of the present study may reveal a possible correlation between paroxetine treatment and changes in personality traits. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Tomita, Tetsu; Kaneda, Ayako; Nakagami, Taku; Kaneko, Sunao; Yasui-Furukori, Norio] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 0368562, Japan	Yasui-Furukori, N (reprint author), Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 0368562, Japan.	yasufuru@cc.hirosaki-u.ac.jp					American Psychiatric Association, 2010, PRACT GUID TREATM PA; Takahashi N, 2004, HUM PSYCHOPHARM CLIN, V19, P187, DOI 10.1002/hup.576; Cloninger CR, 1998, J AFFECT DISORDERS, V51, P21, DOI 10.1016/S0165-0327(98)00153-0; Abrams KY, 2004, PSYCHIAT CLIN NEUROS, V58, P240, DOI 10.1111/j.1440-1819.2004.01226.x; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975; Hirano S, 2002, J AFFECT DISORDERS, V69, P31, DOI 10.1016/S0165-0327(00)00329-3; Corruble E, 2002, PSYCHIAT RES, V109, P17, DOI 10.1016/S0165-1781(01)00366-3; Celikel FC, 2009, COMPR PSYCHIAT, V50, P556, DOI 10.1016/j.comppsych.2008.11.012; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CAVERO I, 1981, BRIT J PHARMACOL, V74, P143; Gormley N, 1999, J AFFECT DISORDERS, V54, P49, DOI 10.1016/S0165-0327(98)00133-5; Gunasekara NS, 1998, DRUGS, V55, P85, DOI 10.2165/00003495-199855010-00007; Kaneda A, 2011, J AFFECT DISORDERS, V135, P321, DOI 10.1016/j.jad.2011.06.050; Kijimas N, 1996, ARCH PSYCHIAT DIAGN, V7, P379; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; Melegari MG, 2015, COMPR PSYCHIAT, V58, P94, DOI 10.1016/j.comppsych.2015.01.001; Miettunen J, 2007, COMPR PSYCHIAT, V48, P161, DOI 10.1016/j.comppsych.2006.10.007; Richter J, 2000, EUR ARCH PSY CLIN N, V250, P40, DOI 10.1007/PL00007538; Richter J, 2000, PSYCHOPATHOLOGY, V33, P36, DOI 10.1159/000029117; SCOTT J, 1992, BRIT J PSYCHIAT, V161, P633, DOI 10.1192/bjp.161.5.633; Tuominen L, 2013, PSYCHOL MED, V43, P881, DOI 10.1017/S003329171200164X; Schellekens AFA, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2013.08.006	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6222	1099-1077		HUM PSYCHOPHARM CLIN	Hum. Psychopharmacol.-Clin. Exp.	SEP	2015	30	5					334	340		10.1002/hup.2479		7	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry; Psychology	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry; Psychology	CR3DA	WOS:000361209500002		
J	Umehara, H; Numata, S; Tajima, A; Kinoshita, M; Nakaaki, S; Imoto, I; Sumitani, S; Ohmori, T				Umehara, Hidehiro; Numata, Shusuke; Tajima, Atsushi; Kinoshita, Makoto; Nakaaki, Shutaro; Imoto, Issei; Sumitani, Satsuki; Ohmori, Tetsuro			No association between the COMT Val158Met polymorphism and the long-term clinical response in obsessive-compulsive disorder in the Japanese population	HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL			English	Article						obsessive-compulsive disorder; COMT; meta-analysis; clinical response	O-METHYLTRANSFERASE COMT; D-1 RECEPTOR-BINDING; SEROTONIN; AUGMENTATION; EXPRESSION; ALLELE; OCD	ObjectiveCatechol-O-methyltransferase (COMT) is an enzyme that participates in the metabolic inactivation of dopamine and norepinephrine, and the Met allele of the COMT Val158Met polymorphism is associated with lower enzymatic activity. The purpose of the present study was to investigate whether this functional variant is associated with obsessive-compulsive disorder (OCD) and the clinical responses in OCD. MethodsWe first performed a case-control association study between the COMT Val158Met polymorphism and OCD (171 cases and 944 controls). Then, we examined the association between this polymorphism and the clinical responses in 91 of the OCD patients. ResultsOur study did not find a significant association between the Met allele and OCD risk or between the Met allele and clinical responses (p>0.05). ConclusionThe present case-control/pharmacogenetic study did not provide clear evidence that the COMT Val158Met polymorphism is a predictor of OCD or of OCD patients' clinical responses. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Umehara, Hidehiro; Numata, Shusuke; Kinoshita, Makoto; Sumitani, Satsuki; Ohmori, Tetsuro] Univ Tokushima, Grad Sch, Dept Psychiat, Inst Biomed Sci, Tokushima 7708503, Japan; [Tajima, Atsushi] Kanazawa Univ, Grad Sch Med Sci, Dept Bioinformat & Genom, Kanazawa, Ishikawa 9201192, Japan; [Tajima, Atsushi; Imoto, Issei] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Human Genet, Tokushima 7708503, Japan; [Nakaaki, Shutaro] Keio Univ, Sch Med, Dept Neuropsychiat, Lab Aging Behav & Cognit, Tokyo, Japan	Numata, S (reprint author), Univ Tokushima, Grad Sch, Dept Psychiat, Course Integrated Brain Sci,Med Informat,Inst Hlt, 3-8-15 Kuramoto Cho, Tokushima 7708503, Japan.	shu-numata@umin.ac.jp	Tajima, Atsushi/C-1053-2008	Tajima, Atsushi/0000-0001-6808-5491	 [90346594]	The authors would like to thank all the volunteers who understood our study purpose and participated in this study and the physicians who helped us to collect clinical data and blood samples at the mental hospitals. The authors would also like to thank Mrs. Akemi Okada for her technical assistance. This work was supported by Grant-in-Aid for Scientific Research (C) (No. 90346594). All the authors report no biomedical financial interests or potential conflicts of interest.	Pooley EC, 2007, MOL PSYCHIATR, V12, P556, DOI 10.1038/sj.mp.4001951; Perani D, 2008, NEUROIMAGE, V42, P306, DOI 10.1016/j.neuroimage.2008.04.233; Niehaus DJH, 2001, J AFFECT DISORDERS, V65, P61, DOI 10.1016/S0165-0327(00)00246-9; Taylor S, 2013, MOL PSYCHIATR, V18, P799, DOI 10.1038/mp.2012.76; Nicolini H, 2009, PSYCHIAT RES, V170, P7, DOI 10.1016/j.psychres.2008.10.011; Bloch MH, 2006, MOL PSYCHIATR, V11, P622, DOI 10.1038/sj.mp.4001823; Mattheisen M, 2015, MOL PSYCHIATR, V20, P337, DOI 10.1038/mp.2014.43; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; Stewart SE, 2013, MOL PSYCHIATR, V18, P788, DOI 10.1038/mp.2012.85; Erzegovesi S, 2001, J CLIN PSYCHOPHARM, V21, P488, DOI 10.1097/00004714-200110000-00006; Pallanti S, 2002, INT J NEUROPSYCHOPH, V5, P181, DOI 10.1017/S1461145702002900; Denys D, 2006, EUR NEUROPSYCHOPHARM, V16, P446, DOI 10.1016/j.euroneuro.2005.12.001; Denys D, 2004, BIOL PSYCHIAT, V55, P1041, DOI 10.1016/j.biopsych.2004.01.023; Arumugham SS, 2013, EXPERT REV NEUROTHER, V13, P187, DOI [10.1586/ern.12.160, 10.1586/ERN.12.160]; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Olver JS, 2009, J AFFECT DISORDERS, V114, P321, DOI 10.1016/j.jad.2008.06.020; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Arumugham SS, 2013, EXPERT REV NEUROTHER, V13, P203; Denys D, 2007, J CLIN PSYCHIAT, V68, P747; Erdal ME, 2003, DEPRESS ANXIETY, V18, P41, DOI 10.1002/da.10114; Hsieh HJ, 2014, PSYCHIAT CLIN NEUROS, V68, P292, DOI 10.1111/pcn.12139; Katerberg H, 2010, AM J MED GENET B, V153B, P167, DOI 10.1002/ajmg.b.30971; Kims C-H, 2011, CLIN PSYCHOPHARMACOL, P23; Meira-Lima I, 2004, GENES BRAIN BEHAV, V3, P75, DOI 10.1046/j.1601-183x.2003.00042.x; Miguita K, 2011, ARQ NEURO-PSIQUIAT, V69, P283, DOI 10.1590/S0004-282X2011000300003; Ohara K, 1998, PSYCHIAT RES, V80, P145, DOI 10.1016/S0165-1781(98)00062-6; Olver JS, 2010, PSYCHIAT RES-NEUROIM, V183, P85, DOI 10.1016/j.pscychresns.2010.04.004; Pauls David L, 2010, Dialogues Clin Neurosci, V12, P149; Poyurovsky M, 2005, NEUROSCI LETT, V389, P21, DOI 10.1016/j.neulet.2005.06.064; Soomro GM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001765.pub3; Tukel R, 2013, J NEUROPSYCH CLIN N, V25, P214, DOI 10.1176/appi.neuropsych.12040103; Vulink NCC, 2012, INT J PSYCHIAT CLIN, V16, P277, DOI 10.3109/13651501.2011.653375	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6222	1099-1077		HUM PSYCHOPHARM CLIN	Hum. Psychopharmacol.-Clin. Exp.	SEP	2015	30	5					372	376		10.1002/hup.2485		5	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry; Psychology	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry; Psychology	CR3DA	WOS:000361209500007		
J	Tanahashi, M; Yamaguchi, K				Tanahashi, Makoto; Yamaguchi, Keiichi			Uncertainty of Out-of-Band Distortion Measurement With a Spectrum Analyzer	IEEE TRANSACTIONS ON BROADCASTING			English	Article						Spectrum analyzer (SA); out-of-band (OOB) distortion; power amplifier; digital modulation; orthogonal frequency division multiplexing (OFDM); adjacent channel power ratio (ACPR); adjacent channel leakage ratio (ACLR); shoulder attention; intermodulation distortion		In broadcasting and wireless communications, modulated signals are deformed by nonlinear radio frequency components, of which power amplifiers are the most significant example. The resulting distortion can leak outside the main signal band, and this leak, called out-of-band (OOB) distortion, can be directly measured with a spectrum analyzer (SA). Little attention has been paid to this measurement. In particular, it is often assumed that there is no measurement uncertainty, regardless of the condition of the instrument. However, in this paper, we show that the measurement of OOB distortion depends strongly on the various setting parameters of the SA because of its intricate internal signal processing for detection and visualization. Our analysis reveals that the underlying reason for this dependence is the difference between envelope amplitude statistics detected inside and outside of the main signal band.	[Tanahashi, Makoto; Yamaguchi, Keiichi] Toshiba Co Ltd, Corp Res & Dev Ctr, Kanagawa 2128582, Japan	Tanahashi, M (reprint author), Toshiba Co Ltd, Corp Res & Dev Ctr, Kanagawa 2128582, Japan.	makoto.tanahashi@toshiba.co.jp					Adnani Adnan, 2013, IEEE Instrumentation & Measurement Magazine, V16, DOI 10.1109/MIM.2013.6616284; Agilent Application Note, 2014, MEAS NOIS NOIS LIK D; Agilent Application Note, 2014, SPECTR AN BAS; Agilent Application Note, 2014, AG X SER SIGN AN; [Anonymous], 2005, HDB MEAS DIG TERR BR; Bertocco M, 2006, IEEE T INSTRUM MEAS, V55, P1494, DOI 10.1109/TIM.2006.880322; [Anonymous], 2003, STDB31 ARIB; [Anonymous], 2001, 101209 ETSI TR; Ghannouchi FM, 2009, IEEE MICROW MAG, V10, P52, DOI 10.1109/MMM.2009.934516; Gorin J., 2003, RF DESIGN        FEB, P32; Olivier C, 2006, IEEE T INSTRUM MEAS, V55, P603, DOI 10.1109/TIM.2006.870330; Tellado J., 1999, THESIS U STANFORD ST; Uehara M, 1999, IEEE T CONSUM ELECTR, V45, P101, DOI 10.1109/30.754424; Wolf J., 1998, 1EF40 DEP EL ENG RHO; Wu YY, 2000, IEEE T BROADCAST, V46, P101	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9316	1557-9611		IEEE T BROADCAST	IEEE Trans. Broadcast.	SEP	2015	61	3					532	540		10.1109/TBC.2015.2421820		9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CQ8XA	WOS:000360892400019		
J	Ishigure, Y; Nitta, T				Ishigure, Yuki; Nitta, Takahiro			Simulating an Actomyosin in Vitro Motility Assay: Toward the Rational Design of Actomyosin-Based Microtransporters	IEEE TRANSACTIONS ON NANOBIOSCIENCE			English	Article						Actin filament; biomedical engineering; bionanotechnology; biophysics; biosensors; microelectromechanical systems; myosin; nanobioscience; nanobiotechnology	POWERED MOLECULAR SHUTTLES; MYOSIN STEP-SIZE; ACTIN-FILAMENTS; MOTOR PROTEINS; BIOLOGICAL MOTORS; MICROTUBULE MOVEMENTS; BIOMOLECULAR MOTORS; PERSISTENCE LENGTH; HEAVY-MEROMYOSIN; KINESIN MOTORS	We present a simulation study of an actomyosin in vitro motility assay. In vitro motility assays have served as an essential element facilitating the application of actomyosin in nanotechnology; such applications include biosensors and biocomputation. Although actomyosin in vitro motility assays have been extensively investigated, some ambiguities remain, as a result of the limited spatio-temporal resolution and unavoidable uncertainties associated with the experimental process. These ambiguities hamper the rational design of nanodevices for practical applications. Here, with the aim of moving toward a rational design process, we developed a 3D computer simulation method of an actomyosin in vitro motility assay, based on a Brownian dynamics simulation. The simulation explicitly included the ATP hydrolysis cycle of myosin. The simulation was validated by the reproduction of previous experimental results. More importantly, the simulation provided new insights that are difficult to obtain experimentally, including data on the number of myosin motors actually binding to actin filaments, the mechanism responsible for the guiding of actin filaments by chemical edges, and the effect of the processivity of motor proteins on the guiding probabilities. The simulations presented here will be useful in interpreting experimental results, and also in designing future nanodevices integrated with myosin motors.	[Ishigure, Yuki; Nitta, Takahiro] Gifu Univ, Dept Math & Design Engn, Gifu 5011193, Japan; [Nitta, Takahiro] Gifu Univ, Appl Phys Course, Gifu 5011193, Japan	Nitta, T (reprint author), Gifu Univ, Dept Math & Design Engn, Gifu 5011193, Japan.	s3129001@edu.gifu-u.ac.jp; nittat@gifu-u.ac.jp			JSPS [24760203]	This work was supported by JSPS Grant-in-Aid for Young Scientists (B) under Grant 24760203.	Korten T, 2010, CURR OPIN BIOTECH, V21, P477, DOI [10.1016/j.copbio.2010.05.001, 10.1016/j.coPbio.2010.115.881]; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Bachand GD, 2009, LAB CHIP, V9, P1661, DOI 10.1039/b821055a; Bakewell DJG, 2007, AUST J CHEM, V60, P314, DOI 10.1071/CH06456; Dong CB, 2013, CURR OPIN BIOTECH, V24, P612, DOI 10.1016/j.copbio.2013.01.007; Vikhorev PG, 2008, BIOPHYS J, V95, P5809, DOI 10.1529/biophysj.108.140335; Walcott S, 2012, BIOPHYS J, V103, P501, DOI 10.1016/j.bpj.2012.06.031; Farsad N, 2012, IEEE T NANOBIOSCI, V11, P304, DOI 10.1109/TNB.2012.2186460; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Dumont ELP, 2013, LANGMUIR, V29, P15142, DOI 10.1021/la4030712; Paxton WF, 2006, ANGEW CHEM INT EDIT, V45, P5420, DOI 10.1002/anie.200600060; Hiratsuka Y, 2001, BIOPHYS J, V81, P1555; NISHIZAKA T, 1995, NATURE, V377, P251, DOI 10.1038/377251a0; Wang J, 2012, ACS NANO, V6, P5745, DOI 10.1021/nn3028997; Fischer T, 2009, NAT NANOTECHNOL, V4, P162, DOI [10.1038/nnano.2008.393, 10.1038/NNANO.2008.393]; Goel A, 2008, NAT NANOTECHNOL, V3, P465, DOI 10.1038/nnano.2008.190; van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570; Nitta T, 2008, NANO LETT, V8, P2305, DOI 10.1021/nl8010885; BOURDIEU L, 1995, PHYS REV LETT, V75, P176, DOI 10.1103/PhysRevLett.75.176; ten Siethoff L, 2014, NANO LETT, V14, P737, DOI 10.1021/nl404032k; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; TOYOSHIMA YY, 1990, P NATL ACAD SCI USA, V87, P7130, DOI 10.1073/pnas.87.18.7130; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0; Wang W, 2013, NANO TODAY, V8, P531, DOI 10.1016/j.nantod.2013.08.009; Hess H, 2011, ANNU REV BIOMED ENG, V13, P429, DOI 10.1146/annurev-bioeng-071910-124644; Hess H, 2002, NANO LETT, V2, P113, DOI 10.1021/nl015647b; Agarwal A, 2010, PROG POLYM SCI, V35, P252, DOI 10.1016/j.progpolymsci.2009.10.007; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Bachand GD, 2014, WIRES NANOMED NANOBI, V6, P163, DOI 10.1002/wnan.1252; Chen Q, 2009, J NANOSCI NANOTECHNO, V9, P5123, DOI 10.1166/jnn.2009.1204; Clemmens J, 2003, LANGMUIR, V19, P10967, DOI 10.1021/la035519y; Debold EP, 2011, AM J PHYSIOL-REG I, V300, pR1401, DOI 10.1152/ajpregu.00772.2010; DUKE T, 1995, PHYS REV LETT, V74, P330, DOI 10.1103/PhysRevLett.74.330; Egan P. F., 2013, J MECH DESIGN, V135; Farkas Z, 2002, NATO SCI S PRT 3 HI, V87, P327; Farsad N, 2014, IEEE T SIGNAL PROCES, V62, P2424, DOI 10.1109/TSP.2014.2311970; Fujimoto K, 2013, ACS NANO, V7, P447, DOI 10.1021/nn3045038; Fulga F, 2009, INTEGR BIOL-UK, V1, P150, DOI 10.1039/b814985b; Hajne J, 2015, IEEE T NANOBIOSCI, V14, P313, DOI 10.1109/TNB.2015.2393052; Ishigure Y, 2014, LANGMUIR, V30, P12089, DOI 10.1021/la5021884; Kabir AMR, 2011, MACROMOL BIOSCI, V11, P1314, DOI 10.1002/mabi.201100060; Kerssemakers J, 2009, SMALL, V5, P1732, DOI 10.1002/smll.200801388; Lard M, 2015, IEEE T NANOBIOSCI, V14, P289, DOI 10.1109/TNB.2015.2412036; Lard M, 2013, BIOSENS BIOELECTRON, V48, P145, DOI 10.1016/j.bios.2013.03.071; Lard M, 2014, NANO LETT, V14, P3041, DOI 10.1021/nl404714b; Lin CT, 2008, NANO LETT, V8, P1041, DOI 10.1021/nl072742x; Mansson A, 2012, J MUSCLE RES CELL M, V33, P219, DOI 10.1007/s10974-012-9298-5; Moorjani SG, 2003, NANO LETT, V3, P633, DOI 10.1021/nl034001b; Nicolau DV, 2006, MICROELECTRON ENG, V83, P1582, DOI 10.1016/j.mee.2006.01.198; Nicolau DV, 1999, BIOPHYS J, V77, P1126; Nitta T, 2013, CELL MOL BIOENG, V6, P109, DOI 10.1007/s12195-012-0262-7; Nitta T, 2005, NANO LETT, V5, P1337, DOI 10.1021/nl050586t; PATE E, 1991, J MUSCLE RES CELL M, V12, P376, DOI 10.1007/BF01738593; Persson M, 2013, BIOPHYS J, V105, P1871, DOI 10.1016/j.bpj.2013.08.044; Persson M, 2010, LANGMUIR, V26, P9927, DOI 10.1021/la100395a; Rupp B, 2012, LAB CHIP, V12, P4903, DOI 10.1039/c2lc40250e; Sanchez S., 2014, ANGEW CHEM INT ED; Schindler TD, 2014, NAT NANOTECHNOL, V9, P33, DOI [10.1038/nnano.2013.229, 10.1038/NNANO.2013.229]; Schmidt JJ, 2004, ANNU REV MATER RES, V34, P315, DOI 10.1146/annurev.34.040203.115827; Spetzler D, 2007, LAB CHIP, V7, P1633, DOI 10.1039/b711066a; Sunagawa T, 2013, LAB CHIP, V13, P2827, DOI 10.1039/c3lc41103f; Sundberg M, 2006, LANGMUIR, V22, P7286, DOI 10.1021/la060854i; Suzuki H, 1997, BIOPHYS J, V72, P1997; Takatsuki H, 2014, BBA-GEN SUBJECTS, V1840, P1933, DOI 10.1016/j.bbagen.2014.01.012	64	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1241	1558-2639		IEEE T NANOBIOSCI	IEEE Trans. Nanobiosci.	SEP	2015	14	6					641	648		10.1109/TNB.2015.2443373		8	Biochemical Research Methods; Nanoscience & Nanotechnology	Biochemistry & Molecular Biology; Science & Technology - Other Topics	CQ7TH	WOS:000360806800009		
J	Mashkovich, EA; Shugurov, AI; Ozawa, S; Estacio, E; Tani, M; Bakunov, MI				Mashkovich, Eugene A.; Shugurov, Alexander I.; Ozawa, Shipei; Estacio, Elmer; Tani, Masahiko; Bakunov, Michael I.			Noncollinear Electro-Optic Sampling of Terahertz Waves in a Thick GaAs Crystal	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Terahertz detection; electro-optic sampling; non-collinear; GaAs	MU-M; LASER-PULSES; GENERATION; WAVELENGTHS; RADIATION	In this paper, we propose and experimentally demonstrate noncollinear EO sampling of terahertz pulses with a femtosecond fiber laser in cm-thick GaAs crystals. This technique provides more than an order of magnitude improvement in spectral resolution and a significant increase in efficiency as compared to previously used collinear EO sampling in mm- and sub-mm-thick GaAs crystals. The optimal incidence angle of the probe beam on the crystal is found to be 42 degrees-50 degrees and the optimal crystal thickness is similar to 1-3 cm.	[Mashkovich, Eugene A.; Shugurov, Alexander I.; Bakunov, Michael I.] Univ Nizhny Novgorod, Gen Phys Dept, Nizhnii Novgorod 603950, Russia; [Ozawa, Shipei; Tani, Masahiko] Univ Fukui, Res Ctr Dev Far Infrared Reg, Fukui 9108507, Japan; [Estacio, Elmer] Univ Philippines, Natl Inst Phys, Quezon City 1101, Philippines	Mashkovich, EA (reprint author), Univ Nizhny Novgorod, Gen Phys Dept, Nizhnii Novgorod 603950, Russia.	bakunov@rf.unn.ru			RFBR Grant [15-02-08328]; Ministry of Education and Science of the Russian Federation [02.B.49.21.0003]; Japan Society for the Promotion of Science (JSPS) [25286066]	This work was supported in part by a RFBR Grant 15-02-08328, and by the Ministry of Education and Science of the Russian Federation through Agreement 02.B.49.21.0003. The work of M. Tani was supported by the Japan Society for the Promotion of Science (JSPS) through the Grant-in-Aid for Scientific Research (B) under Grant 25286066.	Sartorius B, 2008, OPT EXPRESS, V16, P9565, DOI 10.1364/OE.16.009565; Nagai M, 2004, APPL PHYS LETT, V85, P3974, DOI 10.1063/1.1813645; Hebling J, 2008, J OPT SOC AM B, V25, pB6, DOI 10.1364/JOSAB.25.0000B6; Skauli T, 2003, J APPL PHYS, V94, P6447, DOI 10.1063/1.1621740; Han PY, 2000, OPT LETT, V25, P675, DOI 10.1364/OL.25.000675; Wu Q, 1996, APPL PHYS LETT, V68, P1604, DOI 10.1063/1.115665; Chen Q, 2001, J OPT SOC AM B, V18, P823, DOI 10.1364/JOSAB.18.000823; Grischkowsky D, 1990, J OPT SOC AM B, V7, P10; Schneider A, 2006, OPT EXPRESS, V14, P5376, DOI 10.1364/OE.14.005376; STOLEN RH, 1969, APPL PHYS LETT, V15, P74, DOI 10.1063/1.1652908; Tani M, 2011, OPT EXPRESS, V19, P19901, DOI 10.1364/OE.19.019901; Tomasino A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03116; Zhao ZY, 2010, OPT EXPRESS, V18, P15956, DOI 10.1364/OE.18.015956	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	SEP	2015	5	5					732	736		10.1109/TTHZ.2015.2461439		5	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CQ8XT	WOS:000360894600006		
J	Ebrahimi, A; Nirantar, S; Withayachumnankul, W; Bhaskaran, M; Sriram, S; Al-Sarawi, SF; Abbott, D				Ebrahimi, Amir; Nirantar, Shruti; Withayachumnankul, Withawat; Bhaskaran, Madhu; Sriram, Sharath; Al-Sarawi, Said F.; Abbott, Derek			Second-Order Terahertz Bandpass Frequency Selective Surface With Miniaturized Elements	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Bandpass filter; frequency selective surface (FSS); periodic structures; spatial filters; terahertz (THz); THz filter	COMPLEMENTARY METAMATERIAL STRUCTURES; CLOSED-FORM ANALYSIS; SUBMILLIMETER-WAVE; LOW-PROFILE; MILLIMETER-WAVE; SINGLE-LAYER; FILTERS; RESPONSES; REFLECTARRAY; RESONANCE	In this paper, a second-order frequency selective surface (FSS) made of miniaturized elements is proposed and designed for terahertz applications. The FSS is composed of two layers of metallic arrays separated from each other by a polymer dielectric spacer. The unit cells on the front and back layers are smaller than lambda(0/5), where lambda(0) is the free space wavelength. The operation principle of the proposed FSS is described through a circuit model, and a synthesis procedure is presented for designing a desired filtering response. A prototype of the FSS is synthesized to operate at a center frequency of 0.42 THz with 45% fractional bandwidth. The designed FSS is fabricated by using microfabrication process. The performance is evaluated by using terahertz time-domain spectroscopy. Measurement results show a low sensitivity of the FSS response to oblique angles of incidence for both of the TE and TM polarizations.	[Ebrahimi, Amir; Withayachumnankul, Withawat; Al-Sarawi, Said F.; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA 5005, Australia; [Withayachumnankul, Withawat] Univ Adelaide, Sch Elect & Elect Engn, Funct Mat & Microsyst Res Grp, Adelaide, SA 5005, Australia; [Withayachumnankul, Withawat] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528552, Japan; [Nirantar, Shruti; Bhaskaran, Madhu; Sriram, Sharath] RMIT Univ, Funct Mat & Microsyst Res Grp, Sch Elect & Comp Engn, Melbourne, Vic 3001, Australia	Ebrahimi, A (reprint author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA 5005, Australia.	amir.ebrahimi@adelaide.edu.au; amir.ebrahimi@adelaide.edu.au; sharath.sriram@gmail.com	Bhaskaran, Madhu/C-6201-2011; Sriram, Sharath/C-6200-2011	Bhaskaran, Madhu/0000-0003-4319-1081; Sriram, Sharath/0000-0002-8365-7504			Abadi SMAMH, 2014, IEEE T ANTENN PROPAG, V62, P2562, DOI 10.1109/TAP.2014.2303822; Lu MZ, 2011, OPT LETT, V36, P1071, DOI 10.1364/OL.36.001071; Siegel PH, 2004, IEEE T MICROW THEORY, V52, P2438, DOI [10.1109/TMTT.2004.835916, 10.1109/TMTT.2004.83516]; Moallem M, 2012, IEEE T THZ SCI TECHN, V2, P333, DOI 10.1109/TTHZ.2012.2189910; Appleby R, 2007, P IEEE, V95, P1683, DOI 10.1109/JPROC.2007.898832; Zhu YH, 2012, OPT LETT, V37, P296, DOI 10.1364/OL.37.000296; Behdad N, 2010, IEEE T ANTENN PROPAG, V58, P2460, DOI 10.1109/TAP.2010.2048882; Dickie R, 2009, IEEE T ANTENN PROPAG, V57, P1985, DOI 10.1109/TAP.2009.2021933; Salehi M, 2008, IEEE MICROW WIREL CO, V18, P785, DOI 10.1109/LMWC.2008.2007698; Martin RJ, 1996, ELECTRON COMMUN ENG, V8, P37, DOI 10.1049/ecej:19960106; Lan F, 2014, OPT LETT, V39, P1709, DOI 10.1364/OL.39.001709; Euler M, 2010, IEEE T ANTENN PROPAG, V58, P2457, DOI 10.1109/TAP.2010.2048874; Sarabandi K, 2007, IEEE T ANTENN PROPAG, V55, P1239, DOI 10.1109/TAP.2007.895567; Niu TM, 2014, OPT EXPRESS, V22, P16148, DOI 10.1364/OE.22.016148; Niu TM, 2013, OPT EXPRESS, V21, P2875, DOI 10.1364/OE.21.002875; Behdad N, 2008, MICROW OPT TECHN LET, V50, P1639, DOI 10.1002/mop.23445; Li M, 2013, IEEE T ANTENN PROPAG, V61, P677, DOI 10.1109/TAP.2012.2225133; Al-Joumayly MA, 2010, IEEE T ANTENN PROPAG, V58, P4033, DOI 10.1109/TAP.2010.2078474; Paul O, 2009, OPT EXPRESS, V17, P18590, DOI 10.1364/OE.17.018590; Bayatpur F., 2009, THESIS U MICHIGAN AN; Bayatpur F, 2009, IEEE T ANTENN PROPAG, V57, P590, DOI 10.1109/TAP.2008.2011404; Bayatpur F, 2008, IEEE T MICROW THEORY, V56, P2742, DOI 10.1109/TMTT.2008.2007332; Al-Journayly M, 2009, IEEE T ANTENN PROPAG, V57, P452, DOI 10.1109/TAP.2008.2011382; Bromel A., 2012, 37 INT C INFR MILL T; Cavallo D, 2014, IEEE T ANTENN PROPAG, V62, P6256, DOI 10.1109/TAP.2014.2365233; Cavallo D, 2014, IEEE T ANTENN PROPAG, V62, P6265, DOI 10.1109/TAP.2014.2365236; Cheng Y. Z., 2014, ADV OPTICAL MAT; Cheng Y. Z., 2014, APPL PHYS LETT, V105; Chiang Y.-J., 2011, APPL PHYS LETT, V99; Chiu CN, 2009, IEEE ANTENN WIREL PR, V8, P1175, DOI 10.1109/LAWP.2009.2034766; Ebrahimi A, 2013, ASIA PACIF MICROWAVE, P1118, DOI 10.1109/APMC.2013.6695040; Ebrahimi A., 2014, IEEE INT WORTKSHANT, P206; Ebrahimi A., 2014, 2014 39 INT C INFR M, P1; Heyes J. E., 2014, APPL PHYS LETT, V105; Horestani AK, 2013, IEEE T THZ SCI TECHN, V3, P851, DOI 10.1109/TTHZ.2013.2285556; Jam A, 2014, IEEE T THZ SCI TECHN, V4, P515, DOI 10.1109/TTHZ.2014.2329311; Kashanianfard M, 2013, IEEE T ANTENN PROPAG, V61, P4624, DOI 10.1109/TAP.2013.2271231; Li B, 2013, IEEE T ANTENN PROPAG, V61, P3053, DOI 10.1109/TAP.2013.2250237; Pozar D. M., 2009, MICROWAVE ENG; Sanz Fernandez J. J., 2012, FREQUENCY SELECTIVE; Vegesna S, 2012, IEEE T THZ SCI TECHN, V2, P441, DOI 10.1109/TTHZ.2012.2202035; Withayachumnankul W, 2012, OPT EXPRESS, V20, P3345, DOI 10.1364/OE.20.003345; Zverev A. I., 1967, HDB FILTER SYNTHESIS, V47	43	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	SEP	2015	5	5					761	769		10.1109/TTHZ.2015.2452813		9	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CQ8XT	WOS:000360894600010		
J	Glyavin, MY; Idehara, T; Sabchevski, SP				Glyavin, Mikhail Yu.; Idehara, Toshitaka; Sabchevski, Svilen P.			Development of THz Gyrotrons at IAP RAS and FIR UF and Their Applications in Physical Research and High-Power THz Technologies	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Coherent RF sources by intense electron beams; DNP-NMR spectroscopy; EPR spectroscopy; gyrotrons; quasi-optics; RF plasma diagnostics	PID FEEDBACK-CONTROL; TERAHERTZ; FU; STABILIZATION; TRANSMISSION; NMR	In this paper, we present some of the most significant recent results that characterize the state of the art in the development of sub-THz and THz gyrotrons at IAP-RAS and FIR-UF after 15 years of collaboration as well as their applications in various novel and prospective research fields and advanced technologies.	[Glyavin, Mikhail Yu.] Russian Acad Sci IAP RAS, Inst Appl Phys, Nizhnii Novgorod 603950, Russia; [Idehara, Toshitaka] Univ Fukui FIR UF, Res Ctr Dev Far Infrared Reg, Fukui 9108507, Japan; [Sabchevski, Svilen P.] Bulgarian Acad Sci IE BAS, Inst Elect, Sofia 1784, Bulgaria	Glyavin, MY (reprint author), Russian Acad Sci IAP RAS, Inst Appl Phys, Nizhnii Novgorod 603950, Russia.	glyavin@appl.sci-nnov.ru; idehara@fir.u-fukui.ac.jp; sabch@ie.bas.bg			Special Fund for Education and Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan	This work was supported in part by the Special Fund for Education and Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan and was carried out in the framework of the collaboration of an international consortium on the project "Promoting international collaboration for development and application of high-power THz gyrotrons" of the FIR UF Research Center (Fukui, Japan).	Bratman V, 2009, IEEE T PLASMA SCI, V37, P36, DOI 10.1109/TPS.2008.2004787; Rogalev A, 2012, J INFRARED MILLIM TE, V33, P777, DOI 10.1007/s10762-011-9855-9; Thumm M, 2014, IEEE T PLASMA SCI, V42, P590, DOI 10.1109/TPS.2013.2284026; Pike KJ, 2012, J MAGN RESON, V215, P1, DOI 10.1016/j.jmr.2011.12.006; Lewis RA, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/37/374001; Saito T, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4729316; Booske JH, 2011, IEEE T THZ SCI TECHN, V1, P54, DOI 10.1109/TTHZ.2011.2151610; Henderson M, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4908598; Nusinovich GS, 2014, J INFRARED MILLIM TE, V35, P325, DOI 10.1007/s10762-014-0050-7; Bogdashov AA, 2011, J INFRARED MILLIM TE, V32, P823, DOI 10.1007/s10762-011-9787-4; Matsuki Y, 2012, J MAGN RESON, V225, P1, DOI 10.1016/j.jmr.2012.09.008; Idehara T, 2012, J INFRARED MILLIM TE, V33, P667, DOI 10.1007/s10762-011-9862-x; Idehara T, 2008, THIN SOLID FILMS, V517, P1503, DOI 10.1016/j.tsf.2008.09.061; Torrezan AC, 2010, IEEE T PLASMA SCI, V38, P1150, DOI 10.1109/TPS.2010.2046617; Denysenkov V, 2010, PHYS CHEM CHEM PHYS, V12, P5786, DOI 10.1039/c003697h; Matsuki Y, 2012, J INFRARED MILLIM TE, V33, P745, DOI 10.1007/s10762-012-9890-1; Idehara T, 2006, INT J INFRARED MILLI, V27, P319, DOI 10.1007/s10762-006-9084-9; Granatstein VL, 2010, J APPL PHYS, V108, DOI 10.1063/1.3484044; Chang TH, 2009, J APPL PHYS, V105, DOI 10.1063/1.3097334; Asai S., 2012, J INFRARED MILLIM TH, V3, P766; Bratman V. L., J INFRARED MILLIM TH, V34, P837; Bratman VL, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3622202; Bratman VL, 2012, J INFRARED MILLIM TE, V33, P715, DOI 10.1007/s10762-012-9898-6; Bykov Y. V., 2014, THZ SCI TECHNOL, V7, P70; Cengher M., 2014, P 39 INT C INFR MILL, P2; Gantenbein G, 2014, IEEE T ELECTRON DEV, V61, P1806, DOI 10.1109/TED.2013.2294739; Glyavin M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4850435; Glyavin MY, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4900751; Glyavin MY, 2014, RADIOPHYS QUANT EL+, V56, P561, DOI 10.1007/s11141-014-9459-z; Glyavin MY, 2014, RADIOPHYS QUANT EL+, V56, P497, DOI 10.1007/s11141-014-9454-4; Glyavin MY, 2014, J COMMUN TECHNOL EL+, V59, P792, DOI 10.1134/S1064226914080075; Glyavin MY, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4757290; Hogge J.-P., 2013, P 38 INT C IRMMW THZ, P1; Horii F, 2012, J INFRARED MILLIM TE, V33, P756, DOI 10.1007/s10762-012-9874-1; Idehara T, 2001, VACUUM, V62, P123, DOI 10.1016/S0042-207X(00)00456-5; Idehara T., 2015, J INFRARED MILLIM TH, P15; Idehara T, 2012, J INFRARED MILLIM TE, V33, P665, DOI 10.1007/s10762-012-9912-z; Idehara T, 2014, J INFRARED MILLIM TE, V35, P159, DOI 10.1007/s10762-013-0034-z; Idehara T., 2009, J PLASMA FUSION RES, V8, P1508; Ikeda R., 2012, P 37 INT C INFR MILL; Khutoryan EM, 2014, J INFRARED MILLIM TE, V35, P1018, DOI 10.1007/s10762-014-0105-9; Kishko SA, 2014, J COMMUN TECHNOL EL+, V59, P777, DOI 10.1134/S1064226914070079; Litvak A, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/12/124002; Minami R, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063003; Miyazaki A, 2015, PROG THEOR EXP PHYS, DOI 10.1093/ptep/ptu181; Mudiganti J., 2011, P 36 INT C INFR MILL, P1; Nusinovich GS, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4862779; Sabchevski SP, 2010, J INFRARED MILLIM TE, V31, P934, DOI 10.1007/s10762-010-9668-2; Tatematsu Y, 2014, J INFRARED MILLIM TE, V35, P169, DOI 10.1007/s10762-014-0048-1; Tatematsu Y., 2014, P 5 INT WORKSH FAR I; Temkin R.J., 2014, TERAHERTZ SCI TECHNO, V7, P1; Thumm M., 2014, KIT SCI REPORTS, V7662, P1; Urushizaki Y., 2010, P 35 INT C INFR MILL; Yamaguchi Y, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/1/013002; Yamazaki T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.253401	55	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	SEP	2015	5	5					788	797		10.1109/TTHZ.2015.2442836		10	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CQ8XT	WOS:000360894600014		
J	Masuda, H; Hirota, S; Ushiyama, A; Hirata, A; Arima, T; Kawai, H; Wake, K; Watanabe, S; Taki, M; Nagai, A; Ohkubo, C				Masuda, Hiroshi; Hirota, Shogo; Ushiyama, Akira; Hirata, Akimasa; Arima, Takuji; Kawai, Hiroki; Wake, Kanako; Watanabe, Soichi; Taki, Masao; Nagai, Akiko; Ohkubo, Chiyoji			No Dynamic Changes in Inflammation-related Microcirculatory Parameters in Developing Rats During Local Cortex Exposure to Microwaves	IN VIVO			English	Article						Radiofrequency electromagnetic field; local exposure; hemodynamics; plasma velocity; vessel diameter; leukocyte; adhesion; young adult rats; developing stage	BLOOD-BRAIN-BARRIER; MHZ ELECTROMAGNETIC-FIELD; MOUSE-BRAIN; CEREBRAL MICROCIRCULATION; NITRIC-OXIDE; DEVELOPMENTAL NEUROTOXICITY; LEUKOCYTE RECRUITMENT; VASCULAR-PERMEABILITY; CONTINUOUS-WAVE; RADIATION	The biological effects of exposing the developing brain to radiofrequency electromagnetic fields (RF) are still unclear. Our experiments investigated whether three inflammation-related, microcirculatory parameters in juvenile and young adult rats were modified during local cortex exposure to RF under non-thermal conditions. The cortex tissue was locally exposed to 1457 MHz RF at an averaged specific absorption rate of 2.0 W/kg in the target area for 50 min and variations of pial venule parameter were measured directly in vivo. There was no significant difference in hemodynamics, plasma velocity or vessel diameter, between exposed and sham-exposed groups for either rat development stage. No increase related to RF exposure was found in leukocyte adhesion to endothelial cells in any microvessels observed. These findings suggest that RF is unlikely to initiate inflammatory responses, at least under these exposure conditions.	[Masuda, Hiroshi; Nagai, Akiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan; [Masuda, Hiroshi; Hirota, Shogo; Ushiyama, Akira] Natl Inst Publ Hlth, Dept Environm Hlth, Saitama, Japan; [Hirata, Akimasa] Nagoya Inst Technol, Dept Comp Sci & Engn, Nagoya, Aichi, Japan; [Arima, Takuji] Tokyo Univ Agr & Technol, Dept Elect & Elect Engn, Tokyo, Japan; [Kawai, Hiroki; Wake, Kanako; Watanabe, Soichi] Natl Inst Informat & Commun Technol, Appl Electromagnet Res Inst, Electromagnet Compatibil Lab, Tokyo, Japan; [Taki, Masao] Tokyo Metropolitan Univ, Dept Elect & Elect Engn, Tokyo 158, Japan; [Ohkubo, Chiyoji] Japan EMF Informat Ctr, Tokyo, Japan	Masuda, H (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan.	bdxmsd@yahoo.co.jp	Hirata, Akimasa/I-8245-2012	Hirata, Akimasa/0000-0001-8336-1140	Ministry of Internal Affairs and Communications, Japan	This study was financially supported by the Ministry of Internal Affairs and Communications, Japan. The Authors would like to thank Mrs.' Miyuki Takahashi, Kasumi Yamanaka, and Minako Segawa for their helpful assistance.	Altura BM, 2002, NEUROSCI LETT, V334, P21, DOI 10.1016/S0304-3940(02)01061-3; Altura BM, 2002, EUR J PHARMACOL, V448, P89, DOI 10.1016/S0014-2999(02)01899-X; Mayhan WG, 1996, BRAIN RES, V743, P70, DOI 10.1016/S0006-8993(96)01021-9; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; Gavins FNE, 2012, FASEB J, V26, P4977, DOI 10.1096/fj.12-205971; Ritter LS, 2000, STROKE, V31, P1153; Masuda H, 2007, IN VIVO, V21, P471; SWARTZWELDER HS, 1995, ALCOHOL CLIN EXP RES, V19, P320, DOI 10.1111/j.1530-0277.1995.tb01509.x; Mayhan WG, 1999, AM J PHYSIOL-CELL PH, V276, pC1148; Kumlin T, 2007, RADIAT RES, V168, P471, DOI 10.1667/RR1002.1; Yuan H, 2003, BRAIN RES, V969, P59, DOI 10.1016/S0006-8993(03)02278-9; Rumbaut RE, 1999, MICROCIRCULATION, V6, P205, DOI 10.1038/sj.mn.7300068; Fukuda A, 2005, J NEUROCHEM, V92, P569, DOI 10.1111/j.1471-4159.2004.02894.x; Tsurita G, 2000, BIOELECTROMAGNETICS, V21, P364, DOI 10.1002/1521-186X(200007)21:5<364::AID-BEM5>3.0.CO;2-Q; Vergnolle N, 2002, J IMMUNOL, V169, P1467; SALFORD LG, 1994, MICROSC RES TECHNIQ, V27, P535, DOI 10.1002/jemt.1070270608; Arima T, 2011, IEEE T BIO-MED ENG, V58, P2740, DOI 10.1109/TBME.2010.2103942; de Gannes FP, 2009, RADIAT RES, V172, P359, DOI 10.1667/RR1578.1; Finnie JW, 2002, PATHOLOGY, V34, P344, DOI 10.1080/00313020220147186; Finnie JW, 2001, PATHOLOGY, V33, P338; Finnie JW, 2006, PATHOLOGY, V38, P262; Hass U, 2006, REPROD TOXICOL, V22, P148, DOI 10.1016/j.reprotox.2006.04.009; Hass U, 2003, TOXICOL LETT, V140, P155, DOI 10.1016/S0378-4274(02)00499-X; Hirota S, 2004, MICROCIRCULATION ANN, P95; International Commission on Non- Ionizing Radiation Pro- tection (ICNIRP), 1998, HEALTH PHYS, V74, P494; Klose M, 2014, RADIAT RES, V182, P435, DOI 10.1667/RR13695.1; Kubes P, 2001, NEWS PHYSIOL SCI, V16, P76; Kuribayashi M, 2005, BIOELECTROMAGNETICS, V26, P578, DOI 10.1002/bem.20138; Masuda H, 2009, RADIAT RES, V172, P66, DOI 10.1667/RR1542.1; Masuda H, 2015, IN VIVO, V29, P207; Masuda H, 2007, IN VIVO, V21, P563; Masuda H, 2007, IN VIVO, V21, P555; Masuda H, 2015, IN VIVO, V29, P351; Mayhan WG, 1998, BRAIN RES, V792, P353, DOI 10.1016/S0006-8993(98)00259-5; McQuade JMS, 2009, RADIAT RES, V171, P615, DOI 10.1667/RR1507.1; Paulraj R, 2006, ELECTROMAGN BIOL MED, V25, P61, DOI 10.1080/15368370600581939; Pyapali GK, 1999, ALCOHOL, V19, P107, DOI 10.1016/S0741-8329(99)00021-X; Ruiz-Valdepenas L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-5; Sirav B, 2009, ELECTROMAGN BIOL MED, V28, P215, DOI 10.1080/15368370802608738; Waldner MJ, 2012, BRAIN RES, V1448, P163, DOI 10.1016/j.brainres.2012.02.010; Watilliaux A, 2011, NEUROTOX RES, V20, P109, DOI 10.1007/s12640-010-9225-8; WHO World Health Organization, 2010, WHO RES AG RAD FIELD	42	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0258-851X	1791-7549		IN VIVO	In Vivo	SEP-OCT	2015	29	5					561	567				7	Medicine, Research & Experimental	Research & Experimental Medicine	CR0YO	WOS:000361049900010		
J	Nakai, N; Katoh, N				Nakai, Noriaki; Katoh, Norito			Melanoma arising from the epidermis overlying an acquired intradermal nevus on the forehead	INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY			English	Letter									[Nakai, Noriaki; Katoh, Norito] Kyoto Prefectural Univ Med, Dept Dermatol, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan	Nakai, N (reprint author), Kyoto Prefectural Univ Med, Dept Dermatol, Grad Sch Med Sci, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	nnakai@koto.kpu-m.ac.jp					Watt AJ, 2004, PLAST RECONSTR SURG, V113, P1968, DOI 10.1097/01.prs.0000122209.10277.2a; Bevona C, 2003, ARCH DERMATOL, V139, P1620, DOI 10.1001/archderm.139.12.1620; BENISCH B, 1980, ARCH DERMATOL, V116, P696, DOI 10.1001/archderm.116.6.696; Betti R, 2014, J EUR ACAD DERMATOL, V28, P1738, DOI 10.1111/jdv.12395; OKUN MR, 1974, ARCH DERMATOL, V110, P599, DOI 10.1001/archderm.110.4.599	5	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0378-6323	0973-3922		INDIAN J DERMATOL VE	Indian J. Dermatol. Venereol. Leprol.	SEP-OCT	2015	81	5					533	U210		10.4103/0378-6323.158653		3	Dermatology	Dermatology	CQ5HB	WOS:000360632900028		
J	Kanda, K; Obayashi, Y; Jayasinghe, A; Gunawardena, GSPD; Delpitiya, NY; Priyadarshani, NGW; Gamage, CD; Arai, A; Tamashiro, H				Kanda, Koji; Obayashi, Yoshi; Jayasinghe, Ananda; Gunawardena, G. S. P. de S.; Delpitiya, N. Y.; Priyadarshani, N. G. W.; Gamage, Chandika D.; Arai, Asuna; Tamashiro, Hiko			Outcomes of a school-based intervention on rabies prevention among school children in rural Sri Lanka	INTERNATIONAL HEALTH			English	Article						Awareness programme; Edutainment; Intervention; Rabies; School children; Sri Lanka	CANINE RABIES; ELIMINATION	In Sri Lanka, one of the major challenges in rabies control is to manage the dog population and subsequently to protect people, especially young children, from dog bites. In 2009, an educational-entertainment campaign called 'Rabies Edutainment 4 Kids' was introduced in the school curricula in rural Sri Lanka to improve practices on rabies prevention and pet care among school children, and to evaluate its effectiveness through pre- and post-tests. The level of rabies knowledge, attitude and practice among the pupils was dependent on their responses to a survey, and scores were significantly improved both among the study and control groups after the intervention. A lecture accompanied by a rabies awareness leaflet was much more effective in improving knowledge than the leaflet alone. The type of intervention and language used was significantly associated with the score increment (p < 0.001). The threat of rabies to pupils in Sri Lanka would be reduced if they are given appropriate information on rabies prevention as a part of the school curricula. Close collaboration with local education offices is key to successful implementation of school-based rabies control programmes, which is, in turn, crucial to the eradication of rabies from Sri Lanka.	[Kanda, Koji; Obayashi, Yoshi; Delpitiya, N. Y.; Priyadarshani, N. G. W.; Arai, Asuna; Tamashiro, Hiko] Hokkaido Univ, Grad Sch Med, Dept Global Hlth & Epidemiol, Sapporo, Hokkaido 0608638, Japan; [Obayashi, Yoshi] Univ Peradeniya, Fac Med, Dept Community Med, Peradeniya, Sri Lanka; [Gunawardena, G. S. P. de S.] Univ Peradeniya, Fac Vet Med & Anim Sci, Rabies Control Unit, Peradeniya, Sri Lanka; [Gamage, Chandika D.] Univ Peradeniya, Fac Med, Dept Microbiol, Peradeniya, Sri Lanka	Tamashiro, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Global Hlth & Epidemiol, Sapporo, Hokkaido 0608638, Japan.	tamashiro@med.hokudai.ac.jp			Hokkaido University Global COE Programme on 'Establishment of International Collaboration Centers for Zoonosis Control'	This work was supported by the Hokkaido University Global COE Programme on 'Establishment of International Collaboration Centers for Zoonosis Control'.	Matibag Gino C., 2007, Environmental Health and Preventive Medicine, V12, P84, DOI [10.1007/BF02898154, 10.1265/ehpm.12.84]; Matter HC, 2000, ACTA TROP, V75, P95, DOI 10.1016/S0001-706X(99)00085-6; Franka R, 2013, ANTIVIR RES, V100, P220, DOI 10.1016/j.antiviral.2013.07.004; Department of Census and Statistics, 2013, STAT ABSTR 2013; Dodet B, 2006, VACCINE, V24, P3045, DOI 10.1016/j.vaccine.2005.10.015; Dzikwi Asabe Adamu, 2012, Glob J Health Sci, V4, P132, DOI 10.5539/gjhs.v4n5p132; Epidemiology Unit, 2009, EP B SRI LANK; Jayasinghe A., 2009, RABIES DREADFUL DIS; Kanda K., 2010, J INT HLTH, V25, P11; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lamawansa Md, 2008, Indian J Community Med, V33, P238, DOI 10.4103/0970-0218.43229; Lapiz SMD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001891; Lembo T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001388; Matibag GC, 2008, J INT HLTH, V23, P173; Perera I N G, 2007, Ceylon Med J, V52, P69; Public Health Veterinary Services, 2012, RAB STAT B 2012; Public Health Veterinary Services, 2009, RAB CONTR STAT 2009; WHO, 2014, RAB S E AS REG; Wright AE, 2011, ADV PREV MED, V2011, DOI [DOI 10.4061/2011/383870, 10.4061/2011/383870]	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1876-3413	1876-3405		INT HEALTH	Int. Health	SEP	2015	7	5			SI		348	353		10.1093/inthealth/ihu098		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CR3GT	WOS:000361220200009		
J	Misawa, T; Saitoh, T; Kozaki, T; Park, S; Takahama, M; Akira, S				Misawa, Takuma; Saitoh, Tatsuya; Kozaki, Tatsuya; Park, Sehoon; Takahama, Michihiro; Akira, Shizuo			Resveratrol inhibits the acetylated alpha-tubulin-mediated assembly of the NLRP3-inflammasome	INTERNATIONAL IMMUNOLOGY			English	Article						cytokine; inflammasome; innate immunity; microtubule	NLRP3 INFLAMMASOME; MITOCHONDRIAL-FUNCTION; NALP3 INFLAMMASOME; ACTIVATING SIRT1; MICE; ACETYLTRANSFERASE; DEACETYLASE; CRYSTALS; DISEASE; RESISTANCE	With its adaptor protein apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), Nod-like receptor family, pyrin domain containing 3 (NLRP3) forms the inflammasome and mediates inflammatory innate immune responses. Development of an anti-inflammatory drug targeting the NLRP3-inflammasome is urgently required because its aberrant activation often causes inflammatory diseases, including gout. We show that resveratrol, a natural polyphenol in grapes and wine, is a safe and effective phytochemical that inhibits NLRP3-inflammasome activation. Resveratrol inhibits the accumulation of acetylated alpha-tubulin caused by mitochondrial damage in macrophages stimulated with inducers of the NLRP3-inflammasome. Consequently, resveratrol inhibits the acetylated-alpha-tubulin-mediated spatial arrangement of mitochondria and their subsequent contact with the endoplasmic reticulum (ER), causing insufficient assembly of ASC on the mitochondria and NLRP3 on the ER. These findings indicate that resveratrol targets the generation of an optimal site for the assembly of NLRP3 and ASC, thus inhibiting NLRP3-inflammasome activation. Therefore, resveratrol could be an effective medication for the treatment of NLRP3-related inflammatory diseases.	[Misawa, Takuma; Saitoh, Tatsuya; Kozaki, Tatsuya; Park, Sehoon; Takahama, Michihiro; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Labo Host Def, Suita, Osaka 5650871, Japan; [Misawa, Takuma; Saitoh, Tatsuya; Kozaki, Tatsuya; Park, Sehoon; Takahama, Michihiro; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan	Akira, S (reprint author), Osaka Univ, WPI Immunol Frontier Res Ctr, Labo Host Def, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25.6945, 25670027, 25117717, 26713005]; Japan Science and Technology Agency Core Research for Evolutional Science and Technology; Japan Intractable Diseases Research Foundation; LOTTE Foundation; Shimabara Science Promotion Foundation; Ono Medical Research Foundation; Princess Takamatsu Cancer Research Fund; Research Foundation for Pharmaceutical Sciences; Suzuken Memorial Foundation; Naito Foundation; Yamada Research Grant; Takeda Science Foundation	This work was supported by the Japan Society for the Promotion of Science (JSPS) Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program; to S.A.), JSPS Grant-in-Aid for JSPS Fellows (25.6945, to T.M.), JSPS KAKENHI (25670027, 25117717, 26713005, to T.S.), Japan Science and Technology Agency Core Research for Evolutional Science and Technology (to T.S.), Research Grant of the Japan Intractable Diseases Research Foundation (to T.S.), Research Grant of the LOTTE Foundation (to T.S.), Research Grant of the Shimabara Science Promotion Foundation (to T.S.), Research Grant of the Ono Medical Research Foundation (to T.S.), Research Grant of the Princess Takamatsu Cancer Research Fund (to T.S.), Research Grant of the Research Foundation for Pharmaceutical Sciences (to T.S.), Research Grant of the Suzuken Memorial Foundation (to T.S.), Research Grant of the Naito Foundation (to T.S.), Yamada Research Grant (to T.S.), and Visionary Research Grant of the Takeda Science Foundation (to T.S.).	Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Cronstein BN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1908; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Nunez G, 2011, IMMUNOL REV, V243, P5, DOI 10.1111/j.1600-065X.2011.01058.x; Suzuki K, 2007, BIOCHEM BIOPH RES CO, V359, P665, DOI 10.1016/j.jbarc.2007.05.164; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; MOHRI H, 1968, NATURE, V217, P1053, DOI 10.1038/2171053a0; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Li HG, 2012, NITRIC OXIDE-BIOL CH, V26, P102, DOI 10.1016/j.niox.2011.12.006; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Chang Y. P., 2014, J CELL PHYSL, V230, P1567; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fu Y, 2013, INT J MOL SCI, V14, P14105, DOI 10.3390/ijms140714105; Huang MTH, 2009, J IMMUNOL, V182, P2395, DOI 10.4049/jimmunol.0800909; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	SEP	2015	27	9					425	434		10.1093/intimm/dxv018		10	Immunology	Immunology	CR3GX	WOS:000361220800002		
J	Yamashita, N; Jitsuki-Takahashi, A; Ogawara, M; Ohkubo, W; Araki, T; Hotta, C; Tamura, T; Hashimoto, S; Yabuki, T; Tsuji, T; Sasakura, Y; Okumura, H; Takaiwa, A; Koyama, C; Murakami, K; Goshima, Y				Yamashita, Naoya; Jitsuki-Takahashi, Aoi; Ogawara, Miyuki; Ohkubo, Wataru; Araki, Tomomi; Hotta, Chie; Tamura, Tomohiko; Hashimoto, Shu-ichi; Yabuki, Takashi; Tsuji, Toru; Sasakura, Yukie; Okumura, Hiromi; Takaiwa, Aki; Koyama, Chika; Murakami, Koji; Goshima, Yoshio			Anti-Semaphorin 3A neutralization monoclonal antibody prevents sepsis development in lipopolysaccharide-treated mice	INTERNATIONAL IMMUNOLOGY			English	Article						antibody therapy; function-blocking antibody; mice; semaphorin; sepsis	RAPID GENERATION; CELLS; RECEPTORS; EXPRESSION; NEURONS; TLR4; GENE; MUTATIONS; RESPONSES; PROMOTES	A novel anti-semaphorin antibody that ameliorates sepsis.Semaphorin 3A (Sema3A), originally identified as a potent growth cone collapsing factor in developing sensory neurons, is now recognized as a key player in immune, cardiovascular, bone metabolism and neurological systems. Here we established an anti-Sema3A monoclonal antibody that neutralizes the effects of Sema3A both in vitro and in vivo. The anti-Sema3A neutralization chick IgM antibodies were screened by combining an autonomously diversifying library selection system and an in vitro growth cone collapse assay. We further developed function-blocking chick-mouse chimeric and humanized anti-Sema3A antibodies. We found that our anti-Sema3A antibodies were effective for improving the survival rate in lipopolysaccharide-induced sepsis in mice. Our antibody is a potential therapeutic agent that may prevent the onset of or alleviate symptoms of human diseases associated with Sema3A.	[Yamashita, Naoya; Jitsuki-Takahashi, Aoi; Ogawara, Miyuki; Ohkubo, Wataru; Araki, Tomomi; Goshima, Yoshio] Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; [Hotta, Chie; Tamura, Tomohiko] Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa 2360004, Japan; [Hashimoto, Shu-ichi; Yabuki, Takashi; Tsuji, Toru; Sasakura, Yukie; Okumura, Hiromi; Takaiwa, Aki; Koyama, Chika; Murakami, Koji] Chiome Biosci Inc, Tokyo 1510071, Japan	Goshima, Y (reprint author), Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan.	goshima@med.yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [1542140002, 17082006, 0761890004]	Priority Area (17082006); Targeted Proteins Research Program (0761890004); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems (1542140002) from Ministry of Education, Culture, Sports, Science and Technology.	JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kumanogoh A, 2013, NAT REV IMMUNOL, V13, P802, DOI 10.1038/nri3545; Chen P, 2006, J NUCL MED, V47, P827; De Winter F, 2006, MOL CELL NEUROSCI, V32, P102, DOI 10.1016/j.mcn.2006.03.002; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; Taniguchi M, 2003, J NEUROSCI, V23, P1390; Tsurushita N, 2004, J IMMUNOL METHODS, V295, P9, DOI 10.1016/j.jim.2004.08.018; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Seo H, 2006, NAT PROTOC, V1, P1502, DOI 10.1038/nprot.2006.248; Gerber HP, 2005, CANCER RES, V65, P671; Montolio M, 2009, CHEM BIOL, V16, P691, DOI 10.1016/j.chembiol.2009.05.006; Semaeva E, 2010, J IMMUNOL, V184, P4547, DOI 10.4049/jimmunol.0902049; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Buss NAPS, 2012, CURR OPIN PHARMACOL, V12, P615, DOI 10.1016/j.coph.2012.08.001; Hoshino K, 1999, J IMMUNOL, V162, P3749; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Catalano A, 2006, BLOOD, V107, P3321, DOI 10.1182/blood-2005-06-2445; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Madoiwa S, 2006, INT J HEMATOL, V84, P398, DOI 10.1532/IJH97.05190; Good PF, 2004, J NEUROCHEM, V91, P716, DOI 10.1111/j.1471-4159.2004.02766.x; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Bagci T, 2009, ONCOGENE, V28, P3537, DOI 10.1038/onc.2009.204; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Goshima Y, 2012, EXPERT OPIN THER TAR, V16, P933, DOI 10.1517/14728222.2012.710201; Herman JG, 2007, INT J ONCOL, V30, P1231; Katoh S, 2014, HEART VESSELS, V29, P263, DOI 10.1007/s00380-013-0369-3; Lepelletier Y, 2006, EUR J IMMUNOL, V36, P1782, DOI 10.1002/eji.200535601; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Müller Michael W, 2007, Int J Cancer, V121, P2421, DOI 10.1002/ijc.22949; Nakamura F, 2009, J COMP NEUROL, V516, P360, DOI 10.1002/cne.22125; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Semeraro N., 2010, MEDITERR J HEMATOL I, V2; Shirvan A, 1999, J NEUROCHEM, V73, P961, DOI 10.1046/j.1471-4159.1999.0730961.x; Shirvan A, 2002, J BIOL CHEM, V277, P49799, DOI 10.1074/jbc.M204793200; Takahashi T, 1997, J NEUROSCI, V17, P9183; Yamashita N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4424	44	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	SEP	2015	27	9					459	466		10.1093/intimm/dxv014		8	Immunology	Immunology	CR3GX	WOS:000361220800005		
J	Saito, K; Fukuda, N; Shinohara, K; Masuhiro, Y; Hanazawa, S; Matsuda, H; Fujiwara, K; Ueno, T; Soma, M				Saito, Kosuke; Fukuda, Noboru; Shinohara, Ken-ichi; Masuhiro, Yoshikazu; Hanazawa, Shigemasa; Matsuda, Hiroyuki; Fujiwara, Kyoko; Ueno, Takahiro; Soma, Masayoshi			Modulation of the EMT/MET process by pyrrole-imidazole polyamide targeting human transforming growth factor-beta 1	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Epithelial-mesenchymal transition; Mesenchymal-epithelial transition; Pyrrole-imidazole polyamide; Transforming growth factor-beta 1	EPITHELIAL-MESENCHYMAL TRANSITION; PLURIPOTENT STEM-CELLS; SMALL-MOLECULE COMPOUNDS; MOUSE SOMATIC-CELLS; TGF-BETA; TRANSCRIPTIONAL INHIBITION; TGF-BETA-1 PROMOTER; CANCER PROGRESSION; GENE; EXPRESSION	Transforming growth factor-beta 1 (TGF-beta 1) is a potent induction factor for epithelial-mesenchymal transition (EMT). Mesenchymal-epithelial transition (MET), as the inverse process of EMT, has recently been reported to promote the induction of induced pluripotent stem cells (iPSCs). We have developed pyrrole-imidazole (PI) polyamide, a novel gene regulator that targets human TGF-beta 1, and investigated its effects on the EMT/MET process. PI polyamide targeted to TGF-beta 1 significantly inhibited the mRNA expression of TGF-beta 1 and SNAI1 as an EMT marker and increased mRNA and protein expression of E-cadherin in human epithelial cells. To enhance the induction of iPSCs by the MET process, PI polyamide targeted to TGF-beta 1 was applied to human fibroblasts transfected with exogenous reprogramming factors by Sendai virus vector and grown in human iPSCs. The PI polyamide significantly increased the number of alkaline phosphatase-positive colonies. The expression of undifferentiated markers was also observed in these colonies. These results suggest that PI polyamide targeted to human TGF-beta is a novel compound that can control the EMT/MET process of human epithelial cells and enhance the induction of human fibroblasts to iPSCs. (C) 2015 Elsevier Ltd. All rights reserved.	[Saito, Kosuke; Matsuda, Hiroyuki; Fujiwara, Kyoko; Soma, Masayoshi] Nihon Univ, Sch Med, Dept Gen Med, Tokyo 1738610, Japan; [Fukuda, Noboru] Nihon Univ, Sch Med, Adv Res Inst Sci & Humanities, Div Life Sci, Tokyo 1738610, Japan; [Fukuda, Noboru; Ueno, Takahiro] Nihon Univ, Sch Med, Dept Med, Div Nephrol Hypertens & Endocrinol, Tokyo 1738610, Japan; [Shinohara, Ken-ichi] Chiba Canc Ctr, Res Inst, Div Canc Genet, Chiba 2608717, Japan; [Masuhiro, Yoshikazu; Hanazawa, Shigemasa] Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Tokyo, Kanagawa 1738610, Japan	Fukuda, N (reprint author), Nihon Univ, Sch Med, Dept Gen Med, Itabashi Ku, Ooyaguchi Kami 30-1, Tokyo 1738610, Japan.	fukuda.noboru@nihon-u.ac.jp			JSPS KAKENHI [26830134]; MEXT [S1101018]; Nihon University Multidisciplinary Research Grant [sou14-024]	We thank Assistant Professor Shinsuke Yuasa (Department of Cardiology, Keio University School of Medicine, Tokyo, Japan) for his advice in this study. This work was supported in part by JSPS KAKENHI Grant Number 26830134 to K.S., MEXT -Supported program for Strategic Research Foundation at Private Universities, 2011-2015 Grant Number S1101018 to M.S., N.F., T.U., K.F., and Nihon University Multidisciplinary Research Grant for (2014) Grant Number sou14-024 to N.F., Y.M., S.H.	Imamura T, 2012, BREAST CANCER-TOKYO, V19, P118, DOI 10.1007/s12282-011-0321-2; He H, 2010, PROSTATE, V70, P1119, DOI 10.1002/pros.21146; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Bates RC, 2005, CANCER BIOL THER, V4, P365; Yao DB, 2011, MOL CANCER RES, V9, P1608, DOI 10.1158/1541-7786.MCR-10-0568; Morrison CD, 2013, CANCER LETT, V341, P30, DOI 10.1016/j.canlet.2013.02.048; Lai YM, 2005, J PHARMACOL EXP THER, V315, P571, DOI 10.1124/jpet.105.089086; Matsuda H, 2011, KIDNEY INT, V79, P46, DOI 10.1038/ki.2010.330; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; Na YR, 2009, CANCER SCI, V100, P2218, DOI 10.1111/j.1349-7006.2009.01301.x; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Trauger JW, 1996, NATURE, V382, P559, DOI 10.1038/382559a0; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Bando T, 2002, CHEM-EUR J, V8, P4781, DOI 10.1002/1521-3765(20021018)8:20<4781::AID-CHEM4781>3.0.CO;2-J; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Yao EH, 2009, CARDIOVASC RES, V81, P797, DOI 10.1093/cvr/cvn355; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Chen M, 2010, MOL THER, V18, P519, DOI 10.1038/mt.2009.263; Hasegawa Y, 2011, STEM CELLS, V29, P1196, DOI 10.1002/stem.673; Klos KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090722; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li ZH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2059; Fukuda N, 2006, J AM SOC NEPHROL, V17, P422, DOI 10.1681/ASN.2005060650; Wang Y, 2010, STEM CELL REV REP, V6, P282, DOI 10.1007/s12015-010-9137-2; Washio H, 2011, J INVEST DERMATOL, V131, P1987, DOI 10.1038/jid.2011.150	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	SEP	2015	66						112	120		10.1016/j.biocel.2015.07.011		9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CQ9RE	WOS:000360951900013		
J	Stoyanov, D; Collins, DL; Sakuma, I; Abolmaesumi, P; Jannin, P				Stoyanov, Danail; Collins, D. Louis; Sakuma, Ichiro; Abolmaesumi, Purang; Jannin, Pierre			Information processing in computer-assisted interventions: 5th international conference, 2014	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Editorial Material									[Stoyanov, Danail] UCL, Ctr Med Image Comp, Dept Comp Sci, London WC1E 6BT, England; [Sakuma, Ichiro] Univ Tokyo, Sch Engn, Med Device Dev & Regulat Res Ctr, Bunkyo Ku, Tokyo 1138656, Japan; [Collins, D. Louis] McGill Univ, Montreal Neurol Inst, Montreal, PQ H4A 2B4, Canada; [Jannin, Pierre] Univ Rennes 1, INSERM, MediCIS LTSI, F-35043 Rennes, France; [Abolmaesumi, Purang] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z4, Canada	Stoyanov, D (reprint author), UCL, Ctr Med Image Comp, Dept Comp Sci, Front Engn Bldg,Gower St, London WC1E 6BT, England.	danail.stoyanov@ucl.ac.uk; louis.collins@mcgill.ca; sakuma@bmpe.t.u-tokyo.ac.jp; purang@ece.ubc.ca; pierre.jannin@univ-rennes1.fr						0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	SEP	2015	10	9			SI		1355	1356		10.1007/s11548-015-1280-4		2	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CQ9DC	WOS:000360910100001		
J	Horsfield, B; Littke, R; Mori, JJ; Soreghan, GSL				Horsfield, Brian; Littke, Ralf; Mori, James J.; Soreghan, G. S. Lynn			A Snapshot of Research Findings Enabled by Scientific Drilling	INTERNATIONAL JOURNAL OF EARTH SCIENCES			English	Editorial Material									[Horsfield, Brian] Helmholtz Zentrum Potsdam GFZ, D-14473 Potsdam, Germany; [Littke, Ralf] Rhein Westfal TH Aachen, Inst Geol & Geochem Petr & Coal, Energy & Mineral Resources Grp, D-52056 Aachen, Germany; [Mori, James J.] Kyoto Univ, Disaster Prevent Res Inst, Earthquake Hazard Div, Kyoto 6110011, Japan; [Soreghan, G. S. Lynn] Univ Oklahoma, Geol & Geophys, Norman, OK 73019 USA	Horsfield, B (reprint author), Helmholtz Zentrum Potsdam GFZ, Haus B, D-14473 Potsdam, Germany.	Brian.horsfield@gfz-potsdam.de; Ralf.littke@emr.rwth-aachen.de; mori@eqh.dpri.kyoto-u.ac.jp; lsoreg@ou.edu						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1437-3254	1437-3262		INT J EARTH SCI	Int. J. Earth Sci.	SEP	2015	104	6					1497	1498		10.1007/s00531-015-1235-6		2	Geosciences, Multidisciplinary	Geology	CQ6HQ	WOS:000360705700001		
J	Suemori, T; Susumu, N; Iwata, T; Banno, K; Yamagami, W; Hirasawa, A; Sugano, K; Matsumoto, E; Aoki, D				Suemori, Tomohiro; Susumu, Nobuyuki; Iwata, Takashi; Banno, Kouji; Yamagami, Wataru; Hirasawa, Akira; Sugano, Kokichi; Matsumoto, Eri; Aoki, Daisuke			Intratumoral CD8(+) Lymphocyte Infiltration as a Prognostic Factor and Its Relationship With Cyclooxygenase 2 Expression and Microsatellite Instability in Endometrial Cancer	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						CD8(+) T lymphocytes; Cyclooxygenase 2; Endometrial cancer; Microsatellite instability	MISMATCH REPAIR; COLORECTAL-CANCER; T-LYMPHOCYTES; UP-REGULATION; COLON-CANCER; CARCINOMA; CELLS; FREQUENCY; APOPTOSIS; IMPACT	Objective Microsatellite instability (MSI) is caused by a defective DNA mismatch repair system. Colorectal cancer in MSI-positive patients is characterized by an increased number of tumor-infiltrating lymphocytes. On the other hand, it has recently been reported that cyclooxygenase 2 (COX-2) suppresses antitumor immunity. The objectives of the present study were to clarify the relationships among MSI status, COX-2 expression, and antitumor immune status and to verify impact of these factors on the prognosis of endometrial cancer. Methods The data of 123 patients with endometrial cancer were analyzed. The numbers of tumor-infiltrating CD8(+) T lymphocytes within cancer cell nests (TILs), as a representative of the antitumor immunity, and COX-2 expression levels in the tumor cells were analyzed by immunohistochemical staining. Microsatellite instability was evaluated by polymerase chain reaction analysis for 11 markers. Fisher exact probability test, Kaplan-Meier method, and proportional hazards analysis were used for the statistical analyses. Results The MSI-positive tumors showed significantly higher grades (G2 or G3) and significantly larger numbers of TILs than did the MSI-negative tumors. The COX-2-high group showed significantly fewer TILs than did the COX-2-low group. Multivariate analysis identified a low number of TILs (<10), positive lymph node involvement, and high tumor malignancy grade as factors independently associated with poor prognosis. The prognosis was significantly poorer in the patients with MSI-positive tumors with high COX-2 expression than in those with MSI-positive tumors showing low COX-2 expression. Conclusions The number of TILs, which was increased by MSI and decreased by COX-2 expression, was associated with a poorer prognosis in patients with endometrial cancer. We also propose that COX-2 may block MSI-activated TILs in the tumor microenvironment.	[Suemori, Tomohiro; Susumu, Nobuyuki; Iwata, Takashi; Banno, Kouji; Yamagami, Wataru; Hirasawa, Akira; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1608582, Japan; [Suemori, Tomohiro] Tochigiken Saiseikai Utsunomiya Hosp, Dept Pathol, Utsunomiya, Tochigi, Japan; [Sugano, Kokichi; Matsumoto, Eri] Tochigi Canc Ctr Res Inst, Oncogene Res Unit, Canc Prevent Unit, Utsunomiya, Tochigi, Japan	Susumu, N (reprint author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	susumu35@a6.keio.jp			Japan Ministry of Education, Culture, Sports, Science and Technology; Basic Research Foundation C [22591867]; Japan Ministry of Health, Labor and Welfare [21bunshi-9-2]; National Cancer Research and Development Fund [23-A-2]	This study was supported in part by grants from the Japan Ministry of Education, Culture, Sports, Science and Technology, Basic Research Foundation C (#22591867); Grants-in-Aid for Cancer Research and the Third Term Comprehensive Control Research for Cancer from the Japan Ministry of Health, Labor and Welfare (21bunshi-9-2); and the National Cancer Research and Development Fund (23-A-2).	Alexander J, 2001, AM J PATHOL, V158, P525; Wang QX, 2009, J CLIN BIOCHEM NUTR, V45, P163, DOI 10.3164/jcbn.09-21; Sinicrope FA, 2006, GASTROENTEROLOGY, V131, P729, DOI 10.1053/j.gastro.2006.06.005; Kondratiev S, 2004, CLIN CANCER RES, V10, P4450, DOI 10.1158/1078-0432.CCR-0732-3; MacDonald ND, 2000, CANCER RES, V60, P1750; Kapp JA, 2007, J IMMUNOL, V179, P2105; Duval A, 2002, CANCER RES, V62, P2447; Shia J, 2008, HUM PATHOL, V39, P116, DOI 10.1016/j.humpath.2007.05.022; Ishikawa T, 2003, CANCER RES, V63, P5564; Baldinu P, 2002, CANCER, V94, P3157, DOI 10.1002/cncr.10606; Black D, 2006, J CLIN ONCOL, V24, P1745, DOI 10.1200/JCO.2005.04.1574; Ferrandina G, 2002, CANCER, V95, P801, DOI 10.1002/cncr.10736; Fiumicino S, 2001, J CLIN ONCOL, V19, P1008; Hasegawa K, 2011, ARCH GYNECOL OBSTET, V284, P1515, DOI 10.1007/s00404-011-1883-0; Hirasawa A, 2003, CLIN CANCER RES, V9, P5675; Honore LH, 2006, INT J GYNECOL CANCER, V16, P1386, DOI 10.1111/j.1525-1438.2006.00535.x; Huang M, 1998, CANCER RES, V58, P1208; Karnes WE, 1998, CANCER RES, V58, P5473; Kojima M, 2001, ANN SURG ONCOL, V8, P458, DOI 10.1245/aso.2001.8.5.458; Muresu R, 2002, EUR J CANCER, V38, P1802, DOI 10.1016/S0959-8049(02)00152-1; Ohno Y, 2005, INT J CANCER, V114, P696, DOI 10.1002/ijc.20777; Ozalp SS, 2012, EUR J OBSTET GYN R B, V164, P79, DOI 10.1016/j.ejogrb.2012.05.018; Sheug H, 1997, J CLIN INVEST, V99, P2254; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Yamagami W, 2003, INT J GYNECOL CANCER, V21, P1628; Yamauchi T, 2003, ANTICANCER RES, V23, P245	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	SEP	2015	25	7					1165	1172		10.1097/IGC.0000000000000482		8	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CQ5MJ	WOS:000360648300004		
J	Nagao, S; Miwa, M; Maeda, N; Kogiku, A; Yamamoto, K; Morimoto, A; Wakahashi, S; Ichida, K; Sudo, T; Yamaguchi, S; Sakuma, T; Fujiwara, K				Nagao, Shoji; Miwa, Maiko; Maeda, Naoko; Kogiku, Ai; Yamamoto, Kasumi; Morimoto, Akemi; Wakahashi, Senn; Ichida, Kotaro; Sudo, Tamotsu; Yamaguchi, Satoshi; Sakuma, Toshiko; Fujiwara, Kiyoshi			Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix A Single-Institution Retrospective Review	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Small cell carcinoma; Large cell neuroendocrine carcinoma; Cervix; Irinotecan; Cisplatin	SMALL-CELL CARCINOMA; ENDOCRINE TUMORS; STAGE DISEASE; LUNG-CANCER; COMBINATION	Objective Neuroendocrine carcinoma of the cervix is a rare and aggressive subtype of cervical cancer and includes small cell neuroendocrine carcinoma (SCNEC) and large cell neuroendocrine carcinoma (LCNEC). We conducted a single-institution retrospective review to explore the pattern of treatments and outcomes with the aim of defining an optimum treatment strategy for these carcinomas. Methods Twenty-three consecutive patients with SCNEC or LCNEC of the cervix diagnosed at the Hyogo Cancer Center between 1996 and 2013 were included in this study. Pertinent information, including clinical and pathological characteristics, and survival data were collected from clinical records and/or telephone surveys. The pathological review was conducted by a pathologist specializing in gynecologic cancer. Results Eleven patients had SCNEC and 12 had LCNEC. Eighteen patients with International Federation of Gynecology and Obstetrics (FIGO) stage I/II underwent type III radical hysterectomy with pelvic lymphadenectomy. After surgery, 9 received adjuvant chemotherapy (8, irinotecan plus cisplatin; 1, paclitaxel plus carboplatin), 7 received concurrent chemoradiation therapy (CCRT; 6, nedaplatin; 1, cisplatin), and 2 received radiation therapy (RT). Patients who received adjuvant chemotherapy had a better overall survival than did patients who received CCRT or RT (hazard ratio, 0.21; 95% confidence interval, 0.030-1.51; P = 0.12). Although the overall survival rates are not statistically significant, the 9 patients who underwent radical hysterectomy followed by adjuvant chemotherapy are all alive. Among the remaining 5 patients who did not undergo radical hysterectomy, 2 with FIGO stage III and 1 with stage IVa received CCRT, and 2 with stage IVb received palliative RT or chemotherapy. These 5 patients with FIGO stage III/IV died of disease within 36 months. Conclusions Radical hysterectomy followed by platinum-based chemotherapy, especially the irinotecan plus cisplatin combination, is beneficial for long-term survival in patients with early-stage neuroendocrine carcinoma of the cervix.	[Nagao, Shoji; Miwa, Maiko; Kogiku, Ai; Yamamoto, Kasumi; Morimoto, Akemi; Wakahashi, Senn; Ichida, Kotaro; Sudo, Tamotsu; Yamaguchi, Satoshi; Fujiwara, Kiyoshi] Hyogo Canc Ctr, Dept Gynecol Oncol, Akashi, Hyogo 6738558, Japan; [Maeda, Naoko; Sakuma, Toshiko] Hyogo Canc Ctr, Dept Pathol, Akashi, Hyogo 6738558, Japan	Nagao, S (reprint author), Hyogo Canc Ctr, Dept Gynecol Oncol, 13-70 Kitaoji Cho, Akashi, Hyogo 6738558, Japan.	nagao@hp.pref.hyogo.jp					Lima JPSN, 2010, J THORAC ONCOL, V5, P1986, DOI 10.1097/JTO.0b013e3181f2451c; Gardner GJ, 2011, GYNECOL ONCOL, V122, P190, DOI 10.1016/j.ygyno.2011.04.011; Hanna N, 2006, J CLIN ONCOL, V24, P2038, DOI 10.1200/JCO.2005.04.8595; McCusker ME, 2003, GYNECOL ONCOL, V88, P333, DOI 10.1016/S0090-8258(02)00150-6; Zivanovic O, 2009, GYNECOL ONCOL, V112, P590, DOI 10.1016/j.ygyno.2008.11.010; AlboresSaavedra J, 1997, ARCH PATHOL LAB MED, V121, P34; Kuji S, 2013, GYNECOL ONCOL, V129, P522, DOI 10.1016/j.ygyno.2013.02.025; Lee JM, 2008, ANN ONCOL, V19, P321, DOI 10.1093/annonc/mdm465; Cohen JG, 2010, AM J OBSTET GYNECOL, V203, P347; Embry JR, 2011, GYNECOL ONCOL, V120, P444, DOI 10.1016/j.ygyno.2010.11.007; Fisseler-Eckhoff Annette, 2012, Cancers (Basel), V4, P777, DOI 10.3390/cancers4030777; McCann GA, 2013, GYNECOL ONCOL, V129, P135, DOI 10.1016/j.ygyno.2013.01.014; Noda Kazumasa, 2002, New England Journal of Medicine, V346, P85, DOI 10.1056/NEJMoa003034; Satoh T, 2014, INT J GYNECOL CANCER, V24, pS102, DOI 10.1097/IGC.0000000000000262; World Health Organization Classification of Tumors, 2003, TUM BREAST FEM GEN O, P259	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	SEP	2015	25	7					1300	1305		10.1097/IGC.0000000000000495		6	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CQ5MJ	WOS:000360648300023		
J	Nishida, T; Nakamura, K; Haraga, J; Ogawa, C; Kusumoto, T; Seki, N; Masuyama, H; Katayama, N; Kanazawa, S; Hiramatsu, Y				Nishida, Takeshi; Nakamura, Keiichiro; Haraga, Junko; Ogawa, Chikako; Kusumoto, Tomoyuki; Seki, Noriko; Masuyama, Hisashi; Katayama, Norihisa; Kanazawa, Susumu; Hiramatsu, Yuji			The Glasgow Prognostic Score Determined During Concurrent Chemoradiotherapy Is an Independent Predictor of Survival for Cervical Cancer	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Cervical cancer; During concurrent chemoradiotherapy; Glasgow prognostic score; Predictor for poor prognosis	SYSTEMIC INFLAMMATORY RESPONSE; GYNECOLOGIC-ONCOLOGY-GROUP; SQUAMOUS-CELL CARCINOMA; PELVIC IRRADIATION; COLORECTAL-CANCER; RADIATION-THERAPY; RADICAL SURGERY; UTERINE CERVIX; OVARIAN-CANCER; LUNG-CANCER	Objective The Glasgow prognostic score (GPS) determined at pretreatment is important in the prediction of prognosis in various cancers. We investigated if the GPS used both at pretreatment and during concurrent chemoradiotherapy (CCRT) could predict the prognosis of patients with cervical cancer. Methods We collected GPS and clinicopathological data from the medical records of 91 patients who underwent CCRT for cervical cancer; their GPSs at pretreatment and during CCRT were retrospectively analyzed for correlations with recurrence and survival. Statistical analyses were performed using the Mann-Whitney U test. Disease-free survival (DFS) and overall survival (OS) were analyzed using the Kaplan-Meier method. Cox's proportional hazard regression was used for univariate and multivariate analyses. Results The median follow-up for all patients who were alive at the time of last follow-up was 38.0 months (range, 1-108 months). The DFS and OS rates of patients with a high GPS during CCRT (GPS 1 + 2; 55 patients; 60.4%) were significantly shorter than those for patients with a low GPS (GPS 0; 36 patients; 39.6%) (DFS, P < 0.001; OS, P < 0.001). Furthermore, multivariate analyses showed that high GPS during CCRT was an independent prognostic factor of survival for OS (P = 0.008). Conclusions During CCRT, a high GPS was revealed to be an important predictor of survival for cervical cancer.	[Nishida, Takeshi; Nakamura, Keiichiro; Haraga, Junko; Ogawa, Chikako; Kusumoto, Tomoyuki; Seki, Noriko; Masuyama, Hisashi; Hiramatsu, Yuji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Obstet & Gynecol, Okayama 7008558, Japan; [Katayama, Norihisa; Kanazawa, Susumu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Radiol, Okayama 7008558, Japan	Nakamura, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Obstet & Gynecol, Kita Ku, 2-5-1 Shikata Tyo, Okayama 7008558, Japan.	k-nakamu@cc.okayama-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [25482595]	This study was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (grants 25482595).	Mauricio SF, 2013, NUTRITION, V29, P625, DOI 10.1016/j.nut.2012.09.016; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; VANBOMMEL PFJ, 1987, EUR J OBSTET GYN R B, V26, P69, DOI 10.1016/0028-2243(87)90010-4; Ramsey S, 2007, CANCER, V109, P205, DOI 10.1002/cncr.22400; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; Rose PG, 2007, J CLIN ONCOL, V25, P2804, DOI 10.1200/JCO.2006.09.4532; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Leitch EF, 2007, BRIT J CANCER, V97, P1266, DOI 10.1038/sj.bjc.6604027; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Green JA, 2001, LANCET, V358, P781, DOI 10.1016/S0140-6736(01)05965-7; Kirwan JM, 2003, RADIOTHER ONCOL, V68, P217, DOI 10.1016/S0167-8140(03)00197-X; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Forrest LM, 2004, BRIT J CANCER, V90, P1704, DOI 10.1038/sj.bjc.6601789; COX DR, 1972, J R STAT SOC B, V34, P187; BRESLOW NE, 1975, INT STAT REV, V43, P45, DOI 10.2307/1402659; Glen P, 2006, PANCREATOLOGY, V6, P450, DOI 10.1159/000094562; Hefler LA, 2006, GYNECOL ONCOL, V103, P512, DOI 10.1016/j.ygyno.2006.03.058; Al Murri AM, 2006, BRIT J CANCER, V94, P227, DOI 10.1038/sj.bjc.6602922; Kobayashi T, 2008, SURGERY, V144, P729, DOI 10.1016/j.surg.2008.08.015; Tempfer C, 1997, GYNECOL ONCOL, V66, P27, DOI 10.1006/gyno.1997.4726; Whitney CW, 1999, J CLIN ONCOL, V17, P1339; Crumley ABC, 2006, BRIT J CANCER, V94, P637, DOI 10.1038/sj.bjc.6602998; Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N; Benedet J L, 2001, J Epidemiol Biostat, V6, P7; BURGHARDT E, 1987, AM J OBSTET GYNECOL, V156, P988; Funovics PT, 2011, INT ORTHOP, V35, P1529, DOI 10.1007/s00264-011-1208-8; Gabay C, 1999, NEW ENGL J MED, V340, P448; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kodama J, 2008, INT J GYNECOL CANCER, V18, P1037, DOI 10.1111/j.1525-1438.2007.01141.x; Kodama J, 2008, INT J GYNECOL CANCER, V18, P1300, DOI 10.1111/j.1525-1438.2008.01199.x; Lukka H, 2002, CLIN ONCOL-UK, V14, P203, DOI 10.1053/clon.2002.0076; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Polterauer S, 2007, GYNECOL ONCOL, V107, P114, DOI 10.1016/j.ygyno.2007.06.001; Polterauer S, 2010, INT J GYNECOL CANCER, V20, P1052, DOI 10.1111/IGC.0b013e3181e64bb1; Stehman FB, 2007, AM J OBSTET GYNECOL, V197; Wang Chia-Siu, 2009, Chang Gung Med J, V32, P471	39	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	SEP	2015	25	7					1306	1314		10.1097/IGC.0000000000000485		9	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CQ5MJ	WOS:000360648300024		
J	Kamimoto, Y; Wada, H; Ikejiri, M; Nakatani, K; Sugiyama, T; Osato, K; Murabayashi, N; Yamada, N; Matsumoto, T; Ohishi, K; Ishikawa, H; Tomimoto, H; Ito, M; Ikeda, T				Kamimoto, Yuki; Wada, Hideo; Ikejiri, Makoto; Nakatani, Kaname; Sugiyama, Takashi; Osato, Kazuhiro; Murabayashi, Nao; Yamada, Norikazu; Matsumoto, Takeshi; Ohishi, Kohshi; Ishikawa, Hidehiro; Tomimoto, Hidekazu; Ito, Masaaki; Ikeda, Tomoaki			High frequency of decreased antithrombin level in pregnant women with thrombosis	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Pregnancy; Thrombosis; AT; PC; Thrombophilia	DISSEMINATED INTRAVASCULAR COAGULATION; PROTEIN-C DEFICIENCY; VENOUS THROMBOEMBOLISM; JAPANESE PATIENTS; RISK-FACTORS; SUBSTITUTION; HEMOSTASIS; MUTATIONS; MORTALITY	Venous thromboembolism (VTE) occurs frequently in pregnant women and is a significant cause of maternal death. Hemostatic abnormalities were examined in 18 pregnant women with thrombosis. We studied five families with congenital antithrombin (AT) deficiency, and two families with congenital protein C (PC) deficiency. One woman with PC deficiency showed protein S (PS) Tokushima. The AT activity levels were significantly lower at the onset of thrombosis in the pregnant women than during the stable state. The PS activity and antigen levels were also significantly lower at the onset of thrombosis. In the patients with congenital AT deficiency, AT activity was significantly low in the stable state and decreased further at the onset of thrombosis. Although AT levels were normal before pregnancy, they subsequently decreased and in two cases the patients required the administration of AT after pregnancy. Gene analysis revealed one family with AT Budapest, one family with AT Toyama, and three families with AT Glasgow. Additionally, there were one family with PC Tochigi and one family with combined heterozygous of PC deficiency and PS Tokushima. In conclusion, the deficiency of natural anticoagulants, especially AT, is an important cause of pregnancy-related VTE.	[Kamimoto, Yuki; Osato, Kazuhiro; Murabayashi, Nao; Ikeda, Tomoaki] Mie Univ, Grad Sch Med, Dept Obstet & Gynecol, Tsu, Mie 5148507, Japan; [Wada, Hideo; Nakatani, Kaname] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan; [Ikejiri, Makoto] Mie Univ Hosp, Cent Lab, Tsu, Mie 5148507, Japan; [Sugiyama, Takashi] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Yamada, Norikazu; Ito, Masaaki] Mie Univ, Grad Sch Med, Dept Cardiol, Tsu, Mie 5148507, Japan; [Matsumoto, Takeshi; Ohishi, Kohshi] Mie Univ, Grad Sch Med, Blood Transfus Serv, Tsu, Mie 5148507, Japan; [Ishikawa, Hidehiro; Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie 5148507, Japan	Wada, H (reprint author), Mie Univ, Grad Sch Med, Dept Mol & Lab Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	wadahide@clin.medic.mie-u.ac.jp		Nakatani, Kaname/0000-0001-6709-541X	Ministry of Health, Labour and Welfare of Japan for Blood Coagulation Abnormalities; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan for Blood Coagulation Abnormalities and the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Franchini M, 2006, THROMB HAEMOSTASIS, V95, P401, DOI 10.1160/TH05-11-0753; James AH, 2009, ARTERIOSCL THROM VAS, V29, P326, DOI 10.1161/ATVBAHA.109.184127; HAYASHI T, 1994, BLOOD, V83, P683; Bremme KA, 2003, BEST PRACT RES CL HA, V16, P153, DOI 10.1053/ybeha.2003.260; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; Suzuki A, 2010, J BIOL CHEM, V285, P13444, DOI 10.1074/jbc.M109.062430; Gerhardt A, 2000, NEW ENGL J MED, V342, P374, DOI 10.1056/NEJM200002103420602; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327; CONARD J, 1990, THROMB HAEMOSTASIS, V63, P319; Creanga AA, 2015, OBSTET GYNECOL, V125, P5, DOI 10.1097/AOG.0000000000000564; Friederich PW, 1996, ANN INTERN MED, V125, P955; Galambosi PJ, 2014, THROMB RES, V134, P240, DOI 10.1016/j.thromres.2014.04.026; Guimicheva B, 2015, BRIT J HAEMATOL, V168, P163, DOI 10.1111/bjh.13159; Habe K, 2013, INTERNAL MED, V52, P269, DOI 10.2169/internalmedicine.52.8308; Hasegawa M, 2013, CLIN CHIM ACTA, V425, P109, DOI 10.1016/j.cca.2013.07.009; Ikejiri M, 2012, INT J HEMATOL, V95, P257, DOI 10.1007/s12185-012-1006-0; Jacobsen A. F., 2008, AM J OBSTET GYNECOL, V198, P233; Jiang Y, 2014, BLOOD, V123, P1674, DOI 10.1182/blood-2013-11-538900; Liu Shiliang, 2009, J Obstet Gynaecol Can, V31, P611; MacCallum P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4387; Martinelli I, 2006, SEMIN THROMB HEMOST, V32, P709, DOI 10.1055/s-2006-951455; Miyata T, 1996, THROMB HAEMOSTASIS, V76, P302; MIYATA T, 1994, THROMB HAEMOSTASIS, V71, P32; Nelson-Piercy C, 2009, BEHALF GUIDELINES CO; OLDS RJ, 1992, BLOOD, V79, P1206; Pabinger I, 1996, ARTERIOSCL THROM VAS, V16, P742; SAKURAGAWA N, 1983, THROMB RES, V31, P305, DOI 10.1016/0049-3848(83)90333-X; Shindo A, 2014, INT J HEMATOL, V99, P437, DOI 10.1007/s12185-014-1550-x; Tanaka H, 2015, CIRC J, V79, P1357, DOI 10.1253/circj.CJ-14-1228; Terni E, 2015, BLOOD COAGUL FIBRINO; THEIN SL, 1988, BLOOD, V72, P1817	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	SEP	2015	102	3					253	258		10.1007/s12185-015-1822-0		6	Hematology	Hematology	CQ9MO	WOS:000360939400002		
J	Isoda, A; Sato, N; Miyazawa, Y; Matsumoto, Y; Koumoto, M; Ookawa, M; Sawamura, M; Matsumoto, M				Isoda, Atsushi; Sato, Naru; Miyazawa, Yuri; Matsumoto, Yoshinobu; Koumoto, Mina; Ookawa, Masahito; Sawamura, Morio; Matsumoto, Morio			Silent venous thromboembolism in multiple myeloma patients treated with lenalidomide	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Multiple myeloma; Lenalidomide; Venous thromboembolism; Plasma D-dimer level; Venous ultrasonography	DEEP-VEIN THROMBOSIS; PLUS DEXAMETHASONE; D-DIMER; THALIDOMIDE; ASPIRIN; COMPLICATIONS; COMBINATION; PROPHYLAXIS; PREVENTION; THERAPY	Lenalidomide treatment in combination with dexamethasone and/or chemotherapy is associated with a significant risk of venous thromboembolism (VTE) in patients with multiple myeloma (MM). However, the incidence of asymptomatic VTE in lenalidomide-treated MM patients remains unclear. A total of 80 relapsed and refractory MM patients treated with lenalidomide-containing regimens in a single institution between July 2010 and July 2014 were retrospectively analyzed. Of these, eight patients had asymptomatic VTE before starting lenalidomide. The remaining 72 patients received thromboprophylaxis with low-dose aspirin (100 mg daily) and monitoring of plasma D-dimer levels on each visit. During the median follow-up time of 7.3 months (range 1.0-43.5 months), 29 patients (40.3 %) showed an elevation of D-dimer (a parts per thousand yen2.5 mu g/mL), and 13 (18.1 %) showed asymptomatic VTE in a lower extremity. Median time to asymptomatic VTE events from initiation of lenalidomide treatment was 3.0 months (range 1.0-13.1 months). All patients having an asymptomatic VTE continued lenalidomide treatment on warfarinization (target international normalized ratio 1.5-2.5), and none of them developed symptomatic VTE. In conclusion, an asymptomatic VTE event occurred in 18 % of Japanese MM patients receiving lenalidomide-containing therapy despite aspirin prophylaxis. Serial monitoring of plasma D-dimer levels and early intervention may help to prevent symptomatic or lethal VTE events.	[Isoda, Atsushi; Sato, Naru; Miyazawa, Yuri; Matsumoto, Morio] Nishigunma Hosp, Natl Hosp Org, Dept Hematol, Shibukawa, Gunma 3778511, Japan; [Matsumoto, Yoshinobu; Koumoto, Mina; Ookawa, Masahito] Nishigunma Hosp, Natl Hosp Org, Dept Clin Lab, Shibukawa, Gunma 3778511, Japan; [Sawamura, Morio] Nishigunma Hosp, Natl Hosp Org, Dept Clin Res, Shibukawa, Gunma 3778511, Japan	Isoda, A (reprint author), Nishigunma Hosp, Natl Hosp Org, Dept Hematol, 2854 Kanai, Shibukawa, Gunma 3778511, Japan.	aisoda@netnngh.hosp.go.jp					Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; Carrier M, 2011, J THROMB HAEMOST, V9, P653, DOI 10.1111/j.1538-7836.2011.04215.x; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Baz R, 2005, MAYO CLIN PROC, V80, P1568; [Anonymous], 2011, CIRC J, V75, P1258; Nakamura M, 2014, CIRC J, V78, P708, DOI 10.1253/circj.CJ-13-0886; Rajkumar SV, 2005, BLOOD, V106, P4050, DOI 10.1182/blood-2005-07-2817; Palumbo A, 2011, J CLIN ONCOL, V29, P986, DOI 10.1200/JCO.2010.31.6844; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Larocca A, 2012, BLOOD, V119, P933, DOI 10.1182/blood-2011-03-344333; Watanabe R, 2013, INT J HEMATOL, V97, P333, DOI 10.1007/s12185-013-1294-z; Dentali F, 2011, J THROMB HAEMOST, V9, P1081, DOI 10.1111/j.1538-7836.2011.04259.x; Ota S, 2005, AM J HEMATOL, V79, P274, DOI 10.1002/ajh.20396; Palumbo A, 2008, LEUKEMIA, V22, P414, DOI 10.1038/sj.leu.2405062; Lyman GH, 2013, J CLIN ONCOL, V31, P2189, DOI 10.1200/JCO.2013.49.1118; Minnema MC, 2003, J THROMB HAEMOST, V1, P445, DOI 10.1046/j.1538-7836.2003.00083.x; MacDonald PS, 2003, J VASC SURG, V37, P523, DOI 10.1067/mva.2003.149; Fukuoka H, 2014, ENDOCR J, V61, P1003; Barlogie B, 2003, SEMIN HEMATOL, V40, P33, DOI 10.1053/j.seminhematol.2003.09.005; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Kageyama Norimasa, 2008, Ann Vasc Dis, V1, P35, DOI 10.3400/avd.AVDoa07004; Morgan GJ, 2007, BRIT J HAEMATOL, V137, P268, DOI 10.1111/j.1365-2141.2007.06538.x; Yagci M, 2003, AM J HEMATOL, V74, P231, DOI 10.1002/ajh.10433; Zonder JA, 2006, BLOOD, V108, P403, DOI 10.1182/blood-2006-01-0154	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	SEP	2015	102	3					271	277		10.1007/s12185-015-1838-5		7	Hematology	Hematology	CQ9MO	WOS:000360939400004		
J	Miyazaki, K; Kawai, S; Suzuki, K				Miyazaki, Kanji; Kawai, Shigeo; Suzuki, Kenshi			Abdominal subcutaneous fat pad aspiration and bone marrow examination for the diagnosis of AL amyloidosis: the reliability of immunohistochemistry	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						AL amyloidosis; Abdominal subcutaneous fat pad aspiration; Congo red stain; Immunohistochemistry; Bone marrow examination	SYSTEMIC AMYLOIDOSIS; MULTIPLE-MYELOMA; RISK-STRATIFICATION; CLASSIFICATION; PATHOGENESIS; SPECIMENS; DEPOSITS	Tissue biopsy is essential for the diagnosis and typing of amyloidosis. Given its safety and ease, abdominal fat pad (AFP) is the first biopsy site of choice; bone marrow (BM) biopsy should additionally be performed to identify underlying plasma cell dyscrasia. The aim of the present study was to assess the usefulness of combined biopsy and immunohistochemical staining of AFP and BM tissues for the diagnosis and typing of amyloidosis. A total of 65 patients were examined. Congo red staining and immunohistochemical staining with antibodies were performed. Of 51 patients with systemic amyloidosis, 50 patients were examined with fat pad aspirates and 38 (76 %) cases were positive. All 51 patients were also examined by BM analysis and 25 (49 %) cases were positive. Including both AFP aspirates and BM specimens, 90 % of patients with systemic amyloidosis were Congo red positive. Of the 49 patients with AL amyloidosis, immunohistochemical stains were positive in 67.6 % of patients with AFP aspirates and in 50 % with BM specimens. Combining AFP aspirate and BM examination, immunohistochemical stains yielded positive stains for the corresponding circulating monoclonal immunoglobulin in 72.7 % of cases, and hence these analyses appear to be valuable in diagnosing the type of amyloidosis.	[Miyazaki, Kanji; Kawai, Shigeo; Suzuki, Kenshi] Japanese Red Cross Med Ctr, Dept Hematol, Shibuya Ku, Tokyo 1508935, Japan	Miyazaki, K (reprint author), Japanese Red Cross Med Ctr, Dept Hematol, Shibuya Ku, 4-1-22 Hiroo, Tokyo 1508935, Japan.	miyazaki_kanji@med.jrc.or.jp					Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; LIBBEY CA, 1983, ARCH INTERN MED, V143, P1549, DOI 10.1001/archinte.143.8.1549; Chesi M, 2013, INT J HEMATOL, V97, P313, DOI 10.1007/s12185-013-1291-2; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Rajkumar SV, 2011, AM J HEMATOL, V86, P57, DOI 10.1002/ajh.21913; Schonland SO, 2012, BLOOD, V119, P488, DOI 10.1182/blood-2011-06-358507; KYLE RA, 1992, BLOOD, V79, P1817; Leung N, 2012, BLOOD, V120, P3206, DOI 10.1182/blood-2012-03-413682; Arbustini E, 2002, AMYLOID, V9, P108; Kebbel A, 2006, AM J SURG PATHOL, V30, P673, DOI 10.1097/00000478-200606000-00002; Collins AB, 2009, CARDIOVASC PATHOL, V18, P205, DOI 10.1016/j.carpath.2008.05.004; Merlini G, 2011, J CLIN ONCOL, V29, P1924, DOI 10.1200/JCO.2010.32.2271; KYLE RA, 1983, MAYO CLIN PROC, V58, P665; Brambilla F, 2012, BLOOD, V119, P1844, DOI 10.1182/blood-2011-07-365510; Duston M A, 1987, Am J Med, V82, P412, DOI 10.1016/0002-9343(87)90439-6; Lachmann HJ, 2002, NEW ENGL J MED, V346, P1786, DOI 10.1056/NEJMoa013354; Linke RP, 2006, ACTA HISTOCHEM, V108, P197, DOI 10.1016/j.acthis.2006.03.010; Rocken C, 1996, HISTOPATHOLOGY, V29, P325, DOI 10.1111/j.1365-2559.1996.tb01416.x; Shidham VB, 2010, JOVE-J VIS EXP, V44, pe1747; Swan N, 2003, AM J CLIN PATHOL, V120, P610, DOI 10.1309/PFUGHBX0TY20E08U; Vrana JA, 2014, HAEMATOLOGICA, V99, P1239, DOI 10.3324/haematol.2013.102764	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	SEP	2015	102	3					289	295		10.1007/s12185-015-1827-8		7	Hematology	Hematology	CQ9MO	WOS:000360939400006		
J	Nakamae, H; Yoshida, C; Miyata, Y; Hidaka, M; Uike, N; Koga, D; Sogabe, T; Matsumura, I; Kanakura, Y; Naoe, T				Nakamae, Hirohisa; Yoshida, Chikashi; Miyata, Yasuhiko; Hidaka, Michihiro; Uike, Naokuni; Koga, Daisuke; Sogabe, Takayuki; Matsumura, Itaru; Kanakura, Yuzuru; Naoe, Tomoki			A new diagnostic kit, ODK-1201, for the quantitation of low major BCR-ABL mRNA level in chronic myeloid leukemia: correlation of quantitation with major BCR-ABL mRNA kits	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						CML; RT-qPCR; Major BCR-ABL mRNA; ODK-1201	CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITORS; CHRONIC-PHASE; EUROPEAN-LEUKEMIANET; IMATINIB; DASATINIB; RECOMMENDATIONS; NILOTINIB; THERAPY; CML	The current first-line therapy of chronic myeloid leukemia (CML) is based on tyrosine kinase inhibitors. Diagnostic kits that are capable of identifying at least a 4.5 log reduction in the international scale % BCR-ABL/ABL (IS % BCR-ABL/ABL) are needed for use in the clinical evaluation of deeper molecular response to treatment and to determine the timing of dose selection or treatment interruption during the course of treatment. In this study, we evaluated the performance of a new diagnostic kit, ODK-1201, designed to be capable of performing reverse transcription and quantitative PCR in a single tube for the quantitation of major BCR-ABL mRNA. The kit demonstrated excellent assay performance (limit of detection 0.0007 %) and a broader detection range of BCR-ABL mRNA in peripheral blood compared to a commercially available kit for CML (Amp-CML). ODK-1201 was also shown to be as sensitive as Ipsogen and Molecular MD kits in the same assay. Results obtained in this study indicate evidences that ODK-1201 was capable of identifying at least a 4.5 log reduction in the IS % BCR-ABL/ABL.	[Nakamae, Hirohisa] Osaka City Univ, Grad Sch Med, Hematol, Abeno Ku, Osaka 5458585, Japan; [Yoshida, Chikashi] Mito Med Ctr, Natl Hosp Org, Dept Hematol, Ibaraki, Japan; [Miyata, Yasuhiko] Nagoya Med Ctr, Natl Hosp Org, Hematol, Nagoya, Aichi, Japan; [Hidaka, Michihiro] Kumamoto Med Ctr, Natl Hosp Org, Hematol, Kumamoto, Japan; [Uike, Naokuni] Kyushu Canc Ctr, Natl Hosp Org, Hematol, Fukuoka, Japan; [Koga, Daisuke; Sogabe, Takayuki] Otsuka Pharmaceut Co Ltd, Div Diagnost, Tokushima 77101, Japan; [Matsumura, Itaru] Kinki Univ, Sch Med, Dept Internal Med, Hematol, Osaka, Japan; [Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Hematol & Oncol, Osaka, Japan; [Naoe, Tomoki] Nagoya Med Ctr, Natl Hosp Org, Nagoya, Aichi, Japan	Nakamae, H (reprint author), Osaka City Univ, Grad Sch Med, Hematol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	hirohisa@msic.med.osaka-cu.ac.jp			Otsuka; Otsuka Pharmaceutical Co., Ltd.; Bristol-Myers Squibb; Celgene K.K.; Chugai Pharmaceutical Co., Ltd.; Dainippon Sumitomo Pharma Co., Ltd.; Fujifilm Corporation; Kyowa-Hakko Kirin Co., Ltd.; Nippon Boehringer Ingelheim Co., Ltd.; Novartis Pharma; Zenyaku Kogyo Co., Ltd.	These results are summarized from the clinical study of ODK-1201 kit (Sponsored by Otsuka Pharmaceutical Co. Ltd.). H.N. has received research funding and honoraria from Otsuka to report during the conduct of the study. T.N. received grants and personal fees from Otsuka Pharmaceutical Co., Ltd., during the conduct of the study; grants and personal fees from Bristol-Myers Squibb, grants and personal fees from Celgene K.K., grants and personal fees from Chugai Pharmaceutical Co., Ltd., grants and personal fees from Dainippon Sumitomo Pharma Co., Ltd., grants and personal fees from Fujifilm Corporation, grants and personal fees from Kyowa-Hakko Kirin Co., Ltd., grants and personal fees from Nippon Boehringer Ingelheim Co., Ltd., grants and personal fees from Novartis Pharma, grants and personal fees from Otsuka Pharmaceutical Co., Ltd., grants from Zenyaku Kogyo Co., Ltd., outside the submitted work;. Another, relevant to the clinical study, C.Y. received honoraria from Otsuka to report. Y.M., M.H. and N.U. have no COI. K.D. and T.S. are employees of Otsuka. I.M. and Y.K. have provided consultancy and received honoraria from Otsuka.	Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Yoshida C, 2012, INT J CLIN ONCOL, V17, P584, DOI 10.1007/s10147-011-0328-x; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Langabeer SE, 2002, LEUKEMIA, V16, P393, DOI 10.1038/sj/leu/2402392; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Hochhaus A, 2008, LEUKEMIA, V22, P1200, DOI 10.1038/leu.2008.84; Branford S, 1999, BRIT J HAEMATOL, V107, P587; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Fujisawa S, 2014, INT J HEMATOL, V99, P141, DOI 10.1007/s12185-013-1470-1; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Kantarjian H, 2008, BLOOD, V111, P1774, DOI 10.1182/blood-2007-09-110189; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tholen DW, 2004, PROTOCOLS DETERMINAT, V24	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	SEP	2015	102	3					304	311		10.1007/s12185-015-1826-9		8	Hematology	Hematology	CQ9MO	WOS:000360939400008		
J	Tomizawa, D; Watanabe, T; Hanada, R; Horibe, K; Horikoshi, Y; Iwamoto, S; Kinoshita, A; Moritake, H; Nakayama, H; Shimada, A; Taga, T; Takahashi, H; Tawa, A; Terui, K; Hori, H; Kawano, Y; Kikuta, A; Manabe, A; Adachi, S				Tomizawa, Daisuke; Watanabe, Tomoyuki; Hanada, Ryoji; Horibe, Keizo; Horikoshi, Yasuo; Iwamoto, Shotaro; Kinoshita, Akitoshi; Moritake, Hiroshi; Nakayama, Hideki; Shimada, Akira; Taga, Takashi; Takahashi, Hiroyuki; Tawa, Akio; Terui, Kiminori; Hori, Hiroki; Kawano, Yoshifumi; Kikuta, Atsushi; Manabe, Atsushi; Adachi, Souichi			Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Acute myeloid leukemia; Adolescents; Children	ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDRENS ONCOLOGY GROUP; HEMATOPOIETIC-CELL TRANSPLANTATION; COOPERATIVE-STUDY GROUP; YOUNG-ADULTS; CHILDHOOD AML; RANDOMIZED-TRIAL; THERAPY; RELAPSE; CANCER	As past studies of adolescent and young adults (AYA) with acute myeloid leukemia (AML) reported conflicting results, we conducted a retrospective analysis using data from three Japanese pediatric AML studies. Among the 782 patients with de novo AML, 44 were classified as AYA (age a parts per thousand yen15 years at diagnosis), 164 as infants (0-1 year), 413 as younger children (2-11 years), and 161 as older children (12-14 years). While the 5-year event-free survival rate of AYA was not different among the groups, the five-year survival rate (54.7 %) was significantly lower than that of the other three groups (P = 0.019): 68.7 % for infants, 73.2 % for younger children, and 75.5 % for older children. No difference in the 5-year cumulative incidence of relapse was observed, but treatment-related death (TRD) of AYA was significantly higher (29.4 %) than that in infants (14.8 %), younger children (10.2 %), and older children (13.8 %). Multivariate analysis showed age a parts per thousand yen15 years old at diagnosis was associated with both poor survival rate and high TRD. Adolescents with AML had inferior survival due to a higher incidence of TRD, especially after failure of initial frontline treatment.	[Tomizawa, Daisuke] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Setagaya Ku, Tokyo 1578535, Japan; [Watanabe, Tomoyuki] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Dept Nutrit Sci, Nisshin, Japan; [Hanada, Ryoji] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Horibe, Keizo] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi, Japan; [Horikoshi, Yasuo] Shizuoka Childrens Hosp, Div Hematol & Oncol, Shizuoka, Japan; [Iwamoto, Shotaro; Hori, Hiroki] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie 514, Japan; [Kinoshita, Akitoshi] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan; [Moritake, Hiroshi] Miyazaki Univ, Fac Med, Dept Reprod & Dev Med, Div Pediat, Miyazaki, Japan; [Nakayama, Hideki] Fukuoka Higashi Med Ctr, Natl Hosp Org, Dept Pediat, Fukuoka, Japan; [Shimada, Akira] Okayama Univ, Dept Pediat, Okayama, Japan; [Taga, Takashi] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 52021, Japan; [Takahashi, Hiroyuki] Toho Univ, Dept Pediat, Tokyo, Japan; [Tawa, Akio] Osaka Natl Hosp, Natl Hosp Org, Dept Pediat, Osaka, Japan; [Terui, Kiminori] Hirosaki Univ, Grad Sch Med, Dept Pediat, Hirosaki, Aomori, Japan; [Kawano, Yoshifumi] Kagoshima Univ, Dept Pediat, Kagoshima 890, Japan; [Kikuta, Atsushi] Fukushima Med Univ, Ctr Canc, Div Pediat Oncol, Fukushima, Japan; [Manabe, Atsushi] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan; [Adachi, Souichi] Kyoto Univ, Human Hlth Sci, Kyoto, Japan	Tomizawa, D (reprint author), Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	tomizawa-d@ncchd.go.jp			Grant for Innovative Cancer Medicine Research from the Ministry of Health, Labour, and Welfare of Japan [H26-KakushintekiGan-Ippan-061]	The authors thank all the investigators, coworkers, and members of participating hospitals in the AML studies conducted by the CCLSG, TCCSG, JACLS, KYCCSG, and JPLSG. The authors also thank Dr. Julian Tang of the Department of Education for Clinical Research, National Center for Child Health and Development, for critical comments and editorial assistance. This work was supported by a Grant for Innovative Cancer Medicine Research from the Ministry of Health, Labour, and Welfare of Japan (H26-KakushintekiGan-Ippan-061).	Pui CH, 2011, J CLIN ONCOL, V29, P386, DOI 10.1200/JCO.2010.32.0325; Burke MJ, 2014, BONE MARROW TRANSPL, V49, P174, DOI 10.1038/bmt.2013.171; Zwaan CM, 2003, BLOOD, V102, P2387, DOI 10.1182/blood-2002-12-3627; Creutzig U, 2012, BLOOD, V120, P3187, DOI 10.1182/blood-2012-03-362608; Tomizawa D, 2013, INT J HEMATOL, V98, P578, DOI 10.1007/s12185-013-1429-2; Boissel N, 2003, J CLIN ONCOL, V21, P774, DOI 10.1200/JCO.2003.02.053; Abrahamsson J, 2011, J CLIN ONCOL, V29, P310, DOI 10.1200/JCO.2010.30.6829; Stock W, 2008, BLOOD, V112, P1646, DOI 10.1182/blood-2008-01-130237; Barry E, 2007, J CLIN ONCOL, V25, P813, DOI 10.1200/JCO.2006.08.6397; Ho PA, 2009, BLOOD, V113, P6558, DOI 10.1182/blood-2008-10-184747; Woods WG, 2013, CANCER-AM CANCER SOC, V119, P4170, DOI 10.1002/cncr.28344; Creutzig U, 2008, CANCER, V112, P562, DOI 10.1002/cncr.23220; Gibson BES, 2011, BRIT J HAEMATOL, V155, P366, DOI 10.1111/j.1365-2141.2011.08851.x; Rubnitz JE, 2010, LANCET ONCOL, V11, P543, DOI 10.1016/S1470-2045(10)70090-5; Canner J, 2013, CANCER-AM CANCER SOC, V119, P4162, DOI 10.1002/cncr.28342; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Rubnitz JE, 2012, CANCER-AM CANCER SOC, V118, P6253, DOI 10.1002/cncr.27659; Brown P, 2007, BLOOD, V110, P979, DOI 10.1182/blood-2007-02-076604; Kudo K, 2007, J CLIN ONCOL, V25, P5442, DOI 10.1200/JCO.2007.12.3687; Majhail NS, 2012, BIOL BLOOD MARROW TR, V18, P861, DOI 10.1016/j.bbmt.2011.10.031; Bitan M, 2014, BLOOD, V123, P1615, DOI 10.1182/blood-2013-10-535716; Tsukimoto I, 2009, J CLIN ONCOL, V27, P4007, DOI 10.1200/JCO.2008.18.7948; Tomizawa D, 2013, LEUKEMIA, V27, P2413, DOI 10.1038/leu.2013.153; Creutzig U, 2013, BLOOD, V122, P37, DOI 10.1182/blood-2013-02-484097; Chessells JM, 1998, LEUKEMIA, V12, P463, DOI 10.1038/sj.leu.2400959; Gamis AS, 2014, J CLIN ONCOL, V32, P3021, DOI 10.1200/JCO.2014.55.3628; Hayakawa F, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.72; Imaizumi M, 2010, BRIT J HAEMATOL, V152, P89; Kato M, 2014, INT J HEMATOL, V100, P180, DOI 10.1007/s12185-014-1622-y; Nachman JB, 2009, J CLIN ONCOL, V27, P5189, DOI 10.1200/JCO.2008.20.8959; Pichler H, 2013, BRIT J HAEMATOL, V161, P556, DOI 10.1111/bjh.12292; Taga T, 2011, PEDIATR BLOOD CANCER, V57, P36, DOI 10.1002/pbc.22943	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	SEP	2015	102	3					318	326		10.1007/s12185-015-1825-x		9	Hematology	Hematology	CQ9MO	WOS:000360939400010		
J	Nakamura, N; Hara, T; Shimizu, M; Mabuchi, R; Nagano, J; Ohno, T; Kochi, T; Kubota, M; Shirakami, Y; Goto, N; Ito, H; Saito, K; Tanaka, T; Moriwaki, H; Tsurumi, H				Nakamura, Nobuhiko; Hara, Takeshi; Shimizu, Masahito; Mabuchi, Ryoko; Nagano, Junji; Ohno, Tomohiko; Kochi, Takahiro; Kubota, Masaya; Shirakami, Yohei; Goto, Naoe; Ito, Hiroyasu; Saito, Kuniaki; Tanaka, Takuji; Moriwaki, Hisataka; Tsurumi, Hisashi			Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Indoleamine 2,3-dioxygenase; 1-methyl-tryptophan; Cyclophosphamide; Non-Hodgkin lymphoma; Regulatory T cells	REGULATORY T-CELLS; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; HEMATOLOGICAL MALIGNANCIES; INCREASED POPULATIONS; PERIPHERAL-BLOOD; IMMUNOTHERAPY; CANCER; CYCLOPHOSPHAMIDE; PROLIFERATION	Indoleamine 2,3-dioxygenase (IDO) catalyzes the rate-limiting step in the metabolism of tryptophan along the kynurenine pathway. In tumors, increased IDO activity inhibits proliferation and induces apoptosis of T cells and natural killer cells. We investigated the therapeutic potential of IDO inhibitor 1-methyl-d-tryptophan (d-1MT) with cyclophosphamide (CY) in a mouse model of lymphoma. To examine the effect of d-1MT, mice were killed on day 28. Serum concentrations of l-kynurenine and l-tryptophan were measured by high-performance liquid chromatography. Regulatory T cells (Tregs) were counted by flow cytometry, and mRNA expressions of IDO1, Foxp3, IFN-gamma, and COX-2 were examined by quantitative real-time reverse transcription-polymerase chain reaction. d-1MT+CY combination treatment significantly inhibited tumor growth as compared to either treatment alone. There were no significant differences in the serum l-kynurenine/l-tryptophan ratio or the IDO1 expression level in the tumors among the treatment groups. The expression levels of IFN-gamma and COX-2 mRNA in tumor-draining lymph nodes (TDLNs) were found to be significantly up-regulated in the CY and d-1MT+CY groups. The number of Tregs in TDLNs in the d-1MT+CY group was significantly lower than that in CY groups on day 17. These results suggest that d-1MT in combination with CY is an effective treatment for lymphoma in a mouse model.	[Nakamura, Nobuhiko; Hara, Takeshi; Shimizu, Masahito; Mabuchi, Ryoko; Nagano, Junji; Ohno, Tomohiko; Kochi, Takahiro; Kubota, Masaya; Shirakami, Yohei; Goto, Naoe; Moriwaki, Hisataka; Tsurumi, Hisashi] Gifu Univ, Dept Internal Med 1, Grad Sch Med, Gifu 5011194, Japan; [Ito, Hiroyasu] Gifu Univ, Dept Informat Clin Med, Grad Sch Med, Gifu 5011194, Japan; [Saito, Kuniaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Sakyo Ku, Kyoto 6068501, Japan; [Saito, Kuniaki] Kyoto Univ, Fac Med, Sakyo Ku, Kyoto 6068501, Japan; [Tanaka, Takuji] Canc Res & Prevent TCI CaRP, Tohkai Cytopathol Inst, Gifu 5008285, Japan	Tsurumi, H (reprint author), Gifu Univ, Dept Internal Med 1, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.	htsuru@gifu-u.ac.jp					Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Munn DH, 2006, IMMUNOL REV, V213, P146, DOI 10.1111/j.1600-065X.2006.00444.x; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Curti A, 2007, BLOOD, V109, P2871, DOI 10.1182/blood-2006-07-036863; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Ninomiya S, 2011, ANN HEMATOL, V90, P409, DOI 10.1007/s00277-010-1093-z; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Ichihara F, 2003, CLIN CANCER RES, V9, P4404; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; NORTH RJ, 1982, J EXP MED, V155, P1063, DOI 10.1084/jem.155.4.1063; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Yoshida N, 2008, CLIN CANCER RES, V14, P7251, DOI 10.1158/1078-0432.CCR-08-0991; Inaba T, 2009, GYNECOL ONCOL, V115, P185, DOI 10.1016/j.ygyno.2009.07.015; Ghiringhelli F, 2004, EUR J IMMUNOL, V34, P336, DOI 10.1002/eji.200324181; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; KIM KJ, 1979, J IMMUNOL, V122, P549; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Klebanoff CA, 2005, TRENDS IMMUNOL, V26, P111, DOI 10.1016/j.it.2004.12.003; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; Dummer W, 2002, J CLIN INVEST, V110, P185, DOI 10.1172/JCI200215175; Godin-Ethier J, 2011, CLIN CANCER RES, V17, P6985, DOI 10.1158/1078-0432.CCR-11-1331; Bocchia M, 2014, INT J HEMATOL, V99, P107, DOI 10.1007/s12185-013-1497-3; Fujigaki S, 1998, ARCH BIOCHEM BIOPHYS, V358, P329, DOI 10.1006/abbi.1998.0861; Fujiwara H, 2014, INT J HEMATOL, V99, P123, DOI 10.1007/s12185-013-1493-7; Gajewski TF, 2006, CLIN CANCER RES, V12, p2326S, DOI 10.1158/1078-0432.CCR-05-2517; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Ninomiya S, 2012, LEUKEMIA LYMPHOMA, V53, P1143, DOI 10.3109/10428194.2011.643472; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; Yoshikawa T, 2010, EUR J HAEMATOL, V84, P304, DOI 10.1111/j.1600-0609.2009.01393.x	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	SEP	2015	102	3					327	334		10.1007/s12185-015-1835-8		8	Hematology	Hematology	CQ9MO	WOS:000360939400011		
J	Sakurai, M; Mori, T; Karigane, D; Tozawa, K; Matsuki, E; Shimizu, T; Yokoyama, K; Nakajima, H; Kanda, Y; Okamoto, S				Sakurai, Masatoshi; Mori, Takehiko; Karigane, Daiki; Tozawa, Keiichi; Matsuki, Eri; Shimizu, Takayuki; Yokoyama, Kenji; Nakajima, Hideaki; Kanda, Yoshinobu; Okamoto, Shinichiro			Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Chronic myelogenous leukemia; Adolescents and young adults; Tyrosine kinase inhibitors; Adherence	CHRONIC MYELOID-LEUKEMIA; CML WORKING PARTY; OF-THE-LITERATURE; CHRONIC-PHASE; PATIENT CHARACTERISTICS; IMATINIB; THERAPY; CANCER; DASATINIB; SURVIVAL	Tyrosine kinase inhibitor (TKI) treatment has dramatically improved the outcome of chronic myelogenous leukemia in the chronic phase (CML-CP). However, one study has reported a less favorable treatment outcome with TKIs in adolescents and young adults (AYA) when compared with older patients. In the present study, we retrospectively reviewed the response to TKIs in a Japanese population of 133 CML-CP patients divided into an AYA group (n = 19) and an older group (n = 114). At diagnosis, AYA patients presented with higher white blood cell counts and lower percentage of basophils, and with lower Hasford scores, but no difference was observed in EUTOS score. Probability of achieving complete cytogenetic response was not statistically different between the groups. However, the probabilities of achieving major and complete molecular responses were significantly lower in the AYA group compared to the older group (61 vs 87 % and 17 vs. 33 % at 24 months, respectively; P < 0.05). In addition, a 7-year event-free survival was significantly lower in the AYA compared to the older adults (58 vs. 80 %, P < 0.05). These results suggest that AYA Japanese patients with CML-CP tend to have an unfavorable outcome on treatment with TKI.	[Sakurai, Masatoshi; Mori, Takehiko; Karigane, Daiki; Tozawa, Keiichi; Matsuki, Eri; Shimizu, Takayuki; Yokoyama, Kenji; Nakajima, Hideaki; Okamoto, Shinichiro] Keio Univ, Div Hematol, Dept Med, Sch Med,Shinjuku Ku, Tokyo 1608582, Japan; [Kanda, Yoshinobu] Jichi Med Univ, Div Hematol, Shimotsuke, Tochigi, Japan	Sakurai, M (reprint author), Keio Univ, Div Hematol, Dept Med, Sch Med,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	sakurai@z5.keio.jp			Bristol-Myers Squibb; Novartis Pharmaceuticals	SO receives research funding from Bristol-Myers Squibb and Novartis Pharmaceuticals, and honoraria for lectures from Bristol-Myers Squibb. Division of Hematology, Department of Medicine, Keio University School of Medicine had courses endowed by Novartis Pharmaceuticals.	Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Yoshida C, 2012, INT J CLIN ONCOL, V17, P584, DOI 10.1007/s10147-011-0328-x; Bjorkholm M, 2011, J CLIN ONCOL, V29, P2514, DOI 10.1200/JCO.2011.34.7146; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Shah NP, 2010, HAEMATOL-HEMATOL J, V95, P232, DOI 10.3324/haematol.2009.011452; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Prakash S, 2005, J PEDIAT HEMATOL ONC, V27, P179, DOI 10.1097/01.mph.0000157790.81329.47; Kantarjian HM, 2011, BLOOD, V117, P1141, DOI 10.1182/blood-2010-03-277152; Stock W, 2010, HEMATOL-AM SOC HEMAT, P21, DOI 10.1182/asheducation-2010.1.21; Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Jabbour E, 2014, AM J HEMATOL, V89, P547, DOI 10.1002/ajh.23691; Thomas DM, 2010, J CLIN ONCOL, V28, P4781, DOI 10.1200/JCO.2010.30.5128; Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; Hasford J, 1998, J NATL CANCER I, V90, P850, DOI 10.1093/jnci/90.11.850; Fujisawa S, 2014, INT J HEMATOL, V99, P141, DOI 10.1007/s12185-013-1470-1; SOKAL JE, 1984, BLOOD, V63, P789; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Geynisman DM, 2013, DISCOV MED, V83, P231; KANTARJIAN HM, 1985, BLOOD, V66, P1326; Datta RV, 2000, NEW ENGL J MED, V342, P137, DOI 10.1056/NEJM200001133420216; Bixby D, 2009, HEMATOL-AM SOC HEMAT, V2009, P461; Deininger M, 2008, 51 ANN M AM SOC HEM; Gugliotta G, 2011, BLOOD, V117, P5591, DOI 10.1182/blood-2010-12-324228; Kalmanti L, 2014, ANN HEMATOL, V93, P71, DOI 10.1007/s00277-013-1937-4; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Pemmaraju N, 2014, ACTA HAEMATOL-BASEL, V132, P298, DOI 10.1159/000363434; Pemmaraju N, 2012, HAEMATOL-HEMATOL J, V97, P1029, DOI 10.3324/haematol.2011.056721; Pollock BH, 2008, PEDIATR BLOOD CANCER, V50, P1090, DOI 10.1002/pbc.21462; Rosti G, 2007, HAEMATOL-HEMATOL J, V92, P101, DOI 10.3324/haematol.10239; Schmidt C, 2006, J NATL CANCER I, V98, P1760, DOI 10.1093/jnci/djj517; Tsang J, 2006, 2006 ASCO ANN M ATL	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	SEP	2015	102	3					342	348		10.1007/s12185-015-1840-y		7	Hematology	Hematology	CQ9MO	WOS:000360939400013		
J	Moritake, H; Obara, M; Sameshima, N; Asada, Y; Komatsu, H; Hyakuna, N; Sugita, K; Ishida, Y; Kato, M; Tanizawa, A; Deguchi, T; Imamura, T; Kitanaka, A; Shimoda, K; Kamimura, S; Nunoi, H				Moritake, Hiroshi; Obara, Megumi; Sameshima, Naoki; Asada, Yujiro; Komatsu, Hiroyuki; Hyakuna, Nobuyuki; Sugita, Kanji; Ishida, Yasushi; Kato, Motohiro; Tanizawa, Akihiko; Deguchi, Takao; Imamura, Toshihiko; Kitanaka, Akira; Shimoda, Kazuya; Kamimura, Sachiyo; Nunoi, Hiroyuki			Analysis of the molecular mechanism underlying bone marrow necrosis with acute lymphoblastic leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Bone marrow necrosis; Apoptosis; Acute lymphoblastic leukemia	SERUM CYTOCHROME-C; CYTOKINE PATTERN; FAS LIGAND; CHILDREN; CELLS; ENCEPHALOPATHY; APOPTOSIS; HMGB1	Bone marrow necrosis (BMN) is a rare phenomenon in children with malignancies, occurring most commonly in patients with acute lymphoblastic leukemia (ALL). The pathophysiology of this phenomenon has not been identified. We analyzed seven BMN cases with ALL in order to elucidate the underlying mechanism. Serum high-mobility group box 1 (HMGB1), cytochrome C, cytokines, and chemokines were measured, and real-time quantitative reverse transcription-polymerase chain reaction (RQ-RT-PCR) and immunochemistry of death-related molecules were analyzed using bone marrow samples. The serum levels of 17 of 27 cytokines and chemokines were found to be significantly elevated in patients with BMN in comparison to those in healthy volunteers; however, IFN-gamma and IL-10 were not elevated. The cytokine pattern was different to that reported in hemophagocytic lymphohistiocytosis. The HMGB1 and cytochrome C levels in patients with BMN were not elevated. RQ-RT-PCR revealed significant overexpression of Fas-ligand, perforin, and granzyme B in the bone marrow of patients with ALL complicated with BMN compared with that in healthy volunteers and in patients with ALL without BMN. On immunohistochemistry, we identified leukemic cell-eliciting Fas-ligand and macrophage-eliciting TNF-alpha. Thus, no close relationship with massive necrosis or the intrinsic pathway of apoptosis was identified in the occurrence of BMN. These results suggest that the massive cell death phenomenon called BMN is partially induced by the extrinsic pathway of apoptosis.	[Moritake, Hiroshi; Obara, Megumi; Kamimura, Sachiyo; Nunoi, Hiroyuki] Miyazaki Univ, Fac Med, Div Pediat, Kiyotake, Miyazaki 8891692, Japan; [Sameshima, Naoki; Asada, Yujiro] Miyazaki Univ, Dept Pathol, Kiyotake, Miyazaki 8891692, Japan; [Komatsu, Hiroyuki] Miyazaki Univ, Ctr Med Educ, Fac Med, Kiyotake, Miyazaki 8891692, Japan; [Hyakuna, Nobuyuki] Hosp Univ Ryukyus, Ctr Bone Marrow Transplantat, Okinawa, Japan; [Sugita, Kanji] Univ Yamanashi, Dept Pediat, Sch Med, Yamanashi, Japan; [Ishida, Yasushi] Ehime Prefectural Cent Hosp, Pediat Med Ctr, Matsuyama, Ehime, Japan; [Kato, Motohiro] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Tanizawa, Akihiko] Univ Fukui, Fac Med Sci, Dept Pediat, Fukui 910, Japan; [Deguchi, Takao] Mie Univ, Dept Pediat, Grad Sch Med, Tsu, Mie 514, Japan; [Imamura, Toshihiko] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto 602, Japan; [Kitanaka, Akira; Shimoda, Kazuya] Miyazaki Univ, Dept Gastroenterol & Hematol, Fac Med, Kiyotake, Miyazaki 8891692, Japan	Moritake, H (reprint author), Miyazaki Univ, Fac Med, Div Pediat, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	hiroshi_moritake@med.miyazaki-u.ac.jp					JAVAHERIAN K, 1978, SCIENCE, V199, P1345, DOI 10.1126/science.628842; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Tang YM, 2008, BRIT J HAEMATOL, V143, P84, DOI 10.1111/j.1365-2141.2008.07298.x; Adachi N, 2004, CLIN CHIM ACTA, V342, P127, DOI 10.1016/j.cccn.2003.12.011; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Paydas S, 2002, AM J HEMATOL, V70, P300, DOI 10.1002/ajh.10114; Xu XJ, 2012, J PEDIATR-US, V160, P984, DOI 10.1016/j.jpeds.2011.11.046; KIRALY JF, 1976, AM J MED, V60, P361, DOI 10.1016/0002-9343(76)90752-X; Janssens AM, 2000, CANCER, V88, P1769, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1769::AID-CNCR3>3.0.CO;2-H; HICKS DG, 1995, CANCER, V75, P973, DOI 10.1002/1097-0142(19950215)75:4<973::AID-CNCR2820750412>3.0.CO;2-8; Wade LJ, 1941, AM J PATHOL, V17, P47; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Hosoya M, 2006, ARCH DIS CHILD, V91, P469, DOI 10.1136/adc.2005.078436; KNUPP C, 1988, AM J HEMATOL, V29, P215, DOI 10.1002/ajh.2830290408; Lickliter JD, 1999, EXP HEMATOL, V27, P1519, DOI 10.1016/S0301-472X(99)00091-0; Nunoi H, 2005, PEDIATR INT, V47, P175, DOI 10.1111/j.1442-200x.2005.02042.x; Pituch-Noworolska A, 1998, CLIN LAB HAEMATOL, V20, P231, DOI 10.1046/j.1365-2257.1998.00113.x; PUI CH, 1985, CANCER, V56, P1522, DOI 10.1002/1097-0142(19851001)56:7<1522::AID-CNCR2820560708>3.0.CO;2-B; Shah NR, 2011, J PEDIAT HEMATOL ONC, V33, pE316, DOI 10.1097/MPH.0b013e318223fe9b; Volm M, 1999, ANTICANCER RES, V19, P3399	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	SEP	2015	102	3					349	356		10.1007/s12185-015-1843-8		8	Hematology	Hematology	CQ9MO	WOS:000360939400014		
J	He, HP; Nagamura-Inoue, T; Takahashi, A; Mori, Y; Yamamoto, Y; Shimazu, T; Tsunoda, H; Tojo, A				He, Haiping; Nagamura-Inoue, Tokiko; Takahashi, Atsuko; Mori, Yuka; Yamamoto, Yuki; Shimazu, Takahisa; Tsunoda, Hajime; Tojo, Arinobu			Immunosuppressive properties of Wharton's jelly-derived mesenchymal stromal cells in vitro	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Mesenchymal stromal cell; Immunosuppression; Umbilical cord; GVHD; Wharton's jelly	HUMAN BONE-MARROW; THERAPY POSITION STATEMENT; VERSUS-HOST-DISEASE; STEM-CELLS; UMBILICAL-CORD; IFN-GAMMA; INTERNATIONAL-SOCIETY; IMMUNE PROPERTIES; ADIPOSE-TISSUE; PROLIFERATION	Recent studies have reported that mesenchymal stromal cells (MSCs) migrate to areas of inflammation and suppress adverse immune reactions. Bone marrow (BM)-derived MSCs have been successfully used in patients with acute graft versus host disease (GVHD), but the harvesting of BM carries certain risks for the donor. To circumvent these, we obtained MSCs from Wharton's jelly (WJ) derived from umbilical cord and investigated their potential for immunosuppression. In a mixed lymphocyte reaction (MLR), responder T cell proliferation triggered by allogeneic dendritic cells was inhibited efficiently by WJ-MSCs derived from the same donor of responder cells or those from a third party donor. These inhibitory effects were reversed in a dose-dependent manner in the presence of 1-methyl-DL-tryptophan, an inhibitor of the soluble factor indoleamine 2, 3-dioxygenase (IDO). Immunosuppression by WJ-MSCs was also attenuated by blocking cell-cell contact between WJ-MSCs and responder T cells using a Transwell chamber. Moreover, IDO gene expression was induced in both WJ- and BM-MSCs by inflammatory cytokine IFN-gamma, but HLA-DR was expressed in BM-MSCs and not in WJ-MSCs upon stimulation by a relatively low concentration of IFN-gamma. These results indicate that WJ-MSCs exert their immunosuppressive effects by cell-cell contact with activated T cells and in part through IDO, and suggest the need for cells rather than soluble factors secreted from MSCs to achieve immunosuppressive therapy in severe cases of GVHD.	[He, Haiping; Tojo, Arinobu] Univ Tokyo, Div Mol Therapy, Ctr Adv Med Res, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [He, Haiping; Nagamura-Inoue, Tokiko; Takahashi, Atsuko; Mori, Yuka; Yamamoto, Yuki; Shimazu, Takahisa; Tojo, Arinobu] Univ Tokyo, Inst Med Sci, Dept Cell Proc & Transfus, Minato Ku, Tokyo 1088639, Japan; [Tsunoda, Hajime] Tokyo Hosp, NTT Med Ctr, Dept Obstet, Shinagawa, Tokyo 1410022, Japan	Nagamura-Inoue, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Cell Proc & Transfus, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tokikoni@ims.u-tokyo.ac.jp			Ministry of Health, Labor and Welfare and the Ministry of Education, Culture, Sports, Science and Technology of Japan [H26-Regeneration-010]	This study was supported by the Ministry of Health, Labor and Welfare and the Ministry of Education, Culture, Sports, Science and Technology of Japan (H26-Regeneration-010). The authors thank Ms. Y. Yuzawa and Y. Enomoto for their technical support, as well as the staff at the NTT Medical Center Hospital (Tokyo) for assistance with the collection of UC tissue and CB.	Muroi K, 2013, INT J HEMATOL, V98, P206, DOI 10.1007/s12185-013-1399-4; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Bernardo ME, 2012, BONE MARROW TRANSPL, V47, P164, DOI 10.1038/bmt.2011.81; Caimi PF, 2010, CURR OPIN HEMATOL, V17, P505, DOI 10.1097/MOH.0b013e32833e5b18; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Deuse T, 2011, CELL TRANSPLANT, V20, P655, DOI 10.3727/096368910X536473; Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367; Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Ishige I, 2009, INT J HEMATOL, V90, P261, DOI 10.1007/s12185-009-0377-3; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028; Agata H, 2010, TISSUE ENG PT A, V16, P663, DOI 10.1089/ten.TEA.2009.0500; Kronsteiner B, 2011, STEM CELLS DEV, V20, P2115, DOI 10.1089/scd.2011.0031; Girdlestone J, 2009, CYTOTHERAPY, V11, P738, DOI 10.3109/14653240903079401; Ennis J, 2008, CYTOTHERAPY, V10, P174, DOI 10.1080/14653240801891667; He HP, 2014, TISSUE ENG PT A, V20, P1314, DOI [10.1089/ten.TEA.2013.0333, 10.1089/ten.tea.2013.0333]; Kikuchi-Taura A, 2012, CYTOTHERAPY, V14, P441, DOI 10.3109/14653249.2012.658911; Miettinen JA, 2011, EXP CELL RES, V317, P791, DOI 10.1016/j.yexcr.2010.12.010; Nagamura-Inoue Tokiko, 2014, World J Stem Cells, V6, P195, DOI 10.4252/wjsc.v6.i2.195; Prasanna SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009016; Technau A, 2011, CYTOTHERAPY, V13, P310, DOI 10.3109/14653249.2010.504769; Wang D, 2010, EXP CELL RES, V316, P2414, DOI 10.1016/j.yexcr.2010.04.018	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	SEP	2015	102	3					368	378		10.1007/s12185-015-1844-7		11	Hematology	Hematology	CQ9MO	WOS:000360939400017		
J	Ando, T; Kojima, K; Isoda, H; Eguchi, Y; Honda, T; Ishigami, M; Kimura, S				Ando, Toshihiko; Kojima, Kensuke; Isoda, Hiroshi; Eguchi, Yuichiro; Honda, Takashi; Ishigami, Masatoshi; Kimura, Shinya			Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Chronic myeloid leukemia; Dasatinib; Hepatitis B virus; Reactivation; Escape mutant	IMMUNOSUPPRESSIVE THERAPY; T-LYMPHOCYTES; IMATINIB; PROLIFERATION; ACTIVATION; RITUXIMAB; LYMPHOMA; PATIENT	Reactivation of hepatitis B virus (HBV) following immunosuppressive therapy or hematopoietic stem cell transplantation is a potentially fatal complication that may occur even in patients with prior resolution of HBV infection. Dasatinib is a small-molecule inhibitor of the tyrosine kinases SRC and ABL that has been approved for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia. Here, we report the first case of reactivation of resolved infection with the HBV immune escape mutant G145R in a CML patient receiving dasatinib. Although dasatinib is not recognized as an immunosuppressant, our observations suggest that dasatinib may enhance HBV replication and induce its reactivation in immunocompetent patients, that HBV escape mutants may contribute to the pathogenesis of HBV reactivation, and that close monitoring of HBV status is advisable in patients with current or resolved HBV infection.	[Ando, Toshihiko; Kojima, Kensuke; Kimura, Shinya] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 8498501, Japan; [Isoda, Hiroshi] Saga Univ, Fac Med, Dept Internal Med, Div Hepatol Diabet Metab & Endocrinol, Saga 8498501, Japan; [Eguchi, Yuichiro] Saga Med Sch, Ctr Liver, Div Hepatol, Saga, Japan; [Honda, Takashi; Ishigami, Masatoshi] Nagoya Univ, Dept Gastroenterol & Hepatol, Sch Med, Nagoya, Aichi 4648601, Japan	Ando, T (reprint author), Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, 5-1-1 Nabeshima, Saga 8498501, Japan.	ando1013@gmail.com; kkojima@cc.saga-u.ac.jp			Bristol-Myers Squibb	Shinya Kimura has received research grants and lecture fees from Bristol-Myers Squibb.	Oketani M, 2012, HEPATOL RES, V42, P627, DOI 10.1111/j.1872-034X.2012.00998.x; Kimura S, 2014, INT J CLIN ONCOL, V19, P3, DOI 10.1007/s10147-013-0641-7; Sheldon J, 2008, J ANTIMICROB CHEMOTH, V61, P766, DOI 10.1093/jac/dkn014; Westhoff TH, 2003, BLOOD, V102, P1930, DOI 10.1182/blood-2003-05-1403; Cwynarski K, 2004, LEUKEMIA, V18, P1332, DOI 10.1038/sj.leu.2403401; Aoe M, 2014, INT J HEMATOL, V99, P609, DOI 10.1007/s12185-014-1565-3; Seggewiss R, 2005, BLOOD, V105, P2473, DOI 10.1182/blood-2004-07-2527; Kreutzman A, 2011, LEUKEMIA, V25, P1587, DOI 10.1038/leu.2011.135; Sillaber C, 2009, EUR J CLIN INVEST, V39, P1098, DOI 10.1111/j.1365-2362.2009.02206.x; Hwang JP, 2014, NAT REV GASTRO HEPAT, V11, P209, DOI 10.1038/nrgastro.2013.216; Skrabs C, 2002, LEUKEMIA, V16, P1884, DOI 10.1038/sj.leu.2402567; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Wolfl M, 2013, BONE MARROW TRANSPL, V48, P875, DOI 10.1038/bmt.2012.246; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; Coppola N, 2011, J MED VIROL, V83, P1909, DOI 10.1002/jmv.22199; Fujisawa S, 2014, INT J HEMATOL, V99, P141, DOI 10.1007/s12185-013-1470-1; Fukushima N, 2009, ANN ONCOL, V20, P2013, DOI 10.1093/annonc/mdp230; Mustjoki S, 2013, LEUKEMIA, V27, P914, DOI 10.1038/leu.2012.348; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182; Lai GM, 2013, WORLD J GASTROENTERO, V19, P1318, DOI 10.3748/wjg.v19.i8.1318; Kim DH, 2009, HAEMATOL-HEMATOL J, V94, P135, DOI 10.3324/haematol.13151; Chen J, 2008, J CELL MOL MED, V12, P2107, DOI 10.1111/j.1582-4934.2008.00234.x; Ikeda K, 2006, LEUKEMIA LYMPHOMA, V47, P155, DOI 10.1080/14639230500236818; Ishigami M, 2014, LIVER TRANSPLANT, V20, P1211, DOI 10.1002/lt.23935; Kamitsukasa H, 2015, J MED VIROL, V87, P589, DOI 10.1002/jmv.24115; Kang BW, 2009, INT J HEMATOL, V90, P383, DOI 10.1007/s12185-009-0386-2; Liaw YF, 1998, J GASTROEN HEPATOL, V13, P14, DOI 10.1111/j.1440-1746.1998.tb00539.x; Umemura T, 2008, CLIN INFECT DIS, V47, pE52, DOI 10.1086/590968	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	SEP	2015	102	3					379	382		10.1007/s12185-015-1788-y		4	Hematology	Hematology	CQ9MO	WOS:000360939400018		
J	Shimoda, H; Inoue, A; Tsuno, K; Kawakami, N				Shimoda, Haruki; Inoue, Akiomi; Tsuno, Kanami; Kawakami, Norito			One-year test-retest reliability of a Japanese web-based version of the WHO Composite International Diagnostic Interview (CIDI) for major depression in a working population	INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH			English	Article						major depression; WHO-Composite International Diagnostic Interview (WHO-CIDI); reliability; psychiatry; demographic characteristics	WORLD-HEALTH-ORGANIZATION; MENTAL-HEALTH; HIGH AGREEMENT; DISORDERS; PREVALENCE; CONCORDANCE; SEVERITY; SYMPTOMS; INTERNET; VALIDITY	The purpose of this study was to investigate the one-year test-retest reliability and the demographic correlates of a self-administered web-based depression section of the World Health Organization-Composite International Diagnostic Interview (WHO-CIDI) in a working population. Overall, 1060 out of all employees (N=1279) from a manufacturing company in Japan responded to two web-based surveys of depression of the WHO-CIDI within a one-year interval in 2009 and 2010. The concordance between lifetime diagnoses of major depressive disorder on two occasions was calculated as percent agreement (%), Gwet's AC(1), and Yule's Q indicators were compared by gender, age, education, and marital status. For the total sample, percent agreement was 94%, AC(1) was 0.93, and Yule's Q was 0.82. The concordance rate was low (0.15) among those who were diagnosed at either time or both times. The concordance differed significantly across education and marital status. While the agreement indicators were relatively high, consistent with previous reports based on face-to-face interviews conducted within a shorter interval, the low stability of positive cases may challenge the accuracy of lifetime diagnosis of major depressive disorder using a web version of the WHO-CIDI. Education and marital status might affect the test-retest reliability. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Shimoda, Haruki; Kawakami, Norito] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo 1130033, Japan; [Shimoda, Haruki] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Mental Hlth Policy & Evaluat, Tokyo, Japan; [Inoue, Akiomi] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Mental Hlth, Kitakyushu, Fukuoka 807, Japan; [Tsuno, Kanami] Wakayama Med Univ, Sch Med, Dept Hyg, Wakayama, Japan	Shimoda, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	harukis221@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [20240062]	The present study was supported by a Grant-in-Aid for Scientific Research (A) 2009-1011 (No. 20240062) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Agresti A., 2002, CATEGORICAL DATA ANA; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Kendall MG, 1939, ANN MATH STAT, V10, P275, DOI 10.1214/aoms/1177732186; Scott WA, 1955, PUBLIC OPIN QUART, V19, P321, DOI 10.1086/266577; Barnhart HX, 2001, BIOMETRICS, V57, P931, DOI 10.1111/j.0006-341X.2001.00931.x; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Donker T, 2010, J AFFECT DISORDERS, V122, P253, DOI 10.1016/j.jad.2009.07.013; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Bennett EM, 1954, PUBLIC OPIN QUART, V18, P303, DOI 10.1086/266520; Blood E., 2007, SAS GLOBAL FORUM STA, V186, P1; BROMET EJ, 1986, ARCH GEN PSYCHIAT, V43, P435; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Gwet K, 2002, STAT METHODS INTERRA, V2, P1; KAWAKAMI N, 1995, PSYCHOL MED, V25, P1181; Kawakami N, 2006, IGAKUNOAYUMI, V219, P925; Kawakami N., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P474; Peters L, 1998, PSYCHOL MED, V28, P893, DOI 10.1017/S0033291798006655; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Ritter P, 2004, J MED INTERNET RES, V6, P19, DOI 10.2196/jmir.6.3.e29; Vallejo MA, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.1.e2; Vera M. A. D., 2010, AM J EPIDEMIOL, V172, P1190, DOI [10.1093/aje/kwq273, DOI 10.1093/AJE/KWQ273]; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581; Williamson JM, 2000, BIOSTATISTICS, V1, P191, DOI 10.1093/biostatistics/1.2.191; WITTCHEN HU, 1989, ARCH GEN PSYCHIAT, V46, P437; Yule G. U., 1957, INTRO THEORY STAT, V14th, P30	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1049-8931	1557-0657		INT J METH PSYCH RES	Int. J. Methods Psychiatr. Res.	SEP	2015	24	3					204	212		10.1002/mpr.1437		9	Psychiatry	Psychiatry	CQ7AR	WOS:000360755700003		
J	Hwang, YC; Hayashi, T; Fujimoto, WY; Kahn, SE; Leonetti, DL; McNeely, MJ; Boyko, EJ				Hwang, Y-C; Hayashi, T.; Fujimoto, W. Y.; Kahn, S. E.; Leonetti, D. L.; McNeely, M. J.; Boyko, E. J.			Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype	INTERNATIONAL JOURNAL OF OBESITY			English	Article							JAPANESE-AMERICAN MEN; IMPAIRED GLUCOSE-TOLERANCE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; RISK-FACTORS; ALL-CAUSE; PREVALENCE; ASSOCIATION; METAANALYSIS; DEFINITION	BACKGROUND: A proportion of obese subjects appear metabolically healthy (MHO) but little is known about the natural history of MHO and factors predicting its future conversion to metabolically unhealthy obese (MUO). OBJECTIVES: The aim was to determine prospectively the frequency of conversion of MHO to MUO and the clinical variables that independently predicted this conversion, with a particular focus on the role of body composition. METHODS: We identified 85 Japanese Americans with MHO (56 men, 29 women), aged 34-73 years (mean age 49.8 years) who were followed at 2.5, 5 and 10 years after enrollment with measurements of metabolic characteristics, lifestyle and abdominal and thigh fat areas measured by computed tomography. Obesity was defined using the Asian body mass index criterion of >= 25 kg m(-2). Metabolically healthy was defined as the presence of <= 2 of 5 metabolic syndrome components proposed by the National Cholesterol Education Program Adult Treatment Panel III, while metabolically unhealthy was defined as >= 3 components. RESULTS: Over 10 years of follow-up, 55 MHO individuals (64.7%) converted to MUO. Statistically significant univariate predictors of conversion included dyslipidemia, greater insulin resistance and greater visceral abdominal (VAT) and subcutaneous abdominal fat area (SAT). In multivariate analysis, VAT (odds ratio per 1-s.d. increment (95% confidence interval) 2.04 (1.11-3.72), P = 0.021), high-density lipoprotein (HDL) cholesterol (0.24 (0.11-0.53), P<0.001), fasting plasma insulin (2.45 (1.07-5.62), P = 0.034) and female sex (5.37 (1.14-25.27), P = 0.033) were significantly associated with future conversion to MUO. However, SAT was not an independent predictor for future conversion to MUO. CONCLUSIONS: In this population, MHO was a transient state, with nearly two-thirds developing MUO over 10 years, with higher conversion to MUO independently associated with VAT, female sex, higher fasting insulin level and lower baseline HDL cholesterol level.	[Hwang, Y-C; Boyko, E. J.] VA Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, Seattle, WA 98101 USA; [Hwang, Y-C] Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Div Endocrinol & Metab,Dept Med, Seoul, South Korea; [Hayashi, T.] Osaka City Univ, Grad Sch Med, Dept Prevent Med & Environm Hlth, Osaka 558, Japan; [Fujimoto, W. Y.; Kahn, S. E.; McNeely, M. J.; Boyko, E. J.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Kahn, S. E.] VA Puget Sound Hlth Care Syst, Hosp & Specialty Med Serv, Seattle, WA 98101 USA; [Leonetti, D. L.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA	Boyko, EJ (reprint author), VA Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, 1100 Olive Way,Suite 1400, Seattle, WA 98101 USA.	eboyko@uw.edu	Hayashi, Tomoshige/N-8508-2015		Diabetes Research Center [DK-17047]; Clinical Nutrition Research Unit [DK-35816]; General Clinical Research Center at the University of Washington [RR-00037]; VA Puget Sound Health Care System; King County Japanese American community; National Institutes of Health [DK-31170, HL-49293, DK-017047]	This work was supported by facilities and services provided by the Diabetes Research Center (DK-17047), Clinical Nutrition Research Unit (DK-35816), and the General Clinical Research Center (RR-00037) at the University of Washington. VA Puget Sound Health Care System provided support for Drs Boyko and Kahn's involvement in this research. We are grateful to the King County Japanese American community for support and cooperation. Funding was through National Institutes of Health grants DK-31170, HL-49293 and DK-017047. The funding entities had no role in the conduct of this study or interpretation of its results.	Bluher M, 2012, CURR OPIN ENDOCRINOL, V19, P341, DOI 10.1097/MED.0b013e328357f0a3; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Koster A, 2010, OBESITY, V18, P2354, DOI 10.1038/oby.2010.86; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Phillips CM, 2013, REV ENDOCR METAB DIS, V14, P219, DOI 10.1007/s11154-013-9252-x; FUJIMOTO WY, 1987, DIABETES, V36, P730, DOI 10.2337/diabetes.36.6.730; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; BERGSTROM RW, 1990, DIABETOLOGIA, V33, P489, DOI 10.1007/BF00405111; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; Lear SA, 2007, AM J CLIN NUTR, V86, P353; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Bell JA, 2014, OBES REV, V15, P504, DOI 10.1111/obr.12157; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161; van der A DL, 2014, OBESITY, V22, P557, DOI 10.1002/oby.20480; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Soriguer F, 2013, J CLIN ENDOCR METAB, V98, P2318, DOI 10.1210/jc.2012-4253; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; FUJIMOTO WY, 1994, DIABETOLOGIA, V37, P524; Kim TN, 2013, J CLIN ENDOCR METAB, V98, P811, DOI 10.1210/jc.2012-3292; SHUMAN WP, 1986, INVEST RADIOL, V21, P483, DOI 10.1097/00004424-198606000-00007; TSUNEHARA CH, 1990, AM J CLIN NUTR, V52, P731; World Health Organization International Association for the Study of Obesity & International Obesity Task Force, 2000, AS PAC PERSP RED OB	32	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0307-0565	1476-5497		INT J OBESITY	Int. J. Obes.	SEP	2015	39	9					1365	1370		10.1038/ijo.2015.75		6	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CR0BY	WOS:000360984400005		
J	Ueda, P; Kondo, N; Fujiwara, T				Ueda, P.; Kondo, N.; Fujiwara, T.			The global economic crisis, household income and pre-adolescent overweight and underweight: a nationwide birth cohort study in Japan	INTERNATIONAL JOURNAL OF OBESITY			English	Article							CHILDHOOD OBESITY; FAMILY INCOME; SOCIOECONOMIC-FACTORS; FINANCIAL CRISIS; WEIGHT CHANGE; CHILDREN; ADOLESCENTS; ASSOCIATION; PREVALENCE; HEALTH	BACKGROUND: We hypothesized that children from lower income households and in households experiencing a negative income change in connection to the global economic crisis in 2008 would be at increased risk of adverse weight status during the subsequent years of economic downturn. METHODS: Data were obtained from a nationwide longitudinal survey comprising all children born during 2 weeks of 2001. For 16,403 boys and 15,206 girls, information about anthropometric measurements and household characteristics was collected from 2001 to 2011 on multiple occasions. Interactions between the crisis onset (September 2008) and household income group, as well as the crisis onset and a >30% negative income change in connection to the crisis, were assessed with respect to risk of childhood over-and underweight. RESULTS: Adjusted for household and parental characteristics, boys and girls in the lower household income quartiles had a larger increase in risk of overweight after the crisis onset relative to their peers in the highest income group. (Odds ratio (95% confidence interval) for interaction term in boys = 1.23 (1.02-1.24); girls = 1.35 (1.23-1.49) comparing the lowest with the highest income group.) Among girls, an interaction between the crisis onset and a >30% negative change in household income with respect to risk of overweight was observed (odds ratio for interaction term = 1.23 (1.09-1.38)). Girls from the highest income group had an increased risk of underweight after the crisis onset compared with girls from the lowest income group. CONCLUSIONS: Boys and girls from lower household income groups and girls from households experiencing a negative income change in connection to the global economic crisis in 2008, may be at increased risk of overweight. Vulnerability to economic uncertainty could increase risk of overweight in preadolescence.	[Ueda, P.] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Ueda, P.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Kondo, N.] Univ Tokyo, Sch Publ Hlth, Dept Hlth Educ & Hlth Sociol, Dept Hlth & Social Behav, Tokyo, Japan; [Fujiwara, T.] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan	Kondo, N (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Hlth Educ & Hlth Sociol, Dept Hlth & Social Behav,Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	naoki-kondo@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; MEXT, Ministry of Education, Culture, Sports, Science and Technology KAKENHI [25253052, 21119003]; Ministry of Health, Labour and Welfare, Japan [H26-chikyukibo-ippan-001]; AXA Life Insurance Co., Ltd.	Funding was received from Ministry of Education, Culture, Sports, Science and Technology; MEXT (No. 25253052) NK and TF: Grant-in-aid for Scientific Research on Innovative Areas, Ministry of Education, Culture, Sports, Science and Technology KAKENHI (21119003). NK is also supported by the Ministry of Health, Labour and Welfare, Japan (H26-chikyukibo-ippan-001) and 2015 CR Fixed Income Fund by AXA Life Insurance Co., Ltd.	Matsushita Y, 2004, OBES RES, V12, P205, DOI 10.1038/oby.2004.27; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Rajmil L, 2014, INT J ENV RES PUB HE, V11, P6528, DOI 10.3390/ijerph110606528; Kondo N, 2008, J EPIDEMIOL COMMUN H, V62, P869, DOI 10.1136/jech.2007.070334; Gundersen C, 2011, OBES REV, V12, pe54, DOI 10.1111/j.1467-789X.2010.00813.x; Senese LC, 2009, EPIDEMIOL REV, V31, P21, DOI 10.1093/epirev/mxp006; Yoshinaga M, 2010, PEDIATR INT, V52, P213, DOI 10.1111/j.1442-200X.2009.02930.x; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Wang YF, 2006, AM J CLIN NUTR, V84, P707; Gordon-Larsen P, 2003, OBES RES, V11, P121, DOI 10.1038/oby.2003.20; Richardson LP, 2003, ARCH PEDIAT ADOL MED, V157, P739, DOI 10.1001/archpedi.157.8.739; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Dallman MF, 2005, BRAIN BEHAV IMMUN, V19, P275, DOI 10.1016/j.bbi.2004.11.004; Korkeila M, 1998, INT J OBESITY, V22, P949, DOI 10.1038/sj.ijo.0800694; Redmond G, 2013, SOC POLICY ADMIN, V47, P709, DOI 10.1111/spol.12039; Canetti L, 2002, BEHAV PROCESS, V60, P157, DOI 10.1016/S0376-6357(02)00082-7; Anderson SE, 2006, ARCH PEDIAT ADOL MED, V160, P285, DOI 10.1001/archpedi.160.3.285; Watanabe E, 2011, INT J OBESITY, V35, P945, DOI 10.1038/ijo.2011.82; Kaneko K, 1999, PSYCHIAT CLIN NEUROS, V53, P365, DOI 10.1046/j.1440-1819.1999.00559.x; Boynton-Jarrett R, 2010, ARCH PEDIAT ADOL MED, V164, P540, DOI 10.1001/archpediatrics.2010.94; Demment MM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-417; Department for Environment Food and Rural Affairs (DEFRA), 2012, EXPL AN TRENDS INF P; DIPIETRO L, 1992, INT J OBESITY, V16, P745; Hall S, 2013, FAMILY MATTERS UNDER; Hayashi F, 2007, BR J NUTR, V96, P1154; Inaba Miyuki, 2011, Asian Social Work and Policy Review, V5, P79; Inokuchi M, 2009, ANN HUM BIOL, V36, P139, DOI 10.1080/03014460802635213; Kobayashi S, 2010, UFJ RES CONSULT, V2, P158; Lumeng JC, 2013, PEDIATRICS, V132, pE1506, DOI 10.1542/peds.2013-1111; Margerison-Zilko CE, 2013, OBESITY, V21, P1438, DOI 10.1002/oby.20333; Mikolajczyk RT, 2008, INT J PUBLIC HEALTH, V53, P214, DOI 10.1007/s00038-008-7123-0; Mitsuhashi T, 2012, J OCCUP HEALTH, V54, P25, DOI 10.1539/joh.11-0100-OA; Nakano Takuro, 2010, J Med Invest, V57, P124, DOI 10.2152/jmi.57.124; Nakano Takuro, 2010, J Med Invest, V57, P114, DOI 10.2152/jmi.57.114; Nguyen-Rodriguez Selena T, 2008, Eat Behav, V9, P238, DOI 10.1016/j.eatbeh.2007.09.001; Noh JW, 2014, J EPIDEMIOL, V24, P221, DOI 10.2188/jea.JE20130056; OECD, 2011, OECD DIVIDED WE STAN; OECD, 2013, OECD CRISIS SQUEEZES; Kendzor DE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-611; Sarlio-Lahteenkorva S, 2004, INT J OBESITY, V28, P568, DOI 10.1038/sj.ijo.0802596; Sekine Michikazu, 2002, J Epidemiol, V12, P9; Suglia SF, 2012, PEDIATRICS, V129, pE1173, DOI 10.1542/peds.2011-2456; Takimoto H, 2004, AM J PUBLIC HEALTH, V94, P1592, DOI 10.2105/AJPH.94.9.1592	43	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0307-0565	1476-5497		INT J OBESITY	Int. J. Obes.	SEP	2015	39	9					1414	1420		10.1038/ijo.2015.90		7	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CR0BY	WOS:000360984400013		
J	Katakura, N; Murakami, K				Katakura, Norio; Murakami, Kazuo			Field Study on the Influence of Floating Mud on the Long-Term Performance of Sand Capping Technique on Nutrient Release Reduction	INTERNATIONAL JOURNAL OF OFFSHORE AND POLAR ENGINEERING			English	Article						Sand capping; contaminated sediment; nutrient release; floating mud	SEDIMENTS; OXYGEN; BAY	Nutrients released from the contaminated bottom sediments on the seabed are widely known to be a source of water pollution. In order to minimize contaminant release from the sediments, the sand capping technique has been utilized in several coastal regions in Japan. However, the effectiveness of this technique has seldom been questioned due to new deposition on the seabed. This study describes the long-term performance of the sand capping technique on nutrient release reduction from contaminated bottom sediments in field experiments at the MM21 district in Yokohama Port. From the study, it is found that the effect of sand capping is maintained but is decreasing due to newly accumulated contaminated sediments on clean capping sand.	[Katakura, Norio] Taisei Corp, Ctr Technol, Tokyo, Japan; [Murakami, Kazuo] Tokyo City Univ, Kawasaki, Kanagawa, Japan	Katakura, N (reprint author), Taisei Corp, Ctr Technol, Tokyo, Japan.				Ministry of Land, Infrastructure, Transport and Tourism; Kanto Regional Development Bureau; Yokohama Port and Airport Technology Investigation Office	This study was supported by the Ministry of Land, Infrastructure, Transport and Tourism, the Kanto Regional Development Bureau, and the Yokohama Port and Airport Technology Investigation Office. Their provision of data and assistance is acknowledged with deep gratitude.	Kim G, 2007, ENVIRON TECHNOL, V28, P381, DOI 10.1080/09593332808618801; Cowan JLW, 1996, ESTUARIES, V19, P562, DOI 10.2307/1352518; Galvez-Cloutier R, 2006, AM SOC TEST MATER, V1482, P232, DOI 10.1520/STP37691S; Horie T, 1996, DOBOKU GAKKAI RONBUN, V533, P225; Hull JH, 1999, P 1999 C HAZ WAST RE, P286; Ignatieva Natalia V., 1999, Boreal Environment Research, V4, P295; Inoue T, 2009, J ENVIRON ENG-ASCE, V135, P1161, DOI 10.1061/(ASCE)0733-9372(2009)135:11(1161); Inoue T, 2000, J HYDROSCIENCE HYDRA, V18, P183; Inoue T., 2002, Proceedings of the 8th International Symposium on Flow Modeling and Turbulence Measurements. Advances in Fluid Modeling and Turbulence Measurements; Inoue T, 2002, J COASTAL ENG JSCE, V49, P1001; Ishibashi H, 2009, DOBOKU GAKKAI RONBUN, VB65, P1191; Japanese Industrial Standards, 1998, TEST METH IND WAST, P178; Japanese Industrial Standards, 2000, TEST METH PART SIZ D; Katakura N, 2006, J COASTAL ENG JSCE, V53, P1176; Katalcura N, 2007, P AS PAC COAST NANJ, P2136; Koizumi T, 2006, THESIS MUSASHI I TEC; Matsumoto E, 1982, GEOL NEWS, V331, P50; Ministry of the Environment, 1988, MAN BOTT SED SURV; Miyaoka S, 2001, CHARACTERIZATION SIN, V63, P91; Murakami K, 2006, AM SOC TEST MATER, V1482, P240, DOI 10.1520/STP37692S; Nakamura Y, 1994, P COASTAL ENG JSCE, V41, P1081; Nakamura Y, 2000, P COASTAL ENG JSCE, V47, P1081; Ogawa D, 2008, P CIVIL ENG OCEAN JS, V24, P663; Palermo M, 1998, 905B96004 EPA; Port of Yokohama, 2000, ENTR RES REP WAT QUA, pIV6; Ports and Harbors Bureau Ministry of Transport, 1993, REP INV IND SEA BLUE, P247; Ports of Fukuoka, 2005, REP INV IND SEA BLUE, P15; Research Council, 1985, DRP509 USA ENG WAT E, p,; Research Council, 1985, DRP509 USA ENG WAT E, P381; Research Council, 1985, DRP509 USA ENG WAT E, VPorts and Harbors Bureau, Ministry of Trans- port, P246; Sumeri A, 1994, DRP509 USA ENG WAT E; Water Quality Bureau Ministry of the Environment, 1988, SED QUAL ANAL METH	32	0	0	INT SOC OFFSHORE POLAR ENGINEERS	CUPERTINO	PO BOX 189, CUPERTINO, CA 95015-0189 USA	1053-5381			INT J OFFSHORE POLAR	Int. J. Offshore Polar Eng.	SEP	2015	25	3					231	238				8	Engineering, Civil; Engineering, Ocean; Engineering, Mechanical	Engineering	CR2MB	WOS:000361163000010		
J	Inada, E; Saitoh, I; Watanabe, S; Aoki, R; Miura, H; Ohtsuka, M; Murakami, T; Sawami, T; Yamasaki, Y; Sato, M				Inada, Emi; Saitoh, Issei; Watanabe, Satoshi; Aoki, Reiji; Miura, Hiromi; Ohtsuka, Masato; Murakami, Tomoya; Sawami, Tadashi; Yamasaki, Youichi; Sato, Masahiro			PiggyBac transposon-mediated gene delivery efficiently generates stable transfectants derived from cultured primary human deciduous tooth dental pulp cells (HDDPCs) and HDDPC-derived IPS cells	INTERNATIONAL JOURNAL OF ORAL SCIENCE			English	Article						drug selection; electroporation; genetically modified; human deciduous tooth dental pulp cells; PiggyBac	EMBRYONIC STEM-CELLS; BACULOVIRUS GENOME; MAMMALIAN-CELLS; T-ANTIGEN; IN-VITRO; EXPRESSION; MICE; FIBROBLASTS; TRANSGENE; THERAPY	The ability of human deciduous tooth dental pulp cells (HDDPCs) to differentiate into odontoblasts that generate mineralized tissue holds immense potential for therapeutic use in the field of tooth regenerative medicine. Realization of this potential depends on efficient and optimized protocols for the genetic manipulation of HDDPCs. In this study, we demonstrate the use of a Piggy Bac (PB)-based gene transfer system as a method for introducing nonviral transposon DNA into HDDPCs and HDDPC-derived inducible pluripotent stem cells. The transfection efficiency of the PB-based system was significantly greater than previously reported for electroporation-based transfection of plasmid DNA. Using the neomycin resistance gene as a selection marker, HDDPCs were stably transfected at a rate nearly 40-fold higher than that achieved using conventional methods. Using this system, it was also possible to introduce two constructs simultaneously into a single cell. The resulting stable transfectants, expressing tdTomato and enhanced green fluorescent protein, exhibited both red and green fluorescence. The established cell line did not lose the acquired phenotype over three months of culture. Based on our results, we concluded that PB is superior to currently available methods for introducing plasmid DNA into HDDPCs. There may be significant challenges in the direct clinical application of this method for human dental tissue engineering due to safety risks and ethical concerns. However, the high level of transfection achieved with PB may have significant advantages in basic scientific research for dental tissue engineering applications, such as functional studies of genes and proteins. Furthermore, it is a useful tool for the isolation of genetically engineered HDDPC-derived stem cells for studies in tooth regenerative medicine.	[Inada, Emi; Yamasaki, Youichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat Dent, Kagoshima 890, Japan; [Saitoh, Issei; Murakami, Tomoya; Sawami, Tadashi] Niigata Univ, Grad Sch Med & Dent Sci, Div Pediat Dent, Niigata, Japan; [Watanabe, Satoshi] Natl Inst Agrobiol Sci, Div Anim Sci, Anim Genome Res Unit, Ibaraki, Japan; [Aoki, Reiji] Natl Agr & Food Res Org, Funct Biomol Res Grp, Ibaraki, Japan; [Miura, Hiromi; Ohtsuka, Masato] Tokai Univ, Sch Med, Div Basic Mol Sci & Mol Med, Kanagawa 2591100, Japan; [Sato, Masahiro] Kagoshima Univ, Frontier Sci Res Ctr, Sect Gene Express Regulat, Kagoshima 8908544, Japan	Sato, M (reprint author), Kagoshima Univ, Frontier Sci Res Ctr, Sect Gene Express Regulat, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	masasato@ms.kagoshima-u.ac.jp			Ministry of Education, Science, Sports, Culture, and Technology of Japan [25463192]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) (grant no. 25463192) from the Ministry of Education, Science, Sports, Culture, and Technology of Japan.	Wei X, 2007, J ENDODONT, V33, P703, DOI 10.1016/j.joen.2007.02.009; Mir LM, 2014, METHODS MOL BIOL, V1121, P3, DOI 10.1007/978-1-4614-9632-8_1; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; NIWA H, 1991, GENE, V108, P193; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Berrill A, 2004, CYTOTECHNOLOGY, V44, P77, DOI 10.1023/B:CYTO.0000043414.90681.c2; Sato M, 2012, REPROD DOMEST ANIM, V47, P759, DOI 10.1111/j.1439-0531.2011.01964.x; Kim SJ, 2011, J VET MED SCI, V73, P1453; Nagy K, 2011, STEM CELL REV REP, V7, P693, DOI 10.1007/s12015-011-9239-5; Sato Masahiro, 2013, Biology (Basel), V2, P341, DOI 10.3390/biology2010341; Huang GTJ, 2006, CELL TISSUE RES, V324, P225, DOI 10.1007/s00441-005-0117-9; Chew SK, 2011, METHODS, V53, P366, DOI 10.1016/j.ymeth.2010.12.022; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/nmeth.1323, 10.1038/NMETH.1323]; Li RB, 2013, DIS MODEL MECH, V6, P828, DOI 10.1242/dmm.010827; Thibodeau B, 2007, J ENDODONT, V33, P680, DOI 10.1016/j.joen.2007.03.001; Galler KM, 2006, EUR J ORAL SCI, V114, P138, DOI 10.1111/j.1600-0722.2006.00327.x; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/nmeth.1332, 10.1038/NMETH.1332]; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yang XC, 2008, TISSUE ENG PT A, V14, P71, DOI 10.1089/ten.a.2007.0102; Scheller EL, 2008, J DENT RES, V87, P126; Nakayama A, 2007, CLONING STEM CELLS, V9, P523, DOI 10.1089/clo.2007.0021; Nakanishi H, 2010, MOL THER, V18, P707, DOI 10.1038/mt.2009.302; Navabazam AR, 2013, IRAN J REPROD MED, V11, P235; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; Kondo S, 2011, BIOCHEM BIOPH RES CO, V405, P382, DOI 10.1016/j.bbrc.2011.01.034; Bai DP, 2012, BIOSCI BIOTECH BIOCH, V76, P933, DOI 10.1271/bbb.110939; Balu B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-83; Bauser CA, 1999, INSECT MOL BIOL, V8, P223, DOI 10.1046/j.1365-2583.1999.820223.x; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Clark KJ, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-42; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; FRASER MJ, 1995, VIROLOGY, V211, P397, DOI 10.1006/viro.1995.1422; Gronthos S, 2002, J DENT RES, V81, P531; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Gubin AN, 1999, BIOTECHNIQUES, V27, P1162; Gubin AN, 1999, BIOTECHNIQUES, V27, P1166; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Karaoz E, 2010, HISTOCHEM CELL BIOL, V133, P95, DOI 10.1007/s00418-009-0646-5; Kenneth MH, 2002, SELTZER BENDERS DENT; Kettlun C, 2011, MOL THER, V19, P1636, DOI 10.1038/mt.2011.129; Maciejewska I, 2012, J DENT, V40, P542, DOI 10.1016/j.jdent.2012.04.004; Miura H, 2013, ANAL BIOCHEM, V437, P29, DOI 10.1016/j.ab.2013.02.003; Ohlfest JR, 2005, CURR GENE THER, V5, P629, DOI 10.2174/156652305774964749; Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168; Sato M., 1994, Animal Biotechnology, V5, P19; Strober W., 2001, CURR PROTOC IMMUNOL; Suchánek Jakub, 2010, Acta Medica (Hradec Kralove), V53, P93; Suguro H, 2008, INT ENDOD J, V41, P609, DOI 10.1111/j.1365-2591.2008.01409.x; Tabata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091548; Thonemann B, 2000, EUR J ORAL SCI, V108, P432, DOI 10.1034/j.1600-0722.2000.108005432.x; Thonemann B, 2000, ARCH ORAL BIOL, V45, P857, DOI 10.1016/S0003-9969(00)00056-X; Wang GZ, 2011, CHINESE MED J-PEKING, V124, P1395, DOI 10.3760/cma.j.issn.0366-6999.2011.09.022	56	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1674-2818	2049-3169		INT J ORAL SCI	Int. J. Oral Sci.	SEP	2015	7	3					144	154		10.1038/ijos.2015.18		11	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CR3SO	WOS:000361253600002		
J	Taguchi, H; Aono, Y; Kawato, T; Asano, M; Shimizu, N; Saigusa, T				Taguchi, Hiroko; Aono, Yuri; Kawato, Takayuki; Asano, Masatake; Shimizu, Noriyoshi; Saigusa, Tadashi			Intragingival injection of Porphyromonas gingivalis-derived lipopolysaccharide induces a transient increase in gingival tumour necrosis factor-alpha, but not interleukin-6, in anaesthetised rats	INTERNATIONAL JOURNAL OF ORAL SCIENCE			English	Article						Porphyromonas gingivalis; lipopolysaccharide; gingiva; tumour necrosis factor-alpha; microdialysis	PERIODONTAL TISSUE DESTRUCTION; BLACK-PIGMENTED BACTERIA; EPITHELIAL-CELLS; ESCHERICHIA-COLI; GENE-EXPRESSION; IL-6 PRODUCTION; TNF-ALPHA; FIBROBLASTS; RECEPTOR; DISEASE	This study used in vivo microdialysis to examine the effects of intragingival application of lipopolysaccharide (LPS) derived from Porphyromonas gingi va/is (Pg-LPS) on gingival tumour necrosis factor (TNF)-alpha and interleukin (IL)-6 levels in rats. A microdialysis probe with an injection needle attached to the surface of the dialysis membrane was implanted into the gingiva of the upper incisor. For comparison, the effects of LPS derived from Escherichia coli (Ec-LPS) on IL-6 and TNF-alpha levels were also analysed. Pg-LPS (1 mu g/1 mu L) or Ec-LPS (1 or 6 mu g/mu L) was applied by microsyringe, with gingival dialysates collected every hour. Enzyme-linked immunosorbent assay (ELISA) revealed that gingival dialysates contained approximately 389 pg.mL(-1) of IL-6 basally; basal TNF-alpha levels were lower than the detection limit of the ELISA. Pg-LPS failed to alter IL-6 levels but markedly increased TNF-alpha levels, which remained elevated for 2 h after treatment. Neither IL-6 nor TNF-alpha were affected by Ec-LPS. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis revealed that the gingiva expresses Toll-like receptor (TLR) 2 and TLR4 mRNA. Immunohistochemical examination showed that TLR2 and TLR4 are expressed by gingival epithelial cells. The present study provides in vivo evidence that locally applied Pg-LPS, but not Ec-LPS, into the gingiva transiently increases gingival TNF-alpha without affecting IL-6. The present results suggest that TLR2 but not TLR4 expressed on gingival epithelial cells may mediate the Pg-LPS-induced increase in gingival TNF-alpha in rats.	[Taguchi, Hiroko; Shimizu, Noriyoshi] Nihon Univ, Sch Dent, Dept Orthodont, Tokyo 101, Japan; [Aono, Yuri; Saigusa, Tadashi] Nihon Univ, Sch Dent, Dept Pharmacol, Matsudo, Chiba 2701194, Japan; [Aono, Yuri] Nihon Univ, Sch Dent, Dept Pharmacol, Tokyo 101, Japan; [Kawato, Takayuki] Nihon Univ, Sch Dent, Dept Oral Hlth Sci, Tokyo 101, Japan; [Asano, Masatake] Nihon Univ, Sch Dent, Dept Pathol, Tokyo 101, Japan	Saigusa, T (reprint author), Nihon Univ, Sch Dent, Dept Pharmacol, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2701194, Japan.	saigusa.tadashi@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25463100, 25861763]; Promotion and Mutual Aid Corporation for Private Schools of Japan; Nihon University Multidisciplinary Research Grant; Sato Fund; Uemura Fund; Dental Research Centre of the Nihon University School of Dentistry	This study was supported by a Grant-in-Aid for Scientific Research (C) (#25463100 to Tadashi Saigusa) and a Grant-in-Aid for Young Scientists (B) (#25861763 to Yuri Aono) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; a grant for the Promotion and Mutual Aid Corporation for Private Schools of Japan (Hiroko Taguchi, Takayuki Kawato, Masatake Asano, Noriyoshi Shimizu, Tadashi Saigusa); a Nihon University Multidisciplinary Research Grant for 2014-2015 (Yuri Aono, Tadashi Saigusa); and research grants from the Sato Fund (Takayuki Kawato, Masatake Asano, Noriyoshi Shimizu, Tadashi Saigusa), the Uemura Fund (Noriyoshi Shimizu, Tadashi Saigusa) and the Dental Research Centre (Takayuki Kawato, Masatake Asano, Noriyoshi Shimizu, Tadashi Saigusa) of the Nihon University School of Dentistry.	Andrian E, 2005, J CELL PHYSIOL, V204, P178, DOI 10.1002/jcp.20287; Andrukhov O, 2014, ACTA ODONTOL SCAND, V72, P337, DOI 10.3109/00016357.2013.834535; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Costalonga M, 2009, J PERIODONTAL RES, V44, P537, DOI 10.1111/j.1600-0765.2008.01152.x; Nakai K, 2013, BIOCHIMIE, V95, P922, DOI 10.1016/j.biochi.2012.12.016; Koyama S, 1999, EUR RESPIR J, V14, P545, DOI 10.1034/j.1399-3003.1999.14c11.x; Maeno M, 2013, J HARD TISSUE BIOL, V22, P287; Musacchio E, 2009, J RHEUMATOL, V36, P1575, DOI 10.3899/jrheum.081321; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Bette M, 2004, LAB ANIM-UK, V38, P272, DOI 10.1258/002367704323133655; Hajishengallis G, 2012, IMMUNOBIOLOGY, V217, P1111, DOI 10.1016/j.imbio.2012.07.007; Sugiyama A, 2002, J MED MICROBIOL, V51, P27; Burns E, 2010, J IMMUNOL, V184, P1455, DOI 10.4049/jimmunol.0900378; Zhang D, 2008, INNATE IMMUN, V14, P99, DOI 10.1177/1753425907088244; Beklen A, 2009, ORAL MICROBIOL IMMUN, V24, P38, DOI 10.1111/j.1399-302X.2008.00473.x; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Slots J, 2013, PERIODONTOL 2000, V62, P7, DOI 10.1111/prd.12011; Fonseca JE, 2009, AUTOIMMUN REV, V8, P538, DOI 10.1016/j.autrev.2009.01.012; Jones KJ, 2010, J PERIODONTOL, V81, P1850, DOI 10.1902/jop.2010.100226; Matsushita K, 1999, J ENDODONT, V25, P795, DOI 10.1016/S0099-2399(99)80299-4; Okada N, 1997, J PERIODONTAL RES, V32, P559, DOI 10.1111/j.1600-0765.1997.tb00932.x; Noh MK, 2013, EXP THER MED, V6, P847, DOI 10.3892/etm.2013.1222; Chen LL, 2001, ACTA PHARMACOL SIN, V22, P614; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; de la Pena A, 2000, ADV DRUG DELIVER REV, V45, P189, DOI 10.1016/S0169-409X(00)00106-X; de Aquino SG, 2009, ARCH ORAL BIOL, V54, P609, DOI 10.1016/j.archoralbio.2009.03.007; Dornelles FN, 2009, J PHARMACOL EXP THER, V330, P756, DOI 10.1124/jpet.109.155762; Dumltrescu AL, 2004, J CLIN PERIODONTOL, V31, P596; Ekhlassi S, 2008, J PERIODONTAL RES, V43, P431, DOI 10.1111/j.1600-0765.2008.01090.x; Fentoglu O, 2011, J CLIN PERIODONTOL, V38, P8, DOI 10.1111/j.1600-051X.2010.01644.x; Garlet GP, 2007, CLIN EXP IMMUNOL, V147, P128, DOI 10.1111/j.1365-2249.2006.03260.x; Nebel D, 2013, ACTA ODONTOL SCAND, V71, P892, DOI 10.3109/00016357.2012.734415; PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x; Saigusa T, 2009, EUR J PHARMACOL, V624, P10, DOI 10.1016/j.ejphar.2009.10.005; Selleri S, 2007, BRIT J DERMATOL, V156, P1172, DOI 10.1111/j.1365-2133.2007.07899.x; Wilson Michael, 1995, Science Progress, V78, P19	37	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1674-2818	2049-3169		INT J ORAL SCI	Int. J. Oral Sci.	SEP	2015	7	3					155	160		10.1038/ijos.2015.9		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CR3SO	WOS:000361253600003		
J	Hirata, K; Takahashi, T; Tomita, A; Gonda, T; Maeda, Y				Hirata, Kiyotaka; Takahashi, Toshihito; Tomita, Akiko; Gonda, Tomoya; Maeda, Yoshinobu			The Influence of Loading Variables on Implant Strain When Supporting Distal-Extension Removable Prostheses: An In Vitro Study	INTERNATIONAL JOURNAL OF PROSTHODONTICS			English	Article								Purpose: The purpose of this study was to determine the implant stress under distal-extension removable prostheses (DERPs). Materials and Methods: A mandibular distal-extension cast and denture were fabricated. Strain gauges were attached to the implant, which was placed either parallel to the distal abutment or perpendicular to the ridge crest (inclined). Occlusal load was applied in five directions, and strains were compared using the Kruskal-Wallis test (P =.05). Results: When the implant was parallel, the strain was maximum at 20 degrees applied load direction. When the implant was inclined, the strain was minimum at 20 degrees mesial and maximum at 20 degrees applied distal load direction. Conclusions: Implant bending strain is reduced when the implant is loaded on its long axis and oriented parallel with the long axis of the most distal tooth.	[Hirata, Kiyotaka; Takahashi, Toshihito; Tomita, Akiko; Gonda, Tomoya; Maeda, Yoshinobu] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka 5650871, Japan	Takahashi, T (reprint author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	toshi-t@dent.osaka-u.ac.jp					Isidor F, 1996, CLIN ORAL IMPLAN RES, V7, P143, DOI 10.1034/j.1600-0501.1996.070208.x; Quirynen M, 1992, Clin Oral Implants Res, V3, P104, DOI 10.1034/j.1600-0501.1992.030302.x; Brudvik JS, 1999, ADV REMOVABLE PARTIA, P153; Giffin KM, 1996, J PROSTHET DENT, V76, P347, DOI 10.1016/S0022-3913(96)90536-3; Minoretti R, 2009, INT J ORAL MAX IMPL, V24, P1129	5	0	0	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0893-2174	1942-4426		INT J PROSTHODONT	Int. J. Prosthodont.	SEP-OCT	2015	28	5					484	486				3	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CR0HC	WOS:000360998200006		
J	Lau, CS; Chia, F; Harrison, A; Hsieh, TY; Jain, R; Jung, SM; Kishimoto, M; Kumar, A; Leong, KP; Li, Z; Lichauco, JJ; Louthrenoo, W; Luo, SF; Nash, P; Ng, CT; Park, SH; Suryana, BPP; Suwannalai, P; Wijaya, LK; Yamamoto, K; Yang, Y; Yeap, SS				Lau, Chak Sing; Chia, Faith; Harrison, Andrew; Hsieh, Tsu-Yi; Jain, Rahul; Jung, Seung Min; Kishimoto, Mitsumasa; Kumar, Ashok; Leong, Khai Pang; Li, Zhanguo; Javier Lichauco, Juan; Louthrenoo, Worawit; Luo, Shue-Fen; Nash, Peter; Ng, Chin Teck; Park, Sung-Hwan; Suryana, Bagus Putu Putra; Suwannalai, Parawee; Wijaya, Linda Kurniaty; Yamamoto, Kazuhiko; Yang, Yue; Yeap, Swan Sim			APLAR rheumatoid arthritis treatment recommendations	INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES			English	Review						drug treatment; rheumatoid arthritis	MODIFYING ANTIRHEUMATIC DRUGS; TUMOR-NECROSIS-FACTOR; RANDOMIZED CONTROLLED-TRIALS; BRITISH HEALTH-PROFESSIONALS; ALPHA ANTAGONIST THERAPY; SOCIETY-FOR-RHEUMATOLOGY; PLACEBO-CONTROLLED TRIAL; 1ST 2 YEARS; EULAR RECOMMENDATIONS; CONSENSUS STATEMENT	AimsRheumatoid arthritis is a chronic inflammatory condition that affects approximately 1% of the world's population. There are a wide number of guidelines and recommendations available to support the treatment of rheumatoid arthritis; however, the evidence used for these guidelines is predominantly based on studies in Caucasian subjects and may not be relevant for rheumatoid arthritis patients in the Asia-Pacific region. Therefore, the Asia Pacific League of Associations for Rheumatology established a Steering Committee in 2013 to address this issue. Materials and methodsThe AGREE II instrument and the ADAPTE Collaboration framework were applied to systematically identify, appraise, synthesize, and adapt international rheumatoid arthritis guidelines for use in the Asia-Pacific region. ResultsForty rheumatoid arthritis treatment recommendations, based on evidence and expert opinion, were drafted and are presented in this report. ConclusionThe Asia Pacific of Associations for Rheumatology rheumatoid arthritis treatment recommendations are intended to serve as a reference for best practice management of rheumatoid arthritis in Asia-Pacific, focusing on local issues to ensure the delivery of basic care for these patients, and to improve their outcomes. In addition, the document will serve as a reference for national rheumatology associations in Asia-Pacific for developing guidelines in their respective countries.	[Lau, Chak Sing] Univ Hong Kong, Queen Mary Hosp, Div Clin Immunol & Rheumatol, Hong Kong, Hong Kong, Peoples R China; [Chia, Faith; Leong, Khai Pang] Tan Tock Seng Hosp, Dept Rheumatol Allergy & Immunol, Singapore, Singapore; [Harrison, Andrew] Univ Otago Wellington, Dept Med, Wellington, New Zealand; [Hsieh, Tsu-Yi] Taichung Vet Gen Hosp, Sect Allergy Immunol & Rheumatol, Taichung, Taiwan; [Hsieh, Tsu-Yi] Taichung Vet Gen Hosp, Sect Clin Skills Training, Taichung, Taiwan; [Jain, Rahul] Narayana Hosp, Jaipur, Rajasthan, India; [Jung, Seung Min; Park, Sung-Hwan] Catholic Univ Korea, St Marys Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Kishimoto, Mitsumasa] St Lukes Int Hosp, Immunorheumatol Ctr, Tokyo, Japan; [Kumar, Ashok] Fortis Flt Lt Rajan Dhall Hosp, Dept Rheumatol, New Delhi, India; [Li, Zhanguo; Yang, Yue] Peking Univ, Peoples Hosp, Dept Rheumatol, Beijing 100871, Peoples R China; [Javier Lichauco, Juan] St Lukes Med Ctr, Quezon City, Philippines; [Louthrenoo, Worawit] Chiang Mai Univ, Fac Med, Dept Internal Med, Div Rheumatol, Chiang Mai 50000, Thailand; [Luo, Shue-Fen] Chang Gung Mem Hosp, Dept Rheumatol Allergy & Immunol, Taoyuan, Taiwan; [Luo, Shue-Fen] Chang Gung Univ, Taoyuan, Taiwan; [Nash, Peter] Univ Queensland, Dept Med, Brisbane, Qld 4000, Australia; [Ng, Chin Teck] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore; [Suryana, Bagus Putu Putra] Brawijaya Univ, Saiful Anwar Gen Hosp, Dept Internal Med, Div Rheumatol, Malang, Indonesia; [Suwannalai, Parawee] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Internal Med,Allergy Immunol & Rheumatol Div, Bangkok 10400, Thailand; [Wijaya, Linda Kurniaty] Univ Indonesia, Dept Internal Med, Div Rheumatol, Jakarta, Indonesia; [Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Yeap, Swan Sim] Subang Jaya Med Ctr, Selangor, Malaysia	Lau, CS (reprint author), Univ Hong Kong, Queen Mary Hosp, Div Clin Immunol & Rheumatol, Hong Kong, Hong Kong, Peoples R China.	cslau@hku.hk			AbbVie; Janssen; Pfizer; Roche; UCB	APLAR and unrestricted educational grants from the following pharmaceutical companies: AbbVie, Janssen, Pfizer, Roche and UCB.	Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Gaujoux-Viala C, 2010, ANN RHEUM DIS, V69, P1004, DOI 10.1136/ard.2009.127225; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Weinblatt ME, 2003, ARTHRITIS RHEUM, V48, P35, DOI 10.1002/art.10697; Turesson C, 1999, RHEUMATOLOGY, V38, P668, DOI 10.1093/rheumatology/38.7.668; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Elkayam O, 2004, SEMIN ARTHRITIS RHEU, V33, P283, DOI 10.1053/S0049-0172(03)00212-9; Filipovic I, 2011, RHEUMATOLOGY, V50, P1083, DOI 10.1093/rheumatology/keq399; Fonseca JE, 2010, ACTA REUMATOL PORT, V35, P95; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Breedveld FC, 2006, ARTHRITIS RHEUM, V54, P26, DOI 10.1002/art.21519; van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816; Caporali R, 2008, AUTOIMMUN REV, V8, P139, DOI 10.1016/j.autrev.2008.05.001; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Bongartz T, 2009, ANN RHEUM DIS, V68, P1177, DOI 10.1136/ard.2008.094904; Ledingham J, 2005, RHEUMATOLOGY, V44, P157, DOI 10.1093/rheumatology/keh464; Moreland LW, 2012, ARTHRITIS RHEUM-US, V64, P2824, DOI 10.1002/art.34498; Thompson AE, 2011, ARTHRITIS RHEUM-US, V63, P1479, DOI 10.1002/art.30310; Gorter SL, 2010, ANN RHEUM DIS, V69, P1010, DOI 10.1136/ard.2009.127332; Bykerk VP, 2012, J RHEUMATOL, V39, P1559, DOI 10.3899/jrheum.110207; O'Dell JR, 2013, NEW ENGL J MED, V369, P307, DOI 10.1056/NEJMoa1303006; van Vollenhoven RF, 2012, LANCET, V379, P1712, DOI 10.1016/S0140-6736(12)60027-0; Westhovens R, 2006, ARTHRITIS RHEUM, V54, P1075, DOI 10.1002/art.21734; Kennedy T, 2005, RHEUMATOLOGY, V44, P553, DOI 10.1093/rheumatology/keh554; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Askling J, 2007, ANN RHEUM DIS, V66, P1339, DOI 10.1136/ard.2006.062760; Bombardier C, 2012, J RHEUMATOL, V39, P1583, DOI 10.3899/jrheum.120165; Albrecht K, 2014, RHEUMATOL INT, V34, P1, DOI 10.1007/s00296-013-2848-3; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Westlake SL, 2011, RHEUMATOLOGY, V50, P518, DOI 10.1093/rheumatology/keq316; Katchamart W, 2009, ANN RHEUM DIS, V68, P1105, DOI 10.1136/ard.2008.099861; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X; Glaser SL, 2008, INT J CANCER, V123, P1499, DOI 10.1002/ijc.23741; Smolen JS, 2007, ANN RHEUM DIS, V66, P143, DOI 10.1136/ard.2006.061002; Fautrel B, 2007, JOINT BONE SPINE, V74, P627, DOI 10.1016/j.jbspin.2007.10.001; Luqmani R, 2009, RHEUMATOLOGY, V48, P436, DOI 10.1093/rheumatology/ken450a; Buch MH, 2011, ANN RHEUM DIS, V70, P909, DOI 10.1136/ard.2010.144998; Kwong YL, 2009, LANCET ONCOL, V10, P1093, DOI 10.1016/S1470-2045(09)70265-7; Emery P, 2002, ANN RHEUM DIS, V61, P290, DOI 10.1136/ard.61.4.290; Knevel R, 2010, ANN RHEUM DIS, V69, P987, DOI 10.1136/ard.2009.126748; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Listing J, 2008, ARTHRITIS RHEUM-US, V58, P667, DOI 10.1002/art.23281; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; da Mota LMH, 2013, REV BRAS REUMATOL, V53, P158, DOI 10.1590/S0482-50042013000200004; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Kremer J, 2013, ANN INTERN MED, V159, P253, DOI 10.7326/0003-4819-159-4-201308200-00006; Luqmani R, 2006, RHEUMATOLOGY, V45, P1167, DOI 10.1093/rheumatology/kel215a; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Verstappen SMM, 2011, ANN RHEUM DIS, V70, P823, DOI 10.1136/ard.2010.140822; Lu LJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P979, DOI 10.1002/art.24643; Deighton C, 2010, RHEUMATOLOGY, V49, P1197, DOI 10.1093/rheumatology/keq006a; Smolen JS, 2013, ANN RHEUM DIS, V72, P482, DOI 10.1136/annrheumdis-2012-202469; Fonseca JE, 2011, ACTA REUMATOL PORT, V36, P385; Ormerod LP, 2005, THORAX, V60, P800, DOI 10.1136/thx.2005.046797; Bukhari M, 2011, RHEUMATOLOGY, V50, P2311, DOI 10.1093/rheumatology/ker106a; Caporali R, 2011, CLIN EXP RHEUMATOL, V29, pS7; Cardiel M, 2006, RHEUMATOLOGY S2, V45, pii7; da Mota Licia Maria Henrique, 2012, Rev Bras Reumatol, V52, P152; Dudler J, 2010, SWISS MED WEEKLY, V140; Emery P, 2001, RHEUMATOLOGY, V40, P699, DOI 10.1093/rheumatology/40.6.699; Fautrel B, 2006, JOINT BONE SPINE, V73, P433, DOI 10.1016/jbspin.2006.04.001; Favalli EG, 2011, CLIN EXP RHEUMATOL, V29, pS15; Flavell KJ, 2001, BRIT J CANCER, V85, P350, DOI 10.1054/bjoc.2001.1872; Gettings Lynda, 2010, Musculoskeletal Care, V8, P99, DOI 10.1002/msc.171; Gossec L, 2005, JOINT BONE SPINE, V72, P229, DOI 10.1016/j.jbspin.2004.10.011; Hara Masako, 2007, Mod Rheumatol, V17, P1, DOI 10.1007/s10165-006-0542-y; Katchamart W, 2010, J RHEUMATOL, V37, P1422, DOI 10.3899/jrheum.090978; Kawai S, 2011, MOD RHEUMATOL, V21, P458, DOI 10.1007/s10165-011-0425-8; Koike R, 2007, MOD RHEUMATOL, V17, P451, DOI 10.3109/s10165-007-0626-3; Koike R, 2009, MOD RHEUMATOL, V19, P351, DOI 10.1007/s10165-009-0197-6; Lau CS, 2007, NAT CLIN PRACT RHEUM, V3, P305, DOI 10.1038/ncprheum0509; Le Blay P, 2012, CLIN EXP RHEUMATOL, V30, P756; Lichauco JJ, 2006, INT J RHEUM DIS, V9, P184; Mariette X, 2003, Ann Rheum Dis, V62, P791, DOI 10.1136/ard.62.8.791; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Misra R, 2008, INDIAN J RHEUMATO S3, V3, P1; Miyasaka N, 2005, MOD RHEUMATOL, V15, P4; Miyasaka N, 2006, MOD RHEUMATOL, V16, P63; Mok CC, 2011, CLIN RHEUMATOL, V30, P303, DOI 10.1007/s10067-010-1596-y; Moreland L, 2005, ARTHRITIS RES THER, V7, pS2, DOI 10.1186/ar1736; Moulis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048991; Mouterde G, 2010, JOINT BONE SPINE, V77, P597, DOI 10.1016/j.jbspin.2009.12.011; National Collaborating Centre for Chronic Conditions, 2009, RHEUM ARTHR NAT CLIN; Nordgaard- Lassen I, 2012, DAN MED J, V59, pC4480; Ostensen M, 2014, AUTOIMMUN REV, V14, P376; Pham T, 2005, JOINT BONE SPINE, V72, P222, DOI 10.1016/j.jbspin.2004.10.010; Rheumatoid Arthritis Study Group of the Portuguese Society of Rheumatology, 2007, ACTA REUMATOL PORT, V32, P363; Ruyssen-Witrand A, 2014, ANN RHEUM DIS, V2014, P1; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; SALAFFI F, 2009, HEALTH QUAL LIFE OUT, V18, P25, DOI DOI 10.1186/1477-7525-7-25; Salmon D, 2002, JOINT BONE SPINE, V69, P170, DOI 10.1016/S1297-319X(02)00387-1; Schieir O, 2010, ANN RHEUM DIS     S3, V69, P652; Schoels Monika, 2012, Reumatol Clin, V8, P1, DOI 10.1016/j.reuma.2011.07.002; Scott DL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1046; Sekiguchi N, 2006, MOD RHEUMATOL, V16, P85; Takeuchi T, 2014, MOD RHEUMATOL, V24, P8, DOI 10.3109/14397595.2013.854074; Valesini G, 2006, CLIN EXP RHEUMATOL, V24, P413; World Cancer Research Fund International, CANC STAT DAT SPEC C	104	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1756-1841	1756-185X		INT J RHEUM DIS	Int. J. Rheum. Dis.	SEP	2015	18	7					685	713		10.1111/1756-185X.12754		29	Rheumatology	Rheumatology	CQ7FC	WOS:000360767400001		
J	Hanaoka, H; Kuwana, M; Takeuchi, T				Hanaoka, Hironari; Kuwana, Masataka; Takeuchi, Tsutomu			Glomerulomegaly in lupus nephritis: a prognostic marker for renal outcomes	INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES			English	Article						glomerulomegaly; lupus nephritis; systemic lupus erythematosus	ERYTHEMATOSUS; GLOMERULONEPHRITIS; CLASSIFICATION; MORTALITY; DISEASE; INDEX	AimGlomerulomegaly refers to the abnormal enlargement of glomeruli and is associated with an increased risk of progressive chronic kidney disease (CKD). However, it has rarely been investigated in lupus nephritis (LN). We therefore assessed glomerulomegaly as a prognostic factor for renal pathology. MethodPatients with class III or IV LN were retrospectively recruited and divided into two groups according to complete renal response (CR) at 3years after the initiation of induction therapy. Baseline clinical and renal pathological findings were compared to identify prognostic factors, and patients were followed for up to 10years to assess long-term renal outcomes. ResultsNineteen patients with and 19 without CR on 3-year follow-up were analyzed. Long-term disease duration and high levels of proteinuria were frequently observed in patients without CR (P=0.03 and P=0.01, respectively) at baseline compared to those with CR. On renal pathological analysis, a significantly higher proportion of patients without CR had enlarged glomeruli than those with CR (P=0.03) in analysis of segmentally or minimally affected glomeruli. On 10-year follow-up, a higher proportion of patients without enlarged glomeruli maintained CR compared to those with enlarged glomeruli (P=0.004). Further, glomerular area and disease duration were significantly correlated (P=0.04). ConclusionsEnlarged segmentally or minimally affected glomeruli at diagnosis of LN might predict a worse renal prognosis at 3years after induction therapy. Mechanical glomerular injury might influence clinical outcomes.	[Hanaoka, Hironari; Kuwana, Masataka; Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo 1608582, Japan; [Kuwana, Masataka] Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 113, Japan	Hanaoka, H (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hhanaoka1208@yahoo.co.jp	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	AstraZeneca; Abbott; Astellas; Bristol-Myers; Chugai; Daiichi Sankyo; Eisai; Mitsubishi Tanabe; Pfizer; Sanofi; Santen; Takeda; Teijin; AbbVie; Asahi Kasei; Taisho Toyama; Janssen; Eli Lilly; Novartis	HH received consulting fees from AstraZeneca. TT received grants from Abbott, Astellas, Bristol-Myers, Chugai, Daiichi Sankyo, Eisai, Mitsubishi Tanabe, Pfizer, Sanofi, Santen, Takeda, Teijin, AbbVie, Asahi Kasei and Taisho Toyama; lecture fees from Abbott, Bristol-Myers, Chugai, Eisai, Janssen, Mitsubishi Tanabe, Pfizer, Takeda, Astellas and Daiichi Sankyo; and consulting fees from AstraZeneca, Eli Lilly, Novartis, Mitsubishi Tanabe, Asahi Kasei, AbbVie and Daiichi Sankyo.	Houssiau FA, 2004, ARTHRITIS RHEUM-US, V50, P3934, DOI 10.1002/art.20666; Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Macconi D, 2009, AM J PATHOL, V174, P797, DOI 10.2353/ajpath.2009.080227; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Alsuwaida A, 2012, NEPHROL DIAL TRANSPL, V27, P1472, DOI 10.1093/ndt/gfr517; Bertsias GK, 2012, ANN RHEUM DIS, V71, P1771, DOI 10.1136/annrheumdis-2012-201940; Mok CC, 2005, LUPUS, V14, P39, DOI 10.1191/0961203305lu2057oa; Hughson MD, 2011, NEPHROL DIAL TRANSPL, V26, P2202, DOI 10.1093/ndt/gfq688; Faurschou M, 2010, ARTHRIT CARE RES, V62, P873, DOI 10.1002/acr.20116; BALDWIN DS, 1977, AM J MED, V62, P12, DOI 10.1016/0002-9343(77)90345-X; Rahman P, 2001, LUPUS, V10, P93, DOI 10.1191/096120301670679959; Tsuboi N, 2012, CLIN J AM SOC NEPHRO, V7, P735, DOI 10.2215/CJN.07270711; MAGIL AB, 1988, KIDNEY INT, V34, P511, DOI 10.1038/ki.1988.211; Stahl-Hallengren C, 2000, J RHEUMATOL, V27, P685; AUSTIN HA, 1994, KIDNEY INT, V45, P544, DOI 10.1038/ki.1994.70; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; FOGO A, 1991, AM J KIDNEY DIS, V17, P666; Fogo AB, 2001, KIDNEY INT, V59, P804, DOI 10.1046/j.1523-1755.2001.059002804.x; VansVollenhoven RF, 2014, ANN RHEUM DIS, V73, P958	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1756-1841	1756-185X		INT J RHEUM DIS	Int. J. Rheum. Dis.	SEP	2015	18	7					768	775		10.1111/1756-185X.12682		8	Rheumatology	Rheumatology	CQ7FC	WOS:000360767400009		
J	Cirocchi, R; Graziosi, L; Sanguinetti, A; Boselli, C; Polistena, A; Renzi, C; Desiderio, J; Noya, G; Parisi, A; Hirota, M; Donini, A; Avenia, N				Cirocchi, Roberto; Graziosi, Luigina; Sanguinetti, Alessandro; Boselli, Carlo; Polistena, Andrea; Renzi, Claudio; Desiderio, Jacopo; Noya, Giuseppe; Parisi, Amilcare; Hirota, Masahiko; Donini, Annibale; Avenia, Nicola			Can the measurement of amylase in drain after distal pancreatectomy predict post-operative pancreatic fistula?	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Distal pancreatectomy; Drain amylase; Pancreatic fistula	INTERNATIONAL STUDY-GROUP; INTRAPERITONEAL DRAINAGE; RISK-FACTORS; CRITICAL-APPRAISAL; MULTICENTER TRIAL; RANDOMIZED-TRIAL; RESECTION; PANCREATICODUODENECTOMY; CLOSURE; METAANALYSIS	Introduction: The most frequent reason for performing a distal pancreatectomy is the presence of cystic or neuroendocrine tumors, in which the distal pancreatic stump is often soft and non fibrotic. This parenchymal consistence represents the main risk factor for post-operative pancreatic fistula. In order to identify the fistula and assessing its severity postoperative monitoring of amylase from intraperitoneal drains is important. Methods: From a retrospective multicentric database analysis were included 33 patients who underwent distal pancreatectomy for pancreatic neoplastic disease. Results: Postoperative pancreatic fistula occurred in four cases. One patient had a ductal adenocarcinoma, two presented with pancreatic endocrine neoplasms and the last one had an intraductal papillary mucinous neoplasia. Two patients underwent open, the other two laparoscopic distal pancreatectomy. Discussion: Postoperative pancreatic fistulas after distal pancreatectomy worsen the quality of life, prolong the post-operative stay and delay further adjuvant therapy. In patients who underwent distal pancreatectomy literature exposed some advantages deriving from the placement of abdominal drainages only in selected cases and from their early removal. Patients presenting a high risk of pancreatic fistula had higher amylase levels of drainage fluid in the first postoperative day. Conclusion: POPF is the most frequently complication after pancreatectomy. In our analysis DFA1 > 5000 can be considered as a predictive factor for pancreatic fistula. For this reason, the systematic measurement of amylase in drain fluid in first-postoperative day can be considered a good clinical practice. (C) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.	[Cirocchi, Roberto; Desiderio, Jacopo] Univ Perugia, Dept Gen & Oncol Surg, Terni, Italy; [Graziosi, Luigina; Donini, Annibale] Univ Perugia, Santa Maria della Misericordia Hosp, Gen & Emergency Surg, I-06156 Perugia, Italy; [Sanguinetti, Alessandro; Polistena, Andrea; Avenia, Nicola] Univ Perugia, St Mary Hosp, Dept Gen Surg, Terni, Italy; [Boselli, Carlo; Renzi, Claudio; Noya, Giuseppe] Univ Perugia, Dept Gen & Oncol Surg, I-06156 Perugia, Italy; [Parisi, Amilcare] St Maria Hosp, Dept Digest Surg, Terni, Italy; [Hirota, Masahiko] Kumamoto Reg Med Ctr, Kumamoto, Japan	Renzi, C (reprint author), Univ Perugia, Dept Gen & Oncol Surg, St Maria Hosp, Via Gambuli 1, I-06156 Perugia, Italy.	roberto.cirocchi@unipg.it; luiginagraziosi@yahoo.it; a.sanguinetti@aospterni.it; carloboselli@yahoo.it; apolis74@yahoo.it; renzicla@virgilio.it; djdesi85@hotmail.it; giuseppe.noya@unipg.it; amilcareparisi@virgilio.it; mhirota@krmc.or.jp; annibale.donini@unipg.it; nicolaavenia@libero.it					Callery MP, 2009, J GASTROINTEST SURG, V13, P163, DOI 10.1007/s11605-008-0534-7; Lin JW, 2004, J GASTROINTEST SURG, V8, P951, DOI 10.1016/j.gassur.2004.09.044; Mehta SS, 2012, SURG ENDOSC, V26, P402, DOI 10.1007/s00464-011-1887-7; Yamaguchi M, 2003, HEPATO-GASTROENTEROL, V50, P1155; [Anonymous], 2001, ANN SURG, DOI DOI 10.1097/00000658-200110000-00008]; Cecka F, 2013, HEPATOB PANCREAT DIS, V12, P533, DOI 10.1016/S1499-3872(13)60084-3; El Nakeeb A, 2013, WORLD J SURG, V37, P1405, DOI 10.1007/s00268-013-1998-5; Sutcliffe RP, 2012, WORLD J SURG, V36, P879, DOI 10.1007/s00268-012-1460-0; Diener MK, 2011, LANCET, V377, P1514, DOI 10.1016/S0140-6736(11)60237-7; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Rieder B, 2010, GASTROINTEST ENDOSC, V72, P536, DOI 10.1016/j.gie.2010.04.011; Goh BKP, 2008, ARCH SURG-CHICAGO, V143, P956, DOI 10.1001/archsurg.143.10.956; Nathan H, 2009, ANN SURG, V250, P277, DOI 10.1097/SLA.0b013e3181ae34be; Pratt WB, 2007, ANN SURG, V245, P443, DOI 10.1097/01.sla.0000251708.70219.d2; Kaminsky PM, 2013, J SURG RES, V184, P925, DOI 10.1016/j.jss.2013.05.092; Lowy AM, 1997, ANN SURG, V226, P632, DOI 10.1097/00000658-199711000-00008; Kawai M, 2011, J HEPATO-BIL-PAN SCI, V18, P601, DOI 10.1007/s00534-011-0373-x; Okano K, 2008, J HEPATO-BILIARY-PAN, V15, P353, DOI 10.1007/s00534-008-1328-8; Bassi C, 2010, ANN SURG, V252, P207, DOI 10.1097/SLA.0b013e3181e61e88; Sauvanet A, 2002, SURGERY, V132, P836, DOI 10.1067/msy.2002.127552; Ridolfi C, 2014, BIOMED RES INT, DOI 10.1155/2014/641239; Kim JH, 2013, HEPATO-GASTROENTEROL, V60, P1263, DOI 10.5754/hge13260; Van Buren G, 2014, ANN SURG, V259, P605, DOI 10.1097/SLA.0000000000000460; Israel JS, 2014, J AM COLL SURGEONS, V218, P978, DOI 10.1016/j.jamcollsurg.2014.01.048; Molinari E, 2007, ANN SURG, V246, P281, DOI 10.1097/SLA.0b013e3180caa42f; Cirocchi R, 2013, SURG ONCOL, V22, P238, DOI 10.1016/j.suronc.2013.08.003; Lai ECH, 2009, ARCH SURG-CHICAGO, V144, P1074, DOI 10.1001/archsurg.2009.193; Shrikhande SV, 2008, WORLD J GASTROENTERO, V14, P5789, DOI 10.3748/wjg.14.5789; Takeuchi K, 2003, ANZ J SURG, V73, P922, DOI 10.1046/j.1445-2197.2003.02821.x; Abe N, 2006, AM J SURG, V191, P198, DOI 10.1016/j.amjsurg.2005.07.036; Cecka F, 2014, BIOMED RES INT, DOI 10.1155/2014/482906; Montorsi M, 2012, ANN SURG, V256, P853, DOI 10.1097/SLA.0b013e318272dec0; Blansfield JA, 2012, J GASTROINTEST SURG, V16, P524, DOI 10.1007/s11605-011-1794-1; Inchauste SM, 2012, WORLD J SURG, V36, P1517, DOI 10.1007/s00268-012-1598-9; Jusoh AC, 2012, SURG ENDOSC, V26, P904, DOI 10.1007/s00464-011-2016-3; Cirocchi R, 2013, SURG ONCOL, V22, P201, DOI 10.1016/j.suronc.2013.07.002; van der Wilt AA, 2013, HPB, V15, P337, DOI 10.1111/j.1477-2574.2012.00609.x; Fahy BN, 2002, AM J SURG, V183, P237, DOI 10.1016/S0002-9610(02)00790-0; Strasberg SM, 2007, SURGERY, V141, P420, DOI 10.1016/j.surg.2006.12.001; Antila A, 2014, BIOMED RES INT, DOI 10.1155/2014/508714; Atema J. J., 2000, HPB OXF, V17, P38; Behrman SW, 2015, J GASTROINTEST SURG, V19, P72, DOI 10.1007/s11605-014-2608-z; Fingerhut A, 2009, DIGEST SURG, V26, P7, DOI 10.1159/000191284; Hassenpflug M, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-430; Jensen EH, 2013, J GASTROINTEST SURG, V17, P267, DOI 10.1007/s11605-012-2016-1; Kurahara H, 2014, HEPATO-GASTROENTEROL, V61, P2367, DOI 10.5754/hge14782; Lee CW, 2014, J GASTROINTEST SURG, V18, P1902, DOI 10.1007/s11605-014-2601-6; Lillemoe KD, 1999, ANN SURG, V229, P693, DOI 10.1097/00000658-199905000-00012; Nitsche U., 2014, BMC SURG, V8, P76; Parisi A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000537; Parisi A, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-295; Parray F. Q., 2012, CHRONIC PANCREATITIS; Stutchfield BM, 2009, HPB, V11, P210, DOI 10.1111/j.1477-2574.2009.00008.x; Wang Y, 2015, CNS NEUROSCI THER, V21, P8, DOI 10.1111/cns.12316; Zhang H, 2015, BRIT J SURG, V102, P4, DOI 10.1002/bjs.9653	55	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	SEP	2015	21			1			S30	S33		10.1016/j.ijsu.2015.06.048		4	Surgery	Surgery	CR0FE	WOS:000360993000007		
J	Graziosi, L; Marino, E; Rivellini, R; Ciaccio, V; Cirocchi, R; Sanguinetti, A; Hirota, M; Avenia, N; Donini, A				Graziosi, Luigina; Marino, Elisabetta; Rivellini, Roberta; Ciaccio, Vincenzo; Cirocchi, Roberto; Sanguinetti, Alessandro; Hirota, Masahiko; Avenia, Nicola; Donini, Annibale			Retrospective analysis of short term outcomes after spleen-preserving distal pancreatectomy for sodid pseudopapillary tumours	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Laparoscopic distal pancreatectomy; Solid pseudopapillary tumour; Robotic pancreatectomy; Spleen preserving approach	SINGLE-CENTER EXPERIENCE; SPLENIC VESSELS; LAPAROSCOPIC RESECTION; UNCINATE PROCESS; PANCREAS; NEOPLASM; CONSERVATION; ADENOCARCINOMA; SERIES; CHILD	Solid pseudopapillary pancreatic tumour (SPN) is a rare pancreatic tumour representing 0.1%-3% of all exocrine pancreatic tumours. Most SPN show benign and low-grade malignant behaviour; malignant degeneration is observed in 10-15% of the patients. More than 40% of SPN involve the tail of the pancreas leading to a minimal invasive distal pancreatectomy approach. In this report we present the case of a young 22 Caucasian woman suffering from SPN who successfully underwent laparoscopic spleen-preserving distal pancreatectomy. Postoperative course was uneventful. A CT scan control at six months was negative for recurrences. We have also made an analysis of all the laparoscopic treatment of SPN reported in English literature. (C) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.	[Graziosi, Luigina; Marino, Elisabetta; Rivellini, Roberta; Ciaccio, Vincenzo; Donini, Annibale] Univ Perugia, Gen & Emergency Surg, Santa Maria della Misericordia Hosp, I-06100 Perugia, Italy; [Cirocchi, Roberto] Univ Perugia, Hosp Santa Maria, Dept Gen & Oncol Surg, Terni, Italy; [Sanguinetti, Alessandro; Avenia, Nicola] Univ Perugia, Hosp Santa Maria, Dept Gen Surg, Terni, Italy; [Hirota, Masahiko] Kumamoto Reg Med Ctr, Kumamoto, Japan	Graziosi, L (reprint author), Univ Perugia, Gen & Emergency Surg, Santa Maria della Misericordia Hosp, I-06100 Perugia, Italy.	luiginagraziosi@yahoo.it; elisabetta.marino1986@gmail.com; roririvellini@gmail.com; vincenzo.ciaccio@unipg.it; roberto.cirocchi@unipg.it; a.sanguinetti@aospterni.it; mhirota@krmc.or.jp; nicolaavenia@libero.it; annibale.donini@unipg.it					Horiguchi A, 2011, J HEPATO-BIL-PAN SCI, V18, P287, DOI 10.1007/s00534-010-0325-x; Mehta SS, 2012, SURG ENDOSC, V26, P402, DOI 10.1007/s00464-011-1887-7; Ntourakis D, 2011, ANN SURG ONCOL, V18, P642, DOI 10.1245/s10434-010-1376-6; Yu PF, 2010, WORLD J GASTROENTERO, V16, P1209, DOI 10.3748/wjg.v16.i10.1209; Butturini G, 2012, J SURG ONCOL, V105, P387, DOI 10.1002/jso.22117; Melotti G, 2007, ANN SURG, V246, P77, DOI 10.1097/01.sla.0000258607.17194.2b; Kang CM, 2010, SURG ENDOSC, V24, P1533, DOI 10.1007/s00464-009-0806-7; Ntourakis D, 2010, J GASTROINTEST SURG, V14, P1326, DOI 10.1007/s11605-010-1214-y; Iacobone M, 2012, WORLD J GASTROENTERO, V18, P5329, DOI 10.3748/wjg.v18.i38.5329; Tang LH, 2005, AM J SURG PATHOL, V29, P512, DOI 10.1097/01.pas.0000155159.28530.88; Reddy S, 2009, J AM COLL SURGEONS, V208, P950, DOI 10.1016/j.jamcollsurg.2009.01.044; WARSHAW AL, 1988, ARCH SURG-CHICAGO, V123, P550; Laxa BU, 2008, AM SURGEON, V74, P481; Geers C, 2006, AM J SURG PATHOL, V30, P1243, DOI 10.1097/01.pas.0000213311.28682.b2; Song KB, 2011, SURG ENDOSC, V25, P3364, DOI 10.1007/s00464-011-1727-9; Andren-Sandberg A, 1999, DIGEST SURG, V16, P305, DOI 10.1159/000018740; Kim SC, 2008, SURG ENDOSC, V22, P2261, DOI 10.1007/s00464-008-9973-1; Papavramidis T, 2005, J AM COLL SURGEONS, V200, P965, DOI 10.1016/j.jmacollsurg.2005.02.011; Yoon YS, 2009, BRIT J SURG, V96, P633, DOI 10.1002/bjs.6609; Carricaburu E, 2003, Surg Endosc, V17, P2028, DOI 10.1007/s00464-003-4222-0; Cavallini Alvise, 2011, Ann Surg Oncol, V18, P352, DOI 10.1245/s10434-010-1332-5; Chang SK, 2012, MINIM INVASIVE SURG, V2012; Fernandez-Cruz L, 2006, J GASTROINTEST SURG, V10, P752, DOI 10.1016/j.gassur.2005.08.012; Frantz V. K., 1959, TUMORS PANCREAS ATLA; Giovanardi RO, 2013, HEPATO-GASTROENTEROL, V60, P1206, DOI 10.5754/hge11600; HAMOUDI AB, 1970, CANCER, V26, P1126, DOI 10.1002/1097-0142(197011)26:5<1126::AID-CNCR2820260524>3.0.CO;2-K; Hirota M, 2009, J HEPATO-BILIARY-PAN, V16, P792, DOI 10.1007/s00534-009-0113-7; Ikeda Tetsuo, 2013, Fukuoka Acta Medica, V104, P54; Ito M, 2010, HEPATO-GASTROENTEROL, V57, P162; Jarry J, 2012, JSLS-J SOC LAPAROEND, V16, P552, DOI 10.4293/108680812X13462882736970; Kang CM, 2011, J HEPATO-BIL-PAN SCI, V18, P87, DOI 10.1007/s00534-010-0316-y; Kim DH, 2011, HEPATO-GASTROENTEROL, V58, P1805, DOI 10.5754/hge09679; Kim DH, 2011, SURG LAPARO ENDO PER, V21, pE179, DOI 10.1097/SLE.0b013e31821e9e2d; KLOPPEL G, 1981, VIRCHOWS ARCH A, V392, P171, DOI 10.1007/BF00430819; Kooby DA, 2010, J AM COLL SURGEONS, V210, P779, DOI 10.1016/j.jamcollsurg.2009.12.033; Lillemoe KD, 1999, ANN SURG, V229, P693, DOI 10.1097/00000658-199905000-00012; Machado MA, 2009, SURG ENDOSC, V23, P1391, DOI 10.1007/s00464-009-0390-x; MAO CY, 1995, SURGERY, V118, P821, DOI 10.1016/S0039-6060(05)80271-5; Marinis Athanasios, 2010, J Med Case Rep, V4, P387, DOI 10.1186/1752-1947-4-387; Matos JM, 2009, J SURG RES, V157, pE137, DOI 10.1016/j.jss.2009.03.091; Melotti G, 2007, ANN SURG ONCOL, V14, P1065, DOI 10.1245/s10434-006-9133-6; Morales A, 1998, INT J PANCREATOL, V24, P219; Nakamura Y, 2011, J NIPPON MED SCH, V78, P374; Nigri A., 2010, SURG ENDOSC, V2010, P1642; Sasaki A, 2008, SURG TODAY, V38, P955, DOI 10.1007/s00595-007-3738-7; Sherwinter DA, 2012, JSLS-J SOC LAPAROEND, V16, P549, DOI 10.4293/108680812X13462882736943; Sokolov YY, 2009, EUR J PEDIATR SURG, V19, P399, DOI 10.1055/s-0029-1237356; Takamatsu S., 2013, CASE REP MED; Tsai FJ, 2011, J LAPAROENDOSC ADV S, V21, P979, DOI 10.1089/lap.2011.0102; Ueda Junji, 2010, Journal of Nippon Medical School, V77, P175	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	SEP	2015	21			1			S26	S29		10.1016/j.ijsu.2015.06.047		4	Surgery	Surgery	CR0FE	WOS:000360993000006		
J	Regan, EA; Lynch, DA; Curran-Everett, D; Curtis, JL; Austin, JHM; Grenier, PA; Kauczor, HU; Bailey, WC; Demeo, DL; Casaburi, RH; Friedman, P; Van Beek, EJR; Hokanson, JE; Bowler, RP; Beaty, TH; Washko, GR; Han, MK; Kim, V; Kim, SS; Yagihashi, K; Washington, L; McEvoy, CE; Tanner, C; Mannino, DM; Make, BJ; Silverman, EK; Crapo, JD				Regan, Elizabeth A.; Lynch, David A.; Curran-Everett, Douglas; Curtis, Jeffrey L.; Austin, John H. M.; Grenier, Philippe A.; Kauczor, Hans-Ulrich; Bailey, William C.; Demeo, Dawn L.; Casaburi, Richard H.; Friedman, Paul; Van Beek, Edwin J. R.; Hokanson, John E.; Bowler, Russell P.; Beaty, Terri H.; Washko, George R.; Han, MeiLan K.; Kim, Victor; Kim, Song Soo; Yagihashi, Kunihiro; Washington, Lacey; McEvoy, Charlene E.; Tanner, Clint; Mannino, David M.; Make, Barry J.; Silverman, Edwin K.; Crapo, James D.		Genetic Epidemiology COPD Copdgene	Clinical and Radiologic Disease in Smokers With Normal Spirometry	JAMA INTERNAL MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; LUNG-FUNCTION; COMPUTED-TOMOGRAPHY; CIGARETTE-SMOKING; NATURAL-HISTORY; NORTHERN SWEDEN; COPD; EMPHYSEMA; AIRWAYS	IMPORTANCE Airflow obstruction on spirometry is universally used to define chronic obstructive pulmonary disease (COPD), and current or former smokers without airflow obstruction may assume that they are disease free. OBJECTIVE To identify clinical and radiologic evidence of smoking-related disease in a cohort of current and former smokers who did not meet spirometric criteria for COPD, for whom we adopted the discarded label of Global Initiative for Obstructive Lung Disease (GOLD) 0. DESIGN, SETTING, AND PARTICIPANTS Individuals from the Genetic Epidemiology of COPD (COPDGene) cross-sectional observational study completed spirometry, chest computed tomography (CT) scans, a 6-minute walk, and questionnaires. Participants were recruited from local communities at 21 sites across the United States. The GOLD 0 group (n = 4388) (ratio of forced expiratory volume in the first second of expiration [FEV1] to forced vital capacity >0.7 and FEV1 >= 80% predicted) from the COPDGene study was compared with a GOLD 1 group (n = 794), COPD groups (n = 3690), and a group of never smokers (n = 108). Recruitment began in January 2008 and ended in July 2011. MAIN OUTCOMES AND MEASURES Physical function impairments, respiratory symptoms, CT abnormalities, use of respiratory medications, and reduced respiratory-specific quality of life. RESULTS One or more respiratory-related impairments were found in 54.1%(2375 of 4388) of the GOLD 0 group. The GOLD 0 group had worse quality of life (mean [SD] St George's Respiratory Questionnaire total score, 17.0 [18.0] vs 3.8 [6.8] for the never smokers; P < .001) and a lower 6-minute walk distance, and 42.3%(127 of 300) of the GOLD 0 group had CT evidence of emphysema or airway thickening. The FEV1 percent predicted distribution and mean for the GOLD 0 group were lower but still within the normal range for the population. Current smoking was associated with more respiratory symptoms, but former smokers had greater emphysema and gas trapping. Advancing age was associated with smoking cessation and with more CT findings of disease. Individuals with respiratory impairments were more likely to use respiratory medications, and the use of these medications was associated with worse disease. CONCLUSIONS AND RELEVANCE Lung disease and impairments were common in smokers without spirometric COPD. Based on these results, we project that there are 35 million current and former smokers older than 55 years in the United States who may have unrecognized disease or impairment. The effect of chronic smoking on the lungs and the individual is substantially underestimated when using spirometry alone.	[Regan, Elizabeth A.; Lynch, David A.; Curran-Everett, Douglas; Bowler, Russell P.; Tanner, Clint; Make, Barry J.; Crapo, James D.] Natl Jewish Hlth, Denver, CO 80206 USA; [Regan, Elizabeth A.; Hokanson, John E.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Curtis, Jeffrey L.] Vet Affairs Ann Arbor Healthcare Syst, Sect Pulm & Crit Care Med, Med Serv, Ann Arbor, MI USA; [Curtis, Jeffrey L.; Han, MeiLan K.] Univ Michigan Hlth Syst, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Austin, John H. M.] Columbia Univ, Med Ctr, Dept Radiol, New York, NY USA; [Grenier, Philippe A.] Univ Paris 06, Hop Pitie Salpetriere, AP HP, Dept Diagnost Radiol, Paris, France; [Kauczor, Hans-Ulrich] Heidelberg Univ, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Bailey, William C.] Univ Alabama Birmingham, German Ctr Lung Res, Translat Lung Res Ctr Heidelberg, Birmingham, AL USA; [Demeo, Dawn L.; Washko, George R.; Silverman, Edwin K.] Brigham & Womens Hosp, Pulm & Crit Care, Boston, MA 02115 USA; [Demeo, Dawn L.; Washko, George R.; Silverman, Edwin K.] Harvard Univ, Sch Med, Boston, MA USA; [Casaburi, Richard H.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Resp & Crit Care Physiol & Med, Torrance, CA 90509 USA; [Friedman, Paul] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Van Beek, Edwin J. R.] Univ Edinburgh, Dept Radiol, Edinburgh, Midlothian, Scotland; [Beaty, Terri H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Kim, Victor] Temple Univ, Dept Med, Sect Pulm & Crit Care Med, Philadelphia, PA 19122 USA; [Kim, Song Soo] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Dept Radiol, Taejon, South Korea; [Yagihashi, Kunihiro] St Marianna Univ, Sch Med, Dept Radiol, Miyamae Ku, Kawasaki, Kanagawa, Japan; [Washington, Lacey] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [McEvoy, Charlene E.] HealthPartners, Pulm Med, Minneapolis, MN USA; [Mannino, David M.] Univ Kentucky, Coll Publ Hlth, Div Pulm Crit Care & Sleep Med, Dept Prevent Med & Environm Hlth, Lexington, KY 40506 USA	Regan, EA (reprint author), Natl Jewish Hlth, 1400 Jackson St,Room K706, Denver, CO 80206 USA.	regane@njhealth.org			National Heart, Lung, and Blood Institute [R01HL089897, R01HL089856]; COPD Foundation	The project described was supported by grants R01HL089897 and R01HL089856 from the National Heart, Lung, and Blood Institute. The Genetic Epidemiology of COPD (COPDGene) project is also supported by the COPD Foundation through contributions made to an industry advisory board representing AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Siemens, Sunovion, and GlaxoSmithKline.	Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Wan ES, 2011, AM J RESP CRIT CARE, V184, P57, DOI 10.1164/rccm.201101-0021OC; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Hoesein FAAM, 2011, THORAX, V66, P782, DOI 10.1136/thx.2010.145995; Snider GL, 2003, AM J RESP CRIT CARE, V167, P678, DOI 10.1164/rccm.200203-204PP; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; FLETCHER C, 1977, BRIT MED J, V1, P1645; [Anonymous], 2004, N S W PUBLIC HLTH B, V15, P107; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Maltais F, 2013, COPD, V10, P79, DOI 10.3109/15412555.2012.719048; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Behavioral Risk Factor Surveillance System, 2013, SMOK EXP US; BURROWS B, 1981, MED CLIN N AM, V65, P455; Hoesein FAAM, 2014, RESP MED, V108, P136, DOI 10.1016/j.rmed.2013.08.014; JAAKKOLA MS, 1991, THORAX, V46, P907, DOI 10.1136/thx.46.12.907; Jones PW, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-42; Kim SS, 2014, CHRONIC OBSTR PULM D, V1, P88; NIEWOEHN.DE, 1974, NEW ENGL J MED, V291, P755, DOI 10.1056/NEJM197410102911503; REMYJARDIN M, 1993, RADIOLOGY, V186, P107; SANDVIK L, 1995, BRIT MED J, V311, P715; SCADDING JG, 1959, LANCET, V1, P323; Schroeder JD, 2013, AM J ROENTGENOL, V201, pW460, DOI 10.2214/AJR.12.10102; Tylen U, 2000, RESP MED, V94, P38, DOI 10.1053/rmed.1999.0690; U.S. Census Bureau, STAT ABSTR US 2012 T; US National Center for Chronic Disease Prevention and Health Promotion, 2014, HLTH CONSMOK 50 YE; Vehmas T, 2003, EUR RESPIR J, V21, P866, DOI 10.1183/09031936.03.00029002; Wan ES, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0089-y; Xu J, 2010, NATL VITAL STAT REPO	33	3	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6106	2168-6114		JAMA INTERN MED	JAMA Intern. Med.	SEP	2015	175	9					1539	1549		10.1001/jamainternmed.2015.2735		11	Medicine, General & Internal	General & Internal Medicine	CR1CH	WOS:000361059900027		
J	Graff-Guerrero, A; Rajji, TK; Mulsant, BH; Nakajima, S; Caravaggio, F; Suzuki, T; Uchida, H; Gerretsen, P; Mar, W; Pollock, BG; Mamo, DC				Graff-Guerrero, Ariel; Rajji, Tarek K.; Mulsant, Benoit H.; Nakajima, Shinichiro; Caravaggio, Fernando; Suzuki, Takefumi; Uchida, Hiroyuki; Gerretsen, Philip; Mar, Wanna; Pollock, Bruce G.; Mamo, David C.			Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia A Prospective Dopamine D-2/3 Receptor Occupancy Study	JAMA PSYCHIATRY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; OLDER PATIENTS; PET; BINDING; DRUGS; ADULTS; MOTOR; AGE; RISPERIDONE; MANAGEMENT	IMPORTANCE Patients with late-life schizophrenia (LLS) are highly susceptible to antipsychotic adverse effects. Treatment guidelines endorse lower antipsychotic doses. However, the optimal dose of antipsychotics and associated dopamine D-2/3 receptor (D2/3R) occupancies remain largely unexplored in patients with LLS. OBJECTIVE To evaluate effects of antipsychotic dose reduction on striatal dopamine D2/3R occupancies, clinical variables, and blood pharmacokinetic measures in patients with LLS. DESIGN, SETTING, AND PARTICIPANTS An open-label, single-arm prospective study with a 3- to 6-month follow-up period (January 10, 2007, to October 21, 2013) was conducted at an academic tertiary care center with practice for ambulatory care. Participants included 35 outpatients with clinically stable LLS (patients aged >= 50 years receiving olanzapine or risperidone monotherapy at the same dose for 6 to 12 months). Follow-up was completed on October 21, 2013, and analysis was conducted from October 22, 2014, to February 2, 2015. INTERVENTIONS Carbon 11-labeled raclopride positron emission tomography, clinical measures, and blood pharmacokinetic measures performed before and after gradual dose reduction by up to 40% from the baseline dose and at least 3 months after dose reduction. MAIN OUTCOMES AND MEASURES Striatal dopamine D2/3R occupancies with antipsychotics, clinical measures (Positive and Negative Syndrome Scale, Brief Psychiatric Rating Scale, Targeted Inventory on Problems in Schizophrenia, Simpson-Angus Scale, Barnes Rating Scale for Drug-Induced Akathisia, Udvalg for Kliniske Undersogelser Side Effect Rating Scale), and blood pharmacokinetic measures (prolactin and antipsychotic blood levels). RESULTS Dopamine D2/3R occupancy of the entire sample decreased by a mean (SD) of 6.2% (8.2%) following dose reduction (from 70% [12%] to 64% [12%]; P < .001). The lowest D2/3R occupancy associated with clinical stability was 50%. Extrapyramidal symptoms (EPSs) were more likely to occur with D2/3R occupancies higher than 60%: 90.5%(19 of 21) of the participants with baseline EPSs and 76.9%(10 of 13) of the participants with postreduction EPSs had striatal D2/3R occupancies higher than 60%. The baseline D2/3R occupancies were lower in patients with clinical deterioration (n = 5) than in those whose condition remained stable (n = 29) (58%[15%] vs 72%[10%]; P = .03). Following dose reduction, Targeted Inventory on Problems in Schizophrenia score increased (P = .046) and Positive and Negative Syndrome Scale (P = .02), Brief Psychiatric Rating Scale (P = .03), Simpson-Angus Scale (P < .001), Barnes Rating Scale for Drug-Induced Akathisia (P = .03), and Udvalg for Kliniske Undersogelser Side Effect Rating Scale (P < .001) scores and prolactin (P < .001) and blood antipsychotic (olanzapine, P < .001; risperidone plus the metabolite 9-hydroxyrisperidone, P = .02) levels all decreased. CONCLUSIONS AND RELEVANCE Antipsychotic dose reduction is feasible in patients with stable LLS, decreasing adverse effects and improving illness severity measures. The results of the present study suggest a lower therapeutic window of D2/3R occupancy in patients with LLS (50%-60%) than previously reported in younger patients (65%-80%).	[Graff-Guerrero, Ariel; Nakajima, Shinichiro; Caravaggio, Fernando; Gerretsen, Philip; Mar, Wanna] Ctr Addict & Mental Hlth, Res Imaging Ctr, Multimodal Imaging Grp, Toronto, ON M5T 1R8, Canada; [Graff-Guerrero, Ariel; Rajji, Tarek K.; Mulsant, Benoit H.; Nakajima, Shinichiro; Uchida, Hiroyuki; Gerretsen, Philip; Pollock, Bruce G.] Ctr Addict & Mental Hlth, Geriatr Psychiat Div, Toronto, ON, Canada; [Graff-Guerrero, Ariel; Rajji, Tarek K.; Mulsant, Benoit H.; Nakajima, Shinichiro; Gerretsen, Philip; Pollock, Bruce G.] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Graff-Guerrero, Ariel; Rajji, Tarek K.; Mulsant, Benoit H.; Pollock, Bruce G.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Nakajima, Shinichiro; Suzuki, Takefumi; Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Caravaggio, Fernando; Gerretsen, Philip] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Mamo, David C.] Univ Malta, Fac Med, Dept Psychiat, Msida, Malta; [Mamo, David C.] Univ Malta, Fac Hlth Sci, Dept Psychiat, Msida, Malta	Graff-Guerrero, A (reprint author), Ctr Addict & Mental Hlth, Res Imaging Ctr, Multimodal Imaging Grp, 250 Coll St, Toronto, ON M5T 1R8, Canada.	ariel_graff@yahoo.com.mx	Uchida, Hiroyuki/I-4867-2015	Uchida, Hiroyuki/0000-0002-0628-7036	CIHR [MOP-97946]; US National Institutes of Health [RO1MH084886-01A2]; Government of Canada; Japanese Society of Clinical Neuropsychopharmacology; Japan Society for the Promotion of Science; Kanae Foundation; Mochida Memorial Foundation; Nakatomi Foundation; Ontario Graduate Scholarship	This work was funded by CIHR grant MOP-97946 (Drs Graff-Guerrero and Mamo), US National Institutes of Health grant RO1MH084886-01A2 (Drs Graff-Guerrero and Mamo), CIHR fellowship (Dr Nakajima), Government of Canada postdoctoral research fellowships (Dr Suzuki), the Japanese Society of Clinical Neuropsychopharmacology (Dr Suzuki), Japan Society for the Promotion of Science (Dr Nakajima), Kanae Foundation (Dr Suzuki), Mochida Memorial Foundation (Dr Suzuki), Nakatomi Foundation (Dr Nakajima), and an Ontario Graduate Scholarship (Mr Caravaggio).	Alexopoulos GS, 2004, J CLIN PSYCHIAT, V65, P5; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Suzuki T, 2008, SCHIZOPHR RES, V106, P328, DOI 10.1016/j.schres.2008.08.013; Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Suzuki T, 2011, DRUG AGING, V28, P961, DOI 10.2165/11595830-000000000-00000; Graff-Guerrero A, 2008, HUM BRAIN MAPP, V29, P400, DOI 10.1002/hbm.20392; Naber D, 1995, INT CLIN PSYCHOPHARM, V10, P133, DOI 10.1097/00004850-199509000-00017; Peluso MJ, 2012, BRIT J PSYCHIAT, V200, P387, DOI 10.1192/bjp.bp.111.101485; Lieberman JA, 2008, PHARMACOL REV, V60, P358, DOI 10.1124/pr.107.00107; Uchida H, 2011, J CLIN PSYCHOPHARM, V31, P318, DOI 10.1097/JCP.0b013e318218d339; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Uchida H, 2008, AM J GERIAT PSYCHIAT, V16, P584, DOI 10.1097/JGP.0b013e318172b42d; MARKEN PA, 1992, CLIN PHARMACY, V11, P851; Grisso T, 1997, PSYCHIATR SERV, V48, P1415; Schooler NR, 1997, ARCH GEN PSYCHIAT, V54, P453; Uchida H, 2014, AM J GERIAT PSYCHIAT, V22, P1007, DOI 10.1016/j.jagp.2013.01.045; Nakajima S, 2015, SCHIZOPHR RES, V164, P164, DOI 10.1016/j.schres.2015.01.043; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Wilson AA, 2000, NUCL MED BIOL, V27, P529, DOI 10.1016/S0969-8051(00)00132-3; Pappa S, 2009, PSYCHOL MED, V39, P1065, DOI 10.1017/S0033291708004716; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034; Studholme C, 1997, MED PHYS, V24, P25, DOI 10.1118/1.598130; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; FARDE L, 1995, J CLIN PSYCHOPHARM, V15, pS19; Guy W, 1976, ECDEU ASSESSMENT MAN, P218; HOGARTY GE, 1988, ARCH GEN PSYCHIAT, V45, P797; Ismail Z, 2012, AM J GERIAT PSYCHIAT, V20, P53, DOI 10.1097/JGP.0b013e3182118318; Jeste DV, 2013, SCHIZOPHRENIA BULL, V39, P966, DOI 10.1093/schbul/sbt043; KANE JM, 1983, ARCH GEN PSYCHIAT, V40, P893; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; Overall JE, 1962, PSYCHOL REP, V10, P790; Ritchie CW, 2010, INT J GERIATR PSYCH, V25, P411, DOI 10.1002/gps.2354; Sapra M, 2008, SCHIZOPHR RES, V106, P348, DOI 10.1016/j.schres.2008.09.004; Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11; Sproule BA, 2010, CAN J PSYCHIAT, V55, P248; Szewczyk-Krolikowski K, 2014, PARKINSONISM RELAT D, V20, P99, DOI 10.1016/j.parkreldis.2013.09.025; Uchida H, 2009, AM J GERIAT PSYCHIAT, V17, P255, DOI 10.1097/JGP.0b013e318198776d	39	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-622X	2168-6238		JAMA PSYCHIAT	JAMA Psychiatry	SEP	2015	72	9					927	934		10.1001/jamapsychiatry.2015.0891		8	Psychiatry	Psychiatry	CR0DE	WOS:000360987600012		
J	Miyake, M; Saito, M; Yamashiro, K; Sekiryu, T; Yoshimura, N				Miyake, Masahiro; Saito, Masaaki; Yamashiro, Kenji; Sekiryu, Tetsuju; Yoshimura, Nagahisa			Complement factor H R1210C among Japanese patients with age-related macular degeneration	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Age-related macular degeneration; Complement factor H; Genetics; Rare variant; R1210C	HEMOLYTIC-UREMIC SYNDROME; POLYPOIDAL CHOROIDAL VASCULOPATHY; HIGH-RISK; POPULATION; PREVALENCE; VARIANTS; ASSOCIATION; LOCI; C3; MUTATIONS	To evaluate the genotype distribution of a rare age-related macular degeneration (AMD)-susceptibility variant, complement factor H (CFH) R1210C, among a large Japanese cohort with AMD. One thousand three hundred and sixty-four Japanese patients with neovascular AMD were evaluated. We screened for CFH R1210C (rs121913059) by genotyping with the Taqman method; the mutation was confirmed by Sanger sequencing. We also searched for this mutation in the human genome variant database, which contains the whole-exome sequencing data for 1208 Japanese individuals. The detailed characteristics of patients with this mutation were reviewed. The mean age of the patients was 74.5 years (standard deviation 8.7); men accounted for 71.8 % of the patients. The CFH R1210C variant was found in only 1 of the 1364 AMD patients, and was heterozygous (minor allele frequency (MAF) = 0.037 %); it was not found in any of the 1208 individuals in the control group (MAF = 0 %). The patient with CFH R1210C was a 70-year-old woman whose main complaint was visual loss in the right eye. Dilated fundus examination, optical coherence tomography, and fluorescein and indocyanine angiography revealed polypoidal choroidal neovasculopathy (PCV), but no drusen in either eye. Despite treatment, her visual acuity had decreased to 1/50 by 6.8 years after her first visit. The CFH R1210C variant was found to be rare among Japanese patients with AMD. The patient with the mutation did have the PCV subtype, but no drusen formation. Considering their ethnicity-specific nature, such rare variants should be studied by use of next-generation sequencing for each ethnicity.	[Miyake, Masahiro; Yamashiro, Kenji; Yoshimura, Nagahisa] Kyoto Univ, Dept Ophthalmol, Sch Med, Kyoto 606, Japan; [Saito, Masaaki; Sekiryu, Tetsuju] Fukushima Med Univ, Dept Ophthalmol, Fukushima, Japan	Yamashiro, K (reprint author), Kyoto Univ, Dept Ophthalmol, Sch Med, Kyoto 606, Japan.	yamashro@kuhp.kyoto-u.ac.jp			Research Grant for Intractable Diseases from the Japanese Ministry of Health, Labour, and Welfare [201238002A]	Creation of the Human Genetic Variation Database was supported by a Research Grant for Intractable Diseases (no. 201238002A) from the Japanese Ministry of Health, Labour, and Welfare.	Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Kawasaki R, 2008, OPHTHALMOLOGY, V115, P1376, DOI 10.1016/j.ophtha.2007.11.015; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Varma R, 2004, OPHTHALMOLOGY, V111, P1288, DOI 10.1016/j.ophtha.2004.01.023; Fan XP, 2013, MOL IMMUNOL, V54, P238, DOI 10.1016/j.molimm.2012.12.006; Nakata I, 2013, AM J OPHTHALMOL, V156, P1002, DOI 10.1016/j.ajo.2013.06.007; Servais A, 2007, J MED GENET, V44, P193, DOI 10.1136/jmg.2006.045328; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Nakata I, 2012, INVEST OPHTH VIS SCI, V53, P794, DOI 10.1167/iovs.11-8468; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Nakata I, 2012, INVEST OPHTH VIS SCI, V53, P6576, DOI 10.1167/iovs.12-10219; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758; Nakata I, 2013, INVEST OPHTH VIS SCI, V54, P6068, DOI 10.1167/iovs.13-11605; Cheng CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7063; Cho HJ, 2014, JPN J OPHTHALMOL, V59, P29; Inoue M, 2015, JPN J OPHTHALMOL, V59, P173, DOI 10.1007/s10384-015-0374-4; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Martinez-Barricarte R, 2008, J AM SOC NEPHROL, V19, P639, DOI 10.1681/ASN.2007080923; Ogino K, 2014, JPN J OPHTHALMOL, V58, P155, DOI 10.1007/s10384-013-0295-z; Takeuchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046385; Yanagisawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028847	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	SEP	2015	59	5					273	278		10.1007/s10384-015-0394-0		6	Ophthalmology	Ophthalmology	CR1GD	WOS:000361072000001		
J	Morizane, Y; Kimura, S; Hosokawa, M; Shiode, Y; Hirano, M; Doi, S; Hosogi, M; Fujiwara, A; Inoue, Y; Shiraga, F				Morizane, Yuki; Kimura, Shuhei; Hosokawa, Mio; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Hosogi, Mika; Fujiwara, Atsushi; Inoue, Yasushi; Shiraga, Fumio			Planned foveal detachment technique for the resolution of diffuse diabetic macular edema	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Diffuse diabetic macular edema; Vitrectomy; Foveal detachment	SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; OPTICAL COHERENCE TOMOGRAPHY; LIMITING MEMBRANE REMOVAL; VITRECTOMY; TRANSLOCATION; RANIBIZUMAB; DEGENERATION; OXYGENATION; INJECTION	To evaluate the therapeutic efficacy of a novel surgical procedure for diffuse diabetic macular edema (DME), performed in conjunction with conventional vitrectomy. This prospective, interventional case series involved 20 eyes of 18 consecutive DME patients with best-corrected visual acuities (BCVAs) between 0.301 and 1.221 logarithm of the minimal angle of resolution (logMAR) units and central retinal thicknesses (CRTs) greater than 275 mu m. After vitrectomy, a small retinal detachment was made in the macula by injecting 50-100 mu l balanced salt solution into the subretinal space using a 38-gauge needle. Before finishing the surgery, fluid-air exchange was performed. Patients were asked to remain in prone position for 1 day postoperatively. The main outcome measures were CRT and BCVA. The mean CRT of 554.6 +/- A 152.7 mu m before surgery significantly decreased to 295.6 +/- A 92.5 mu m (p < 0.0001) 1 week after surgery and to 185.8 +/- A 67.4 mu m (p < 0.0001) at 6 months after surgery. The CRT was less than 250 mu m in 18 eyes (90 %) at 6 months after surgery. The mean BCVA before surgery (0.706 +/- A 0.348) significantly improved at 6 months after surgery (0.431 +/- A 0.392, p < 0.0001). Postoperative BCVAs improved by more than 0.3 logMAR units in 13 eyes (65 %), remained unchanged in six eyes (30 %) and worsened in one eye (5 %). Macular edema recurred in three eyes (15 %) 2 months after surgery. This novel planned foveal detachment technique facilitated a rapid resolution of DME and contributed to improved visual acuity.	[Morizane, Yuki; Kimura, Shuhei; Hosokawa, Mio; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Hosogi, Mika; Fujiwara, Atsushi; Shiraga, Fumio] Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Okayama 7008558, Japan; [Inoue, Yasushi] Inoue Eye Clin, Tamano City, Okayama, Japan	Shiraga, F (reprint author), Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	shiraga@okayama-u.ac.jp					WILSON CA, 1994, ARCH OPHTHALMOL-CHIC, V112, P839; Stefansson E, 2006, SURV OPHTHALMOL, V51, P364, DOI 10.1016/j.survophthal.2006.04.005; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Otani T, 1999, AM J OPHTHALMOL, V127, P688, DOI 10.1016/S0002-9394(99)00033-1; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Sakamoto A, 2009, GRAEF ARCH CLIN EXP, V247, P1325, DOI 10.1007/s00417-009-1107-5; Stefansson E, 2001, ACTA OPHTHALMOL SCAN, V79, P435, DOI 10.1034/j.1600-0420.2001.790502.x; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; Hillenkamp J, 2010, GRAEF ARCH CLIN EXP, V248, P5, DOI 10.1007/s00417-009-1158-7; Haupert CL, 2001, AM J OPHTHALMOL, V131, P208, DOI 10.1016/S0002-9394(00)00734-0; Massin P, 2003, AM J OPHTHALMOL, V135, P169, DOI 10.1016/S0002-9394(02)01837-8; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Harbour JW, 1996, AM J OPHTHALMOL, V121, P405; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Yanyali A, 2011, OPHTHALMOLOGICA, V226, P57, DOI 10.1159/000327597; Christoforidis John B., 2004, International Ophthalmology Clinics, V44, P139, DOI 10.1097/00004397-200404410-00015; Doi N, 2011, GRAEFES ARCH CLIN EX, V250, P71; Elman MJ, 2010, OPHTHALMOLOGY, V117, pe35; Haller JA, 2010, OPHTHALMOLOGY, V117, pe3; Kadonosono K, 2000, AM J OPHTHALMOL, V130, P740, DOI 10.1016/S0002-9394(00)00575-4; Kimura S, 2015, AM J OPHTHALMOL, V159; Korobelnik JF, 2014, OPHTHALMOLOGY, V121, P2247, DOI 10.1016/j.ophtha.2014.05.006; Machemer R, 1998, AM J OPHTHALMOL, V125, P698, DOI 10.1016/S0002-9394(98)00020-8; Morizane Y, 2002, AM J OPHTHALMOL, V133, P848, DOI 10.1016/S0002-9394(02)01413-7; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; Okamoto Y, 2014, JPN J OPHTHALMOL, V58, P369, DOI 10.1007/s10384-014-0323-7; Photocoagulation for diabetic macular edema, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796; Pieramici DJ, 2000, AM J OPHTHALMOL, V130, P419, DOI 10.1016/S0002-9394(00)00533-X; Shamsi Hanan N Al, 2013, World J Diabetes, V4, P324, DOI 10.4239/wjd.v4.i6.324; Song Su Jeong, 2007, Korean J Ophthalmol, V21, P146, DOI 10.3341/kjo.2007.21.3.146; Stolba U, 2005, AM J OPHTHALMOL, V140, P295, DOI 10.1016/j.ajo.2005.03.045; Takagi H, 1999, OPHTHALMOLOGY, V106, P256; Takagi H, 1999, OPHTHALMOLOGY, V106, P249, DOI 10.1016/S0161-6420(99)90054-4; Yamamoto T, 2003, AM J OPHTHALMOL, V135, P14, DOI 10.1016/S0002-9394(02)01819-6; Yanyali A, 2007, RETINA-J RET VIT DIS, V27, P557, DOI 10.1097/01.iae.0000249390.61854.d5	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	SEP	2015	59	5					279	287		10.1007/s10384-015-0390-4		9	Ophthalmology	Ophthalmology	CR1GD	WOS:000361072000002		
J	Yokota, R; Inoue, M; Itoh, Y; Rii, T; Hirota, K; Hirakata, A				Yokota, Reiji; Inoue, Makoto; Itoh, Yuji; Rii, Tosho; Hirota, Kazunari; Hirakata, Akito			Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Proliferative diabetic retinopathy; Microincision vitrectomy; Pars plana vitrectomy; Neovascular glaucoma	TRANSCONJUNCTIVAL SUTURELESS VITRECTOMY; PARS-PLANA VITRECTOMY; RECURRENT VITREOUS HEMORRHAGE; ULTRASOUND BIOMICROSCOPY; SCLEROTOMY SITES; 25-GAUGE VITRECTOMY; CLINICAL-OUTCOMES; CAVITY HEMORRHAGE; 14-YEAR INCIDENCE; COMPLICATIONS	To compare the outcomes of 23-gauge (G) and 25G vitrectomy to 20G vitrectomy on eyes with severe proliferative diabetic retinopathy (PDR). The medical records of 424 eyes of 347 patients with severe PDR were reviewed. There were 80 eyes that had 23G, 174 eyes that had 25G, and 170 eyes that had 20G vitrectomy. The incidences of postoperative vitreous hemorrhage, intraoperative retinal breaks, retinal detachment, and neovascular glaucoma were compared. The incidence of intraoperative retinal breaks was significantly lower in the 23G group (21 %) than in the 20G group (35 %, P = 0.03) but not in the 25G group (26 %, P = 0.057). The incidence of postoperative retinal detachment was not significantly different among the three groups (P = 0.73). The incidence of postoperative vitreous hemorrhage that developed a parts per thousand yen1 month after vitrectomy was not different whether the eyes had panretinal photocoagulation or not (P = 0.15). The incidence of postoperative neovascular glaucoma was significantly lower in the 25G group (3 %) than in the 20G group (11 %, P = 0.01) but not significant compared with that in the 23G group (8 %, P = 0.72). The lower incidence of intraoperative retinal breaks and postoperative neovascular glaucoma after microincision vitrectomy indicates that microincision vitrectomy should be considered for eyes with severe PDR.	[Yokota, Reiji; Inoue, Makoto; Itoh, Yuji; Rii, Tosho; Hirota, Kazunari; Hirakata, Akito] Kyorin Univ, Kyorin Eye Ctr, Sch Med, Mitaka, Tokyo 1818611, Japan; [Rii, Tosho] Shin Kong Wu Ho Mem Hosp, Dept Ophthalmol, Taipei, Taiwan	Inoue, M (reprint author), Kyorin Univ, Kyorin Eye Ctr, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	inoue@eye-center.org					Abe S, 2013, JPN J OPHTHALMOL, V57, P553, DOI 10.1007/s10384-013-0275-3; [Anonymous], 1985, ARCH OPHTHALMOL-CHIC, V103, P1644; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Fujii GY, 2002, OPHTHALMOLOGY, V109, P1807, DOI 10.1016/S0161-6420(02)01179-X; Nagpal M, 2009, RETINA-J RET VIT DIS, V29, P225, DOI 10.1097/IAE.0b013e3181934908; Steel DHW, 2010, BRIT J OPHTHALMOL, V94, P1219, DOI 10.1136/bjo.2009.170126; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; Eckardt C, 2005, RETINA-J RET VIT DIS, V25, P208, DOI 10.1097/00006982-200502000-00015; Mason JO, 2006, CURR OPIN OPHTHALMOL, V17, P281, DOI 10.1097/01.icu.0000193098.28798.18; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; Ozone D, 2011, OPHTHALMOLOGICA, V226, P76, DOI 10.1159/000328407; Farouk MM, 2011, GRAEF ARCH CLIN EXP, V249, P369, DOI 10.1007/s00417-010-1506-7; Hershberger VS, 2004, OPHTHALMOLOGY, V111, P1215, DOI 10.1016/j.ophtha.2003.08.043; Arumí José G, 2009, Curr Diabetes Rev, V5, P63; Gündüz Kaan, 2007, Compr Ophthalmol Update, V8, P245; Beebe DC, 2014, JPN J OPHTHALMOL, V58, P225, DOI 10.1007/s10384-014-0318-4; Bhende M, 2000, OPHTHALMOLOGY, V107, P1729, DOI 10.1016/S0161-6420(00)00213-X; Grauslund J, 2009, OPHTHALMOLOGY, V116, P2170, DOI 10.1016/j.ophtha.2009.04.043; Issa SA, 2011, CLIN OPHTHALMOL, V20, P109; KREIGER AE, 1993, RETINA-J RET VIT DIS, V13, P335; Lee BJ, 2010, RETINA-J RET VIT DIS, V30, P1671, DOI 10.1097/IAE.0b013e3181dcfb79; LEWIS H, 1987, AM J OPHTHALMOL, V104, P607; Michels R G, 1981, Retina, V1, P1; Nadal J, 2012, RETINA-J RET VIT DIS, V32, P1310, DOI 10.1097/IAE.0b013e318236e7ef; Neely KA, 1998, AM J OPHTHALMOL, V126, P82, DOI 10.1016/S0002-9394(98)00066-X; Park DH, 2010, RETINA-J RET VIT DIS, V30, P1662, DOI 10.1097/IAE.0b013e3181d95261; Sawa H, 2000, JPN J OPHTHALMOL, V44, P154, DOI 10.1016/S0021-5155(99)00194-X; Scartozzi R, 2007, AM J OPHTHALMOL, V143, P155, DOI 10.1016/j.ajo.2006.07.038; Schoenberger SD, 2011, OPHTHAL SURG LAS IM, V42, P474, DOI 10.3928/15428877-20110901-02; Smiddy WE, 1999, SURV OPHTHALMOL, V43, P491, DOI 10.1016/S0039-6257(99)00036-3; Steel DHW, 2008, OPHTHALMOLOGY, V115, P525, DOI 10.1016/j.ophtha.2007.08.034; Yang SJ, 2009, OPHTHAL SURG LAS IM, V40, P461, DOI 10.3928/15428877-20090901-04; Yeh PT, 2005, OPHTHALMOLOGY, V112, P2095, DOI 10.1016/j.ophtha.2005.07.010	33	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	SEP	2015	59	5					288	294		10.1007/s10384-015-0396-y		7	Ophthalmology	Ophthalmology	CR1GD	WOS:000361072000003		
J	Notani, S; Mori, R; Yuzawa, M; Kawamura, A				Notani, Satoko; Mori, Ryusaburo; Yuzawa, Mitsuko; Kawamura, Akiyuki			Retinal pigment epithelial detachment associated with retinal pigment epithelium thinning revealed by optical coherence tomography	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Retinal pigment epithelial detachment (PED); Retinal pigment epithelium (RPE); RPE thinning; RPE atrophy	FUNDUS AUTOFLUORESCENCE; LIPOFUSCIN	To clarify the characteristics and outcomes of unusual retinal pigment epithelial detachments (PEDs). These PEDs had one or several sites of apparent thinning of the RPE, or no RPE at all, as shown on optical coherence tomography (OCT). Eight cases with PEDs showed apparent thinning of the RPE in the roof of the PED at one or more sites on OCT. Color fundus photographs, fundus examination records, fluorescein angiograms (FAs) and/or indocyanine green angiograms (ICGAs), obtained with simultaneous OCT using Spectralis(A (R)), and fundus autofluorescence were evaluated. Macular findings, prior to baseline PED detection, were investigated in three cases. Follow-up results were also reviewed in three cases. Well-delineated grayish-white lesions at the level of the choroid observed through a hypo- or unpigmented area corresponding to the area of thinning in the RPE on OCT. These lesions showed intense hyperfluorescence due to staining on both FAs and ICGAs as well as hypofluorescence on fundus autofluorescence. In three eyes, smaller PEDs had been observed at the same locations and were thus taken as the baseline PEDs on images obtained 22-94 months before this study. In two of the three eyes followed up for at least 35 months from baseline, the PEDs collapsed, leaving RPE-choriocapillaris atrophy in one eye and RPE tear in the other. Lesions corresponding to the area of thinning in the RPE on OCT may indicate hypo- or unpigmented RPE, possibly as a result of focal damage due to longstanding PEDs. These PEDs may lead to unexpected complications during long-term follow-up.	[Notani, Satoko; Mori, Ryusaburo; Yuzawa, Mitsuko; Kawamura, Akiyuki] Nihon Univ, Nihon Univ Hosp, Sch Med, Div Ophthalmol,Dept Visual Sci,Chiyoda Ku, Tokyo 1018309, Japan	Mori, R (reprint author), Nihon Univ, Nihon Univ Hosp, Sch Med, Div Ophthalmol,Dept Visual Sci,Chiyoda Ku, 1-6 Surugadai, Tokyo 1018309, Japan.	ryu-m@sa2.so-net.ne.jp			Research Committee on Chorioretinal Degeneration and Optic Atrophy, The Ministry of Health, Labour and Welfare of Japan	This study was funded in part by the Research Committee on Chorioretinal Degeneration and Optic Atrophy, The Ministry of Health, Labour and Welfare of Japan.	VONRUCKMANN A, 1995, BRIT J OPHTHALMOL, V79, P407, DOI 10.1136/bjo.79.5.407; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; FEENEYBURNS L, 1980, AM J OPHTHALMOL, V90, P783; CASSWELL AG, 1985, BRIT J OPHTHALMOL, V69, P397, DOI 10.1136/bjo.69.6.397; GOLDSTEIN BG, 1987, BRIT J OPHTHALMOL, V71, P676, DOI 10.1136/bjo.71.9.676; KISHI S, 1985, ARCH OPHTHALMOL-CHIC, V103, P1189; Matsumoto Yoko, 1998, Rinsho Ganka, V52, P1729; Murphy R P, 1985, Trans Am Ophthalmol Soc, V83, P63; Schmitz-Valckenberg S, 2008, RETINA-J RET VIT DIS, V28, P385, DOI 10.1097/IAE.0b013e318164a907; Shiraki K, 2001, GRAEF ARCH CLIN EXP, V239, P430, DOI 10.1007/s004170100304; Takahashi Kanji, 1998, Rinsho Ganka, V52, P1489; YUZAWA M, 1995, OPHTHALMOLOGY, V102, P622	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	SEP	2015	59	5					305	311		10.1007/s10384-015-0391-3		7	Ophthalmology	Ophthalmology	CR1GD	WOS:000361072000005		
J	Sawada, A; Kuwayama, Y; Yamamoto, T				Sawada, Akira; Kuwayama, Yasuaki; Yamamoto, Tetsuya			Changes in filtering bleb morphology after bleb-related infection	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Bleb-related infection; Bleb morphology; Glaucoma; Glaucoma surgery; Trabeculectomy	OPEN-ANGLE GLAUCOMA; MITOMYCIN-C; CLINICAL-FEATURES; VISUAL-ACUITY; RISK-FACTORS; ENDOPHTHALMITIS; SURGERY; TRABECULECTOMY; PRESSURE; JAPAN	To verify, by use of data collected by the Japan Glaucoma Society Survey of Bleb-related Infection (JGSSBI), that bleb morphology changes within 12 months of the development of bleb-related infection. JGSSBI data from 57 eyes of 57 patients with primary open-angle glaucoma and normal tension glaucoma who developed a bleb-related infection were analyzed. Morphological features of the blebs were graded by use of a predetermined grading system. Multiple logistic regression analysis was conducted to identify factors relating to bleb morphology which were associated with poor outcome. Bleb sizes, including both circumferential and tangential lengths, were significantly smaller for stage IIIa/IIIb infections than for stage I/II bleb infections (P = 0.009 and P = 0.026 for the circumferential and tangential lengths, respectively; Fisher's direct probability test). The bleb wall also became significantly thicker during stage IIIa/IIIb infections (P = 0.003). After infection, intraocular pressure (IOP) increased significantly for all cases but was no different in the three subgroups (i.e. stage I, stage II, and stage IIIa/IIIb bleb infections). Multiple logistic regression analysis revealed that a stage III infection was significantly associated with a poor outcome for the bleb. This study revealed that the filtering bleb became smaller, both tangentially and circumferentially, and thicker, after stage III infections than after stage I or II infections.	[Sawada, Akira; Yamamoto, Tetsuya] Gifu Univ, Grad Sch Med, Dept Ophthalmol, Gifu Shi 5011194, Japan; [Kuwayama, Yasuaki] Fukushima Eye Clin, Osaka, Japan	Sawada, A (reprint author), Gifu Univ, Grad Sch Med, Dept Ophthalmol, 1-1 Yanagido, Gifu Shi 5011194, Japan.	sawadaa-gif@umin.ac.jp					Greenfield DS, 1996, ARCH OPHTHALMOL-CHIC, V114, P943; Yamamoto T, 2011, OPHTHALMOLOGY, V118, P453, DOI 10.1016/j.ophtha.2010.07.002; Higginbotham EJ, 1996, OPHTHALMOLOGY, V103, P650; Hori Nobuhide, 2009, Nippon Ganka Gakkai Zasshi, V113, P951; Freedman J, 2013, INVEST OPHTH VIS SCI, V54, P4851, DOI 10.1167/iovs.13-12274; Yamamoto T, 2014, OPHTHALMOLOGY, V121, P1001, DOI 10.1016/j.ophtha.2013.11.025; Song A, 2002, OPHTHALMOLOGY, V109, P985, DOI 10.1016/S0161-6420(02)00965-X; Wells AP, 2004, J GLAUCOMA, V13, P454, DOI 10.1097/00061198-200412000-00005; Ciulla TA, 1997, OPHTHALMOLOGY, V104, P986; Yamamoto T, 2013, ACTA OPHTHALMOL, V91, P619, DOI 10.1111/j.1755-3768.2012.02480.x; Cantor LB, 2003, J GLAUCOMA, V12, P266, DOI 10.1097/00061198-200306000-00015; Kangas TA, 1997, OPHTHALMOLOGY, V104, P746; Azuara-Blanco A, 1998, SURV OPHTHALMOL, V43, P93, DOI 10.1016/S0039-6257(98)00025-3; Leng T, 2011, RETINA-J RET VIT DIS, V31, P344, DOI 10.1097/IAE.0b013e3181e09810; Bayraktar Z, 2005, JPN J OPHTHALMOL, V49, P315, DOI 10.1007/S10384-005-0202-3; Engel LA, 2014, GRAEF ARCH CLIN EXP, V252, P791, DOI 10.1007/s00417-014-2607-5; Furrer S, 2012, BMC OPHTHALMOL, V17, P24; Greenfield D S, 1998, J Glaucoma, V7, P132; Park HYL, 2012, JPN J OPHTHALMOL, V56, P38, DOI 10.1007/s10384-011-0101-8; Wells AP, 2006, OPHTHALMOLOGY, V113, P77, DOI 10.1016/j.ophtha.2005.06.037; Yamada H, 2014, JPN J OPHTHALMOL, V58, P490, DOI 10.1007/s10384-014-0346-0; Yamamoto T, 2013, ACTA OPHTHALMOL, V91, pe420, DOI 10.1111/aos.12079; Yamamoto T, 1995, OPHTHALMOLOGY, V102, P1770	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	SEP	2015	59	5					312	317		10.1007/s10384-015-0398-9		6	Ophthalmology	Ophthalmology	CR1GD	WOS:000361072000006		
J	Sawada, M; Hikoya, A; Negishi, T; Hotta, Y; Sato, M				Sawada, Mayu; Hikoya, Akiko; Negishi, Takashi; Hotta, Yoshihiro; Sato, Miho			Characteristics and surgical outcomes of consecutive exotropia of different etiologies	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Consecutive exotropia; Stretched scar; Slipped muscle; Overcorrection; Esotropia	MEDIAL RECTUS MUSCLE; STRABISMUS SURGERY; ADVANCEMENT; RECESSION; MANAGEMENT; RESECTION	To investigate the surgical results for consecutive exotropia with or without insertion abnormalities on the basis of the position of the lateral rectus muscle at surgery. Patients with consecutive exotropia who had undergone medial rectus recession as a primary procedure or advancement of previously recessed medial rectus muscles from 2002 to 2012 were included in the study. The characteristics, postoperative courses, and final results were compared among 3 patient groups. The patients' characteristics including sex, refractive error, and age at the initial surgery were compared. The main outcome measures were the angles of deviation in the primary position and the average divergent drift per month after the exotropia surgery. Twenty-four eyes of 23 patients were investigated. The patients were divided into 3 groups according to insertion status: with normal muscle insertion (4 men, 4 women), slipped muscles (9 women), and stretched scars (2 men, 4 women). The preoperative angles of deviation at near differed significantly between the slipped muscle group and the normal muscle insertion group (P = 0.02). Only patients with normal insertions had significantly greater hyperopia in the nondominant eye (0.95 D) than in the dominant eye (0.53 D). The postoperative divergent shift per month was similar among the groups (0.3, 0.1, and 0.2 prism diopters per month in the slipped muscle, stretched scar, and normal muscle insertion groups, respectively; P = 0.70). Hyperopic anisometropia is an important factor in the natural course of outward drift. The postoperative course of advancement of the medial rectus muscle was equally stable in all 3 patient groups.	[Sawada, Mayu; Hikoya, Akiko; Hotta, Yoshihiro; Sato, Miho] Hamamatsu Univ, Sch Med, Dept Ophthalmol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Negishi, Takashi] Juntendo Univ, Sch Med, Dept Ophthalmol, Tokyo 113, Japan	Sato, M (reprint author), Hamamatsu Univ, Sch Med, Dept Ophthalmol, Higashi Ku, 1-20-1 Handa Yama, Hamamatsu, Shizuoka 4313192, Japan.	mihosato@hama-med.ac.jp					FOLK ER, 1983, BRIT J OPHTHALMOL, V67, P546, DOI 10.1136/bjo.67.8.546; Donaldson MJ, 2004, J AAPOS, V8, P230, DOI 10.1016/j.jaapos.2004.01.001; Ganesh A, 2011, ACTA OPHTHALMOL, V89, P691, DOI 10.1111/j.1755-3768.2009.01791.x; Chatzistefanou KI, 2009, BRIT J OPHTHALMOL, V93, P742, DOI 10.1136/bjo.2007.127613; BRADBURY JA, 1993, J PEDIATR OPHTHALMOL, V30, P163; Cho YA, 2013, CAN J OPHTHALMOL, V48, P300, DOI 10.1016/j.jcjo.2013.03.003; COOPER E L, 1961, Trans Am Acad Ophthalmol Otolaryngol, V65, P595; Kasi SK, 2013, J AAPOS, V17, P465, DOI 10.1016/j.jaapos.2013.06.016; Ludwig IH, 2000, J AAPOS, V4, P326, DOI 10.1067/mpa.2000.107899; MIMS JL, 1992, OPHTHALMIC SURG LAS, V23, P477; Murray A D, 1998, J AAPOS, V2, P133, DOI 10.1016/S1091-8531(98)90003-9; Negishi T, 2010, OPHTHALMOLOGY, V117, P1876, DOI 10.1016/j.ophtha.2010.02.006; OHTSUKI H, 1993, J PEDIATR OPHTHALMOL, V30, P301; PARKS MM, 1979, OPHTHALMOLOGY, V86, P1389; PLAGER DA, 1990, OPHTHALMOLOGY, V97, P131; Plager DA, 1990, OPHTHALMOLOGY, V97, P136; THOMPSON JT, 1983, OPHTHALMOLOGY, V90, P204; Tinley C, 2010, J AAPOS, V14, P120, DOI 10.1016/j.jaapos.2009.10.013	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	SEP	2015	59	5					335	340		10.1007/s10384-015-0395-z		6	Ophthalmology	Ophthalmology	CR1GD	WOS:000361072000009		
J	Asakawa, K; Ishikawa, H; Uga, S; Mashimo, K; Shimizu, K; Kondo, M; Terasaki, H				Asakawa, Ken; Ishikawa, Hitoshi; Uga, Shigekazu; Mashimo, Kimiyo; Shimizu, Kimiya; Kondo, Mineo; Terasaki, Hiroko			Functional and morphological study of retinal photoreceptor cell degeneration in transgenic rabbits with a Pro347Leu rhodopsin mutation	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Retinitis pigmentosa; Rabbit; Retinal photoreceptor cell; Pupil light response; Pyknosis	RETINITIS-PIGMENTOSA; GANGLION-CELLS; MAMMALIAN RETINA; P347L; ROD; OPSIN; MICE; ELECTRORETINOGRAMS; RESPONSES; LIGHT	To investigate the process of retinal degeneration by analyzing the functional and morphological findings in transgenic rabbits with a Pro347Leu rhodopsin mutation. Wild-type (WT) and transgenic (Tg) rabbits at ages 4, 8 and 12 months were used. We conducted functional evaluation by recording the changes in the pupil response to red and blue light stimulation and the amplitude of the electroretinography (ERG). Morphologically, rod and cone distribution was examined using light and electron microscopy. Immunostaining for the identification of retinal ganglion cells (RGCs) was also confirmed by injecting a TUJ-1 monoclonal antibody. Pupil constriction for infrared pupillography and the a- and b-waves for ERG in Tg rabbits decreased with increasing age; the differences were compared to the age-matched WT rabbits. The subnormal ERG in the Tg rabbits, especially the a-wave decrease and pupil constriction with a long latency time, was induced only during exposure to blue light stimulation at 12 months. Light and electron microscopic findings showed a progressive loss of photoreceptor cells over time manifesting by 8 months in the peripheral retina. Moreover, pyknotic nuclei of the outer nuclear layer in the center of the visual streak were observed. At 12 months, there was disappearance of the rods and ballooning degeneration of the cones. Some remaining RGCs had large cell bodies with long branching dendrites. The changes in the pupil light response and amplitude of the ERG could be used to predict the state of retinal degeneration in the Tg rabbit.	[Asakawa, Ken; Ishikawa, Hitoshi; Uga, Shigekazu] Kitasato Univ, Sch Allied Hlth Sci, Dept Orthopt & Visual Sci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Mashimo, Kimiyo; Shimizu, Kimiya] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa 2520373, Japan; [Kondo, Mineo] Mie Univ Grad Sch, Sch Med, Dept Ophthalmol, Tsu, Mie, Japan; [Terasaki, Hiroko] Nagoya Univ Grad Sch, Sch Med, Dept Ophthalmol, Nagoya, Aichi, Japan	Asakawa, K (reprint author), Kitasato Univ, Sch Allied Hlth Sci, Dept Orthopt & Visual Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	asaken@kitasato-u.ac.jp			Kitasato University, School of Allied Health Sciences [2011-1023]; JSPS KAKENHI [23592586, 24791871]	The authors thank Mr. Robert E. Brandt, Founder, CEO and CME of MedEd Japan, for editing the manuscript. We are also grateful to Dr. Hidehiro Oku of Osaka Medical College for the technical assistance in TUJ-1 immunostaining, Mr. Shigeyoshi Maruyama of the Center for Genetic Studies of Integrated Biological Functions and Mrs. Noriko Nemoto of the Research Center for Biological Imaging, Kitasato University, School of Medicine, for the anesthesia and the electron and confocal laser scanning microscopy. This study was supported by a grant from Kitasato University, School of Allied Health Sciences (grant-in-aid for research project no. 2011-1023). This work was also supported by JSPS KAKENHI, grant no. 23592586, 24791871.	Alfinito PD, 2002, P NATL ACAD SCI USA, V99, P5655, DOI 10.1073/pnas.072557799; WALD G, 1945, SCIENCE, V101, P653, DOI 10.1126/science.101.2635.653; WASSLE H, 1991, PHYSIOL REV, V71, P447; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Provencio I, 2000, J NEUROSCI, V20, P600; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Jones BW, 2012, JPN J OPHTHALMOL, V56, P289, DOI 10.1007/s10384-012-0147-2; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; BERSON EL, 1991, AM J OPHTHALMOL, V111, P614; Brown NL, 2001, DEVELOPMENT, V128, P2497; Peng YW, 2000, NAT NEUROSCI, V3, P1121; Kraft TW, 2005, MOL VIS, V11, P1246; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; DODT E, 1960, EXPERIENTIA, V16, P313, DOI 10.1007/BF02157769; FAMIGLIETTI EV, 1995, VISUAL NEUROSCI, V12, P1151; FUKUDA Y, 1985, VISION RES, V25, P319, DOI 10.1016/0042-6989(85)90056-2; GARTNER S, 1981, BRIT J OPHTHALMOL, V65, P23, DOI 10.1136/bjo.65.1.23; Hirota R, 2012, INVEST OPHTH VIS SCI, V53, P1467, DOI 10.1167/iovs.11-9006; Ishikawa H, 2012, JPN J OPHTHALMOL, V56, P181, DOI 10.1007/s10384-011-0116-1; Jones BW, 2011, J COMP NEUROL, V519, P2713, DOI 10.1002/cne.22703; JULIUSSON B, 1994, INVEST OPHTH VIS SCI, V35, P811; Kondo M, 2009, INVEST OPHTH VIS SCI, V50, P1371, DOI 10.1167/iovs.08-2863; Morimoto T, 2012, INVEST OPHTH VIS SCI, V53, P4254, DOI 10.1167/iovs.11-9067; Muraoka Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036135; Nishimura T, 2011, INVEST OPHTH VIS SCI, V52, P7610, DOI 10.1167/iovs.11-7611; NUBOER JFW, 1971, DOC OPHTHALMOL, V30, P279, DOI 10.1007/BF00142525; PERRY VH, 1979, EXP BRAIN RES, V35, P85; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Sakai T, 2009, INVEST OPHTH VIS SCI, V50, P4402, DOI 10.1167/iovs.09-3458; STONE JL, 1992, ARCH OPHTHALMOL-CHIC, V110, P1634; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Ueno S, 2013, VISION RES, V91, P118, DOI 10.1016/j.visres.2013.08.006; Witkin AJ, 2006, AM J OPHTHALMOL, V142, P945, DOI 10.1016/j.ajo.2006.07.024; Yokoyama D, 2010, JPN J OPHTHALMOL, V54, P458, DOI 10.1007/s10384-010-0842-9	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	SEP	2015	59	5					353	363		10.1007/s10384-015-0400-6		11	Ophthalmology	Ophthalmology	CR1GD	WOS:000361072000012		
J	Hirosawa, M; Sambe, T; Uchida, N; Lee, XP; Sato, K; Kobayashi, S				Hirosawa, Makiko; Sambe, Takehiko; Uchida, Naoki; Lee, Xiao-Pen; Sato, Keizo; Kobayashi, Shinichi			Determination of nonsteroidal anti-inflammatory drugs in human tear and plasma samples using ultra-fast liquid chromatography-tandem mass spectrometry	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Nonsteroidal anti-inflammatory drugs (NSAIDs); Tandem mass spectrometry (MS/MS); Human tears and plasma	ALCOHOL METABOLITES; LC-MS; LOXOPROFEN; IBUPROFEN; VALIDATION; COLUMN	To evaluate a new rapid and sensitive method for analyzing human tears and plasma for nonsteroidal anti-inflammatory drugs (NSAIDs) and investigate the influence of the transfer of NSAIDs in an ocular lesion. In this cross-over study, a single dose of 200 mg of ibuprofen and 60 mg of loxoprofen sodium were orally administered to six healthy Japanese subjects. Collected samples were analyzed by ultra-fast liquid chromatography tandem mass spectrometry (UFLC-MS/MS). Recoveries of the two drugs spiked in the tears and plasma were 96.0-117.0 % in the tears and 99.0-105.7 % in the plasma. Regression equations for both NSAIDs showed excellent linearity from 0.02-1.0 mu g/ml for the tears and 0.1-5.0 mu g/ml for the plasma, with the limits of detection at 0.02 mu g/ml for tears and 0.1 mu g/ml for plasma. This new high-throughput NSAID determination method only requires a small tear amount (10 mu l) and plasma volume (20 mu l) and thus will be useful in clinical and toxicological analyses. Analytical results also showed the presence of ibuprofen and loxoprofen in the actual tears and plasma, which confirms the transition of NSAIDs from the tears to the plasma.	[Hirosawa, Makiko] Showa Univ, Sch Med, Dept Ophthalmol, Shinagawa Ku, Tokyo 1428555, Japan; [Hirosawa, Makiko; Sambe, Takehiko; Uchida, Naoki] Showa Univ, Sch Med, Dept Pharmacol, Tokyo 1428555, Japan; [Uchida, Naoki; Kobayashi, Shinichi] Showa Univ, Clinial Res Inst Clin Pharmacol & Therapeut, Tokyo 1578577, Japan; [Lee, Xiao-Pen; Sato, Keizo] Showa Univ, Sch Med, Dept Legal Med, Tokyo 1428555, Japan	Hirosawa, M (reprint author), Showa Univ, Sch Med, Dept Ophthalmol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	mhiro@med.showa-u.ac.jp					Choo KS, 2001, J PHARMACEUT BIOMED, V25, P639, DOI 10.1016/S0731-7085(00)00583-5; Canaparo R, 2000, BIOMED CHROMATOGR, V14, P219, DOI 10.1002/1099-0801(200006)14:4<219::AID-BMC969>3.0.CO;2-Z; Nemoto T, 2014, J PHARMACEUT BIOMED, V88, P71, DOI 10.1016/j.jpba.2013.08.023; Arnold DR, 2008, J CHROMATOGR B, V867, P105, DOI 10.1016/j.jchromb.2008.03.025; Davies NM, 1998, CLIN PHARMACOKINET, V34, P101, DOI 10.2165/00003088-199834020-00002; Suenami K, 2006, ANAL BIOANAL CHEM, V384, P1501, DOI 10.1007/s00216-006-0352-2; Cho HY, 2006, J CHROMATOGR B, V835, P27, DOI 10.1016/j.jchromb.2006.02.058; TERADA A, 1984, J MED CHEM, V27, P212, DOI 10.1021/jm00368a019; Bushra Rabia, 2010, Oman Med J, V25, P155, DOI 10.5001/omj.2010.49; Chiambaretta F, 2008, EUR J OPHTHALMOL, V18, P13; Farrar H, 2002, J CHROMATOGR B, V780, P341, DOI 10.1016/S1570-0232(02)00543-3; FRAUNFELDER FT, 1985, AM J OPHTHALMOL, V100, P534; Fraunfelder FW, 2006, ARCH OPHTHALMOL-CHIC, V124, P277, DOI 10.1001/archopht.124.2.277; Lee HW, 2009, BIOMED CHROMATOGR, V23, P714, DOI 10.1002/bmc.1175; Lee XP, 2010, FORENSIC TOXICOL, V28, P96, DOI 10.1007/s11419-010-0096-8; LUTZ EG, 1975, AM J PSYCHIAT, V132, P548; MIREJOVSKY D, 1991, OPTOMETRY VISION SCI, V68, P858, DOI 10.1097/00006324-199111000-00005; MONACO F, 1982, EPILEPSIA, V23, P23, DOI 10.1111/j.1528-1157.1982.tb05049.x; Mora P, 2008, GRAEF ARCH CLIN EXP, V246, P1047, DOI 10.1007/s00417-008-0825-4; Nakajima Masaharu, 2003, Drug Metab Pharmacokinet, V18, P139, DOI 10.2133/dmpk.18.139; Tsurumaki N, 2013, JAPANESE J MED PHARM, V69, P275; United States Food and Drug Administration, 2014, GUID IND AN PROC MET	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	SEP	2015	59	5					364	371		10.1007/s10384-015-0389-x		8	Ophthalmology	Ophthalmology	CR1GD	WOS:000361072000013		
J	Jutel, M; Agache, I; Bonini, S; Burks, AW; Calderon, M; Canonica, W; Cox, L; Demoly, P; Frew, AJ; O'Hehir, R; Kleine-Tebbe, J; Muraro, A; Lack, G; Larenas, D; Levin, M; Nelson, H; Pawankar, R; Pfaar, O; van Ree, R; Sampson, H; Santos, AF; Du Toit, G; Werfel, T; van Wijk, RG; Zhang, L; Akdis, CA				Jutel, Marek; Agache, Ioana; Bonini, Sergio; Burks, A. Wesley; Calderon, Moises; Canonica, Walter; Cox, Linda; Demoly, Pascal; Frew, Antony J.; O'Hehir, Robin; Kleine-Tebbe, Joerg; Muraro, Antonella; Lack, Gideon; Larenas, Desiree; Levin, Michael; Nelson, Harald; Pawankar, Ruby; Pfaar, Oliver; van Ree, Ronald; Sampson, Hugh; Santos, Alexandra F.; Du Toit, George; Werfel, Thomas; van Wijk, Roy Gerth; Zhang, Luo; Akdis, Cezmi A.			International consensus on allergy immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						International consensus; allergy; immunotherapy; allergen vaccine; allergic rhinitis; asthma; food allergy; atopic dermatitis	PEANUT ORAL IMMUNOTHERAPY; LONG-TERM EFFICACY; COWS MILK ALLERGY; SUBLINGUAL IMMUNOTHERAPY; ATOPIC-DERMATITIS; SUBCUTANEOUS IMMUNOTHERAPY; POSITION PAPER; FOOD ALLERGY; CLINICAL IMMUNOLOGY; RESPIRATORY ALLERGY	Allergen immunotherapy (AIT) has been used to treat allergic disease since the early 1900s. Despite numerous clinical trials and meta-analyses proving AIT efficacious, it remains underused and is estimated to be used in less than 10% of patients with allergic rhinitis or asthma worldwide. In addition, there are large differences between regions, which are not only due to socioeconomic status. There is practically no controversy about the use of AIT in the treatment of allergic rhinitis and allergic asthma, but for atopic dermatitis or food allergy, the indications for AIT are not well defined. The elaboration of a wider consensus is of utmost importance because AIT is the only treatment that can change the course of allergic disease by preventing the development of asthma and new allergen sensitizations and by inducing allergen-specific immune tolerance. Safer and more effective AIT strategies are being continuously developed both through elaboration of new allergen preparations and adjuvants and alternate routes of administration. A number of guidelines, consensus documents, or both are available on both the international and national levels. The international community of allergy specialists recognizes the need to develop a comprehensive consensus report to harmonize, disseminate, and implement the best AIT practice. Consequently, the International Collaboration in Asthma, Allergy and Immunology, formed by the European Academy of Allergy and Clinical Immunology; the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the World Allergy Organization, has decided to issue an international consensus on AIT.	[Jutel, Marek] Wroc1aw Med Univ, Dept Clin Immunol, PL-50368 Wroclaw, Poland; [Jutel, Marek] ALL MED Med Res Inst, Wroclaw, Poland; [Agache, Ioana] Transylvania Univ, Fac Med, Brasov, Romania; [Bonini, Sergio] Univ Naples 2, Rome, Italy; [Bonini, Sergio] IFT CNR, Rome, Italy; [Bonini, Sergio] Expert On Secondment European Med Agcy, London, England; [Burks, A. Wesley] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Calderon, Moises] Royal Brompton Hosp, Sect Allergy & Clin Immunol, Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England; [Canonica, Walter] Univ Genoa, DIMI, Allergy & Resp Dis Clin, IRCCS AOU S Martino, Genoa, Italy; [Cox, Linda] Ctr Asthma & Allergy, Ft Lauderdale, FL USA; [Demoly, Pascal] Univ Hosp Montpellier, INSERM U657, Montpellier, France; [Frew, Antony J.] Royal Sussex Cty Hosp, Dept Resp Med, Brighton BN2 5BE, E Sussex, England; [O'Hehir, Robin] Monash Univ, AMREP, Dept Immunol, Melbourne, Vic 3004, Australia; [Kleine-Tebbe, Joerg] Allergy & Asthma Ctr Westend, Berlin, Germany; [Muraro, Antonella] Padua Gen Univ Hosp, Dept Mother & Child Hlth, Padua, Italy; [Lack, Gideon] Kings Coll London, MRC & Asthma UK Ctr Allerg Mech Asthma, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England; [Lack, Gideon] Guys & St Thomas NHS Fdn Trust, Childrens Allergy Unit, London, England; [Larenas, Desiree] Hosp Med Sur, Mexico City, DF, Mexico; [Levin, Michael] Red Cross War Mem Childrens Hosp, Div Allergy, Sch Child & Adolescent Hlth, Cape Town, South Africa; [Nelson, Harald] Natl Jewish Hlth, Denver, CO USA; [Pawankar, Ruby] Nippon Med Sch, Dept Pediat, Tokyo 113, Japan; [Pfaar, Oliver] Univ Hosp Mannheim, Ctr Rhinol & Allergol, Dept Otorhinolaryngol Head & Neck Surg, Mannheim, Germany; [van Ree, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1012 WX Amsterdam, Netherlands; [van Ree, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1012 WX Amsterdam, Netherlands; [Sampson, Hugh] Icahn Sch Med Mt Sinai, Dept Pediat, Div Allergy Immunol, New York, NY 10029 USA; [Sampson, Hugh] Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, New York, NY 10029 USA; [Santos, Alexandra F.; Du Toit, George] Kings Coll London, Div Asthma Allergy & Lung Biol, Dept Pediat Allergy, London WC2R 2LS, England; [Santos, Alexandra F.; Du Toit, George] MRC & Asthma UK Ctr Allerg Mech Asthma, London, England; [Werfel, Thomas] Hannover Med Sch, Dept Dermatol & Allergy, Div Immunodermatol & Allergy Res, Hannover, Germany; [van Wijk, Roy Gerth] Erasmus MC, Rotterdam, Netherlands; [Zhang, Luo] Beijing Inst Otolaryngol, Beijing, Peoples R China; [Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res, Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland	Jutel, M (reprint author), Wroc1aw Med Univ, Dept Clin Immunol, Chalubinskiego 5, PL-50368 Wroclaw, Poland.	marek.jutel@umed.wroc.pl		Bonini, Sergio/0000-0003-0079-3031	Polish National Science Centre; Allergopharma and Stallergenes; Gerson Lehrman Group; ActoGeniX; Genentech; Sanofi US; Valeant Pharmaceuticals North America; ALK-Abello; STG; Hal Allergy; ALK-Abello STG; Allergopharma; Allergy Therapeutics; Lofarma; Stallergenes; Greer; Circassia and Biomay; Southeastern Allergy Asthma Immunology Association; Circassia; Thermo Fisher Scientific; DBV; Pierre Febre Medicaments; Menarini; MSD; AstraZeneca; GlaxoSmithKline; Merck; Bencard; LETI; Novartis; Meda; Nutricia; MIT; Boehringer Ingelheim; Glenmark; UCB; Sunovion; Sanofi; Commet; Bencard (Germany); HAL-Allergy (The Netherlands); Novartis/LETI (Germany); MEDA (Germany); ALK-Abello (Germany/Denmark); Allergopharma (Germany); Biotech Tools s.a. (Belgium); GfK Bridgehead (United Kingdom); NAVIGANT-consulting (United States); Sanofi (United States); Guidepoint Global Advisors (United States); Stallergenes (Germany/France); Mobile Chamber Experts (MCX); GA2LEN Partner (Germany); HAL-Allergy (Germany/The Netherlands); Artu Biologicals (The Netherlands); Allergy Therapeutics/Bencard (UK/Germany); Hartington (Spain); Lofarma (Italy); Novartis/Leti (Germany/Spain); GlaxoSmithKline (United Kingdom/Germany); Essex-Pharma (Germany); Cytos (Switzerland); Curalogic (Denmark); Roxall (Germany); Biomay (Austria); Thermo Fisher (Germany); Circassia (UK); E.U (FP-7-Health); Biotech Tools s. a. (Belgium); MEDA-Pharma GmbH (Germany); Allergy Therapeutics/Bencard (United Kingdom/Germany)many); HAL Allergy BV; European Union; Thermo Fisher; NWO; STW; Biomay; Allergopharma and Thermo Fisher; Actellion; Aventis; PREDICTA; Swiss National Science Foundation; MeDALL [261357]; Christine-Kuhne Center for Allergy Research and Education	M. Jutel has received research support from the Polish National Science Centre and lecture fees from Allergopharma and Stallergenes. S. Bonini has provided expert testimony for the European Medicines Agency. A. W. Burks is on the FARE and World Allergy Organization boards; is on the Murdoch Children's Research Institute advisory board; has received consultancy fees from Gerson Lehrman Group, ActoGeniX, Genentech, Sanofi US, Valeant Pharmaceuticals North America; has provided unpaid consultation for Dynavax Technologies, Perrigo Company (PBN Nutritionals), and Perosphere; is employed by the University of North Carolina; has patents (US5558869, US55973121, US6441142, US6486311, US6835824, US7485708, and US7879977); has received payment for developing educational presentations from Current Views 2012; and has stock/stock options in Allertein and Mastcell Pharmaceuticals. M. Calderon has received consultancy fees from ALK-Abello, STG, and Hal Allergy; has received lecture fees from ALK-Abello STG, and Allergopharma; and has received travel support from ALK-Abello, STG, Allergopharma, and Hal Allergy. W. Canonica has received consulting fees from ALK-Abello, Allergy Therapeutics, Lofarma, and Stallergenes. L. Cox has received consulting fees from Greer, has received fees for participation in review activities from Circassia and Biomay, is on the American Board of Allergy and Immunology and American Academy of Allergy, Asthma & Immunology Boards, and has received lecture fees from Southeastern Allergy Asthma Immunology Association. P. Demoly has received consultancy fees from ALK-Abello, Circassia, Stallergenes, Allergopharma, Thermo Fisher Scientific, DBV, Chiesi, and Pierre Febre Medicaments and has received lecture fees from Menarini, MSD, AstraZeneca, and GlaxoSmithKline. J. Kleine-Tebbe is on the ALK-Abello, Novartis, Leti, and Bencard advisory boards; has received consultancy fees from Merck and Circassia; has received research support from Circassia; and has received lecture fees from Allergopharma, ALK-Abello, Bencard, HAL Allergy, LETI, Lofarma, Novartis, and Stallergenes. A. Muraro has received consultancy fees from Meda, Nutricia, Allergopharma, and Novartis. G. Lack has stock/stock options in DBV Technologies. D. Larenas is on the CMICA board; has received consultancy fees from Meda, Pfizer, MIT, Boehringer Ingelheim, Novartis, and Glenmark; has received research support from Novartis, Pfizer, Meda, UCB, GlaxoSmithKline, AstraZeneca, Sunovion, Sanofi, MSD, Teva, and Commet; has received lecture fees from AstraZeneca, Glenmark, MSD, UCB, Meda, and Pfizer; has received payment for developing educational presentations from Glenmark; and has received travel support from MSD, UCB, AstraZeneca, Pfizer, Meda, Senosiain, Glenmark, ALK-Abello, Novartis, and Chiesi. H. Nelson is on the advisory board for Merck and Circassia, is on the data monitoring board for AstraZeneca and Pearl Therapeutics, and has received research support from Circassia. O. Pfaar has received consultancy fees from Bencard (Germany), HAL-Allergy (The Netherlands), Novartis/LETI (Germany), MEDA (Germany), ALK-Abello (Germany/Denmark), Allergopharma (Germany), Biotech Tools s.a.; (Belgium), GfK Bridgehead (United Kingdom), NAVIGANT-consulting (United States), Sanofi (United States), Guidepoint Global Advisors (United States), Stallergenes (Germany/France), and Mobile Chamber Experts (MCX), a GA2LEN Partner (Germany); is employed by Universitatsmedizin Mannheim, Heidelberg University; has received research support from ALK-Abello (Germany/Denmark), Allergopharma (Germany), Stallergenes (Germany/France), HAL-Allergy (Germany/The Netherlands), Artu Biologicals (The Netherlands), Allergy Therapeutics/Bencard (UK/Germany), Hartington (Spain), Lofarma (Italy), Novartis/Leti (Germany/Spain), GlaxoSmithKline (United Kingdom/Germany), Essex-Pharma (Germany), Cytos (Switzerland), Curalogic (Denmark), Roxall (Germany), Biomay (Austria), Thermo Fisher (Germany), Circassia (UK), E.U (FP-7-Health-2013-Innovation 1), Biotech Tools s. a. (Belgium), and MEDA-Pharma GmbH (Germany); has received lecture fees from ALK-Abello (Germany/Denmark), Allergopharma (Germany), Stallergenes (Germany/France), HAL-Allergy (Germany/The Netherlands), Allergy Therapeutics/Bencard (United Kingdom/Germany), Hartington (Spain), Lofarma (Italy), Novartis/Leti (Germany/Spain), GlaxoSmithKline (United Kingdom/Germany), Roxall (Germany), Thermo Fisher (Germany), and MEDA-Pharma GmbH (Germany); is coeditor and author of textbook "Allergien bei Kindern und Jugendlichen'' (Schattauer, Germany), author of different chapters of "Allergologie-Handbuc" (Schattauer, Germany), and author of 1 chapter in "Allergologie" (Springer, Germany); has received payment for developing educational presentations from GlaxoSmithKline (Germany), Bencard (Germany), and Novartis (Germany); has received travel support from HAL-Allergy (Netherlands/Germany) and Allergopharma (Germany); and is current chairman of IT IG of European Academy of Allergy and Clinical Immunology (EAACI), and current secretary of ENT-section of DGAKI. R. van Ree is on the EAACI board, has received consultancy fees from HAL Allergy BV, has received research support from the European Union, and has received lecture fees from Thermo Fisher Scientific. H. Sampson is an unpaid consultant on the DBV Scientific Advisory Board. G. Du Toit has received lecture fees from Thermo Fisher, owns 2% equity of the FoodMaestro app, and has received travel support from the EAACI as secretary of the paediatric section. R. Gerth van Wijk has received consultancy fees from MSD, HAL, Crucell, ALK-Abello, and Novartis; has received research support from NWO, STW, Novartis, Biomay, and DBV; has received lecture fees from Allergopharma and Thermo Fisher; has received payment for manuscript preparation from Chiesi; and receives royalties from de Tijdstroom and Bohn, Stafleu, van Loghum. C. A. Akdis has received consultancy fees from Actellion, Aventis, Stallergenes, Allergopharma, and Circacia; is employed by the Swiss Institute of Allergy and Asthma Research, University of Zuurich; has received research support from Novartis, PREDICTA, Swiss National Science Foundation, MeDALL (Programme no. 261357), and the Christine-Kuhne Center for Allergy Research and Education. The rest of the authors declare that they have no relevant conflicts of interest.	Abramson MJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001186.pub2; Anagnostou Katherine, 2014, Clin Transl Allergy, V4, P30, DOI 10.1186/2045-7022-4-30; Lin SY, 2013, JAMA-J AM MED ASSOC, V309, P1278, DOI 10.1001/jama.2013.2049; Casale TB, 2014, J ALLERGY CLIN IMMUN, V133, P612, DOI 10.1016/j.jaci.2014.01.007; Calderon MA, 2012, J ALLERGY CLIN IMMUN, V129, P929, DOI 10.1016/j.jaci.2011.11.019; Calderon MA, 2012, ALLERGY, V67, P302, DOI 10.1111/j.1398-9995.2011.02761.x; Kelso JM, 2004, ANN ALLERG ASTHMA IM, V92, P225; [Anonymous], 2007, J ALLERGY CLIN IMM S, V120, pS25; Nadeau KC, 2012, IMMUNOL ALLERGY CLIN, V32, P111, DOI 10.1016/j.iac.2011.11.004; Krishna MT, 2011, CLIN EXP ALLERGY, V41, P1201, DOI 10.1111/j.1365-2222.2011.03788.x; Cox LS, 2006, J ALLERGY CLIN IMMUN, V117, P1021, DOI 10.1016/j.jaci.2006.02.040; Gillis D, 1997, MED J AUSTRALIA, V167, P540; Zuberbier T, 2010, ALLERGY, V65, P1525, DOI 10.1111/j.1398-9995.2010.02474.x; Mosbech H, 2014, J ALLERGY CLIN IMMUN, V134, P568, DOI 10.1016/j.jaci.2014.03.019; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; Rosner-Friese K, 2015, J ALLERGY CLIN IMMUN, V135, P636, DOI 10.1016/j.jaci.2014.10.045; Kim JM, 2013, PEDIATRICS, V131, P1155, DOI 10.1542/peds.2013-0343; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Bae JM, 2013, J ALLERGY CLIN IMMUN, V132, P110, DOI 10.1016/j.jaci.2013.02.044; Kim JS, 2011, J ALLERGY CLIN IMMUN, V128, P125, DOI 10.1016/j.jaci.2011.04.036; Kim EH, 2011, J ALLERGY CLIN IMMUN, V127, P640, DOI 10.1016/j.jaci.2010.12.1083; Malling HJ, 1998, ALLERGY, V53, P933, DOI 10.1111/j.1398-9995.1998.tb03793.x; Passalacqua G, 2013, J ALLERGY CLIN IMMUN, V132, P93, DOI 10.1016/j.jaci.2013.03.039; Anagnostou K, 2014, LANCET, V383, P1297, DOI 10.1016/S0140-6736(13)62301-6; Epstein TG, 2014, J ALLER CL IMM-PRACT, V2, P161, DOI 10.1016/j.jaip.2014.01.004; Buchanan AD, 2007, J ALLERGY CLIN IMMUN, V119, P199, DOI 10.1016/j.jaci.2006.09.016; Pajno GB, 2007, J ALLERGY CLIN IMMUN, V120, P164, DOI 10.1016/j.jaci.2007.04.008; Narisety SD, 2015, J ALLERGY CLIN IMMUN, V135, P1275, DOI 10.1016/j.jaci.2014.11.005; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007; Pfaar O, 2014, ALLERGY, V69, P854, DOI 10.1111/all.12383; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Canonica GW, 2007, ALLERGY, V62, P317, DOI 10.1111/j.1398-9995.2006.01312.x; HAMERTON JL, 1989, LANCET, V1, P1; Canonica GW, 2009, ALLERGY, V64, P1, DOI 10.1111/j.1398-9995.2009.02309.x; Berto P, 2008, CURR OPIN ALLERGY CL, V8, P585, DOI 10.1097/ACI.0b013e32831411e9; Purello-D'Ambrosio F, 2001, CLIN EXP ALLERGY, V31, P1295, DOI 10.1046/j.1365-2222.2001.01027.x; de Silva D, 2014, ALLERGY, V69, P159, DOI 10.1111/all.12314; Marogna M, 2010, J ALLERGY CLIN IMMUN, V126, P969, DOI 10.1016/j.jaci.2010.08.030; Alvarez-Cuesta E, 2006, ALLERGY, V61, P1, DOI 10.1111/j.1398-9995.2006.01219_1.x; Amar SM, 2009, J ALLERGY CLIN IMMUN, V124, P150, DOI 10.1016/j.jaci.2009.04.037; Tahamiler R, 2007, LARYNGOSCOPE, V117, P965, DOI 10.1097/MLG.0b013e31804f8141; Nowak-Wegrzyn A, 2008, J ALLERGY CLIN IMMUN, V122, P342, DOI 10.1016/j.jaci.2008.05.043; Walker SM, 2011, CLIN EXP ALLERGY, V41, P1177, DOI 10.1111/j.1365-2222.2011.03794.x; [Anonymous], 2011, ZHONGHUA ER BI YAN H, V46, P976; Erekosima N, 2014, LARYNGOSCOPE, V124, P616, DOI 10.1002/lary.24295; Cox L, 2010, J ALLERGY CLIN IMMUN, V125, P569, DOI 10.1016/j.jaci.2009.10.060; Shekelle PG, 1999, BRIT MED J, V318, P593; Bousquet J, 1998, ANN ALLERG ASTHMA IM, V81, P401, DOI 10.1016/S1081-1206(10)63136-5; Okubo Kimihiro, 2011, Allergology International, V60, P171, DOI [10.2332/allergolint. 11-RAI-0334, 10.2332/allergolint.11-RAI-0334]; Penagos M, 2008, CHEST, V133, P599, DOI 10.1378/chest.06-1425; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Novak N, 2012, J ALLERGY CLIN IMMUN, V130, P925, DOI 10.1016/j.jaci.2012.08.004; Keet CA, 2012, J ALLERGY CLIN IMMUN, V129, P448, DOI 10.1016/j.jaci.2011.10.023; Schofield AT, 1908, LANCET, V1, P716; Bernstein DI, 2010, ANN ALLERG ASTHMA IM, V104, P530, DOI 10.1016/j.anai.2010.04.008; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1176, DOI 10.1111/j.1468-3083.2012.04636.x; [Anonymous], 2008, ALLERGY S86, V63, P8; Wilson DR, 2005, ALLERGY, V60, P4, DOI 10.1111/j.1398-9995.2005.00699.x; de Groot H, 2009, ALLERGY, V64, P963, DOI 10.1111/j.1398-9995.2009.01998.x; Amin HS, 2006, J ALLERGY CLIN IMMUN, V117, P169, DOI 10.1016/j.jaci.2005.10.010; Burks AW, 2013, J ALLERGY CLIN IMMUN, V131, P1288, DOI 10.1016/j.jaci.2013.01.049; Jutel M, 2013, ALLERGOL INT, V62, P425, DOI 10.2332/allergolint.13-RAI-0608; Agache I, 2012, ALLERGY, V67, P835, DOI 10.1111/j.1398-9995.2012.02832.x; Bauer CS, 2014, J ALLERGY CLIN IMMUN, V134, P765, DOI 10.1016/j.jaci.2014.07.024; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Calderon M, 2012, ALLERGY, V67, P462, DOI 10.1111/j.1398-9995.2012.02785.x; Calderon MA, 2014, J ALLER CL IMM-PRACT, V2, P136, DOI 10.1016/j.jaip.2013.12.008; Canonica Giorgio Walter, 2014, World Allergy Organ J, V7, P6, DOI 10.1186/1939-4551-7-6; Committee on the Safety of Medicines (CSM) in Great Britain, 1986, BR MED J, V293, P948; Coop CA, 2008, ANN ALLERG ASTHMA IM, V101, P96, DOI 10.1016/S1081-1206(10)60841-1; Cox L, 2013, J ALLER CL IMM-PRACT, V1, P455, DOI 10.1016/j.jaip.2013.08.001; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Darsow U, 2012, CURR OPIN ALLERGY CL, V12, P665, DOI 10.1097/ACI.0b013e3283588cf4; de Blay F, 2014, RESP MED, V10, P1430; DesRoches A, 1997, J ALLERGY CLIN IMMUN, V99, P450, DOI 10.1016/S0091-6749(97)70069-1; Gendelman SR, 2013, ANN ALLERG ASTHMA IM, V111, P555, DOI 10.1016/j.anai.2013.08.020; Global Initiative for Asthma (GINA), 2014, GLOB STRAT ASTHM MAN; von Moos S, 2014, J ALLERGY CLIN IMMUN, V134, P965, DOI 10.1016/j.jaci.2014.07.037; Jutel M, 2014, POLISH J ALLERGOL, V1, P30; Keet CA, 2012, J ALLERGY CLIN IMMUN, V129, pe1; Larenas-Linnemann Désirée, 2011, Rev Alerg Mex, V58, P3; Leith Eric, 2006, Allergy Asthma Clin Immunol, V2, P47, DOI 10.1186/1710-1492-2-2-47; Lin SY, 2013, COMP EFFECTIVENESS R; Lucendo AJ, 2014, ANN ALLERG ASTHMA IM, V113, P624, DOI 10.1016/j.anai.2014.08.004; Makatsori M, 2014, ALLERGY, V69, P571, DOI 10.1111/all.12385; MALLING HJ, 1993, ALLERGY, V48, P9; Malling Hans-Jørgen, 2008, Clin Allergy Immunol, V21, P343; Malling H-J, 1988, ALLERGY S6, V43, P9; Marogna M, 2013, ALLERGOL IMMUNOPATH, V41, P216, DOI 10.1016/j.aller.2012.07.004; Miehlke Stephan, 2013, Case Rep Gastroenterol, V7, P363, DOI 10.1159/000355161; Nelson HS, 2009, J ALLERGY CLIN IMMUN, V123, P763, DOI 10.1016/j.jaci.2008.12.013; Nurmatov U, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009014.pub2; Okamoto Y, 2014, AURIS NASUS LARYNX, V41, P1, DOI 10.1016/j.anl.2013.06.003; Des Roches A., 1996, Allergy (Copenhagen), V51, P430; Passalacqua Giovanni, 2007, Curr Drug Saf, V2, P117, DOI 10.2174/157488607780598340; Pfaar O, 2014, ALLERGO J INT, V23, P282; Rieker-Schwienbacher Juliane, 2013, Clin Transl Allergy, V3, P16, DOI 10.1186/2045-7022-3-16; Roy SR, 2007, ANN ALLERG ASTHMA IM, V99, P82; Saranz RJ, 2010, ARCH ARGENT PEDIATR, V108, P258; Schiappoli M, 2009, CLIN EXP ALLERGY, V39, P1569, DOI 10.1111/j.1365-2222.2009.03286.x; Stelmach I, 2012, ANN ALLERG ASTHMA IM, V109, P274, DOI 10.1016/j.anai.2012.07.015; Tabar AI, 2005, J ALLERGY CLIN IMMUN, V116, P109, DOI 10.1016/j.jaci.2005.05.005; Tankersley MS, 2000, J ALLERGY CLIN IMMUN, V106, P840, DOI 10.1067/mai.2000.110468; Temino VM, 2013, ALLERGY ASTHMA PROC, V34, P255, DOI 10.2500/aap.2013.34.3651; TINKELMAN DG, 1995, J ALLERGY CLIN IMMUN, V95, P8, DOI 10.1016/S0091-6749(95)70146-X; Valovirta Erkka, 2012, Duodecim, V128, P108; Vidal Carmen, 2014, Clin Transl Allergy, V4, P36, DOI 10.1186/2045-7022-4-36; Werfel T, 2006, ALLERGY, V61, P202, DOI 10.1111/j.1398-9995.2006.00974.x; Zuidmeer-Jongejan Laurian, 2012, Clin Transl Allergy, V2, P5, DOI 10.1186/2045-7022-2-5	112	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					556	568		10.1016/j.jaci.2015.04.047		13	Allergy; Immunology	Allergy; Immunology	CQ9EA	WOS:000360913300005		
J	Persson, H; Kwon, AT; Ramilowski, JA; Silberberg, G; Soderhall, C; Orsmark-Pietras, C; Nordlund, B; Konradsen, JR; de Hoon, MJL; Melen, E; Hayashizaki, Y; Hedlin, G; Kere, J; Daub, CO				Persson, Helena; Kwon, Andrew T.; Ramilowski, Jordan A.; Silberberg, Gilad; Soderhall, Cilla; Orsmark-Pietras, Christina; Nordlund, Bjorn; Konradsen, Jon R.; de Hoon, Michiel J. L.; Melen, Erik; Hayashizaki, Yoshihide; Hedlin, Gunilla; Kere, Juha; Daub, Carsten O.			Transcriptome analysis of controlled and therapy-resistant childhood asthma reveals distinct gene expression profiles	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Therapy-resistant asthma; childhood asthma; peripheral blood leukocytes; transcriptome; long noncoding RNA	PROBLEMATIC SEVERE ASTHMA; GENOME-WIDE ASSOCIATION; DIFFERENTIAL EXPRESSION; CHILDREN; EXACERBATIONS; PHENOTYPES; CELLS; LOCI; SETS	Background: Children with problematic severe asthma have poor disease control despite high doses of inhaled corticosteroids and additional therapy, leading to personal suffering, early deterioration of lung function, and significant consumption of health care resources. If no exacerbating factors, such as smoking or allergies, are found after extensive investigation, these children are given a diagnosis of therapy-resistant (or therapy-refractory) asthma (SA). Objective: We sought to deepen our understanding of childhood SA by analyzing gene expression and modeling the underlying regulatory transcription factor networks in peripheral blood leukocytes. Methods: Gene expression was analyzed by using Cap Analysis of Gene Expression in children with SA (n = 13), children with controlled persistent asthma (n = 15), and age-matched healthy control subjects (n = 9). Cap Analysis of Gene Expression sequencing detects the transcription start sites of known and novel mRNAs and noncoding RNAs. Results: Sample groups could be separated by hierarchical clustering on 1305 differentially expressed transcription start sites, including 816 known genes and several novel transcripts. Ten of 13 tested novel transcripts were validated by means of RT-PCR and Sanger sequencing. Expression of RAR-related orphan receptor A (RORA), which has been linked to asthma in genome-wide association studies, was significantly upregulated in patients with SA. Gene network modeling revealed decreased glucocorticoid receptor signaling and increased activity of the mitogen-activated protein kinase and Jun kinase cascades in patients with SA. Conclusion: Circulating leukocytes from children with controlled asthma and those with SA have distinct gene expression profiles, demonstrating the possible development of specific molecular biomarkers and supporting the need for novel therapeutic approaches.	[Persson, Helena; Soderhall, Cilla; Orsmark-Pietras, Christina; Kere, Juha; Daub, Carsten O.] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Persson, Helena; Soderhall, Cilla; Orsmark-Pietras, Christina; Kere, Juha; Daub, Carsten O.] Karolinska Inst, Ctr Innovat Med CIMED, Stockholm, Sweden; [Silberberg, Gilad] Karolinska Inst, Unit Computat Med, Dept Med, Stockholm, Sweden; [Soderhall, Cilla; Nordlund, Bjorn; Konradsen, Jon R.; Melen, Erik; Hedlin, Gunilla; Kere, Juha] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Nordlund, Bjorn; Konradsen, Jon R.; Hedlin, Gunilla] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Melen, Erik] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Kwon, Andrew T.; Ramilowski, Jordan A.; de Hoon, Michiel J. L.; Hayashizaki, Yoshihide; Daub, Carsten O.] Omics Sci Ctr, Yokohama, Kanagawa, Japan; RIKEN Yokohama Inst, Yokohama, Kanagawa, Japan; [Kwon, Andrew T.; Ramilowski, Jordan A.; de Hoon, Michiel J. L.; Daub, Carsten O.] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Nordlund, Bjorn; Konradsen, Jon R.; Hedlin, Gunilla] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Melen, Erik] Karolinska Inst, Sachs Childrens Hosp, Stockholm, Sweden; [Hayashizaki, Yoshihide] RIKEN Res Cluster Innovat, Prevent Med & Diag Innovat Program, Wako, Saitama, Japan; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Kere, Juha] Univ Helsinki, Res Programs Unit, FIN-00014 Helsinki, Finland	Kere, J (reprint author), Karolinska Inst, Dept Biosci & Nutr, Halsovagen 7-9, SE-14183 Huddinge, Sweden.	juha.kere@ki.se	Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271	MEXT; Swedish Foundation for Strategic Research [RBc08-0027]; Swedish Research Council [2009-5091]; Freemason Child House Foundation in Stockholm; Konsul Th. C. Bergh's Foundation; Swedish Asthma and Allergy Association's Research Foundation; Centre for Allergy Research at Karolinska Institutet; Swedish Heart-Lung Foundation; Karolinska Institutet; Bernard Osher Initiative for Research on Severe Asthma	Supported by a research grant for the RIKEN Omics Science Center from MEXT (to Y.H.) and grants from the Swedish Foundation for Strategic Research (RBc08-0027) and the Swedish Research Council (2009-5091; to J.K.). Patient sample collection was supported by grants from the Freemason Child House Foundation in Stockholm, the Konsul Th. C. Bergh's Foundation, the Swedish Asthma and Allergy Association's Research Foundation, the Centre for Allergy Research at Karolinska Institutet, the Swedish Heart-Lung Foundation, Karolinska Institutet, and the Bernard Osher Initiative for Research on Severe Asthma.	Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Aoki T, 2009, CLIN EXP ALLERGY, V39, P213, DOI 10.1111/j.1365-2222.2008.03186.x; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Just J, 2012, EUR RESPIR J, V40, P55, DOI 10.1183/09031936.00123411; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Hedlin G, 2010, EUR RESPIR J, V36, P196, DOI 10.1183/09031936.00104809; Lang A, 2008, ALLERGY, V63, P1054, DOI 10.1111/j.1398-9995.2008.01672.x; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Choy DF, 2011, J IMMUNOL, V186, P1861, DOI 10.4049/jimmunol.1002568; Baines KJ, 2010, EUR RESPIR J, V35, P522, DOI 10.1183/09031936.00027409; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; [Anonymous], 2013, CHRON RESP DIS ASTHM; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Hakonarson H, 2005, P NATL ACAD SCI USA, V102, P14789, DOI 10.1073/pnas.0409904102; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Bjornsdottir US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021902; Bosco A, 2012, J ALLERGY CLIN IMMUN, V129, P88, DOI 10.1016/j.jaci.2011.10.038; Chamberland A, 2009, EXP LUNG RES, V35, P399, DOI 10.1080/01902140902745174; Chen E, 2009, THORAX, V64, P38, DOI 10.1136/thx.2007.095091; Costa C, 2011, BLOOD, V118, P1099, DOI 10.1182/blood-2010-12-324756; *ENCODE PROJ CONS, 2011, PLOS BIOL, V0009; Fleming L, 2007, CURR OPIN ALLERGY CL, V7, P190, DOI 10.1097/ACI.0b013e3280895d0c; Global Initiative for Asthma (GINA), 2012, GLOB STRAT ASTHM MAN; Hindorff LA, CATALOG PUBLISHED GE; Hudson NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-356; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Konradsen JR, 2011, PEDIAT ALLERG IMM-UK, V22, P9, DOI 10.1111/j.1399-3038.2010.01098.x; Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21; Marin-Bejar O, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r104; Melen E, 2012, J INTERN MED, V272, P108, DOI 10.1111/j.1365-2796.2012.02555.x; Orsmark-Pietrast C, 2013, EUR RESPIR J, V42, P65, DOI 10.1183/09031936.00077712; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Vitezic M, 2010, NUCLEIC ACIDS RES, V38, P8141, DOI 10.1093/nar/gkq729; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917	40	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					638	648		10.1016/j.jaci.2015.02.026		11	Allergy; Immunology	Allergy; Immunology	CQ9EA	WOS:000360913300014		
J	Amano, W; Nakajima, S; Kunugi, H; Numata, Y; Kitoh, A; Egawa, G; Dainichi, T; Honda, T; Otsuka, A; Kimoto, Y; Yamamoto, Y; Tanimoto, A; Matsushita, M; Miyachi, Y; Kabashima, K				Amano, Wataru; Nakajima, Saeko; Kunugi, Hayato; Numata, Yasuharu; Kitoh, Akihiko; Egawa, Gyohei; Dainichi, Teruki; Honda, Tetsuya; Otsuka, Atsushi; Kimoto, Yukari; Yamamoto, Yasuo; Tanimoto, Atsuo; Matsushita, Mutsuyoshi; Miyachi, Yoshiki; Kabashima, Kenji			The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; filaggrin; signal transducer and activator of transcription 3; Janus kinase inhibitor; keratinocyte differentiation	OF-FUNCTION MUTATIONS; ATOPIC-DERMATITIS; FILAGGRIN MUTATIONS; CORNIFIED ENVELOPE; STRATUM-CORNEUM; JAK INHIBITOR; NC/NGA MICE; EXPRESSION; RESPONSES; DISEASE	Background: Barrier disruption and the resulting continuous exposure to allergens are presumed to be responsible for the development of atopic dermatitis (AD). However, the mechanism through which skin barrier function is disrupted in patients with AD remains unclear. Objectives: Taking into account the fact that the T(H)2 milieu impairs keratinocyte terminal differentiation, we sought to clarify our hypothesis that the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway plays a critical role in skin barrier function and can be a therapeutic target for AD. Methods: We analyzed the mechanism of keratinocyte differentiation using a microarray and small interfering RNA targeting STATs. We studied the effect of the JAK inhibitor JTE-052 on keratinocyte differentiation using the human skin equivalent model and normal human epidermal keratinocytes. We applied topical JAK inhibitor onto NC/Nga mice, dry skin model mice, and human skin grafted to immunocompromised mice. Results: IL-4 and IL-13 downregulated genes involved in keratinocyte differentiation. STAT3 and STAT6 are involved in keratinocyte differentiation and chemokine production by keratinocytes, respectively. Topical application of the JAK inhibitor suppressed STAT3 activation and improved skin barrier function, permitting increases in levels of terminal differentiation proteins, such as filaggrin, and natural moisturizing factors in models of AD and dry skin and in human skin. Conclusion: STAT3 signaling is a key element that regulates keratinocyte differentiation. The JAK inhibitor can be a new therapeutic tool for the treatment of disrupted barrier function in patients with AD.	[Amano, Wataru; Nakajima, Saeko; Kitoh, Akihiko; Egawa, Gyohei; Dainichi, Teruki; Honda, Tetsuya; Otsuka, Atsushi; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Amano, Wataru; Kunugi, Hayato; Numata, Yasuharu; Kimoto, Yukari; Yamamoto, Yasuo; Tanimoto, Atsuo; Matsushita, Mutsuyoshi] Japan Tobacco, Cent Pharmaceut Res Inst, Tokyo, Japan; [Kabashima, Kenji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Kabashima, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, 54 Shogoin Kawaharamachi, Kyoto 6068507, Japan.	mutsuyoshi.matsushita@jt.com; kaba@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour and Welfare; Precursory Research for Embryonic Science and Technology; Japan Tobacco	Supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (to K.K.) and from the Ministry of Health, Labour and Welfare (to K.K.); Precursory Research for Embryonic Science and Technology (to K.K.); a Grant-in-Aid from the Japan Society for the Promotion of Science Fellows (to S.N.), and by Japan Tobacco.	Suto H, 1999, INT ARCH ALLERGY IMM, V120, P70, DOI 10.1159/000053599; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; Ashino S, 2014, J ALLERGY CLIN IMMUN, V133, P1162, DOI 10.1016/j.jaci.2013.10.036; Nakagawa R, 2011, J IMMUNOL, V187, P4611, DOI 10.4049/jimmunol.1100649; Heimall J, 2012, EXPERT REV CLIN IMMU, V8, P189, DOI [10.1586/eci.11.100, 10.1586/ECI.11.100]; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Nomura I, 2003, J IMMUNOL, V171, P3262; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Elias PM, 2009, CURR OPIN ALLERGY CL, V9, P437, DOI 10.1097/ACI.0b013e32832e7d36; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Umeshita-Suyama R, 2000, INT IMMUNOL, V12, P1499, DOI 10.1093/intimm/12.11.1499; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Proksch E, 2006, J DERMATOL SCI, V43, P159, DOI 10.1016/j.jdermsci.2006.06.003; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Kezic S, 2008, J INVEST DERMATOL, V128, P2117, DOI 10.1038/jid.2008.29; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Ashburner M, 2000, NAT GENET, V25, P25; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Madden KB, 2002, J IMMUNOL, V169, P4417; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Owczarek W, 2010, CYTOKINE, V50, P181, DOI 10.1016/j.cyto.2010.02.016; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Akdis CA, 2006, ALLERGY, V61, P969, DOI 10.1111/j.1398-9995.2006.01153.x; Kagami S, 2005, CLIN EXP IMMUNOL, V141, P459, DOI 10.1111/j.1365-2249.2005.02875.x; Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Gittler JK, 2013, J ALLERGY CLIN IMMUN, V131, P300, DOI 10.1016/j.jaci.2012.06.048; Vainchenker W, 2008, SEMIN CELL DEV BIOL, V19, P385, DOI 10.1016/j.semcdb.2008.07.002; Gao PS, 2009, J ALLERGY CLIN IMMUN, V124, P507, DOI 10.1016/j.jaci.2009.07.034; Kim BE, 2008, CLIN IMMUNOL, V126, P332, DOI 10.1016/j.clim.2007.11.006; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P867, DOI 10.1016/j.jaci.2014.08.011; Egawa G, 2011, J INVEST DERMATOL, V131, P2178, DOI 10.1038/jid.2011.198; Fukushi S, 2011, BRIT J DERMATOL, V165, P990, DOI 10.1111/j.1365-2133.2011.10498.x; Gao PS, 2009, J ALLERGY CLIN IMMUN, V124, pe1; Harding Clive R, 2004, Dermatol Ther, V17 Suppl 1, P6, DOI 10.1111/j.1396-0296.2004.04S1001.x; Hirai T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-3; Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Leung DYM, 2014, J ALLERGY CLIN IMMUN, V134, P769, DOI 10.1016/j.jaci.2014.08.008; Moniaga Catharina Sagita, 2011, Inflammation & Allergy Drug Targets, V10, P477; Nakajima S, 2010, J IMMUNOL, V184, P5595, DOI 10.4049/jimmunol.0903260; Otsuka A, 2014, J ALLERGY CLIN IMMUN, V133, pe1; Otsuka A, 2014, J ALLERGY CLIN IMMUN, V133, P139, DOI 10.1016/j.jaci.2013.07.027; Rawlings A V, 2004, Dermatol Ther, V17 Suppl 1, P43, DOI 10.1111/j.1396-0296.2004.04S1005.x; Sehra S, 2010, J IMMUNOL, V184, P3186, DOI 10.4049/jimmunol.0901860; Simpson EL, 2014, J ALLERGY CLIN IMMUN, V134, P818, DOI 10.1016/j.jaci.2014.08.005; Tanimoto A, 2015, INFLAMM RES, V64, P41, DOI 10.1007/s00011-014-0782-9; Thyssen JP, 2014, J ALLERGY CLIN IMMUN, V134, P792, DOI 10.1016/j.jaci.2014.06.014; van den Oord RAHM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2433	54	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					667	+		10.1016/j.jaci.2015.03.051		18	Allergy; Immunology	Allergy; Immunology	CQ9EA	WOS:000360913300019		
J	Kim, KW; Myers, RA; Lee, JH; Igartua, C; Lee, KE; Kim, YH; Kim, EJ; Yoon, D; Lee, JS; Hirota, T; Tamari, M; Takahashi, A; Kubo, M; Choi, JM; Kim, KE; Nicolae, DL; Ober, C; Sohn, MH				Kim, Kyung Won; Myers, Rachel A.; Lee, Ji Hyun; Igartua, Catherine; Lee, Kyung Eun; Kim, Yoon Hee; Kim, Eun-Jin; Yoon, Dankyu; Lee, Joo-Shil; Hirota, Tomomitsu; Tamari, Mayumi; Takahashi, Atsushi; Kubo, Michiaki; Choi, Je-Min; Kim, Kyu-Earn; Nicolae, Dan L.; Ober, Carole; Sohn, Myung Hyun			Genome-wide association study of recalcitrant atopic dermatitis in Korean children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Genome-wide association study; atopic dermatitis; allergic sensitization; IgE; severity; children	SUSCEPTIBILITY LOCI; GENE-EXPRESSION; ALLERGIC SENSITIZATION; JAPANESE POPULATION; ASTHMA; METAANALYSIS; DISEASE; FILAGGRIN; ECZEMA; CELLS	Background: Atopic dermatitis (AD) is a heterogeneous chronic inflammatory skin disease. Most AD during infancy resolves during childhood, but moderate-to-severe AD with allergic sensitization is more likely to persist into adulthood and more often occurs with other allergic diseases. Objective: We sought to find susceptibility loci by performing the first genome-wide association study (GWAS) of AD in Korean children with recalcitrant AD, which was defined as moderate-to-severe AD with allergic sensitization. Methods: Our study included 246 children with recalcitrant AD and 551 adult control subjects with a negative history of both allergic disease and allergic sensitization. DNA from these subjects was genotyped; sets of common single nucleotide polymorphisms (SNPs) were imputed and used in the GWAS after quality control checks. Results: SNPs at a region on 13q21.31 were associated with recalcitrant AD at a genome-wide threshold of significance (P < 2.0 x 10(-8)). These associated SNPs are more than 1 Mb from the closest gene, protocadherin (PCDH)(9). SNPs at 4 additional loci had P values of less than 1 x 10(-6), including SNPs at or near the neuroblastoma amplified sequence (NBAS; 2p24.3), thymus-expressed molecule involved in selection (THEMIS; 6q22.33), GATA3 (10p14), and S-phase cyclin A-associated protein in the ER (SCAPER; 15q24.3) genes. Further analysis of total serum IgE levels suggested 13q21.31 might be primarily an IgE locus, and analyses of published data demonstrated that SNPs at the 15q24.3 region are expression quantitative trait loci for 2 nearby genes, ISL2 and proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1), in immune cells. Conclusion: Our GWAS of recalcitrant AD identified new susceptibility regions containing genes involved in epithelial cell function and immune dysregulation, 2 key features of AD, and potentially extend our understanding of their role in pathogenesis.	[Kim, Kyung Won; Lee, Kyung Eun; Kim, Yoon Hee; Kim, Kyu-Earn; Sohn, Myung Hyun] Yonsei Univ, Coll Med, Dept Pediat, Severance Hosp,Inst Allergy,Brain Korea PLUS Proj, Seoul 120752, South Korea; [Kim, Kyung Won; Myers, Rachel A.; Igartua, Catherine; Nicolae, Dan L.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Med & Stat, Chicago, IL 60637 USA; [Lee, Ji Hyun] Yonsei Univ, Dept Oral Biol, Coll Dent, Seoul 120752, South Korea; [Kim, Eun-Jin; Yoon, Dankyu; Lee, Joo-Shil] Korea Natl Inst Hlth, Div Allergy & Chron Resp Dis, Ctr Biomed Sci, Osong, South Korea; [Hirota, Tomomitsu; Tamari, Mayumi] RIKEN, Lab Resp & Allerg Dis, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Lab Genotyping Dev, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Takahashi, Atsushi] RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Tokyo, Japan; [Choi, Je-Min] Hanyang Univ, Dept Life Sci, Res Inst Nat Sci, Seoul 133791, South Korea	Sohn, MH (reprint author), Yonsei Univ, Coll Med, Dept Pediat, Inst Allergy, 50 Yonsei Ro, Seoul 120752, South Korea.	mhsohn@yuhs.ac	Tamari, Mayumi/N-5378-2015		Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI11C1404, HI14C0234, A092076]; National Research Foundation of Korea (NRF) grant - Korean Government (MSIP) [2007-0056092]; Korea Research Foundation Grant - Korean Government [KRF-2010-0025171]; National Institutes of Health [U19 AI095230, R01 HL085197]; Korean Genome Analysis Project [4845-301]; Korean Genome and Epidemiology Study [4851-302]; Korea Biobank Project [4851-307, KBP-2014-033]; Korea Center for Disease Control and Prevention, Republic of Korea	Supported by the grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI11C1404, HI14C0234, and A092076), a National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP; no. 2007-0056092), the Korea Research Foundation Grant funded by the Korean Government (KRF-2010-0025171), and National Institutes of Health grants U19 AI095230 and R01 HL085197 (to C.O.). This study included biospecimens and data from the Korean Genome Analysis Project (4845-301), the Korean Genome and Epidemiology Study (4851-302), and the Korea Biobank Project (4851-307, KBP-2014-033), which were supported by the Korea Center for Disease Control and Prevention, Republic of Korea.	Abecasis GR, 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Lichtenstein P, 1997, ALLERGY, V52, P1079, DOI 10.1111/j.1398-9995.1997.tb00179.x; Wang G, 2014, GENETICS, V196, P413, DOI 10.1534/genetics.113.157503; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Levin AM, 2013, J ALLERGY CLIN IMMUN, V131, P1176, DOI 10.1016/j.jaci.2012.10.002; Yoon D, 2012, BMB REP, V45, P305, DOI 10.5483/BMBRep.2012.45.5.305; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Maksimova N, 2010, J MED GENET, V47, P538, DOI 10.1136/jmg.2009.074815; Reubsaet LL, 2014, ALLERGY, V69, P406, DOI 10.1111/all.12366; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Nystad W, 2005, INT J EPIDEMIOL, V34, P1302, DOI 10.1093/ije/dyi061; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Smith EJ, 2010, CURR GENOMICS, V11, P519, DOI 10.2174/138920210793175921; Garmhausen D, 2013, ALLERGY, V68, P498, DOI 10.1111/all.12112; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Kaneko S, 2007, J CANCER RES CLIN, V133, P185, DOI 10.1007/s00432-006-0156-y; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Mortensen LJ, 2014, EUR RESPIR J, V43, P792, DOI 10.1183/09031936.00021613; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Fu G, 2014, TRENDS IMMUNOL, V35, P311, DOI 10.1016/j.it.2014.05.003; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1176, DOI 10.1111/j.1468-3083.2012.04636.x; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Koning H, 2012, PEDIAT ALLERG IMM-UK, V23, P270, DOI 10.1111/j.1399-3038.2011.01201.x; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Toncheva AA, 2012, PEDIAT ALLERG IMM-UK, V23, P636, DOI 10.1111/j.1399-3038.2012.01334.x; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, pe1, DOI DOI 10.1016/J.JACI.2009.11.008; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Chabod M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002461; Eichenfield Lawrence F, 2003, J Am Acad Dermatol, V49, P1088, DOI 10.1016/S0190-9622(03)02539-8; STALDER JF, 1993, DERMATOLOGY, V186, P23; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Thyssen JP, 2014, J ALLERGY CLIN IMMUN, V134, P792, DOI 10.1016/j.jaci.2014.06.014; van den Oord RAHM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2433; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Yatagai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080941	57	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					678	+		10.1016/j.jaci.2015.03.030		11	Allergy; Immunology	Allergy; Immunology	CQ9EA	WOS:000360913300020		
J	Herro, R; Antunes, RD; Aguilera, AR; Tamada, K; Croft, M				Herro, Rana; Antunes, Ricardo Da Silva; Aguilera, Amelia Roman; Tamada, Koji; Croft, Michael			Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Pulmonary fibrosis; asthma; IPF; bronchial epithelial cell; TNFSF14; LIGHT; TSLP; HVEM	ATOPIC-DERMATITIS; DISEASE; MECHANISMS; PATHOGENESIS; EXPRESSION; CHEMOKINES; RESPONSES; TARGET; TSLP; MICE	Background: Pulmonary fibrosis is characterized by excessive accumulation of collagen and a-smooth muscle actin in the lung. The key molecules that promote these phenotypes are of clinical interest. Objectives: Thymic stromal lymphopoietin (TSLP) has been found at high levels in patients with asthma and idiopathic pulmonary fibrosis, and TSLP has been proposed as a primary driver of lung fibrotic disease. We asked whether tumor necrosis factor superfamily protein 14 (TNFSF14) (aka LIGHT) controls TSLP production to initiate fibrosis. Methods: Expression of TSLP and initiation of pulmonary fibrosis induced by bleomycin were assessed in mice deficient in LIGHT. The ability of recombinant LIGHT, given intratracheally to naive mice, to promote TSLP and fibrosis was also determined. Results: Genetic deletion of LIGHT abolished lung TSLP expression driven by bleomycin, accompanied by near-complete absence of accumulation of lung collagen and alpha-smooth muscle actin. Furthermore, recombinant LIGHT administered in vivo induced lung expression of TSLP in the absence of other inflammatory stimuli, and strikingly reproduced the primary features of bleomycin-driven disease in a TSLP-dependent manner. Blockade of LIGHT binding to either of its receptors, herpes virus entry mediator and lymphotoxin beta receptor, inhibited clinical symptoms of pulmonary fibrosis, and correspondingly both receptors were found on human bronchial epithelial cells, a primary source of TSLP. Moreover, LIGHT induced TSLP directly in human bronchial epithelial cells and synergized with IL-13 and TGF-beta in vivo to promote TSLP in the lungs and drive fibrosis. Conclusions: These results show that LIGHT is a profibrogenic cytokine that may be a key driver of TSLP production during the initiation and development of lung fibrotic disease.	[Herro, Rana; Antunes, Ricardo Da Silva; Aguilera, Amelia Roman; Croft, Michael] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA 92037 USA; [Tamada, Koji] Yamaguchi Univ, Sch Med, Dept Immunol, Yamaguchi, Japan	Croft, M (reprint author), La Jolla Inst Allergy & Immunol, Div Immune Regulat, 9420 Athena Circle, La Jolla, CA 92037 USA.	mick@lji.org			National Institutes of Health [AI070535, AI100905]	This work was supported by the National Institutes of Health (grant nos. AI070535 and AI100905 to M.C.).	Anand S, 2006, J CLIN INVEST, V116, P1045, DOI 10.1172/JCI27083; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Doherty TA, 2011, NAT MED, V17, P596, DOI 10.1038/nm.2356; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Ying S, 2008, J IMMUNOL, V181, P2790; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.55.091902.103810; Izuhara K, 2014, ALLERGOL INT, V63, P143, DOI 10.2332/allergolint.13-RAI-0663; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Comeau MR, 2010, MUCOSAL IMMUNOL, V3, P138, DOI 10.1038/mi.2009.134; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Ying S, 2005, J IMMUNOL, V174, P8183; Boin F, 2009, NAT REV RHEUMATOL, V5, P357, DOI 10.1038/nrrheum.2009.108; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051268; Datta A, 2013, J IMMUNOL, V191, P4867, DOI 10.4049/jimmunol.1300588; Hastie A, 2009, J ALLERGY CLIN IMMUN, V125, P1028; Huaux F, 2003, J IMMUNOL, V171, P5470; Kirstein F, 2010, J ALLERGY CLIN IMMUN, V126, P347, DOI 10.1016/j.jaci.2010.04.028; Llop-Guevara A, 2013, J ALLERGY CLIN IMMUN, V131, pe1, DOI DOI 10.1016/HACI.2012.08.002; Miyata M, 2009, EUR J IMMUNOL, V39, P3078, DOI 10.1002/eji.200939302; Zhu Z, 2011, SCI REP-UK, V1, DOI 10.1038/srep00023	29	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					757	768		10.1016/j.jaci.2014.12.1936		12	Allergy; Immunology	Allergy; Immunology	CQ9EA	WOS:000360913300028		
J	Yamanaka, K; Mizutani, H				Yamanaka, Keiichi; Mizutani, Hitoshi			"Inflammatory skin march'': IL-1-mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Yamanaka, Keiichi; Mizutani, Hitoshi] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan	Yamanaka, K (reprint author), Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan.	yamake@clin.medic.mie-u.ac.jp					Silverberg JI, 2015, J ALLERGY CLIN IMMUN, V135, P721, DOI 10.1016/j.jaci.2014.11.023; Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x; Prodanovich S, 2009, ARCH DERMATOL, V145, P700, DOI 10.1001/archdermatol.2009.94; Yamanaka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104479	4	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					823	+		10.1016/j.jaci.2015.06.009		2	Allergy; Immunology	Allergy; Immunology	CQ9EA	WOS:000360913300045		
J	Segawa, H; Kaji, Y; Leproux, P; Couderc, V; Ozawa, T; Oshika, T; Kano, H				Segawa, Hiroki; Kaji, Yuichi; Leproux, Philippe; Couderc, Vincent; Ozawa, Takeaki; Oshika, Tetsuro; Kano, Hideaki			Multimodal and multiplex spectral imaging of rat cornea ex vivo using a white-light laser source	JOURNAL OF BIOPHOTONICS			English	Article						spectrum analysis Raman; instrumentation; molecular imaging; multimodal imaging; cornea	STOKES-RAMAN SCATTERING; SUM-FREQUENCY GENERATION; 2ND-HARMONIC GENERATION; CROSS-LINKING; LIVING CELLS; MICROSCOPY; CARS; AUTOFLUORESCENCE; MICROSTRUCTURE; FLUORESCENCE	We applied our multimodal nonlinear spectral imaging microscope to the measurement of rat cornea. We successfully obtained multiple nonlinear signals of coherent anti-Stokes Raman scattering (CARS), third-order sum frequency generation (TSFG), and second harmonic generation (SHG). Depending on the nonlinear optical processes, the cornea tissue was visualized with different image contrast mechanism simultaneously. Due to white-light laser excitation, multiplex CARS and TSFG spectra were obtained. Combined multimodal and spectral analysis clearly elucidated the layered structure of rat cornea with molecular structural information. This study indicates that our multimodal nonlinear spectral microscope is a promising bioimaging method for tissue study. [GRAPHICS] Multimodal nonlinear spectral images of rat cornea at corneal epithelium and corneal stroma in the in-plane (XY) direction. With use of the combinational analysis of different nonlinear optical processes, detailed molecular structural information is available without staining or labelling.	[Segawa, Hiroki; Ozawa, Takeaki] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Kaji, Yuichi; Oshika, Tetsuro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Leproux, Philippe; Couderc, Vincent] Univ Limoges, CNRS, Xlim Res Inst, F-87060 Limoges, France; [Kano, Hideaki] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan	Kano, H (reprint author), Univ Tsukuba, Inst Appl Phys, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	hkano@bk.tsukuba.ac.jp			JSPS bilateral joint research project (SAKURA program); NOVARTIS Foundation (Japan) for the Promotion of Science	This work is supported by JSPS bilateral joint research project (SAKURA program) and The NOVARTIS Foundation (Japan) for the Promotion of Science. The authors thank the LEUKOS company for technical support with the dual-output supercontinuum light source. The authors gratefully acknowledge J. Ukon, UKON CRAFT SCIENCE, Ltd. for assisting with a fruitful collaboration between Japanese and French labs.	Ammar DA, 2013, INVEST OPHTH VIS SCI, V54, P5258, DOI 10.1167/iovs.12-11513; Guthoff RF, 2009, CLIN EXP OPHTHALMOL, V37, P100, DOI 10.1111/j.1442-9071.2009.02016.x; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Ranka JK, 2000, OPT LETT, V25, P25, DOI 10.1364/OL.25.000025; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI [10.1038/nchembio.525, 10.1038/NCHEMBIO.525]; Parekh SH, 2010, BIOPHYS J, V99, P2695, DOI 10.1016/j.bpj.2010.08.009; Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520; Steven P, 2010, J CATARACT REFR SURG, V36, P2150, DOI 10.1016/j.jcrs.2010.06.068; Wang MC, 2011, NAT METHODS, V8, P135, DOI [10.1038/nmeth.1556, 10.1038/NMETH.1556]; Okuno M, 2010, ANGEW CHEM INT EDIT, V49, P6773, DOI 10.1002/anie.201001560; Olivier N, 2010, OPT EXPRESS, V18, P5028, DOI 10.1364/OE.18.005028; Han M, 2005, OPT EXPRESS, V13, P5791, DOI 10.1364/OPEX.13.005791; Raghunathan V, 2011, OPT LETT, V36, P3891, DOI 10.1364/OL.36.003891; Aptel F, 2010, INVEST OPHTH VIS SCI, V51, P2459, DOI [10.1167/iovs.09-4586, 10.1167/iovs.09-04586]; Chung CY, 2013, ANNU REV PHYS CHEM, V64, P77, DOI 10.1146/annurev-physchem-040412-110103; Pena AM, 2005, J AM CHEM SOC, V127, P10314, DOI 10.1021/ja0520969; Toyama A, 1999, J RAMAN SPECTROSC, V30, P623, DOI 10.1002/(SICI)1097-4555(199908)30:8<623::AID-JRS407>3.3.CO;2-0; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Vartiainen EM, 2006, OPT EXPRESS, V14, P3622, DOI 10.1364/OE.14.003622; Bueno JM, 2011, INVEST OPHTH VIS SCI, V52, P5325, DOI 10.1167/iovs.11-7184; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/nphoton.2012.336, 10.1038/NPHOTON.2012.336]; Chen S. -Y., 2009, J BIOMED OPT, V14; Ozeki Y, 2012, NAT PHOTONICS, V6, P844, DOI [10.1038/nphoton.2012.263, 10.1038/NPHOTON.2012.263]; Savoldelli M., 2007, J BIOMED OPT, V12; Segawa H, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.009551; Segawa H, 2014, OPT EXPRESS, V22, P10416, DOI 10.1364/OE.22.010416; Sharma R, 2013, BIOMED OPT EXPRESS, V4, P1285, DOI 10.1364/BOE.4.001285; vansManen H. -J., 2004, J PHYS CHEM B, V108, P18762; Yeh AT, 2002, OPT LETT, V27, P2082, DOI 10.1364/OL.27.002082	30	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	SEP	2015	8	9					705	713		10.1002/jbio.201400059		9	Biochemical Research Methods; Biophysics; Optics	Biochemistry & Molecular Biology; Biophysics; Optics	CR1CK	WOS:000361060200002		
J	Ferraresi, C; Parizotto, NA; de Sousa, MVP; Kaippert, B; Huang, YY; Koiso, T; Bagnato, VS; Hamblin, MR				Ferraresi, Cleber; Parizotto, Nivaldo Antonio; Pires de Sousa, Marcelo Victor; Kaippert, Beatriz; Huang, Ying-Ying; Koiso, Tomoharu; Bagnato, Vanderlei Salvador; Hamblin, Michael R.			Light-emitting diode therapy in exercise-trained mice increases muscle performance, cytochrome c oxidase activity, ATP and cell proliferation	JOURNAL OF BIOPHOTONICS			English	Article						LLLT; LEDT; muscle performance; muscle recovery; ATP	BIPHASIC DOSE-RESPONSE; LEVEL LASER THERAPY; SKELETAL-MUSCLE; OXIDATIVE STRESS; PHOTOTHERAPY; MECHANISMS; RADIATION; RATS; IRRADIATION; FATIGUE	Light-emitting diode therapy (LEDT) applied over the leg, gluteus and lower-back muscles of mice using a LED cluster (630nm and 850nm, 80mW/cm(2), 7.2J/cm(2)) increased muscle performance (repetitive climbing of a ladder carrying a water-filled tube attached to the tail), ATP and mitochondrial metabolism; oxidative stress and proliferative myocyte markers in mice subjected to acute and progressive strength training. Six bi-daily training sessions LEDT-After and LEDT-Before-After regimens more than doubled muscle performance and increased ATP more than tenfold. The effectiveness of LEDT on improving muscle performance and recovery suggest applicability for high performance sports and in training programs. [GRAPHICS] Positioning of the mice and light-emitting diode therapy (LEDT) applied on mouse legs, gluteus and lower-back muscles without contact.	[Ferraresi, Cleber; Parizotto, Nivaldo Antonio] Univ Fed Sao Carlos, Dept Phys Therapy, Lab Electrothermophototherapy, BR-13560 Sao Carlos, SP, Brazil; [Ferraresi, Cleber; Parizotto, Nivaldo Antonio] Univ Fed Sao Carlos, Postgrad Program Biotechnol, BR-13560 Sao Carlos, SP, Brazil; [Ferraresi, Cleber; Bagnato, Vanderlei Salvador] Univ Sao Paulo, Phys Inst Sao Carlos, Opt Grp, Sao Carlos, SP, Brazil; [Ferraresi, Cleber; Pires de Sousa, Marcelo Victor; Kaippert, Beatriz; Huang, Ying-Ying; Koiso, Tomoharu; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Pires de Sousa, Marcelo Victor] Univ Sao Paulo, Inst Phys, Lab Radiat Dosimetry & Med Phys, BR-05508 Sao Paulo, Brazil; [Kaippert, Beatriz] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil; [Huang, Ying-Ying; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Koiso, Tomoharu] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan; [Hamblin, Michael R.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA	Hamblin, MR (reprint author), Massachusetts Gen Hosp, Wellman Ctr Photomed, 40 Blossom St, Boston, MA 02114 USA.	mhamblin@partners.org			FAPESP [2010/07194-7, 2012/05919-0]; US NIH [R01AI050875]	Cleber Ferraresi would like to thank FAPESP for his Ph.D. scholarships (numbers 2010/07194-7 and 2012/05919-0). MR Hamblin was supported by US NIH grant R01AI050875. We acknowledge Andrea L. Brissette for administrative assistance and Jenny Zhao for assistance with the core laboratory of histopathology, microscopy and digital imaging of the Wellman Center for Photomedicine, Massachusetts General Hospital.	Karu T, 2013, PHOTOMED LASER SURG, V31, P189, DOI 10.1089/pho.2013.3510; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Lopes-Martins RAB, 2006, J APPL PHYSIOL, V101, P283, DOI 10.1152/japplphysiol.01318.2005; Borsa PA, 2013, J ATHL TRAINING, V48, P57, DOI 10.4085/1062-6050-48.1.12; Ferraresi C, 2011, LASER MED SCI, V26, P349, DOI 10.1007/s10103-010-0855-0; Silveira PCL, 2011, LASER MED SCI, V26, P125, DOI 10.1007/s10103-010-0839-0; Karu TI, 2010, IUBMB LIFE, V62, P607, DOI 10.1002/iub.359; Tumilty S, 2010, PHOTOMED LASER SURG, V28, P3, DOI 10.1089/pho.2008.2470; Enwemeka CS, 2004, PHOTOMED LASER SURG, V22, P323, DOI 10.1089/1549541041797841; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Silveira PCL, 2009, J PHOTOCH PHOTOBIO B, V95, P89, DOI 10.1016/j.jphotobiol.2009.01.004; Banerjee AK, 2003, MOL CELL BIOCHEM, V253, P307, DOI 10.1023/A:1026032404105; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Leal ECP, 2010, J ORTHOP SPORT PHYS, V40, P524, DOI 10.2519/jospt.2010.3294; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Karu TI, 2004, PHOTOCHEM PHOTOBIOL, V80, P366, DOI 10.1562/2004-03-25-RA-123.1; Luo L, 2013, LASER MED SCI, V28, P725, DOI 10.1007/s10103-012-1133-0; Vieira WHD, 2012, LASER MED SCI, V27, P497, DOI 10.1007/s10103-011-0984-0; Lee S, 2004, J APPL PHYSIOL, V96, P1097, DOI 10.1152/japplphysiol.00479.2003; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Enwemeka CS, 2005, PHOTOMED LASER SURG, V23, P159, DOI 10.1089/pho.2005.23.159; KARU T, 1995, J PHOTOCH PHOTOBIO B, V27, P219, DOI 10.1016/1011-1344(94)07078-3; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Finaud J, 2006, SPORTS MED, V36, P327, DOI 10.2165/00007256-200636040-00004; Baroni BM, 2010, PHOTOMED LASER SURG, V28, P653, DOI 10.1089/pho.2009.2688; Nakano J, 2009, EXP PHYSIOL, V94, P1005, DOI 10.1113/expphysiol.2009.047738; Corazza AV, 2013, LASER MED SCI, V28, P1467, DOI 10.1007/s10103-012-1251-8; Ferraresi C, 2012, PHOTONICS LASERS MED, V1, P267, DOI DOI 10.1515/PLM-2012-0032; Gupta A., 2012, BIOTECHNOL ADV; Karu TI, 2008, PHOTOMED LASER SURG, V26, P593, DOI 10.1089/pho.2008.2246; Khan HA, 2003, J BIOSCIENCES, V28, P379, DOI 10.1007/BF02705114; Leal Junior E. C., 2013, LASERS MED SCI; Santos L. A., 2014, LASERS MED SCI; Sommer AP, 2002, J PROTEOME RES, V1, P475, DOI 10.1021/pr0255396	38	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	SEP	2015	8	9					740	754		10.1002/jbio.201400087		15	Biochemical Research Methods; Biophysics; Optics	Biochemistry & Molecular Biology; Biophysics; Optics	CR1CK	WOS:000361060200006		
J	Doi, H; Yasuoka, K				Doi, Hideo; Yasuoka, Kenji			Approaches for Controlling the Temperature and Pressure Range in Generalized NPT Ensembles	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							MULTIBARIC-MULTITHERMAL ENSEMBLE; MOLECULAR-DYNAMICS SIMULATIONS; LENNARD-JONES PARTICLES; MONTE-CARLO; PHASE-TRANSITIONS; ALGORITHM	Isobaric-multithermal and multibaric-isothermal methods are powerful methods for sampling in a wide energy and/or volume space. A finite temperature or pressure is required to study phase diagrams and many properties of many types of systems. However, it is difficult to control the temperature or pressure range because these systems move randomly in energy or volume space. Here, we develop a method to control the temperature range in the isobaric multithermal ensemble and a method to control the pressure range in the multibaric isothermal ensemble. These methods have the advantage of adequately determining the weight factor to create the multicanonical ensemble and can be applied to study thermodynamic properties.	[Doi, Hideo; Yasuoka, Kenji] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan	Doi, H (reprint author), Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan.	hideo-doi@keio.jp			Japan Science and Technology Agency (JST)	This research was supported in part by the Core Research of Evolutional Science and Technology (CREST) research program "Highly Productive, High Performance Application Frameworks for Post Petascale Computing" of the Japan Science and Technology Agency (JST).	FERRENBERG AM, 1988, PHYS REV LETT, V61, P2635, DOI 10.1103/PhysRevLett.61.2635; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; BERG BA, 1992, PHYS REV LETT, V68, P9, DOI 10.1103/PhysRevLett.68.9; Okumura H, 2001, J PHYS SOC JPN, V70, P1990, DOI 10.1143/JPSJ.70.1990; Kim J, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3503503; Sugita Y, 2000, CHEM PHYS LETT, V329, P261, DOI 10.1016/S0009-2614(00)00999-4; Mitsutake A, 2001, BIOPOLYMERS, V60, P96, DOI 10.1002/1097-0282(2001)60:2<96::AID-BIP1007>3.0.CO;2-F; Okamoto Y, 2004, J MOL GRAPH MODEL, V22, P425, DOI 10.1016/j.jmgm.2003.12.009; Kim J, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3432176; Wang FG, 2001, PHYS REV LETT, V86, P2050, DOI 10.1103/PhysRevLett.86.2050; Kaneko T, 2013, J CHEM THEORY COMPUT, V9, P3299, DOI 10.1021/ct400221h; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376; Bonomi M., 2010, PHYS REV LETT, V104, P1, DOI DOI 10.1103/PHYSREVLETT.104.190601; Doi HD, 2014, CHEM PHYS LETT, V595, P55, DOI 10.1016/j.cplett.2014.01.044; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; Frenkel D., 2002, UNDERSTANDING MOL SI; Jiang P, 2013, J CHEM THEORY COMPUT, V9, P3816, DOI 10.1021/ct400312d; Kaneko T, 2012, J PHYS SOC JPN, V81; Kaneko T, 2011, J CHEM THEORY COMPUT, V7, P3083, DOI 10.1021/ct200458m; Kaneko T, 2012, MOL SIMULAT, V38, P373, DOI 10.1080/08927022.2010.539216; MCDONALD IR, 1972, MOL PHYS, V23, P41, DOI 10.1080/00268977200100031; Metropolis N., 1953, CHEM PHYS, V21, P1087, DOI DOI 10.1063/1.1699114; Muguruma C, 2007, CROAT CHEM ACTA, V80, P203; Okumura H, 2004, CHEM PHYS LETT, V383, P391, DOI 10.1016/j.cplett.2003.10.152; Okumura H, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.026702; Okumura H, 2006, J COMPUT CHEM, V27, P379, DOI 10.1002/jcc.20351; Okumura H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2970883; Okumura H, 2011, PHYS CHEM CHEM PHYS, V13, P114, DOI 10.1039/c0cp00371a; Okumura H, 2004, CHEM PHYS LETT, V391, P248, DOI 10.1016/j.cplett.2004.04.073; Zhang C., 2008, J CHEM PHYS, V129, P1	35	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	SEP	2015	11	9					4370	4376		10.1021/acs.jctc.5b00195		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CR1LZ	WOS:000361087600040		
J	Takahashi, HG; Adachi, SA; Sato, T; Hara, M; Ma, XY; Kimura, F				Takahashi, Hiroshi G.; Adachi, Sachiho A.; Sato, Tomonori; Hara, Masayuki; Ma, Xieyao; Kimura, Fujio			An Oceanic Impact of the Kuroshio on Surface Air Temperature on the Pacific Coast of Japan in Summer: Regional H2O Greenhouse Gas Effect	JOURNAL OF CLIMATE			English	Article							ATMOSPHERIC RESPONSE; SST ANOMALIES; GULF-STREAM; CIRCULATION; RADIATION; MODEL	This study used a 4-km resolution regional climate model to examine the sensitivity of surface air temperature on the Pacific coast of Japan to sea surface temperature (SST) south of the Pacific coast of Japan during summer. The authors performed a control simulation (CTL) driven by reanalysis and observational SST datasets. A series of sensitivity experiments using climatological values from the CTL SST datasets over a 31-yr period was conducted. The interannual variation in surface air temperature over the Pacific coast was well simulated in CTL. The interannual variation in SST over the Kuroshio region amplified the interannual variation in surface air temperature over the Pacific coast. It was found that 30% of the total variance of interannual variation in surface air temperature can be controlled by interannual variation in SST. The calculated surface air temperature on the Pacific coast increased by 0.4 K per 1-K SST warming in the Kuroshio region. Note that this sensitivity was considerably greater during nighttime than during daytime. Concurrent with the warming in surface air temperature, downward longwave radiation at the surface was also increased. In summer, the increase in latent heat flux was considerably larger than that in sensible heat flux over the ocean because of SST warming, according to the temperature dependence of the Bowen ratio. This implies that the primary factor for the increase in surface air temperature in summer is increased moisture in the lower troposphere, indicating that the regional warming was caused by an increase in H2O greenhouse gas.	[Takahashi, Hiroshi G.] Tokyo Metropolitan Univ, Hachioji, Tokyo 1920397, Japan; [Takahashi, Hiroshi G.; Ma, Xieyao; Kimura, Fujio] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa, Japan; [Adachi, Sachiho A.] RIKEN, Adv Inst Computat Sci, Kobe, Hyogo, Japan; [Sato, Tomonori] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan; [Hara, Masayuki] Ctr Environm Sci Saitama, Kazo, Saitama, Japan	Takahashi, HG (reprint author), Tokyo Metropolitan Univ, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	hiroshi3@tmu.ac.jp			Global Environment Research Fund of the Ministry of the Environment (MOE) [2RF-1304]; Tokyo Metropolitan University; Green Network of Excellence (GRENE) program; Research Program on Climate Change Adaptation (RECCA) Fund by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	We thank four anonymous referees for their constructive and valuable comments. The authors thank Mikiko Fujita and Kouichi Masuda for their valuable comments. This work was partly supported by the Global Environment Research Fund (2RF-1304) of the Ministry of the Environment (MOE); the start-up research fund of the Tokyo Metropolitan University; the Green Network of Excellence (GRENE) program; and the Research Program on Climate Change Adaptation (RECCA) Fund by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Minobe S, 2010, J CLIMATE, V23, P3699, DOI 10.1175/2010JCLI3359.1; LINDZEN RS, 1987, J ATMOS SCI, V44, P2418, DOI 10.1175/1520-0469(1987)044<2418:OTROSS>2.0.CO;2; Enomoto T, 2003, Q J ROY METEOR SOC, V129, P157, DOI 10.1256/gj.01.211; WALLACE JM, 1989, J CLIMATE, V2, P1492, DOI 10.1175/1520-0442(1989)002<1492:TIOSST>2.0.CO;2; JANJIC ZI, 1994, MON WEATHER REV, V122, P927, DOI 10.1175/1520-0493(1994)122<0927:TSMECM>2.0.CO;2; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Koseki S, 2010, J CLIMATE, V23, P2492, DOI 10.1175/2009JCLI2915.1; Kobayashi S, 2015, J METEOROL SOC JPN, V93, P5, DOI 10.2151/jmsj.2015-001; Zhang T, 2011, J CLIMATE, V24, P4874, DOI 10.1175/2011JCLI3944.1; Chen F, 2001, MON WEATHER REV, V129, P569, DOI 10.1175/1520-0493(2001)129<0569:CAALSH>2.0.CO;2; Prata AJ, 1996, Q J ROY METEOR SOC, V122, P1127, DOI 10.1002/qj.49712253306; Allan RP, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004816; Kosaka Y, 2006, Q J ROY METEOR SOC, V132, P2009, DOI 10.1256/qj.05.204; NITTA T, 1987, J METEOROL SOC JPN, V65, P373; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; Peng SL, 1997, J CLIMATE, V10, P971, DOI 10.1175/1520-0442(1997)010<0971:TMARTM>2.0.CO;2; Wild M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019188; Iacono MJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009944; Berrisford P., 2009, ERA REPORT SERIES, V1, P16, DOI DOI 10.1175/2008BAMS2639.1; Fujita M, 2012, PROCEEDINGS OF THE 25TH INTERNATIONAL TECHNICAL MEETING OF THE SATELLITE DIVISION OF THE INSTITUTE OF NAVIGATION (ION GNSS 2012), P3454; Hong S.-Y., 2006, J KOREAN METEOR SOC, V42, P129, DOI DOI 10.1002/QJ.49712656914; Skamarock W. C., 2008, 475 NCAR, V475, P113, DOI DOI 10.5065/D68S4MVH; Xu HM, 2010, J CLIMATE, V23, P4704, DOI 10.1175/2010JCLI3267.1	24	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	SEP	2015	28	18					7128	7144		10.1175/JCLI-D-14-00763.1		17	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CR0TT	WOS:000361036800008		
J	Yang, YL; Xie, SP; Du, Y; Tokinaga, H				Yang, Yali; Xie, Shang-Ping; Du, Yan; Tokinaga, Hiroki			Interdecadal Difference of Interannual Variability Characteristics of South China Sea SSTs Associated with ENSO	JOURNAL OF CLIMATE			English	Article							TROPICAL INDIAN-OCEAN; INDO-WESTERN PACIFIC; EAST-ASIAN CLIMATE; EL-NINO; SURFACE TEMPERATURE; ATMOSPHERIC BRIDGE; SUMMER; TELECONNECTION; CIRCULATION; OSCILLATION	The correlation between sea surface temperature (SST) and El Nino-Southern Oscillation (ENSO) persists into post-ENSO September over the South China Sea (SCS), the longest correlation in the World Ocean. Slow modulations of this correlation are analyzed by using the International Comprehensive Ocean-Atmosphere Dataset (ICOADS). ENSO's influence on SCS SST has experienced significant interdecadal changes over the past 138 years (1870-2007), with a double-peak structure correlation after the 1960s compared to a single-peak before the 1940s. According to the ENSO correlation character, the analysis period is divided into four epochs. In epoch 3, 1960-83, the SST warming and enhanced precipitation over the southeastern tropical Indian Ocean, rather than the Indian Ocean basinwide warming, induce easterly wind anomalies and warm up the SCS in the summer following El Nino. Besides the Indian Ocean effect, during epochs 2 (1930-40) and 4 (1984-2007), the Pacific-Japan (PJ) pattern of atmospheric circulation anomalies helps sustain the SCS SST warming through summer (June-August) with easterly wind anomalies. The associated increase in shortwave radiation and decrease in upward latent heat flux cause the SCS SST warming to persist into the summer. Meanwhile, the rainfall response around the SCS to ENSO shows interdecadal variability, with stronger variability after the 1980s. The results suggest that both the remote forcing from the tropical Indian Ocean and the PJ pattern are important for the ENSO teleconnection to the SCS and its interdecadal modulations.	[Yang, Yali; Du, Yan] Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China; [Yang, Yali] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xie, Shang-Ping] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Xie, Shang-Ping] Ocean Univ China, Phys Oceanog Lab, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Qingdao, Peoples R China; [Tokinaga, Hiroki] Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan; [Tokinaga, Hiroki] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan	Du, Y (reprint author), South China Sea Inst Oceanol, State Key Lab Trop Oceanog, 164 West Xingang Rd, Guangzhou 510301, Guangdong, Peoples R China.	duyan@scsio.ac.cn	Vecchi, Gabriel/A-2413-2008; Kosaka, Yu/C-2792-2009	Vecchi, Gabriel/0000-0002-5085-224X; 	Ministry of Science and Technology [2012CB955603]; Chinese Academy of Sciences [XDA11010103]; National Science Foundation of China [41176024]; CAS/SAFEA International Partnership Program for Creative Research Teams	We thank J. S. Chowdary of the Indian Institute of Tropical Meteorology, Y. Kosaka of the University of Tokyo, and G. Li of LTO/SCSIO for their valuable and constructive comments, which helped to improve the manuscript. We acknowledge the Research Data Archive at the National Center for Atmospheric Research, Computational and Information Systems Laboratory (http://rda.ucar.edu/datasets/ds540.0) for providing ICOADS version 2.5 and the Met Office Hadley Centre (http://www.metoffice.gov.uk) for providing HadISST. The ERSST, Kaplan SST, OISST, COBE-SST, the University of Delaware precipitation, GPCP precipitation, and the 20th Century Reanalysis datasets were obtained from NOAA/ESRL (http://www.esrl.noaa.gov/psd/data). The Philippine stations precipitation and PJ/EAP pattern index were provided by H. Kubota. This work is supported by the Ministry of Science and Technology (2012CB955603), the Chinese Academy of Sciences (XDA11010103), the National Science Foundation of China (41176024), and the CAS/SAFEA International Partnership Program for Creative Research Teams.	ALLAN RJ, 1991, J CLIMATE, V4, P743, DOI 10.1175/1520-0442(1991)004<0743:AFEOTT>2.0.CO;2; Deser C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043321; Chowdary JS, 2012, J CLIMATE, V25, P1722, DOI 10.1175/JCLI-D-11-00070.1; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Xie SP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001867; Wang B, 2000, J CLIMATE, V13, P1517, DOI 10.1175/1520-0442(2000)013<1517:PEATHD>2.0.CO;2; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Klein SA, 1999, J CLIMATE, V12, P917, DOI 10.1175/1520-0442(1999)012<0917:RSSTVD>2.0.CO;2; Ishii M, 2005, INT J CLIMATOL, V25, P865, DOI 10.1002/joc.1169; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Kubota H, 2009, J CLIMATE, V22, P5495, DOI 10.1175/2009JCLI2646.1; Wang B, 2003, J CLIMATE, V16, P1195, DOI 10.1175/1520-0442(2003)16<1195:AOIAII>2.0.CO;2; Xie SP, 2010, J CLIMATE, V23, P3352, DOI 10.1175/2010JCLI3429.1; Kubota H, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038108; Huang G, 2010, J CLIMATE, V23, P5294, DOI 10.1175/2010JCLI3577.1; Tokinaga H, 2011, J CLIMATE, V24, P267, DOI 10.1175/2010JCLI3789.1; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; Qu X, 2012, INT J CLIMATOL, V32, P2073, DOI 10.1002/joc.2378; Weisberg RH, 1997, GEOPHYS RES LETT, V24, P779, DOI 10.1029/97GL00689; Smith TM, 2004, J CLIMATE, V17, P2466, DOI 10.1175/1520-0442(2004)017<2466:IEROS>2.0.CO;2; Alory G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028044; Kosaka Y, 2006, Q J ROY METEOR SOC, V132, P2009, DOI 10.1256/qj.05.204; Wang B, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022709; Xie SP, 2009, J CLIMATE, V22, P730, DOI 10.1175/2008JCLI2544.1; Du Y, 2009, J CLIMATE, V22, P2023, DOI 10.1175/2008JCLI2590.1; Wu R, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009316; Liu QY, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002179; Wang CZ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003333; Woodruff SD, 2011, INT J CLIMATOL, V31, P951, DOI 10.1002/joc.2103; Wang CZ, 1999, J GEOPHYS RES-OCEANS, V104, P5131, DOI 10.1029/1998JC900090; NITTA T, 1987, J METEOROL SOC JPN, V65, P373; Lau NC, 2000, J CLIMATE, V13, P4287, DOI 10.1175/1520-0442(2000)013<4287:IOEOTV>2.0.CO;2; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Worley SJ, 2005, INT J CLIMATOL, V25, P823, DOI 10.1002/joc.1166; Kosaka Y, 2013, P NATL ACAD SCI USA, V110, P7574, DOI 10.1073/pnas.1215582110; Du Y, 2013, J CLIMATE, V26, P7240, DOI 10.1175/JCLI-D-12-00678.1; Tokinaga H, 2012, NATURE, V491, P439, DOI 10.1038/nature11576; Norris JR, 1999, J CLIMATE, V12, P1864, DOI 10.1175/1520-0442(1999)012<1864:OTAPAI>2.0.CO;2; Huang G, 1999, CHINESE SCI BULL, V44, P1325, DOI 10.1007/BF02885855; Alexander MA, 2002, J CLIMATE, V15, P2205, DOI 10.1175/1520-0442(2002)015<2205:TABTIO>2.0.CO;2; de Szoeke SP, 2007, J CLIMATE, V20, P2500, DOI 10.1175/JCLI4173.1; Du Y, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033631; Giese BS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006695; Huang R., 1987, P INT C GEN CIRC E A, P40; 黄荣辉, 1989, Advances in Atmospheric Sciences, V6, P21; Kaplan A., 1998, J GEOPHYS RES, V103, P18, DOI [10.1029/97JC01736, DOI 10.1029/97JC01736]; Kent EC, 2007, J ATMOS OCEAN TECH, V24, P214, DOI 10.1175/JTECH1949.1; Kubota H., 2015, INT J CLIMA IN PRESS; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Tokinaga H, 2012, J CLIMATE, V25, P1689, DOI 10.1175/JCLI-D-11-00263.1; Tokinaga H, 2004, J METEOROL SOC JPN, V82, P1007, DOI 10.2151/jmsj.2004.1007; Trenberth KE, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000298; Willmott C. J., 2001, TERRESTRIAL AIR TEMP; Wu RG, 2014, J GEOPHYS RES-ATMOS, V119, P5046, DOI 10.1002/2013JD021095; Wu Y. L., 2012, ATMOSPHERIC OCEANIC, V5, P295; Yang JL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028571	56	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	SEP	2015	28	18					7145	7160		10.1175/JCLI-D-15-0057.1		16	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CR0TT	WOS:000361036800009		
J	Doi, T; Yuan, CX; Behera, SK; Yamagata, T				Doi, Takeshi; Yuan, Chaoxia; Behera, Swadhin K.; Yamagata, Toshio			Predictability of the California Nino/Nina*	JOURNAL OF CLIMATE			English	Article							NORTHEAST PACIFIC-OCEAN; SARDINE SARDINOPS-SAGAX; EL-NINO; INTERANNUAL VARIABILITY; ENSO PREDICTION; COUPLED OAGCM; TELECONNECTIONS; ANOMALIES; CLIMATE; MODEL	Predictability of a recently discovered regional coupled climate mode called the California Nino (Nina) off Baja California and California is explored using a seasonal prediction system based on the Scale Interaction Experiment-Frontier, version 1 (SINTEX-F1) coupled ocean-atmosphere general circulation model. Because of the skillful prediction of basin-scale El Nino (La Nina), the California Nino (Nina) that co-occurs with El Nino (La Nina) with a peak in boreal winter is found to be predictable at least a couple of seasons ahead. On the other hand, the regional coupled phenomenon peaking in boreal summer without co-occurrence with El Nino (La Nina) is difficult to predict. The difficulty in predicting such an intrinsic regional climate phenomenon may be due to model deficiency in resolving the regional air-sea-land positive feedback processes. The model may also underestimate coastal Kelvin waves with a small offshore scale, which may play an important role in the generation of the California Nino/Nina. It may be improved by increasing horizontal resolution of the ocean component of the coupled model. The present study may provide a guideline to improve seasonal prediction of regional climate modes for important industrial as well as social applications.	[Doi, Takeshi; Yuan, Chaoxia; Behera, Swadhin K.; Yamagata, Toshio] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa 2360001, Japan	Doi, T (reprint author), Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	takeshi.doi@jamstec.go.jp	Doi, Takeshi/C-1989-2013; Yamagata, Toshio/A-1807-2009		Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [2-1405]	The SINTEX-F1 seasonal climate prediction system was produced by the Earth Simulator at JAMSTEC. We are grateful to Drs. Jing-Jia Luo, Sebastian Masson, and our European colleagues of INGV/CMCC and Laboratoire d'Oceanographie et du Climat: Experimentations et Approches Numeriques (L'OCEAN) for their contribution to developing the prototype of the system. This research was supported by the Environment Research and Technology Development Fund (2-1405) of the Ministry of the Environment, Japan.	ENFIELD DB, 1980, J PHYS OCEANOGR, V10, P557, DOI 10.1175/1520-0485(1980)010<0557:OTSADO>2.0.CO;2; Behringer DW, 1998, MON WEATHER REV, V126, P1013, DOI 10.1175/1520-0493(1998)126<1013:AICMFE>2.0.CO;2; JACOBSON LD, 1995, CAN J FISH AQUAT SCI, V52, P566, DOI 10.1139/f95-057; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Kataoka T, 2014, CLIM DYNAM, V43, P1463, DOI 10.1007/s00382-013-1961-z; Demer DA, 2012, FISH B-NOAA, V110, P52; Depczynski M, 2013, CORAL REEFS, V32, P233, DOI 10.1007/s00338-012-0974-0; Luo JJ, 2007, J CLIMATE, V20, P2178, DOI 10.1175/JCLI4132.1; Alexander MA, 2010, J CLIMATE, V23, P2885, DOI 10.1175/2010JCLI3205.1; Tozuka T, 2014, CLIM DYNAM, V43, P2197, DOI 10.1007/s00382-013-2044-x; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Doi T, 2015, J GEOPHYS RES-OCEANS, V120, P1388, DOI 10.1002/2014JC010562; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Pearce AF, 2013, J MARINE SYST, V111, P139, DOI 10.1016/j.jmarsys.2012.10.009; Wang SY, 2014, GEOPHYS RES LETT, V41, P3220, DOI 10.1002/2014GL059748; Goddard L, 2001, INT J CLIMATOL, V21, P1111, DOI 10.1002/joc.636; Luo JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032793; Luo JJ, 2005, J CLIMATE, V18, P4474, DOI 10.1175/JCLI3526.1; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Luo JJ, 2008, J CLIMATE, V21, P84, DOI 10.1175/2007JCLI1412.1; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Schwing FB, 2002, PROG OCEANOGR, V54, P459, DOI 10.1016/S0079-6611(02)00064-2; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; WALLACE JM, 1981, MON WEATHER REV, V109, P784, DOI 10.1175/1520-0493(1981)109<0784:TITGHF>2.0.CO;2; Jin EK, 2008, CLIM DYNAM, V31, P647, DOI 10.1007/s00382-008-0397-3; Luo JJ, 2005, J CLIMATE, V18, P2344, DOI 10.1175/JCLI3404.1; MYSAK LA, 1986, CAN J FISH AQUAT SCI, V43, P464; Alexander MA, 2002, J CLIMATE, V15, P2205, DOI 10.1175/1520-0442(2002)015<2205:TABTIO>2.0.CO;2; BJERKNES J, 1969, MON WEATHER REV, V97, P163, DOI 10.1175/1520-0493(1969)097<0163:ATFTEP>2.3.CO;2; Doi T, 2010, J CLIMATE, V23, P455, DOI 10.1175/2009JCLI3198.1; Doi T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02892; EMERY WJ, 1985, J GEOPHYS RES-OCEANS, V90, P857, DOI 10.1029/JC090iC01p00857; Feng M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01277; Mendelssohn R, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001568; Morioka Y, 2010, CLIM DYNAM, V35, P1075, DOI 10.1007/s00382-010-0843-x; RASMUSSON EM, 1982, MON WEATHER REV, V110, P354, DOI 10.1175/1520-0493(1982)110<0354:VITSST>2.0.CO;2; Reimer JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125177; Richter I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044461; SHANNON LV, 1986, J MAR RES, V44, P495; Strub PT, 2002, PROG OCEANOGR, V53, P185, DOI 10.1016/S0079-6611(02)00030-7; Wolter K, 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Yuan CX, 2014, CLIM DYNAM, V42, P1291, DOI 10.1007/s00382-013-1704-1; Yuan CX, 2014, SCI REP-UK, V4, DOI 10.1038/srep04801; Zinke J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4607	44	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	SEP	2015	28	18					7237	7249		10.1175/JCLI-D-15-0112.1		13	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CR0TT	WOS:000361036800014		
J	Hasegawa, T; Saito, I; Takeda, D; Iwata, E; Yonezawa, N; Kakei, Y; Sakakibara, A; Akashi, M; Minamikawa, T; Komori, T				Hasegawa, Takumi; Saito, Izumi; Takeda, Daisuke; Iwata, Eiji; Yonezawa, Natsuki; Kakei, Yasumasa; Sakakibara, Akiko; Akashi, Masaya; Minamikawa, Tsutomu; Komori, Takahide			Risk factors associated with postoperative delirium after surgery for oral cancer	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Delirium; Postoperative; Oral cancer; Risk factor; Surgery	CARDIAC-SURGERY; PREOPERATIVE PREDICTORS; HEAD	Objective: The purpose of this study was to retrospectively investigate the multivariate relationships among the various risk factors for postoperative delirium in patients undergoing oral cancer surgery. Material and methods: The medical records of all patients with oral cancer who underwent curative head and neck surgery between April 2011 and March 2013 at our institution were retrospectively reviewed. There was a total of 188 patients, including 110 males and 78 females. Results: We found that older age, extensive surgical procedure, longer operation, excessive hemorrhage, blood transfusion, longer postoperative management in the intensive care unit, longer postoperative hospital stay, lower albumin level in the preoperative blood test, and lower total protein, albumi, n and hemoglobin levels and a higher C-reactive protein (CRP) level in the postoperative blood tests were significant variables in the univariate analysis (p < 0.05). We also determined that an older age (odds ratio [OR] = 6.83), intraoperative lower hemoglobin levels (OR = 6.82), and excessive hemorrhage (OR = 3.62) during surgery were significant variables in the multivariate analysis. Conclusion: Clinicians should pay special attention to preventing delirium during the postoperative management of older patients with these risk factors. Furthermore, increasing the hemoglobin levels during surgery may be able to prevent postoperative delirium. (C) 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Hasegawa, Takumi; Saito, Izumi; Takeda, Daisuke; Iwata, Eiji; Yonezawa, Natsuki; Kakei, Yasumasa; Sakakibara, Akiko; Akashi, Masaya; Minamikawa, Tsutomu; Komori, Takahide] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 6500017, Japan	Hasegawa, T (reprint author), Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hasetaku@med.kobe-u.acjp					American Psychiatric Association, 1997, DIAGN STAT MAN MENT; Marcantonio ER, 1998, AM J MED, V105, P380, DOI 10.1016/S0002-9343(98)00292-7; Yamagata K, 2005, INT J ORAL MAX SURG, V34, P33, DOI 10.1016/j.ijom.2004.03.005; Kazmierski J, 2006, GEN HOSP PSYCHIAT, V28, P536, DOI 10.1016/j.genhosppsych.2006.08.007; DYER CB, 1995, ARCH INTERN MED, V155, P461, DOI 10.1001/archinte.155.5.461; Takeuchi M, 2012, ANN SURG ONCOL, V19, P3963, DOI 10.1245/s10434-012-2432-1; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Schneider F, 2002, GEN HOSP PSYCHIAT, V24, P28, DOI 10.1016/S0163-8343(01)00168-2; Sasajima Y, 2012, EUR J VASC ENDOVASC, V44, P411, DOI 10.1016/j.ejvs.2012.06.028; Zakriya KJ, 2002, ANESTH ANALG, V94, P1628, DOI 10.1097/00000539-200206000-00050; PARIKH SS, 1995, ANESTH ANALG, V80, P1223, DOI 10.1097/00000539-199506000-00027; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; HAMMEKE TA, 1988, J THORAC CARDIOV SUR, V96, P326; Koolhoven I, 1996, GEN HOSP PSYCHIAT, V18, P448, DOI 10.1016/S0163-8343(96)00089-8; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; Merchant RA, 2005, ANN ACAD MED SINGAP, V34, P163; MORSE RM, 1969, AM J PSYCHIAT, V126, P388; OKEEFE ST, 1994, BRIT J ANAESTH, V73, P673, DOI 10.1093/bja/73.5.673; Rudolph JL, 2005, J AM GERIATR SOC, V53, P462, DOI 10.1111/j.1532-5415.2005.53165.x; SCHOR JD, 1992, JAMA-J AM MED ASSOC, V267, P827, DOI 10.1001/jama.267.6.827; Schrader SLP, 2008, NEUROLOGIST, V14, P134, DOI 10.1097/NRL.0b013e318166b88c; Shiiba M, 2009, INT J ORAL MAX SURG, V38, P661, DOI 10.1016/j.ijom.2009.01.011; SMITH LW, 1989, AM J PSYCHIAT, V146, P452; van der Mast RC, 1999, J PSYCHOSOM RES, V46, P479, DOI 10.1016/S0022-3999(99)00002-1; WEED HG, 1995, LARYNGOSCOPE, V105, P1066, DOI 10.1288/00005537-199510000-00011	25	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	SEP	2015	43	7					1094	1098		10.1016/j.jcms.2015.06.011		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CR1IP	WOS:000361078700019		
J	Moroi, A; Yoshizawa, K; Iguchi, R; Hiroumi, I; Kosaka, A; Hotta, A; Tsutsui, T; Saita, Y; Ueki, K				Moroi, Akinori; Yoshizawa, Kunio; Iguchi, Ran; Hiroumi, Ikawa; Kosaka, Akihiko; Hotta, Asami; Tsutsui, Takamitsu; Saita, Yuriko; Ueki, Koichiro			Comparison of skeletal stability after sagittal split ramus osteotomy with and without extraction of the third molar in patients with mandibular prognathism	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Extraction of third molar; Sagittal split ramus osteotomy; Skeletal stability	PLATE FIXATION; DISTAL SEGMENT; DENTAL CHANGES; BAD SPLIT; REMOVAL; RELAPSE; COMPLICATIONS; ADVANCEMENT; SEPARATORS; SETBACK	Purpose: The purpose of this study was to evaluate, through cephalometric analysis, the skeletal stability following BSSRO performed with and without extraction of the third molar, and to examine the healing of the extraction sockets through computed tomography (CT). Patients and methods: Sixty Japanese patients (male: 14, female: 46) diagnosed with mandibular prognathism were included in this study. While 30 patients underwent BSSRO along with extraction of the third molar (extraction group), the other 30 patients underwent BSSRO alone (non-extraction group). Skeletal stability was assessed using axial, frontal, and lateral cephalograms. CT scans were obtained 1 week after surgery and at the 1-year follow-up for all the patients. CT value was measured at the point of the extraction socket on the horizontal plane parallel to the Frankfurt plane using computer software (SimPlant 2011; Materialise Dental, Leuven, Belgium). The region of interest (ROI) was approximately 4 mm(2) and the mean value was recorded. Healing of the extraction sockets was examined through CT 1 year postoperatively. Results: There were no significant differences between the groups for any of the parameters at any observation interval. In the extraction group, there were significant differences between the values of CT obtained 1 week postoperatively and 1 year postoperatively in the extraction socket (P = 0.0003). Conclusion: The results of this study indicate that there is no significant difference in the skeletal stability between BSSRO performed with and without third molar extraction. (C) 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Moroi, Akinori; Yoshizawa, Kunio; Iguchi, Ran; Hiroumi, Ikawa; Kosaka, Akihiko; Hotta, Asami; Tsutsui, Takamitsu; Saita, Yuriko; Ueki, Koichiro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Med, Dept Oral & Maxillofacial Surg,Chuo Ku, Yamanashi 4093898, Japan	Moroi, A (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Med, Dept Oral & Maxillofacial Surg,Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	amoroi@yamanashi.ac.jp					KERSTENS HCJ, 1990, ORAL SURG ORAL MED O, V69, P274, DOI 10.1016/0030-4220(90)90286-2; Doucet JC, 2012, J ORAL MAXIL SURG, V70, P1935, DOI 10.1016/j.joms.2011.08.018; WOLFORD LM, 1987, ORAL SURG ORAL MED O, V64, P146, DOI 10.1016/0030-4220(87)90080-6; FRANCO JE, 1989, J ORAL MAXIL SURG, V47, P451, DOI 10.1016/0278-2391(89)90276-0; Ueki K, 2005, INT J ORAL MAX SURG, V34, P627, DOI 10.1016/j.ijom.2005.02.013; KOBAYASHI T, 1986, J ORAL MAXIL SURG, V44, P693; VANSICKELS JE, 1986, J ORAL MAXIL SURG, V44, P698; Ueki K, 2009, J ORAL MAXIL SURG, V67, P1062, DOI 10.1016/j.joms.2008.11.016; Mehra P, 2001, J ORAL MAXIL SURG, V59, P854, DOI 10.1053/joms.2001.25013; Ueki K, 2001, INT J ORAL MAX SURG, V30, P490, DOI 10.1054/ijom.2001.0171; Beukes J, 2013, INT J ORAL MAX SURG, V42, P303, DOI 10.1016/j.ijom.2012.09.020; Mensink G, 2012, J CRANIO MAXILL SURG, V40, P763, DOI 10.1016/j.jcms.2012.02.003; Ueki K, 2014, J CRANIO MAXILL SURG, V42, P351, DOI 10.1016/j.jcms.2013.06.001; Colella G, 2003, J ORAL MAXIL SURG, V61, P975, DOI 10.1016/S0278-2391(03)0005-6; Dolce C, 2002, AM J ORTHOD DENTOFAC, V121, P610, DOI 10.1067/mod.2002.123341; Doucet JC, 2012, J ORAL MAXIL SURG, V70, P2153, DOI 10.1016/j.joms.2011.08.029; Falter B, 2010, ORAL SURG ORAL MED O, V110, P430, DOI 10.1016/j.tripleo.2010.02.003; Hunsuck E E, 1968, J Oral Surg, V26, P250; Kim CH, 2007, J ORAL MAXIL SURG, V65, P192, DOI 10.1016/j.joms.2005.12.064; Kim MJ, 2002, J CRANIO MAXILL SURG, V30, P35, DOI 10.1054/jcms.2001.0272; KOMORI E, 1989, AM J ORTHOD DENTOFAC, V95, P29, DOI 10.1016/0889-5406(89)90132-7; Kriwalsky MS, 2008, BRIT J ORAL MAX SURG, V46, P177, DOI 10.1016/j.bjoms.2007.09.011; Mensink G, 2013, BRIT J ORAL MAX SURG, V51, P525, DOI 10.1016/j.bjoms.2012.10.009; Mobarak K A, 2000, Int J Adult Orthodon Orthognath Surg, V15, P83; Precious DS, 2004, J ORAL MAXIL SURG, V62, P1144, DOI 10.1016/j.joms.2004.04.014; Precious DS, 1998, ORAL SURG ORAL MED O, V85, P362, DOI 10.1016/S1079-2104(98)90057-9; Proffit William R, 2007, Head Face Med, V3, P21, DOI 10.1186/1746-160X-3-21; REITZIK M, 1980, J ORAL SURG, V38, P109; Reyneke JP, 2002, J ORAL MAXIL SURG, V60, P654, DOI 10.1053/joms.2002.33114; Schwartz HC, 2004, J ORAL MAXIL SURG, V62, P1147, DOI 10.1016/j.joms.2004.04.015; Thomas P M, 1986, Int J Adult Orthodon Orthognath Surg, V1, P171; TRAUNER R, 1957, Oral Surg Oral Med Oral Pathol, V10, P677, DOI 10.1016/S0030-4220(57)80063-2; Tuker M, 1995, J ORAL MAXILLODAC SU, V53, P80; Ueki K, 2014, J CRANIO MAXILL SURG, V42, P1748, DOI 10.1016/j.jcms.2014.06.010; Verweij JP, 2014, J CRANIOMAXILLOFAC S, V42, P359; Yang HJ, 2014, J CRANIO MAXILL SURG, V42, pE165, DOI 10.1016/j.jcms.2013.07.015	36	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	SEP	2015	43	7					1104	1108		10.1016/j.jcms.2015.04.010		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CR1IP	WOS:000361078700021		
J	Ardjomandi, N; Duttenhoefer, F; Xavier, S; Oshima, T; Kuenz, A; Sauerbier, S				Ardjomandi, N.; Duttenhoefer, F.; Xavier, S.; Oshima, T.; Kuenz, A.; Sauerbier, S.			In vivo comparison of hard tissue regeneration with ovine mesenchymal stem cells processed with either the FICOLL method or the BMAC method	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						BMAC system; Density centrifugation; Mesenchymal stem cell isolation; Sinus augmentation	SINUS FLOOR AUGMENTATION; MAXILLARY SINUS; LIFT PROCEDURES; BONE; IDENTIFICATION; COMBINATION; GRAFTS; BLOOD	Introduction: The aim of this work was to analyse the suitability of mesenchymal stem cell isolation by FICOLL density centrifugation and the closed bone marrow aspirate concentrate (BMAC) system for sinus augmentation with bovine bone mineral (BBM) in the sheep model. Methods: 16 sheep underwent sinus augmentation with BBM and MSCs; they were divided between two groups with survival points of 8 and 16 weeks. For the FICOLL control arm three, and for the BMAC test arm, five augmentations were performed for each time point. The derived cell numbers were counted; a colony forming unit (CFU) assay was performed; the pluripotency of the MSCs was proved; histological and histomorphometrical analysis were performed. Results: The approach of using BBM and MSCs in combination with fibrin adhesive was sufficient for new bone formation as the FICOLL experiment indicated. However, due to significantly lower cell numbers isolated using the BMAC in sheep, less new bone was formed in the test arm. Conclusions: The BMAC system is well suited for human MSC isolation but it needs to be optimized to fit sheep cell characteristics if it is to be used in this animal model. (C) 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Ardjomandi, N.; Sauerbier, S.] Univ Tubingen Hosp, Dept Oral & Maxillofacial Surg, D-72076 Tubingen, Germany; [Duttenhoefer, F.; Oshima, T.; Kuenz, A.; Sauerbier, S.] Univ Med Ctr Freiburg, Dept Oral & Craniomaxillofacial Surg, Freiburg, Germany; [Xavier, S.] Univ Sao Paulo, Fac Dent, Dept Oral & Maxillofacial Surg, BR-14049 Ribeirao Preto, SP, Brazil; [Oshima, T.] Inst Int Cooperat, Fac Hlth Sci, Okayama, Japan	Ardjomandi, N (reprint author), Univ Med Ctr Tuebingen, Dept Oral & Craniomaxillofacial Surg, Osianderstr 2-8, D-72076 Tubingen, Germany.	N.ardjomandi@gmail.com			Camlog Foundation, Basel, Switzerland; Geistlich Biomaterials	Laboratory work was financially supported by the Camlog Foundation, Basel, Switzerland. Financial and technical support was given by Geistlich Biomaterials. Technical support was given by Harvest Technologies.	Alexander D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081674; Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x; Thorwarth M, 2005, ORAL SURG ORAL MED O, V100, P278, DOI 10.1016/j.tripleo.2004.12.017; Kirmeier R, 2008, CLIN ORAL IMPLAN RES, V19, P366, DOI 10.1111/j.1600-0501.2007.01487.x; Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018; Yamada Y, 2006, INT J PERIODONT REST, V26, P363; Terheyden H, 1999, CLIN ORAL IMPLAN RES, V10, P510, DOI 10.1034/j.1600-0501.1999.100609.x; Sauerbier S, 2011, TISSUE ENG PT A, V17, P2187, DOI [10.1089/ten.TEA.2010.0516, 10.1089/ten.tea.2010.0516]; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Hall SRR, 2013, STEM CELL TRANSL MED, V2, P567, DOI 10.5966/sctm.2012-0155; Wadajkar AS, 2014, BIOMATERIALS, V35, P654, DOI 10.1016/j.biomaterials.2013.10.015; Sauerbier S, 2010, TISSUE ENG PART C-ME, V16, P215, DOI 10.1089/ten.TEC.2009.0269; Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050; Ardjomandi N, 2012, J BIOMED MATER RES A, V100A, P2034, DOI 10.1002/jbm.a.34062; Ardjomandi N, 2013, NUCLEIC ACID THER, V23, P44, DOI 10.1089/nat.2012.0349; Bates D, 2009, R LANG ENV STAT COMP; Duttenhoefer Fabian, 2014, Biores Open Access, V3, P75, DOI 10.1089/biores.2014.0003; Gonshor A, 2011, INT J ORAL MAX IMPL, V26, P123; Hermann PC, 2007, CELL TRANSPLANT, V16, P1059, DOI 10.3727/000000007783472363; Hibino N, 2011, TISSUE ENG PART C-ME, V17, P993, DOI [10.1089/ten.TEC.2011.0110, 10.1089/ten.tec.2011.0110]; Horn P, 2008, CYTOTHERAPY, V10, P676, DOI 10.1080/14653240802398845; Aditya Kumar, 2010, Haryana Veterinarian, V49, P28; McAllister BS, 2009, J PERIODONTOL, V80, P679, DOI 10.1902/jop.2009.080345; Oshima T, 2014, J ORAL MAXIL SURG, V72, P485, DOI 10.1016/j.joms.2013.10.026; Pinheiro J. C., 2000, MIXED EFFECTS MODELS; Sauerbier S, 2009, TISSUE ENG PART C-ME, V15, P455, DOI 10.1089/ten.tec.2008.0626; Sauerbier S, 2010, TISSUE ENG PART C-ME, V16, P1033, DOI 10.1089/ten.TEC.2009.0734; Sauerbier S, 2013, J CRANIOMAXILLOFAC S, V41, P128; Schmelzeisen R, 2011, BRIT J ORAL MAX SURG, V49, P480, DOI 10.1016/j.bjoms.2010.06.020; Ueda M, 2001, ARTIF ORGANS, V25, P164, DOI 10.1046/j.1525-1594.2001.025003164.x; Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328; Wildburger A, 2013, CLIN ORAL IMPLANT RE; Wongchuensoontorn C, 2009, J CRANIO MAXILL SURG, V37, P155, DOI 10.1016/j.jcms.2008.11.002; Zhang WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088794	36	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	SEP	2015	43	7					1177	1183		10.1016/j.jcms.2015.05.020		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CR1IP	WOS:000361078700032		
J	Ueki, K; Yoshizawa, K; Moroi, A; Iguchi, R; Kosaka, A; Ikawa, H; Saida, Y; Hotta, A; Tsutsui, T				Ueki, Koichiro; Yoshizawa, Kunio; Moroi, Akinori; Iguchi, Ran; Kosaka, Akihiko; Ikawa, Hiroumi; Saida, Yuriko; Hotta, Asami; Tsutsui, Takamitsu			Changes in computed tomography values of mandibular condyle and temporomandibular joint disc position after sagittal split ramus osteotomy	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Sagittal split ramus osteotomy; Computed tomography (CT) value; Disc position; Condyle	CLASS-III PATIENTS; LE-FORT-I; ORTHOGNATHIC SURGERY; PLATE FIXATION; MORPHOLOGY; ASYMMETRY; BONE	Purpose: The purpose of this study was to evaluate change in computed tomography (CT) value of condyle and temporomandibular joint (TMJ) disc position after sagittal split ramus osteotomy (SSRO) setback surgery, retrospectively. Subjects and methods: The subjects were 76 patients (152 condyles) who underwent bilateral SSRO setback surgery. They were divided into 2 groups (43 symmetric patients and 33 asymmetric patients). CT values (pixel values) of 5 sites of the condyle and condylar width, length, horizontal angle were measured pre-operatively and 1 year post-operatively. Disc position was classified as anterior disc displacement, anterior type, fully covered type and posterior type, preoperatively and postoperatively using magnetic resonance imaging (MRI). Results: In maximum CT value at the center of the condyle, post-operative value was significantly lower than pre-operative value bilaterally (Deviation side: P = 0.0003, Non-deviation side: P = 0.0003) in asymmetry group. In minimum CT value at the center of the condyle, the post-operative value was significantly lower than the pre-operative value bilaterally (Deviation side: P = 0.0309, Non-deviation side: P = 0.0004) in the symmetry group. With regard to maximum CT value at the lateral site of the condyle in the deviation side, the value for the anterior disc displacement group was significantly larger than that of the posterior type preoperatively (P = 0.0123). CT value of the anterior disc displacement group was significantly larger than those of some other areas pre- and post-operatively (P < 0.05). Conclusion: This study suggested that CT value of condylar bone changes after 1 year in SSRO and anterior disc displacement may partially affect the CT value of the condyle in the TMJ in mandibular prognathism patients. (C) 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Ueki, Koichiro; Yoshizawa, Kunio; Moroi, Akinori; Iguchi, Ran; Kosaka, Akihiko; Ikawa, Hiroumi; Saida, Yuriko; Hotta, Asami; Tsutsui, Takamitsu] Univ Yamanashi, Dept Oral & Maxillofacial Surg, Div Med, Interdisciplinary Grad Sch,Chuo Ku, Yamanashi 4093893, Japan	Ueki, K (reprint author), Univ Yamanashi, Dept Oral & Maxillofacial Surg, Div Med, Interdisciplinary Grad Sch,Chuo Ku, 1110 Shimokato, Yamanashi 4093893, Japan.	kueki@yamanashi.ac.jp					ROTSKOFF KS, 1991, J ORAL MAXIL SURG, V49, P2, DOI 10.1016/0278-2391(91)90256-L; Lettry S, 2003, BONE, V32, P35, DOI 10.1016/S8756-3282(02)00921-3; Ueki K, 2013, J CRANIO MAXILL SURG, V41, P129, DOI 10.1016/j.jcms.2012.06.004; Ueki K, 2008, ORAL SURG ORAL MED O, V106, P656, DOI 10.1016/j.tripleo.2008.03.016; HOFFMAN EJ, 1979, J COMPUT ASSIST TOMO, V3, P299; Ueki K, 2009, ORAL SURG ORAL MED O, V108, P679, DOI 10.1016/j.tripleo.2009.05.042; LEONARD M, 1976, J ORAL SURG, V34, P942; Ueki K, 2001, INT J ORAL MAX SURG, V30, P490, DOI 10.1054/ijom.2001.0171; Dahlberg G, 1940, STAT METHODS MED BIO, P122; ELLIS E, 1991, J ORAL MAXIL SURG, V49, P1316, DOI 10.1016/0278-2391(91)90311-9; Gerressen M, 2006, J ORAL MAXIL SURG, V64, P1624, DOI 10.1016/j.joms.2005.11.110; Harada K, 1996, PLAST RECONSTR SURG, V98, P363, DOI 10.1097/00006534-199608000-00026; Isberg A M, 1986, Cranio, V4, P143; TRAUNER R, 1957, Oral Surg Oral Med Oral Pathol, V10, P677, DOI 10.1016/S0030-4220(57)80063-2; Ueki K, 2012, J CRANIOMAXILLOFAC S, V40, P119; Ueki K, 2005, EUR J ORTHODONT, V27, P501, DOI 10.1093/ejo/cji029; Ueki K, 2000, J CRANIO MAXILL SURG, V28, P362, DOI 10.1054/jcms.2000.0181; Ueki K, 2008, ORTHOD CRANIOFAC RES, V11, P43, DOI 10.1111/j.1601-6343.2008.00413.x; Ueki K, 2010, EUR J ORTHODONT, V32, P522, DOI 10.1093/ejo/cjp143; Ueki K, 2007, INT J ORAL MAX SURG, V36, P301, DOI 10.1016/j.ijom.2006.09.022; Ueki K, 2009, ORTHOD CRANIOFAC RES, V12, P312, DOI 10.1111/j.1601-6343.2009.01467.x; Ueki K, 2006, EUR J ORTHODONT, V28, P433, DOI 10.1093/ejo/cjl003	22	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	SEP	2015	43	7					1208	1217		10.1016/j.jcms.2015.05.007		10	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CR1IP	WOS:000361078700036		
J	Otawa, N; Sumida, T; Kitagaki, H; Sasaki, K; Fujibayashi, S; Takemoto, M; Nakamura, T; Yamada, T; Mori, Y; Matsushita, T				Otawa, Naruto; Sumida, Tomoki; Kitagaki, Hisashi; Sasaki, Kiyoyuki; Fujibayashi, Shunsuke; Takemoto, Mitsuru; Nakamura, Takashi; Yamada, Tomohiro; Mori, Yoshihide; Matsushita, Tomiharu			Custom-made titanium devices as membranes for bone augmentation in implant treatment: Modeling accuracy of titanium products constructed with selective laser melting	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Computer aided design; Guided bone regeneration; Modeling accuracy; Rapid prototyping; Selective laser melting; Titanium	POROUS BIOACTIVE TITANIUM; COMPUTER-AIDED-DESIGN; MECHANICAL-PROPERTIES; FABRICATION; TECHNOLOGY; BEHAVIOR; DRUG; CAD; CT	Objective: The purpose of this study was to verify the modeling accuracy of various products, and to produce custom-made devices for bone augmentation in individual patients requiring implantation. Materials and methods: Two-(2D) and three-dimensional (3D) specimens and custom-made devices that were designed as membranes for guided bone regeneration (GBR) were produced using a computer-aided design (CAD) and rapid prototyping (RP) method. The CAD design was produced using a 3D printing machine and selective laser melting (SLM) with pure titanium (Ti) powder. The modeling accuracy was evaluated with regard to: the dimensional accuracy of the 2D and 3D specimens; the accuracy of pore structure of the 2D specimens; the accuracy of porosity of the 3D specimens; and the error between CAD design and the scanned real product by overlapped images. Results: The accuracy of the 2D and 3D specimens indicated precise results in various parameters, which were tolerant in ISO 2768-1. The error of overlapped images between the CAD and scanned data indicated that accuracy was sufficient for GBR. In integrating area of all devices, the maximum and average error were 292 and 139 mu m, respectively. Conclusions: High modeling accuracy can be achieved in various products using the CAD/RP-SLM method. These results suggest the possibility of clinical applications. (C) 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Otawa, Naruto; Sumida, Tomoki; Yamada, Tomohiro; Mori, Yoshihide] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Surg,Higashi Ku, Fukuoka 8128582, Japan; [Kitagaki, Hisashi] Osaka Yakin Kogyo Co Ltd, Yodogawa Ku, Osaka 5330005, Japan; [Sasaki, Kiyoyuki] Sagawa Printing Co Ltd, Hyuga City, Kyoto 6178588, Japan; [Fujibayashi, Shunsuke; Takemoto, Mitsuru; Nakamura, Takashi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Sakyo Ku, Kyoto 6068507, Japan; [Matsushita, Tomiharu] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan	Sumida, T (reprint author), Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Surg,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tomoki94530@gmail.com			Japanese Ministry of Economy, Trade, and Industry [23-033]; Amada Foundation [AF-2012204]	This study was supported by a grant from the Japanese Ministry of Economy, Trade, and Industry (No. 23-033) and a grant from the Amada Foundation (AF-2012204). The authors gratefully acknowledge this financial support. We would like to thank Editage (www.editage.jp) for English language editing.	Barakat AAM, 2014, J CRANIO MAXILL SURG, V42, pE195, DOI 10.1016/j.jcms.2013.08.007; Sallica-Leva E, 2013, J MECH BEHAV BIOMED, V26, P98, DOI 10.1016/j.jmbbm.2013.05.011; Giger ML, 2008, MED PHYS, V35, P5799, DOI 10.1118/1.3013555; Porter MM, 2014, ADV FUNCT MATER, V24, P1978, DOI 10.1002/adfm.201302958; Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013; Silva DN, 2008, J CRANIO MAXILL SURG, V36, P443, DOI 10.1016/j.jcms.2008.04.003; Girolami A, 2013, MEAT SCI, V93, P111, DOI 10.1016/j.meatsci.2012.08.010; [Anonymous], 1987, 27681 ISO; Ibrahim D, 2009, J CRANIO MAXILL SURG, V37, P167, DOI 10.1016/j.jcms.2008.10.008; Fasbinder DJ, 2013, AM J DENT, V26, P115; Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219; Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788; Veselovsky AV, 2014, SAR QSAR ENVIRON RES, V25, P457, DOI 10.1080/1062936X.2014.898689; Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019; Cano J, 2006, ORAL SURG ORAL MED O, V101, P11, DOI 10.1016/j.tripleo.2005.04.015; Pattanayak DK, 2011, ACTA BIOMATER, V7, P1398, DOI 10.1016/j.actbio.2010.09.034; Dahab GM, 2004, J GASTROEN HEPATOL, V19, P78, DOI 10.1111/j.1440-1746.2004.03183.x; Cho SH, 2013, J PROSTHET DENT, V109, P75, DOI 10.1016/S0022-3913(13)60018-9; Calamia JR, 1995, J PHILIPP DENT ASS, V48, P31; Chen YJ, 2011, J MATER SCI-MATER M, V22, P839, DOI 10.1007/s10856-011-4280-0; Duke E S, 2001, Compend Contin Educ Dent, V22, P968; Garcia MJ, 2009, J CARDIOVASC SURG, V50, P7; Gelalis L D, 2001, Orthopedics, V24, P1065; GOH J C H, 1990, Annals Academy of Medicine Singapore, V19, P706; Horsch K, 2008, ACAD RADIOL, V15, P139, DOI 10.1016/j.acra.2007.09.015; Kang H, 2012, J BIOMECH, V45, P2241, DOI 10.1016/j.jbiomech.2012.06.011; Kimura G, 2013, J PHARM SCI-US, V102, P2166, DOI 10.1002/jps.23541; Lima JMC, 2014, J PROSTHODONT; Lipinski P, 2013, J MECH BEHAV BIOMED, V28, P274, DOI 10.1016/j.jmbbm.2013.08.011; Narayanan C M, 2013, Recent Pat Biotechnol, V7, P47; Olszewski R, 2014, J CRANIO MAXILL SURG, V42, P1847, DOI 10.1016/j.jcms.2014.07.002; Otsuki B, 2013, INT ORTHOP, V37, P1033, DOI 10.1007/s00264-013-1873-x; Pevzner Y, 2014, J CHEM INF MODEL, V54, P2612, DOI 10.1021/ci500322k; PHO R W H, 1990, Annals Academy of Medicine Singapore, V19, P691; Rekow E D, 1992, Curr Opin Dent, V2, P25; Sanchez-Lite A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072703; Sanders JE, 2011, PROSTHET ORTHOT INT, V35, P81, DOI 10.1177/0309364610394476; Shqaidef A, 2014, BRIT J ORAL MAX SURG, V52, P609, DOI 10.1016/j.bjoms.2014.04.010; Simion M, 1994, Int J Periodontics Restorative Dent, V14, P496; Tang XAN, 2010, J NEUROSCI METH, V190, P240, DOI 10.1016/j.jneumeth.2010.05.004; Warnke PH, 2008, TISSUE ENG PART C-ME, V15, P115; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079289	42	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	SEP	2015	43	7					1289	1295		10.1016/j.jcms.2015.05.006		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CR1IP	WOS:000361078700048		
J	Suzuki, N; Takimoto, K; Kawashima, N				Suzuki, Noriyuki; Takimoto, Koyo; Kawashima, Nobuyuki			Cathepsin K Inhibitor Regulates Inflammation and Bone Destruction in Experimentally Induced Rat Periapical Lesions	JOURNAL OF ENDODONTICS			English	Article						Cathepsin K inhibitor; major histocompatibility complex class II molecules; osteoclasts; periapical bone destruction; periapical lesions; proinflammatory cytokines	ACTIVATION; RESORPTION; EXPRESSION; CYTOKINES; MOLARS; CELLS; DIFFERENTIATION; MACROPHAGES; MODULATION; KINETICS	Introduction: Cathepsin K is highly expressed in osteoclasts and plays an essential role in bone resorption. NC-2300 is an artificially designed cathepsin K inhibitor, and its application to experimentally induced arthritis induces down-regulation of bone destruction. In this study, we evaluated the effects of NC-2300 on inflammation and bone destruction in experimentally induced rat periapical lesions. Methods: The dental pulps of lower first molars in rats were extirpated, and the pulp chambers were left open to the oral environment. NC-2300 and phosphate-buffered saline were administered orally twice a day in the experimental and control groups, respectively. Animals were sacrificed on day 21, and the mandibles were extracted. The left hennimandibles were used for micro computed tomographic and histologic examination. For the right hemimandibles, RNA was extracted from the periapical tissues surrounding the root apices, and inflammatory mediator expression was examined by real-time polymerase chain reaction using complementary DNA converted from extracted RNA. Results: The size of the periapical lesion, number of tartrate-resistant acid phosphatase positive osteoclasts and major histocompatibility complex class II molecule expressing macrophages in the experimental group decreased significantly when compared with the control group. The expression of proinflammatory cytokines in the experimental group was significantly suppressed when compared with the control group. Conclusions: These results suggest that the cathepsin K inhibitor may inhibit not only cathepsin K activity in osteoclasts but also inflammatory mediator synthesis relating to osteoclastogenesis, and these synergistic effects may be involved in the suppression of periapical lesion expansion.	[Suzuki, Noriyuki; Takimoto, Koyo; Kawashima, Nobuyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Oral Hlth Sci, Dept Pulp Biol & Endodont, Tokyo 1138549, Japan	Suzuki, N (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Oral Hlth Sci, Dept Pulp Biol & Endodont,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	n.suzuki.endo@tmd.ac.jp			Japan Society for the Promotion of Science [25253101, 25293386]	Supported by grants-in-aid from the Japan Society for the Promotion of Science (nos. 25253101 and 25293386).	Kawashima N, 1999, ARCH ORAL BIOL, V44, P55, DOI 10.1016/S0003-9969(98)00094-6; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Kawashima N, 2007, ORAL SURG ORAL MED O, V103, P707, DOI 10.1016/j.tripleo.2006.11.036; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Buhling F, 2001, J PATHOL, V195, P375; Kawanishi HK, 2004, EUR J ORAL SCI, V112, P332, DOI 10.1111/j.1600-0722.2004.00139.x; Sasaki H, 2000, J IMMUNOL, V165, P3626; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Stashenko P, 1998, CRIT REV ORAL BIOL M, V9, P498; TANIISHII N, 1995, ORAL MICROBIOL IMMUN, V10, P213, DOI 10.1111/j.1399-302X.1995.tb00145.x; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Kawashima N, 1996, J ENDODONT, V22, P311, DOI 10.1016/S0099-2399(96)80266-4; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Gao B, 2012, J DENT RES, V92, P180; Hirai T, 2013, J IMMUNOL, V190, P4805, DOI 10.4049/jimmunol.1200901; Ma JQ, 2013, INFECT IMMUN, V81, P1021, DOI 10.1128/IAI.00756-12; OKIJI T, 1994, J ENDODONT, V20, P27, DOI 10.1016/S0099-2399(06)80023-3; Stashenko P, 2007, AM J PATHOL, V170, P203, DOI 10.2353/ajpath.2007.060597; STASHENKO P, 1995, J DENT RES, V74, P323; Suzuki N, 1999, ARCH ORAL BIOL, V44, P67, DOI 10.1016/S0003-9969(98)00089-2; WANG CY, 1993, ORAL MICROBIOL IMMUN, V8, P50, DOI 10.1111/j.1399-302X.1993.tb00543.x	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399	1878-3554		J ENDODONT	J. Endod.	SEP	2015	41	9					1474	1479		10.1016/j.joen.2015.04.013		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CR1JY	WOS:000361082300016		
J	Heiss, AA; Lee, WJ; Ishida, K; Simpson, AGB				Heiss, Aaron A.; Lee, Won J.; Ishida, Ken-ichiro; Simpson, Alastair G. B.			Cultivation and Characterisation of New Species of Apusomonads (the Sister Group to Opisthokonts), Including Close Relatives of Thecamonas (Chelonemonas n. gen.)	JOURNAL OF EUKARYOTIC MICROBIOLOGY			English	Article						Amorphea; culturing; electron microscopy; pellicle; protozoa; taxonomy	FLAGELLATES PROTISTA; SIGNALING MACHINERY; MOLECULAR PHYLOGENY; MARINE-SEDIMENTS; ANCIENT ORIGIN; SP-NOV; ULTRASTRUCTURE; EVOLUTION; APUSOZOA; ANIMALS	Apusomonads comprise an understudied and undersampled group of heterotrophic flagellates that is closely related to opisthokonts, the supergroup containing animals and fungi. We cultured representatives of a new clade of apusomonads, Chelonemonas n. gen., which is sister to marine forms of Thecamonas in SSU rRNA gene phylogenies. Scanning electron microscopy shows that members of Chelonemonas have a hexagonal patterning to their submembranous pellicle, which is not known to exist in other apusomonads. We propose that the subfamily Thecamonadinae refer to the marine Thecamonas/Chelonomonas clade. We also report two new strains of Multimonas, one of which is genetically divergent from previously described strains, and here described as a new species, Multimonas koreensis. Both strains of Multimonas have appendages on their dorsal surface that could be extrusomes, and a frilled appearance to the border of their pellicle. Explorations of taxon sampling in SSU rRNA gene phylogenies confirm the new strains' evolutionary affinities, but do not resolve relationships among the five main apusomonad clades. These phylogenies also separate the freshwater species "Thecamonas" oxoniensis from the marine members of the genus Thecamonas. The new strains described here may provide valuable genetic and morphological data for evaluating the relationships and evolution of apusomonads.	[Heiss, Aaron A.] Amer Museum Nat Hist, Dept Invertebrate Zool, New York, NY 10024 USA; [Heiss, Aaron A.; Ishida, Ken-ichiro] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Lee, Won J.] Kyungnam Univ, Dept Urban Environm Engn, Chang Won 631701, South Korea; [Simpson, Alastair G. B.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada; [Simpson, Alastair G. B.] Canadian Inst Adv Res, Program Integrated Microbial Divers, Ottawa, ON, Canada	Simpson, AGB (reprint author), Dalhousie Univ, Dept Biol, 1355 Oxford St, Halifax, NS B3H 4R2, Canada.	alastair.simpson@dal.ca			National Institute of Biological Resources, Korea (NIBR) [2014-02-001]; Japan Society for the Promotion of Science; Gerstner Foundation; Lerner-Gray Fund	The authors thank Ping Li and Pat Scallion (Dalhousie University), Takashi Shiratori (University of Tsukuba), and Grace Avecilla and Henry Towbin (American Museum of Natural History) for assistance with SEM specimen preparation and instrument operation. Additional gratitude is due to Yana Eglit (Dalhousie University), who assisted with interpreting Russian literature, and Lee Herman and Randall T. Schuh (American Museum of Natural History), for discussions and clarifications about taxonomy. This study was supported by a grant from the National Institute of Biological Resources, Korea (NIBR no. 2014-02-001). AAH acknowledges support by the Japan Society for the Promotion of Science, the Gerstner Foundation, and the Lerner-Gray Fund.	Paps J, 2013, PROTIST, V164, P2, DOI 10.1016/j.protis.2012.09.002; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Cai XJ, 2012, MOL BIOL EVOL, V29, P91, DOI 10.1093/molbev/msr149; Cavalier-Smith T, 2014, MOL PHYLOGENET EVOL, V81, P71, DOI 10.1016/j.ympev.2014.08.012; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Kim E, 2013, PROTIST, V164, P160, DOI 10.1016/j.protis.2012.10.002; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Zhao S, 2013, MOL PHYLOGENET EVOL, V69, P462, DOI 10.1016/j.ympev.2013.08.005; Cai XJ, 2012, J MEMBRANE BIOL, V245, P117, DOI 10.1007/s00232-012-9415-9; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Glucksman E, 2013, EUR J PROTISTOL, V49, P179, DOI 10.1016/j.ejop.2012.08.007; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Brown MW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1755; CAVALIERSMITH T, 1995, P ROY SOC B-BIOL SCI, V261, P1, DOI 10.1098/rspb.1995.0108; Cavalier-Smith T, 2010, PROTIST, V161, P549, DOI 10.1016/j.protis.2010.04.002; Cavalier-Smith T, 2008, PROTIST, V159, P535, DOI 10.1016/j.protis.2008.06.002; Glucksman E, 2011, PROTIST, V162, P207, DOI 10.1016/j.protis.2010.06.004; Hausmann K, 2006, ACTA PROTOZOOL, V45, P415; Heiss AA, 2013, PROTIST, V164, P598, DOI 10.1016/j.protis.2013.05.005; Karpov S. A., 2011, HANDBOOK IN ZOOLOGY, P308; Karpov SA., 2007, PROTISTOLOGY, V5, P146; KARPOV SA, 1989, ZOOL ZH, V68, P5; Katz LA, 2011, PROTIST, V162, P762, DOI 10.1016/j.protis.2011.05.002; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; LARSEN J, 1990, J NAT HIST, V24, P801, DOI 10.1080/00222939000770571; Lee WJ, 2000, J NAT HIST, V34, P483, DOI 10.1080/002229300299435; MOLINA FI, 1991, EUR J PROTISTOL, V27, P386, DOI 10.1016/S0932-4739(11)80257-9; Myl'nikov AP, 2012, ZOOL ZH, V91, P387; Myl'nikov AP, 1999, ZOOL ZH, V78, P771; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; VICKERMAN K, 1974, Archiv fuer Protistenkunde, V116, P254; Yabuki A, 2013, PROTIST, V164, P75, DOI 10.1016/j.protis.2012.04.005	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5234	1550-7408		J EUKARYOT MICROBIOL	J. Eukaryot. Microbiol.	SEP-OCT	2015	62	5					637	649		10.1111/jeu.12220		13	Microbiology	Microbiology	CQ9XT	WOS:000360970100008		
J	Nakayama, M; Tanida, Y; Saito, S				Nakayama, Masataka; Tanida, Yuki; Saito, Satoru			Long-Term Phonological Knowledge Supports Serial Ordering in Working Memory	JOURNAL OF EXPERIMENTAL PSYCHOLOGY-LEARNING MEMORY AND COGNITION			English	Article						serial order control; long-term phonological knowledge; working memory; immediate serial recall; nonword	LANGUAGE PRODUCTION; PHONOTACTIC CONSTRAINTS; SPEECH ERRORS; MODEL; JAPANESE; PROGRAM; MORA	Serial ordering mechanisms have been investigated extensively in psychology and psycholinguistics. It has also been demonstrated repeatedly that long-term phonological knowledge contributes to serial ordering. However, the mechanisms that contribute to serial ordering have yet to be fully understood. To understand these mechanisms, we demonstrate 2 effects using triples of Japanese nonwords in immediate serial recall. One, a type of bielement frequency effect, is a retrograde compatibility effect. Bielement frequency effects are well-established phenomena whereby a 2-element sequence (e.g., "ka-re") that frequently appears in a language instantiates better recall of any sequence that includes this element (e.g., "ka-re-su-mo"). We demonstrate that bielement frequency affected both the first (e.g., "ka" for "ka-re"; retrograde compatibility effect) and second part of a sequence, indicating the existence of minicontext representations of 2-element sequences. The other effects are the position-element(s) frequency effects, whereby an element (e.g., the mora "ka") that more frequently appears in 1 position of a sequence (e.g., in the first mora of a word) than in other positions facilitates better recall of that element (i.e., the first mora). The effects demonstrated in this article indicate the long-term associations of position representations and elements. These effects are discussed in terms of the extensive learning hypothesis, which assumes that phonological structures are learned gradually. Implications for computational models are also discussed.	[Nakayama, Masataka; Tanida, Yuki; Saito, Satoru] Kyoto Univ, Grad Sch Educ, Kyoto 6068501, Japan; [Nakayama, Masataka; Tanida, Yuki] Japan Soc Promot Sci, Tokyo, Japan	Nakayama, M (reprint author), Kyoto Univ, Grad Sch Educ, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	nakayama.masataka.36x@st.kyoto-u.ac.jp; saito.satoru.2z@kyoto-u.ac.jp			Japan Society for the Promotion of Sciences KAKENHI [11J07208, 25380980]	Parts of the present data were presented at the 10th Annual Conference of the Japan Society for Working Memory, December 2012, Kyoto, Japan; the 18th Conference of the European Society for Cognitive Psychology, Audust 2013, Budapest Hungary; and the Meeting of the Experimental Psychology Society, January 2014, London UK. This research was supported in part by Japan Society for the Promotion of Sciences KAKENHI Grants 11J07208 (to Mastaka Nakayama) and 25380980 (to Saturo Saito). We appreciate Yuya Ishibashi, Megumi Masuda, Yuki Nozaki, and Atsuko Tominaga for data collection. We are also grateful to David Plaut for helpful comments on an earlier version of the manuscript of this article.	Amano S, 2000, JAPANESE NTT DATABAS; LEWANDOWSKY S, 1989, PSYCHOL REV, V96, P25, DOI 10.1037/0033-295X.96.1.25; Gathercole SE, 1999, J EXP PSYCHOL LEARN, V25, P84, DOI 10.1037//0278-7393.25.1.84; Botvinick MM, 2006, PSYCHOL REV, V113, P201, DOI 10.1037/0033-295X.113.2.201; Tamaoka K, 2004, BEHAV RES METH INS C, V36, P531, DOI 10.3758/BF03195600; Warker JA, 2006, J EXP PSYCHOL LEARN, V32, P387, DOI 10.1037/0278-7393.32.2.387; Dell GS, 2000, J EXP PSYCHOL LEARN, V26, P1355, DOI 10.1037//0278-7393.26.6.1355; Henson RNA, 1998, COGNITIVE PSYCHOL, V36, P73, DOI 10.1006/cogp.1998.0685; van Casteren M, 2006, BEHAV RES METHODS, V38, P584; OTAKE T, 1993, J MEM LANG, V32, P258; van Casteren M, 2007, BEHAV RES METHODS, V39, P973; Hitch GJ, 2005, MEMORY, V13, P247, DOI 10.1080/09658210344000314; Majerus S, 2012, J MEM LANG, V66, P38, DOI 10.1016/j.jml.2011.07.006; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Acheson DJ, 2009, PSYCHOL BULL, V135, P50, DOI 10.1037/a0014411; Dell GS, 1997, PSYCHOL REV, V104, P123, DOI 10.1037/0033-295X.104.1.123; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Botvinick MA, 2005, COGNITION, V97, P135, DOI 10.1016/j.cognition.2004.09.007; Cer D. M., 2006, HDB BINDING MEMORY P, P192; Cumming N, 2003, MEMORY, V11, P43, DOI 10.1080/741938175; Estes W. K., 1972, CODING PROCESS HUM, P161; Gupta P, 2009, J MEM LANG, V61, P481, DOI 10.1016/j.jml.2009.08.001; Hartley T, 1996, J MEM LANG, V35, P1, DOI 10.1006/jmla.1996.0001; Hebb D. O., 1961, BRAIN MECH LEARNING, P37; Hurlstone MJ, 2014, PSYCHOL BULL, V140, P339, DOI 10.1037/a0034221; Nakayama M, 2014, COGNITION, V131, P415, DOI 10.1016/j.cognition.2014.03.002; Page MPA, 2009, PHILOS T R SOC B, V364, P3737, DOI 10.1098/rstb.2009.0173; R Core Team, 2013, R LANG ENV STAT COMP; Saito S., 2014, INT C WORK MEM U ARM; STEMBERGER JP, 1990, COGNITION, V35, P123, DOI 10.1016/0010-0277(90)90012-9; Szmalec A, 2009, Q J EXP PSYCHOL, V62, P435, DOI 10.1080/17470210802386375	32	1	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0278-7393	1939-1285		J EXP PSYCHOL LEARN	J. Exp. Psychol.-Learn. Mem. Cogn.	SEP	2015	41	5					1570	1578		10.1037/a0038825		9	Psychology; Psychology, Experimental	Psychology	CR0UO	WOS:000361038900023		
J	Kikkawa, HS; Tahara, M; Sugita, R				Kikkawa, Hitomi S.; Tahara, Makoto; Sugita, Ritsuko			Forensic DNA Analysis of Wheat Flour as Commonly Used in White Powder Cases	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; criminalistics; white powder material; DNA barcoding; ribulose bisphosphate carboxylase large subunit gene; DNA typing; short tandem repeats	EST-SSR MARKERS; CHLOROPLAST GENOME; IDENTIFICATION; ANTHRAX; L.; CULTIVARS; BOTANY; DEATH; SNP	In the wake of terrorist attacks using anthrax and ricin, white powder is often encountered in cases of malicious mischief and terrorist threats. Wheat flour is a common white powder encountered in such criminal investigations. We used DNA analysis to investigate wheat flour samples for identification and discrimination as trace evidence. Species identification of commercially available wheat flour was carried out by sequencing a partial region of the ribulose bisphosphate carboxylase large subunit gene (rbcL). Samples were discriminated using short tandem repeat (STR) analysis. The rbcL sequences of all wheat flour samples were identical and showed a high level of similarity to known wheat (Triticum aestivum L.) sequences. Furthermore, flours had characteristic patterns in STR analyses, with specific cultivars showing distinctive patterns. These results suggested that the identification of wheat flour species is possible using rbcL sequencing, and that STR analysis is useful for discriminating between samples.	[Kikkawa, Hitomi S.; Sugita, Ritsuko] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan; [Tahara, Makoto] Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Okayama 7008530, Japan	Kikkawa, HS (reprint author), Natl Res Inst Police Sci, Dept Forens Sci 4, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	kikkawa@nrips.go.jp					Schieltz DM, 2011, FORENSIC SCI INT, V209, P70, DOI 10.1016/j.forsciint.2010.12.013; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2006.01678.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554; He C, 2003, THEOR APPL GENET, V106, P363, DOI 10.1007/s00122-002-1076-0; Koopman WJM, 2012, FORENSIC SCI INT-GEN, V6, P366, DOI 10.1016/j.fsigen.2011.07.013; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI 10.1051/gse:2002009; Keim P, 2001, J CLIN MICROBIOL, V39, P4566, DOI 10.1128/JCM.39.12.4566-4567.2001; Beltrami D, 2011, ANAL BIOANAL CHEM, V401, P1401, DOI 10.1007/s00216-011-5149-2; Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195; Fujita Y, 2009, BREEDING SCI, V59, P159, DOI 10.1270/jsbbs.59.159; Higgins JA, 2003, APPL ENVIRON MICROB, V69, P593, DOI 10.1128/AEM.69.1.593-599.2003; Ferri G, 2009, INT J LEGAL MED, V123, P395, DOI 10.1007/s00414-009-0356-5; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rotherham D, 2011, FORENSIC SCI INT, V207, P193, DOI 10.1016/j.forsciint.2010.10.006; Aoki Y, 2002, J IWATE MED ASS, V54, P81; Bock JH, 1997, J FORENSIC SCI, V42, P364; Carrier C, 2012, FORENSIC SCI INT-GEN, V7, P194; CBOL Plant Working Group, 2009, PNAS, V106, P12794; Cocchi M, 2004, J AGR FOOD CHEM, V52, P1062, DOI 10.1021/jf034441o; Coyle HM, 2003, CROAT MED J, V44, P315; Coyle HM, 2005, CROAT MED J, V46, P606; Fernandez Manny, 2013, NY TIMES; FISHER RA, 1951, HEREDITY, V5, P95, DOI 10.1038/hdy.1951.5; Fricano A, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-18; Inglesby TV, 1999, EMERG INFECT DIS, V5, P556; Kikkawa HS, 2010, ANAL SCI, V26, P913; Leask Alexander, 2003, N S W Public Health Bull, V14, P218, DOI 10.1071/NB03059; Lee EJ, 2011, J FORENSIC SCI, V56, P1131, DOI 10.1111/j.1556-4029.2011.01810.x; Ly T, 2012, BREEDING SCI, V62, P99, DOI 10.1270/jsbbs.62.99; Ministry of Agriculture Forestry and Fisheries, 2003, GUID EXAM PLANT VAR; Ministry of Agriculture Forestry and Fisheries, 2008, ANN REP FOOD AGR RUR; Natsuga Motoyasu, 1994, Memoirs of the Faculty of Agriculture Hokkaido University, V19, P257; Sasaki H, 2002, J J DISAST MED, V7, P23; Tsai LC, 2006, FORENSIC SCI INT, V164, P193, DOI 10.1016/j.forsciint.2006.01.007; Tsai LC, 2008, FORENSIC SCI INT-GEN, V2, P35, DOI 10.1016/j.fsigen.2007.07.005; Weir BS, 1996, GENETIC DATA ANAL; Wills Brandon, 2008, J Med Toxicol, V4, P93	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	SEP	2015	60	5					1316	1321		10.1111/1556-4029.12789		6	Medicine, Legal	Legal Medicine	CR0CE	WOS:000360985000030		
J	Kawashima, H				Kawashima, Hiroto			The Measurement of Stable Carbon Isotope Ratios of Eight Methamidophos Samples	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; food terrorism; food poisoning; profiling; pesticide; organophosphorus compound; compound-specific isotope analysis; gas chromatography-mass spectrometry/combustion/isotope ratio mass spectrometry	GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; FRACTIONATION; HYDROCARBONS; CONTAMINANTS	Between December 2007 and January 2008, people suffered from food poisoning in the Japanese prefectures of Chiba and Hyogo after eating frozen dumplings (gyoza) produced in China, which had very high concentrations (1490-19,290ppm) of methamidophos (O,S-dimethyl phosphoramidothioate). Thus, we measured the stable carbon isotope ratio of methamidophos using GC/C/IRMS to identify the source. We analyzed seven methamidophos reagents and one Chinese agricultural methamidophos chemical (MTD600) that contained many impurities. The C-13 values of the seven methamidophos reagents and MTD600 ranged from -49.23 parts per thousand to -31.90 parts per thousand, with an average SD of 0.20 parts per thousand, very high precision. This difference (17.33 parts per thousand) was very large compared with that in previous reports and may be attributable to the material itself and the chemical processing of methamidophos. Criminals can easily obtain pesticides such as methamidophos; therefore, it is very important to identify the pesticide source and distribution route using stable isotopic science in the future.	Akita Prefectural Univ, Fac Syst Sci & Technol, Dept Management Sci & Engn, Yurihonjo City, Akita 0150055, Japan	Kawashima, H (reprint author), Akita Prefectural Univ, Fac Syst Sci & Technol, Dept Management Sci & Engn, 84-4 Ebinokuchi, Yurihonjo City, Akita 0150055, Japan.	kawashima@akita-pu.ac.jp			Ministry of Education, Science, Sports and Culture [24681034, 15H02980]; Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grant, Research on Food Sefety	We are extremely grateful to Professor Naoki Motoyama at the Tokyo University of Agriculture who kindly donated the Chinese methamidophos pesticide samples used in this research. Furthermore, we thank Isao Asakura of Akita Prefectural University and Mami Ohashi and Toshiyuki Ino of JASCO International Co. Ltd., Japan, for their help with isotope analysis by Isoprime. They offered many helpful suggestions. We express our sincere thanks to all these people. We hope that this research will support pesticide risk management in the future. Funding provided by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Young Scientists (A), 2012-2015, 24681034 and Grant-in-Aid for Scientific Research (B), 2015-2019, 15H02980, and the Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grant, Research on Food Safety.	Annable WK, 2007, APPL GEOCHEM, V22, P1530, DOI 10.1016/j.apgeochem.2007.03.049; [Anonymous], 2008, MAINICHI DAILY  0130; Hartenbach AE, 2008, ENVIRON SCI TECHNOL, V42, P7751, DOI 10.1021/es800356h; [Anonymous], 2010, DUMPLING SUSPECT QUI; [Anonymous], 2014, PLANT WORKER ARRESTE; MATTHEWS DE, 1978, ANAL CHEM, V50, P1465, DOI 10.1021/ac50033a022; Bouchard D, 2008, ENVIRON SCI TECHNOL, V42, P7801, DOI 10.1021/es800391s; Tsujikawa K, 2013, FORENSIC SCI INT, V227, P42, DOI 10.1016/j.forsciint.2012.08.036; Meier-Augenstein W, 2002, ANAL CHIM ACTA, V465, P63, DOI 10.1016/S0003-2670(02)00194-0; [Anonymous], 2008, DAILY YOMIURI O 0131; Sumi Y, 2008, J TOXICOL SCI, V33, P485, DOI 10.2131/jts.33.485; Elsner M, 2010, J ENVIRON MONITOR, V12, P2005, DOI 10.1039/c0em00277a; Harrington RR, 1999, ORG GEOCHEM, V30, P765, DOI 10.1016/S0146-6380(99)00059-5; [Anonymous], 2013, 10 FALL ILL EATING F; [Anonymous], 2008, MAINICHI DAILY  0131; Shin WJ, 2010, RAPID COMMUN MASS SP, V24, P1636, DOI 10.1002/rcm.4562; Meier-Augenstein W, 1999, J CHROMATOGR A, V842, P351, DOI 10.1016/S0021-9673(98)01057-7; Chinese Government's official web portal, 2008, WATCHD JAP DUMPL POI; Dreznek NJ, 2002, ORGANIC GEOCHEMISTRY, V33, P437; EWELS BA, 1985, ANAL CHEM, V57, P2774, DOI 10.1021/ac00291a009; Fuh CB, 1999, ANAL CHIM ACTA, V395, P257, DOI 10.1016/S0003-2670(99)00330-X; Japan Frozen Food Association, 2012, STAT DAT 2012; Japan Ministry of Health Labour and Welfare Food Safety Department, 2008, PEST POIS ACC CHIN M; Kawashima H, 2010, ENVIRON FORENSICS, V11, P363, DOI 10.1080/15275922.2010.522217; Lurie IS, 2013, FORENSIC SCI INT, V231, P300, DOI 10.1016/j.forsciint.2013.06.008; Meier-Augenstein W., 2004, HDB STABLE ISOTOPE A, P157; Meyer AH, 2008, ENVIRON SCI TECHNOL, V42, P7757, DOI 10.1021/es800534h; Ohta H., 2009, BUNSEKI, V4, P146; Reidy LJ, 2005, RAPID COMMUN MASS SP, V19, P1899, DOI 10.1002/rcm.2000; Sano M, 1996, BIOMED MASS SPECTROM, V3, P1; Sun L, 2009, C PESTI SCI SOC JAP, V34, P113; Vetter W, 2008, ENVIRON INT, V34, P357, DOI 10.1016/j.envint.2007.03.010; Yamaguchi Y., 2010, SEIKATSU EISEI, V52, P215; Yamamoto Y, 2004, J PESTIC SCI, V29, P53	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	SEP	2015	60	5					1360	1364		10.1111/1556-4029.12825		5	Medicine, Legal	Legal Medicine	CR0CE	WOS:000360985000038		
J	Morine, Y; Shimada, M				Morine, Yuji; Shimada, Mitsuo			The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics	JOURNAL OF GASTROENTEROLOGY			English	Review						Intrahepatic cholangiocarcinoma; Lymphatic system; Lymph node metastasis; Lymph node dissection	LONG-TERM SURVIVAL; AGGRESSIVE SURGICAL RESECTION; PROGNOSTIC-FACTORS; CLINICOPATHOLOGICAL FACTORS; HEPATIC LYMPHATICS; PREDICTIVE FACTORS; CISPLATIN GFP; METASTASIS; RECURRENCE; CARCINOMA	Lymph node (LN) metastasis from intrahepatic cholangiocarcinoma (IHCC) might be one of the most important indicators of aggressive surgical resection, yet the value of LN dissection is still controversial. To address this clinical problem, we need to better understand the multidirectional lymphatic outflow from the liver. Although most hepatic lymph flows into the hilar LNs along portal triads, there are also several lymphatic outflows directly communicating with distant areas or the general lymphatic system. Moreover, it has been revealed that LN metastasis spreads to more distal LNs through the hepatoduodenal ligament or other multidirectional lymphatic pathways connected to the general lymphatic system. Therefore, systematic LN dissection might merely be LN sampling in IHCC with LN metastasis. A multidisciplinary strategy focusing on adjuvant treatment after surgery is immediately necessary in these cases. In IHCC without LN metastasis, the accuracy of preoperative imaging assessment of LN metastasis is unsatisfactory and useless for detecting metastatic LNs in clinical settings. Therefore, prophylactic systematic LN dissection for IHCC without preoperative LN swelling is recommended for accurate LN status assessment and reduction of local recurrences. However, this procedure might not offer any clinical benefit according to the results of retrospective comparative studies. In this review, we summarize previous reports regarding lymphatic outflow of the liver and discuss LN dissection for IHCC.	[Morine, Yuji; Shimada, Mitsuo] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Surg, Tokushima 7708503, Japan	Morine, Y (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Surg, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	ymorine@tokushima-u.ac.jp			Japan Society for the promotion of Science [26293288, 25462091]	This study was partly supported by Japan Society for the promotion of Science (Grant-in-Aid for Scientific Research B: No. 26293288 and C: 25462091).	Ali SM, 2015, HPB, V17, P244, DOI 10.1111/hpb.12333; Amini N, 2014, J GASTROINTEST SURG, V18, P2136, DOI 10.1007/s11605-014-2667-1; Ercolani G, 2004, ANN SURG, V239, P202, DOI 10.1097/01.sla.0000109154.00020.e0; Tamandl D, 2008, ANN SURG ONCOL, V15, P2787, DOI 10.1245/s10434-008-0081-1; Cho SY, 2010, ANN SURG ONCOL, V17, P1823, DOI 10.1245/s10434-010-0938-y; Okami J, 2000, CLIN CANCER RES, V6, P2326; Nakagawa T, 2005, WORLD J SURG, V29, P728, DOI 10.1007/s00268-005-7761-9; Yamamoto M, 1999, JPN J CLIN ONCOL, V29, P147, DOI 10.1093/jjco/29.3.147; Ohtsuka M, 2002, BRIT J SURG, V89, P1525, DOI 10.1046/j.1365-2168.2002.02268.x; TRUTMANN M, 1994, ANAT EMBRYOL, V190, P201; Inoue K, 2000, SURGERY, V127, P498, DOI 10.1067/msy.2000.104673; Adachi T, 2014, J HEPATO-BIL-PAN SCI, V21, P162, DOI 10.1002/jhbp.30; Guglielmi A, 2013, J GASTROINTEST SURG, V17, P1917, DOI 10.1007/s11605-013-2331-1; Shimada K, 2009, SURGERY, V145, P411, DOI 10.1016/j.surg.2008.11.010; Vilgrain V, 2008, HPB, V10, P106, DOI 10.1080/13651820801992617; Ribero D, 2012, ARCH SURG-CHICAGO, V147, P1107, DOI 10.1001/archsurg.2012.1962; Endo I, 2008, ANN SURG, V248, P84, DOI 10.1097/SLA.0b013e318176c4d3; Dodson RM, 2013, J AM COLL SURGEONS, V217, P736, DOI 10.1016/j.jamcollsurg.2013.05.021; Weber SM, 2001, J AM COLL SURGEONS, V193, P384, DOI 10.1016/S1072-7515(01)01016-X; Fisher SB, 2012, HPB, V14, P514, DOI 10.1111/j.1477-2574.2012.00489.x; Park TG, 2014, CLIN NUCL MED, V39, P1, DOI 10.1097/RLU.0b013e3182867b99; Uenishi T, 2008, J HEPATO-BILIARY-PAN, V15, P417, DOI 10.1007/s00534-007-1315-5; Higuchi R, 2006, SURG TODAY, V36, P559, DOI 10.1007/s00595-006-3201-1; Ercolani G, 2010, ANN SURG, V252, P107, DOI 10.1097/SLA.0b013e3181e462e6; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Marubashi S, 2014, DIGEST DIS SCI, V59, P201, DOI 10.1007/s10620-013-2894-4; Nakagohri T, 2003, WORLD J SURG, V27, P289, DOI 10.1007/s00268-002-6696-7; Yamashita YI, 2008, ANTICANCER RES, V28, P2353; Choi SB, 2009, ANN SURG ONCOL, V16, P3048, DOI 10.1245/s10434-009-0631-1; Lee SW, 2010, J GASTROENTEROL, V45, P560, DOI 10.1007/s00535-009-0188-6; Ohtani O, 2008, ANAT REC, V291, P643, DOI 10.1002/ar.20681; de Jong MC, 2011, J CLIN ONCOL, V29, P3140, DOI 10.1200/JCO.2011.35.6519; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Asakura H, 2005, HEPATO-GASTROENTEROL, V52, P722; Bektas H, 2015, J HEPATO-BIL-PAN SCI, V22, P131, DOI 10.1002/jhbp.158; Casavilla FA, 1997, J AM COLL SURGEONS, V185, P429, DOI 10.1016/S1072-7515(01)00953-X; Chu KM, 1997, WORLD J SURG, V21, P301; Chung Chuhan, 2013, Clin Mol Hepatol, V19, P99, DOI 10.3350/cmh.2013.19.2.99; Clark CJ, 2011, HPB, V13, P612, DOI 10.1111/j.1477-2574.2011.00340.x; Grobmyer SR, 2006, ANN SURG, V244, P260, DOI 10.1097/01.sla.0000217606.59625.9d; Igami T, 2011, WORLD J SURG, V35, P2501, DOI 10.1007/s00268-011-1242-0; Isa T, 2001, AM J SURG, V181, P507, DOI 10.1016/S0002-9610(01)00628-6; Isaji S, 1999, J Hepatobiliary Pancreat Surg, V6, P108, DOI 10.1007/s005340050092; Kaczynski J, 1998, ACTA ONCOL, V37, P77; Kawarada Y, 2002, AM J SURG, V183, P679, DOI 10.1016/S0002-9610(02)00853-X; Kim DH, 2015, SURGERY; Kitazume N, 1983, KANZO LIVER, V24, P581; Li DY, 2013, WORLD J GASTROENTERO, V19, P9084, DOI 10.3748/wjg.v19.i47.9084; Miwa S, 2006, J GASTROENTEROL, V41, P893, DOI 10.1007/s00535-006-1877-z; Morine Y, 2009, HEPATO-GASTROENTEROL, V56, P307; Morine Y, 2012, SURG TODAY, V42, P147, DOI 10.1007/s00595-011-0057-9; Murakami Y, 2000, SURGERY, V127, P105, DOI 10.1067/msy.2000.99057; Noji T, 2005, J GASTROENTEROL, V40, P739, DOI 10.1007/s00535-005-1618-8; Ohtsuka Masayuki, 2003, J Hepatobiliary Pancreat Surg, V10, P259, DOI 10.1007/s00534-002-0724-8; OKUDA K, 1976, RADIOLOGY, V120, P321; Park MS, 2006, J COMPUT ASSIST TOMO, V30, P362, DOI 10.1097/00004728-200605000-00003; Pupulim LF, 2015, ABDOM IMAGING, V40, P1997, DOI 10.1007/s00261-015-0350-y; RITCHIE HD, 1959, AM J PHYSIOL, V196, P105; Roayaie S, 1998, J AM COLL SURGEONS, V187, P365, DOI 10.1016/S1072-7515(98)00203-8; Saiura A, 2011, AM J SURG, V201, P203, DOI 10.1016/j.amjsurg.2008.12.035; Seo S, 2008, SURGERY, V143, P769, DOI 10.1016/j.surg.2008.01.010; Shimada M, 2001, BRIT J SURG, V88, P1463, DOI 10.1046/j.0007-1323.2001.01879.x; Sobin LH, 2009, TNM CLASSIFICATION M; Suzuki S, 2002, WORLD J SURG, V26, P687, DOI 10.1007/s00268-001-0291-1; Tsuji T, 2001, SURGERY, V129, P401; Turner M A, 1987, Radiographics, V7, P1067; Uchiyama K, 2011, J HEPATO-BIL-PAN SCI, V18, P443, DOI 10.1007/s00534-010-0349-2; Uenishi T, 2006, J GASTROENTEROL, V41, P391, DOI 10.1007/s00535-006-1757-6; WASHBURN WK, 1995, ARCH SURG-CHICAGO, V130, P270; Yamamoto M, 2002, JPN J CLIN ONCOL, V32, P206, DOI 10.1093/jjco/hyf044; Yamamoto M, 1999, J Hepatobiliary Pancreat Surg, V6, P117, DOI 10.1007/s005340050093; Yamashita Y, 2010, JPN J CLIN ONCOL, V40, P24, DOI 10.1093/jjco/hyp119	72	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	SEP	2015	50	9					913	927		10.1007/s00535-015-1071-2		15	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8IL	WOS:000360850600001		
J	Kanai, T; Mikami, Y; Hayashi, A				Kanai, Takanori; Mikami, Yohei; Hayashi, Atsushi			A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease	JOURNAL OF GASTROENTEROLOGY			English	Review						Clostridium butyricum; Probiotics; Macrophages; Interleukin-10	INNATE LYMPHOID-CELLS; SEGMENTED FILAMENTOUS BACTERIA; DEXTRAN SODIUM-SULFATE; TOLL-LIKE RECEPTORS; CHRONIC INTESTINAL INFLAMMATION; INDUCED EXPERIMENTAL COLITIS; GENE-DEFICIENT MICE; T-HELPER-CELL; CROHNS-DISEASE; ULCERATIVE-COLITIS	Intestinal immune homeostasis is regulated by gut microbiota, including beneficial and pathogenic microorganisms. Imbalance in gut bacterial constituents provokes host proinflammatory responses causing diseases such as inflammatory bowel disease (IBD). The development of next-generation sequencing technology allows the identification of microbiota alterations in IBD. Several studies have shown reduced diversity in the gut microbiota of patients with IBD. Advances in gnotobiotic technology have made possible analysis of the role of specific bacterial strains in immune cells in the intestine. Using these techniques, we have shown that Clostridium butyricum as a probiotic induces interleukin-10-producing macrophages in inflamed mucosa via the Toll-like receptor 2/myeloid differentiation primary response gene 88 pathway to prevent acute experimental colitis. In this review, we focus on the new approaches for the role of specific bacterial strains in immunological responses, as well as the potential of bacterial therapy for IBD treatments.	[Kanai, Takanori; Mikami, Yohei] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1608582, Japan; [Hayashi, Atsushi] Miyarisan Pharmaceut Co Ltd, Res Lab, Tokyo 1140016, Japan	Kanai, T (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1608582, Japan.	takagast@z2.keio.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labour and Welfare; Keio University Medical Fund	We thank Shinta Mizuno, Hiroki Kiyohara, Mari Arai, Mina Kitazume, Kozue Takeshita, Keiichiro Saigusa, Makoto Naganuma, Katsuyoshi Matsuoka, Toshiro Sato, and Tadakazu Hisamatsu (Keio University) for technical assistance and for valuable discussion. This study was supported in part by Grants-in-Aid for Scientific Research, Scientific Research on Priority Areas, Exploratory Research and Creative Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Japanese Ministry of Health, Labour and Welfare, and the Keio University Medical Fund.	Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Mowat AM, 2011, J INNATE IMMUN, V3, P550, DOI 10.1159/000329099; Sheehan D, 2015, J GASTROENTEROL, V50, P495, DOI 10.1007/s00535-015-1064-1; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Sellon RK, 1998, INFECT IMMUN, V66, P5224; Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Becker C, 2006, J IMMUNOL, V177, P2760; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Boonstra A, 2006, J IMMUNOL, V177, P7551; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; GRIMM MC, 1995, CLIN EXP IMMUNOL, V100, P291; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Kanai T, 2006, INFLAMM BOWEL DIS, V12, P89, DOI 10.1097/01.MIB.0000197237.21387.mL; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Kim TW, 2006, WORLD J GASTROENTERO, V12, P302; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Woo TDH, 2011, J MED MICROBIOL, V60, P1617, DOI 10.1099/jmm.0.033423-0; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Dillon S, 2004, J IMMUNOL, V172, P4733; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Mikami Y, 2010, EUR J IMMUNOL, V40, P2409, DOI 10.1002/eji.201040379; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Axelsson LG, 1996, INFLAMM RES, V45, P181, DOI 10.1007/BF02285159; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Wang Y, 2014, MUCOSAL IMMUNOL, V7, P1106, DOI 10.1038/mi.2013.126; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Groux H, 1997, NATURE, V389, P737; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Sujino T, 2011, GASTROENTEROLOGY, V141, P1014, DOI 10.1053/j.gastro.2011.05.052; Mizoguchi A, 2012, INFLAMM BOWEL DIS, V18, P1777, DOI 10.1002/ibd.22929; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Smith PD, 2001, J IMMUNOL, V167, P2651; Seki H, 2003, PEDIATR INT, V45, P86, DOI 10.1046/j.1442-200X.2003.01671.x; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Madsen KL, 2000, GASTROENTEROLOGY, V118, P1094, DOI 10.1016/S0016-5085(00)70362-3; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Takahashi M, 2004, FEMS IMMUNOL MED MIC, V41, P219, DOI 10.1016/j.femsim.2004.03.010; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Davidson NJ, 1998, J IMMUNOL, V161, P3143; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Corinti S, 2001, J IMMUNOL, V166, P4312; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Goldsmith JR, 2014, J GASTROENTEROL, V49, P785, DOI 10.1007/s00535-014-0953-z; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Kimura K, 2012, BIOCHEM BIOPH RES CO, V427, P694, DOI 10.1016/j.bbrc.2012.09.091; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Balish E, 2002, AM J PATHOL, V160, P2253, DOI 10.1016/S0002-9440(10)61172-8; Chen WX, 2000, J GASTROEN HEPATOL, V15, P1145, DOI 10.1046/j.1440-1746.2000.02331.x; de Waal Malefyt R., 1991, J EXP MED, V174, P1209, DOI DOI 10.1084/JEM.174.5.1209; Diefenbach A, 2015, NAT IMMUNOL, V16, P222, DOI 10.1038/ni.3107; Eberl Gérard, 2015, Nat Immunol, V16, P1, DOI 10.1038/ni.3059; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063388; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hayashi A, 2013, CELL HOST MICROBE, V13, P711, DOI 10.1016/j.chom.2013.05.013; Hoentjen F, 2003, GUT, V52, P1721, DOI 10.1136/gut.52.12.1721; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Katakura T, 2004, J IMMUNOL, V172, P1407; Kayaba H, 2001, J IMMUNOL, V167, P995; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Matsuoka Katsuyoshi, 2014, Keio Journal of Medicine, V63, P69, DOI 10.2302/kjm.2014-0006-RE; Mizuno S, 2014, INFLAMM BOWEL DIS, V20, P1426, DOI 10.1097/MIB.0000000000000105; Okamoto T, 2000, J GASTROENTEROL, V35, P341, DOI 10.1007/s005350050358; Clavijo GO, 2015, GASTROENT HEPAT-BARC, V38, P442, DOI 10.1016/j.gastrohep.2014.07.001; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Romani L, 1997, J IMMUNOL, V158, P5349; Saigusa K, 2014, INFLAMM BOWEL DIS, V20, P1820, DOI 10.1097/MIB.0000000000000149; Sato R, 1997, MICROBIOL IMMUNOL, V41, P665; Seo M, 2013, DIGEST DIS SCI, V58, P3534, DOI 10.1007/s10620-013-2879-3; Shimbo I, 2005, WORLD J GASTROENTERO, V11, P7520; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tamura K, 2002, J GASTROENTEROL, V37, P111; Totsuka T, 2007, J IMMUNOL, V178, P4737	143	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	SEP	2015	50	9					928	939		10.1007/s00535-015-1084-x		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8IL	WOS:000360850600002		
J	Umeda, J; Itoi, T				Umeda, Junko; Itoi, Takao			Current status of preoperative biliary drainage	JOURNAL OF GASTROENTEROLOGY			English	Review						Preoperative biliary drainage; Distal biliary strictures; Proximal biliary strictures	POSTOPERATIVE INFECTIOUS COMPLICATIONS; BILE-DUCT CANCER; INCREASE POSTPANCREATICODUODENECTOMY COMPLICATIONS; OUTCOME FOLLOWING PANCREATICODUODENECTOMY; ENDOSCOPIC NASOBILIARY DRAINAGE; MALIGNANT OBSTRUCTIVE-JAUNDICE; SINGLE-CENTER EXPERIENCE; EXPANDABLE METAL STENTS; HILAR CHOLANGIOCARCINOMA; PANCREATIC-CANCER	Preoperative biliary drainage (PBD) has been thought to be preferable regardless of the site of biliary strictures, e.g., distal or proximal strictures because PBD by endoscopy or interventional radiology decreases postoperative mortality and morbidity rates. However, recently, several studies have revealed that PBD strategy showed an increased mortality rate or a high frequency of surgical site infection. Herein, we reviewed reports in the literature regarding the current status of PBD and investigated the effects of PBD on patients with distal and proximal biliary obstructions due to potentially resectable pancreatobiliary cancers. Our summary demonstrated that there is as yet no optimal PBD method regardless of the distal and proximal biliary strictures because of the small sample size and the lack of better control groups in previous studies. Thus, prospective randomized studies with a large sample size are needed to establish the optimal mode of PBD and to evaluate the potential benefits of PBD in patients with both distal and proximal biliary obstructions.	[Umeda, Junko; Itoi, Takao] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1600023, Japan	Itoi, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	itoi@tokyo-med.ac.jp					Abdullah SA, 2009, WORLD J GASTROENTERO, V15, P2908, DOI 10.3748/wjg.15.2908; GOUMA DJ, 1986, AM J SURG, V151, P476, DOI 10.1016/0002-9610(86)90107-8; De Palma GD, 2001, GASTROINTEST ENDOSC, V53, P547, DOI 10.1067/mge.2001.113381; GREVE JW, 1990, GASTROENTEROLOGY, V98, P478; Singhirunnusorn J, 2013, LANGENBECK ARCH SURG, V398, P295, DOI 10.1007/s00423-012-1000-2; Pisters PWT, 2001, ANN SURG, V234, P47, DOI 10.1097/00000658-200107000-00008; HATFIELD ARW, 1982, LANCET, V2, P896; Howard TJ, 2006, J GASTROINTEST SURG, V10, P523, DOI 10.1016/j.gassur.2005.08.011; Kaassis M, 2003, GASTROINTEST ENDOSC, V57, P178, DOI 10.1067/mge.2003.66; Arakura N, 2009, J HEPATO-BILIARY-PAN, V16, P473, DOI 10.1007/s00534-009-0076-8; Liu F, 2011, DIGEST DIS SCI, V56, P663, DOI 10.1007/s10620-010-1338-7; Xiong JJ, 2013, WORLD J GASTROENTERO, V19, P8731, DOI 10.3748/wjg.v19.i46.8731; DIXON JM, 1983, GUT, V24, P845, DOI 10.1136/gut.24.9.845; Soderlund C, 2006, GASTROINTEST ENDOSC, V63, P986, DOI 10.1016/j.gie.2005.11.052; Kawakami H, 2011, J GASTROENTEROL, V46, P242, DOI 10.1007/s00535-010-0298-1; Shigeta H, 2002, LANGENBECK ARCH SURG, V387, P117, DOI 10.1007/s00423-002-0301-2; Coates JM, 2009, ARCH SURG-CHICAGO, V144, P841, DOI 10.1001/archsurg.2009.152; Su CH, 1996, ANN SURG, V223, P384, DOI 10.1097/00000658-199604000-00007; Siddiqui AA, 2013, DIGEST DIS SCI, V58, P1744, DOI 10.1007/s10620-012-2482-z; Li ZJ, 2009, PANCREAS, V38, P379, DOI 10.1097/MPA.0b013e31819f638b; Chen VK, 2005, CLIN GASTROENTEROL H, V3, P1229, DOI 10.1016/S1542-3565(05)00886-4; Decker C, 2011, SURG ENDOSC, V25, P2364, DOI 10.1007/s00464-010-1552-6; Neuhaus P, 2003, LANGENBECK ARCH SURG, V388, P194, DOI 10.1007/s00423-003-0383-5; Hwang S, 2012, WORLD J SURG, V36, P379, DOI 10.1007/s00268-011-1364-4; Jinkins LJ, 2013, SURGERY, V154, P179, DOI 10.1016/j.surg.2013.03.016; Kawasaki S, 2003, ANN SURG, V238, P84, DOI 10.1097/01.SLA.0000074984.83031.02; Hochwald SN, 1999, ARCH SURG-CHICAGO, V134, P261, DOI 10.1001/archsurg.134.3.261; Farges O, 2013, BRIT J SURG, V100, P274, DOI 10.1002/bjs.8950; Sewnath ME, 2001, J AM COLL SURGEONS, V192, P726, DOI 10.1016/S1072-7515(01)00819-5; Ercolani G, 2010, J HEPATO-BIL-PAN SCI, V17, P329, DOI 10.1007/s00534-009-0249-5; Herzog T, 2009, J CLIN GASTROENTEROL, V43, P457, DOI 10.1097/MCG.0b013e318186b19b; van der Gaag NA, 2009, J GASTROINTEST SURG, V13, P814, DOI 10.1007/s11605-008-0618-4; Jagannath P, 2005, BRIT J SURG, V92, P356, DOI 10.1002/bjs.4864; Hodul P, 2003, AM J SURG, V186, P420, DOI 10.1016/j.amjsurg.2003.07.005; Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1; Gerhards MF, 2000, SURGERY, V127, P395, DOI 10.1067/msy.2000.104250; PITT HA, 1985, ANN SURG, V201, P545, DOI 10.1097/00000658-198505000-00002; Cherqui D, 2000, ARCH SURG-CHICAGO, V135, P302, DOI 10.1001/archsurg.135.3.302; MCPHERSON GAD, 1984, BRIT J SURG, V71, P371, DOI 10.1002/bjs.1800710522; Engelken FJF, 2003, EUR J SURG ONCOL, V29, P368, DOI 10.1053/ejso.2002.1405; Sudo T, 2007, WORLD J SURG, V31, P2230, DOI 10.1007/s00268-007-9210-4; MICHELASSI F, 1989, ANN SURG, V210, P544, DOI 10.1097/00000658-198910000-00015; Grandadam S, 2010, ANN SURG ONCOL, V17, P3155, DOI 10.1245/s10434-010-1168-z; Garcea G, 2010, PANCREAS, V39, P119, DOI 10.1097/MPA.0b013e3181bd65de; Pop GH, 2011, SURG ENDOSC, V25, P613, DOI 10.1007/s00464-010-1231-7; Ferrero A, 2009, WORLD J SURG, V33, P318, DOI 10.1007/s00268-008-9830-3; Maguchi H, 2007, J HEPATO-BILIARY-PAN, V14, P441, DOI 10.1007/s00534-006-1192-3; van der Gaag NA, 2010, NEW ENGL J MED, V362, P129, DOI 10.1056/NEJMoa0903230; Kawashima H, 2013, ANN SURG, V257, P121, DOI 10.1097/SLA.0b013e318262b2e9; SPEER AG, 1987, LANCET, V2, P57; El-Hanafy E, 2010, HEPATO-GASTROENTEROL, V57, P414; Saleh MMA, 2002, GASTROINTEST ENDOSC, V56, P529, DOI 10.1067/mge.2002.128161; Moss AC, 2007, CANCER TREAT REV, V33, P213, DOI 10.1016/j.ctrv.2006.10.006; BAKKEVOLD KE, 1993, ANN SURG, V217, P356, DOI 10.1097/00000658-199304000-00007; Povoski SP, 1999, ANN SURG, V230, P131, DOI 10.1097/00000658-199908000-00001; Smith RA, 2008, SURGERY, V143, P658, DOI 10.1016/j.surg.2007.12.014; Strasberg SM, 2014, HPB, V16, P150, DOI 10.1111/hpb.12094; BISMUTH H, 1975, SURG GYNECOL OBSTET, V140, P170; Barnett SA, 2006, ANZ J SURG, V76, P563, DOI 10.1111/j.1445-2197.2006.03778.x; Baron TH, 2010, NEW ENGL J MED, V362, P170, DOI 10.1056/NEJMe0908773; Belghiti Jacques, 2005, HPB (Oxford), V7, P252, DOI 10.1080/13651820500372335; BLAMEY SL, 1983, BRIT J SURG, V70, P535, DOI 10.1002/bjs.1800700910; Boulay BR, 2010, J CLIN GASTROENTEROL, V44, P452, DOI 10.1097/MCG.0b013e3181d2ef06; Cavell LK, 2013, AM J GASTROENTEROL, V108, P1168, DOI 10.1038/ajg.2013.93; Cheng JLS, 2002, GASTROINTEST ENDOSC, V56, P33, DOI 10.1067/mge.2002.125364; DENNING DA, 1981, AM J SURG, V141, P61, DOI 10.1016/0002-9610(81)90013-1; Doucas H, 2007, SURG ENDOSC, V21, P1147, DOI 10.1007/s00464-006-9093-8; Eshuis EJ, 2010, ANN SURG, V252, P840; Fang Y, 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD005444.PUB3; Figueras J, 2000, LIVER TRANSPLANT, V6, P786, DOI 10.1053/jlts.2000.18507; Garcea Giuseppe, 2008, JOP, V9, P99; Gouma DJ, 2013, BRIT J SURG, V100, P283, DOI 10.1002/bjs.8977; Grunhagen DJ, 2013, HPB, V15, P372, DOI 10.1111/j.1477-2574.2012.00588.x; GUNDRY SR, 1984, ARCH SURG-CHICAGO, V119, P703; Heslin MJ, 1998, ARCH SURG-CHICAGO, V133, P149, DOI 10.1001/archsurg.133.2.149; Isayama H, 2013, DIGEST ENDOSC, V25, P71, DOI 10.1111/den.12078; Ishizawa T, 2007, AM J SURG, V193, P149, DOI 10.1016/j.amjsurg.2006.07.015; Karsten TM, 1996, EUR J SURG, V162, P881; Kimmings AN, 2000, GUT, V46, P725, DOI 10.1136/gut.46.5.725; KLINKENBIJL JHG, 1993, BRIT J SURG, V80, P1575, DOI 10.1002/bjs.1800801227; LAI ECS, 1994, BRIT J SURG, V81, P1195, DOI 10.1002/bjs.1800810839; Launois B, 1999, ANN SURG, V230, P266, DOI 10.1097/00000658-199908000-00018; Lin SC, 2010, HEPATO-GASTROENTEROL, V57, P698; LYGIDAKIS NJ, 1987, ACTA CHIR SCAND, V153, P665; Marcus SG, 1998, J CLIN GASTROENTEROL, V26, P125, DOI 10.1097/00004836-199803000-00008; Martignoni ME, 2001, AM J SURG, V181, P52, DOI 10.1016/S0002-9610(00)00528-6; Mezhir JJ, 2009, J GASTROINTEST SURG, V13, P2163, DOI 10.1007/s11605-009-1046-9; Michelassi F, 1989, ANN SURG, V210, P554; MULLEN JT, 2005, HEPATOL J GASTROINTE, V9, P1094, DOI DOI 10.1016/J.GASSUR.2005.08.006; Mullen JT, 2005, HEPATOL J GASTROINTE, V9, P1104; Nagino M, 2001, WORLD J SURG, V25, P1277; Nakeeb A, 1996, ANN SURG, V224, P463, DOI 10.1097/00000658-199610000-00005; NEFF RA, 1983, CLIN RADIOL, V34, P143, DOI 10.1016/S0009-9260(83)80293-1; NORLANDER A, 1982, SURG GYNECOL OBSTET, V155, P161; Povoski SP, 1999, J GASTROINTEST SURG, V3, P496, DOI 10.1016/S1091-255X(99)80103-6; SMITH RC, 1985, SURGERY, V97, P641; Soares Kevin C, 2014, Hepatobiliary Surg Nutr, V3, P18, DOI 10.3978/j.issn.2304-3881.2014.02.05; Tsiotos G, 2000, J GASTROINTEST SURG, V4, P267; Sohn TA, 2000, J GASTROINTEST SURG, V4, P258, DOI 10.1016/S1091-255X(00)80074-8; Srivastava S, 2001, DIGEST SURG, V18, P381, DOI 10.1159/000050178; TREDE M, 1988, ANN SURG, V207, P39, DOI 10.1097/00000658-198801000-00009; van Berkel AM, 2005, ENDOSCOPY, V37, P729, DOI 10.1055/s-870131; Velanovich Vic, 2009, JOP, V10, P24; Wig J D, 1999, J Assoc Physicians India, V47, P271; Wiggers JK, 2014, ANN SURG, DOI [10.1097/SLA.0000000000000521., DOI 10.1097/SLA.0000000000000521]; Yu FX, 2013, AM J MED SCI, V346, P353, DOI 10.1097/MAJ.0b013e3182755de6	106	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	SEP	2015	50	9					940	954		10.1007/s00535-015-1096-6		15	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8IL	WOS:000360850600003		
J	Nakagaki, S; Arimura, Y; Nagaishi, K; Isshiki, H; Nasuno, M; Watanabe, S; Idogawa, M; Yamashita, K; Naishiro, Y; Adachi, Y; Suzuki, H; Fujimiya, M; Imai, K; Shinomura, Y				Nakagaki, Suguru; Arimura, Yoshiaki; Nagaishi, Kanna; Isshiki, Hiroyuki; Nasuno, Masanao; Watanabe, Shuhei; Idogawa, Masashi; Yamashita, Kentaro; Naishiro, Yasuyoshi; Adachi, Yasushi; Suzuki, Hiromu; Fujimiya, Mineko; Imai, Kohzoh; Shinomura, Yasuhisa			Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft model	JOURNAL OF GASTROENTEROLOGY			English	Article						Mesenchymal stem cell; Niche; Pericyte; Cancer-associated fibroblast; Angiogenesis	COLON-CANCER; STROMAL CELLS; RAT; ANGIOGENESIS; METASTASIS; MICROENVIRONMENT; TRANSPLANTATION; INTERLEUKIN-6; RECRUITMENT; ENGRAFTMENT	The role of mesenchymal stem/stromal cells (MSCs) in tumorigenesis remains controversial. This study aimed to determine whether heterotypic interactions between MSCs and colon cancer cells can supply contextual signals towards tumor progression. Xenografts consisting of co-implanted human colorectal cancer cells with rat MSCs in immunodeficient mice were evaluated by tumor progression, angiogenic profiles, and MSC fate. Furthermore, we investigated how MSCs function as a cancer cell niche by co-culture experiments in vitro. Tumor growth progressed in two ways, either independent of or dependent on MSCs. Such cell line-specific dependency could not be explained by host immune competency. COLO 320 xenograft angiogenesis was MSC-dependent, but less dependent on vascular endothelial growth factor (VEGF), whereas HT-29 angiogenesis was not MSC-dependent, but was VEGF-dependent. MSCs and COLO 320 cells established a functional positive feedback loop that triggered formation of a cancer cell niche, leading to AKT activation. Subsequently, MSCs differentiated into pericytes that enhanced angiogenesis as a perivascular niche. In contrast, the MSC niche conferred an anti-proliferative property to HT-29 cells, through mesenchymal-epithelial transition resulting in p38 activation. In conclusion, MSCs demonstrate pleiotropic capabilities as a cancer cell or perivascular niche to modulate colorectal cancer cell fate in a cell line-dependent manner in a xenogeneic context.	[Nakagaki, Suguru; Arimura, Yoshiaki; Isshiki, Hiroyuki; Nasuno, Masanao; Watanabe, Shuhei; Yamashita, Kentaro; Adachi, Yasushi; Shinomura, Yasuhisa] Sapporo Med Univ, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido 0608543, Japan; [Nagaishi, Kanna; Fujimiya, Mineko] Sapporo Med Univ, Dept Anat, Sapporo, Hokkaido 0608543, Japan; [Idogawa, Masashi] Sapporo Med Univ, Dept Med Genome Sci, Res Inst Frontier Med, Sapporo, Hokkaido 0608543, Japan; [Naishiro, Yasuyoshi] Sapporo Med Univ, Dept Educ Dev, Sapporo, Hokkaido 0608543, Japan; [Suzuki, Hiromu] Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido 0608543, Japan; [Imai, Kohzoh] Univ Tokyo, Ctr Antibody & Vaccine Therapy, Tokyo 1088639, Japan	Arimura, Y (reprint author), Sapporo Med Univ, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido 0608543, Japan.	arimura@sapmed.ac.jp			Ministry of Health, Labour, and Welfare of Japan	We are very grateful to Ms. K. Fujii of First Department of Internal Medicine, for technical assistance, and Dr. Y. Sasaki of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University, for critical comments. We are also thankful to Dr. M. Tsuji of Chromosome Science Labo Inc., for providing FISH probes and technical advice. This work was supported in part by Health and Labor Sciences Research Grants for research on intractable diseases from the Ministry of Health, Labour, and Welfare of Japan (K.I. and Y.A.).	Javazon EH, 2001, STEM CELLS, V19, P219, DOI 10.1634/stemcells.19-3-219; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Hakamata Y, 2001, BIOCHEM BIOPH RES CO, V286, P779, DOI 10.1006/bbrc.2001.5452; Liu Y, 2011, J BIOL CHEM, V286, P25007, DOI 10.1074/jbc.M110.213108; De Boeck A, 2013, GUT, V62, P550, DOI 10.1136/gutjnl-2011-301393; Tanaka H, 2011, J GASTROENTEROL, V46, P143, DOI 10.1007/s00535-010-0320-7; Hall B., 2007, V180, P263; Rattigan Y, 2010, EXP CELL RES, V316, P3417, DOI 10.1016/j.yexcr.2010.07.002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Mele V, 2014, INT J CANCER, V134, P2583, DOI 10.1002/ijc.28598; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Hogan NM, 2012, INT J CANCER, V131, P1, DOI 10.1002/ijc.27458; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lin JT, 2013, EXP CELL RES, V319, P2216, DOI 10.1016/j.yexcr.2013.06.003; Tsai KS, 2011, GASTROENTEROLOGY, V141, P1046, DOI 10.1053/j.gastro.2011.05.045; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Yabana T, 2009, J PATHOL, V218, P350, DOI 10.1002/path.2535; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Iyonaga K, 1997, HISTOCHEM J, V29, P105, DOI 10.1023/A:1026477104227; KUAN SF, 1987, CANCER RES, V47, P5715; Nasuno M, 2014, STEM CELLS, V32, P913, DOI 10.1002/stem.1594; Tamaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001789; Vertelov G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt153	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	SEP	2015	50	9					962	974		10.1007/s00535-015-1049-0		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8IL	WOS:000360850600005		
J	Tanaka, T; Li, TS; Urata, Y; Goto, S; Ono, Y; Kawakatsu, M; Matsushima, H; Hirabaru, M; Adachi, T; Kitasato, A; Takatsuki, M; Kuroki, T; Eguchi, S				Tanaka, Takayuki; Li, Tao-Sheng; Urata, Yoshishige; Goto, Shinji; Ono, Yusuke; Kawakatsu, Miho; Matsushima, Hajime; Hirabaru, Masataka; Adachi, Tomohiko; Kitasato, Amane; Takatsuki, Mitsuhisa; Kuroki, Tamotsu; Eguchi, Susumu			Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma	JOURNAL OF GASTROENTEROLOGY			English	Article						HIF-1 alpha; PDH3; CD44; VEGF; Pancreatic ductal adenocarcinoma	HYPOXIA-INDUCIBLE FACTOR; CANCER STEM-CELLS; PROSPECTIVE IDENTIFICATION; PROLYL-HYDROXYLASES; TUMOR-GROWTH; FACTOR-I; UBIQUITINATION; DEGRADATION; THERAPY; PROTEIN	Pancreatic ductal adenocarcinoma (PDAC) is known as one of the most malignant potential diseases with poor neovascularization. By comparing PDAC to hepatocellular carcinoma (HCC), which is well vascularized, we investigated the mechanisms and tumor biological significance of the poor neovascularization in PDAC. Surgical specimens from primary PDAC and HCC patients were immunohistologically stained to detect the expressions of CD105, CD44, HIF-1 alpha, PHD3, and Siah2. We also used two PDAC and two HCC cell lines to compare the expressions of HIF-1 alpha, PHD3, and CD44, as well as the production of VEGF in hypoxic condition. The role of PHD3 in regulating HIF-1 alpha expression was further confirmed by siRNA knockdown in a PDAC cell line that highly expressed PHD3. There were significantly fewer microvessels but more cancer stem cells in PDAC specimens compared to HCC specimens. The expression of CD105 was reversely related to the expression of CD44 in PDAC and HCC specimens. PDAC specimens also showed higher expressions of PHD3 but lower expressions of HIF-1 alpha. Similarly, the expression of PHD3 was observed clearly in PDAC cell lines, but was almost completely negative in HCC cell lines. Hypoxic stimulation clearly enhanced HIF-1 alpha expression and VEGF secretion in both HCC cell lines, but did not significantly change in PDAC cell lines. The knockdown of PHD3 in PDAC cells restored the hypoxic-induced HIF-1 alpha expression, which accordingly stimulated the cells' VEGF secretion. The enhanced expression of PHD3 might likely contribute to the poor neovascularization and affect the biological characterization in PDAC cancer cells.	[Tanaka, Takayuki; Li, Tao-Sheng; Urata, Yoshishige; Goto, Shinji; Ono, Yusuke; Kawakatsu, Miho] Nagasaki Univ, Atom Bomb Dis Inst, Dept Stem Cell Biol, Nagasaki 8528523, Japan; [Tanaka, Takayuki; Matsushima, Hajime; Hirabaru, Masataka; Adachi, Tomohiko; Kitasato, Amane; Takatsuki, Mitsuhisa; Kuroki, Tamotsu; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan	Tanaka, T (reprint author), Nagasaki Univ, Atom Bomb Dis Inst, Dept Stem Cell Biol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	pay-it-forward.197675@hotmail.co.jp; litaoshe@nagasaki-u.ac.jp; urata@nagasaki-u.ac.jp; sgoto@nagasaki-u.ac.jp; yusuke-ono@nagasaki-u.ac.jp; mkawa@nagasaki-u.ac.jp; h.matsushima.1020@ever.ocn.ne.jp; m.hirabaru@hotmail.co.jp; adatomo@nifty.com; a-kit@bg8.so-net.ne.jp; takapon@nagasaki-u.ac.jp; tkuroki-gi@umin.ac.jp; sueguchi@nagasaki-u.ac.jp					Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Ohh M, 2000, NAT CELL BIOL, V2, P423; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; Kitano M, 2004, GUT, V53, P854, DOI 10.1136/gut.2003.029934; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Su Y, 2010, BRIT J CANCER, V103, P1571, DOI 10.1038/sj.bjc.6605936; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Duffy John P, 2003, Mol Cancer, V2, P12, DOI 10.1186/1476-4598-2-12; Rantanen K, 2008, MOL BIOL CELL, V19, P2231, DOI 10.1091/mbc.E07-11-1124; Semenza GL, 2007, CANCER METAST REV, V26, P223, DOI 10.1007/s10555-007-9058-y; Wang WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071189	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	SEP	2015	50	9					975	983		10.1007/s00535-014-1030-3		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8IL	WOS:000360850600006		
J	Sasaki, M; Yoshimura-Miyakoshi, M; Sato, Y; Nakanuma, Y				Sasaki, Motoko; Yoshimura-Miyakoshi, Masami; Sato, Yasunori; Nakanuma, Yasuni			A possible involvement of endoplasmic reticulum stress in biliary epithelial autophagy and senescence in primary biliary cirrhosis	JOURNAL OF GASTROENTEROLOGY			English	Article						Primary biliary cirrhosis; Endoplasmic reticulum stress; Autophagy; Biliary epithelial cells; Cellular senescence	SMALL BILE-DUCTS; GENOME-WIDE ASSOCIATION; CELLULAR SENESCENCE; ER STRESS; MITOCHONDRIAL AUTOANTIGENS; SELECTIVE AUTOPHAGY; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; FATTY-ACID; CELLS	Deregulated autophagy followed by cellular senescence in biliary epithelial cells (BECs) may be closely related to the abnormal expression of mitochondrial antigens and following autoimmune pathogenesis in primary biliary cirrhosis (PBC). We examined an involvement of endoplasmic reticulum (ER) stress in the deregulated autophagy and cellular senescence in PBC. We examined the degree of ER stress using markers; glucose-regulated protein 78 (GRP78) and protein disulfide isomerases (PDI), autophagy and cellular senescence in cultured BECs treated with an ER stress inducer, tunicamycin (TM), glycochenodeoxycholic acid (GCDC), and palmitic acid (PA), and the effect of pretreatment with tauroursodeoxycholic acid (TUDCA). We examined the expression of PDI and GRP78 in livers taken from the patients with PBC (n = 43) and 75 control livers. The expression of ER stress markers was significantly increased in cultured BECs treated with TM, GCDC or PA in BECs (p < 0.05), and pretreatment with TUDCA significantly suppressed the induced ER stress (p < 0.05). Autophagy, deregulated autophagy, and cellular senescence were induced in BECs treated with TM, GCDC, or PA. Pretreatment with TUDCA further increased autophagy in BECs treated with PA and suppressed cellular senescence caused by treatments with TM, GCDC, or PA (p < 0.05). A granular expression of PDI and GRP78 was significantly more extensive in small bile ducts in PBC, compared with control livers (p < 0.05). The expression of GRP78 was seen in senescent BECs in PBC. ER stress may play a role in the pathogenesis of deregulated autophagy and cellular senescence in biliary epithelial lesions in PBC.	[Sasaki, Motoko; Yoshimura-Miyakoshi, Masami; Sato, Yasunori; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan; [Nakanuma, Yasuni] Shizuoka Canc Ctr, Dept Pathol, Shizuoka 4118777, Japan	Sasaki, M (reprint author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.	m8sasaki@med.kanazawa-u.ac.jp	Sasaki, Motoko/K-5913-2015	Sasaki, Motoko/0000-0003-2514-760X	Ministry of Education, Culture, Sports, and Science and Technology of Japan [21590366, 24590409]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, and Science and Technology of Japan (21590366 and 24590409).	Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Sasaki M, 2013, LIVER INT, V33, P312, DOI 10.1111/liv.12049; Kaser A, 2011, GASTROENTEROLOGY, V140, P1738, DOI 10.1053/j.gastro.2011.02.048; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Anderson CD, 2011, LIVER TRANSPLANT, V17, P189, DOI 10.1002/lt.22220; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Kita H, 2002, J CLIN INVEST, V109, P1231, DOI 10.1172/JCI200214698; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; FUSSEY SPM, 1988, P NATL ACAD SCI USA, V85, P8654, DOI 10.1073/pnas.85.22.8654; Shimoda S, 1998, J CLIN INVEST, V102, P1831, DOI 10.1172/JCI4213; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Sasaki M, 2012, LIVER INT, V32, P487, DOI 10.1111/j.1478-3231.2011.02656.x; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Katayanagi K, 1998, LIVER, V18, P90; Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Sasaki M, 2010, LAB INVEST, V90, P835, DOI 10.1038/labinvest.2010.56; Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005; NAKANUMA Y, 1979, GASTROENTEROLOGY, V76, P1326; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Chen Y, 2008, AM J NEPHROL, V28, P1014, DOI 10.1159/000148209; Bernales S, 2007, AUTOPHAGY, V3, P285; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1016/0270-9139(94)90250-X; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V17, pe1179; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209; Portmann B, 2011, PATHOLOGY LIVER, P491; Sasaki M, 2001, HEPATOLOGY, V34, P631, DOI 10.1053/jhep.2001.27544	46	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	SEP	2015	50	9					984	995		10.1007/s00535-014-1033-0		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8IL	WOS:000360850600007		
J	Sumida, Y; Kanemasa, K; Imai, S; Mori, K; Tanaka, S; Shimokobe, H; Kitamura, Y; Fukumoto, K; Kakutani, A; Ohno, T; Taketani, H; Seko, Y; Ishiba, H; Hara, T; Okajima, A; Yamaguchi, K; Moriguchi, M; Mitsuyoshi, H; Yasui, K; Minami, M; Itoh, Y				Sumida, Yoshio; Kanemasa, Kazuyuki; Imai, Shunsuke; Mori, Kojiro; Tanaka, Saiyu; Shimokobe, Hideto; Kitamura, Yoko; Fukumoto, Kohei; Kakutani, Akira; Ohno, Tomoyuki; Taketani, Hiroyoshi; Seko, Yuya; Ishiba, Hiroshi; Hara, Tasuku; Okajima, Akira; Yamaguchi, Kanji; Moriguchi, Michihisa; Mitsuyoshi, Hironori; Yasui, Kohichiroh; Minami, Masahito; Itoh, Yoshito			Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease	JOURNAL OF GASTROENTEROLOGY			English	Article						Hepatocyte ballooning; Helicobacter pylori; Nonalcoholic steatohepatitis	NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; JAPANESE POPULATION; METABOLIC SYNDROME; CHRONIC HEPATITIS; SCORING SYSTEM; STEATOHEPATITIS; ASSOCIATION; IRON; STOMACH	Clinical data regarding Helicobacter pylori (H. pylori) infection in nonalcoholic fatty liver disease (NAFLD) are limited. The aim was to evaluate H. pylori infection in patients with NAFLD and its association with disease severity. One hundred and thirty patients with biopsy-proven NAFLD [43 with nonalcoholic fatty liver (NAFL) and 87 with nonalcoholic steatohepatitis (NASH)] were recruited for blood samples for anti-H. pylori immunoglobulin G (IgG) and standard biochemical tests were obtained after overnight fasting. Glucose tolerance was evaluated by 75-g oral glucose tolerance test. Liver biopsies were scored for NAFLD activity score (NAS), fibrosis and iron deposits. H. pylori IgG seropositivity was found in 40 % of patients overall. The prevalence of NASH was significantly higher in the patients with H. pylori IgG seropositivity (81 %) than in those without (58 %, p = 0.008). Glucose intolerance was similar between the two groups. The total NAS and the grade of hepatocyte ballooning were higher in the patients with H. pylori IgG seropositivity than in those without, while the hepatic iron grade was lower in the patients with H. pylori IgG seropositivity than in those without. H. pylori infection (p = 0.030), female gender (p = 0.029), and NAFIC score a parts per thousand yen 2 points (p < 0.001) could independently predict NASH in logistic regression analysis, independent of age, obesity and glucose tolerance. The association of H. pylori seropositivity with hepatocyte ballooning suggests that H. pylori infection may represent another contributing factor in the progression from NAFL to NASH. Eradicating H. pylori infection may have therapeutic prospects in NASH treatment.	[Sumida, Yoshio; Taketani, Hiroyoshi; Seko, Yuya; Ishiba, Hiroshi; Hara, Tasuku; Okajima, Akira; Yamaguchi, Kanji; Moriguchi, Michihisa; Mitsuyoshi, Hironori; Yasui, Kohichiroh; Minami, Masahito; Itoh, Yoshito] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kamigyo Ku, Kyoto 6028566, Japan; [Kanemasa, Kazuyuki; Mori, Kojiro; Tanaka, Saiyu; Shimokobe, Hideto; Kitamura, Yoko; Fukumoto, Kohei; Kakutani, Akira; Ohno, Tomoyuki] Nara City Hosp, Ctr Digest & Liver Dis, Nara, Japan; [Imai, Shunsuke] Nara City Hosp, Dept Pathol, Nara, Japan	Sumida, Y (reprint author), Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kamigyo Ku, Kyoto 6028566, Japan.	sumida@koto.kpu-m.ac.jp					Abenavoli L, 2013, MED HYPOTHESES, V81, P913, DOI 10.1016/j.mehy.2013.08.011; Akbas HS, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-92; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Pellicano R, 2008, LANCET INFECT DIS, V8, P254, DOI 10.1016/S1473-3099(08)70066-5; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Sumida Y, 2003, J HEPATOL, V38, P32, DOI 10.1016/S0168-8278(02)00331-8; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Polyzos SA, 2013, METABOLISM, V62, P121, DOI 10.1016/j.metabol.2012.06.007; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Sumida Y, 2011, J GASTROENTEROL, V46, P257, DOI 10.1007/s00535-010-0305-6; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Basso D, 2010, HELICOBACTER, V15, P14, DOI 10.1111/j.1523-5378.2010.00781.x; Gunji T, 2009, HELICOBACTER, V14, P144, DOI 10.1111/j.1523-5378.2009.00705.x; Sumida Y, 2009, HEPATOL RES, V39, P213, DOI 10.1111/j.1872-034X.2008.00442.x; Huang Y, 2004, J CLIN PATHOL, V57, P1273, DOI 10.1136/jcp.2004.018556; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Gunji T, 2008, AM J GASTROENTEROL, V103, P3005, DOI 10.1111/j.1572-0241.2008.02151.x; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Satoh H, 2010, J ATHEROSCLER THROMB, V17, P1041; Kamada Y, 2013, PROTEOM CLIN APPL, V7, P648, DOI 10.1002/prca.201200137; Kebapcilar L, 2010, CLINICS, V65, P799, DOI 10.1590/S1807-59322010000800011; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720; Nwokolo CU, 2003, GUT, V52, P637, DOI 10.1136/gut.52.5.637; Polyzos SA, 2011, HELICOBACTER, V16, P79, DOI 10.1111/j.1523-5378.2011.00822.x; Barabino A, 2002, HELICOBACTER, V7, P71, DOI 10.1046/j.1083-4389.2002.00073.x; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Wu MS, 2005, ARCH INTERN MED, V165, P1552, DOI 10.1001/archinte.165.13.1552; Li M, 2013, WORLD J GASTROENTERO, V19, P7024, DOI 10.3748/wjg.v19.i41.7024; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Fukuda Y, 2001, DIGESTION, V63, P93, DOI 10.1159/000051918; Oliveira CPMS, 2002, J CELL MOL MED, V6, P399, DOI 10.1111/j.1582-4934.2002.tb00518.x; Ando T, 2013, HELICOBACTER, V18, P158, DOI 10.1111/hel.12028; Cindoruk M, 2008, EUR J GASTROEN HEPAT, V20, P33; DIBISCEGLIE AM, 1992, GASTROENTEROLOGY, V102, P2108; Dogan Z, 2013, EUR J GASTROEN HEPAT, V25, P107, DOI 10.1097/MEG.0b013e3283590c10; Gavin JR, 1997, DIABETES CARE, V20, P1183; Horikawa C, 2014, J DIABETES RES, DOI 10.1155/2014/250620; Huang Y, 2009, CLIN MICROBIOL INFEC, V15, P843, DOI 10.1111/j.1469-0691.2009.02719.x; Jamali R, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.14679; Japanese Society for the Study of Obesity, 2000, J JPN SOC STUDY OBES, V6, P18; Kamada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066328; National Cholesterol Education Program (NCEP) Expert Panel on Detection, 2001, JAMA-J AM MED ASSOC, V285; Pirouz T, 2009, DIGEST DIS SCI, V54, P1456, DOI 10.1007/s10620-008-0522-5; Saibara T, 2005, HEPATOL RES, V33, P64, DOI 10.1016/j.hepres.2005.09.005; Salehi Hassan, 2014, Adv Biomed Res, V3, P131, DOI 10.4103/2277-9175.133256; Stalke P, 2005, SCAND J GASTROENTERO, V40, P1032, DOI 10.1080/00365520510023251; Suganuma M, 2006, J BIOCHEM MOL BIOL, V39, P1; Sumida Y, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-2; Sumida Y, 2006, LIVER INT, V26, P827, DOI 10.1111/j.1478-3231.2006.01305.x; Takuma Yoshitaka, 2011, Gan To Kagaku Ryoho, V38, P362	53	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	SEP	2015	50	9					996	1004		10.1007/s00535-015-1039-2		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8IL	WOS:000360850600008		
J	Ishikawa, K; Hamasuna, R; Uehara, S; Yasuda, M; Yamamoto, S; Hayami, H; Takahashi, S; Matsumoto, T; Minamitani, S; Kadota, J; Iwata, S; Kaku, M; Watanabe, A; Sunakawa, K; Sato, J; Hanaki, H; Tsukamoto, T; Kiyota, H; Egawa, S; Deguchi, T; Matsumoto, M; Tanaka, K; Arakawa, S; Fujisawa, M; Kumon, H; Kobayashi, K; Matsubara, A; Wakeda, H; Amemoto, Y; Onodera, S; Goto, H; Komeda, H; Yamashita, M; Takenaka, T; Fujimoto, Y; Tsugawa, M; Takahashi, Y; Maeda, H; Onishi, H; Ishitoya, S; Nishimura, K; Mitsumori, K; Ito, T; Togo, Y; Nakamura, I; Ito, N; Kanamaru, S; Hirose, T; Muranaka, T; Yamada, D; Ishihara, S; Oka, H; Inatomi, H; Matsui, T; Kobuke, M; Kunishima, Y; Kimura, T; Ichikawa, T; Kagara, I; Matsukawa, M; Takahashi, K; Mita, K; Kato, M; Okumura, K; Kawanishi, H; Hashimura, T; Aoyama, T; Shigeta, M; Koda, S; Taguchi, K; Matsuda, Y				Ishikawa, Kiyohito; Hamasuna, Ryoichi; Uehara, Shinya; Yasuda, Mitsuru; Yamamoto, Shingo; Hayami, Hiroshi; Takahashi, Satoshi; Matsumoto, Tetsuro; Minamitani, Shinichi; Kadota, Jun-ichi; Iwata, Satoshi; Kaku, Mitsuo; Watanabe, Akira; Sunakawa, Keisuke; Sato, Junko; Hanaki, Hideaki; Tsukamoto, Taiji; Kiyota, Hiroshi; Egawa, Shin; Deguchi, Takashi; Matsumoto, Minori; Tanaka, Kazushi; Arakawa, Soichi; Fujisawa, Masato; Kumon, Hiromi; Kobayashi, Kanao; Matsubara, Akio; Wakeda, Hironobu; Amemoto, Yoshinosuke; Onodera, Shoichi; Goto, Hirokazu; Komeda, Hisao; Yamashita, Masuo; Takenaka, Tadasu; Fujimoto, Yoshinori; Tsugawa, Masaya; Takahashi, Yoshito; Maeda, Hiroshi; Onishi, Hiroyuki; Ishitoya, Satoshi; Nishimura, Kazuo; Mitsumori, Kenji; Ito, Toru; Togo, Yoshikazu; Nakamura, Ichiro; Ito, Noriyuki; Kanamaru, Sojun; Hirose, Takaoki; Muranaka, Takashi; Yamada, Daisuke; Ishihara, Satoshi; Oka, Hiroya; Inatomi, Hisato; Matsui, Takashi; Kobuke, Makoto; Kunishima, Yasuharu; Kimura, Takahiro; Ichikawa, Takaharu; Kagara, Ichiro; Matsukawa, Masanori; Takahashi, Koichi; Mita, Koji; Kato, Masao; Okumura, Kazuhiro; Kawanishi, Hiroaki; Hashimura, Takayuki; Aoyama, Teruyoshi; Shigeta, Masanobu; Koda, Shuntaro; Taguchi, Keisuke; Matsuda, Yohei			Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Surveillance; Susceptibility; Complicated urinary tract infection	MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS-AUREUS INFECTIONS; ACUTE UNCOMPLICATED CYSTITIS; RESISTANT ESCHERICHIA-COLI; SPECTRUM BETA-LACTAMASES; RISK-FACTORS; METAANALYSIS; OUTCOMES; PYELONEPHRITIS; ASSOCIATION	To investigate antimicrobial susceptibility patterns of various bacterial pathogens isolated from complicated urinary tract infection (UTI) cases, the Japanese Society of Chemotherapy, the Japanese Association of Infectious Disease, and the Japanese Society of Clinical Microbiology conducted the second nationwide surveillance from January to September 2011. With the cooperation of 42 medical institutions throughout Japan, 1036 strains belonging to 8 clinically relevant bacterial species were collected. Among methicillin-resistant Staphylococcus aureus (MRSA) strain, the vancomycin (VCM) MIC for 5.5% (3/55) of the strains was 2 mu g/mL. Ampicillin, VCM, and linezolid were relatively active against 209 Enterococcus faecalis strains. The proportion of fluoroquinolone (FQ)-resistant strains was >20%. The MIC90 of FQs against the 382 Escherichia coli strains was 2-64 mg/L and the proportion resistant to FQs was approximately 30%. However, susceptibility of E. coli to sitafloxacin was still high (MIC90 = 2 mg/L). Fifty-eight (15.2%) of 382 E. coli, 6 (4.5%) of 132 Klebsiella pneumoniae, 1 (2.4%) of 41 Klebsiella oxytoca and 4 (6.8%) of 59 Proteus mirabilis strains were suspected of producing extended-spectrum beta-lactamase. Of 93 Pseudomonas aeruginosa strains, the proportions resistant to imipenem, amikacin, and ciprofloxacin were 21.5%, 4.3%, and 20.4%, respectively. Four strains (4.3%) were found to be multidrug-resistant. In complicated UTI cases, all of MRSA and E. faecalis were susceptible to all anti-MRSA agents. Sitafloxacin was active against other FQ-resistant E. coli strains. The isolation of extended-spectrum betalactamase-producing and multidrug-resistant strains increased. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Ishikawa, Kiyohito; Hamasuna, Ryoichi; Uehara, Shinya; Yasuda, Mitsuru; Yamamoto, Shingo; Hayami, Hiroshi; Takahashi, Satoshi; Matsumoto, Tetsuro; Minamitani, Shinichi] Japanese Assoc Infect Dis, Japanese Soc Chemotherapy, Urogenital Subcomm & Surveillance Comm, Tokyo, Japan; [Ishikawa, Kiyohito; Hamasuna, Ryoichi; Uehara, Shinya; Yasuda, Mitsuru; Yamamoto, Shingo; Hayami, Hiroshi; Takahashi, Satoshi; Matsumoto, Tetsuro; Minamitani, Shinichi] Japanese Soc Clin Microbiol, Tokyo, Japan; [Ishikawa, Kiyohito] Fujita Hlth Univ, Sch Med, Dept Urol, Toyoake, Aichi 4701192, Japan; [Hamasuna, Ryoichi; Matsumoto, Tetsuro] Univ Occupat & Environm Hlth, Dept Urol, Fukuoka, Japan; [Uehara, Shinya; Kumon, Hiromi] Okayama Univ, Dept Urol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Yasuda, Mitsuru; Deguchi, Takashi] Gifu Univ, Dept Urol, Grad Sch Med, Gifu, Japan; [Yamamoto, Shingo; Togo, Yoshikazu] Hyogo Coll Med, Dept Urol, Nishinomiya, Hyogo, Japan; [Hayami, Hiroshi] Kagoshima Univ Hosp, Blood Purificat Ctr, Kagoshima, Japan; [Takahashi, Satoshi; Tsukamoto, Taiji] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido, Japan; [Kadota, Jun-ichi; Iwata, Satoshi; Kaku, Mitsuo; Watanabe, Akira; Sunakawa, Keisuke; Sato, Junko] Surveillance Comm JSC JAID & JSCM, Tokyo, Japan; [Hanaki, Hideaki] Kitasato Univ, Kitasato Inst Life Sci, Res Ctr Antiinfect Drugs, Tokyo, Japan; [Kiyota, Hiroshi] Jikei Univ, Dept Urol, Katsushika Med Ctr, Tokyo, Japan; [Egawa, Shin; Kimura, Takahiro] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan; [Matsumoto, Minori; Tanaka, Kazushi; Arakawa, Soichi; Fujisawa, Masato] Kobe Univ, Grad Sch Med, Div Urol, Kobe, Hyogo, Japan; [Kobayashi, Kanao; Matsubara, Akio] Hiroshima Univ, Dept Urol, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Wakeda, Hironobu] Miyazaki Univ, Fac Med, Dept Urol, Miyazaki, Japan; [Amemoto, Yoshinosuke] Minami Med Hlth Cooperat, Dept Urol, Aichi, Japan; [Onodera, Shoichi; Goto, Hirokazu] Fuji City Gen Hosp, Dept Urol, Shizuoka, Japan; [Komeda, Hisao] Gifu Municipal Hosp, Dept Urol, Gifu, Japan; [Yamashita, Masuo] Shinko Hosp, Dept Urol, Kobe, Hyogo, Japan; [Takenaka, Tadasu] Japanese Red Cross Okayama Hosp, Dept Urol, Okayama, Japan; [Fujimoto, Yoshinori] Ogaki Municipal Hosp, Dept Urol, Gifu, Japan; [Tsugawa, Masaya] Okayama City Hosp, Dept Urol, Okayama, Japan; [Takahashi, Yoshito] Gifu Prefectural Gen Med Ctr, Dept Urol, Gifu, Japan; [Maeda, Hiroshi] Yodogawa Christians Hosp, Dept Urol, Osaka, Japan; [Onishi, Hiroyuki; Ishitoya, Satoshi] Shiga Med Ctr Adults, Dept Urol, Shiga, Japan; [Nishimura, Kazuo; Mitsumori, Kenji] Osaka Red Cross Hosp, Dept Urol, Osaka, Japan; [Ito, Toru] Nagoya Ekisaikai Hosp, Dept Urol, Aichi, Japan; [Nakamura, Ichiro] Kobe City Med Ctr West Hosp, Dept Urol, Kobe, Hyogo, Japan; [Ito, Noriyuki; Kanamaru, Sojun] Nishi Kobe Med Ctr, Dept Urol, Kobe, Hyogo, Japan; [Hirose, Takaoki; Muranaka, Takashi] Japan Community Hlth Care Org, Hokkaido Hosp, Dept Urol, Sapporo, Hokkaido, Japan; [Yamada, Daisuke] Mitoyo Gen Hosp, Dept Urol, Kagawa, Japan; [Ishihara, Satoshi] Kizawa Mem Hosp, Dept Urol, Gifu, Japan; [Oka, Hiroya] Nara Social Insurance Hosp, Dept Urol, Nara, Japan; [Inatomi, Hisato] Munakata Suikokai Gen Hosp, Dept Urol, Fukutsu, Japan; [Matsui, Takashi] Japanese Red Cross Kobe Hosp, Dept Urol, Kobe, Hyogo, Japan; [Kobuke, Makoto] Natl Hosp Org, Iwakuni Clin Ctr, Dept Urol, Yamaguchi, Japan; [Kunishima, Yasuharu] Hokkaido Social Work Assoc Obihiro Hosp, Dept Urol, Sapporo, Hokkaido, Japan; [Kimura, Takahiro; Ichikawa, Takaharu] Tottori Municipal Hosp, Dept Urol, Tottori, Japan; [Kagara, Ichiro] Kagoshima Prefectural Ohshima Hosp, Dept Urol, Kagoshima, Japan; [Matsukawa, Masanori] Takikawa Municipal Hosp, Dept Urol, Sapporo, Hokkaido, Japan; [Takahashi, Koichi] Fukuoka Shin Mizumaki Hosp, Dept Urol, Fukuoka, Japan; [Mita, Koji; Kato, Masao] Hiroshima City Asa Hosp, Dept Urol, Hiroshima, Japan; [Okumura, Kazuhiro; Kawanishi, Hiroaki] Tenri Hosp, Dept Urol, Nara, Japan; [Hashimura, Takayuki; Aoyama, Teruyoshi] Kansai Elect Power Hosp, Dept Urol, Osaka, Japan; [Shigeta, Masanobu; Koda, Shuntaro] Natl Hosp Org, Kure Med Ctr, Dept Urol, Kure, Japan; [Shigeta, Masanobu; Koda, Shuntaro] Chugoku Canc Ctr, Kure, Japan; [Taguchi, Keisuke; Matsuda, Yohei] Oji Gen Hosp, Dept Urol, Sapporo, Hokkaido, Japan	Ishikawa, K (reprint author), Fujita Hlth Univ, Sch Med, Dept Urol, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	kiyo@fujita-hu.ac.jp			Nankodo Co., Ltd.; Nikon Corporation; Kyorin Pharmaceutical Co., Ltd.; Shionogi Co., Ltd.; Taisho Pharmaceutical Co., Ltd.; Toyama Chemical Co., Ltd.; Daiichi Sankyo Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd.; Taiho Pharmaceutical Co., Ltd.; Meiji Seika Pharma Co., Ltd.; RichHill Medical Inc.	Mitsuru Yasuda has received donation from Astellas Pharma Inc. Jun-ichi Kadota has received speaker's honorarium from Taisho Toyama Pharmaceutical Co., Ltd., Pfizer Japan Inc., MSD K.K., Kyorin Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Glaxo SmithKline K.K., payments for a manuscript drafting and editing from Nankodo Co., Ltd. and donation from Astellas Pharma Inc. Satoshi Iwata has received speaker's honorarium from Astellas Pharma Inc., Pfizer Japan Inc., Taisho Toyama Pharmaceutical Co., Ltd., MSD K.K., Meiji Seika Pharma Co., Ltd., Daiichi Sankyo Co., Ltd. and Japan Vaccine Co., Ltd., donation from Taisho Toyama Pharmaceutical Co., Ltd. and supported, in part, by a fund from Nikon Corporation. Mitsuo Kaku has received speaker's honorarium from Taisho Toyama Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Pfizer Japan Inc. and Sumitomo Dainippon Pharma Co., Ltd. and donation from Astellas Pharma Inc. Akira Watanabe has received speaker's honorarium from MSD K.K., Glaxo SmithKline K.K., Shionogi & Co., Ltd., Daiichi Sankyo Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd. and Pfizer Japan Inc.; grant support from Kyorin Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Taisho Pharmaceutical Co., Ltd., Toyama Chemical Co., Ltd., Daiichi Sankyo Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Taiho Pharmaceutical Co., Ltd. and Meiji Seika Pharma Co., Ltd. Keisuke Sunakawa has received speaker's honorarium from Taisho Toyama Pharmaceutical Co., Ltd., Toyama Chemical Co., Ltd. and Meiji Seika Pharma Co., Ltd. Hideaki Hanaki is a member of a laboratory endowed chair from Kohjin Bio Co., Ltd. Taiji Tsukamoto has received speaker's honorarium from Astellas Pharma Inc., and payments for a manuscript drafting and editing from RichHill Medical Inc. Shin Egawa has received donation from Takeda Pharmaceutical Co., Ltd., Astellas Pharma Inc., Asahi Kasei Corp. and Euro Meditech Co., Ltd. Takashi Deguchi has received donation from Astellas Pharma Inc. Soichi Arakawa has received speaker's honorarium from Taisho Toyama Pharmaceutical Co., Ltd.	Aeslen H, 2005, J ANTIMICROB CHEMOTH, V56, P914; Shigemura K, 2012, INT J ANTIMICROB AG, V40, P516, DOI 10.1016/j.ijantimicag.2012.07.019; Cohen-Nahum K, 2010, INFECTION, V38, P41, DOI 10.1007/s15010-009-8460-5; Dizbay M, 2014, J INFECT DEV COUNTR, V8, P44, DOI 10.3855/jidc.3091; van Hal SJ, 2012, CLIN INFECT DIS, V54, P755, DOI 10.1093/cid/cir935; Colodner R, 2006, EUR J CLIN MICROBIOL, V25, P49, DOI 10.1007/s10096-005-0074-y; [Anonymous], INF DIS WEEKL REP JA; Killgore KM, 2004, ANN PHARMACOTHER, V38, P1148, DOI 10.1345/aph.1D622; Naber KG, 2001, EUR UROL, V40, P576, DOI 10.1159/000049840; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI 10.1093/cid/ciq257; Carrie AG, 2004, J ANTIMICROB CHEMOTH, V53, P512, DOI 10.1093/jac/dkh100; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; Clinical and Laboratory Standards Institute, 2006, M7A7 CLSI; Clinical and Laboratory Standards Institute, 2006, M45A CLSI; Committee on Revision of UTI Drug Efficacy Evaluation Standards, 2009, JPN J CHEMOTHER, V57, P511; Jacob JT, 2013, INT J INFECT DIS, V17, pE93, DOI 10.1016/j.ijid.2012.08.005; ENA J, 1995, J UROLOGY, V153, P117, DOI 10.1097/00005392-199501000-00040; Gilbert DN, 2013, KIDNEY BLADDER PROST, V43th, P34; Grabe M, 2013, COMPLICATED UTIS DUE, P28; Hanaki H, 2004, J ANTIMICROB CHEMOTH, V53, P888, DOI 10.1093/jac/dkh166; Hayami H, 2013, J INFECT CHEMOTHER, V19, P393, DOI 10.1007/s10156-013-0606-9; Ishikawa K., 2013, KANSEN KOUKINYAKU, V16, P74; Ishikawa K, 2011, J INFECT CHEMOTHER, V17, P126, DOI 10.1007/s10156-010-0174-1; Kalil AC, 2014, JAMA-J AM MED ASSOC, V312, P1552, DOI 10.1001/jama.2014.6364; Khair HN, 2013, J HOSP INFECT, V85, P183, DOI 10.1016/j.jhin.2013.07.007; Kung CH, 2013, J MICROBIOL IMMUNOL; Matumoto T, 2012, J INFECT CHEMOTHER, V18, P597; Matumoto T, 2008, INT J ANTIMICROB AG, V2011, P210; Morrissey Ian, 2013, Pharmaceuticals (Basel), V6, P1335, DOI 10.3390/ph6111335; Muratani Tetsuro, 2007, Nihon Rinsho, V65 Suppl 2 Pt. 1, P513; Takesue Y, 2011, J INFECT CHEMOTHER, V17, P52, DOI 10.1007/s10156-010-0086-0; Tiengrim Surapee, 2012, J Med Assoc Thai, V95 Suppl 2, pS6	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	SEP	2015	21	9					623	633		10.1016/j.jiac.2015.05.014		11	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CR2PG	WOS:000361172000001		
J	Ikematsu, H; Kawai, N; Iwaki, N; Kashiwagi, S				Ikematsu, Hideyuki; Kawai, Naoki; Iwaki, Norio; Kashiwagi, Seizabro			In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Influenza; 50% Inhibitory concentration; Oseltamivir; Zanamivir; Laninamivir; Peramivir	HYDRATE; PCR	To assess the extent of viral resistance, we measured the 50% inhibitory concentration (IC50) of neuraminidase inhibitors (NAIs) for the influenza virus isolates in the 2013-2014 influenza season and compared the results to those of the 2010-2011 to 2012-2013 influenza seasons. Viral isolation was done with specimens obtained prior to treatment, and the type and subtype of influenza was determined by RT-PCR using type-and subtype-specific primers. The IC50 was determined by a neuraminidase inhibition assay using a fluorescent substrate. A total of 327 influenza viruses were isolated: 172 influenza A(H1N1) pdm09 (52.6%), 49 A(H3N2) (15.0%), and 106 B (32.4%). Numbers of Victoria and Yamagata lineage isolates were 36 and 70, respectively. Two A(H1N1) pdm09 isolates showed a high IC50 for oseltamivir (130 and 150 nM) exceeding by 100 times the geometric mean of the IC50 of oseltamivir for A(H1N1) pdm09 isolates (0.76 nM). No isolate showed a very high IC50 for A(H3N2) or B. The IC50 of the NAIs except for oseltamivir for A(H1N1) pdm09 were significantly higher than those of the 2010-2011 season (P < 0.05). The IC50 of all four NAIs for A(H3N2) were significantly lower than those of the 2012-2013 season (P < 0.001). The IC50 of the NAIs for B except for oseltamivir were significantly lower than those of the 2012-2013 season (P < 0.001). Although there are some isolates that show highly reduced sensitivity to oseltamivir among A(H1N1) pdm09 isolates, the currently epidemic influenza A(H1N1) pdm09, A(H3N2) and B viruses are susceptible to all four NAIs with no trend toward decreased sensitivity. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Ikematsu, Hideyuki; Kawai, Naoki; Iwaki, Norio; Kashiwagi, Seizabro] Japan Phys Assoc, Tokyo, Japan	Ikematsu, H (reprint author), 2-18-30 Hakataekihigashi,Hakata Ku, Fukuoka 8120013, Japan.	ikematsu@gray.plala.or.jp			Daiichi Sankyo Company, Limited	This investigation was sponsored by Daiichi Sankyo Company, Limited.	Kawai N, 2006, CLIN INFECT DIS, V43, P439, DOI 10.1086/505868; Yamashita M, 2009, ANTIMICROB AGENTS CH, V53, P186, DOI 10.1128/AAC.00333-08; Ikematsu H, 2014, J INFECT CHEMOTHER, V20, P77, DOI 10.1016/j.jiac.2013.07.002; Ikematsu H, 2014, J INFECT CHEMOTHER, V20, P81, DOI 10.1016/j.jiac.2013.07.013; Stockton J, 1998, J CLIN MICROBIOL, V36, P2990; Ikematsu H, 2012, J INFECT CHEMOTHER, V18, P529, DOI 10.1007/s10156-012-0377-8; Ikematsu H, 2015, J INFECT CHEMOTHER, V21, P39, DOI 10.1016/j.jiac.2014.08.030; Ikematsu H, 2014, J INFECT CHEMOTHER, V20, P799, DOI 10.1016/j.jiac.2014.08.023; Nakauchi M, 2014, J VIROL METHODS, V205, P110, DOI 10.1016/j.jviromet.2014.04.016; World Health Organization, 2012, WKLY EPIDEMIOL REC, V39, P369	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	SEP	2015	21	9					634	638		10.1016/j.jiac.2015.05.004		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CR2PG	WOS:000361172000002		
J	Oguchi, K; Miyata, A; Kazuyama, Y; Noda, A; Suzuki, E; Watanabe, M; Nakayama, T				Oguchi, Kaoru; Miyata, Akiko; Kazuyama, Yukimasa; Noda, Atsuya; Suzuki, Eri; Watanabe, Mineo; Nakayama, Tetsuo			Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Pertussis; LAMP; PT; FHA; Fim2; Fim3	ADENYLATE-CYCLASE TOXIN; BORDETELLA-PERTUSSIS; ADULTS; JAPAN; IMMUNIZATION; INFANTS; INFECTION; CHILDREN; VACCINE; ADOLESCENTS	Isolation of Bordetella pertussis and detection of the pertussis genome are not always successful because of low bacterial loads in adult patients with pertussis. Antibodies against pertussis toxin (PT) are measured but have low sensitivity in vaccinated subjects. There is no reliable diagnostic method at present. In this study, a fluorescent-EIA against several pertussis antigens and genome detection were investigated to establish clinical laboratory diagnostic methods for pertussis. The study was conducted in an outpatient clinic between September 2007 and 2013. Subjects consisted of 209 patients including adults suspected of pertussis and 35 staff members of the clinic. Loop-mediated isothermal amplification (LAMP) was performed to detect the pertussis genome in 5' UTR of the pertussis toxin (PT) gene. The catalytic region of the adenylate cyclase toxin (catACT), C-terminal of filamentous hemagglutinin (cFHA), and type 3 fimbria (Fim3) were selected, which are not pertussis vaccine component. Conventional PT and FHA antibodies were examined together with type 2 fimbria (Fim2) antibodies, and these are vaccine antigens. Pertussis DNA was detected in 23 (11%) out of 209. Detection sensitivity was high in young infants. Antibodies against Fim3 showed a higher positive rate in all age groups. Staff members at the pediatric outpatient clinic showed serological booster responses in Fim2 and Fim3 antibodies more sensitively than those in PT antibodies during outbreaks. LAMP was useful for detecting the pertussis genome in young infants, whereas a serological assay for fluorescent-EIA against Fim2 and Fim3 was preferable for adolescents and adults. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Oguchi, Kaoru; Miyata, Akiko] Saiwai Pediat Clin, Tachikawa, Tokyo, Japan; [Kazuyama, Yukimasa; Noda, Atsuya] Kitasato Biomed Assay Res Inst, Sagamihara, Kanagawa, Japan; [Suzuki, Eri; Watanabe, Mineo] Kitasato Inst Life Sci, Immunoregulat Lab, Minato Ku, Tokyo, Japan; [Nakayama, Tetsuo] Kitasato Inst Life Sci, Lab Virus Infect, Minato Ku, Tokyo, Japan	Nakayama, T (reprint author), Kitasato Univ, Kitasato Inst Life Sci, Lab Viral Infect 1, Minato Ku, Shirokane 5-9-1, Tokyo 1088641, Japan.	tetsuo-n@lisci.kitasato-u.ac.jp			Ministry of Health, Labour, and Welfare of Japan [0401-9]	This work was supported by the Ministry of Health, Labour, and Welfare of Japan (0401-9).	Riffelmann M, 2005, J CLIN MICROBIOL, V43, P4925, DOI 10.1128/JCM.43.10.4925-4929.2005; Reischl U, 2001, J CLIN MICROBIOL, V39, P1963, DOI 10.1128/JCM.39.5.1963-1966.2001; Tondella ML, 2009, VACCINE, V27, P803, DOI 10.1016/j.vaccine.2008.11.072; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Dragsted DM, 2004, J MED MICROBIOL, V53, P749, DOI 10.1099/jmm.0.45585-0; Kowalzik F, 2007, PEDIATR INFECT DIS J, V26, P238, DOI 10.1097/01.inf.0000256750.07118.ee; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.61464.6d; SATO Y, 1984, LANCET, V1, P122; Guiso N, 2011, EUR J CLIN MICROBIOL, V30, P307, DOI 10.1007/s10096-010-1104-y; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Le T, 2004, J INFECT DIS, V190, P535, DOI 10.1086/422035; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Edelman K, 2007, CLIN INFECT DIS, V44, P1271, DOI 10.1086/514338; Advani A, 2011, VACCINE, V29, P3438, DOI 10.1016/j.vaccine.2011.02.070; Cherry JD, 2012, CLIN INFECT DIS, V54, P1756, DOI 10.1093/cid/cis302; Zepp F, 2011, LANCET INFECT DIS, V11, P557, DOI 10.1016/S1473-3099(11)70007-X; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI [10.2217/fmb.09.133, 10.2217/FMB.09.133]; Watanabe M, 2006, CLIN VACCINE IMMUNOL, V13, P341, DOI 10.1128/CVI.13.3.341-348.2006; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; Kamachi K, 2006, J CLIN MICROBIOL, V44, P1899, DOI 10.1128/JCM.44.5.1899-1902.2006; Watanabe M, 2005, EXPERT REV VACCINES, V4, P173, DOI 10.1586/14760584.4.2.173; Birkebaek NH, 2001, DAN MED BULL, V48, P77; Centers for Disease Control and Prevention, 2005, MMWR-MORBID MORTAL W, V55, P1; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P13; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Cherry JD, 2004, CLIN INFECT DIS, V38, P502, DOI 10.1086/381204; De Schutter I, 2003, CLIN INFECT DIS, V36, P1391, DOI 10.1086/375071; Han HJ, 2008, VACCINE, V26, P1530, DOI 10.1016/j.vaccine.2008.01.020; KIMURA M, 1990, LANCET, V336, P30, DOI 10.1016/0140-6736(90)91530-N; KIMURA M, 1988, Acta Paediatrica Japonica, V30, P143; Kuno-Sakai H, 2004, BIOLOGICALS, V32, P29, DOI 10.1016/j.biologicals.2003.11.001; KUNOSAKAI H, 1992, VACCINE, V10, P350, DOI 10.1016/0264-410X(92)90377-V; Miyashita N, 2011, INTERNAL MED, V50, P879, DOI 10.2169/internalmedicine.50.4768; Miyashita N, 2011, RESPIROLOGY, V16, P1189, DOI 10.1111/j.1440-1843.2011.02024.x; Nakamura A, 2008, EUR J PEDIATR, V168, P347; Otsuka N, 2011, PLOS ONE, V7; Riffelmann M, 2009, EUR J CLIN MICROBIOL, V28, P275, DOI 10.1007/s10096-008-0625-0; Takeuchi M, 2012, EPIDEMIOL INFECT, V140, P1497, DOI 10.1017/S0950268811002044; Tarr GAM, 2013, AM J EPIDEMIOL, V178, P309, DOI 10.1093/aje/kws465; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	SEP	2015	21	9					639	646		10.1016/j.jiac.2015.05.006		8	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CR2PG	WOS:000361172000003		
J	Kawai, A; Yamagishi, Y; Mikamo, H				Kawai, Akira; Yamagishi, Yuka; Mikamo, Hiroshige			In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Antifungals; Biofilms; Candida tropicalis; Candida parapsilosis; Candida glabrata; Paradoxical growth effect (PGE)	ANTIFUNGAL AGENTS; SUSCEPTIBILITY; CASPOFUNGIN; ECHINOCANDINS; INFECTION; THERAPY; PARAPSILOSIS; OUTCOMES; SERUM; MODEL	Non-albicans Candida species are being isolated with increasing frequency. In this study, biofilm formation by Candida tropicalis, Candida parapsilosis and Candida glabrata was evaluated and the activities of liposomal amphotericin B (LAB), micafungin (MFG) and fluconazole (FLC) against these biofilms were assessed using a clinically relevant in vitro model system. LAB exhibited strong activities against the three non-albicans Candida species and showed dose-dependent efficacy. MFG displayed a paradoxical growth effect against the C. tropicalis biofilm. FLC was ineffective for non-albicans biofilms. This study shows that Candida biofilms have unique susceptibility to LAB. The dose-dependent effects of LAB indicate that this drug may be a useful treatment for biofilm formation by non-albicans Candida species in cases in which the catheter cannot be removed for clinical reasons. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Kawai, Akira; Yamagishi, Yuka; Mikamo, Hiroshige] Aichi Med Univ, Grad Sch Med, Dept Clin Infect Dis, Aichi, Japan	Mikamo, H (reprint author), 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	mikamo@aichi-med-u.ac.jp			Sumitomo Dainippon Pharma	Sumitomo Dainippon Pharma is acknowledged for financial support of this study.	Ramage G, 2001, ANTIMICROB AGENTS CH, V45, P2475, DOI 10.1128/AAC.45.9.2475-2479.2001; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Uppuluri P, 2011, ANTIMICROB AGENTS CH, V55, P3591, DOI 10.1128/AAC.01701-10; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Shuford JA, 2006, J INFECT DIS, V194, P710, DOI 10.1086/506452; Choi HW, 2007, ANTIMICROB AGENTS CH, V51, P1520, DOI 10.1128/AAC.01141-06; Fortun J, 2012, J INFECTION, V65, P64, DOI 10.1016/j.jinf.2012.02.011; Walker LA, 2013, ANTIMICROB AGENTS CH, V57, P146, DOI 10.1128/AAC.01486-12; Ferreira JAG, 2009, ANTIMICROB AGENTS CH, V53, P4377, DOI 10.1128/AAC.00316-09; Stevens DA, 2004, ANTIMICROB AGENTS CH, V48, P3407, DOI 10.1128/AAC.48.9.3407-3411.2004; Nagao M, 2013, CLIN MICROBIOL INFEC, V19, P852, DOI 10.1111/1469-0691.12083; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Tumbarello M, 2007, J CLIN MICROBIOL, V45, P1843, DOI 10.1128/JCM.00131-07; Hawser SP, 1998, J CLIN MICROBIOL, V36, P1450; Schinabeck MK, 2004, ANTIMICROB AGENTS CH, V48, P1727, DOI 10.1128/AAC.48.5.1727-1732.2004; Takakura S, 2004, J ANTIMICROB CHEMOTH, V53, P283, DOI 10.1093/jac/dkh053; Kumamoto CA, 2002, CURR OPIN MICROBIOL, V5, P608, DOI 10.1016/S1369-5274(02)00371-5; Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002; Pfaller MA, 2010, DRUG RESIST UPDATE, V13, P180, DOI 10.1016/j.drup.2010.09.002; Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002; Odabasi Z, 2007, ANTIMICROB AGENTS CH, V51, P4214, DOI 10.1128/AAC.01589-06; Bizerra FC, 2008, FEMS YEAST RES, V8, P442, DOI 10.1111/j.1567-1364.2007.00347.x; Jacobson MJ, 2008, ANTIMICROB AGENTS CH, V52, P2242, DOI 10.1128/AAC.00211-08; Paderu P, 2007, ANTIMICROB AGENTS CH, V51, P2253, DOI 10.1128/AAC.01536-06; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Melo AS, 2007, ANTIMICROB AGENTS CH, V51, P3081, DOI 10.1128/AAC.00676-07; Silva S, 2011, TRENDS MICROBIOL, V19, P241, DOI 10.1016/j.tim.2011.02.003; Chamilos G, 2007, ANTIMICROB AGENTS CH, V51, P2257, DOI 10.1128/AAC.00095-07; Ramage G, 2002, ANTIMICROB AGENTS CH, V46, P3634, DOI 10.1128/AAC.46.11.3634-3636.2002; Kuhn DM, 2002, INFECT IMMUN, V70, P878, DOI 10.1128/IAI.70.2.878-888.2002; Katragkou A, 2015, J ANTIMICROB CHEMOTH, V70, P470, DOI 10.1093/jac/dku374; Kuhn Duncan M, 2004, Curr Opin Investig Drugs, V5, P186; TUMBARELLO M, 2012, PLOS ONE, V0007; Wayne PA., 2008, M27A3 CLSI	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	SEP	2015	21	9					647	653		10.1016/j.jiac.2015.05.007		7	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CR2PG	WOS:000361172000004		
J	Tamura, K; Akiyama, N; Kanda, Y; Saito, M				Tamura, Kazuo; Akiyama, Nobu; Kanda, Yoshinobu; Saito, Masahiro			Efficacy and safety of tazobactam/piperacillin as an empirical treatment for the patients of adult and child with febrile neutropenia in Japan	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Tazobactam/piperacillin; Febrile neutropenia; Clinical trial; Pharmacokinetics	PHASE-III TAZOBACTAM/PIPERACILLIN; COMMUNITY-ACQUIRED PNEUMONIA; PEDIATRIC CANCER-PATIENTS; OPEN-LABEL; PIPERACILLIN-TAZOBACTAM; MULTICENTER; CEFEPIME; THERAPY; MONOTHERAPY; INFECTIONS	Tazobactam/piperacillin (4.5 g for adults and 90 mg/kg body weight for children, every 6 h) was administered to Japanese patients with febrile neutropenia to evaluate its defervescence and clinical efficacy and safety. The pharmacokinetics in children were also examined. Defervescence efficacy at day 4 of the treatment was achieved in 50.0% of 94 adult and 62.5% of 8 pediatric patients, respectively. The defervescence efficacy rate in relation to the neutrophil count in adults was 37.5% for the patients with a neutrophil count of less than 100/mu L and 62.5% for that between 100 and 500/mu L. The clinical efficacy rate at day 7 and at the end or discontinuation of the treatment was 79.6% and 59.1% in adult patients, respectively, and 57.1% and 75.0% in pediatric patients, respectively. Fifteen strains of causative bacteria were isolated in 13 adult patients at baseline. All strains were eradicated within 4 days of the treatment. The side effects that occurred in adult and pediatric patients during the treatment were all known and not specific to febrile neutropenia patients. The pharmacokinetics profiles of tazobactam/piperacillin in children with febrile neutropenia are unlikely to be different from those in children with a common bacterial infection and without any immunosuppressive conditions. The study results in Japanese patients with febrile neutropenia demonstrate that tazobactam/piperacillin treatment is efficacious and safe in adults. As for pediatric patients, given the limited number of cases studied, further investigation is needed (Clinical trial number: Japic CTI-121728). (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Tamura, Kazuo] Fukuoka Univ Hosp, Dept Internal Med, Div Med Oncol Hematol & Infect Dis, Fukuoka 8140180, Japan; [Akiyama, Nobu] Teikyo Univ, Sch Med, Dept Hematol Oncol, Tokyo, Japan; [Kanda, Yoshinobu] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Shimotsuke, Tochigi, Japan; [Saito, Masahiro] Juntendo Univ, Sch Med, Dept Pediat & Adolescent Med, Chiba, Japan	Tamura, K (reprint author), Fukuoka Univ Hosp, Dept Internal Med, Div Med Oncol Hematol & Infect Dis, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	ktamura@fukuoka-u.ac.jp			Taiho Pharmaceutical Co., Ltd.	This study was implemented with the financial support of Taiho Pharmaceutical Co., Ltd. The sponsor monitored the study and provided the study drugs at no charge. The protocol was designed by the authors in collaboration with the sponsor. Yoshio Yamamoto, Yoshikazu Hashimoto and Tatsuya Uji of Taiho Pharmaceutical Co., Ltd. cooperated article review.	AIKAWA N, 2010, JPN J CHEMOTHER S1, V58, P50; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Baden LR, 2012, J NATL COMPR CANC NE, V10, P1412; Bow EJ, 2006, CLIN INFECT DIS, V43, P447, DOI 10.1086/505393; ARAKAWA S, 2010, JPN J CHEMOTHER S1, V58, P62; Corapcioglu F, 2006, PEDIATR HEMAT ONCOL, V23, P177, DOI 10.1080/08880010500506370; Del Favero A, 2001, CLIN INFECT DIS, V33, P1295, DOI 10.1086/322646; Imajo Kenji, 2012, Jpn J Antibiot, V65, P271; Jeffrey JC, 2015, PEDIAT BLOOD CANC, V62, P477; MIKAMO H, 2012, JPN J CHEMOTHER, V60, P560; Practical guideline of febrile neutropenia (FN), 2012, PRACT GUID FEBR NEUT, P18; Sezgin G, 2014, ASIAN PAC J CANCER P, V15, P4549, DOI 10.7314/APJCP.2014.15.11.4549; SHIBA K, 2010, JPN J CHEMOTHER S1, V58, P73; SUNAKAWA K, 2010, JPN J CHEMOTHER S1, V58, P88; Tamura K, 2004, CLIN INFECT DIS, V39, pS15, DOI 10.1086/383046; Uygun V, 2009, PEDIATR BLOOD CANCER, V53, P610, DOI 10.1002/pbc.22100; WATANABE A, 2010, JPN J CHEMOTHER S1, V58, P29; WATANABE A, 2010, JPN J CHEMOTHER S1, V58, P11	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	SEP	2015	21	9					654	662		10.1016/j.jiac.2015.05.009		9	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CR2PG	WOS:000361172000005		
J	Tanimura, K; Nishikawa, A; Tairaku, S; Shinozaki, N; Deguchi, M; Morizane, M; Ebina, Y; Morioka, I; Yamada, H				Tanimura, Kenji; Nishikawa, Akira; Tairaku, Shinya; Shinozaki, Nanae; Deguchi, Masashi; Morizane, Mayumi; Ebina, Yasuhiko; Morioka, Ichiro; Yamada, Hideto			The IgG avidity value for the prediction of Toxoplasma gondii infection in the amniotic fluid	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Amniotic fluid; Congenital toxoplasma infection; IgG avidity index; Multiplex nested PCR; Screening during pregnancy; Toxoplasma gondii	POLYMERASE-CHAIN-REACTION; MULTIPLEX-NESTED PCR; CONGENITAL TOXOPLASMOSIS; PRENATAL-DIAGNOSIS; IMMUNOGLOBULIN-M; PREGNANCY; TESTS; WOMEN	Primary Toxoplasma gondii (T. gondii) infection during pregnancy may lead to congenital toxoplasmosis. Maternal screening using T. gondii IgG avidity measurement and multiplex nested PCR was performed. The aim of this prospective cohort study was to determine a cut-off value of IgG avidity index (AI) for the prediction of the presence of T. gondii DNA in the amniotic fluid. One hundred thirty-nine women with positive or equivocal tests for IgM underwent both serum IgG avidity measurement and PCR analysis for the amniotic fluid. Nine had positive PCR results, and three of them were diagnosed as having congenital infection. A cut-off value of IgG AI was determined using receiver operating characteristic analysis. IgG AI (mean 13%) in women with positive PCR results was significantly lower than that (39%) in women with negative results. A cut-off value of <25% IgG AI yields the best results with 77.8% sensitivity and 81.5% specificity for the presence of T. gondii DNA in the amniotic fluid. None of women with IgG AI of >= 30% had a positive PCR result or congenital infection. This study firstly demonstrated that a cut-off value of 25 -30% IgG AI might be useful for the prediction of the presence of T. gondii DNA in the amniotic fluid and congenital infection. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Tanimura, Kenji; Tairaku, Shinya; Shinozaki, Nanae; Deguchi, Masashi; Morizane, Mayumi; Ebina, Yasuhiko; Yamada, Hideto] Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Kobe, Hyogo 6500017, Japan; [Nishikawa, Akira] NTT East Sapporo Med Ctr, Sapporo, Hokkaido, Japan; [Morioka, Ichiro] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan	Yamada, H (reprint author), Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yhideto@med.kobe-u.ac.jp			Ministry of Health, Labour and Welfare of Japan [H23-Jisedai-Ippan-001, H25-Jisedai-Shitei-003]; Japan Association of Obstetricians and Gynecologists [H22-Ogyah-Kenkin]	This work was supported in part by Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan (Grant No. H23-Jisedai-Ippan-001 and No. H25-Jisedai-Shitei-003) and the Japan Association of Obstetricians and Gynecologists (Grant No. H22-Ogyah-Kenkin).	WONG SY, 1994, CLIN INFECT DIS, V18, P853; HEDMAN K, 1989, J INFECT DIS, V159, P736; Liesenfeld O, 1997, J CLIN MICROBIOL, V35, P174; HOHLFELD P, 1994, NEW ENGL J MED, V331, P695, DOI 10.1056/NEJM199409153311102; Yamada H, 2011, J CLIN MICROBIOL, V49, P2552, DOI 10.1128/JCM.02092-10; DELBONO V, 1989, J CLIN MICROBIOL, V27, P2133; Gras L, 2004, EPIDEMIOL INFECT, V132, P541, DOI 10.1017/S0950268803001948; Lebech M, 1996, EUR J CLIN MICROBIOL, V15, P799, DOI 10.1007/BF01701522; MCAULEY J, 1994, CLIN INFECT DIS, V18, P38; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Romand S, 2001, OBSTET GYNECOL, V97, P296, DOI 10.1016/S0029-7844(00)01118-2; LAPPALAINEN M, 1993, J INFECT DIS, V167, P691; BOBIC B, 1991, GYNECOL OBSTET INVES, V31, P182; Montoya JG, 2005, CLIN PERINATOL, V32, P705, DOI 10.1016/j.clp.2005.04.011; BERREBI A, 1994, LANCET, V344, P950, DOI 10.1016/S0140-6736(94)92298-5; Fricker-Hidalgo H, 2006, DIAGN MICR INFEC DIS, V56, P167, DOI 10.1016/j.diagmicrobio.2006.04.001; Lachaud L, 2009, DIAGN MICR INFEC DIS, V64, P267, DOI 10.1016/j.diagmicrobio.2009.02.014; Nishikawa A, 2009, J OBSTET GYNAECOL RE, V35, P372, DOI 10.1111/j.1447-0756.2008.00953.x; Sickinger E, 2008, DIAGN MICR INFEC DIS, V62, P235, DOI 10.1016/j.diagmicrobio.2008.07.005; Wallon M, 2010, OBSTET GYNECOL, V115, P727, DOI 10.1097/AOG.0b013e3181d57b09; Yamada H, 2015, J INFECT CHEMOTHER, V21, P161, DOI 10.1016/j.jiac.2014.10.013	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	SEP	2015	21	9					668	671		10.1016/j.jiac.2015.05.013		4	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CR2PG	WOS:000361172000007		
J	Horiuchi, A; Kubota, N; Hidaka, E; Shimabukuro, A; Yasukochi, S; Nakamura, T; Oana, K; Kawakami, Y				Horiuchi, Ayaka; Kubota, Noriko; Hidaka, Eiko; Shimabukuro, Atsuya; Yasukochi, Satoshi; Nakamura, Tomohiko; Oana, Kozue; Kawakami, Yoshiyuki			Notable alkaline tolerance of Kocuria marina isolate from blood of a pediatric patient with continuous intravenous epoprostenol therapy	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Kocuria marina; Alkaline tolerance; Alkalophilic; Epoprostenol; Catheter-related blood stream infection	CATHETER-RELATED BACTEREMIA; PRIMARY PULMONARY-HYPERTENSION; PERITONEAL-DIALYSIS; ARTERIAL-HYPERTENSION; STREAM INFECTIONS; SP. NOV.; KRISTINAE; ROSEA; TREPROSTINIL; ENDOCARDITIS	This study was the first to describe the hitherto deficiently evaluated alkaline tolerance of Kocuria marina isolate from a pediatric patient with continuous intravenous epoprostenol dosing therapy. Our isolate from blood of a 7-year-old Japanese boy was finally identified as K. marina by the morphological, cultural, and biochemical properties together with the comparative sequence analyses of the 16S rRNA genes. The K. marina isolate, the causative agent of catheter-related blood-stream infection, was not only revealed to be salt tolerant (NaCl 15%), but also demonstrated to be stably survived with no apparent decrease of cell counts for long periods (120 h) in an alkaline environment (pH 8, 9, 10, and 11) at 35 degrees C. Its remarkable tolerance to the stresses of high alkalinity compared with a clinical Staphylococcus aureus strain should provide consistent interpretation that the environment of high alkalinity (pH 10.2-10.8) measures should be insufficient to inactivate almost all the causative agents including K. marina strains in the solution of epoprostenol (pH 10.4) (Flolan (R), GlaxoSmithKline, Ltd., Tokyo, Japan.). To the best of our knowledge, the first description of the property of being tolerant to high alkalinity that the K. marina isolate exhibited was noteworthy and a useful piece of information. In conclusion, we believe that the present study should be a notification regarding the potential risk of catheter-related blood-stream infections due to K. marina, suggestive of an alkalophile, especially in patients receiving continuous intravenous epoprostenol dosing therapy. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Horiuchi, Ayaka; Kubota, Noriko; Hidaka, Eiko] Nagano Childrens Hosp, Dept Lab Med, Azumino 3998288, Japan; [Kubota, Noriko; Hidaka, Eiko; Nakamura, Tomohiko] Nagano Childrens Hosp, Dept Life Sci, Res Ctr, Azumino 3998288, Japan; [Shimabukuro, Atsuya; Yasukochi, Satoshi] Nagano Childrens Hosp, Dept Pediat Cardiol, Azumino 3998288, Japan; [Nakamura, Tomohiko] Nagano Childrens Hosp, Dept Infect Control, Azumino 3998288, Japan; [Oana, Kozue; Kawakami, Yoshiyuki] Shinshu Univ, Grad Sch Med, Dept Hlth & Med Sci, Div Infect Control & Microbiol Regulat, Matsumoto, Nagano 3908621, Japan; [Oana, Kozue; Kawakami, Yoshiyuki] Shinshu Univ, Dept Biomed Lab Sci, Div Clin Microbiol, Sch Hlth Sci,Sch Med, Matsumoto, Nagano 3908621, Japan	Kawakami, Y (reprint author), Shinshu Univ, Grad Sch Med, Dept Hlth & Med Sci, Div Infect Control & Microbiol Regulat, Matsumoto, Nagano 3908621, Japan.	yk23724@shinshu-u.ac.jp					Altuntas F, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-62; STACKEBRANDT E, 1995, INT J SYST BACTERIOL, V45, P682; Kim SB, 2004, INT J SYST EVOL MICR, V54, P1617, DOI 10.1099/ijs.0.02742-0; McLaughlin VV, 1998, NEW ENGL J MED, V338, P273, DOI 10.1056/NEJM199801293380501; Kovacs G, 1999, INT J SYST BACTERIOL, V49, P167; BARST RJ, 1994, ANN INTERN MED, V121, P409; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Becker K, 2008, J CLIN MICROBIOL, V46, P3537, DOI 10.1128/JCM.00823-08; Moissenet D, 2012, J CLIN MICROBIOL, V50, P1495, DOI 10.1128/JCM.06038-11; Basaglia G, 2002, J CLIN MICROBIOL, V40, P311, DOI 10.1128/JCM.40.1.311-313.2002; Ben-Ami R, 2003, J CLIN MICROBIOL, V41, P2444, DOI 10.1128/JCM.41.6.2444-2447.2003; Brandle G, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0719-5; Carlini A, 2011, PERITON DIALYSIS INT, V31, P105, DOI 10.3747/pdi.2010.00132; Barst R., 2007, Morbidity and Mortality Weekly Report, V56, P170; Chen HM, 2015, J MICROBIOL IMMUNOL, V48, P80, DOI 10.1016/j.jmii.2013.07.001; Cheung CY, 2011, PERITON DIALYSIS INT, V31, P107, DOI 10.3747/pdi.2010.00125; Citro R, 2013, J MED MICROBIOL, V62, P932, DOI 10.1099/jmm.0.054536-0; Corti M, 2012, REV CHIL INFECTOL, V29, P355, DOI 10.4067/S0716-10182012000300019; Domont F, 2014, JMM CASE REP; Dotis J, 2012, PERITON DIALYSIS INT, V32, P577, DOI 10.3747/pdi.2011.00300; Dunn R, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-31; Kallen AJ, 2008, INFECT CONT HOSP EP, V29, P342, DOI 10.1086/529552; Kilic EK, 2009, MIKROBIYOL BUL, V43, P335; Kubota N, 2013, J MED MICROBIOL, V62, P1883, DOI 10.1099/jmm.0.062752-0; Lai CC, 2011, CLIN MICROBIOL INFEC, V17, P190, DOI 10.1111/j.1469-0691.2010.03211.x; Lee JY, 2009, J CLIN MICROBIOL, V47, P3376, DOI 10.1128/JCM.00847-09; Ma ES, 2005, BMC INFECT DIS, V19, P5; Martinaud C, 2008, MED MALADIES INFECT, V38, P165, DOI 10.1016/j.medmal.2007.11.006; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; McLaughlin VV, 2003, J CARDIOVASC PHARM, V41, P293, DOI 10.1097/00005344-200302000-00019; Meletis G, 2012, NEFROLOGIA, V32, P541, DOI 10.3265/Nefrologia.pre2012.Apr.11471; Mi-Na Lee MD, 2014, LAB MED ONLINE, V2014, P51; Moreira JS, 2015, BRAZ J INFECT DIS, V19, P82, DOI 10.1016/j.bjid.2014.09.007; Oncel EK, 2012, EUR J PEDIATR, V171, P593, DOI 10.1007/s00431-011-1573-8; Rich JD, 2012, CHEST, V141, P36, DOI 10.1378/chest.11-0245; Sipahi OR, 2014, SURG INFECT, V15, P659, DOI 10.1089/sur.2013.220; Sohn KM, 2015, J INFECT CHEMOTHER, V21, P305, DOI 10.1016/j.jiac.2014.11.005; Srinivasa KH, 2013, BMJ CASE REP, V2013; Tsai CY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-102	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	SEP	2015	21	9					680	686		10.1016/j.jiac.2015.06.004		7	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CR2PG	WOS:000361172000009		
J	Onozawa, K; Miyake, N; Iwasaki, N; Nishida, R; Chong, Y; Shimoda, S; Shimono, N; Akashi, K				Onozawa, Kyoko; Miyake, Noriko; Iwasaki, Noriko; Nishida, Ruriko; Chong, Yong; Shimoda, Shinji; Shimono, Nobuyuki; Akashi, Koichi			A case of Candida albicans fungus balls in the urinary tract appeared during the course of antifungal treatment for Candida endophthalmitis	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Candida albicans; Fungus ball; Antifungal agent; Pharmacokinetics	BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; RISK-FACTORS; PROSPECTIVE MULTICENTER; PHARMACOKINETICS; SURVEILLANCE; MANAGEMENT; HUMANS	Fungus balls have been rarely implicated as a cause of urinary tract obstruction. Here, we report a case of Candida albicans fungus balls in the urinary tract after the treatment of Candida endophthalmitis that has enough periods and adequate amount of antifungal agents. The patient completely recovered from this rare complication by irrigating through single-J stent and changing antifungal agents. Here we emphasize that we should take into account not only the susceptibility test results but also the difference in excretion route and tissue distribution of antifungal agents. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Onozawa, Kyoko; Miyake, Noriko; Iwasaki, Noriko; Nishida, Ruriko; Chong, Yong; Shimoda, Shinji; Shimono, Nobuyuki; Akashi, Koichi] Kyushu Univ, Fac Med, Dept Med & Biosyst Sci, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan	Miyake, N (reprint author), Kyushu Univ, Grad Sch Med Sci, Fac Med & Biosyst Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	tsuchy@intmed1.med.kyushu-u.ac.jp					Puzniak L, 2004, INFECT CONT HOSP EP, V25, P628, DOI 10.1086/502452; Sobel JD, 2011, CLIN INFECT DIS, V52, pS433, DOI 10.1093/cid/cir109; Sallam A, 2012, RETINA-J RET VIT DIS, V32, P1129, DOI 10.1097/IAE.0b013e31822d3a34; Chow JK, 2008, CRIT CARE MED, V36, P1993, DOI 10.1097/CCM.0b013e31816fc4cd; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Lashof AMLO, 2011, CLIN INFECT DIS, V53, P262, DOI 10.1093/cid/cir355; Kauffman CA, 2000, CLIN INFECT DIS, V30, P14, DOI 10.1086/313583; Johnson LB, 2003, CLIN INFECT DIS, V36, P630, DOI 10.1086/367933; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; IRBY PB, 1990, J UROLOGY, V143, P447; Blumberg HM, 2001, CLIN INFECT DIS, V33, P177, DOI 10.1086/321811; Bekersky I, 2002, ANTIMICROB AGENTS CH, V46, P828, DOI 10.1128/AAC.46.3.828-833.2002; BRAMMER KW, 1990, REV INFECT DIS, V12, pS318; Chavan Randhir, 2012, Case Rep Ophthalmol, V3, P277, DOI 10.1159/000342135; Martinez-Vasquez C, 1998, CLIN INFECT DIS, V27, P1130; Nucci M, 1998, INFECT CONT HOSP EP, V19, P846; SCERPELLA EG, 1994, CLIN INFECT DIS, V18, P440; Simpson C, 2004, J INFECTION, V49, P248, DOI 10.1016/j.jinf.2003.08.008	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	SEP	2015	21	9					687	690		10.1016/j.jiac.2015.04.009		4	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CR2PG	WOS:000361172000010		
J	Enomoto, Y; Oba, M; Ishii, N; Nakanaga, K; Yagi, Y; Hasegawa, H; Ozawa, Y; Matsui, T; Yokomura, K; Suda, T				Enomoto, Yasunori; Oba, Misao; Ishii, Norihisa; Nakanaga, Kazue; Yagi, Yuki; Hasegawa, Hirotsugu; Ozawa, Yuichi; Matsui, Takashi; Yokomura, Koshi; Suda, Takafumi			Rhinosinusitis and disseminated cutaneous infection caused by Mycobacterium chelonae in an immunocompromised patient	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Mycobacterium chelonae; Disseminated cutaneous infection; Rhinosinusitis	IDENTIFICATION; OUTBREAK	Mycobacterium chelonae frequently involves the skin, and the disseminated form can be observed in immunocompromised patients. In contrast, rhinosinusitis caused by the bacterium is a rare manifestation, which occurs independently of immune status. We report here a rare case of M. chelonae infection presenting as both disseminated cutaneous infection and rhinosinusitis in an immunocompromised patient. He had received systemic corticosteroids for 11 months due to cryptogenic organizing pneumonia. Before admission, he sustained injuries to his left arm and hand; those injuries succumbed to an infection that would subsequently spread to his other limbs, face, and even nasal cavities. This valuable case suggests that disseminated cutaneous infection by M. chelonae could spread to other organs. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Enomoto, Yasunori; Hasegawa, Hirotsugu; Ozawa, Yuichi; Matsui, Takashi; Yokomura, Koshi] Seirei Mikatahara Gen Hosp, Resp Dis Ctr, Dept Resp Med, Hamamatsu, Shizuoka 4338558, Japan; [Oba, Misao] Seirei Mikatahara Gen Hosp, Dept Dermatol, Hamamatsu, Shizuoka 4338558, Japan; [Ishii, Norihisa; Nakanaga, Kazue] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan; [Yagi, Yuki] Seirei Mikatahara Gen Hosp, Dept Otorhinolaryngol, Hamamatsu, Shizuoka 4338558, Japan; [Enomoto, Yasunori; Suda, Takafumi] Hamamatsu Univ, Sch Med, Dept Internal Med 2, Hamamatsu, Shizuoka, Japan	Enomoto, Y (reprint author), Seirei Mikatahara Gen Hosp, Resp Dis Ctr, Dept Resp Med, Kita Ku, 3453 Mikatahara Cho, Hamamatsu, Shizuoka 4338558, Japan.	yasuyasuyasu29@yahoo.co.jp					Thompson GR, 2012, J ALLERGY CLIN IMMUN, V129, P321, DOI 10.1016/j.jaci.2011.11.039; WALLACE RJ, 1992, J INFECT DIS, V166, P405; Carpenter JB, 2010, J AM ACAD DERMATOL, V62, P831, DOI 10.1016/j.jaad.2008.07.031; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Solyar A, 2012, OTOLARYNG HEAD NECK, V146, P1012, DOI 10.1177/0194599812437333; Wentworth AB, 2013, MAYO CLIN PROC, V88, P38, DOI 10.1016/j.mayocp.2012.06.029; Nakanaga K, 2013, J DERMATOL, V40, P151, DOI 10.1111/1346-8138.12047; Kennedy BS, 2012, NEW ENGL J MED, V367, P1020, DOI 10.1056/NEJMoa1205114; Mali Swapna A, 2014, Indian J Dermatol, V59, P495, DOI 10.4103/0019-5154.139904; Mullin D, 2009, ANN OTO RHINOL LARYN, V118, P714; Pandita D, 1999, CLIN INFECT DIS, V28, P1183, DOI 10.1086/517780; Salmanzadeh S, 2014, INT J INFECT DIS, V27, P67, DOI 10.1016/j.ijid.2014.04.004; SINGH N, 1992, CLIN INFECT DIS, V14, P156; SOTO LE, 1991, J HOSP INFECT, V19, P99, DOI 10.1016/0195-6701(91)90102-E; Spring PM, 1999, ENT-EAR NOSE THROAT, V78; Suh JD, 2011, AM J RHINOL ALLERGY, V25, P421, DOI 10.2500/ajra.2011.25.3677; Takekoshi D, 2013, J INFECT CHEMOTHER, V19, P754, DOI 10.1007/s10156-012-0492-6; Yap Felix Boon-Bin, 2011, Int J Infect Dis, V15, pe727, DOI 10.1016/j.ijid.2011.05.005	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	SEP	2015	21	9					691	694		10.1016/j.jiac.2015.04.014		4	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CR2PG	WOS:000361172000011		
J	Magarifuchi, H; Kusaba, K; Yamakuchi, H; Hamada, Y; Urakami, T; Aoki, Y				Magarifuchi, Hiroki; Kusaba, Koji; Yamakuchi, Hiroki; Hamada, Yohei; Urakami, Toshiharu; Aoki, Yosuke			Staphylococcus saprophyticus native valve endocarditis in a diabetic patient with neurogenic bladder: A case report	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Staphylococcus saprophyticus; Coagulase-negative Staphylococcus; Native valve endocarditis; Urinary tract catheterization	COAGULASE-NEGATIVE STAPHYLOCOCCI; UNDERLYING CARDIAC LESIONS; INFECTIVE ENDOCARDITIS; AUREUS BACTEREMIA; BACTERIURIA; ADULTS; ASSOCIATION	A 61-year-old man was admitted to our hospital with 2-day history of malaise and dyspnea. He had mitral prolapse and type II diabetes mellitus with neurogenic bladder, which was cared for by catheterization on his own. On arrival the patient was in septic condition with hypoxemia, and physical examination revealed systolic murmur at the apex. Transthoracic echocardiography revealed vegetation of the mitral and the aortic valve. The presence of continuous bacteremia was confirmed by multiple sets of blood culture, whereby gram-positive cocci was retrieved and identified as Staphylococcus saprophyticus (S. saprophyticus) both phenotypically and genetically. Because two major criteria of the Modified Duke Criteria were met, the patient was diagnosed with native valve endocarditis due to S. saprophyticus. The urine culture was also positive for gram-positive cocci, phenotypically identified as Staphylococcus warneri, which was subsequently identified as S. saprophyticus with the use of 16S rRNA gene sequence analysis and MALDI-TOF MS (matrix-assisted laser desorption ionization time of flight mass spectrometry), indicating strongly that the intermittent catheterization-associated urinary tract infection resulted in bacteremia that eventually lead to infective endocarditis. This patient was treated with vancomycin and clindamycin. Because of multiple cerebral infarctions, the patient underwent mitral and aortic valve replacement on hospital day 5. Blood culture turned negative at 6th hospital day. Antibiotic therapy was continued for six weeks after surgery. The patient's clinical course was uneventful thereafter, and was discharged home. This is the first case report of native valve endocarditis caused by S. saprophyticus of confirmed urinary origin. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Magarifuchi, Hiroki; Yamakuchi, Hiroki; Hamada, Yohei; Urakami, Toshiharu; Aoki, Yosuke] Saga Univ Hosp, Div Infect Dis & Hosp Epidemiol, Saga, Japan; [Kusaba, Koji] Saga Univ Hosp, Div Clin Lab, Saga, Japan; [Aoki, Yosuke] Saga Univ, Fac Med, Dept Int Med, Div Clin Infect Dis, Saga, Japan	Magarifuchi, H (reprint author), 5-1-1 Nabeshima, Saga 8498501, Japan.	h.magari@hotmail.co.jp					Raz R, 2005, CLIN INFECT DIS, V40, P896, DOI 10.1086/428353; Piette A, 2009, VET MICROBIOL, V134, P45, DOI 10.1016/j.vetmic.2008.09.009; Chu VH, 2008, CLIN INFECT DIS, V46, P232, DOI 10.1086/524666; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Koh GCKW, 2012, EUR J CLIN MICROBIOL, V31, P379, DOI 10.1007/s10096-011-1337-4; Darley ESR, 2004, J ANTIMICROB CHEMOTH, V53, P928, DOI 10.1093/jac/dkh191; Calvet HM, 2001, INFECT DIS CLIN N AM, V15, P407, DOI 10.1016/S0891-5520(05)70153-7; MCKINSEY DS, 1987, AM J MED, V82, P681, DOI 10.1016/0002-9343(87)90001-5; Muder RR, 2006, CLIN INFECT DIS, V42, P46, DOI 10.1086/498518; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Gupta S, 2007, INFECT DIS CLIN N AM, V21, P617, DOI 10.1016/j.idc.2007.07.003; Widerstrom M, 2012, EUR J CLIN MICROBIOL, V31, P7, DOI 10.1007/s10096-011-1270-6; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Asgeirsson H, 2012, J INFECTION, V64, P41, DOI 10.1016/j.jinf.2011.10.009; Baddour LM, 2005, CIRCULATION, V111, P394; Becker K, 2011, MANUAL CLIN MICROBIO, V1, P308; Chihara S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-225; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Garduno E, 2005, SCAND J INFECT DIS, V37, P690, DOI 10.1080/00365540510027200; Hebert C, 2012, INFECT CONT HOSP EP, V33, P381, DOI 10.1086/664768; Hessen MT, 2000, INFECT DIS CLIN N AM, V14, P265, DOI 10.1016/S0891-5520(05)70247-6; Huggan PJ, 2008, J HOSP INFECT, V69, P345, DOI 10.1016/j.jhin.2008.04.027; LEE BK, 1978, AM J MED, V65, P303, DOI 10.1016/0002-9343(78)90824-0; Rupp ME, 2010, MANDELL DOUGLAS BENN, V1, P2579; Seifert H, 2009, CLIN INFECT DIS S4, V48, P238; SINGH VR, 1990, J INFECT DIS, V162, P783; WEINBERGER I, 1990, CLIN CARDIOL, V13, P94	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	SEP	2015	21	9					695	699		10.1016/j.jiac.2015.05.008		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CR2PG	WOS:000361172000012		
J	Uehara, Y; Ito, T; Ogawa, Y; Hirotaki, S; Shoji, T; Tame, T; Horikoshi, Y; Hiramatsu, K				Uehara, Yuki; Ito, Teruyo; Ogawa, Yu; Hirotaki, Shintaro; Shoji, Takayo; Tame, Tomoyuki; Horikoshi, Yuho; Hiramatsu, Keiichi			Molecular epidemiologic study of community-associated methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin gene among family members in Japan	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Community-associated methicillin-resistant; Staphylococcus aureus; Skin and soft tissue infection; Panton-Valentine leukocidin; USA300; Intrafamilial transmission	USA300; STRAIN; CLONE; INFECTION	Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is one of the worldwide concerns of antimicrobial chemotherapy. An accumulation of ten patients in five families (A-E) suffering from skin and soft tissue infection (SSTI) of CA-MRSA was experienced in 2012, in Fuchu-shi, Tokyo, Japan. Molecular epidemiological investigation was performed for the 10 MRSA strains obtained from 8 children and 2 of their parents to assess endemic patterns of CA-MRSA in the community. Results of molecular typing, presence of toxin genes and antimicrobial susceptibilities were analyzed combined with the patients' clinical information. Each family had its own unique MRSA strain: A, ST30-SCCmec IVd; B, ST8-SCCmec IVd; C, ST8-SCCmec IVa; D, ST8-SCCmec IVl; E, ST8-SCCmec IVl and ST858-SCCmec IVl. Seven strains from the families A-C carried Panton-Valentine leukocidin gene. Three strains from the families D and E carried toxic shock syndrome toxin gene. Strains belonged to the same family demonstrated genetically related banding patterns of pulsed-filed gel electrophoresis. The family C experienced intrafamilial transmission of USA300-0114. Our data showed the MRSA clones disseminating in this community were highly diverse. They contained USA300-0114 clone, the rapidly distributing clone in the world, as well as MRSA clones identified in Japan. Our results suggested intrafamilial transmission of MRSA could be initial phenomenon of wide transmission in a community, therefore CA-MRSA SSTI in children and their family members should be monitored closely in order to notice the spread of highly pathogenic and transmittable strains. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Uehara, Yuki; Ito, Teruyo; Ogawa, Yu; Hiramatsu, Keiichi] Juntendo Univ, Dept Infect Control Sci, Fac Med, Tokyo 1138421, Japan; [Hirotaki, Shintaro; Horikoshi, Yuho] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat, Div Infect Dis, Hachioji, Tokyo, Japan; [Shoji, Takayo] Shizuoka Childrens Hosp, Dept Infect Dis, Shizuoka, Japan; [Tame, Tomoyuki] Tokyo Metropolitan Childrens Med Ctr, Div Clin Lab, Hachioji, Tokyo, Japan	Uehara, Y (reprint author), Juntendo Univ, Dept Infect Control Sci, Fac Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yuuehara@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology Supported Program for the Strategic Research Foundation at Private University [S1201013]	This study was supported in part by a Grant-in-Aid (S1201013) from Ministry of Education, Culture, Sports, Science, and Technology Supported Program for the Strategic Research Foundation at Private University, 2012-2016.	Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Nerby JM, 2011, PEDIATR INFECT DIS J, V30, P927, DOI 10.1097/INF.0b013e31822256c3; Yanagihara K, 2012, DIAGN MICR INFEC DIS, V72, P253, DOI 10.1016/j.diagmicrobio.2011.11.010; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Uehara Y, 2013, J HOSP INFECT, V84, P81, DOI 10.1016/j.jhin.2013.01.004; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; Iwao Y, 2012, J INFECT CHEMOTHER, V18, P96, DOI 10.1007/s10156-011-0348-5; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Shibuya Yasuhiro, 2008, Journal of Infection and Chemotherapy, V14, P439, DOI 10.1007/s10156-008-0640-1; Nimmo GR, 2012, CLIN MICROBIOL INFEC, V18, P725, DOI 10.1111/j.1469-0691.2012.03822.x; Hosoya S., 2014, Journal of the Japanese Association for Infectious Diseases, V88, P840; Isobe H, 2012, BIOMED RES-TOKYO, V33, P97, DOI 10.2220/biomedres.33.97; Nakamura I, 2013, JPN J INFECT DIS, V66, P416; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	SEP	2015	21	9					700	702		10.1016/j.jiac.2015.05.005		3	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	CR2PG	WOS:000361172000013		
J	Kawada, K; Toda, K; Nakamoto, Y; Iwamoto, M; Hatano, E; Chen, FS; Hasegawa, S; Togashi, K; Date, H; Uemoto, S; Sakai, Y				Kawada, Kenji; Toda, Kosuke; Nakamoto, Yuji; Iwamoto, Masayoshi; Hatano, Etsuro; Chen, Fengshi; Hasegawa, Suguru; Togashi, Kaori; Date, Hiroshi; Uemoto, Shinji; Sakai, Yoshiharu			Relationship Between F-18-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer	JOURNAL OF NUCLEAR MEDICINE			English	Article						metastatic colorectal cancer; genetics; KRAS; F-18-FDG PET/CT; imaging	K-RAS MUTATIONS; ACCUMULATION; EGFR; HETEROGENEITY; CONCORDANCE; CETUXIMAB; THERAPY; HYPOXIA; TUMORS; SITES	Several studies have shown that KRAS mutations in colorectal cancer (CRC) result in the lack of response to anti-epidermal growth factor receptor-based therapy; thus, KRAS mutational testing has been incorporated into routine clinical practice. However, 1 limitation of this test is the heterogeneity of KRAS status, which can be either intratumoral heterogeneity within an individual primary CRC or discordant KRAS status between a primary CRC and its corresponding metastases. We previously reported that F-18-FDG accumulation was significantly higher in primary CRCs with mutated KRAS than in those with wild-type KRAS. However, the clinical utility of the previous report has been limited because endoscopic biopsy for testing KRAS status is safe and feasible only in primary CRC. The purpose of this study was to investigate whether KRAS status is associated with F-18-FDG accumulation in metastatic CRC and whether F-18-FDG PET/CT scans can be used to predict the KRAS status of metastatic CRC. Methods: A retrospective analysis was performed on 55 metastatic CRC tumors that were identified by F-18-FDG PET/CT before surgical resection. Maximum standardized uptake value (SUVmax) of the respective metastatic tumor was calculated from F-18-FDG accumulation. Results: From the analysis with the 55 tumors, no significant correlation was found between SUVmax and KRAS status. We next analyzed only tumors larger than 10 mm to minimize the bias of partial-volume effect and found that SUVmax was significantly higher in the KRAS-mutated group than in the wild-type group (8.3 +/- 4.1 vs. 5.7 +/- 2.4, respectively; P = 0.03). Multivariate analysis indicated that SUVmax remained significantly associated with KRAS mutations (P = 0.04). KRAS status could be predicted with an accuracy of 71.4% when an SUVmax cutoff value of 6.0 was used. Conclusion: F-18-FDG accumulation into metastatic CRC was associated with KRAS status. F-18-FDG PET/CT scans may be useful for predicting the KRAS status of metastatic CRC and help in determining the therapeutic strategies against metastatic CRC.	[Kawada, Kenji; Toda, Kosuke; Iwamoto, Masayoshi; Hatano, Etsuro; Hasegawa, Suguru; Uemoto, Shinji; Sakai, Yoshiharu] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto 6068507, Japan; [Nakamoto, Yuji; Togashi, Kaori] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto 6068507, Japan; [Chen, Fengshi; Date, Hiroshi] Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto 6068507, Japan	Kawada, K (reprint author), Kyoto Univ, Dept Surg, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawara Cho, Kyoto 6068507, Japan.	kkawada@kuhp.kyoto-u.ac.jp					Etienne-Grimaldi MC, 2008, CLIN CANCER RES, V14, P4830, DOI 10.1158/1078-0432.CCR-07-4906; Kawada K, 2012, CLIN CANCER RES, V18, P1696, DOI 10.1158/1078-0432.CCR-11-1909; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Kikuchi H, 2009, CANCER RES, V69, P8499, DOI 10.1158/0008-5472.CAN-09-2213; Miles KA, 2014, J NUCL MED, V55, P386, DOI 10.2967/jnumed.113.120485; Baas JM, 2011, ONCOLOGIST, V16, P1239, DOI 10.1634/theoncologist.2011-0024; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Albanese I, 2004, BIOCHEM BIOPH RES CO, V325, P784, DOI 10.1016/j.bbrc.2004.10.111; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Jadvar H, 2009, J NUCL MED, V50, P1820, DOI 10.2967/jnumed.108.054098; Santini D, 2008, ONCOLOGIST, V13, P1270, DOI 10.1634/theoncologist.2008-0181; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Pauwels EKJ, 1998, NUCL MED BIOL, V25, P317, DOI 10.1016/S0969-8051(97)00226-6; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Chen SW, 2014, CLIN NUCL MED, V39, P685, DOI 10.1097/RLU.0000000000000481; Molinari F, 2009, BRIT J CANCER, V100, P1087, DOI 10.1038/sj.bjc.6604848; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Akhurst T, 2005, J CLIN ONCOL, V23, P8713, DOI 10.1200/JCO.2005.04.4222; Caicedo C, 2014, EUR J NUCL MED MOL I, V41, P2058, DOI 10.1007/s00259-014-2833-4; Gillies Robert J, 2008, J Nucl Med, V49 Suppl 2, p24S, DOI 10.2967/jnumed.107.047258; Iwamoto M, 2014, J NUCL MED, V55, P2038, DOI 10.2967/jnumed.114.142927; Plathow C, 2008, J NUCL MED, V49, P43, DOI DOI 10.2967/JNUMED.107.045930; Suenaga Y, 2013, EUR J RADIOL, V82, P1696, DOI 10.1016/j.ejrad.2013.05.019	26	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	SEP	2015	56	9					1322	1327		10.2967/jnumed.115.160614		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CR2IV	WOS:000361153000014		
J	Kimura, Y; Ichise, M; Ito, H; Shimada, H; Ikoma, Y; Seki, C; Takano, H; Kitamura, S; Shinotoh, H; Kawamura, K; Zhang, MR; Sahara, N; Suhara, T; Higuchi, M				Kimura, Yasuyuki; Ichise, Masanori; Ito, Hiroshi; Shimada, Hitoshi; Ikoma, Yoko; Seki, Chie; Takano, Harumasa; Kitamura, Soichiro; Shinotoh, Hitoshi; Kawamura, Kazunori; Zhang, Ming-Rong; Sahara, Naruhiko; Suhara, Tetsuya; Higuchi, Makoto			PET Quantification of Tau Pathology in Human Brain with C-11-PBB3	JOURNAL OF NUCLEAR MEDICINE			English	Article						PET quantification; tau; C-11-PBB3; Alzheimer disease	POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; AMYLOID-BETA; DISTRIBUTION VOLUME; HYPOTHETICAL MODEL; DYNAMIC BIOMARKERS; GRAPHICAL ANALYSIS; PHASE-2 TRIAL; MOUSE MODEL; BINDING	Tau accumulation in the brain is a pathologic hallmark of Alzheimer disease and other tauopathies. Quantitative visualization of tau pathology in humans can be a powerful method as a diagnostic aid and for monitoring potential therapeutic interventions. We established methods of PET quantification of tau pathology with C-11-PBB3 (2-((1E,3E)-4-(6-(C-11-methylamino)pyridin-3-yl)buta-1,3-dienyl) benzo[d]thiazol-6-ol), considering its radiometabolite entering the brain. Methods: Seven Alzheimer disease patients and 7 healthy subjects underwent dynamic 11C-PBB3 PET scanning. Arterial blood was sampled to obtain the parent and metabolite input functions. Quantification of C-11-PBB3 binding was performed using dual-input models that take the brain metabolite activity into consideration, traditional single-input models without such considerations, and the reference tissue model (MRTMO) and standardized uptake value ratio (SUVR). The cerebellar cortex was used as the reference tissue for all methods. Results: The dual-input graphical models estimated binding parameter (BPND*) stably (similar to 0.36 in high-binding regions). The MRTMO BPND* matched the corresponding BPND* by the dual-input graphical model (r(2) = 1.00). SUVR minus 1 correlated well with MRTMO BPND* (r(2) > 0.97). However, BPND by the single-input models did not correlate with BPND* by the dual-input graphical model (r(2) = 0.04). Conclusion: The dual-input graphical model BPND* is consistent with the reference tissue BPND* and SUVR-1, suggesting that these parameters can accurately quantify binding of C-11-PBB3 despite the entry of its radiometabolites into the brain.	[Kimura, Yasuyuki; Ichise, Masanori; Ito, Hiroshi; Shimada, Hitoshi; Ikoma, Yoko; Seki, Chie; Takano, Harumasa; Kitamura, Soichiro; Shinotoh, Hitoshi; Kawamura, Kazunori; Zhang, Ming-Rong; Sahara, Naruhiko; Suhara, Tetsuya; Higuchi, Makoto] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba, Chiba 2638555, Japan; [Ito, Hiroshi] Fukushima Med Univ, Adv Clin Res Ctr, Fukushima, Japan	Kimura, Y (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, 4-9-1 Anagawa, Chiba, Chiba 2638555, Japan.	y-kimura@nirs.go.jp; ichisem@nirs.go.jp					Herrmann M, 1999, EUR NEUROL, V42, P205, DOI 10.1159/000008108; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Ichise M, 2008, J CEREBR BLOOD F MET, V28, P420, DOI 10.1038/sj.jcbfm.9600530; Villemagne VL, 2014, EUR J NUCL MED MOL I, V41, P816, DOI 10.1007/s00259-013-2681-7; MORRIS JC, 1993, NEUROLOGY, V43, P2412; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Varrone A, 2011, J NUCL MED, V52, P132, DOI 10.2967/jnumed.110.077651; Vandenberghe R, 2010, ANN NEUROL, V68, P319, DOI 10.1002/ana.22068; Giacobini E, 2013, NAT REV NEUROL, V9, P677, DOI 10.1038/nrneurol.2013.223; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; van Berckel BNM, 2013, J NUCL MED, V54, P1570, DOI 10.2967/jnumed.112.113654; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Hashimoto H, 2014, J NUCL MED, V55, P1532, DOI 10.2967/jnumed.114.139550; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Wischik C, 2009, J NUTR HEALTH AGING, V13, P367, DOI 10.1007/s12603-009-0046-5; Dickson DW, 2001, NEUROLOGY, V56, pS16; Dickson DW, 1999, J NEUROL S2, V246, pII6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujita M, 1999, SYNAPSE, V34, P290, DOI 10.1002/(SICI)1098-2396(19991215)34:4<290::AID-SYN5>3.0.CO;2-B; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096; Ichise M, 1999, J NUCL MED, V40, P1902; MCKHANN G, 1984, NEUROLOGY, V34, P939; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Okamura N, 2014, EUR J NUCL MED MOL I, V41, pS260; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; Shimada H, 2013, ALZHEIMERS DEMENT S, V9, pP845; Villemagne V, 2014, ALZHEIMERS DEMENT S, V10, pP241	36	1	1	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	SEP	2015	56	9					1359	1365		10.2967/jnumed.115.160127		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CR2IV	WOS:000361153000020		
J	Oyama, Y; Yonekura, Y; Fukahori, H				Oyama, Yumiko; Yonekura, Yuki; Fukahori, Hiroki			Nurse health-related quality of life: associations with patient and ward characteristics in Japanese general acute care wards	JOURNAL OF NURSING MANAGEMENT			English	Article						health-related quality of life; health status; nurses	HOSPITAL NURSES; DEMOGRAPHIC CHARACTERISTICS; WORKPLACE STRESSORS; ASSISTIVE PERSONNEL; WORKING-CONDITIONS; INTENSIVE-CARE; MENTAL-HEALTH; PREDICTORS; INTERVENTIONS; DELEGATION	AimTo investigate the factors affecting nurse health-related quality of life (HRQOL) by considering the patient characteristics and ward characteristics. BackgroundNurse health-related quality of life is an important health outcome, and should be promoted for quality nursing care. MethodThis cross-sectional study was conducted on nurses who work in general acute care wards in three university hospitals in metropolitan Japan. Multilevel analysis was conducted to investigate possible factors related to nurse health-related quality of life. ResultNurses who worked at a ward had a significantly lower physical health score (=-0.13, P<0.01). These nurses had a higher ratio of patients who could not understand medical instructions, had cognitive disabilities, or required assistance with activities of daily living (ADL). The number of beds was the only factor significantly related to mental health status of nurses (=0.19, P<0.05). ConclusionWork conditions that sustain nurse health should take into account not only the number of nurses, but also patient characteristics. Further large-scale studies are needed in order to investigate the effect of hospital characteristics on nurse health-related quality of life. Implications for nursing managementIncreasing the number of nurses' aides and delegating assistance with ADL to them could support nurse health-related quality of life in the acute care setting.	[Oyama, Yumiko] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Syst Management Nursing, Doctoral Program Comprehens Hlth Nursing Sci, Tokyo, Japan; [Yonekura, Yuki] Univ Tokyo, Inst Social Sci, Ctr Social Res & Data Arch, Tokyo, Japan; [Fukahori, Hiroki] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Syst Management Nursing, Tokyo, Japan	Oyama, Y (reprint author), 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138510, Japan.	yum_kanr@tmd.ac.jp			Policy Based Medical Service Foundation in Japan	This study was supported by a grant from the Policy Based Medical Service Foundation in Japan.	Potter P, 2010, J NURS MANAGE, V18, P157, DOI 10.1111/j.1365-2834.2010.01062.x; Lambert VA, 2007, INT NURS REV, V54, P85, DOI 10.1111/j.1466-7657.2007.00512.x; Letvak S, 2005, NURS OUTLOOK, V53, P66, DOI 10.1016/j.outlook.2004.09.005; Lambert VA, 2004, INT J NURS STUD, V41, P671, DOI 10.1016/j.ijnurstu.2004.02.003; Adomat R, 2003, J ADV NURS, V42, P402, DOI 10.1046/j.1365-2648.2003.02632.x; Aiken LH, 2013, INT J NURS STUD, V50, P143, DOI 10.1016/j.ijnurstu.2012.11.009; Gershon RRM, 2007, IND HEALTH, V45, P622, DOI 10.2486/indhealth.45.622; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Shiao JSC, 2010, INT ARCH OCC ENV HEA, V83, P823, DOI 10.1007/s00420-009-0501-y; Fronteira I, 2011, J CLIN NURS, V20, P2404, DOI 10.1111/j.1365-2702.2011.03721.x; Chang EML, 2007, INT J NURS STUD, V44, P1354, DOI 10.1016/j.ijnurstu.2006.06.003; Chang EM, 2006, J PROF NURS, V22, P30, DOI 10.1016/j.profnurs.2005.12.002; Kiekkas P, 2008, J NURS SCHOLARSHIP, V40, P385, DOI 10.1111/j.1547-5069.2008.00254.x; Kawakami N, 1995, INT J BEHAV MED, V2, P358, DOI 10.1207/s15327558ijbm0204_5; Asaoka S., 2011, 26 RES AID REPORT ME, V26, P15; Badovinac CC, 1999, NURS ECON, V17, P194; Bittner NP, 2009, J NURS ADMIN, V39, P142, DOI 10.1097/NNA.0b013e31819894b7; Centers for Disease Control and Prevention, 2000, MEAS HLTH DAYS POP A; Chan CW, 2012, J CLIN NURS, V21, P2247, DOI 10.1111/j.1365-2702.2012.04213.x; Fukuhara S, 2004, MANUAL SF 8 JAPANESE; Hox J. J., 2010, MULTILEVEL ANAL TECH, P54; Japanese Nursing Association, 2010, REP ACT SURV NIGHT S; Japanese Nursing Association, 2010, GUID ASS LEV NURS CA; Jordan K, 2003, J EPIDEMIOL COMMUN H, V57, P109, DOI 10.1136/jech.57.2.109; Katz M. H., 2006, MULTIVARIABLE ANAL P, P71; Kerr M., 2002, MONITORING HLTH NURS; Kiyohara K, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-44; Kobayashi T, 2011, PSYCHOGERIATRICS, V11, P177, DOI 10.1111/j.1479-8301.2011.00363.x; Kudo Y, 2012, TOHOKU J EXP MED, V228, P59, DOI 10.1620/tjem.228.59; Leary Simon, 2007, Health Serv J, V117, P26; McDowell I, 2006, MEASURING HLTH GUIDE, P10; Ministry of Health Labour and Welfare, 2010, SUMM STAT DYN SURV M; Musshauser D, 2006, J OCCUP HEALTH, V48, P383, DOI 10.1539/joh.48.383; National Institute of Health and Nutrition, 2004, OUTL RES NAT HLTH NU; Niks IMW, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-66; O'Brien-Pallas L, 2004, EVIDENCE BASED STAND; O'Brien-Pallas L, 2011, J CLIN NURS, V20, P1640, DOI 10.1111/j.1365-2702.2010.03391.x; Ono R, 2012, QUAL LIFE RES, V21, P1705, DOI 10.1007/s11136-011-0087-1; Oyama Y, 2015, J NURS MANAGE, V23, P661, DOI 10.1111/jonm.12194; Shen HC, 2005, J OCCUP HEALTH, V47, P218, DOI 10.1539/joh.47.218; Silva AA, 2010, REV SAUDE PUBL, V44, P718, DOI 10.1590/s0034-89102010000400016; Wang R., 2008, BMC PUBLIC HEALTH, V8, P92; World Health Organization (WHO) Division of Mental Health and Prevention of Substance Abuse, 1997, WHOQOL MEAS QUAL LIF; Wu SY, 2011, IND HEALTH, V49, P158, DOI 10.2486/indhealth.MS1160	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0966-0429	1365-2834		J NURS MANAGE	J. Nurs. Manag.	SEP	2015	23	6					775	783		10.1111/jonm.12207		9	Management; Nursing	Business & Economics; Nursing	CQ8EW	WOS:000360840300010		
J	Ohba, T; Arakawa, S; Koizumi, Y; Murata, M				Ohba, Toshihiko; Arakawa, Shin'ichi; Koizumi, Yuki; Murata, Masayuki			Scalable Design Method of Attractors in Noise-Induced Virtual Network Topology Control	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Attractor selection; Virtual network topology; VNT control; Wavelength division multiplexing; Wavelength-routed network	WDM NETWORK; RECONFIGURATION	One approach to accommodating IP traffic on a wavelength-routed network is to construct a virtual network topology (VNT) and reconfigure the VNT according to traffic changes. Our research group has proposed a VNT control method based on attractor selection, which is a model of the behavior by which living organisms adapt to unknown changes in their surrounding environment. Guided by attractors, the VNT control method searches for a solution: a VNT that can accommodate the IP traffic. Attractors are a subset of the equilibrium points in the solution space and correspond to VNT candidates. It is crucial to design the attractors properly, since they define the attractive states in the VNT control. If the VNT candidates are not designed properly, it takes a long time for the method to find a solution. This paper therefore proposes a method for designing VNT candidates. Our basic approach is to prepare VNT candidates in which the bottleneck links (lightpaths) are different from each other. However, our exhaustive algorithm based on this approach has the problem of requiring large amounts of computational time for large-scale networks. We therefore propose a method that hierarchically contracts a network topology to enable application of our algorithm to large-scale networks. Evaluation results show that the VNT control method using attractors obtained by our method achieves shorter convergence times.	[Ohba, Toshihiko; Arakawa, Shin'ichi; Koizumi, Yuki; Murata, Masayuki] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan	Ohba, T (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan.	t-ohba@ist.osaka-u.ac.jp			National Institute of Information and Communications Technology (NICT)	Part of this work was supported by the National Institute of Information and Communications Technology (NICT).	Agrawal G., 2006, P IEEE GLOBECOM; Ari I, 2003, PROCEEDINGS OF THE 11TH IEEE/ACM INTERNATIONAL SYMPOSIUM ON MODELING, ANALYSIS AND SIMULATION OF COMPUTER TELECOMMUNICATIONS SYSTEMS, P246; Banerjee D, 2000, IEEE ACM T NETWORK, V8, P598, DOI 10.1109/90.879346; Koizumi Y, 2010, J LIGHTWAVE TECHNOL, V28, P1720, DOI 10.1109/JLT.2010.2048412; Ohsita Y, 2010, IEEE ACM T NETWORK, V18, P177, DOI 10.1109/TNET.2009.2022263; Wu J, 2011, COMPUT NETW, V55, P2622, DOI 10.1016/j.comnet.2011.05.012; Baram Y., 1988, 100060 NASA; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Din D.-R., 2014, P INT C COMP COMM NE; Furusawa C., 2008, PLOS COMPUTATIONAL B, V4, P35; GIESELMAN SF, 2005, P IEEE ICC, P1787; Minami Yuki, 2010, Proceedings of the Second International Conference on Evolving Internet (INTERNET 2010). First International Conferences on Access Networks, Services and Technologies (ACCESS 2010), DOI 10.1109/INTERNET.2010.18; Ricciato F, 2002, IEEE INFOCOM SER, P57; Rojas R., 1996, NEURAL NETWORKS SYST; Schaeffer A, 2014, IEEE COMMUN MAG, V52, P108, DOI 10.1109/MCOM.2014.6852091; Zhang XN, 2014, COMPUT NETW, V59, P62, DOI 10.1016/j.bjp.2013.12.011	16	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	SEP	2015	7	9					851	863		10.1364/JOCN.7.000851		13	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	CR3BE	WOS:000361204300003		
J	Sato, T; Ashizawa, K; Takeshita, H; Okamoto, S; Yamanaka, N; Oki, E				Sato, Takehiro; Ashizawa, Kunitaka; Takeshita, Hidetoshi; Okamoto, Satoru; Yamanaka, Naoaki; Oki, Eiji			Logical Optical Line Terminal Placement Optimization in the Elastic Lambda Aggregation Network With Optical Distribution Network Constraints	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Energy efficient network; Integer linear programming; Next generation networking; Optical access network	ARCHITECTURE	The elastic lambda aggregation network (E lambda AN) has been presented as an access/aggregation integrated network that can accommodate multiple network services. In the E.AN, optical line terminals (OLTs) become programmable and configure logical OLTs (L-OLTs) to support network services that have different protocols and quality of service requirements. To achieve the flexible utilization of network resources and improve energy efficiency, L-OLTs are migrated between programmable OLTs like virtual machines. In this paper, an integer linear programming (ILP) model of the L-OLT placement optimization problem with optical distribution network constraints is presented. Based on this ILP model, the communication suspension time that occurs with L-OLT migration is investigated. We discuss the modification of the L-OLT migration sequence to reduce the communication suspension time. The impact of the modification on the energy saving effect of L-OLT placement optimization is evaluated in this paper.	[Sato, Takehiro; Ashizawa, Kunitaka; Takeshita, Hidetoshi; Okamoto, Satoru; Yamanaka, Naoaki; Oki, Eiji] Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Okamoto, Satoru; Oki, Eiji] Univ Electrocommun, Fac Informat & Engn, Chofu, Tokyo 1828585, Japan	Sato, T (reprint author), Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	takehiro.sato@yamanaka.ics.keio.ac.jp			Research and Development of Elastic Optical Aggregation Network;  [246849]	This work is supported by "Research and Development of Elastic Optical Aggregation Network," the commissioned research of the National Institute of Information and Communications Technology (NICT). This work is also supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows, grant No. 246849.	Altera Corporation, 2014, STRAT 5 DEV DAT VER; Jinno M, 2009, IEEE COMMUN MAG, V47, P66, DOI 10.1109/MCOM.2009.5307468; [Anonymous], 2009, 8023AV IEEE; Pickavet M, 2008, ANTS: 2008 2ND INTERNATIONAL SYMPOSIUM ON ADVANCED NETWORKS AND TELECOMMUNICATION SYSTEMS, P1; Zhang Y, 2010, IEEE COMMUN SURV TUT, V12, P441, DOI 10.1109/SURV.2011.062410.00034; [Anonymous], 2011, C RAN ROAD GREEN RAN; Velasco L, 2012, PHOTONIC NETW COMMUN, V24, P177, DOI 10.1007/s11107-012-0378-7; Baxter G., 2006, OPT FIB COMM C NAT F; Cisco Visual Networking Index, 2013, CISCO VISUAL NETWORK; Finisar Corporation, 2012, WAVESHAPER 4000S PRO; Higuchi Y., 2013, 9 INT C IP OPT NETW; Ikeda H, 2012, IEICE T COMMUN, VE95B, P696, DOI 10.1587/transcom.E95.B.696; Kaneko S., 2014, OPT FIB COMM C OFC P; Kimura S., 2013, 18 OPTOELECTRONICS C; Kotsugai A., 2014, EUR C OPT COMM ECOC; McGettrick S., 2013, 39 EUR C EXH OPT COM; Otaka A., 2008, IEEE 802 3 INT M SEO; Sakurai Y., 2011, OPT FIB COMM C NAT F; Sato T., 2014, IEICE T COMMUN, VJ97-B, P474; Sato T, 2013, IEEE INT CONF HIGH, P29, DOI 10.1109/HPSR.2013.6602286; Yamaguchi T., 2014, 12 INT C OPT INT COI	21	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	SEP	2015	7	9					928	941		10.1364/JOCN.7.000928		14	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	CR3BE	WOS:000361204300010		
J	Jia, XF; Tagawa, M; Yatsuya, H; Naito, H; Hayashi, Y; Yetti, H; Sasaki, S; Araki, A; Miyashita, C; Ikeno, T; Kishi, R; Nakajima, T				Jia, Xiaofang; Tagawa, Masahiro; Yatsuya, Hiroshi; Naito, Hisao; Hayashi, Yumi; Yetti, Husna; Sasaki, Seiko; Araki, Atsuko; Miyashita, Chihiro; Ikeno, Tamiko; Kishi, Reiko; Nakajima, Tamie			Association of maternal whole blood fatty acid status during the prenatal period with term birth dimensions: a cross-sectional study	JOURNAL OF PERINATAL MEDICINE			English	Article						Association study; fatty acid status; pregnancy; term birth outcomes	PLASMA PHOSPHOLIPIDS; CHOLESTERYL ESTERS; NORMAL-PREGNANCY; WEIGHT; STIFFNESS; DELIVERY; PROFILE; COHORT; WOMEN; N-3	Objective: To investigate selected fatty acid (FA) profiles in maternal whole blood during normal pregnancy and to evaluate their associations with term birth dimensions. Methods: We characterized nine major maternal blood FAs representing four FA families during the second and third trimester of pregnancy, and explored their associations with birth weight, length, and chest or head circumferences by multivariate regression models, using data from 318 mother-newborn pairs of the Hokkaido Study. Results: The absolute and/or relative contents of maternal blood docosahexaenoic acid and arachidonic acid were lowest at 35-41 gestational weeks during pregnancy, as was the essential FA status index. Different from palmitic and stearic acids, palmitoleic and oleic acid contents were higher at 35-41 gestational weeks than those at 23-31 gestational weeks. Three FA components were identified through principal component analysis, and were used in association analysis. Component 3, which was positively and significantly loaded by eicosapentaenoic acid (EPA), was associated with chest circumference [beta=0.281, 95% confidence interval (CI): 0.006, 0.556] at 35-41 gestational weeks (P=0.046). No significant associations were observed for Component 1 and 2 loaded by FAs except EPA. Conclusion: Maternal blood EPA content may have an important influence on infant chest circumference.	[Nakajima, Tamie] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan; [Jia, Xiaofang; Tagawa, Masahiro; Naito, Hisao; Yetti, Husna; Nakajima, Tamie] Nagoya Univ, Grad Sch Med, Dept Occupat & Environm Hlth, Nagoya, Aichi 4648601, Japan; [Jia, Xiaofang] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China; [Yatsuya, Hiroshi] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi 47011, Japan; [Hayashi, Yumi] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4648601, Japan; [Sasaki, Seiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth Sci, Sapporo, Hokkaido, Japan; [Araki, Atsuko; Miyashita, Chihiro; Ikeno, Tamiko; Kishi, Reiko] Hokkaido Univ, Ctr Environm Hlth & Sci, Sapporo, Hokkaido, Japan	Nakajima, T (reprint author), Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan.	tnasu23@med.nagoya-u.ac.jp			Japan Society for the Promotion of Science [25253050]	This work was funded by Grants-in-Aid for Health Scientific Research from the Japan Society for the Promotion of Science (25253050). Additionally, we would like to thank the medical staff and the participants at Sapporo Toho Hospital, and staff of the "Hokkaido Study on Environment and Children's Health". We also thank Ms Aiko Tajima at the Department of Occupational and Environmental Health of Nagoya University Graduate School of Medicine for the maternal blood TG and FA measurements.	Agostoni C, 2011, CLIN NUTR, V30, P503, DOI 10.1016/j.clnu.2011.01.016; Al MDM, 1996, J AM COLL NUTR, V15, P49; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; De Vriese SR, 2003, LIPIDS, V38, P1, DOI 10.1007/s11745-003-1023-y; Matorras R, 2001, J PERINAT MED, V29, P293, DOI 10.1515/JPM.2001.042; Sekikawa A, 2013, AM J HYPERTENS, V26, P1321, DOI 10.1093/ajh/hpt107; Washino N, 2009, ENVIRON HEALTH PERSP, V117, P660, DOI 10.1289/ehp.11681; AL MDM, 1995, BRIT J NUTR, V74, P55, DOI 10.1079/BJN19950106; Anderson SG, 2009, HYPERTENSION, V53, P839, DOI 10.1161/HYPERTENSIONAHA.108.123885; Kishi R, 2011, INT J EPIDEMIOL, V40, P611, DOI 10.1093/ije/dyq071; De Vriese SR, 2001, LIPIDS, V36, P15; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Konishi K, 2009, ENVIRON RES, V109, P906, DOI 10.1016/j.envres.2009.07.010; Nakashima R, 2013, TOXICOLOGY, V309, P52, DOI 10.1016/j.tox.2013.04.010; SANJURJO P, 1993, HORM METAB RES, V25, P590, DOI 10.1055/s-2007-1002183; De Vriese SR, 2003, PROSTAG LEUKOTR ESS, V68, P331, DOI 10.1016/S0952-3278(03)00024-3; De Vriese SR, 2001, ANN NUTR METAB, V45, P273, DOI 10.1159/000046738; Dirix CEH, 2009, BRIT J NUTR, V101, P399, DOI 10.1017/S0007114508006740; FOLCH J, 1957, J BIOL CHEM, V226, P497; Godfrey K. M., 2000, AM J CLIN NUTR, V71, P1344; Larque E, 1908, AM J CLIN NUTR S, V94, p1908S; Ortega-Senovilla H, 2010, CLIN SCI, V118, P351, DOI 10.1042/CS20090292; Rump P, 2001, AM J CLIN NUTR, V73, P797; Smits LJM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-23; van Eijsden M, 2008, AM J CLIN NUTR, V87, P887; Wheeler SJ, 2011, BRIT J NUTR, V105, P601, DOI 10.1017/S0007114510004083	26	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0300-5577	1619-3997		J PERINAT MED	J. Perinat. Med.	SEP	2015	43	5					565	575		10.1515/jpm-2014-0277		11	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CQ9UL	WOS:000360960600009		
J	Yamaguchi, M; Fukami, T; Asakura, H; Takeshita, T				Yamaguchi, Michiko; Fukami, Tekehiko; Asakura, Hirobumi; Takeshita, Toshiyuki			Predicting onset of labor from echogenicity of the cervical gland area on vaginal ultrasonography at term	JOURNAL OF PERINATAL MEDICINE			English	Article						Cervical echogenicity; cervical gland area; cervical ripeness; onset of labor; prediction of onset of labor	LEVEL HISTOGRAM WIDTH; TISSUE CHARACTERIZATION; TRANSVAGINAL ULTRASONOGRAPHY; FETAL FIBRONECTIN; PRETERM DELIVERY; LENGTH; SONOGRAPHY; PREGNANCY; MATURATION	Background and aim: On vaginal ultrasonography, cervical gland area (CGA) gradually disappears with advancing gestation. This is attributed in part to the echogenicity of the CGA becoming equal to that of the cervical stroma. The present study aimed to assess the usefulness of echogenicity in the CGA at term for predicting the time of spontaneous onset of labor. Methods: The ratio of mean grayscale level (MGL) in the CGA to that in the cervical stroma (CGA/stroma MGL ratio) was estimated as an index of echogenicity in the CGA in women after 36 weeks of gestation (n=190). Using this ratio, time until onset of labor was predicted among women between 37 and 38 weeks (n=104). Results: CGA/stroma MGL ratio increased with advancing gestation, decreasing cervical length (CL), and increasing Bishop score. Univariate logistic analysis indicated that a combination of CL <20 mm and CGA/stroma MGL ratio >= 100% predicted onset of labor within a week [odds ratio (OR), 22.2; 95% confidence interval (CI), 2.4-202.0] was even better than short CL alone (OR, 6.8; 95%CI, 1.7-26.7; P=0.006). Stepwise logistic analysis identified that this combination was an only independent predictor (OR, 20.8; 95%CI, 2.3-188.5; P=0.007). Conclusion: The combination of CGA/stroma MGL ratio >= 100% and short CL may offer a useful predictor of onset of labor.	[Yamaguchi, Michiko; Fukami, Tekehiko; Asakura, Hirobumi; Takeshita, Toshiyuki] Nippon Med Sch, Musashi Kosugi Hosp, Dept Obstet & Gynecol, Nakahara Ku, Kawasaki, Kanagawa 2110063, Japan	Asakura, H (reprint author), Nippon Med Sch, Musashi Kosugi Hosp, Dept Obstet & Gynecol, Nakahara Ku, 1-396 Kosugityo, Kawasaki, Kanagawa 2110063, Japan.	morgen@nms.ac.jp					ALLISON JW, 1994, RADIOGRAPHICS, V14, P1099; Asakura H, 2009, GYNECOL OBSTET INVES, V68, P1, DOI 10.1159/000209394; Maeda K, 1999, ULTRASOUND MED BIOL, V25, P201, DOI 10.1016/S0301-5629(98)00160-4; Pires CR, 2006, INT J GYNECOL OBSTET, V93, P214, DOI 10.1016/j.ijgo.2005.12.010; Kuwata T, 2010, J PERINAT MED, V38, P491, DOI 10.1515/JPM.2010.079; Maeda K, 1998, ULTRASOUND MED BIOL, V24, P225, DOI 10.1016/S0301-5629(97)00266-4; McFarlin BL, 2010, ULTRASOUND OBST GYN, V36, P218, DOI 10.1002/uog.7643; McFarlin BL, 2006, J ULTRAS MED, V25, P1031; Bayramoglu O, 2005, AM J PERINAT, V22, P35, DOI 10.1055/s-2004-837268; Bieger GM, 1997, ACTA OBSTET GYNECOL, V76, P118; Blickstein I, 1997, GYNECOL OBSTET INVES, V44, P244; FLUHMANN CF, 1958, OBSTET GYNECOL, V11, P543; Fukami Takehiko, 2003, Journal of Nippon Medical School, V70, P135; Furtado MR, 2010, AUST NZ J OBSTET GYN, V50, P444, DOI 10.1111/j.1479-828X.2010.01202.x; Goldberg J, 1997, AM J OBSTET GYNECOL, V177, P853, DOI 10.1016/S0002-9378(97)70282-5; Ito T, 2007, J MED ULTRASON, V34, P189, DOI 10.1007/s10396-007-0153-z; LEPPERT PC, 1995, CLIN OBSTET GYNECOL, V38, P267, DOI 10.1097/00003081-199506000-00009; Maeda K, 2002, ULTRASOUND REV OBSTE, V2, P124, DOI 10.1080/14722240208500466; Miura H, 2010, ACTA OBSTET GYN SCAN, V89, P757, DOI 10.3109/00016341003611212; Rozenberg P, 2000, AM J OBSTET GYNECOL, V182, P108, DOI 10.1016/S0002-9378(00)70498-4; Sekiya T, 1998, ULTRASOUND OBST GYN, V12, P328, DOI 10.1046/j.1469-0705.1998.12050328.x; Takesin I, 2005, J PERINAT MED, V33, P382; Takesin I, 2003, AM J OBSTET GYNECOL, V189, P532; Tateyama N, 2013, J PERINAT MED, V41, P151, DOI 10.1515/jpm-2012-0112; Tolaymat LL, 2007, J PERINATOL, V27, P749, DOI 10.1038/sj.jp.7211819; Yoshimatsu K, 2002, GYNECOL OBSTET INVES, V53, P149, DOI 10.1159/000058366	26	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0300-5577	1619-3997		J PERINAT MED	J. Perinat. Med.	SEP	2015	43	5					577	584		10.1515/jpm-2014-0080		8	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CQ9UL	WOS:000360960600010		
J	Toyama, K; Iwasaki, A; Suga, T				Toyama, Katsuya; Iwasaki, Aiko; Suga, Toshio			Interannual Variation of Annual Subduction Rate in the North Pacific Estimated from a Gridded Argo Product	JOURNAL OF PHYSICAL OCEANOGRAPHY			English	Article							SUBTROPICAL MODE WATER; DECADAL VARIABILITY; CIRCULATION; OCEAN; VENTILATION; REANALYSIS; REGION; BASIN; GYRE	Spatiotemporal variability of the subduction rate in the North Pacific from 2005 to 2012 is examined based on the Argo observational data. The subduction rate in the subtropical North Pacific varies significantly from year to year between 25 and 50 Sverdrups (Sv; 1 Sv equivalent to 10(6) m(3) s(-1)), and it is well correlated with the Pacific decadal oscillation. The temporal change of the subduction rate is largely determined by that of the late winter mixed layer depth through the lateral induction term. The increase (decrease) in the subduction rate in the subtropical mode water areas accompanies densification (lightening) of the mode density class of the subducted water. The subduction rate variability in the central mode water and eastern subtropical mode water regions is anticorrelated as found in the previous study using the output from an ocean GCM. The subduction rate in the central mode water density range changes dramatically, which is very large in 2005 and 2010 but almost disappears in 2009. The subduction rate variability in the western subtropical mode water regions seems to be correlated with the Pacific decadal oscillation with a lag of a few years.	[Toyama, Katsuya] Princeton Univ, Atmospher & Ocean Sci, Princeton, NJ 08544 USA; [Iwasaki, Aiko; Suga, Toshio] Tohoku Univ, Grad Sch Sci, Dept Geophys, Sendai, Miyagi 980, Japan; [Suga, Toshio] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	Toyama, K (reprint author), Meteorol Res Inst, Oceanog & Geochem Res Dept, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	ktoyama@mri-jma.go.jp			Global Center-Of-Excellence (GCOE) Program, "Global Education and Research Center for Earth and Planetary Dynamics" at Tohoku University; Sasakawa Scientific Research Grant from Japan Science Society; Japanese Society for Promotion of Science [21340133, 25287118]; Ministry of Education, Culture, Sports, Science and Technology [22106007]; NSF [OCE-1155983]	The authors appreciate the valuable comments offered by members of the Physical Oceanography Group at Tohoku University, Keith Rodgers, and two anonymous reviewers. The first author (KT) was supported by the Global Center-Of-Excellence (GCOE) Program, "Global Education and Research Center for Earth and Planetary Dynamics" at Tohoku University. The second author (AI) was supported by the Sasakawa Scientific Research Grant from Japan Science Society. The third author (TS) was supported in part by the funds from the Japanese Society for Promotion of Science [Grants-in-Aid for Scientific Research (B) 21340133 and 25287118] and from the Ministry of Education, Culture, Sports, Science and Technology [Grants-in-Aid for Scientific Research on Innovative Areas 22106007 ("A 'hot spot' in the climate system: Extra-tropical air-sea interaction under the East Asian monsoon system'')]. This work was also supported in part by NSF Award OCE-1155983.	Roemmich D, 2009, OCEANOGRAPHY, V22, P46; MASUZAWA J, 1969, DEEP-SEA RES, V16, P463, DOI 10.1016/0011-7471(69)90034-5; Suga T, 2008, PROG OCEANOGR, V77, P285, DOI 10.1016/j.pocean.2006.12.005; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; QIU B, 1995, J PHYS OCEANOGR, V25, P2374, DOI 10.1175/1520-0485(1995)025<2374:VOTNAA>2.0.CO;2; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Oka E, 2012, J OCEANOGR, V68, P5, DOI 10.1007/s10872-011-0032-5; Qu TD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040914; HELLERMAN S, 1983, J PHYS OCEANOGR, V13, P1093, DOI 10.1175/1520-0485(1983)013<1093:NMWSOT>2.0.CO;2; Oka E, 2011, J PHYS OCEANOGR, V41, P113, DOI 10.1175/2010JPO4419.1; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Liu LL, 2012, J CLIMATE, V25, P1096, DOI 10.1175/2011JCLI4228.1; Suga T, 1997, J PHYS OCEANOGR, V27, P140, DOI 10.1175/1520-0485(1997)027<0140:TDITNP>2.0.CO;2; Rainville L, 2007, OCEAN MODEL, V17, P338, DOI 10.1016/j.ocemod.2007.03.002; AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Oka E, 2012, J OCEANOGR, V68, P355, DOI 10.1007/s10872-011-0098-0; Chen J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045239; Curry R., 2001, 9601 WOODS HOL OC I, V96-01; Freeland H. J., 2010, ESA PUBLICATION WPP, V2, DOI [10.5270/OceanObs09.cwp.32, DOI 10.5270/OCEANOBS09.CWP.32]; Hanawa K., 2001, OCEAN CIRCULATION CL, V77, P373, DOI DOI 10.1016/S0074-6142(01)80129-7; Hautala SL, 1998, J GEOPHYS RES-OCEANS, V103, P13055, DOI 10.1029/98JC01015; Hosoda S., 2008, JAMSTEC REP RES DEV, V8, P47, DOI DOI 10.5918/JAMSTECR.8.47; HUANG RX, 1994, J PHYS OCEANOGR, V24, P1608, DOI 10.1175/1520-0485(1994)024<1608:TDSOTW>2.0.CO;2; Levitus S., 1982, CLIMATOLOGICAL ATLAS; Macdonald AM, 2001, J ATMOS OCEAN TECH, V18, P394, DOI 10.1175/1520-0426(2001)018<0394:AIANPC>2.0.CO;2; Nakamura H, 1996, J OCEANOGR, V52, P171, DOI 10.1007/BF02235668; Oka E, 2005, J PHYS OCEANOGR, V35, P1997, DOI 10.1175/JPO2811.1; Qiu B, 2006, J PHYS OCEANOGR, V36, P1365, DOI 10.1175/JPO2918.1; Qu TD, 2002, J PHYS OCEANOGR, V32, P746, DOI 10.1175/1520-0485(2002)032<0746:SOTNPM>2.0.CO;2; Robbins P. E., 2014, P 15 M INT ARG STEER, P12; Saitoi H, 2007, J OCEANOGR, V63, P589, DOI 10.1007/s10872-007-0052-3; Sasaki H., 2004, MTTS IEEE TECHNO OCE, V3, P1535, DOI [10.1109/OCEANS.2004.1406350, DOI 10.1109/OCEANS.2004.1406350]; Sugimoto S, 2013, GEOPHYS RES LETT, V40, P3102, DOI 10.1002/grl.50600; White WB, 1995, PROG OCEANOGR, V36, P169, DOI 10.1016/0079-6611(95)00017-8; Williams R. G., 2001, ENCY OCEAN SCI, P1982; ZHANG HM, 1992, J MAR RES, V50, P385, DOI 10.1357/002224092784797629	36	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-3670	1520-0485		J PHYS OCEANOGR	J. Phys. Oceanogr.	SEP	2015	45	9					2276	2293		10.1175/JPO-D-14-0223.1		18	Oceanography	Oceanography	CR0TQ	WOS:000361036500007		
J	Nagai, T; Tandon, A; Kunze, E; Mahadevan, A				Nagai, Takeyoshi; Tandon, Amit; Kunze, Eric; Mahadevan, Amala			Spontaneous Generation of Near-Inertial Waves by the Kuroshio Front	JOURNAL OF PHYSICAL OCEANOGRAPHY			English	Article							INTERNAL GRAVITY-WAVES; MESOSCALE OCEAN MODEL; CRITICAL LAYER; ENERGY FLUX; PART I; WIND; CIRCULATION; DYNAMICS; SHEAR; TURBULENCE	While near-inertial waves are known to be generated by atmospheric storms, recent observations in the Kuroshio Front find intense near-inertial internal-wave shear along sloping isopycnals, even during calm weather. Recent literature suggests that spontaneous generation of near-inertial waves by frontal instabilities could represent a major sink for the subinertial quasigeostrophic circulation. An unforced three-dimensional 1-km-resolution model, initialized with the observed cross-Kuroshio structure, is used to explore this mechanism. After several weeks, the model exhibits growth of 10-100-km-scale frontal meanders, accompanied by O(10) mW m(-2) spontaneous generation of near-inertial waves associated with readjustment of submesoscale fronts forced out of balance by mesoscale confluent flows. These waves have properties resembling those in the observations. However, they are reabsorbed into the model Kuroshio Front with no more than 15% dissipating or radiating away. Thus, spontaneous generation of near-inertial waves represents a redistribution of quasigeostrophic energy rather than a significant sink.	[Nagai, Takeyoshi] Tokyo Univ Marine Sci & Technol, Tokyo, Japan; [Tandon, Amit] Univ Massachusetts Dartmouth, N Dartmouth, MA USA; [Kunze, Eric] NorthWest Res Associates, Redmond, WA USA; [Mahadevan, Amala] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Nagai, T (reprint author), Japan Tokyo Univ Marine Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	tnagai@kaiyodai.ac.jp			MEXT [KAKENHI 24684036]; MIT-Hayashi Seed Fund; ONR [N000140910196, N000141210101]; NSF [OCE 0928617, 0928138]	We thank Captain Noda and crews of R.T.V Umitaka-maru, Captain Ukekura and crews of R/V Natsushima, Dr. Sasaki at JAMSTEC for OFES outputs, JSPS (KAKENHI 24684036), "The Study of Kuroshio Ecosystem Dynamics for Sustainable Fisheries (SKED)" supported by MEXT, MIT-Hayashi Seed Fund, ONR (Awards N000140910196 and N000141210101), NSF (Award OCE 0928617, 0928138) for support, and two anonymous reviewers for their insights.	Alford MH, 2013, J PHYS OCEANOGR, V43, P1225, DOI 10.1175/JPO-D-12-0146.1; Rossby CG, 1938, J MAR RES, V1, P239; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Plueddemann AJ, 2006, DEEP-SEA RES PT II, V53, P5, DOI 10.1016/j.dsr2.2005.10.017; Alford MH, 2001, J PHYS OCEANOGR, V31, P2359, DOI 10.1175/1520-0485(2001)031<2359:ISGTSD>2.0.CO;2; BOOKER JR, 1967, J FLUID MECH, V27, P513, DOI 10.1017/S0022112067000515; Mahadevan A, 2006, OCEAN MODEL, V14, P241, DOI 10.1016/j.ocemod.2006.05.006; Mahadevan A, 1996, J PHYS OCEANOGR, V26, P1868, DOI 10.1175/1520-0485(1996)026<1868:ANMOMP>2.0.CO;2; FORD R, 1994, J FLUID MECH, V281, P81, DOI 10.1017/S0022112094003046; Williams PD, 2008, J ATMOS SCI, V65, P3543, DOI 10.1175/2008JAS2480.1; SNYDER C, 1993, J ATMOS SCI, V50, P3194, DOI 10.1175/1520-0469(1993)050<3194:FDNAFF>2.0.CO;2; Wunsch C, 2004, ANNU REV FLUID MECH, V36, P281, DOI 10.1146/annurev.fluid.36.050802.122121; Plougonven R, 2007, J ATMOS SCI, V64, P2502, DOI 10.1175/JAS3953.1; Furuichi N, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004768; Kouketsu S, 2007, J PHYS OCEANOGR, V37, P644, DOI 10.1175/JPO3026.1; KUNZE E, 1995, J PHYS OCEANOGR, V25, P942, DOI 10.1175/1520-0485(1995)025<0942:TEBIAW>2.0.CO;2; HOSKINS BJ, 1978, Q J ROY METEOR SOC, V104, P31, DOI 10.1256/smsqj.43902; Wunsch C, 1998, J PHYS OCEANOGR, V28, P2332, DOI 10.1175/1520-0485(1998)028<2332:TWDBTW>2.0.CO;2; POLLARD RT, 1970, DEEP-SEA RES, V17, P813, DOI 10.1016/0011-7471(70)90043-4; Ferrari R, 2009, ANNU REV FLUID MECH, V41, P253, DOI 10.1146/annurev.fluid.40.111406.102139; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; KUNZE E, 1993, J PHYS OCEANOGR, V23, P2589, DOI 10.1175/1520-0485(1993)023<2589:SDNASP>2.0.CO;2; KUNZE E, 1985, J PHYS OCEANOGR, V15, P544, DOI 10.1175/1520-0485(1985)015<0544:NIWPIG>2.0.CO;2; Doubell MJ, 2009, J PLANKTON RES, V31, P1441, DOI 10.1093/plankt/fbp092; Buhler O, 2005, J FLUID MECH, V534, P67, DOI 10.1017/S0022112005004374; Danioux E, 2012, J FLUID MECH, V699, P153, DOI 10.1017/jfm.2012.90; Fofonoff N. P., 1981, EVOLUTION PHYSICAL O, P112; Gill A.E, 1982, INT GEOPHYS SERIES, V30, P662; Inoue R, 2010, J MAR RES, V68, P643; Lelong M. -P., 1999, DYN OC INT GRAV WAV, P197; LIEN RC, 1992, J PHYS OCEANOGR, V22, P1583, DOI 10.1175/1520-0485(1992)022<1583:NMDOSS>2.0.CO;2; Mahadevan A, 1996, J PHYS OCEANOGR, V26, P1881, DOI 10.1175/1520-0485(1996)026<1881:ANMOMP>2.0.CO;2; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; Mooers C. N. K., 1975, Geophysical Fluid Dynamics, V6, DOI 10.1080/03091927509365797; MULLER P, 1976, DEEP-SEA RES, V23, P613, DOI 10.1016/0011-7471(76)90004-8; MULLER P, 1976, J FLUID MECH, V77, P789; Nagai T, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007228; Nagai T, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038832; Nasmyth P. W., 1970, THESIS U BRIT COLUMB; Nikurashin M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046576; OORT AH, 1994, J GEOPHYS RES-OCEANS, V99, P7665, DOI 10.1029/93JC03556; Polzin KL, 2008, J PHYS OCEANOGR, V38, P2556, DOI 10.1175/2008JPO3666.1; Polzin KL, 2010, J PHYS OCEANOGR, V40, P789, DOI 10.1175/2009JPO4039.1; Rainville L, 2004, J PHYS OCEANOGR, V34, P1495, DOI 10.1175/1520-0485(2004)034<1495:OOEHIW>2.0.CO;2; Rimac A, 2013, GEOPHYS RES LETT, V40, P4882, DOI 10.1002/grl.50929; Shakespeare CJ, 2014, J FLUID MECH, V757, P817, DOI 10.1017/jfm.2014.514; Thomas LN, 2012, J FLUID MECH, V711, P620, DOI 10.1017/jfm.2012.416; Whitt DB, 2013, J PHYS OCEANOGR, V43, P706, DOI 10.1175/JPO-D-12-0132.1; Winkel DP, 2002, J PHYS OCEANOGR, V32, P3269, DOI 10.1175/1520-0485(2002)032<3269:POSATA>2.0.CO;2	49	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-3670	1520-0485		J PHYS OCEANOGR	J. Phys. Oceanogr.	SEP	2015	45	9					2381	2406		10.1175/JPO-D-14-0086.1		26	Oceanography	Oceanography	CR0TQ	WOS:000361036500012		
J	Qiu, B; Chen, SM; Rudnick, DL; Kashino, Y				Qiu, Bo; Chen, Shuiming; Rudnick, Daniel L.; Kashino, Yuji			A New Paradigm for the North Pacific Subthermocline Low-Latitude Western Boundary Current System	JOURNAL OF PHYSICAL OCEANOGRAPHY			English	Article							NORTHEASTWARD CURRENT SOUTHEAST; EQUATORIAL UNDERCURRENT JETS; MINDANAO CURRENT; PHILIPPINE SEA; KUROSHIO EAST; SUBTROPICAL COUNTERCURRENT; TROPICAL PACIFIC; MESOSCALE EDDIES; PROFILING FLOATS; LUZON STRAIT	Subthermocline western boundary circulation along the low-latitude North Pacific Ocean (2 degrees-25 degrees N) is investigated by using profiling float and historical CTD/expendable CTD (XCTD) data and by analyzing an eddy-resolving global OGCM output. In contrast to the existing paradigm depicting it as a reversed pattern of the wind-driven circulation above the ventilated thermocline (i.e., depth < 26.8 sigma(theta)), the subthermocline western boundary circulation is found to comprise two components governed by distinct dynamical processes. For meridional scales shorter than 400 km, the boundary flows along the Philippine coast exhibit convergent patterns near 7 degrees, 10 degrees, 13 degrees, and 18 degrees N, respectively. These short-scale boundary flows are driven by the subthermocline eastward zonal jets that exist coherently across the interior North Pacific basin and are generated by the triad instability of wind-forced annual baroclinic Rossby waves. For meridional scales longer than 400 km, a time-mean Mindanao Undercurrent (MUC) is observed from 6 degrees to 13 degrees N together with another northward-flowing boundary flow beneath the Kuroshio from 16 degrees to 24 degrees N. Rather than remote eddy forcing from the interior Pacific Ocean, both of these broad-scale subthermocline boundary flows are induced by baroclinic instability of the overlying wind-driven western boundary currents, the Mindanao Current, and Kuroshio.	[Qiu, Bo; Chen, Shuiming] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Rudnick, Daniel L.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Kashino, Yuji] Japan Agcy Marine Earth Sci & Technol, Ctr Earth Informat Sci & Technol, Yokohama, Kanagawa, Japan	Qiu, B (reprint author), Univ Hawaii Manoa, Dept Oceanog, 1000 Pope Rd, Honolulu, HI 96822 USA.	bo@soest.hawaii.edu			ONR project Origins of the Kuroshio and Mindanao Current (OKMC) [N00014-10-1-0267, N00014-10-1-0273]	This study benefitted from discussions with Mike Spall and Seth Travis. We thank the anonymous reviewers whose detailed comments helped improve an early version of the manuscript. The Argo profiling float data used in this study were provided by the U.S. GODAE Argo Global Data Assembly Center and the historical T-S data by U.S. National Oceanographic Data Center (NODC) and Japan Oceanographic Data Center (JODC). This study was supported by the ONR project Origins of the Kuroshio and Mindanao Current (OKMC): N00014-10-1-0267 (BQ and SC) and N00014-10-1-0273 (DLR). Arnold Gordon generously supplied additional in situ T-S data from the recent OKMC cruises.	Qiu B, 1999, J PHYS OCEANOGR, V29, P2471, DOI 10.1175/1520-0485(1999)029<2471:SEFMOT>2.0.CO;2; Wang F, 2015, J GEOPHYS RES-OCEANS, V120, P131, DOI 10.1002/2013JC009690; Kashino Y, 2001, GEOPHYS RES LETT, V28, P1263, DOI 10.1029/2000GL011630; Qiu B, 1996, J GEOPHYS RES-OCEANS, V101, P12315, DOI 10.1029/95JC03204; Zhang DX, 2001, J PHYS OCEANOGR, V31, P1054, DOI 10.1175/1520-0485(2001)031<1054:TKEOTM>2.0.CO;2; Zhu XH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015867; Kobashi F, 2012, J OCEANOGR, V68, P21, DOI 10.1007/s10872-011-0083-7; TOOLE JM, 1988, DEEP-SEA RES, V35, P1451, DOI 10.1016/0198-0149(88)90097-0; Hu DX, 2013, J PHYS OCEANOGR, V43, P1417, DOI 10.1175/JPO-D-12-0165.1; RHINES PB, 1979, DYNAM ATMOS OCEANS, V3, P289, DOI 10.1016/0377-0265(79)90015-0; Roemmich D, 2009, OCEANOGRAPHY, V22, P34, DOI 10.5670/oceanog.2009.36; Kashino Y, 2013, J GEOPHYS RES-OCEANS, V118, P6543, DOI 10.1002/2013JC009207; Qu TD, 2003, J PHYS OCEANOGR, V33, P5, DOI 10.1175/1520-0485(2003)033<0005:TBOTNE>2.0.CO;2; Qiu B, 2013, GEOPHYS RES LETT, V40, P2183, DOI 10.1002/grl.50394; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Andres M, 2008, J OCEANOGR, V64, P937, DOI 10.1007/s10872-008-0077-2; Qu TD, 1998, J GEOPHYS RES-OCEANS, V103, P7537, DOI 10.1029/98JC00263; Cravatte S, 2012, J PHYS OCEANOGR, V42, P1475, DOI 10.1175/JPO-D-11-0206.1; Centurioni LR, 2004, J PHYS OCEANOGR, V34, P113, DOI 10.1175/1520-0485(2004)034<0113:OOIOPS>2.0.CO;2; Gordon AL, 1996, NATURE, V379, P146, DOI 10.1038/379146a0; Lien RC, 2014, J GEOPHYS RES-OCEANS, V119, P2129, DOI 10.1002/2013JC009548; Park JJ, 2005, J ATMOS OCEAN TECH, V22, P1294, DOI 10.1175/JTECH1748.1; Ichikawa H, 2004, J OCEANOGR, V60, P351, DOI 10.1023/B:JOCE.0000038341.27622.73; Qu TD, 1997, DEEP-SEA RES PT I, V44, P413, DOI 10.1016/S0967-0637(96)00121-5; Kashino Y, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023880; Kobashi F, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001225; LUKAS R, 1991, J GEOPHYS RES-OCEANS, V96, P7089, DOI 10.1029/91JC00062; Johns WE, 2001, J PHYS OCEANOGR, V31, P1031, DOI 10.1175/1520-0485(2001)031<1031:TKEOTM>2.0.CO;2; Gordon AL, 2014, J GEOPHYS RES-OCEANS, V119, P4251, DOI 10.1002/2014JC009882; Chen SM, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004005; Firing E, 2005, DEEP-SEA RES PT II, V52, P605, DOI 10.1016/j.dsr2.2004.12.007; Gilson J, 2002, J OCEANOGR, V58, P183, DOI 10.1023/A:1015841120927; Hu D., 1991, CHIN J OCEANOL LIMN, V9, P1, DOI [10.1007/BF02849784, DOI 10.1007/BF02849784]; HUANG RX, 1994, J PHYS OCEANOGR, V24, P1608, DOI 10.1175/1520-0485(1994)024<1608:TDSOTW>2.0.CO;2; Imawaki S., 2013, OCEAN CIRCULATION CL, V2nd, P305; Kim YY, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002013; Lebedev K. V., 2007, 4 IPRC; Lee TN, 2001, J GEOPHYS RES-OCEANS, V106, P22143, DOI 10.1029/2000JC000535; Locarnini R. A., 2013, NOAA ATLAS NESDIS, V1, P40; Nakamura H, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003595; PEDLOSKY J., 1987, GEOPHYS FLUID DYNAMI; Qiu B., 2001, KUROSHIO OYASHIO CUR, P1413; Qiu B, 2013, J PHYS OCEANOGR, V43, P2682, DOI 10.1175/JPO-D-13-099.1; Sasaki H, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P157, DOI 10.1007/978-0-387-49791-4_10; Schonau MC, 2015, J GEOPHYS RES-OCEANS, V120, P3586, DOI 10.1002/2014JC010595; TALLEY LD, 1985, J PHYS OCEANOGR, V15, P633, DOI 10.1175/1520-0485(1985)015<0633:VOTSNP>2.0.CO;2; Vianna ML, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005494; Wang F., 1998, P 4 PAC OC REM SENS, P551; Wang QY, 2014, J GEOPHYS RES-OCEANS, V119, P3792, DOI 10.1002/2013JC009694; WIJFFELS S, 1995, J GEOPHYS RES-OCEANS, V100, P18421, DOI 10.1029/95JC01347; Zhang LL, 2014, J GEOPHYS RES-OCEANS, V119, P3617, DOI 10.1002/2013JC009693; Zweng M. M., 2013, SALINITY, V2	52	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-3670	1520-0485		J PHYS OCEANOGR	J. Phys. Oceanogr.	SEP	2015	45	9					2407	2423		10.1175/JPO-D-15-0035.1		17	Oceanography	Oceanography	CR0TQ	WOS:000361036500013		
J	Saito, H				Saito, Hisamitsu			FIRM HETEROGENEITY, MULTIPLANT CHOICE, AND AGGLOMERATION	JOURNAL OF REGIONAL SCIENCE			English	Article							FOREIGN DIRECT-INVESTMENT; TRADE; PRODUCTIVITY; ECONOMIES; INTRAINDUSTRY; SELECTION; CROWD	We examine the organization and location choice of heterogeneous firms in a two-region economy. When some high-productivity firms engage in multiplant production, a reduction in transport costs causes two changes in a small region: the closure of plants by high-productivity multiplant firms and the relocation of low-productivity single-plant firms to the region. In the presence of high-productivity multiplant firms, therefore, a decline in transport costs reinforces the spatial sorting of firms by productivity, enlarging the productivity gap between large and small regions. Conversely, reducing investment costs weakens the spatial sorting effects on regional productivity disparities.	Hokkaido Univ, Kita Ku, Sapporo, Hokkaido 0600809, Japan	Saito, H (reprint author), Hokkaido Univ, Kita Ku, Kita 9 Nishi 7, Sapporo, Hokkaido 0600809, Japan.	saitoh@econ.hokudai.ac.jp			JSPS KAKENHI [24780213]	I thank Munisamy Gopinath at Oregon State University, Toshihiro Okubo at Keio University, Yasuhiro Sato at Osaka University, two anonymous referees, and JRS Co-Editor Gianmarco Ottaviano for valuable suggestions on earlier versions of the manuscript. This work was supported by JSPS KAKENHI Grant Number 24780213.	Helpman E, 2004, AM ECON REV, V94, P300, DOI 10.1257/000282804322970814; Ottaviano G, 2002, INT ECON REV, V43, P409; De Backer K, 2003, REV IND ORGAN, V22, P67, DOI 10.1023/A:1022180317898; Syverson C, 2004, J POLIT ECON, V112, P1181, DOI 10.1086/424743; Melitz MJ, 2003, ECONOMETRICA, V71, P1695, DOI 10.1111/1468-0262.00467; Henderson JV, 2003, J URBAN ECON, V53, P1, DOI 10.1016/S0094-1190(02)00505-3; Okubo T, 2010, J INT ECON, V82, P230, DOI 10.1016/j.jinteco.2010.07.003; Puga D, 2010, J REGIONAL SCI, V50, P203, DOI 10.1111/j.1467-9787.2009.00657.x; Melitz MJ, 2008, REV ECON STUD, V75, P295, DOI 10.1111/j.1467-937X.2007.00463.x; Bernard AB, 1999, J INT ECON, V47, P1, DOI 10.1016/S0022-1996(98)00027-0; Markusen JR, 2000, J INT ECON, V52, P209, DOI 10.1016/S0022-1996(99)00055-0; Chen MX, 2010, J INT ECON, V80, P188, DOI 10.1016/j.jinteco.2009.08.007; Kosova R, 2010, REV ECON STAT, V92, P861, DOI 10.1162/REST_a_00035; Head K, 2004, REV ECON STAT, V86, P959, DOI 10.1162/0034653043125257; MARKUSEN JR, 1984, J INT ECON, V16, P205, DOI 10.1016/S0022-1996(84)80001-X; Baldwin R., 2003, EC GEOGRAPHY PUBLIC; Brainard L. S., 1997, AM ECON REV, V87, P520; Combes Pierre-Philippe, 2008, J URBAN ECON, V63, P723; Combes Pierre-Philippe, 2012, ECONOMETRICA, V80, P2543; Fujita M., 1999, SPATIAL EC CITIES RE; Saito H, 2009, J ECON GEOGR, V9, P539, DOI 10.1093/jeg/lbp010; NAKAMURA R, 1985, J URBAN ECON, V17, P108, DOI 10.1016/0094-1190(85)90040-3; Nocke V, 2006, J EUR ECON ASSOC, V4, P929, DOI 10.1162/JEEA.2006.4.5.929; Okubo T, 2012, J REGIONAL SCI, V52, P285, DOI 10.1111/j.1467-9787.2011.00736.x; Baldwin RE, 2006, J ECON GEOGR, V6, P323, DOI 10.1093/jeg/lbi020; Ottaviano Gianmarco, 2008, EIB PAPERS, V13, P8; Ottaviano Gianmarco, 2004, HDB REGIONAL URBAN E, V4, P2563; Behrens K, 2007, CAN J ECON, V40, P1118; Poelhekke S, 2009, J REGIONAL SCI, V49, P749, DOI 10.1111/j.1467-9787.2009.00632.x; Saito H, 2011, CAN J ECON, V44, P541, DOI 10.1111/j.1540-5982.2011.01643.x	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4146	1467-9787		J REGIONAL SCI	J. Reg. Sci.	SEP	2015	55	4					540	559		10.1111/jors.12163		20	Economics; Environmental Studies; Planning & Development	Business & Economics; Environmental Sciences & Ecology; Public Administration	CR0IA	WOS:000361000700002		
J	Zhao, Y; Haward, SJ; Shen, AQ				Zhao, Ya; Haward, Simon J.; Shen, Amy Q.			Rheological characterizations of wormlike micellar solutions containing cationic surfactant and anionic hydrotropic salt	JOURNAL OF RHEOLOGY			English	Article							AMPLITUDE OSCILLATORY SHEAR; DYNAMIC LIGHT-SCATTERING; THREAD-LIKE MICELLES; FOURIER-TRANSFORM RHEOLOGY; CONVECTIVE CONSTRAINT RELEASE; CTAB/NASAL AQUEOUS-SOLUTION; ENTANGLED POLYMER-SOLUTIONS; ANGLE NEUTRON-SCATTERING; ROD-LIKE MICELLES; CETYLTRIMETHYLAMMONIUM BROMIDE	Aqueous micellar solutions of cationic surfactant cetyltrimethylammonium bromide (CTAB) and organic hydrotropic salt 3-hydroxy naphthalene-2-carboxylate (SHNC) in the semidilute regime have been characterized by linear and nonlinear rheology, and dynamic light scattering. The strong hydrophobicity and naphthalene structure present in the SHNC induces significant growth of CTAB wormlike micelles and promotes stable micellar network formation. Focusing primarily on 75mM CTAB/SHNC solution, we correlate the rich rheological behavior with structural transitions of the micellar network under different deformation histories with temperatures in the range of 20 degrees C < T < 40 degrees C. Viscous dissipation dominates at low temperature, while short range interactions among micellar head groups, reorganization of micellar networks play important roles at higher temperatures, leading to complex stress responses under large deformations. The influence of double benzene rings on the response of transient and large amplitude oscillatory shear flows in the system was further elucidated by comparing the rheological behavior of CTAB/SHNC with CTAB/NaSal at the same salt and surfactant concentrations. Our studies distinguished SHNC as a stable hydrotrope in a semidilute cationic surfactant system under thermal variations, with potential applications such as drag reduction and fracturing fluids in oil recovery. (C) 2015 Author(s).	[Zhao, Ya; Shen, Amy Q.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Haward, Simon J.; Shen, Amy Q.] Okinawa Inst Sci & Technol Grad Univ, Micro Bio Nanofluid Unit, Onna, Okinawa 9040495, Japan	Shen, AQ (reprint author), Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.	amy.shen@oist.jp	Shen, Amy/B-5981-2015	Shen, Amy/0000-0002-1222-6264	OIST Graduate University; Cabinet Office, Government of Japan	The authors gratefully acknowledge the support from the OIST Graduate University with subsidy funding from the Cabinet Office, Government of Japan (AQS and SJH).	Abdel-Rahem R, 2005, TENSIDE SURFACT DET, V42, P95; Abdel-Rahem R, 2008, ADV COLLOID INTERFAC, V141, P24, DOI 10.1016/j.cis.2008.02.002; Schubert BA, 2003, LANGMUIR, V19, P4079, DOI 10.1021/la020821c; KHATORY A, 1993, LANGMUIR, V9, P1456, DOI 10.1021/la00030a005; Subramanian D, 2013, FARADAY DISCUSS, V167, P217, DOI 10.1039/c3fd00070b; Vasudevan M, 2010, NAT MATER, V9, P436, DOI [10.1038/nmat2724, 10.1038/NMAT2724]; Gurnon AK, 2014, SOFT MATTER, V10, P2889, DOI 10.1039/c3sm53113a; BERRET JF, 1994, J PHYS II, V4, P1261, DOI 10.1051/jp2:1994198; Mendes E, 1997, J PHYS CHEM B, V101, P2256, DOI 10.1021/jp962790y; Milner ST, 2001, J RHEOL, V45, P539, DOI 10.1122/1.1349122; Verma G, 2011, J COLLOID INTERF SCI, V359, P163, DOI 10.1016/j.jcis.2011.03.061; OHLENDORF D, 1986, RHEOL ACTA, V25, P468, DOI 10.1007/BF01774397; Giacomin AJ, 2011, J NON-NEWTON FLUID, V166, P1081, DOI 10.1016/j.jnnfm.2011.04.002; Kim WJ, 2000, J COLLOID INTERF SCI, V232, P225, DOI 10.1006/jcis.2000.7207; KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283; Berret JF, 1997, PHYS REV E, V55, P1668, DOI 10.1103/PhysRevE.55.1668; Hyun K, 2006, RHEOL ACTA, V45, P239, DOI 10.1007/s00397-005-0014-x; Britton MM, 1997, PHYS REV LETT, V78, P4930, DOI 10.1103/PhysRevLett.78.4930; Lerouge S, 2010, ADV POLYM SCI, V230, P1, DOI 10.1007/12_2009_13; Milner ST, 1998, PHYS REV LETT, V81, P725, DOI 10.1103/PhysRevLett.81.725; Mendes E, 1998, J PHYS CHEM B, V102, P338, DOI 10.1021/jp972392a; Hyun K, 2011, PROG POLYM SCI, V36, P1697, DOI 10.1016/j.progpolymsci.2011.02.002; SHIKATA T, 1988, LANGMUIR, V4, P354, DOI 10.1021/la00080a019; REHAGE H, 1988, J PHYS CHEM-US, V92, P4712, DOI 10.1021/j100327a031; Ouchi M, 2006, J RHEOL, V50, P341, DOI 10.1122/1.2193742; Britton MM, 1999, J RHEOL, V43, P897, DOI 10.1122/1.551008; Rogers SA, 2012, J RHEOL, V56, P1, DOI 10.1122/1.3662962; Fischer P, 2002, RHEOL ACTA, V41, P35; Lerouge S, 1998, PHYS REV LETT, V81, P5457, DOI 10.1103/PhysRevLett.81.5457; Lin YY, 2012, J COLLOID INTERF SCI, V369, P238, DOI 10.1016/j.jcis.2011.11.067; Mewis J, 2009, ADV COLLOID INTERFAC, V147-48, P214, DOI 10.1016/j.cis.2008.09.005; Dubash N, 2012, SOFT MATTER, V8, P5847, DOI 10.1039/c2sm25215e; Ewoldt RH, 2008, J RHEOL, V52, P1427, DOI 10.1122/1.2970095; Hu YT, 2005, J RHEOL, V49, P1001, DOI 10.1122/1.2008295; Rogers SA, 2012, J RHEOL, V56, P1129, DOI 10.1122/1.4726083; Graham RS, 2003, J RHEOL, V47, P1171, DOI 10.1122/1.1595099; Helgeson ME, 2009, J RHEOL, V53, P727, DOI 10.1122/1.3089579; Rogers SA, 2011, J RHEOL, V55, P435, DOI 10.1122/1.3544591; Carver M, 1996, LANGMUIR, V12, P691, DOI 10.1021/la950965+; Neidhofer T, 2003, J RHEOL, V47, P1351, DOI 10.1122/1.1608954; Fardin MA, 2012, SOFT MATTER, V8, P2535, DOI 10.1039/c2sm06992j; Divoux T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.018304; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; BROWN W, 1989, J PHYS CHEM-US, V93, P5888, DOI 10.1021/j100352a047; GRANEK R, 1992, J CHEM PHYS, V96, P4758, DOI 10.1063/1.462787; Oelschlaeger C, 2010, LANGMUIR, V26, P7045, DOI 10.1021/la9043705; Hatzopoulos MH, 2011, LANGMUIR, V27, P12346, DOI 10.1021/la2025846; Da Cruz F, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051305; Cardiel JJ, 2013, P NATL ACAD SCI USA, V110, pE1653, DOI 10.1073/pnas.1215353110; Hyun K, 2002, J NON-NEWTON FLUID, V107, P51, DOI 10.1016/S0377-0257(02)00141-6; Salmon JB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.228303; Garg G, 2006, COLLOID SURFACE A, V275, P161, DOI 10.1016/j.colsurfa.2005.10.001; Berret JF, 1997, LANGMUIR, V13, P2227, DOI 10.1021/la961078p; Manneville S, 2004, EUR PHYS J-APPL PHYS, V28, P361, DOI 10.1051/epjap:2004165; Liberatore MW, 2009, J RHEOL, V53, P441, DOI 10.1122/1.3072077; Fielding SM, 2007, SOFT MATTER, V3, P1262, DOI 10.1039/b707980j; Lerouge S, 2008, SOFT MATTER, V4, P1808, DOI 10.1039/b804915g; Helgeson ME, 2009, SOFT MATTER, V5, P3858, DOI 10.1039/b900948e; Wilhelm M, 2002, MACROMOL MATER ENG, V287, P83, DOI 10.1002/1439-2054(20020201)287:2<83::AID-MAME83>3.3.CO;2-2; MISHRA BK, 1993, LANGMUIR, V9, P894, DOI 10.1021/la00028a004; Ewoldt RH, 2013, J RHEOL, V57, P177, DOI 10.1122/1.4764498; Horbaschek K, 1998, J COLLOID INTERF SCI, V206, P439, DOI 10.1006/jcis.1998.5690; Hartmann V, 1997, COLLOID SURFACE A, V121, P151, DOI 10.1016/S0927-7757(96)03773-9; Bhattacharjee PK, 2003, J RHEOL, V47, P269, DOI 10.1122/1.1530625; Han YX, 2011, J PHYS CHEM B, V115, P6893, DOI 10.1021/jp2004634; Ouchi M, 2007, NIHON REOROJI GAKK, V35, P107, DOI 10.1678/rheology.35.107; Abdel-Rahem R, 2005, J COLLOID INTERF SCI, V288, P570, DOI 10.1016/j.jcis.2005.03.040; Kalur GC, 2005, LANGMUIR, V21, P10998, DOI 10.1021/la052069w; Ewoldt RH, 2013, RHEOL ACTA, V52, P201, DOI 10.1007/s00397-013-0686-6; CATES ME, 1990, J PHYS-CONDENS MAT, V2, P6869, DOI 10.1088/0953-8984/2/33/001; Soltero JFA, 1996, LANGMUIR, V12, P2654, DOI 10.1021/la950368n; Gurnon AK, 2012, J RHEOL, V56, P333, DOI 10.1122/1.3684751; Vasudevan M, 2008, J RHEOL, V52, P527, DOI 10.1122/1.2833594; BRACKMAN JC, 1991, LANGMUIR, V7, P2097, DOI 10.1021/la00058a022; REHAGE H, 1991, MOL PHYS, V74, P933, DOI 10.1080/00268979100102721; SHIKATA T, 1987, LANGMUIR, V3, P1081, DOI 10.1021/la00078a035; Lu YY, 2014, ACS MACRO LETT, V3, P569, DOI 10.1021/mz500260h; Dimitriou CJ, 2012, RHEOL ACTA, V51, P395, DOI 10.1007/s00397-012-0619-9; Yin HQ, 2009, J COLLOID INTERF SCI, V338, P177, DOI 10.1016/j.jcis.2009.05.076; Miller E, 2007, J NON-NEWTON FLUID, V143, P22, DOI 10.1016/j.jnnfm.2006.12.005; Hassan PA, 1996, LANGMUIR, V12, P4350, DOI 10.1021/la960269p; Hodgdon TK, 2007, CURR OPIN COLLOID IN, V12, P121, DOI 10.1016/j.cocis.2007.06.004; Holmes WM, 2004, EUROPHYS LETT, V66, P132, DOI 10.1209/epl/i2003-10189-8; Tapadia P, 2006, PHYS REV LETT, V96, DOI [10.1103/PhysRevLett.96.196001, 10.1103/PhysRevLett.96.016001]; Grand C, 1997, J PHYS II, V7, P1071, DOI 10.1051/jp2:1997172; Wang SQ, 2013, MACROMOLECULES, V46, P3147, DOI 10.1021/ma300398x; CATES ME, 1987, MACROMOLECULES, V20, P2289, DOI 10.1021/ma00175a038; Becu L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.018301; Bird R. B., 1968, T SOC RHEOL, V12, P479; Blackwell BC, 2014, J NON-NEWTON FLUID, V208, P27, DOI 10.1016/j.jnnfm.2014.03.006; Buhler E, 2004, J PHYS CHEM B, V108, P11236, DOI 10.1021/jp049466k; Cappelaere E, 1997, PHYS REV E, V56, P1869, DOI 10.1103/PhysRevE.56.1869; CAPPELAERE E, 1995, COLLOID SURFACE A, V104, P353, DOI 10.1016/0927-7757(95)03332-2; Cardiel JJ, 2014, LAB CHIP, V14, P3912, DOI 10.1039/c4lc00610k; Cardiel JJ, 2014, SOFT MATTER, V10, P9300, DOI 10.1039/c4sm01920b; CATES ME, 1990, J PHYS CHEM-US, V94, P371, DOI 10.1021/j100364a063; Daniel C, 2001, RHEOL ACTA, V40, P39, DOI 10.1007/s003970000124; Debbaut B, 2002, J RHEOL, V46, P1155, DOI 10.1122/1.1495493; Decruppe JP, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061509; Dodge J. S., 1971, Transactions of the Society of Rheology, V15; Doi M, 1986, THEORY POLYM DYNAMIC; Dubash N, 2011, SOFT MATTER, V7, P876, DOI 10.1039/c0sm00920b; Fardin MA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.178303; Fardin MA, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/44004; Fielding SM, 2010, J NON-NEWTON FLUID, V165, P196, DOI 10.1016/j.jnnfm.2009.12.001; Frounfelker B. D., 2008, LANGMUIR, V25, P167; Giacomin A., 1993, TECHNIQUES RHEOLOGIC, P99; Giacomin A. J., 1998, RHEOLOGICAL MEASUREM, P327; Giacomin AJ, 2011, RHEOL ACTA, V50, P741, DOI 10.1007/s00397-011-0553-2; GRAVSHOLT S, 1976, J COLLOID INTERF SCI, V57, P575, DOI 10.1016/0021-9797(76)90236-8; Hoffmann H, 1985, TENSIDE DETERGENTS, V22, P290; Hu YT, 2008, J RHEOL, V52, P379, DOI 10.1122/1.2836937; Ianniruberto G, 2002, J NON-NEWTON FLUID, V102, P383, DOI 10.1016/S0377-0257(01)00188-4; Israelachvili J. N., 1985, INTERMOLECULAR SURFA; Krishnaswamy R, 2005, LANGMUIR, V21, P10439, DOI 10.1021/la051781q; Lee JY, 2005, J RHEOL, V49, P537, DOI 10.1122/1.1849179; Liberatore MW, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.020504; Lu DL, 2010, ADV MATER, V22, P2809, DOI 10.1002/adma.201000189; MANOHAR C, 1986, J CHEM SOC CHEM COMM, P379, DOI 10.1039/c39860000379; Martinetti L, 2014, J RHEOL, V58, P821, DOI 10.1122/1.4874322; MISHRA S, 1993, LANGMUIR, V9, P2804, DOI 10.1021/la00035a013; Moorcroft RL, 2014, J RHEOL, V58, P103, DOI 10.1122/1.4842155; NEMOTO N, 1993, LANGMUIR, V9, P419, DOI 10.1021/la00026a010; NEMOTO N, 1994, COLLOID POLYM SCI, V272, P846, DOI 10.1007/BF00652426; NEMOTO N, 1995, LANGMUIR, V11, P30, DOI 10.1021/la00001a009; Oelschlaeger C, 2003, LANGMUIR, V19, P10495, DOI 10.1021/la035082u; Ouchi M, 2006, NIHON REOROJI GAKK, V34, P229, DOI 10.1678/rheology.34.229; Provencher S. W., 1976, Journal of Chemical Physics, V64, DOI 10.1063/1.432601; PROVENCHER SW, 1976, BIOPHYS J, V16, P27; RAO URK, 1987, J PHYS CHEM-US, V91, P3286, DOI 10.1021/j100296a036; SHIKATA T, 1991, J NON-CRYST SOLIDS, V131, P831, DOI 10.1016/0022-3093(91)90690-8; STEPANEK P, 1987, POLYM BULL, V18, P175, DOI 10.1007/BF00261897; Takahashi T, 2002, J SOC RHEOL JPN, V30, P109; Takahashi T, 2001, NIHON REOROJI GAKK, V29, P27, DOI 10.1678/rheology.29.27; Takahashi T, 2011, J RHEOL, V55, P225, DOI 10.1122/1.3528042; Tapadia P, 2004, MACROMOLECULES, V37, P9083, DOI 10.1021/ma0490855; Yoon C, 2014, FUEL, V128, P467, DOI 10.1016/j.fuel.2014.02.051	137	0	0	JOURNAL RHEOLOGY AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0148-6055			J RHEOL	J. Rheol.	SEP	2015	59	5					1229	1259		10.1122/1.4928454		31	Mechanics	Mechanics	CQ9LP	WOS:000360936600005		
J	Tanaka, M; Sakai, R; Koike, R; Harigai, M				Tanaka, Michi; Sakai, Ryoko; Koike, Ryuji; Harigai, Masayoshi			Pneumocystis Jirovecii Pneumonia in Japanese Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Pooled Analysis of 3 Agents	JOURNAL OF RHEUMATOLOGY			English	Letter							POSTMARKETING SURVEILLANCE; CARINII-PNEUMONIA; RISK-FACTORS; INFLIXIMAB; SAFETY; ETANERCEPT; ADALIMUMAB		[Tanaka, Michi; Sakai, Ryoko; Koike, Ryuji; Harigai, Masayoshi] Tokyo Med Dent Univ, Dept Pharmacovigilance, Grad Sch Med & Dent Sci, Tokyo, Japan; [Tanaka, Michi; Sakai, Ryoko; Koike, Ryuji; Harigai, Masayoshi] Tokyo Med Dent Univ, Dept Rheumatol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Koike, Ryuji] Tokyo Med Dent Univ Hosp, Clin Res Ctr, Tokyo, Japan	Harigai, M (reprint author), Tokyo Med & Dent Univ, Dept Pharmacovigilance, Grad Sch, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	mharigai.mpha@tmd.ac.jp					Takeuchi T, 2008, ANN RHEUM DIS, V67, P189, DOI 10.1136/ard.2007.072967; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Tanaka M, 2012, MOD RHEUMATOL, V22, P849, DOI 10.1007/s10165-012-0615-z; Koike T, 2012, MOD RHEUMATOL, V22, P498, DOI 10.1007/s10165-011-0541-5; Watanabe K, 2013, MOD RHEUMATOL, V23, P1085, DOI 10.1007/s10165-012-0796-5; PHAIR J, 1990, NEW ENGL J MED, V322, P161, DOI 10.1056/NEJM199001183220304; Koike T, 2009, J RHEUMATOL, V36, P898, DOI 10.3899/jrheum.080791; Harigai M, 2007, NEW ENGL J MED, V357, P1874, DOI 10.1056/NEJMc070728; Komano Y, 2009, ARTHRIT RHEUM-ARTHR, V61, P305, DOI 10.1002/art.24283; OIEN KA, 1995, BRIT J RHEUMATOL, V34, P677	10	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	SEP	2015	42	9					1726	1728		10.3899/jrheum.141510		3	Rheumatology	Rheumatology	CQ6SF	WOS:000360733600032		
J	Sato, K; Nomoto, M				Sato, Kaoru; Nomoto, Masahiro			Gravity Wave-Induced Anomalous Potential Vorticity Gradient Generating Planetary Waves in the Winter Mesosphere	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							MIDDLE-ATMOSPHERE; CIRCULATION MODEL; 2-DAY WAVE; DOWNWARD CONTROL; 4-DAY WAVE; BREAKING; STRATOSPHERE; CLIMATOLOGY; STRATOPAUSE; MECHANISM	This study shows that gravity wave (GW) forcing (GWF) plays a crucial role in the barotropic/baroclinic instability that is frequently observed in the mesosphere and considered an origin of planetary waves (PWs) such as quasi-2-day and quasi-4-day waves. Simulation data from a GW-resolving general circulation model were analyzed, focusing on the winter Northern Hemisphere where PWs are active. The unstable field is characterized by a significant potential vorticity (PV) maximum with an anomalous latitudinal gradient at higher latitudes that suddenly appears in the midlatitudes of the upper mesosphere. This PV maximum is attributed to an enhanced static stability [GRAPHICS] that develops through the following two processes: 1) strong PWs from the troposphere break in the middle stratosphere, causing a poleward and downward shift of the westerly jet to higher latitudes, and 2) strong GWF located above the jet simultaneously shifts and forms an upwelling in the midlatitudes, causing a significant increase in [GRAPHICS] . An interesting feature is that the PV maximum is not zonally uniform but is observed only at longitudes with strong GWF. This longitudinally dependent GWF can be explained by selective filtering in the stratospheric mean flow modified by strong PWs. In the upper mesosphere, the Eliassen-Palm flux divergence by PWs has a characteristic structure, which is positive poleward and negative equatorward of the enhanced PV maximum, attributable to eastward- and westward-propagating PWs, respectively. This fact suggests that the barotropic/baroclinic instability is eliminated by simultaneous generation of eastward and westward PWs causing PV flux divergence.	[Sato, Kaoru; Nomoto, Masahiro] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan	Sato, K (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	kaoru@eps.s.u-tokyo.ac.jp			MEXT, Japan [19204047]	We thank Elisa Manzini, Kota Okamoto, and Yoshihiro Tomikawa for their invaluable comments. Thanks are also due to three anonymous reviewers for their constructive comments. Several figures were drawn by Akihiro Masuda. This work was supported by a Grant-in-Aid for Scientific Research (19204047) from MEXT, Japan. The model simulations were conducted using the Earth Simulator. Figures were prepared using the GFD-DENNOU library.	Andrews D. G., 1987, INT GEOPHYS SERIES, V40, P489; Baumgaertner AJG, 2008, J ATMOS SOL-TERR PHY, V70, P1336, DOI 10.1016/j.jastp.2008.04.007; HAYNES PH, 1991, J ATMOS SCI, V48, P651, DOI 10.1175/1520-0469(1991)048<0651:OTCOED>2.0.CO;2; Manney GL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009097; Kawatani Y, 2010, J ATMOS SCI, V67, P963, DOI 10.1175/2009JAS3222.1; Siskind DE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029293; Hitchcock P, 2013, J CLIMATE, V26, P2096, DOI 10.1175/JCLI-D-12-00202.1; LAIT LR, 1994, J ATMOS SCI, V51, P1754, DOI 10.1175/1520-0469(1994)051<1754:AAFFPV>2.0.CO;2; Sigmond M, 2014, J CLIMATE, V27, P5601, DOI 10.1175/JCLI-D-13-00644.1; BALDWIN MP, 1988, J ATMOS SCI, V45, P1123, DOI 10.1175/1520-0469(1988)045<1123:COTSPV>2.0.CO;2; MCLANDRESS C, 1993, J ATMOS SCI, V50, P1966, DOI 10.1175/1520-0469(1993)050<1966:IBOGWD>2.0.CO;2; HOLTON JR, 1983, J ATMOS SCI, V40, P2497, DOI 10.1175/1520-0469(1983)040<2497:TIOGWB>2.0.CO;2; CHARNEY JG, 1962, J ATMOS SCI, V19, P159, DOI 10.1175/1520-0469(1962)019<0159:OTSOIB>2.0.CO;2; Watanabe S, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010026; Ern M, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015821; Lieberman RS, 2013, J GEOPHYS RES-ATMOS, V118, P3139, DOI 10.1002/jgrd.50319; Cohen NY, 2013, J ATMOS SCI, V70, P3780, DOI 10.1175/JAS-D-12-0346.1; Sato K, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039908; Geller MA, 2013, J CLIMATE, V26, P6383, DOI 10.1175/JCLI-D-12-00545.1; Sato K, 2012, J ATMOS SCI, V69, P1378, DOI 10.1175/JAS-D-11-0101.1; PLUMB RA, 1983, J ATMOS SCI, V40, P262, DOI 10.1175/1520-0469(1983)040<0262:BIOTSM>2.0.CO;2; Plumb RA, 2002, J METEOROL SOC JPN, V80, P793, DOI 10.2151/jmsj.80.793; Miller A, 2013, J ATMOS SOL-TERR PHY, V97, P11, DOI 10.1016/j.jastp.2013.02.008; HOLTON JR, 1984, J ATMOS SCI, V41, P3427, DOI 10.1175/1520-0469(1984)041<3427:TGOMPW>2.0.CO;2; Liu HL, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001533; Chandran A, 2013, J GEOPHYS RES-ATMOS, V118, P1234, DOI 10.1002/jgrd.50123; Fritts DC, 1999, J GEOPHYS RES-ATMOS, V104, P3953, DOI 10.1029/1998JD200024; Greer K, 2013, J GEOPHYS RES-ATMOS, V118, P4168, DOI 10.1002/jgrd.50289; Kinoshita T, 2013, J ATMOS SCI, V70, P1577, DOI 10.1175/JAS-D-12-0137.1; Limpasuvan V, 2012, J ATMOS SOL-TERR PHY, V78-79, P84, DOI 10.1016/j.jastp.2011.03.004; Lu X, 2013, J GEOPHYS RES-ATMOS, V118, P9565, DOI 10.1002/jgrd.50717; MANNEY GL, 1993, J ATMOS SCI, V50, P3928, DOI 10.1175/1520-0469(1993)050<3928:IATWSA>2.0.CO;2; Meyer CK, 1999, J GEOPHYS RES-SPACE, V104, P28181, DOI 10.1029/1999JA900346; Miyazaki K, 2010, J ATMOS SCI, V67, P1293, DOI 10.1175/2009JAS3221.1; Norton WA, 1996, GEOPHYS RES LETT, V23, P2113, DOI 10.1029/96GL01956; RANDEL WJ, 1994, J ATMOS SCI, V51, P306, DOI 10.1175/1520-0469(1994)051<0306:OOTDWI>2.0.CO;2; RANDEL WJ, 1991, J ATMOS SCI, V48, P2496, DOI 10.1175/1520-0469(1991)048<2496:DOTDWI>2.0.CO;2; Sato K, 2014, J ATMOS SOL-TERR PHY, V118, P2, DOI 10.1016/j.jastp.2013.08.022; Sato K, 2013, J ATMOS SCI, V70, P3756, DOI 10.1175/JAS-D-12-0352.1; Smith A, 2003, IEEE IND APPL MAG, V9, P2, DOI 10.1109/MIA.2003.1245786; Thayer JP, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014278; Tomikawa Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009786; Tomikawa Y, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017243; Watanabe S, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011636; Zulicke C, 2013, J GEOPHYS RES-ATMOS, V118, P2255, DOI 10.1002/jgrd.50219	45	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	SEP	2015	72	9					3609	3624		10.1175/JAS-D-15-0046.1		16	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CR0TW	WOS:000361037100019		
J	Yokota, S; Niino, H; Yanase, W				Yokota, Sho; Niino, Hiroshi; Yanase, Wataru			Tropical Cyclogenesis due to ITCZ Breakdown: Idealized Numerical Experiments and a Case Study of the Event in July 1988	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							STORM EUGENE 2005; INTERTROPICAL CONVERGENCE ZONE; SYSTEM MOVING OFFSHORE; YAMADA LEVEL-3 MODEL; CONVECTIVE PARAMETERIZATION; OCEANIC CYCLOGENESIS; POTENTIAL VORTICITY; HADLEY CIRCULATION; BAROTROPIC MODEL; CYCLONE GENESIS	The mechanism of tropical cyclogenesis due to the breakdown of the intertropical convergence zone (ITCZ breakdown) and the structure of associated vortices are studied by numerical experiments using a nonhydrostatic mesoscale model. First, an idealized numerical experiment, in which a simple initial state without external disturbances is assumed, is performed without cumulus parameterization. A zonally uniform forcing of high sea surface temperature (SST) is imposed to generate an ITCZ-like structure. This "ITCZ" starts to undulate and eventually breaks down to form several tropical cyclones (TCs). These TCs merge and end up with a single TC. The energy budget analysis shows that barotropic instability of the low-level flow associated with the ITCZ is responsible for the genesis of vortices, and TC-scale buoyancy production soon takes over to contribute to the intensification of TCs. Conversion from the cumulus-scale kinetic energy into the TC-scale kinetic energy is found to be insignificant during ITCZ breakdown. Additional experiments show that the presence of the warm SST belt and an inclusion of the beta effect are not essential for the occurrence of ITCZ breakdown. A numerical simulation of ITCZ breakdown over the Pacific Ocean in July 1988 shows that the mechanism of the tropical cyclogenesis is similar to that in the idealized numerical experiments from the viewpoint of the energy budget. Therefore, horizontal shear instability of the low-level flow and TC-scale buoyancy production are generally more essential than mergers of cumulus-scale vortices for the tropical cyclogenesis due to ITCZ breakdown.	[Yokota, Sho] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan; [Niino, Hiroshi; Yanase, Wataru] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Yokota, S (reprint author), Japan Meteorol Agcy, Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	syokota@mri-jma.go.jp			Japan Society for the Promotion of Science [24244074]; Cooperative Program of Atmosphere and Ocean Research Institute [131]; University of Tokyo; High Performance Computing Infrastructure Strategic Program for Innovation Research Field 3 [hp120282, hp130012, hp140220]	We thank Prof. Keita Iga for many useful suggestions on fluid-mechanical aspects of the problem, Dr. Wataru Mashiko for instructions for the use of the JMANHM, and anonymous reviewers for thoughtful comments, which contributed to improve the manuscript significantly. This work was supported in part by a Grant-in-Aid for Scientific Research (A) 24244074 from the Japan Society for the Promotion of Science, the Cooperative Program (131, 2014) of Atmosphere and Ocean Research Institute, the University of Tokyo, and by High Performance Computing Infrastructure Strategic Program for Innovation Research Field 3 (ID: hp120282, hp130012, and hp140220). The computation was mainly carried out using the computer facilities at Atmosphere and Ocean Research Institute at the University of Tokyo. Supplemental idealized numerical experiments were carried out using K computer provided by the RIKEN Advanced Institute for Computational Science.	AGEE EM, 1972, MON WEATHER REV, V100, P733, DOI 10.1175/1520-0493(1972)100<0733:NOIWDA>2.3.CO;2; OGURA Y, 1962, J ATMOS SCI, V19, P173, DOI 10.1175/1520-0469(1962)019<0173:SAODAS>2.0.CO;2; Ritchie EA, 1999, MON WEATHER REV, V127, P2027, DOI 10.1175/1520-0493(1999)127<2027:LSPAWT>2.0.CO;2; OOYAMA K, 1969, J ATMOS SCI, V26, P3, DOI 10.1175/1520-0469(1969)026<0003:NSOTLC>2.0.CO;2; Nakanishi M, 2006, BOUND-LAY METEOROL, V119, P397, DOI 10.1007/s10546-005-9030-8; Fujiwhara S, 1921, Q J ROY METEOR SOC, V47, P287; Nakanishi M, 2004, BOUND-LAY METEOROL, V112, P1, DOI 10.1023/B:BOUN.0000020164.04146.98; Frank WM, 2006, MON WEATHER REV, V134, P2397, DOI 10.1175/MWR3204.1; Houze RA, 2009, MON WEATHER REV, V137, P2778, DOI 10.1175/2009MWR2727.1; MICHALKE A, 1964, J FLUID MECH, V19, P543, DOI 10.1017/S0022112064000908; Hendricks EA, 2004, J ATMOS SCI, V61, P1209, DOI 10.1175/1520-0469(2004)061<1209:TROVHT>2.0.CO;2; GUINN TA, 1993, J ATMOS SCI, V50, P3380, DOI 10.1175/1520-0469(1993)050<3380:HSB>2.0.CO;2; Nakanishi M, 2001, BOUND-LAY METEOROL, V99, P349, DOI 10.1023/A:1018915827400; CHARNEY JG, 1964, J ATMOS SCI, V21, P68, DOI 10.1175/1520-0469(1964)021<0068:OTGOTH>2.0.CO;2; KUO HI, 1949, J METEOROL, V6, P105, DOI 10.1175/1520-0469(1949)006<0105:DIOTDN>2.0.CO;2; EMANUEL KA, 1986, J ATMOS SCI, V43, P585, DOI 10.1175/1520-0469(1986)043<0585:AASITF>2.0.CO;2; Ritchie EA, 1997, MON WEATHER REV, V125, P1377, DOI 10.1175/1520-0493(1997)125<1377:SIDTFO>2.0.CO;2; KRISHNAMURTI TN, 1981, MON WEATHER REV, V109, P344, DOI 10.1175/1520-0493(1981)109<0344:OTOVOT>2.0.CO;2; LANDER M, 1993, Q J ROY METEOR SOC, V119, P1347, DOI 10.1002/qj.49711951406; Bister M, 1997, MON WEATHER REV, V125, P2662, DOI 10.1175/1520-0493(1997)125<2662:TGOHGT>2.0.CO;2; Camargo SJ, 2009, J ATMOS SCI, V66, P3061, DOI 10.1175/2009JAS3101.1; KAIN JS, 1990, J ATMOS SCI, V47, P2784, DOI 10.1175/1520-0469(1990)047<2784:AODEPM>2.0.CO;2; DEMARIA M, 1985, MON WEATHER REV, V113, P1199, DOI 10.1175/1520-0493(1985)113<1199:TCMIAN>2.0.CO;2; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Fujiwhara S, 1923, Q J ROY METEOR SOC, V49, P75; Kain JS, 2004, J APPL METEOROL, V43, P170, DOI 10.1175/1520-0450(2004)043<0170:TKCPAU>2.0.CO;2; Ferreira RN, 1997, J ATMOS SCI, V54, P261, DOI 10.1175/1520-0469(1997)054<0261:BAOIB>2.0.CO;2; Simpson J, 1997, MON WEATHER REV, V125, P2643, DOI 10.1175/1520-0493(1997)125<2643:MIITCG>2.0.CO;2; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; Montgomery MT, 2006, J ATMOS SCI, V63, P355, DOI 10.1175/JAS3604.1; MADDEN RA, 1994, MON WEATHER REV, V122, P814, DOI 10.1175/1520-0493(1994)122<0814:OOTDTO>2.0.CO;2; Wang CC, 2006, MON WEATHER REV, V134, P1405, DOI 10.1175/MWR3130.1; Zhang DL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053140; AVILA LA, 1989, MON WEATHER REV, V117, P2260, DOI 10.1175/1520-0493(1989)117<2260:ATSO>2.0.CO;2; Cao X, 2012, ADV ATMOS SCI, V29, P744, DOI 10.1007/s00376-012-1121-0; Emanuel K. A., 2004, 26 C HURR TROP MET M, V10A, P2; HACK JJ, 1989, J ATMOS SCI, V46, P2957, DOI 10.1175/1520-0469(1989)046<2957:ROTHCT>2.0.CO;2; Kieu CQ, 2008, J ATMOS SCI, V65, P3419, DOI 10.1175/2008JAS2605.1; Kieu CQ, 2010, J ATMOS SCI, V67, P1745, DOI 10.1175/2010JAS3227.1; Kieu CQ, 2009, J ATMOS SCI, V66, P1980, DOI 10.1175/2008JAS2905.1; KRAICHNA.RH, 1967, PHYS FLUIDS, V10, P1417, DOI 10.1063/1.1762301; Kuo H. L., 1973, ADV APPL MECH, V13, P248; KUO HL, 1978, J ATMOS SCI, V35, P1840, DOI 10.1175/1520-0469(1978)035<1840:ATLMSO>2.0.CO;2; LIN YL, 1983, J CLIM APPL METEOROL, V22, P1065, DOI 10.1175/1520-0450(1983)022<1065:BPOTSF>2.0.CO;2; Miyamoto Y, 2013, J ATMOS SCI, V70, P112, DOI 10.1175/JAS-D-11-0285.1; Nolan DS, 2010, J ATMOS SCI, V67, P4028, DOI 10.1175/2010JAS3417.1; SCHUBERT WH, 1991, J ATMOS SCI, V48, P1493, DOI 10.1175/1520-0469(1991)048<1493:PVMOTI>2.0.CO;2; SMITH RK, 1990, Q J ROY METEOR SOC, V116, P337, DOI 10.1002/qj.49711649206; THOMPSON OE, 1976, MON WEATHER REV, V104, P1194, DOI 10.1175/1520-0493(1976)104<1194:HCAOAW>2.0.CO;2; Unisys Weather, 2015, E PAC TROP STORM TRA; Wang CC, 2005, J ATMOS SCI, V62, P1497, DOI 10.1175/JAS3409.1; Wang CC, 2010, J ATMOS SCI, V67, P1247, DOI 10.1175/2009JAS3164.1; YAMASAKI M, 1989, J METEOROL SOC JPN, V67, P529; Yokota S, 2012, SOLA, V8, DOI 10.2151/sola.2012-026; Zhang DL, 1996, MON WEATHER REV, V124, P1449, DOI 10.1175/1520-0493(1996)124<1449:OCAIBA>2.0.CO;2; Zhang DL, 1996, MON WEATHER REV, V124, P2206, DOI 10.1175/1520-0493(1996)124<2206:OCAIBA>2.0.CO;2; Zhang M., 2009, ATMOS OCEAN SCI LETT, V2, P189	57	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	SEP	2015	72	9					3663	3684		10.1175/JAS-D-14-0328.1		22	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CR0TW	WOS:000361037100023		
J	Yanase, W; Niino, H				Yanase, Wataru; Niino, Hiroshi			Idealized Numerical Experiments on Cyclone Development in the Tropical, Subtropical, and Extratropical Environments	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							SEA INTERACTION THEORY; WESTERN NORTH PACIFIC; VERTICAL WIND SHEAR; FEATURE TRACKING; PHASE-SPACE; CLIMATOLOGY; TRANSITION; MODEL; INTENSITY; ATLANTIC	The development of cyclones, particularly in the Southern Hemisphere summer, is active in the tropics and extratropics but is inactive in the subtropics. To elucidate the influence of environmental fields on the cyclone development in the tropics, subtropics, and extratropics, idealized numerical experiments are conducted using a nonhydrostatic channel model. The experiments examine the development of a weak initial vortex within a zonally uniform environmental field that consists of five factors: the Coriolis parameter, zonal wind, potential temperature, relative humidity, and surface temperature difference between the ocean and atmosphere. The idealized experiments successfully reproduce the significant cyclone development in the tropical and extratropical environment as well as no cyclone development in the subtropical environment. This result confirms the dominant role of the environmental field in controlling the cyclone development. To clarify which environmental factor is responsible for the suppression of cyclone development in the subtropics, a series of sensitivity experiments is performed. A tropical cyclone cannot develop in the subtropics because of low temperature, strong stratification, and strong vertical shear compared to the tropics. On the other hand, an extratropical cyclone cannot develop in the subtropics because of the small Coriolis parameter and weak vertical shear compared to the extratropics. The relative humidity and surface temperature difference play only secondary roles. These results provide useful insights into the climatological distribution of various types of synoptic-scale cyclones.	[Yanase, Wataru; Niino, Hiroshi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Yanase, W (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778564, Japan.	wtryanase@gmail.com			JSPS KAKENHI [23740349, 24244074, 25106703]	We acknowledge helpful comments by Drs. Christopher A. Davis, Kensuke Nakajima, David S. Nolan, Tetsuya Takemi, Shigeo Yoden, and Yuqing Wang. The atmosphere and ocean datasets made use of JRA-25/JCDAS and NOAA OI-SST. Potential intensity was calculated using the FORTRAN program from the website of Dr. Kerry A. Emanuel. This research was supported by JSPS KAKENHI Grants 23740349, 24244074, and 25106703.	Evans JL, 2009, MON WEATHER REV, V137, P2065, DOI 10.1175/2009MWR2468.1; Otkin JA, 2004, MON WEATHER REV, V132, P1502, DOI 10.1175/1520-0493(2004)132<1502:ASCOTS>2.0.CO;2; Wernli H, 1998, J ATMOS SCI, V55, P2080, DOI 10.1175/1520-0469(1998)055<2080:TEOBSO>2.0.CO;2; BELJAARS ACM, 1995, Q J ROY METEOR SOC, V121, P255; Nakanishi M, 2004, BOUND-LAY METEOROL, V112, P1, DOI 10.1023/B:BOUN.0000020164.04146.98; Hodges KI, 1999, MON WEATHER REV, V127, P1362, DOI 10.1175/1520-0493(1999)127<1362:ACFFT>2.0.CO;2; HODGES KI, 1994, MON WEATHER REV, V122, P2573, DOI 10.1175/1520-0493(1994)122<2573:AGMFTA>2.0.CO;2; Frank WM, 2001, MON WEATHER REV, V129, P2249, DOI 10.1175/1520-0493(2001)129<2249:EOVWSO>2.0.CO;2; Frank WM, 2006, MON WEATHER REV, V134, P2397, DOI 10.1175/MWR3204.1; CHARNEY JG, 1964, J ATMOS SCI, V21, P68, DOI 10.1175/1520-0469(1964)021<0068:OTGOTH>2.0.CO;2; Jones SC, 2003, WEATHER FORECAST, V18, P1052, DOI 10.1175/1520-0434(2003)018<1052:TETOTC>2.0.CO;2; Chan JCL, 2005, ANNU REV FLUID MECH, V37, P99, DOI 10.1146/annurev.fluid.37.061903.175702; HOSKINS BJ, 1990, J ATMOS SCI, V47, P1854, DOI 10.1175/1520-0469(1990)047<1854:OTEOST>2.0.CO;2; Riemer M, 2010, ATMOS CHEM PHYS, V10, P3163; Smith RK, 1997, Q J ROY METEOR SOC, V123, P407, DOI 10.1002/qj.49712353808; Guishard MP, 2009, J CLIMATE, V22, P3574, DOI 10.1175/2008JCLI2346.1; Braun SA, 2012, J ATMOS SCI, V69, P236, DOI 10.1175/JAS-D-10-05007.1; EMANUEL KA, 1986, J ATMOS SCI, V43, P585, DOI 10.1175/1520-0469(1986)043<0585:AASITF>2.0.CO;2; Bu YP, 2014, J ATMOS SCI, V71, P1644, DOI 10.1175/JAS-D-13-0265.1; Hart RE, 2001, J CLIMATE, V14, P546, DOI 10.1175/1520-0442(2001)014<0546:ACOTET>2.0.CO;2; Deveson ACL, 2002, Q J ROY METEOR SOC, V128, P93, DOI 10.1256/00359000260498806; EADY ET, 1949, TELLUS, V1, P33; HODGES KI, 1995, MON WEATHER REV, V123, P3458, DOI 10.1175/1520-0493(1995)123<3458:FTOTUS>2.0.CO;2; Hart RE, 2006, MON WEATHER REV, V134, P553, DOI 10.1175/MWR3082.1; CHARNEY JG, 1947, J METEOROL, V4, P135; ROTUNNO R, 1987, J ATMOS SCI, V44, P542, DOI 10.1175/1520-0469(1987)044<0542:AAITFT>2.0.CO;2; Nolan DS, 2007, Q J ROY METEOR SOC, V133, P2085, DOI 10.1002/qj.170; KAIN JS, 1990, J ATMOS SCI, V47, P2784, DOI 10.1175/1520-0469(1990)047<2784:AODEPM>2.0.CO;2; Yanase W, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL020469; Davis CA, 2010, J ATMOS SCI, V67, P2871, DOI 10.1175/2010JAS3411.1; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Hart RE, 2003, MON WEATHER REV, V131, P585, DOI 10.1175/1520-0493(2003)131<0585:ACPSDF>2.0.CO;2; LINDZEN RS, 1980, J ATMOS SCI, V37, P1648, DOI 10.1175/1520-0469(1980)037<1648:ASARFT>2.0.CO;2; Saito K, 2007, J METEOROL SOC JPN, V85B, P271, DOI 10.2151/jmsj.85B.271; Yanase W, 2007, J ATMOS SCI, V64, P3044, DOI 10.1175/JAS4001.1; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; MURAKAMI M, 1990, J METEOROL SOC JPN, V68, P107; Kitabatake N, 2011, J METEOROL SOC JPN, V89, P309, DOI 10.2151/jmsj.2011-402; Hill KA, 2009, MON WEATHER REV, V137, P3294, DOI 10.1175/2009MWR2679.1; Smith RK, 2011, Q J ROY METEOR SOC, V137, P1841, DOI 10.1002/qj.862; Evans JL, 2012, J CLIMATE, V25, P7328, DOI 10.1175/JCLI-D-11-00212.1; McTaggart-Cowan R, 2013, MON WEATHER REV, V141, P1963, DOI 10.1175/MWR-D-12-00186.1; Bister M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000776; Chavas DR, 2014, J ATMOS SCI, V71, P1663, DOI 10.1175/JAS-D-13-0155.1; Davis CA, 2004, B AM METEOROL SOC, V85, P1657, DOI 10.1175/BAMS-85-11-1657; Emanuel K. A., 1989, Tellus, Series A (Dynamic Meteorology and Oceanography), V41A; Gray W. M., 1975, 234 COL STAT U DEP A; Holton J.R., 2013, INTRO DYNAMIC METEOR; HOSKINS BJ, 1976, Q J ROY METEOR SOC, V102, P103, DOI 10.1002/qj.49710243109; Kitabatake N, 2008, MON WEATHER REV, V136, P2066, DOI 10.1175/2007MWR1958.1; LIN YL, 1983, J CLIM APPL METEOROL, V22, P1065, DOI 10.1175/1520-0450(1983)022<1065:BPOTSF>2.0.CO;2; Ooyama K., 1964, GEOFIS INT, V4, P187; Shay L. K., 2010, GLOBAL PERSPECTIVES, V4, P93, DOI DOI 10.1142/9789814293488_0003; Yanase W, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042516; Yanase W, 2014, J CLIMATE, V27, P652, DOI 10.1175/JCLI-D-13-00153.1	56	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	SEP	2015	72	9					3699	3714		10.1175/JAS-D-15-0051.1		16	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CR0TW	WOS:000361037100025		
J	Yamaguchi, Y; Jeon, SW; Song, BS; Tanaka, Y; Asano, T; Noda, S				Yamaguchi, Yuki; Jeon, Seung-Woo; Song, Bong-Shik; Tanaka, Yoshinori; Asano, Takashi; Noda, Susumu			Analysis of Q-factors of structural imperfections in triangular cross-section nanobeam photonic crystal cavities	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							NANOCAVITIES; DIAMOND	We present comprehensive and quantitative analysis of the effect of structural imperfections on quality (Q)factors in triangular cross-section nanobeam photonic crystal cavities. We investigated statistically the optical losses due to the various imperfections in the air holes' positions, radii, alignments, and surface roughness, among other factors. It is revealed that the Q-factor decreases significantly from an ideally designed value due to such imperfections, with the main influence being the asymmetric alignment of the air hole line relative to the center of the nanobeam in the currently used fabrication process. Our analysis provides important information for achieving higher Q-factors in the cavities. (C) 2015 Optical Society of America	[Yamaguchi, Yuki; Jeon, Seung-Woo; Song, Bong-Shik; Tanaka, Yoshinori; Asano, Takashi; Noda, Susumu] Kyoto Univ, Dept Elect Sci & Engn, Kyoto, Japan; [Song, Bong-Shik] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea	Song, BS (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto, Japan.	yuki.yamaguchi@qoe.kuee.kyoto-u.ac.jp; songwiz@skku.edu			Japan Society for the Promotion of Science (JSPS) KAKENHI [15H03993]; National Research Foundation of Korea (NRF) [2011-0022699, 2013R1A1A2058866]	Japan Society for the Promotion of Science (JSPS) KAKENHI (15H03993); National Research Foundation of Korea (NRF) (2011-0022699, 2013R1A1A2058866).	Fuchs GD, 2010, NAT PHYS, V6, P668, DOI 10.1038/NPHYS1716; Quan QM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3429125; Taguchi Y, 2011, OPT EXPRESS, V19, P11916, DOI 10.1364/OE.19.011916; Burek MJ, 2012, NANO LETT, V12, P6084, DOI 10.1021/nl302541e; Song BS, 2005, NAT MATER, V4, P207, DOI 10.1038/nmat1320; Takahashi S, 2009, NAT MATER, V8, P721, DOI [10.1038/nmat2507, 10.1038/NMAT2507]; Asano T, 2006, OPT EXPRESS, V14, P1996, DOI 10.1364/OE.14.001996; Noda S, 2000, NATURE, V407, P608, DOI 10.1038/35036532; Bayn I, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025018; Babinec T. M., 2010, J VAC SCI TECHNOL B, V29; Burek M. J., 2014, CLEO; Hagino H, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085112; HALL DG, 1985, J OPT SOC AM A, V2, P747, DOI 10.1364/JOSAA.2.000747; Kojima T, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4773882; Lee JY, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906923; Sekoguchi H, 2014, OPT EXPRESS, V22, P916, DOI 10.1364/OE.22.000916; Tanaka Y, 2003, APPL PHYS LETT, V82, P1661, DOI 10.1063/1.1559947; Widmann M., 2014, NAT MATER, V14, P164; Yamada S, 2011, OPT LETT, V36, P3981, DOI 10.1364/OL.36.003981	19	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	SEP 1	2015	32	9					1792	1796		10.1364/JOSAB.32.001792		5	Optics	Optics	CQ7VO	WOS:000360813800004		
J	Naruse, M; Tani, T; Inoue, T; Yasuda, H; Hori, H; Naya, M				Naruse, Makoto; Tani, Takeharu; Inoue, Tetsuya; Yasuda, Hideki; Hori, Hirokazu; Naya, Masayuki			Local circular polarizations in nanostructures induced by linear polarization via optical near-fields	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							NANOPARTICLES; SCATTERING	We previously reported [Sci. Rep. 4, 6077 (2014)] that the geometrical randomness of disk-shaped silver nanoparticles, which exhibit high reflection at near-infrared wavelengths, serves as the origin of a particle-dependent localization and hierarchical distribution of optical near-fields in the vicinity of the nanostructure. In this study, we show that the induced polarizations are circular, particularly at resonant wavelengths. We formulate optical near-field processes between nanostructures, accounting for their polarizations and geometries, and attribute circular polarization to the layout-dependent phase difference between the electrical susceptibilities associated with longitudinal and transverse-electric components. This study clarifies the fundamental optical properties of random nanostructured matter and offers generic theoretical concepts for implementing nanoscale polarizations of optical near-fields. (C) 2015 Optical Society of America	[Naruse, Makoto] Natl Inst Informat & Commun Technol, Photon Network Res Inst, Koganei, Tokyo 1848795, Japan; [Tani, Takeharu; Yasuda, Hideki; Naya, Masayuki] Fujifilm Corp, Res & Dev Management Headquarters, Frontier Core Technol Labs, Minamiashigara, Kanagawa 2500193, Japan; [Inoue, Tetsuya] Yamanashi Ind Technol Coll, Kosyu, Yamanashi 4040042, Japan; [Hori, Hirokazu] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008511, Japan	Naruse, M (reprint author), Natl Inst Informat & Commun Technol, Photon Network Res Inst, 4-2-1 Nukui Kita, Koganei, Tokyo 1848795, Japan.	naruse@nict.go.jp			Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS).	ALVARADO SF, 1992, PHYS REV LETT, V68, P1387, DOI 10.1103/PhysRevLett.68.1387; Redding B, 2012, NAT PHOTONICS, V6, P355, DOI [10.1038/nphoton.2012.90, 10.1038/NPHOTON.2012.90]; Xu HX, 1999, PHYS REV LETT, V83, P4357, DOI 10.1103/PhysRevLett.83.4357; Tamaru H, 2002, APPL PHYS LETT, V80, P1826, DOI 10.1063/1.1461072; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Born M., 1999, PRINCIPLES OPTICS; Gresillon S., PHYS REV LETT, V82, P4520; Kadic M, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/12/126501; Kiyoto N., 2013, FUJIFILM RES DEV, V58-2013, P55; Naruse M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06077; Naruse M, 2005, OPT EXPRESS, V13, P9265, DOI 10.1364/OPEX.13.009265; Ohdaira Y, 2008, OPT EXPRESS, V16, P2915, DOI 10.1364/OE.16.002915; Ohtsu M., 1999, NEAR FIELD NANOOPTIC; Tani T, 2014, OPT EXPRESS, V22, P9262, DOI 10.1364/OE.22.009262	14	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	SEP 1	2015	32	9					1797	1803		10.1364/JOSAB.32.001797		7	Optics	Optics	CQ7VO	WOS:000360813800005		
J	Mishima, Y; Habara, H; Tanaka, KA				Mishima, Y.; Habara, H.; Tanaka, K. A.			Two plasmonic mode excitation using a double-step rectangle grating	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							ENHANCED RAMAN-SCATTERING; RESONANCE; DESIGN; CELLS	Excitation of plasmonic modes is investigated on a grating having a double-step rectangle profile. A single-step grating excites one side of a plasmonic mode, whereas the double-step profile can induce odd and even plasmonic modes simultaneously. The mode wavelength of the double-step grating can be individually controlled by selecting the rule density and the depths of the steps. In addition, the field intensity on the double-step grating has wider and stronger distributions than that appearing on the single-step grating. (C) 2015 Optical Society of America	[Mishima, Y.; Habara, H.; Tanaka, K. A.] Osaka Univ, Grad Sch Engn, Div Elect Informat & Energy Engn, Suita, Osaka 5650871, Japan	Mishima, Y (reprint author), Osaka Univ, Grad Sch Engn, Div Elect Informat & Energy Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mishima-y@eie.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS); Osaka University [26-008];  [22246122];  [23360412]	Grants-in-Aid for Scientific Research (22246122, 23360412); Japan Society for the Promotion of Science (JSPS); Osaka University (26-008).	Ferry VE, 2008, NANO LETT, V8, P4391, DOI 10.1021/nl8022548; Oskooi AF, 2010, COMPUT PHYS COMMUN, V181, P687, DOI 10.1016/j.cpc.2009.11.008; Lu D, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4812242; Sammito D, 2012, MICROELECTRON ENG, V98, P440, DOI 10.1016/j.mee.2012.05.060; Leveque G, 2006, J APPL PHYS, V100, DOI 10.1063/1.2401025; Barnes WL, 1996, PHYS REV B, V54, P6227, DOI 10.1103/PhysRevB.54.6227; Hori H, 2010, J APPL PHYS, V107, DOI 10.1063/1.3408446; Matthaus C, 2007, BIOPHYS J, V93, P668, DOI 10.1529/biophysj.106.102061; Otto A, 2005, J RAMAN SPECTROSC, V36, P497, DOI 10.1002/jrs.1355; Shioi M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4883743; Tawa K, 2008, OPT EXPRESS, V16, P9781, DOI 10.1364/OE.16.009781; Dhawan A, 2011, OPT EXPRESS, V19, P787, DOI 10.1364/OE.19.000787; Chu YZ, 2010, ACS NANO, V4, P2804, DOI 10.1021/nn901826q; Kang H, 2013, ADV FUNCT MATER, V23, P3719, DOI 10.1002/adfm.201203726; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Guillot N, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462068; Polyakov A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3592567; Yuen JM, 2010, ANAL CHEM, V82, P8382, DOI 10.1021/ac101951j; Dostalek J., SENS ACTUATORS B, V129, P303; H'Dhili F, 2011, OPT COMMUN, V284, P561, DOI 10.1016/j.optcom.2010.09.052; Kocabas A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.195130; Liu YF, 2011, J OPT SOC AM B, V28, P1934; Okamoto T., 2010, PLASMONICS KISO TO O; Okamoto T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115425; Okamoto T, 2004, APPL PHYS LETT, V85, P3968, DOI 10.1063/1.1814793	25	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	SEP 1	2015	32	9					1804	1808		10.1364/JOSAB.32.001804		5	Optics	Optics	CQ7VO	WOS:000360813800006		
J	Teranishi, J; Yamamoto, R; Nagasawa, Y; Shoji, T; Iwatani, H; Okada, N; Moriyama, T; Yamauchi, A; Tsubakihara, Y; Imai, E; Rakugi, H; Isaka, Y				Teranishi, Junya; Yamamoto, Ryohei; Nagasawa, Yasuyuki; Shoji, Tatsuya; Iwatani, Hirotsugu; Okada, Noriyuki; Moriyama, Toshiki; Yamauchi, Atsushi; Tsubakihara, Yoshiharu; Imai, Enyu; Rakugi, Hiromi; Isaka, Yoshitaka			ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathy	JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM			English	Article						Candidate gene approach; ACE I; D; AT1R A1166C; AGT T704C; renal prognosis; interaction; PREDICT-IgAN	I-CONVERTING-ENZYME; IMMUNOGLOBULIN-A NEPHROPATHY; CANDIDATE GENE APPROACH; URINARY ANGIOTENSINOGEN; ESSENTIAL-HYPERTENSION; ACEI/ATRA THERAPY; KIDNEY-DISEASE; PROGRESSION; INHIBITORS; JAPAN	Introduction: Little is known about genetic predictors that modify the renoprotective effect of renin-angiotensin system (RAS) blockade in IgA nephropathy (IgAN). Materials and methods: The present multicenter retrospective observational study examined effect modification between RAS blockade and three RAS-related gene polymorphisms in 237 IgAN patients, including ACE I/D (rs1799752), AT1R A1166C (rs5186) and AGT T704C (rs699). Results: During 9.9 4.2 years of observation, 63 patients progressed to a 50% increase in serum creatinine level. Only ACE I/D predicted the outcome (ACE DD vs ID/II, hazard ratio 1.86 (95% confidence interval 1.03, 3.33)) and modified the renoprotective effect of RAS blockade (p for interaction between ACE DD and RAS blockade = 0.087). RAS blockade suppressed progression in ACE DD patients but not in ID/II patients (ACE ID/II with RAS blockade as a reference; ID/II without RAS blockade 1.45 (0.72, 2.92); DD without RAS blockade 3.06 (1.39, 6.73); DD with RAS blockade 1.51 (0.54, 4.19)), which was ascertained in a model with the outcome of slope of estimated glomerular filtration rate (p = 0.045 for interaction). Conclusion:ACE I/D predicted the IgAN progression and the renoprotective effect of RAS blockade in IgAN patients whereas neither AT1R A1166C nor AGT T704C did.	[Teranishi, Junya; Yamamoto, Ryohei; Nagasawa, Yasuyuki; Iwatani, Hirotsugu; Imai, Enyu; Rakugi, Hiromi; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Shoji, Tatsuya; Tsubakihara, Yoshiharu] Osaka Gen Med Ctr, Dept Kidney Dis & Hypertens, Osaka, Japan; [Okada, Noriyuki] Osaka Gen Med Ctr, Clin Lab Med, Osaka, Japan; [Moriyama, Toshiki] Osaka Univ, Hlth Care Ctr, Suita, Osaka 565, Japan; [Yamauchi, Atsushi] Osaka Rosai Hosp, Dept Internal Med, Div Nephrol, Osaka, Japan; [Tsubakihara, Yoshiharu] Osaka Univ, Grad Sch Med, Japan Dept Comprehens Kidney Dis Res, Suita, Osaka 565, Japan	Isaka, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, 2-2-B6 Yamada Oka, Suita, Osaka 5650871, Japan.	isaka@kid.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [18790563, 21790809, 22590891, 23790940]; Osaka Kidney Foundation [OKF 09-0004, 10-0003]; ERA-EDTA	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI (18790563, 21790809, 22590891 and 23790940); the Osaka Kidney Foundation (OKF 09-0004 and 10-0003); and a travel grant from the 49th ERA-EDTA Congress in 2012.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Nishiyama A, 2011, NEPHROL DIAL TRANSPL, V26, P170, DOI 10.1093/ndt/gfq371; Yong D, 2006, AM J NEPHROL, V26, P511, DOI 10.1159/000097367; Kobori H, 2007, BIOCHEM BIOPH RES CO, V358, P156, DOI 10.1016/j.bbrc.2007.04.105; Koyama A, 1999, NEPHRON, V82, P205; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; TIRET L, 1992, AM J HUM GENET, V51, P197; DAMICO G, 1987, Q J MED, V64, P709; DANSER AHJ, 1995, CIRCULATION, V92, P1387; Praga M, 2003, J AM SOC NEPHROL, V14, P1578, DOI 10.1097/01.ASN.0000068460.37369.DC; Yamamoto R, 2010, AM J KIDNEY DIS, V56, P313, DOI 10.1053/j.ajkd.2010.02.351; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P1558, DOI 10.1681/ASN.2006060554; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; COSTEROUSSE O, 1993, BIOCHEM J, V290, P33; Mizuiri S, 2001, KIDNEY INT, V60, P1124, DOI 10.1046/j.1523-1755.2001.0600031124.x; Li PKT, 2006, AM J KIDNEY DIS, V47, P751, DOI 10.1053/a.ajkd.2006.01.017; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Matsuzaki K, 2013, CLIN EXP NEPHROL, V17, P827, DOI 10.1007/s10157-013-0779-7; Danser AHJ, 2007, PHARMACOL THERAPEUT, V113, P607, DOI 10.1016/j.pharmthera.2006.12.001; Glesby MJ, 1996, ANN INTERN MED, V124, P999; Nair R, 2006, KIDNEY INT, V69, P1455, DOI 10.1038/sj.ki.5000292; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Mathew A, 2010, J AM SOC NEPHROL, V21, P145, DOI 10.1681/ASN.2009030287; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63; Higaki J, 2000, CIRCULATION, V101, P2060; Kidney Disease Improving Global Outcomes, 2012, KIDNEY INT S2, V2, P209; Kim YG, 2011, CLIN EXP NEPHROL, V15, P720, DOI 10.1007/s10157-011-0475-4; Laupacis A, 2004, ANN INTERN MED, V140, P923; Nakamura T, 2000, AM J NEPHROL, V20, P373, DOI 10.1159/000013619; Narita I, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.12.e130; O'Donnell CJ, 1998, CIRCULATION, V97, P1766; Perna A, 2000, KIDNEY INT, V57, P274, DOI 10.1046/j.1523-1755.2000.00818.x; Shinzawa M, 2012, CLIN EXP NEPHROL, V16, P250, DOI 10.1007/s10157-011-0553-7; Suzuki S, 2000, AM J KIDNEY DIS, V35, P896, DOI 10.1016/S0272-6386(00)70261-7; Wiwanitkit V, 2006, RENAL FAILURE, V28, P697, DOI 10.1080/08860220600925636; Woo KT, 2000, KIDNEY INT, V58, P2485, DOI 10.1046/j.1523-1755.2000.00432.x; Woo KT, 2007, CELL MOL IMMUNOL, V4, P227; Wu SJ, 2013, NEUROBIOL AGING, V34; Yamamoto R, 2009, NEPHROL DIAL TRANSPL, V24, P3686, DOI 10.1093/ndt/gfp210; Yamamoto R, 2012, NEPHROL DIAL TRANSPL, V27, P1020, DOI 10.1093/ndt/gfr369; Zhou TB, 2012, J RENIN-ANGIO-ALDO S, V14, P235	42	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1470-3203	1752-8976		J RENIN-ANGIO-ALDO S	J. Renin-Angiotensin-Aldosterone Syst.	SEP	2015	16	3					633	641		10.1177/1470320313515036		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR1DZ	WOS:000361065100020		
J	Huang, B; Kanemoto, T				Huang, Bin; Kanemoto, Toshiaki			Performance and Internal Flow of a Counter-rotating Type Tidal Stream Turbine	JOURNAL OF THERMAL SCIENCE			English	Article						Counter-rotating; tidal stream turbine; internal flow; CFD; experimental validation	MARINE CURRENT TURBINES; HYDRODYNAMIC PERFORMANCE; POWER	In the past decade, the tidal energies have caused worldwide concern as it can provide regular and predictable renewable energy resource for power generation. The majority of technologies for exploiting the tidal stream energy are based on the concept of the horizontal axis propellers, which can be derived from the design and operation of wind turbines. However, there are some peculiar features such as the propeller working in the seawater with free surface and the possible occurrence of cavitation as compared with wind turbines. Especially, for a counter-rotating type tidal stream power turbine, it is difficult to accurately predict the interaction between the front and rear blades at the design stage by blade element momentum theory. As a result, CFD shows its advantage to predict the performance of counter-rotating type propellers of the tidal stream turbine. In order to improve the accuracy of CFD predictions, the predicted results must be verified with experimental values. In this paper, a CFD model using block-structured grid was set up and experimental test was performed in a water tunnel for a tidal stream turbine with counter-rotating type propellers. The comparison between CFD predictions and experimental data shows quite good agreement on the power coefficients, which provides an evidence of validation of the CFD model. Such results offer the necessary confidence in the accuracy of the set up CFD model for the counter-rotating type tidal stream turbine.	[Huang, Bin; Kanemoto, Toshiaki] Kyushu Inst Technol, Fac Engn, Kitakyushu, Fukuoka 8048550, Japan	Huang, B (reprint author), Kyushu Inst Technol, Fac Engn, Sensui 1-1, Kitakyushu, Fukuoka 8048550, Japan.				New Energy and Industrial Technology Development Organization in Japan	The authors wish to thank to Dr. Yuta Usui and Mr. Kohei Takaki who graduated from Kyushu Institute of Technology, Japan. Some parts of the researches were co-sponsored by the New Energy and Industrial Technology Development Organization in Japan, and Research Project: Grant-in-aid for Science Research C in Japan (2012-2014).	Batten WMJ, 2008, RENEW ENERG, V33, P1085, DOI 10.1016/j.renene.2007.05.043; Bahaj AS, 2007, RENEW ENERG, V32, P407, DOI 10.1016/j.renene.2006.01.012; Bedard R, 2010, OCEANOGRAPHY, V23, P22; Ellabban O, 2014, RENEW SUST ENERG REV, V39, P748, DOI 10.1016/j.rser.2014.07.113; Batten WMJ, 2007, OCEAN ENG, V34, P1013, DOI 10.1016/j.oceaneng.2006.04.008; Bahaj AS, 2007, RENEW ENERG, V32, P2479, DOI 10.1016/j.renene.2007.10.001; Batten WMJ, 2006, RENEW ENERG, V31, P249, DOI 10.1016/j.renene.2005.08.020; Burton T., 2000, WIND ENERGY HDB; Elghali S. Ben, 2007, EL MACH DRIV C 2007, V2, P1407; Fang L. F., 2013, MYTH CHINAS ENDLESS; Fraenkel P., 2012, P IMECHE A, V216, P1; Greenwood C., 2007, GLOBAL TRENDS SUSTAI; Suzuki T, 2013, J ENERGY POWER ENG, V7, P2381; Usui Y, 2013, J THERM SCI, V22, P580, DOI 10.1007/s11630-013-0665-3; Usui Y., 2013, IMECE2013; World Energy Council, 2010, 2010 SURV EN RES	16	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	SEP-OCT	2015	24	5					410	416		10.1007/s11630-015-0803-1		7	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CR1IE	WOS:000361077500002		
J	Fujita, M; Shintai, K; Nakata, S; Maeda, N; Hatano, N; Seki, Y				Fujita, Mitsugu; Shintai, Kazunari; Nakata, Susumu; Maeda, Nagako; Hatano, Norikazu; Seki, Yukio			Intimo-Intimal Intussusception: A Rare Form of Common Carotid Artery Dissection	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Letter									[Fujita, Mitsugu; Shintai, Kazunari; Hatano, Norikazu; Seki, Yukio] Nagoya Daini Red Cross Hosp, Dept Neurosurg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Maeda, Nagako] Nagoya Daini Red Cross Hosp, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Fujita, Mitsugu] Kindai Univ, Fac Med, Dept Microbiol, Osaka, Osaka, Japan; [Fujita, Mitsugu] Kindai Univ, Fac Med, Dept Acute Med, Osaka, Osaka, Japan; [Nakata, Susumu] Kyoto Pharmaceut Univ, Dept Clin Oncol, Kyoto, Kyoto 607, Japan	Fujita, M (reprint author), Nagoya Daini Red Cross Hosp, Dept Neurosurg, Showa Ku, 2-9 Myoken Cho, Nagoya, Aichi 4668550, Japan.						HUFNAGEL CA, 1962, AM J SURG, V103, P727, DOI 10.1016/0002-9610(62)90255-6; Zach V, 2012, J STROKE CEREBROVASC, V21, P52, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.001; ODWYER JA, 1980, RADIOLOGY, V137, P379; Salvati B, 2014, ANN GAL CHI IN PRESS	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	SEP	2015	26	9					1414	1416		10.1016/j.jvir.2015.06.015		3	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CR1KV	WOS:000361084600033		
J	Takagi, S; Chijiiwa, H; Arahori, M; Tsuzuki, M; Hyuga, A; Fujita, K				Takagi, Saho; Chijiiwa, Hitomi; Arahori, Minori; Tsuzuki, Mana; Hyuga, Ayami; Fujita, Kazuo			Do cats (Felis catus) predict the presence of an invisible object from sound?	JOURNAL OF VETERINARY BEHAVIOR-CLINICAL APPLICATIONS AND RESEARCH			English	Article						domestic cats; cognition; causal-logical understanding; sound; ecological background	MONKEYS CEBUS-APELLA; FOOD LOCATION; INFERENCES; DISCRIMINATION; PERMANENCE; PERCEPTION; INFANTS; EVENTS; APES	Recognizing invisible entities from auditory information is advantageous to animals in various situations including predator avoidance and foraging. In 2 experiments we asked whether cats could predict the presence of an unseen object on hearing noise it made, based on a causal-logical rule. After observing an experimenter shaking an opaque container for 15 seconds (observation phase), the cats freely explored the environment for 15 seconds (response phase). Experiment 1 tested 3 conditions. In the first, "contingent noise" condition, the object inside the container made a rattling noise when shaken. In the second, "irrelevant noise" condition, white noise accompanied the shaking action. In the third, "no noise" condition, the shaking action was silent. Experiment 2 tested a "noncontingent noise" condition, in which the rattling noise and movement of the container were out of synchrony. In both experiments cats looked at the container for longer in the "contingent noise" condition than the other conditions. These results suggest that cats used a causal-logical understanding of auditory stimuli to predict the presence of invisible objects. This ability may be related to the ecology of cats' natural hunting style. (C) 2015 Elsevier Inc. All rights reserved.	[Takagi, Saho; Chijiiwa, Hitomi; Arahori, Minori; Tsuzuki, Mana; Hyuga, Ayami; Fujita, Kazuo] Kyoto Univ, Grad Sch Letters, Dept Psychol, Kyoto 6068501, Japan	Takagi, S (reprint author), Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	sahonekosan@yahoo.co.jp			Japan Society for the Promotion of Science (JSPS) [25240020]	This study was financially supported by the Grant-in-aide for Scientific Research No. 25240020 to Kazuo Fujita from the Japan Society for the Promotion of Science (JSPS). The authors thank all owners and cats who volunteered to participate in this study. The authors also thank James R. Anderson and Yuya Hataji for editing the article. Saho Takagi designed this study, conducted experiments, analyzed data, and drafted the article. Hitomi Chijiiwa, Minori Arahori, Mana Tsuzuki, and Ayami Hyuga contributed to data collection. Kazuo Fujita provided critical discussion regarding the analyses and the article.	TRIANA E, 1981, ANIM LEARN BEHAV, V9, P135, DOI 10.3758/BF03212035; SPELKE ES, 1983, PERCEPTION, V12, P719, DOI 10.1068/p120719; Sabbatini G, 2008, J COMP PSYCHOL, V122, P156, DOI 10.1037/0735-7036.122.2.156; Paukner A, 2009, J COMP PSYCHOL, V123, P26, DOI 10.1037/a0013128; SPELKE ES, 1979, DEV PSYCHOL, V15, P626; Whitt E, 2009, ANIM COGN, V12, P739, DOI 10.1007/s10071-009-0228-x; DUMAS C, 1992, J COMP PSYCHOL, V106, P404, DOI 10.1037/0735-7036.106.4.404; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Penn DC, 2007, PHILOS T R SOC B, V362, P731, DOI 10.1098/rstb.2006.2023; Schmitt V, 2009, J COMP PSYCHOL, V123, P316, DOI 10.1037/a0016218; Hill A, 2012, J COMP PSYCHOL, V126, P243, DOI 10.1037/a0024449; BAHRICK LE, 1987, INFANT BEHAV DEV, V10, P387, DOI 10.1016/0163-6383(87)90039-7; Bradshaw J., 2013, CAT SENSE FELINE ENI; DAMATO MR, 1982, ANIM LEARN BEHAV, V10, P126, DOI 10.3758/BF03212259; HEFFNER RS, 1985, HEARING RES, V19, P85, DOI 10.1016/0378-5955(85)90100-5; Heimbauer LA, 2012, ANIM COGN, V15, P45, DOI 10.1007/s10071-011-0430-5; Maille A, 2012, ANIM COGN, V15, P1075, DOI 10.1007/s10071-012-0531-9; Petit O, 2015, ANIM COGN, V18, P821, DOI 10.1007/s10071-015-0848-2; Plotnik JM, 2014, ANIM BEHAV, V88, P91, DOI 10.1016/j.anbehav.2013.11.011; R Core Team, 2015, R LANG ENV STAT COMP; Tabor R., 1983, WILDLIFE DOMESTIC CA; Turner D.C., 1988, DOMESTIC CAT BIOL IT, P111	22	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1558-7878	1878-7517		J VET BEHAV	J. Vet. Behav.-Clin. Appl. Res.	SEP-OCT	2015	10	5					407	412		10.1016/j.jveb.2015.06.002		6	Behavioral Sciences; Veterinary Sciences	Behavioral Sciences; Veterinary Sciences	CQ5MI	WOS:000360648200006		
J	Lee, J; Mizuno, M; Mizuno, T; Harada, K; Uechi, M				Lee, J.; Mizuno, M.; Mizuno, T.; Harada, K.; Uechi, M.			Pathologic Manifestations on Surgical Biopsy and Their Correlation with Clinical Indices in Dogs with Degenerative Mitral Valve Disease	JOURNAL OF VETERINARY INTERNAL MEDICINE			English	Article						Heart failure; Mitral regurgitation; Myocardial degeneration; Myocardial fibrosis	ACQUIRED MYASTHENIA-GRAVIS; RISK-FACTORS; THYMOMA; CAT; THYMECTOMY; THYMUS; CANINE; ANTIBODY; RECEPTOR	Background: Evaluation of myocardial function is clinically challenging in dogs with degenerative mitral valve disease ( DMVD). Although myocardial dysfunction is caused by pathologic degeneration, histopathologic progression is poorly understood. Objectives: To characterize myocardial and pulmonary pathologic changes according to severity in dogs with naturally occurring DMVD, and to investigate whether or not pathologic degeneration is reflected by traditional clinical indices. Animals: One hundred and seventeen dogs with naturally occurring DMVD. Methods: Prospective observational study. Biopsied left atrium ( LA), left ventricle ( LV), and lung were evaluated histologically, and an attempt was made to correlate pathologic findings with clinical indices. Results: Severe myocardial changes were observed in all International Small Animal Cardiac Health Council classes. In the lung, heart failure cell levels were significantly increased in class III patients ( P <.0001). In a paired comparison, the LA showed significantly more severe degeneration than the LV, including myocardial fatty replacement, immune cell infiltration, and interstitial fibrosis ( P <.0001). In contrast, myocardial cells were more hypertrophied in the LV than in the LA ( P <.0001). Left ventricular end- diastolic dimension ( LVEDd) was associated with fatty replacement ( P =.033, R 2 = 0.584) and myocardial vacuolization ( P =.003, R 2 = 0.588) in the LA. Conclusions and Clinical Importance: In DMVD, although severe pathologic changes may be evident even in early stages, there may be pathologic discrepancy between the LA and the LV. Myocardial degeneration may be reflected by clinical indices such as LVEDd and EF.	[Lee, J.; Mizuno, M.; Mizuno, T.; Harada, K.; Uechi, M.] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Vet Cardiovasc Med & Surg Unit, Fujisawa, Kanagawa, Japan; [Mizuno, M.; Mizuno, T.; Harada, K.; Uechi, M.] Japan Anim Specialty Med Inst Inc, JASMINE Vet Cardiovasc Med Ctr, Yokohama, Kanagawa 2240001, Japan	Uechi, M (reprint author), Japan Anim Specialty Med Inst Inc, JASMINE Vet Cardiovasc Med Ctr, 2-7-3 Nakagawa, Yokohama, Kanagawa 2240001, Japan.	uechi.masami@cardiovets.jp					Shilo Y, 2011, VET ANAESTH ANALG, V38, P603, DOI 10.1111/j.1467-2995.2011.00648.x; Shelton GD, 2010, VET CLIN PATH, V39, P278, DOI 10.1111/j.1939-165X.2010.00244.x; Deymeer F, 2007, NEUROLOGY, V68, P609, DOI 10.1212/01.wnl.0000254620.45529.97; Shelton GD, 2002, VET CLIN N AM-SMALL, V32, P189, DOI 10.1016/S0195-5616(03)00085-8; Fujii Y, 2013, SURG TODAY, V43, P461, DOI 10.1007/s00595-012-0318-2; Lainesse MFC, 1996, J AM ANIM HOSP ASSOC, V32, P111; Spillane J, 2013, J NEUROL, V260, P1798, DOI 10.1007/s00415-013-6880-8; Nikolic A, 2013, CLIN NEUROL NEUROSUR, V115, P432, DOI 10.1016/j.clineuro.2012.06.013; Silvestri NJ, 2012, SEMIN NEUROL, V32, P215, DOI 10.1055/s-0032-1329200; Attaran S, 2012, INTERACT CARDIOV TH, V15, P494, DOI 10.1093/icvts/ivs263; Nakajima J, 2008, ANN THORAC SURG, V86, P941, DOI 10.1016/j.athoracsur.2008.04.070; JOSEPH RJ, 1988, J VET INTERN MED, V2, P75; Lindstrom JM, 2000, MUSCLE NERVE, V23, P453, DOI 10.1002/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O; Shelton GD, 1997, J AM VET MED ASSOC, V211, P1428; Lindstrom JM, 1998, NEUROLOGY, V51, P933; Garneau MS, 2015, VET SURG, V44, P557, DOI 10.1111/j.1532-950X.2014.12304.x; ARONSOHN MG, 1984, J AM VET MED ASSOC, V184, P1355; ATWATER SW, 1994, J AM VET MED ASSOC, V205, P1007; Bell ET, 2012, J SMALL ANIM PRACT, V53, P661, DOI 10.1111/j.1748-5827.2012.01273.x; CUDDON PA, 1989, J SMALL ANIM PRACT, V30, P511, DOI 10.1111/j.1748-5827.1989.tb01623.x; Dawson JRB, 1970, VET REC, V85, P562; Ducote JM, 1999, COMP CONT EDUC PRACT, V21, P440; GARLEPP MJ, 1984, CLIN IMMUNOL IMMUNOP, V31, P301, DOI 10.1016/0090-1229(84)90250-2; Gilhus N. E., 2011, AUTOIMMUNE DIS, V2011; GORES BR, 1994, J AM VET MED ASSOC, V204, P1782; Kaser-Hotz B, 2001, J AM ANIM HOSP ASSOC, V37, P483; KLEBANOW ER, 1992, J AM ANIM HOSP ASSOC, V28, P63; Mao ZF, 2010, EUR J NEUROL, V7, P913; Mao ZF, 2012, J CLIN NEUROL, V8, P161, DOI 10.3988/jcn.2012.8.3.161; MASON KV, 1976, J SMALL ANIM PRACT, V17, P467, DOI 10.1111/j.1748-5827.1976.tb06987.x; ODAIR HA, 1991, J SMALL ANIM PRACT, V32, P198, DOI 10.1111/j.1748-5827.1991.tb00543.x; Oh Shin J, 2012, J Clin Neuromuscul Dis, V14, P57, DOI 10.1097/CND.0b013e318275197c; SCOTTMONCRIEFF JC, 1990, J AM VET MED ASSOC, V196, P1291; Shelton GD, 2000, J AM VET MED ASSOC, V216, P55, DOI 10.2460/javma.2000.216.55; Shelton GD, 2001, NEUROLOGY, V57, P2139; Smith AN, 2001, J AM ANIM HOSP ASSOC, V37, P489; Sun XG, 2011, J CLIN NEUROSCI, V18, P57, DOI 10.1016/j.jocn.2010.05.018; Trepanier LA, 2006, CLIN TECH SMALL AN P, V21, P22, DOI 10.1053/j.ctsap.2005.12.004; Uchida K, 2002, J VET MED SCI, V64, P637, DOI 10.1292/jvms.64.637; Vachlas Konstantinos, 2012, Asian Cardiovasc Thorac Ann, V20, P48, DOI 10.1177/0218492311433189; Zitz JC, 2008, J AM VET MED ASSOC, V232, P1138	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0891-6640	1939-1676		J VET INTERN MED	J. Vet. Intern. Med.	SEP-OCT	2015	29	5					1313	1321		10.1111/jvim.13587		9	Veterinary Sciences	Veterinary Sciences	CQ9FA	WOS:000360916700007		
J	Takenaka-Uema, A; Murata, Y; Gen, F; Ishihara-Saeki, Y; Watanabe, K; Uchida, K; Kato, K; Murakami, S; Haga, T; Akashi, H; Horimoto, T				Takenaka-Uema, Akiko; Murata, Yousuke; Gen, Fumihiro; Ishihara-Saeki, Yukari; Watanabe, Ken-ichi; Uchida, Kazuyuki; Kato, Kentaro; Murakami, Shin; Haga, Takeshi; Akashi, Hiroomi; Horimoto, Taisuke			Generation of a Recombinant Akabane Virus Expressing Enhanced Green Fluorescent Protein	JOURNAL OF VIROLOGY			English	Article							VALLEY FEVER VIRUS; TRANSCRIPTION-TERMINATION SIGNAL; BUNYAMWERA-VIRUS; S-RNA; FAMILY BUNYAVIRIDAE; GC GLYCOPROTEIN; VACCINIA VIRUS; GENOME SEGMENT; ORTHOBUNYAVIRUS; RESCUE	We generated a recombinant Akabane virus (AKAV) expressing enhanced green fluorescence protein (eGFP-AKAV) by using reverse genetics. We artificially constructed an ambisense AKAV S genome encoding N/NSs on the negative-sense strand, and eGFP on the positive-sense strand with an intergenic region (IGR) derived from the Rift Valley fever virus (RVFV) S genome. The recombinant virus exhibited eGFP fluorescence and had a cytopathic effect in cell cultures, even after several passages. These results indicate that the gene encoding eGFP in the ambisense RNA could be stably maintained. Transcription of N/NSs and eGFP mRNAs of eGFP-AKAV was terminated within the IGR. The mechanism responsible for this appears to be different from that in RVFV, where the termination sites for N and NSs are determined by a defined signal sequence. We inoculated suckling mice intraperitoneally with eGFP-AKAV, which resulted in neurological signs and lethality equivalent to those seen for the parent AKAV. Fluorescence from eGFP in frozen brain slices from the eGFP-AKAV-infected mice was localized to the cerebellum, pons, and medulla oblongata. Our approach to producing a fluorescent virus, using an ambisense genome, helped obtain eGFP-AKAV, a fluorescent bunyavirus whose viral genes are intact and which can be easily visualized. IMPORTANCE AKAV is the etiological agent of arthrogryposis-hydranencephaly syndrome in ruminants, which causes considerable economic loss to the livestock industry. We successfully generated a recombinant enhanced green fluorescent protein-tagged AKAV containing an artificial ambisense S genome. This virus could become a useful tool for analyzing AKAV pathogenesis in host animals. In addition, our approach of using an ambisense genome to generate an orthobunyavirus stably expressing a foreign gene could contribute to establishing alternative vaccine strategies, such as bivalent vaccine virus constructs, for veterinary use against infectious diseases.	[Takenaka-Uema, Akiko; Gen, Fumihiro; Ishihara-Saeki, Yukari; Kato, Kentaro; Murakami, Shin; Akashi, Hiroomi; Horimoto, Taisuke] Univ Tokyo, Dept Vet Microbiol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Takenaka-Uema, Akiko; Gen, Fumihiro; Haga, Takeshi] Univ Tokyo, Dept Infect Control & Dis Prevent, Grad Sch Agr & Life Sci, Tokyo, Japan; [Murata, Yousuke; Watanabe, Ken-ichi; Uchida, Kazuyuki] Univ Tokyo, Dept Vet Pathol, Grad Sch Agr & Life Sci, Tokyo, Japan	Horimoto, T (reprint author), Univ Tokyo, Dept Vet Microbiol, Grad Sch Agr & Life Sci, Tokyo, Japan.	akashi@mail.ecc.u-tokyo.ac.jp; ahorimo@mail.ecc.u-tokyo.ac.jp			Research and Development Project for Application in Promoting New Policies in Agriculture, Forestry and Fisheries grant from the Ministry of Agriculture, Forestry and Fisheries; Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported in part by a Research and Development Project for Application in Promoting New Policies in Agriculture, Forestry and Fisheries grant from the Ministry of Agriculture, Forestry and Fisheries and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ANDERSEN AA, 1978, AM J VET RES, V39, P301; KUROGI H, 1976, ARCH VIROL, V51, P67, DOI 10.1007/BF01317835; FULLER F, 1983, J GEN VIROL, V64, P1705, DOI 10.1099/0022-1317-64-8-1705; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; MIYAZATO S, 1989, JPN J VET SCI, V51, P128; Ogawa Y, 2007, VET MICROBIOL, V124, P16, DOI 10.1016/j.vetmic.2007.03.020; Akashi H, 1997, J GEN VIROL, V78, P2847; KUROGI H, 1978, NATL I ANIM HEALTH Q, V18, P1; Habjan M, 2008, J GEN VIROL, V89, P2157, DOI 10.1099/vir.0.2008/002097-0; KUROGI H, 1979, NATL I ANIM HEALTH Q, V19, P12; MCPHEE DA, 1984, INFECT IMMUN, V43, P413; FULLER F, 1982, J VIROL, V41, P643; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Shi XH, 2010, J VIROL, V84, P8460, DOI 10.1128/JVI.00902-10; Billecocq A, 2008, VIROLOGY, V378, P377, DOI 10.1016/j.virol.2008.05.033; Shi XH, 2009, J GEN VIROL, V90, P2483, DOI 10.1099/vir.0.013540-0; Ito N, 2003, MICROBIOL IMMUNOL, V47, P613; Ogawa Y, 2007, J GEN VIROL, V88, P3385, DOI 10.1099/vir.0.83173-0; Bird BH, 2008, J VIROL, V82, P2681, DOI 10.1128/JVI.02501-07; Barr JN, 2005, J VIROL, V79, P12602, DOI 10.1128/JVI.79.19.12602-12607.2005; Barr JN, 2006, J GEN VIROL, V87, P189, DOI 10.1099/vir.0.81355-0; Barr JN, 2005, J VIROL, V79, P3586, DOI 10.1128/JVI.79.6.3586.3594.2005; Blakqori G, 2012, J GEN VIROL, V93, P1449, DOI 10.1099/vir.0.042390-0; ELLIOTT RM, 1989, J GEN VIROL, V70, P1281, DOI 10.1099/0022-1317-70-5-1281; Ikegami T, 2007, J VIROL, V81, P8421, DOI 10.1128/JVI.02641-06; Inaba Y., 1990, VIRUS INFECT VERTEBR, VIII, P467; JIN H, 1993, J VIROL, V67, P1396; Lara E, 2011, J VIROL, V85, P12134, DOI 10.1128/JVI.05322-11; Murata Y, J COMP PATH IN PRESS; Tsuda T, 2004, J VET DIAGN INVEST, V16, P571; van Knippenberg I, 2015, J VIROL, V89, P5525, DOI 10.1128/JVI.03595-14	33	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	SEP	2015	89	18					9477	9484		10.1128/JVI.00681-15		8	Virology	Virology	CQ6HE	WOS:000360704400029		
J	Toyoda, M; Ogata, Y; Mahiti, M; Maeda, Y; Kuang, XMT; Miura, T; Jessen, H; Walker, BD; Brockman, MA; Brumme, ZL; Ueno, T				Toyoda, Mako; Ogata, Yoko; Mahiti, Macdonald; Maeda, Yosuke; Kuang, Xiaomei T.; Miura, Toshiyuki; Jessen, Heiko; Walker, Bruce D.; Brockman, Mark A.; Brumme, Zabrina L.; Ueno, Takamasa			Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors	JOURNAL OF VIROLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-LEUKOCYTE ANTIGEN; TYPE-1 NEF; INDUCED CD4; T-CELLS; ELITE CONTROLLERS; DYNAMIC-RANGE; INFECTION; RESISTANCE; PROTEIN	HIV-1 Nef downregulates the viral entry receptor CD4 as well as the coreceptors CCR5 and CXCR4 from the surface of HIV-infected cells, and this leads to promotion of viral replication through superinfection resistance and other mechanisms. Nef sequence motifs that modulate these functions have been identified via in vitro mutagenesis with laboratory HIV-1 strains. However, it remains unclear whether the same motifs contribute to Nef activity in patient-derived sequences and whether these motifs may differ in Nef sequences isolated at different infection stages and/or from patients with different disease phenotypes. Here, nef clones from 45 elite controllers (EC), 46 chronic progressors (CP), and 43 acute progressors (AP) were examined for their CD4, CCR5, and CXCR4 downregulation functions. Nef clones from EC exhibited statistically significantly impaired CD4 and CCR5 downregulation ability and modestly impaired CXCR4 downregulation activity compared to those from CP and AP. Nef's ability to downregulate CD4 and CCR5 correlated positively in all cohorts, suggesting that they are functionally linked in vivo. Moreover, impairments in Nef's receptor downregulation functions increased the susceptibility of Nef-expressing cells to HIV-1 infection. Mutagenesis studies on three functionally impaired EC Nef clones revealed that multiple residues, including those at novel sites, were involved in the alteration of Nef functions and steady-state protein levels. Specifically, polymorphisms at highly conserved tryptophan residues (e.g., Trp-57 and Trp-183) and immune escape-associated sites were responsible for reduced Nef functions in these clones. Our results suggest that the functional modulation of primary Nef sequences is mediated by complex polymorphism networks. IMPORTANCE HIV-1 Nef, a key factor for viral pathogenesis, downregulates functionally important molecules from the surface of infected cells, including the viral entry receptor CD4 and coreceptors CCR5 and CXCR4. This activity enhances viral replication by protecting infected cells from cytotoxicity associated with superinfection and may also serve as an immune evasion strategy. However, how these activities are maintained under selective pressure in vivo remains elusive. We addressed this question by analyzing functions of primary Nef clones isolated from patients at various infection stages and with different disease phenotypes, including elite controllers, who spontaneously control HIV-1 viremia to undetectable levels. The results indicated that downregulation of HIV-1 entry receptors, particularly CCR5, is impaired in Nef clones from elite controllers. These functional impairments were driven by rare Nef polymorphisms and adaptations associated with cellular immune responses, underscoring the complex molecular pathways responsible for maintaining and attenuating viral protein function in vivo.	[Toyoda, Mako; Ogata, Yoko; Mahiti, Macdonald; Ueno, Takamasa] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Maeda, Yosuke] Kumamoto Univ, Fac Life Sci, Dept Microbiol, Kumamoto, Japan; [Kuang, Xiaomei T.; Brockman, Mark A.; Brumme, Zabrina L.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Miura, Toshiyuki] Univ Tokyo, Tokyo, Japan; [Jessen, Heiko] Jessen Praxis, Berlin, Germany; [Walker, Bruce D.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA; [Walker, Bruce D.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Brockman, Mark A.; Brumme, Zabrina L.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Ueno, Takamasa] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan	Ueno, T (reprint author), Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan.	uenotaka@kumamoto-u.ac.jp	Ueno, Takamasa/F-5788-2013	Ueno, Takamasa/0000-0003-4852-4236	Bill and Melinda Gates Foundation; Schwartz Foundation; Harvard University Center for AIDS Research; Ministry of Education, Science, Sports, and Culture of Japan; Japan Agency for Medical Research and Development, AMED (Research Program on HIV/AIDS); Otsuka Toshimi Scholarship Foundation; Canadian Association for HIV Research; Bristol-Myers Squibb Canada; ViiV Healthcare; Canadian Institutes for Health Research; Michael Smith Foundation for Health Research	We thank Philip Mwimanzi, Hirohito Ootsuka, Michiyo Tokunaga, and Hua Qian for their technical contributions to the initial stage of this study and Martin Markowitz for access to clinical specimens. We also acknowledge and thank the International HIV Controllers Study group, funded by the Bill and Melinda Gates Foundation, the Schwartz Foundation, and the Harvard University Center for AIDS Research.; This study was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan and by a grant from the Japan Agency for Medical Research and Development, AMED (Research Program on HIV/AIDS) (to T.U.). M.M. is supported by the Otsuka Toshimi Scholarship Foundation. X.T.K. was supported by a Master's scholarship from the Canadian Association for HIV Research in partnership with Bristol-Myers Squibb Canada and ViiV Healthcare. M.A.B. holds a Canada Research Chair in Viral Pathogenesis and Immunity from the Canada Research Chairs Program. Z.L.B. is the recipient of a New Investigator Award from the Canadian Institutes for Health Research and a Scholar Award from the Michael Smith Foundation for Health Research.	ANDERSON S, 1993, J VIROL, V67, P4923; Lundquist CA, 2002, J VIROL, V76, P4625, DOI 10.1128/JVI.76.9.4625-4633.2002; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; Hrecka K, 2005, J VIROL, V79, P10650, DOI 10.1128/JVI.79.16.10650-10659.2005; Mangasarian A, 1999, J VIROL, V73, P1964; Piguet V, 2000, NAT CELL BIOL, V2, P163; Ueno T, 2008, J IMMUNOL, V180, P1107; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Glushakova S, 2001, J VIROL, V75, P10113, DOI 10.1128/JVI.75.21.10113-10117.2001; Kuang XMT, 2014, J VIROL, V88, P10200, DOI 10.1128/JVI.01334-14; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Yu HX, 2015, J VIROL, V89, P1986, DOI 10.1128/JVI.03104-14; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Akari H, 2000, J VIROL, V74, P2907, DOI 10.1128/JVI.74.6.2907-2912.2000; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Venzke S, 2006, J VIROL, V80, P11141, DOI 10.1128/JVI.01556-06; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Lama J, 2003, CURR HIV RES, V1, P167, DOI 10.2174/1570162033485276; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Ueno T, 2007, J IMMUNOL, V178, P5513; Breiner KM, 2001, J VIROL, V75, P143, DOI 10.1128/JVI.75.1.143-150.2001; Chandrasekaran P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086998; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Jere A, 2010, MICROBES INFECT, V12, P65, DOI 10.1016/j.micinf.2009.09.009; Laguette N, 2009, J VIROL, V83, P7117, DOI 10.1128/JVI.01648-08; Lewis MJ, 2012, J VIROL, V86, P7126, DOI 10.1128/JVI.00878-12; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Maeda Y, 2015, J VIROL, V89, P502, DOI 10.1128/JVI.02686-14; Mahiti M, 2015, BIOCHEM BIOPH RES CO, V463, P248, DOI 10.1016/j.bbrc.2015.05.038; Mann JK, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-100; Marschall M, 1997, ARCH VIROL, V142, P1155, DOI 10.1007/s007050050149; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Mwimanzi P, 2012, VIRUSES-BASEL, V4, P1711, DOI 10.3390/v4091711; Mwimanzi P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-1; Mwimanzi P, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-50; Mwimanzi P, 2013, VIROLOGY, V439, P74, DOI 10.1016/j.virol.2013.02.005; Mwimanzi P, 2010, BIOCHEM BIOPH RES CO, V403, P422, DOI 10.1016/j.bbrc.2010.11.047; PAUZA CD, 1990, J EXP MED, V172, P1035, DOI 10.1084/jem.172.4.1035; PELCHENMATTHEWS A, 1991, J EXP MED, V173, P575, DOI 10.1084/jem.173.3.575; Pham TNQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-15; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; ROBINSON HL, 1990, J VIROL, V64, P4836; SCHNEIDERSCHAULIES J, 1995, P NATL ACAD SCI USA, V92, P3943, DOI 10.1073/pnas.92.9.3943; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Yamada T, 2003, J VIROL, V77, P1589, DOI 10.1128/JVI.77.2.1589-1594.2003; Yusa K, 2002, J VIROL, V76, P3031, DOI 10.1128/JVI.76.6.3031-3137.2002	54	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	SEP	2015	89	18					9639	9652		10.1128/JVI.01548-15		14	Virology	Virology	CQ6HE	WOS:000360704400043		
J	Tamura, Y; Phuc, PV				Tamura, Yukio; Pham Van Phuc			Development of CFD and applications: Monologue by a non-CFD-expert	JOURNAL OF WIND ENGINEERING AND INDUSTRIAL AERODYNAMICS			English	Article; Proceedings Paper	6th International Symposium on Computational Wind Engineering (CWE)	JUN 08-12, 2014	Hamburg, GERMANY	German Wind Engn Community, German Res Fdn		Wind engineering; CFD; Wind tunnel test; CWE; AIJ; Japanese Research Institutes	PEDESTRIAN WIND ENVIRONMENT; NUMERICAL PREDICTION; BUILDINGS; LOADS; VIBRATION	This paper first introduces personal observations of CFD activities in the wind engineering field from the past to today by the first author, who is not a CFD expert. Some impressive matters related to wind engineering CFD in the past four decades are introduced, and study topics presented in the first CWE1992 and the most recent wind engineering conferences including CWE2010 are summarized with the aid of the second author. The accuracy of CFD, wind tunnel tests, and codes and standards is also discussed. The current status of practical applications of CFD is examined based on questionnaire studies at six major research institutes working on wind engineering in Japan, and relevant AIJ activities are also introduced. Finally, recent sophisticated CFD results using the world's fastest class computer are introduced and concluding remarks are given. (C) 2015 Elsevier Ltd. All rights reserved.	[Tamura, Yukio] Beijing Jiaotong Univ, Beijing, Peoples R China; [Tamura, Yukio] Tokyo Polytech Univ, Atsugi, Kanagawa, Japan; [Pham Van Phuc] Shimizu Corp, Res Inst, Tokyo 135, Japan	Tamura, Y (reprint author), Beijing Jiaotong Univ, Beijing, Peoples R China.	yukio@arch.t-kougei.ac.jp					AIAA, 1998, AIAAG0771998; AIJ-GWE, 2007, AIJ GUID PRACT APPL; AIJ-GWL, 2005, AIJ GUID NUM PRED WI; AIJ-RLB, 2004, AIJ REC LOADS BUILD; Akagi H, 1980, J WIND ENG, P7; Kwon DK, 2008, J STRUCT ENG-ASCE, V134, P1139, DOI 10.1061/(ASCE)0733-9445(2008)134:7(1139); Tamura T, 2008, J WIND ENG IND AEROD, V96, P1974, DOI 10.1016/j.jweia.2008.02.020; Sadek F, 2002, J ENG MECH-ASCE, V128, P530, DOI 10.1061/(ASCE)0733-9399(2002)128:5(530); Zhou Y, 2003, J STRUCT ENG-ASCE, V129, P394, DOI 10.1061/(ASCE)0733-9445(2003)129:3(394); Tominaga Y, 2008, J WIND ENG IND AEROD, V96, P1749, DOI 10.1016/j.jweia.2008.02.058; Yoshie R, 2007, J WIND ENG IND AEROD, V95, P1551, DOI 10.1016/j.jweia.2007.02.023; Tamura T, 1998, J WIND ENG IND AEROD, V74-6, P531, DOI 10.1016/S0167-6105(98)00048-8; ROACHE PJ, 1986, J FLUID ENG-T ASME, V108, P2; Blocken B, 2013, P 6 EUR AFR C WIND E, P181; Cheng C.M., 2008, P 3 INT S WIND EFF B, P127; DECKER R, 1993, J WIND ENG IND AEROD, V46-7, P863, DOI 10.1016/0167-6105(93)90364-T; ERCOFTAC, 2000, BEST PRACT GUID IND; Franke J, 2006, P 4 INT S COMP WIND; Franke J., 2004, P INT C URB WIND ENG; Holmes J., 2008, P 4 INT C ADV WIND S, P1247; Holmes JD, 2014, WIND STRUCT, V18, P457; Maruyama Y., 2012, PAN DISC STEER COMM, P25; Meuer H.W., 2012, SUPERCOMPUTERS PREST, V1, P63; Murakami S., 1986, J ARCHIT PLAN, V300, P1; MURAKAMI S, 1990, J WIND ENG IND AEROD, V36, P517; Murakami S., 1988, J WIND ENG, P37; Murakami S., 1987, P 7 INT C WIND ENG S; Phuc P.V., 2014, P 6 INT S COMP WIND; Phuc P.V., 2012, TSUBAME E SCI J, V8, P17; Quan Y., 2007, P 12 INT C WIND ENG, P1615; Sabatino S.D., 2010, P 5 INT S COMP WIND; Shimada K, 1999, J AEROSPACE ENG, V12, P122, DOI 10.1061/(ASCE)0893-1321(1999)12:4(122); Takeuchi M., 1971, P 3 INT C WIND EFF B, P285; Tamura T, 1997, JAPAN SOC COMPUTATIO, V2, P2; Tamura Y., 2008, P INT C BLUFF BOD AE; Tamura Y, 1985, J WIND ENG, V26, P49; Tamura Y, 2003, P 11 INT C WIND ENG, V1, P81; Tamura Y., 2009, P 5 EUR AFR C WIND E; Tamura Y., 2009, P 7 AS PAC C WIND EN; Tamura Y., 2013, P 6 INT S WIND EFF B, P1; Tanaka H., 2012, PAN DISC STEER COMM, P15; Wang J., 2003, P 11 INT C WIND ENG, V1, P511; Whalen T, 1998, J WIND ENG IND AEROD, V77-8, P685, DOI 10.1016/S0167-6105(98)00183-4; Yoshikawa M., 2012, PAN DISC STEER COMM, P21	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6105	1872-8197		J WIND ENG IND AEROD	J. Wind Eng. Ind. Aerodyn.	SEP	2015	144				SI		3	13		10.1016/j.jweia.2015.05.003		11	Engineering, Civil; Mechanics	Engineering; Mechanics	CQ8RA	WOS:000360874900002		
J	Nozu, T; Tamura, T; Takeshi, K; Akira, K				Nozu, Tsuyoshi; Tamura, Tetsuro; Takeshi, Kishida; Akira, Katsumura			Mesh-adaptive LES for wind load estimation of a high-rise building in a city	JOURNAL OF WIND ENGINEERING AND INDUSTRIAL AERODYNAMICS			English	Article; Proceedings Paper	6th International Symposium on Computational Wind Engineering (CWE)	JUN 08-12, 2014	Hamburg, GERMANY	German Wind Engn Community, German Res Fdn		LES; Urban canopy; Wind pressure coefficient; Turbulent structure; Wind load estimation	BOUNDARY-LAYER	This paper discusses the applicability of large eddy simulation (LES) to the wind-resistant design of buildings in cities. In order to accurately predict wind pressures and forces on actual buildings with complicated shapes, we partially introduce the unstructured grid system, which is formulated on the open-source CFD code. Applying the LES method for modeling the urban flow, where a specified high-rise building focuses on safety under wind loading, the combined model is employed to investigate aerodynamic characteristics. This model uses overset grids, consisting of the Cartesian grid and the unstructured-grids. According to previous studies, the Cartesian grid method can accurately generate the turbulent structures in the urban canopy, whereas the unstructured grid method can reproduce detailed patterns of the near-wake flows around a specified building inside a densely built-up area. In this study, we have applied the combined model consisting of the Cartesian grid and unstructured grid for wind load estimation of a high-rise building in a city. Particularly, at inclined wind direction to the main streets, there is a presumption of different effects of wind impact at each vertical level of a high-rise building along the street. Accordingly, relatively a large torsional force tends to be present. On the basis of the results obtained, their accuracy is checked in comparison with the previous data by wind tunnel experiment, and wind pressure distributions on the surfaces as well as wind force coefficients of a highrise building are estimated and discussed in view of structural safety. (C) 2015 Elsevier Ltd. All rights reserved.	[Nozu, Tsuyoshi] Shimizu Corp, Inst Technol, Koto Ku, Tokyo 135, Japan; [Tamura, Tetsuro] Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 227, Japan; [Takeshi, Kishida; Akira, Katsumura] Wind Engn Inst Co Ltd, Chiyoda Ku, Tokyo, Japan	Nozu, T (reprint author), Shimizu Corp, Inst Technol, Koto Ku, 3-4-17 Etchujima, Tokyo 135, Japan.						Nozawa K, 2002, J WIND ENG IND AEROD, V90, P1151, DOI 10.1016/S0167-6105(02)00228-3; Lund TS, 1998, J COMPUT PHYS, V140, P233, DOI 10.1006/jcph.1998.5882; Yoshie R, 2007, J WIND ENG IND AEROD, V95, P1551, DOI 10.1016/j.jweia.2007.02.023; Blocken B, 2009, J WIND ENG IND AEROD, V97, P255, DOI 10.1016/j.jweia.2009.06.007; Blocken B, 2004, J WIND ENG IND AEROD, V92, P849, DOI 10.1016/j.jweia.2004.04.004; Kajishima T., 1993, P 5 INT S COMP FLUID, V1, P414; Nozu T, 2012, J WIND ENG IND AEROD, V104, P492, DOI 10.1016/j.jweia.2012.02.024; Tamura T., 2010, CWE2010; Tamura T., 2012, BBAA7	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6105	1872-8197		J WIND ENG IND AEROD	J. Wind Eng. Ind. Aerodyn.	SEP	2015	144				SI		62	69		10.1016/j.jweia.2015.05.007		8	Engineering, Civil; Mechanics	Engineering; Mechanics	CQ8RA	WOS:000360874900008		
J	Okaze, T; Ono, A; Mochida, A; Kannuki, Y; Watanabe, S				Okaze, T.; Ono, A.; Mochida, A.; Kannuki, Y.; Watanabe, S.			Evaluation of turbulent length scale within urban canopy layer based on LES data	JOURNAL OF WIND ENGINEERING AND INDUSTRIAL AERODYNAMICS			English	Article; Proceedings Paper	6th International Symposium on Computational Wind Engineering (CWE)	JUN 08-12, 2014	Hamburg, GERMANY	German Wind Engn Community, German Res Fdn		Turbulent length scale; Large-eddy simulation; Canopy model; Eddy viscosity	PEDESTRIAN LEVEL; WIND ENVIRONMENT; AIR-FLOW; PREDICTION	In this study, a new evaluation method was developed for the turbulent length scale using large-eddy simulation (LES) data. An LES was performed on the wind flow over urban-like roughness elements with periodic boundary conditions to investigate the influence of urban configurations on turbulent characteristics within the urban canopy layer. Spatial distributions of the grid scale turbulent kinetic energy (k(GS)) and mean strain rate (S-ij) were obtained from the LES results, and the value of the turbulent length scale was estimated from the k(GS) and S-ij values. A modeling approach previously proposed by the authors to reproduce the influence of urban configurations on the turbulent flow field within the canopy layer in a Reynolds-averaged Navier-Stokes simulation was examined by using the spatial distribution of the turbulent length scale provided by the LES data. (C) 2015 Elsevier Ltd. All rights reserved.	[Okaze, T.; Mochida, A.; Kannuki, Y.; Watanabe, S.] Tohoku Univ, Sendai, Miyagi 980, Japan; [Ono, A.] Shimizu Corp, Tokyo 135, Japan	Okaze, T (reprint author), Tohoku Univ, Sendai, Miyagi 980, Japan.	okaze@sabine.pin.archi.tohoku.ac.jp					Mochida A, 2008, J WIND ENG IND AEROD, V96, P1667, DOI 10.1016/j.jweia.2008.02.055; Kanda M, 2013, BOUND-LAY METEOROL, V148, P357, DOI 10.1007/s10546-013-9818-x; Mochida A, 2008, J WIND ENG IND AEROD, V96, P1498, DOI 10.1016/j.jweia.2008.02.033; Coceal O, 2006, BOUND-LAY METEOROL, V121, P491, DOI 10.1007/s10546-006-9076-2; Hagishima A, 2009, BOUND-LAY METEOROL, V132, P315, DOI 10.1007/s10546-009-9403-5; Santiago JL, 2008, BOUND-LAY METEOROL, V128, P445, DOI 10.1007/s10546-008-9294-x; Green SR, 1992, J COMPUTATIONAL FLUI, V5, P294; HIRAOKA H, 1993, J WIND ENG IND AEROD, V46-7, P173, DOI 10.1016/0167-6105(93)90127-A; Kajishima T., 1994, T JSME B, V60, P2058; Konno N., 2011, USB P 13 INT C WIND; LILLY DK, 1992, PHYS FLUIDS A-FLUID, V4, P633, DOI 10.1063/1.858280; Liu J, 1996, BOUND-LAY METEOROL, V77, P21, DOI 10.1007/BF00121857; Martilli A, 2007, BOUND-LAY METEOROL, V122, P635, DOI 10.1007/s10546-006-9124-y; MARUYAMA T, 1993, J WIND ENG IND AEROD, V46-7, P165, DOI 10.1016/0167-6105(93)90126-9; Ohashi M., 2004, J ENV ENG AIJ    APR, P91; Pope S. B., 2000, TURBULENT FLOWS; Tabata Y., 2011, J ENV ENG, V76, P831; WERNER H, 1991, 8 S TURB SHEAR FLOWS, V34, P155; Yoshida S., 2006, P 6 INT C URB CLIM I	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6105	1872-8197		J WIND ENG IND AEROD	J. Wind Eng. Ind. Aerodyn.	SEP	2015	144				SI		79	83		10.1016/j.jweia.2014.11.016		5	Engineering, Civil; Mechanics	Engineering; Mechanics	CQ8RA	WOS:000360874900010		
J	Okaze, T; Takano, Y; Mochida, A; Tominaga, Y				Okaze, T.; Takano, Y.; Mochida, A.; Tominaga, Y.			Development of a new k-epsilon model to reproduce the aerodynamic effects of snow particles on a flow field	JOURNAL OF WIND ENGINEERING AND INDUSTRIAL AERODYNAMICS			English	Article; Proceedings Paper	6th International Symposium on Computational Wind Engineering (CWE)	JUN 08-12, 2014	Hamburg, GERMANY	German Wind Engn Community, German Res Fdn		Saltation; Effect of snow particles on flow field; Canopy model; k-epsilon model	BOUNDARY-LAYER; NUMERICAL-SIMULATION; PEDESTRIAN LEVEL; WIND ENVIRONMENT; TURBULENT FLOWS; DRIFTING SNOW; PREDICTION; SNOWDRIFT; ANTARCTICA; STATION	This study aims to develop a new k-epsilon model that incorporates the effects of snow particles on a flow field. In the first part of this paper, the results of wind-tunnel measurements of a flow over a loose-snow surface are presented. The spatial distributions of the mass flux of drifting snow, wind velocity, and turbulence were simultaneously measured under several different wind-speed conditions. The wind-tunnel data clearly show that wind velocity near the snow surface decreased because of the snow particles. In the latter part of this paper, the basic equations of the k-epsilon model are modified to include new terms to express the effect of snow particles as moving obstacles on a flow field based on the concept of canopy-flow modeling. The model parameters included in the new terms, namely, R-p [which is a model parameter related to the moving particle speed in terms of the wind velocity (0 < R-p < 1)] and C-p epsilon (which is a model coefficient included in the transport equation of energy dissipation rate), are optimized by comparing the wind-tunnel measurements and computational fluid dynamics predictions. (C) 2015 Elsevier Ltd. All rights reserved.	[Okaze, T.; Takano, Y.; Mochida, A.] Tohoku Univ, Sendai, Miyagi 980, Japan; [Tominaga, Y.] Niigata Inst Technol, Kashiwazaki, Japan	Okaze, T (reprint author), Tohoku Univ, Sendai, Miyagi 980, Japan.	okaze@sabine.pin.archi.tohoku.ac.jp					Mochida A, 2008, J WIND ENG IND AEROD, V96, P1667, DOI 10.1016/j.jweia.2008.02.055; ELGHOBASHI S, 1994, APPL SCI RES, V52, P309, DOI 10.1007/BF00936835; Tominaga Y, 2011, BUILD ENVIRON, V46, P899, DOI 10.1016/j.buildenv.2010.10.020; Mochida A, 2008, J WIND ENG IND AEROD, V96, P1498, DOI 10.1016/j.jweia.2008.02.033; BANG B, 1994, ENERG BUILDINGS, V21, P235, DOI 10.1016/0378-7788(94)90039-6; Beyers JHM, 2003, J WIND ENG IND AEROD, V91, P551, DOI 10.1016/S0167-6105(02)00409-9; Beyers JHM, 2004, J WIND ENG IND AEROD, V92, P725, DOI 10.1016/j.jweia.2004.03.011; HIRAOKA H, 1993, J WIND ENG IND AEROD, V46-7, P173, DOI 10.1016/0167-6105(93)90127-A; Iversen J.D., 1980, ICARUS, V26, P321; KOBAYASHI S, 1985, ANN GLACIOL, V6, P229; Konno N., 2011, USB P 13 INT C WIND; Maeno N., 1985, LOW TEMP SCI A, V44, P131; MARUYAMA T, 1993, J WIND ENG IND AEROD, V46-7, P165, DOI 10.1016/0167-6105(93)90126-9; Murakami S, 2003, J WIND ENG IND AEROD, V91, P1759, DOI 10.1016/j.jweia.2003.09.040; Naaim M, 1998, ANN GLACIOL, V26, P191; Nishimura K, 2014, J GEOPHYS RES-ATMOS, V119, P9901, DOI 10.1002/2014JD021686; Nishimura K, 2000, J FLUID MECH, V417, P77, DOI 10.1017/S0022112000001014; Okaze T., 2008, P 6 INT C SNOW ENG W; Okaze T, 2012, J WIND ENG IND AEROD, V104, P532, DOI 10.1016/j.jweia.2012.04.002; SATO T, 1993, ANN GLACIOL-SER, V18, P149; Thiis K.T., 2000, WIND STRUCT, V3, P73; Tominaga Y, 2013, J VISUAL-JAPAN, V16, P95, DOI 10.1007/s12650-012-0156-8; Tominaga Y., 2006, 4 INT S COMP WIND EN, P941; UEMATSU T, 1991, COLD REG SCI TECHNOL, V20, P65, DOI 10.1016/0165-232X(91)90057-N	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6105	1872-8197		J WIND ENG IND AEROD	J. Wind Eng. Ind. Aerodyn.	SEP	2015	144				SI		118	124		10.1016/j.jweia.2015.04.016		7	Engineering, Civil; Mechanics	Engineering; Mechanics	CQ8RA	WOS:000360874900014		
J	Shi, S; Srivastava, SP; Kanasaki, M; He, JH; Kitada, M; Nagai, T; Nitta, K; Takagi, S; Kanasaki, K; Koya, D				Shi, Sen; Srivastava, Swayam Prakash; Kanasaki, Megumi; He, Jianhua; Kitada, Munehiro; Nagai, Takako; Nitta, Kyoko; Takagi, Susumu; Kanasaki, Keizo; Koya, Daisuke			Interactions of DPP-4 and integrin beta 1 influences endothelial-to-mesenchymal transition	KIDNEY INTERNATIONAL			English	Article						CD26; CD29; EndMT; Flt1; Flk1; smad3	DIPEPTIDYL-PEPTIDASE-IV; GROWTH-FACTOR-BETA; RENAL FIBROSIS; DIABETIC GLOMERULOPATHY; KIDNEY FIBROSIS; MOUSE MODEL; MICE; CELLS; BETA-1-INTEGRIN; STREPTOZOTOCIN	Integrin beta 1 and dipeptidyl peptidase (DPP)-4 play roles in endothelial cell biology. Vascular endothelial growth factor (VEGF)-A inhibits endothelial-to-mesenchymal transition (EndMT) through VEGF-R2, but through VEGF-R1 promotes EndMT by reducing the bioavallability of VEGF-A. Here we tested whether DPP-4-integrin beta 1 interactions have a role in EndMT in the renal fibrosis of diabetic nephropathy. In streptozotocin-induced fibrotic kidneys in diabetic CD-1 mice, levels of endothelial DPP-4, integrin beta 1, and phospho-integrin beta 1 were all higher and associated with plasma cystatin C elevation. The DPP-4 inhibitor linagliptin ameliorated kidney fibrosis, reduced plasma cystatin C levels, and suppressed endothelial levels of DPP-4, integrin beta 1, and phospho-integrin beta 1. In cultured endothelial cells, DPP-4 and integrin beta 1 physically interacted. Suppression of DPP-4 by siRNA was associated with suppression of integrin beta 1 and vice versa. Knockdown of either integrin beta 1 or DPP-4 resulted in the silencing of TGF-beta 2-induced TGF-beta receptor heterodimer formation, smad3 phosphorylation, and EndMT. DPP-4 negatively regulated endothelial viability signaling by VEGF-R2 suppression and VEGF-R1 induction in endothelial cells. Thus, DPP-4 and integrin beta 1 interactions regulate key endothelial cell signal transduction in both physiological and pathological conditions including EndMT. Hence, inhibiting DPP-4 may be a therapeutic target for treating kidney fibrosis in diabetes.	[Shi, Sen; Srivastava, Swayam Prakash; Kanasaki, Megumi; He, Jianhua; Kitada, Munehiro; Nagai, Takako; Nitta, Kyoko; Takagi, Susumu; Kanasaki, Keizo; Koya, Daisuke] Kanazawa Med Univ, Dept Diabetol & Endocrinol, Uchinada, Ishikawa 9200293, Japan; [Kitada, Munehiro; Kanasaki, Keizo; Koya, Daisuke] Kanazawa Med Univ, Med Res Inst, Div Anticipatory Mol Food Sci & Technol, Uchinada, Ishikawa 9200293, Japan	Kanasaki, K (reprint author), Kanazawa Med Univ, Dept Diabetol & Endocrinol, Uchinada, Ishikawa 9200293, Japan.	kkanasak@kanazawa-med.ac.jp; koya0516@kanazawa-med.ac.jp			Japan Society for Promotion of Science [23790381, 25282028, 25670414]; Japan Research Foundation for Clinical Pharmacology; Kanazawa Medical University [C2011-4, C2012-1, S2011-1, S2012-5]; Grant for Precursory Alumni Research(B) from Kanazawa Medical University [PR2012-10]; Daiichi-Sankyo Foundation of Life Science; Ono Medical Research Foundation; NOVARTIS Foundation (Japan) for Promotion of Science; Takeda Science Foundation; Banyu Foundation; Japanese Government MEXT (Ministry of Education, Culture, Sports, Science, and Technology) Fellowship Program	We thank Boehringer Ingelheim for providing linagliptin via an MTA. This work was partially supported by grants from the Japan Society for the Promotion of Science for KK (23790381) and DK (25282028, 25670414) and research grants from the Japan Research Foundation for Clinical Pharmacology to KK (2011). This work was partially supported by a Grant for Collaborative Research awarded to DK (C2011-4, C2012-1) and a Grant for Promoted Research awarded to KK (S2011-1, S2012-5) from Kanazawa Medical University. This work was also supported by Grant for Precursory Alumni Research(B) from Kanazawa Medical University for TK (PR2012-10). KK was also supported by several foundational grants, including grants from the Japan Research Foundation for Clinical Pharmacology, the Daiichi-Sankyo Foundation of Life Science, the Ono Medical Research Foundation, the NOVARTIS Foundation (Japan) for the Promotion of Science, the Takeda Science Foundation, and the Banyu Foundation. SPS is supported by the Japanese Government MEXT (Ministry of Education, Culture, Sports, Science, and Technology) Fellowship Program. JH and SS are supported by foreign scholar grants from Kanazawa Medical University.	Abd El Motteleb DM, 2013, EUR J PHARMACOL, V720, P158, DOI 10.1016/j.ejphar.2013.10.033; Chen S, 2003, BIOCHEM BIOPH RES CO, V300, P16, DOI 10.1016/S0006-291X(02)02708-0; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Drucker DJ, 2003, EXPERT OPIN INV DRUG, V12, P87; Ghersi G, 2006, CANCER RES, V66, P4652, DOI 10.1158/0008-5372.CAN-05-1245; He JH, 2013, CLIN EXP NEPHROL, V17, P488, DOI 10.1007/s10157-013-0781-0; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Li JH, 2010, NEPHROLOGY, V15, P507, DOI 10.1111/j.1440-1797.2010.01319.x; dos Santos L, 2013, CIRC-HEART FAIL, V6, P1029, DOI 10.1161/CIRCHEARTFAILURE.112.000057; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; FLEISCHER B, 1994, IMMUNOL TODAY, V15, P180, DOI 10.1016/0167-5699(94)90316-6; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Sato T, 2005, CANCER RES, V65, P6950, DOI 10.1158/0008-5472.CAN-05-0647; Sundqvist A, 2013, ONCOGENE, V32, P3606, DOI 10.1038/onc.2012.370; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187; Kovacic JC, 2012, CIRCULATION, V125, P1795, DOI 10.1161/CIRCULATIONAHA.111.040352; Vallance BA, 2005, AM J PHYSIOL-GASTR L, V289, pG116, DOI 10.1152/ajpgi.00051.2005; Kanasaki K, 2013, FASEB J, V27, P1950, DOI 10.1096/fj.12-223404; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Ayaori M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003277; Campbell ID, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A004994; Hu Y, 2013, MOL BIOL REP, V40, P2273, DOI 10.1007/s11033-012-2290-8; Ito M, 1999, BIOL PHARM BULL, V22, P988; Kanasaki Keizo, 2013, Front Endocrinol (Lausanne), V4, P7, DOI 10.3389/fendo.2013.00007; Lee Young Ki, 2013, Diabetes Metab J, V37, P465, DOI 10.4093/dmj.2013.37.6.465; Liu SX, 2009, ARTHRITIS RHEUM, V60, P2817, DOI 10.1002/art.24801; Mulrooney JP, 2001, J CELL SCI, V114, P2525; Okamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086671; Samikannu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082639; Sortino Maria Angela, 2013, Front Endocrinol (Lausanne), V4, P16, DOI 10.3389/fendo.2013.00016; Tanjore H, 2008, DEV DYNAM, V237, P75, DOI 10.1002/dvdy.21385; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Xiwu C, 2014, J CLIN INVEST, V124, P3295; Yeh YC, 2010, AM J PATHOL, V177, P1743, DOI 10.2353/ajpath.2010.091183	44	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	SEP	2015	88	3					479	489		10.1038/ki.2015.103		11	Urology & Nephrology	Urology & Nephrology	CR1JA	WOS:000361079800013		
J	Komaba, H; Taniguchi, M; Wada, A; Iseki, K; Tsubakihara, Y; Fukagawa, M				Komaba, Hirotaka; Taniguchi, Masatomo; Wada, Atsushi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu; Fukagawa, Masafumi			Parathyroidectomy: better late than never Reply	KIDNEY INTERNATIONAL			English	Letter							HEMODIALYSIS; OUTCOMES		[Komaba, Hirotaka; Fukagawa, Masafumi] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa 2591193, Japan; [Taniguchi, Masatomo; Wada, Atsushi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan	Komaba, H (reprint author), Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, 143 Shimo Kasuya, Isehara, Kanagawa 2591193, Japan.	hkomaba@tokai-u.jp					Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Elias RM, 2015, KIDNEY INT, V88, P638, DOI 10.1038/ki.2015.217; Goldenstein PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068870; Ishani A, 2015, CLIN J AM SOC NEPHRO, V10, P90, DOI 10.2215/CJN.03520414; Komaba H, KIDNEY INT IN PRESS; Tentori F, 2015, CLIN J AM SOC NEPHRO, V10, P98, DOI 10.2215/CJN.12941213	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	SEP	2015	88	3					638	639		10.1038/ki.2015218		2	Urology & Nephrology	Urology & Nephrology	CR1JA	WOS:000361079800032		
J	Yokoyama, K; Nakashima, A; Maruyama, Y; Ohkido, I; Yokoo, T				Yokoyama, Keitaro; Nakashima, Akio; Maruyama, Yukio; Ohkido, Ichiro; Yokoo, Takashi			Does bone structure accurately reflect serum FGF23 levels in patients with chronic kidney disease?	KIDNEY INTERNATIONAL			English	Letter									[Yokoyama, Keitaro; Nakashima, Akio; Maruyama, Yukio; Ohkido, Ichiro; Yokoo, Takashi] Jikei Univ, Sch Med, Div Nephrol & Hypertens, Dept Internal Med,Div Kidney & Hypertens, Tokyo, Japan	Yokoyama, K (reprint author), Jikei Univ, Sch Med, Div Nephrol & Hypertens, Dept Internal Med,Div Kidney & Hypertens, Tokyo, Japan.	keitaro@jikei.ac.jp					Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ohkido I, 2010, KIDNEY INT, V77, P743, DOI 10.1038/ki.2009.534; Pereira RC, 2015, KIDNEY INT, V87, P593, DOI 10.1038/ki.2014.347	4	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	SEP	2015	88	3					640	640		10.1038/ki.2015.206		1	Urology & Nephrology	Urology & Nephrology	CR1JA	WOS:000361079800035		
J	Ene, V; Herzog, J; Hibi, T				Ene, Viviana; Herzog, Juergen; Hibi, Takayuki			Linear flags and Koszul filtrations	KYOTO JOURNAL OF MATHEMATICS			English	Article							ALGEBRAS; IDEALS	We show that the graded maximal ideal of a graded K-algebra R has linear quotients for a suitable choice and order of its generators if the defining ideal of R has a quadratic Grobner basis with respect to the reverse lexicographic order, and we show that this linear quotient property for algebras defined by binomial edge ideals characterizes closed graphs. Furthermore, for algebras defined by binomial edge ideals attached to a closed graph and for join-meet rings attached to a finite distributive lattice we present explicit Koszul filtrations.	[Ene, Viviana] Ovidius Univ, Fac Math & Comp Sci, Constanta, Romania; [Ene, Viviana] Acad Romana, Simion Stoilow Inst Math, Bucharest, Romania; [Herzog, Juergen] Univ Duisburg Essen, Fachbereich Math, Essen, Germany; [Hibi, Takayuki] Osaka Univ, Dept Pure & Appl Math, Grad Sch Informat Sci & Technol, Toyonaka, Osaka 560, Japan	Ene, V (reprint author), Ovidius Univ, Fac Math & Comp Sci, Constanta, Romania.	vivian@univ-ovidius.ro; juergen.herzog@uni-essen.de; hibi@math.sci.osaka-u.ac.jp			Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI) [PN-II-ID-PCE-2011-3-1023]	Ene's work supported by grant PN-II-ID-PCE-2011-3-1023 from Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI).	Ohtani M, 2011, COMMUN ALGEBRA, V39, P905, DOI 10.1080/00927870903527584; Ene V, 2011, NAGOYA MATH J, V204, P57, DOI 10.1215/00277630-1431831; Ohsugi H, 1999, J ALGEBRA, V218, P509, DOI 10.1006/jabr.1999.7918; Conca A, 2001, COMPOS MATH, V129, P95, DOI 10.1023/A:1013160203998; Herzog J, 2010, ADV APPL MATH, V45, P317, DOI 10.1016/j.aam.2010.01.003; Conca A, 2001, MATH SCAND, V89, P201; Conca A, 2000, MATH ANN, V317, P329, DOI 10.1007/s002080000100; Cox D. A., ARXIV13065149V2MATHC; Ene V., 2014, SPRINGER P MATH STAT, V96, P125, DOI [10.1007/978-3-319-09186-0_8, DOI 10.1007/978-3-319-09186-0_8]; Herzog J, 2000, MATH SCAND, V86, P161; Herzog J., 2010, GRAD TEXTS MATH, V260, DOI 10.1007/978-0-85729-106-6; Hibi T., 2015, INT J ALGEBRA, V9, P7; ROOS JE, 1993, CR ACAD SCI I-MATH, V316, P1123; Sturmfels B., 1995, U LECT SER, V8	14	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	SEP	2015	55	3					517	530		10.1215/21562261-3089028		14	Mathematics	Mathematics	CR1TW	WOS:000361109000002		
J	Ikoma, H				Ikoma, Hideaki			A Bertini-type theorem for free arithmetic linear series	KYOTO JOURNAL OF MATHEMATICS			English	Article							ALGEBRAIC VARIETY; NULLSTELLENSATZ; SINGULARITIES; RESOLUTION; FIELD	In this paper, we prove a version of the arithmetic Bertini theorem asserting that there exists a strictly small and generically smooth section of a given arithmetically free graded arithmetic linear series.	Univ Tokyo, Grad Sch Math Sci, Tokyo, Japan	Ikoma, H (reprint author), Univ Tokyo, Grad Sch Math Sci, Tokyo, Japan.	ikoma@ms.u-tokyo.ac.jp			Japan Society for the Promotion of Science	Author's work supported by a research fellowship from the Japan Society for the Promotion of Science.	Moriwaki A, 1996, MATH RES LETT, V3, P173; KLEIMAN SL, 1974, COMPOS MATH, V28, P287; Yuan XY, 2008, INVENT MATH, V173, P603, DOI 10.1007/s00222-008-0127-9; Alon N, 1999, COMB PROBAB COMPUT, V8, P7, DOI 10.1017/S0963548398003411; Jelonek Z, 2005, INVENT MATH, V162, P1, DOI 10.1007/s00222-004-0434-8; HIRONAKA H, 1964, ANN MATH, V79, P109, DOI 10.2307/1970486; Moriwaki A, 2011, INT MATH RES NOTICES, P1245, DOI 10.1093/imrn/rnq116; MORIWAKI A, 1995, AM J MATH, V117, P1325, DOI 10.2307/2374978; Mumford D., 1976, GRUND MATH WISS, V221; Yuan X., ARXIV13043538V1MATHN	10	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	SEP	2015	55	3					531	541		10.1215/21562261-3089037		11	Mathematics	Mathematics	CR1TW	WOS:000361109000003		
J	Tatsuuma, N				Tatsuuma, Nobuhiko			Duality theorem for topological semigroups	KYOTO JOURNAL OF MATHEMATICS			English	Article								For topological semigroups S, we consider Tannaka-type duality theorems, which are extensions of the notion of weak Tannaka duality theorem for topological groups. In the case of topological semigroups, we must set as the dual object of S all isometric representations of S instead of all unitary representations. We define a property T-type for S. After arguments analogous to previous work from the author, we can prove that our Tannaka-type duality theorem is valid if and only if S is a T-type semigroup.		Tatsuuma, N (reprint author), Matsuoi Cho 10-8, Nishinomiya, Hyogo, Japan.						Bourbaki N., 1951, TOPOLOGIE GEN; Tatsuuma N, 2014, KYOTO J MATH, V54, P75, DOI 10.1215/21562261-2400283; Tatsuuma N., 2008, RIMS KOKYUROKU BES B, V7, P13; Tatsuuma N., 1967, J MATH KYOTO U, V6, P187; Tatsuuma N, 2014, KYOTO J MATH, V54, P51, DOI 10.1215/21562261-2400274; Yosida K., 1971, FUNCTIONAL ANAL	6	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	SEP	2015	55	3					543	554		10.1215/21562261-3089046		12	Mathematics	Mathematics	CR1TW	WOS:000361109000004		
J	Higashitani, A				Higashitani, Akihiro			Smooth Fano polytopes arising from finite directed graphs	KYOTO JOURNAL OF MATHEMATICS			English	Article							CLASSIFICATION; VARIETIES; NUMBER	In this paper, we consider terminal reflexive polytopes arising from finite directed graphs and study the problem of deciding which directed graphs yield smooth Fano polytopes (SFPs). We show that any centrally symmetric or pseudosymmetric SFPs can be obtained from directed graphs. Moreover, by using directed graphs, we provide new examples of SFPs whose corresponding varieties admit Kahler-Einstein metrics.	Kyoto Sangyo Univ, Dept Math, Kita Ku, Kyoto 603, Japan	Higashitani, A (reprint author), Kyoto Sangyo Univ, Dept Math, Kita Ku, Kyoto 603, Japan.	ahigashi@cc.kyoto-su.ac.jp					Casagrande C, 2006, ANN I FOURIER, V56, P121; Batyrev VV, 1999, J REINE ANGEW MATH, V512, P225; EWALD G, 1988, DISCRETE COMPUT GEOM, V3, P49, DOI 10.1007/BF02187895; Hibi T, 2011, DISCRETE COMPUT GEOM, V45, P449, DOI 10.1007/s00454-010-9271-2; Kasprzyk AM, 2006, TOHOKU MATH J, V58, P101, DOI 10.2748/tmj/1145390208; Kasprzyk AM, 2010, CAN J MATH, V62, P1293, DOI 10.4153/CJM-2010-070-3; Kreuzer M, 2000, ADV THEOR MATH PHYS, V4, P1209; Kreuzer M., 1998, ADV THEOR MATH PHYS, V2, P853; Matsui T, 2011, J ALGEBR COMB, V34, P721, DOI 10.1007/s10801-011-0290-8; Nill B, 2006, CONTEMP MATH, V423, P269; Nill B., 2011, BEITR ALGEBRA GEOM, V52, P297; Nill B, 2010, TOHOKU MATH J, V62, P1; Obro M., ARXIV07040049V1MATHC; Ohsugi H, 2002, EUR J COMBIN, V23, P463, DOI 10.1006/eujc.2002.0572; Ohsugi H, 1998, J ALGEBRA, V207, P409, DOI 10.1006/jabr.1998.7476; Reid M., 1983, ADV STUDIES PURE MAT, V1, P131; Schrijver A., 1986, THEORY LINEAR INTEGE; Voskresenski V. E., 1985, MATH USSR IZV, V24, P221, DOI 10.1070/IM1985v024n02ABEH001229; Wilson R. J., 1996, INTRO GRAPH THEORY, V4th	19	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	SEP	2015	55	3					579	592		10.1215/21562261-3089073		14	Mathematics	Mathematics	CR1TW	WOS:000361109000007		
J	Koike, T				Koike, Takayuki			On the minimality of canonically attached singular Hermitian metrics on certain nef line bundles	KYOTO JOURNAL OF MATHEMATICS			English	Article								We apply Ueda theory to a study of singular Hermitian metrics of a (strictly) nef line bundle L. Especially we study minimal singular metrics of L, metrics of L with the mildest singularities among singular Hermitian metrics of L whose local weights are plurisubharmonic. In some situations, we determine a minimal singular metric of L. As an application, we give new examples of (strictly) nef line bundles which admit no smooth Hermitian metric with semipositive curvature.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Koike, T (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	tkoike@ms.u-tokyo.ac.jp			Program for Leading Graduate Schools, Ministry of Education, Culture, Sports, Science, and Technology, Japan;  [25-2869]	Author's work supported by the grant-in-aid for scientific research KAKENHI no. 25-2869, the grant-in-aid for Japan Society for the Promotion of Science fellows, and the Program for Leading Graduate Schools, Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Demailly JP, 2001, INT J MATH, V12, P689, DOI 10.1142/S0129167X01000861; Demailly J.-P., 1994, J ALGEBRAIC GEOM, V3, P295; Demailly J.-P., 2012, SURV MODERN MATH, V1; Fujino O, 2013, J REINE ANGEW MATH, V681, P149, DOI 10.1515/crelle-2012-0036; Hartshorne R., 1970, LECT NOTES MATH, V156; NARASIMH.MS, 1965, ANN MATH, V82, P540, DOI 10.2307/1970710; Neeman A., 1989, AM MATH SOC, V81, DOI [10.1090/memo/0415, DOI 10.1090/MEM0/0415]; Ueda T., 1982, J MATH KYOTO U, V22, P583	8	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	SEP	2015	55	3					607	616		10.1215/21562261-3089091		10	Mathematics	Mathematics	CR1TW	WOS:000361109000009		
J	Nakada, M				Nakada, Masayuki			On homological stability for orthogonal and special orthogonal groups	KYOTO JOURNAL OF MATHEMATICS			English	Article								We shall prove that the map H-i(SOn(K), Z) -> H-i(SOn+1(K), Z) is bijective for 2i < n and surjective for 2i <= n. Here K is an arbitrary Pythagorean field and the special orthogonal group SOn(K) is the subgroup of K-linear automorphisms over K-n with determinant one which preserve the Euclidean quadratic form q(x) = x(1)(2) + ... + x(n)(2). It is derived from the homological stability of the orthogonal groups O-n(K) with twisted coefficients Z(t).	Kobe Univ, Secondary Sch, Kobe, Hyogo 6580011, Japan	Nakada, M (reprint author), Kobe Univ, Secondary Sch, Kobe, Hyogo 6580011, Japan.	mnakada@people.kobe-u.ac.jp					Brown K. S., 1982, GRADUATE TEXTS MATH, V87; Cathelineau JL, 2007, ANN SCI ECOLE NORM S, V40, P487, DOI 10.1016/j.ansens.2007.03.001; Dupont J. L., 2001, NANKAI TRACTS MATH, V1, DOI 10.1142/9789812810335.; Lam T. Y., 1973, ALGEBRAIC THEORY QUA; SAH CH, 1986, COMMENT MATH HELV, V61, P308, DOI 10.1007/BF02621918; Weibel C., 1994, STUD ADV MATH, V38	6	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	SEP	2015	55	3					627	640		10.1215/21562261-3089109		14	Mathematics	Mathematics	CR1TW	WOS:000361109000011		
J	Fujita, T				Fujita, Takahiko			Special values of the Riemann zeta function via arcsine random variables	KYOTO JOURNAL OF MATHEMATICS			English	Article							CAUCHY VARIABLES; ELEMENTARY PROOF	In this paper, using arcsine variables, we get a new elementary proof of zeta( 2) = pi(2)/6, known as the Basel problem, and the Euler formula. Using exponential variables, we get an Euler-like formula. We can also solve the Basel problem by using Wigner's semicircle law and the Legendre generating function.	Chuo Univ, Dept Ind & Syst Engn, Bunkyo Ku, Tokyo 1128551, Japan	Fujita, T (reprint author), Chuo Univ, Dept Ind & Syst Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	rankstatistics@gmail.com					Bourgade P, 2007, ELECTRON COMMUN PROB, V12, P73; CASTELLANOS D., 1988, MATH MAG, V61, P67; CHOE BR, 1987, AM MATH MON, V94, P662, DOI 10.2307/2322220; Fujita T, 2012, KYOTO J MATH, V52, P465, DOI 10.1215/21562261-1625163; Fujita T., 2008, RIMS KOKYUROKU, V1590, P1; Holme F., 1970, NORDISK MAT TIDSKR, V18, p[91, 120]; MATSUOKA Y, 1961, AM MATH MON, V68, P485, DOI 10.2307/2311110; PAPADIMI.I, 1973, AM MATH MON, V80, P424, DOI 10.2307/2319092; STARK EL, 1969, AM MATH MON, V76, P552, DOI 10.2307/2316976	9	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	SEP	2015	55	3					673	686		10.1215/21562261-3089145		14	Mathematics	Mathematics	CR1TW	WOS:000361109000014		
J	Suzuki, Y				Suzuki, Yuriko			Psychiatric morbidity after a major yet transient disaster	LANCET PSYCHIATRY			English	Editorial Material							MENTAL-HEALTH CONSEQUENCES		Natl Ctr Neurol & Psychiat, NIMH, Dept Adult Mental Hlth, Kodaira, Tokyo 1878553, Japan	Suzuki, Y (reprint author), Natl Ctr Neurol & Psychiat, NIMH, Dept Adult Mental Hlth, Kodaira, Tokyo 1878553, Japan.	yrsuzuki@ncnp.go.jp					American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Kun P, 2013, PUBLIC HEALTH, V127, P644, DOI 10.1016/j.puhe.2013.04.018; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Norris FH, 2006, J TRAUMA STRESS, V19, P173, DOI 10.1002/jts.20109; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; Arnberg FK, 2015, LANCET PSYCHIAT; Galea S, 2008, INT J METH PSYCH RES, V17, pS21, DOI 10.1002/mpr.267; Inter-Agency Standing Committee, 2007, IASC GUID MENT HLTH; van Ommeren M, 2005, BRIT MED J, V330, P1160, DOI 10.1136/bmj.330.7501.1160	9	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2215-0374			LANCET PSYCHIAT	Lancet Psychiatry	SEP	2015	2	9					770	771		10.1016/S2215-0366(15)00174-1		3	Psychiatry	Psychiatry	CQ9WY	WOS:000360967200007		
J	Fukushima, K				Fukushima, Kazuhiko			Compositionality, lexical integrity, and agglutinative morphology	LANGUAGE SCIENCES			English	Article						Compositionality; Lexical integrity; Word structure; Agglutinative morphology; Bracketing paradox; Japanese	V-V COMPOUNDS; LINGUISTIC SEMANTICS; BRACKETING PARADOX; JAPANESE; GRAMMAR	Based on morphological phenomena found mostly in Japanese, a highly agglutinative language, this paper investigates how we might approach intra-word compositionality in a manner faithful to lexical integrity. First, we observe some word-formation phenomena that seem to apparently contradict lexical (or morphological) integrity and 'direct compositionality'. These involve mismatches - bracketing paradoxes - between morphological constituency vis-a-vis syntactic or semantic constituency. We also survey how researchers have dealt or would deal with instances of such mismatches. Upon concluding that these mismatches are not obstacles to direct compositionality or lexical integrity, an even more drastic bracketing paradox, namely, the one involving the sized inalienable possession construction is introduced as a case study to give the concept of direct compositionality a further stress test. The viability and, arguably, advantage of a direct compositional semantically-oriented (as opposed to syntactic) approach to word-formation is demonstrated. Finally, after a summary of the paper, further conceptual issues regarding compositionality and word-formation are taken up. (C) 2015 Elsevier Ltd. All rights reserved.	Kansai Gaidai Univ, Hirakata, Osaka 5731001, Japan	Fukushima, K (reprint author), Kansai Gaidai Univ, 16-1 Nakamiya Higashino Cho, Hirakata, Osaka 5731001, Japan.	kaz@kansaigaidai.ac.jp					Ackerman Farrell, 1998, THEORY PREDICATES; KLEIN E, 1985, LINGUIST PHILOS, V8, P163, DOI 10.1007/BF00632365; DALRYMPLE M, 1991, LINGUIST PHILOS, V14, P399, DOI 10.1007/BF00630923; BARWISE J, 1981, LINGUIST PHILOS, V4, P159, DOI 10.1007/BF00350139; Recanati F, 2001, MIND, V110, P637, DOI 10.1093/mind/110.439.637; Jacobson P, 1999, LINGUIST PHILOS, V22, P117, DOI 10.1023/A:1005464228727; PESETSKY D, 1985, LINGUIST INQ, V16, P193; Bach E., 2005, REFERENCE QUANTIFICA, P107; Barker C., 2007, DIRECT COMPOSITIONAL, P1; Bekki D., 2010, P 140 M LING SOC JAP, P140; Bekki D., 2010, NIHONGO BUNPOU NO KE; BITTNER M, 1994, LINGUIST PHILOS, V17, P53, DOI 10.1007/BF00985041; Bittner Maria, 1994, CASE SCOPE BINDING; Booij G., 2005, LINGUE LING, VIV, P163; BRESNAN J, 1995, NAT LANG LINGUIST TH, V13, P181, DOI 10.1007/BF00992782; Bybee J.L., 1985, MORPHOLOGY; Contini-Morava E., 1995, MEANING EXPLANATION, P1; De Brabanter P., 2010, EXPLICIT COMMUNICATI, P199; Dowty D, 1996, DISCONTINUOUS CONSTI, P11; Egg M, 2004, P 11 INT C HEAD DRIV, P119; Fukushima K, 2005, LANGUAGE, V81, P568, DOI 10.1353/lan.2005.0125; Fukushima K, 2008, GENGO KENKYU, V134, P119; Fukushima K, 1999, J LINGUIST, V35, P297, DOI 10.1017/S002222679900763X; Fukushima K, 2014, J LINGUIST, V50, P91; Fukushima K, 1998, P 34 M CHIC LING SOC, P171; Fukushima K, 2004, P 40 M CHIC LING SOC, P177; Gazdar Gerald, 1985, GEN PHRASE STRUCTURE; Gunji T, 1999, STUDIES CONT PHRASE, P119; Halliday Michael A., 2004, INTRO FUNCTIONAL GRA; Harada S.I., 1973, ANN B, V7, P113; Harley H., 2008, OXFORD HDB JAPANESE, P20; Hendriks H., 2001, Journal of Logic, Language and Information, V10, DOI 10.1023/A:1026592526654; Hodges W., 2001, Journal of Logic, Language and Information, V10, DOI 10.1023/A:1026502210492; Hoeksema J., 1985, THESIS U GRONINGEN; Jacobson P., 2014, COMPOSITIONAL SEMANT; Jacobson P., 2000, NAT LANG SEMANT, V8, P77, DOI DOI 10.1023/A:1026517717879; Jacobson P, 2002, LINGUIST PHILOS, V25, P601, DOI 10.1023/A:1020851413268; Janssen T.M.V., 2011, HDB LOGIC LANGUAGE, Vsecond, P3; Janssen T.M.V., 1986, FDN APPL MONTAGUE GR; Kageyama T, 2009, OXFORD HDB COMPOUNDI, P512; Kageyama T., 1993, BUNPOO TO GOKEISEI; Kaz J.J., 1964, LANGUAGE, V39, P170; Kindaichi H., 1957, NIHONGO; KITAGAWA Y, 1986, LINGUIST INQ, V17, P177; Kitagawa Yoshi, 1986, THESIS U MASSACHUSET; Kornfilt J., 2012, FUNCTIONAL HEADS CAR, V7, P181; Kubota Y, 2007, J LINGUIST, V43, P489, DOI 10.1017/S0022226707004756; Kuno Susumu, 1973, STRUCTURE JAPANESE L; Kuroda SY, 2003, LINGUA, V113, P447, DOI 10.1016/S0024-3841(02)00082-7; Lapointe Steven G., 1980, THESIS U MASSACHUSET; Larson R. K., 1998, P SEM LING THEOR SAL, P145; Manning Christopher D., 1999, STUDIES CONT PHRASE, P39; Matsumoto Y., 1996, COMPLEX PREDICATES J; Miyagawa S., 1999, HDB JAPANESE LINGUIS, P236; Montague Richard, 1970, LINGUAGGI NELLA SOC, P189; Montague Richard, 1973, APPROACHES NATURAL L, P221, DOI DOI 10.1007/978-94-010-2506-5_10; Moortgat M, 1988, CATEGORIAL INVESTIGA; Morita Y., 2003, WORKING PAPERS OTSUM, V35, P11; Muraki M., 1978, PROBLEMS JAPANESE SY, P155; Niikawa T., 1989, GENGO KENKYUKAI, P163; Nishiyama K, 1998, J EAST ASIAN LINGUIS, V7, P175, DOI 10.1023/A:1008265805417; Oehrle R., 1988, CATEGORIAL GRAMMARS; Oshima D., 2012, P 19 INT C HEAD DRIV, P292; Pagin P, 2010, LINGUIST PHILOS, V33, P381, DOI 10.1007/s10988-011-9083-8; Partee B., 1996, HDB CONT SEMANTIC TH, P11; Pollard Carl, 1987, INFORM BASED SYNTAX; Pollard Carl, 1994, HEAD DRIVEN PHRASE S; Potts C., 2007, DIRECT COMPOSITIONAL, P405; Sadock J., 2012, MODULAR ARCHITECTURE; Saiki M., 1987, THESIS STANFORD U ST; Shibatani M., 1973, F LANGUAGE, V9, P327; SHIBATANI M, 1988, LANGUAGE, V64, P451, DOI 10.2307/414529; SHIBATANI M, 1977, LANGUAGE, V53, P789, DOI 10.2307/412912; Spencer A., 2005, HDB WORD FORMATION, P73; Steele S., 1981, ENCY AUX; Stump G., 2009, THEORY EVIDENCE SEMA, P215; Stump G., 2007, DEPONENCY MORPHOLOGI, V145, P71; Stump Gregory T, 2001, INFLECTIONAL MORPHOL; Sugioka Y., 1984, THESIS U CHICAGO; Werning M., 2012, OXFORD HDB COMPOSITI; Williams Edwin, 1987, DEFINITION WORD; Yoda Y., 2013, THESIS OSAKA U; Yoon JHS, 1994, MIT WORKING PAPERS L, V22, P251; Yuhara I., 2008, THESIS U CHICAGO; Yuhara I., 2010, JAPANESE KOREAN LING, V19, P247; Yumoto Y., 2005, FUKUGODOSHI HASEIDOS	86	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0388-0001	1873-5746		LANG SCI	Lang. Sci.	SEP	2015	51						67	85		10.1016/j.langsci.2015.05.012		19	Linguistics; Language & Linguistics	Linguistics	CQ8QZ	WOS:000360874800005		
J	Uematsu, A; Tan, BZ; Johansen, JP				Uematsu, Akira; Tan, Bao Zhen; Johansen, Joshua P.			Projection specificity in heterogeneous locus coeruleus cell populations: implications for learning and memory	LEARNING & MEMORY			English	Review							DORSAL NORADRENERGIC BUNDLE; MEDIAL PREFRONTAL CORTEX; VENTRAL TEGMENTAL AREA; DOUBLE-LABELING TECHNIQUE; CERULEUS NEURONS; CONDITIONED FEAR; NEURAL CIRCUITS; NOREPINEPHRINE RELEASE; BASOLATERAL AMYGDALA; AFFERENT-PROJECTIONS	Noradrenergic neurons in the locus coeruleus (LC) play a critical role in many functions including learning and memory. This relatively small population of cells sends widespread projections throughout the brain including to a number of regions such as the amygdala which is involved in emotional associative learning and the medial prefrontal cortex which is important for facilitating flexibility when learning rules change. LC noradrenergic cells participate in both of these functions, but it is not clear how this small population of neurons modulates these partially distinct processes. Here we review anatomical, behavioral, and electrophysiological studies to assess how LC noradrenergic neurons regulate these different aspects of learning and memory. Previous work has demonstrated that subpopulations of LC noradrenergic cells innervate specific brain regions suggesting heterogeneity of function in LC neurons. Furthermore, noradrenaline in mPFC and amygdala has distinct effects on emotional learning and cognitive flexibility. Finally, neural recording data show that LC neurons respond during associative learning and when previously learned task contingencies change. Together, these studies suggest a working model in which distinct and potentially opposing subsets of LC neurons modulate particular learning functions through restricted efferent connectivity with amygdala or mPFC. This type of model may provide a general framework for understanding other neuromodulatory systems, which also exhibit cell type heterogeneity and projection specificity.	[Uematsu, Akira; Tan, Bao Zhen; Johansen, Joshua P.] RIKEN, Brain Sci Inst, Lab Neural Circuitry Memory, Wako, Saitama 3510198, Japan; [Johansen, Joshua P.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan	Johansen, JP (reprint author), RIKEN, Brain Sci Inst, Lab Neural Circuitry Memory, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	jjohans@brain.riken.jp			Ministry of Education, Culture, Sports, Science and Technology [11041047]; RIKEN Foreign Postdoctoral Fellowship (FPR) [55800]; RIKEN Special Postdoctoral Researcher Fellowship (SPDR);  [25710003];  [25116531];  [26750380]	We thank Thomas McHugh and Tamas Madarasz for helpful comments on the manuscript. This work was supported by grants to J.P.J. from the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology (11041047) and Grants-in-Aid for Scientific Research on Innovative areas and Kiban B (25710003, 25116531), a grant to A.U. from Grants-in-Aid for Young Scientists B (26750380), a RIKEN Special Postdoctoral Researcher Fellowship (SPDR) A.U. and a RIKEN Foreign Postdoctoral Fellowship (FPR, 55800) to B.Z.T.	AGHAJANIAN GK, 1977, BRAIN RES, V136, P570, DOI 10.1016/0006-8993(77)90083-X; AMARAL DG, 1975, SCIENCE, V188, P377, DOI 10.1126/science.1118734; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Buffalari DM, 2007, J NEUROSCI, V27, P12358, DOI 10.1523/JNEUROSCI.2007-07.2007; Tully K, 2007, P NATL ACAD SCI USA, V104, P14146, DOI 10.1073/pnas.0704621104; FALLON JH, 1978, J COMP NEUROL, V180, P509, DOI 10.1002/cne.901800308; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Fields HL, 2015, TRENDS NEUROSCI, V38, P217, DOI 10.1016/j.tins.2015.01.002; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Galvez R, 1996, NEUROBIOL LEARN MEM, V66, P253, DOI 10.1006/nlme.1996.0067; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Van Bockstaele EJ, 1998, J NEUROENDOCRINOL, V10, P743, DOI 10.1046/j.1365-2826.1998.00254.x; McGaughy J, 2008, NEUROSCIENCE, V153, P63, DOI 10.1016/j.neuroscience.2008.01.064; CEDARBAUM JM, 1978, J COMP NEUROL, V178, P1, DOI 10.1002/cne.901780102; LaLumiere RT, 2010, LEARN MEMORY, V17, P168, DOI 10.1101/lm.1576810; Berlau DJ, 2006, NEUROBIOL LEARN MEM, V86, P123, DOI 10.1016/j.nlm.2005.12.008; Waddell S, 2013, CURR OPIN NEUROBIOL, V23, P324, DOI 10.1016/j.conb.2013.01.005; FALLON JH, 1981, J NEUROSCI, V1, P1361; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; ROOM P, 1981, BRAIN RES, V221, P219, DOI 10.1016/0006-8993(81)90773-3; SARA SJ, 1991, PROG BRAIN RES, V88, P571; Chen FJ, 2007, NEUROSCIENCE, V144, P472, DOI 10.1016/j.neuroscience.2006.09.037; Bouret S, 2004, EUR J NEUROSCI, V20, P791, DOI 10.1111/j.1460-9568.2004.03526.x; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; NAGAI T, 1981, NEUROSCI LETT, V23, P117, DOI 10.1016/0304-3940(81)90027-6; PALKOVITS M, 1977, BRAIN RES, V130, P121, DOI 10.1016/0006-8993(77)90847-2; Chandler DJ, 2014, P NATL ACAD SCI USA, V111, P6816, DOI 10.1073/pnas.1320827111; Sears RM, 2013, P NATL ACAD SCI USA, V110, P20260, DOI 10.1073/pnas.1320325110; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Johansen JP, 2012, BIOL PSYCHIAT, V71, P1053, DOI 10.1016/j.biopsych.2011.10.023; Tervo DGR, 2014, CELL, V159, P21, DOI 10.1016/j.cell.2014.08.037; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Alvarez VA, 2002, P NATL ACAD SCI USA, V99, P4032, DOI 10.1073/pnas.062716299; HERVEMINVIELLE A, 1995, NEUROREPORT, V6, P1363, DOI 10.1097/00001756-199507100-00001; Fiorenza NG, 2012, BEHAV BRAIN RES, V232, P210, DOI 10.1016/j.bbr.2012.04.015; ASTONJONES G, 1986, SCIENCE, V234, P734, DOI 10.1126/science.3775363; MASON ST, 1979, J COMP NEUROL, V187, P703, DOI 10.1002/cne.901870405; AstonJones G, 1997, NEUROSCIENCE, V80, P697, DOI 10.1016/S0306-4522(97)00060-2; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Chandler DJ, 2013, BRAIN RES, V1522, P38, DOI 10.1016/j.brainres.2013.04.057; Soya S, 2013, J NEUROSCI, V33, P14549, DOI 10.1523/JNEUROSCI.1130-13.2013; Do-Monte FHM, 2010, BEHAV BRAIN RES, V211, P89, DOI 10.1016/j.bbr.2010.03.014; LOUGHLIN SE, 1986, NEUROSCIENCE, V18, P307, DOI 10.1016/0306-4522(86)90156-9; WATERHOUSE BD, 1993, J COMP NEUROL, V336, P345, DOI 10.1002/cne.903360304; Debiec J, 2011, DEPRESS ANXIETY, V28, P186, DOI 10.1002/da.20803; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; Rajkowski J, 2004, J NEUROPHYSIOL, V92, P361, DOI 10.1152/jn.00673.2003; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Ishimatsu M, 1996, J NEUROSCI, V16, P5196; Bouret S, 2015, J NEUROSCI, V35, P4005, DOI 10.1523/JNEUROSCI.4553-14.2015; ARNSTEN AFT, 1984, BRAIN RES, V306, P9, DOI 10.1016/0006-8993(84)90351-2; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Hugues S, 2007, SYNAPSE, V61, P933, DOI 10.1002/syn.20448; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Bouret S, 2009, J NEUROPHYSIOL, V101, P898, DOI 10.1152/jn.91048.2008; Bush DEA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00154; Caetano Marcelo S, 2012, Front Integr Neurosci, V6, P125, DOI 10.3389/fnint.2012.00125; Chandler D, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00020; Chandler Daniel J, 2014, Front Neural Circuits, V8, P53, DOI 10.3389/fncir.2014.00053; CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584; CHRISTIE MJ, 1993, NEUROSCIENCE, V56, P129, DOI 10.1016/0306-4522(93)90568-Z; COLE BJ, 1987, BEHAV NEUROSCI, V101, P476, DOI 10.1037//0735-7044.101.4.476; DEUTCH AY, 1986, BRAIN RES, V363, P307, DOI 10.1016/0006-8993(86)91016-4; EGAN TM, 1983, J PHYSIOL-LONDON, V345, P477; ENNIS M, 1986, BRAIN RES, V374, P299, DOI 10.1016/0006-8993(86)90424-5; Feenstra MGP, 2001, EUR J NEUROSCI, V13, P1051, DOI 10.1046/j.0953-816x.2001.01471.x; FIBIGER HC, 1978, BRIT J PHARMACOL, V64, P601; HARRIS GC, 1991, J NEUROSCI, V11, P2314; Herry C, 2014, NAT NEUROSCI, V17, P1644, DOI 10.1038/nn.3869; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Johansen JP, 2014, P NATL ACAD SCI USA, V111, pE5584, DOI 10.1073/pnas.1421304111; Kalwani RM, 2014, J NEUROSCI, V34, P13656, DOI 10.1523/JNEUROSCI.2566-14.2014; KOOB GF, 1978, PHYSIOL BEHAV, V20, P709, DOI 10.1016/0031-9384(78)90296-2; LANGLAIS PJ, 1993, BEHAV BRAIN RES, V54, P81, DOI 10.1016/0166-4328(93)90050-Z; LUPPI PH, 1995, NEUROSCIENCE, V65, P119, DOI 10.1016/0306-4522(94)00481-J; MASON ST, 1975, NATURE, V258, P422, DOI 10.1038/258422a0; NAKAMURA S, 1975, BRAIN RES, V99, P372, DOI 10.1016/0006-8993(75)90039-6; Neophytou SI, 2001, PROG NEURO-PSYCHOPH, V25, P1307, DOI 10.1016/S0278-5846(01)00181-6; Newman LA, 2008, PSYCHOPHARMACOLOGY, V200, P39, DOI 10.1007/s00213-008-1097-8; ORNSTEIN K, 1987, J NEURAL TRANSM, V70, P183, DOI 10.1007/BF01253597; Paxinos G, 1982, RAT BRAIN STEREOTAXI; PLAZNIK A, 1980, ACTA NEUROBIOL EXP, V40, P217; Quirarte GL, 1998, BRAIN RES, V808, P134, DOI 10.1016/S0006-8993(98)00795-1; RASMUSSEN K, 1986, BRAIN RES, V371, P335, DOI 10.1016/0006-8993(86)90371-9; Reyes BAS, 2005, EUR J NEUROSCI, V22, P93, DOI 10.1111/j.1460-9568.2005.04197.x; SELDEN NRW, 1990, J NEUROSCI, V10, P531; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Simpson KL, 1997, J COMP NEUROL, V385, P135; Travagli R A, 1995, J Neurophysiol, V74, P518; TSALTAS E, 1984, BEHAV BRAIN RES, V13, P115, DOI 10.1016/0166-4328(84)90142-6; TSALTAS E, 1989, BEHAV BRAIN RES, V31, P243, DOI 10.1016/0166-4328(89)90006-5; Valentino RJ, 2015, NEUROBIOL STRESS, V1, P23; Van Bockstaele EJ, 1998, BRAIN RES, V784, P123, DOI 10.1016/S0006-8993(97)01250-X; WATERHOUSE BD, 1983, J COMP NEUROL, V217, P418, DOI 10.1002/cne.902170406	107	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1072-0502	1549-5485		LEARN MEMORY	Learn. Mem.	SEP	2015	22	9					444	451		10.1101/lm.037283.114		8	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	CQ6KC	WOS:000360712200006		
J	Maruyama, K; Kagota, S; Van Vliet, BN; Wakuda, H; Shinozuka, K				Maruyama, Kana; Kagota, Satomi; Van Vliet, Bruce N.; Wakuda, Hirokazu; Shinozuka, Kazumasa			A maternal high salt diet disturbs cardiac and vascular function of offspring	LIFE SCIENCES			English	Article						Cardiac function; Dietary salt; Fetal programming; Prenatal nutrition physiology; Maternal effects; Nurse environment; And vascular function	SPONTANEOUSLY HYPERTENSIVE-RATS; RENIN-ANGIOTENSIN SYSTEM; IN-UTERO EXPOSURE; BLOOD-PRESSURE; NITRIC-OXIDE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; PROTEIN RESTRICTION; SODIUM CHLORIDE; ANIMAL-MODEL	Aims: High salt intake is an environmental factor that promotes increased blood pressure. We previously demonstrated that high salt diet causes aggravation of hypertension and impaired vasodilation in response to nitric oxide (NO) in young spontaneously hypertensive rats (SHR), which exhibit low sensitivity to salt in adulthood. Changes in offspring blood pressure and cardiovascular structures have been reported. However, it remains unclear to what extent a maternal high salt intake may affect cardiac and/or vascular function in offspring. Therefore, we investigated influence of exposure to a maternal high salt diet during gestation and lactation on offspring's cardiac and arterial functions in SHR. Main methods: SHR dams were fed either a high salt diet or a control diet. After weaning, the offspring were fed the high salt diet or control diet for 8 weeks. Key findings: Compared with offspring of control diet-fed dams, at 12 weeks of age, offspring of the high-salt diet-fed dams had lower blood pressure, heart rate, indices of both left ventricular systolic and diastolic function, and a decreased aortic vasodilation response to NO. Postnatal high salt intake did not affect blood pressure, vasodilatory response, or cardiac function in offspring of high-salt diet-fed dams. Neither maternal nor postnatal dietary salt altered levels of lipid peroxide, superoxide dismutase, or angiotensinogen mRNA in serum and ventricle of the offspring. Significance: Exposure to high maternal dietary salt induces cardiac and vascular dysfunction in offspring. These results point to the possible importance of avoiding excess dietary salt during gestation and lactation. (C) 2015 Elsevier Inc. All rights reserved.	[Maruyama, Kana; Kagota, Satomi; Wakuda, Hirokazu; Shinozuka, Kazumasa] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Nishinomiya, Hyogo 6638179, Japan; [Van Vliet, Bruce N.] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, St John, NF A1B 3V6, Canada	Kagota, S (reprint author), Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmacol, 11-68 Koshien Kyuban Cho, Nishinomiya, Hyogo 6638179, Japan.	skagota@mukogawa-u.ac.jp			Salt Sciences Research Foundation in Japan [1231]	This research was partly supported by a grant from the Salt Sciences Research Foundation (No. 1231, to S. Kagota) in Japan. The authors gratefully thank Ms. Yuka Higashihara, Ms. Ayaka Yoshino, Ms. Riho Hirota, and Ms. Yasuko Mino for their technical support.	Franco MCP, 2007, LIFE SCI, V80, P709, DOI 10.1016/j.lfs.2006.10.028; Porter JP, 2007, AM J PHYSIOL-REG I, V293, pR334, DOI 10.1152/ajpregu.00887.2006; Piecha G, 2012, NEPHROL DIAL TRANSPL, V27, P3464, DOI 10.1093/ndt/gfs027; Kubota Y, 2006, BIOL PHARM BULL, V29, P1756, DOI 10.1248/bpb.29.1756; Kagota S, 2002, J PHARMACOL EXP THER, V302, P344, DOI 10.1124/jpet.302.1.344; Hayakawa H, 1997, HYPERTENSION, V29, P235; NAVA E, 1995, J HYPERTENS, V13, pS39, DOI 10.1097/00004872-199508001-00007; BOEGEHOLD MA, 1992, HYPERTENSION, V19, P290; Mao CP, 2013, J ENDOCRINOL, V218, P61, DOI 10.1530/JOE-13-0139; Franco MDP, 2003, CARDIOVASC RES, V59, P767, DOI 10.1016/S0008-6363(03)00461-9; Matrougui K, 1998, J HYPERTENS, V16, P1485, DOI 10.1097/00004872-199816100-00013; Matsuoka H, 1997, HYPERTENSION, V29, P242; Kagota S, 2010, CLIN EXP PHARMACOL P, V37, P1035, DOI 10.1111/j.1440-1681.2010.05432.x; Cambonie G, 2007, AM J PHYSIOL-REG I, V292, pR1236, DOI 10.1152/ajpregu.00227.2006; Kawamura M, 2007, ENDOCRINOLOGY, V148, P1218, DOI 10.1210/en.2006-0706; LUSCHER TF, 1987, HYPERTENSION, V9, P157; Koleganova N, 2011, AM J PHYSIOL-RENAL, V301, pF344, DOI 10.1152/ajprenal.00626.2010; RAIJ L, 1988, HYPERTENSION, V12, P562; Yokoe S, 2010, GLYCOBIOLOGY, V20, P1217, DOI 10.1093/glycob/cwq071; Kagota S, 2001, BRIT J PHARMACOL, V134, P737, DOI 10.1038/sj.bjp.0704300; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; AZAR S, 1991, J HYPERTENS, V9, P309, DOI 10.1097/00004872-199104000-00003; Balbi APC, 2004, PEDIATR NEPHROL, V19, P1212, DOI 10.1007/s00467-004-1586-x; Boegehold MA, 2002, MICROCIRCULATION, V9, P225, DOI 10.1038/sj.mn.7800139; CONTRERAS RJ, 1993, AM J PHYSIOL, V264, pR296; DENE H, 1985, CLIN EXP HYPERTENS A, V7, P1121, DOI 10.3109/10641968509073579; DIETZ R, 1980, CLIN SCI, V59, pS171; Ding Y, 2010, J HYPERTENS, V28, P1290, DOI 10.1097/HJH.0b013e328337da8f; DINICOLANTONIO R, 1990, HYPERTENSION, V15, P177; Gray C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072682; HAZON N, 1988, J HYPERTENS, V6, P517, DOI 10.1097/00004872-198807000-00002; Howerton CL, 2014, P NATL ACAD SCI USA, V111, P9639, DOI 10.1073/pnas.1401203111; HUNT RA, 1993, HYPERTENSION, V22, P542; Kagota S, 2013, CAN J PHYSIOL PHARM, V91, P124, DOI 10.1139/cjpp-2012-0226; Kagota S, 2009, J PHARMACOL SCI, V109, P556, DOI 10.1254/jphs.08273FP; KARRDULLIEN V, 1979, P SOC EXP BIOL MED, V160, P421; Leandro SM, 2008, PHYSIOL BEHAV, V95, P145, DOI 10.1016/j.physbeh.2008.05.011; Mervaala EMA, 1997, N-S ARCH PHARMACOL, V356, P107, DOI 10.1007/PL00005017; Otani L, 2012, J NUTR BIOCHEM, V23, P892, DOI 10.1016/j.jnutbio.2011.04.014; Payne JA, 2004, HYPERTENSION, V43, P420, DOI 10.1161/01.HYP.0000111832.47667.13; Roghair RD, 2009, AM J PHYSIOL-REG I, V296, pR651, DOI 10.1152/ajpregu.90756.2008; Susic Dinko, 2009, Ochsner J, V9, P197; Szostak-Wegierek Dorota, 2014, Int J Womens Health, V6, P647, DOI 10.2147/IJWH.S48751; Tada Y, 2010, BIOL PHARM BULL, V33, P1971, DOI 10.1248/bpb.33.1971; Tzanetakou Irene P, 2011, Open Cardiovasc Med J, V5, P103, DOI 10.2174/1874192401105010103; Van Vliet BN, 2008, INT J OBESITY, V32, pS35, DOI 10.1038/ijo.2008.205; Williams L, 2014, BBA-MOL BASIS DIS, V1842, P507, DOI 10.1016/j.bbadis.2013.07.006; Zohdi V, 2015, NUTRIENTS, V7, P119, DOI 10.3390/nu7010119	48	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	SEP 1	2015	136						42	51		10.1016/j.lfs.2015.06.023		10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CR0TG	WOS:000361035500007		
J	Naito, Y; Ikuta, N; Okano, A; Okamoto, H; Nakata, D; Terao, K; Matsumoto, K; Kajiwara, N; Yasui, H; Yoshikawa, Y				Naito, Yuki; Ikuta, Naoko; Okano, Ayaka; Okamoto, Hinako; Nakata, Daisuke; Terao, Keiji; Matsumoto, Kinuyo; Kajiwara, Naemi; Yasui, Hiroyuki; Yoshikawa, Yutaka			Isomeric effects of anti-diabetic alpha-lipoic acid with gamma-cyclodextrin	LIFE SCIENCES			English	Article						R-alpha-lipoic acid/gamma-cyclodextrin (gamma CD) complex; Anti-diabetic effect; High fat diet (HFD); Peroxisome proliferator-activated receptor (PPAR); AMP-activated protein kinase	ACTIVATED PROTEIN-KINASE; DIABETIC POLYNEUROPATHY; ADIPONECTIN; TRIAL; METABOLISM; COMPLEX; STIMULATION; NEUROPATHY; RECEPTORS; STABILITY	Aims: Previous studies reported the anti-diabetic effects of a-lipoic acid (alpha LA) isomers: racemic-alpha LA, R-alpha LA, or S-alpha LA. Previously, we examined the anti-diabetic effects of alpha LA administered as a food additive, but were unable to demonstrate the differences among different isomers. In this study, alpha LAs were complexed with.-cyclodextrin (gamma CD) for the stability. We then investigated the anti-diabetic effects of racemic-, R-, and S-alpha LA/gamma CDs in KKA(y) mice. Main methods: Male type 2 diabetic KKAy mice were divided into 5 groups, and fed either a high-fat-diet (HFD), HFD supplemented with gamma CD, or HFD supplemented with racemic-alpha LA/gamma CD, R-alpha LA/gamma CD, or S-alpha LA/gamma CD for 4 weeks. At the end of the feeding period, HbA1c and adiponectin levels were measured, PPAR gamma 2 mRNA expression levels were assessed in adipose tissues using real-time PCR, and AMP-activated protein kinase (AMPK) phosphorylation levels were evaluated in the liver by Western blotting. Key findings: The anti-diabetic effects of alpha LA; the isomeric compounds racemic-, R-, and S-alpha LA/gamma CD were investigated using a male type 2 diabetic KKAy mouse model. Significant differences were observed in HbA1c and plasma adiponectin levels between R-alpha LA/gamma CD-treated mice and control mice. PPAR gamma 2 mRNA expression levels were slightly higher in racemic-and R-alpha LA/gamma CD-treated mice. Moreover, AMPK phosphorylation levels were elevated in racemic-alpha LA/gamma CD- and R-alpha LA/gamma CD-treated mice, but remained unchanged in S-alpha LA/gamma CD-treated mice. Significance: These results suggested that the stereoisomerism mediates a difference in the anti-diabetic effects of racemic-, R-, and S-alpha LA/gamma CDs. Furthermore, the anti-diabetic mechanism of alpha LA/gamma CD action may be attributed to the activation of AMPK in the liver. (C) 2015 Elsevier Inc. All rights reserved.	[Naito, Yuki; Okano, Ayaka; Yasui, Hiroyuki; Yoshikawa, Yutaka] Kyoto Pharmaceut Univ, Div Analyt & Phys Sci, Dept Analyt & Bioinorgan Chem, Kyoto, Japan; [Ikuta, Naoko] Kobe Univ, Grad Sch Med, Dept Social Community Med & Hlth Sci Food & Drug, Kobe, Hyogo, Japan; [Okamoto, Hinako; Nakata, Daisuke; Terao, Keiji] CycloChem Bio Co Ltd, Kobe, Hyogo, Japan; [Matsumoto, Kinuyo; Kajiwara, Naemi] Kobe Womens Univ, Fac Hlth & Welf, Dept Hlth Sports & Nutr, Kobe, Hyogo, Japan	Yoshikawa, Y (reprint author), 4-7-2 Minatojima Nakamachi,Chuo Ku, Kobe, Hyogo 6500046, Japan.	y-yoshikawa@yg.kobe-wu.ac.jp			CycloChem Bio Co., Ltd.; CycloChem Co., Ltd. [2012/140020]	We would like to thank CycloChem Bio Co., Ltd. and CycloChem Co., Ltd. (president KT) for providing funding for this study [project name: "R(+)-Alpha Lipoic Acid Cyclodextrin Complex Research projects collaborating with Kyoto Pharmaceutical University (No. 2012/140020)"]. The authors are deeply grateful to members of the Department of Analytical and Bioinorganic Chemistry, Division of Analytical and Physical Sciences of Kyoto Pharmaceutical University.	Ametov AS, 2003, DIABETES CARE, V26, P770, DOI 10.2337/diacare.26.3.770; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Wang Y, 2010, METABOLISM, V59, P967, DOI 10.1016/j.metabol.2009.10.018; Astapova O, 2012, VITAM HORM, V90, P143, DOI 10.1016/B978-0-12-398313-8.00006-3; Packer L, 2011, J CLIN BIOCHEM NUTR, V48, P26, DOI 10.3164/jcbn.11-005FR; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Takahashi H, 2011, BIOSCI BIOTECH BIOCH, V75, P633, DOI 10.1271/bbb.100596; Ikuta N, 2013, INT J MOL SCI, V14, P3639, DOI 10.3390/ijms14023639; Packer L, 2001, NUTRITION, V17, P888, DOI 10.1016/S0899-9007(01)00658-X; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Ziegler D, 2006, DIABETES CARE, V29, P2365, DOI 10.2337/dc06-1216; Estrada DE, 1996, DIABETES, V45, P1798, DOI 10.2337/diabetes.45.12.1798; Yaworsky K, 2000, DIABETOLOGIA, V43, P294, DOI 10.1007/s001250050047; Nikolai S, 2014, NUTRITION, V30, P228, DOI 10.1016/j.nut.2013.08.002; ZIEGLER D, 1995, DIABETOLOGIA, V38, P1425, DOI 10.1007/BF00400603; Smith AR, 2004, CURR MED CHEM, V11, P1135; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Matsugo S, 1996, BIOCHEM MOL BIOL INT, V38, P51; Cao SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051709; GAL EM, 1965, NATURE, V207, P535, DOI 10.1038/207535a0; Guangda X., 2011, METAB CLIN EXP, V60, P480; Ikuta N., 2013, J BIOCH PHARM RES, V4, P212; Krämer K., 2001, Nutraceuticals in health and disease prevention, P129; Kristensen JM, 2007, J PHYSIOL-LONDON, V585, P897, DOI 10.1113/jphysiol.2007.143123; Kuo YT, 2012, EUR J PHARMACOL, V692, P10, DOI 10.1016/j.ejphar.2012.07.028; Maitra I, 1996, BIOCHEM BIOPH RES CO, V221, P422, DOI 10.1006/bbrc.1996.0611; Murakami H, 2012, CHEM PHARM BULL, V60, P1096; Naito Y, 2014, J CLIN BIOCHEM NUTR, V55, P97, DOI 10.3164/jcbn.14-56; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Walgren JL, 2004, METABOLISM, V53, P165, DOI 10.1016/j.metabol.2003.09.008; Watkins P., 2008, EPIDEMIOLOGY DIABETE, P16; Wessel K., 1997, US Patent, Patent No. [5693664A, 5693664]; Ziegler D., 1997, DIABETES S2, V46, P562; Ziegler D, 1997, DIABETES CARE, V20, P369, DOI 10.2337/diacare.20.3.369	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	SEP 1	2015	136						73	78		10.1016/j.lfs.2015.06.016		6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CR0TG	WOS:000361035500011		
J	Okai, H; Okazaki, R; Kawamura, M; Yoshimura, M				Okai, Hisashi; Okazaki, Ryohei; Kawamura, Minoru; Yoshimura, Megumu			Excitatory effect of Neurotropin (R) on noradrenergic neurons in rat locus coeruleus	LIFE SCIENCES			English	Article						Neurotropin; Neuropathic pain; Locus coeruleus; Descending pain inhibitory system; Noradrenaline; In vivo patch clamp	SUBSTANTIA-GELATINOSA NEURONS; SPINAL NERVE LIGATION; ROSTRAL VENTROMEDIAL MEDULLA; PAIN INHIBITORY SYSTEMS; DORSAL-HORN; MECHANISM; HYPERALGESIA; PROJECTIONS; NOCICEPTION; RECEPTORS	Aims: Although the clinical use of Neurotropin (R) as an analgesic for chronic pain has been firmly established, its analgesic mechanism is still unclear. In this study, we investigate the direct effects of Neurotropin using an electrophysiological method. Main methods: Blind patch-clamp recordings were made from rat locus coeruleus (LC) and periaqueductal gray (PAG) neurons in brainstem slices of normal rats. The effects of intracerebroventricular (icv) injection of Neurotropin on nociceptive transmission were recorded from spinal substantia gelatinosa (SG) neurons in fifth lumbar spinal nerve-ligated (L5-SNL) rats using an in vivo patch-clamp method. Key findings: Neurotropin (0.2-1.0 NU/mL) dose-dependently increased the firing rate in noradrenergic LC neurons of normal rats. Under the voltage-clamp condition, Neurotropin induced an inward current in 90% of LC neurons that was not affected by tetrodotoxin or an injection of GDP-beta-S (G protein inhibitor) through recording pipettes. In contrast, Neurotropin had no effects on all PAG neurons tested. Using in vivo patch-clamp recordings, the icv injection of Neurotropin inhibited both frequency and amplitude of pinch-evoked excitatory postsynaptic currents of SG neurons in L5-SNL rats. These results suggest that Neurotropin directly excites the descending noradrenergic LC neurons and inhibits nociceptive transmission in the spinal dorsal horn. Significance: This study is the first direct demonstration that Neurotropin activates the noradrenergic descending pain inhibitory systems, and this would reinforce the usefulness of Neurotropin in the treatment of human neuropathic pain. (C) 2015 Elsevier Inc. All rights reserved.	[Okai, Hisashi; Okazaki, Ryohei; Kawamura, Minoru] Nippon Zoki Pharmaceut Co Ltd, Dept Pharmacol Res, Inst Bioact Sci, Kato, Hyogo 6731461, Japan; [Yoshimura, Megumu] Kumamoto Hlth Sci Univ, Grad Sch Hlth Sci, Kumamoto 8615598, Japan	Okai, H (reprint author), Nippon Zoki Pharmaceut Co Ltd, Dept Pharmacol Res, Inst Bioact Sci, 442-1 Kinashi, Kato, Hyogo 6731461, Japan.	h-okai@nippon-zoki.co.jp					DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Sonohata M, 2004, J PHYSIOL-LONDON, V555, P515, DOI 10.1113/jphysiol.2003.054932; Bajic D, 1999, J COMP NEUROL, V405, P359; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Kawasaki Y, 2003, ANESTHESIOLOGY, V98, P682, DOI 10.1097/00000542-200303000-00016; Hickey L, 2014, J NEUROSCI, V34, P4148, DOI 10.1523/JNEUROSCI.4835-13.2014; HATA T, 1988, J AUTON PHARMACOL, V8, P45, DOI 10.1111/j.1474-8673.1988.tb00168.x; KIM SH, 1992, PAIN, V50, P355; Antal M, 1996, NEUROSCIENCE, V73, P509, DOI 10.1016/0306-4522(96)00063-2; Nakatsuka T, 1999, PAIN, V82, P39, DOI 10.1016/S0304-3959(99)00037-8; Rampon C, 1996, NEUROSCIENCE, V75, P737, DOI 10.1016/0306-4522(96)00278-3; WEST WL, 1993, BRAIN RES, V626, P127, DOI 10.1016/0006-8993(93)90571-4; FIELDS HL, 1991, ANNU REV NEUROSCI, V14, P219, DOI 10.1146/annurev.neuro.14.1.219; Suto T, 2014, NEUROPHARMACOLOGY, V81, P95, DOI 10.1016/j.neuropharm.2014.01.040; Furue H, 1999, J PHYSIOL-LONDON, V521, P529, DOI 10.1111/j.1469-7793.1999.00529.x; HATA T, 1988, JPN J PHARMACOL, V48, P165, DOI 10.1254/jjp.48.165; Hayashida KI, 2008, ANESTHESIOLOGY, V109, P1077, DOI 10.1097/ALN.0b013e31818dac9c; Hokfelt T, 2000, J CHEM NEUROANAT, V18, P75, DOI 10.1016/S0891-0618(99)00037-X; ITOH E, 1989, JPN J PHARMACOL, V51, P267, DOI 10.1254/jjp.51.267; JONES SL, 1986, BRAIN RES, V364, P315, DOI 10.1016/0006-8993(86)90844-9; Kawamura M, 1998, LIFE SCI, V62, P2181, DOI 10.1016/S0024-3205(98)00195-7; Miura T, 2005, J PHARMACOL SCI, V97, P429, DOI 10.1254/jphs.FPJ04050X; NORTH RA, 1986, NEUROSCIENCE, V17, P899, DOI 10.1016/0306-4522(86)90070-9; OHARA H, 1991, JPN J PHARMACOL, V57, P243, DOI 10.1254/jjp.57.243; Okai H., 2008, PAIN RES, V23, P11; Okazaki R, 2008, ANESTH ANALG, V107, P1064, DOI 10.1213/ane.0b013e31817e7a59; Osborne PB, 1996, J PHYSIOL-LONDON, V490, P383; Paxinos G., 1986, RAT BRAIN STEREOTAXI; Suzuki T, 2005, ANESTH ANALG, V101, P793, DOI 10.1213/01.ANE.0000160582.25368.B9; The Committee for the Guidelines for the Pharmacologic Management of Neuropathic Pain of JPSC, 2011, GUID PHARM MAN NEUR, V1st; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	SEP 1	2015	136						79	86		10.1016/j.lfs.2015.06.013		8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CR0TG	WOS:000361035500012		
J	Yamaori, S; Kinugasa, Y; Jiang, R; Takeda, S; Yamamoto, I; Watanabe, K				Yamaori, Satoshi; Kinugasa, Yuka; Jiang, Rongrong; Takeda, Shuso; Yamamoto, Ikuo; Watanabe, Kazuhito			Cannabidiol induces expression of human cytochrome P450 1A1 that is possibly mediated through aryl hydrocarbon receptor signaling in HepG2 cells	LIFE SCIENCES			English	Article						Marijuana; Cannabidiol; CYP1A1; Induction; AhR; Protein tyrosine kinase	PROTEIN-TYROSINE KINASES; AROMATIC-HYDROCARBONS; SIDESTREAM MARIJUANA; HABITUAL SMOKERS; AND/OR TOBACCO; DELTA(9)-TETRAHYDROCANNABINOL; CANNABINOIDS; MUTAGENICITY; INDUCTION; ACTIVATION	Aims: We herein investigated the inducibility of cytochrome P450 1A1 (CYP1A1) by Delta(9)-tetrahydrocannabinol, cannabidiol (CBD), and cannabinol, three major phytocannabinoids, using human hepatoma HepG2 cells. Main methods: The expression of CYP1A1 and the aryl hydrocarbon receptor (AhR) was measured by a quantitative real-time polymerase chain reaction and/or Western blotting. Key findings:Delta(9)-Tetrahydrocannabinol and CBD concentration-dependently induced the expression of CYP1A1 mRNA, whereas cannabinol showed little or no induction. Among the phytocannabinoids tested, CBD was the most potent inducer of CYP1A1 expression. The induction of CYP1A1 expression by CBD was significantly attenuated by the knockdown of AhR expression with AhR small interfering RNAs. The role of protein tyrosine kinases (PTKs) in the CBD-mediated induction of CYP1A1 was then examined using herbimycin A, a PTK inhibitor. The upregulation of CYP1A1 by CBD was significantly suppressed by herbimycin A as was the induction by omeprazole but not 3-methylcholanthrene. The inducibility of CYP1A1 by CBD-related compounds was examined to clarify the structural requirements for CBD-mediated CYP1A1 induction. Olivetol, which corresponds to the pentylresorcinol moiety of CBD, significantly induced the expression of CYP1A1, whereas d-limonene, CBD-2'-monomethyl ether, and CBD-2',6'-dimethyl ether did not. Significance: These results showed that CBD may have induced human CYP1A1 expression through the activation of PTK-dependent AhR signaling, in which two phenolic hydroxyl groups in the pentylresorcinol moiety of CBD may play structurally important roles. (C) 2015 Elsevier Inc. All rights reserved.	[Yamaori, Satoshi] Shinshu Univ Hosp, Dept Pharm, Matsumoto, Nagano 3908621, Japan; [Kinugasa, Yuka; Jiang, Rongrong; Watanabe, Kazuhito] Hokuriku Univ, Dept Hyg Chem, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201181, Japan; [Takeda, Shuso; Watanabe, Kazuhito] Hokuriku Univ, Org Frontier Res Prevent Pharmaceut Sci, Kanazawa, Ishikawa 9201181, Japan; [Yamamoto, Ikuo] Kyushu Univ Hlth & Welf, Dept Hyg Chem, Sch Pharmaceut Sci, Nobeoka 8828508, Japan	Watanabe, K (reprint author), Hokuriku Univ, Dept Hyg Chem, Fac Pharmaceut Sci, Ho 3,Kanagawa Machi, Kanazawa, Ishikawa 9201181, Japan.	k-watanabe@hokuriku-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [21790135, 20590217, 05F016]	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan [Grant-in-Aid for Young Scientists (B) (grant number 21790135) and Grant-in-Aid for Scientific Research (C) (grant number 20590217)] and by the 'Academic Frontier' Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (2005-2009) (grant number 05F016). We thank the RIKEN cell bank (Tsukuba, Japan) for providing the human hepatoma HepG2 cell line and Dr. Tsutomu Matsubara (National Cancer Institute, National Institutes of Health) for his advice.	GOHDA H, 1990, CHEM PHARM BULL, V38, P1697; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Zhang ZF, 1999, CANCER EPIDEM BIOMAR, V8, P1071; Roth MD, 2001, AM J RESP CELL MOL, V24, P339; ElSohly MA, 2005, LIFE SCI, V78, P539, DOI 10.1016/j.lfs.2005.09.011; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; OHLSSON A, 1980, CLIN PHARMACOL THER, V28, P409; Watanabe K, 2005, TOXICOLOGY, V206, P471, DOI 10.1016/j.tox.2004.08.005; Kim J, 2004, TOXICOL SCI, V81, P518, DOI 10.1093/toxsci/kfh221; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Fligiel SEG, 1997, CHEST, V112, P319, DOI 10.1378/chest.112.2.319; Moir D, 2008, CHEM RES TOXICOL, V21, P494, DOI 10.1021/tx700275p; Chan PC, 1996, FUND APPL TOXICOL, V30, P109, DOI 10.1006/faat.1996.0048; Kawajiri K, 2007, ARCH BIOCHEM BIOPHYS, V464, P207, DOI 10.1016/j.abb.2007.03.038; Mehmedic Z, 2010, J FORENSIC SCI, V55, P1209, DOI 10.1111/j.1556-4029.2010.01441.x; Backlund M, 2005, CELL SIGNAL, V17, P39, DOI 10.1016/j.cellsig.2004.05.010; ARAMAKI H, 1968, CHEM PHARM BULL, V16, P822; Barsky SH, 1998, J NATL CANCER I, V90, P1198, DOI 10.1093/jnci/90.16.1198; BERRYMAN SH, 1992, MUTAT RES, V278, P47, DOI 10.1016/0165-1218(92)90285-8; BORNHEIM LM, 1989, BIOCHEM PHARMACOL, V38, P2789, DOI 10.1016/0006-2952(89)90432-2; BUSCH FW, 1979, CANCER LETT, V6, P319, DOI 10.1016/S0304-3835(79)80088-9; CHAKRAVARTI D, 1995, P NATL ACAD SCI USA, V92, P10422, DOI 10.1073/pnas.92.22.10422; Feng Q, 2002, XENOBIOTICA, V32, P1033, DOI 10.1080/0049825021000012583; GLATT H, 1979, MUTAT RES, V66, P329, DOI 10.1016/0165-1218(79)90043-0; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; Kikuchi H, 1998, ARCH BIOCHEM BIOPHYS, V358, P351, DOI 10.1006/abbi.1998.0869; LEE ML, 1976, ANAL CHEM, V48, P405, DOI 10.1021/ac60366a048; Lemaire G, 2004, LIFE SCI, V74, P2265, DOI 10.1016/j.lfs.2003.09.056; Maertens RM, 2009, CHEM RES TOXICOL, V22, P1406, DOI 10.1021/tx9000286; Mechoulam R, 2002, J CLIN PHARMACOL, V42, P11; Ohlsson A., 1984, CANNABINOIDS CHEM PH, P219; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Sarafian T, 2005, TOXICOL LETT, V158, P95, DOI 10.1016/j.toxlet.2005.03.008; Takeda S, 2014, TOXICOLOGY, V326, P18, DOI 10.1016/j.tox.2014.09.011; UEHARA Y, 1988, VIROLOGY, V164, P294, DOI 10.1016/0042-6822(88)90649-6; VANWENT GF, 1978, EXPERIENTIA, V34, P324; WEHNER FC, 1980, MUTAT RES, V77, P135, DOI 10.1016/0165-1218(80)90130-5; WITSCHI H, 1972, TOXICOL APPL PHARM, V23, P165, DOI 10.1016/0041-008X(72)90216-5; YAMAMOTO I, 1991, PHARMACOL BIOCHEM BE, V40, P541; ZIMMERMAN AM, 1978, PHARMACOLOGY, V16, P333, DOI 10.1159/000136789	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	SEP 1	2015	136						87	93		10.1016/j.lfs.2015.07.007		7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CR0TG	WOS:000361035500013		
J	Kawai, Y; Ajima, K; Nagai, T; Yokoyama, Y; Kaidoh, M; Seto, E; Honda, T; Ohhashi, T				Kawai, Yoshiko; Ajima, Kumiko; Nagai, Takashi; Yokoyama, Yumiko; Kaidoh, Maki; Seto, Emi; Honda, Takayuki; Ohhashi, Toshio			Abdominal Respiration Induces Hemodilution and Related Reduction in ADH Concentration of Blood	LYMPHATIC RESEARCH AND BIOLOGY			English	Article							LYMPH PROTEIN-CONCENTRATION; TUMOR LYMPHANGIOGENESIS; NODE; METASTASIS; PRESSURE	To establish effective lymph drainage methods and develop concise and accurate clinical techniques for evaluating lymph drainage in healthy individuals and patients with cancer treatment-related lymph edema, we investigated the numbers of red (RBC) and white (WBC) blood cells, and platelets (PLT) in blood, hematocrit (Ht), and the blood concentrations of total protein (TP), albumin (Alb), and anti-diuretic hormone (ADH) before and after 5min manual lymph drainage, followed by 30min rest with or without abdominal respiration in the supine or sitting position in 48 healthy volunteers. The 5min facial, upper and lower extremities lymph drainage, followed by 30min rest in the supine position induced significant reductions of the TP and Alb in all subjects, and their RBC and Ht levels in some subjects. The 30min rest only in the supine position without lymph drainage produced also significant reductions of blood TP and Alb. In addition, abdominal respiration in the supine position without manual lymph drainage caused more significant hemodilution, being significant reductions of TP, Alb, RBC, Ht, and ADH in all volunteers. These findings may be related to effective lymph drainage from the chylocyst. Furthermore, it also resulted in a significantly increased micturition desire. In conclusion, abdominal respiration during 30min rest in the supine position is effective at inducing lymph drainage, and the associated induction of hemodilution and lowering of the blood ADH concentration (and increased micturition desire in some cases) can be used to accurately assess the extent of lymph drainage.	[Kawai, Yoshiko; Yokoyama, Yumiko; Kaidoh, Maki; Ohhashi, Toshio] Shinshu Univ, Sch Med, Dept Innovat Med & Hlth Sci Res, Matsumoto, Nagano 3908621, Japan; [Kawai, Yoshiko; Ajima, Kumiko; Nagai, Takashi; Yokoyama, Yumiko; Kaidoh, Maki] Shinshu Univ, Sch Med, Dept Physiol, Matsumoto, Nagano 3908621, Japan; [Seto, Emi] Shinshu Univ, Sch Med, Dept Nursing, Matsumoto, Nagano 3908621, Japan; [Honda, Takayuki] Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; Shinshu Univ Hosp, Matsumoto, Nagano, Japan	Ohhashi, T (reprint author), Shinshu Univ, Sch Med, Dept Innovat Med & Hlth Sci Res, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	ohhashi@shinshu-u.ac.jp			Japanese Ministry of Education, Science, Sports, and Culture [19209044, 2229052, 24659098, 24590272]; Intelligent Surgical Instrument Project of the METI (Japan)	This study was financially supported, in part, by Grants-in-Aid for Scientific Research (19209044, 2229052, 24659098, and 24590272) from the Japanese Ministry of Education, Science, Sports, and Culture and the Intelligent Surgical Instrument Project of the METI (Japan) (2009-2012).	Cao RH, 2012, P NATL ACAD SCI USA, V109, P15894, DOI 10.1073/pnas.1208324109; ADAIR TH, 1982, AM J PHYSIOL, V243, pH351; ADAIR TH, 1983, AM J PHYSIOL, V245, pH616; Olszewski Waldemar L., 2009, Lymphatic Research and Biology, V7, P239, DOI 10.1089/lrb.2008.1023; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Ono N, 2000, JPN J PHYSIOL, V50, P25, DOI 10.2170/jjphysiol.50.25; ADAIR TH, 1985, AM J PHYSIOL, V249, pH777; QUIN JW, 1977, J PHYSIOL-LONDON, V264, P307; Cao RH, 2011, NAT PROTOC, V6, P817, DOI 10.1038/nprot.2011.359; KNOX P, 1983, J PHYSIOL-LONDON, V345, P1; Badger C, 2004, COCHRANE DB SYST REV, V18; BRACE RA, 1977, MICROVASC RES, V14, P243, DOI 10.1016/0026-2862(77)90023-1; Cao YH, 2009, CURR MOL MED, V9, P928; Cao Yihai, 2008, Lymphatic Research and Biology, V6, P145, DOI 10.1089/lrb.2008.1007; HARGENS AR, 1976, MICROVASC RES, V11, P89, DOI 10.1016/0026-2862(76)90080-7; JACOBSSON S, 1964, ACTA PHYSIOL SCAND, V60, P278, DOI 10.1111/j.1748-1716.1964.tb02889.x; Ji H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5944; Kawai Y, 2014, LYMPHAT RES BIOL, V12, P124, DOI 10.1089/lrb.2014.0002; Ohhashi T, 2015, J PHYSIOL SCI, V65, P51, DOI 10.1007/s12576-014-0343-6; Ohhashi T, 1990, PROGR LYMPHOLOGY, VXII, P135; Rockson S G, 2003, Lymphat Res Biol, V1, P181, DOI 10.1089/153968503768330210; Vojackova N, 2012, DERMATOL THER, V25, P352, DOI 10.1111/j.1529-8019.2012.01534.x	22	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1539-6851	1557-8585		LYMPHAT RES BIOL	Lymphat. Res. Biol.	SEP 1	2015	13	3					202	207		10.1089/lrb.2015.0017		6	Medicine, Research & Experimental; Physiology	Research & Experimental Medicine; Physiology	CR1UA	WOS:000361109400006		
J	Khan, SA; Miyashita, Y; Mutoh, Y				Khan, S. A.; Miyashita, Y.; Mutoh, Y.			Corrosion fatigue behavior of AM6O magnesium alloy with anodizing layer and chemical-conversion-coating layer	MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION			English	Article								The status of poor corrosion resistance of die cast AM60 magnesium (Mg) alloys can be improved by applying various types of surface coatings above them. However, coating can sometimes alter the fatigue properties and initiation mechanism, which is not reported so far for this group of alloy. Present study focuses on this issue investigating influence of anodizing layer and chemical-conversion-coating layer on corrosion fatigue properties of Mg alloy, AM60. Coating performance was assessed in two different corrosive environments: high humidity (50 degrees C, 80% RH) and 5wt% NaCl medium. The key observation for humid environment was that the chemical-conversion-coating without a painting layer showed better corrosion resistance than that of the anodized layer without a painting layer. Moreover, chemical-conversion-coating with a painting layer can effectively protect the underlying AM60 alloy even under the most severe corrosive environments (5wt% NaCl). Our results show, for the first time, that chemical conversion coating can be successfully used in machine parts loaded in aggressive medium without severely compromising the fatigue strength.	[Khan, S. A.] Univ Tokyo, Dept Mech & Biofunct Syst, Meguro Ku, Tokyo 1538505, Japan; [Khan, S. A.] Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata, Japan; [Miyashita, Y.] Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan; [Mutoh, Y.] Nagaoka Univ Technol, Dept Syst Safety, Nagaoka, Niigata 9402188, Japan	Khan, SA (reprint author), Univ Tokyo, Dept Mech & Biofunct Syst, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	sabrina@iis.u-tokyo.ac.jp					Hilpert M, 2000, J MATER ENG PERFORM, V9, P402, DOI 10.1361/105994900770345791; [Anonymous], 2000, E64799 ASTM, P591; Blawert C, 2006, ADV ENG MATER, V8, P511, DOI 10.1002/adem.200500257; GOODENBERGER DL, 1993, J ENG MATER-T ASME, V115, P391, DOI 10.1115/1.2904236; Pardo A, 2008, CORROS SCI, V50, P823, DOI 10.1016/j.corsci.2007.11.005; Bhuiyan MS, 2010, MAT SCI ENG A-STRUCT, V527, P4978, DOI 10.1016/j.msea.2010.04.059; Bhuiyan MS, 2011, INT J FATIGUE, V33, P1548, DOI 10.1016/j.ijfatigue.2011.06.011; Chong KZ, 2003, MATER CHEM PHYS, V80, P191, DOI 10.1016/S0254-0584(02)00481-9; Ishihara S, 2008, SURF COAT TECH, V202, P2085, DOI 10.1016/j.surfcoat.2007.08.061; Khan SA, 2011, MAT SCI ENG A-STRUCT, V528, P1961, DOI 10.1016/j.msea.2010.11.033; Khana SA, 2008, MAT SCI ENG A-STRUCT, V474, P261, DOI 10.1016/j.msea.2007.04.078; Khan SA, 2008, MAT SCI ENG A-STRUCT, V498, P377, DOI 10.1016/j.msea.2008.08.015; Kobayashi Y., 1998, 94 C JAP I LIGHT MET, P267; Kobayashi Y., 1999, 96 C JAP I LIGHT MET, P81; Nan ZY, 2008, INT J FATIGUE, V30, P1181, DOI 10.1016/j.ijfatigue.2007.09.005; OGAREVIC VV, 1990, ANNU REV MATER SCI, V20, P141; Sajuri Z. B., 2002, FAT 2002 W MIDL UK, P3301; Sajuri Z. B., 2006, INT J MECH SCI, V48, P198, DOI 10.1016/j.ijmecsci.2005.09.003; SURESH S, 1993, SCRIPTA METALL MATER, V29, P237, DOI 10.1016/0956-716X(93)90315-J	19	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0947-5117	1521-4176		MATER CORROS	Mater. Corros.	SEP	2015	66	9					940	948		10.1002/maco.201407946		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CQ9WH	WOS:000360965400013		
J	Asano, Y				Asano, Yoshihide			Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features	MEDICAL MOLECULAR MORPHOLOGY			English	Review						Systemic sclerosis; Epigenetics; Fli1; KLF5; Ultrastructure of collagen fibrils	GROWTH-FACTOR-BETA; INTERSTITIAL LUNG-DISEASE; TRANSCRIPTION FACTOR FLI1; PROTEIN-ASSOCIATED FACTOR; RECEPTOR-TYPE-I; SCLERODERMA SKIN; TRANSGENIC MICE; DOWN-REGULATION; MOUSE MODEL; COLLAGEN	The lack of animal models recapitulating the three cardinal features of systemic sclerosis (SSc), such as immune activation, vasculopathy, and tissue fibrosis, hinders the understanding of the pathogenesis of this disease. A series of clinical studies has suggested that environmental factors largely contribute to the development of SSc in individuals predisposed by genetic factors. This notion is supported by the establishment of a new murine SSc model which recapitulates three cardinal features of SSc by simultaneous haploinsufficiency of Klf5 and Fli1 genes, both of which are epigenetically suppressed in SSc dermal fibroblasts. In addition to enhanced dermal thickness, Klf5 (+/-) and Fli1 (+/-) mice resemble dermal fibrosis of SSc at the ultrastructural level. Furthermore, these mice simulate altered vascular structure and B cell activation characteristic of SSc. Further studies on the pathological events in Klf5 (+/-) and Fli1 (+/-) mice and the roles of KLF5 and Fli1 in various types of cells may provide us with a useful clue to better understand the developmental process of SSc.	Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp					Altorok N, 2014, RHEUMATOLOGY, DOI [10.1093/rheumatology/keu155, DOI 10.1093/RHEUMATOLOGY/KEU155]; Servettaz A, 2009, J IMMUNOL, V182, P5855, DOI 10.4049/jimmunol.0803705; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Asano Y, 2009, MOL CELL BIOL, V29, P425, DOI 10.1128/MCB.01278-08; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Sumida H, 2014, J DERMATOL, V41, P418, DOI 10.1111/1346-8138.12461; Khan K, 2012, ANN RHEUM DIS, V71, P1235, DOI 10.1136/annrheumdis-2011-200955; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Asano Y, 2007, J BIOL CHEM, V282, P34672, DOI 10.1074/jbc.M703907200; Lafyatis R, 2007, ARTHRITIS RHEUM, V56, P3167, DOI 10.1002/art.22847; Jordan S, 2015, ANN RHEUM DIS, V74, P1188, DOI 10.1136/annrheumdis-2013-204522; Maurer B, 2009, CIRCULATION, V120, P2367, DOI 10.1161/CIRCULATIONAHA.109.855114; Yoshizaki A, 2011, ARTHRITIS RHEUM-US, V63, P3575, DOI 10.1002/art.30539; Sonnylal S, 2007, ARTHRITIS RHEUM-US, V56, P334, DOI 10.1002/art.22328; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Pannu J, 2006, ARTHRITIS RHEUM, V54, P3011, DOI 10.1002/art.22063; Beyer C, 2010, ARTHRITIS RHEUM-US, V62, P2831, DOI 10.1002/art.27647; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Maurer B, 2012, ANN RHEUM DIS, V71, P1382, DOI 10.1136/annrheumdis-2011-200940; Pannu J, 2004, ARTHRITIS RHEUM, V50, P1566, DOI 10.1002/art.20225; Feghali-Bostwick C, 2003, ARTHRITIS RHEUM, V48, P1956, DOI 10.1002/art.11173; Wang YQ, 2006, ARTHRITIS RHEUM, V54, P2271, DOI 10.1002/art.21948; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Yamamoto T, 2010, J DERMATOL, V37, P26, DOI 10.1111/j.1346-8138.2009.00764.x; BOCCHIERI MH, 1991, ARTHRITIS RHEUM, V34, P599, DOI 10.1002/art.1780340512; Broen JCA, 2014, NAT REV RHEUMATOL, V10, P671, DOI 10.1038/nrrheum.2014.128; Chujo S, 2005, J CELL PHYSIOL, V203, P447, DOI 10.1002/jcp.20251; Denton CP, 2003, J BIOL CHEM, V278, P25109, DOI 10.1074/jbc.M300636200; Fujimoto M, 2005, CURR OPIN RHEUMATOL, V17, P746, DOI 10.1097/01.bor.0000179945.73518.28; Giacomelli R, 1996, J RHEUMATOL, V23, P291; Leask Andrew, 2009, Front Biosci (Elite Ed), V1, P115; MENTON DN, 1980, J INVEST DERMATOL, V74, P139, DOI 10.1111/1523-1747.ep12535041; Noda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6797; PERLISH JS, 1988, J INVEST DERMATOL, V90, P48, DOI 10.1111/1523-1747.ep12462561; Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300; Stawski L, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4028; SZAPIEL SV, 1981, AM REV RESPIR DIS, V123, P680; Taniguchi T, 2015, ARTHRITIS RHEUMATOL, V67, P517, DOI 10.1002/art.38948; Varga John, 2009, Front Biosci (Schol Ed), V1, P226, DOI 10.2741/s22; Wu Minghua, 2008, Curr Rheumatol Rep, V10, P173, DOI 10.1007/s11926-008-0030-9	43	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	SEP	2015	48	3					123	128		10.1007/s00795-015-0107-2		6	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CR1GG	WOS:000361072300001		
J	Yamada, T; Ohno, S; Kitamura, N; Sasabe, E; Yamamoto, T				Yamada, Tomohiro; Ohno, Seiji; Kitamura, Naoya; Sasabe, Eri; Yamamoto, Tetsuya			SPARC is associated with carcinogenesis of oral squamous epithelium and consistent with cell competition	MEDICAL MOLECULAR MORPHOLOGY			English	Article						SPARC; Carcinogenesis; Oral cancer; Leukoplakia; Dysplasia	POOR-PROGNOSIS; PANCREATIC ADENOCARCINOMA; GENE-EXPRESSION; CANCER; CARCINOMA; SURVIVAL; MARKERS; PROTEIN	The matricellular protein, secreted protein acidic and rich in cysteine (SPARC) is thought to be involved in cell competition. The objective of this study is to investigate the role of SPARC in cancerization of oral squamous epithelium. Clinical specimens from 57 pre- and early cancerous lesion, 66 invasive squamous cell carcinoma (SCC) and controls were immunostained with SPARC. Clinical features and SPARC expression were evaluated. Furthermore, effects of SPARC knockdown and overexpression were examined in oral cancer and keratinocyte cell lines. Leukoplakia, carcinoma in situ, and early invasive SCC had more SPARC-positive cells than normal mucous epithelium. However, there were no significant differences between leukoplakia, carcinoma in situ, and early SCC, and there were no correlations between SPARC immunoreactivity and prognosis of invasive oral SCCs. Cell proliferation was down-regulated by SPARC siRNA, and enhanced by SPARC transformed keratinocytes. But SPARC overexpression did not enhance cell migration activity. SPARC is induced by dysplastic cells in the early stage of cancerization, and may improve survival capability, but is not involved in malignancy. SPARC may act to escape from elimination by cell competition.	[Yamada, Tomohiro] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Surg,Higashi Ku, Fukuoka 8128582, Japan; [Ohno, Seiji; Kitamura, Naoya; Sasabe, Eri; Yamamoto, Tetsuya] Kochi Univ, Kochi Med Sch, Dept Oral & Maxillofacial Surg, Nankoku, Kochi 7838505, Japan	Yamada, T (reprint author), Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Surg,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamada.tomohiro.733@m.kyushu-u.ac.jp					SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Chin D, 2005, INT J CANCER, V113, P789, DOI 10.1002/ijc.20608; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Portela M, 2010, DEV CELL, V19, P562, DOI 10.1016/j.devcel.2010.09.004; Koukourakis MI, 2003, CANCER RES, V63, P5376; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Mantoni TS, 2008, CANCER BIOL THER, V7, P1806, DOI 10.4161/cbt.7.11.6846; Grimm M, 2012, EUR J CANCER, V48, P3186, DOI 10.1016/j.ejca.2012.05.027; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Rhiner C, 2009, CARCINOGENESIS, V30, P723, DOI 10.1093/carcin/bgp003; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Atsumi N, 2008, BIOCHEM BIOPH RES CO, V373, P36, DOI 10.1016/j.bbrc.2008.05.163; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Bhoopathi P, 2011, CELL SIGNAL, V23, P1978, DOI 10.1016/j.cellsig.2011.07.008; Dalla-Torre CA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-237; Fenouille N, 2011, PIGM CELL MELANOMA R, V24, P219, DOI 10.1111/j.1755-148X.2010.00790.x; Kato Y, 2005, INT J MOL MED, V16, P263; Kitamura R, 2012, J CANCER RES CLIN, V138, P1299, DOI 10.1007/s00432-012-1202-6; Liang JF, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-71; Massi D, 1999, HUM PATHOL, V30, P339, DOI 10.1016/S0046-8177(99)90014-X; Mok SC, 1996, ONCOGENE, V12, P1895; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Petrova Evgeniya, 2011, Commun Integr Biol, V4, P171, DOI 10.4161/cib.4.2.14232; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Witkiewicz AK, 2010, CANCER BIOL THER, V10, P391; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	SEP	2015	48	3					129	137		10.1007/s00795-014-0089-5		9	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CR1GG	WOS:000361072300002		
J	Yoshida, K; Sato, J; Takai, R; Uehara, O; Kurashige, Y; Nishimura, M; Chiba, I; Saitoh, M; Abiko, Y				Yoshida, Koki; Sato, Jun; Takai, Rie; Uehara, Osamu; Kurashige, Yoshihito; Nishimura, Michiko; Chiba, Itsuo; Saitoh, Masato; Abiko, Yoshihiro			Differentiation of mouse iPS cells into ameloblast-like cells in cultures using medium conditioned by epithelial cell rests of Malassez and gelatin-coated dishes	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Induced pluripotent stem; iPS; Ameloblast; Epithelial rests of Malassez; Feeder-free	PLURIPOTENT STEM-CELLS; IN-VITRO; ES CELLS; GENERATION; GROWTH	Induced pluripotent stem (iPS) cells are generated from adult cells and are potentially of great value in regenerative medicine. Recently, it was shown that iPS cells can differentiate into ameloblast-like cells in cultures using feeder cells. In the present study, we sought to induce differentiation of ameloblast-like cells from iPS cells under feeder-free conditions using medium conditioned by cultured epithelial cell rests of Malassez (ERM) cells and gelatin-coated dishes. Two culture conditions were compared: co-cultures of iPS cells and ERM cells; and, culture of iPS cells in ERM cell-conditioned medium. Differentiation of ameloblast-like cells in the cultures was assessed using real-time RT-PCR assays of expression of the marker genes keratin 14, amelogenin, and ameloblastin and by immunocytochemical staining for amelogenin. We found greater evidence of ameloblast-like cell differentiation in the cultures using the conditioned medium. In the latter, the level of amelogenin expression increased daily and was significantly higher than controls on the 7th, 10th, and 14th days. Expression of ameloblastin also increased daily and was significantly higher than controls on the 14th day. The present study demonstrates that mouse iPS cells can be induced to differentiate into ameloblast-like cells in feeder-free cell cultures using ERM cell-conditioned medium and gelatin-coated dishes.	[Yoshida, Koki; Sato, Jun; Takai, Rie; Nishimura, Michiko; Abiko, Yoshihiro] Hlth Sci Univ Hokkaido, Sch Dent, Dept Human Biol & Pathophysiol, Div Oral Med & Pathol, Ishikari, Hokkaido 0610293, Japan; [Uehara, Osamu; Chiba, Itsuo] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Growth & Dev, Div Dis Control & Mol Epidemiol, Ishikari, Hokkaido 0610293, Japan; [Kurashige, Yoshihito; Saitoh, Masato] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Growth & Dev, Div Pediat Dent, Ishikari, Hokkaido 0610293, Japan	Abiko, Y (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Human Biol & Pathophysiol, Div Oral Med & Pathol, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.	yoshi-ab@hoku-iryo-u.ac.jp					Abiko Yoshihiro, 2001, Medical Electron Microscopy, V34, P185, DOI 10.1007/s007950100014; Sakurai M, 2011, J ARTIF ORGANS, V14, P58, DOI 10.1007/s10047-010-0547-3; Ning F, 2010, BIOCHEM BIOPH RES CO, V394, P342, DOI 10.1016/j.bbrc.2010.03.007; Bilousova G, 2011, J INVEST DERMATOL, V131, P857, DOI 10.1038/jid.2010.364; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Taura D, 2009, ARTERIOSCL THROM VAS, V29, P1100, DOI 10.1161/ATVBAHA.108.182162; Shinmura Y, 2008, J CELL PHYSIOL, V217, P728, DOI 10.1002/jcp.21546; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yamanaka S, 2010, CELL STEM CELL, V7, P1, DOI 10.1016/j.stem.2010.06.009; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Jernvall J, 1998, DEVELOPMENT, V125, P161; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38; Cao HJ, 2013, DEVELOPMENT, V140, P3348, DOI 10.1242/dev.089193; Arakaki M, 2012, J BIOL CHEM, V287, P10590, DOI 10.1074/jbc.M111.285874; Aberg T, 1997, DEV DYNAM, V210, P383, DOI 10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO;2-C; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Koike M, 2007, J BIOSCI BIOENG, V104, P294, DOI 10.1263/jbb.104.294; Lim JWE, 2002, PROTEOMICS, V2, P1187, DOI 10.1002/1615-9861(200209)2:9<1187::AID-PROT1187>3.0.CO;2-T; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Coin R, 1999, EUR J ORAL SCI, V107, P487, DOI 10.1046/j.0909-8836.1999.eos107611.x; Egusa H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012743; Haku Ken, 2011, Bull Tokyo Dent Coll, V52, P173; Hatakeyama S, 2004, J ORAL PATHOL MED, V33, P622, DOI 10.1111/j.1600-0714.2004.00245.x; Koshihara T., 2010, INT J DENT, V2010; Miyoshi Keiko, 2008, J Med Invest, V55, P216, DOI 10.2152/jmi.55.216; Nadiri A, 2004, J HISTOCHEM CYTOCHEM, V52, P103; Nishimura Michiko, 1999, Medical Electron Microscopy, V32, P127, DOI 10.1007/s007950050019; Shimonishi M, 2007, J PERIODONTAL RES, V42, P456, DOI 10.1111/j.1600-0765.2007.00969.x; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	SEP	2015	48	3					138	145		10.1007/s00795-014-0088-6		8	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CR1GG	WOS:000361072300003		
J	Matsuo, Y; Tashiro, H; Yanai, H; Moriya, T; Katabuchi, H				Matsuo, Yuji; Tashiro, Hironori; Yanai, Hiroyuki; Moriya, Takuya; Katabuchi, Hidetaka			Clinicopathological heterogeneity in ovarian clear cell adenocarcinoma: a study on individual therapy practice	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Ovarian clear cell adenocarcinoma; Molecular pathology; Endometriosis; Heterogeneity; Prognosis; Therapeutic strategy	GRADE SEROUS CARCINOMA; ENDOMETRIOID CARCINOMA; TUMOR-SUPPRESSOR; IMPROVED SURVIVAL; ARID1A MUTATIONS; P53 GENE; EXPRESSION; PLATINUM; CHEMOTHERAPY; PATHOGENESIS	Ovarian clear cell adenocarcinoma (CCA) has been believed to be a lethal histological subtype of an epithelial ovarian adenocarcinoma (EOA); its precursor has been assumed to be endometriosis. However, it has been reported that CCAs occasionally exhibit different clinical behaviors, suggesting that CCAs might not belong to a single category. We focused on CCAs combined with other histological types of EOAs; we re-evaluated the pathology of 46 CCAs and divided them into two subgroups: 35 CCAs alone (pure-type CCAs); and 11 CCAs with other histological types, endometrioid adenocarcinomas (EAs) or/and serous adenocarcinomas (SAs) (mixed-type CCAs). Immunohistochemical analysis for expression of ARID1A, p53, PTEN, Annexin 4, hepatocyte nuclear factor-1 beta (HNF-1 beta), and WT-1 was employed. We identified that patients with endometriosis were younger than those without endometriosis in pure-type CCAs (P < 0.005). In mixed-type CCAs, the immunohistochemical-staining patterns revealed internal transition of each histological component. In pure-type CCAs, expressions of ARID1A and p53 were mutually altered, and altered expression of p53 was associated with worse prognosis than that of ARID1A (P < 0.001). Our results provide evidence that CCAs would have clinicopathological heterogeneity, determining the patient's prognosis. Furthermore, immunohistochemical analysis may shed light on the selection of appropriate treatment, including chemotherapy.	[Matsuo, Yuji; Tashiro, Hironori; Katabuchi, Hidetaka] Kumamoto Univ, Fac Life Sci, Dept Obstet & Gynecol, Chuou Ku, Kumamoto 8608556, Japan; [Yanai, Hiroyuki] Okayama Univ Hosp, Dept Pathol, Okayama, Japan; [Moriya, Takuya] Kawasaki Med Univ, Dept Pathol 2, Kurashiki, Okayama, Japan	Katabuchi, H (reprint author), Kumamoto Univ, Fac Life Sci, Dept Obstet & Gynecol, Chuou Ku, Honjo 1-1-1, Kumamoto 8608556, Japan.	buchi@kumamoto-u.ac.jp			 [21390454]	We thank Dr. Ken-ichi Iyama (Department of Surgical Pathology, Kumamoto University Hospital) for his help with the diagnosis of the 46 cases. We also thank Ms. Ai Aoki (Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University) for her technical assistance. This research was supported by a grant from Grants-in-Aid for Scientific Research (B) 21390454.	An HJ, 2002, HISTOPATHOLOGY, V41, P437, DOI 10.1046/j.1365-2559.2002.01455.x; Sato N, 2000, CANCER RES, V60, P7052; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Han G, 2008, AM J SURG PATHOL, V32, P955, DOI 10.1097/PAS.0b013e318164edf7; Guan B, 2012, NEOPLASIA, V14, P986, DOI 10.1593/neo.121218; Wu CH, 2012, INT J GYNECOL PATHOL, V31, P297, DOI 10.1097/PGP.0b013e31823f8482; DeLair D, 2011, AM J SURG PATHOL, V35, P36, DOI 10.1097/PAS.0b013e3181ff400e; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; KURMAN RJ, 1972, CANCER, V29, P1653, DOI 10.1002/1097-0142(197206)29:6<1653::AID-CNCR2820290633>3.0.CO;2-E; Veras E, 2009, AM J SURG PATHOL, V33, P844, DOI 10.1097/PAS.0b013e31819c4271; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Utsunomiya H, 2006, INT J GYNECOL CANCER, V16, P52, DOI 10.1111/j.1525-1438.2006.00289.x; Miao Y, 2009, INT J GYNECOL CANCER, V19, P1545, DOI 10.1111/IGC.0b013e3181a844c8; Rauh-Hain JA, 2012, GYNECOL ONCOL, V125, P376, DOI 10.1016/j.ygyno.2012.02.016; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kajihara H, 2010, ONCOL REP, V23, P1193, DOI 10.3892/or_00000750; del Carmen MG, 2012, GYNECOL ONCOL, V126, P481, DOI 10.1016/j.ygyno.2012.04.021; Jiang XX, 1998, CANCER RES, V58, P1707; Tashiro H, 1997, AM J PATHOL, V150, P177; Takano M, 2006, BRIT J CANCER, V94, P1369, DOI 10.1038/sj.bjc.6603116; Ayhan A, 2012, INT J GYNECOL CANCER, V22, P1310, DOI 10.1097/IGC.0b013e31826b5dcc; Kobel M, 2011, INT J GYNECOL PATHOL, V30, P366, DOI 10.1097/PGP.0b013e31820d20ba; Pectasides D, 2006, GYNECOL ONCOL, V102, P285, DOI 10.1016/j.ygyno.2005.12.038; SCULLY RE, 1967, CANCER, V20, P1405, DOI 10.1002/1097-0142(196709)20:9<1405::AID-CNCR2820200907>3.0.CO;2-B; Ho CM, 2004, GYNECOL ONCOL, V94, P197, DOI 10.1016/j.ygyno.2004.04.004; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Ichikawa A, 1997, NEW ENGL J MED, V337, P529, DOI 10.1056/NEJM199708213370804; Peham H, 1899, MONATSCHR GEBURTSCH, V10, P685; Recio F, 1996, CANCER, V78, P2157, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2157::AID-CNCR17>3.0.CO;2-Y; Schiller W, 1939, AM J CANCER, V35, P1; Serov SF, 1973, INT HISTOLOGICAL CLA, P37; Yamamoto S, 2011, INT J GYNECOL PATHOL, V30, P431, DOI 10.1097/PGP.0b013e3182165eba	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	SEP	2015	48	3					146	154		10.1007/s00795-014-0090-z		9	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CR1GG	WOS:000361072300004		
J	Kawabe, M; Ohyama, H; Kato-Kogoe, N; Yamada, N; Yamanegi, K; Nishiura, H; Hirano, H; Kishimoto, H; Nakasho, K				Kawabe, Mutsuki; Ohyama, Hideki; Kato-Kogoe, Nahoko; Yamada, Naoko; Yamanegi, Koji; Nishiura, Hiroshi; Hirano, Hirotugu; Kishimoto, Hiromitsu; Nakasho, Keiji			Expression of interleukin-34 and colony stimulating factor-1 in the stimulated periodontal ligament cells with tumor necrosis factor-alpha	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Interleukin-34; Colony-stimulating factor-1; Osteoclastogenesis; Periodontal ligament cells; Tumor necrosis factor-alpha	TNF-ALPHA; CSF-1; IL-34; RECEPTOR; DISEASE; HEALTH; CSF1R	Tumor necrosis factor-alpha (TNF-alpha) directly and indirectly plays a crucial role in osteoclastogenesis. However, the indirect effects of TNF-alpha on colony-stimulating factor-1 receptor (CSF-1R)-mediated osteoclastogenesis achieved via periodontal ligament (PDL) cells are not fully understood. We herein examined the potency of osteoclast differentiation and maturation induced by fivefold supernatants in the stimulated human PDL cells with a physiologically high concentration (10 ng/mL) of recombinant TNF-alpha to human peripheral blood monocytes/macrophages in the simultaneous presence of the receptor activator of nuclear factor kappa-B ligand. The number of tartrate-resistant acid phosphatase-positive cells with multiple nuclei, but not those with a single nucleus, was decreased by approximately 50 % by neutralization with rabbit IgG against either interleukin-34 (IL-34) or CSF-1. Small and large amounts of IL34 and CSF1 transcripts were measured in the stimulated PDL cells using real-time polymerase chain reaction. The corresponding amounts of proteins to IL34 and CSF1 transcripts were observed in the stimulated PDL cells on immunohistochemical staining or Western blotting. Moreover, 0.13 ng/mL of IL-34 and 5.0 ng/mL of CSF-1 were measured in the supernatants of the stimulated PDL cells using an enzyme-linked immunosorbent assay. IL-34 derived from the stimulated PDL cells with TNF-alpha appeared to synergistically function with CSF-1 in the CSF-1R-mediated maturation of osteoclastogenesis.	[Kawabe, Mutsuki; Kishimoto, Hiromitsu] Hyogo Coll Med, Dept Oral & Maxillofacial Surg, Nishinomiya, Hyogo 6638501, Japan; [Ohyama, Hideki; Kato-Kogoe, Nahoko; Yamada, Naoko; Yamanegi, Koji; Nishiura, Hiroshi; Nakasho, Keiji] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; [Hirano, Hirotugu] Toneyama Natl Hosp, Dept Lab Med, Osaka 5608552, Japan	Kawabe, M (reprint author), Hyogo Coll Med, Dept Oral & Maxillofacial Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	muttsu@hyo-med.ac.jp			Hyogo College of Medicine; Japan Society for the Promotion of Science [26463150, 26463151]	This study was supported in part by a Grant-in-Aid for Researchers, Hyogo College of Medicine and Grant-in-Aid for Scientific Research (C) (No. 26463150 and No. 26463151) from the Japan Society for the Promotion of Science. We have no competing interests. The protocol and consent guidelines for the experiments were approved by the Human Ethics Committee of the Hyogo College of Medicine (Approval No. 223) according to the Declaration of Helsinki. All subjects provided their informed consent for the use of their tissues for research in this study.	Abiko Y, 2007, MED MOL MORPHOL, V40, P179, DOI 10.1007/s00795-007-0381-8; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463; SCHUTZE S, 1992, SEMIN ONCOL, V19, P16; Garceau V, 2010, J LEUKOCYTE BIOL, V87, P753, DOI 10.1189/jlb.0909624; Nakamichi Y, 2013, J BONE MINER METAB, V31, P486, DOI 10.1007/s00774-013-0476-3; Droin N, 2010, J LEUKOCYTE BIOL, V87, P745, DOI 10.1189/jlb.1209780; Kotake S, 2014, BBA-GEN SUBJECTS, V1840, P1209, DOI 10.1016/j.bbagen.2013.12.013; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Asschert JGW, 1997, EUR J CANCER, V33, P2246, DOI 10.1016/S0959-8049(97)00240-2; Barve RA, 2013, CYTOKINE, V63, P10, DOI 10.1016/j.cyto.2013.04.019; Bostrom EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081665; Espinosa I, 2011, AM J PATHOL, V179, P2100, DOI 10.1016/j.ajpath.2011.06.021; Foucher ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056045; Park JC, 2001, BIOCHEM BIOPH RES CO, V282, P1145, DOI 10.1006/bbrc.2001.4694; Rhim EM, 2013, CRYOBIOLOGY, V67, P156, DOI 10.1016/j.cryobiol.2013.06.006; Sawada T, 2015, MED MOL MORPHOL, V48, P104, DOI 10.1007/s00795-014-0085-9; Sedgley Christine M, 2012, Dent Clin North Am, V56, P549, DOI 10.1016/j.cden.2012.05.004; Sokos D, 2015, J PERIODONTAL RES, V50, P152, DOI 10.1111/jre.12197; YE J, 1995, J DENT RES, V74, P1303; Yu YQ, 2014, MOL MED REP, V10, P1371, DOI 10.3892/mmr.2014.2353	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	SEP	2015	48	3					169	176		10.1007/s00795-014-0094-8		8	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CR1GG	WOS:000361072300007		
J	Tate, G; Kishimoto, K; Mitsuya, T				Tate, Genshu; Kishimoto, Koji; Mitsuya, Toshiyuki			Biallelic alterations of the large tumor suppressor 1 (LATS1) gene in infiltrative, but not superficial, basal cell carcinomas in a Japanese patient with nevoid basal cell carcinoma syndrome	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Biallelic disruption; Large tumor suppressor 1; Loss of heterozygosity; Nevoid basal cell carcinoma syndrome	HUMAN HOMOLOG; DROSOPHILA LATS; MUTATIONS; GROWTH	The present study was conducted to address the molecular pathogenesis underlying the progression of basal cell carcinoma (BCC) in a nevoid basal cell carcinoma syndrome (NBCCS) patient. We analyzed infiltrative BCCs that invaded the subcutaneous tissue of the scalp and penetrated the skull in a 61-year-old Japanese female. Whole-exome sequencing validated by Sanger sequencing was applied to assess the subcutaneously infiltrative BCCs. Differences in genetic alterations between the superficial and infiltrative BCCs were also examined. Of particular note, the infiltrative BCCs showed a nonsense mutation, c.943C > T, resulting in p.Q315X in the large tumor suppressor 1 (LATS1) gene, as well as the loss of the wild-type allele of LATS1 (6q25.1), thus indicating that the LATS1 gene was biallelically disrupted. In contrast, no alterations in the LATS1 gene were observed in the superficial BCCs. Additionally, a loss of heterozygosity analysis revealed that the distal region of chromosome 6q where LATS1 locates was deleted in a heterozygous manner. The present results imply that the biallelic disruption of LATS1 is a progressive factor of the infiltrative BCCs observed in this NBCCS patient and suggest that the Hippo pathway is a potential therapeutic target in cases of infiltrative BCC.	[Tate, Genshu; Kishimoto, Koji; Mitsuya, Toshiyuki] Showa Univ, Fujigaoka Hosp, Dept Pathol, Yokohama, Kanagawa 2278501, Japan	Tate, G (reprint author), Showa Univ, Dept Pathol, Shinagawa Ku, Hatanodai 1-5-8, Tokyo 1428555, Japan.	gentate@yahoo.co.jp					Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817; Yabuta N, 2013, J CELL SCI, V126, P508, DOI 10.1242/jcs.113431; Tao WF, 1999, NAT GENET, V21, P177; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Xia H, 2002, ONCOGENE, V21, P1233, DOI 10.1038/sj.onc.1205174; XU TA, 1995, DEVELOPMENT, V121, P1053; St John MAR, 1999, NAT GENET, V21, P182; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Liu AM, 2012, BBA-REV CANCER, V1826, P357, DOI 10.1016/j.bbcan.2012.05.006; Tate G, 2003, JPN J CLIN ONCOL, V33, P47, DOI 10.1093/jjco/hyg005; Tate G, 2015, MED MOL MORPHOL, V48, P116, DOI 10.1007/s00795-014-0079-7; Tate G, 2014, ACTA MED OKAYAMA, V68, P163	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	SEP	2015	48	3					177	182		10.1007/s00795-014-0086-8		6	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	CR1GG	WOS:000361072300008		
J	Jeong, D; Jung, W; Kim, Y; Goto, M; Kim, S				Jeong, Daeho; Jung, Woojin; Kim, Youngju; Goto, Masahiro; Kim, Sangshik			Stress Corrosion Cracking Behavior of X80 Steel in Artificial Seawater Under Controlled Strain Rate and Applied Potentials	METALS AND MATERIALS INTERNATIONAL			English	Article						alloys; thermomechanical processing; corrosion; scanning electron microscopy (SEM); X80 steel	FACILITATED ANODIC-DISSOLUTION; HYDROGEN-INDUCED-CRACKING; HIGH-STRENGTH STEELS; S-N FATIGUE; CATHODIC PROTECTION; STAINLESS-STEELS; PIPELINE STEELS; EMBRITTLEMENT; ALLOY; MICROSTRUCTURE	The effect of applied potential on the stress corrosion cracking (SCC) behavior of X80 steel was examined in artificial seawater (ASW) at different strain rates of 1x10(-4), 1x10(-5) and 1x10(-6)/sec. The controlled potential of -650, -850, -950 and -1,050 mV(SCE), respectively, was applied during strainig. It was found that X80 steel was susceptible to SCC in seawater environment under both anodic and cathodic applied potentials and the susceptibility was sensitive to strain rate. The SCC was initiated at the surface pits under an anodic applied potential of -650 mV(SCE). The effect of cathodic applied potential on the SCC behavior of X80 steel in ASW was more complex, such that the combined effect of surface damage, including pits and hydrogen-induced cracking, and hydrogen concentration generated on the surface tended to determine the SCC susceptibility. The SCC behavior of X80 steel with different applied potentials in ASW was discussed based on the microstructural and the fractographic observations.	[Jeong, Daeho; Jung, Woojin; Kim, Sangshik] Gyeongsang Natl Univ, ReCAPT, Dept Mat Sci & Engn, Chinju 660701, South Korea; [Kim, Youngju] KIGAM, Mineral Resources Res Div, Taejon 305350, South Korea; [Goto, Masahiro] Oita Univ, Dept Mech Engn, Oita 8701192, Japan	Kim, S (reprint author), Gyeongsang Natl Univ, ReCAPT, Dept Mat Sci & Engn, Chinju 660701, South Korea.	sang@gnu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [2011-0030058]; Development of Drill Riser System Project of the KIGAM - Ministry of Knowledge Economy of Korea [14-9807]; Basic Research Project "development of optimum technologies of exploration geophysics and mining for the ore deposit targeting" of the KIGAM - Ministry of Knowledge Economy of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2011-0030058). This research was also supported by the Development of Drill Riser System Project (14-9807) and the Basic Research Project "development of optimum technologies of exploration geophysics and mining for the ore deposit targeting" of the KIGAM funded by the Ministry of Knowledge Economy of Korea.	Pedeferri P, 1996, CONSTR BUILD MATER, V10, P391, DOI 10.1016/0950-0618(95)00017-8; Fournier L, 1999, MAT SCI ENG A-STRUCT, V269, P111, DOI 10.1016/S0921-5093(99)00167-7; Qiao LJ, 1998, CORROSION, V54, P281; Wang YX, 2011, CORROS SCI, V53, P2761, DOI 10.1016/j.corsci.2011.05.011; PARKINS RN, 1990, CORROSION, V46, P178; Kannan MB, 2007, SCRIPTA MATER, V57, P579, DOI 10.1016/j.scriptamat.2007.06.019; HOGE KG, 1977, J MATER SCI, V12, P1666, DOI 10.1007/BF00542818; Delafosse D, 2001, ENG FRACT MECH, V68, P693, DOI 10.1016/S0013-7944(00)00121-1; Yoon YS, 2014, CORROS SCI, V80, P28, DOI 10.1016/j.corsci.2013.09.014; Tian WM, 2015, CORROS SCI, V93, P242, DOI 10.1016/j.corsci.2015.01.034; GEST RJ, 1974, CORROSION, V30, P274; Li MC, 2007, ELECTROCHIM ACTA, V52, P8111, DOI 10.1016/j.electacta.2007.07.015; Gu B, 1999, CORROSION, V55, P96; Wang W, 2009, MAT SCI ENG A-STRUCT, V502, P38, DOI 10.1016/j.msea.2008.10.042; [Anonymous], 1990, ANN BOOK ASTM STAND; Song YP, 2015, MET MATER INT, V21, P7, DOI 10.1007/s12540-015-1002-z; Arup H., 1991, CORROS ENG SCI TECHN, V26, P169; ASTM American Society for Testing and Materials, 2000, ANN BOOK ASTM STAND; BARTH CF, 1972, CORROSION, V28, P259; Baxter D. P., 2007, 26 INT C OFFSH MECH, P117; Billingham J., 2003, REV PERFORMANCE HIGH; Hardie D., 1979, Metal Science, V13; Jung DH, 2014, METALL MATER TRANS A, V45A, P654, DOI 10.1007/s11661-013-2012-4; KERMANI M, 1979, CORROS SCI, V19, P89, DOI 10.1016/0010-938X(79)90043-X; Kim Y, 2014, MET MATER INT, V20, P851, DOI 10.1007/s12540-014-5009-7; Kwon JK, 2014, KOREAN J MET MATER, V52, P757, DOI 10.3365/KJMM.2014.52.10.757; Lee H. J., 2011, CORROS SCI, V55, P10; Lijie Q., 1993, METALL TRANS A, V24, P959, DOI 10.1007/BF02656517; Lindley C., 2001, MAR STRUCT, V14, P397, DOI 10.1016/S0951-8339(00)00048-4; Liua Z. Y., 2009, CORROS SCI, V51, P2863; Lu BT, 2006, CORROSION, V62, P129; LYNCH SP, 1985, J MATER SCI, V20, P3329, DOI 10.1007/BF00545203; NORSOK and Materials Selection, 1997, M503 NORSOK; Parkins RN, 2003, CORROSION, V59, P258; PETERSON MH, 1967, CORROSION, V23, P142; PRESSOUYRE GM, 1979, ACTA METALL MATER, V27, P89, DOI 10.1016/0001-6160(79)90059-2; RIECK RM, 1989, METALL TRANS A, V20, P889, DOI 10.1007/BF02651655; SCAMANS GM, 1976, CORROS SCI, V16, P443, DOI 10.1016/0010-938X(76)90065-2; Serebrinsky SA, 1999, CORROS SCI, V41, P191, DOI 10.1016/S0010-938X(98)00118-8; Shin SY, 2009, J KOREAN INST MET MA, V47, P155; TAKANO M, 1974, CORROSION, V30, P441; Yoon YS, 2014, CORROS SCI, V88, P337, DOI 10.1016/j.corsci.2014.07.048	42	0	0	KOREAN INST METALS MATERIALS	SEOUL	KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881, SOUTH KOREA	1598-9623	2005-4149		MET MATER INT	Met. Mater.-Int.	SEP	2015	21	5					785	792		10.1007/s12540-015-5132-0		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CQ8YC	WOS:000360895700001		
J	Choi, YI; Kuroda, K; Okido, M				Choi, Yun-Il; Kuroda, Kensuke; Okido, Masazumi			Temperature Dependence of Initial Passivity Breakdown of AZ61 and AZ91D Mg Alloys in 0.1 M NaCl Solution	METALS AND MATERIALS INTERNATIONAL			English	Article						magnesium; pitting corrosion; passivity; surface; electrochemistry	AZ31 MAGNESIUM ALLOY; CORROSION BEHAVIOR; PITTING CORROSION; IRON DISSOLUTION; PIT INITIATION; CHLORIDE; MICROSTRUCTURE; MODEL; ENVIRONMENTS; MECHANISMS	The effects of solution temperature on the initial corrosion characteristics of wrought AZ61 and die-cast AZ91D Mg alloys in 0.1M NaCl were analyzed. Systematic studies indicate that AZ91D exhibits higher corrosion resistance than AZ61 at room temperature. However, at high temperatures of around 55 degrees C, we observed contradictory corrosion behavior, as demonstrated by cyclic corrosion tests and electrochemical tests including potentio-dynamic polarization, potentiostatic polarization, and elecrochemical impedance spectroscopy. As a result, AZ61 rather showed higher corrosion resistance from the point of view of pit initiation during the immersion at 55 degrees C resulting from the strengthening of surface passivation. These results can be attributed to the microstructure of AZ61 which contains sub-micron scale beta-phase particles dispersed effectively within the alpha-Mg grains whereas AZ91D has many alpha-Mg that do not containing any beta-phases.	[Choi, Yun-Il] Doosan Heavy Ind & Construct, Corp R&D Inst, Mat Technol Dev Team, Chang Won 642792, Gyeongnam, South Korea; [Kuroda, Kensuke; Okido, Masazumi] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Choi, YI (reprint author), Doosan Heavy Ind & Construct, Corp R&D Inst, Mat Technol Dev Team, 22 DoosanVolvo Ro, Chang Won 642792, Gyeongnam, South Korea.	yooniri@hotmail.com					Raman RKS, 2004, METALL MATER TRANS A, V35A, P2525; Merino MC, 2010, CORROS SCI, V52, P1696, DOI 10.1016/j.corsci.2010.01.020; LIN LF, 1981, J ELECTROCHEM SOC, V128, P1194, DOI 10.1149/1.2127592; Pardo A, 2008, ELECTROCHIM ACTA, V53, P7890, DOI 10.1016/j.electacta.2008.06.001; Wen ZH, 2009, J ALLOY COMPD, V488, P392, DOI 10.1016/j.jallcom.2009.08.147; Atrens A, 2007, ADV ENG MATER, V9, P292, DOI 10.1002/adem.200600275; Frankel GS, 1998, J ELECTROCHEM SOC, V145, P2186, DOI 10.1149/1.1838615; BUZZA DW, 1995, J ELECTROCHEM SOC, V142, P1104, DOI 10.1149/1.2044137; Walton CA, 2012, CORROS SCI, V56, P194, DOI 10.1016/j.corsci.2011.12.008; Wang L, 2012, MATER DESIGN, V33, P345, DOI 10.1016/j.matdes.2011.02.019; Song GL, 1999, ADV ENG MATER, V1, P11; Feliu S, 2011, CORROS SCI, V53, P1865, DOI 10.1016/j.corsci.2011.02.003; Frankel GS, 2013, CORROS SCI, V70, P104, DOI 10.1016/j.corsci.2013.01.017; Song GL, 1998, CORROS SCI, V40, P1769, DOI 10.1016/S0010-938X(98)00078-X; Samaniego A, 2013, CORROS SCI, V68, P66, DOI 10.1016/j.corsci.2012.10.034; Cruz RPV, 1998, CORROS SCI, V40, P125, DOI 10.1016/S0010-938X(97)00124-8; Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405; Jonsson M, 2010, CORROS SCI, V52, P1077, DOI 10.1016/j.corsci.2009.11.036; Beom WJ, 2010, CORROS SCI, V52, P734, DOI 10.1016/j.corsci.2009.10.033; Pardo A, 2008, CORROS SCI, V50, P823, DOI 10.1016/j.corsci.2007.11.005; Apachitei I, 2007, SCRIPTA MATER, V57, P1012, DOI 10.1016/j.scriptamat.2007.08.002; Chen J, 2009, CORROS SCI, V51, P477, DOI 10.1016/j.corsci.2008.11.024; Cole G., 2006, SOUTHFIELD; Froats A. F., 1987, METALS HDB, V13, P740; KEDDAM M, 1981, J ELECTROCHEM SOC, V128, P257, DOI 10.1149/1.2127401; Kim YH, 2015, MET MATER INT, V21, P374, DOI 10.1007/s12540-015-4338-5; Lee BD, 2013, MET MATER INT, V19, P135, DOI 10.1007/s12540-013-2001-6; SCHWEICKERT H, 1980, J ELECTROCHEM SOC, V127, P1693, DOI 10.1149/1.2129982; Zhang T, 2006, CORROS SCI, V48, P1249, DOI 10.1016/j.corsci.2005.05.011	29	0	0	KOREAN INST METALS MATERIALS	SEOUL	KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881, SOUTH KOREA	1598-9623	2005-4149		MET MATER INT	Met. Mater.-Int.	SEP	2015	21	5					857	864		10.1007/s12540-015-5044-z		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CQ8YC	WOS:000360895700010		
J	Motoyama, K; Mitsuyasu, R; Akao, C; Abu Hashim, II; Sato, N; Tanaka, T; Higashi, T; Arima, H				Motoyama, Keiichi; Mitsuyasu, Ryosuke; Akao, Chiho; Abu Hashim, Irhan Ibrahim; Sato, Nana; Tanaka, Takahiro; Higashi, Taishi; Arima, Hidetoshi			Potential Use of Thioalkylated Mannose-Modified Dendrimer (G3)/alpha-Cyclodextrin Conjugate as an NF-kappa B siRNA Carrier for the Treatment of Fulminant Hepatitis	MOLECULAR PHARMACEUTICS			English	Article						dendrimer; cyclodextrin; siRNA; fulminant hepatitis; NF-kappa B	SITE-SPECIFIC DELIVERY; TUMOR-NECROSIS-FACTOR; CYCLODEXTRIN CONJUGATE; GENE-TRANSFER; POLYAMIDOAMINE DENDRIMER; ALPHA-CYCLODEXTRIN; TNF-ALPHA; RECEPTOR; FAILURE; MACROPHAGES	NF-kappa B and its associated pathways are complicatedly concerned about hepatic homeostasis. Discriminating inhibition of NF-kappa B signaling has been expected to treat various liver diseases including fulminant hepatitis. To clarify the potential use of thioalkylated mannose-appended dendrimer (generation 3; G3) conjugates with alpha-cyclodextrin with average degree of substitution of mannose (DSM4) (Man-S-alpha-CDE (G3, DSM4) as a novel antigen presenting cell (APC)-specific siRNA carrier, we evaluated the RNAi effect of NF-kappa B p65 siRNA (sip65) complex with Man-S-alpha-CDE (G3, DSM4) both in vitro and in vivo. Man-S-alpha-CDE (G3, DSM4)/sip65 complex significantly suppressed NP-kappa B p65 mRNA expression and nitric oxide (NO) production from lipopolysaccharide (LPS)-stimulated NR8383 cells, a rat alveolar macrophage cell line, by adequate physicochemical properties and mannose receptor-mediated cellular uptake. Intravenous injection of Man-S-alpha-CDE (G3, DSM4)/sip65 complex extended the survival rate of LPS-induced fulminant hepatitis model mice. In addition, intravenous administration of Man-S-alpha-ODE (G3, DSM4)/sip65 complex had the potential to induce the in vivo RNAi effect by significant suppression of mRNA expression of NT-kappa B p65 and inflammatory cytokines in the liver of fulminant hepatitis model mice induced by LPS/D-galactosamine (D-Gal) without any significant side effects. Also, the serum levels of enzymes were significantly attenuated by injection of Man-S-alpha-ODE (G3, DSM4)/sip65 complex in fulminant hepatitis model mice. Collectively, these results suggest that Man-S-alpha-ODE (G3, DSM4) has the potential as a novel APC-selective sip65 carrier for the treatment of LPS/D-Gal-induced fulminant hepatitis in mice.	[Motoyama, Keiichi; Mitsuyasu, Ryosuke; Akao, Chiho; Abu Hashim, Irhan Ibrahim; Sato, Nana; Tanaka, Takahiro; Higashi, Taishi; Arima, Hidetoshi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Phys Pharmaceut, Chuo Ku, Kumamoto 8620973, Japan; [Abu Hashim, Irhan Ibrahim] Mansoura Univ, Fac Pharm, Mansoura 35516, Egypt; [Arima, Hidetoshi] Kumamoto Univ, Program Leading Grad Sch, HIGO Hlth Life Sci Interdisciplinary & Glocal Ori, Kumamoto 8620973, Japan	Arima, H (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Phys Pharmaceut, Chuo Ku, 5-1 Oehonmachi, Kumamoto 8620973, Japan.	arimah@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science [16590114, 18590144, 20590037]	This work was partially supported by Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (16590114, 18590144, 20590037).	Akao C, 2014, J CONTROL RELEASE, V193, P35, DOI 10.1016/j.jconrel.2014.07.004; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; STAHL P, 1980, CELL, V19, P207, DOI 10.1016/0092-8674(80)90402-X; Arima H, 2011, EUR J PHARM SCI, V44, P375, DOI 10.1016/j.ejps.2011.08.019; Jiang HL, 2008, BIOMATERIALS, V29, P1931, DOI 10.1016/j.biomaterials.2007.12.025; Tsutsumi T, 2007, J CONTROL RELEASE, V119, P349, DOI 10.1016/j.jconrel.2007.03.013; Inoue M, 2008, INT J CANCER, V123, P2696, DOI 10.1002/ijc.23867; Linehan SA, 2001, EUR J IMMUNOL, V31, P1857, DOI 10.1002/1521-4141(200106)31:6<1857::AID-IMMU1857>3.0.CO;2-D; ARAI M, 1993, GASTROENTEROLOGY, V104, P1466; Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Kihara F, 2003, BIOCONJUGATE CHEM, V14, P342, DOI 10.1021/bc025613a; Xiao B, 2013, J BIOMED MATER RES A, V101, P1888, DOI 10.1002/jbm.a.34493; Monsigny M, 2004, BBA-GEN SUBJECTS, V1673, P94, DOI 10.1016/j.bbagen.2004.03.015; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Tsutsui H, 1997, J IMMUNOL, V159, P3961; Chen Y, 2008, PHARM RES, V25, P72, DOI 10.1007/s11095-007-9504-0; Jain SK, 2008, NANOMED-NANOTECHNOL, V4, P41, DOI 10.1016/j.nano.2007.11.004; DINARELLO CA, 1993, JAMA-J AM MED ASSOC, V269, P1829, DOI 10.1001/jama.269.14.1829; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; STAHL PD, 1978, P NATL ACAD SCI USA, V75, P1399, DOI 10.1073/pnas.75.3.1399; Streetz K, 2000, GASTROENTEROLOGY, V119, P446, DOI 10.1053/gast.2000.9364; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100; Wang J, 2010, AAPS J, V12, P492, DOI 10.1208/s12248-010-9210-4; Kim N, 2012, INT J PHARMACEUT, V427, P123, DOI 10.1016/j.ijpharm.2011.08.014; Gotthardt D, 2007, NEPHROL DIAL TRANSPL, V22, P5, DOI 10.1093/ndt/gfm650; Oh YK, 2009, ADV DRUG DELIVER REV, V61, P850, DOI 10.1016/j.addr.2009.04.018; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Jain A, 2010, J CONTROL RELEASE, V148, P359, DOI [10.1016/j.jconrel.2010.09.003, 10.1016/j.conrel.2010.09.003]; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; MUTO Y, 1988, LANCET, V2, P72; Arima H, 2006, J CONTROL RELEASE, V116, P64, DOI 10.1016/j.jconrel.2006.08.026; Diebold Sandra S., 2002, Somatic Cell and Molecular Genetics, V27, P65, DOI 10.1023/A:1022975705406; Hayden M.S., 2006, CELL, V127; IIMURO Y, 1994, J LEUKOCYTE BIOL, V55, P723; Kang BK, 1998, INFECT IMMUN, V66, P2769; Kihara F, 2002, BIOCONJUGATE CHEM, V13, P1211, DOI 10.1021/bc025557d; Motoyama K, 2014, AAPS J, V16, P1298, DOI 10.1208/s12248-014-9665-9; Osada S, 2004, J SURG ONCOL, V85, P48, DOI 10.1002/jso.20006; Roche AC, 2003, CELL MOL LIFE SCI, V60, P288, DOI 10.1007/s000180300024; Ruetten H, 1997, J PHYSIOL PHARMACOL, V48, P605; Sass DA, 2005, LIVER TRANSPLANT, V11, P594, DOI 10.1002/lt.20435; Takeuchi O, 2002, MICROBES INFECT, V4, P887, DOI 10.1016/S1286-4579(02)01615-5; Trejo-Avila L, 2007, ANN HEPATOL, V6, P174; Tsutsumi T, 2008, J PHARM SCI-US, V97, P3022, DOI 10.1002/jps.21206; Vaquero Javier, 2003, Curr Gastroenterol Rep, V5, P39, DOI 10.1007/s11894-003-0008-8; Zhou Jiehua, 2010, Silence, V1, P4, DOI 10.1186/1758-907X-1-4	48	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	SEP	2015	12	9					3129	3136		10.1021/mp500814f		8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CR1LR	WOS:000361086800003		
J	Sakai-Kato, K; Nanjo, K; Kusuhara, H; Nishiyama, N; Kataoka, K; Kawanishi, T; Okuda, H; Goda, Y				Sakai-Kato, Kumiko; Nanjo, Kunie; Kusuhara, Hiroyuki; Nishiyama, Nobuhiro; Kataoka, Kazunori; Kawanishi, Toru; Okuda, Haruhiro; Goda, Yukihiro			Effect of Knockout of Mdr1a and Mdr1b ABCB1 Genes on the Systemic Exposure of a Doxorubicin-Conjugated Block Copolymer in Mice	MOLECULAR PHARMACEUTICS			English	Article						block copolymer micelles; ABCB1; systemic exposure; clearance	P-GLYCOPROTEIN; POLYMERIC MICELLES; INTRACELLULAR TRAFFICKING; DRUG; EXCRETION; PHARMACOKINETICS; NEUROTOXICITY; DELIVERY; DIGOXIN; REDUCE	We previously elucidated that ATP-binding cassette subfamily B member 1 (ABCB1) mediates the efflux of doxorubicin-conjugated block copolymers from HeLa cells. Here, we investigated the role of ABCB1 in the in vivo behavior of a doxorubicin-conjugated polymer in Mdr1a/1b(-/-) mice. The area under the curve for intravenously administered polymer in Mdr1a/1b(-/-) mice was 2.2-fold greater than that in wild-type mice. The polymer was mostly distributed in the liver followed by spleen and less so in the brain, heart, kidney, and lung. The amount of polymer excreted in the urine was significantly decreased in Mdr1a/1b(-/-) mice. The amounts of polymers excreted in the feces were similar in both groups despite the higher systemic exposure in Mdr1a/1b(-/-) mice. Confocal microscopy images showed polymer localized in CD68(+) macrophages in the liver. These results show that knockout of ABCB1 prolonged systemic exposure of the doxorubicin-conjugated polymer in mice. Our results suggest that ABCB1 mediated the excretion of doxorubicin-conjugated polymer in urine and feces. Our results provide valuable information about the behavior of block copolymers in vivo, which is important for evaluating the pharmacokinetics of active substances conjugated to block copolymers or the accumulation of block copolymers in vivo.	[Sakai-Kato, Kumiko; Nanjo, Kunie; Goda, Yukihiro] Natl Inst Hlth Sci, Div Drugs, Setagaya Ku, Tokyo 1588501, Japan; [Kusuhara, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Bunkyo Ku, Tokyo 1130033, Japan; [Kataoka, Kazunori] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Nishiyama, Nobuhiro] Tokyo Inst Technol, Chem Resources Lab, Div Polymer Chem, Yokohama, Kanagawa 2268503, Japan; [Kawanishi, Toru; Okuda, Haruhiro] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan	Sakai-Kato, K (reprint author), Natl Inst Hlth Sci, Div Drugs, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	kumikato@nihs.go.jp			Public-Private Sector Joint Research on Publicly Essential Drugs from the Japan Health Sciences Foundation; Research on Development of New Drugs from Japan Agency for Medical Research and Development; AMED; JSPS KAKENHI [24590070]; Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan	This work was supported in part by the Public-Private Sector Joint Research on Publicly Essential Drugs from the Japan Health Sciences Foundation, Research on Development of New Drugs from Japan Agency for Medical Research and Development, AMED, JSPS KAKENHI (Grant Number 24590070), and Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan. We thank Nippon Kayaku Co. Ltd. for providing the doxorubicin-conjugated block copolymers and DBD-conjugated block copolymers, and Ms. M. Sakurai, Dr. K. Un and Dr. Y. Abe for assisting with the data acquisition.	Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003; Kabanov A, 2005, ADV GENET, V53, P231, DOI 10.1016/S0065-2660(05)53009-8; Sakai-Kato K, 2010, J CHROMATOGR B, V878, P1466, DOI 10.1016/j.jchromb.2010.03.040; Kodaira H, 2010, J PHARMACOL EXP THER, V333, P788, DOI 10.1124/jpet.109.162321; Longley CB, 2013, J PHARM SCI-US, V102, P2362, DOI 10.1002/jps.23506; Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006; Koizumi F, 2006, CANCER RES, V66, P10048, DOI 10.1158/0008-5472.CAN-06-1605; Uchino H, 2005, BRIT J CANCER, V93, P678, DOI 10.1038/sj.bjc.6602772; Nakanishi T, 2001, J CONTROL RELEASE, V74, P295, DOI 10.1016/S0168-3659(01)00341-8; Torchilin VP, 2002, ADV DRUG DELIVER REV, V54, P235, DOI 10.1016/S0169-409X(02)00019-4; Tanigawara Y, 2000, THER DRUG MONIT, V22, P137, DOI 10.1097/00007691-200002000-00029; Schinkel AH, 1998, INT J CLIN PHARM TH, V36, P9; Duncan R, 2011, MOL PHARMACEUT, V8, P2101, DOI 10.1021/mp200394t; Matsumura Y, 2014, JPN J CLIN ONCOL, V44, P515, DOI 10.1093/jjco/hyu046; CROOP JM, 1989, MOL CELL BIOL, V9, P1346; Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866; Cabral H, 2014, J CONTROL RELEASE, V190, P465, DOI 10.1016/j.jconrel.2014.06.042; [Anonymous], 2014, JOINT MHLW EMA REFLE; Hamaguchi T, 2005, BRIT J CANCER, V92, P1240, DOI 10.1038/sj.bjc.6602479; Takahashi A, 2010, CLIN CANCER RES, V16, P4822, DOI 10.1158/1078-0432.CCR-10-1467; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; LEVEILLEWEBSTER CR, 1995, J MEMBRANE BIOL, V143, P89; Bourzac K, 2012, NATURE, V491, pS58; Harada M, 2011, J CONTROL RELEASE, V156, P101, DOI 10.1016/j.jconrel.2011.06.024; HASHIDA M, 1990, J PHARMACOBIO-DYNAM, V13, P441; HORI R, 1993, J PHARMACOL EXP THER, V266, P1620; Kusuhara H, 1997, J PHARMACOL EXP THER, V283, P574; OKAMURA N, 1993, J PHARMACOL EXP THER, V266, P1614; Sakai-Kato K, 2014, BIOMATERIALS, V35, P1347, DOI 10.1016/j.biomaterials.2013.11.027; Sakai-Kato K, 2012, INT J PHARMACEUT, V423, P401, DOI 10.1016/j.ijpharm.2011.12.022; Sakai-Kato K, 2012, CHEM PHARM BULL, V60, P391; YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432	32	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	SEP	2015	12	9					3175	3183		10.1021/acs.molpharmaceut.5b00234		9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CR1LR	WOS:000361086800008		
J	Ohmine, K; Kawaguchi, K; Ohtsuki, S; Motoi, F; Ohtsuka, H; Kamiie, J; Abe, T; Unno, M; Terasaki, T				Ohmine, Ken; Kawaguchi, Kei; Ohtsuki, Sumio; Motoi, Fuyuhiko; Ohtsuka, Hideo; Kamiie, Junichi; Abe, Takaaki; Unno, Michiaki; Terasaki, Tetsuya			Quantitative Targeted Proteomics of Pancreatic Cancer: Deoxycytidine Kinase Protein Level Correlates to Progression-Free Survival of Patients Receiving Gemcitabine Treatment	MOLECULAR PHARMACEUTICS			English	Article						gemcitabine; drug resistance; pancreatic cancer; targeted proteomics; deoxycytidine kinase	EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-1; RIBONUCLEOTIDE REDUCTASE; ADJUVANT CHEMOTHERAPY; PEPTIDE SELECTION; CELLS; EXPRESSION; PHOSPHORYLATION; METABOLISM; RESISTANCE; 2,2-DIFLUORODEOXYCYTIDINE	The purpose of the present study is to identify the determinant(s) of gemcitabine (dFdC)-sensitivity in pancreatic cancer tissues of patients treated with dFdC alone and in pancreatic cancer cell lines exposed to dFdC in vitro. Protein expression levels of 12 enzymes and 13 transporters potentially involved in transport and metabolism of dFdC in pancreatic cancer cell lines and tissues were quantified by means of our LC-MS/MS-based quantitative targeted proteomics technology. Protein expression levels of deoxycytidine kinase (dCK), uridine monophosphate-cytidine monophosphate (UMP-CMP) kinase, cytosolic nucleotidase III (cN-III), and equilibrative nucleoside transporter 1 (ENT1) were significantly correlated with IC50 or 1/IC50 in five cell lines with different sensitivities to dFdC (p < 0.05). Expression levels of the selected proteins in pancreatic cancer tissues of 10 patients with different progression-free survival (PFS) (49-955 days) were quantified, and their relationship with PFS was examined. Only the protein expression level of dCK was significantly correlated with PFS < 0.05). Multiple regression analysis was also performed, and combinations of ENT1, UMP-CMP kinase, CTPS1, and dCK were highly correlated with PFS. Our results indicate that the protein expression level of dCK in pancreatic cancer tissue is a good predictor of PFS, and thus dCK may be the best biomarker of dFdC sensitivity in pancreatic cancer patients treated with dFdC, although other proteins would also contribute to dFdC-sensitivity at the cellular level in vivo and in vitro.	[Ohmine, Ken; Terasaki, Tetsuya] Tohoku Univ, Grad Sch Pharmaceut Sci, Membrane Transport & Drug Targeting Lab, Sendai, Miyagi 9808578, Japan; [Kawaguchi, Kei; Motoi, Fuyuhiko; Ohtsuka, Hideo; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg, Sendai, Miyagi 9808578, Japan; [Ohtsuki, Sumio] Kumamoto Univ, Fac Life Sci, Dept Pharmaceut Microbiol, Kumamoto, Japan; [Kamiie, Junichi] Azabu Univ, Sch Vet Med, Lab Vet Pathol, Sagamihara, Kanagawa, Japan; [Abe, Takaaki] Tohoku Univ, Grad Sch Med, Dept Clin Biol & Hormonal Regulat, Sendai, Miyagi 9808578, Japan	Terasaki, T (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Membrane Transport & Drug Targeting Lab, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	terasaki.tetsuya@m.tohoku.ac.jp			Japan Society for the Promotion of Science; Japan Science and Technology Agency; Industrial Technology Research Grant Program from the New Energy and the Industrial Technology Development Organization of Japan; Funding Program for Next Generation World-Leading Researchers by the Cabinet Office, Government of Japan	This study was supported in part by a Grant-in-Aid for JSPS Fellows, a Global COE Program from the Japan Society for the Promotion of Science, and a Grant for Development of Creative Technology Seeds Supporting Program for Creating University Ventures from Japan Science and Technology Agency. This study was also supported in part by the Industrial Technology Research Grant Program from the New Energy and the Industrial Technology Development Organization of Japan, and the Funding Program for Next Generation World-Leading Researchers by the Cabinet Office, Government of Japan.	Aksoy P, 2009, PHARMACOGENET GENOM, V19, P567, DOI 10.1097/FPC.0b013e32832c14b8; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; HEINEMANN V, 1995, SEMIN ONCOL, V22, P11; Wei CH, 2013, PANCREAS, V42, P1303, DOI 10.1097/MPA.0b013e3182a23ae4; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; HUANG P, 1991, CANCER RES, V51, P6110; Hunsucker SA, 2001, J BIOL CHEM, V276, P10498, DOI 10.1074/jbc.M011218200; Mackey JR, 1999, J NATL CANCER I, V91, P1876, DOI 10.1093/jnci/91.21.1876; Kamiie J, 2008, PHARM RES, V25, P1469, DOI 10.1007/s11095-008-9532-4; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Chimploy K, 2000, J BIOL CHEM, V275, P39267, DOI 10.1074/jbc.M006233200; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Marechal R, 2012, GASTROENTEROLOGY, V143, P664, DOI 10.1053/j.gastro.2012.06.006; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; Kawakami H, 2011, J PHARM SCI-US, V100, P341, DOI 10.1002/jps.22255; Van Rompay AR, 1999, MOL PHARMACOL, V56, P562; Matsuno S, 2004, PANCREAS, V28, P219, DOI 10.1097/00006676-200404000-00002; Rauchwerger DR, 2000, CANCER RES, V60, P6075; Brischwein K, 1997, EUR J BIOCHEM, V244, P286, DOI 10.1111/j.1432-1033.1997.00286.x; Fujita H, 2010, NEOPLASIA, V12, P807, DOI 10.1593/neo.10458; Giovannetti E, 2004, CLIN CANCER RES, V10, P2936, DOI 10.1158/1078-0432.CCR-03-0520; Giovannetti E, 2007, PHARMACOL RES, V55, P343, DOI 10.1016/j.phrs.2007.01.003; Gounaris Ioannis, 2010, JOP, V11, P113; HEINEMANN V, 1988, CANCER RES, V48, P4024; KAWASAKI H, 1991, CANCER INVEST, V9, P409, DOI 10.3109/07357909109084638; Lotfi K, 2006, BIOCHEM PHARMACOL, V71, P882, DOI 10.1016/j.bcp.2005.12.007; Marce S, 2006, HAEMATOL-HEMATOL J, V91, P895; Mori R, 2007, ONCOL REP, V17, P1201; Nakai Y, 2010, JPN J CLIN ONCOL, V40, P774, DOI 10.1093/jjco/hyq059; Ohmine K, 2012, PHARM RES-DORDR, V29, P2006, DOI 10.1007/s11095-012-0728-2; Saiki Y, 2012, BIOCHEM BIOPH RES CO, V421, P98, DOI 10.1016/j.bbrc.2012.03.122; RANNIGER K, 1966, RADIOLOGY, V86, P470; SPASOKOUKOTSKAJA T, 1995, EUR J CANCER, V31A, P202, DOI 10.1016/0959-8049(94)00435-8; Takadate Tatsuyuki, 2012, Clin Proteomics, V9, P8, DOI 10.1186/1559-0275-9-8; Trouilloud I, 2011, CLIN RES HEPATOL GAS, V35, P364, DOI 10.1016/j.clinre.2011.02.002; Tsujie M, 2007, ANTICANCER RES, V27, P2241; Tsujie M, 2006, PANCREAS, V33, P142, DOI 10.1097/01.mpa.0000226882.48204.26; Van Bree C, 2009, INT J ONCOL, V34, P813, DOI 10.3892/ijo_00000207	39	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	SEP	2015	12	9					3282	3291		10.1021/acs.molpharmaceut.5b00282		10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CR1LR	WOS:000361086800018		
J	Tsukamoto, Y; Iwasaki, K; Okuzumi, S; Machida, MN; Inutsuka, S				Tsukamoto, Y.; Iwasaki, K.; Okuzumi, S.; Machida, M. N.; Inutsuka, S.			Effects of Ohmic and ambipolar diffusion on formation and evolution of first cores, protostars, and circumstellar discs	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						MHD; methods: numerical; protoplanetary discs; stars: formation	SMOOTHED PARTICLE MAGNETOHYDRODYNAMICS; MOLECULAR CLOUD CORES; PROTOSTELLAR COLLAPSE; RADIATIVE-TRANSFER; STELLAR DENSITIES; MAGNETIC BRAKING; PROTOPLANETARY DISKS; 2ND COLLAPSE; HYDRODYNAMICS; SIMULATIONS	We investigate the formation and evolution of a first core, protostar, and circumstellar disc with a three-dimensional non-ideal (including both Ohmic and ambipolar diffusion) radiation magnetohydrodynamics simulation. We found that the magnetic flux is largely removed by magnetic diffusion in the first-core phase and that the plasma beta of the centre of the first core becomes large, beta > 10(4). Thus, proper treatment of first-core phase is crucial in investigating the formation of protostar and disc. On the other hand, in an ideal simulation, beta similar to 10 at the centre of the first core. The simulations with magnetic diffusion show that the circumstellar disc forms at almost the same time of protostar formation even with a relatively strong initial magnetic field (the value for the initial mass-to-flux ratio of the cloud core relative to the critical value is mu = 4). The disc has a radius of r similar to 1 AU at the protostar formation epoch. We confirm that the disc is rotationally supported. We also show that the disc is massive (Q similar to 1) and that gravitational instability may play an important role in the subsequent disc evolution.	[Tsukamoto, Y.] RIKEN, Lab Computat Astrophys, Saitama, Japan; [Iwasaki, K.; Inutsuka, S.] Nagoya Univ, Dept Phys, Aichi, Japan; [Iwasaki, K.] Doshisha Univ, Fac Sci & Engn, Dept Environm Syst Sci, Kyoto 602, Japan; [Okuzumi, S.] Tokyo Inst Technol, Dept Earth & Planetary Sci, Tokyo 152, Japan; [Machida, M. N.] Kyushu Univ, Dept Earth & Planetary Sci, Fukuoka 812, Japan	Tsukamoto, Y (reprint author), RIKEN, Lab Computat Astrophys, Saitama, Japan.	yusuke.tsukamoto@riken.jp			JSPS	We thank Dr. K. Tomida, Dr. T. Matsumoto, and Dr. D. Stamatellos for their fruitful discussions. We also thank Dr. K. Tomida and Dr. Y. Hori to provide their EOS table to us. We also thank anonymous referee for helpful comments. The computations were performed on a parallel computer, XC30 system at CfCA of NAOJ. YT and KI are financially supported by Research Fellowships of JSPS for Young Scientists.	Alexiades V., 1996, COM NUM METH ENG, V12, P12; Nakano T, 2002, ASTROPHYS J, V573, P199, DOI 10.1086/340587; Matsumoto T, 2004, ASTROPHYS J, V616, P266, DOI 10.1086/424897; Iwasaki K, 2013, ASTR SOC P, V474, P239; Mellon RR, 2008, ASTROPHYS J, V681, P1356, DOI 10.1086/587542; Wardle M, 1999, MON NOT R ASTRON SOC, V303, P239, DOI 10.1046/j.1365-8711.1999.02211.x; Machida MN, 2011, PUBL ASTRON SOC JPN, V63, P555; Heiles C, 2005, ASTROPHYS J, V624, P773, DOI 10.1086/428896; Troland TH, 2008, ASTROPHYS J, V680, P457, DOI 10.1086/587546; Inutsuka S, 2010, ASTROPHYS J LETT, V718, pL58, DOI 10.1088/2041-8205/718/2/L58; Semenov D, 2003, ASTRON ASTROPHYS, V410, P611, DOI 10.1051/0004-6361:20031279; Tsukamoto Y, 2011, MON NOT R ASTRON SOC, V416, P591, DOI 10.1111/j.1365-2966.2011.19081.x; Masunaga H, 2000, ASTROPHYS J, V531, P350, DOI 10.1086/308439; Machida MN, 2014, MON NOT R ASTRON SOC, V438, P2278, DOI 10.1093/mnras/stt2343; BARNES J, 1986, NATURE, V324, P446, DOI 10.1038/324446a0; Machida MN, 2007, ASTROPHYS J, V670, P1198, DOI 10.1086/521779; Tsukamoto Y, 2013, MON NOT R ASTRON SOC, V428, P1321, DOI 10.1093/mnras/sts111; MOUSCHOVIAS TC, 1979, ASTROPHYS J, V230, P204, DOI 10.1086/157077; Ferguson JW, 2005, ASTROPHYS J, V623, P585, DOI 10.1086/428642; MOUSCHOVIAS TC, 1976, ASTROPHYS J, V210, P326, DOI 10.1086/154835; Whitehouse SC, 2004, MON NOT R ASTRON SOC, V353, P1078, DOI 10.1111/j.1365-2966.2004.08131.x; Bate MR, 2010, MON NOT R ASTRON SOC, V404, pL79, DOI 10.1111/j.1745-3933.2010.00839.x; Bate MR, 2014, MON NOT R ASTRON SOC, V437, P77, DOI 10.1093/mnras/stt1865; Bate MR, 2011, MON NOT R ASTRON SOC, V417, P2036, DOI 10.1111/j.1365-2966.2011.19386.x; Bate MR, 1998, ASTROPHYS J, V508, pL95, DOI 10.1086/311719; Dapp WB, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201117876; Hennebelle P, 2008, ASTRON ASTROPHYS, V477, P9, DOI 10.1051/0004-6361:20078309; Iwasaki K, 2011, MON NOT R ASTRON SOC, V418, P1668, DOI 10.1111/j.1365-2966.2011.19588.x; Joos M, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201118730; LARSON RB, 1969, MON NOT R ASTRON SOC, V145, P271; Laughlin G, 1998, ASTROPHYS J, V504, P945, DOI 10.1086/306117; Li ZY, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/180; Machida MN, 2011, MON NOT R ASTRON SOC, V413, P2767, DOI 10.1111/j.1365-2966.2011.18349.x; Machida MN, 2008, ASTROPHYS J, V676, P1088, DOI 10.1086/528364; Okuzumi S, 2009, ASTROPHYS J, V698, P1122, DOI 10.1088/0004-637X/698/2/1122; Price DJ, 2012, MON NOT R ASTRON SOC, V423, pL45, DOI 10.1111/j.1745-3933.2012.01254.x; Tomida K, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/117; Tomida K, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/6; Tomisaka K, 2002, ASTROPHYS J, V575, P306, DOI 10.1086/341133; Tsukamoto Y, 2015, MON NOT R ASTRON SOC, V446, P1175, DOI 10.1093/mnras/stu2160; Tsukamoto Y, 2013, MON NOT R ASTRON SOC, V434, P2593, DOI 10.1093/mnras/stt1205; Tsukamoto Y, 2013, MON NOT R ASTRON SOC, V436, P1667, DOI 10.1093/mnras/stt1684; Vaytet N, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321423; Vaytet N, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201219427; Wardle M, 2007, ASTROPHYS SPACE SCI, V311, P35, DOI 10.1007/s10509-007-9575-8; Whitehouse SC, 2005, MON NOT R ASTRON SOC, V364, P1367, DOI 10.1111/j.1365-2966.2005.09683.x; Whitehouse SC, 2006, MON NOT R ASTRON SOC, V367, P32, DOI 10.1111/j.1365-2966.2005.09950.x; Wurster J, 2014, MON NOT R ASTRON SOC, V444, P1104, DOI 10.1093/mnras/stu1524	48	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	SEP 1	2015	452	1					278	288		10.1093/mnras/stv1290		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CQ8IP	WOS:000360851100021		
J	Bonato, M; Negrello, M; Cai, ZY; De Zotti, G; Bressan, A; Wada, T; Kohno, K; Maiolino, R; Gruppioni, C; Pozzi, F; Lapi, A				Bonato, M.; Negrello, M.; Cai, Z. -Y.; De Zotti, G.; Bressan, A.; Wada, T.; Kohno, K.; Maiolino, R.; Gruppioni, C.; Pozzi, F.; Lapi, A.			Predictions for surveys with the SPICA Mid-infrared Instrument	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						galaxies: active; galaxies: evolution; galaxies: starburst; infrared: galaxies	ACTIVE GALACTIC NUCLEI; ULTRALUMINOUS INFRARED GALAXIES; HIGH-RESOLUTION SPECTROSCOPY; SPECTRAL ENERGY-DISTRIBUTION; EMISSION-LINE DIAGNOSTICS; BLACK-HOLE ACCRETION; 24 MU-M; STARBURST GALAXIES; STAR-FORMATION; LUMINOSITY FUNCTIONS	We present predictions for number counts and redshift distributions of galaxies detectable in continuum and in emission lines with the Mid-infrared (MIR) Instrument (SMI) proposed for the Space Infrared Telescope for Cosmology and Astrophysics. We have considered 24 MIR fine-structure lines, four polycyclic aromatic hydrocarbon bands (at 6.2, 7.7, 8.6 and 11.3 mu m) and two silicate bands (in emission and in absorption) at 9.7 and 18.0 mu m. Six of these lines are primarily associated with active galactic nuclei (AGNs), the others with star formation. A survey with the SMI spectrometers of 1-h integration per field of view (FoV) over an area of 1 deg(2) will yield 5 sigma detections of similar or equal to 140 AGN lines and of similar or equal to 5.2 x 10(4) star-forming galaxies, similar or equal to 1.6 x 10(4) of which will be detected in at least two lines. The combination of a shallow (20.0 deg(2), 1.4 x 10(-1) h integration per FoV) and a deep survey (6.9 x 10(-3) deg(2), 635 h integration time), with the SMI camera, for a total of similar to 1000 h, will accurately determine the MIR number counts of galaxies and of AGNs over five orders of magnitude in flux density, reaching values more than one order of magnitude fainter than the deepest Spitzer 24 mu m surveys. This will allow us to determine the cosmic star formation rate (SFR) function down to SFRs more than 100 times fainter than reached by the Herschel Observatory.	[Bonato, M.] Univ Padua, Dipartimento Fis & Astronom G Galilei, I-35122 Padua, Italy; [Bonato, M.; Negrello, M.; De Zotti, G.] INAF, Osservatorio Astronom Padova, I-35122 Padua, Italy; [Cai, Z. -Y.] Univ Sci & Technol China, Dept Astron, CAS Key Lab Res Galaxies & Cosmol, Hefei 230026, Anhui, Peoples R China; [De Zotti, G.; Bressan, A.; Lapi, A.] SISSA, I-34136 Trieste, Italy; [Wada, T.] JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Kohno, K.] Univ Tokyo, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Kohno, K.] Univ Tokyo, Res Ctr Early Univ WPI, Bunkyo Ku, Tokyo 1130033, Japan; [Maiolino, R.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Maiolino, R.] Univ Cambridge, Kavli Inst Cosmol, Cambridge CB3 0HA, England; [Gruppioni, C.] INAF, Osservatorio Astronom Bologna, I-40127 Bologna, Italy; [Pozzi, F.] Univ Bologna, Dipartimento Fis & Astron, I-40127 Bologna, Italy; [Lapi, A.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy	Bonato, M (reprint author), Univ Padua, Dipartimento Fis & Astronom G Galilei, Vicolo Osservatorio 3, I-35122 Padua, Italy.	matteo.bonato@oapd.inaf.it		Cai, Zhen-Yi/0000-0002-4223-2198; Gruppioni, Carlotta/0000-0002-5836-4056; De Zotti, Gianfranco/0000-0003-2868-2595	ASI/INAF [2014-024-R.0]; PRIN INAF; China Postdoctoral Science Foundation [2014M560515]	We acknowledge financial support from ASI/INAF Agreement 2014-024-R.0 for the Planck LFI activity of Phase E2 and from PRIN INAF 2012, project 'Looking into the dust-obscured phase of galaxy formation through cosmic zoom lenses in the Herschel Astrophysical Large Area Survey'. Z-YC is supported by the China Postdoctoral Science Foundation grant no. 2014M560515.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Imanishi M, 2007, ASTROPHYS J SUPPL S, V171, P72, DOI 10.1086/513715; Veilleux S, 2009, ASTROPHYS J SUPPL S, V182, P628, DOI 10.1088/0067-0049/182/2/628; Silk J, 2012, RES ASTRON ASTROPHYS, V12, P917, DOI 10.1088/1674-4527/12/8/004; Spoon HWW, 2007, ASTROPHYS J, V654, pL49, DOI 10.1086/511268; Bonato M, 2014, MON NOT R ASTRON SOC, V438, P2547, DOI 10.1093/mnras/stt2375; Brown MJI, 2006, ASTROPHYS J, V638, P88, DOI 10.1086/498843; Papovich C, 2004, ASTROPHYS J SUPPL S, V154, P70, DOI 10.1086/422880; SPINOGLIO L, 1992, ASTROPHYS J, V399, P504, DOI 10.1086/171943; De Zotti G, 2010, ASTRON ASTROPHYS REV, V18, P1, DOI 10.1007/s00159-009-0026-0; Spinoglio L, 2005, ASTROPHYS J, V623, P123, DOI 10.1086/428495; Bernardi M, 2010, MON NOT R ASTRON SOC, V404, P2087, DOI 10.1111/j.1365-2966.2010.16425.x; Bianchi S, 2012, ADV ASTRON, DOI 10.1155/2012/782030; Lapi A, 2006, ASTROPHYS J, V650, P42, DOI 10.1086/507122; Clements DL, 2011, MON NOT R ASTRON SOC, V411, P373, DOI 10.1111/j.1365-2966.2010.17689.x; Granato GL, 2004, ASTROPHYS J, V600, P580, DOI 10.1086/379875; Tommasin S, 2008, ASTROPHYS J, V676, P836, DOI 10.1086/527290; Negrello M, 2014, MON NOT R ASTRON SOC, V440, P1999, DOI 10.1093/mnras/stu413; Groves BA, 2004, ASTROPHYS J SUPPL S, V153, P75, DOI 10.1086/421114; Sanders DB, 2003, ASTRON J, V126, P1607, DOI 10.1086/376841; Tommasin S, 2010, ASTROPHYS J, V709, P1257, DOI 10.1088/0004-637X/709/2/1257; Sturm E, 2002, ASTRON ASTROPHYS, V393, P821, DOI 10.1051/0004-6361:20021043; Bock JJ, 2000, ASTRON J, V120, P2904, DOI 10.1086/316871; Negrello M, 2010, SCIENCE, V330, P800, DOI 10.1126/science.1193420; Vieira JD, 2013, NATURE, V495, P344, DOI 10.1038/nature12001; Bernard-Salas J, 2009, ASTROPHYS J SUPPL S, V184, P230, DOI 10.1088/0067-0049/184/2/230; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Imanishi M, 2010, ASTROPHYS J, V709, P801, DOI 10.1088/0004-637X/709/2/801; Groves B, 2008, ASTROPHYS J SUPPL S, V176, P438, DOI 10.1086/528711; Bethermin M., 2010, ASTRON ASTROPHYS, V512, pA78; Bonato M, 2014, MON NOT R ASTRON SOC, V444, P3446, DOI 10.1093/mnras/stu1657; Brandt WN, 2015, ASTRON ASTROPHYS REV, V23, DOI 10.1007/s00159-014-0081-z; Cai ZY, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/21; Chen CTJ, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/3; Croom SM, 2009, MON NOT R ASTRON SOC, V399, P1755, DOI 10.1111/j.1365-2966.2009.15398.x; Dopita MA, 2006, ASTROPHYS J SUPPL S, V167, P177, DOI 10.1086/508261; Fang F, 2008, ASTR SOC P, V381, P225; Schreiber NMF, 2006, ASTROPHYS J, V645, P1062; Gallimore JF, 2010, ASTROPHYS J SUPPL S, V187, P172, DOI 10.1088/0067-0049/187/1/172; Gruppioni C, 2013, MON NOT R ASTRON SOC, V432, P23, DOI 10.1093/mnras/stt308; Hasinger G, 2008, ASTRON ASTROPHYS, V490, P905, DOI 10.1051/0004-6361:200809839; Imanishi M, 2009, ASTROPHYS J, V694, P751, DOI 10.1088/0004-637X/694/2/751; Kataza H, 2012, PROC SPIE, V8442, DOI 10.1117/12.926082; Lapi A, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/24; Le Floc'h E, 2009, ASTROPHYS J, V703, P222, DOI 10.1088/0004-637X/703/1/222; Magnelli B, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/200913941; Peebles P. J. E, 1980, LARGE SCALE STRUCTUR; Roelfsema P., 2012, SPIE, V8442; RUBIN RH, 1989, ASTROPHYS J SUPPL S, V69, P897, DOI 10.1086/191330; Shupe DL, 2008, ASTRON J, V135, P1050, DOI 10.1088/0004-6256/135/3/1050; Stierwalt S, 2013, ASTROPHYS J SUPPL S, V206, DOI 10.1088/0067-0049/206/1/1; Takagi T, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117759; Treister E, 2006, ASTROPHYS J, V640, P603, DOI 10.1086/500237; VOIT GM, 1992, ASTROPHYS J, V399, P495, DOI 10.1086/171942; Willett KW, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/1/18	55	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	SEP 1	2015	452	1					356	367		10.1093/mnras/stv1316		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CQ8IP	WOS:000360851100027		
J	Warren, DC; Ellison, DC; Bykov, AM; Lee, SH				Warren, Donald C.; Ellison, Donald C.; Bykov, Andrei M.; Lee, Shiu-Hang			Electron and ion acceleration in relativistic shocks with applications to GRB afterglows	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						acceleration of particles; MHD; shock waves; turbulence; gamma-ray burst: general; cosmic rays	GAMMA-RAY BURST; NONLINEAR PARTICLE-ACCELERATION; GALACTIC COSMIC-RAYS; MAGNETIC-FIELD AMPLIFICATION; MONTE-CARLO SIMULATIONS; COLLISIONLESS SHOCKS; SUPERNOVA-REMNANTS; ELECTROMAGNETIC INSTABILITIES; ULTRARELATIVISTIC SHOCKS; MAXIMUM ENERGY	We have modelled the simultaneous first-order Fermi shock acceleration of protons, electrons, and helium nuclei by relativistic shocks. By parametrizing the particle diffusion, our steady-state Monte Carlo simulation allows us to follow particles from particle injection at non-relativistic thermal energies to above PeV energies, including the non-linear smoothing of the shock structure due to cosmic ray (CR) backpressure. We observe the mass-to-charge (A/Z) enhancement effect believed to occur in efficient Fermi acceleration in non-relativistic shocks and we parametrize the transfer of ion energy to electrons seen in particle-in-cell (PIC) simulations. For a given set of environmental and model parameters, the Monte Carlo simulation determines the absolute normalization of the particle distributions and the resulting synchrotron, inverse Compton, and pion-decay emission in a largely self-consistent manner. The simulation is flexible and can be readily used with a wide range of parameters typical of gamma-ray burst (GRB) afterglows. We describe some preliminary results for photon emission from shocks of different Lorentz factors and outline how the Monte Carlo simulation can be generalized and coupled to hydrodynamic simulations of GRB blast waves. We assume Bohm diffusion for simplicity but emphasize that the non-linear effects we describe stem mainly from an extended shock precursor where higher energy particles diffuse further upstream. Quantitative differences will occur with different diffusion models, particularly for the maximum CR energy and photon emission, but these non-linear effects should be qualitatively similar as long as the scattering mean-free path is an increasing function of momentum.	[Warren, Donald C.] RIKEN, Astrophys Big Bang Lab, Saitama 3510198, Japan; [Ellison, Donald C.] N Carolina State Univ, Phys Dept, Raleigh, NC 27695 USA; [Bykov, Andrei M.] Ioffe Inst Phys & Technol, St Petersburg 194021, Russia; [Bykov, Andrei M.] ISSI, CH-3012 Bern, Switzerland; [Bykov, Andrei M.] St Petersburg Polytech Univ, St Petersburg, Russia; [Lee, Shiu-Hang] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan	Warren, DC (reprint author), RIKEN, Astrophys Big Bang Lab, Saitama 3510198, Japan.	donald.warren@riken.jp; don_ellison@ncsu.edu; ambykov@yahoo.com	Bykov, Andrei/E-3131-2014		NASA [NNX11AE03G]; RAS Presidium Programm; RAS OFN Programm [15]; JAXA International Top Young Fellowship	The authors acknowledge useful comments by an anonymous referee and wish to thank Hirotaka Ito, John Kirk, Davide Lazzati, Martin Lemoine, Guy Pelletier, Steve Reynolds, and Lorenzo Sironi for helpful discussions. DCE and DCW acknowledge support from NASA grant NNX11AE03G. AMB was partially supported by the RAS Presidium Programm and the RAS OFN Programm n15. S-HL acknowledges support from a JAXA International Top Young Fellowship. DCE and S-HL wish to thank the International Space Science Institute (ISSI) in Bern where part of this work was done.	Ackermann M, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/71; Ellison DC, 2004, ASTROPART PHYS, V22, P323, DOI 10.1016/j.astropartphys.2004.08.005; Kulkarni SR, 1999, NATURE, V398, P389, DOI 10.1038/18821; Soderberg AM, 2010, NATURE, V463, P513, DOI 10.1038/nature08714; Achterberg A, 2001, MON NOT R ASTRON SOC, V328, P393, DOI 10.1046/j.1365-8711.2001.04851.x; Lemoine M, 2003, ASTROPHYS J, V589, pL73, DOI 10.1086/376353; Bykov A, 2012, SPACE SCI REV, V173, P309, DOI 10.1007/s11214-012-9896-y; Kato TN, 2007, ASTROPHYS J, V668, P974, DOI 10.1086/521297; Ellison DC, 2002, ASTROPART PHYS, V18, P213, DOI 10.1016/S0927-6505(02)00142-1; ELLISON DC, 1990, ASTROPHYS J, V352, P376, DOI 10.1086/168544; JONES FC, 1968, PHYS REV, V167, P1159, DOI 10.1103/PhysRev.167.1159; Piran T, 2001, ASTROPHYS J, V560, pL167, DOI 10.1086/324409; Kirk JG, 2000, ASTROPHYS J, V542, P235, DOI 10.1086/309533; Reville B, 2014, MON NOT R ASTRON SOC, V439, P2050, DOI 10.1093/mnras/stu088; Baring MG, 1999, ASTROPHYS J, V513, P311, DOI 10.1086/306829; Kirk JG, 2010, ASTROPHYS J LETT, V710, pL16, DOI 10.1088/2041-8205/710/1/L16; Keshet U, 2009, ASTROPHYS J LETT, V693, pL127, DOI 10.1088/0004-637X/693/2/L127; Double GP, 2004, ASTROPHYS J, V600, P485, DOI 10.1086/379702; Bednarz J, 1998, PHYS REV LETT, V80, P3911, DOI 10.1103/PhysRevLett.80.3911; Stockem A, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/68; Casse F, 2013, MON NOT R ASTRON SOC, V433, P940, DOI 10.1093/mnras/stt772; Sironi L, 2015, MON NOT R ASTRON SOC, V450, P183, DOI 10.1093/mnras/stv641; Lemoine M, 2011, MON NOT R ASTRON SOC, V417, P1148, DOI 10.1111/j.1365-2966.2011.19331.x; Haugbolle T, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L42; McKinney JC, 2012, MON NOT R ASTRON SOC, V419, P573, DOI 10.1111/j.1365-2966.2011.19721.x; ELLISON DC, 1984, ASTROPHYS J, V286, P691, DOI 10.1086/162644; Sironi L, 2009, ASTROPHYS J, V698, P1523, DOI 10.1088/0004-637X/698/2/1523; JONES FC, 1991, SPACE SCI REV, V58, P259, DOI 10.1007/BF01206003; Meszaros P, 2006, REP PROG PHYS, V69, P2259, DOI 10.1088/0034-4885/69/8/R01; Berezhko EG, 1999, ASTROPHYS J, V526, P385, DOI 10.1086/307993; Plotnikov I, 2013, MON NOT R ASTRON SOC, V430, P1280, DOI 10.1093/mnras/sts696; Lemoine M, 2010, MON NOT R ASTRON SOC, V402, P321, DOI 10.1111/j.1365-2966.2009.15869.x; Kamae T, 2006, ASTROPHYS J, V647, P692, DOI 10.1086/505189; HOSHINO M, 1992, ASTROPHYS J, V390, P454, DOI 10.1086/171296; Keshet U, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111102; Baring MG, 1997, ASTROPHYS J, V476, P889, DOI 10.1086/303645; Bell AR, 2004, MON NOT R ASTRON SOC, V353, P550, DOI 10.1111/j.1365-2966.2004.08097.x; Binns WR, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/18; Bykov AM, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/137; Bykov AM, 2011, ASTRON ASTROPHYS REV, V19, DOI 10.1007/s00159-011-0042-8; Chakraborti S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1178; EICHLER D, 1984, ASTROPHYS J, V277, P429, DOI 10.1086/161711; Ellison DC, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/46; Ellison DC, 1997, ASTROPHYS J, V487, P197, DOI 10.1086/304580; Ellison DC, 1996, ASTROPHYS J, V473, P1029, DOI 10.1086/178213; ELLISON DC, 1981, J GEOPHYS-Z GEOPHYS, V50, P110; Gedalin M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026403; JOKIPII JR, 1971, REV GEOPHYS SPACE GE, V9, P27, DOI 10.1029/RG009i001p00027; Kamae T, 2007, ASTROPHYS J, V662, P779, DOI 10.1086/513602; Kelner SR, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.039901; Kumar P., 2015, PHYS REP, V506, P1; Kumar R, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/165; Lemoine M, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/55001; LEVINSON A, 1992, ASTROPHYS J, V401, P73, DOI 10.1086/172039; Meyer JP, 1997, ASTROPHYS J, V487, P182, DOI 10.1086/304599; Meyer JP, 1999, ASTR SOC P, V171, P187; Niemiec J, 2006, ASTROPHYS J, V641, P984, DOI 10.1086/500541; Nishikawa KI, 2007, ASTROPHYS SPACE SCI, V307, P319, DOI 10.1007/s10509-006-9234-5; Nishikawa KI, 2006, ASTROPHYS J, V642, P1267, DOI 10.1086/501426; Nishikawa KI, 2011, ADV SPACE RES, V47, P1434, DOI 10.1016/j.asr.2011.01.032; Orlando S, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015505; Piran T, 2004, REV MOD PHYS, V76, P1143, DOI 10.1103/RevModPhys.76.1143; Plotnikov I, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201117182; Rauch BF, 2010, ASTROPHYS J, V722, P970, DOI 10.1088/0004-637X/722/1/970; Rybicki G. B., 1979, RAD PROCESSES ASTROP; Sagi E, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/80; Schlickeiser R., 2015, ARXIV150304737; Sironi L, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/75; Sironi L, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/54; Summerlin EJ, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/63; Vladimirov AE, 2008, ASTROPHYS J, V688, P1084, DOI 10.1086/592240; Vladimirov AE, 2009, ASTROPHYS J LETT, V703, pL29, DOI 10.1088/0004-637X/703/1/L29; Warren D. C., 2015, THESIS N CAROLINA ST	73	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	SEP 1	2015	452	1					431	443		10.1093/mnras/stv1304		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CQ8IP	WOS:000360851100032		
J	Riguccini, L; Le Floc'h, E; Mullaney, JR; Menendez-Delmestre, K; Aussel, H; Berta, S; Calanog, J; Capak, P; Cooray, A; Ilbert, O; Kartaltepe, J; Koekemoer, A; Lutz, D; Magnelli, B; McCracken, H; Oliver, S; Roseboom, I; Salvato, M; Sanders, D; Scoville, N; Taniguchi, Y; Treister, E				Riguccini, L.; Le Floc'h, E.; Mullaney, J. R.; Menendez-Delmestre, K.; Aussel, H.; Berta, S.; Calanog, J.; Capak, P.; Cooray, A.; Ilbert, O.; Kartaltepe, J.; Koekemoer, A.; Lutz, D.; Magnelli, B.; McCracken, H.; Oliver, S.; Roseboom, I.; Salvato, M.; Sanders, D.; Scoville, N.; Taniguchi, Y.; Treister, E.			The composite nature of Dust-Obscured Galaxies (DOGs) at z similar to 2-3 in the COSMOS field - I. A far-infrared view	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						galaxies: high-redshift; cosmology: observations; infrared: galaxies	SPECTRAL ENERGY-DISTRIBUTIONS; ACTIVE GALACTIC NUCLEI; STAR-FORMING GALAXIES; SPITZER-SPACE-TELESCOPE; MULTIWAVELENGTH PROPERTIES; MASSIVE GALAXIES; GOODS-HERSCHEL; SOURCE CATALOG; REDSHIFT; EVOLUTION	Dust-Obscured Galaxies (DOGs) are bright 24 mu m-selected sources with extreme obscuration at optical wavelengths. They are typically characterized by a rising power-law continuum of hot dust (T-D similar to 200-1000 K) in the near-IR indicating that theirmid-IR luminosity is dominated by an active galactic nucleus (AGN). DOGs with a fainter 24 mu m flux display a stellar bump in the near-IR and their mid-IR luminosity appears to be mainly powered by dusty star formation. Alternatively, it may be that the mid-IR emission arising from AGN activity is dominant but the torus is sufficiently opaque to make the near-IR emission from the AGN negligible with respect to the emission from the host component. In an effort to characterize the astrophysical nature of the processes responsible for the IR emission in DOGs, this paper exploits Herschel data (PACS + SPIRE) on a sample of 95 DOGs within the COSMOS field. We derive a wealth of far-IR properties (e.g. total IR luminosities; mid-to-far-IR colours; dust temperatures and masses) based on spectral energy distribution fitting. Of particular interest are the 24 mu m-bright DOGs (F-24 mu m > 1 mJy). They present bluer far-IR/mid-IR colours than the rest of the sample, unveiling the potential presence of an AGN. The AGN contribution to the total 8-1000 mu m flux increases as a function of the rest-frame 8 mu m-luminosity irrespective of the redshift. This confirms that faint DOGs (L-8 mu m < 10(12) L-circle dot) are dominated by star formation while brighter DOGs show a larger contribution from an AGN.	[Riguccini, L.; Menendez-Delmestre, K.] Univ Fed Rio de Janeiro, Observ Valongo, BR-20080090 Rio De Janeiro, RJ, Brazil; [Le Floc'h, E.; Aussel, H.] CEA DSM CNRS Univ Paris Diderot, Lab AIM, IRFU Serv Astrophys, F-91191 Gif Sur Yvette, France; [Mullaney, J. R.] Univ Sheffield, Dep Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Berta, S.; Lutz, D.; Magnelli, B.] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Calanog, J.; Cooray, A.] Univ Calif Irvine, Ctr Cosmol, Dept Phys & Astron, Irvine, CA 92697 USA; [Capak, P.] Spitzer Sci Ctr, Pasadena, CA 91125 USA; [Ilbert, O.] Lab Astrophys Marseille, F-13376 Marseille 12, France; [Kartaltepe, J.] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Koekemoer, A.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [McCracken, H.] Univ Paris 06, Inst Astrophys Paris, CNRS, UMR7095, F-75014 Paris, France; [Oliver, S.] Univ Sussex, Astron Ctr, Dept Phys & Astron, Brighton BN1 9QH, E Sussex, England; [Roseboom, I.] Univ Edinburgh, Inst Astron, Royal Observ, Edinburgh EH9 3HJ, Midlothian, Scotland; [Salvato, M.] Max Planck Inst Plasma Phys, D-85748 Garching, Germany; [Sanders, D.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Scoville, N.] CALTECH, Pasadena, CA 91125 USA; [Taniguchi, Y.] Ehime Univ, Res Ctr Space & Cosm Evolut, Matsuyama, Ehime 7908577, Japan; [Treister, E.] Univ Concepcion, Dept Astron, Concepcion, Chile	Riguccini, L (reprint author), Univ Fed Rio de Janeiro, Observ Valongo, Ladeira Pedro Antonio 43, BR-20080090 Rio De Janeiro, RJ, Brazil.	riguccini@astro.ufrj.br			NASA [NAS 5-26555]; ESA Member States; NASA; European Southern Observatory, Chile; Kitt Peak National Observatory; Cerro Tololo Inter-American Observatory; National Optical Astronomy Observatory; BMVIT (Austria); ESA-PRODEX (Belgium); CEA/CNES (France); DLR (Germany); ASI/INAF (Italy); CICYT/MCYT (Spain); CSA (Canada); NAOC (China); CEA (France); CNES (France); CNRS (France); ASI (Italy); MCINN (Spain); SNSB (Sweden); STFC (UK); UKSA (UK); NASA (USA)	COSMOS is based on observations with the NASA/ESA HST, obtained at the Space Telescope Science Institute, which is operated by AURA, Inc., under NASA contract NAS 5-26555; also based on data collected at: the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan; XMM-Newton, an ESA science mission with instruments and contributions directly funded by ESA Member States and NASA; the European Southern Observatory, Chile; Kitt Peak National Observatory, Cerro Tololo Inter-American Observatory, and the National Optical Astronomy Observatory, which are operated by the Association of Universities for Research in Astronomy (AURA), Inc., under cooperative agreement with the National Science Foundation; the National Radio Astronomy Observatory, which is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc; and the Canada-France-Hawaii Telescope, operated by the National Research Council of Canada, the Centre National de la Recherche Scientifique de France, and the University of Hawaii.; PACS has been developed by a consortium of institutes led by MPE (Germany) and including UVIE (Austria); KU Leuven, CSL, IMEC (Belgium); CEA, LAM (France); MPIA (Germany); INAF-IFSI/OAA/OAP/OAT, LENS, SISSA (Italy); IAC (Spain). This development has been supported by the funding agencies BMVIT (Austria), ESA-PRODEX (Belgium), CEA/CNES (France), DLR (Germany), ASI/INAF (Italy), and CICYT/MCYT (Spain).; SPIRE has been developed by a consortium of institutes led by Cardiff University (UK) and including University of Lethbridge (Canada), NAOC (China), CEA, LAM (France), IFSI, University of Padua (Italy), IAC (Spain), Stockholm Observatory (Sweden), Imperial College London, RAL, UCL-MSSL, UKATC, University of Sussex (UK), Caltech, JPL, NHSC, University of Colorado (USA). This development has been supported by national funding agencies: CSA (Canada); NAOC (China); CEA, CNES, CNRS (France); ASI (Italy); MCINN (Spain); SNSB (Sweden); STFC, UKSA (UK) and NASA (USA). SPIRE has been developed by a consortium of institutes led by Cardiff Univ. (UK) and including Univ. Lethbridge (Canada); NAOC (China); CEA, LAM (France); IFSI, Univ. Padua (Italy); IAC (Spain); Stockholm Observatory (Sweden); Imperial College London, RAL, UCL-MSSL, UKATC, Univ. Sussex (UK); Caltech, JPL, NHSC, Univ. Colorado (USA). This development has been supported by national funding agencies: CSA (Canada); NAOC (China); CEA, CNES, CNRS (France); ASI (Italy); MCINN (Spain); SNSB (Sweden); STFC, UKSA (UK); and NASA (USA).	Amblard A, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/135; Pannella M, 2009, ASTROPHYS J LETT, V698, pL116, DOI 10.1088/0004-637X/698/2/L116; Dunne L, 2000, MON NOT R ASTRON SOC, V315, P115, DOI 10.1046/j.1365-8711.2000.03386.x; SANDERS DB, 1988, ASTROPHYS J, V325, P74, DOI 10.1086/165983; Daddi E, 2007, ASTROPHYS J, V670, P156, DOI 10.1086/521818; Fiore F, 2009, ASTROPHYS J, V693, P447, DOI 10.1088/0004-637X/693/1/447; Magdis GE, 2010, MON NOT R ASTRON SOC, V401, P1521, DOI 10.1111/j.1365-2966.2009.15779.x; Magnelli B, 2009, ASTRON ASTROPHYS, V496, P57, DOI 10.1051/0004-6361:200811443; Mullaney JR, 2011, MON NOT R ASTRON SOC, V414, P1082, DOI 10.1111/j.1365-2966.2011.18448.x; Houck JR, 2005, ASTROPHYS J, V622, pL105, DOI 10.1086/429405; Capak P, 2007, ASTROPHYS J SUPPL S, V172, P99, DOI 10.1086/519081; Farrah D, 2008, ASTROPHYS J, V677, P957, DOI 10.1086/529485; SANDERS DB, 1988, ASTROPHYS J, V328, pL35, DOI 10.1086/185155; Salvato M, 2009, ASTROPHYS J, V690, P1250, DOI 10.1088/0004-637X/690/2/1250; Weedman DW, 2006, ASTROPHYS J, V638, P613, DOI 10.1086/498887; Scoville N, 2007, ASTROPHYS J SUPPL S, V172, P38, DOI 10.1086/516580; Donley JL, 2007, ASTROPHYS J, V660, P167, DOI 10.1086/512798; Schinnerer E, 2007, ASTROPHYS J SUPPL S, V172, P46, DOI 10.1086/516587; Brusa M, 2007, ASTROPHYS J SUPPL S, V172, P353, DOI 10.1086/516575; Lacy M, 2004, ASTROPHYS J SUPPL S, V154, P166, DOI 10.1086/422816; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; Ilbert O, 2009, ASTROPHYS J, V690, P1236, DOI 10.1088/0004-637X/690/2/1236; Brusa M, 2010, ASTROPHYS J, V716, P348, DOI 10.1088/0004-637X/716/1/348; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; Roseboom IG, 2010, MON NOT R ASTRON SOC, V409, P48, DOI 10.1111/j.1365-2966.2010.17634.x; Treister E, 2009, ASTROPHYS J, V706, P535, DOI 10.1088/0004-637X/706/1/535; Fiore F, 2008, ASTROPHYS J, V672, P94, DOI 10.1086/523348; Chary R, 2001, ASTROPHYS J, V556, P562, DOI 10.1086/321609; Merloni A, 2008, MON NOT R ASTRON SOC, V388, P1011, DOI [10.1111/j.1365-2966.2008.13472.x, 10.1111/j.1365-2966.2009.13472.x]; Dey A, 2008, ASTROPHYS J, V677, P943, DOI 10.1086/529516; HUGHES DH, 1993, MON NOT R ASTRON SOC, V263, P607; Taniguchi Y, 2007, ASTROPHYS J SUPPL S, V172, P9, DOI 10.1086/516596; Hasinger G, 2007, ASTROPHYS J SUPPL S, V172, P29, DOI 10.1086/516576; Lilly SJ, 2007, ASTROPHYS J SUPPL S, V172, P70, DOI 10.1086/516589; Sanders DB, 2007, ASTROPHYS J SUPPL S, V172, P86, DOI 10.1086/517885; Mullaney JR, 2012, MON NOT R ASTRON SOC, V419, P95, DOI 10.1111/j.1365-2966.2011.19675.x; Berta S, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116844; Bussmann RS, 2009, ASTROPHYS J, V705, P184, DOI 10.1088/0004-637X/705/1/184; Bussmann RS, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/150; Calanog JA, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/61; Desai V, 2009, ASTROPHYS J, V700, P1190, DOI 10.1088/0004-637X/700/2/1190; Donley JL, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/142; Elbaz D, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117239; Elbaz D, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014687; Elvis M, 2009, ASTROPHYS J SUPPL S, V184, P158, DOI 10.1088/0067-0049/184/1/158; Griffin MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014519; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Le Floc'h E, 2005, ASTROPHYS J, V632, P169, DOI 10.1086/432789; Le Floc'h E, 2009, ASTROPHYS J, V703, P222, DOI 10.1088/0004-637X/703/1/222; Lutz D, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201117107; Magdis GE, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/6; Magnelli B, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118312; Magnelli B, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201220074; McCracken HJ, 2010, ASTROPHYS J, V708, P202, DOI 10.1088/0004-637X/708/1/202; Melbourne J, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/5/125; Melbourne J, 2009, ASTRON J, V137, P4854, DOI 10.1088/0004-6256/137/6/4854; Netzer H, 2007, ASTROPHYS J, V666, P806, DOI 10.1086/520716; Nguyen HT, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014680; Nordon R, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014621; Nordon R, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/182; Oliver SJ, 2012, MON NOT R ASTRON SOC, V424, P1614, DOI 10.1111/j.1365-2966.2012.20912.x; Penner K, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/28; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Poglitsch A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014535; Pope A, 2008, ASTROPHYS J, V689, P127, DOI 10.1086/592739; Riguccini L, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201116950; Smolcic V, 2014, MON NOT R ASTRON SOC, V443, P2590, DOI 10.1093/mnras/stu1331	67	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	SEP 1	2015	452	1					470	485		10.1093/mnras/stv1297		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CQ8IP	WOS:000360851100034		
J	Geach, JE; More, A; Verma, A; Marshall, PJ; Jackson, N; Belles, PE; Beswick, R; Baeten, E; Chavez, M; Cornen, C; Cox, BE; Erben, T; Erickson, NJ; Garrington, S; Harrison, PA; Harrington, K; Hughes, DH; Ivison, RJ; Jordan, C; Lin, YT; Leauthaud, A; Lintott, C; Lynn, S; Kapadia, A; Kneib, JP; Macmillan, C; Makler, M; Miller, G; Montana, A; Mujica, R; Muxlow, T; Narayanan, G; Briain, DO; O'Brien, T; Oguri, M; Paget, E; Parrish, M; Ross, P; Rozo, E; Rusu, CE; Rykoff, ES; Sanchez-Argules, D; Simpson, R; Snyder, C; Schloerb, FP; Tecza, M; Wang, WH; Van Waerbeke, L; Wilcox, J; Viero, M; Wilson, GW; Yun, MS; Zeballos, M				Geach, J. E.; More, A.; Verma, A.; Marshall, P. J.; Jackson, N.; Belles, P. -E.; Beswick, R.; Baeten, E.; Chavez, M.; Cornen, C.; Cox, B. E.; Erben, T.; Erickson, N. J.; Garrington, S.; Harrison, P. A.; Harrington, K.; Hughes, D. H.; Ivison, R. J.; Jordan, C.; Lin, Y. -T.; Leauthaud, A.; Lintott, C.; Lynn, S.; Kapadia, A.; Kneib, J. -P.; Macmillan, C.; Makler, M.; Miller, G.; Montana, A.; Mujica, R.; Muxlow, T.; Narayanan, G.; Briain, D. O.; O'Brien, T.; Oguri, M.; Paget, E.; Parrish, M.; Ross, P.; Rozo, E.; Rusu, C. E.; Rykoff, E. S.; Sanchez-Argueeles, D.; Simpson, R.; Snyder, C.; Schloerb, F. P.; Tecza, M.; Wang, W-H.; Van Waerbeke, L.; Wilcox, J.; Viero, M.; Wilson, G. W.; Yun, M. S.; Zeballos, M.			The Red Radio Ring: a gravitationally lensed hyperluminous infrared radio galaxy at z=2.553 discovered through the citizen science project SPACE WARPS	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						methods: miscellaneous; galaxies: high-redshift	STAR-FORMING GALAXY; AUTOMATED DETECTION; HIGH-RESOLUTION; STELLAR MASS; IMAGING DATA; STRIPE 82; REDSHIFT; GHZ; TELESCOPE; REDUCTION	We report the discovery of a gravitationally lensed hyperluminous infrared galaxy (intrinsic L-IR approximate to 10(13) L-circle dot) with strong radio emission (intrinsic L-1.4 GHz approximate to 10(25) WHz(-1)) at z = 2.553. The source was identified in the citizen science project SPACE WARPS through the visual inspection of tens of thousands of iJK(s) colour composite images of luminous red galaxies (LRGs), groups and clusters of galaxies and quasars. Appearing as a partial Einstein ring (r(e) approximate to 3 arcsec) around an LRG at z = 0.2, the galaxy is extremely bright in the sub-millimetre for a cosmological source, with the thermal dust emission approaching 1 Jy at peak. The redshift of the lensed galaxy is determined through the detection of the CO(3 -> 2) molecular emission line with the Large Millimetre Telescope's Redshift Search Receiver and through [O III] and Ha line detections in the near-infrared from Subaru/Infrared Camera and Spectrograph. We have resolved the radio emission with high-resolution (300-400 mas) eMERLIN L-band and Very Large Array C-band imaging. These observations are used in combination with the near-infrared imaging to construct a lens model, which indicates a lensing magnification of mu approximate to 10. The source reconstruction appears to support a radio morphology comprised of a compact (<250 pc) core and more extended component, perhaps indicative of an active nucleus and jet or lobe.	[Geach, J. E.] Univ Hertfordshire, Sci & Technol Res Inst, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [More, A.] Univ Tokyo, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778582, Japan; [Verma, A.] Oxford Astrophys, Oxford OX1 3RH, England; [Marshall, P. J.] Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94309 USA; [Jackson, N.] Univ Manchester, Sch Phys & Astron, E MERLIN Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Belles, P. -E.; Baeten, E.; Cornen, C.; Miller, G.; Wilcox, J.] Oxford Astrophys, Zooniverse, Oxford OX1 3RH, England; [Chavez, M.; Hughes, D. H.; Montana, A.; Sanchez-Argueeles, D.; Zeballos, M.] Inst Nacl Astrofis Opt & Electr, Puebla 72840, Mexico; [Belles, P. -E.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Erben, T.] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany; [Erickson, N. J.; Harrington, K.; Narayanan, G.; Schloerb, F. P.; Wilson, G. W.; Yun, M. S.] Univ Massachusetts, Dept Astron, Amherst, MA 01002 USA; [Ivison, R. J.; Ross, P.] Univ Edinburgh, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; [Ivison, R. J.] European So Observ, D-85748 Garching, Germany; [Lin, Y. -T.; Wang, W-H.] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Lynn, S.; Kneib, J. -P.; Snyder, C.] Ecole Polytech Ferale Lausanne, Observ Sauverny, Lab Astrophys, CH-1290 Versoix, Switzerland; [Kapadia, A.] Adler Planetarium, Chicago, IL 60605 USA; [Kneib, J. -P.] Aix Marseille Univ, CNRS, Lab Astrophys Marseille, F-13388 Marseille, France; [Makler, M.] Ctr Brasileiro Pesquisas Fis, BR-22290180 Rio De Janeiro, RJ, Brazil; [Briain, D. O.] British Broadcasting Corp, London W1A 1AA, England; [Oguri, M.] Univ Tokyo, Res Ctr Early Univ, Tokyo 1130033, Japan; [Rozo, E.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Rozo, E.] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; [Rusu, C. E.] Natl Astron Observ, Opt & Infrared Astron Div, Mitaka, Tokyo 1818588, Japan; [Van Waerbeke, L.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada	Geach, JE (reprint author), Univ Hertfordshire, Sci & Technol Res Inst, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England.	j.geach@herts.ac.uk			Royal Society University Research Fellowship; World Premier International Research Center Initiative (WPIInitiative), MEXT, Japan; Japan Society for Promotion of Science (JSPS); Leverhulme Trust; European Research Council [321302]; ERC LIDA; CNRS; CNPq; FAPERJ; Canada Foundation for Innovation; National Aeronautics and Space Administration; US National Science Foundation via University Radio Observatory program; Instituto Nacional de Astrofisica, Optica y Electronica (INAOE); University of Massachusetts (UMASS); NSF URO; ATI [AST-0096854, AST-0704966]	JEG is supported by a Royal Society University Research Fellowship. AM is supported by World Premier International Research Center Initiative (WPIInitiative), MEXT, Japan. AM also acknowledges the support of the Japan Society for Promotion of Science (JSPS) fellowship. e-MERLIN is a National Facility operated by the University of Manchester at Jodrell Bank Observatory on behalf of the UK Science and Technology Facilities Council (STFC). AV acknowledges support from a Leverhulme Trust Research Fellowship. RJI acknowledges support from the European Research Council in the form of Advanced Grant, 321302, COSMICISM. J-PK acknowledges support from the ERC advanced grant LIDA and from CNRS. MM is partially supported by CNPq and FAPERJ. e-MERLIN is a National Facility operated by the University of Manchester at Jodrell Bank Observatory on behalf of the STFC. Based in part on data collected at Subaru telescope, which is operated by the National Astronomical Observatory of Japan. This work is based on observations carried out with the VLA. The NRAO is a facility of the NSF operated under cooperative agreement by Associated Universities, Inc. The James Clerk Maxwell Telescope has historically been operated by the Joint Astronomy Centre on behalf of the STFC, the National Research Council of Canada and the Netherlands Organization for Scientific Research. Additional funds for the construction of SCUBA-2 were provided by the Canada Foundation for Innovation. This research has made use of the NASA/IPAC Extragalactic Database (NED) which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration. Based on observations obtained with WIRCam a joint project of Taiwan, Korea, Canada, France, and the Canada-France-Hawaii Telescope (CFHT) - and MegaPrime/MegaCam - a joint project of CFHT and CEA/DAPNIA - at CFHT and VIRCAM at the VISTA/ESO Telescope at the Paranal Observatory. CFHT is operated by the National Research Council (NRC) of Canada, the Institut National des Sciences de l'Univers of the Centre National de la Recherche Scientifique (CNRS) of France, and the University of Hawaii. The Brazilian partnership on CFHT is managed by the Laboratorio Nacional de Astrofisica (LNA). We thank Terapix for the VISTA data reduction. We thank the CFHTLens team for their pipeline development on which the CS82 reductions were based. We thank the Mexican Science and Technology Funding Agency, CONACYT (Consejo Nacional de Ciencia y TecnologAsa) during the construction and early operational phase of the Large Millimeter Telescope Alfonso Serrano, as well as support from the US National Science Foundation via the University Radio Observatory program, the Instituto Nacional de Astrofisica, Optica y Electronica (INAOE) and the University of Massachusetts (UMASS). The UMASS LMT group acknowledges support from NSF URO and ATI grants (AST-0096854 and AST-0704966) for the LMT project and the construction of the RSR.	Richard J, 2014, MON NOT R ASTRON SOC, V444, P268, DOI 10.1093/mnras/stu1395; Jenness T, 2011, ASTR SOC P, V442, P281; Stark DP, 2008, NATURE, V455, P775, DOI 10.1038/nature07294; Zheng W, 2012, NATURE, V489, P406, DOI 10.1038/nature11446; Coppin K, 2010, ASTROPHYS J, V713, P503, DOI 10.1088/0004-637X/713/1/503; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Scott KS, 2008, MON NOT R ASTRON SOC, V385, P2225, DOI 10.1111/J.1365-2966.2008.12989.x; Koopmans LVE, 2006, ASTROPHYS J, V649, P599, DOI 10.1086/505696; Chapin EL, 2013, MON NOT R ASTRON SOC, V430, P2545, DOI 10.1093/mnras/stt052; Erickson N, 2007, ASTR SOC P, V375, P71; BECKER RH, 1994, ASTROPHYS J SUPPL S, V91, P347, DOI 10.1086/191941; Ivison RJ, 2010, MON NOT R ASTRON SOC, V402, P245, DOI 10.1111/j.1365-2966.2009.15918.x; Negrello M, 2010, SCIENCE, V330, P800, DOI 10.1126/science.1193420; Vieira JD, 2013, NATURE, V495, P344, DOI 10.1038/nature12001; Kobayashi N, 2000, PROC SPIE, V4008, P1056, DOI 10.1117/12.395423; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; REFSDAL S, 1964, MON NOT R ASTRON SOC, V128, P307; Brault F, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425275; Chan J. H. H., 2014, ARXIV14115398; Dempsey JT, 2013, MON NOT R ASTRON SOC, V430, P2534, DOI 10.1093/mnras/stt090; Gavazzi R, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/144; Hodge JA, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/1/3; Keeton C. R., 2011, ASCL1102003 ASTR SOU; Kneib JP, 2005, ASTRON ASTROPHYS, V434, P819, DOI 10.1051/0004-6361:20042034; Kneib JP, 2004, ASTROPHYS J, V607, P697, DOI 10.1086/386281; Marshall P. J., 2015, ARXIV150406148; Marshall PJ, 2009, ASTROPHYS J, V694, P924, DOI 10.1088/0004-637X/694/2/924; Moraes B., 2014, REV MEXICANA ASTRONO, V44, P202; More A., 2015, ARXIV150405587; More A, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/38; Perley RA, 2013, ASTROPHYS J SUPPL S, V206, DOI 10.1088/0067-0049/206/2/16; Ruff AJ, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/96; Sonnenfeld A, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/98; Suyu SH, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/70; Swinbank AM, 2009, MON NOT R ASTRON SOC, V400, P1121, DOI 10.1111/j.1365-2966.2009.15617.x; Tewes M, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220123; Viero MP, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/2/22; Wilson GW, 2008, MON NOT R ASTRON SOC, V386, P807, DOI 10.1111/j.1365-2966.2008.12980.x; Zitrin A, 2014, ASTROPHYS J LETT, V793, DOI 10.1088/2041-8205/793/1/L12	39	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	SEP 1	2015	452	1					502	510		10.1093/mnras/stv1243		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CQ8IP	WOS:000360851100036		
J	Murga, M; Zhu, GT; Menard, B; Lan, TW				Murga, Maria; Zhu, Guangtun; Menard, Brice; Lan, Ting-Wen			Calcium H&K and sodium D absorption induced by the interstellar and circumgalactic media of the Milky Way	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						surveys; Galaxy: abundances; quasars: absorption lines	DIGITAL SKY SURVEY; INTERMEDIATE-VELOCITY CLOUDS; HEAVY ELEMENT DEPLETION; 7TH DATA RELEASE; MG II ABSORBERS; MOLECULAR CLOUDS; GALAXY HALOS; DUST; STELLAR; GAS	We map out calcium II and sodium I absorption (Fraunhofer H, K & D lines) induced by both the interstellar medium and the circumgalactic medium of the Milky Way. Our measurements cover more than 9000 deg(2) and make use of about 300 000 extragalactic spectra from the Sloan Digital Sky Survey. We present absorption maps for these two species and then compare their distributions to those of neutral hydrogen and dust. We show that the abundance of Na I with respect to neutral hydrogen stays roughly constant in different environments, while that of Ca II decreases with hydrogen column density. Studying how these tracers vary as a function of velocity, we show that, on average, the N-Na I / N-Ca II ratio decreases at higher velocity with respect to the local standard of rest, similar to the local Routly-Spitzer effect but seen on Galactic scale. We show that it is likely caused by higher gas/ dust density at lower velocity. Finally, we show that Galactic Ca II and Na I absorption needs to be taken into account for precision photometry and, more importantly, for photometric redshift estimation with star-forming galaxies. Our maps of Ca II and Na I absorption are publicly available.	[Murga, Maria] Russian Acad Sci, Inst Astron, Moscow 119017, Russia; [Zhu, Guangtun; Menard, Brice; Lan, Ting-Wen] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Menard, Brice] Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan	Murga, M (reprint author), Russian Acad Sci, Inst Astron, Pyatnitskaya Str 48, Moscow 119017, Russia.	murga@inasan.ru		Zhu, Guangtun/0000-0002-7574-8078	NSF [AST-1109665]; Alfred P. Sloan foundation; Theodore Dunham, Jr, Grant of Fund for Astrophysical Research; RFBR [14-02-31456]; NASA through Hubble Fellowship by Space Telescope Science Institute [HST-HF2-51351]; Astronomy, Inc. [NAS 5-26555]; National Science Foundation; US Department of Energy; National Aeronautics and Space Administration; Japanese Monbukagakusho; Max Planck Society; Higher Education Funding Council for England; U.S. Department of Energy Office of Science	We thank Philipp Richter and Bart Wakker for useful discussions. This work was supported by NSF Grant AST-1109665, the Alfred P. Sloan foundation and a grant from Theodore Dunham, Jr, Grant of Fund for Astrophysical Research and RFBR grant 14-02-31456. GZ acknowledges partial support provided by NASA through Hubble Fellowship grant # HST-HF2-51351 awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under contract NAS 5-26555.; Funding for the SDSS and SDSS-II has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, the National Science Foundation, the US Department of Energy, the National Aeronautics and Space Administration, the Japanese Monbukagakusho, the Max Planck Society, and the Higher Education Funding Council for England. The SDSS website is http://www.sdss.org/. Funding for SDSS-III has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, the National Science Foundation, and the U.S. Department of Energy Office of Science. The SDSS-III website is http://www.sdss3.org/.	ALONGI M, 1993, ASTRON ASTROPHYS SUP, V97, P851; Putman ME, 2012, ANNU REV ASTRON ASTR, V50, P491, DOI 10.1146/annurev-astro-081811-125612; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; VALLERGA JV, 1993, ASTROPHYS J, V411, P729, DOI 10.1086/172875; Safronova MS, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.012503; Blanton MR, 2007, ASTRON J, V133, P734, DOI 10.1086/510127; Hewett PC, 2010, MON NOT R ASTRON SOC, V405, P2302, DOI 10.1111/j.1365-2966.2010.16648.x; BOGGESS NW, 1992, ASTROPHYS J, V397, P420, DOI 10.1086/171797; Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Gorski KM, 2005, ASTROPHYS J, V622, P759, DOI 10.1086/427976; Wakker BP, 1999, NATURE, V402, P388, DOI 10.1038/46498; Wakker BP, 2000, ASTROPHYS J, V544, pL107, DOI 10.1086/317316; Tremonti CA, 2004, ASTROPHYS J, V613, P898, DOI 10.1086/423264; Lee DD, 1999, NATURE, V401, P788; ROUTLY PM, 1952, ASTROPHYS J, V115, P227; DRAINE BT, 1979, ASTROPHYS J, V231, P438, DOI 10.1086/157206; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Zhu G, 2010, ASTROPHYS J, V722, P491, DOI 10.1088/0004-637X/722/1/491; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Kelleher DE, 2008, J PHYS CHEM REF DATA, V37, P267, DOI 10.1063/1.2735328; Kalberla PMW, 2009, ANNU REV ASTRON ASTR, V47, P27, DOI 10.1146/annurev-astro-082708-101823; Dame TM, 2001, ASTROPHYS J, V547, P792, DOI 10.1086/318388; Zhu GT, 2014, MON NOT R ASTRON SOC, V439, P3139, DOI 10.1093/mnras/stu186; Arnal EM, 2000, ASTRON ASTROPHYS SUP, V142, P35, DOI 10.1051/aas:2000134; Land K, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.087301; Savage BD, 1996, ANNU REV ASTRON ASTR, V34, P279, DOI 10.1146/annurev.astro.34.1.279; JONES AP, 1994, ASTROPHYS J, V433, P797, DOI 10.1086/174689; Bajaja E, 2005, ASTRON ASTROPHYS, V440, P767, DOI 10.1051/0004-6361:20041863; Schneider DP, 2010, ASTRON J, V139, P2360, DOI 10.1088/0004-6256/139/6/2360; Baron D, 2015, MON NOT R ASTRON SOC, V447, P545, DOI 10.1093/mnras/stu2448; Poznanski D, 2012, MON NOT R ASTRON SOC, V426, P1465, DOI 10.1111/j.1365-2966.2012.21796.x; BARLOW MJ, 1978, MON NOT R ASTRON SOC, V183, P417; BARLOW MJ, 1977, ASTROPHYS J, V211, pL83, DOI 10.1086/182346; Ben Bekhti N, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118673; BLADES JC, 1981, MON NOT R ASTRON SOC, V194, P669; BOKSENBERG A, 1978, ASTROPHYS J, V220, P42, DOI 10.1086/155880; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Courteau S, 1999, ASTRON J, V118, P337, DOI 10.1086/300942; Fox AJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/110; Fraunhofer J., 1814, DENKSCHRIFTEN KONIGL, V5, P193; Hartmann D., 1997, ATLAS GALACTIC NEUTR; Hartmann J, 1904, ASTROPHYS J, V19, P268, DOI 10.1086/141112; Herschel W., 1785, PHIL T, V75, P213, DOI 10.1098/rstl.1785.0012; Lan TW, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/1/31; Lu LM, 1998, ASTRON J, V115, P162, DOI 10.1086/300181; MCKEE CF, 1989, ASTROPHYS J, V345, P782, DOI 10.1086/167950; Menard B, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/116; Morton DC, 2003, ASTROPHYS J SUPPL S, V149, P205, DOI 10.1086/377639; PHILLIPS AP, 1984, MON NOT R ASTRON SOC, V206, P337; Richter P, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015566; Richter P, 2001, ASTROPHYS J, V559, P318, DOI 10.1086/322401; Richter P, 2003, ASTROPHYS J, V586, P230, DOI 10.1086/346204; WAKKER BP, 1991, ASTRON ASTROPHYS, V250, P499; Wheelock S. L., 1994, 9522539 NASA STI REC; Zasowski G, 2015, ASTROPHYS J, V798, DOI [10.1088/0004-637X/798/1/35, 10.1088/0004-637X/798/1/135]; Zhu GT, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/130; Zhu GT, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/16	58	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	SEP 1	2015	452	1					511	519		10.1093/mnras/stv1277		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CQ8IP	WOS:000360851100037		
J	Sakurai, Y; Hosokawa, T; Yoshida, N; Yorke, HW				Sakurai, Y.; Hosokawa, T.; Yoshida, N.; Yorke, H. W.			Formation of primordial supermassive stars by burst accretion	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						stars: formation; galaxies: formation; cosmology: theory; early Universe	MASSIVE BLACK-HOLES; ATOMIC COOLING HALOES; 1ST STARS; DIRECT COLLAPSE; SUPERGIANT PROTOSTARS; EARLY UNIVERSE; EVOLUTION; FEEDBACK; SIMULATIONS; REDSHIFT	Recent observations show that supermassive black holes (BHs) with similar to 10(9) M-circle dot exist at redshift z greater than or similar to 6. A promising formation channel is the so-called direct collapse model, which posits that a massive seed BH forms through gravitational collapse of a similar to 10(5) M-circle dot supermassive star (SMS). We study the evolution of such an SMS growing by rapid mass accretion. In particular, we examine the impact of time-dependent mass accretion of repeating burst and quiescent phases expected to occur with a self-gravitating circumstellar disc. We show that protostars growing via episodic accretion can substantially contract during the quiescent phases, in contrast to the case of constant mass accretion, whereby the star expands roughly monotonically. The stellar effective temperature and ionizing photon emissivity increase accordingly, which can cause strong ionizing feedback and halt the mass accretion. With a fixed duration of the quiescent phase Delta t(q), this contraction occurs in early evolutionary phases, i.e. for M-* less than or similar to 10(3) M-circle dot with Delta t(q) similar or equal to 10(3) yr. For later epochs and larger masses but the same Delta t(q), contraction is negligible even during quiescent phases. With larger Delta t(q), however, the star continues to contract during quiescent phases even for the higher stellar masses. We show that this behaviour is well understood by comparing the interval time and the thermal relaxation time for a bloated surface layer. We conclude that the feedback becomes effective, if Delta t(q) greater than or similar to 10(3) yr, which is possible in an accretion disc forming in the direct collapse model.	[Sakurai, Y.] Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; [Hosokawa, T.] Univ Tokyo, Dept Phys & Res Ctr Early Univ, Tokyo 1130033, Japan; [Yoshida, N.] Univ Tokyo, Kavli Inst Phys & Math Univ WPI, Kashiwa, Chiba 2778583, Japan; [Yorke, H. W.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Sakurai, Y (reprint author), Univ Tokyo, Dept Phys, Tokyo 1130033, Japan.	sakurai@utap.phys.s.u-tokyo.ac.jp			Advanced Leading Graduate Course for Photon Science; JSPS Promotion of Science [25800102, 15H00776, 25287050, 15J08816]; National Aeronautics and Space Administration (NASA)	We thank Kazuyuki Omukai, Kohei Inayoshi and Eduard Vorobyov for fruitful discussions. The calculations were in part carried out on PC cluster at Center for Computational Astrophysics, National Astronomical Observatory of Japan. YS is supported by Advanced Leading Graduate Course for Photon Science. This work is supported in part by Grant-in-Aid for Scientific Research from the JSPS Promotion of Science (25800102, 15H00776, 25287050, and 15J08816). Portions of this research were conducted at the Jet Propulsion Laboratory, California Institute of Technology, operating under a contract with the National Aeronautics and Space Administration (NASA).	Machida MN, 2013, MON NOT R ASTRON SOC, V431, P1719, DOI 10.1093/mnras/stt291; Bromm V, 2003, ASTROPHYS J, V596, P34, DOI 10.1086/377529; Greif TH, 2012, MON NOT R ASTRON SOC, V424, P399, DOI 10.1111/j.1365-2966.2012.21212.x; Hosokawa T, 2011, SCIENCE, V334, P1250, DOI 10.1126/science.1207433; Visbal E, 2014, MON NOT R ASTRON SOC, V445, P1056, DOI 10.1093/mnras/stu1794; Omukai K, 2003, ASTROPHYS J, V589, P677, DOI 10.1086/374810; Wu XB, 2015, NATURE, V518, P512, DOI 10.1038/nature14241; Stacy A, 2010, MON NOT R ASTRON SOC, V403, P45, DOI 10.1111/j.1365-2966.2009.16113.x; Hosokawa T, 2009, ASTROPHYS J, V691, P823, DOI 10.1088/0004-637X/691/1/823; Mortlock DJ, 2011, NATURE, V474, P616, DOI 10.1038/nature10159; Yoshida N, 2008, SCIENCE, V321, P669, DOI 10.1126/science.1160259; Madau P, 2001, ASTROPHYS J, V551, pL27, DOI 10.1086/319848; Agarwal B, 2014, MON NOT R ASTRON SOC, V443, P648, DOI 10.1093/mnras/stu1112; Becerra F, 2015, MON NOT R ASTRON SOC, V446, P2380; Baraffe I, 2009, ASTROPHYS J LETT, V702, pL27, DOI 10.1088/0004-637X/702/1/L27; Inayoshi K, 2012, MON NOT R ASTRON SOC, V422, P2539, DOI 10.1111/j.1365-2966.2012.20812.x; Inayoshi K, 2014, MON NOT R ASTRON SOC, V445, P1549, DOI 10.1093/mnras/stu1870; Shibata M, 2002, ASTROPHYS J, V572, pL39, DOI 10.1086/341516; Latif MA, 2013, MON NOT R ASTRON SOC, V436, P2989, DOI 10.1093/mnras/stt1786; Inayoshi K, 2014, MON NOT R ASTRON SOC, V445, pL109, DOI 10.1093/mnrasl/slu151; Marziani P, 2012, NEW ASTRON REV, V56, P49, DOI 10.1016/j.newar.2011.09.001; Alvarez MA, 2009, ASTROPHYS J LETT, V701, pL133, DOI 10.1088/0004-637X/701/2/L133; Schneider R, 2002, ASTROPHYS J, V571, P30, DOI 10.1086/339917; Omukai K, 2008, ASTROPHYS J, V686, P801, DOI 10.1086/591636; Reisswig C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.151101; DeSouza AL, 2015, MON NOT R ASTRON SOC, V450, P295, DOI 10.1093/mnras/stv523; Greif TH, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/75; Hirano S, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/60; Hosokawa T, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/93; Hosokawa T, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/140; Hosokawa T, 2009, ASTROPHYS J, V703, P1810, DOI 10.1088/0004-637X/703/2/1810; Hosokawa T, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/178; Inayoshi K, 2013, MON NOT R ASTRON SOC, V431, P3036, DOI 10.1093/mnras/stt362; Inoue T, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/1/73; Jeon M, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/34; Johnson JL, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/116; Katz H., 2015, ARXIV150203448; Kuiper R, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/61; Di Matteo T, 2012, ASTROPHYS J LETT, V745, DOI 10.1088/2041-8205/745/2/L29; Mckee CF, 2008, ASTROPHYS J, V681, P771, DOI 10.1086/587434; Omukai K, 2001, ASTROPHYS J, V546, P635, DOI 10.1086/318296; Regan JA, 2014, MON NOT R ASTRON SOC, V439, P1160, DOI 10.1093/mnras/stu068; Schleicher DRG, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321949; Smith RJ, 2012, MON NOT R ASTRON SOC, V424, P457, DOI 10.1111/j.1365-2966.2012.21211.x; STAHLER SW, 1986, ASTROPHYS J, V302, P590, DOI 10.1086/164018; Van Borm C, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201424658; Vorobyov EI, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/131; Vorobyov EI, 2013, MON NOT R ASTRON SOC, V433, P3256, DOI 10.1093/mnras/stt970; Yorke H. W., 2008, ASP C SER, V387, P189	49	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	SEP 1	2015	452	1					755	764		10.1093/mnras/stv1346		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CQ8IP	WOS:000360851100055		
J	Hoshino, H; Leauthaud, A; Lackner, C; Hikage, C; Rozo, E; Rykoff, E; Mandelbaum, R; More, S; More, A; Saito, S; Vulcani, B				Hoshino, Hanako; Leauthaud, Alexie; Lackner, Claire; Hikage, Chiaki; Rozo, Eduardo; Rykoff, Eli; Mandelbaum, Rachel; More, Surhud; More, Anupreeta; Saito, Shun; Vulcani, Benedetta			Luminous red galaxies in clusters: central occupation, spatial distributions and miscentring	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						galaxies: clusters: general	DIGITAL SKY SURVEY; OSCILLATION SPECTROSCOPIC SURVEY; BRIGHTEST HALO GALAXIES; DARK-MATTER HALOES; COSMOLOGICAL CONSTRAINTS; SDSS-III; X-RAY; OPTICAL RICHNESS; TARGET SELECTION; MASS FUNCTION	Luminous red galaxies (LRG) from the Sloan Digital Sky Survey are among the best understood samples of galaxies and are employed in a broad range of cosmological studies. In this paper, we study how LRGs occupy massive haloes via counts in clusters and reveal several unexpected trends. Using the red-sequence Matched-filter Probabilistic Percolation (redMaPPer) cluster catalogue, we derive the central occupation of LRGs as a function richness. We show that clusters contain a significantly lower fraction of central LRGs than predicted from the two-point correlation function. At halo masses of 10(14.5) M-circle dot, we find N-cen = 0.73 compared to N-cen = 0.89 from correlation studies. Our central occupation function for LRGs converges to 0.95 at large halo masses. A strong anticorrelation between central luminosity and cluster mass at fixed richness is required to reconcile our results with those based on clustering studies. We derive the probability that the brightest cluster member is not the central galaxy. We find P-BNC approximate to 20-30 per cent which is a factor of similar to 2 lower than the value found by Skibba et al. Finally, we study the radial offsets of bright non-central LRGs from cluster centres and show that bright non-central LRGs follow a different radial distribution compared to red cluster members. This work demonstrates that even the most massive clusters do not always have an LRG at the centre, and that the brightest galaxy in a cluster is not always the central galaxy.	[Hoshino, Hanako] Nagoya Univ, Dept Phys & Astrophys, Nagoya, Aichi 4648602, Japan; [Leauthaud, Alexie; Lackner, Claire; More, Surhud; More, Anupreeta; Saito, Shun; Vulcani, Benedetta] Univ Tokyo, UTIAS, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan; [Hikage, Chiaki] Nagoya Univ, Kobayashi Maskawa Inst, Nagoya, Aichi 4648602, Japan; [Rozo, Eduardo] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; [Rykoff, Eli] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Mandelbaum, Rachel] Carnegie Mellon Univ, Dept Phys, McWilliams Ctr Cosmol, Pittsburgh, PA 15213 USA	Hoshino, H (reprint author), Nagoya Univ, Dept Phys & Astrophys, Nagoya, Aichi 4648602, Japan.	hoshino.hanako@e.mbox.nagoya-u.ac.jp; alexie.leauthaud@me.com	Mandelbaum, Rachel/N-8955-2014	Mandelbaum, Rachel/0000-0003-2271-1527	World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; Department of Energy Early Career Award program; Japan Society for the Promotion of Science (JSPS) [26870140]	We thank Tamas Budavari for helping us with querying the SDSS data base. Jeremy Tinker kindly provided us with the LOWZ target catalogue, and Naoshi Sugiyama supported us with helpful discussions. We thank the anonymous referee for useful comments that helped improve this paper. AL, CL, AM, SM, SS, and BV were supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan. RM acknowledges the support of the Department of Energy Early Career Award program. BV was supported by the Kakenhi Grant-in-Aid for Young Scientists (B)(26870140) from the Japan Society for the Promotion of Science (JSPS). AM was supported by a research fellowship from the Japan Society for the Promotion of Science (JSPS).	Aihara H, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/2/29; Annis J, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/120; Cacciato M, 2009, MON NOT R ASTRON SOC, V394, P929, DOI 10.1111/j.1365-2966.2008.14362.x; Peacock JA, 2000, MON NOT R ASTRON SOC, V318, P1144, DOI 10.1046/j.1365-8711.2000.03779.x; Reid BA, 2009, ASTROPHYS J, V702, P249, DOI 10.1088/0004-637X/702/1/249; Seljak U, 2000, MON NOT R ASTRON SOC, V318, P203, DOI 10.1046/j.1365-8711.2000.03715.x; Eisenstein DJ, 2001, ASTRON J, V122, P2267, DOI 10.1086/323717; Blanton MR, 2007, ASTRON J, V133, P734, DOI 10.1086/510127; van den Bosch FC, 2005, MON NOT R ASTRON SOC, V361, P1203, DOI 10.1111/j.1365-2966.2005.09260.x; Budzynski JM, 2012, MON NOT R ASTRON SOC, V423, P104, DOI 10.1111/j.1365-2966.2012.20663.x; Padmanabhan N, 2008, ASTROPHYS J, V674, P1217, DOI 10.1086/524677; Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Bernardi M, 2013, MON NOT R ASTRON SOC, V436, P697, DOI 10.1093/mnras/stt1607; van den Bosch FC, 2013, MON NOT R ASTRON SOC, V430, P725, DOI 10.1093/mnras/sts006; Cacciato M, 2013, MON NOT R ASTRON SOC, V430, P767, DOI 10.1093/mnras/sts525; Reid BA, 2009, ASTROPHYS J, V698, P143, DOI 10.1088/0004-637X/698/1/143; Weinmann SM, 2006, MON NOT R ASTRON SOC, V366, P2, DOI 10.1111/j.1365-2966.2005.09865.x; D'Onghia E, 2005, ASTROPHYS J, V630, pL109, DOI 10.1086/491651; Jones LR, 2003, MON NOT R ASTRON SOC, V343, P627, DOI 10.1046/j.1365-8711.2003.06702.x; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Sanderson AJR, 2009, MON NOT R ASTRON SOC, V398, P1698, DOI 10.1111/j.1365-2966.2009.15214.x; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; van den Bosch FC, 2004, MON NOT R ASTRON SOC, V352, P1302, DOI 10.1111/j.1365-2966.2004.08021.x; Berlind AA, 2002, ASTROPHYS J, V575, P587, DOI 10.1086/341469; Tinker J, 2008, ASTROPHYS J, V688, P709, DOI 10.1086/591439; Hansen SM, 2005, ASTROPHYS J, V633, P122, DOI 10.1086/444554; Yang XH, 2007, ASTROPHYS J, V671, P153, DOI 10.1086/522027; Mandelbaum R, 2006, MON NOT R ASTRON SOC, V372, P758, DOI 10.1111/j.1365-2966.2006.10906.x; Strauss MA, 2002, ASTRON J, V124, P1810, DOI 10.1086/342343; Reyes R, 2008, MON NOT R ASTRON SOC, V390, P1157, DOI 10.1111/j.1365-2966.2008.13818.x; Skibba RA, 2011, MON NOT R ASTRON SOC, V410, P417, DOI 10.1111/j.1365-2966.2010.17452.x; Zheng Z, 2005, ASTROPHYS J, V633, P791, DOI 10.1086/466510; Zentner AR, 2005, ASTROPHYS J, V624, P505, DOI 10.1086/428898; Padmanabhan N, 2009, MON NOT R ASTRON SOC, V397, P1862, DOI 10.1111/j.1365-2966.2008.14071.x; Parejko JK, 2013, MON NOT R ASTRON SOC, V429, P98, DOI 10.1093/mnras/sts314; Weinberg DH, 2013, PHYS REP, V530, P87, DOI 10.1016/j.physrep.2013.05.001; Eisenstein DJ, 2005, ASTROPHYS J, V633, P560, DOI 10.1086/466512; Zehavi I, 2005, ASTROPHYS J, V621, P22, DOI 10.1086/427495; Scoccimarro RN, 2001, ASTROPHYS J, V546, P20, DOI 10.1086/318261; Samushia L, 2012, MON NOT R ASTRON SOC, V420, P2102, DOI 10.1111/j.1365-2966.2011.20169.x; Cabre A, 2009, MON NOT R ASTRON SOC, V393, P1183, DOI 10.1111/j.1365-2966.2008.14281.x; Coziol R, 2009, ASTRON J, V137, P4795, DOI 10.1088/0004-6256/137/6/4795; Dawson KS, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/10; Einasto M, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/51; Einasto M, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118697; George MR, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/2; Hikage C, 2013, MON NOT R ASTRON SOC, V435, P2345, DOI 10.1093/mnras/stt1446; Hikage C, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/08/019; Ho S, 2009, ASTROPHYS J, V697, P1358, DOI 10.1088/0004-637X/697/2/1358; Johnston D. E., 2007, ARXIV07091159; Kazin EA, 2010, ASTROPHYS J, V710, P1444, DOI 10.1088/0004-637X/710/2/1444; Koester BP, 2007, ASTROPHYS J, V660, P239, DOI 10.1086/509599; Lauer TR, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/2/82; Leauthaud A, 2010, ASTROPHYS J, V709, P97, DOI 10.1088/0004-637X/709/1/97; Masjedi M, 2006, ASTROPHYS J, V644, P54, DOI 10.1086/503536; Miyatake H., 2013, ARXIV13111480; More S, 2013, MON NOT R ASTRON SOC, V430, P747, DOI 10.1093/mnras/sts697; More S, 2011, ASTROPHYS J SUPPL S, V195, DOI 10.1088/0067-0049/195/1/4; More S., 2014, ARXIV14071856; Reid BA, 2010, MON NOT R ASTRON SOC, V404, P60, DOI 10.1111/j.1365-2966.2010.16276.x; Rozo E., 2014, ARXIV14101193; Rozo E., 2014, ARXIV14017716; Rozo E, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/.0; Rykoff ES, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/104; Rykoff ES, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/178; Sehgal N, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/38; Tinker JL, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/16; Wu HY, 2013, MON NOT R ASTRON SOC, V436, P460, DOI 10.1093/mnras/stt1582	68	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	SEP 1	2015	452	1					998	1013		10.1093/mnras/stv1271		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CQ8IP	WOS:000360851100077		
J	Zhao, P; Tian, CM; Yao, YJ; Wang, Q; Yamaoka, Y; Kakishima, M				Zhao, Peng; Tian, Cheng-Ming; Yao, Yi-Jian; Wang, Qi; Yamaoka, Yuichi; Kakishima, Makoto			Two new species and one new record of Melampsora on willows from China	MYCOLOGICAL PROGRESS			English	Article						Melampsoraceae; Mophology; Pucciniales; rDNA phylogenies; Taxonomy	NORTH-AMERICA; RUST FUNGUS; SALIX	Two new species of rust fungi, Melampsora salicis-purpureae sp. nov. and M. salicis-argyraceae sp. nov., and a new record, M. iranica, are described from China based on morphological characteristics and molecular phylogeny of the internal transcribed spacer (ITS1 and ITS2) regions including 5.8S of the ribosomal RNA gene. Melampsora salicis-purpureae on Salix purpurea was characterized by amphigenous uredinia, subepidermal teliospores, and relatively shorter teliospores and amphigenous telia. Melampsora salicis-argyraceae on S. argyaceae possessed sparse spines on urediniospores, epiphyllous telia and subepidermal teliospores with slightly thickened apex. In addition, specimens on S. alba and S. psammophyla were identified as M. iranica.	[Zhao, Peng] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan; [Tian, Cheng-Ming] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing 100083, Peoples R China; [Yao, Yi-Jian] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing 100101, Peoples R China; [Wang, Qi; Kakishima, Makoto] Jilin Agr Univ, Chinese Minist Educ Edible & Med Fungi, Engn Res Ctr, Changchun 130118, Jilin Province, Peoples R China; [Yamaoka, Yuichi; Kakishima, Makoto] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan	Zhao, P (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan.	zpengima@163.com					Zhao P, 2014, MYCOSCIENCE, V55, P390, DOI 10.1016/j.myc.2013.12.005; PEI MH, 1993, MYCOL RES, V97, P845; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Zhao P, 2013, MYCOTAXON, V123, P81, DOI 10.5248/123.81; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; ROYLE DJ, 1992, BIOMASS BIOENERG, V2, P45, DOI 10.1016/0961-9534(92)90087-7; Samils B, 2011, TREE GENET GENOMES, V7, P1219, DOI 10.1007/s11295-011-0408-0; Milne JM, 2012, FUNGAL BIOL-UK, V116, P603, DOI 10.1016/j.funbio.2012.02.008; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Pei MH, 2005, MYCOL RES, V109, P401, DOI 10.1017/S0935756205002479; Yamaoka Yuichi, 2010, Nippon Kingakukai Kaiho, V51, P35; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Tian Cheng-Ming, 2004, Mycoscience, V45, P56, DOI 10.1007/s10267-003-0150-z; Smith JA, 2004, MYCOLOGIA, V96, P1330, DOI 10.2307/3762149; Damadi SM, 2011, FOREST PATHOL, V41, P392, DOI 10.1111/j.1439-0329.2010.00699.x; Spiers AG, 1996, MYCOL RES, V100, P1163; Feau N, 2009, MYCOL RES, V113, P713, DOI 10.1016/j.mycres.2009.02.007; Bennett C, 2011, MYCOLOGIA, V103, P1004, DOI 10.3852/10-289; Azbukina ZM, 1974, RUST FUNGI SOVIET FA, P120; Bagyanarayana G, 2005, RUST DIS WILLOW POPL, P20; Cao ZM, 1999, RUST FUNGI QINLING M; Castagne L, 1843, OBSERVATIONS QUELQUE; Cummins GB, 2003, ILLUSTRATED GENERA R; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Hiratsuka N, 1982, TAXONOMIC REVISION M, V20, P1; Hiratsuka N, 1992, RUST FLORA JAPAN; Ito S, 1938, MYCOLOGICAL FLORA JA, VII; Klebahn H, 1914, KRYPTOGAMENFLORA MAR, P69; Kuprevich VF, 1957, CRYPTOGAMIC PLANTS U, V4, P423; Lee Seung Kyu, 1999, Mycoscience, V40, P121, DOI 10.1007/BF02464290; Liang YM, 2006, THESIS U TSUKUBA TSU; Liu WX, 2005, THESIS INNNER MONGOL; Pei MH, 2005, RUST DIS WILLOW POPL, P20; Sydow P, 2015, MONOGRAPHIA UREDINEA; Tai FL, 1979, SYLLOGE FUNGORUM SIN; Thumen F, 1979, MITT FORSTLICHEN VER, V2, P25; Virtudazo Eric V., 2001, Journal of General Plant Pathology, V67, P28, DOI 10.1007/PL00012983; Wahyuno Dono, 2001, Mycoscience, V42, P519, DOI 10.1007/BF02460950; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wilson M, 1966, BRIT RUST FUNGI; Zhuang J. Y., 1986, Acta Mycologica Sinica, V5, P75; Zhuang JianYun, 2002, Journal of Jilin Agricultural University, V24, P5; Zhuang WY, 2005, FUNGI NW CHINA; Ziller WG, 1974, TREE RUSTS W CANADA; Zwickl DJ, 2006, THESIS U TEXAS AUSTI	46	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-416X	1861-8952		MYCOL PROG	Mycol. Prog.	SEP	2015	14	9							66	10.1007/s11557-015-1091-6		11	Mycology	Mycology	CR0IF	WOS:000361001200005		
J	Akera, T; Goto, Y; Sato, M; Yamamoto, M; Watanabe, Y				Akera, Takashi; Goto, Yuhei; Sato, Masamitsu; Yamamoto, Masayuki; Watanabe, Yoshinori			Mad1 promotes chromosome congression by anchoring a kinesin motor to the kinetochore	NATURE CELL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; FISSION YEAST; CELL-CYCLE; CENP-E; SCHIZOSACCHAROMYCES-POMBE; MITOTIC CHECKPOINT; CROSS-LINKS; IN-VIVO; PROTEIN; MICROTUBULES	For proper partitioning of genomes in mitosis, all chromosomes must be aligned at the spindle equator before the onset of anaphase. The spindle assembly checkpoint (SAC) monitors this process, generating a 'wait anaphase' signal at unattached kinetochores of misaligned chromosomes. However, the link between SAC activation and chromosome alignment is poorly understood. Here we show that Mad1, a core SAC component, plays a hitherto concealed role in chromosome alignment. Protein-protein interaction screening revealed that fission yeast Mad1 binds the plus-end-directed kinesin-5 motor protein Cut7 (Eg5 homologue), which is generally thought to promote spindle bipolarity. We demonstrate that Mad1 recruits Cut7 to kinetochores of misaligned chromosomes and promotes chromosome gliding towards the spindle equator. Similarly, human Mad1 recruits another kinetochore motor CENP-E, revealing that Mad1 is the conserved dual-function protein acting in SAC activation and chromosome gliding. Our results suggest that the mitotic checkpoint has co-evolved with a mechanism to drive chromosome congression.	[Akera, Takashi; Goto, Yuhei; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Akera, Takashi; Goto, Yuhei; Sato, Masamitsu; Yamamoto, Masayuki; Watanabe, Yoshinori] Univ Tokyo, Grad Program Biophys & Biochem, Grad Sch Sci, Tokyo 1130032, Japan	Watanabe, Y (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp			JSPS Research Fellowship; MEXT KAKENHI Grant [25000014]	We thank the Yeast Genetic Resource Center (YGRC) for yeast strains, S. Hauf for critically reading the manuscript, J. Pines (Gurdon Institutein UK) for hMad1 RNAi information and all members of the Watanabe laboratory for their support and discussion. This work was supported in part by a JSPS Research Fellowship (to T.A.) and MEXT KAKENHI Grant Number 25000014 (to Y.W.).	Acar S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2348; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Barisic M, 2014, NAT CELL BIOL, V16, P1249, DOI 10.1038/ncb3060; Emre D, 2011, J CELL SCI, V124, P1664, DOI 10.1242/jcs.081216; West RR, 1998, MOL BIOL CELL, V9, P2839; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Moyle MW, 2014, J CELL BIOL, V204, P647, DOI 10.1083/jcb.201311015; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Schweizer N, 2013, J CELL BIOL, V203, P883, DOI 10.1083/jcb.201309076; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Blangy A, 1995, CELL, V83, P1159; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Cross RA, 2014, NAT REV MOL CELL BIO, V15, P257, DOI 10.1038/nrm3768; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; London N, 2014, GENE DEV, V28, P140, DOI 10.1101/gad.233700.113; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Yao XB, 2000, NAT CELL BIOL, V2, P484; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; Foley EA, 2011, NAT CELL BIOL, V13, P1265, DOI 10.1038/ncb2327; Windecker H, 2009, EMBO REP, V10, P1022, DOI 10.1038/embor.2009.183; Bernard P, 1998, J CELL BIOL, V143, P1775, DOI 10.1083/jcb.143.7.1775; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Silva PMA, 2014, FEBS LETT, V588, P3265, DOI 10.1016/j.febslet.2014.07.011; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Drummond DR, 1998, J CELL SCI, V111, P853; Espert A, 2014, J CELL BIOL, V206, P833, DOI 10.1083/jcb.201406109; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Grishchuk EL, 2007, MOL BIOL CELL, V18, P2216, DOI 10.1091/mbc.E06-11-098; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Heinrich S, 2012, J CELL SCI, V125, P4720, DOI 10.1242/jcs.110387; Hildebrandt ER, 2006, J BIOL CHEM, V281, P26004, DOI 10.1074/jbc.M604817200; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Murray AW, 2011, NAT CELL BIOL, V13, P1178, DOI 10.1038/ncb2348; Nijenhuis W, 2014, NAT CELL BIOL, V16, P1257, DOI 10.1038/ncb3065; Rodriguez-Bravo V, 2014, CELL, V156, P1017, DOI 10.1016/j.cell.2014.01.010; Sacristan C., 2014, TRENDS CELL BIOL, V25, P21; Su XL, 2013, NAT CELL BIOL, V15, P948, DOI 10.1038/ncb2801; Suijkerbuijk S. J., 2014, DEV CELL, V23, P745; van den Wildenberg SMJL, 2008, CURR BIOL, V18, P1860, DOI 10.1016/j.cub.2008.10.026; Vanoosthuyse V, 2004, MOL CELL BIOL, V24, P9786, DOI 10.1128/MCB.24.22.97886-9801.2004; Vitre B, 2014, MOL BIOL CELL, V25, P2272, DOI 10.1091/mbc.E14-01-0698; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435	55	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1124	+		10.1038/ncb3219		21	Cell Biology	Cell Biology	CR1VQ	WOS:000361113700006		
J	Yassine, HM; Boyington, JC; McTamney, PM; Wei, CJ; Kanekiyo, M; Kong, WP; Gallagher, JR; Wang, LS; Zhang, Y; Joyce, MG; Lingwood, D; Moin, SM; Andersen, H; Okuno, Y; Rao, SS; Harris, AK; Kwong, PD; Mascola, JR; Nabel, GJ; Graham, BS				Yassine, Hadi M.; Boyington, Jeffrey C.; McTamney, Patrick M.; Wei, Chih-Jen; Kanekiyo, Masaru; Kong, Wing-Pui; Gallagher, John R.; Wang, Lingshu; Zhang, Yi; Joyce, M. Gordon; Lingwood, Daniel; Moin, Syed M.; Andersen, Hanne; Okuno, Yoshinobu; Rao, Srinivas S.; Harris, Audray K.; Kwong, Peter D.; Mascola, John R.; Nabel, Gary J.; Graham, Barney S.			Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection	NATURE MEDICINE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; STALK-SPECIFIC ANTIBODIES; VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; LETHAL CHALLENGE; IN-VIVO; VACCINATION; EPITOPE; DESIGN	The antibody response to influenza is primarily focused on the head region of the hemagglutinin (HA) glycoprotein, which in turn undergoes antigenic drift, thus necessitating annual updates of influenza vaccines. In contrast, the immunogenically subdominant stem region of HA is highly conserved and recognized by antibodies capable of binding multiple HA subtypes(1-6). Here we report the structure-based development of an H1 HA stem-only immunogen that confers heterosubtypic protection in mice and ferrets. Six iterative cycles of structure-based design (Gen1-Gen6) yielded successive H1 HA stabilized-stem (HA-SS) immunogens that lack the immunodominant head domain. Antigenic characterization, determination of two HA-SS crystal structures in complex with stem-specific monoclonal antibodies and cryo-electron microscopy analysis of HA-SS on ferritin nanoparticles (H1-SS-np) confirmed the preservation of key structural elements. Vaccination of mice and ferrets with H1-SS-np elicited broadly cross-reactive antibodies that completely protected mice and partially protected ferrets against lethal heterosubtypic H5N1 influenza virus challenge despite the absence of detectable H5N1 neutralizing activity in vitro. Passive transfer of immunoglobulin from H1-SS-np-immunized mice to naive mice conferred protection against H5N1 challenge, indicating that vaccine-elicited HA stem-specific antibodies can protect against diverse group 1 influenza strains.	[Yassine, Hadi M.; Boyington, Jeffrey C.; McTamney, Patrick M.; Wei, Chih-Jen; Kanekiyo, Masaru; Kong, Wing-Pui; Wang, Lingshu; Zhang, Yi; Joyce, M. Gordon; Lingwood, Daniel; Moin, Syed M.; Rao, Srinivas S.; Kwong, Peter D.; Mascola, John R.; Nabel, Gary J.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Gallagher, John R.; Harris, Audray K.] NIAID, Struct Informat Unit, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Andersen, Hanne] BIOQUAL Inc, Rockville, MD USA; [Okuno, Yoshinobu] Osaka Univ, Res Fdn Microbial Dis, Kanonji Inst, Kanonji, Japan	Graham, BS (reprint author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gary.nabel@sanofi.com; bgraham@nih.gov			Vaccine Research Center; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]	We thank A. Taylor, H. Bao, J.P. Todd and C. Chiedi for help with the animal studies, U. Baxa for EM studies, K. Dai and X. Chen for technical support and B. Hartman for manuscript preparation. We thank M.C. Nason for excellent statistical advice and support. We also thank K. Modjarrad and laboratory members for helpful discussions. This work was supported by the Intramural Research Program of the Vaccine Research Center and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health. X-ray data were collected at the SER-CAT 22-BM beamline at the Advanced Photon Source (APS), Argonne National Laboratory. Use of APS was supported by the US Department of Energy, Basic Energy Sciences, Office of Science under contract no. W-31-109-Eng-38.	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Jegaskanda S, 2014, J IMMUNOL, V193, P469, DOI 10.4049/jimmunol.1400432; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.00641]; Luo XM, 2009, BLOOD, V113, P1422, DOI 10.1182/blood-2008-09-177139; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Sagawa H, 1996, J GEN VIROL, V77, P1483, DOI 10.1099/0022-1317-77-7-1483; Krammer F, 2014, J VIROL, V88, P3432, DOI 10.1128/JVI.03004-13; OKUNO Y, 1993, J VIROL, V67, P2552; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Lu Y, 2014, P NATL ACAD SCI USA, V111, P125, DOI 10.1073/pnas.1308701110; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; O'Hagan DT, 2013, EXPERT REV VACCINES, V12, P13, DOI [10.1586/erv.12.140, 10.1586/ERV.12.140]; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bommakanti G, 2012, J VIROL, V86, P13434, DOI 10.1128/JVI.01429-12; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; Dreyfus C, 2013, J VIROL, V87, P7149, DOI 10.1128/JVI.02975-12; Kleywegt G.J., 2001, INT TABLES CRYSTALLO, P353; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wei C.J., 2010, SCI TRANSL MED, V2, pra21, DOI DOI 10.1126/SCITRANSLMED.3000799; Wei CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004273; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865	48	5	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1065	+		10.1038/nm.3927		9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	WOS:000360961300020		
J	Calado, VE; Goswami, S; Nanda, G; Diez, M; Akhmerov, AR; Watanabe, K; Taniguchi, T; Klapwijk, TM; Vandersypen, LMK				Calado, V. E.; Goswami, S.; Nanda, G.; Diez, M.; Akhmerov, A. R.; Watanabe, K.; Taniguchi, T.; Klapwijk, T. M.; Vandersypen, L. M. K.			Ballistic Josephson junctions in edge-contacted graphene	NATURE NANOTECHNOLOGY			English	Article							QUANTUM INTERFERENCE; SUSPENDED GRAPHENE; SUPERCURRENT	Hybrid graphene-superconductor devices have attracted much attention since the early days of graphene research(1-18). So far, these studies have been limited to the case of diffusive transport through graphene with poorly defined and modest-quality graphene/superconductor interfaces, usually combined with small critical magnetic fields of the superconducting electrodes. Here, we report graphene-based Josephson junctions with one-dimensional edge contacts(19) of molybdenum rhenium. The contacts exhibit a well-defined, transparent interface to the graphene, have a critical magnetic field of 8 T at 4 K, and the graphene has a high quality due to its encapsulation in hexagonal boron nitride(19,20). This allows us to study and exploit graphene Josephson junctions in a new regime, characterized by ballistic transport. We find that the critical current oscillates with the carrier density due to phase-coherent interference of the electrons and holes that carry the supercurrent caused by the formation of a Fabry-Perot cavity. Furthermore, relatively large supercurrents are observed over unprecedented long distances of up to 1.5 mu m. Finally, in the quantum Hall regime we observe broken symmetry states while the contacts remain superconducting. These achievements open up new avenues to exploit the Dirac nature of graphene in interaction with the superconducting state.	[Calado, V. E.; Goswami, S.; Nanda, G.; Akhmerov, A. R.; Klapwijk, T. M.; Vandersypen, L. M. K.] Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; [Diez, M.] Leiden Univ, Inst Lorentz, NL-2300 RA Leiden, Netherlands; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan; [Klapwijk, T. M.] Moscow State Pedag Univ, Dept Phys, Lab Quantum Ltd Devices, Moscow 119992, Russia	Calado, VE (reprint author), Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands.	l.m.k.vandersypen@tudelft.nl		Akhmerov, Anton/0000-0001-8031-1340	EC-FET Graphene Flagship; European Research Council [339306]; European Research Council Synergy grant; Ministry of Education and Science of the Russian Federation [14.B25.31.0007]; Dutch Science Foundation OCW/NWO/FOM	The authors thank V. Singh for sharing the MoRe sputtering recipe and C. Beenakker for discussions. The authors acknowledge support from the EC-FET Graphene Flagship, from the European Research Council (advanced grant no. 339306; METIQUM), from a European Research Council Synergy grant (QC-LAB) and from the Ministry of Education and Science of the Russian Federation (contract no. 14.B25.31.0007). This work is part of the Nanofront Consortium, funded by the Dutch Science Foundation OCW/NWO/FOM.	Maher P, 2014, SCIENCE, V345, P61, DOI 10.1126/science.1252875; Akhmerov AR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.157003; Du X, 2008, NAT NANOTECHNOL, V3, P491, DOI 10.1038/nnano.2008.199; Du X, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.184507; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Popinciuc M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.205404; Varlet A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.116601; Girit C, 2009, NANO LETT, V9, P198, DOI 10.1021/nl802765x; Heersche HB, 2007, NATURE, V446, P56, DOI 10.1038/nature05555; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Beenakker CWJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.067007; Martin I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.036804; Groth CW, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/6/063065; Rickhaus P, 2012, NANO LETT, V12, P1942, DOI 10.1021/nl204415s; Coskun UC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.097003; Young AF, 2009, NAT PHYS, V5, P222, DOI 10.1038/NPHYS1198; Komatsu K, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115412; Miao F, 2009, SOLID STATE COMMUN, V149, P1046, DOI 10.1016/j.ssc.2009.01.035; Borzenets IV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.137005; Borzenets IV, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.027001; Choi JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3525; Choi JH, 2010, J KOREAN PHYS SOC, V57, P149, DOI 10.3938/jkps.57.149; Chtchelkatchev NM, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.214510; Heida JP, 1998, PHYS REV B, V57, pR5618, DOI 10.1103/PhysRevB.57.R5618; Hoppe H, 2000, PHYS REV LETT, V84, P1804, DOI 10.1103/PhysRevLett.84.1804; Jeong D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.094503; Kanda A, 2010, PHYSICA C, V470, P1477, DOI 10.1016/j.physc.2010.05.142; Ledermann U, 1999, PHYS REV B, V59, pR9027, DOI 10.1103/PhysRevB.59.R9027; Lee GH, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.146605; Mizuno N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3716; Ojeda-Aristizabal C, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.165436; Schneider BH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00599; Sheehy DE, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.144514; Tinkham M., 2004, INTRO SUPERCONDUCTIV; Voutilainen J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.045419	35	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-3387	1748-3395		NAT NANOTECHNOL	Nat. Nanotechnol.	SEP	2015	10	9					761	+		10.1038/NNANO.2015.156		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CQ9JY	WOS:000360932000010		
J	Adachi, H				Adachi, Hiroto			Back to basics	NATURE PHYSICS			English	News Item									[Adachi, Hiroto] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Adachi, Hiroto] Japan Sci & Technol Agcy, Spin Quantum Rectificat Project, ERATO, Sendai, Miyagi 9808577, Japan	Adachi, H (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan.	adachi.hiroto@jaea.go.jp	ADACHI, Hiroto/C-7889-2012	ADACHI, Hiroto/0000-0002-6844-6477			TEDROW PM, 1973, PHYS REV B, V7, P318, DOI 10.1103/PhysRevB.7.318; COHEN MH, 1962, PHYS REV LETT, V8, P316, DOI 10.1103/PhysRevLett.8.316; Jin ZM, 2015, NAT PHYS, V11, P761, DOI 10.1038/NPHYS3384; Coey J. M., 2009, MAGNETISM MAGNETIC M; Mott N.F., 1936, Proceedings of the Royal Society of London, Series A (Mathematical and Physical Sciences), V153, DOI 10.1098/rspa.1936.0031; Soulen R.J, 1998, J COEY SCI, V282, P85	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	SEP	2015	11	9					707	708				3	Physics, Multidisciplinary	Physics	CQ6IY	WOS:000360709200007		
J	Andersen, UL; Neergaard-Nielsen, JS; van Loock, P; Furusawa, A				Andersen, Ulrik L.; Neergaard-Nielsen, Jonas S.; van Loock, Peter; Furusawa, Akira			Hybrid discrete- and continuous-variable quantum information	NATURE PHYSICS			English	Article							ENTANGLEMENT DISTILLATION; MECHANICAL RESONATOR; SUPERPOSITION STATE; SINGLE-PHOTON; TELEPORTATION; LIGHT; GENERATION; CAVITY; COMMUNICATION; AMPLIFICATION	Research in quantum information processing has followed two different directions: the use of discrete variables (qubits) and that of high-dimensional, continuous-variable Gaussian states (coherent and squeezed states). Recently, these two approaches have been converging in potentially more powerful hybrid protocols.	[Andersen, Ulrik L.; Neergaard-Nielsen, Jonas S.] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark; [van Loock, Peter] Johannes Gutenberg Univ Mainz, Inst Phys, D-55128 Mainz, Germany; [Furusawa, Akira] Univ Tokyo, Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan	Andersen, UL (reprint author), Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark.	ulrik.andersen@fysik.dtu.dk			Danish Council for Independent Research (Sapere Aude programme under FTP); Danish Council for Independent Research (Sapere Aude programme under FNU); Lundbeck Foundation; Villum Foundation Young Investigator Programme; Federal Ministry for Education and Research in Germany (Q.com); ERA-NET CHISTERA (Hipercom); Ministry of Education, Culture, Sports, Science and Technology of Japan (PDIS - Project for Developing Innovation Systems, GIA); Ministry of Education, Culture, Sports, Science and Technology of Japan (APSA - Advanced Photon Science Alliance); Universities Denmark; Japan Society for the Promotion of Science	The authors gratefully acknowledge support from the Danish Council for Independent Research (Sapere Aude programmes under FTP and FNU), the Lundbeck Foundation, the Villum Foundation Young Investigator Programme, the Federal Ministry for Education and Research in Germany (Q.com), ERA-NET CHISTERA (Hipercom), the Ministry of Education, Culture, Sports, Science and Technology of Japan (PDIS - Project for Developing Innovation Systems, GIA - Grant-in-Aid for Scientific Research, and APSA - Advanced Photon Science Alliance), Universities Denmark, and Japan Society for the Promotion of Science.	Andersen UL, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.022337; Eichler C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.113601; Gottesman D, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012310; Hofheinz M, 2008, NATURE, V454, P310, DOI 10.1038/nature07136; Dakna M, 1997, PHYS REV A, V55, P3184, DOI 10.1103/PhysRevA.55.3184; Andersen UL, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.050504; Takahashi H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.233605; Jeong H, 2014, NAT PHOTONICS, V8, P564, DOI 10.1038/NPHOTON.2014.136; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241; van Loock P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.240501; Opatrny T, 2000, PHYS REV A, V61, part. no., DOI 10.1103/PhysRevA.61.032302; Stannigel K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.220501; Lvovsky AI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.050402; Bimbard E, 2010, NAT PHOTONICS, V4, P243, DOI 10.1038/NPHOTON.2010.6; Lund AP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.030503; Braunstein SL, 1998, PHYS REV LETT, V80, P869, DOI 10.1103/PhysRevLett.80.869; Andersen UL, 2010, LASER PHOTONICS REV, V4, P337, DOI 10.1002/lpor.200910010; Vlastakis B, 2013, SCIENCE, V342, P607, DOI 10.1126/science.1243289; Ramos T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.193602; Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Blandino R, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013017; Lee N, 2011, SCIENCE, V332, P330, DOI 10.1126/science.1201034; Palomaki TA, 2013, SCIENCE, V342, P710, DOI 10.1126/science.1244563; Kurochkin Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.070402; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; McConnell R, 2015, NATURE, V519, P439, DOI 10.1038/nature14293; Teissier J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.020503; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; Zhang S, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062309; Galland C, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.143602; Xiang GY, 2010, NAT PHOTONICS, V4, P316, DOI 10.1038/NPHOTON.2010.35; Ourjoumtsev A, 2006, SCIENCE, V312, P83, DOI 10.1126/science.1122858; Eisaman MD, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3610677; Monroe C, 1996, SCIENCE, V272, P1131, DOI 10.1126/science.272.5265.1131; Babichev SA, 2003, EUROPHYS LETT, V64, P1, DOI 10.1209/epl/i2003-00504-y; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Lee SW, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.022326; Bennett SD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.156402; Ourjoumtsev A, 2009, NAT PHYS, V5, P189, DOI 10.1038/NPHYS1199; Wakui K, 2007, OPT EXPRESS, V15, P3568, DOI 10.1364/OE.15.003568; Marek P, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.053802; Yukawa M, 2013, OPT EXPRESS, V21, P5529, DOI 10.1364/OE.21.005529; Raussendorf R, 2001, PHYS REV LETT, V86, P5188, DOI 10.1103/PhysRevLett.86.5188; Datta A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.060502; Ourjoumtsev A, 2007, NATURE, V448, P784, DOI 10.1038/nature06054; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Lvovsky AI, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.250401; Christensen SL, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015002; Tipsmark A, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.050301; Morin O, 2014, NAT PHOTONICS, V8, P570, DOI [10.1038/nphoton.2014.137, 10.1038/NPHOTON.2014.137]; Nemoto K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.250502; Ourjoumtsev A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.030502; Calsamiglia J, 2001, APPL PHYS B-LASERS O, V72, P67, DOI 10.1007/s003400000484; Wilson-Rae I, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.075507; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Ralph TC, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.042319; Wenger J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.153601; Takahashi H, 2010, NAT PHOTONICS, V4, P178, DOI 10.1038/NPHOTON.2010.1; Hofer SG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.170404; Ralph TC, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.022339; Laghaout A, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062127; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Zavatta A, 2004, SCIENCE, V306, P660, DOI 10.1126/science.1103190; Eichler C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.220503; Leghtas Z, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.042315; Bimbard E, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.033601; Jeong H, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052308; Esteve J, 2008, NATURE, V455, P1216, DOI 10.1038/nature07332; Ferreyrol F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.123603; Menicucci NC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.110501; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Mallet F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.220502; Chang DE, 2014, NAT PHOTONICS, V8, P685, DOI [10.1038/nphoton.2014.192, 10.1038/NPHOTON.2014.192]; Law CK, 1996, PHYS REV LETT, V76, P1055, DOI 10.1103/PhysRevLett.76.1055; Lloyd S, 1999, PHYS REV LETT, V82, P1784, DOI 10.1103/PhysRevLett.82.1784; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; Namekata N, 2010, NAT PHOTONICS, V4, P655, DOI [10.1038/nphoton.2010.158, 10.1038/NPHOTON.2010.158]; Rudner MS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.206806; Weedbrook C, 2012, REV MOD PHYS, V84, P621, DOI 10.1103/RevModPhys.84.621; Usuga MA, 2010, NAT PHYS, V6, P767, DOI 10.1038/NPHYS1743; Haas F, 2014, SCIENCE, V344, P180, DOI 10.1126/science.1248905; Chaves R, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062110; Mirrahimi M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/4/045014; YURKE B, 1986, PHYS REV LETT, V57, P13, DOI 10.1103/PhysRevLett.57.13; Takeda S, 2013, NATURE, V500, P315, DOI 10.1038/nature12366; Ourjoumtsev A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.213601; van Enk SJ, 2001, PHYS REV A, V64, part. no., DOI 10.1103/PhysRevA.64.022313; Babichev SA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.047903; Bell J.S., 1964, Physics, V1; Blandino R., 2014, CHANNEL PURIFICATION; Brask JB, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.160501; Castellanos-Beltran M. A., 2008, NATURE PHYS, V4, P929; Cooper M., 2013, OPT EXPRESS, V21, P5311; Eisert J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.137903; Fiurasek J, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012335; Fiurasek J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.137904; Garcia-Patron R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130409; Gerrits T, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.031802; Giedke G, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.032316; Glancy S, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.022317; Hammerer K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.063005; Ji SW, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.170404; Marek P, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.062321; Neergaard-Nielsen J. S., 2006, PHYS REV LETT, V97; Neergaard-Nielsen JS, 2013, NAT PHOTONICS, V7, P440, DOI [10.1038/nphoton.2013.101, 10.1038/NPHOTON.2013.101]; Neergaard-Nielsen JS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053602; Nielsen M, 2000, QUANTUM COMPUTATION; Ovartchaiyapong P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5429; Paternostro M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.183601; Quintino MT, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/21/215308; Rabl P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.041302; Ralph T. C., 2009, AIP C P, P155; Resch KJ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.113601; Sangouard N, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052122; Spiller TP, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/030; Suzuki S, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.042304; Teo C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3104; Tipsmark A, 2013, OPT EXPRESS, V21, P6670, DOI 10.1364/OE.21.006670; Zaidi HA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.260501; Zavatta A., 2010, NATURE PHOTON, V5, P52	121	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	SEP	2015	11	9					713	719		10.1038/NPHYS3410		7	Physics, Multidisciplinary	Physics	CQ6IY	WOS:000360709200010		
J	Ishiuchi, T; Enriquez-Gasca, R; Mizutani, E; Boskovic, A; Ziegler-Birling, C; Rodriguez-Terrones, D; Wakayama, T; Vaquerizas, JM; Torres-Padilla, ME				Ishiuchi, Takashi; Enriquez-Gasca, Rocio; Mizutani, Eiji; Boskovic, Ana; Ziegler-Birling, Celine; Rodriguez-Terrones, Diego; Wakayama, Teruhiko; Vaquerizas, Juan M.; Torres-Padilla, Maria-Elena			Early embryonic-like cells are induced by downregulating replication-dependent chromatin assembly	NATURE STRUCTURAL & MOLECULAR BIOLOGY			English	Article							EARLY MOUSE DEVELOPMENT; DNA-REPLICATION; CONSTITUTIVE HETEROCHROMATIN; NUCLEAR TRANSFER; STEM-CELLS; IN-VIVO; TOTIPOTENCY; REQUIRES; INVITRO; CAF-1	Cellular plasticity is essential for early embryonic cells. Unlike pluripotent cells, which form embryonic tissues, totipotent cells can generate a complete organism including embryonic and extraembryonic tissues. Cells resembling 2-cell-stage embryos (2C-like cells) arise at very low frequency in embryonic stem (ES) cell cultures. Although induced reprogramming to pluripotency is well established, totipotent cells remain poorly characterized, and whether reprogramming to totipotency is possible is unknown. We show that mouse 2C-like cells can be induced in vitro through downregulation of the chromatin-assembly activity of CAF-1. Endogenous retroviruses and genes specific to 2-cell embryos are the highest-upregulated genes upon CAF-1 knockdown. Emerging 2C-like cells exhibit molecular characteristics of 2-cell embryos and higher reprogrammability than ES cells upon nuclear transfer. Our results suggest that early embryonic-like cells can be induced by modulating chromatin assembly and that atypical histone deposition may trigger the emergence of totipotent cells.	[Ishiuchi, Takashi; Boskovic, Ana; Ziegler-Birling, Celine; Rodriguez-Terrones, Diego; Torres-Padilla, Maria-Elena] CNRS, UMR7104, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Ishiuchi, Takashi; Boskovic, Ana; Ziegler-Birling, Celine; Rodriguez-Terrones, Diego; Torres-Padilla, Maria-Elena] INSERM, U964, Illkirch Graffenstaden, France; [Enriquez-Gasca, Rocio; Vaquerizas, Juan M.] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Mizutani, Eiji; Wakayama, Teruhiko] Univ Yamanashi, Fac Life & Environm Sci, Yamanashi, Japan	Torres-Padilla, ME (reprint author), CNRS, UMR7104, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France.	metp@igbmc.fr		Vaquerizas, Juan M/0000-0002-6583-6541	EpiGeneSys NoE; ERC-Stg 'NuclearPotency'; FP7 Marie-Curie Actions ITN Nucleosome4D; European Molecular Biology Organization Young Investigator Programme; Fondation Schlumberger pour l'Education et la Recherche; Deutsche Forschungsgemeinschaft Cells-in-Motion Cluster of Excellence [EXC 1003-CiM]; University of Munster; Max Planck Society; KAKENHI [23248048]; Takeda Science Foundation; Uehara Memorial Foundation; Human Frontier Science Programme; Association pour la Recherche Contre le Cancer; Direccion General de Cooperacion e Internacionalizacion fellowship from the National University of Mexico;  [ANR-10-LABX-0030-INRT]	We thank G. Almouzni and J.P. Quivy (Institut Curie) for providing antibodies to p150 and p60 and for helpful discussions, M. Takeichi (RIKEN Center for Developmental Biology) for pCAG-IRES-Hygro vector, S. Matoba for sharing the list of RRRs, M. Oginuma for help with embryo analysis, B. Jost, M. Philips and S. Vicaire from the Sequencing facility of the Institut Genetique Biologie Moleculaire Cellulaire, C. Ebel for support with FACS, M. Koch for advice on imaging, C. Noll for help in western blotting analysis, R. Diaz-Uriarte for statistical advice, C. Hug for help with code testing, P. Andre and M. Wattenhofer-Donze from the Institut Clinique de la Souris (ICS) for help with ES-cell work and A. J. Bannister for critical reading of the manuscript. M.-E. T.-P. acknowledges funding from EpiGeneSys NoE, ERC-Stg 'NuclearPotency', the FP7 Marie-Curie Actions ITN Nucleosome4D, the European Molecular Biology Organization Young Investigator Programme and the Fondation Schlumberger pour l'Education et la Recherche. J.M.V. acknowledges funding from EpiGeneSys NoE, Deutsche Forschungsgemeinschaft Cells-in-Motion Cluster of Excellence (EXC 1003-CiM), University of Munster and the Max Planck Society. Work in T.W.'s laboratory is funded through KAKENHI 23248048 and the Takeda Science Foundation. T.I. is supported as a recipient of postdoctoral fellowships from Uehara Memorial Foundation and Human Frontier Science Programme, and A.B. was supported as a recipient of a fellowship from the Association pour la Recherche Contre le Cancer. D.R.-T. is supported by a Direccion General de Cooperacion e Internacionalizacion fellowship from the National University of Mexico. R.E.-G. is a member of the graduate school International Max Planck Research School-Molecular Biomedicine, Munster, Germany. This work received partial support from ANR-10-LABX-0030-INRT.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; HOWLETT SK, 1987, DEVELOPMENT, V101, P915; TARKOWSKI AK, 1959, NATURE, V184, P1286, DOI 10.1038/1841286a0; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Casanova M, 2013, CELL REP, V4, P1156, DOI 10.1016/j.celrep.2013.08.015; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Huang H, 2010, J CELL SCI, V123, P2853, DOI 10.1242/jcs.063610; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Ben-Shahar TR, 2009, MOL CELL BIOL, V29, P6353, DOI 10.1128/MCB.01051-09; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Nabatiyan A, 2004, MOL CELL BIOL, V24, P2853, DOI 10.1128/MCB.24.7.2853-2862.2004; Evsikov AV, 2004, CYTOGENET GENOME RES, V105, P240, DOI 10.1159/000078195; Ishiuchi T, 2013, CURR OPIN GENET DEV, V23, P512, DOI 10.1016/j.gde.2013.06.006; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Quivy JP, 2008, NAT STRUCT MOL BIOL, V15, P972, DOI 10.1038/nsmb.1470; Terranova R, 2005, EXP CELL RES, V310, P344, DOI 10.1016/j.yexcr.2005.07.031; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Boskovic A, 2014, GENE DEV, V28, P1042, DOI 10.1101/gad.238881.114; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Probst AV, 2007, CHROMOSOMA, V116, P403, DOI 10.1007/s00412-007-0106-8; Inoue A, 2012, CELL RES, V22, P1640, DOI 10.1038/cr.2012.160; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Hiiragi T, 2005, MOL REPROD DEV, V70, P417, DOI 10.1002/mrd.20126; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Love M. I., 2014, BIORXIV, V15, P550, DOI [10.1101/002832, DOI 10.1101/002832]; Maksakova IA, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-12; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; SMITH S, 1991, EMBO J, V10, P971; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; WOOD SA, 1993, P NATL ACAD SCI USA, V90, P4582, DOI 10.1073/pnas.90.10.4582	43	6	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1545-9993	1545-9985		NAT STRUCT MOL BIOL	Nat. Struct. Mol. Biol.	SEP	2015	22	9					662	U35		10.1038/nsmb.3066		13	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CQ9KK	WOS:000360933200008		
J	Sakai, K; Ikeda, Y; Ishida, C; Matsumoto, Y; Ono, K; Iwasa, K; Yamada, M				Sakai, Kenji; Ikeda, Yoshihisa; Ishida, Chiho; Matsumoto, Yasuko; Ono, Kenjiro; Iwasa, Kazuo; Yamada, Masahito			Inclusion body myositis with granuloma formation in muscle tissue	NEUROMUSCULAR DISORDERS			English	Article						Inclusion body myositis; Granuloma; Rimmed vacuole; Autophagy	IDIOPATHIC INFLAMMATORY MYOPATHIES; SARCOIDOSIS; AUTOPHAGY	Inclusion body myositis is a form of inflammatory myopathy. We identified 4 cases of inclusion body myositis showing granuloma formation in muscle tissue and aimed to assess the features of this atypical form of inclusion body myositis. We retrospectively reviewed consecutive patients who satisfied European Neuromuscular Centre IBM Research Diagnostic Criteria 2011. Then, we assessed clinical profiles and pathological findings in patients with inclusion body myositis with granuloma and compared these findings with those of typical inclusion body myositis without granuloma. We identified 15 patients with inclusion body myositis. Four patients showed granuloma formation in muscle tissue in addition to typical pathological features of inclusion body myositis. Granulomas comprised a mixture of inflammatory cells, such as macrophages, epithelioid histiocytic cells, and lymphocytes. One patient was found to have mediastinal granulomatous lymphadenopathy; however, the evidence in other patients was insufficient for a diagnosis of systemic sarcoidosis. There were no significant differences between groups with and without granuloma regarding clinical manifestations, laboratory findings, response to immunomodulating therapies, or myopathological profiles. We established a new form of inclusion body myositis showing granuloma formation in muscle tissue. Inclusion body myositis and granuloma formation could have identical pathomechanisms concerning dysregulation of autophagy. (C) 2015 Elsevier B.V. All rights reserved.	[Sakai, Kenji; Ikeda, Yoshihisa; Ishida, Chiho; Matsumoto, Yasuko; Ono, Kenjiro; Iwasa, Kazuo; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa 9208640, Japan; [Ikeda, Yoshihisa; Ishida, Chiho] Natl Hosp Org Iou Hosp, Dept Neurol, Kanazawa, Ishikawa, Japan; [Matsumoto, Yasuko] Ishikawa Prefectural Cent Hosp, Dept Neurol, Kanazawa, Ishikawa, Japan	Sakai, K (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	ksakai@med.kanazawa-u.ac.jp					Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; Brunn A, 2012, J NEUROPATH EXP NEUR, V71, P855, DOI 10.1097/NEN.0b013e31826bf7f3; Benveniste O, 2015, ACTA NEUROPATHOL, V129, P611, DOI 10.1007/s00401-015-1384-5; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Vattemi G, 2008, RHEUMATOLOGY, V47, P1433, DOI 10.1093/rheumatology/ken252; De Paepe B, 2005, ACTA NEUROPATHOL, V109, P576, DOI 10.1007/s00401-005-0989-5; Lloyd TE, 2014, NEUROLOGY, V83, P426, DOI 10.1212/WNL.0000000000000642; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Banker BQ, 2004, MYOLOGY, P1445; Brinar M, 2012, J CROHNS COLITIS, V6, P43, DOI 10.1016/j.crohns.2011.06.008; Cappelletti C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111490; DANON MJ, 1986, CAN J NEUROL SCI, V13, P334; Kitazawa M, 2006, AM J PATHOL, V168, P1986, DOI 10.2353/ajpath.2006.051232; Larue S, 2011, J NEUROL NEUROSUR PS, V82, P674, DOI 10.1136/jnnp.2009.190751; Le Roux K, 2007, MUSCLE NERVE, V35, P171, DOI 10.1002/mus.20683; MHIRI C, 1990, NEUROPATH APPL NEURO, V16, P333, DOI 10.1111/j.1365-2990.1990.tb01267.x; Mikol J, 2004, MYOLOGY, V3rd, P1367; Prayson RA, 1999, AM J CLIN PATHOL, V112, P63; Prieto-Gonzalez S, 2014, AUTOIMMUN REV, V13, P372, DOI 10.1016/j.autrev.2014.01.017; Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	SEP	2015	25	9					706	712		10.1016/j.nmd.2015.06.460		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CQ7IF	WOS:000360775500005		
J	Izumida, Y; Okuda, K				Izumida, Yuki; Okuda, Koji			Linear irreversible heat engines based on local equilibrium assumptions	NEW JOURNAL OF PHYSICS			English	Article						linear irreversible thermodynamics; local equilibrium assumptions; finite-time Carnot cycle; efficiency at maximum power	MAXIMUM POWER; OPTIMAL CONFIGURATION; SOLVABLE MODEL; EFFICIENCY; THERMODYNAMICS; CYCLES	We formulate an endoreversible finite-time Carnot cycle model based on the assumptions of local equilibrium and constant energy flux, where the efficiency and the power are expressed in terms of the thermodynamic variables of the working substance. By analyzing the entropy production rate caused by the heat transfer in each isothermal process during the cycle, and using the endoreversible condition applied to the linear response regime, we identify the thermodynamic flux and force of the present system and obtain a linear relation that connects them. We calculate the efficiency at maximum power in the linear response regime by using the linear relation, which agrees with the Curzon-Ahlborn (CA) efficiency known as the upper bound in this regime. This reason is also elucidated by rewriting our model into the form of the Onsager relations, where our model turns out to satisfy the tight-coupling condition leading to the CA efficiency.	[Izumida, Yuki] Ochanomizu Univ, Dept Informat Sci, Tokyo 1128610, Japan; [Okuda, Koji] Hokkaido Univ, Div Phys, Sapporo, Hokkaido 0600810, Japan	Izumida, Y (reprint author), Nagoya Univ, Dept Complex Syst Sci, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan.	izumida@is.nagoya-u.ac.jp			 [25-9748]	The authors are grateful to anonymous referees for helpful comments on the manuscript. Y I acknowledges the financial support from a Grant-in-Aid for JSPS Fellows (Grant No. 25-9748).	Abe S, 2010, PHYS REV E, V83; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; Esposito M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.130602; Jarzynski C, 1999, PHYS REV E, V59, P6448, DOI 10.1103/PhysRevE.59.6448; Esposito M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041106; Izumida Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.180603; Izumida Y, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021121; LANDSBERG PT, 1989, J PHYS A-MATH GEN, V22, P4019, DOI 10.1088/0305-4470/22/18/034; Tu ZC, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/31/312003; Salamon P, 2001, ENERGY, V26, P307, DOI 10.1016/S0360-5442(00)00059-1; Van den Broeck C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.190602; Nakagawa N, 2006, EUROPHYS LETT, V75, P22, DOI 10.1209/epl/i2006-10080-2; Seifert U, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126001; RUBIN MH, 1979, PHYS REV A, V19, P1277, DOI 10.1103/PhysRevA.19.1277; Birjukov J, 2008, EUR PHYS J B, V64, P105, DOI 10.1140/epjb/e2008-00270-2; Hoppenau J, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062127; Abah O, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.203006; RUBIN MH, 1979, PHYS REV A, V19, P1272, DOI 10.1103/PhysRevA.19.1272; Gaveau B, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.060601; Rutten B, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235122; Apertet Y, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/28001; Bejan A, 1996, J APPL PHYS, V79, P1191, DOI 10.1063/1.362674; CURZON FL, 1975, AM J PHYS, V43, P22, DOI 10.1119/1.10023; Allahverdyan AE, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041118; Goupil C, 2011, ENTROPY-SWITZ, V13, P1481, DOI 10.3390/e13081481; Esposito M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.150603; Blickle V, 2012, NAT PHYS, V8, P143, DOI [10.1038/nphys2163, 10.1038/NPHYS2163]; Apertet Y, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041144; Apertet Y, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.031116; Benenti G, 2011, PHYS REV LETT, V106, P23602; Benenti G., 2013, ARXIV13114430; Berry R S, 2000, THERMODYNAMICS OPTIM; Brandner K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.070603; Callen H B, 1985, THERMODYNAMICS INTRO; de Groot S.R, 1984, NONEQUILIBRIUM THERM; de Tomas C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.010104; Gomez-Marin A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.062102; GORDON JM, 1989, AM J PHYS, V57, P1136, DOI 10.1119/1.16130; Izumida Y, 2010, EUR PHYS J B, V77, P499, DOI 10.1140/epjb/e2010-00285-0; Izumida Y, UNPUB; Izumida Y, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40569-1; Izumida Y, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/60003; Izumida Y, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/10004; de Cisneros BJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.130602; de Cisneros BJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041127; KEDEM O, 1965, T FARADAY SOC, V61, P1897, DOI 10.1039/tf9656101897; Moran M. J., 2010, FUNDAMENTALS ENG THE; Novikov I.I., 1958, Journal of Nuclear Energy, V7, DOI 10.1016/0891-3919(58)90244-4; Reif F., 2009, FUNDAMENTALS STAT TH; Rossnagel J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.030602; Sano T G, 2014, ARXIV14124468; Schmiedl T, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/20003; Seifert U, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.020601; Sheng SQ, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012129; Sheng S, 2014, PHYS REV E, V91; Tu ZC, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/2/020513; Van den Broeck C, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10009; Van den Broeck C, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/10006; Vaudrey A, 2014, J NON-EQUIL THERMODY, V39, P199, DOI 10.1515/jnet-2014-0018; Verley G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5721; Wang Y, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/40001; Yvon Y, 1955, P INT C PEAC US AT E, V2, P337	62	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1367-2630			NEW J PHYS	New J. Phys.	SEP 1	2015	17								085011	10.1088/1367-2630/17/8/085011		11	Physics, Multidisciplinary	Physics	CQ9TW	WOS:000360959100001		
J	Farneti, R; Downes, SM; Griffies, SM; Marsland, SJ; Behrens, E; Bentsen, M; Bi, DH; Biastoch, A; Boning, C; Bozec, A; Canuto, VM; Chassignet, E; Danabasoglu, G; Danilov, S; Diansky, N; Drange, H; Fogli, PG; Gusev, A; Hallberg, RW; Howard, A; Ilicak, M; Jung, T; Kelley, M; Large, WG; Leboissetier, A; Long, M; Lu, JH; Masina, S; Mishra, A; Navarra, A; Nurser, AJG; Patara, L; Samuels, BL; Sidorenko, D; Tsujino, H; Uotila, P; Wang, Q; Yeager, SG				Farneti, Riccardo; Downes, Stephanie M.; Griffies, Stephen M.; Marsland, Simon J.; Behrens, Erik; Bentsen, Mats; Bi, Daohua; Biastoch, Arne; Boening, Claus; Bozec, Alexandra; Canuto, Vittorio M.; Chassignet, Eric; Danabasoglu, Gokhan; Danilov, Sergey; Diansky, Nikolay; Drange, Helge; Fogli, Pier Giuseppe; Gusev, Anatoly; Hallberg, Robert W.; Howard, Armando; Ilicak, Mehmet; Jung, Thomas; Kelley, Maxwell; Large, William G.; Leboissetier, Anthony; Long, Matthew; Lu, Jianhua; Masina, Simona; Mishra, Akhilesh; Navarra, Antonio; Nurser, A. J. George; Patara, Lavinia; Samuels, Bonita L.; Sidorenko, Dmitry; Tsujino, Hiroyuki; Uotila, Petteri; Wang, Qiang; Yeager, Steve G.			An assessment of Antarctic Circumpolar Current and Southern Ocean meridional overturning circulation during 1958-2007 in a suite of interannual CORE-II simulations	OCEAN MODELLING			English	Article						Global oceara--sea ice modeling; Model comparisons; Southern Ocean meridional overturning circulation; Antarctic Circumpolar Current; Southern Ocean dynamics	NORTH-ATLANTIC SIMULATIONS; COUPLED CLIMATE MODEL; DRAKE PASSAGE; ANNULAR MODE; GLOBAL CLIMATE; SEA-ICE; PART I; THICKNESS DIFFUSIVITY; CMIP5 MODELS; MIXED-LAYER	In the framework of the second phase of the Coordinated Ocean-ice Reference Experiments (CORE-II), we present an analysis of the representation of the Antarctic Circumpolar Current (ACC) and Southern Ocean meridional overturning circulation (MOC) in a suite of seventeen global ocean-sea ice models. We focus on the mean, variability and trends of both the ACC and MOC over the 1958-2007 period, and discuss their relationship with the surface forcing. We aim to quantify the degree of eddy saturation and eddy compensation in the models participating in CORE-II, and compare our results with available observations, previous fineresolution numerical studies and theoretical constraints. Most models show weak ACC transport sensitivity to changes in forcing during the past five decades, and they can be considered to be in an eddy saturated regime. Larger contrasts arise when considering MOC trends, with a majority of models exhibiting significant strengthening of the MOC during the late 20th and early 21st century. Only a few models show a relatively small sensitivity to forcing changes, responding with an intensified eddy-induced circulation that provides some degree of eddy compensation, while still showing considerable decadal trends. Both ACC and MOC interannual variabilities are largely controlled by the Southern Annular Mode (SAM). Based on these results, models are clustered into two groups. Models with constant or two-dimensional (horizontal) specification of the eddy-induced advection coefficient K show larger ocean interior decadal trends, larger ACC transport decadal trends and no eddy compensation in the MOC. Eddy-permitting models or models with a threedimensional time varying K show smaller changes in isopycnal slopes and associated ACC trends, and partial eddy compensation. As previously argued, a constant in time or space lc is responsible for a poor representation of mesoscale eddy effects and cannot properly simulate the sensitivity of the ACC and MOC to changing surface forcing. Evidence is given for a larger sensitivity of the MOC as compared to the ACC transport, even when approaching eddy saturation. Future process studies designed for disentangling the role of momentum and buoyancy forcing in driving the ACC and MOC are proposed. (C) 2015 Elsevier Ltd. All rights reserved.	[Farneti, Riccardo] Abdus Salaam Int Ctr Theoret Phys, Trieste, Italy; [Downes, Stephanie M.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Downes, Stephanie M.] Australian Natl Univ, ARC Ctr Excellence Climate Syst Sci, Canberra, ACT 0200, Australia; [Griffies, Stephen M.; Hallberg, Robert W.; Samuels, Bonita L.] NOAA Geophys Fluid Dynam Lab GFDL, Princeton, NJ USA; [Marsland, Simon J.; Bi, Daohua; Uotila, Petteri] Ctr Australian Weather & Climate Res, Aspendale, Vic, Australia; [Behrens, Erik; Biastoch, Arne; Boening, Claus; Patara, Lavinia] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Bentsen, Mats; Ilicak, Mehmet] Uni Res Ltd, Bergen, Norway; [Bozec, Alexandra; Chassignet, Eric; Lu, Jianhua; Mishra, Akhilesh] Florida State Univ, COAPS, Tallahassee, FL 32306 USA; [Canuto, Vittorio M.; Howard, Armando; Kelley, Maxwell; Leboissetier, Anthony] NASA Goddard Inst Space Studies GISS, New York, NY USA; [Danabasoglu, Gokhan; Large, William G.; Long, Matthew; Yeager, Steve G.] NCAR, Boulder, CO USA; [Danilov, Sergey; Jung, Thomas; Sidorenko, Dmitry; Wang, Qiang] AWI, Helmholtz Ctr Polar & Marine Res, Bremerhaven, Germany; [Diansky, Nikolay; Gusev, Anatoly] Russian Acad Sci, Inst Numer Math, Moscow, Russia; [Drange, Helge] Univ Bergen, Bergen, Norway; [Fogli, Pier Giuseppe; Masina, Simona; Navarra, Antonio] Ctr Euromediterraneo Cambiamenti Climat CMCC, Bologna, Italy; [Leboissetier, Anthony] Trinnovim LLC, New York, NY USA; [Masina, Simona; Navarra, Antonio] INGV, Bologna, Italy; [Nurser, A. J. George] NOCS, Southampton, Hants, England; [Tsujino, Hiroyuki] Japan Meteorol Agcy, MRI, Tsukuba, Ibaraki, Japan; [Uotila, Petteri] Finnish Meteorol Inst, FIN-00101 Helsinki, Finland; [Howard, Armando] CUNY Medgar Evers Coll, New York, NY USA	Farneti, R (reprint author), Abdus Salaam Int Ctr Theoret Phys, Trieste, Italy.	rfarneti@ictp.it	Marsland, Simon/A-1453-2012; Boening, Claus/B-1686-2012; Uotila, Petteri/A-1703-2012; Farneti, Riccardo/B-5183-2011; ILICAK, Mehmet/H-2219-2011; Bi, Daohua/O-4508-2015; Gusev, Anatoly/A-8528-2014	Boening, Claus/0000-0002-6251-5777; Uotila, Petteri/0000-0002-2939-7561; ILICAK, Mehmet/0000-0002-4777-8835; Gusev, Anatoly/0000-0002-6463-3179	international CLIVAR office; U.S. CLIVAR project office; Australian Government Department of the Environment; Bureau of Meteorology; CSIRO through the Australian Climate Change Science Programme; ARC Centre of Excellence for Climate System Science [CE110001028]; Helmholtz Climate Initiative REKLIM (Regional Climate Change) project; Research Council of Norway through the EarthClim project [207711/E10]; Research Council of Norway through the NOTUR/NorStore project; Centre for Climate Dynamics at the Bjerknes Centre for Climate Research; Italian Ministry of Education, University, and Research; Italian Ministry of Environment, Land, and Sea; U. S. National Science Foundation (NSF); Cluster of Excellence 'The Future Ocean'; Excellence Initiative by the DFG; Russian Science Foundation [14-27-00126]; NOAA Climate Program Office under Climate Variability and Predictability Program [NA09OAR4310163, NA130AR4310138]; NSF [OCE-1243015]	The WCRP/CLIVAR Ocean Model Development Panel (OMDP) is responsible for organizing the Coordinated Ocean-sea ice Reference Experiments, with support from the international CLIVAR and U.S. CLIVAR project offices. We are grateful for the efforts of modelers who have contributed to the simulation and processing of the CORE-II experiments. Dedicated disk space has been secured at NCAR to host and disseminate the CORE-II simulation data sets produced by the participating groups. The infrastructure is currently being tested. Guidelines on how to access the dataset will be posted on the following website http://www.clivar.org/clivar-panels/omdp/core-2#data as soon as the data is available. In the meantime, data can be requested from the individual modeling groups.; The ACCESS model is supported by the Australian Government Department of the Environment, the Bureau of Meteorology and CSIRO through the Australian Climate Change Science Programme. S. M. Downes was supported by the ARC Centre of Excellence for Climate System Science (grant CE110001028). AWI is a member of the Helmholtz Association of German Research Centers. Q. Wang and D. Sidorenko are funded by the Helmholtz Climate Initiative REKLIM (Regional Climate Change) project. The BERGEN contribution is supported by the Research Council of Norway through the EarthClim (207711/E10) and NOTUR/NorStore projects, as well as the Centre for Climate Dynamics at the Bjerknes Centre for Climate Research. The CMCC contribution received funding from the Italian Ministry of Education, University, and Research and the Italian Ministry of Environment, Land, and Sea under the GEMINA project. NCAR is sponsored by the U. S. National Science Foundation (NSF). The GEOMAR experiments were performed at the North German Supercomputing Alliance (HLRN). L. Patara was financially supported by the Cluster of Excellence 'The Future Ocean' funded within the framework of the Excellence Initiative by the DFG. The INMOM model was sponsored by the Russian Science Foundation (project number 14-27-00126). S. G. Yeager was supported by the NOAA Climate Program Office under Climate Variability and Predictability Program Grant NA09OAR4310163 and NA130AR4310138 and by the NSF Collaborative Research EaSM2 grant OCE-1243015. We thank Carolina Dufour, Adele Morrison and Ivy Frenger for comments on earlier drafts. The authors would also like to thank the three anonymous reviewers for their insightful and constructive comments and suggestions on the manuscript.	Allison LC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043355; Thompson DWJ, 2011, NAT GEOSCI, V4, P741, DOI [10.1038/ngeo1296, 10.1038/NGEO1296]; REDI MH, 1982, J PHYS OCEANOGR, V12, P1154, DOI 10.1175/1520-0485(1982)012<1154:OIMBCR>2.0.CO;2; Curry R, 2003, NATURE, V426, P826, DOI 10.1038/nature02206; Russell JL, 2006, J CLIMATE, V19, P6382, DOI 10.1175/JCLI3984.1; Sijp WP, 2004, J PHYS OCEANOGR, V34, P1254, DOI 10.1175/1520-0485(2004)034<1254:EOTDPT>2.0.CO;2; Danabasoglu G, 1995, J CLIMATE, V8, P2967, DOI 10.1175/1520-0442(1995)008<2967:SOTGOC>2.0.CO;2; Eden C, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026157; Chassignet EP, 2003, J PHYS OCEANOGR, V33, P2504, DOI 10.1175/1520-0485(2003)033<2504:NASWTH>2.0.CO;2; Hallberg R, 2006, J PHYS OCEANOGR, V36, P2232, DOI 10.1175/JPO2980.1; Renault A, 2011, DEEP-SEA RES PT II, V58, P2572, DOI 10.1016/j.dsr2.2011.01.004; Talley LD, 2008, PROG OCEANOGR, V78, P257, DOI 10.1016/j.pocean.2008.05.001; Bentsen M, 2013, GEOSCI MODEL DEV, V6, P687, DOI 10.5194/gmd-6-687-2013; Cessi P, 2008, J PHYS OCEANOGR, V38, P1807, DOI 10.1175/2007JPO3812.1; Wang Q, 2014, GEOSCI MODEL DEV, V7, P663, DOI 10.5194/gmd-7-663-2014; Ferrari R, 2010, OCEAN MODEL, V32, P143, DOI 10.1016/j.ocemod.2010.01.004; Zika JD, 2013, J PHYS OCEANOGR, V43, P941, DOI 10.1175/JPO-D-12-0178.1; Yukimoto S, 2012, J METEOROL SOC JPN, V90A, P23, DOI 10.2151/jmsj.2012-A02; Fox-Kemper B, 2011, OCEAN MODEL, V39, P61, DOI 10.1016/j.ocemod.2010.09.002; Sen Gupta A, 2006, J CLIMATE, V19, P4457, DOI 10.1175/JCLI3843.1; Marshall J, 2012, NAT GEOSCI, V5, P171, DOI [10.1038/ngeo1391, 10.1038/NGEO1391]; Fox-Kemper B, 2008, J PHYS OCEANOGR, V38, P1145, DOI 10.1175/2007JPO3792.1; Viebahn J, 2012, J PHYS OCEANOGR, V42, P1486, DOI 10.1175/JPO-D-11-087.1; Downes SM, 2013, J CLIMATE, V26, P7198, DOI 10.1175/JCLI-D-12-00504.1; Ferrari R, 2010, J PHYS OCEANOGR, V40, P1501, DOI 10.1175/2010JPO4278.1; Marshall DP, 2010, OCEAN MODEL, V32, P188, DOI 10.1016/j.ocemod.2010.02.001; Marshall J, 2003, J PHYS OCEANOGR, V33, P2341, DOI 10.1175/1520-0485(2003)033<2341:RSFTAC>2.0.CO;2; Bi DH, 2013, AUST METEOROL OCEAN, V63, P213; Watson AJ, 2006, TELLUS B, V58, P73, DOI 10.1111/j.1600-0889.2005.00167.x; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Hughes CW, 1999, J PHYS OCEANOGR, V29, P1971, DOI 10.1175/1520-0485(1999)029<1971:WDTFTD>2.0.CO;2; Meredith MP, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026499; Gent PR, 2011, J CLIMATE, V24, P4992, DOI 10.1175/JCLI-D-10-05011.1; Dunne JP, 2012, J CLIMATE, V25, P6646, DOI 10.1175/JCLI-D-11-00560.1; Griffies SM, 2009, OCEAN MODEL, V26, P1, DOI 10.1016/j.ocemod.2008.08.007; Dufour CO, 2012, J CLIMATE, V25, P6958, DOI 10.1175/JCLI-D-11-00309.1; Sallee JB, 2008, J MAR RES, V66, P441; Danabasoglu G, 2007, OCEAN MODEL, V18, P122, DOI 10.1016/j.ocemod.2007.03.006; Wang Z, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006757; MARSHALL J, 1993, J PHYS OCEANOGR, V23, P465, DOI 10.1175/1520-0485(1993)023<0465:PVCOTD>2.0.CO;2; Volodin EM, 2010, IZV ATMOS OCEAN PHY+, V46, P414, DOI 10.1134/S000143381004002X; Halliwell GR, 2004, OCEAN MODEL, V7, P285, DOI 10.1016/j.ocemod.2003.10.002; Yeager S, 2014, J CLIMATE, V27, P3222, DOI 10.1175/JCLI-D-13-00125.1; Delworth TL, 2012, J CLIMATE, V25, P2755, DOI 10.1175/JCLI-D-11-00316.1; Frolicher TL, 2015, J CLIMATE, V28, P862, DOI 10.1175/JCLI-D-14-00117.1; Danabasoglu G, 2012, J CLIMATE, V25, P1361, DOI 10.1175/JCLI-D-11-00091.1; DOOS K, 1994, J PHYS OCEANOGR, V24, P429, DOI 10.1175/1520-0485(1994)024<0429:TDCATO>2.0.CO;2; Meredith MP, 2012, J CLIMATE, V25, P99, DOI 10.1175/2011JCLI4204.1; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Treguier AM, 2007, OCEAN SCI, V3, P491; Cerovecki I, 2011, J CLIMATE, V24, P6283, DOI 10.1175/2011JCLI3858.1; Viebahn J, 2010, OCEAN MODEL, V34, P150, DOI 10.1016/j.ocemod.2010.05.005; Tsujino H, 2011, J OCEANOGR, V67, P449, DOI 10.1007/s10872-011-0050-3; Ballarotta M, 2013, OCEAN MODEL, V64, P46, DOI 10.1016/j.ocemod.2013.01.005; McDougall TJ, 2001, J PHYS OCEANOGR, V31, P1222, DOI 10.1175/1520-0485(2001)031<1222:TTRMVP>2.0.CO;2; Meijers AJS, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008412; Morrison AK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048031; Cunningham SA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001147; Kuhlbrodt T, 2007, REV GEOPHYS, V45, DOI 10.1029/2004RG000166; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Abernathey R, 2011, J PHYS OCEANOGR, V41, P2261, DOI 10.1175/JPO-D-11-023.1; Marshall J, 2006, PROG OCEANOGR, V70, P331, DOI 10.1016/j.pocean.2006.07.004; Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; Downes SM, 2011, J PHYS OCEANOGR, V41, P1756, DOI 10.1175/2011JPO4586.1; Langlais CE, 2015, J PHYS OCEANOGR, V45, P1051, DOI 10.1175/JPO-D-14-0053.1; Hallberg R, 2001, J PHYS OCEANOGR, V31, P3312, DOI 10.1175/1520-0485(2001)031<3312:AEOTRO>2.0.CO;2; Morrison AK, 2013, J PHYS OCEANOGR, V43, P140, DOI 10.1175/JPO-D-12-057.1; Griffies SM, 1998, J PHYS OCEANOGR, V28, P831, DOI 10.1175/1520-0485(1998)028<0831:TGMSF>2.0.CO;2; Munday DR, 2013, J PHYS OCEANOGR, V43, P507, DOI 10.1175/JPO-D-12-095.1; Olbers D, 2005, J PHYS OCEANOGR, V35, P1190, DOI 10.1175/JPO2750.1; Griesel A, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007573; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Bi DH, 2013, AUST METEOROL OCEAN, V63, P41; Treguier AM, 1997, J PHYS OCEANOGR, V27, P567, DOI 10.1175/1520-0485(1997)027<0567:POQEIP>2.0.CO;2; Eden C, 2008, OCEAN MODEL, V20, P223, DOI 10.1016/j.ocemod.2007.09.002; Large WG, 2009, CLIM DYNAM, V33, P341, DOI 10.1007/s00382-008-0441-3; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; GENT PR, 1995, J PHYS OCEANOGR, V25, P463, DOI 10.1175/1520-0485(1995)025<0463:PEITTI>2.0.CO;2; Bryan FO, 2014, J CLIMATE, V27, P411, DOI 10.1175/JCLI-D-12-00759.1; STRAUB DN, 1993, J PHYS OCEANOGR, V23, P776, DOI 10.1175/1520-0485(1993)023<0776:OTTAAM>2.0.CO;2; Abernathey RP, 2013, J GEOPHYS RES-OCEANS, V118, P901, DOI 10.1002/jgrc.20066; ANDREWS DG, 1976, J ATMOS SCI, V33, P2031, DOI 10.1175/1520-0469(1976)033<2031:PWIHAV>2.0.CO;2; Sallee JB, 2013, J GEOPHYS RES-OCEANS, V118, P1830, DOI 10.1002/jgrc.20135; Allison LC, 2011, J MAR RES, V69, P167; Griffies SM, 1998, J PHYS OCEANOGR, V28, P805, DOI 10.1175/1520-0485(1998)028<0805:IDIAZC>2.0.CO;2; Griffies SM, 2014, OCEAN MODEL, V78, P35, DOI 10.1016/j.ocemod.2014.03.004; Jones DC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048145; Mazloff MR, 2010, J PHYS OCEANOGR, V40, P880, DOI 10.1175/2009JPO4236.1; Jansen MF, 2014, OCEAN MODEL, V80, P36, DOI 10.1016/j.ocemod.2014.06.002; Canuto VM, 2006, OCEAN MODEL, V11, P123, DOI 10.1016/j.ocemod.2004.12.002; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; Ferreira D, 2005, J PHYS OCEANOGR, V35, P1891, DOI 10.1175/JPO2785.1; Large WG, 1997, J PHYS OCEANOGR, V27, P2418, DOI 10.1175/1520-0485(1997)027<2418:STSFAB>2.0.CO;2; GENT PR, 1990, J PHYS OCEANOGR, V20, P150, DOI 10.1175/1520-0485(1990)020<0150:IMIOCM>2.0.CO;2; Chidichimo MP, 2014, J PHYS OCEANOGR, V44, P1829, DOI 10.1175/JPO-D-13-071.1; Sen Gupta A, 2009, J CLIMATE, V22, P3047, DOI 10.1175/2008JCLI2827.1; Marshall J, 2006, J PHYS OCEANOGR, V36, P1806, DOI 10.1175/JPO2949.1; Griffies SM, 2005, OCEAN SCI, V1, P45; Ito T, 2008, J PHYS OCEANOGR, V38, P2832, DOI 10.1175/2008JPO3878.1; Farneti R, 2010, J PHYS OCEANOGR, V40, P1539, DOI 10.1175/2010JPO4353.1; Olbers D, 2004, ANTARCT SCI, V16, P439, DOI 10.1017/S0954102004002251; Eden C, 2009, OCEAN MODEL, V26, P47, DOI 10.1016/j.ocemod.2008.08.004; Visbeck M, 2009, J CLIMATE, V22, P940, DOI 10.1175/2008JCLI2260.1; Abernathey R, 2014, J PHYS OCEANOGR, V44, P2107, DOI 10.1175/JPO-D-14-0014.1; Bintanja R., 2013, NAT GEOSCI, V6, P1; Bryden HL, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001296; Danabasoglu G, 2014, OCEAN MODEL, V73, P76, DOI 10.1016/j.ocemod.2013.10.005; Danabasoglu G, 2008, J CLIMATE, V21, P1192, DOI 10.1175/2007JCLI1508.1; Downes S.M., 2015, OCEAN MODEL IN PRESS; Downes SM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047668; Farneti R, 2011, OCEAN MODEL, V39, P135, DOI 10.1016/j.ocemod.2011.02.005; Ferrari R., 2008, J CLIMATE, V31, P2770, DOI DOI 10.1175/2007JCLI1510.1; Gnanadesikan A, 2000, J PHYS OCEANOGR, V30, P2013, DOI 10.1175/1520-0485(2000)030<2013:OTROTC>2.0.CO;2; Griffies S.M., 2007, 6 NOAA GFDL OC GROUP; Griffies S.M., 2012, 7 NOAA GFDL OC GROUP; Griffies SM, 2011, J CLIMATE, V24, P3520, DOI 10.1175/2011JCLI3964.1; Gusev AV, 2014, IZV ATMOS OCEAN PHY+, V50, P1, DOI 10.1134/S0001433813060078; Heuze C, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50287; Hirabara M., 2012, J OCEANOGR, V5, P771; Hofmann M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045972; Hogg AM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044777; Johns WE, 2011, J CLIMATE, V24, P2429, DOI 10.1175/2010JCLI3997.1; Koshlyakov MN, 2007, OCEANOLOGY+, V47, P451, DOI 10.1134/S0001437007040029; Kuhlbrodt T, 2012, OCEAN MODEL, V52-53, P1, DOI 10.1016/j.ocemod.2012.04.006; Lee MM, 2003, OCEAN MODEL, V5, P249, DOI 10.1016/S1463-5003(02)00044-6; Liu JP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001167; Madec G., 2008, 27 IPSL, V27; Marshall G.J., 2003, J CLIMATE, V16, P1734; Marsland S.J., 2001, J GEOPHYS RES, V106; McIntosh PC, 1996, J PHYS OCEANOGR, V26, P1655, DOI 10.1175/1520-0485(1996)026<1655:IAATRM>2.0.CO;2; Garabato ACN, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006818; Rintoul S.R., 2013, INT GEOPHYS SER, P471; Saenko OA, 2012, J CLIMATE, V25, P1349, DOI 10.1175/JCLI-D-11-00040.1; Sidorenko D, 2015, CLIM DYNAM, V44, P757, DOI 10.1007/s00382-014-2290-6; Sloyan BM, 2001, J PHYS OCEANOGR, V31, P143, DOI 10.1175/1520-0485(2001)031<0143:TSOLOT>2.0.CO;2; Smith R, 2010, LAUR1001853 LOS AL N; Speer K, 2000, J PHYS OCEANOGR, V30, P3212, DOI 10.1175/1520-0485(2000)030<3212:TDDC>2.0.CO;2; Stocker TF, 2013, CLIM CHANG 2013 PHYS, P1535, DOI DOI 10.1017/CBO9781107415324; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Treguier AM, 2010, J PHYS OCEANOGR, V40, P1659, DOI 10.1175/2010JPO4364.1; Volkov DL, 2010, OCEAN DYNAM, V60, P791, DOI 10.1007/s10236-010-0288-0; Yang XY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030526; Zika JD, 2013, J PHYS OCEANOGR, V43, P2772, DOI 10.1175/JPO-D-13-091.1	144	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1463-5003	1463-5011		OCEAN MODEL	Ocean Model.	SEP	2015	93						84	120		10.1016/j.ocemod.2015.07.009		37	Meteorology & Atmospheric Sciences; Oceanography	Meteorology & Atmospheric Sciences; Oceanography	CR0AP	WOS:000360980600007		
J	Takeuchi, Y; Innan, H				Takeuchi, Yayoi; Innan, Hideki			Evaluating the performance of neutrality tests of a local community using a niche-structured simulation model	OIKOS			English	Article							SPECIES-ABUNDANCE DISTRIBUTIONS; EWENS SAMPLING DISTRIBUTION; TROPICAL FORESTS; DIVERSITY; ECOLOGY; BIODIVERSITY; PATTERNS; POPULATION; MECHANISMS; COEXISTENCE	Understanding the processes that underlie species diversity and abundance in a community is a fundamental issue in community ecology. While the species abundance distributions (SADs) of various natural communities may be well explained by Hubbell's neutral model, it has been repeatedly pointed out that Hubbell's SAD-fitting approach lacks the ability to detect the effects of non-neutral factors such as niche differentiation; however, our understanding of its quantitative effect is limited. Herein, we conducted extensive simulations to quantitatively evaluate the performance of the SAD-fitting method and other recently developed tests. For simulations, we developed a niche model that incorporates the random stochastic demography of individuals and the nonrandom replacements of those individuals, i.e. niche differentiation. It therefore allows us to explore situations with various degrees of niche differentiation. We found that niche differentiation has strong effects on SADs and the number of species in the community under this model. We then examined the performance of these neutrality tests, including Hubbell's SAD-fitting method, using extensive simulations. It was demonstrated that all these tests have relatively poor performance except for the cases with very strong niche structure, which is in accordance with previous studies. This is likely because two important parameters in Hubbell's model are usually unknown and are commonly estimated from the data to be tested. To demonstrate this point, we showed that the precise estimation of the two parameters substantially improved the performance of these neutrality tests, indicating that poor performance can be owed to overfitting Hubbell's neutral model with unrealistic parameters. Our results therefore emphasize the importance of accurate parameter estimation, which should be obtained from data independent of the local community to be tested.	[Takeuchi, Yayoi] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, JP-3058506 Tsukuba, Ibaraki, Japan; [Innan, Hideki] Grad Univ Adv Studies, JP-2400193 Hayama, Kanagawa, Japan	Takeuchi, Y (reprint author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, JP-3058506 Tsukuba, Ibaraki, Japan.	takeuchi.yayoi@nies.go.jp					Akaike H., 1973, P 2 INT S INF THEOR, P267; Chisholm RA, 2010, P NATL ACAD SCI USA, V107, P15821, DOI 10.1073/pnas.1009387107; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Chisholm RA, 2009, ECOL LETT, V12, P1385, DOI 10.1111/j.1461-0248.2009.01389.x; Matthews TJ, 2014, ECOL EVOL, V4, P2263, DOI 10.1002/ece3.1092; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Purves Drew W., 2005, P107, DOI 10.1017/CBO9780511541971.006; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; Locey KJ, 2013, ECOL LETT, V16, P1177, DOI 10.1111/ele.12154; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Rosindell J, 2012, TRENDS ECOL EVOL, V27, P203, DOI 10.1016/j.tree.2012.01.004; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Etienne RS, 2007, ECOL LETT, V10, P608, DOI 10.1111/j.1461-0248.2007.01052.x; Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Gotelli NJ, 2006, ECOGRAPHY, V29, P793, DOI 10.1111/j.2006.0906-7590.04714.x; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Jabot F, 2011, AM NAT, V178, pE37, DOI 10.1086/660829; Ulrich W, 2010, OIKOS, V119, P1149, DOI 10.1111/j.1600-0706.2009.18236.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Magurran AE, 2007, ECOL LETT, V10, P347, DOI 10.1111/j.1461-0248.2007.01024.x; SLATKIN M, 1994, GENET RES, V64, P71; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Innan H, 2005, GENETICS, V169, P1763, DOI 10.1534/genetics.104.032219; Etienne RS, 2007, J STAT PHYS, V128, P485, DOI 10.1007/s10955-006-9163-2; Bell G, 2005, ECOLOGY, V86, P1757, DOI 10.1890/04-1028; CASWELL H, 1976, ECOL MONOGR, V46, P327, DOI 10.2307/1942257; Clark JS, 2012, TRENDS ECOL EVOL, V27, P198, DOI 10.1016/j.tree.2012.02.001; Etienne RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014717; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; Etienne RS, 2007, J THEOR BIOL, V248, P522, DOI 10.1016/j.jtbi.2007.06.010; Etienne RS, 2005, ECOL LETT, V8, P493, DOI 10.1111/j.1461-0248.2005.00745.x; Harpole SW, 2006, ECOL LETT, V9, P15; He F, 2005, FUNCT ECOL, V19, P187, DOI 10.1111/j.0269-8463.2005.00944.x; Hubbell S.P., 2001, UNIFIED NEUTRAL THEO, V32; KEMPTON RA, 1974, J ANIM ECOL, V43, P381, DOI 10.2307/3371; Lande R., 2003, STOCHASTIC POPULATIO; Magurran AE, 2004, MEASURING BIOL DIVER; May R.M., 1975, P81; O'Hara R., 2003, FISHERFIT VEGAN FIT; Rosindell J, 2008, ECOL INFORM, V3, P259, DOI 10.1016/j.ecoinf.2008.05.001; Slatkin M, 1996, GENET RES, V68, P259; Tilman D, 1982, RESOURCE COMPETITION, V17; TOKESHI M, 1992, RES POPUL ECOL, V34, P249, DOI 10.1007/BF02514796; TOKESHI M, 1990, J ANIM ECOL, V59, P1129, DOI 10.2307/5036; Tsai C. H., 2015, ECOLOGY, V95, P3335; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197	59	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0030-1299	1600-0706		OIKOS	Oikos	SEP	2015	124	9					1203	1214		10.1111/oik.01703		12	Ecology	Environmental Sciences & Ecology	CQ7YS	WOS:000360823400010		
J	Ito, T; Shingu, K; Maeda, C; Kitazawa, M; Mizukami, Y; Hiraguri, M; Horigome, N; Kaneko, G; Itoh, N; Ito, KI				Ito, Tokiko; Shingu, Kiyoshi; Maeda, Chika; Kitazawa, Masato; Mizukami, Yoshiki; Hiraguri, Manabu; Horigome, Naoto; Kaneko, Gengo; Itoh, Nobuo; Ito, Ken-Ichi			Acute airway obstruction due to benign asymptomatic nodular goiter in the cervical region: A case report	ONCOLOGY LETTERS			English	Article						adenomatous goiter; acute airway obstruction	SPORADIC NONTOXIC GOITER; THYROID-DISEASE	Benign nodular goiter is a common disease. Although large goiters with obstructive symptoms including shortness of breath and dyspnea are a clear indication for surgery, acute upper airway obstruction, particularly in benign cervical goiter cases, is rare. We herein report the case of 46-year-old female with acute upper airway obstruction due to benign nodular goiter. The patient had a large and elastic goiter which was more pronounced on the left side of her neck, and surgery was scheduled for within a few months. Three months after the initial presentation, while still waiting for surgery, the patient was brought to the emergency room due to loss of consciousness and breathing difficulty and was immediately intubated. A computed tomography (CT) scan revealed that the trachea was markedly compressed by a nodular lesion in the left lobe, and bilateral pneumonia was also evident. Total thyroidectomy was immediately performed via the supraclavicular approach. The patient had an uneventful postoperative course and recovered well. The resected specimen included a well-encapsulated solid and cystic mass. Histopathological examination mainly revealed adenomatous goiter. The present case suggests that benign asymptomatic nodular goiter mostly located in the neck may cause acute airway obstruction, even if the nodules are not large. Early surgery should be performed when tracheal deviation and stenosis due to a large goiter is prominent by CT scan.	[Ito, Tokiko; Shingu, Kiyoshi; Maeda, Chika; Kitazawa, Masato; Mizukami, Yoshiki; Hiraguri, Manabu; Horigome, Naoto; Kaneko, Gengo; Itoh, Nobuo; Ito, Ken-Ichi] Iida Municipal Hosp, Div Breast & Endocrine Surg, Iida, Nagano 3958502, Japan	Shingu, K (reprint author), Iida Municipal Hosp, Div Breast & Endocrine Surg, 438 Yawata Machi, Iida, Nagano 3958502, Japan.	0374@imh.jp					Abraham D, 2007, ANZ J SURG, V77, P364, DOI 10.1111/j.1445-2197.2007.04061.x; SHAHA AR, 1990, OTOLARYNG CLIN N AM, V23, P391; BERGHOUT A, 1990, AM J MED, V89, P602, DOI 10.1016/0002-9343(90)90178-G; Clark OH, 2005, TXB ENDOCRINE SURG, V2nd; Raftos JR, 1996, AUST NZ J SURG, V66, P331, DOI 10.1111/j.1445-2197.1996.tb01199.x; Kadhim AL, 2006, J LARYNGOL OTOL, V120, P1038, DOI 10.1017/S0022215106003045; MELLIERE D, 1988, SURGERY, V103, P367; Nakadate Y, 2011, J ANESTH, V25, P745, DOI 10.1007/s00540-011-1181-9; Rios A, 2008, ARCH BRONCONEUMOL, V44, P504; Sajja Lokeswara R, 2006, Asian Cardiovasc Thorac Ann, V14, P416; Samuels MH, 2001, J CLIN ENDOCR METAB, V86, P994, DOI 10.1210/jc.86.3.994; Sharma Anu, 2010, J Med Case Rep, V4, P258, DOI 10.1186/1752-1947-4-258; TSENG KH, 1987, OTOLARYNG HEAD NECK, V97, P72	13	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	SEP	2015	10	3					1453	1455		10.3892/ol.2015.3464		3	Oncology	Oncology	CQ9GZ	WOS:000360923000035		
J	Hirano, H; Maeda, H; Yamaguchi, T; Yokota, S; Mori, M; Sakoda, S				Hirano, Hiroshi; Maeda, Hajime; Yamaguchi, Toshihiko; Yokota, Soichiro; Mori, Masahide; Sakoda, Saburo			Survivin expression in lung cancer: Association with smoking, histological types and pathological stages	ONCOLOGY LETTERS			English	Article						survivin; lung cancer; smoking; histological type; Ki-67	NUCLEAR SURVIVIN; CIGARETTE-SMOKING; POOR-PROGNOSIS; CELL CARCINOMA; APOPTOSIS; ADENOCARCINOMAS; PROLIFERATION; GENE	Survivin is expressed in the nucleus and/or cytoplasm of various malignant cells. Nuclear survivin is critical for the completion of mitosis, while cytoplasmic survivin functions as an inhibitor of apoptosis. The expression of survivin has been reported to he associated with the aggressiveness of certain types of cancer. The present study examined the association between cigarette smoking history and the expression of survivin and Ki-67 in lung adenocarcinomas of pathological (p) stages 1, II and III. The expression of survivin and Ki-67 in adenocarcinomas was also compared with that of other p-stage I lung cancers, including squamous cell carcinoma (SqCC), large cell neuroendocrine carcinoma (LCNEC) and small cell carcinoma (SmCCs), of patients with a smoking history. In adenocarcinomas at p-stage I, labeling indices (Us) of nuclear survivin and Ki-67 were significantly higher in tissue samples from smokers than those from non-smokers; however, the nuclear survivin and Ki-67 Lis in p-stage II and III adenocarcinomas from non-smokers and smokers were similar to those in p-stage I adenocarcinomas of smokers. The nuclear survivin and Ki-67 Us in adenocarcinomas of smokers at p-stage I were lower than those in SqCCs, LCNECs and SmCCs of smokers at the same stage. Smokers with adenocarcinoma also exhibited a higher survival rate compared with that of smokers with SqCCs, LCNECs and SmCCs. The present results indicated that a history of smoking is associated with increased nuclear survivin and Ki-67 expression in lung adenocarcinomas of p-stage I, but not p-stages II or III. In addition it was revealed that, in smokers, the nuclear survivin and Ki-67 expression in p-stage I adenocarcinomas was lower than that of other p-stage I lung cancer types, and was associated with an enhanced survival rate. In conclusion, smoking is associated with the histogenesis of lung adenocarcinoma but not with the development of lung adenocarcinoma, based on the nuclear expression levels of Ki-67 and survivin.	[Hirano, Hiroshi] Toneyama Natl Hosp, Dept Pathol, Toyonaka, Osaka 5608552, Japan; [Maeda, Hajime] Toneyama Natl Hosp, Dept Surg, Toyonaka, Osaka 5608552, Japan; [Yamaguchi, Toshihiko; Yokota, Soichiro; Mori, Masahide; Sakoda, Saburo] Toneyama Natl Hosp, Dept Internal Med, Toyonaka, Osaka 5608552, Japan	Hirano, H (reprint author), Toneyama Natl Hosp, Dept Pathol, 1-1,Toneyama 5 Chome, Toyonaka, Osaka 5608552, Japan.	hi-hi-hirano@hotmail.com					Hernandez JM, 2011, CLIN COLORECTAL CANC, V10, P188, DOI 10.1016/j.clcc.2011.03.014; Storlazzi CT, 2006, J PATHOL, V209, P492, DOI 10.1002/path.1998; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Connell CM, 2008, J BIOL CHEM, V283, P3289, DOI 10.1074/jbc.M704461200; Vallbohmer D, 2009, J SURG ONCOL, V99, P409, DOI 10.1002/jso.21271; Vivas-Mejia PE, 2011, CLIN CANCER RES, V17, P3716, DOI 10.1158/1078-0432.CCR-11-0233; Sun YW, 2013, GENET MOL RES, V12, P1045, DOI 10.4238/2013.April.2.21; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Zhu HX, 2011, TUMOR BIOL, V32, P1147, DOI 10.1007/s13277-011-0217-y; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Nguyen VN, 2000, ACTA HISTOCHEM, V102, P323, DOI 10.1078/S0065-1281(04)70039-2; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Morinaga S, 2004, ONCOL REP, V12, P1189; Hirano H, 2014, MED MOL MORPHOL, V47, P196, DOI 10.1007/s00795-013-0061-9; Ichiki Y, 2005, LUNG CANCER-J IASLC, V48, P281, DOI 10.1016/j.lungcan.2004.10.017; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Maeda R, 2012, ANN THORAC SURG, V93, P1626, DOI 10.1016/j.athoracsur.2012.01.005; Maeshima AM, 2008, J THORAC ONCOL, V3, P698, DOI 10.1097/JTO.0b013e31817c60ae; Mull AN, 2014, STEM CELL RES, V12, P539, DOI 10.1016/j.scr.2014.01.002; Xie YL, 2012, CLIN CHIM ACTA, V414, P41, DOI 10.1016/j.cca.2012.08.012	23	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	SEP	2015	10	3					1456	1462		10.3892/ol.2015.3374		7	Oncology	Oncology	CQ9GZ	WOS:000360923000036		
J	Takahashi, K; Hosokawa, M; Kasajima, H; Hatanaka, K; Kudo, K; Shimoyama, N; Miyashita, K				Takahashi, Kazuto; Hosokawa, Masashi; Kasajima, Hiroyuki; Hatanaka, Kazuteru; Kudo, Kazuhiro; Shimoyama, Norihiko; Miyashita, Kazuo			Anticancer effects of fucoxanthin and fucoxanthinol on colorectal cancer cell lines and colorectal cancer tissues	ONCOLOGY LETTERS			English	Article						fucoxanthin; fucoxanthinol; colorectal cancer; anticancer effects	IN-VITRO CHEMOSENSITIVITY; INDUCE APOPTOSIS; HEPG2 CELLS; COLON; MICE; METABOLITES; INHIBITION; CULTURE	Colorectal cancer is one of the most malignant neoplasms worldwide. Fucoxanthin is a carotenoid present in the chloroplasts of brown seaweeds. In the present study, the anticancer effects of fucoxanthin and its metabolite, fucoxanthinol, on 6 colorectal cancer cell lines and 20 tissue samples from surgically resected Clinical colorectal cancer specimens were examined using a collagen-gel droplet embedded culture drug sensitivity test (CD-DST). The in vitro sensitivity to fiicoxanthin, fucoxanthinol and the anticancer drugs is expressed as T/C (%), where T is the absorbance of cells which stained by neutral red treated with carotenoids and C is the absorbance of non-staining cells. Fucoxanthin and fucoxanthinol decreased the T/C (%) of Caco-2, WiDr, HCI116, and DLD-1 cell lines at doses of 20 mu M. Fucoxanthinol also decreased the TIC (%) of SW620 cells, while the T/C (%) of Colo205 cells was not reduced by treatment with either carotenoid. Specifically, the TIC (%) of Caco-2 and Wi Dr cells, which were incubated in carotenoid-free medium for 6 days following treatment with 20 mu M fucaxanthinol for 24 h, was markedly decreased to 1.4 +/- 0.2 and 12.0 +/- 0.3%, respectively. Furthermore, fucoxanthin and fucoxanthinol decreased the TV (%) in colorectal cancer tissue samples. Notably, 20 mu M fucoxanthinol treatment resulted in a higher proportion of colorectal cancer samples with a T/C (%) of <50% (13/20, 65%) compared with samples treated with 20 mu M fucoxanthin (2/20, 10%). The median TIC (%) value of 35.1% for the 20 cancers specimens treated with 20 mu M fucoxanthinol was lower than the median T/C (%) values of 86.3% and 75.8% for those treated with fluorouracil and paclitaxel, respectively. These results suggested that fucoxanthin and fucoxanthinol may be of use as Chemotherapeutic agents in colorectal cancer.	[Takahashi, Kazuto; Hosokawa, Masashi; Miyashita, Kazuo] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Takahashi, Kazuto; Kudo, Kazuhiro; Shimoyama, Norihiko] Hakodate Municipal Hosp, Dept Clin Pathol, Hakodate, Hokkaido 0418680, Japan; [Kasajima, Hiroyuki; Hatanaka, Kazuteru] Hakodate Municipal Hosp, Dept Digest Surg, Hakodate, Hokkaido 0418680, Japan	Takahashi, K (reprint author), Hokkaido Univ, Fac Fisheries Sci, 3-1-1 Minato, Hakodate, Hokkaido 0418611, Japan.	k-takahashi@hospital.hakodate.hokkaido.jp	Hosokawa, Masashi/C-3024-2008				Konishi I, 2006, COMP BIOCHEM PHYS C, V142, P53, DOI 10.1016/j.cbpc.2005.10.005; Kotake-Nara E, 2005, CANCER LETT, V220, P75, DOI 10.1016/j.canlet.2004.07.048; Das SK, 2008, BBA-GEN SUBJECTS, V1780, P743, DOI 10.1016/j.bbagen.2008.01.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Beppu F, 2009, J TOXICOL SCI, V34, P501; Kobayashi H, 2003, RECENT RES CANCER, V161, P48; Miyashita K, 2011, J SCI FOOD AGR, V91, P1166, DOI 10.1002/jsfa.4353; Hosokawa M, 2004, BBA-GEN SUBJECTS, V1675, P113, DOI 10.1016/j.bbagen.2004.08.012; Kim KN, 2013, ENVIRON TOXICOL PHAR, V35, P39, DOI 10.1016/j.etap.2012.10.002; Das SK, 2005, BBA-GEN SUBJECTS, V1726, P328, DOI 10.1016/j.bbagen.2005.09.007; Asai A, 2004, DRUG METAB DISPOS, V32, P205, DOI 10.1124/dmd.32.2.205; Airanthi MKWA, 2011, J AGR FOOD CHEM, V59, P4156, DOI 10.1021/jf104643b; Hashimoto T, 2012, BRIT J NUTR, V107, P1566, DOI 10.1017/S0007114511004879; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Zhang ZY, 2008, ONCOL REP, V20, P1099, DOI 10.3892/or_00000115; Hashimoto T, 2009, BRIT J NUTR, V102, P242, DOI 10.1017/S0007114508199007; Hosokawa M, 1999, FOOD SCI TECHNOL RES, V5, P243, DOI DOI 10.3136/FSTR.5.243; Imbs TI, 2013, MAR BIOTECHNOL, V15, P606, DOI 10.1007/s10126-013-9507-2; Kobayashi H, 1995, Gan To Kagaku Ryoho, V22, P1933; Kobayashi H, 2005, METH MOLEC MED, V110, P59; Simmonds P C, 2000, BMJ, V321, P531	21	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	SEP	2015	10	3					1463	1467		10.3892/ol.2015.3380		5	Oncology	Oncology	CQ9GZ	WOS:000360923000037		
J	Tomizawa, M; Shinozaki, F; Motoyoshi, Y; Sugiyama, T; Yamamoto, S; Ishige, N				Tomizawa, Minoru; Shinozaki, Fuminobu; Motoyoshi, Yasufumi; Sugiyama, Takao; Yamamoto, Shigenori; Ishige, Naoki			SU11274 suppresses proliferation and motility of pancreatic cancer cells	ONCOLOGY LETTERS			English	Article						mesenchymal-epithelial transition factor; quantitative polymerase chain reaction	FACTOR-I RECEPTOR; C-MET; GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; VITRO; GEMCITABINE; THERAPY; TARGET	Mesenchymal-epithelial transition factor (c-Met) is associated with the proliferation and motility of cancer cells. c-Met expression has been detected in surgical pancreatic cancer specimens, and its overexpression is associated with a poor prognosis. SU11274 is a specific inhibitor of c-Met. In the present study, the cell proliferation and motility of pancreatic cancer cells treated with SU11274 was investigated. The PANC-1, MIA-Paca2, NOR-P1, PK745H, PR-1 and PK-59 pancreatic cancer cell lines were used. The expression of c-Met and cyclin D1 was analyzed by quantitative polymerase chain reaction. In addition, a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sutfophenyl)-2 H-tetrazolium inner salt assay was performed to assess cell proliferation, and a scratch assay was performed to assess cell motility, c-Met expression was higher in PANC-1, PK-45H, PR-1 and PK-59 cell lines compared with that in normal pancreatic tissue. Following treatment with 30 mu M SU11274, the proliferation of MIA-Paca2 and PK-45H cells was suppressed to 19.8 10.7% (P<0.05) and 45.8 +/- 14.8% (P<0.05) of the control level, respectively. Furthermore, cyclin D1 expression was downregulated to 43.7 +/- 17.9% (P<0.05) and 53.2 +/- 18.6% (P<0.05) of the control level in the MIA-Paca2 and PK-45H cell lines, respectively, following treatment with 30 mu M SU11274. In addition, cell motility was reduced to 1.0 +/- 0.3% in MIA-Paca2 (P<0.05) and 14.7 +/- 3.5% in PK-45H (P<0.05) following treatment with 30 mu M SU11274, compared with the motility of untreated cells. These results indicated that SU11274 suppresses the proliferation of pancreatic cancer cells via the downregulation of cyclin D1. The present study also demonstrated that cell motility was suppressed by treatment with SU11274.	[Tomizawa, Minoru] Natl Hosp Org, Shimoshizu Hosp, Dept Gastroenterol, Chiba 2840003, Japan; [Shinozaki, Fuminobu] Natl Hosp Org, Shimoshizu Hosp, Dept Radiol, Chiba 2840003, Japan; [Motoyoshi, Yasufumi] Natl Hosp Org, Shimoshizu Hosp, Dept Neurol, Chiba 2840003, Japan; [Sugiyama, Takao] Natl Hosp Org, Shimoshizu Hosp, Dept Rheumatol, Chiba 2840003, Japan; [Yamamoto, Shigenori] Natl Hosp Org, Shimoshizu Hosp, Dept Pediat, Chiba 2840003, Japan; [Ishige, Naoki] Natl Hosp Org, Shimoshizu Hosp, Dept Neurosurg, Chiba 2840003, Japan	Tomizawa, M (reprint author), Natl Hosp Org, Shimoshizu Hosp, Dept Gastroenterol, 934-5 Shikawatashi, Chiba 2840003, Japan.	nihminor-cib@umin.ac.jp					Pant S, 2014, ANN ONCOL, V25, P1416, DOI 10.1093/annonc/mdu157; Lennon AM, 2014, CANCER RES, V74, P3381, DOI 10.1158/0008-5472.CAN-14-0734; Avan A, 2013, CANCER RES, V73, P6745, DOI 10.1158/0008-5472.CAN-13-0837; Chan B, 2013, BIOCHEM BIOPH RES CO, V439, P247, DOI 10.1016/j.bbrc.2013.08.048; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Goetsch L, 2013, FRONT BIOSCI-LANDMRK, V18, P454, DOI 10.2741/4114; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; TOMIZAWA M, 1995, PATHOL INT, V45, P352, DOI 10.1111/j.1440-1827.1995.tb03468.x; Gardian K, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/585674; Gresham GK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-471; Inagaki Y, 2011, BIOSCI TRENDS, V5, P52, DOI 10.5582/bst.2011.v5.2.52; Mughal A, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-13; Neesse Albrecht, 2013, Onco Targets Ther, V7, P33, DOI 10.2147/OTT.S38111; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Tomizawa M, 2012, J CELL BIOCHEM, V113, P2714, DOI 10.1002/jcb.24149; Tomizawa M, 2010, WORLD J GASTROENTERO, V16, P1854, DOI 10.3748/wjg.v16.i15.1854; Tomizawa M, 2014, ONCOL LETT, V7, P74; Ucar DA, 2013, ANTI-CANCER AGENT ME, V13, P595; VILA MR, 1995, LAB INVEST, V73, P409; Wörmann Sonja Maria, 2013, Front Oncol, V3, P282, DOI 10.3389/fonc.2013.00282; Yasui T, 2011, CANCER SCI, V102, P484, DOI 10.1111/j.1349-7006.2010.01783.x; Zhu GH, 2011, DIGEST DIS SCI, V56, P1090, DOI 10.1007/s10620-010-1416-x	22	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	SEP	2015	10	3					1468	1472		10.3892/ol.2015.3452		5	Oncology	Oncology	CQ9GZ	WOS:000360923000038		
J	Adachi, Y; Hino, T; Ohsawa, M; Ueki, K; Murao, T; Li, M; Cui, YZ; Okigaki, M; Ito, M; Ikehara, S				Adachi, Yasushi; Hino, Takuya; Ohsawa, Masahiko; Ueki, Kazuhito; Murao, Tomoko; Li, Ming; Cui, Yunze; Okigaki, Mitsuhiko; Ito, Mitsuhiro; Ikehara, Susumu			A case of CD10-negative angioimmunoblastic T cell lymphoma with leukemic change and increased plasma cells mimicking plasma cell leukemia: A case report	ONCOLOGY LETTERS			English	Article						angioimmunoblastic T cell lymphoma; plasmacytosis; leukemic change; hypergammaglobulinemia; lymph node; peripheral blood; bone marrow	PERIPHERAL-BLOOD PLASMACYTOSIS; PATIENT; IMMUNOGLOBULIN; PROLIFERATION; EXPRESSION; MARROW	Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell lymphoma, known to express CD3 and CD4, and, frequently, also CD10 and c-Maf-1. Hypergamma-globulinemia is not particularly rare in patients with AITL. However, AITL in conjunction with plasmacytosis in the peripheral blood is rare. The current report presents a case of CD10-negative AITL demonstrating leukemic change and plasmacytosis in the peripheral blood mimicking plasma cell leukemia. A 78-year-old male was admitted to hospital due to systemic lymph node enlargement, high serum IgG and IgA, and increased counts of plasmacytoid cells and lymphoid cells with atypical nuclei in the peripheral blood. Initially, plasma cell leukemia was suspected, due to the extreme increase in the number of plasma cells in the peripheral blood. However, the plasma cells did not show clonal expansion on examination by flow cytometry. Based on histological analyses, following a biopsy of an enlarged lymph node, the patient was diagnosed with AITL. This case suggests that when hypergammaglobulinemia and increases in B-lineage cells are observed, AITL should be considered in addition to disorders of B-lineage cells.	[Adachi, Yasushi] Toyooka Hosp, Div Surg Pathol, Toyooka City, Hyogo 6688501, Japan; [Adachi, Yasushi; Li, Ming; Cui, Yunze; Ikehara, Susumu] Kansai Med Univ, Dept Stem Cell Disorders, Hirakata, Osaka 5731010, Japan; [Hino, Takuya; Ueki, Kazuhito] Toyooka Hosp, Dept Internal Gen Med, Toyooka City, Hyogo 6688501, Japan; [Ohsawa, Masahiko] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Osaka 5450051, Japan; [Murao, Tomoko] Toyooka Hosp, Dept Clin Lab, Toyooka City, Hyogo 6688501, Japan; [Cui, Yunze] Japan Immunores Labs Co Ltd, Takasaki, Gumma 3700021, Japan; [Okigaki, Mitsuhiko] Otokoyama Hosp, Dept Internal Med, Yawata City, Kyoto 6148366, Japan; [Ito, Mitsuhiro] Kobe Univ, Div Med Biophys, Grad Sch Hlth Sci, Kobe, Hyogo 6500017, Japan	Ikehara, S (reprint author), Kansai Med Univ, Dept Stem Cell Disorders, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	ikehara@hirakata.kmu.ac.jp					Ahsanuddin AN, 2011, INT J CLIN EXP PATHO, V4, P416; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Went P, 2006, J CLIN ONCOL, V24, P2472, DOI 10.1200/JCO.2005.03.6327; Gawoski JM, 2003, ARCH PATHOL LAB MED, V127, P1026; Murakami YI, 2007, AM J SURG PATHOL, V31, P1695; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Touzeau C, 2007, LEUKEMIA LYMPHOMA, V48, P207, DOI 10.1080/10428190601016159; KYLE RA, 1974, ARCH INTERN MED, V133, P813, DOI 10.1001/archinte.133.5.813; Li L, 2006, ANN CLIN LAB SCI, V36, P479; Baseggio L, 2006, LEUKEMIA, V20, P296, DOI 10.1038/sj.leu.2404013; Thai KTD, 2011, CLIN MICROBIOL INFEC, V17, P1823, DOI 10.1111/j.1469-0691.2010.03434.x; Shtalrid M, 2003, LEUKEMIA LYMPHOMA, V44, P379, DOI 10.1080/1042819021000029713; Yamane A, 2007, ACTA HAEMATOL-BASEL, V117, P74, DOI 10.1159/000096894; Iannitto E, 2008, CRIT REV ONCOL HEMAT, V68, P264, DOI 10.1016/j.critrevonc.2008.06.012; Koduri PR, 1996, ANN HEMATOL, V72, P49; KOMIYA I, 1991, EUR J HAEMATOL, V46, P61; Mori I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002109; Sakai H, 2007, INTERNAL MED, V46, P419, DOI 10.2169/internalmedicine.46.6121; Wada T, 2007, INT J HEMATOL, V85, P191, DOI 10.1532/IJH97.06200	19	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	SEP	2015	10	3					1555	1560		10.3892/ol.2015.3490		6	Oncology	Oncology	CQ9GZ	WOS:000360923000054		
J	Soh, J; Toyooka, S; Matsuo, K; Yamamoto, H; Wistuba, II; Lam, S; Fong, KM; Gazdar, AF; Miyoshi, S				Soh, Junichi; Toyooka, Shinichi; Matsuo, Keitaro; Yamamoto, Hiromasa; Wistuba, Ignacio I.; Lam, Stephen; Fong, Kwun M.; Gazdar, Adi F.; Miyoshi, Shinichiro			Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma	ONCOLOGY LETTERS			English	Article						lung adenocarcinoma; EGFR; KRAS; mutation; copy number gain; ethnicity	FACTOR RECEPTOR GENE; COPY NUMBER GAINS; SIGNALING PATHWAY; CANCER; MUTATIONS; GEFITINIB; SENSITIVITY; CARCINOMA; ONCOGENE; PROFILES	Mutations or copy number gains (CNGs) of the EGFR and KRAS genes are representative alterations in lung adenocarcinomas that are individually associated with patient characteristics such as ethnicity, smoking status and gender. However, the effects of combinations of these genetic alterations have not been statistically examined. The present study analyzed previously examined lung adenocarcinoma cases in Asian (n=166) and non-Asian (n=136) individuals in whom all four EGFR and KRAS alterations had been studied. The polynomial logistic regression models were used following adjustment for gender and smoking status, and using patients without any type of EGFR/KRAS alterations as a reference. Between the two ethnic groups, EGFR CNGs (gEGFR) occurred more frequently than EGFR mutations (mEGFR) (46 vs. 38% in Asians; 21 vs. 10% in non-Asians), whereas KRAS mutations (mKRAS) were more frequent than KRAS CNGs (gKRAS) (13 vs. 7% and 35 vs. 4%, respectively). Additionally, gEGFR and gKRAS occurred significantly more frequently in respective mutant cases, and all EGFR alterations were almost exclusive of all KRAS alterations. The polynomial logistic regression models confirmed that all types of EGFR alterations were significantly more frequent among Asian individuals than among non-Asian individuals, independent of gender and smoking status (odds ratios, 2.36-6.67). KRAS alterations occurred less frequently among Asian individuals than among non-Asian individuals, although a significant difference was not detected. The present study results indicated that the EGFR and KRAS profiles, including mutations and CNGs, differ between Asian and non-Asian individuals with lung adenocarcinoma, suggesting that ethnicity strongly affects the molecular characteristics of lung adenocarcinoma.	[Soh, Junichi; Toyooka, Shinichi; Yamamoto, Hiromasa; Miyoshi, Shinichiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Surg, Okayama, Okayama 7008530, Japan; [Soh, Junichi; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Okayama, Okayama 7008530, Japan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka, Fukuoka 812, Japan; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Lam, Stephen] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Fong, Kwun M.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	Toyooka, S (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	toyooka@md.okayama-u.ac.jp			National Cancer Center Research and Development Fund [22700916]; Lung Cancer SPORE grant [P50 CA70907]	The authors would like to thank Dr. Makoto Suzuki (Department of Thoracic Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumomoto, Japan) for providing clinical DNA samples of Japanese patients from Chiba University. This study was partly supported by the National Cancer Center Research and Development Fund (grant no. 22700916), and a Lung Cancer SPORE grant (P50 CA70907).	Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Reinersman JM, 2011, J THORAC ONCOL, V6, P28, DOI 10.1097/JTO.0b013e3181fb4fe2; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Leidner RS, 2009, J CLIN ONCOL, V27, P5620, DOI 10.1200/JCO.2009.23.1431; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Ichihara S, 2007, INT J CANCER, V120, P1239, DOI 10.1002/ijc.22513; Cote ML, 2011, J THORAC ONCOL, V6, P627, DOI 10.1097/JTO.0b013e31820a0ec0; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Shigematsu H, 2005, J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Dahabreh IJ, 2011, ANN ONCOL, V22, P545, DOI 10.1093/annonc/mdq432; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Cappuzzo F, 2005, J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Tsao AS, 2006, J THORAC ONCOL, V1, P231; Sasaki H, 2011, J THORAC ONCOL, V6, P15, DOI 10.1097/JTO.0b013e31820594f0; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Hirsch FR, 2007, ANN ONCOL, V18, P752, DOI 10.1093/annonc/mdm003; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Dahabreh IJ, 2010, CLIN CANCER RES, V16, P291, DOI 10.1158/1078-0432.CCR-09-1660; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Ho C, 2005, LUNG CANCER-J IASLC, V49, P225, DOI 10.1016/j.lungcan.2005.02.011; Naoki K, 2002, CANCER RES, V62, P7001; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Wagner PL, 2009, AM J CLIN PATHOL, V132, P500, DOI 10.1309/AJCPF10ZUNSOLIFG	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	SEP	2015	10	3					1775	1782		10.3892/ol.2015.3414		8	Oncology	Oncology	CQ9GZ	WOS:000360923000095		
J	Iwai, T; Hoshi, M; Takada, J; Oebisu, N; Aono, M; Takami, M; Ieguchi, M; Nakamura, H				Iwai, Tadashi; Hoshi, Manabu; Takada, Jun; Oebisu, Naoto; Aono, Masanari; Takami, Masatsugu; Ieguchi, Makoto; Nakamura, Hiroaki			Prognostic factors for elderly patients with primary malignant bone and soft tissue tumors	ONCOLOGY LETTERS			English	Article						elderly; bone and soft tissue tumor; American Society of Anesthesiologists-Physical Status; prognostic factor; tumor grade; surgery	SARCOMA; CANCER; SURGERY	The number of patients with primary malignant bone and soft tissue tumors in Japan is increasing in line with the increasing size of the elderly population. The aim of the present study was to determine the prognostic factors of primary malignant bone or soft tissue tumors in elderly patients. Clinical data was obtained from 90 patients, aged >= 65 years, with primary malignant bone or soft tissue tumors (bone, 20 cases; and soft tissue, 70 cases), treated at the Osaka City University Hospital between 1993 and 2013. Clinical information prior to treatment and tumor type, location, size, depth, grade and American Society of Anesthesiologists-Physical Status (ASA-PS) score were evaluated in order to identify prognostic factors using the Cox proportional hazards regression model. In addition, 5-year survival rates were evaluated using the Kaplan-Meier method. The average follow-up period was 44.8 months and the 5-year overall survival rate was 77.5%. In the multivariate analysis, ASA-PS score and high-grade sarcoma were found to be associated with a poorer overall survival. No significant differences were observed between the patient group aged 65-74 years and that aged >= 75 years. In general, aging is associated with physically reduced function and an increased prevalence of comorbidities. It was therefore expected that increasing age may be a predictive factor for poor prognosis. However, the results of the present study suggested that ASA-PS score and tumor grade were significant factors associated with poor prognosis, whereas increasing age was not. Therefore, the treatment of elderly patients with primary bone and soft tissue tumors should not be based on age.	[Iwai, Tadashi; Hoshi, Manabu; Takada, Jun; Oebisu, Naoto; Aono, Masanari; Takami, Masatsugu; Ieguchi, Makoto; Nakamura, Hiroaki] Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Abeno Ku, Osaka 5458585, Japan	Iwai, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	qq329xpd@opal.ocn.ne.jp					Anisimov VN, 2003, CRIT REV ONCOL HEMAT, V45, P277, DOI 10.1016/S1040-8428(02)00121-X; TROJANI M, 1984, INT J CANCER, V33, P37, DOI 10.1002/ijc.2910330108; Balducci L, 2005, NAT REV CANCER, V5, P655, DOI 10.1038/nrc1675; Matushansky I, 2013, CANCER INVEST, V31, P83, DOI 10.3109/07357907.2012.756112; Linch M, 2014, NAT REV CLIN ONCOL, V11, P187, DOI 10.1038/nrclinonc.2014.26; Lahat G, 2009, ANN SURG ONCOL, V16, P2579, DOI 10.1245/s10434-009-0574-6; COX DR, 1972, J R STAT SOC B, V34, P187; Al-Refaie WB, 2010, ANN SURG ONCOL, V17, P1732, DOI 10.1245/s10434-010-1034-z; Boden RA, 2006, EJSO-EUR J SURG ONC, V32, P1154, DOI 10.1016/j.ejso.2006.05.016; Broders AC, 1920, J AMER MED ASSOC, V74, P656; Edge S, 2010, AJCC CANC STAGING MA, P291; Edge SB, 2010, AJCC CANC STAGING MA, P281; ESMO/European Sarcoma Network Working Group, 2012, ANN ONCOL S7, V23, P92, DOI DOI 10.1093/ANNONC/MDS253; Farry JK, 2012, EUR J CANCER, V48, P1326, DOI 10.1016/j.ejca.2012.03.009; Flecher C, 2002, WHO CLASSIFICATION T, P10; HOSKING MP, 1989, JAMA-J AM MED ASSOC, V261, P1909; Japanese Orthopedic Association Musculoskeletal Tumor Committee, 2008, BON TUM REG MAL SOFT; Kaplan EL, 1958, J AM STAT ASSOC, V53, P448; Kawaguchi N, 2004, CLIN ORTHOP RELAT R, P165, DOI 10.1097/01.blo.0000116308.86761.f5; Kozawa E, 2014, INT J CLIN ONCOL, V19, P384, DOI 10.1007/s10147-013-0543-8; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Ministry of Health Labor and Welfare of Japan, ELD PEOPL NAT LIF EX; Osaka S, 2003, J Orthop Surg (Hong Kong), V11, P28; Suemitsu R, 2008, ANN THORAC CARDIOVAS, V14, P154; Takano S, 2000, EUR J SURG ONCOL, V26, P67, DOI 10.1053/ejso.1999.0743; Torigoe Tomoaki, 2010, J Orthop Surg (Hong Kong), V18, P58; Vigorito C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00051; World Health Organization, HLTH STAT INF SYST D; Yoneda Y, 2014, EJSO-EUR J SURG ONC, V40, P49, DOI 10.1016/j.ejso.2013.09.004	29	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	SEP	2015	10	3					1799	1804		10.3892/ol.2015.3432		6	Oncology	Oncology	CQ9GZ	WOS:000360923000099		
J	Hokka, D; Ogawa, H; Tane, S; Tanaka, Y; Tauchi, S; Maniwa, Y				Hokka, Daisuke; Ogawa, Hiroyuki; Tane, Shinya; Tanaka, Yugo; Tauchi, Shunsuke; Maniwa, Yoshimasa			Ruptured thymoma causing a hemothorax: A case report	ONCOLOGY LETTERS			English	Article						ruptured thymoma; chest pain; urgent surgery; hemothorax	TUMORS	A thymoma is a neoplasm that arises from the epithelial cells of the thymus, and may cause various signs and symptoms dependent upon its local extent. A nontrau-matic hemothorax is extremely rare. The present study reports the case of a 77-year-old female who presented with an acute onset of chest pain. Imaging procedures revealed a mass occupying the anterior mediastinum and left hemithorax, and a left pleural effusion. Progressive anemia was noted following admission. Left hemothorax due to rupture of the anterior mediastinal mass was suspected, and emergency surgery was performed. Hemorrhage was observed on the cut surface of the tumor. An analysis of frozen sections indicated a thymoma, and a thymo-partial thymectomy was subsequently performed to remove as much of the hematoma as possible. The patient was discharged on post-operative day 13 following an uneventful recovery. The present case suggests that in previously healthy individuals, sudden-onset dyspnea and chest pain co-occurring with an acute widening of the mediastinum observed on roentgenograph may be indicative of a ruptured thymoma.	[Hokka, Daisuke; Ogawa, Hiroyuki; Tane, Shinya; Tanaka, Yugo; Tauchi, Shunsuke; Maniwa, Yoshimasa] Kobe Univ, Grad Sch Med, Dept Surg, Div Thorac Surg, Kobe, Hyogo 6500017, Japan	Hokka, D (reprint author), Kobe Univ, Grad Sch Med, Dept Surg,Div Thorac Surg, Chuo Ku, 7-5-2 Kusunoki, Kobe, Hyogo 6500017, Japan.	daigoro1019@yahoo.co.jp					Okumura M, 2002, CANCER, V94, P624, DOI 10.1002/cncr.10226; Loehrer PJ, 2001, CANCER, V91, P2010, DOI 10.1002/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2; Sasaka K, 1998, AM J ROENTGENOL, V170, P323; Choi SJ, 1998, AM J ROENTGENOL, V171, P591; Thomas CR, 1999, J CLIN ONCOL, V17, P2280; CAPLIN JL, 1985, JPN HEART J, V26, P123; Fukuse T, 1991, Nihon Kyobu Geka Gakkai Zasshi, V39, P930; GEREIN AN, 1978, AM J SURG, V136, P49, DOI 10.1016/0002-9610(78)90199-X; Janik M, 2014, FORENSIC SCI INT, V236, P22, DOI 10.1016/j.forsciint.2013.12.013; Santoprete S, 2007, ANN THORAC SURG, V83, P1526, DOI 10.1016/j.athoracsur.2006.10.016; Shimokawa S, 2001, ANN THORAC SURG, V71, P370, DOI 10.1016/S0003-4975(00)02234-7; Sobin LH, 1999, WHO INT HISTOLOGICAL, V2nd; TEMPLETON PA, 1988, CHEST, V93, P828, DOI 10.1378/chest.93.4.828	13	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	SEP	2015	10	3					1810	1812		10.3892/ol.2015.3476		3	Oncology	Oncology	CQ9GZ	WOS:000360923000101		
J	Obayashi, T; Funasaka, K; Ohno, E; Miyahara, R; Hirooka, Y; Hamaguchi, M; Goto, H; Senga, T				Obayashi, Tomohiko; Funasaka, Kohei; Ohno, Eizaburo; Miyahara, Ryoji; Hirooka, Yoshiki; Hamaguchi, Michinari; Goto, Hidemi; Senga, Takeshi			Treatment with near-infrared radiation promotes apoptosis in pancreatic cancer cells	ONCOLOGY LETTERS			English	Article						near-infrared radiation; apoptosis; gemcitabine; caspase-3; pancreatic cancer	ENERGY LASER IRRADIATION; CYTOCHROME-C-OXIDASE; IR RADIATION; MYOCARDIAL-INFARCTION; MAMMALIAN-CELLS; CHEMOTHERAPY; DEVICE; LIGHT; TRIAL; RATS	Cancer remains one of the leading causes of human mortality worldwide. Radiation and chemotherapy are commonly used for cancer treatment; however, the combination of these therapies and surgery do not completely eradicate cancer cells. Near-infrared radiation (NIR) is a low-energy form of radiation that exerts multiple effects on mammalian cells. Previous studies have reported that NIR induces DNA double-strand breaks and apoptosis of cancer cells. In the present study, a 915-nm laser was used to examine the effects of NIR on pancreatic cancer cells. Irradiation of pancreatic cancer cells using a 915-nm laser significantly induced caspase-3 activation and apoptosis. In addition, the combination of gemcitabine treatment and a 915-nm laser synergistically increased the number of apoptotic cells. The results of the present study indicate the use of infrared irradiation and chemotherapy may be a possible therapy for the treatment of cancer.	[Obayashi, Tomohiko; Funasaka, Kohei; Ohno, Eizaburo; Miyahara, Ryoji; Hirooka, Yoshiki; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4668550, Japan; [Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan	Senga, T (reprint author), Nagoya Univ, Grad Sch Med, Div Canc Biol, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	hgoto@med.nagoya-u.ac.jp; tsenga@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [2583114, 23107010]	The authors would like to thank the members of the Division of Cancer Biology for their helpful discussions and technical assistance. This study was partially funded by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant nos. 2583114 and 23107010).	Karu T, 2011, IUBMB LIFE, V63, P747, DOI 10.1002/iub.514; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Schroeder P, 2007, FREE RADICAL BIO MED, V43, P128, DOI 10.1016/j.freeradbiomed.2007.04.002; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Karu TI, 2010, IUBMB LIFE, V62, P607, DOI 10.1002/iub.359; Grossman N, 1998, LASER SURG MED, V22, P212, DOI 10.1002/(SICI)1096-9101(1998)22:4<212::AID-LSM5>3.0.CO;2-S; Salama JK, 2008, CLIN CANCER RES, V14, P5255, DOI 10.1158/1078-0432.CCR-08-0358; KARU T, 1994, INT J RADIAT BIOL, V65, P691, DOI 10.1080/09553009414550811; Anders JJ, 2008, IEEE J SEL TOP QUANT, V14, P118, DOI [10.1109/JSTQE.2008.916181, 10.1109/JSTQE.2007.916181]; Oron U, 2001, LASER SURG MED, V28, P204, DOI 10.1002/lsm.1039; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Shefer G, 2003, BBA-MOL CELL RES, V1593, P131, DOI 10.1016/S0167-4889(02)00350-6; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Oron U, 2001, CIRCULATION, V103, P296; Berlin J, 2010, NAT REV CLIN ONCOL, V7, P135, DOI 10.1038/nrclinonc.2010.16; Davis A.J., 2013, TRANSL CANC RES, V2, P130, DOI DOI 10.3978/J.ISSN.2218-676X.2013.04.02; Dees C, 2002, PHOTOCHEM PHOTOBIOL, V75, P296, DOI 10.1562/0031-8655(2002)075<0296:TOMCMW>2.0.CO;2; Tirlapur Uday K., 2001, Cellular and Molecular Biology Online Papers, V47, pOL131; Santana-Blank LA, 2002, CLIN CANCER RES, V8, P3082; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI [10.3322/caac.21208, DOI 10.3322/CAAC.21208]; Tanaka Yohei, 2011, Eplasty, V11, pe12; Tanaka Y, 2012, CANCER SCI, V103, P1467, DOI 10.1111/j.1349-7006.2012.02310.x; Tanaka Y, 2010, CANCER SCI, V101, P1396, DOI 10.1111/j.1349-7006.2010.01548.x; Tanaka Y, 2011, EPLASTY, V11, pe22	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	SEP	2015	10	3					1836	1840		10.3892/ol.2015.3399		5	Oncology	Oncology	CQ9GZ	WOS:000360923000107		
J	Hiroshige, T; Matsuo, M; Ueda, K; Nakiri, M; Nishihara, K; Igawa, T				Hiroshige, Tasuku; Matsuo, Mitsunori; Ueda, Kosuke; Nakiri, Makoto; Nishihara, Kiyoaki; Igawa, Tsukasa			Transarterial embolization for pelvic hematoma following laparoscopic radical prostatectomy: A case report and review of the literature	ONCOLOGY LETTERS			English	Review						laparoscopic radical prostatectomy; transarterial embolization	PUDENDAL ARTERY PSEUDOANEURYSM; RETROPUBIC PROSTATECTOMY; SUCCESSFUL MANAGEMENT; CANCER; HEMORRHAGE; EXPERIENCE; METAANALYSIS; OUTCOMES; THERAPY; TRENDS	The present study reports a case of hemorrhage from branches of the right obturator artery following laparoscopic radical prostatectomy. On post-operative day 9, the patient complained of lower abdominal pain, and the hemoglobin and hematocrit levels had decreased. Emergency computed tomography angiography showed a large pelvic hematoma suggesting active bleeding. Transarterial embolization (TAE) was performed using microcoils. There were no post-procedure complications. At 3 months post-surgery, using computed tomography, the pelvic hematoma was shown to have been absorbed. To the best of our knowledge, TAE for a hemorrhage from the obturator artery following laparoscopic prostatectomy has not previously been described. TAE is a safe and minimally invasive treatment compared with surgical intervention, and should be considered as a treatment for post-operative arterial hemorrhage.	[Hiroshige, Tasuku; Matsuo, Mitsunori; Ueda, Kosuke; Nakiri, Makoto; Nishihara, Kiyoaki; Igawa, Tsukasa] Kurume Univ, Dept Urol, Sch Med, Kurume, Fukuoka 8300011, Japan	Hiroshige, T (reprint author), Kurume Univ, Dept Urol, Sch Med, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	tkkn19841220@yahoo.co.jp					Akand M, 2015, EUR REV MED PHARMACO, V19, P525; Moran PS, 2013, INT J UROL, V20, P312, DOI 10.1111/iju.12070; Greco F, 2010, BJU INT, V106, P543, DOI 10.1111/j.1464-410X.2009.09157.x; Katanoda K, 2015, JPN J CLIN ONCOL, V45, P390, DOI 10.1093/jjco/hyv002; Schuessler WW, 1997, UROLOGY, V50, P854, DOI 10.1016/S0090-4295(97)00543-8; Wang MQ, 2013, ABDOM IMAGING, V38, P465, DOI 10.1007/s00261-012-9931-1; Raboy A, 1997, UROLOGY, V50, P849, DOI 10.1016/S0090-4295(97)00485-8; REINER WG, 1979, J UROLOGY, V121, P198; Tewari A, 2012, EUR UROL, V62, P1, DOI 10.1016/j.eururo.2012.02.029; BEAUJEUX R, 1995, J UROLOGY, V153, P14, DOI 10.1097/00005392-199501000-00007; Teloken C, 2005, J UROLOGY, V174, P2178, DOI 10.1097/01.ju.0000181818.51977.29; Ferronha F, 2011, INT BRAZ J UROL, V37, P146, DOI 10.1590/S1677-55382011000200002; Beckley I, 2007, J ENDOUROL, V21, P923, DOI 10.1089/end.2006.0419; BRATT O, 1994, SCAND J UROL NEPHROL, V28, P265; Cheng S, 2012, ONCOL LETT, V4, P521, DOI 10.3892/ol.2012.749; Drouin SJ, 2009, WORLD J UROL, V27, P599, DOI 10.1007/s00345-009-0379-z; Feng T, 2013, UROLOGY, V81, pE5, DOI 10.1016/j.urology.2012.09.002; Foss HL, 1923, ANN SURG, V78, P802, DOI 10.1097/00000658-192312000-00010; Fratezi AC, 2001, J TRAUMA, V50, P581, DOI 10.1097/00005373-200103000-00033; Guillonneau B, 1999, EUR UROL, V36, P14, DOI 10.1159/000019921; HEDICAN SP, 1994, J UROLOGY, V152, P1181; Ibarra R, 2003, J UROLOGY, V169, P276, DOI 10.1097/01.ju.0000042060.73886.7f; Jeong CW, 2010, J ENDOUROL, V24, P1529, DOI 10.1089/end.2009.0686; Kaufman JD, 2005, UROLOGY, V66, P561, DOI 10.1016/j.urolog.2005.04.015; Lopes RI, 2009, J ENDOUROL, V23, P297, DOI 10.1089/end.2008.0494; Onozawa M, 2014, JPN J CLIN ONCOL, V44, P969, DOI 10.1093/jjco/hyu104; Park YH, 2008, J ENDOUROL, V22, P2687, DOI 10.1089/end.2008.0287; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tooher R, 2006, J UROLOGY, V175, P2011, DOI 10.1016/S0022-5347(06)00265-5	29	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	SEP	2015	10	3					1889	1892		10.3892/ol.2015.3381		4	Oncology	Oncology	CQ9GZ	WOS:000360923000116		
J	Refaat, A; Abdelhamed, S; Saiki, I; Sakurai, H				Refaat, Alaa; Abdelhamed, Sherif; Saiki, Ikuo; Sakurai, Hiroaki			Inhibition of p38 mitogen-activated protein kinase potentiates the apoptotic effect of berberine/tumor necrosis factor-related apoptosis-inducing ligand combination therapy	ONCOLOGY LETTERS			English	Article						apoptosis; berberine; epidermal growth factor receptor; mitogen-activated protein kinase; tumor necrosis factor-related apoptosis-inducing ligand	TRAIL-INDUCED APOPTOSIS; GASTRIC-CANCER CELLS; BREAST-CANCER; PHOSPHORYLATION; EGFR	It was previously reported that berberine (BBR) and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) exhibited a synergistic apoptotic effect on triple negative breast cancer (TNBC) cells. In addition, the BBR/TRAIL combination treatment sensitized TRAILresis-tant TNBC cells to TRAIL. The aim of the present study was to investigate a novel pathway for enhancing the apoptotic effect of BBR/TRAIL through mitogen-activated protein kinases (MAPKs). Selective inhibitors and small interfering RNAs were utilized to understand the role of p38 MAPK in this pathway. The results demonstrated that p38 MAPK was activated in response to the combination therapy in TRAIL-resistant TNBC cells. In addition, it was revealed that the inhibition of p38 enhanced apoptosis in epidermal growth factor receptor (EGFR) -overexpressing MDA-MB-468 TNBC cells and EGFR-mutant PC-9 non-small-cell lung carcinoma cells, which was associated with the downregulation of EGFR serine phosphorylation. Viability assays for these two cell lines also confirmed the significant reduction of cell viability following p38 inhibition in BBR/TRAIL-treated cells. In conclusion, the present study provided novel evidence for the role of p38 in suppressing BBR/TRAIL-mediated apoptosis and its association with EGFR, which may explain the mechanism of treatment resistance in certain types of cancer.	[Refaat, Alaa; Abdelhamed, Sherif; Saiki, Ikuo] Toyama Univ, Inst Nat Med, Dept Biosci, Div Pathogen Biochem, Toyama 9300194, Japan; [Refaat, Alaa; Sakurai, Hiroaki] Toyama Univ, Grad Sch Pharmaceut Sci, Div Canc Cell Biol, Toyama 9300194, Japan; [Refaat, Alaa] Zewail City Sci & Technol, Ctr Aging & Associated Dis, Giza 12588, Egypt	Refaat, A (reprint author), Zewail City Sci & Technol, Ctr Aging & Associated Dis, 26 July Axis, Giza 12588, Egypt.	arefaat@zewailcity.edu.eg; hsakurai@pha.u-toyama.ac.jp		Sakurai, Hiroaki/0000-0003-0657-9570	short-term fellowship grant from the Science and Technology Development Fund, Egypt [6093]	The present study was supported, in part, by a short-term fellowship grant from the Science and Technology Development Fund, Egypt (no. 6093).	Refaat A, 2015, BIOCHEM BIOPH RES CO, V458, P856, DOI 10.1016/j.bbrc.2015.02.044; Refaat A, 2011, J BIOL CHEM, V286, P21092, DOI 10.1074/jbc.M110.200907; Zhou Y, 2014, FEBS LETT, V588, P131, DOI 10.1016/j.febslet.2013.11.020; Wang C, 2009, J BIOL CHEM, V284, P3804, DOI 10.1074/jbc.M807191200; Refaat A, 2013, ONCOL LETT, V6, P840, DOI 10.3892/ol.2013.1434; Abdelhamed S, 2014, ANTICANCER RES, V34, P1893; Keane MM, 1999, CANCER RES, V59, P734; Refaat A, 2014, ONCOL LETT, V7, P1327, DOI 10.3892/ol.2014.1922; Xu L, 2014, ONCOL REP, V32, P318, DOI 10.3892/or.2014.3183; Tolcher AW, 2007, J CLIN ONCOL, V25, P1390, DOI 10.1200/JCO.2006.08.8898; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Zhang Y, 2014, J PHARMACOL EXP THER, V349, P417, DOI 10.1124/jpet.114.212795; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Lee SJ, 2011, INT J ONCOL, V38, P485, DOI 10.3892/ijo.2010.878; Choo MK, 2006, MOL CANCER THER, V5, P2970, DOI 10.1158/1535-7163.MCT-06-0379; Dyer MJS, 2007, J CLIN ONCOL, V25, P4505, DOI 10.1200/JCO.2007.13.1011; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Xu L, 2012, EUR J CANCER, V48, P3288, DOI 10.1016/j.ejca.2012.03.005; Zaidi SF, 2015, HELICOBACTER	19	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	SEP	2015	10	3					1907	1911		10.3892/ol.2015.3494		5	Oncology	Oncology	CQ9GZ	WOS:000360923000119		
J	Keloth, J; Sadgrove, M; Yalla, R; Hakuta, K				Keloth, Jameesh; Sadgrove, Mark; Yalla, Ramachandrarao; Hakuta, Kohzo			Diameter measurement of optical nanofibers using a composite photonic crystal cavity	OPTICS LETTERS			English	Article							FLUORESCENCE; FIBERS	We demonstrate a method for making precise measurements of the diameter of a tapered optical fiber with a sub-wavelength diameter waist (an optical nanofiber). The essence of the method is to create a composite photonic crystal cavity by mounting a defect-mode grating on an optical nanofiber. The resultant cavity has a resonance wavelength that is sensitive to the nanofiber's diameter, allowing the diameter to be inferred from optical measurements. This method offers a precise, nondestructive, and in situ way to characterize the nanofiber diameter. (C) 2015 Optical Society of America	[Keloth, Jameesh; Yalla, Ramachandrarao; Hakuta, Kohzo] Univ Electrocommun, Ctr Photon Innovat, Chofu, Tokyo 1828585, Japan; [Sadgrove, Mark] Tohoku Univ, Res Inst Elect Commun, Aoba Ku, Sendai, Miyagi 9808577, Japan	Hakuta, K (reprint author), Univ Electrocommun, Ctr Photon Innovat, Chofu, Tokyo 1828585, Japan.	k.hakuta@cpi.uec.ac.jp			Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [15K13544]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) (15K13544); Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Morrissey MJ, 2013, SENSORS-BASEL, V13, P10449, DOI 10.3390/s130810449; Schroder T, 2012, OPT EXPRESS, V20, P10490, DOI 10.1364/OE.20.010490; Vetsch E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203603; Sumetsky M, 2010, OPT LETT, V35, P4006, DOI 10.1364/OL.35.004006; Yalla R, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.063602; Birks TA, 2000, IEEE PHOTONIC TECH L, V12, P182, DOI 10.1109/68.823510; Liebermeister L, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862207; Ward JM, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4901098; Lou JY, 2014, SENSORS-BASEL, V14, P5823, DOI 10.3390/s140405823; Nayak KP, 2007, OPT EXPRESS, V15, P5431, DOI 10.1364/OE.15.005431; Goban A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.033603; Le Kien F, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.053826; Nayak KP, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053003; Nayak KP, 2011, OPT EXPRESS, V19, P14040, DOI 10.1364/OE.19.014040; Nayak KP, 2013, OPT EXPRESS, V21, P2480, DOI 10.1364/OE.21.002480; Sadgrove M, 2013, OPT LETT, V38, P2542, DOI 10.1364/OL.38.002542; Sumetsky M, 2006, OPT LETT, V31, P2393, DOI 10.1364/OL.31.002393; Wiedemann U, 2010, OPT EXPRESS, V18, P7693, DOI 10.1364/OE.18.007693; Yalla R, 2012, OPT EXPRESS, V20, P2932, DOI 10.1364/OE.20.002932; Yalla R, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.143601	20	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	SEP 1	2015	40	17					4122	4125		10.1364/OL.40.004122		4	Optics	Optics	CQ7UM	WOS:000360810200051		
J	Hiramatsu, K; Leproux, P; Couderc, V; Nagata, T; Kano, H				Hiramatsu, Kotaro; Leproux, Philippe; Couderc, Vincent; Nagata, Takashi; Kano, Hideaki			Raman optical activity spectroscopy by visible-excited coherent anti-Stokes Raman scattering	OPTICS LETTERS			English	Article							INSTRUMENT	We developed a Raman optical activity (ROA) spectroscopic system with visible-excited coherent anti-Stokes Raman scattering (CARS). A supercontinuum within the visible region was generated with a photonic crystal fiber pumped with both 532 and 1064 nm excitation, generating a multiplexed CARS-ROA spectrum covering the whole fingerprint region. In visible excitation, the CARS-ROA spectrum of (-)-beta-pinene shows a higher contrast ratio of the chirality-induced signal to the achiral background than that of the previously reported near-infrared CARS-ROA spectrum. (C) 2015 Optical Society of America	[Hiramatsu, Kotaro] Univ Tokyo, Dept Chem, Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Leproux, Philippe; Couderc, Vincent] UMR CNRS, Inst Rech XLIM, F-87060 Limoges, France; [Nagata, Takashi] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan; [Kano, Hideaki] Univ Tsukuba, Fac Pure & Appl Sci, Div Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Kano, Hideaki] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan	Kano, H (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Appl Phys, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	hkano@bk.tsukuba.ac.jp	Hiramatsu, Kotaro/M-1731-2015	Hiramatsu, Kotaro/0000-0003-0767-019X	Japan Society for the Promotion of Science (JSPS) Bilateral Program (Japan-France)	Japan Society for the Promotion of Science (JSPS) Bilateral Program (Japan-France).	Hecht L, 1999, J RAMAN SPECTROSC, V30, P815, DOI 10.1002/(SICI)1097-4555(199909)30:9<815::AID-JRS453>3.0.CO;2-1; Unno M, 2013, J PHYS CHEM B, V117, P1321, DOI 10.1021/jp4001187; Hiramatsu K, 2013, OPT EXPRESS, V21, P13515, DOI 10.1364/OE.21.013515; Barron LD, 2010, CHEM PHYS LETT, V492, P199, DOI 10.1016/j.cplett.2010.03.090; Nafie LA, 2007, APPL SPECTROSC, V61, P1103, DOI 10.1366/000370207782217752; Hug W, 1999, J RAMAN SPECTROSC, V30, P841, DOI 10.1002/(SICI)1097-4555(199909)30:9<841::AID-JRS456>3.0.CO;2-1; Barron L D, 2004, MOL LIGHT SCATTERING; Champert PA, 2004, OPT EXPRESS, V12, P4366, DOI 10.1364/OPEX.12.004366; Frisch M. J., 2004, GAUSSIAN 03 REVISION; HECHT L, 1994, J RAMAN SPECTROSC, V25, P443, DOI 10.1002/jrs.1250250703; Hiramatsu K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.083901; Hug W, 2003, APPL SPECTROSC, V57, P1, DOI 10.1366/000370203321165142; Nafie LA, 2011, VIBRATIONAL OPTICAL ACTIVITY: PRINCIPLES AND APPLICATIONS, P1, DOI 10.1002/9781119976516; Okuno M, 2007, OPT LETT, V32, P3050, DOI 10.1364/OL.32.003050	14	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	SEP 1	2015	40	17					4170	4173		10.1364/OL.40.004170		4	Optics	Optics	CQ7UM	WOS:000360810200063		
J	Kishi, T; Miyamae, T; Morimoto, R; Ishiguro, N; Hamaguchi, Y; Fujimoto, M; Nagata, S; Yamanaka, H				Kishi, Takayuki; Miyamae, Takako; Morimoto, Ryoko; Ishiguro, Naoko; Hamaguchi, Yasuhito; Fujimoto, Manabu; Nagata, Satoru; Yamanaka, Hisashi			Childhood-Onset Anti-Ku Antibody-Positive Generalized Morphea with Polymyositis: A Japanese Case Study	PEDIATRIC DERMATOLOGY			English	Article							AUTOANTIBODIES	We report a 16-year-old Japanese girl with anti-Ku antibody-positive generalized morphea and polymyositis who, at the age of 7 years, developed multiple brownish plaques on her left forearm that gradually extended to her upper arm, back, and left thigh, which a skin biopsy revealed as morphea. Laboratory testing was positive for antinuclear antibody and a high serum creatine kinase level. Although there were no clinical signs of muscular involvement, magnetic resonance imaging revealed findings consistent with myositis. The patient is one of the youngest reported cases positive for anti-Ku antibody. Anti-Ku positivity concomitant with generalized morphea is rare.	[Kishi, Takayuki; Miyamae, Takako; Nagata, Satoru] Tokyo Womens Med Univ, Dept Pediat, Tokyo, Japan; [Kishi, Takayuki; Miyamae, Takako; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan; [Morimoto, Ryoko; Ishiguro, Naoko] Tokyo Womens Med Univ, Dept Dermatol, Tokyo, Japan; [Hamaguchi, Yasuhito] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Med, Dept Dermatol, Kanazawa, Ishikawa, Japan; [Fujimoto, Manabu] Univ Tsukuba, Dept Dermatol, Tsukuba, Ibaraki, Japan	Kishi, T (reprint author), 8-1 Kawada Cho,Shinjuku Ku, Tokyo 1628666, Japan.	kishi.takayuki@twmu.ac.jp					BIRDI N, 1993, ARTHRITIS RHEUM, V36, P410, DOI 10.1002/art.1780360318; MIMORI T, 1981, J CLIN INVEST, V68, P611, DOI 10.1172/JCI110295; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; MIMORI T, 1986, J BIOL CHEM, V261, P2274; Nagai Y, 2001, J DERMATOL, V28, P576	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-8046	1525-1470		PEDIATR DERMATOL	Pediatr. Dermatol.	SEP-OCT	2015	32	5					E224	E225		10.1111/pde.12644		2	Dermatology; Pediatrics	Dermatology; Pediatrics	CR2TR	WOS:000361184000010		
J	Yao, W; Zhang, JC; Dong, C; Zhuang, C; Hirota, S; Inanaga, K; Hashimoto, K				Yao, Wei; Zhang, Ji-chun; Dong, Chao; Zhuang, Cun; Hirota, Susumu; Inanaga, Kazutoyo; Hashimoto, Kenji			Effects of amycenone on serum levels of tumor necrosis factor-alpha, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Hericium erinaceum; Amycenone; Cytokine; Depression; Anti-inflammatory activity	HERICIUM-ERINACEUS; MAJOR DEPRESSION; INFLAMMATION; PATHOPHYSIOLOGY; METAANALYSIS; CYTOKINES; BRAIN	Accumulating evidence suggests that inflammation plays a role in the pathophysiology of depression and that anti-inflammatory substances have antidepressant effects. Amycenone is obtained from extracts of the Yamabushitake (Hericium erinaceum). The purpose of this study is to examine whether amycenone shows anti-inflammatory and antidepressant effects in an inflammation-induced mouse model of depression. First, we examined the effects of amycenone on the serum levels of the pro-inflammatory cytokine, tumor necrosis factor-alpha (TNF-alpha), and the anti-inflammatory cytokine, interleukin-10 (IL-10), after intraperitoneal administration of the bacterial endotoxin lipopolysaccharide (LPS). Oral administration of amycenone (50, 100, or 200 mg/kg) markedly blocked an increase in the serum TNF-alpha levels after a single administration of LPS (0.5 mg/kg). Furthermore, amycenone (200 mg/kg) markedly increased the serum IL-10 levels by a single administration of LPS (0.5 mg/kg). Next, we examined the effects of amycenone on depression-like behaviors in the tail-suspension test (TST) and forced swimming test (FST). Pretreatment with amycenone (200 mg/kg) significantly attenuated LPS (0.5 mg/kg)-induced increase of the immobility time by the TST and FST, indicating antidepressant effects of amycenone. In addition, oral administration of paroxetine (30 mg/kg) showed anti-inflammatory and antidepressant effects in the same model. These findings suggest that amycenone has antidepressant effects in LPS-induced inflammation model of depression. Therefore, amycenone could represent a potential supplement to prevent inflammation-related depression. (C) 2015 Elsevier Inc. All rights reserved.	[Yao, Wei; Zhang, Ji-chun; Dong, Chao; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan; [Zhuang, Cun] Mushroom Wisdom Ltd, East Rutherford, NJ USA; [Hirota, Susumu] Hirota Clin, Kurume, Fukuoka, Japan; [Inanaga, Kazutoyo] Chikusuikai Hosp, Chikusuikai Inst Neuroinformat, Fukuoka, Japan	Hashimoto, K (reprint author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp					Jiang SJ, 2014, APPL MICROBIOL BIOT, V98, P7661, DOI 10.1007/s00253-014-5955-5; Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52; Mori K, 2009, PHYTOTHER RES, V23, P367, DOI 10.1002/ptr.2634; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Chen HX, 2012, PSYCHOPHARMACOLOGY, V222, P37, DOI 10.1007/s00213-011-2619-3; Hashimoto K, 2014, EXPERT OPIN THER TAR, V18, P1049, DOI 10.1517/14728222.2014.934225; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Hashimoto K, 2015, INT J MOL SCI, V16, P7796, DOI 10.3390/ijms16047796; Raison CL, 2010, ARCH GEN PSYCHIAT, V67, P1211, DOI 10.1001/archgenpsychiatry.2010.161; Ma Min, 2014, Clin Psychopharmacol Neurosci, V12, P31, DOI 10.9758/cpn.2014.12.1.31; Abdullah N, 2012, EVID-BASED COMPL ALT, P1, DOI 10.1155/2012/464238; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; Mori K, 2008, BIOL PHARM BULL, V31, P1727, DOI 10.1248/bpb.31.1727; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Wong KH, 2009, FOOD TECHNOL BIOTECH, V47, P47; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Bredesen DE, 2014, AGING-US, V6, P707; El-Behadli AF, 2015, BRIT J NUTR, V113, pS55, DOI 10.1017/S000711451400333X; Inanaga K., 2014, PERS MED UNIVERSE, V3, P49; Inanaga K, 2012, PERS MED U, V1, P13; Inanaga K., 2015, INT J EMERG MENT HLT, V17, P203; Inanaga K., 2014, PERS MED UNIVERSE, V3, P46; Khan M. A., 2013, Journal of Complementary & Integrative Medicine, V10, P253; Lai JS, 2014, AM J CLIN NUTR, V99, P181, DOI 10.3945/ajcn.113.069880; Liu JQ, 2015, EXP THER MED, V9, P483, DOI 10.3892/etm.2014.2139; Ma XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020955; Ma XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056053; Mello AH, 2014, ACTA NEUROPSYCHIATR, V26, P178, DOI 10.1017/neu.2013.52; Mukakami K., 2010, MOL NUTR FOOD RES, V54, P471; Noh HJ, 2014, IMMUNOPHARM IMMUNOT, V36, P349, DOI 10.3109/08923973.2014.947036; Ohgi Y, 2013, PHARM BIOCH BEHAV, V103, P856; Opie RS., 2014, PUBLIC HEALTH NUTR, V3, P1; Shirai Yumi, 2012, Clin Psychopharmacol Neurosci, V10, P94, DOI 10.9758/cpn.2012.10.2.94; Walker E.R., 2015, JAMA PSYCHIAT; Wang J C, 2001, Kaohsiung J Med Sci, V17, P461; Wasser Solomon P, 2014, Biomed J, V37, P345, DOI 10.4103/2319-4170.138318; Whiteford HA, 2010, LANCET, V382, P1575, DOI DOI 10.1016/S0140-6736(13)61611-6; Yang BK, 2003, BIOSCI BIOTECH BIOCH, V67, P1292, DOI 10.1271/bbb.67.1292; Zhang JC, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu077; Zhuang C., 2009, US Patent US, Patent No. [0274720 Al, 0274720]	42	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	SEP	2015	136						7	12		10.1016/j.pbb.2015.06.012		6	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	CQ9PX	WOS:000360948300002		
J	Hou, CL; Cai, MY; Ma, XR; Zang, Y; Jia, FJ; Lin, YQ; Chiu, HFK; Ungvari, GS; Ng, CH; Zhong, BL; Cao, XL; Li, Y; Shinfuku, N; Xiang, YT				Hou, C. -L.; Cai, M. -Y.; Ma, X. -R.; Zang, Y.; Jia, F. -J.; Lin, Y. -Q.; Chiu, H. F. K.; Ungvari, G. S.; Ng, C. H.; Zhong, B. -L.; Cao, X. -L.; Li, Y.; Shinfuku, N.; Xiang, Y. -T.			Clozapine Prescription and Quality of Life in Chinese Patients with Schizophrenia Treated in Primary Care	PHARMACOPSYCHIATRY			English	Article						schizophrenia; clozapine; primary care; China	TREATMENT-REFRACTORY SCHIZOPHRENIA; RESISTANT SCHIZOPHRENIA; ANTIPSYCHOTIC TREATMENT; CLINICAL-PRACTICE; MENTAL-HEALTH; DOUBLE-BLIND; GUIDELINES; RECOMMENDATIONS; CHLORPROMAZINE; SUICIDALITY	Objective: Clozapine is frequently used to treat schizophrenia in China. Maintenance treatment for clinically stable patients with schizophrenia is usually provided by Chinese primary care physicians, but no study has investigated the frequency of its use prescribed by primary care physicians. This study described the frequency, demographic and clinical characteristics of clozapine treatment and its impact on insight and quality of life (QOL) of patients with schizophrenia treated in primary care in China. Method: A total of 623 patients with schizophrenia treated in 22 primary care services in Guangzhou, China in 2013 formed the study sample. Patients' socio-demographic and clinical characteristics including psychopathology, medication side effects and QOL were recorded using a standardized protocol and data collection. Results: The frequency of clozapine prescription was 35.6% with a mean daily dose of 127.788.2mg. There were no significant differences between the patients with and without clozapine in either of the QOL domains after controlling the confounding factors. Multiple logistic regression analyses revealed that patients on clozapine had younger age of onset, more hospitalizations, more severe extrapyramidal side effects, but better insight and fewer prescriptions of first generation antipsychotics. Conclusions: Clozapine use was found to be common and associated with better insight in patients with schizophrenia treated in primary care in China. Further examination of the rationale and appropriateness of clozapine in primary care in China is warranted.	[Hou, C. -L.; Jia, F. -J.; Lin, Y. -Q.] Guangdong Gen Hosp, Guangdong Mental Hlth Ctr, Guangzhou, Guangdong, Peoples R China; [Hou, C. -L.; Jia, F. -J.; Lin, Y. -Q.] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Cai, M. -Y.] Guangzhou Yuexiu Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Ma, X. -R.] Ningxia Ning An Hosp, Ningxia Mental Hlth Ctr, Yinchuan, Ningxia Provinc, Peoples R China; [Zang, Y.; Cao, X. -L.] Shenzhen Kangning Hosp, Shenzhen Key Lab Psychol Healthcare, Shenzhen, Peoples R China; [Zang, Y.; Cao, X. -L.] Shenzhen Kangning Hosp, Shenzhen Inst Mental Hlth, Shenzhen, Peoples R China; [Zang, Y.; Cao, X. -L.] Shenzhen Mental Hlth Ctr, Shenzhen, Peoples R China; [Chiu, H. F. K.; Zhong, B. -L.; Li, Y.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Ungvari, G. S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia; [Ungvari, G. S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Ng, C. H.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Shinfuku, N.] Kobe Univ, Sch Med, Int Ctr Med Res, Kobe, Hyogo 650, Japan; [Xiang, Y. -T.] Univ Macau, Fac Hlth Sci, Unit Psychiat, Macau, Macao Sar, Peoples R China	Jia, FJ (reprint author), Guang Dong Mental Hlth Ctr, Guangzhou, Guangdong, Peoples R China.	jiafujun@126.com; xyutly@gmail.com					Alessi-Severini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083539; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Lam CLK, 2005, QUAL LIFE RES, V14, P539, DOI 10.1007/s11136-004-0704-3; Esposito D, 2005, EUR J CLIN PHARMACOL, V60, P759, DOI 10.1007/s00228-004-0835-z; Xiang YT, 2007, HUM PSYCHOPHARM CLIN, V22, P17, DOI 10.1002/hup.821; Young CR, 1998, SCHIZOPHRENIA BULL, V24, P381; Voruganti L, 1998, PSYCHOL MED, V28, P165, DOI 10.1017/S0033291797005874; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Henderson DC, 2005, J CLIN PSYCHIAT, V66, P1116; Howes OD, 2012, BRIT J PSYCHIAT, V201, P481, DOI 10.1192/bjp.bp.111.105833; Nielsen J, 2012, EUR NEUROPSYCHOPHARM, V22, P818, DOI 10.1016/j.euroneuro.2012.03.003; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Kane JM, 1998, EUR NEUROPSYCHOPHARM, V8, P55, DOI 10.1016/S0924-977X(97)00045-X; Walker AM, 1997, EPIDEMIOLOGY, V8, P671, DOI 10.1097/00001648-199710000-00010; Liang HG, 2004, INT J INFORM MANAGE, V24, P507, DOI 10.1016/j.ijinfomgt.2004.08.001; Xiang YT, 2011, AUST NZ J PSYCHIAT, V45, P968, DOI 10.3109/00048674.2011.607426; Warnez S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-102; Malalagama G, 2011, AUST NZ J PSYCHIAT, V45, P498, DOI 10.3109/00048674.2011.561482; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82; Xiang YT, 2012, PHARMACOPSYCHIATRY, V45, P7, DOI 10.1055/s-0031-1286345; Haro JM, 2006, CNS DRUGS, V20, P293, DOI 10.2165/00023210-200620040-00003; Schulte PFJ, 2003, CLIN PHARMACOKINET, V42, P607, DOI 10.2165/00003088-200342070-00001; Xiang YT, 2012, LANCET, V380, P1715, DOI 10.1016/S0140-6736(11)60893-3; Ng CH, 2009, ASIA-PAC PSYCHIAT, V1, P90, DOI 10.1111/j.1758-5872.2009.00021.x; Remington G, 2005, CNS DRUGS, V19, P843, DOI 10.2165/00023210-200519100-00004; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; APA, 1997, PRACT GUID TREATM PA; Chinese Medical Association, 2003, GUID PREV TREATM PSY; Harrison J, 2010, PHARM WORLD SCI, V32, P503, DOI 10.1007/s11096-010-9398-5; Kreinin A, 2006, INT CLIN PSYCHOPHARM, V21, P99, DOI 10.1097/01.yic.0000188216.92408.69; Lane HY, 1999, J CLIN PSYCHIAT, V60, P487; Latimer Eric, 2013, Clin Schizophr Relat Psychoses, V7, P33, DOI 10.3371/CSRP.LAWY.012513; Liu T L, 2003, MED J CHIN PEOPLES H, V15, P289; MCEVOY JP, 1981, HOSP COMMUNITY PSYCH, V32, P856; MELTZER HY, 1995, AM J PSYCHIAT, V152, P183; Meltzer Herbert Y, 2012, Clin Schizophr Relat Psychoses, V6, P134; Miller AL, 2004, J CLIN PSYCHIAT, V65, P500; Modestin J, 2005, J CLIN PSYCHIAT, V66, P534; NICE, 2002, GUID US NEW AT ANT D; OVERALL JE, 1984, J GERONTOL, V39, P187; Si TM, 2004, CHIN J PSYCHIAT, V37, P152; Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11; Suzuki T, 2011, PSYCHOPHARMACOL BULL, V44, P32; Taylor D, 2003, MAUDSLEY PRESCRIBING; Weissman EM, 2002, SCHIZOPHRENIA BULL, V28, P31; Williams R, 2001, J CLIN PSYCHIAT, V62, P282; Yang H C, 2005, MED J CHINESE PEOPLE, V17, P257; Zhang M. Y., 1983, CHINESE J NERVOUS ME, V9, P76	49	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0176-3679	1439-0795		PHARMACOPSYCHIATRY	Pharmacopsychiatry	SEP	2015	48	6					200	204		10.1055/s-0035-1555939		5	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	CQ9ON	WOS:000360944600002		
J	Kuwahara, VS; Taguchi, S				Kuwahara, Victor S.; Taguchi, Satoru			Estimating the Diurnal Cycle and Daily Insolation of Ultraviolet and Photosynthetically Active Radiation at the Sea Surface	PHOTOCHEMISTRY AND PHOTOBIOLOGY			English	Article							SOLAR UV-RADIATION; OZONE DEPLETION; EARTHS SURFACE; CLIMATE-CHANGE; OCEAN COLOR; PHYTOPLANKTON; LIGHT; COASTAL; WATER; PRODUCTIVITY	Accurate determination of the diurnal variability and daily insolation of surface (0(+)) and subsurface (0(-)) irradiance are essential to estimate several physical, chemical and biological processes occurring at the surface layer of marine environments. Natural downwelling PAR and spectral UVR were examined on eight occasions at 0(+) and 0(-) to refine empirical models, particularly in the UVR spectrum. The diurnal variability in UVR and PAR were wavelength dependent and were modeled by a sinusoidal equation. The best fit for PAR at 0(+) and 0(-) was the sinusoid power of n=2 and n=2.5, respectively. In the UVR spectrum, sinusoids increased as wavelengths decreased ranging from n=2-5. Higher n values in the UV-B spectrum suggest sharper increase/decrease near sunrise and sunset hours, ultimately reducing the final value of daily insolation at specified wavelengths. Calculated daily insolation of UV-B/(UV-A+PAR) ratio suggests that photoinhibition from exposure to UV-B occurs within a shorter biologically effective day length than PAR, and is high during summer and low during winter. These results suggest that biogeochemical calculations based on diurnal models of irradiance measurements would benefit from accurate solar noon references and wavelength specificity, particularly in the UVR spectrum.	[Kuwahara, Victor S.; Taguchi, Satoru] Soka Univ, Grad Sch Engn, Hachioji, Tokyo, Japan	Kuwahara, VS (reprint author), Soka Univ, Grad Sch Engn, Hachioji, Tokyo, Japan.	victor@soka.ac.jp			Ministry of the Environment, Japan; Soka University's Internal Grants	This research was partially funded by the Ministry of the Environment, Japan and Soka University's Internal Grants. We are grateful to Professor T. Kikuchi at the Faculty of Environment and Information Sciences, Yokohama National University who allowed field determinations of UVR and PAR in Manazuru Bay. We also thank the graduate students from "Team Manazuru" who participated in monthly field work during the study.	MOREL A, 1991, PROG OCEANOGR, V26, P263, DOI 10.1016/0079-6611(91)90004-6; Harris DC, 1998, J CHEM EDUC, V75, P119; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Westberry T, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003078; Sugawara T, 2003, HYDROBIOLOGIA, V493, P17, DOI 10.1023/A:1025497817677; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Hargreaves BR, 2003, COMP SER PHOTOCHEM, V1, P59; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Dickey T, 2006, REV GEOPHYS, V44, DOI 10.1029/2003RG000148; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1479; PLATT T, 1993, J GEOPHYS RES-OCEANS, V98, P14561, DOI 10.1029/93JC01001; Zepp RG, 2011, PHOTOCH PHOTOBIO SCI, V10, P261, DOI 10.1039/c0pp90037k; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; FROUIN R, 1995, REMOTE SENS ENVIRON, V51, P98, DOI 10.1016/0034-4257(94)00068-X; SMITH RC, 1992, SCIENCE, V255, P952, DOI 10.1126/science.1546292; MOREL A, 1974, LIMNOL OCEANOGR, V19, P591; Blondeau-Patissier D, 2014, PROG OCEANOGR, V123, P123, DOI 10.1016/j.pocean.2013.12.008; Cullen JJ, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003914; Darecki M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007338; DONEY SC, 1995, J MAR RES, V53, P341, DOI 10.1357/0022240953213133; Engelsen O, 2005, OPT ENG, V44, DOI 10.1117/1.1885472; Erickson DJ, 2015, PHOTOCH PHOTOBIO SCI, V14, P127, DOI 10.1039/c4pp90036g; Frederick JE, 1998, PHOTOCHEM PHOTOBIOL, V68, P183, DOI 10.1111/j.1751-1097.1998.tb02487.x; Ichikawa T., 2001, VERH INT VEREIN LIMN, V27, P3343; IKUSIMA I, 1967, BOT MAG TOKYO, V80, P57; Iqbal M, 1983, INTRO SOLAR RAD, P390; Kaneshiro T., 1999, 14 DIAT S, P227; Kirk J. T. O., 1994, LIGHT PHOTOSYNTHESIS; Kitidis V, 2014, LIMNOL OCEANOGR, V59, P299, DOI 10.4319/lo.2014.59.2.0299; Kuwahara VS, 2000, PHOTOCHEM PHOTOBIOL, V72, P193, DOI 10.1562/0031-8655(2000)072<0193:VOBOFI>2.0.CO;2; Monteith J.L., 1973, PRINCIPLES ENV PHYSI, P241; PLATT T, 1990, P ROY SOC B-BIOL SCI, V241, P101, DOI 10.1098/rspb.1990.0072; Preisendorfer R. W., 1976, HYDROLOGIC OPTICS, V1; Roth M. S., 2014, FRONT MICROBIOL, V5, P1; RYTHER JH, 1957, LIMNOL OCEANOGR, V2, P281; RYTHER JH, 1956, LIMNOL OCEANOGR, V1, P61; SMITH RC, 1995, REV GEOPHYS, V33, P1211, DOI 10.1029/95RG00801; Smyth T. J., 2011, J GEOPHYS RES, V16; Vernet Maria, 1994, Antarctic Research Series, V62, P143; Vincent W. F., 2004, EFFECTS UV RAD MARIN, P149; Wambeke F. V., 2009, MAR ECOL PROG SER, V387, P97; Wang S., 2002, EVALUATION ENV CHANG, P1; Yoshida T, 2004, MAR BIOL, V145, P505, DOI 10.1007/s00227-004-1343-5; You Y, 2010, APPL OPTICS, V49, P1041, DOI 10.1364/AO.49.001041	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-8655	1751-1097		PHOTOCHEM PHOTOBIOL	Photochem. Photobiol.	SEP-OCT	2015	91	5					1103	1111		10.1111/php.12474		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CQ7CX	WOS:000360761600013		
J	Su, ZH; Lian, GJ; Mawatari, K; Tang, P; He, SY; Shimohata, T; Wu, YM; Yin, WD; Takahashi, A				Su, Zehong; Lian, Gaojian; Mawatari, Kazuaki; Tang, Ping; He, Shuya; Shimohata, Takaaki; Wu, Yimou; Yin, Weidong; Takahashi, Akira			Identification and Purification of the CPD Photolyase in Vibrio parahaemolyticus RIMD2210633	PHOTOCHEMISTRY AND PHOTOBIOLOGY			English	Article							BLUE-LIGHT PHOTORECEPTORS; ESCHERICHIA-COLI; DNA PHOTOLYASES; CIRCADIAN CLOCK; REPAIR; MECHANISM; INACTIVATION; HEMOLYSIN; CHOLERAE; GENE	Photoreactivation is an error-free mechanism of DNA repair, utilized by prokaryotes and most eukaryotes and is catalyzed by specific enzymes called DNA photolyases. Photoreactivation has been reported in Vibrio parahaemolyticus WP28; however, information on photolyases in V. parahaemolyticus (V.p) strains has not been reported. This study examined the photoreactivation in V.p RIMD2210633. The photolyase responsible for repairing cyclobutane pyrimidine dimer (CPD) in DNA was identified, and the corresponding gene was determined as VPA1471. The protein was overexpressed in Escherichia coli and was purified for functional assessment invitro. The mRNA level and protein expression level of this gene increased after ultraviolet A (UVA) illumination following ultraviolet C (UVC) irradiation. In vitro experiments confirmed that the protein encoded by VPA1471 could reduce the quantity of CPD in DNA. We designated the corresponding gene and protein of VPA1471 phr and Phr, respectively, although the function of two other photolyase/cryptochrome family members, VPA0203 and VPA0204, remains unclear. UV (ultraviolet) irradiation experiments suggest that these two genes possess some photorepairing ability. Therefore, we hypothesize that VPA0203 and VPA0204 encode (6-4) photolyase in V.parahaemolyticus RIMD2210633.	[Su, Zehong; Lian, Gaojian; Tang, Ping; He, Shuya; Yin, Weidong] Univ South China, Sch Pharmacol & Life Sci & Technol, Dept Biotechnol, Hengyang, Peoples R China; [Su, Zehong; Mawatari, Kazuaki; Shimohata, Takaaki; Takahashi, Akira] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Prevent Environm & Nutr, Tokushima 770, Japan; [Wu, Yimou] Univ South China, Dept Microbiol & Immunol, Hengyang, Peoples R China	Yin, WD (reprint author), Univ South China, Sch Pharmacol & Life Sci & Technol, Dept Biotechnol, Hengyang, Peoples R China.	akiratak@nutr.med.tokushima-u.ac.jp; akiratak@nutr.med.tokushima-u.ac.jp			Japan Science and Technology Agency; natural science foundation of Hunan province [13JJ3081]; outstanding youth fund of Hunan province department of education [13B102]	This work has been supported by Japan Science and Technology Agency, the natural science foundation of Hunan province (13JJ3081) and outstanding youth fund of Hunan province department of education (13B102).	Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; CHANG JCH, 1985, APPL ENVIRON MICROB, V49, P1361; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; Ahmad M, 1998, NATURE, V392, P720, DOI 10.1038/33701; Kaper JB, 2005, INT J MED MICROBIOL, V295, P355, DOI 10.1016/j.ijmm.2005.06.008; Nakano M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-155; Kodama T, 2002, CELL MICROBIOL, V4, P213, DOI 10.1046/j.1462-5822.2002.00176.x; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; Worthington EN, 2003, J BIOL CHEM, V278, P39143, DOI 10.1074/jbc.M305792200; Brettel K, 2010, CURR OPIN STRUC BIOL, V20, P693, DOI 10.1016/j.sbi.2010.07.003; Zhang F, 2013, P NATL ACAD SCI USA, V110, P7217, DOI 10.1073/pnas.1302377110; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Weber S, 2005, BBA-BIOENERGETICS, V1707, P1, DOI 10.1016/j.bbabio.2004.02.010; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Walker EL, 2006, APPL ENVIRON MICROB, V72, P6600, DOI 10.1128/AEM.01272-06; Berrocal-Tito G, 1999, J BIOL CHEM, V274, P14288, DOI 10.1074/jbc.274.20.14288; Biernat MA, 2012, J BIOL RHYTHM, V27, P3, DOI 10.1177/0748730411429665; Carell T, 2001, CURR OPIN CHEM BIOL, V5, P491, DOI 10.1016/S1367-5931(00)00239-8; Doyle JJ, 1990, FOCUS, V12, P13; Guzman-Moreno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100625; Hamamoto A, 2010, ENV MICROBIOL REP, V2, P660, DOI 10.1111/j.1758-2229.2010.00154.x; HARM W, 1968, MUTAT RES, V6, P371, DOI 10.1016/0027-5107(68)90054-7; Matallana-Surget S, 2009, PHOTOCH PHOTOBIO SCI, V8, P1313, DOI 10.1039/b902715g; Nomura T, 2000, MICROB PATHOGENESIS, V28, P25, DOI 10.1006/mpat.1999.0321; Oberpichler I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026775; OKAICHI K, 1984, PHOTOCHEM PHOTOBIOL, V39, P771, DOI 10.1111/j.1751-1097.1984.tb08857.x; Rosales-Saavedra T, 2006, MICROBIOL-SGM, V152, P3305, DOI 10.1099/mic.0.29000-0; Sancar A, 2000, COLD SPRING HARB SYM, V65, P157, DOI 10.1101/sqb.2000.65.157; Sancar A, 2008, J BIOL CHEM, V283, P32153, DOI 10.1074/jbc.R800052200; SANCAR GB, 1990, MUTAT RES, V236, P147, DOI 10.1016/0921-8777(90)90002-M	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-8655	1751-1097		PHOTOCHEM PHOTOBIOL	Photochem. Photobiol.	SEP-OCT	2015	91	5					1165	1172		10.1111/php.12481		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CQ7CX	WOS:000360761600020		
J	Yoshimoto, N; Onuma, M; Sugino, Y; Nakabayashi, R; Imai, S; Tsuneyoshi, T; Sumi, S; Saito, K				Yoshimoto, Naoko; Onuma, Misato; Sugino, Yuka; Nakabayashi, Ryo; Imai, Shinsuke; Tsuneyoshi, Tadamitsu; Sumi, Shin-ichiro; Saito, Kazuki			Identification of a flavin-containing S-oxygenating monooxygenase involved in alliin biosynthesis in garlic	PLANT JOURNAL			English	Article						alliin; S-oxygenation; flavin-containing monooxygenase; Allium sativum; secondary metabolism; AB924383 (AsFMO1); LC008010 (AsGGT1); LC008011 (AsGGT2); LC008012 (AsGGT3)	GAMMA-GLUTAMYL-TRANSPEPTIDASE; ALLYL-L-CYSTEINE; ALIPHATIC GLUCOSINOLATE BIOSYNTHESIS; S-ALK(EN)YL-L-CYSTEINE SULFOXIDES; QUANTITATIVE-DETERMINATION; ORGANOSULFUR COMPOUNDS; LIQUID-CHROMATOGRAPHY; PRECURSORS; ONION; SATIVUM	S-Alk(en)yl-l-cysteine sulfoxides are cysteine-derived secondary metabolites highly accumulated in the genus Allium. Despite pharmaceutical importance, the enzymes that contribute to the biosynthesis of S-alk-(en)yl-l-cysteine sulfoxides in Allium plants remain largely unknown. Here, we report the identification of a flavin-containing monooxygenase, AsFMO1, in garlic (Allium sativum), which is responsible for the S-oxygenation reaction in the biosynthesis of S-allyl-l-cysteine sulfoxide (alliin). Recombinant AsFMO1 protein catalyzed the stereoselective S-oxygenation of S-allyl-l-cysteine to nearly exclusively yield (RCSS)-S-allylcysteine sulfoxide, which has identical stereochemistry to the major natural form of alliin in garlic. The S-oxygenation reaction catalyzed by AsFMO1 was dependent on the presence of nicotinamide adenine dinucleotide phosphate (NADPH) and flavin adenine dinucleotide (FAD), consistent with other known flavin-containing monooxygenases. AsFMO1 preferred S-allyl-l-cysteine to -glutamyl-S-allyl-l-cysteine as the S-oxygenation substrate, suggesting that in garlic, the S-oxygenation of alliin biosynthetic intermediates primarily occurs after deglutamylation. The transient expression of green fluorescent protein (GFP) fusion proteins indicated that AsFMO1 is localized in the cytosol. AsFMO1 mRNA was accumulated in storage leaves of pre-emergent nearly sprouting bulbs, and in various tissues of sprouted bulbs with green foliage leaves. Taken together, our results suggest that AsFMO1 functions as an S-allyl-l-cysteine S-oxygenase, and contributes to the production of alliin both through the conversion of stored -glutamyl-S-allyl-l-cysteine to alliin in storage leaves during sprouting and through the de novo biosynthesis of alliin in green foliage leaves.	[Yoshimoto, Naoko; Onuma, Misato; Sugino, Yuka; Nakabayashi, Ryo; Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Nakabayashi, Ryo; Saito, Kazuki] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Imai, Shinsuke] House Foods Grp Inc, Cent Res & Dev Inst, Chiba 2840033, Japan; [Tsuneyoshi, Tadamitsu] Wakunaga Pharmaceut Co Ltd, Cent Res Inst, Hiroshima 7391195, Japan; [Sumi, Shin-ichiro] Wakunaga Pharmaceut Co Ltd, Res Planning Dept, Hiroshima 7391195, Japan	Saito, K (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	ksaito@faculty.chiba-u.jp	Yoshimoto, Naoko/A-9038-2010; Saito, Kazuki/D-2670-2009		JSPS KAKENHI [23770036, 26460118, 22108008]; Japan Advanced Plant Science Network	The authors would like to thank Dr. Toshiaki Mitsui (Niigata University) for the pDsRed vector. This work was supported in part by JSPS KAKENHI Grant Numbers 23770036 and 26460118 (to N.Y.), and Grant Number 22108008 (to K.S.). This research was partially supported by Japan Advanced Plant Science Network.	Vergara F, 2008, PHYTOCHEMISTRY, V69, P2737, DOI 10.1016/j.phytochem.2008.09.008; Iciek M, 2009, ENVIRON MOL MUTAGEN, V50, P247, DOI 10.1002/em.20474; Novick RM, 2008, DRUG METAB DISPOS, V36, P2468, DOI 10.1124/dmd.108.021436; Hansen BG, 2007, PLANT J, V50, P902, DOI 10.1111/j.1365-313X.2007.03101.x; LANCASTER JE, 1989, PHYTOCHEMISTRY, V28, P455, DOI 10.1016/0031-9422(89)80031-7; Li J, 2008, PLANT PHYSIOL, V148, P1721, DOI 10.1104/pp.108.125757; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Kitajima A, 2009, PLANT CELL, V21, P2844, DOI 10.1105/tpc.109.068288; Jones MG, 2004, J EXP BOT, V55, P1903, DOI 10.1093/jxb/erh138; Cashman JR, 2006, ANNU REV PHARMACOL, V46, P65, DOI 10.1146/annurev.pharmtox.46.120604.141043; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; [Anonymous], 1991, METHOD ENZYMOL, DOI DOI 10.1016/0076-6879(91)94004-V; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Rose P, 2005, NAT PROD REP, V22, P351, DOI 10.1039/b417639c; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Nakabayashi R, 2013, ANAL CHEM, V85, P1310, DOI 10.1021/ac302733c; Block E, 2010, GARLIC AND OTHER ALLIUMS: THE LORE AND THE SCIENCE, P1; Cho J, 2012, J SCI FOOD AGR, V92, P253, DOI 10.1002/jsfa.4610; Ichikawa M, 2006, J AGR FOOD CHEM, V54, P4849, DOI 10.1021/jf060083o; Ichikawa M, 2006, J AGR FOOD CHEM, V54, P1535, DOI 10.1021/jf051742k; Koch H. P., 1996, GARLIC SCI THERAPEUT; Krause RJ, 2002, DRUG METAB DISPOS, V30, P1137, DOI 10.1124/dmd.30.10.1137; Krest I, 1999, PLANTA MED, V65, P139, DOI 10.1055/s-1999-13975; Kubec R, 1999, J CHROMATOGR A, V862, P85, DOI 10.1016/S0021-9673(99)00902-4; Kubec R, 2008, J CHROMATOGR A, V1212, P154, DOI 10.1016/j.chroma.2008.10.024; Kuhl JC, 2004, PLANT CELL, V16, P114, DOI 10.1105/tpc.017202; LANCASTER JE, 1988, PHYTOCHEMISTRY, V27, P2123; LANCASTER JE, 1994, PHYTOCHEMISTRY, V36, P1351, DOI 10.1016/S0031-9422(00)89723-X; LANCASTER JE, 1986, PHYSIOL PLANTARUM, V66, P293, DOI 10.1111/j.1399-3054.1986.tb02423.x; Matsuura H, 1996, PLANTA MED, V62, P70, DOI 10.1055/s-2006-957805; OHSUMI C, 1993, PHYTOCHEMISTRY, V33, P107, DOI 10.1016/0031-9422(93)85404-F; Ripp SL, 1997, MOL PHARMACOL, V51, P507; Sambrook J., 1989, MOL CLONING LAB MANU; Shaw ML, 2005, PHYTOCHEMISTRY, V66, P515, DOI 10.1016/j.phytochem.2005.01.017; Suh JK, 1999, P NATL ACAD SCI USA, V96, P2687, DOI 10.1073/pnas.96.6.2687; SUZUKI T, 1962, CHEM PHARM BULL, V10, P328; TURNBULL A, 1980, NEW PHYTOL, V85, P483, DOI 10.1111/j.1469-8137.1980.tb00762.x; UEDA Y, 1991, J JPN SOC FOOD SCI, V38, P429; Yamazaki Y, 2005, J JPN SOC FOOD SCI, V52, P160, DOI 10.3136/nskkk.52.160; Yoshimoto N, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00758; YU TH, 1994, J AGR FOOD CHEM, V42, P146, DOI 10.1021/jf00037a026	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	SEP	2015	83	6					941	951		10.1111/tpj.12954		11	Plant Sciences	Plant Sciences	CR0KY	WOS:000361008700001		
J	Abe, M; Kaya, H; Watanabe-Taneda, A; Shibuta, M; Yamaguchi, A; Sakamoto, T; Kurata, T; Ausin, I; Araki, T; Alonso-Blanco, C				Abe, Mitsutomo; Kaya, Hidetaka; Watanabe-Taneda, Ayako; Shibuta, Mio; Yamaguchi, Ayako; Sakamoto, Tomoaki; Kurata, Tetsuya; Ausin, Israel; Araki, Takashi; Alonso-Blanco, Carlos			FE, a phloem-specific Myb-related protein, promotes flowering through transcriptional activation of FLOWERING LOCUS T and FLOWERING LOCUS T INTERACTING PROTEIN 1	PLANT JOURNAL			English	Article						Arabidopsis thaliana; flowering; florigen; FLOWERING LOCUS T; long-distance transport; Myb-related protein	ARABIDOPSIS-THALIANA; FLORAL INDUCTION; LONG-DISTANCE; COMPANION CELLS; FT PROTEIN; CONSTANS; TIME; SIGNAL; FLORIGEN; COMPLEX	In many flowering plants, the transition to flowering is primarily affected by seasonal changes in day length (photoperiod). An inductive photoperiod promotes flowering via synthesis of a floral stimulus, called florigen. In Arabidopsis thaliana, the FLOWERING LOCUS T (FT) protein is an essential component of florigen, which is synthesized in leaf phloem companion cells and is transported through phloem tissue to the shoot apical meristem where floral morphogenesis is initiated. However, the molecular mechanism involved in the long-distance transport of FT protein remains elusive. In this study, we characterized the classic Arabidopsis mutant fe, which is involved in the photoperiodic induction of flowering, and showed that FE encodes a phloem-specific Myb-related protein that was previously reported as ALTERED PHLOEM DEVELOPMENT. Phenotypic analyses of the fe mutant showed that FT expression is reduced in leaf phloem companion cells. In addition, the transport of FT protein from leaves to the shoot apex is impaired in the fe mutant. Expression analyses further demonstrated that FE is also required for transcriptional activation of FLOWERING LOCUS T INTERACTING PROTEIN 1 (FTIP1), an essential regulator for selective trafficking of the FT protein from companion cells to sieve elements. These findings indicate that FE plays a dual role in the photoperiodic induction of flowering: as a transcriptional activator of FT on the one hand, and its transport machinery component, FTIP1, on the other hand. Thus, FE is likely to play a role in regulating FT by coordinating FT synthesis and FT transport in phloem companion cells.	[Abe, Mitsutomo; Kaya, Hidetaka; Watanabe-Taneda, Ayako; Shibuta, Mio; Yamaguchi, Ayako] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yamaguchi, Ayako; Araki, Takashi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; [Sakamoto, Tomoaki; Kurata, Tetsuya] Nara Inst Sci & Technol, Plant Global Educ Project, Grad Sch Biol Sci, Nara 6300192, Japan; [Ausin, Israel; Alonso-Blanco, Carlos] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, E-28049 Madrid, Spain	Abe, M (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mabe@bs.s.u-tokyo.ac.jp	Araki, Takashi/G-1760-2013; Ausin, Israel/A-7065-2011	Araki, Takashi/0000-0002-3616-1493; 	Ministry of Education, Culture, Sports, Science and Technology, Japan; BRAIN, Japan; Ministerio de Economia y Competitividad of Spain [BIO2013-45407-P]; CSIC JAE-Doc Program; European Social Funds	We thank J. M. Martinez-Zapater for helpful discussions and A. Imai for experimental assistance. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to MA and to TA) and BRAIN, Japan (to MA). CA-B's laboratory was funded by grant BIO2013-45407-P from the Ministerio de Economia y Competitividad of Spain. IA was the recipient of a contract from the CSIC JAE-Doc Program (co-financed by the European Social Funds). The authors declare no conflicts of interest.	Alonso-Blanco C, 1998, GENETICS, V149, P749; GABRIELSEN OS, 1991, SCIENCE, V253, P1140, DOI 10.1126/science.1887237; Yan YY, 2014, DEV CELL, V30, P437, DOI 10.1016/j.devcel.2014.07.004; Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Stadler R, 1996, BOT ACTA, V109, P299; Kim JY, 2005, CURR OPIN PLANT BIOL, V8, P45, DOI 10.1016/j.pbi.2004.11.005; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Oparka KJ, 1999, PLANT CELL, V11, P739, DOI 10.1105/tpc.11.4.739; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Notaguchi M, 2008, PLANT CELL PHYSIOL, V49, P1645, DOI 10.1093/pcp/pcn154; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Koornneef M, 1998, GENETICS, V148, P885; Song YH, 2012, PLANT J, V69, P332, DOI 10.1111/j.1365-313X.2011.04793.x; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Yoo SC, 2013, PLANT J, V75, P456, DOI 10.1111/tpj.12213; Takahashi H, 2000, PLANT J, V23, P171, DOI 10.1046/j.1365-313x.2000.00768.x; Yoshimoto N, 2003, PLANT PHYSIOL, V131, P1511, DOI 10.1104/pp.014712; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wigge PA, 2011, CURR BIOL, V21, pR374, DOI 10.1016/j.cub.2011.03.038; Aukerman MJ, 1998, CELL, V93, P491, DOI 10.1016/S0092-8674(00)81178-2; Liu L., 2012, EURASIP J WIREL COMM, V2012, P1, DOI DOI 10.1371/J0URNAL.PBI0.1001313; Rose A, 1999, PLANT J, V20, P641, DOI 10.1046/j.1365-313X.1999.00638.x; Song ZT, 2015, P NATL ACAD SCI USA, V112, P2900, DOI 10.1073/pnas.1419703112; Uchida N, 2011, PLANT CELL PHYSIOL, V52, P716, DOI 10.1093/pcp/pcr029	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	SEP	2015	83	6					1059	1068		10.1111/tpj.12951		10	Plant Sciences	Plant Sciences	CR0KY	WOS:000361008700010		
J	Cheng, CY; Tarutani, Y; Miyao, A; Ito, T; Yamazaki, M; Sakai, H; Fukai, E; Hirochika, H				Cheng, Chaoyang; Tarutani, Yoshiaki; Miyao, Akio; Ito, Tasuku; Yamazaki, Muneo; Sakai, Hiroaki; Fukai, Eigo; Hirochika, Hirohiko			Loss of function mutations in the rice chromomethylase OsCMT3a cause a burst of transposition	PLANT JOURNAL			English	Article						DNA methylation; chromomethylase; rice; transposable elements; transposition; silencing; genome dynamics	TERMINAL REPEAT ELEMENT; BASE RESOLUTION MAPS; DNA METHYLATION; TRANSPOSABLE ELEMENTS; TOS17 RETROTRANSPOSON; ARABIDOPSIS-THALIANA; LTR RETROTRANSPOSON; EPIGENETIC CONTROL; CPNPG METHYLATION; TISSUE-CULTURE	Methylation patterns of plants are unique as, in addition to the methylation at CG dinucleotides that occurs in mammals, methylation also occurs at non-CG sites. Genes are methylated at CG sites, but transposable elements (TEs) are methylated at both CG and non-CG sites. The role of non-CG methylation in transcriptional silencing of TEs is being extensively studied at this time, but only very rare transpositions have been reported when non-CG methylation machineries have been compromised. To understand the role of non-CG methylation in TE suppression and in plant development, we characterized rice mutants with changes in the chromomethylase gene, OsCMT3a. oscmt3a mutants exhibited a dramatic decrease in CHG methylation, changes in the expression of some genes and TEs, and pleiotropic developmental abnormalities. Genome resequencing identified eight TE families mobilized in oscmt3a during normal propagation. These TEs included tissue culture-activated copia retrotransposons Tos17 and Tos19 (Lullaby), a pericentromeric clustered high-copy-number non-autonomous gypsy retrotransposon Dasheng, two copia retrotransposons Osr4 and Osr13, a hAT-tip100 transposon DaiZ, a MITE transposon mPing, and a LINE element LINE1-6_OS. We confirmed the transposition of these TEs by polymerase chain reaction (PCR) and/or Southern blot analysis, and showed that transposition was dependent on the oscmt3a mutation. These results demonstrated that OsCMT3a-mediated non-CG DNA methylation plays a critical role in development and in the suppression of a wide spectrum of TEs. These in planta mobile TEs are important for studying the interaction between TEs and the host genome, and for rice functional genomics.	[Cheng, Chaoyang; Tarutani, Yoshiaki; Ito, Tasuku] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Cheng, Chaoyang; Miyao, Akio; Yamazaki, Muneo; Sakai, Hiroaki; Fukai, Eigo; Hirochika, Hirohiko] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	Hirochika, H (reprint author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan.	hirohiko@nias.affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan (Rice Genome Project) [MP-2102]	We are deeply grateful to Tetsuji Kakutani for advice on designing NGS experiment and data analysis. We also thank staff members at National Institute of Agrobiological Sciences and Department of Integrated Genetics, and Experimental Farm, of National Institute of Genetics for technical assistance. We are also grateful to the staff at Super Computer Facilities of National Institute of Genetics for technical support for NGS data analysis. This work was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Rice Genome Project MP-2102).	Wei LY, 2014, P NATL ACAD SCI USA, V111, P3877, DOI 10.1073/pnas.1318131111; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Tsukahara S, 2012, GENE DEV, V26, P705, DOI 10.1101/gad.183871.111; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Cheng C, 2006, MOL GENET GENOMICS, V276, P378, DOI 10.1007/s00438-006-0141-9; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Jiang N, 2002, GENETICS, V161, P1293; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Li X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-300; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Komatsu M, 2003, PLANT CELL, V15, P1934, DOI 10.1105/tpc.011809; Huang J, 2009, GENOMICS, V93, P274, DOI 10.1016/j.ygeno.2008.11.007; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Flavell AJ, 1998, PLANT J, V16, P643, DOI 10.1046/j.1365-313x.1998.00334.x; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Fu Y, 2013, EMBO J, V32, P2407, DOI 10.1038/emboj.2013.169; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Hu LJ, 2014, P NATL ACAD SCI USA, V111, P10642, DOI 10.1073/pnas.1410761111; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Wang NL, 2013, MOL PLANT, V6, P596, DOI 10.1093/mp/sss142; Picault N, 2009, PLANT J, V58, P754, DOI 10.1111/j.1365-313X.2009.03813.x; KUNZE R, 1989, EMBO J, V8, P3177; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; GIERL A, 1988, EMBO J, V7, P4045; HIROCHIKA H, 1992, MOL GEN GENET, V233, P209, DOI 10.1007/BF00587581; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jiang N, 2002, PLANT PHYSIOL, V130, P1697, DOI 10.1104/pp.015412; Kaul S, 2000, NATURE, V408, P796; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; McCarthy E. M., 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-10-research0053, DOI 10.1186/GB-2002-3-10-RESEARCH0053]; Moritoh S, 2012, PLANT J, V71, P85, DOI 10.1111/j.1365-313X.2012.04974.x; Papa CM, 2001, PLANT CELL, V13, P1919, DOI 10.1105/tpc.13.8.1919; Teramoto S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004396; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; Wu JZ, 2004, PLANT CELL, V16, P967, DOI 10.1105/tpc.019273; Yang GJ, 2007, P NATL ACAD SCI USA, V104, P10962, DOI 10.1073/pnas.0702080104; Nakagome M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-71; Yin H, 2014, GENOME BIOL EVOL, V6, P1423, DOI 10.1093/gbe/evu114; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	SEP	2015	83	6					1069	1081		10.1111/tpj.12952		13	Plant Sciences	Plant Sciences	CR0KY	WOS:000361008700011		
J	Hirose, Y; Suda, K; Liu, YG; Sato, S; Nakamura, Y; Yokoyama, K; Yamamoto, N; Hanano, S; Takita, E; Sakurai, N; Suzuki, H; Nakamura, Y; Kaneko, T; Yano, K; Tabata, S; Shibata, D				Hirose, Yoshitsugu; Suda, Kunihiro; Liu, Yao-Guang; Sato, Shusei; Nakamura, Yukino; Yokoyama, Koji; Yamamoto, Naoki; Hanano, Shigeru; Takita, Eiji; Sakurai, Nozomu; Suzuki, Hideyuki; Nakamura, Yasukazu; Kaneko, Takakazu; Yano, Kentaro; Tabata, Satoshi; Shibata, Daisuke			The Arabidopsis TAC Position Viewer: a high-resolution map of transformation-competent artificial chromosome (TAC) clones aligned with the Arabidopsis thaliana Columbia-0 genome	PLANT JOURNAL			English	Article						Arabidopsis thaliana; transformation-competent artificial chromosome; Arabidopsis TAC clones; Arabidopsis TAC library; Arabidopsis genome; genomics; bioinformatics; GBrowse	INFORMATION RESOURCE TAIR; SYSTEMS ANALYSES; PLANT FUNCTIONS; FLOWERING TIME; DNA FRAGMENTS; PHYSICAL MAP; GENE; CLONING; BIOINFORMATICS; ANNOTATION	We present a high-resolution map of genomic transformation-competent artificial chromosome (TAC) clones extending over all Arabidopsis thaliana (Arabidopsis) chromosomes. The Arabidopsis genomic TAC clones have been valuable genetic tools. Previously, we constructed an Arabidopsis genomic TAC library consisting of more than 10000 TAC clones harboring large genomic DNA fragments extending over the whole Arabidopsis genome. Here, we determined 13577 end sequences from 6987 Arabidopsis TAC clones and mapped 5937 TAC clones to precise locations, covering approximately 90% of the Arabidopsis chromosomes. We present the large-scale data set of TAC clones with high-resolution mapping information as a Java application tool, the Arabidopsis TAC Position Viewer, which provides ready-to-go transformable genomic DNA clones corresponding to certain loci on Arabidopsis chromosomes. The TAC clone resources will accelerate genomic DNA cloning, positional walking, complementation of mutants and DNA transformation for heterologous gene expression.	[Hirose, Yoshitsugu] Honda Res Inst Japan Co Ltd, Wako, Saitama 3510188, Japan; [Suda, Kunihiro; Sato, Shusei; Yamamoto, Naoki; Hanano, Shigeru; Takita, Eiji; Sakurai, Nozomu; Suzuki, Hideyuki; Nakamura, Yasukazu; Kaneko, Takakazu; Tabata, Satoshi; Shibata, Daisuke] Kazusa DNA Res Inst, Chiba 2920818, Japan; [Liu, Yao-Guang] South China Agr Univ, Genet Engn Lab, Gungzhou 510642, Peoples R China; [Liu, Yao-Guang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Gungzhou 510642, Peoples R China; [Sato, Shusei] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Nakamura, Yukino; Yokoyama, Koji; Yamamoto, Naoki; Yano, Kentaro] Meiji Univ, Sch Agr, Dept Life Sci, Bioinformat Lab,Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Hanano, S (reprint author), Kazusa DNA Res Inst, 2-6-7 Kazusa Kamatari, Chiba 2920818, Japan.	hanano@kazusa.or.jp; shibata@kazusa.or.jp			Kazusa DNA Research Institute Foundation; Japan Society for Promotion of Science (JSPS) [26113716]; MEXT; Meiji University	We thank the technical staff in the DNA sequencing team at Kazusa DNA Research Institute. This work was supported by the Kazusa DNA Research Institute Foundation. Development of the web-based GBrowse database is supported by Grants-in-Aid for Scientific Research on Innovative Areas (no. 26113716 to KY) from the Japan Society for Promotion of Science (JSPS), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2014-2018) and Research Funding for Computational Software Supporting Program from Meiji University.	Hamilton JP, 2012, PLANT J, V70, P177, DOI 10.1111/j.1365-313X.2012.04894.x; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Edwards D, 2013, THEOR APPL GENET, V126, P1, DOI 10.1007/s00122-012-1964-x; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Zhou Rongrong, 2011, Plant J, V66, P712, DOI 10.1111/j.1365-313X.2011.04524.x; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Liu YG, 2002, GENE, V282, P247, DOI 10.1016/S0378-1119(01)00849-6; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Shibata D, 2000, TRENDS PLANT SCI, V5, P354, DOI 10.1016/S1360-1385(00)01689-7; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796; European Union Chromosome 3 Arabidopsis Sequencing Consortium, 2000, NATURE, V408, P820; Kim YS, 1998, MOL CELLS, V8, P705; Kotani H, 1997, DNA Res, V4, P371, DOI 10.1093/dnares/4.6.371; Li Y, 2003, BIOINFORMATICS, V19, P1441, DOI 10.1093/bioinformatics/btg170; Liu YG, 2000, PLANT J, V23, P687, DOI 10.1046/j.1365-313x.2000.00827.x; Meinke DW, 1998, SCIENCE, V282, P679; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; Sato S, 1998, DNA Res, V5, P163, DOI 10.1093/dnares/5.3.163; Sato S, 1997, DNA Res, V4, P215, DOI 10.1093/dnares/4.3.215; Sato S, 1999, DNA Res, V6, P117, DOI 10.1093/dnares/6.2.117; SCHMIDT R, 1995, SCIENCE, V270, P480, DOI 10.1126/science.270.5235.480; Shibata D, 1998, GENE, V225, P31, DOI 10.1016/S0378-1119(98)00534-4; Shinozaki K, 2009, PLANT CELL PHYSIOL, V50, P1177, DOI 10.1093/pcp/pcp085; Somerville C. R., 1994, ARABIDOPSIS; Takita E, 2013, DNA RES, V20, P583, DOI 10.1093/dnares/dst032	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	SEP	2015	83	6					1114	1122		10.1111/tpj.12949		9	Plant Sciences	Plant Sciences	CR0KY	WOS:000361008700014		
J	Thao, NP; Khan, MIR; Thu, NBA; Hoang, XLT; Asgher, M; Khan, NA; Tran, LSP				Thao, Nguyen Phuong; Khan, M. Iqbal R.; Thu, Nguyen Binh Anh; Hoang, Xuan Lan Thi; Asgher, Mohd; Khan, Nafees A.; Tran, Lam-Son Phan			Role of Ethylene and Its Cross Talk with Other Signaling Molecules in Plant Responses to Heavy Metal Stress	PLANT PHYSIOLOGY			English	Article							INDUCED OXIDATIVE STRESS; ACTIVATED PROTEIN-KINASE; EXOGENOUS SALICYLIC-ACID; BRASSICA-NAPUS L.; NITRIC-OXIDE; ARABIDOPSIS-THALIANA; CADMIUM TOXICITY; JASMONIC ACID; PHOTOSYNTHETIC CAPACITY; LIPID-PEROXIDATION	Excessive heavy metals (HMs) in agricultural lands cause toxicities to plants, resulting in declines in crop productivity. Recent advances in ethylene biology research have established that ethylene is not only responsible for many important physiological activities in plants but also plays a pivotal role in HM stress tolerance. The manipulation of ethylene in plants to cope with HM stress through various approaches targeting either ethylene biosynthesis or the ethylene signaling pathway has brought promising outcomes. This review covers ethylene production and signal transduction in plant responses to HM stress, cross talk between ethylene and other signaling molecules under adverse HM stress conditions, and approaches to modify ethylene action to improve HM tolerance. From our current understanding about ethylene and its regulatory activities, it is believed that the optimization of endogenous ethylene levels in plants under HM stress would pave the way for developing transgenic crops with improved HM tolerance.	[Thao, Nguyen Phuong; Thu, Nguyen Binh Anh; Hoang, Xuan Lan Thi] Vietnam Natl Univ, Int Univ, Sch Biotechnol, Ho Chi Minh 70000, Vietnam; [Khan, M. Iqbal R.; Asgher, Mohd; Khan, Nafees A.] Aligarh Muslim Univ, Plant Physiol & Biochem Sect, Dept Bot, Aligarh 202002, Uttar Pradesh, India; [Tran, Lam-Son Phan] RIKEN Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa 2300045, Japan	Tran, LSP (reprint author), Vietnam Natl Univ, Int Univ, Sch Biotechnol, Ho Chi Minh 70000, Vietnam.	son.tran@riken.jp	Tran, Lam-Son/A-1346-2009	Tran, Lam-Son/0000-0001-9883-9768	Vietnam National University [C2014-28-07]; University Grants Commission, New Delhi [F.40-3(M/S)/2009, SA-III/MANF]	This work was supported by Vietnam National University (grant no. C2014-28-07 to N.P.T.) and by the University Grants Commission, New Delhi [grant no. F.40-3(M/S)/2009 (SA-III/MANF) to M.I.R.K. and N.A.K.].	Ahmad P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114571; Schellingen K, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0214-6; Maksymiec W, 2007, BIOL PLANTARUM, V51, P322, DOI 10.1007/s10535-007-0062-4; Mhamdi A, 2010, PLANT PHYSIOL, V153, P1144, DOI 10.1104/pp.110.153767; Wang YS, 2005, PLANT CELL PHYSIOL, V46, P1915, DOI 10.1093/pcp/pci202; Serek M, 2006, BIOTECHNOL ADV, V24, P368, DOI 10.1016/j.biotechadv.2006.01.007; Yokotani N, 2004, POSTHARVEST BIOL TEC, V32, P247, DOI 10.1016/j.postharvbio.2004.01.001; Zhang W, 2010, PLANT PHYSIOL BIOCH, V48, P45, DOI 10.1016/j.plaphy.2009.10.002; Shan XY, 2012, CURR OPIN PLANT BIOL, V15, P84, DOI 10.1016/j.pbi.2011.09.006; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Mostofa MG, 2015, SCI REP-UK, V5, DOI 10.1038/srep11433; Klee HJ, 2004, PLANT PHYSIOL, V135, P660, DOI 10.1104/pp.104.040998; Thapa G, 2012, BIOMETALS, V25, P489, DOI 10.1007/s10534-012-9541-y; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Verstraeten S, 2008, ARCH TOXICOL, V82, P789, DOI 10.1007/s00204-008-0345-3; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Iakimova ET, 2008, CELL BIOL INT, V32, P1521, DOI 10.1016/j.cellbi.2008.08.021; Ecker JR, 2004, PLANT CELL, V16, P3169, DOI 10.1105/tpc.104.161210; Wen X, 2012, CELL RES, V22, P1613, DOI 10.1038/cr.2012.145; Gazzarrini S, 2003, ANN BOT-LONDON, V91, P605, DOI 10.1093/aob/mcg064; Yuan HM, 2013, PLANT CELL PHYSIOL, V54, P766, DOI 10.1093/pcp/pct030; Sun P, 2010, J EXP BOT, V61, P347, DOI 10.1093/jxb/erp306; Ribeiro EA, 1999, FEBS LETT, V445, P283, DOI 10.1016/S0014-5793(99)00138-6; Bethke G, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0810206106; Besson-Bard A, 2009, PLANT PHYSIOL, V149, P1302, DOI 10.1104/pp.108.133348; Lequeux H, 2010, PLANT PHYSIOL BIOCH, V48, P673, DOI 10.1016/j.plaphy.2010.05.005; Corpas FJ, 2004, PLANT PHYSIOL, V136, P2722, DOI 10.1104/pp.104.042812; Khan MIR, 2014, PROTOPLASMA, V251, P1007, DOI 10.1007/s00709-014-0610-7; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Xiang CB, 1998, PLANT CELL, V10, P1539, DOI 10.1105/tpc.10.9.1539; PALIT S, 1994, BOT REV, V60, P149, DOI 10.1007/BF02856575; Montero-Palmero MB, 2014, NEW PHYTOL, V201, P116, DOI 10.1111/nph.12486; LANAHAN MB, 1994, PLANT CELL, V6, P521; Canovas D, 2004, J BIOL CHEM, V279, P51234, DOI 10.1074/jbc.M408622200; Kovacs V, 2014, J HAZARD MATER, V280, P12, DOI 10.1016/j.jhazmat.2014.07.048; Dugardeyn J, 2008, PLANT SCI, V175, P59, DOI 10.1016/j.plantsci.2008.02.003; Pierik R, 2006, TRENDS PLANT SCI, V11, P176, DOI 10.1016/j.tplants.2006.02.006; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007; Ma WW, 2010, PLANTA, V232, P325, DOI 10.1007/s00425-010-1177-y; Hahn A, 2009, PLANT PHYSIOL, V149, P1207, DOI 10.1104/pp.108.132241; Wang Q, 2013, J EXP BOT, V64, P4863, DOI 10.1093/jxb/ert272; Maksymiec W, 2011, BIOL PLANTARUM, V55, P112, DOI 10.1007/s10535-011-0015-9; Leshem YY, 1996, J PLANT PHYSIOL, V148, P258; FUHRER J, 1982, PLANT PHYSIOL, V70, P162, DOI 10.1104/pp.70.1.162; Laspina NV, 2005, PLANT SCI, V169, P323, DOI 10.1016/j.plantsci.2005.02.007; Monteiro CC, 2011, ENVIRON EXP BOT, V71, P306, DOI 10.1016/j.envexpbot.2010.12.020; Penarrubia L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00255; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Khan N. A., 2004, BMC Plant Biology, V4, P21, DOI 10.1186/1471-2229-4-21; Metwally A, 2003, PLANT PHYSIOL, V132, P272, DOI 10.1104/pp.102.018457; Malik A, 2004, ENVIRON INT, V30, P261, DOI 10.1016/j.envint.2003.08.001; Maksymiec W, 1996, J PLANT PHYSIOL, V149, P196; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Ye Y, 2013, PLANT CELL ENVIRON, V36, P1, DOI 10.1111/j.1365-3040.2012.02543.x; Asgher M, 2014, ECOTOX ENVIRON SAFE, V106, P54, DOI 10.1016/j.ecoenv.2014.04.017; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Singh HP, 2008, ENVIRON EXP BOT, V63, P158, DOI 10.1016/j.envexpbot.2007.12.005; Wuriyanghan H, 2009, PLANT CELL, V21, P1473, DOI 10.1105/tpc.108.065391; Liu XM, 2010, PHYTOCHEMISTRY, V71, P614, DOI 10.1016/j.phytochem.2010.01.005; Pell EJ, 1997, PHYSIOL PLANTARUM, V100, P264, DOI 10.1034/j.1399-3054.1997.1000207.x; Clarke A, 2000, PLANT J, V24, P667, DOI 10.1046/j.1365-313x.2000.00911.x; Jakubowicz M, 2010, J EXP BOT, V61, P3475, DOI 10.1093/jxb/erq177; Gratao PL, 2009, ENVIRON EXP BOT, V67, P387, DOI 10.1016/j.envexpbot.2009.06.017; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Maksymiec W, 2006, ENVIRON EXP BOT, V57, P187, DOI 10.1016/j.envexpbot.2005.05.006; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Masood A, 2012, PLANT CELL ENVIRON, V35, P524, DOI 10.1111/j.1365-3040.2011.02432.x; Blankenship SM, 2003, POSTHARVEST BIOL TEC, V28, P1, DOI 10.1016/S0925-5214(02)00246-6; Maksymiec W, 2007, ACTA PHYSIOL PLANT, V29, P177, DOI 10.1007/s11738-007-0036-3; Anjum NA, 2012, ENVIRON EXP BOT, V75, P307, DOI 10.1016/j.envexpbot.2011.07.002; Van der Does D, 2013, PLANT CELL, V25, P744, DOI 10.1105/tpc.112.108548; Groppa MD, 2008, PHYTOCHEMISTRY, V69, P2609, DOI 10.1016/j.phytochem.2008.07.016; Garcia-Mata C, 2002, PLANT PHYSIOL, V128, P790, DOI 10.1104/pp.011020; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Yildiz M, 2009, CHEMOSPHERE, V75, P934, DOI 10.1016/j.chemosphere.2009.01.023; Atici O, 2005, BIOL PLANTARUM, V49, P215, DOI 10.1007/s10535-005-5222-9; Cao SQ, 2009, PLANT PHYSIOL BIOCH, V47, P308, DOI 10.1016/j.plaphy.2008.12.013; Sisler EC, 1997, PHYSIOL PLANTARUM, V100, P577, DOI 10.1034/j.1399-3054.1997.1000320.x; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Iqbal N, 2012, ENVIRON EXP BOT, V78, P84, DOI 10.1016/j.envexpbot.2011.12.025; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108; Arteca RN, 2007, J PLANT PHYSIOL, V164, P1480, DOI 10.1016/j.jplph.2006.09.006; Neill SJ, 2002, PLANT PHYSIOL, V128, P13, DOI 10.1104/pp.128.1.13; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Carrio-Segui A, 2015, PLANT CELL PHYSIOL, V56, P442, DOI 10.1093/pcp/pcu180; Hayat S, 2007, ENVIRON EXP BOT, V60, P33, DOI 10.1016/j.envexpbot.2006.06.002; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; Kim HJ, 2008, PLANT CELL ENVIRON, V31, P1744, DOI 10.1111/j.1365-3040.2008.01886.x; Asgher M, 2015, PROTOPLASMA, V252, P399, DOI 10.1007/s00709-014-0710-4; Chmielowska-Bak J, 2014, ACTA SOC BOT POL, V83, P201, DOI 10.5586/asbp.2014.027; COOKE AR, 1968, NATURE, V218, P974, DOI 10.1038/218974a0; DalCorso Giovanni, 2010, Plant Signal Behav, V5, P663, DOI 10.4161/psb.5.6.11425; De Grauwe Liesbeth, 2008, Plant Signal Behav, V3, P1113; Feng XQ, 2000, POSTHARVEST BIOL TEC, V20, P143, DOI 10.1016/S0925-5214(00)00126-5; Franchin C, 2007, PHYSIOL PLANTARUM, V130, P77, DOI 10.1111/j.1399-3054.2007.00886.x; Grimmig B, 2003, PLANT MOL BIOL, V51, P599, DOI 10.1023/A:1022385104386; Hasan Syed Aiman, 2011, Brazilian Journal of Plant Physiology, V23, P175, DOI 10.1590/S1677-04202011000300001; Hossain M.A., 2012, J BOT, V2012, P37, DOI DOI 10.1155/2012/872875; Huang JY, 2003, PLANT PHYSIOL BIOCH, V41, P283, DOI 10.1016/S0981-9428(03)00020-2; Ichimura K, 2014, J PLANT PHYSIOL, V171, P1679, DOI 10.1016/j.jplph.2014.08.006; Iqbal N., 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.22478, DOI 10.4161/PSB.22478]; Kazemi N, 2010, SCI HORTIC-AMSTERDAM, V126, P402, DOI 10.1016/j.scienta.2010.07.037; Khademi S., 2014, International Journal of Biosciences (IJB), V5, P64; Khan MIR, 2015, J PLANT PHYSIOL, V173, P9, DOI 10.1016/j.jplph.2014.09.011; Khan MIR, 2015, PLANT GROWTH REGUL; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Liu KL, 2008, J INTEGR PLANT BIOL, V50, P415, DOI 10.1111/j.1744-7909.2007.00621.x; Ma B, 2014, PHYTOHORMONES WINDOW, P81; Magalhaes JR, 1999, PHYSL PLANT MOL BIOL, V5, P115; Maksymiec W, 2005, J PLANT PHYSIOL, V162, P1338, DOI 10.1016/j.jplph.2005.01.013; Masood A., 2013, J PLANT BIOCH PHYSL, V1, P1; Montero-Palmero MB, 2014, ENVIRON TOXICOL, V2, P34; Mostofa M, 2015, PLANT GROWTH REGUL; Noriega G, 2012, BIOMETALS, V25, P1155, DOI 10.1007/s10534-012-9577-z; Opdenakker K, 2012, INT J MOL SCI, V13, P7828, DOI 10.3390/ijms13067828; Pacifici S, 2014, J PLANT PHYSL C, V173C, P116; Pedroso MC, 2000, PLANT SCI, V157, P173, DOI 10.1016/S0168-9452(00)00278-8; Piotrowska-Niczyporuk A, 2012, PLANT PHYSIOL BIOCH, V52, P52, DOI 10.1016/j.plaphy.2011.11.009; RODECAP KD, 1981, Z PFLANZENPHYSIOL, V105, P65; Rodriguez-Serrano M, 2006, PLANT CELL ENVIRON, V29, P1532, DOI 10.1111/j.1365-3040.2006.01531.x; SANDMANN G, 1980, PLANT PHYSIOL, V66, P797, DOI 10.1104/pp.66.5.797; Schlagnhaufer CD, 1997, PLANT MOL BIOL, V35, P683, DOI 10.1023/A:1005857717196; Sharma J, 2013, MOL STRESS PHYSL PLA, P289; Shukla D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00652; Srivastava AK, 2014, CRIT REV BIOTECHNOL, P1; Srivastava MK, 1998, J PLANT PHYSIOL, V153, P409; Steffens B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00685; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Trinh NN, 2014, PHYSIOL PLANTARUM, V150, P205, DOI 10.1111/ppl.12088; WISE RR, 1988, J PLANT PHYSIOL, V133, P62; Xu J, 2015, ETHYLENE IN PLANTS, P1, DOI [10.1007/978-94-017-9484-8, DOI 10.1007/978-94-017-9484-8]; Zapata PJ, 2003, PLANT SCI, V164, P557, DOI 10.1016/S0168-9452(03)00005-0; Zhang GB, 2014, PLANT CELL, V26, P3984, DOI 10.1105/tpc.114.129296; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635	140	1	1	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	SEP	2015	169	1					73	84		10.1104/pp.15.00663		12	Plant Sciences	Plant Sciences	CQ9JM	WOS:000360930600009		
J	Ueda, H; Kusaba, M				Ueda, Hiroaki; Kusaba, Makoto			Strigolactone Regulates Leaf Senescence in Concert with Ethylene in Arabidopsis	PLANT PHYSIOLOGY			English	Article							F-BOX PROTEIN; PHOSPHATE DEFICIENCY; MOLECULAR-MECHANISM; RESPONSE PATHWAY; CELL-DEATH; TRANSCRIPTION; CARLACTONE; DISTINCT; RICE; MAX1	Leaf senescence is not a passive degenerative process; it represents a process of nutrient relocation, in which materials are salvaged for growth at a later stage or to produce the next generation. Leaf senescence is regulated by various factors, such as darkness, stress, aging, and phytohormones. Strigolactone is a recently identified phytohormone, and it has multiple functions in plant development, including repression of branching. Although strigolactone is implicated in the regulation of leaf senescence, little is known about its molecular mechanism of action. In this study, strigolactone biosynthesis mutant strains of Arabidopsis (Arabidopsis thaliana) showed a delayed senescence phenotype during dark incubation. The strigolactone biosynthesis genes MORE AXIALLY GROWTH3 (MAX3) and MAX4 were drastically induced during dark incubation and treatment with the senescence-promoting phytohormone ethylene, suggesting that strigolactone is synthesized in the leaf during leaf senescence. This hypothesis was confirmed by a grafting experiment using max4 as the stock and Columbia-0 as the scion, in which the leaves from the Columbia-0 scion senesced earlier than max4 stock leaves. Dark incubation induced the synthesis of ethylene independent of strigolactone. Strigolactone biosynthesis mutants showed a delayed senescence phenotype during ethylene treatment in the light. Furthermore, leaf senescence was strongly accelerated by the application of strigolactone in the presence of ethylene and not by strigolactone alone. These observations suggest that strigolactone promotes leaf senescence by enhancing the action of ethylene. Thus, dark-induced senescence is regulated by a two-step mechanism: induction of ethylene synthesis and consequent induction of strigolactone synthesis in the leaf.	[Ueda, Hiroaki; Kusaba, Makoto] Hiroshima Univ, Grad Sch Sci, Hiroshima 7398526, Japan	Kusaba, M (reprint author), Hiroshima Univ, Grad Sch Sci, Hiroshima 7398526, Japan.	akusaba@hiroshima-u.ac.jp			Core Research for Evolutional Science and Technology; Japan Society for Scientific Research (KAKENHI) [26292006]	This work was supported by Core Research for Evolutional Science and Technology (to M.K.) and, in part, by the Japan Society for Scientific Research (KAKENHI grant no. 26292006).	Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Kusaba M, 2013, PHOTOSYNTH RES, V117, P221, DOI 10.1007/s11120-013-9862-x; Kim HJ, 2014, J EXP BOT, V65, P4023, DOI 10.1093/jxb/eru112; Waters MT, 2014, PLANT J, V79, P623, DOI 10.1111/tpj.12430; Rauf M, 2013, EMBO REP, V14, P382, DOI 10.1038/embor.2013.24; Scaffidi A, 2014, PLANT PHYSIOL, V165, P1221, DOI 10.1104/pp.114.240036; Shen H, 2012, MOL PLANT, V5, P750, DOI 10.1093/mp/sss029; Bleecker AB, 1997, PLANT CELL, V9, P1169, DOI 10.1105/tpc.9.7.1169; Kohlen W, 2011, PLANT PHYSIOL, V155, P974, DOI 10.1104/pp.110.164640; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Yan H, 2007, GENES GENET SYST, V82, P361, DOI 10.1266/ggs.82.361; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Ha CV, 2014, P NATL ACAD SCI USA, V111, P851, DOI 10.1073/pnas.1322135111; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; Notaguchi M, 2009, J PLANT RES, V122, P201, DOI 10.1007/s10265-008-0209-1; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Seto Y, 2012, PLANT CELL PHYSIOL, V53, P1843, DOI 10.1093/pcp/pcs142; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878; Yamada Y, 2014, PLANTA, V240, P399, DOI 10.1007/s00425-014-2096-0; Waldie T, 2014, PLANT J, V79, P607, DOI 10.1111/tpj.12488; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc104.027714; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Seto Y, 2014, P NATL ACAD SCI USA, V111, P1640, DOI 10.1073/pnas.1314805111; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Jing HC, 2005, J EXP BOT, V56, P2915, DOI 10.1093/jxb/eri287; Abe S, 2014, P NATL ACAD SCI USA, V111, P18084, DOI 10.1073/pnas.1410801111; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Seto Y, 2014, CURR OPIN PLANT BIOL, V21, P1, DOI 10.1016/j.pbi.2014.06.001; Thomas H, 2014, J EXP BOT, V65, P3889, DOI 10.1093/jxb/eru037; Penfold CA, 2014, J EXP BOT, V65, P3859, DOI 10.1093/jxb/eru054; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Khanna R, 2007, PLANT CELL, V19, P3915, DOI 10.1105/tpc.107.051508; Boutrot F, 2010, P NATL ACAD SCI USA, V107, P14502, DOI 10.1073/pnas.1003347107; Beveridge CA, 2009, PLANT PHYSIOL, V151, P985, DOI 10.1104/pp.109.143909; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Grbic V, 2003, PHYSIOL PLANTARUM, V119, P263, DOI 10.1034/j.1399-3054.2003.00168.x; Matallana-Ramirez LP, 2013, MOL PLANT, V6, P1438, DOI 10.1093/mp/sst012; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nooden LD, 2004, PLANT CELL DEATH PRO, P1, DOI 10.1016/B978-012520915-1/50004-7; Sakuraba Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5636; Scaffidi A, 2013, PLANT J, V76, P1, DOI 10.1111/tpj.12265; Shakeel SN, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt010; Song Y, 2014, MOL PLANT, V7, P1776, DOI 10.1093/mp/ssu109; Xu AB, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-48; Zhang YX, 2014, NAT CHEM BIOL, V10, P1028, DOI 10.1038/nchembio.1660	59	2	3	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	SEP	2015	169	1					138	147		10.1104/pp.15.00325		10	Plant Sciences	Plant Sciences	CQ9JM	WOS:000360930600014		
J	Dubois, M; Van den Broeck, L; Claeys, H; Van Vlierberghe, K; Matsui, M; Inze, D				Dubois, Marieke; Van den Broeck, Lisa; Claeys, Hannes; Van Vlierberghe, Kaatje; Matsui, Minami; Inze, Dirk			The ETHYLENE RESPONSE FACTORs ERF6 and ERF11 Antagonistically Regulate Mannitol-Induced Growth Inhibition in Arabidopsis	PLANT PHYSIOLOGY			English	Article							WATER-LIMITING CONDITIONS; TRANSCRIPTION FACTOR HY5; GENE-EXPRESSION; LEAF DEVELOPMENT; ANALYSIS REVEALS; OSMOTIC-STRESS; BINDING-SITES; ABSCISIC-ACID; DNA-BINDING; THALIANA	Leaf growth is a tightly regulated and complex process, which responds in a dynamic manner to changing environmental conditions, but the mechanisms that reduce growth under adverse conditions are rather poorly understood. We previously identified a growth inhibitory pathway regulating leaf growth upon exposure to a low concentration of mannitol and characterized the ETHYLENE RESPONSE FACTOR (ERF)/APETALA2 transcription factor ERF6 as a central activator of both leaf growth inhibition and induction of stress tolerance genes. Here, we describe the role of the transcriptional repressor ERF11 in relation to the ERF6-mediated stress response in Arabidopsis (Arabidopsis thaliana). Using inducible overexpression lines, we show that ERF6 induces the expression of ERF11. ERF11 in turn molecularly counteracts the action of ERF6 and represses at least some of the ERF6-induced genes by directly competing for the target gene promoters. As a phenotypical consequence of the ERF6-ERF11 antagonism, the extreme dwarfism caused by ERF6 overexpression is suppressed by overexpression of ERF11. Together, our data demonstrate that dynamic mechanisms exist to fine-tune the stress response and that ERF11 counteracts ERF6 to maintain a balance between plant growth and stress defense.	[Dubois, Marieke; Van den Broeck, Lisa; Claeys, Hannes; Van Vlierberghe, Kaatje; Inze, Dirk] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Dubois, Marieke; Van den Broeck, Lisa; Claeys, Hannes; Van Vlierberghe, Kaatje; Inze, Dirk] Vlaams Inst Biotechnol, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Matsui, Minami] RIKEN Ctr Sustainable Resource Sci, Kanagawa 2300045, Japan	Inze, D (reprint author), Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium.	diinz@psb.vib-ugent.be			Interuniversity Attraction Poles Program [IUAP P7/29 MARS]; Belgian Science Policy Office, Ghent University (Bijzonder Onderzoeksfonds Methusalem project) [BOF08/01M00408]; Multidisciplinary Research Partnership Biotechnology for a Sustainable Economy project [01MRB510W]; Agency for Innovation by Science and Technology; Research Foundation Flanders	This work was supported by the Interuniversity Attraction Poles Program (IUAP P7/29 MARS) initiated by the Belgian Science Policy Office, Ghent University (Bijzonder Onderzoeksfonds Methusalem project no. BOF08/01M00408 and Multidisciplinary Research Partnership Biotechnology for a Sustainable Economy project no. 01MRB510W), the Agency for Innovation by Science and Technology (predoctoral fellowship to L.V.d.B.), and the Research Foundation Flanders (predoctoral fellowship to H.C.).	Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Gruber H, 2010, P NATL ACAD SCI USA, V107, P20132, DOI 10.1073/pnas.0914532107; Vogel MO, 2014, PLANT CELL, V26, P1151, DOI 10.1105/tpc.113.121061; Claeys H, 2012, PLANT PHYSIOL, V159, P739, DOI 10.1104/pp.112.195032; Meng XZ, 2013, PLANT CELL, V25, P1126, DOI 10.1105/tpc.112.109074; Boron AK, 2014, PLANT CELL REP, V33, P697, DOI 10.1007/s00299-014-1591-x; Wang PC, 2013, PLANT PHYSIOL, V161, P1392, DOI 10.1104/pp.112.210724; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Skirycz A, 2010, PLANT PHYSIOL, V152, P226, DOI 10.1104/pp.109.148965; Lawlor DW, 2013, J EXP BOT, V64, P83, DOI 10.1093/jxb/ers326; Trontin C, 2014, PLANT J, V78, P121, DOI 10.1111/tpj.12454; Claeys H, 2014, PLANT PHYSIOL, V165, P519, DOI 10.1104/pp.113.234641; Son GH, 2012, MOL PLANT MICROBE IN, V25, P48, DOI 10.1094/MPMI-06-11-0165; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Hectors K, 2007, NEW PHYTOL, V175, P255, DOI 10.1111/j.1469-8137.2007.02092.x; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Riechmann JL, 1998, BIOL CHEM, V379, P633; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Claeys H, 2013, PLANT PHYSIOL, V162, P1768, DOI 10.1104/pp.113.220921; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Li ZF, 2011, PLANT J, V68, P88, DOI 10.1111/j.1365-313X.2011.04670.x; Dubois M, 2013, PLANT PHYSIOL, V162, P319, DOI 10.1104/pp.113.216341; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Vergnolle C, 2005, PLANT PHYSIOL, V139, P1217, DOI 10.1104/pp.105.068171; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Skirycz A, 2011, PLANT CELL, V23, P1876, DOI 10.1105/tpc.111.084160; Hampton CR, 2004, PLANT PHYSIOL, V136, P3824, DOI 10.1104/pp.104.046672; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; De Sutter V, 2005, PLANT J, V44, P1065, DOI 10.1111/j.1365-313X.2005.02586.x; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; [Anonymous], 1962, PHYSIOL PLANTARUM, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Hruz T, 2008, ADV BIOINFORMATICS, V2008, DOI [10.1155/2008/420747, DOI 10.1155/2008/420747]; Hu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002589; Kim SH, 2014, PLANT J, V78, P978, DOI 10.1111/tpj.12527; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Moffat CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035995; Ragni L, 2014, PHYSIOL PLANTARUM, V151, P164, DOI 10.1111/ppl.12118; Sewelam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070289; Song YH, 2008, PLANT PHYSIOL, V146, P1862, DOI 10.1104/pp.107.113217; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Vermeirssen V, 2014, PLANT CELL, V26, P4656, DOI 10.1105/tpc.114.131417; Vogel MO, 2012, INT J MOL SCI, V13, P5933, DOI 10.3390/ijms13055933; Wang PC, 2006, J INTEGR PLANT BIOL, V48, P62, DOI 10.1111/j.1744-7909.2006.00213.x	54	1	1	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	SEP	2015	169	1					166	+		10.1104/pp.15.00335		18	Plant Sciences	Plant Sciences	CQ9JM	WOS:000360930600016		
J	Yamauchi, T; Shiono, K; Nagano, M; Fukazawa, A; Ando, M; Takamure, I; Mori, H; Nishizawa, NK; Kawai-Yamada, M; Tsutsumi, N; Kato, K; Nakazono, M				Yamauchi, Takaki; Shiono, Katsuhiro; Nagano, Minoru; Fukazawa, Aya; Ando, Miho; Takamure, Itsuro; Mori, Hitoshi; Nishizawa, Naoko K.; Kawai-Yamada, Maki; Tsutsumi, Nobuhiro; Kato, Kiyoaki; Nakazono, Mikio			Ethylene Biosynthesis Is Promoted by Very-Long-Chain Fatty Acids during Lysigenous Aerenchyma Formation in Rice Roots	PLANT PHYSIOLOGY			English	Article							ZEA-MAYS-L; RADIAL OXYGEN LOSS; SMALL PARTIAL PRESSURES; GAS-SPACE FORMATION; ORYZA-SATIVA-L; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; ADVENTITIOUS ROOTS; ARABIDOPSIS-THALIANA; CELL-DEATH; FLOODING TOLERANCE	In rice (Oryza sativa) roots, lysigenous aerenchyma, which is created by programmed cell death and lysis of cortical cells, is constitutively formed under aerobic conditions, and its formation is further induced under oxygen-deficient conditions. Ethylene is involved in the induction of aerenchyma formation. reduced culm number1 (rcn1) is a rice mutant in which the gene encoding the ATP-binding cassette transporter RCN1/OsABCG5 is defective. Here, we report that the induction of aerenchyma formation was reduced in roots of rcn1 grown in stagnant deoxygenated nutrient solution (i.e. under stagnant conditions, which mimic oxygen-deficient conditions in waterlogged soils). 1-Aminocyclopropane-1-carboxylic acid synthase (ACS) is a key enzyme in ethylene biosynthesis. Stagnant conditions hardly induced the expression of ACS1 in rcn1 roots, resulting in low ethylene production in the roots. Accumulation of saturated very-long-chain fatty acids (VLCFAs) of 24, 26, and 28 carbons was reduced in rcn1 roots. Exogenously supplied VLCFA (26 carbons) increased the expression level of ACS1 and induced aerenchyma formation in rcn1 roots. Moreover, in rice lines in which the gene encoding a fatty acid elongase, CUT1-LIKE (CUT1L; a homolog of the gene encoding Arabidopsis CUT1, which is required for cuticular wax production), was silenced, both ACS1 expression and aerenchyma formation were reduced. Interestingly, the expression of ACS1, CUT1L, and RCN1/OsABCG5 was induced predominantly in the outer part of roots under stagnant conditions. These results suggest that, in rice under oxygen-deficient conditions, VLCFAs increase ethylene production by promoting 1-aminocyclopropane-1-carboxylic acid biosynthesis in the outer part of roots, which, in turn, induces aerenchyma formation in the root cortex.	[Yamauchi, Takaki; Fukazawa, Aya; Mori, Hitoshi; Nakazono, Mikio] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Shiono, Katsuhiro] Fukui Prefectural Univ, Dept Biosci, Fukui 9101195, Japan; [Nagano, Minoru; Kawai-Yamada, Maki] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Ando, Miho; Nishizawa, Naoko K.; Tsutsumi, Nobuhiro] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Takamure, Itsuro] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Kato, Kiyoaki] Obihiro Univ Agr & Vet Med, Dept Crop Sci, Obihiro, Hokkaido 0808555, Japan	Nakazono, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	nakazono@agr.nagoya-u.ac.jp			Bio-oriented Technology Research Advancement Institution (Promotion of Basic Research Activities for Innovative Biosciences); Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement [GMO1005b]; Japan Society for the Promotion of Science	This work was supported by the Bio-oriented Technology Research Advancement Institution (Promotion of Basic Research Activities for Innovative Biosciences to Mik.N.), the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement [grant no. GMO1005b to Mik.N.]), and the Japan Society for the Promotion of Science (post-doctoral fellowship to T.Y.).	Evans DE, 2004, NEW PHYTOL, V161, P35, DOI 10.1046/j.1469-8137.2003.00907.x; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; Colmer TD, 2008, NEW PHYTOL, V178, P326, DOI 10.1111/j.1469-8137.2007.02364.x; Tsuda K, 2013, PLANT CELL PHYSIOL, V54, P209, DOI 10.1093/pcp/pcs169; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Setter TL, 2003, PLANT SOIL, V253, P1, DOI 10.1023/A:1024573305997; Takahashi H, 2010, J PLANT RES, V123, P807, DOI 10.1007/s10265-010-0319-4; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Steffens B, 2009, PLANT CELL, V21, P184, DOI 10.1105/tpc.108.061887; Takahashi H, 2015, ANN BOT-LONDON, V115, P879, DOI 10.1093/aob/mcv018; Wiengweera A, 1997, ANN BOT-LONDON, V80, P115, DOI 10.1006/anbo.1996.0405; Lorbiecke R, 1999, PLANT PHYSIOL, V119, P21, DOI 10.1104/pp.119.1.21; Jackson MB, 1999, PLANT BIOLOGY, V1, P274, DOI 10.1055/s-2007-978516; VOESENEK LACJ, 1993, PLANT PHYSIOL, V103, P783; Ito Y, 2011, PLANT J, V66, P680, DOI 10.1111/j.1365-313X.2011.04530.x; Visser EJW, 1996, PLANT PHYSIOL, V112, P1687; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Sauter M, 2013, CURR OPIN PLANT BIOL, V16, P282, DOI 10.1016/j.pbi.2013.03.013; Yamauchi T, 2013, FIELD CROP RES, V152, P8, DOI 10.1016/j.fcr.2012.12.008; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; LIZADA MCC, 1979, ANAL BIOCHEM, V100, P140, DOI 10.1016/0003-2697(79)90123-4; Shiono K, 2011, ANN BOT-LONDON, V107, P89, DOI 10.1093/aob/mcq221; Trenkamp S, 2004, P NATL ACAD SCI USA, V101, P11903, DOI 10.1073/pnas.0404600101; Dunn TM, 2004, ANN BOT-LONDON, V93, P483, DOI 10.1093/aob/mch071; Panikashvili D, 2010, MOL PLANT, V3, P563, DOI 10.1093/mp/ssp103; Kunst L, 2009, CURR OPIN PLANT BIOL, V12, P721, DOI 10.1016/j.pbi.2009.09.009; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; Rajhi I, 2011, NEW PHYTOL, V190, P351, DOI 10.1111/j.1469-8137.2010.03535.x; Roudier F, 2010, PLANT CELL, V22, P364, DOI 10.1105/tpc.109.071209; He CJ, 1996, PLANT PHYSIOL, V112, P1679; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Franke R, 2007, CURR OPIN PLANT BIOL, V10, P252, DOI 10.1016/j.pbi.2007.04.004; Drew MC, 2000, TRENDS PLANT SCI, V5, P123, DOI 10.1016/S1360-1385(00)01570-3; Kulichikhin K, 2014, PLANT CELL ENVIRON, V37, P2406, DOI 10.1111/pce.12294; VOESENEK LACJ, 1989, PLANT CELL ENVIRON, V12, P433, DOI 10.1111/j.1365-3040.1989.tb01959.x; Joubes J, 2008, PLANT MOL BIOL, V67, P547, DOI 10.1007/s11103-008-9339-z; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Geisler-Lee J, 2010, J EXP BOT, V61, P857, DOI 10.1093/jxb/erp362; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; van Veen H, 2013, PLANT CELL, V25, P4691, DOI 10.1105/tpc.113.119016; Hakata M, 2010, BREEDING SCI, V60, P575, DOI 10.1270/jsbbs.60.575; Armstrong W., 1979, Advances in Botanical Research, V7, P225; ATWELL BJ, 1988, PHYSIOL PLANTARUM, V72, P15, DOI 10.1111/j.1399-3054.1988.tb06616.x; Black PN, 2000, J NUTR, V130, p305S; BRADFORD KJ, 1980, PLANT PHYSIOL, V65, P322, DOI 10.1104/pp.65.2.322; Colmer TD, 2006, NEW PHYTOL, V170, P767, DOI 10.1111/j.1469-8137.2006.01725.x; DREW MC, 1979, PLANTA, V147, P83, DOI 10.1007/BF00384595; DREW MC, 1981, PLANTA, V153, P217, DOI 10.1007/BF00383890; ENGLISH PJ, 1995, PLANT PHYSIOL, V109, P1435; Funabiki A, 2013, PLANT SCI, V211, P70, DOI 10.1016/j.plantsci.2013.06.011; Iwai T, 2006, PLANT PHYSIOL, V142, P1202, DOI 10.1104/pp.106.085258; JACKSON MB, 1985, PLANTA, V165, P486, DOI 10.1007/BF00398093; JACKSON MB, 1985, J EXP BOT, V36, P1566, DOI 10.1093/jxb/36.10.1566; JUSTIN SHFW, 1991, NEW PHYTOL, V118, P49, DOI 10.1111/j.1469-8137.1991.tb00564.x; Kawai M, 1998, PLANTA, V204, P277, DOI 10.1007/s004250050257; KONINGS H, 1982, PHYSIOL PLANTARUM, V54, P119, DOI 10.1111/j.1399-3054.1982.tb06313.x; KUNST L, 1992, PLANT PHYSIOL BIOCH, V30, P425; Licausi F, 2009, ADV BOT RES, V50, P139, DOI 10.1016/S0065-2296(08)00804-5; Matsuda S, 2014, PLANT SCI, V224, P103, DOI 10.1016/j.plantsci.2014.04.011; Matsukura C, 2000, ANN BOT-LONDON, V85, P19, DOI 10.1006/anbo.1999.0993; MCKEON TA, 1982, PLANTA, V155, P437, DOI 10.1007/BF00394473; Ng CKY, 2001, ANN BOT-LONDON, V88, P957, DOI 10.1006/anbo.2001.1543; Nobusawa T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001531; Padmalatha KV, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-624; Reina-Pinto JJ, 2009, PLANT CELL, V21, P1252, DOI 10.1105/tpc.109.065565; Shiono K, 2008, PLANT SCI, V175, P52, DOI 10.1016/j.plantsci.2008.03.002; Shiono K, 2014, J EXP BOT, V65, P4795, DOI 10.1093/jxb/eru235; Shiono K, 2014, PLANT J, V80, P40, DOI 10.1111/tpj.12614; Steffens B, 2011, NEW PHYTOL, V190, P369, DOI 10.1111/j.1469-8137.2010.03496.x; TAKAMURE I, 1985, JPN J BREED, V35, P17; Takasugi Tomoaki, 2011, Plant Signal Behav, V6, P887; TONUTTI P, 1991, PHYSIOL PLANTARUM, V81, P295; Ureshi A., 2012, Plant Root, V6, P28, DOI 10.3117/plantroot.6.28; Visser EJW, 1996, J EXP BOT, V47, P403, DOI 10.1093/jxb/47.3.403; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; VOESENEK LACJ, 1990, PLANT PHYSIOL, V94, P1071, DOI 10.1104/pp.94.3.1071; Worrall D, 2003, TRENDS PLANT SCI, V8, P317, DOI 10.1016/S1360-1385(03)00128-6; Yamauchi T, 2014, PLANT SIGNAL BEHAV, V9; Yamauchi T, 2014, J EXP BOT, V65, P261, DOI 10.1093/jxb/ert371; Yasuno N, 2007, J HERED, V98, P169, DOI 10.1093/jhered/esl069; Yasuno N, 2009, NEW PHYTOL, V182, P91, DOI 10.1111/j.1469-8137.2008.02724.x; YIP WK, 1988, PLANT PHYSIOL, V88, P553, DOI 10.1104/pp.88.3.553; Yukiyoshi K, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu043	86	1	1	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	SEP	2015	169	1					180	+		10.1104/pp.15.00106		23	Plant Sciences	Plant Sciences	CQ9JM	WOS:000360930600017		
J	Yasumura, Y; Pierik, R; Kelly, S; Sakuta, M; Voesenek, LACJ; Harberd, NP				Yasumura, Yuki; Pierik, Ronald; Kelly, Steven; Sakuta, Masaaki; Voesenek, Laurentius A. C. J.; Harberd, Nicholas P.			An Ancestral Role for CONSTITUTIVE TRIPLE RESPONSE1 Proteins in Both Ethylene and Abscisic Acid Signaling	PLANT PHYSIOLOGY			English	Article							LAND-PLANT EVOLUTION; MOSS PHYSCOMITRELLA-PATENS; ARABIDOPSIS-THALIANA; DESICCATION TOLERANCE; GENE-EXPRESSION; SUBMERGENCE TOLERANCE; REGULATORY MECHANISM; RESISTANT MUTANTS; STRESS RESPONSES; ABA	Land plants have evolved adaptive regulatory mechanisms enabling the survival of environmental stresses associated with terrestrial life. Here, we focus on the evolution of the regulatory CONSTITUTIVE TRIPLE RESPONSE1 (CTR1) component of the ethylene signaling pathway that modulates stress-related changes in plant growth and development. First, we compare CTR1-like proteins from a bryophyte, Physcomitrella patens (representative of early divergent land plants), with those of more recently diverged lycophyte and angiosperm species (including Arabidopsis [Arabidopsis thaliana]) and identify a monophyletic CTR1 family. The fully sequenced P. patens genome encodes only a single member of this family (PpCTR1L). Next, we compare the functions of PpCTR1L with that of related angiosperm proteins. We show that, like angiosperm CTR1 proteins (e.g. AtCTR1 of Arabidopsis), PpCTR1L modulates downstream ethylene signaling via direct interaction with ethylene receptors. These functions, therefore, likely predate the divergence of the bryophytes from the land-plant lineage. However, we also show that PpCTR1L unexpectedly has dual functions and additionally modulates abscisic acid (ABA) signaling. In contrast, while AtCTR1 lacks detectable ABA signaling functions, Arabidopsis has during evolution acquired another homolog that is functionally distinct from AtCTR1. In conclusion, the roles of CTR1-related proteins appear to have functionally diversified during land-plant evolution, and angiosperm CTR1-related proteins appear to have lost an ancestral ABA signaling function. Our study provides new insights into how molecular events such as gene duplication and functional differentiation may have contributed to the adaptive evolution of regulatory mechanisms in plants.	[Yasumura, Yuki; Kelly, Steven; Harberd, Nicholas P.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Sakuta, Masaaki] Ochanomizu Univ, Dept Biol Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Pierik, Ronald; Voesenek, Laurentius A. C. J.] Univ Utrecht, Inst Environm Biol, Plant Ecophysiol, NL-3584 CH Utrecht, Netherlands	Harberd, NP (reprint author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	nicholas.harberd@plants.ox.ac.uk	Kelly, Steven/F-7237-2011	Kelly, Steven/0000-0001-8583-5362	Biotechnological and Biological Science Research Council [BB/F020759/1]; St. John's College, University of Oxford	This work was supported by the Biotechnological and Biological Science Research Council (grant no. BB/F020759/1) and by St. John's College, University of Oxford (research support to N.P.H.).	Abeles F. B., 1992, ETHYLENE PLANT BIOL; Adams-Phillips L, 2004, PLANT MOL BIOL, V54, P387, DOI 10.1023/B:PLAN.0000036371.30528.26; Ju CL, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2014.4; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Voesenek LACJ, 2013, CURR OPIN PLANT BIOL, V16, P647, DOI 10.1016/j.pbi.2013.06.008; Sharp RE, 2002, J EXP BOT, V53, P33, DOI 10.1093/jexbot/53.366.33; Wang FF, 2013, PLANT CELL REP, V32, P1099, DOI 10.1007/s00299-013-1421-6; Wilson RL, 2014, PLANT PHYSIOL, V165, P1353, DOI 10.1104/pp.114.241695; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; Prigge MJ, 2010, CURR BIOL, V20, P1907, DOI 10.1016/j.cub.2010.08.050; Qiu LP, 2012, PLANT PHYSIOL, V159, P1263, DOI 10.1104/pp.112.193979; Yasumura Y, 2012, PLANT J, V72, P947, DOI 10.1111/tpj.12005; Verslues PE, 2005, BIOCHEM SOC T, V33, P375; Zhong SL, 2008, J EXP BOT, V59, P965, DOI 10.1093/jxb/ern021; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Arc E, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00063; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Pierik R, 2006, TRENDS PLANT SCI, V11, P176, DOI 10.1016/j.tplants.2006.02.006; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Yotsui I, 2013, NEW PHYTOL, V199, P101, DOI 10.1111/nph.12251; Beaudoin N, 2000, PLANT CELL, V12, P1103, DOI 10.1105/tpc.12.7.1103; LANGDALE JA, 1988, GENE DEV, V2, P106, DOI 10.1101/gad.2.1.106; ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Voesenek LACJ, 2013, PLANT BIOLOGY, V15, P426, DOI 10.1111/plb.12014; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Hall BP, 2012, PLANT PHYSIOL, V159, P682, DOI 10.1104/pp.112.196790; Paponov IA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-126; Yasumura Y, 2007, CURR BIOL, V17, P1225, DOI 10.1016/j.cub.2007.06.037; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; ROMAN G, 1995, GENETICS, V139, P1393; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Kamisugi Y, 2005, PLANT MOL BIOL, V59, P723, DOI 10.1007/s11103-005-0909-z; Frye CA, 1998, PLANT CELL, V10, P947; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Yin XR, 2008, J EXP BOT, V59, P2097, DOI [10.1093/jxb/ern067, 10.1093/jxb/em067]; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Shen XL, 2011, PLANT CELL ENVIRON, V34, P179, DOI 10.1111/j.1365-3040.2010.02219.x; Khandelwal A, 2010, SCIENCE, V327, P546, DOI 10.1126/science.1183672; Lin ZF, 2008, PLANT J, V54, P1083, DOI 10.1111/j.1365-313X.2008.03481.x; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Komatsu K, 2009, PLANT MOL BIOL, V70, P327, DOI 10.1007/s11103-009-9476-z; Maia J, 2014, NEW PHYTOL, V203, P81, DOI 10.1111/nph.12785; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Chater C, 2011, CURR BIOL, V21, P1025, DOI 10.1016/j.cub.2011.04.032; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Benschop JJ, 2007, PLANT PHYSIOL, V143, P1013, DOI 10.1104/pp.106.092700; Cao Yang-Rong, 2008, Plant Signal Behav, V3, P761; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Collingridge PW, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-117; Eklund DM, 2010, DEVELOPMENT, V137, P1275, DOI 10.1242/dev.039594; Finkelstein Ruth R, 2002, Arabidopsis Book, V1, pe0058, DOI 10.1199/tab.0058; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kelly S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058537; Komatsu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3219; Marella HH, 2006, PLANT J, V46, P1032, DOI 10.1111/j.1365-313X.2006.02764.x; McManus M.T., 2012, PLANT HORMONE ETHYLE, V44; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Romanel EAC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005791; Ruijter J.M., 2009, NUCLEIC ACIDS RES, V6, pe45, DOI DOI 10.1093/NAR/GKP045; Saavedra L, 2006, PLANT J, V45, P237, DOI 10.1111/j.1365-313X.2005.02603.x; Sakata Yoichi, 2010, Plant Signal Behav, V5, P1061; SCHAEFER D, 1991, MOL GEN GENET, V226, P418; Subbiah V, 2010, J BIOSCIENCES, V35, P451, DOI 10.1007/s12038-010-0050-2; Zou C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000581; Zuiderveld K., 1994, GRAPHICS GEMS, P474	76	1	1	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	SEP	2015	169	1					283	+		10.1104/pp.15.00233		22	Plant Sciences	Plant Sciences	CQ9JM	WOS:000360930600023		
J	Nishizawa-Yokoi, A; Nonaka, S; Osakabe, K; Saika, H; Toki, S				Nishizawa-Yokoi, Ayako; Nonaka, Satoko; Osakabe, Keishi; Saika, Hiroaki; Toki, Seiichi			A Universal Positive-Negative Selection System for Gene Targeting in Plants Combining an Antibiotic Resistance Gene and Its Antisense RNA	PLANT PHYSIOLOGY			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; HOMOLOGOUS RECOMBINATION; DIPHTHERIA-TOXIN; CYTOSINE DEAMINASE; RICE; ARABIDOPSIS; ABLATION; TOBACCO; MARKER; DNA	Gene targeting (GT) is a useful technology for accurate genome engineering in plants. A reproducible approach based on a positive-negative selection system using hygromycin resistance and the diphtheria toxin A subunit gene as positive and negative selection markers, respectively, is now available. However, to date, this selection system has been applied exclusively in rice (Oryza sativa). To establish a universally applicable positive-negative GT system in plants, we designed a selection system using a combination of neomycin phosphotransferaseII (nptII) and an antisense nptII construct. The concomitant transcription of both sense and antisense nptII suppresses significantly the level of expression of the sense nptII gene, and transgenic calli and plants become sensitive to the antibiotic geneticin. In addition, we were able to utilize the sense nptII gene as a positive selection marker and the antisense nptII construct as a negative selection marker for knockout of the endogenous rice genes Waxy and 33-kD globulin through GT, although negative selection with this system is relatively less efficient compared with diphtheria toxin A subunit. The approach developed here, with some additional improvements, could be applied as a universal selection system for the enrichment of GT cells in several plant species.	[Nishizawa-Yokoi, Ayako; Nonaka, Satoko; Osakabe, Keishi; Saika, Hiroaki; Toki, Seiichi] Natl Inst Agrobiol Sci, Plant Genome Engn Res Unit, Ibaraki 3058602, Japan; [Osakabe, Keishi] Univ Tokushima, Ctr Collaborat Agr Ind & Commerce, Tokushima 7708503, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 2440813, Japan	Toki, S (reprint author), Natl Inst Agrobiol Sci, Plant Genome Engn Res Unit, Ibaraki 3058602, Japan.	stoki@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [PGE1001]; Japan Society for the Promotion of Science (KAKENHI) [23658012, 23310142]; Cross Ministerial Strategic Innovation Promotion Program; Program for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry	This work was supported by the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation Grant no. PGE1001), Japan Society for the Promotion of Science (KAKENHI grant nos. 23658012 and 23310142), the Cross Ministerial Strategic Innovation Promotion Program, and the Program for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry.	Terada R, 2007, PLANT PHYSIOL, V144, P846, DOI 10.1104/pp.107.095992; Hohn B, 2003, TRENDS PLANT SCI, V8, P51, DOI 10.1016/S1360-1385(03)00004-9; Yamauchi T, 2009, PLANT J, V60, P386, DOI 10.1111/j.1365-313X.2009.03947.x; Nilsson O, 1998, PLANT J, V15, P799, DOI 10.1046/j.1365-313X.1998.00260.x; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; OFFRINGA R, 1993, P NATL ACAD SCI USA, V90, P7346, DOI 10.1073/pnas.90.15.7346; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Thykjaer T, 1997, PLANT MOL BIOL, V35, P523, DOI 10.1023/A:1005865600319; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Weijers D, 2003, PLANT PHYSIOL, V133, P1882, DOI 10.1104/pp.103.030692; Ozawa K, 2012, PLANT CELL PHYSIOL, V53, P755, DOI 10.1093/pcp/pcs016; Terada R, 2002, NAT BIOTECHNOL, V20, P1030, DOI 10.1038/nbt737; Toki S, 1997, PLANT MOL BIOL REP, V15, P16, DOI 10.1007/BF02772109; Hanin M, 2001, PLANT J, V28, P671, DOI 10.1046/j.1365-313x.2001.01183.x; [Anonymous], 1962, PHYSIOL PLANTARUM, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Tsugeki R, 1999, P NATL ACAD SCI USA, V96, P12941, DOI 10.1073/pnas.96.22.12941; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4989; CZAKO M, 1992, MOL GEN GENET, V235, P33, DOI 10.1007/BF00286178; Dang TT, 2013, PLANT CELL PHYSIOL, V54, P2058, DOI 10.1093/pcp/pct147; DAY CD, 1995, DEVELOPMENT, V121, P2887; Endo M, 2007, PLANT J, V52, P157, DOI 10.1111/j.1365-313X.2007.03230.x; Endo M, 2006, PLANT CELL PHYSIOL, V47, P372, DOI 10.1098/pcp/pcj003; Gallego ME, 1999, PLANT MOL BIOL, V39, P83, DOI 10.1023/A:1006192225464; Johnson ET, 2014, MOL GENET GENOMICS, V289, P895, DOI 10.1007/s00438-014-0860-2; Kim HU, 1998, MOL CELLS, V8, P310; Lee YH, 2003, PLANT CELL REP, V22, P268, DOI 10.1007/s00299-003-0688-4; Mahan SD, 2004, BIOCHEMISTRY-US, V43, P8957, DOI 10.1021/bi049720z; Moritoh S, 2012, PLANT J, V71, P85, DOI 10.1111/j.1365-313X.2012.04974.x; Nishizawa-Yokoi A, 2014, PLANT J, V77, P454, DOI 10.1111/tpj.12367; Nishizawa-Yokoi A, 2015, PLANT J, V81, P160, DOI 10.1111/tpj.12693; OFFRINGA R, 1990, EMBO J, V9, P3077; Ono A, 2012, PLANT J, V71, P564, DOI 10.1111/j.1365-313X.2012.05009.x; Osakabe K, 2014, PLANT CELL PHYSIOL, V55, P658, DOI 10.1093/pcp/pct183; PASZKOWSKI J, 1988, EMBO J, V7, P4021; PERERA RJ, 1993, PLANT MOL BIOL, V23, P793, DOI 10.1007/BF00021534; Shimatani Zenpei, 2014, Front Plant Sci, V5, P748, DOI 10.3389/fpls.2014.00748; Tamaki S, 2015, P NATL ACAD SCI USA, V112, pE901, DOI 10.1073/pnas.1417623112; THORSNESS MK, 1993, PLANT CELL, V5, P253; TWELL D, 1995, PROTOPLASMA, V187, P144, DOI 10.1007/BF01280243; Usui Y, 2001, J BIOL CHEM, V276, P11376, DOI 10.1074/jbc.M010337200; Wang Helen Xiaohui, 2001, Gene (Amsterdam), V272, P249; XIANG CB, 1993, PLANT PHYSIOL, V102, P287	42	0	0	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	SEP	2015	169	1					362	+		10.1104/pp.15.00638		12	Plant Sciences	Plant Sciences	CQ9JM	WOS:000360930600029		
J	Petti, C; Hirano, K; Stork, J; DeBolt, S				Petti, Carloalberto; Hirano, Ko; Stork, Jozsef; DeBolt, Seth			Mapping of a Cellulose-Deficient Mutant Named dwarf1-1 in Sorghum bicolor to the Green Revolution Gene gibberellin20-oxidase Reveals a Positive Regulatory Association between Gibberellin and Cellulose Biosynthesis	PLANT PHYSIOLOGY			English	Article							DEUTERATED ABSCISIC-ACID; SOYBEAN GH3 PROMOTER; ARABIDOPSIS-THALIANA; MASS-SPECTROMETRY; CELL EXPANSION; L. MOENCH; TRANSCRIPTIONAL REGULATION; SYNTHASE COMPLEXES; RESPONSE ELEMENT; ACTING ELEMENTS	Here, we show a mechanism for expansion regulation through mutations in the green revolution gene gibberellin20 (GA20)-oxidase and show that GAs control biosynthesis of the plants main structural polymer cellulose. Within a 12,000 mutagenized Sorghum bicolor plant population, we identified a single cellulose-deficient and male gametophyte-dysfunctional mutant named dwarf1-1 (dwf1-1). Through the Sorghum propinquum male/dwf1-1 female F2 population, we mapped dwf1-1 to a frameshift in GA20-oxidase. Assessment of GAs in dwf1-1 revealed ablation of GA. GA ablation was antagonistic to the expression of three specific cellulose synthase genes resulting in cellulose deficiency and growth dwarfism, which were complemented by exogenous bioactive gibberellic acid application. Using quantitative polymerase chain reaction, we found that GA was positively regulating the expression of a subset of specific cellulose synthase genes. To cross reference data from our mapped Sorghum sp. allele with another monocotyledonous plant, a series of rice (Oryza sativa) mutants involved in GA biosynthesis and signaling were isolated, and these too displayed cellulose deficit. Taken together, data support a model whereby suppressed expansion in green revolution GA genes involves regulation of cellulose biosynthesis.	[Petti, Carloalberto; Stork, Jozsef; DeBolt, Seth] Univ Kentucky, Dept Hort, Lexington, KY 40546 USA; [Hirano, Ko] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	DeBolt, S (reprint author), Univ Kentucky, Dept Hort, Lexington, KY 40546 USA.	sdebo2@uky.edu			Japan Society for Promotion of Science (KAKENHI) [26660278]; U.S. Department of Energy [10-0000368]; National Science Foundation [1256029, 1355438]	This work was supported by the Japan Society for the Promotion of Science (KAKENHI grant no. 26660278 to K.H.), the U.S. Department of Energy (grant no. Department of Energy-Funding Opportunity Announcement 10-0000368 to S.D.), and the National Science Foundation (grant nos. 1256029 and 1355438 to S.D.).	Abrams SR, 2003, J LABELLED COMPD RAD, V46, P273, DOI 10.1002/jlcr.670; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Chen PW, 2006, PLANT CELL, V18, P2326, DOI 10.1105/tpc.105.038844; Wolf S, 2012, ANNU REV PLANT BIOL, V63, P381, DOI 10.1146/annurev-arplant-042811-105449; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Asano K, 2009, MOL GENET GENOMICS, V281, P223, DOI 10.1007/s00438-008-0406-6; Ross ARS, 2004, ANAL BIOCHEM, V329, P324, DOI 10.1016/j.ab.2004.02.026; Downes BP, 1998, PLANT MOL BIOL, V37, P437, DOI 10.1023/A:1005920732211; Xie LQ, 2011, J EXP BOT, V62, P4495, DOI 10.1093/jxb/err164; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; Kong WQ, 2013, G3-GENES GENOM GENET, V3, P101, DOI 10.1534/g3.112.004499; Ko JH, 2006, MOL GENET GENOMICS, V276, P517, DOI 10.1007/s00438-006-0157-1; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; KEYES GJ, 1989, ANN BOT-LONDON, V64, P683; XU YL, 1995, P NATL ACAD SCI USA, V92, P6640, DOI 10.1073/pnas.92.14.6640; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Yamaguchi M, 2010, PLANT CELL, V22, P1249, DOI 10.1105/tpc.108.064048; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Bischoff V, 2011, CURR BIOL, V21, P1822, DOI 10.1016/j.cub.2011.09.026; Ordonio RL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05287; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Paque S, 2014, PLANT CELL, V26, P280, DOI 10.1105/tpc.113.120048; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Menz MA, 2002, PLANT MOL BIOL, V48, P483, DOI 10.1023/A:1014831302392; Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Fusada N, 2005, PLANT MOL BIOL, V59, P631, DOI 10.1007/s11103-005-0579-x; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Chen SL, 2010, P NATL ACAD SCI USA, V107, P17188, DOI 10.1073/pnas.1012348107; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; Plackett ARG, 2012, PLANT CELL, V24, P941, DOI 10.1105/tpc.111.095109; Liu GQ, 2012, PLANT CELL REP, V31, P999, DOI 10.1007/s00299-011-1218-4; Lacombe E, 2000, PLANT J, V23, P663, DOI 10.1046/j.1365-313x.2000.00838.x; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Huang DB, 2015, PLANT CELL, V27, P1681, DOI 10.1105/tpc.15.00015; Daras G, 2009, NEW PHYTOL, V184, P114, DOI 10.1111/j.1469-8137.2009.02960.x; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; LIU ZB, 1994, PLANT CELL, V6, P645; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732.; Sethaphong L, 2013, P NATL ACAD SCI USA, V110, P7512, DOI 10.1073/pnas.1301027110; Tsekos I, 1999, J PHYCOL, V35, P635, DOI 10.1046/j.1529-8817.1999.3540635.x; Mena M, 2002, PLANT PHYSIOL, V130, P111, DOI 10.1104/pp.005561; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Held MA, 2008, P NATL ACAD SCI USA, V105, P20534, DOI 10.1073/pnas.0809408105; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; BALLAS N, 1993, J MOL BIOL, V233, P580, DOI 10.1006/jmbi.1993.1537; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Kim DW, 2006, PLANT CELL, V18, P2958, DOI 10.1105/tpc.106.045229; Bhattramakki D, 2000, GENOME, V43, P988, DOI 10.1139/gen-43-6-988; Billot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059714; Burke IC, 2007, WEED TECHNOL, V21, P23, DOI 10.1614/WT-05-171.1; Cercos M, 1999, PLANT J, V19, P107, DOI 10.1046/j.1365-313X.1999.00499.x; Cosgrove DJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00204; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.128.2.482; Elliott K. A., PROMOTER REGIONS EXT; Frigerio M, 2006, PLANT PHYSIOL, V142, P553, DOI 10.1104/pp.106.084871; Gonneau M, 2014, PLANT PHYSIOL, V166, P1709, DOI 10.1104/pp.114.250159; Gubler F., 1999, PLANT J, V17, P1; Guilfoyle T, 1998, PLANT PHYSIOL, V118, P341, DOI 10.1104/pp.118.2.341; Irie Kenji, 2008, Journal of Agricultural Science Tokyo Nogyo Daigaku, V53, P69; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Kong L, 2000, THEOR APPL GENET, V101, P438, DOI 10.1007/s001220051501; LANSAC AR, 1994, ANN BOT-LONDON, V74, P27, DOI 10.1093/aob/74.1.27; Lee I.-J., 1998, Journal of Plant Growth Regulation, V17, P185, DOI 10.1007/PL00007034; Lei L., 2012, PLANT SIGNAL BEHAV, V7, P714; Liu ZB, 1997, PLANT PHYSIOL, V115, P397, DOI 10.1104/pp.115.2.397; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; OGI Y, 1993, JPN J BREED, V43, P267; Okuno A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086870; Paterson AH, 2008, INT J PLANT GENOMICS, V2008, DOI DOI 10.1155/2008/362451; Peterson R, 2010, INT J PLANT BIOL, V1, pe13, DOI DOI 10.4081/PB.2010.E13; Petti C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00181; Tuinstra MR, 2000, CROP SCI, V40, P968; UPDEGRAF.DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; XIA BS, 1991, JPN J CROP SCI, V60, P36; Xu NF, 1997, PLANT SCI, V126, P193, DOI 10.1016/S0168-9452(97)00110-6; Zaharia LI, 2005, J LABELLED COMPD RAD, V48, P435, DOI 10.1002/jlcr.939	89	0	0	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	SEP	2015	169	1					705	+		10.1104/pp.15.00928		26	Plant Sciences	Plant Sciences	CQ9JM	WOS:000360930600053		
J	Waadt, R; Manalansan, B; Rauniyar, N; Munemasa, S; Booker, MA; Brandt, B; Waadt, C; Nusinow, DA; Kay, SA; Kunz, HH; Schumacher, K; DeLong, A; Yates, JR; Schroeder, JI				Waadt, Rainer; Manalansan, Bianca; Rauniyar, Navin; Munemasa, Shintaro; Booker, Matthew A.; Brandt, Benjamin; Waadt, Christian; Nusinow, Dmitri A.; Kay, Steve A.; Kunz, Hans-Henning; Schumacher, Karin; DeLong, Alison; Yates, John R., III; Schroeder, Julian I.			Identification of Open Stomatal-Interacting Proteins Reveals Interactions with Sucrose Non-fermenting1-Related Protein Kinases2 and with Type 2A Protein Phosphatases That Function in Abscisic Acid Responses	PLANT PHYSIOLOGY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; ARABIDOPSIS GUARD-CELLS; DIFFERENT PHOSPHORYLATION MECHANISMS; SLOW ANION CHANNELS; SIGNAL-TRANSDUCTION; REGULATORY SUBUNIT; GENE-EXPRESSION; FREEZING TOLERANCE; IN-VIVO; OSMOTIC-STRESS	The plant hormone abscisic acid (ABA) controls growth and development and regulates plant water status through an established signaling pathway. In the presence of ABA, pyrabactin resistance/regulatory component of ABA receptor proteins inhibit type 2C protein phosphatases (PP2Cs). This, in turn, enables the activation of Sucrose Nonfermenting1-Related Protein Kinases2 (SnRK2). Open Stomata1 (OST1)/SnRK2.6/SRK2E is a major SnRK2-type protein kinase responsible for mediating ABA responses. Arabidopsis (Arabidopsis thaliana) expressing an epitope-tagged OST1 in the recessive ost1-3 mutant background was used for the copurification and identification of OST1-interacting proteins after osmotic stress and ABA treatments. These analyses, which were confirmed using bimolecular fluorescence complementation and coimmunoprecipitation, unexpectedly revealed homo- and heteromerization of OST1 with SnRK2.2, SnRK2.3, OST1, and SnRK2.8. Furthermore, several OST1-complexed proteins were identified as type 2A protein phosphatase (PP2A) subunits and as proteins involved in lipid and galactolipid metabolism. More detailed analyses suggested an interaction network between ABA-activated SnRK2-type protein kinases and several PP2A-type protein phosphatase regulatory subunits. pp2a double mutants exhibited a reduced sensitivity to ABA during seed germination and stomatal closure and an enhanced ABA sensitivity in root growth regulation. These analyses add PP2A-type protein phosphatases as another class of protein phosphatases to the interaction network of SnRK2-type protein kinases.	[Waadt, Rainer; Manalansan, Bianca; Munemasa, Shintaro; Brandt, Benjamin; Kunz, Hans-Henning; Schroeder, Julian I.] Univ Calif San Diego, Cell & Dev Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Waadt, Rainer; Manalansan, Bianca; Munemasa, Shintaro; Brandt, Benjamin; Kunz, Hans-Henning; Schroeder, Julian I.] Univ Calif San Diego, Ctr Food & Fuel 21st Century, La Jolla, CA 92093 USA; [Waadt, Rainer; Schumacher, Karin] Heidelberg Univ, Ctr Organismal Studies, Plant Dev Biol, D-69120 Heidelberg, Germany; [Rauniyar, Navin; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Munemasa, Shintaro] Okayama Univ, Grad Sch Environm & Life Sci, Div Agr & Life Sci, Okayama 7008530, Japan; [Booker, Matthew A.; DeLong, Alison] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Nusinow, Dmitri A.] Donald Danforth Plant Sci Ctr, Dept Biol, St Louis, MO 63132 USA; [Kay, Steve A.] Univ So Calif, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA	Schroeder, JI (reprint author), Univ Calif San Diego, Cell & Dev Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	jischroeder@ucsd.edu	Nusinow, Dmitri/K-9129-2013	Nusinow, Dmitri/0000-0002-0497-1723	Alexander von Humboldt Foundation; National Institutes of Health [GM060396, F32GM083585, R01GM056006, R01GM067837, P41 GM103533]; National Science Foundation [MCB1414339, IOS-1145585]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-03ER15449]	This work was supported by the Alexander von Humboldt Foundation (Feodor Lynen Fellowship to R.W.), the National Institutes of Health (grant no. GM060396 to J.I.S.; the development of the 6xHIS-3xFLAG tag used was supported by grant nos. F32GM083585 to D.A.N., R01GM056006 to S.A.K., and R01GM067837 to S.A.K.; and grant no. P41 GM103533 to J.R.Y. for proteomics analyses), the National Science Foundation (grant no. MCB1414339 to J.I.S. and grant no. IOS-1145585 to A.D. for biochemical analyses of type 2A protein phosphatase-type protein phosphatases), and the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy (grant no. DE-FG02-03ER15449 to J.I.S. for root growth analyses).	Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Mosquna A, 2011, P NATL ACAD SCI USA, V108, P20838, DOI 10.1073/pnas.1112838108; Garbers C, 1996, EMBO J, V15, P2115; Acharya BR, 2013, NEW PHYTOL, V200, P1049, DOI 10.1111/nph.12469; Imes D, 2013, PLANT J, V74, P372, DOI 10.1111/tpj.12133; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Wang PC, 2013, P NATL ACAD SCI USA, V110, P11205, DOI 10.1073/pnas.1308974110; Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; Krebs M, 2012, PLANT J, V69, P181, DOI 10.1111/j.1365-313X.2011.04780.x; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Peters C, 2010, PLANT CELL, V22, P2642, DOI 10.1105/tpc.109.071720; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Schlucking K, 2013, MOL PLANT, V6, P1814, DOI 10.1093/mp/sst065; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.0224018; Muday GK, 2006, PLANT PHYSIOL, V141, P1617, DOI 10.1104/pp.106.083212; Hu RB, 2014, PLANT PHYSIOL, V164, P721, DOI 10.1104/pp.113.233684; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Deruere J, 1999, PLANT J, V20, P389, DOI 10.1046/j.1365-313x.1999.00607.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; Szostkiewicz I, 2010, PLANT J, V61, P25, DOI 10.1111/j.1365-313X.2009.04025.x; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Camilleri C, 2002, PLANT CELL, V14, P833, DOI 10.1105/tpc.010402; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Tran HT, 2012, PLANT J, V71, P263, DOI 10.1111/j.1365-313X.2012.04984.x; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; De Smet I, 2006, TRENDS PLANT SCI, V11, P434, DOI 10.1016/j.tplants.2006.07.003; Nakamura Y, 2005, J BIOL CHEM, V280, P7469, DOI 10.1074/jbc.M408799200; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Dai MQ, 2012, PLANT CELL, V24, P2497, DOI 10.1105/tpc.112.098905; Larsen PB, 2003, PLANT J, V34, P709, DOI 10.1046/j.1365-313X.2003.01762.x; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Trotta A, 2011, PLANT PHYSIOL, V156, P1464, DOI 10.1104/pp.111.178442; Moellering ER, 2011, TRENDS PLANT SCI, V16, P98, DOI 10.1016/j.tplants.2010.11.004; Pernas M, 2007, PLANT J, V51, P763, DOI 10.1111/j.1365-313X.2007.03179.x; Sirichandra C, 2009, FEBS LETT, V583, P2982, DOI 10.1016/j.febslet.2009.08.033; Dormann P, 1998, PLANT J, V13, P641, DOI 10.1046/j.1365-313X.1998.00067.x; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Kirik A, 2012, PLANT CELL, V24, P1158, DOI 10.1105/tpc.111.094367; Kocourkova D, 2011, J EXP BOT, V62, P3753, DOI 10.1093/jxb/err039; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.N509820200; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Sasaki T, 2010, PLANT CELL PHYSIOL, V51, P354, DOI 10.1093/pcp/pcq016; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Fujii H, 2011, P NATL ACAD SCI USA, V108, P1717, DOI 10.1073/pnas.1018367108; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fonslow BR, 2012, J PROTEOME RES, V11, P2697, DOI 10.1021/pr300200x; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Merilo E, 2013, PLANT PHYSIOL, V162, P1652, DOI 10.1104/pp.113.220608; Kim TH, 2012, PLANT CELL, V24, P5177, DOI 10.1105/tpc.112.107235; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Xue SW, 2011, EMBO J, V30, P1645, DOI 10.1038/emboj.2011.68; NORRIS SR, 1993, PLANT MOL BIOL, V21, P895, DOI 10.1007/BF00027120; Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Matre P, 2009, PLANTA, V230, P935, DOI 10.1007/s00425-009-0998-z; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; Duan LN, 2013, PLANT CELL, V25, P324, DOI 10.1105/tpc.112.107227; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Kwak JM, 2002, PLANT CELL, V14, P2849, DOI 10.1105/tpc.003335; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Vlad F, 2010, PLANT J, V63, P778, DOI 10.1111/j.1365-313X.2010.04281.x; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; Boudsocq M, 2007, PLANT MOL BIOL, V63, P491, DOI 10.1007/s11103-006-9103-1; Umezawa T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003509; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; James P, 1996, GENETICS, V144, P1425; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Farkas I, 2007, TRENDS PLANT SCI, V12, P169, DOI 10.1016/j.tplants.2007.03.003; Skottke KR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001370; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Nagaya S, 2010, PLANT CELL PHYSIOL, V51, P328, DOI 10.1093/pcp/pcp188; Ng LM, 2011, P NATL ACAD SCI USA, V108, P21259, DOI 10.1073/pnas.1118651109; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Ballesteros I, 2013, PLANT J, V73, P862, DOI 10.1111/tpj.12078; Blakeslee JJ, 2008, PLANT PHYSIOL, V146, P539, DOI 10.1104/pp.107.112995; Bucholc M, 2011, J BIOL CHEM, V286, P3429, DOI 10.1074/jbc.M110.115535; Charpentier M, 2014, PLANT PHYSIOL, V166, P2077, DOI 10.1104/pp.114.246371; DeLong A, 2006, CURR OPIN PLANT BIOL, V9, P470, DOI 10.1016/j.pbi.2006.07.015; Ding YL, 2015, DEV CELL, V32, P278, DOI 10.1016/j.devcel.2014.12.023; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; Fisher RH, 1996, PLANT PHYSIOL, V110, P1109; Haynes JG, 1999, EUR J BIOCHEM, V260, P127, DOI 10.1046/j.1432-1327.1999.00154.x; Hey SJ, 1997, PLANTA, V202, P85, DOI 10.1007/s004250050106; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Lillo C, 2014, PLANT CELL ENVIRON, V37, P2631, DOI 10.1111/pce.12364; McClinton RS, 1997, PLANTA, V201, P252, DOI 10.1007/s004250050064; Saito N, 2008, PLANT CELL PHYSIOL, V49, P1396, DOI 10.1093/pcp/pcn106; SCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9535, DOI 10.1073/pnas.92.21.9535; Schwarz M, 1998, FEBS LETT, V428, P177, DOI 10.1016/S0014-5793(98)00526-2; Segonzac C, 2014, EMBO J, V33, P2069, DOI 10.15252/embj.201488698; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Sirichandra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013935; Stacey J, 1994, Methods Mol Biol, V28, P9; Tian W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7057; Tseng TS, 2010, PLANT CELL, V22, P392, DOI 10.1105/tpc.109.066423; Vlad F, 2008, PLANT J, V55, P104, DOI 10.1111/j.1365-313X.2008.03488.x; Waadt R, 2014, ELIFE, V3, DOI 10.7554/eLife.01739; Waadt R, 2014, METHODS MOL BIOL, V1062, P629, DOI 10.1007/978-1-62703-580-4_33; Warren G, 1996, PLANT PHYSIOL, V111, P1011, DOI 10.1104/pp.111.4.1011; Wege S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005140; Wu G, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001258; Xie T, 2012, J BIOL CHEM, V287, P794, DOI 10.1074/jbc.M111.313106; Yunta C, 2011, J MOL BIOL, V414, P135, DOI 10.1016/j.jmb.2011.09.041; Zhou HW, 2004, PLANT CELL, V16, P709, DOI 10.1105/tpc.018994	134	0	0	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	SEP	2015	169	1					760	+		10.1104/pp.15.00575		28	Plant Sciences	Plant Sciences	CQ9JM	WOS:000360930600057		
J	Hayami, N; Sakai, Y; Kimura, M; Saito, T; Tokizawa, M; Iuchi, S; Kurihara, Y; Matsui, M; Nomoto, M; Tada, Y; Yamamoto, YY				Hayami, Natsuki; Sakai, Yusaku; Kimura, Mitsuhiro; Saito, Tatsunori; Tokizawa, Mutsutomo; Iuchi, Satoshi; Kurihara, Yukio; Matsui, Minami; Nomoto, Mika; Tada, Yasuomi; Yamamoto, Yoshiharu Y.			The Responses of Arabidopsis Early Light-Induced Protein2 to Ultraviolet B, High Light, and Cold Stress Are Regulated by a Transcriptional Regulatory Unit Composed of Two Elements	PLANT PHYSIOLOGY			English	Article							INDUCIBLE PROTEIN ELIP; GENE-EXPRESSION; MEDIATED TRANSFORMATION; LOW-TEMPERATURE; EXCESS LIGHT; THALIANA; PROMOTER; DNA; REVEALS; GENOME	The Arabidopsis (Arabidopsis thaliana) Early Light-Induced Protein (FLIP) is thought to act as a photoprotectant, reducing the damaging effects of high light (HL). Expression of ELIP2 is activated by multiple environmental stresses related to photoinhibition. We have identified putative regulatory elements in an ELIP2 promoter using an octamer-based frequency comparison method, analyzed the role of these elements using synthetic promoters, and revealed a key transcriptional regulatory unit for ultraviolet B (UV-B) radiation, HL, and cold stress responses. The unit is composed of two elements, designated as Elements A (TACACACC) and B (GGCCACGCCA), and shows functionality only when paired. Our genome-wide correlation analysis between possession of these elements in the promoter region and expression profiles in response to UV-B, HL, and cold suggests that Element B receives and integrates these multiple stress signals. In vitro protein-DNA binding assays revealed that LONG HYPOCOTYL5 (HY5), a basic domain-Leucine zipper transcription factor, directly binds to Element B. In addition, mutant analysis of HY5 showed partial involvement in the UV-B and HL responses but not in the cold stress response. These results suggest that signals for UV-B, HL, and cold stress join at Element B, which recognizes the signals of multiple transcription factors, including HY5.	[Hayami, Natsuki; Sakai, Yusaku; Saito, Tatsunori; Yamamoto, Yoshiharu Y.] Gifu Univ, Fac Appl Biol Sci, Gifu 5011103, Japan; [Tokizawa, Mutsutomo; Yamamoto, Yoshiharu Y.] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011103, Japan; [Kimura, Mitsuhiro] Kazusa DNA Res Inst, Dept Frontier Res, Kisarazu, Chiba 2920818, Japan; [Iuchi, Satoshi] RIKEN Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Kurihara, Yukio; Matsui, Minami; Yamamoto, Yoshiharu Y.] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Nomoto, Mika; Tada, Yasuomi] Nagoya Univ, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Yamamoto, YY (reprint author), Gifu Univ, Fac Appl Biol Sci, Gifu 5011103, Japan.	yyy@gifu-u.ac.jp	Yamamoto, Yoshiharu Y./B-6574-2011	Yamamoto, Yoshiharu Y./0000-0002-9667-0572	Japan Science and Technology Agency-Advanced Low Carbon Technology Research and Development Program [23120511, 25120712, 24657029]	This work was supported in part by the Japan Science and Technology Agency-Advanced Low Carbon Technology Research and Development Program (to S.I., MM., and Y.Y.Y.), a Grant-in-Aid for Scientific Research on Innovative Areas Plant Perception (nos. 23120511 and 25120712 to Y.Y.Y.), and a Grant-in-Aid for Challenging Exploratory Research (no. 24657029 to Y.Y.Y.).	ADAMSKA I, 1992, J BIOL CHEM, V267, P24732; ADAMSKA I, 1994, J BIOL CHEM, V269, P30221; ADAMSKA I, 1991, PLANT MOL BIOL, V16, P209, DOI 10.1007/BF00020553; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Brown BA, 2008, PLANT PHYSIOL, V146, P576, DOI 10.1104/pp.107.108456; Tokizawa M, 2015, PLANT PHYSIOL, V167, P991, DOI 10.1104/pp.114.256552; MEYER G, 1984, EUR J BIOCHEM, V138, P201, DOI 10.1111/j.1432-1033.1984.tb07900.x; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Heddad M, 2000, P NATL ACAD SCI USA, V97, P3741, DOI 10.1073/pnas.050391397; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; KLOPPSTECH K, 1985, PLANTA, V165, P502, DOI 10.1007/BF00398095; SHEN QX, 1995, PLANT CELL, V7, P295, DOI 10.1105/tpc.7.3.295; Yamamoto YY, 2009, PLANT J, V60, P350, DOI 10.1111/j.1365-313X.2009.03958.x; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Chattopadhyay S, 1998, PLANT CELL, V10, P673; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; Tuteja N, 2009, MUTAT RES-REV MUTAT, V681, P134, DOI 10.1016/j.mrrev.2008.06.004; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Adamska I, 1999, EUR J BIOCHEM, V260, P453, DOI 10.1046/j.1432-1327.1999.00178.x; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Rossel JB, 2002, PLANT PHYSIOL, V130, P1109, DOI 10.1104/pp.005595; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Puente P, 1996, EMBO J, V15, P3732; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Allahverdiyeva Y, 2012, ADV PHOTOSYNTH RESP, V34, P275, DOI 10.1007/978-94-007-1579-0_13; Li JG, 2013, PROTEIN CELL, V4, P485, DOI 10.1007/s13238-013-3036-7; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Zarter CR, 2006, NEW PHYTOL, V172, P272, DOI 10.1111/j.1469-8137.2006.01815.x; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Heddad M, 2012, ADV PHOTOSYNTH RESP, V34, P299, DOI 10.1007/978-94-007-1579-0_14; BARTELS D, 1992, EMBO J, V11, P2771; Binkert M, 2014, PLANT CELL, V26, P4200, DOI 10.1105/tpc.114.130716; Brosche M, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P91, DOI 10.1007/978-90-481-3112-9_5; Brown BA, 2009, PHOTOCHEM PHOTOBIOL, V85, P1147, DOI 10.1111/j.1751-1097.2009.00579.x; Falk S, 1996, ADV PHOTOSYNTHESIS R, V5, P367; FOSTER R, 1994, FASEB J, V8, P192; Hieno A, 2014, NUCLEIC ACIDS RES, V42, pD1188, DOI 10.1093/nar/gkt1027; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P668, DOI 10.1562/0031-8655(2003)077<0668:AOHPEO>2.0.CO;2; Kimura M, 2001, GENES CELLS, V6, P607, DOI 10.1046/j.1365-2443.2001.00446.x; Kurihara Y, 2014, GENES-BASEL, V5, P1115, DOI 10.3390/genes5041115; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Alvarez-Canterbury AMR, 2014, PLANT MOL BIOL, V84, P259, DOI 10.1007/s11103-013-0130-4; Safrany J, 2008, PLANT J, V54, P402, DOI 10.1111/j.1365-313X.2008.03435.x; Shimosaka E, 1999, PLANT CELL PHYSIOL, V40, P319; Teramura A.H, 1996, PHOTOSYNTHESIS ENV, P435; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; VORST O, 1993, PLANT J, V4, P933, DOI 10.1046/j.1365-313X.1993.04060933.x; Yamamoto YY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-39; Yamamoto YY, 2004, ENDOCYT CELL RES, V15, P438; Yamamoto YY, 2003, PLANT J, V35, P273, DOI 10.1046/j.1365-313X.2003.01797.x; Yamamoto YY, 2009, COMPUTATIONAL BIOLOGY: NEW RESEARCH, P361; Yu X. H., 2010, Arabidopsis Book, V8, pe0135; Zou C, 2011, P NATL ACAD SCI USA, V108, P14992, DOI 10.1073/pnas.1103202108	57	0	0	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	SEP	2015	169	1					840	+		10.1104/pp.15.00398		21	Plant Sciences	Plant Sciences	CQ9JM	WOS:000360930600063		
J	Abe, Y; Tokunaga, S				Abe, Yoshihiro; Tokunaga, Susumu			Surgical Technique and Clinical Results for Trapeziometacarpal Arthrodesis Using Locking Plate Fixation in Women Aged 50 Years or Older	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							TENDON INTERPOSITION ARTHROPLASTY; CARPO-METACARPAL JOINT; LIGAMENT RECONSTRUCTION; CARPOMETACARPAL JOINT; BASAL JOINT; FOLLOW-UP; THUMB; OSTEOARTHRITIS; ARTHRITIS; TRAPEZIECTOMY	Background: The authors hypothesized that locking plates have the potential to decrease the risk of nonunion for trapeziometacarpal joint arthrodesis and eliminate the period of postoperative immobilization. The surgical technique is described and the clinical results are reported for Eaton stage III trapeziometacarpal joint arthrodesis using locking plate fixation in elderly women. Methods: The outcomes of 18 fusion operations with a 2-year follow-up were assessed during this prospective study. Patients were evaluated for bone union, grip strength, tip and key pinch strength, and Kapandji opposition scores. The Disabilities of the Arm, Shoulder and Hand questionnaire and visual analogue scale pain scores were obtained from the patients and evaluated. In addition, complications were assessed. Results: Bone unions were obtained for 16 of 18 fusions. Grip strength was 18.3 kg (range, 12.5 to 26.0 kg), tip pinch strength was 5.6 kg (range, 3.5 to 7.5 kg), and key pinch strength was 6.4 kg (range, 4.0 to 7.5 kg). The Kapandji opposition score was 8.3 points (range, 8 to 10). Disabilities of the Arm, Shoulder and Hand questionnaire score decreased from 54.2 (range, 68.8 to 39.4) to 8.8 (range, 3.9 to 22.0), and visual analogue scale pain scores decreased from 8.3 (range, 8 to 10) preoperatively to 0.9 (range, 0 to 4) postoperatively. Malpositioned devices were removed from two patients. One symptomatic patient required removal of the fixation device as a result of hardware loosening. Conclusion: The results for arthrodesis with a locking plate are comparable to results with a nonlocking plate and are quite satisfactory in the appropriate hands. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.	[Abe, Yoshihiro; Tokunaga, Susumu] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chiba 2608677, Japan	Abe, Y (reprint author), Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Cyuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	abe-yosh@pk9.so-net.ne.jp					AMADIO P C, 1990, Annales de Chirurgie de la Main et du Membre Superieur, V9, P358, DOI 10.1016/S0753-9053(05)80509-5; Vermeulen GM, 2014, J BONE JOINT SURG AM, V96A, P726, DOI 10.2106/JBJS.L.01344; Kubiak EN, 2006, J BONE JOINT SURG AM, V88A, P189, DOI 10.2106/JBJS.F.00703; TOMAINO MM, 1995, J BONE JOINT SURG AM, V77A, P346; Forseth MJ, 2003, J HAND SURG-AM, V28A, P342, DOI 10.1053/jhsu.2003.50042; Hartigan BJ, 2001, J BONE JOINT SURG AM, V83A, P1470; BAMBERGER HB, 1992, J HAND SURG-AM, V17A, P605, DOI 10.1016/0363-5023(92)90302-6; EATON RG, 1969, J BONE JOINT SURG AM, VA 51, P661; Taylor EJ, 2005, J HAND SURG-BRIT EUR, V30B, P45, DOI 10.1016/j.jhsb.2004.08.006; Smith WR, 2007, J BONE JOINT SURG AM, V89A, P2298; DHAR S, 1994, J HAND SURG-BRIT EUR, V19B, P485, DOI 10.1016/0266-7681(94)90214-3; Blank J, 1997, ATLAS HAND CLIN, V2, P217; BURTON RI, 1986, J HAND SURG-AM, V11A, P324; CAPUTO RJ, 1993, J HAND SURG-AM, V18A, P926, DOI 10.1016/0363-5023(93)90067-D; CARROLL RE, 1987, CLIN ORTHOP RELAT R, P106; Carroll R E, 1973, J Bone Joint Surg Br, V55, P292; CHAMAY A, 1994, J HAND SURG-BRIT EUR, V19B, P489, DOI 10.1016/0266-7681(94)90215-1; CLOUGH DA, 1990, J HAND SURG-AM, V15A, P706, DOI 10.1016/0363-5023(90)90141-D; CONOLLY WB, 1993, AUST NZ J SURG, V63, P596, DOI 10.1111/j.1445-2197.1993.tb00465.x; De Smet L, 2010, ACTA ORTHOP BELG, V76, P719; EATON RG, 1979, J BONE JOINT SURG AM, V61, P76; Fulton DB, 2001, J HAND SURG-AM, V26A, P109, DOI 10.1053/jhsu.2001.20964; Hanel DP, 1998, ATLAS HAND CLIN, V3, P41; KAPANDJI A, 1986, Annales de Chirurgie de la Main, V5, P67, DOI 10.1016/S0753-9053(86)80053-9; LANZETTA M, 1995, J HAND SURG-BRIT EUR, V20B, P105, DOI 10.1016/S0266-7681(05)80027-0; LEACH RE, 1968, J BONE JOINT SURG AM, VA 50, P1171; MATTSSON HS, 1969, ACTA ORTHOP SCAND, V40, P602, DOI 10.3109/17453676908989525; Mureau MAM, 2001, J HAND SURG-AM, V26A, P869, DOI 10.1053/jhsu.2001.26659; Raven EEJ, 2007, INT ORTHOP, V31, P547, DOI 10.1007/s00264-006-0217-5; Schwendeman LJ, 1997, ATLAS HAND CLIN, V2, P169; STARK HH, 1977, J BONE JOINT SURG AM, V59, P22; Wajon A, 2009, COCHRANE DB SYST REV, V4, P4631	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	SEP	2015	136	3					521	528		10.1097/PRS.0000000000001534		8	Surgery	Surgery	CQ5YR	WOS:000360682100001		
J	Ishihara, K				Ishihara, Kazuhiko			Highly lubricated polymer interfaces for advanced artificial hip joints through biomimetic design	POLYMER JOURNAL			English	Review							CROSS-LINKED POLYETHYLENE; PHOTOINDUCED GRAFT-POLYMERIZATION; CORONARY-ARTERY-DISEASE; REVISION TOTAL HIP; PHOSPHORYLCHOLINE-COATED STENT; MOLECULAR-WEIGHT POLYETHYLENE; ORTHOPEDIC BEARING SURFACE; POLY(ETHER ETHER KETONE); 2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE; POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE)	For long-lasting artificial hip joint implants, it is necessary to reduce the wear of the acetabular liner composed of ultra-high-molecular- weight polyethylene (UHMWPE) and to eliminate periprosthetic osteolysis. An articular cartilage-mimicking technology has been developed for nanoscale surface modification by grafting poly(2-methacryloyloxyethyl phosphorylcholine) (MPC) onto a highly cross-linked UHMWPE (X-UHMWPE) using photoinduced polymerization. The thickness of the poly(MPC) graft layer is 100-200 nm. This treatment increases the surface hydrophilicity. Other hydrophilic polymers grafted onto the X-UHMWPE are not suitable for long-term functioning under biological conditions. Studies of the tribological and biological effects with poly (MPC) grafted onto the X-UHMWPE substrate revealed that this grafting decreases the production of wear particles and bone resorption responses. The poly(MPC)-grafted X-UHMWPE has been introduced onto an artificial hip joint as a liner for lubrication. This artificial hip joint has been used clinically since 2011 and has been implanted in more than 20 000 patients. This technology has also been applied to the surface modification of PMPC on poly(ether ether ketone) (PEEK), using self-initiated photoinduced grafting, for the development of a new type of artificial joint. This articular cartilage-mimicking technology, which is applied to obtain highly lubricating surfaces, is therefore suitable for preparing artificial hip joint substrates.	Univ Tokyo, Sch Engn, Dept Mat Engn, Tokyo 1138656, Japan	Ishihara, K (reprint author), Univ Tokyo, Sch Engn, Dept Mat Engn, 7-3-1 Hongo, Tokyo 1138656, Japan.	ishihara@mpc.t.u-tokyo.ac.jp			Japan Science and Technology Agency (JST); Japan Agency for Medical Research and Development (AMED)	This review summarizes the research that won the Award of the Society of Polymer Science, Japan (2013). I express sincere appreciation to Dr Toru Moro, Dr Yoshio Takatori, Dr Sakae Tanaka, Dr Hiroshi Kawaguchi and Dr Kozo Nakamura of the University of Tokyo, and Dr Masayuki Kyomoto of KYOCERA Medical Corporation. Additionally, I thank all of the staff: Dr Junji Watanabe, Dr Tomohiro Konno, Dr Ryosuke Matsuno, Dr Yuuki Inoue, Dr Kyoko Fukazawa and students belonging to the laboratory for providing a fine support to this research. This research was carried out with excellent cooperation with Medical School of the University of Tokyo and KYOCERA Medical Corporation and supported financially by Japan Science and Technology Agency (JST) and Japan Agency for Medical Research and Development (AMED).	Airoldi F, 2005, AM J CARDIOL, V96, P664, DOI 10.1016/j.amjcard.2005.04.040; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Kyomoto M, 2013, BIOMATERIALS, V34, P7829, DOI 10.1016/j.biomaterials.2013.07.023; Rodriguez A, 2005, AM J MED, V118, P743, DOI 10.1016/j.amjmed.2005.03.030; Ishihara K, 2000, COLLOID SURFACE B, V18, P325, DOI 10.1016/S0927-7765(99)00158-7; UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259; Takatori Y, 2015, MOD RHEUMATOL, V25, P286, DOI 10.3109/14397595.2014.941438; Takatori Y, 2013, J ARTIF ORGANS, V16, P170, DOI 10.1007/s10047-012-0681-1; Abizaid A, 2007, AM J CARDIOL, V99, P1403, DOI 10.1016/j.amjcard.2006.12.064; Moro T, 2014, J ORTHOP RES, V32, P369, DOI 10.1002/jor.22526; Moro T, 2009, BIOMATERIALS, V30, P2995, DOI 10.1016/j.biomaterials.2009.02.020; Collier JP, 2003, CLIN ORTHOP RELAT R, P289, DOI 10.1097/01.blo.0000073343.50837.03; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Lewis AL, 2000, COLLOID SURFACE B, V18, P261, DOI 10.1016/S0927-7765(99)00152-6; Goda T, 2008, COLLOID SURFACE B, V63, P64, DOI 10.1016/j.colsurfb.2007.11.014; Muratoglu OK, 2001, J ARTHROPLASTY, V16, P149, DOI 10.1054/arth.2001.20540; Briscoe WH, 2006, NATURE, V444, P191, DOI 10.1038/nature05196; Kyomoto M, 2014, BIOMATERIALS, V35, P6677, DOI 10.1016/j.biomaterials.2014.04.051; Sakurai R, 2007, AM J CARDIOL, V100, P818, DOI 10.1016/j.amjcard.2007.04.016; Grenadier E, 2002, CATHETER CARDIO INTE, V55, P303, DOI 10.1002/ccd.10130; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Kyomoto M, 2009, ACS APPL MATER INTER, V1, P537, DOI 10.1021/am800260t; Kyomoto M, 2008, J BIOMED MATER RES A, V86A, P439, DOI 10.1002/jbm.a.31511; Kyomoto M, 2009, J BIOMED MATER RES A, V90A, P362, DOI 10.1002/jbm.a.32092; Dumbleton JH, 2002, J ARTHROPLASTY, V17, P649, DOI 10.1054/arth.2002.33664; GLANT TT, 1993, J BONE MINER RES, V8, P1071; Abizaid A, 2007, CATHETER CARDIO INTE, V70, P914, DOI 10.1002/ccd.21279; Kyomoto M, 2011, CLIN ORTHOP RELAT R, V469, P2327, DOI 10.1007/s11999-010-1718-5; Oonishi H, 2006, J ARTHROPLASTY, V21, P944, DOI 10.1016/j.arth.2006.03.009; Raviv U, 2008, LANGMUIR, V24, P8678, DOI 10.1021/la7039724; Kobayashi M, 2010, CHEM REC, V10, P208, DOI 10.1002/tcr.201000001; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C; Hausleiter J, 2004, J INTERN MED, V256, P388, DOI 10.1111/j.1365-2796.2004.01398.x; Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441; Muratoglu OK, 1999, BIOMATERIALS, V20, P1463, DOI 10.1016/S0142-9612(99)00039-3; KIRK TB, 1993, J ORTHOP RHEUMATOL, V6, P21; Snyder TA, 2007, J BIOMED MATER RES A, V81A, P85, DOI 10.1002/jbm.a.31006; Kim S, 2008, ARTHRIT RHEUM-ARTHR, V59, P481, DOI 10.1002/art.23525; Wroblewski BM, 2005, J BONE JOINT SURG BR, V87B, P1220, DOI 10.1302/0301-620X.87B9.16265; Kurtz SM, 2007, J BONE JOINT SURG AM, V89A, P144, DOI 10.2106/JBJS.G.00587; Kyomoto M, 2015, CLIN ORTHOP RELAT R, V473, P942, DOI 10.1007/s11999-014-3995-x; Chen M, 2009, SCIENCE, V323, P1698, DOI 10.1126/science.1169399; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i; WRIGHT V, 1976, J ANAT, V121, P107; Ishikawa Y, 2006, WEAR, V261, P500, DOI 10.1016/j.wear.2005.12.001; BUCKWALTER JA, 1983, COLLAGEN REL RES, V3, P489; Tipper JL, 2006, J BIOMED MATER RES A, V78A, P473, DOI 10.1002/jbm.a.30824; ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355; Kyomoto M, 2010, BIOMATERIALS, V31, P1017, DOI 10.1016/j.biomaterials.2009.10.055; Kandzari DE, 2006, J AM COLL CARDIOL, V48, P2440, DOI 10.1016/j.jacc.2006.08.035; Jacobs JJ, 2001, CLIN ORTHOP RELAT R, P71; Kitano K, 2009, COLLOID SURFACE B, V74, P350, DOI 10.1016/j.colsurfb.2009.08.004; MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905; Kyomoto M, 2012, BIOMATERIALS, V33, P4451, DOI 10.1016/j.biomaterials.2012.03.028; Merx H, 2003, ANN RHEUM DIS, V62, P222, DOI 10.1136/ard.62.3.222; Morisaku T, 2008, POLYMER, V49, P4652, DOI 10.1016/j.polymer.2008.08.025; Bakhai A, 2005, INT J CARDIOL, V102, P95, DOI 10.1016/j.ijcard.2004.04.001; Obara T, 1997, CLIN BIOMECH, V12, P246, DOI 10.1016/S0268-0033(97)00004-1; Kobayashi M, 2014, ACS APPL MATER INTER, V6, P20365, DOI 10.1021/am505906h; Serro AP, 2006, J BIOMED MATER RES A, V78A, P581, DOI 10.1002/jbm.a.30754; Edmondson S, 2004, CHEM SOC REV, V33, P14, DOI 10.1039/b210143m; McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203; Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673; Kyomoto M, 2007, J MATER SCI-MATER M, V18, P1809, DOI 10.1007/s10856-007-3063-0; Fang HW, 2009, COLLOID SURFACE B, V68, P171, DOI 10.1016/j.colsurfb.2008.09.029; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Crockett R, 2009, J BIOMED MATER RES A, V89A, P1011, DOI 10.1002/jbm.a.32036; Kuiper KKJ, 2000, AM J CARDIOL, V85, P698, DOI 10.1016/S0002-9149(99)00843-7; Raviv U, 2002, SCIENCE, V297, P1540, DOI 10.1126/science.1074481; Atienza Cesar Jr, 2008, J Surg Orthop Adv, V17, P27; Boland J. L., 2000, INT J CARDIOVASC INT, V3, P215; Capello William N, 2005, Instr Course Lect, V54, P171; Chen M, 2007, CHEMPHYSCHEM, V8, P1303, DOI 10.1002/cphc.200700131; Czichos H., 1978, TRIBOLOGY SYSTEMS AP, P1; Goda T., 2015, J APPL POLYM SCI, V132, P41766; Han S. H., 2006, AM HEART J, V152; HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46; Yoshida H, 2003, TRIBOLOGICAL RESEARCH AND DESIGN FOR ENGINEERING SYSTEMS, P425; Ikeuchi K, 1999, WEAR, V225, P656, DOI 10.1016/S0043-1648(98)00376-7; Ishihara K, 2014, PHOSPHORUS BASED POL, P68; ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107; Ishihara K., 2000, SCI TECHNOL ADV MAT, V1, P131, DOI 10.1016/S1468-6996(00)00012-7; Iwasaki Y, 2012, SCI TECHNOL ADV MAT, V13; Cale A, 2007, J BONE JOINT SURG AM, V89A, P2779, DOI 10.2106/JBJS.G.00043; Kandzari David E, 2006, J Interv Cardiol, V19, P405, DOI 10.1111/j.1540-8183.2006.00184.x; Kobayashi M, 2007, SOFT MATTER, V3, P740, DOI 10.1039/b615780g; Kobayashi M, 2014, J BIOMAT SCI-POLYM E, V25, P1673, DOI 10.1080/09205063.2014.952992; Kobayashi M, 2012, FARADAY DISCUSS, V156, P403, DOI 10.1039/c2fd00123c; Kwok OH, 2005, CATHETER CARDIO INTE, V66, P541, DOI 10.1002/ccd.20558; Kyomoto M., 2014, RECONST REV, V4, P36; Longfield M D, 1969, Biomed Eng, V4, P517; Manley MT, 2002, CLIN ORTHOP RELAT R, P129, DOI 10.1097/01.blo.0000038468.05771.74; Moro T, 2006, CLIN ORTHOP RELAT R, P58, DOI 10.1097/01.blo.0000246553.33434.5f; Myers Gerard J, 2005, J Extra Corpor Technol, V37, P201; Myers Gerard J, 2003, J Extra Corpor Technol, V35, P6; Nagasaki Y, 1996, TRENDS POLYM SCI, V4, P59; Ratner B. D., 2013, BIOMATERIALS SCI, V3rd; Santin M., 2012, BIOMIMETIC BIORESPON; Shinozaki N, 2005, CIRC J, V69, P295, DOI 10.1253/circj.69.295; Silver F. H., 1999, BIOMATERIALS SCI BIO; Tateishi T, 2014, J BIOMED MATER RES A, V102, P1342, DOI 10.1002/jbm.a.34809; Tsuruta T., 1993, BIOMEDICAL APPL POLY	103	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	SEP	2015	47	9					585	597		10.1038/pj.2015.45		13	Polymer Science	Polymer Science	CQ9ZM	WOS:000360976700001		
J	Tagaya, M				Tagaya, Motohiro			In situ QCM-D study of nano-bio interfaces with enhanced biocompatibility	POLYMER JOURNAL			English	Review							QUARTZ-CRYSTAL MICROBALANCE; COMPETITIVE PROTEIN ADSORPTION; INDUCED CONFORMATIONAL-CHANGES; GLOMERULAR BASEMENT MEMBRANE; SURFACE-PLASMON RESONANCE; TEQUILANA WEBER BAGASSE; SHEAR-WAVE RESONATORS; CELL-ADHESION; HYDROXYAPATITE PARTICLES; VISCOELASTIC PROPERTIES	When biomaterials are implanted into an animal body, the body fluid proteins initially adsorb and then cells recognize these surfaces. Adherent cell functions respond differently to diverse biomaterial surfaces with different properties. Thus, an understanding of cellular responses to biomaterials is crucial for effective control of biomaterial - cell interactions. I have researched how to clarify interfacial phenomena via protein adsorption and subsequent cell adhesion to hydroxyapatite nanocrystals using a quartz crystal microbalance with a dissipation technique. In this review, I focused on the current understanding of enhanced biocompatibility by exploring the roles of protein mediation at the interface. The most promising nano-bio interfaces are explained, and different protein adsorption and cell adhesion processes are highlighted depending on their interfacial states. This approach will clarify several ambiguities of interfacial phenomena between biomaterials and cells and will help in the design of novel biomaterials that can be implanted.	[Tagaya, Motohiro] Nagaoka Univ Technol, Runner Incubat Ctr Acad Ind Fus, Nagaoka, Niigata 9402188, Japan; [Tagaya, Motohiro] Nagaoka Univ Technol, Dept Mat Sci & Technol, Grad Sch Engn, Nagaoka, Niigata 9402188, Japan	Tagaya, M (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	tagaya@mst.nagaokaut.ac.jp			MEXT/JSPS KAKENHI [26709052]; Izumi Science and Technology Foundation [H26-J-028]	This work was partially supported by a Grant-in-Aid for Young Scientists (A) (grant no. 26709052) from MEXT/JSPS KAKENHI and was also partially supported by Izumi Science and Technology Foundation (grant no. H26-J-028).	Aneslme K, 2000, BIOMATERIALS, V21, P667; Tagaya M, 2012, J MATER CHEM, V22, P18741, DOI 10.1039/c2jm34155g; Venegas-Sanchez JA, 2013, ULTRASON SONOCHEM, V20, P1081, DOI 10.1016/j.ultsonch.2013.01.002; Bannasch H, 2003, CLIN PLAST SURG, V30, P573, DOI 10.1016/S0094-1298(03)00075-0; Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006; Li F, 2008, SENSOR ACTUAT B-CHEM, V128, P399, DOI 10.1016/j.snb.2007.06.032; El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307; Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4; Tagaya M, 2011, LANGMUIR, V27, P7645, DOI 10.1021/la200621p; Fohlerova Z, 2007, BIOSENS BIOELECTRON, V22, P1896, DOI 10.1016/j.bios.2006.08.015; Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316; Yin G, 2002, CHEM ENG J, V87, P181, DOI 10.1016/S1385-8947(01)00248-0; Marx KA, 2005, ANAL BIOCHEM, V343, P23, DOI 10.1016/j.ab.2005.05.013; Mizushima Y, 2006, J CONTROL RELEASE, V110, P260, DOI 10.1016/j.jconrel.2005.09.051; Serro AP, 2004, J BIOMED MATER RES A, V70A, P420, DOI 10.1002/jbm.a.30096; McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H; Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l; Venegas-Sanchez JA, 2013, POLYM J, V45, P1224, DOI 10.1038/pj.2013.47; Holmberg M, 2009, LANGMUIR, V25, P2081, DOI 10.1021/la8031978; Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a; Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X; MURAMATSU H, 1988, ANAL CHEM, V60, P2142, DOI 10.1021/ac00170a032; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Rodahl M, 1996, ANAL CHEM, V68, P2219, DOI 10.1021/ac951203m; Kurrat R, 1997, J COLLOID INTERF SCI, V185, P1, DOI 10.1006/jcis.1996.4528; Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u; Okuda M, 2009, MICRON, V40, P665, DOI 10.1016/j.micron.2009.04.001; Rodahl M, 1996, REV SCI INSTRUM, V67, P3238, DOI 10.1063/1.1147494; Nudelman F, 2010, NAT MATER, V9, P1004, DOI [10.1038/nmat2875, 10.1038/NMAT2875]; Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501; Tagaya M, 2012, MATER EXPRESS, V2, P1, DOI 10.1166/mex.2012.1053; Hanagata N, 2007, J BIOMED MATER RES A, V83A, P362, DOI 10.1002/jbm.a.31240; GLIMCHER MJ, 1984, PHILOS T ROY SOC B, V304, P479, DOI 10.1098/rstb.1984.0041; Hemmersam AG, 2008, J COLLOID INTERF SCI, V320, P110, DOI 10.1016/j.jcis.2007.11.047; LUNDSTROM I, 1990, J COLLOID INTERF SCI, V136, P68, DOI 10.1016/0021-9797(90)90079-4; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Zhou T, 2000, BIOTECHNOL PROGR, V16, P268, DOI 10.1021/bp000003f; Paul W, 2003, J BIOMATER APPL, V17, P253, DOI 10.1177/088532803030571; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; [Anonymous], 1995, ACS SYM SER; RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396; Tagaya M, 2014, INORG CHEM, V53, P6817, DOI 10.1021/ic500609g; Kandori K, 2004, J COLLOID INTERF SCI, V273, P406, DOI 10.1016/j.jcis.2004.01.069; Rodahl M, 1996, SENSOR ACTUAT A-PHYS, V54, P448, DOI 10.1016/S0924-4247(97)80002-7; Okuda M, 2011, MICROSC MICROANAL, V17, P788, DOI 10.1017/S1431927611011949; Kim HW, 2005, J BIOMED MATER RES B, V74B, P686, DOI 10.1002/jbm.b.30236; Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1; Tagaya M, 2013, MICRON, V46, P22, DOI 10.1016/j.micron.2012.11.009; HAYNES CA, 1995, J COLLOID INTERF SCI, V169, P313, DOI 10.1006/jcis.1995.1039; AOKI H, 1987, MED PROG TECHNOL, V12, P213; Modin C, 2006, BIOMATERIALS, V27, P1346, DOI 10.1016/j.biomaterials.2005.09.022; Ikoma T, 2009, J AM CERAM SOC, V92, P1125, DOI 10.1111/j.1551-2916.2009.02957.x; Liao SS, 2004, TISSUE ENG, V10, P73, DOI 10.1089/107632704322791718; Monkawa A, 2006, BIOMATERIALS, V27, P5748, DOI 10.1016/j.biomaterials.2006.07.029; Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182; LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003; SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Tagaya M, 2012, ACS APPL MATER INTER, V4, P6169, DOI 10.1021/am301789v; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Tagaya M, 2012, IND ENG CHEM RES, V51, P11294, DOI 10.1021/ie301755z; Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001; Ozeki T, 2007, ANAL CHEM, V79, P79, DOI 10.1021/ac060873x; Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3; KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0; Tagaya M, 2011, LANGMUIR, V27, P7635, DOI 10.1021/la200008z; Wegener J, 2000, BIOPHYS J, V78, P2821; Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7; Yunoki S, 2006, MATER LETT, V60, P999, DOI 10.1016/j.matlet.2005.10.064; VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5; Lubarsky GV, 2007, BIOSENS BIOELECTRON, V22, P1275, DOI 10.1016/j.bios.2006.05.024; BEISSINGER RL, 1981, T AM SOC ART INT ORG, V27, P225; BERTHETCOLOMINAS C, 1979, J MOL BIOL, V134, P431, DOI 10.1016/0022-2836(79)90362-0; Cans S., 2001, ANAL CHEM, V73, P5805; Cho Nam-Joon, 2007, Anal Chem, V79, P7027, DOI 10.1021/ac0709504; Choi KH, 2002, APPL PHYS LETT, V81, P1335, DOI 10.1063/1.1500777; DEJARDIN P, 1995, LANGMUIR, V11, P4001, DOI 10.1021/la00010a061; Dolatshahi-Pirouz A, 2009, LANGMUIR, V25, P2971, DOI 10.1021/la803142u; Fernandez P, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/419; Fredriksson C, 1998, J MATER SCI-MATER M, V9, P785, DOI 10.1023/A:1008927624337; Furuzono F, 2009, J BIOMED MATER RES B, V89B, P77; Grainger DW, 2003, J BIOMAT SCI-POLYM E, V14, P973, DOI 10.1163/156856203322381456; Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4; HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11; Hanagata N, 2006, BIOCHEM BIOPH RES CO, V344, P1234, DOI 10.1016/j.bbrc.2006.04.021; Hemmersam AG, 2005, COLLOID SURFACE B, V43, P208, DOI 10.1016/j.colsurfb.2005.04.007; Holmberg M, 2008, J MATER SCI-MATER M, V19, P2179, DOI 10.1007/s10856-007-3318-9; HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174; Ikoma T, 2007, J NANOSCI NANOTECHNO, V7, P822, DOI 10.1166/jnn.2007.523; Janshoff A, 1996, EUR BIOPHYS J BIOPHY, V25, P93, DOI 10.1007/s002490050021; KATZ EP, 1973, J MOL BIOL, V80, P1, DOI 10.1016/0022-2836(73)90230-1; KEFALIDE.NA, 1969, BIOCHEMISTRY-US, V8, P4613, DOI 10.1021/bi00839a057; KEFALIDE.NA, 1966, BIOCHEMISTRY-US, V5, P702, DOI 10.1021/bi00866a043; Keselowsky G., 2003, J BIOMEDICAL MAT RES, V66A, P247; Le Guillou-Buffello D, 2008, TISSUE ENG PT A, V14, P1445, DOI 10.1089/ten.tea.2007.0292; Letic-Gavrilovic L, 2003, J MATER SCI-MATER M, V14, P95; Lord MS, 2008, BIOMATERIALS, V29, P2581, DOI 10.1016/j.biomaterials.2008.03.002; LUTANIE E, 1992, P NATL ACAD SCI USA, V89, P9890, DOI 10.1073/pnas.89.20.9890; Marx A., 2003, BIOTECHNOL PROGR, V19, P987; Marx A., 2001, BIOSENS BIOELECTRON, V16, P773; Marxer CM, 2003, ANAL BIOANAL CHEM, V377, P578, DOI 10.1007/s00216-003-2080-1; Moseke C, 2009, MATERIALWISS WERKST, V40, P36, DOI 10.1002/mawe.200800414; NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4; Rouahi M, 2006, COLLOID SURFACE B, V47, P10, DOI 10.1016/j.colsurfb.2005.11.015; SPIRO RG, 1967, J BIOL CHEM, V242, P1915; Steele JG, 1992, J BIOMED MATER RES, V26, P681; Tagaya M, 2013, KOBUNSHI RONBUNSHU, V70, P398; Tagaya M., 2011, SCI TECHNOL ADV MAT, V12; Tagaya M., 2012, HDB ADV CERAMICS MAT, V7.2, P557; Tagaya M., 2011, BIOCERAM DEV APPL, V1; Tagaya M., 2011, IOP C SER MAT SCI EN, V18; Tagaya M., 2011, BIOCERAM DEV APPL, V1; Tovar-Carrillo K. L., 2013, J MAT SCI CHEM ENG, V1, P1; Tovar-Carrillo KL, 2014, MAT SCI ENG C-MATER, V42, P808, DOI 10.1016/j.msec.2014.06.023; Tovar-Carrillo KL, 2013, IND ENG CHEM RES, V52, P11607, DOI 10.1021/ie401793w; Tovar-Carrillo KL, 2014, IND ENG CHEM RES, V53, P4650, DOI 10.1021/ie403257a; Venegas-Sánchez Josué Addiel, 2014, Ultrason Sonochem, V21, P295, DOI 10.1016/j.ultsonch.2013.06.011; Wei T, 2009, J PHYS CHEM C, V113, P2053, DOI 10.1021/jp806586n; Yamada R, 2014, J BIOSCI BIOENG, V118, P315, DOI 10.1016/j.jbiosc.2014.02.009; Yongli C, 1999, J COLLOID INTERF SCI, V214, P38, DOI DOI 10.1006/JCIS.1999.6159	121	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	SEP	2015	47	9					599	608		10.1038/pj.2015.43		10	Polymer Science	Polymer Science	CQ9ZM	WOS:000360976700002		
J	Imoto, H; Nakao, Y; Nishizawa, N; Fujii, S; Nakamura, Y; Naka, K				Imoto, Hiroaki; Nakao, Yuka; Nishizawa, Nobuyuki; Fujii, Syuji; Nakamura, Yoshinobu; Naka, Kensuke			Tripodal polyhedral oligomeric silsesquioxanes as a novel class of three-dimensional emulsifiers	POLYMER JOURNAL			English	Article							TRANSPARENT THERMOPLASTIC FILMS; THIOL-ENE PHOTOPOLYMERIZATION; DECKER-SHAPED SILSESQUIOXANE; BLOCK-COPOLYMER FILMS; OCTA-SUBSTITUTED POSS; SIDE-CHAIN; MAIN-CHAIN; HYDROXYAPATITE NANOPARTICLES; PARTICULATE EMULSIFIERS; RADICAL POLYMERIZATION	Tripodal amphiphilic molecules toward organic-inorganic hybrid emulsions were successfully synthesized based on incompletely condensed polyhedral oligomeric silsesquioxanes (POSSs). The three silanol groups provide an excellent scaffold for the construction of three-dimensional amphiphilic molecules, thus well-defined tripodal amphiphilic POSS derivatives were readily synthesized. Thermal analyses revealed that an incompletely condensed POSS exhibited lower crystallinity without loss of thermal stability in comparison with a completely condensed POSS, whereas readily forms aggregates because of its high crystallinity. The newly synthesized tripodal amphiphilic POSSs possessed good solubility in water and effectively stabilized oil-in-water emulsions, while a conventional mono-substituted amphiphilic POSS did not work as an emulsifier because of its lack of water solubility. The prepared organic-inorganic hybrid emulsions were stable against coalescence, and no demulsification occurred over 1 month.	[Imoto, Hiroaki; Nakao, Yuka; Naka, Kensuke] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Chem & Mat Technol, Kyoto 6068585, Japan; [Nishizawa, Nobuyuki; Fujii, Syuji; Nakamura, Yoshinobu] Osaka Inst Technol, Fac Engn, Dept Appl Chem, Osaka 535, Japan	Naka, K (reprint author), Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Chem & Mat Technol, Sakyo Ku, Goshokaido Cho, Kyoto 6068585, Japan.	kenaka@kit.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [2401, 24102003]	This study is part of a Grant-in-Aid for Scientific Research on Innovative Areas 'New Polymeric Materials Based on Element-Blocks (no. 2401)' (no. 24102003) of The Ministry of Education, Culture, Sports, Science and Technology of Japan.	Itami K, 2002, J ORG CHEM, V67, P2645, DOI 10.1021/jo0163389; Fina A, 2010, J MATER CHEM, V20, P9297, DOI 10.1039/c0jm00480d; Tamaki R, 2003, CHEM MATER, V15, P793, DOI 10.1021/cm020797o; Tanaka K, 2009, MACROMOLECULES, V42, P3489, DOI 10.1021/ma900113j; Sun D, 2014, ACS APPL MATER INTER, V6, P18635, DOI 10.1021/am503633t; Aveyard R, 2003, ADV COLLOID INTERFAC, V100, P503, DOI 10.1016/S0001-8686(02)00069-6; SPEIER JL, 1957, J AM CHEM SOC, V79, P974, DOI 10.1021/ja01561a054; Wang DY, 2005, SOFT MATTER, V1, P412, DOI 10.1039/b511911a; Ishida Y, 2011, J POLYM SCI POL CHEM, V49, P2653, DOI 10.1002/pola.24697; Araki H, 2011, MACROMOLECULES, V44, P6039, DOI 10.1021/ma2008095; Tanaka K, 2011, B CHEM SOC JPN, V84, P612, DOI 10.1246/bcsj.20110032; Franczyk A, 2014, ACS MACRO LETT, V3, P799, DOI 10.1021/mz5003799; Hirai T, 2008, MACROMOLECULES, V41, P4558, DOI 10.1021/ma800872v; Wu S, 2007, MACROMOLECULES, V40, P5698, DOI 10.1021/ma070547z; Lin Y, 2003, SCIENCE, V299, P226, DOI 10.1126/science.1078616; Tanaka K, 2012, J MATER CHEM, V22, P1733, DOI 10.1039/c1jm14231c; Takahara YK, 2005, J AM CHEM SOC, V127, P6271, DOI 10.1021/ja043581r; Yue K, 2012, MACROMOLECULES, V45, P8126, DOI 10.1021/ma3013256; USUKI A, 1993, J MATER RES, V8, P1179, DOI 10.1557/JMR.1993.1179; Ramsden W, 1903, P R SOC LONDON, V72, P156, DOI 10.1098/rspl.1903.0034; Wu S, 2008, MACROMOLECULES, V41, P3481, DOI 10.1021/ma7027227; Cordes DB, 2010, CHEM REV, V110, P2081, DOI 10.1021/cr900201r; Tamaki R, 2001, J AM CHEM SOC, V123, P12416, DOI 10.1021/ja011781m; Tanaka K, 2009, J POLYM SCI POL CHEM, V47, P5690, DOI 10.1002/pola.23612; Kageyama K, 1999, SCIENCE, V285, P2113, DOI 10.1126/science.285.5436.2113; Kuo SW, 2011, PROG POLYM SCI, V36, P1649, DOI 10.1016/j.progpolymsci.2011.05.002; Liu H, 2014, J AM CHEM SOC, V136, P10691, DOI 10.1021/ja504497h; Hoque MA, 2009, MACROMOLECULES, V42, P3309, DOI 10.1021/ma900124x; Pickering SU, 1907, J CHEM SOC, V91, P2001, DOI 10.1039/ct9079102001; Li YW, 2012, ACS MACRO LETT, V1, P834, DOI 10.1021/mz300196x; Laine RM, 2005, J MATER CHEM, V15, P3725, DOI 10.1039/b506815k; Zhang WB, 2014, MACROMOLECULES, V47, P1221, DOI 10.1021/ma401724p; Asuncion MZ, 2007, MACROMOLECULES, V40, P555, DOI 10.1021/ma062305p; Bian Y, 2009, POLYMER, V50, P1541, DOI 10.1016/j.polymer.2009.01.036; Binks B.P., 2006, COLLOIDAL PARTICLES; Blanco I, 2014, POLYM COMPOSITE, V35, P151, DOI 10.1002/pc.22644; Di Iulio C, 2010, INORG CHEM, V49, P10232, DOI 10.1021/ic101809r; Feng X., 2014, LANGMUIR, V3, P900; Fujii S, 2013, LANGMUIR, V29, P5457, DOI 10.1021/la400697a; Fujii S, 2009, LANGMUIR, V25, P9759, DOI 10.1021/la901100z; Fujii S, 2007, J COLLOID INTERF SCI, V315, P287, DOI 10.1016/j.jcis.2007.06.071; Hayakawa T, 2006, POLYM J, V38, P567, DOI 10.1295/polymj.PJ20051401; Hirai T, 2009, MACROMOLECULES, V42, P8835, DOI 10.1021/ma9018944; Ionescu G, 2005, TETRAHEDRON-ASYMMETR, V16, P3970, DOI 10.1016/j.tetasy.2005.10.033; Jeon JH, 2013, J POLYM SCI POL CHEM, V51, P3583, DOI 10.1002/pola.26757; JOUSSEAUME B, 1995, ORGANOMETALLICS, V14, P685, DOI 10.1021/om00002a016; Liu DD, 2013, LANGMUIR, V29, P5307, DOI 10.1021/la400098c; Liu DD, 2014, LANGMUIR, V30, P7213, DOI 10.1021/la501531g; Lu CH, 2011, J COLLOID INTERF SCI, V358, P93, DOI 10.1016/j.jcis.2011.03.003; Maegawa T, 2014, CHEM LETT, V43, P1532, DOI 10.1246/cl.140515; Miyasaka M, 2010, POLYM J, V42, P799, DOI 10.1038/pj.2010.79; Moore WC, 1919, J AM CHEM SOC, V41, P940, DOI 10.1021/ja02227a004; Naka K, 1999, CHEM MATER, V11, P849, DOI 10.1021/cm980661j; Ogi K, 2015, POLYM J, V47, P259; Pramoda KP, 2014, POLYM COMPOSITE, V35, P118, DOI 10.1002/pc.22641; Tanaka K, 2010, J POLYM SCI POL CHEM, V48, P5712, DOI 10.1002/pola.24370; Wu JC, 2014, RSC ADV, V4, P44030, DOI 10.1039/c4ra04886e; Yamahiro M., 2004, PCT Int. Appl., Patent No. [WO 2004026883: A1, 2004026883]; Zhou JL, 2011, NEW J CHEM, V35, P2781, DOI 10.1039/c1nj20577c	59	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	SEP	2015	47	9					609	615		10.1038/pj.2015.38		7	Polymer Science	Polymer Science	CQ9ZM	WOS:000360976700003		
J	Nakabayashi, K; Otani, H; Mori, H				Nakabayashi, Kazuhiro; Otani, Hiroshi; Mori, Hideharu			Benzodithiophene-based low band-gap polymers with deep HOMO levels: synthesis, characterization, and photovoltaic performance	POLYMER JOURNAL			English	Article							ORGANIC SOLAR-CELLS; POWER CONVERSION EFFICIENCY; OPEN-CIRCUIT VOLTAGE; CONJUGATED POLYMERS; SIDE-CHAIN; COPOLYMERS	A series of benzo[1,2-b:4,5-b'] dithiophene-based low band-gap polymers were synthesized using Stille coupling reactions. The polymers with electron-withdrawing side chains (P1, P2, P4 and P5) exhibited wide absorption due to the bathochromic effect derived from the electron-withdrawing side chains compared with P3 and P6, which possessed hexyl side chains. Furthermore, as donor materials, P1, P2, P4 and P5 exhibited deep HOMO levels (-5.53 to -5.65 eV) due to the incorporation of electron-withdrawing side chains. An organic photovoltaic (OPV) device with a P1/[6,6]-phenyl-C-61-butyric acid methyl ester (PC61BM) active layer achieved a power conversion efficiency (PCE) of 2.68% with an open-circuit voltage (V-oc) of 0.71 V, a short-circuit current density (J(sc)) of 10.64 mA cm(-2) and a fill factor (FF) of 0.35. By contrast, the OPV device with the P3/PC61BM active layer exhibited a PCE of 0.86% with a V-oc of 0.59 V, J(sc) of 4.93 mA cm(-2) and FF of 0.30. This comparison demonstrates that the deep HOMO level derived from the incorporation of the electron-withdrawing side chains contributed to the larger Voc and higher PCE values for P1 than those of P3.	[Nakabayashi, Kazuhiro; Otani, Hiroshi; Mori, Hideharu] Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, Yonezawa, Yamagata 9928510, Japan	Nakabayashi, K (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	nakabayashi.k@yz.yamagata-u.ac.jp					Huo LJ, 2011, ANGEW CHEM INT EDIT, V50, P9697, DOI 10.1002/anie.201103313; Hou JH, 2008, J AM CHEM SOC, V130, P16144, DOI 10.1021/ja806687u; Nakabayashi K, 2013, CHEM LETT, V42, P717, DOI 10.1246/cl.130201; He YJ, 2010, J POLYM SCI POL CHEM, V48, P1822, DOI 10.1002/pola.23952; Khlyabich PP, 2014, J POLYM SCI POL CHEM, V52, P1055, DOI 10.1002/pola.27095; Zou YP, 2010, J AM CHEM SOC, V132, P5330, DOI 10.1021/ja101888b; Tan L, 2002, MACROMOLECULES, V35, P4628, DOI 10.1021/ma012183v; Sun YM, 2012, NAT MATER, V11, P44, DOI [10.1038/nmat3160, 10.1038/NMAT3160]; Liang YY, 2009, J AM CHEM SOC, V131, P7792, DOI 10.1021/ja901545q; Zhan XW, 2011, ADV MATER, V23, P268, DOI 10.1002/adma.201001402; He ZC, 2012, NAT PHOTONICS, V6, P591, DOI 10.1038/NPHOTON.2012.190; Zhang MJ, 2013, ADV MATER, V25, P4944, DOI 10.1002/adma.201301494; Nakabayashi K, 2012, MACROMOLECULES, V45, P9618, DOI 10.1021/ma302170e; Zhang Y, 2010, CHEM MATER, V22, P2696, DOI 10.1021/cm100417z; Chen HY, 2009, NAT PHOTONICS, V3, P649, DOI 10.1038/NPHOTON.2009.192; Muhlbacher D, 2006, ADV MATER, V18, P2884, DOI 10.1002/adma.200600160; Ma ZF, 2012, J MATER CHEM, V22, P2306, DOI 10.1039/c1jm14940g; Chung HS, 2014, MACROMOLECULES, V47, P97, DOI 10.1021/ma402245t; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Son HJ, 2011, J AM CHEM SOC, V133, P1885, DOI 10.1021/ja108601g; Wienk MM, 2008, ADV MATER, V20, P2556, DOI 10.1002/adma.200800456; Peet J, 2007, NAT MATER, V6, P497, DOI 10.1038/nmat1928; Zhou HX, 2012, MACROMOLECULES, V45, P607, DOI 10.1021/ma201648t; Paoprasert P, 2010, J MATER CHEM, V20, P2651, DOI 10.1039/b920233a; Liang YY, 2010, ADV MATER, V22, pE135, DOI 10.1002/adma.200903528; Hsu SL, 2011, J POLYM SCI POL CHEM, V49, P603, DOI 10.1002/pola.24465; Cho MJ, 2012, POLYMER, V53, P3835, DOI 10.1016/j.polymer.2012.07.007; Dennler G., 2009, ADV MATER, V21, P323; Harada K., 2010, Japanese patent, Patent No. [2010-057917, 2010057917]; Lee J. K., 2008, J AM CHEM SOC, V130, P3618; Nie YJ, 2011, J POLYM SCI POL CHEM, V49, P3604, DOI 10.1002/pola.24799; Thompson BC, 2008, ANGEW CHEM INT EDIT, V47, P58, DOI 10.1002/anie.200702506	32	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	SEP	2015	47	9					617	623		10.1038/pj.2015.41		7	Polymer Science	Polymer Science	CQ9ZM	WOS:000360976700004		
J	Ikai, T; Takagi, Y; Shinohara, K; Maeda, K; Kanoh, S				Ikai, Tomoyuki; Takagi, Yugaku; Shinohara, Ken-ichi; Maeda, Katsuhiro; Kanoh, Shigeyoshi			Synthesis of polyisocyanides bearing oligothiophene pendants: higher-order structural control through pendant framework design	POLYMER JOURNAL			English	Article							HELICAL POLYMERS; NANOSCALE ARCHITECTURE; ARRAYS; CONFORMATION; FOLDAMERS; TRANSPORT	L-Alanine-based polyisocyanides bearing oligothiophene (OT) pendants (poly-3a and poly-3b) were synthesized and the influence of the OT pendants on the chiroptical properties and helix-forming abilities of the polymers was investigated. Poly-3a bearing a quinquethiophene unit with two n-hexyl chains successfully formed a preferred-handed helical conformation by simultaneous interactions of the OT-pendant pi-pi stacking and hydrogen bonding of the amide groups. In contrast, poly-3b, which possesses a branched alkyl chain on behalf of the terminal n-hexyl chain of poly-3a, did not form a higher-ordered helical conformation. The results suggest that the structure of the alkyl chains positioned far from the polymer backbones remotely and sensitively affected the ability of the polymer to form a helical conformation. We also found that the structure of the OT pendants significantly affect the molecular weight as observed by AFM measurements. The polyisocyanide poly-3c bearing a bithiophene unit was additionally synthesized to examine the influence of the number of thiophene rings within the OT pendants on the higher-order structure formation.	[Ikai, Tomoyuki; Takagi, Yugaku; Maeda, Katsuhiro; Kanoh, Shigeyoshi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Shinohara, Ken-ichi] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Japan	Ikai, T (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	ikai@se.kanazawa-u.ac.jp	Shinohara, Ken-ichi/E-9142-2011		Kurata Memorial Hitachi Science and Technology Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI [26410129]	This work was supported by the Kurata Memorial Hitachi Science and Technology Foundation and the Japan Society for the Promotion of Science (JSPS) KAKENHI Grants-in-Aid for Scientific Research (C), Grant No. 26410129.	Rudick JG, 2008, ACCOUNTS CHEM RES, V41, P1641, DOI 10.1021/ar800086w; Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427; Finlayson CE, 2008, ADV FUNCT MATER, V18, P3947, DOI 10.1002/adfm.200800943; Cornelissen JJLM, 2001, SCIENCE, V293, P676, DOI 10.1126/science.1062224; Fujiki M, 2001, MACROMOL RAPID COMM, V22, P539, DOI 10.1002/1521-3927(20010501)22:8<539::AID-MARC539>3.0.CO;2-K; Nakano T, 2001, CHEM REV, V101, P4013, DOI 10.1021/cr0000978; Cornelissen JJLM, 2001, CHEM REV, V101, P4039, DOI 10.1021/cr990126i; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Schwartz E, 2013, CHEM-EUR J, V19, P13168, DOI 10.1002/chem.201300073; Schwartz E, 2011, POLYM CHEM-UK, V2, P33, DOI 10.1039/c0py00246a; Schwartz E, 2010, CHEM MATER, V22, P2597, DOI 10.1021/cm903664g; Foster S, 2009, MACROMOLECULES, V42, P2023, DOI 10.1021/ma801959w; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Zhang L, 2014, ACS APPL MATER INTER, V6, P5327, DOI 10.1021/am4060468; Palermo V, 2008, J AM CHEM SOC, V130, P14605, DOI 10.1021/ja804069n; NOLTE RJM, 1994, CHEM SOC REV, V23, P11, DOI 10.1039/cs9942300011; Takagi K, 2013, POLYM J, V45, P1171, DOI 10.1038/pj.2013.52; Mishra A, 2009, CHEM REV, V109, P1141, DOI 10.1021/cr8004229; Cornelissen JJLM, 2003, J POLYM SCI POL CHEM, V41, P1725, DOI 10.1002/pola.10713; Cornelissen JJLM, 2001, J POLYM SCI POL CHEM, V39, P4255, DOI 10.1002/pola.10083; Dabirian R, 2009, J AM CHEM SOC, V131, P7055, DOI 10.1021/ja809731e; de Witte PAJ, 2006, J PHYS CHEM B, V110, P7803, DOI 10.1021/jp057009d; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; Gowda CM, 2012, MACROMOLECULES, V45, P2209, DOI 10.1021/ma300102e; Green M. M., 1999, Angewandte Chemie (International Edition), V38, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3138::AID-ANIE3138>3.0.CO;2-C; Morisaki Y, 2015, POLYM J, V47, P278; Shinohara K, 2014, Dynamic analysis method for polymer chain, manufacturing method for polymer, polymer, manufacturing method for synthetic polymer, and synthetic polymer, Patent No. [WO/2014/104172, 2014104172]; Shinohara KI, 2010, J POLYM SCI POL CHEM, V48, P4103, DOI 10.1002/pola.24201; Shinohara KI, 2006, J POLYM SCI POL CHEM, V44, P801, DOI 10.1002/pola.21175	29	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	SEP	2015	47	9					625	630		10.1038/pj.2015.42		6	Polymer Science	Polymer Science	CQ9ZM	WOS:000360976700005		
J	Shima, F; Akagi, T; Shudo, M; Mochizuki, E; Tsuda, T; Kuwabata, S; Akashi, M				Shima, Fumiaki; Akagi, Takami; Shudo, Manami; Mochizuki, Eiko; Tsuda, Tetsuya; Kuwabata, Susumu; Akashi, Mitsuru			Interaction between living cells and polymeric particles: potential application of ionic liquid for evaluating the cellular uptake of biodegradable polymeric particles composed of poly(amino acid)	POLYMER JOURNAL			English	Article							SCANNING-ELECTRON-MICROSCOPE; POLY(GAMMA-GLUTAMIC ACID); DENDRITIC CELLS; NANOPARTICLES; PHAGOCYTOSIS; ADJUVANTS; DELIVERY; VACCINES; SEM	The cellular uptake of biodegradable particles as drug or vaccine carriers was observed by scanning electron microscopy employing an ionic liquid. The samples were observed by simply dipping them into the ionic liquid, and high-resolution images (sub-nanometer order) were achieved. The cellular uptake of polymeric nanoparticles (NPs) composed of biodegradable amphiphilic polymers was observed using an ionic liquid method for the first time. In particular, these NPs were observed when the quantum dots were immobilized on the NPs. In addition, when the cells were incubated with microparticles (MPs), the filopodia that covered the MPs were observed, and the cellular uptake of the MPs was evaluated in a time-dependent manner. This ionic liquid method is a promising technique for evaluating the cellular uptake behavior of drug or vaccine carriers. This method also provides a strategy for observing carriers that are sensitive to conventional pretreatment conditions by choosing a suitable ionic liquid.	[Shima, Fumiaki; Akagi, Takami; Shudo, Manami; Mochizuki, Eiko; Tsuda, Tetsuya; Kuwabata, Susumu; Akashi, Mitsuru] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Akashi, M (reprint author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamada Oka, Suita, Osaka 5650871, Japan.	akashi@fbs.osaka-u.ac.jp			Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology [23225004]	This work was supported by Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST) and partially supported by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science, and Technology (23225004).	Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Akagi T, 2012, LANGMUIR, V28, P5249, DOI 10.1021/la205093j; Arimoto S, 2008, ELECTROCHIM ACTA, V53, P6228, DOI 10.1016/j.electacta.2008.01.001; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Bogner A, 2005, ULTRAMICROSCOPY, V104, P290, DOI 10.1016/j.ultramic.2005.05.005; Ishigaki Y, 2011, MICROSC RES TECHNIQ, V74, P415, DOI 10.1002/jemt.20924; Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005; Uto T, 2009, IMMUNOL LETT, V125, P46, DOI 10.1016/j.imlet.2009.05.008; Tsuda T, 2011, CHEMBIOCHEM, V12, P2547, DOI 10.1002/cbic.201100476; O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176; Thiberge S, 2004, P NATL ACAD SCI USA, V101, P3346, DOI 10.1073/pnas.0400088101; Rice-Ficht AC, 2010, CURR OPIN MICROBIOL, V13, P106, DOI 10.1016/j.mib.2009.12.001; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Hagiwara R, 2000, J FLUORINE CHEM, V105, P221, DOI 10.1016/S0022-1139(99)00267-5; Shima F, 2013, ACTA BIOMATER, V9, P8894, DOI 10.1016/j.actbio.2013.06.010; Kim H, 2009, MACROMOL BIOSCI, V9, P842, DOI 10.1002/mabi.200800367; Kuwabata S, 2006, CHEM LETT, V35, P600, DOI 10.1246/cl.2006.600; Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI [10.1586/erv.10.89, 10.1586/ERV.10.89]; Diwan Manish, 2003, J Drug Target, V11, P495; DIXON AE, 1991, NATURE, V351, P551, DOI 10.1038/351551a0; Matsusaki M, 2004, CHEM LETT, V33, P398, DOI 10.1246/cl.2004.398; Shima F., 2014, BIOMATERIALS, V34, P9709; Shima F, 2013, B CHEM SOC JPN, V86, P153, DOI 10.1246/bcsj.20120227; Shima F, 2014, J BIOMAT SCI-POLYM E, V25, P203, DOI 10.1080/09205063.2013.848328; Thiberge S, 2004, REV SCI INSTRUM, V75, P2280, DOI 10.1063/1.1763262; WALTERS MNI, 1976, J PATHOL, V118, P221, DOI 10.1002/path.1711180404; WILKES JS, 1992, J CHEM SOC CHEM COMM, P965, DOI 10.1039/c39920000965	28	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	SEP	2015	47	9					631	638		10.1038/pj.2015.40		8	Polymer Science	Polymer Science	CQ9ZM	WOS:000360976700006		
J	Lee, CH; Takagi, H; Okamoto, H; Kato, M				Lee, Chi-Han; Takagi, Hideki; Okamoto, Hirotaka; Kato, Makoto			Preparation and mechanical properties of a copolycarbonate composed of bio-based isosorbide and bisphenol A	POLYMER JOURNAL			English	Article							PHASE-TRANSFER CATALYSIS; DICARBOXYLIC-ACID UNITS; RENEWABLE RESOURCES; CARBONIC-ACID; EFFICIENT SYNTHESIS; POLYMERS; POLYURETHANES; POLYESTERS; POLYCARBONATES; DIOLS	A series of copolycarbonates were prepared by transesterification polymerization of isosorbide, bisphenol A and diphenylcarbonate using several catalysts. The copolymers with the highest molecular weights were obtained using N,N-dimethylaminopyridine as a catalyst. The storage moduli of the polymers ranged from 2.3 to 3.5 GPa at 25 degrees C, and the tensile moduli were 1.7-2.6 GPa, increasing with the isosorbide content. The storage and tensile moduli of the polymers indicated that they could exhibit better strength than bisphenol A-based polycarbonates. These properties endow the polymers with potential for use as high-performance materials.	[Lee, Chi-Han; Takagi, Hideki; Okamoto, Hirotaka; Kato, Makoto] Toyota Cent Res & Dev Labs Inc, Toyota, Aichi, Japan	Lee, CH (reprint author), Toyota Boshoku Corp, Res Labs, 1-1 Toyoda Cho, Kariya, Aichi 4488651, Japan.	chihan.lee@toyota-boshoku.com					Chatti S, 2002, EUR POLYM J, V38, P1851, DOI 10.1016/S0014-3057(02)00071-X; Chatti S, 2003, J APPL POLYM SCI, V90, P1255, DOI 10.1002/app.12719; STORBECK R, 1993, MAKROMOL CHEM, V194, P53; Yoon WJ, 2013, MACROMOLECULES, V46, P7219, DOI 10.1021/ma4015092; Kricheldorf HR, 1996, MACROMOLECULES, V29, P8077, DOI 10.1021/ma960494d; Okada M, 1996, J APPL POLYM SCI, V62, P2257; Marin R, 2012, J APPL POLYM SCI, V123, P986, DOI 10.1002/app.34545; Okada M, 2000, J APPL POLYM SCI, V77, P338; THIEM J, 1991, MAKROMOL CHEM, V192, P2163; Bachmann F, 1998, MACROMOL RAPID COMM, V19, P21, DOI 10.1002/marc.1998.030190106; THIEM J, 1984, POLYM BULL, V11, P365; COGNETGEORJON E, 1995, MACROMOL CHEM PHYSIC, V196, P3733, DOI 10.1002/macp.1995.021961125; Bachmann F, 2001, MACROMOL CHEM PHYSIC, V202, P3410, DOI 10.1002/1521-3935(20011101)202:17<3410::AID-MACP3410>3.0.CO;2-Q; Lin Q, 2003, J POLYM SCI POL CHEM, V41, P2512, DOI 10.1002/pola.10787; Kricheldorf HR, 2003, MACROMOL RAPID COMM, V24, P359, DOI 10.1002/marc.200390063; THIEM J, 1984, STARKE, V36, P170, DOI 10.1002/star.19840360506; Chatti S, 2006, J POLYM SCI POL CHEM, V44, P3616, DOI 10.1002/pola.21444; Chatti S, 2006, MACROMOLECULES, V39, P9064, DOI 10.1021/ma0606051; Kumar S, 2005, TETRAHEDRON, V61, P4141, DOI 10.1016/j.tet.2005.02.010; Lee CH, 2009, J POLYM SCI POL CHEM, V47, P6025, DOI 10.1002/pola.23645; Lee CH, 2013, J APPL POLYM SCI, V127, P530, DOI 10.1002/app.37838; THIEM J, 1986, MAKROMOL CHEM, V187, P2775; Jasinska L, 2010, J POLYM SCI POL CHEM, V48, P5907, DOI 10.1002/pola.24402; Beldi M, 2007, EUR POLYM J, V43, P3415, DOI 10.1016/j.eurpolymj.2007.06.003; BRAUN D, 1992, J PRAK CHEM-CHEM ZTG, V334, P298, DOI 10.1002/prac.19923340403; Casarano R, 2009, J BRAZIL CHEM SOC, V20, P1414, DOI 10.1590/S0103-50532009000800005; Chatti S, 2000, TETRAHEDRON, V56, P5877, DOI 10.1016/S0040-4020(00)00539-1; Hsu JP, 2006, IND ENG CHEM RES, V45, P2672, DOI 10.1021/ie050726+; Kricheldorf HR, 2003, J POLYM SCI POL CHEM, V41, P3414, DOI 10.1002/pola.10933; Kricheldorf HR, 1997, J POLYM SCI POL CHEM, V35, P1611, DOI 10.1002/(SICI)1099-0518(19970715)35:9<1611::AID-POLA2>3.0.CO;2-U; Loupy A, 1996, TETRAHEDRON LETT, V37, P7023, DOI 10.1016/0040-4039(96)01539-0; Medem H., 1985, US patent, Patent No. [4,506,066, 4506066]; Okada M, 1999, J APPL POLYM SCI, V74, P3342; Sheldon R. A., 1993, CHIROTECHNOLOGY IND, P145; Sun SJ, 1999, J POLYM SCI POL CHEM, V37, P1125, DOI 10.1002/(SICI)1099-0518(19990415)37:8<1125::AID-POLA9>3.0.CO;2-J; Tan LC, 2011, J APPL POLYM SCI, V121, P2291, DOI 10.1002/app.33935; Varkey EC, 2010, J MATER SCI, V45, P1912, DOI 10.1007/s10853-009-4177-1; Vogler M, 2004, SYNTHESIS-STUTTGART, P1211, DOI 10.1055/s-2004-822356; Yokoe M, 2005, J POLYM SCI POL CHEM, V43, P3909, DOI 10.1002/pola.20830	39	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	SEP	2015	47	9					639	643		10.1038/pj.2015.39		5	Polymer Science	Polymer Science	CQ9ZM	WOS:000360976700007		
J	Kataoka, T; Abe, T; Ikehara, T				Kataoka, Toshiyuki; Abe, Toshitaka; Ikehara, Takayuki			Crystalline layered morphology in the phase-separated blend of poly(butylene succinate) and poly(ethylene succinate)	POLYMER JOURNAL			English	Article							2 ALIPHATIC POLYESTERS; POLYMER BLENDS; BIODEGRADABLE BLENDS; SPHERULITIC GROWTH; CRYSTALLINE/CRYSTALLINE BLENDS; MISCIBILITY; BEHAVIOR; OXIDE); 3-HYDROXYBUTYRATE-CO-HYDROXYVALERATE; POLY(EPSILON-CAPROLACTONE)		[Kataoka, Toshiyuki; Abe, Toshitaka; Ikehara, Takayuki] Kanagawa Univ, Fac Engn, Dept Mat & Life Chem, Yokohama, Kanagawa 2218686, Japan	Kataoka, T (reprint author), Kanagawa Univ, Fac Engn, Dept Mat & Life Chem, Kanagawa Ku, 3-27-1 Rokkakubashi, Yokohama, Kanagawa 2218686, Japan.	tkataoka@kanagawa-u.ac.jp			Japan Society for the Promotion of Science [26410228]; MEXT (Ministry of Education, Culture, Sports, Science and Technology)	This work was partly supported by a Grand-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (26410228) and by the MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017.	Papageorgiou GZ, 2006, J POLYM SCI POL PHYS, V44, P584, DOI 10.1002/polb.20727; Qiu ZB, 2003, POLYMER, V44, P7519, DOI 10.1016/j.polymer.2003.09.029; Zeng JB, 2010, J PHYS CHEM B, V114, P14827, DOI 10.1021/jp104709z; Jiang N, 2015, POLYMER, V60, P260, DOI 10.1016/j.polymer.2015.01.060; Ikehara T, 2000, POLYM J, V32, P683, DOI 10.1295/polymj.32.683; Wang TC, 2011, J PHYS CHEM B, V115, P7814, DOI 10.1021/jp203680e; Kataoka T, 2014, POLYM J, V46, P405, DOI 10.1038/pj.2014.11; Ikehara T, 2009, J POLYM SCI POL PHYS, V47, P539, DOI 10.1002/polb.21661; Di Lorenzo ML, 2003, PROG POLYM SCI, V28, P663, DOI 10.1016/S0079-6700(02)00035-7; Ikehara T, 2007, MACROMOLECULES, V40, P8726, DOI 10.1021/ma070973k; Qiu ZB, 2003, POLYMER, V44, P2799, DOI 10.1016/S0032-3861(03)00149-6; Qiu ZB, 2003, POLYMER, V44, P7749, DOI 10.1016/j.polymer.2003.10.013; Chen ZG, 2012, VIB SPECTROSC, V62, P299, DOI 10.1016/j.vibspec.2012.06.005; He YS, 2012, THERMOCHIM ACTA, V529, P80, DOI 10.1016/j.tca.2011.11.031; Ikehara T, 2012, J POLYM SCI POL PHYS, V50, P563, DOI 10.1002/polb.23036; Ikehara T, 2010, J POLYM SCI POL PHYS, V48, P706, DOI 10.1002/polb.21940; Kabe T, 2014, POLYMER, V55, P271, DOI 10.1016/j.polymer.2013.11.038; Kuo PC, 2015, J POLYM SCI POL PHYS, V53, P192, DOI 10.1002/polb.23607; O'Shaughnessy B, 2005, J PHYS-CONDENS MAT, V17, pR63, DOI 10.1088/0953-8984/17/2/R01; Qiu ZB, 2004, MACROMOL SYMP, V216, P255, DOI 10.1002/masy.200451224; Qiu ZB, 2005, POLYMER, V46, P11814, DOI 10.1016/j.polymer.2005.10.058; STROMBERG RR, 1959, J RES NAT BUR STAND, V62, P71, DOI 10.6028/jres.062.014; Zhao LF, 2013, POLYM J, V45, P929, DOI 10.1038/pj.2013.10	23	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	SEP	2015	47	9					645	648		10.1038/pj.2015.46		4	Polymer Science	Polymer Science	CQ9ZM	WOS:000360976700008		
J	Yoshida, M; Ueda, T; Nagoya, H				Yoshida, Masahiro; Ueda, Taito; Nagoya, Hiroshi			Study on improvement of unstable discharge at start of electrical discharge machining using external high-voltage superimposition method: Comparison of external and internal superimposition methods and influence of externally superimposed voltage on machining characteristics	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART B-JOURNAL OF ENGINEERING MANUFACTURE			English	Article						Electrical discharge machining; detected working voltage; unstable discharge; superimposed voltage; frontal gap distance; discharge frequency; abnormal discharge rate; machining characteristics		In this study, attempts were made to resolve the problem of unstable discharge at the start of electrical discharge machining using the external superimposition method. In general, electrical discharge machining (EDM), the frontal gap distance is controlled by detecting the working voltage. Electrical discharge machining experiments were thus conducted to compare conventional power supplies for electrical discharge machining machines, which superimpose high voltage on the detected working voltage (internal superimposition) with a power supply that superimposes high voltage externally so that no superimposed voltage is added to the detected working voltage (external superimposition). Differences in abnormal discharge rate, discharge frequency, frontal gap distance, and machining characteristics between the two superimposition methods were also investigated. The results showed that external superimposition is better than internal superimposition in that it widens the frontal gap distance immediately after the start of electrical discharge machining, which decreases the abnormal discharge rate to more or less 0 and increases the discharge frequency in a very short time, and that machining characteristics are better with the external superimposition method. Consequently, the effects of the superimposed voltage level on the machining characteristics of electrical discharge machining applying external superimposition were also investigated. It was found that (1) the discharge frequency increases with increasing superimposition voltage, thereby improving the machining rate; (2) the frontal gap distance increases and the surface roughness of the machined surface improves with increasing superimposition voltage; and (3) the tool electrode wear ratio is the smallest when superimposition voltage is around 200 V.	[Yoshida, Masahiro] Tokyo Metropolitan Coll Ind Technol, Mech Syst Engn Course, Monozukuri Dept, Tokyo 1400011, Japan; [Ueda, Taito] Univ Tokyo, Dept Precis Engn, Sch Engn, Tokyo, Japan; [Nagoya, Hiroshi] Tokyo Univ Agr & Technol, Dept Ind Technol & Innovat, Grad Sch Engn, Tokyo, Japan	Yoshida, M (reprint author), Tokyo Metropolitan Coll Ind Technol, Mech Syst Engn Course, Monozukuri Dept, 1-10-40 Higashi Ooi, Tokyo 1400011, Japan.	myoshida@s.metro-cit.ac.jp			Idemitsu Kousan Co., Ltd.	This study was partly financial supported by a study donation from Idemitsu Kousan Co., Ltd.	Cui X, 1991, SEISAN KENKYU, V43, P489; Cui X, 1979, J JPN SOC ELECT MACH, V26, P1; Goto A, 1998, INT J ELECT MACH, V3, P1; Hayakawa S, 1998, P ANN M JAP SOC EL M, P71; Kobayashi K, 1999, J SOC PRECIS ENG, V65, P1492; Kojima A, 2008, CIRP ANN-MANUF TECHN, V37, P191; Masui K, 1977, J JPN SOC ELECT MACH, V10, P12; Masui K, 1977, 1977 JSPE SPRING M J, P381; Masuzawa T, 1973, SEISAN KENKYU, V25, P437; Masuzawa T, 1971, J JSPE, V37, P52; Masuzawa T, 1984, SEISAN KENKYU, V36, P47; Oomori Y, 2000, P 2000 ANN M JSEME J, P7; Saito N, 1971, 1971 JSPE AUT M JAP, P479; Saito N Kobayashi K, 1970, 1970 JSPE SPRING M J, P145; Sato T, 1979, J JPN SOC ELECT MACH, V29, P27; Takeuchi H, 2007, IJEM, V12, P17; Ueide Y, 1979, J JPN SOC ELECT MACH, V22, P1	17	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4054	2041-2975		P I MECH ENG B-J ENG	Proc. Inst. Mech. Eng. Part B-J. Eng. Manuf.	SEP	2015	229	9					1492	1503		10.1177/0954405414538629		12	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CQ8DL	WOS:000360836400002		
J	Sugahara, D; Tomioka, A; Sato, T; Narimatsu, H; Kaji, H				Sugahara, Daisuke; Tomioka, Azusa; Sato, Takashi; Narimatsu, Hisashi; Kaji, Hiroyuki			Large-scale identification of secretome glycoproteins recognized by Wisteria floribunda agglutinin: A glycoproteomic approach to biomarker discovery	PROTEOMICS			English	Article						Glycobiomarker; Glycoproteomics; IGOT; LC-MS; Protein glycosylation; Wisteria floribunda agglutinin	TUMOR-ASSOCIATED ANTIGEN; N-ACETYLGALACTOSAMINE-TRANSFERASE; ASN-LINKED OLIGOSACCHARIDES; CHINESE-HAMSTER OVARY; HEPATOCELLULAR-CARCINOMA; MEMBRANE-PROTEINS; ALPHA-FETOPROTEIN; MOLECULAR-CLONING; AFFINITY CAPTURE; GLYCO-BIOMARKERS	One of the promising approaches to the development of cancer diagnostic systems is quantification of a specific protein carrying cancerous glycans. Potential utility of Wisteria floribunda agglutinin (WFA) for such assays has been suggested for several cancer types. To develop such diagnostic systems, identification of WFA-recognized glycoproteins is essential. Here, we successfully identified 504 WFA-recognized glycoproteins from the secretome of HEK293T cells. Most of the identified proteins were likely soluble or single-pass transmembrane proteins, which may serve as specific proteins for the diagnosis using biological fluids. Our method may help to discover marker glycoproteins for various cancers generating WFA-recognized glycans.	[Sugahara, Daisuke; Tomioka, Azusa; Sato, Takashi; Narimatsu, Hisashi; Kaji, Hiroyuki] Natl Inst Adv Ind Sci & Technol, RCMG, Tsukuba, Ibaraki 3058568, Japan	Kaji, H (reprint author), Natl Inst Adv Ind Sci & Technol, RCMG, Tsukuba Cent 2, Umezono 1-1-1, Tsukuba, Ibaraki 3058568, Japan.	kaji-rcmg@aist.go.jp					Angata T, 2012, ANN NY ACAD SCI, V1253, P159, DOI 10.1111/j.1749-6632.2012.06469.x; Zeck A, 2011, J PROTEOME RES, V10, P3031, DOI 10.1021/pr1012653; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Stastna M, 2012, PROTEOMICS, V12, P722, DOI 10.1002/pmic.201100346; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Sogabe M, 2014, J PROTEOME RES, V13, P1624, DOI 10.1021/pr401109n; Ito H, 2009, J PROTEOME RES, V8, P1358, DOI 10.1021/pr800735j; Kaji H, 2006, NAT PROTOC, V1, P3019, DOI 10.1038/nprot.2006.444; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Chandler K, 2013, MOL CELL PROTEOMICS, V12, P836, DOI 10.1074/mcp.R112.026930; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Kulasingam V, 2008, INT J CANCER, V123, P2007, DOI 10.1002/ijc.23844; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; STEINBERG W, 1990, AM J GASTROENTEROL, V85, P350; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Fukuda M, 1996, CANCER RES, V56, P2237; Matsuda A, 2013, J PROTEOMICS, V85, P1, DOI 10.1016/j.jprot.2013.04.017; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502; Kaji H, 2012, J PROTEOME RES, V11, P4553, DOI 10.1021/pr300346c; Ashburner M, 2000, NAT GENET, V25, P25; Ocho M, 2014, J PROTEOME RES, V13, P1428, DOI 10.1021/pr400986t; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; Debruyne EN, 2008, CLIN CHIM ACTA, V395, P19, DOI 10.1016/j.cca.2008.05.010; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Orntoft TF, 1999, ELECTROPHORESIS, V20, P362, DOI 10.1002/(SICI)1522-2683(19990201)20:2<362::AID-ELPS362>3.3.CO;2-M; Kaji H, 2013, J PROTEOME RES, V12, P2630, DOI 10.1021/pr301217b; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Narimatsu H, 2010, FEBS J, V277, P95, DOI 10.1111/j.1742-4658.2009.07430.x; Dabelsteen E, 1996, J PATHOL, V179, P358; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; Ballehaninna Umashankar K, 2012, J Gastrointest Oncol, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Cummings R. D., 2009, ESSENTIALS GLYCOBIOL, V2nd, P633; CUMMINGS RD, 1989, METHOD CELL BIOL, V32, P141; Freeze H. H., 2001, CURR PROTOC PROTEIN, V00, P911; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; Gene Ontology Consortium, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI [10.1093/nar/gkp1018, DOI 10.1093/NAR/GKP1018]; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; HERLYN M, 1982, J CLIN IMMUNOL, V2, P135, DOI 10.1007/BF00916897; Hsu WM, 2011, AM J PATHOL, V179, P1394, DOI 10.1016/j.ajpath.2011.05.025; Huang J, 2007, MOL CANCER RES, V5, P543, DOI 10.1158/1541-7786.MCR-06-0431; Kaji Hiroyuki, 2013, Methods Mol Biol, V951, P217, DOI 10.1007/978-1-62703-146-2_14; Kaji H, 2007, MOL CELL PROTEOMICS, V6, P2100, DOI 10.1074/mcp.M600392-MCP200; Kitamura N, 2003, INT J CANCER, V105, P533, DOI 10.1002/ijc.11115; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; Matsuda A, 2008, BIOCHEM BIOPH RES CO, V370, P259, DOI 10.1016/j.bbrc.2008.03.090; METZGAR RS, 1982, CANCER RES, V42, P601; Ohkura T, 2002, J BIOCHEM, V132, P891; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1992, J BIOL CHEM, V267, P19140; Sugahara D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00680; Van den Nieuwenhof IM, 2000, EUR J BIOCHEM, V267, P4753, DOI 10.1046/j.1432-1327.2000.01528.x; Wedepohl S, 2010, J PROTEOME RES, V9, P3403, DOI 10.1021/pr100170c; YAN SB, 1993, GLYCOBIOLOGY, V3, P597, DOI 10.1093/glycob/3.6.597	60	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	SEP	2015	15	17					2921	2933		10.1002/pmic.201400443		13	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CQ9WM	WOS:000360965900006		
J	Mizuta, Y; Kurihara, D; Higashiyama, T				Mizuta, Yoko; Kurihara, Daisuke; Higashiyama, Tetsuya			Two-photon imaging with longer wavelength excitation in intact Arabidopsis tissues	PROTOPLASMA			English	Article						Two-photon excitation microscopy (2PEM); Deep imaging; Live-cell analysis; Autofluorescence; Multicolor; Arabidopsis thaliana	RED FLUORESCENT PROTEIN; MULTIPHOTON MICROSCOPY; IN-VIVO; CELL ANALYSIS; POLLEN TUBES; LASER; DEEP; GENE; SECTIONS; DYNAMICS	In vivo imaging of living organisms is an important tool to investigate biological phenomena. Two-photon excitation microscopy (2PEM) is a laser-scanning microscopy that provides noninvasive, deep imaging in living organisms based on the principle of multiphoton excitation. However, application of 2PEM to plant tissues has not been fully developed, as plant-specific autofluorescence, optically dense tissues, and multiple light-scattering structures diminish the clarity of imaging. In this study, the advantages of 2PEM were identified for deep imaging of living and intact Arabidopsis thaliana tissues. When compared to single-photon imaging, near-infrared 2PEM, especially at 1000 nm, reduced chloroplast autofluorescence; autofluorescence also decreased in leaves, roots, pistils, and pollen grains. For clear and deep imaging, longer excitation wavelengths using the orange fluorescent proteins (FPs) TagRFP and tdTomato gave better results than with other colors. 2PEM at 980 nm also provided multicolor imaging by simultaneous excitation, and the combination of suitable FPs and excitation wavelengths allowed deep imaging of intact cells in root tips and pistils. Our results demonstrated the importance of choosing both suitable FPs and excitation wavelengths for clear two-photon imaging. Further advances in in vivo analysis using 2PEM will facilitate more extensive studies in the plant biological sciences.	[Mizuta, Yoko; Kurihara, Daisuke; Higashiyama, Tetsuya] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Mizuta, Yoko; Kurihara, Daisuke; Higashiyama, Tetsuya] Nagoya Univ, Higashiyama Live Holon Project, JST, ERATO,Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Higashiyama, Tetsuya] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Mizuta, Y (reprint author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	mizuta.yoko@f.mbox.nagoya-u.ac.jp			Japan Science and Technology Agency (ERATO project); Ministry of Education, Culture, Sports, Science and Technology, Japan [26840104]	We thank Dr. A. Kadota (Tokyo Metropolitan University) and Dr. Y. Sato (Nagoya University) for kindly providing seeds of GFP-mTalin and Dr. R. Gross-Hardt (University of Bremen) for kindly providing seeds of FGR8.0. We thank Dr. D. Maruyama (Nagoya University) and Dr. Y. Hamamura (Universite de Montreal) for providing plasmids. We thank S. Nasu, T. Nishii and T. Shinagawa for plant culture and S. Nagahara for providing plant material. This work was supported by grants from the Japan Science and Technology Agency (ERATO project to T.H.) and the Ministry of Education, Culture, Sports, Science and Technology, Japan (no. 26840104 to Y.M.).	Drobizhev M, 2011, NAT METHODS, V8, P393, DOI [10.1038/nmeth.1596, 10.1038/NMETH.1596]; Cahalan MD, 2003, CURR OPIN IMMUNOL, V15, P372, DOI 10.1016/S0952-7915(03)00079-7; Cheung AY, 2010, J EXP BOT, V61, P1907, DOI 10.1093/jxb/erq062; Kurihara D, 2008, PLANT CELL PHYSIOL, V49, P1256, DOI 10.1093/pcp/pcn098; Narusaka M, 2010, PLANT BIOTECHNOL-NAR, V27, P349, DOI 10.5511/plantbiotechnology.27.349; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Oikawa K, 2003, PLANT CELL, V15, P2805, DOI 10.1105/tpc.016428; Rubart M, 2004, CIRC RES, V95, P1154, DOI 10.1161/01.RES.0000150593.30324.42; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Feijo JA, 2004, PROTOPLASMA, V223, P1, DOI 10.1007/s00709-003-0026-2; Maruyama D, 2013, DEV CELL, V25, P317, DOI 10.1016/j.devcel.2013.03.013; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Volz R, 2013, DEV CELL, V25, P310, DOI 10.1016/j.devcel.2013.04.001; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; BRAKENHOFF GJ, 1985, NATURE, V317, P748, DOI 10.1038/317748a0; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Chen IH, 2002, OPT QUANT ELECTRON, V34, P1251, DOI 10.1023/A:1021303426482; Helmchen F, 2002, CURR OPIN NEUROBIOL, V12, P593, DOI 10.1016/S0959-4388(02)00362-8; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Centonze VE, 1998, BIOPHYS J, V75, P2015; Langhans M, 2014, PROTOPLASMA, V251, P277, DOI 10.1007/s00709-013-0601-0; Molitoris BA, 2005, AM J PHYSIOL-RENAL, V288, pF1084, DOI 10.1152/ajprenal.00473.2004; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Albota MA, 1998, APPL OPTICS, V37, P7352, DOI 10.1364/AO.37.007352; Weijers D, 2001, DEVELOPMENT, V128, P4289; TWELL D, 1989, MOL GEN GENET, V217, P240, DOI 10.1007/BF02464887; Kogure T, 2008, METHODS, V45, P223, DOI 10.1016/j.ymeth.2008.06.009; Kadota A, 2009, P NATL ACAD SCI USA, V106, P13106, DOI 10.1073/pnas.0906250106; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/nphoton.2012.336, 10.1038/NPHOTON.2012.336]; Hamamura Y, 2012, CURR OPIN PLANT BIOL, V15, P70, DOI 10.1016/j.pbi.2011.11.001; Adachi S, 2011, P NATL ACAD SCI USA, V108, P10004, DOI 10.1073/pnas.1103584108; Schwille P, 1999, BIOPHYS J, V77, P2251; Benninger RK, 2013, CURR PROTOC CELL BIO, V4, P1; Berg RH, 2008, METHOD CELL BIOL, V85, P153, DOI 10.1016/S0091-679X(08)85008-X; Berg RH, 2004, J MICROSC-OXFORD, V214, P174, DOI 10.1111/j.0022-2720.2004.01347.x; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Chapman S, 2005, CURR OPIN PLANT BIOL, V8, P565, DOI 10.1016/j.pbi.2005.09.011; Drobizhev M, 2009, J PHYS CHEM B, V113, P855, DOI 10.1021/jp8087379; Kawakami R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01014; Kitano M, 2012, METHOD ENZYMOL, V506, P437, DOI 10.1016/B978-0-12-391856-7.00047-0; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Tirlapur Uday K., 2001, Cellular and Molecular Biology Online Papers, V47, pOL131; Kurihara D, 2013, DEV GROWTH DIFFER, V55, P462, DOI 10.1111/dgd.12040; Laiho LH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1891370; Mizuta Y, 2014, PLANT J, V78, P516, DOI 10.1111/tpj.12461; Müller Sara M, 2013, Front Plant Sci, V4, P413, DOI 10.3389/fpls.2013.00413; PAWLEY J.B., 2006, HDB BIOL CONFOCAL MI; Roshchina VV, 2012, INT J SPECTROSC; Rost F. W., 1995, FLUORESCENCE MICROSC; Salomonnson E, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.096001; Tillo SE, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-6; Tirlapur UK, 2001, PLANTA, V214, P1, DOI 10.1007/s004250000471; Tsai TH, 2006, OPT LETT, V31, P930, DOI 10.1364/OL.31.000930; WHITE JG, 1987, J CELL BIOL, V105, P41, DOI 10.1083/jcb.105.1.41; Xu C., 1996, Bioimaging, V4, DOI 10.1002/1361-6374(199609)4:3<198::AID-BIO10>3.3.CO;2-O; Zinselmeyer BH, 2009, METHOD ENZYMOL, V461, P349, DOI 10.1016/S0076-6879(09)05416-0	58	2	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0033-183X	1615-6102		PROTOPLASMA	Protoplasma	SEP	2015	252	5					1231	1240		10.1007/s00709-014-0754-5		10	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CQ8WF	WOS:000360890000005		
J	Weiss, A; Staes, N; Pereboom, JJM; Inoue-Murayama, M; Stevens, JMG; Eens, M				Weiss, Alexander; Staes, Nicky; Pereboom, Jeffrey J. M.; Inoue-Murayama, Miho; Stevens, Jeroen M. G.; Eens, Marcel			Personality in Bonobos	PSYCHOLOGICAL SCIENCE			English	Article						behavior; chimpanzee; evolution; Pan paniscus; Pan troglodytes; primate	CHIMPANZEE PAN-TROGLODYTES; ZOOLOGICAL PARKS; RELIABILITY; STABILITY; DOMINANCE; PANISCUS; BEHAVIOR; RATINGS; GORILLA; RANK	To better understand human and chimpanzee personality evolution, we obtained trait ratings of personality for 154 captive bonobos (similar to 80% of the U.S. and European population). We found factors that we labeled Assertiveness, Conscientiousness, Openness, Agreeableness, Attentiveness, and Extraversion. The interrater reliabilities and test-retest reliabilities for these factors were comparable to those found in humans and other species. Using orthogonal targeted Procrustes rotations, we compared the bonobo dimensions with those of three samples of captive chimpanzees. Overall congruence coefficients indicated a fair degree of similarity; at the factor level, there was good evidence for Assertiveness, Conscientiousness, Openness, and Agreeableness in the chimpanzee samples; evidence for Attentiveness and Extraversion was poor. These findings suggest that, as expected given their close phylogenetic relationship, bonobo personality structure resembles chimpanzee personality structure in some respects. However, divergent evolution, perhaps as a result of socioecological differences between bonobos and chimpanzees, also appears to have shaped personality structure in these species.	[Weiss, Alexander] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Staes, Nicky; Stevens, Jeroen M. G.; Eens, Marcel] Univ Antwerp, Dept Biol, Ethol Res Grp, Antwerp, Belgium; [Staes, Nicky; Pereboom, Jeffrey J. M.; Stevens, Jeroen M. G.] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto 6068501, Japan	Weiss, A (reprint author), Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland.	alex.weiss@ed.ac.uk; nicky.staes@kmda.org			University of Antwerp; University of Edinburgh Development Trust [2828]; Daiwa Foundation [6515/6818]; Japanese Ministry of Education, Culture, Sports, Science and Technology [25290082, 25118005]; Cooperation Research Program of the Primate Research Institute, Kyoto University; Flemish Government; National Institute of Neurological Disorders and Stroke [NS36605, NS42867]; National Center for Research Resources [RR00165]	This work was supported by funding from the University of Antwerp (to M. Eens); University of Edinburgh Development Trust Grant 2828 (to A. Weiss); Daiwa Foundation Small Grant 6515/6818 (to A. Weiss); Japanese Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Science Research 25290082 and 25118005 (to M. Inoue-Murayama); and funding from the Cooperation Research Program of the Primate Research Institute, Kyoto University (to M. Inoue-Murayama). Support for the Center for Research and Conservation of the Royal Zoological Society of Antwerp was provided by the Flemish Government. The collection of chimpanzee data at Yerkes National Primate Research Center was supported by National Institute of Neurological Disorders and Stroke Grants NS36605 and NS42867 and by National Center for Research Resources Grant RR00165 (all to the Yerkes National Primate Research Center). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the U.S. Government.	Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037//0033-2909.86.2.420; King JE, 1997, J RES PERS, V31, P257, DOI 10.1006/jrpe.1997.2179; Gosling SD, 2007, J GEN PSYCHOL, V134, P259, DOI 10.3200/GENP.134.2.259-278; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Vervaecke H, 2000, BEHAVIOUR, V137, P1463, DOI 10.1163/156853900502673; Weiss A, 2011, J COMP PSYCHOL, V125, P72, DOI 10.1037/a0021187; GOLD KC, 1994, ZOO BIOL, V13, P509, DOI 10.1002/zoo.1430130513; Stevens JMG, 2007, INT J PRIMATOL, V28, P1417, DOI 10.1007/s10764-007-9186-9; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P418, DOI 10.1002/ajpa.20289; Dutton DM, 2008, PRIMATES, V49, P253, DOI 10.1007/s10329-008-0094-1; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Weiss A, 2007, AM J PRIMATOL, V69, P1264, DOI 10.1002/ajp.20428; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Freeman HD, 2013, AM J PRIMATOL, V75, P1042, DOI 10.1002/ajp.22168; McCrae RR, 1996, J PERS SOC PSYCHOL, V70, P552, DOI 10.1037/0022-3514.70.3.552; King JE, 2005, J PERS, V73, P389, DOI 10.1111/j.1467-6494.2005.00313.x; Behncke I, 2015, CURR BIOL, V25, pR24, DOI 10.1016/j.cub.2014.11.020; Costa P., 1992, REVISED NEO PERSONAL; de Waal Frans B.M., 1995, Scientific American, V272, P58; Eckardt W, 2015, J COMP PSYCHOL, V129, P26, DOI 10.1037/a0038370; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037//0022-3514.59.6.1216; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; King JE, 2008, J COMP PSYCHOL, V122, P418, DOI 10.1037/a0013125; Konecna M, 2008, J COMP PSYCHOL, V122, P379, DOI 10.1037/a0012625; Konecna M, 2012, J RES PERS, V46, P581, DOI 10.1016/j.jrp.2012.06.004; Lorenzo-Seva U., 2006, METHODOLOGY, V2, P57, DOI [10.1027/1614-2241.2.2.57, DOI 10.1027/1614-2241.2.2.57]; McCrae R. R., 1999, HDB PERSONALITY PSYC, V2nd, P159; Morton FB, 2013, J COMP PSYCHOL, V127, P282, DOI 10.1037/a0031723; R Development Core Team, 2013, R LANG ENV STAT COMP; Reinartz G. E., 1997, THESIS U WISCONSIN M; Revelle W., 2015, PSYCH PACKAGE R VERS; Robbins MM, 2011, PRIMATES PERSPECTIVE, P326; Schaefer SA, 2014, AM J PRIMATOL, V76, P879, DOI 10.1002/ajp.22275; Stevens JMG, 2015, BEHAVIOUR, V152, P259; Weiss A, 2009, AM J PRIMATOL, V71, P283, DOI 10.1002/ajp.20649; Weiss A, 2006, J PERS SOC PSYCHOL, V90, P501, DOI 10.1037/0022-3514.90.3.501	40	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0956-7976	1467-9280		PSYCHOL SCI	Psychol. Sci.	SEP	2015	26	9					1430	1439		10.1177/0956797615589933		10	Psychology, Multidisciplinary	Psychology	CR2OY	WOS:000361171200009		
J	Liu, Y; Kobayashi, A; Fu, QB; Yang, G; Konishi, T; Uchihori, Y; Hei, TK; Wang, YG				Liu, Yu; Kobayashi, Alisa; Fu, Qibin; Yang, Gen; Konishi, Teruaki; Uchihori, Yukio; Hei, Tom K.; Wang, Yugang			Rescue of Targeted Nonstem-Like Cells from Bystander Stem-Like Cells in Human Fibrosarcoma HT1080	RADIATION RESEARCH			English	Article							NITRIC-OXIDE; ADAPTIVE RESPONSE; GLIOMA-CELLS; MICROBEAM IRRADIATION; CANCER; RADIORESISTANCE; RESISTANCE; INDUCE; GROWTH	Cancer stem-like cells (CSCs) have been suggested to be the principal cause of tumor radioresistance, dormancy and recurrence after radiotherapy. However, little is known about CSC behavior in response to clinical radiotherapy, particularly with regard to CSC communication with bulk cancer cells. In this study, CSCs and nonstem-like cancer cells (NSCCs) were co-cultured, and defined cell types were chosen and irradiated, respectively, with proton microbeam. The bidirectional rescue effect in the combinations of the two cell types was then investigated. The results showed that out of all four combinations, only the targeted, proton irradiated NSCCs were protected by bystander CSCs and showed less accumulation of 53BP1, which is a widely used indicator for DNA double-strand breaks. In addition, supplementation with c-PTIO, a specific nitric oxide scavenger, can show a similar effect on targeted NSCCs. These results, showed that the rescue effect of CSCs on targeted NSCCs involves nitric oxide in the process, suggesting that the cellular communication between CSCs and NSCCs may be important in determining the survival of tumor cells after radiation therapy. To our knowledge, this is the first report demonstrating a rescue effect of CSCs to irradiated NSCCs that may help us better understand CSC behavior in response to cancer radiotherapy. (C) 2015 by Radiation Research Society	[Liu, Yu; Fu, Qibin; Yang, Gen; Wang, Yugang] Peking Univ, Sch Phys, State Key Lab Nucl Phys & Technol, Beijing 100871, Peoples R China; [Liu, Yu; Kobayashi, Alisa; Yang, Gen; Konishi, Teruaki; Uchihori, Yukio; Hei, Tom K.] Natl Inst Radiol Sci, Space Radiat Res Unit, Int Open Lab, Chiba 2638555, Japan; [Kobayashi, Alisa; Konishi, Teruaki; Uchihori, Yukio] Natl Inst Radiol Sci, Dept Tech Support & Dev, Chiba 2638555, Japan; [Hei, Tom K.] Columbia Univ, Ctr Radiol Res, Coll Phys & Surg, New York, NY 10032 USA	Yang, G (reprint author), Peking Univ, Sch Phys, State Key Lab Nucl Phys & Technol, Chengfu Rd 201, Beijing 100871, Peoples R China.	gen.yang@pku.edu.cn; tkonishi@nirs.go.jp	Konishi, Teruaki/B-9638-2008	Konishi, Teruaki/0000-0002-2485-9659	National Natural Science Foundation of China [11434001]; National Grand Instrument Program of China [2012YQ030142]; International Open Laboratory Program of the NIRS	The authors thank Mr. Masakazu Oikawa and the engineering staff at the Electrostatic Accelerator Facility of National Institute of Radiological Sciences (NIRS) for their technical support with microbeam irradiation, as well as Ms. Keiko Warren for administrative support for this international collaboration. This work was supported by the National Natural Science Foundation of China (grant no. 11434001), the National Grand Instrument Program of China (2012YQ030142) and the International Open Laboratory Program of the NIRS. Microbeam irradiation experiments were conducted as a part of the Joint-use Research Facility for Collaborative Projects with NIRS-SPICE (proposal no. S13-YG01).	Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Mancuso M, 2008, P NATL ACAD SCI USA, V105, P12445, DOI 10.1073/pnas.0804186105; Iyer R, 2002, MUTAT RES-FUND MOL M, V503, P1, DOI 10.1016/S0027-5107(02)00068-4; Kadhim MA, 2004, MUTAT RES-FUND MOL M, V568, P21, DOI 10.1016/j.mrfmmm.2004.06.043; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Ye S, 2013, INT J RADIAT BIOL, V89, P898, DOI 10.3109/09553002.2013.806832; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; De Ridder M, 2008, NITRIC OXIDE-BIOL CH, V19, P164, DOI 10.1016/j.niox.2008.04.015; Wu WJ, 2013, CYTOTECHNOLOGY, V65, P287, DOI 10.1007/s10616-012-9485-7; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; He MY, 2014, MUTAT RES-FUND MOL M, V763, P1, DOI 10.1016/j.mrfmmm.2014.03.001; Konishi T, 2013, J RADIAT RES, V54, P736, DOI 10.1093/jrr/rrs132; Zhang Y, 2012, J EXP BIOL, V215, P3813, DOI 10.1242/jeb.070235; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Tapio S, 2007, RADIAT ENVIRON BIOPH, V46, P1, DOI 10.1007/s00411-006-0078-8; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Januchowski R, 2013, BIOMED PHARMACOTHER, V67, P669, DOI 10.1016/j.biopha.2013.04.005; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Asaithamby A, 2011, P NATL ACAD SCI USA, V108, P8293, DOI 10.1073/pnas.1016045108; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Lam RKK, 2015, INT J MOL SCI, V16, P2591, DOI 10.3390/ijms16022591; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Choi VWY, 2013, J RADIOL PROT, V33, P91, DOI 10.1088/0952-4746/33/1/91; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Shao C, 2005, INT J CANCER, V116, P45, DOI 10.1002/ijc.21003; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Kim RK, 2013, CANCER SCI, V104, P1172, DOI 10.1111/cas.12207; Hale JS, 2012, CELL ADHES MIGR, V6, P346, DOI 10.4161/cam.21294; Iyer R, 2002, RADIAT RES, V157, P3, DOI 10.1667/0033-7587(2002)157[0003:APIIIT]2.0.CO;2; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Shao C, 2003, CANCER RES, V63, P8437; Desai S, 2014, MUTAT RES-FUND MOL M, V763, P39, DOI 10.1016/j.mrfmmm.2014.03.004; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Han W, 2010, MUTAT RES-FUND MOL M, V684, P81, DOI 10.1016/j.mrfmmm.2009.12.004; Lall R, 2014, CELL DEATH DIFFER, V21, P836, DOI 10.1038/cdd.2014.24; Chen S, 2011, MUTAT RES-FUND MOL M, V706, P59, DOI 10.1016/j.mrfmmm.2010.10.011; Hei Tom K, 2011, Curr Mol Pharmacol, V4, P96; Honoki, 2010, ONCOL REP, V24, P501; Kirk Rebecca, 2012, Nat Rev Clin Oncol, V9, P552, DOI 10.1038/nrclinonc.2012.149; Kobayashi Y, 2009, J RADIAT RES, V50, pA29, DOI 10.1269/jrr.09009S; Peitzsch C, 2014, INT J RADIAT BIOL, P1; Widel M, 2012, MUTAT RES-FUND MOL M, V731, P117, DOI 10.1016/j.mrfmmm.2011.12.007	47	0	0	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	SEP	2015	184	3					334	340		10.1667/RR14050.1		7	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	CR3NB	WOS:000361238600011		
J	Nishikiori, H; Takikawa, T; Ito, K; Nagaya, S; Wagata, H; Teshima, K; Fujii, T				Nishikiori, Hiromasa; Takikawa, Takumi; Ito, Kazuki; Nagaya, Satoshi; Wagata, Hajime; Teshima, Katsuya; Fujii, Tsuneo			Interaction between dye and zinc in the dye-dispersing ZnO films prepared by a wet process	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article						ZnO; Eosin Y; Wet process; Steam treatment; Dye-zinc interaction; Photoinduced electron injection	PHOTOELECTRIC CONVERSION PROPERTIES; SENSITIZED SOLAR-CELLS; TITANIA GEL FILMS; PHOTOINDUCED ELECTRON-TRANSFER; MOLECULAR-FORMS; RHODAMINE-B; ACETIC-ACID; FLUORESCEIN; ACETATE; FTIR	Dye-dispersing ZnO precursor gel films were prepared on indium tin oxide electrodes from a zinc acetate solution containing eosin Y by dip-coating, steam treatment, and then heating at a low temperature. The electronic interaction between the dye and zinc in the dye-dispersing gel films were investigated by spectroscopic and electrochemical measurements. A photocurrent was observed in the dye-dispersing gel electrodes before the steam treatment. The photocurrent value increased by the steam treatment and heating due to crystallization of the gel and removal of organic impurities. The dye molecules existed between the interlayers of the layered zinc hydroxide coexisting with the ZnO. The photoexcited electron in the dye should be injected into the ZnO conduction band via the layered zinc hydroxide. The value increased with an increase in the dye content even though the ZnO crystallinity decreased. The dye-zinc interaction, i.e., the complex formation and photoinduced electron injection, played an important role in the electron transport and photoelectric conversion.	[Nishikiori, Hiromasa; Takikawa, Takumi; Ito, Kazuki; Wagata, Hajime; Teshima, Katsuya] Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, Wakasato, Nagano 3808553, Japan; [Nagaya, Satoshi] Nagano Prefecture Gen Ind Technol Ctr, Okaya, Nagano 3940084, Japan; [Fujii, Tsuneo] Nagano Prefectural Inst Technol, Ueda, Nagano 3861211, Japan	Nishikiori, H (reprint author), Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, Wakasato, Nagano 3808553, Japan.	nishiki@shinshu-u.ac.jp			JSPS KAKENHI [24550153]	This work has been supported by JSPS KAKENHI Grant Number 24550153.	Latip AFA, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-119; DISLICH H, 1971, ANGEW CHEM INT EDIT, V10, P363, DOI 10.1002/anie.197103631; AVNIR D, 1984, J PHYS CHEM-US, V88, P5956, DOI 10.1021/j150668a042; Hasan MA, 2003, APPL CATAL A-GEN, V243, P81, DOI 10.1016/S0926-860X(02)00539-2; BRINKER CJ, 1991, THIN SOLID FILMS, V201, P97, DOI 10.1016/0040-6090(91)90158-T; Moezzi A, 2013, EUR J INORG CHEM, V2013, P5133, DOI 10.1002/ejic.201300650; Nishikiori H, 2013, CATAL SCI TECHNOL, V3, P2786, DOI 10.1039/c3cy00467h; Poul L, 2000, CHEM MATER, V12, P3123, DOI 10.1021/cm991179j; SPANHEL L, 1991, J AM CHEM SOC, V113, P2826, DOI 10.1021/ja00008a004; Max JJ, 2004, J PHYS CHEM A, V108, P3324, DOI 10.1021/jp036401t; Wang LL, 2001, SPECTROCHIM ACTA A, V57, P1781, DOI 10.1016/S1386-1425(01)00408-5; Chondroudis K, 1999, CHEM MATER, V11, P3028, DOI 10.1021/cm990561t; Pu KY, 2010, ADV MATER, V22, P643, DOI 10.1002/adma.200902409; Anta JA, 2012, J PHYS CHEM C, V116, P11413, DOI 10.1021/jp3010025; [Anonymous], 291159 ICDD PDF; Nishikiori H, 1997, J PHYS CHEM B, V101, P3680, DOI 10.1021/jp962734x; Kajiwara Y, 2013, J MATER CHEM C, V1, P4437, DOI 10.1039/c3tc30276h; Bruckner A, 2005, CATAL TODAY, V99, P123, DOI 10.1016/j.cattod.2004.09.031; Maegawa Y, 2010, J MATER CHEM, V20, P4399, DOI 10.1039/c0jm00275e; Gratzel M, 2003, J PHOTOCH PHOTOBIO C, V4, P145, DOI 10.1016/S1389-5567(03)00026-1; York SM, 2003, SURF SCI, V522, P34, DOI 10.1016/S0039-6028(02)02248-3; Nishikiori H, 2010, J PHOTOCH PHOTOBIO A, V212, P62, DOI 10.1016/j.jphotochem.2010.03.017; [Anonymous], 331464 ICDD PDF; Tarat A, 2012, SURF SCI, V606, P715, DOI 10.1016/j.susc.2011.12.010; Hosono E, 2004, ELECTROCHIM ACTA, V49, P2287, DOI 10.1016/j.electacta.2004.01.009; Li FS, 2005, ORG ELECTRON, V6, P237, DOI 10.1016/j.orgel.2005.08.002; El Mekkawi D, 2005, INT J PHOTOENERGY, V7, P95, DOI 10.1155/S1110662X05000140; Brinker C. J., 1991, J CERAM SOC JPN, V99, P862; Brinker C.J., 1990, SOL GEL SCI PHYS CHE; DISLICH H, 1983, J NON-CRYST SOLIDS, V57, P371, DOI 10.1016/0022-3093(83)90425-8; FUJII T, 1990, J PHOTOCH PHOTOBIO A, V54, P231, DOI 10.1016/1010-6030(90)85036-V; Guadalupe G., 2008, COLLOID INTERFACE SC, V320, P168; Hosono E, 2012, J CERAM SOC JPN, V120, P171, DOI 10.2109/jcersj2.120.171; Kitsui T., 2006, J PHOTOCH PHOTOBIO A, V192, P220; Lide D. R., 2004, CRC HDB CHEM PHYS; Maeda, 1984, LASER DYES PROPERTIE; MCHEDLOVPETROSSYAN NO, 1994, J CHEM SOC FARADAY T, V90, P629, DOI 10.1039/ft9949000629; Morioka H, 1999, J MATER SCI LETT, V18, P995, DOI 10.1023/A:1006639913554; NARANG U, 1993, APPL SPECTROSC, V47, P229, DOI 10.1366/0003702934048253; Nishikiori H, 2006, J PHOTOCH PHOTOBIO A, V179, P125, DOI 10.1016/j.jphotochem.2005.08.010; Nishikiori H, 2009, J PHOTOCH PHOTOBIO A, V207, P204, DOI 10.1016/j.jphotochem.2009.07.011; Nishikiori H, 2014, PHOTOCHEM PHOTOBIOL, V90, P747, DOI 10.1111/php.12254; Nishikiori H, 2013, CATAL SCI TECHNOL, V3, P1512, DOI 10.1039/c3cy00007a; Nishikiori H, 2007, J PHYS CHEM C, V111, P9008, DOI 10.1021/jp072625q; Nishikiori H, 2011, J PHYS CHEM C, V115, P2880, DOI 10.1021/jp109958z; Nishikiori H, 2013, CHEM LETT, V42, P556, DOI 10.1246/cl.130089; Nishikiori H, 2012, RSC ADV, V2, P4258, DOI 10.1039/c2ra00495j; Nishikiori H, 2012, J PHYS CHEM C, V116, P4848, DOI 10.1021/jp2094388; REISFELD R, 1988, CHEM PHYS LETT, V147, P142, DOI 10.1016/0009-2614(88)85073-5; Sakthivel S, 2003, SOL ENERG MAT SOL C, V77, P65, DOI 10.1016/S0927-0248(02)00255-6; Setiawan RA, 2013, J PHYS CHEM C, V117, P10308, DOI 10.1021/jp4024537; Setiawan RA, 2013, CHEM LETT, V42, P1391, DOI 10.1246/cl.130647; Sharma GD, 2009, MATER SCI ENG B-ADV, V162, P32, DOI 10.1016/j.mseb.2009.01.033; Zimmermann A, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0224-3	54	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	SEP	2015	41	9					6559	6574		10.1007/s11164-014-1761-z		16	Chemistry, Multidisciplinary	Chemistry	CR2FA	WOS:000361140200050		
J	Tanaka, S				Tanaka, Shigeru			Carboplatin and weekly paclitaxel chemotherapy in hemodialysis patient with advanced lung cancer and severe comorbidity: effect of the drugs and their chemical intermediates	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article						Non-small-cell lung cancer; Hemodialysis; Carboplatin; Weekly paclitaxel; Comorbidity; Drawbacks of the intermediates	OVARIAN-CANCER; RENAL-FUNCTION; PHARMACOKINETICS; TAXOL; CISPLATIN; DOSAGE; TRIALS; METAANALYSIS; COMBINATION; DIALYSIS	In advanced non-small-cell lung cancer (NSCLC) patients with severe comorbidity or who are elderly, significant differences exist at the induction of chemotherapy. A 68-year-old man with a history of severe aortic stenosis and cerebral infarction had been receiving hemodialysis for end-stage renal disease. On admission due to loss of consciousness caused by aortic stenosis, a mass in the upper lobe of the right lung with a small amount of pleural effusion was detected. The patient was diagnosed with adenocarcinoma of lung (cT2bN1M1a, stage IV). A weekly regimen of paclitaxel in combination with carboplatin is less toxic than the standard regimen of administering both simultaneously. Therefore, this regimen is preferable for patients with severe comorbidity or who are elderly. For the present case, combination chemotherapy of carboplatin and weekly paclitaxel was selected and administered for four cycles. Tumor response was evaluated as stable disease and adverse events were tolerable. This combination was found to be a candidate regimen for advanced NSCLC patients receiving hemodialysis with severe comorbidity.	Okazaki City Hosp, Dept Gen Med, Okazaki, Aichi 4448553, Japan	Tanaka, S (reprint author), Okazaki City Hosp, Dept Gen Med, 3-1 Goshoai, Okazaki, Aichi 4448553, Japan.	geruta@med.nagoya-u.ac.jp					Abe Yumiko, 2010, Nihon Kokyuki Gakkai Zasshi, V48, P769; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Oguri T, 2010, CANCER CHEMOTH PHARM, V66, P813, DOI 10.1007/s00280-010-1366-1; Belani CP, 2008, J CLIN ONCOL, V26, P468, DOI 10.1200/JCO.2007.13.1912; Verbeeck RK, 2009, EUR J CLIN PHARMACOL, V65, P757, DOI 10.1007/s00228-009-0678-8; Hiraike M, 2012, CANCER CHEMOTH PHARM, V69, P845, DOI 10.1007/s00280-011-1802-x; EGORIN MJ, 1984, CANCER RES, V44, P5432; Sakakibara T, 2010, ANN ONCOL, V21, P795, DOI 10.1093/annonc/mdp401; Asmis TR, 2008, J CLIN ONCOL, V26, P54, DOI 10.1200/JCO.2007.12.8322; Sooriyaarachchi M, 2011, METALLOMICS, V3, P49, DOI 10.1039/c0mt00058b; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Hotta K, 2004, J CLIN ONCOL, V22, P3852, DOI 10.1200/JCO.2004.02.109; Go RS, 1999, J CLIN ONCOL, V17, P409; Benedetti M, 2002, ENVIRON HEALTH PERSP, V110, P779; CRESTEIL T, 1994, CANCER RES, V54, P386; Hashimoto Hiroshi, 2010, Gan To Kagaku Ryoho, V37, P1553; Hirose T., 2008, JPN J LUNG CANC, V48, P285; Jeyabalan N, 2000, INT J GYNECOL CANCER, V10, P463, DOI 10.1046/j.1525-1438.2000.00072.x; Kingston DGI, 2007, PHYTOCHEMISTRY, V68, P1844, DOI 10.1016/j.phytochem.2006.11.009; Niikura H, 2003, ANTI-CANCER DRUG, V14, P735, DOI 10.1097/01.cad.0000092786.37568.11; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Pastan S, 1998, NEW ENGL J MED, V338, P1428, DOI 10.1056/NEJM199805143382006; Quiox E., 2011, LANCET, V378, P1079; Silverman AP, 2002, J BIOL CHEM, V277, P49743, DOI 10.1074/jbc.M206979200; Tomita M, 2001, ANTI-CANCER DRUG, V12, P485, DOI 10.1097/00001813-200106000-00010; Watanabe M, 2002, GYNECOL ONCOL, V84, P335, DOI 10.1006/gyno.2001.6527; Woo MH, 1999, CANCER CHEMOTH PHARM, V43, P92, DOI 10.1007/s002800050868	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	SEP	2015	41	9					6825	6832		10.1007/s11164-014-1780-9		8	Chemistry, Multidisciplinary	Chemistry	CR2FA	WOS:000361140200069		
J	Ito, F; Sagawa, T; Koshiyama, H				Ito, Fuyuki; Sagawa, Takehiro; Koshiyama, Hirotaka			Fluorescence properties of nanoaggregates of pyrene ammonium derivative and its photoinduced dissolution and reaction in tetrahydrofuran/aqueous solutions	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article						Organic nanocrystal; Fluorescence properties; Size dependence; Photochemical reaction; Photoinduced dissolution	ORGANIC NANOPARTICLES; EMISSION; MICROCRYSTALS; WATER	We studied the fluorescence properties of nanoaggregates of pyrene ammonium derivative (PyAm) and their photoinduced dissolution and reaction in tetrahydrofuran (THF)/aqueous solution. The final concentration (dye concentration after reprecipitation) dependence of the fluorescence peak was measured. The fluorescence peak of PyAm that originated from the excimer is shifted to the long wavelength side increasing with the final concentration, which is ascribable to the characteristic fluorescence spectral changes depending on their size. The size-dependent fluorescence change in the nanoaggregates is related to some molecular conformation, packing, and elastic properties of the nanoparticles at the surface. To understand the fluorescence properties of the intermediates from aggregates to crystals is important for the studies of organic nanocrystals/aggregates prepared by the reprecipitation methods. We also determined the fluorescence spectra of the PyAm nanoaggregates in a THF/aqueous solution by photoinduced dissolution and reaction. It originated from the photochemical reaction between PyAm and THF. Changes in the perpendicular light scattering intensity by photoirradiation supports the photoinduced dissolution of PyAm in the THF/aqueous solution. These findings are important in the research field of photochemical reactions in organic nanocrystals.	[Ito, Fuyuki; Sagawa, Takehiro; Koshiyama, Hirotaka] Shinshu Univ, Fac Educ, Dept Chem, Nagano 3808544, Japan	Ito, F (reprint author), Shinshu Univ, Fac Educ, Dept Chem, 6-Ro Nishinagano, Nagano 3808544, Japan.	fito@shinshu-u.ac.jp	Ito, Fuyuki/F-6472-2010	Ito, Fuyuki/0000-0002-1549-3915	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japanese Government [21750021]; Iketani Science and Technology Foundation; Shinshu University	This work partly supported by a Grant-in-Aid for Young Scientist (B) (No. 21750021) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japanese Government, by the Iketani Science and Technology Foundation, and by a Grant-in-Aid for Young Scientist of Exploratory Research from Shinshu University.	Ito F, 2012, CHEM LETT, V41, P282, DOI 10.1246/cl.2012.282; An BK, 2002, J AM CHEM SOC, V124, P14410, DOI 10.1021/ja0269082; Nakashima N, 2005, J PHYS CHEM B, V109, P13076, DOI 10.1021/jp050958m; Xiao DB, 2003, J AM CHEM SOC, V125, P6740, DOI 10.1021/ja028674s; Ito F, 2010, PHYS CHEM CHEM PHYS, V12, P10923, DOI 10.1039/c003023f; Fu HB, 2001, J AM CHEM SOC, V123, P1434, DOI 10.1021/ja0026298; Asahi T, 2008, ACCOUNTS CHEM RES, V41, P1790, DOI 10.1021/ar800125s; Kasai H, 1997, CHEM LETT, P1181, DOI 10.1246/cl.1997.1181; KASAI H, 1992, JPN J APPL PHYS 2, V31, pL1132; Masuhara H., 2003, SINGLE ORGANIC NANOP; Rohr U, 1998, ANGEW CHEM INT EDIT, V37, P1434; Toyozawa Y, 1997, PURE APPL CHEM, V69, P1171, DOI 10.1351/pac199769061171	12	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	SEP	2015	41	9					6897	6906		10.1007/s11164-014-1786-3		10	Chemistry, Multidisciplinary	Chemistry	CR2FA	WOS:000361140200075		
J	Otchia, CS				Otchia, Christian S.			Mining-based growth and productive transformation in the Democratic Republic of Congo: What can an African lion learn from an Asian tiger?	RESOURCES POLICY			English	Article						Mining growth; Dutch disease; CGE-microsimulation; Productive transformation	ECONOMIC-GROWTH; TRADE	The impressive recent GDP growth performance in DRC has not contributed to significantly reduce the high levels of initial poverty that were inherited from long years of war and mismanagement. Using a CGE-microsimulation model of the DRC, this study assesses the economywide growth and distributional effects of mining-based growth. Unlike other studies, this paper went a step further by comparing the results of mining-led growth to an alternative more broad-based development strategy where DRC develops shared capabilities required to engineer growth in the manufacturing sector. The findings suggest that mining will remain the key driver of DRC exports but not possibly the source of economic growth. The most plausible reason is the existence of the Dutch disease and the structural change that it generates. These structural effects will remain permanent even in the long-run unless the government implements a deliberative industrial policy. Interestingly, the results highlight the possible role of artisanal mining and demand for domestic agricultural and food products in improving the welfare of poor rural households. Finally, the findings show that policies to develop shared capabilities required to engineer growth in the manufacturing sector generate a productive transformation that produces pro-poor effects. (C) 2015 Elsevier Ltd. All rights reserved.	Nagoya Univ, Grad Sch Int Dev, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Otchia, CS (reprint author), Nagoya Univ, Grad Sch Int Dev, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	cotchia@gmail.com		OTCHIA, Christian/0000-0003-1471-8630			AfDB OECD UNDP UNECA, 2013, AFR EC OUTL 2013 STR; Agosin M. R., 2007, 233 U CHIL DEP EC; Amin Guitierrez de Pineres S., 2000, EXPORT DYNAMICS EC G; Gylfason T, 1999, MACROECON DYN, V3, P204; McMillan M, 2014, WORLD DEV, V63, P11, DOI 10.1016/j.worlddev.2013.10.012; Bleaney M, 2001, J DEV ECON, V65, P491, DOI 10.1016/S0304-3878(01)00147-X; MATSUYAMA K, 1992, J ECON THEORY, V58, P317, DOI 10.1016/0022-0531(92)90057-O; Herzer D, 2006, APPL ECON, V38, P1825, DOI 10.1080/00036840500426893; Page J, 2012, J AFR ECON, V21, P86, DOI 10.1093/jae/ejr045; Porto GG, 2006, J INT ECON, V70, P140, DOI 10.1016/j.jinteco.2005.09.003; Arndt C, 2000, J DEV STUD, V37, P121, DOI 10.1080/713600061; Banque Centrale du Congo, 1996, RAPP ANN BANQ CENTR; Chen SH, 2004, WORLD BANK ECON REV, V18, P29, DOI 10.1093/wber/lhh031; CHENERY H., 1979, STRUCTURAL CHANGE DE; De Pineres S., 1997, INT EXEC, V39, P465, DOI 10.1002/tie.5060390403; Dervis K., 1982, GEN EQUILIBRIUM MODE; Diao X., 2014, 01380 IFPRI; Dimaranan BV, 2006, GLOBAL TRADE ASSISTA; DRC, 2011, DOC POL STRAT IND RE; GHOSH AR, 1994, INT MONET FUND S PAP, V41, P214; Harrold P., 1996, WORLD BANK DISCUSSIO; Hausmann R, 2003, J DEV ECON, V72, P603, DOI 10.1016/S0304-3878(03)00124-X; Hausmann R, 2006, 128 HARV U CTR INT D; Hausmann R., 2006, JOURNAL OF ECONOMIC, V12, P1; Hesse H., 2008, 21 WORLD BANK; Hirschman A.O., 1958, STRATEGY EC DEV; Lederman D, 2007, LATIN AMER DEVELOP, P1, DOI 10.1596/978-0-8213-6545-8; lmbs J, 2003, AM ECON REV, V93, P63; Lofgren H., 2002, MICROCOMPUTERS POLIC; McMillan MS, 2011, NATL BUREAU EC RES W, DOI 10. 3386/w17143; McMillan MS, 2014, NATL BUREAU EC RES W, DOI 10.3386/w20077; Naude W., 2011, EC CHANGE RESTRUCT, V44, P99; Otchia C., 2013, J EC POLICY STUD, V8, P89; Otchia C., 2014, J EC STRUCT, V3, P1; Syrquin M., 1989, HDB EC DEV; The World Bank, 2013, ENT SURV; UNCTAD, 2014, UNCTADSTATS YEARL; UNCTAD, 2013, LEAST DEV COUNTR REP; UNCTAD, 2013, WORLD INV REP 2013 G; UNECA, 2013, MAK MOST AFR COMM IN; UNIDO, 2013, SUST EMPL GROWTH ROL; Vlassenroot K., 2004, CONFLICT SOCIAL TRAN; Wiebe K. D., 2001, AGR INVESTMENT PRODU	43	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-4207	1873-7641		RESOUR POLICY	Resour. Policy	SEP	2015	45						227	238		10.1016/j.resourpol.2015.06.003		12	Environmental Studies	Environmental Sciences & Ecology	CQ9QZ	WOS:000360951300024		
J	Takada, T; Aoki, A; Asakawa, K; Sakagami, T; Moriyama, H; Narita, I; Sato, S				Takada, Toshinori; Aoki, Ami; Asakawa, Katsuaki; Sakagami, Takuro; Moriyama, Hiroshi; Narita, Ichiei; Sato, Shinji			Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody positive amyopathic dermatomyositis	RESPIRATORY MEDICINE			English	Article						Dermatomyositis; Interstitial lung disease; Cytokine; Chemokine CX3CL1	GENE 5 ANTIBODY; RHEUMATOID-ARTHRITIS; JUVENILE DERMATOMYOSITIS; ENDOTHELIAL-CELLS; JAPANESE PATIENTS; POLYMYOSITIS; FRACTALKINE; AUTOANTIBODIES; EXPRESSION; CX3CL1/FRACTALKINE	Background: Patients with amyopathic dermatomyositis (ADM) sometimes develop rapidly progressive interstitial lung disease (ILD) predominantly in Asia. Although anti-CADM-140/MDA5 antibody titer could correlate with disease activity and predict the course of ILD associated with ADM, it is not clear how this antibody is involved in the pathogenesis of ILD in ADM. Methods: We retrospectively collected clinical records and preserved serum before treatment of consecutive patients with ADM-ILD treated in the Niigata University Medical and Dental Hospital since 2000. We measured anti-CADM-140/MDA5 antibody titer and compared it between survivors and non-survivors. Serum cytokine/growth factor protein concentration was measured using a multiplex immunoassay system. The associations between anti-CADM-140/MDA5 antibody titer and each cytokine/growth factor protein concentration were evaluated. Results: Thirteen patients were enrolled into the study. Among them, four patients did not respond to intensive immunosuppressive therapy and died. The mean anti-CADM-140/MDA5 antibody titer was significantly higher in patients who did not responded to therapy than in those who survived (p < 0.05). Relationship analyses between the antibody titer and each cytokine/GF protein concentration revealed that Spearman's rank correlation coefficients were more than 0.4 in thirteen cytokine/GF proteins. In particular, the strongest correlation was found between anti-CADM-140/MDA5 antibody titer and CX3CL1 (r = 0.8897). Conclusions: These results confirmed that anti-CADM-140/MDA5 antibody levels could predict outcomes of ADM-ILD. Relationship analyses suggested that CX3CL1 might be involved in the pathogenesis of anti-CADM-140/MDA5 antibody positive ADM-ILD. (C) 2015 Elsevier Ltd. All rights reserved.	[Takada, Toshinori; Aoki, Ami; Asakawa, Katsuaki; Sakagami, Takuro; Moriyama, Hiroshi; Narita, Ichiei] Niigata Univ, Med & Dent Hosp, Div Resp Med, Niigata 9518520, Japan; [Takada, Toshinori] Niigata Univ, Med & Dent Hosp, Uonuma Inst Community Med, Niigata 9518520, Japan; [Sato, Shinji] Tokai Univ, Sch Med, Dept Internal Med, Div Rheumatol, Isehara, Kanagawa 25911, Japan	Takada, T (reprint author), Niigata Univ, Med & Dent Hosp, Uonuma Inst Community Med, 1-754 Asahimachi Dori, Niigata 9518520, Japan.	ttakada@med.niigata-u.ac.jp			JSPS KAKENHI [25461151]	This work was supported by JSPS KAKENHI Grant Number 25461151. The authors thank Dr. Takahiro Tanaka, Bioscience Medical Research Center, Niigata University Medical and Dental Hospital, for useful discussion on statistical analyses.	Suda T, 2006, EUR RESPIR J, V28, P1005, DOI 10.1183/09031936.06.00038806; Fiorentino D, 2011, J AM ACAD DERMATOL, V65, P25, DOI 10.1016/j.jaad.2010.09.016; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; De Lauretis A, 2013, J RHEUMATOL, V40, P435, DOI 10.3899/jrheum.120725; Matsumiya T, 2010, J IMMUNOL, V184, P4205, DOI 10.4049/jimmunol.0903212; Sontheimer RD, 2003, J AM ACAD DERMATOL, V48, P797, DOI 10.1067/mjd.2003.199; Nakano M, 2012, CLIN EXP IMMUNOL, V170, P94, DOI 10.1111/j.1365-2249.2012.04638.x; Koga T, 2012, RHEUMATOLOGY, V51, P1278, DOI 10.1093/rheumatology/ker518; Nomiyama H, 1998, CYTOGENET CELL GENET, V81, P10, DOI 10.1159/000015000; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Hasegawa M, 2005, ANN RHEUM DIS, V64, P21, DOI 10.1136/ard.2003.018705; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Sato S, 2013, MOD RHEUMATOL, V23, P496, DOI 10.1007/s10165-012-0663-4; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Kang EH, 2005, RHEUMATOLOGY, V44, P1282, DOI 10.1093/rheumatology/keh723; Sakurai N, 2011, J RHEUMATOL, V38, P963, DOI 10.3899/jrheum.101220; Sato S, 2005, ARTHRITIS RHEUM, V52, P1571, DOI 10.1002/art.21023; High WA, 2003, J AM ACAD DERMATOL, V49, P295, DOI 10.1067/S0190-9622(03)01482-8; Kobayashi I, 2011, J PEDIATR-US, V158, P675, DOI 10.1016/j.jpeds.2010.11.033; Moon SO, 2006, MOL PHARMACOL, V70, P112, DOI 10.1124/mol.106.022392; Odai T, 2009, J RHEUMATOL, V36, P1158, DOI 10.3899/jrheum.081074; Cao H, 2012, ARTHRIT CARE RES, V64, P1602, DOI 10.1002/acr.21728; Marie I, 2011, ARTHRITIS RHEUM-US, V63, P3439, DOI 10.1002/art.30513; Douglas WW, 2001, AM J RESP CRIT CARE, V164, P1182; Ruth JH, 2001, ARTHRITIS RHEUM, V44, P1568, DOI 10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Okamoto H, 1997, ARTHRITIS RHEUM, V40, P1096, DOI 10.1002/art.1780400614; Umehara H, 2001, TRENDS IMMUNOL, V22, P602, DOI 10.1016/S1471-4906(01)02051-8; Arshanapalli Ashish, 2015, Cytokine, V73, P319, DOI 10.1016/j.cyto.2014.11.026; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Gono T, 2014, RHEUMATOLOGY, V53, P2196, DOI 10.1093/rheumatology/keu258; Gono T, 2012, RHEUMATOLOGY, V51, P1563, DOI 10.1093/rheumatology/kes102; Isozaki T., 2011, J LAB CLIN MED, V157, P64, DOI [10.1016/j.trsl.2010.11.007, DOI 10.1016/J.TRSL.2010.11.007]; Matsuki Y, 2012, MOD RHEUMATOL, V22, P243, DOI 10.1007/s10165-011-0502-z; Muro Y, 2012, RHEUMATOLOGY, V51, P800, DOI 10.1093/rheumatology/ker408; Narang NS, 2015, ARTHRIT CARE RES, V67, P667, DOI 10.1002/acr.22498; Sakamoto N, 2004, INTERNAL MED, V43, P838, DOI 10.2169/internalmedicine.43.838; Sato S, 2012, MOD RHEUMATOL, V22, P625, DOI 10.1007/s10165-011-0558-9; Suzuki F, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3761; Tansley SL, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4600	42	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0954-6111	1532-3064		RESP MED	Respir. Med.	SEP	2015	109	9					1174	1180		10.1016/j.rmed.2015.07.004		7	Cardiac & Cardiovascular Systems; Respiratory System	Cardiovascular System & Cardiology; Respiratory System	CQ9HY	WOS:000360925800011		
J	Ikezoe, K; Handa, T; Tanizawa, K; Kubo, T; Oguma, T; Hamada, S; Watanabe, K; Aihara, K; Sokai, A; Nakatsuka, Y; Muro, S; Nagai, S; Uno, K; Chin, K; Fukui, M; Hirai, T; Mishima, M				Ikezoe, Kohei; Handa, Tomohiro; Tanizawa, Kiminobu; Kubo, Takeshi; Oguma, Tsuyoshi; Hamada, Satoshi; Watanabe, Kizuku; Aihara, Kensaku; Sokai, Akihiko; Nakatsuka, Yoshinari; Muro, Shigeo; Nagai, Sonoko; Uno, Kazuko; Chin, Kazuo; Fukui, Motonari; Hirai, Toyohiro; Mishima, Michiaki			Bone mineral density in patients with idiopathic pulmonary fibrosis	RESPIRATORY MEDICINE			English	Article						Bone mineral density; Combined pulmonary fibrosis and emphysema; Idiopathic pulmonary fibrosis	QUANTITATIVE COMPUTED-TOMOGRAPHY; X-RAY ABSORPTIOMETRY; LUNG-DISEASE; MATRIX METALLOPROTEINASES; CYSTIC-FIBROSIS; COPD PATIENTS; OSTEOPOROSIS; EMPHYSEMA; MATRIX-METALLOPROTEINASE-9; WOMEN	Background: Decreased bone mineral density (BMD) has been reported in patients with interstitial lung disease. However, BMD has not been evaluated in steroid-naive patients with idiopathic pulmonary fibrosis (IPF). We aimed to measure vertebral BMD and investigate its relationship with clinical features in steroid-naive patients with IPF. Methods: We recruited 55 consecutive male patients with steroid-naive IPF; 55 male smokers without chronic obstructive pulmonary disease or interstitial lung disease, matched by age, body mass index, and pack-years of smoking (control smokers); and 27 healthy young adults. Thoracic vertebral BMD was measured by computed tomography (CT). We further investigated the relationship of BMD with clinical features and quantitative CT indices of lung density in patients with IPF. Results: The thoracic vertebral BMD of patients with IPF was significantly lower than that of control smokers (139.9 +/- 28.5 mg/mL vs 160.9 +/- 39.5 mg/mL, p < 0.01). Fifteen patients (27.2%) had BMD more than 2.5 SD below the mean BMD of young adults. In patients with IPF, emphysema volume (EV) and its ratio to total lung volume (EV%) had a significantly negative correlation with BMD (r = -0.28, p = 0.04 and r = -0.39, p < 0.01, respectively). In stepwise multiple regression analysis, EV% was an independent explanatory variable for thoracic vertebral BMD. Conclusion: A substantial percentage of steroid-naive IPF patients had decreased BMD, and a significant association was observed between the extent of emphysema and BMD in IPF. (C) 2015 Elsevier Ltd. All rights reserved.	[Ikezoe, Kohei; Handa, Tomohiro; Oguma, Tsuyoshi; Hamada, Satoshi; Sokai, Akihiko; Nakatsuka, Yoshinari; Muro, Shigeo; Hirai, Toyohiro; Mishima, Michiaki] Kyoto Univ, Dept Resp Med, Grad Sch Med, Kyoto 6068507, Japan; [Tanizawa, Kiminobu; Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto 6068507, Japan; [Kubo, Takeshi] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan; [Watanabe, Kizuku] Fukui Red Cross Hosp, Dept Resp Med, Fukui, Japan; [Aihara, Kensaku] Saiseikai Noe Hosp, Dept Resp Med, Osaka, Japan; [Nagai, Sonoko] Kyoto Cent Clin, Clin Res Ctr, Kyoto, Japan; [Uno, Kazuko] Louis Pasteur Ctr Med Res, Kyoto, Japan; [Fukui, Motonari] Kitano Hosp, Tazuke Kofukai Med Res Inst, Resp Dis Ctr, Osaka, Japan	Handa, T (reprint author), Kyoto Univ, Dept Resp Med, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	hanta@kuhp.kyoto-u.ac.jp			respiratory failure research group of the Ministry of Health, Labour and Welfare, Japan [H26-Nanchi-Ippan-Japan-076]; Japan Society for the Promotion of Science [26461187]	We thank Dr. Hirofumi Kiyokawa (Department of Respiratory Medicine, Kishiwada City Hospital) for his technical advice in measuring BMD by chest CT. We are grateful to Hiroshi Kondoh (Geriatric unit, Kyoto University Hospital) for his academic advice. This study was supported by grants from the respiratory failure research group of the Ministry of Health, Labour and Welfare, Japan (H26-Nanchi-Ippan-Japan-076), and the Japan Society for the Promotion of Science (26461187).	Aihara K, 2013, RESP MED, V107, P269, DOI 10.1016/j.rmed.2012.10.005; Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; De Vries J, 2001, EUR RESPIR J, V17, P954, DOI 10.1183/09031936.01.17509540; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Ryerson CJ, 2013, CHEST, V144, P234, DOI 10.1378/chest.12-2403; Fell CD, 2012, CLIN CHEST MED, V33, P51, DOI 10.1016/j.ccm.2011.12.005; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Jorgensen NR, 2007, RESP MED, V101, P177, DOI 10.1016/j.rmed.2006.03.029; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Link TM, 2012, RADIOLOGY, V263, P3, DOI 10.1148/radiol.12110462; Gansner JM, 2013, TRANSL RES, V162, P343, DOI 10.1016/j.trsl.2013.04.001; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; Kiyokawa H, 2012, COPD, V9, P235, DOI 10.3109/15412555.2011.650243; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Lehouck A, 2011, CHEST, V139, P648, DOI 10.1378/chest.10-1427; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285; Walter Nicholas, 2006, Proc Am Thorac Soc, V3, P330, DOI 10.1513/pats.200602-016TK; Shin KE, 2011, J COMPUT ASSIST TOMO, V35, P266, DOI 10.1097/RCT.0b013e31820ccf18; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; Pignolo RJ, 2008, AGING CELL, V7, P23, DOI 10.1111/j.1474-9726.2007.00350.x; Valdes AM, 2007, OSTEOPOROSIS INT, V18, P1203, DOI 10.1007/s00198-007-0357-5; Chilosi M, 2013, TRANSL RES, V162, P156, DOI 10.1016/j.trsl.2013.06.004; Bergot C, 2001, CALCIFIED TISSUE INT, V68, P74, DOI 10.1007/BF02678144; Bolton C E, 2009, Chron Respir Dis, V6, P81, DOI 10.1177/1479972309103131; Caplan-Shaw CE, 2006, CHEST, V129, P140, DOI 10.1378/chest.129.1.140; Chen FS, 2011, J HEART LUNG TRANSPL, V30, P572, DOI 10.1016/j.healun.2010.11.019; Conway SP, 2000, THORAX, V55, P798, DOI 10.1136/thorax.55.9.798; Haworth CS, 1999, THORAX, V54, P961; Kozu R, 2014, ARCH PHYS MED REHAB, V95, P950, DOI 10.1016/j.apmr.2014.01.016; Malemud CJ, 2006, FRONT BIOSCI, V11, P1702, DOI 10.2741/1916; Ohara T, 2008, CHEST, V134, P1244, DOI 10.1378/chest.07-3054; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; STRICKLAND NH, 1993, AM J ROENTGENOL, V161, P719; Tschopp O, 2002, AM J TRANSPLANT, V2, P167, DOI 10.1034/j.1600-6143.2002.020208.x; Vrieze A, 2007, OSTEOPOROSIS INT, V18, P1197, DOI 10.1007/s00198-007-0355-7; Yu W, 1995, OSTEOPOROSIS INT, V5, P433, DOI 10.1007/BF01626604; Zhang PF, 2013, COPD, V10, P650, DOI 10.3109/15412555.2013.813928	38	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0954-6111	1532-3064		RESP MED	Respir. Med.	SEP	2015	109	9					1181	1187		10.1016/j.rmed.2015.06.014		7	Cardiac & Cardiovascular Systems; Respiratory System	Cardiovascular System & Cardiology; Respiratory System	CQ9HY	WOS:000360925800012		
J	Ogawa, T; Long, JL; Sutherland, K; Chan, ASL; Sasaki, K; Cistulli, PA				Ogawa, Toru; Long, Jianlan; Sutherland, Kate; Chan, Andrew S. L.; Sasaki, Keiichi; Cistulli, Peter A.			Effect of mandibular advancement splint treatment on tongue shape in obstructive sleep apnea	SLEEP AND BREATHING			English	Article						Obstructive sleep apnea; Mandibular advancement splint; Tongue; Airway; MRI	UPPER AIRWAY; ADULTS; VOLUME; APPLIANCES; DIMENSIONS; PREDICTORS; DISORDERS; DEVICE; LOADS; SIZE	Mandibular advancement splints (MAS) can effectively treat obstructive sleep apnea (OSA); however, treatment response is variable, and the mechanisms behind differences in treatment outcomes are still not well understood. The aims of this study were (1) to assess the effects of MAS on tongue shape and (2) to compare tongue shape changes with MAS between treatment responders and nonresponders. Sixty-eight adults with symptomatic mild to severe OSA were included. A custom-made MAS was provided to patients, and treatment outcome was determined by polysomnography. Two-dimensional tongue measurements were evaluated using sagittal and axial MRI image slices without and with MAS in situ. Tongue measurements of height, length, width, area, and shape (height/length) were collected. Additional measurements of surrounding upper airway structures, soft palate length width and area and upper airway area, length and minimum width were measured on sagittal image slices. Based on polysomnography with MAS in situ, 47 patients were classified as responders (a parts per thousand yen50 % reduction in apnea-hypopnea index [AHI] from baseline), and 21 were nonresponders (< 50 % AHI reduction). There was no change in sagittal tongue area with insertion of MAS, although there was a change in most of parameters of tongue shape. Responders showed a greater decrease in tongue length with MAS in situ compared to nonresponders (-0.64 +/- 0.46 vs -0.32 +/- 0.51 cm, p = 0.016). This study reports a detailed two-dimensional analysis of tongue dimensions as well as assessment of adjacentsoft palate shape and upper airway structures without and with MAS treatment for OSA. Our finding suggests that MAS does induce changes in tongue shape. MAS treatment responders showed a greater decrease in tongue length (between the tongue tip and hyoid bone) with MAS in situ; whether differences in alteration of tongue position with MAS explain differences in treatment response requires further investigation.	[Ogawa, Toru; Long, Jianlan; Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ogawa, Toru; Sutherland, Kate; Chan, Andrew S. L.; Cistulli, Peter A.] Royal N Shore Hosp, Ctr Sleep Hlth & Res, Dept Resp Med, St Leonards, NSW 2065, Australia; [Sutherland, Kate] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Sutherland, Kate] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Long, JL (reprint author), Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	ogat-thk@umin.ac.jp			National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia. SomnoMed provided the oral appliances for this study.	Almeida FR, 2011, EUR RESPIR J, V37, P209, DOI 10.1183/09031936.00194809; Flemons WW, 1999, SLEEP, V22, P667; Hoffstein V, 2007, SLEEP BREATH, V11, P1, DOI 10.1007/s11325-006-0084-8; Watanabe T, 2002, AM J RESP CRIT CARE, V165, P260; POUDEROUX P, 1995, GASTROENTEROLOGY, V108, P1418, DOI 10.1016/0016-5085(95)90690-8; Mostafiz W, 2011, CHEST, V139, P1331, DOI 10.1378/chest.10-2224; LOWE AA, 1995, AM J ORTHOD DENTOFAC, V107, P589, DOI 10.1016/S0889-5406(95)70101-X; Okubo M, 2006, SLEEP, V29, P909; Kyung SH, 2005, ANGLE ORTHOD, V75, P15; Furuhashi A, 2013, J ORAL REHABIL, V40, P582, DOI 10.1111/joor.12059; Poon KH, 2008, ANN ACAD MED SINGAP, V37, P637; Zeng B, 2008, SLEEP, V31, P543; Cistulli PA, 2004, SLEEP MED REV, V8, P443, DOI 10.1016/j.smrv.2004.04.002; Giles TL, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001106.pub3, 10.1002/14651858.CD001106.pub2]; Shen HL, 2012, J AM DENT ASSOC, V143, P1209; Zeng B, 2007, AM J RESP CRIT CARE, V175, P726, DOI 10.1164/rccm.200608-1205OC; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Menn SJ, 1996, SLEEP, V19, P794; Chan ASL, 2010, THORAX, V65, P726, DOI 10.1136/thx.2009.131094; Brown EC, 2013, SLEEP, V36, P397, DOI 10.5665/sleep.2458; Choi JK, 2010, ORAL SURG ORAL MED O, V109, P712, DOI 10.1016/j.tripleo.2009.11.034; Do KL, 2000, LARYNGOSCOPE, V110, P1552, DOI 10.1097/00005537-200009000-00027; Iida-Kondo Chisato, 2006, Journal of Medical and Dental Sciences, V53, P119; Johal A, 2007, CLIN PHYSIOL FUNCT I, V27, P47, DOI 10.1111/j.1475-097X.2007.00714.x; Kato T, 2013, J PROSTHODONT RES, V57, P69, DOI 10.1016/j.jpor.2013.03.001; Kumar Prince, 2013, J Indian Prosthodont Soc, V13, P571, DOI 10.1007/s13191-012-0220-z; Liu ZJ, 2008, J ORAL MAXIL SURG, V66, P1351, DOI 10.1016/j.joms.2007.11.005; Pae EK, 1999, ANGLE ORTHOD, V69, P147; Sutherland K, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13276; Tsuiki S, 2000, SLEEP BREATH, V4, P53, DOI 10.1055/s-2000-9836	30	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1520-9512	1522-1709		SLEEP BREATH	Sleep Breath.	SEP	2015	19	3					857	863		10.1007/s11325-014-1101-y		7	Clinical Neurology; Respiratory System	Neurosciences & Neurology; Respiratory System	CQ7DL	WOS:000360763000016		
J	Okubo, R; Kondo, M; Hoshi, S; Yamagata, K				Okubo, Reiko; Kondo, Masahide; Hoshi, Shu-ling; Yamagata, Kunihiro			Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease	SLEEP AND BREATHING			English	Article						Screening; Obstructive sleep apnea; Chronic kidney disease; Diabetes; Cost-effectiveness; Quality-adjusted life year	POSITIVE AIRWAY PRESSURE; ACUTE MYOCARDIAL-INFARCTION; ECONOMIC-ANALYSIS; BLOOD-PRESSURE; RISK-FACTORS; JAPAN; ADULTS; EPIDEMIOLOGY; PREVALENCE; PREVENTION	Obstructive sleep apnea (OSA) is a common disorder with a high prevalence among patients with cardiovascular disease (CVD), diabetes, and chronic kidney disease (CKD). Routine evaluation of OSA for patients with CVD including hypertension has been performed according to the clinical guidelines for both OSA and CVD. However, most patients with diabetes and CKD who could benefit from treatment remain undiagnosed because routine screening of OSA is not recognized as part of standard practice. This study aims to evaluate the cost-effectiveness of OSA screening for patients with diabetes and CKD. Cost-effectiveness analysis by a decision tree and Markov modeling from the societal perspective in Japan was carried out to provide evidence based on the economic evaluation of current clinical practice concerning diabetes and CKD. Incremental cost-effectiveness ratios of OSA screening compared with do-nothing were calculated as Ayen3,516,976 to 4,514,813/quality-adjusted life year (QALY) (US$35,170 to 45,148/QALY) for diabetes patients and Ayen3,666,946 to 4,006,866/QALY (US$36,669 to 40,069/QALY) for CKD patients. Taking the threshold to judge cost-effectiveness according to a suggested value of social willingness to pay for one QALY gain in Japan as Ayen5 million/QALY (US$50,000QALY), OSA screening is cost-effective. Our results suggest that active case screening and treatment of OSA for untreated middle-aged male patients with diabetes or CKD could be justifiable as an efficient use of finite health-care resources in the world with high prevalence of these diseases.	[Okubo, Reiko; Yamagata, Kunihiro] Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki 3058577, Japan; [Kondo, Masahide; Hoshi, Shu-ling] Univ Tsukuba, Fac Med, Dept Hlth Care Policy & Hlth Econ, Tsukuba, Ibaraki 3058577, Japan	Kondo, M (reprint author), Univ Tsukuba, Fac Med, Dept Hlth Care Policy & Hlth Econ, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	mkondo@md.tsukuba.ac.jp					Izumi Y, 2009, DIABETES RES CLIN PR, V83, P126, DOI 10.1016/j.diabres.2008.09.005; Brunetti M, 2013, J CLIN EPIDEMIOL, V66, P140, DOI 10.1016/j.jclinepi.2012.04.012; Sakaguchi Y, 2011, CLIN J AM SOC NEPHRO, V6, P995, DOI 10.2215/CJN.08670910; Yokoyama H, 1997, DIABETES CARE, V20, P844, DOI 10.2337/diacare.20.5.844; Chin K, 2006, J HYPERTENS, V24, P2091, DOI 10.1097/01.hjh.0000244960.69985.4c; Shaw JE, 2008, DIABETES RES CLIN PR, V81, P2, DOI 10.1016/j.diabres.2008.04.025; Pietzsch JB, 2011, SLEEP, V34, P695, DOI 10.5665/SLEEP.1030; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Sadatsafavi M, 2009, SLEEP BREATH, V13, P241, DOI 10.1007/s11325-009-0248-4; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Nakayama M, 2010, CLIN EXP NEPHROL, V14, P333, DOI 10.1007/s10157-010-0295-y; Weatherly HLA, 2009, INT J TECHNOL ASSESS, V25, P26, DOI 10.1017/S0266462309090047; Mar J, 2003, EUR RESPIR J, V21, P515, DOI 10.1183/09031936.03.00040903; Turek NF, 2012, AM J KIDNEY DIS, V60, P823, DOI 10.1053/j.ajkd.2012.04.027; Harada Y, 2012, J SLEEP RES, V21, P410, DOI 10.1111/j.1365-2869.2012.00997.x; Buchner NJ, 2007, AM J RESP CRIT CARE, V176, P1274, DOI 10.1164/rccm.200611-1588OC; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Bazzano LA, 2007, HYPERTENSION, V50, P417, DOI 10.1161/HYPERTENSIONAHA.106.085175; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Marshall NS, 2008, SLEEP, V31, P1079; Nakayama-Ashida Y, 2008, SLEEP, V31, P419; Kondo M, 2012, CLIN EXP NEPHROL, V16, P279, DOI 10.1007/s10157-011-0567-1; Drummond M, 2005, METHODS EC EVALUATIO; [Anonymous], 2011, CAN RESPIR J, V18, P25; Fukiyama K, 2000, HYPERTENS RES, V23, P127, DOI 10.1291/hypres.23.127; Gold RM, 1996, COSTEFECTIVENESS HLT; Hisashige T, 2000, ESTIMATION QUALITY L, P67; Hisashige T, 2001, ESTIMATION BURDEN DI, P91; Ikeda Shunya, 2010, Journal of the Japan Diabetes Society, V53, P469; Japanese association of dialysis physicians, 2012, J JPN ASS DIAL PHYS, V27, P91; Jenkinson C, 1997, J SLEEP RES, V6, P199, DOI 10.1046/j.1365-2869.1997.00043.x; Jordan AS, 2013, LANCET, V383, P736; Kimura Y, 1998, INTERNAL MED, V37, P736, DOI 10.2169/internalmedicine.37.736; Ministry of Health Labour and Welfare, 2013, VIT STAT JAP 2011; Saito I, 2008, HYPERTENS RES, V31, P1373, DOI 10.1291/hypres.31.1373; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Tajima R, 2010, CLIN EXP NEPHROL, V14, P340, DOI 10.1007/s10157-010-0304-1; Unwin N, 2000, BRIT J SURG, V87, P328; Tsutani K, 2007, INTERNAL MED, V46, P157, DOI 10.2169/internalmedicine.46.1843; Yokoyama H, 2012, DIABETOLOGIA, V55, P1911, DOI 10.1007/s00125-012-2536-y	40	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1520-9512	1522-1709		SLEEP BREATH	Sleep Breath.	SEP	2015	19	3					1081	1092		10.1007/s11325-015-1134-x		12	Clinical Neurology; Respiratory System	Neurosciences & Neurology; Respiratory System	CQ7DL	WOS:000360763000044		
J	Toyohara, T; Mae, SL; Sueta, SL; Inoue, T; Yamagishi, Y; Kawamoto, T; Kasahara, T; Hoshina, A; Toyoda, T; Tanaka, H; Araoka, T; Sato-Otsubo, A; Takahashi, K; Sato, Y; Yamaji, N; Ogawa, S; Yamanaka, S; Osafune, K				Toyohara, Takafumi; Mae, Shin-lchi; Sueta, Shin-lchi; Inoue, Tatsuyuki; Yamagishi, Yukiko; Kawamoto, Tatsuya; Kasahara, Tomoko; Hoshina, Azusa; Toyoda, Taro; Tanaka, Hiromi; Araoka, Toshikazu; Sato-Otsubo, Aiko; Takahashi, Kazutoshi; Sato, Yasunori; Yamaji, Noboru; Ogawa, Seishi; Yamanaka, Shinya; Osafune, Kenji			Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Nephrons; Kidney; Cell- and tissue-based therapy; Induced pluripotent stem cells; Acute kidney injury; SIX2 protein; Renal progenitors	ISCHEMIA-REPERFUSION INJURY; NEPHRON PROGENITORS; METANEPHRIC MESENCHYME; INTERMEDIATE MESODERM; HUMAN FIBROBLASTS; MAMMALIAN KIDNEY; DIFFERENTIATION; SIX2; EXPRESSION; LINES	Acute kidney injury (AKI) is defined as a rapid loss of renal function resulting from various etiologies, with a mortality rate exceeding 60% among intensive care patients. Because conventional treatments have failed to alleviate this condition, the development of regenerative therapies using human induced pluripotent stem cells (hiPSCs) presents a promising new therapeutic option for AKI. We describe our methodology for generating renal progenitors from hiPSCs that show potential in ameliorating AKI. We established a multistep differentiation protocol for inducing hiPSCs into OSR1(+)SIX2(+) renal progenitors capable of reconstituting three-dimensional proximal renal tubule-like structures in vitro and in vivo. Moreover, we found that renal subcapsular transplantation of hiPSC-derived renal progenitors ameliorated the AKI in mice induced by ischemia/reperfusion injury, significantly suppressing the elevation of blood urea nitrogen and serum creatinine levels and attenuating histopathological changes, such as tubular necrosis, tubule dilatation with casts, and interstitial fibrosis. To our knowledge, few reports demonstrating the therapeutic efficacy of cell therapy with renal lineage cells generated from hiPSCs have been published. Our results suggest that regenerative medicine strategies for kidney diseases could be developed using hiPSC-derived renal cells.	[Toyohara, Takafumi; Mae, Shin-lchi; Sueta, Shin-lchi; Inoue, Tatsuyuki; Kasahara, Tomoko; Hoshina, Azusa; Toyoda, Taro; Tanaka, Hiromi; Araoka, Toshikazu; Takahashi, Kazutoshi; Yamanaka, Shinya; Osafune, Kenji] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Yamagishi, Yukiko; Kawamoto, Tatsuya; Yamaji, Noboru] Astellas Pharma Inc, Drug Discovery Res, Ibaraki, Japan; [Sato-Otsubo, Aiko; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Sato, Yasunori] Chiba Univ Med, Clin Res Ctr, Chiba, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Osafune, K (reprint author), Ctr iPS Cell Res & Applicat, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	osafu@cira.kyoto-u.ac.jp			Leading Project of MEXT; Japan Society for the Promotion of Science through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Japan Science and Technology Agency (JST) through PRESTO; JST Yamanaka iPS Cell Special Project; research grant Core Center for iPS Cell Research and Technological Development; Uehara Memorial Foundation; Takeda Science Foundation; iPS Cell Research Fund; Research Center Network for Realization of Regenerative Medicine	We thank Tomomi Sudo, Nagisa Sakurai, and Yasuhide Masuhara for excellent technical assistance; Erika Moriguchi for excellent secretarial assistance; Katsuhiko Asanuma for the gift of antibodies; Hiroyuki Sakurai, Jonathan Barasch, and Andrew P. McMahon for the gift of cell lines; and Takanori Takebe, Masahiro Enomura, Hiroyuki Koike, Emi Yoshizawa, Hideki Taniguchi, Motoko Yanagita, Satomi Nishijima, Yoh Terada, Kunio Yasunaga, Koji Takakura, Kenichi Suzuki, Hiromu Sato, Kanae Mitsunaga, Akitsu Hotta, Makoto Ikeya, Knut Woltjen, Yasuhiro Yamada, Keisuke Okita, Shinji Masui, Yoshinori Yoshida, Hidetoshi Sakurai, and Kohnosuke Mitani for valuable help and scientific comments. This work was supported by a research grant from the Leading Project of MEXT (to S.Y. and K.O.), the Japan Society for the Promotion of Science through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) (to S.Y. and K.O.), a Grant-in-Aid for Young Scientists (B) (to T. Toyohara), the Japan Science and Technology Agency (JST) through PRESTO (to K.O.), the JST Yamanaka iPS Cell Special Project (to S.Y. and K.O.), the research grant Core Center for iPS Cell Research and Technological Development, Research Center Network for Realization of Regenerative Medicine (to S.Y. and K.O.), and the Uehara Memorial Foundation, Takeda Science Foundation, and iPS Cell Research Fund.	Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Noiri E, 1996, J CLIN INVEST, V97, P2377, DOI 10.1172/JCI118681; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Harari-Steinberg O, 2013, EMBO MOL MED, V5, P1556, DOI 10.1002/emmm.201201584; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Brown AC, 2013, P NATL ACAD SCI USA, V110, P4640, DOI 10.1073/pnas.1213971110; Plisov SY, 2001, DEVELOPMENT, V128, P1045; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Faure S, 2002, DEV BIOL, V244, P44, DOI 10.1006/dbio.2002.0579; Xu JY, 2014, DEVELOPMENT, V141, P1442, DOI 10.1242/dev.103283; SOLEZ K, 1979, MEDICINE, V58, P362; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; De Chiara L, 2014, J AM SOC NEPHROL, V25, P316, DOI 10.1681/ASN.2013040367; Colvin JS, 1999, DEV DYNAM, V216, P72; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Imberti B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08826; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Tena JJ, 2007, DEV BIOL, V301, P518, DOI 10.1016/j.ydbio.2006.08.063; Cantaluppi V, 2013, AM J KIDNEY DIS, V61, P300, DOI 10.1053/j.ajkd.2012.05.027; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; KELLEHER SP, 1987, KIDNEY INT, V31, P725, DOI 10.1038/ki.1987.58; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; James RG, 2006, DEVELOPMENT, V133, P2995, DOI 10.1242/dev.02442; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Kispert A, 1998, DEVELOPMENT, V125, P4225; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Park JS, 2012, DEV CELL, V23, P637, DOI 10.1016/j.devcel.2012.07.008; Araoka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084881; Barasch J, 1997, AM J PHYSIOL-RENAL, V273, pF757; Boucher CA, 2000, GENE, V247, P145, DOI 10.1016/S0378-1119(00)00105-0; Fitzmaurice G, 2004, APPL LONGITUDINAL AN; Jiang S, 2012, EUR J PHARMACOL, V688, P56, DOI 10.1016/j.ejphar.2012.05.001; Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094888; KAWACHI H, 1995, AM J PATHOL, V147, P823; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Oxburgh L, 2004, DEVELOPMENT, V131, P4593, DOI 10.1242/dev.01324; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Prowle JR, 2014, PEDIATR NEPHROL, V29, P13, DOI 10.1007/s00467-013-2411-1; Sakurai H, 1997, P NATL ACAD SCI USA, V94, P6279, DOI 10.1073/pnas.94.12.6279; Susa D, 2009, AGING CELL, V8, P192, DOI 10.1111/j.1474-9726.2009.00463.x; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Wang YX, 2009, J AM SOC NEPHROL, V20, P1544, DOI 10.1681/ASN.2008080843; Xing L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt489	53	0	0	ALPHAMED PRESS	DURHAM	318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	SEP	2015	4	9					980	992		10.5966/sctm.2014-0219		13	Cell & Tissue Engineering	Cell Biology	CQ8PO	WOS:000360871000003		
J	Seki, D; Takeshita, N; Oyanagi, T; Sasaki, S; Takano, I; Hasegawa, M; Takano-Yamamoto, T				Seki, Daisuke; Takeshita, Nobuo; Oyanagi, Toshihito; Sasaki, Shutaro; Takano, Ikuko; Hasegawa, Masakazu; Takano-Yamamoto, Teruko			Differentiation of Odontoblast-Like Cells From Mouse Induced Pluripotent Stem Cells by Pax9 and Bmp4 Transfection	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Induced pluripotent stem cells; Differentiation; Transcriptional factors; Cytokines	DENTAL MESENCHYMAL CELLS; MATRIX PROTEIN-1 DMP1; TOOTH MORPHOGENESIS; EXPRESSION; GENES; TEETH	The field of tooth regeneration has progressed in recent years, and human tooth regeneration could become viable in the future. Because induced pluripotent stem (iPS) cells can differentiate into odontogenic cells given appropriate conditions, iPS cells are a potential cell source for tooth regeneration. However, a definitive method to induce iPS cell-derived odontogenic cells has not been established. We describe a novel method of odontoblast differentiation from iPS cells using gene transfection. We generated mouse iPS cell-derived neural crest-like cells (iNCLCs), which exhibited neural crest markers. Next, we differentiated iNCLCs into odontoblast-like cells by transfection of Pax9 and Bmp4 expression plasmids. Exogenous Pax9 upregulated expression of Msx1 and dentin matrix protein 1(Dmp1) in iNCLCs but not bone morphogenetic protein 4 (Bmp4) or dentin sialophosphoprotein (Dspp). Exogenous Bmp4 upregulated expression of Msx1, Dmp1, and Dspp in iNCLCs, but not Pax9. Moreover, cotransfection of Pax9 and Bmp4 plasmids in iNCLCs revealed a higher expression of Pax9 than when Pax9 plasmid was used alone. In contrast, exogenous Pax9 downregulated Bmp4 overexpression. Cotransfection of Pax9 and Bmp4 synergistically upregulated Dmp1 expression; however, Pax9 overexpression downregulated exogenous Bmp4-induced Dspp expression. Together, these findings suggest that an interaction between exogenous Pax9- and Bmp4-induced signaling modulated Dmp1 and Dspp expression. In conclusion, transfection of Pax9 and Bmp4 expression plasmids in iNCLCs induced gene expression associated with odontoblast differentiation, suggesting that iNCLCs differentiated into odontoblast-like cells. The iPS cell-derived odontoblast-like cells could be a useful cell source for tooth regeneration.	[Seki, Daisuke; Takeshita, Nobuo; Oyanagi, Toshihito; Sasaki, Shutaro; Takano, Ikuko; Hasegawa, Masakazu; Takano-Yamamoto, Teruko] Tohoku Univ, Grad Sch Dent, Div Orthodont & Dentofacial Orthoped, Sendai, Miyagi 9808575, Japan	Takano-Yamamoto, T (reprint author), Tohoku Univ, Grad Sch Dent, Div Orthodont & Dentofacial Orthoped, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	t-yamamo@m.tohoku.ac.jp			Japan Society for the Promotion of Science; Japan Science and Technology Agency	This study was supported by grants from the Japan Society for the Promotion of Science (to T.T.-Y.) and in part from the Japan Science and Technology Agency (to T.T.-Y.).	Otsu K, 2012, STEM CELLS DEV, V21, P1156, DOI 10.1089/scd.2011.0210; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Deshpande AS, 2011, BIOMACROMOLECULES, V12, P2933, DOI 10.1021/bm2005214; Zhou J, 2013, DEVELOPMENT, V140, P4709, DOI 10.1242/dev.099028; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Hirai T, 2014, J BIOL CHEM, V289, P17174, DOI 10.1074/jbc.M113.546135; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Arakaki M, 2012, J BIOL CHEM, V287, P10590, DOI 10.1074/jbc.M111.285874; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Duailibi MT, 2004, J DENT RES, V83, P523; Jia SH, 2013, DEVELOPMENT, V140, P423, DOI 10.1242/dev.081927; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Feng XY, 2013, EUR J ORAL SCI, V121, P412, DOI 10.1111/eos.12078; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Hu B, 2006, TISSUE ENG, V12, P2069, DOI 10.1089/ten.2006.12.2069; LORING J, 1981, DEV BIOL, V82, P86, DOI 10.1016/0012-1606(81)90430-9; Maurin JC, 2009, J ENDODONT, V35, P992, DOI 10.1016/j.joen.2009.04.009; Miletich Isabelle, 2004, Birth Defects Res C Embryo Today, V72, P200, DOI 10.1002/bdrc.20012; Ogawa T, 2006, J BIOL CHEM, V281, P18363, DOI 10.1074/jbc.M601543200; Oshima M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021531; Ozeki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080026; Trainor PA, 2013, NEURAL CREST CELLS E	25	0	0	ALPHAMED PRESS	DURHAM	318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	SEP	2015	4	9					993	997		10.5966/sctm.2014-0292		5	Cell & Tissue Engineering	Cell Biology	CQ8PO	WOS:000360871000004		
J	Mori, E; Minematsu, K; Nakagawara, J; Hasegawa, Y; Nagahiro, S; Okada, Y; Truelsen, T; Lindsten, A; Ogawa, A; Yamaguchi, T				Mori, Etsuro; Minematsu, Kazuo; Nakagawara, Jyoji; Hasegawa, Yasuhiro; Nagahiro, Shinji; Okada, Yasushi; Truelsen, Thomas; Lindsten, Annika; Ogawa, Akira; Yamaguchi, Takenori		DIAS-J Investigators	Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke	STROKE			English	Article						acute ischemic stroke; desmoteplase; DIAS-J; fibrin-dependent plasminogen activator; safety; thrombolysis	MG/KG INTRAVENOUS ALTEPLASE; CHINESE PATIENTS; J-ACT; TRIAL; EFFICACY; THROMBOLYSIS; OCCLUSION; OUTCOMES	Background and Purpose-This study investigated the safety and tolerability of desmoteplase administered within 3 to 9 hours after stroke symptoms onset in Japanese patients with acute ischemic stroke. Methods-Patients were randomized to treatment with either desmoteplase or placebo in a 2: 1 ratio in 2 consecutive cohorts (70 mu g/kg and then 90 mu g/kg). Included patients had a baseline National Institutes of Health Stroke Scale score of 4 to 24 and occlusion or high-grade stenosis in the middle cerebral artery segment M1 or M2 on magnetic resonance angiography. The incidence of symptomatic intracranial hemorrhage (<= 72 hours) was defined as the primary end point. The occurrence of asymptomatic ICH, symptomatic cerebral edemas, and adverse events were other safety outcomes of special interest. Results-Symptomatic intracranial hemorrhage was observed within 72 hours in 2 patients treated with placebo and in 1 patient treated with 70 mu g/kg desmoteplase. Any ICH (symptomatic or asymptomatic ICH) within 72 hours were observed in 7 (43.8%) patients treated with placebo, in 8 (50%) patients treated with 70 mu g/kg desmoteplase, and in 9 (56.3%) patients treated with 90 mu g/kg desmoteplase. Desmoteplase treatment with 70 or 90 mu g/kg was not associated with an increased risk of symptomatic cerebral edema compared with placebo. There were no other serious safety concerns associated with desmoteplase. Conclusions-Desmoteplase in both 70 and 90 mu g/kg doses had a favorable safety profile and was well tolerated in Japanese patients with acute ischemic stroke when administered 3 to 9 hours after stroke symptoms onset.	[Mori, Etsuro] Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 980, Japan; [Minematsu, Kazuo; Yamaguchi, Takenori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Nakagawara, Jyoji] Natl Cerebral & Cardiovasc Ctr, Dept Integrat Stroke Imaging Ctr, Suita, Osaka, Japan; [Hasegawa, Yasuhiro] St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa, Japan; [Nagahiro, Shinji] Univ Tokushima, Grad Sch, Dept Neurosurg, Tokushima 770, Japan; [Okada, Yasushi] Natl Hosp Org, Kyushu Med Ctr, Dept Cerebrovasc Dis, Fukuoka, Japan; [Truelsen, Thomas] H Lundbeck & Co AS, Int Clin Res Neurol, Valby, Denmark; [Lindsten, Annika] H Lundbeck & Co AS, Biostat, Valby, Denmark; [Ogawa, Akira] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 020, Japan	Mori, E (reprint author), Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 980, Japan.	morie@med.tohoku.ac.jp			H. Lundbeck A/S	This study was funded by H. Lundbeck A/S.	Nakagawara J, 2010, STROKE, V41, P1984, DOI 10.1161/STROKEAHA.110.589606; Medcalf RL, 2012, BRIT J PHARMACOL, V165, P75, DOI 10.1111/j.1476-5381.2011.01514.x; Hacke W, 2005, STROKE, V36, P66, DOI 10.1161/01.STR.0000149938.08731.2c; Yamaguchi T, 2006, STROKE, V37, P1810, DOI 10.1161/01.STR.0000227191.01792e3; Hacke W, 2009, LANCET NEUROL, V8, P141, DOI 10.1016/S1474-4422(08)70267-9; Albers GW, 2015, LANCET NEUROL, V14, P575, DOI 10.1016/S1474-4422(15)00047-2; Furlan AJ, 2006, STROKE, V37, P1227, DOI 10.1161/01.STR.0000217403.66996.6d; Chao AC, 2014, STROKE, V45, P2359, DOI 10.1161/STROKEAHA.114.005245; Chao AC, 2010, STROKE, V41, P885, DOI 10.1161/STROKEAHA.109.575605; Mori E, 2012, ANN NY ACAD SCI, V1268, P108, DOI 10.1111/j.1749-6632.2012.06689.x; Mori E, 2010, STROKE, V41, P461, DOI 10.1161/STROKEAHA.109.573477	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	SEP	2015	46	9					2549	2554		10.1161/STROKEAHA.115.009917		6	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CQ9FZ	WOS:000360919700036		
J	Yamauchi, H; Kagawa, S; Kishibe, Y; Takahashi, M; Nishii, R; Mizuma, H; Takahashi, K; Onoe, H; Higashi, T				Yamauchi, Hiroshi; Kagawa, Shinya; Kishibe, Yoshihiko; Takahashi, Masaaki; Nishii, Ryuichi; Mizuma, Hiroshi; Takahashi, Kazuhiro; Onoe, Hirotaka; Higashi, Tatsuya			Increase in [F-18]-Fluoroacetate Uptake in Patients With Chronic Hemodynamic Cerebral Ischemia	STROKE			English	Article						carotid artery, internal; fluoroacetates; infarction; positron-emission tomography; stroke	POSITRON-EMISSION-TOMOGRAPHY; METABOLISM; PERFUSION	Background and Purpose-[F-18]-fluoroacetate (F-18-FACE) can be used for evaluating glial cell metabolism. Experimental studies have shown an increase in F-18-FACE uptake in rodent models of cerebral ischemia. The aim of this study was to determine whether F-18-FACE uptake is increased in the noninfarcted cerebral cortex in patients with hemodynamic ischemia owing to atherosclerotic internal carotid artery or middle cerebral artery disease. Methods-We evaluated 9 symptomatic patients with unilateral atherosclerotic internal carotid artery or middle cerebral artery disease and no cortical infarction using positron emission tomography with F-18-FACE and O-15-gases. F-18-FACE uptake during 40 to 60 minutes after injection was compared with the cerebral blood flow, cerebral metabolic rate of oxygen, oxygen extraction fraction, and cerebral blood volume in the middle cerebral artery distributions. Results-Significant decreases of cerebral blood flow and cerebral metabolic rate of oxygen and increases of oxygen extraction fraction and cerebral blood volume were found in the hemisphere ipsilateral to the arterial lesion, and F-18-FACE uptake in this region was greater than that in the contralateral hemisphere. The relative F-18-FACE uptake (ipsilateral/contralateral ratio) was negatively correlated with cerebral blood flow or cerebral metabolic rate of oxygen values and was positively correlated with oxygen extraction fraction values. Multivariate analysis showed that the ipsilateral/contralateral F-18-FACE uptake ratio was independently correlated with the cerebral blood flow (or oxygen extraction fraction) and cerebral metabolic rate of oxygen values. Conclusions-In patients with atherosclerotic internal carotid artery or middle cerebral artery disease, F-18-FACE uptake is increased in the noninfarcted cerebral cortex with chronic hemodynamic ischemia characterized by misery perfusion with decreased oxygen metabolism. Increased F-18-FACE uptake may indicate the cortical regions that are at particular risk for ischemic damage.	[Yamauchi, Hiroshi; Kagawa, Shinya; Kishibe, Yoshihiko; Takahashi, Masaaki; Higashi, Tatsuya] Shiga Med Ctr, Res Inst, Div PET Imaging, Moriyama 5248524, Japan; [Nishii, Ryuichi] Miyazaki Univ, Fac Med, Dept Radiol, Miyazaki, Japan; [Mizuma, Hiroshi; Onoe, Hirotaka] RIKEN Ctr Life Sci Technol, Biofunct Imaging Team, Kobe, Hyogo, Japan; [Takahashi, Kazuhiro] RIKEN Ctr Life Sci Technol, Clin Applicat Unit, Kobe, Hyogo, Japan	Yamauchi, H (reprint author), Shiga Med Ctr, Res Inst, Div PET Imaging, 5-4-30 Moriyama, Moriyama 5248524, Japan.	yamauchi@res.med.shiga-pref.jp			Japan Society for the Promotion of Science KAKENHI [26461323, 26461816, 23300361]	This study was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 26461323, 26461816, and 23300361.	Marik J, 2009, J NUCL MED, V50, P982, DOI 10.2967/jnumed.108.057356; POWERS WJ, 1991, ANN NEUROL, V29, P231, DOI 10.1002/ana.410290302; BARON JC, 1981, STROKE, V12, P454; Mizuma H, 2013, J NUCL MED S2, V54, P1758; Nishii R, 2012, MOL IMAGING BIOL, V14, P213, DOI 10.1007/s11307-011-0485-3; Okazawa H, 2001, J CEREBR BLOOD F MET, V21, P793; Ouyang Y, 2014, J CEREBR BLOOD F MET, V34, P836, DOI 10.1038/jcbfm.2014.22; Takemoto K, 2014, ANN NUCL MED, V28, P371, DOI 10.1007/s12149-014-0823-z; YAMAUCHI H, 1990, STROKE, V21, P1400; Yamauchi H, 2007, ANN NEUROL, V61, P454, DOI 10.1002/ana.21104	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	SEP	2015	46	9					2669	2672		10.1161/STROKEAHA.115.010080		4	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CQ9FZ	WOS:000360919700053		
J	Maheshwari, A; Obbineni, JM; Bui, KH; Shibata, K; Toyoshima, YY; Ishikawa, T				Maheshwari, Aditi; Obbineni, Jagan Mohan; Bui, Khanh Huy; Shibata, Keitaro; Toyoshima, Yoko Y.; Ishikawa, Takashi			alpha- and beta-Tubulin Lattice of the Axonemal Microtubule Doublet and Binding Proteins Revealed by Single Particle Cryo-Electron Microscopy and Tomography	STRUCTURE			English	Article							INNER DYNEIN ARMS; MOLECULAR ARCHITECTURE; FLAGELLAR MICROTUBULES; RADIAL SPOKES; MOTOR DOMAIN; IN-SITU; CHLAMYDOMONAS; CILIA; VISUALIZATION; ARRANGEMENT	Microtubule doublet (MTD) is the main skeleton of cilia/flagella. Many proteins, such as dyneins and radial spokes, bind to MTD, and generate or regulate force. While the structure of the reconstituted microtubule has been solved at atomic resolution, nature of the axonemal MTD is still unclear. There are a few hypotheses of the lattice arrangement of its alpha- and beta-tubulins, but it has not been described how dyneins and radial spokes bind to MTD. In this study, we analyzed the three-dimensional structure of Tetrahymena MTD at similar to 19 angstrom resolution by single particle cryo-electron microscopy. To identify alpha- and beta-tubulins, we combined image analysis of MTD with specific kinesin decoration. This work reveals that alpha-and beta-tubulins form a B-lattice arrangement in the entire MTD with a seam at the outer junction. We revealed the unique way in which inner arm dyneins, radial spokes, and proteins inside MTD bind and bridge protofilaments.	[Maheshwari, Aditi; Obbineni, Jagan Mohan; Bui, Khanh Huy; Ishikawa, Takashi] Paul Scherrer Inst, Biomol Res Lab, CH-5232 Villigen, Switzerland; [Maheshwari, Aditi] ETH, Dept Biol, CH-8093 Zurich, Switzerland; [Shibata, Keitaro; Toyoshima, Yoko Y.] Univ Tokyo, Dept Life Sci Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	Ishikawa, T (reprint author), Paul Scherrer Inst, Biomol Res Lab, CH-5232 Villigen, Switzerland.	takashi.ishikawa@psi.ch			Swiss National Science Foundation [NF31003A-125131/1, NF3100A-144035]; NCCBI; ETHIIRA; Swiss-Japan Cooperative Research Fund	We thank Dr. Andrea Prota, Prof. Michel Steinmetz (PSI), and Prof. Masahide Kikkawa (U. Tokyo) for helpful discussion, Prof. Timothy J. Richmond (ETH Zurich) for biochemical facilities, Dr. Roger Wepf and Peter Tittmann (EMEZ, ETH Zurich) for technical support on EM, and Dr. David F. Sargent (ETH Zurich) and Ms Katherine Marie Thieltges (PSI) for critical reading of the manuscript. This work was funded by grants from the Swiss National Science Foundation (NF31003A-125131/1 and NF3100A-144035), NCCBI, Swiss-Japan Cooperative Research Fund, and ETHIIRA (to T.I.). All commercial affiliations/conflicts of interest have been disclosed.	Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Bui KH, 2012, J CELL BIOL, V198, P913, DOI 10.1083/jcb.201201120; Pigino G, 2011, J CELL BIOL, V195, P673, DOI 10.1083/jcb.201106125; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Pigino G, 2012, J STRUCT BIOL, V178, P199, DOI 10.1016/j.jsb.2012.02.012; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Movassagh T, 2010, NAT STRUCT MOL BIOL, V17, P761, DOI 10.1038/nsmb.1832; Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; Heuser T, 2012, P NATL ACAD SCI USA, V109, pE2067, DOI 10.1073/pnas.1120690109; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; AMOS LA, 1974, J CELL SCI, V14, P523; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Bui KH, 2008, J CELL BIOL, V183, P923, DOI 10.1083/jcb.200808050; Maheshwari A, 2012, J STRUCT BIOL, V179, P235, DOI 10.1016/j.jsb.2012.04.018; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sui HX, 2006, NATURE, V442, P475, DOI 10.1038/nature04816; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Bui KH, 2009, J CELL BIOL, V186, P437, DOI 10.1083/jcb.200903082; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; GOODENOUGH UW, 1985, CELL, V41, P341, DOI 10.1016/S0092-8674(85)80003-9; GOODENOUGH UW, 1985, J CELL BIOL, V100, P2008, DOI 10.1083/jcb.100.6.2008; KIKKAWA M, 1994, J CELL BIOL, V127, P1965, DOI 10.1083/jcb.127.6.1965; Konno A, 2012, INT REV CEL MOL BIO, V294, P133, DOI 10.1016/B978-0-12-394305-7.00003-3; Linck R, 2014, J BIOL CHEM, V289, P17427, DOI 10.1074/jbc.M114.568949; Linck RW, 2007, CELL MOTIL CYTOSKEL, V64, P489, DOI 10.1002/cm.20202; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Nicastro D, 2011, P NATL ACAD SCI USA, V108, pE845, DOI 10.1073/pnas.1106178108; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Orias E, 2000, METHOD CELL BIOL, V62, P189; Porter ME, 1996, CURR OPIN CELL BIOL, V8, P10, DOI 10.1016/S0955-0674(96)80042-1; SONG YH, 1993, P NATL ACAD SCI USA, V90, P1671, DOI 10.1073/pnas.90.5.1671; SONG YH, 1995, J CELL BIOL, V128, P81, DOI 10.1083/jcb.128.1.81; Yanagisawa H, 2014, MOL BIOL CELL, V25, P1472, DOI 10.1091/mbc.E13-08-0464	41	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0969-2126	1878-4186		STRUCTURE	Structure	SEP 1	2015	23	9					1584	1595		10.1016/j.str.2015.06.017		12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CR1VJ	WOS:000361113000005		
J	Maruyama, Y; Itoh, T; Kaneko, A; Nishitani, Y; Mikami, B; Hashimoto, W; Murata, K				Maruyama, Yukie; Itoh, Takafumi; Kaneko, Ai; Nishitani, Yu; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			Structure of a Bacterial ABC Transporter Involved in the Import of an Acidic Polysaccharide Alginate	STRUCTURE			English	Article							SPHINGOMONAS SP A1; BINDING CASSETTE TRANSPORTER; SP STRAIN A1; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MALTOSE TRANSPORTER; PRIMARY RECEPTOR; CELL SURFACE; MECHANISM; PROTEIN	The acidic polysaccharide alginate represents a promising marine biomass for the microbial production of biofuels, although themolecular and structural characteristics of alginate transporters remain to be clarified. In Sphingomonas sp. A1, the ATP-binding cassette transporter AlgM1M2SS is responsible for the import of alginate across the cytoplasmic membrane. Here, we present the substrate-transport characteristics and quaternary structure of AlgM1M2SS. The addition of poly-or oligoalginate enhanced the ATPase activity of reconstituted AlgM1M2SS coupled with one of the periplasmic solute-binding proteins, AlgQ1 or AlgQ2. External fluorescence-labeled oligoalginates were specifically imported into AlgM1M2SS-containing proteoliposomes in the presence of AlgQ2, ATP, and Mg2+. The crystal structure of AlgQ2-bound AlgM1M2SS adopts an inward-facing conformation. The interaction between AlgQ2 and AlgM1M2SS induces the formation of an alginate-binding tunnel-like structure accessible to the solvent. The translocation route inside the transmembrane domains contains charged residues suitable for the import of acidic saccharides.	[Maruyama, Yukie; Itoh, Takafumi; Kaneko, Ai; Nishitani, Yu; Hashimoto, Wataru; Murata, Kousaku] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Uji, Kyoto 6110011, Japan	Murata, K (reprint author), Setsunan Univ, Fac Sci & Engn, Neyagawa, Osaka 5728508, Japan.	whasimot@kais.kyoto-u.ac.jp; k-murata@lif.setsunan.ac.jp			Japanese Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology in Japan	We thank Ms. Kasumi Uenishi, Ms. Chizuru Tokunaga, Ms. Ai Matsunami, and Mr. Takuya Yokoyama for their excellent technical assistance. The synchrotron radiation experiments were performed at beamlines BL38B1, BL41XU, and BL44XU of SPring-8 with the approval of the Japanese Synchrotron Radiation Research Institute (JASRI) (Proposal Nos. 2013A1106, 2012B1265, 2012A1317, 2011B1108, 2011B2055, 2011A1186, 2010B6500, 2010A1279, and 2009B1177). This work was supported in part by Grants-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science and Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (B.M., W.H., and K.M.).	Takeda H, 2011, ENERG ENVIRON SCI, V4, P2575, DOI 10.1039/c1ee01236c; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; Momma K, 2000, J BACTERIOL, V182, P3998, DOI 10.1128/JB.182.14.3998-4004.2000; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; Edwards MC, 2012, APPL MICROBIOL BIOT, V95, P565, DOI 10.1007/s00253-012-4173-2; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Hayashi C, 2014, J BACTERIOL, V196, P2691, DOI 10.1128/JB.01666-14; HISANO T, 1995, J FERMENT BIOENG, V79, P538, DOI 10.1016/0922-338X(95)94744-C; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Oldham ML, 2013, P NATL ACAD SCI USA, V110, P18132, DOI 10.1073/pnas.1311407110; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Losen M, 2004, BIOTECHNOL PROGR, V20, P1062, DOI 10.1021/bp034821; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Grohmann K, 1998, BIOTECHNOL LETT, V20, P195, DOI 10.1023/A:1005349112770; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Aso Y, 2006, NAT BIOTECHNOL, V24, P188, DOI 10.1038/nbt1181; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hisano T, 1996, BIOCHEM BIOPH RES CO, V220, P979, DOI 10.1006/bbrc.1996.0526; Hugouvieux-Cotte-Pattat N, 2001, MOL MICROBIOL, V41, P1113, DOI 10.1046/j.1365-2958.2001.02564.x; Ishii T, 2002, CARBOHYD RES, V337, P1023, DOI 10.1016/S0008-6215(02)00087-3; Maruyama Y, 2012, ACTA CRYSTALLOGR F, V68, P317, DOI 10.1107/S1744309112001893; Mishima Y, 2003, J BIOL CHEM, V278, P6552, DOI 10.1074/jbc.M209932200; Momma K, 2005, BIOCHEMISTRY-US, V44, P5053, DOI 10.1021/bi047781r; Nishitani Y, 2012, BIOCHEMISTRY-US, V51, P3622, DOI 10.1021/bi300194f; Slotboom DJ, 2014, NAT REV MICROBIOL, V12, P79, DOI 10.1038/nrmicro3175; Sugiyama S, 1996, J BIOL CHEM, V271, P9519; Tan KM, 2013, PROTEINS, V81, P1709, DOI 10.1002/prot.24305; Wang SP, 2014, ACTA CRYSTALLOGR D, V70, P196, DOI 10.1107/S1399004713026333; YONEMOTO Y, 1992, J FERMENT BIOENG, V73, P225, DOI 10.1016/0922-338X(92)90165-Q; Yoon HJ, 2000, PROTEIN EXPRES PURIF, V19, P84, DOI 10.1006/prep.2000.1226	39	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0969-2126	1878-4186		STRUCTURE	Structure	SEP 1	2015	23	9					1643	1654		10.1016/j.str.2015.06.021		12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CR1VJ	WOS:000361113000010		
J	Honda, RP; Xu, M; Yamaguchi, K; Roder, H; Kuwata, K				Honda, Ryo P.; Xu, Ming; Yamaguchi, Kei-ichi; Roder, Heinrich; Kuwata, Kazuo			A Native-like Intermediate Serves as a Branching Point between the Folding and Aggregation Pathways of the Mouse Prion Protein	STRUCTURE			English	Article							MOLTEN GLOBULE STATE; ULTRARAPID MIXING EXPERIMENTS; STRUCTURAL-CHARACTERIZATION; DOMAIN PRP(121-231); NMR-SPECTROSCOPY; ACIDIC PH; APOMYOGLOBIN; SCRAPIE; KINETICS; BETA(2)-MICROGLOBULIN	Transient folding intermediates and/or partially unfolded equilibrium states are thought to play a key role in the formation of protein aggregates. However, there is only indirect evidence linking accumulation of folding intermediates to aggregation, and the underlying mechanism remains to be elucidated. Here, we show that a partially unfolded state of the prion protein accumulates both as a stable equilibrium state at acidic pH (A-state) and as a late folding intermediate. With a time resolution of approximately 60 ms, we systematically studied the kinetics of folding and unfolding, starting from various initial conditions including the U-, N-, and A-states. Quantitative modeling showed that the observed kinetic data are completely consistent with a sequential four-state mechanism where the A-state is a late folding intermediate. Combined with previous evidence linking A-state accumulation to aggregation, the results indicate that this native-like state serves as a branching point between the folding and aggregation pathways.	[Honda, Ryo P.] Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Gifu 5011193, Japan; [Xu, Ming; Roder, Heinrich] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Yamaguchi, Kei-ichi; Kuwata, Kazuo] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011194, Japan; [Roder, Heinrich] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Kuwata, Kazuo] Gifu Univ, Grad Sch Med, Dept Gene Dev, Gifu 5011193, Japan	Kuwata, K (reprint author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	heinrich.roder@fccc.edu; kuwata@gifu-u.ac.jp	Roder, Heinrich/B-3455-2009		Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; NSF [MCB-1412378]; NIH [R01 GM056250, CA06927]	We thank Yumiko Okuda and the Life Science Research Center in Gifu University for assistance with the experiments. This work was supported by grants from the Ministry of Health, Labor, and Welfare of Japan (Research on Measures for Intractable Diseases [Prion Disease and Slow Virus Infections, and Development of Low Molecular Weight Medical Chaperone Therapeutics for Prion Diseases]) and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grants-in Aid for Scientific Research, and X-ray Free Electron Laser [XFEL] Program). Funding was also received from NSF grant MCB-1412378 and NIH grant R01 GM056250 (to H.R.) and an NIH P30 grant CA06927 (to the Fox Chase Cancer Center).	Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Singh J, 2014, J AM CHEM SOC, V136, P16704, DOI 10.1021/ja510964t; Apetri AC, 2006, J AM CHEM SOC, V128, P11673, DOI 10.1021/ja063880b; Hart T, 2009, P NATL ACAD SCI USA, V106, P5651, DOI 10.1073/pnas.0811457106; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Mukaiyama A, 2013, J MOL BIOL, V425, P257, DOI 10.1016/j.jmb.2012.11.004; Kamatari YO, 2013, PROTEIN SCI, V22, P22, DOI 10.1002/pro.2180; Apetri AC, 2002, J BIOL CHEM, V277, P44589, DOI 10.1074/jbc.C200507200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Singh J, 2015, ANGEW CHEM INT EDIT, V54, P7529, DOI 10.1002/anie.201501011; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Miller MB, 2013, STRUCTURE, V21, P2061, DOI 10.1016/j.str.2013.08.025; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Gorski SA, 2001, J MOL BIOL, V312, P849, DOI 10.1006/jmbi.2001.5001; Arai M, 2002, J MOL BIOL, V321, P121, DOI 10.1016/S0022-2836(02)00566-1; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Jain S, 2008, J MOL BIOL, V382, P1228, DOI 10.1016/j.jmb.2008.07.052; Raschke TM, 1997, NAT STRUCT BIOL, V4, P298, DOI 10.1038/nsb0497-298; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Kuwata K, 2007, P NATL ACAD SCI USA, V104, P11921, DOI 10.1073/pnas.0702671104; Capaldi AP, 2001, NAT STRUCT BIOL, V8, P68; Chen KC, 2011, BIOPHYS J, V101, P1221, DOI 10.1016/j.bpj.2011.07.024; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Honda RP, 2014, J BIOL CHEM, V289, P30355, DOI 10.1074/jbc.M114.559450; Eliezer D, 1997, FEBS LETT, V417, P92, DOI 10.1016/S0014-5793(97)01256-8; ELIEZER D, 1995, SCIENCE, V270, P487, DOI 10.1126/science.270.5235.487; JENG MF, 1990, BIOCHEMISTRY-US, V29, P10433, DOI 10.1021/bi00498a001; Masel J, 2005, J MOL BIOL, V345, P1243, DOI 10.1016/j.jmb.2004.10.088; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Mukaiyama A, 2013, J MOL BIOL, V425, P273, DOI 10.1016/j.jmb.2012.11.002; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; Roder H, 2006, CHEM REV, V106, P1836, DOI 10.1021/cr040430y; Roder H, 2004, METHODS, V34, P15, DOI 10.1016/j.ymeth.2004.03.003; Shastry MCR, 1998, BIOPHYS J, V74, P2714; Xu M, 2012, J PHYS CHEM B, V116, P7014, DOI 10.1021/jp3012365	51	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0969-2126	1878-4186		STRUCTURE	Structure	SEP 1	2015	23	9					1735	1742		10.1016/j.str.2015.07.001		8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CR1VJ	WOS:000361113000018		
J	Hauer, F; Gerle, C; Fischer, N; Oshima, A; Shinzawa-Itoh, K; Shimada, S; Yokoyama, K; Fujiyoshi, Y; Stark, H				Hauer, Florian; Gerle, Christoph; Fischer, Niels; Oshima, Atsunori; Shinzawa-Itoh, Kyoko; Shimada, Satoru; Yokoyama, Ken; Fujiyoshi, Yoshinori; Stark, Holger			GraDeR: Membrane Protein Complex Preparation for Single-Particle Cryo-EM	STRUCTURE			English	Article							BOVINE HEART-MITOCHONDRIA; ELECTRON CRYOMICROSCOPY; ION-CHANNEL; 2-DIMENSIONAL CRYSTALLIZATION; THERMUS-THERMOPHILUS; RYANODINE RECEPTOR; AQUEOUS-SOLUTIONS; V-ATPASE; SYNTHASE; CONFORMATIONS	We developed a method, named GraDeR, which substantially improves the preparation of membrane protein complexes for structure determination by single-particle cryo-electron microscopy (cryo-EM). In GraDeR, glycerol gradient centrifugation is used for the mild removal of free detergent monomers and micelles from lauryl maltose-neopentyl glycol detergent stabilized membrane complexes, resulting in mono-disperse and stable complexes to which standard processes for water-soluble complexes can be applied. We demonstrate the applicability of the method on three different membrane complexes, including the mammalian FoF1 ATP synthase. For this highly dynamic and fragile rotary motor, we show that GraDeR allows visualizing the asymmetry of the F-1 domain, which matches the ground state structure of the isolated domain. Therefore, the present cryo-EM structure of FoF1 ATP synthase provides direct structural evidence for Boyer's binding change mechanism in the context of the intact enzyme.	[Hauer, Florian; Fischer, Niels; Stark, Holger] Max Planck Inst Biophys Chem, Electron Cryomicroscopy Grp 3D, D-37077 Gottingen, Germany; [Gerle, Christoph; Shinzawa-Itoh, Kyoko; Shimada, Satoru] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, Dept Life Sci, Ako, Hyogo 6781297, Japan; [Gerle, Christoph] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Oshima, Atsunori; Fujiyoshi, Yoshinori] Nagoya Univ, Cellular & Struct Physiol Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yokoyama, Ken] Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan; [Stark, Holger] Univ Gottingen, Inst Microbiol & Genet, Dept Electron Cryomicroscopy 3D, D-37077 Gottingen, Germany	Stark, H (reprint author), Max Planck Inst Biophys Chem, Electron Cryomicroscopy Grp 3D, Fassberg 11, D-37077 Gottingen, Germany.	gerle.christoph@gmail.com; hstark1@gwdg.de			Special Coordination Fund for Promoting Science and Technology of MEXT, Japan; MEXT, Japan; JST/CREST; Japan New Energy and Industrial Technology Development Organization (NEDO); National Institute of Biomedical Innovation; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 860];  [22227004]	We would like to thank Dario Ortiz for purification of Streptomyces reticuli HbpS, and Masasuke Yoshida and Hiroyuki Noji for the discussion of PS3 F<INF>o</INF>F<INF>1</INF> ATP synthase crosslinking experiments in synthesis mode. We are grateful to Tomitake Tsukihara and Shinya Yoshikawa for continuous encouragement and assistance. This research was supported by the Special Coordination Fund for Promoting Science and Technology of MEXT, Japan (to C.G.), a Platform for Drug Design, Discovery and Development grant from MEXT, Japan (to C.G. and A.O.), the JST/CREST (to C.G.), a Grants-in-Aid for Scientific Research (S) (22227004), by the Japan New Energy and Industrial Technology Development Organization (NEDO), the National Institute of Biomedical Innovation (to Y.F.), and the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 860 (to H.S.). Purification of bovine F<INF>o</INF>F<INF>1</INF> ATP synthase was supported by a Grants-in-Aid for Scientific Research (A) (to S.Y. and K.S-I.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Oshima A, 2013, J BIOL CHEM, V288, P10513, DOI 10.1074/jbc.M112.428383; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Schmidt-Krey I, 2011, MICRON, V42, P107, DOI 10.1016/j.micron.2010.07.004; HARAUZ G, 1986, OPTIK, V73, P146; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Chung KY, 2012, J BIOL CHEM, V287, P36305, DOI 10.1074/jbc.M112.406371; Signorell GA, 2007, J STRUCT BIOL, V157, P321, DOI 10.1016/j.jsb.2006.07.011; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Sander B, 2003, J STRUCT BIOL, V142, P392, DOI 10.1016/S1047-8477(03)00072-8; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Chae PS, 2010, NAT METHODS, V7, P1003, DOI [10.1038/nmeth.1526, 10.1038/NMETH.1526]; Gerle C, 2006, J STRUCT BIOL, V153, P200, DOI 10.1016/j.jsb.2005.11.004; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Tao HC, 2013, NAT METHODS, V10, P759, DOI [10.1038/nmeth.2533, 10.1038/NMETH.2533]; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; Runswick MJ, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120160; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; Maeda S, 2013, ACTA CRYSTALLOGR F, V69, P1368, DOI 10.1107/S1744309113029072; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Rubinstein JL, 2007, METHODS, V41, P409, DOI 10.1016/j.ymeth.2006.07.019; Wallin E, 1998, PROTEIN SCI, V7, P1029; Oshima A, 2014, FEBS LETT, V588, P1230, DOI 10.1016/j.febslet.2014.01.042; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Jiko C., 2015, ELIFE, V4, DOI [10.7554/eLife.06119, DOI 10.7554/ELIFE.06119]; Kim JM, 2015, NATURE, V517, P396, DOI 10.1038/nature13872; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Liao MF, 2014, CURR OPIN STRUC BIOL, V27, P1, DOI 10.1016/j.sbi.2014.02.005; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Popot JL, 2010, ANNU REV BIOCHEM, V79, P737, DOI 10.1146/annurev.biochem.052208.114057; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950	42	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0969-2126	1878-4186		STRUCTURE	Structure	SEP 1	2015	23	9					1769	1775		10.1016/j.str.2015.06.029		7	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CR1VJ	WOS:000361113000021		
J	Fujishiro, H; Itoh, Y; Yanagi, Y; Nakamura, T				Fujishiro, Hiroyuki; Itoh, Yoshitaka; Yanagi, Yousuke; Nakamura, Takashi			Drastic improvement of the trapped field homogeneity in a superconducting hollow bulk by the insertion of a high-J(c) superconducting cylinder for NMR bulk magnets	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						numerical simulation; superconducting bulks; NMR magnet; trapped field	MAGNETIZATION	Three-dimensional (3D) numerical simulation has been performed for the field-cooled magnetization (FCM) process of REBaCuO superconducting bulk cylinders applicable to the bulk magnet for a 200 MHz (4.7 T) nuclear magnetic resonance (NMR). The influence of the position and size of the defect in the bulk on the inhomogeneity of the trapped field in the hollow space has been investigated. The trapped field profile changes depending on the position and the size of the defect, and the inhomogeneity of the trapped field can be drastically improved by inserting a superconducting thin cylinder with a critical current density (J(c2)) higher than that of the bulk cylinder (J(c1)). The superconducting current flows mainly on the outermost surface of the inserted thin cylinder to compensate for the inhomogeneous trapped field caused by the defect. The insertion of the superconducting thin cylinder with a higher J(c2) is significantly effective for the practical realization of a compact NMR bulk magnet.	[Fujishiro, Hiroyuki] Iwate Univ, Fac Engn, Morioka, Iwate 0208551, Japan; [Itoh, Yoshitaka; Yanagi, Yousuke] IMRA Mat R&D Co Ltd, Kariya, Aichi 4480032, Japan; [Nakamura, Takashi] RIKEN, Wako, Saitama 3510198, Japan	Fujishiro, H (reprint author), Iwate Univ, Fac Engn, 4-3-5 Ueda, Morioka, Iwate 0208551, Japan.	fujishiro@iwate-u.ac.jp			'Development of System and Technology for Advanced Measurement and Analysis' project of the Japan Science and Technology Agency (JST)	The authors thank Dr T Naito of Iwate University for the valuable discussion. This study was financially supported by the 'Development of System and Technology for Advanced Measurement and Analysis' project of the Japan Science and Technology Agency (JST).	Hashi K, 2015, J MAGN RESON, V256, P30, DOI 10.1016/j.jmr.2015.04.009; BEAN CP, 1962, PHYS REV LETT, V8, P250, DOI 10.1103/PhysRevLett.8.250; Durrell JH, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/8/082001; Fujishiro H, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/6/065019; Tamada D, 2013, PHYSICA C, V492, P174, DOI 10.1016/j.physc.2013.06.016; Tomita M, 2003, NATURE, V421, P517, DOI 10.1038/nature01350; Nakamura T, 2007, CONCEPT MAGN RESON B, V31B, P65, DOI 10.1002/cmr.b.20083; Ogawa K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3598440; Fujishiro H, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/10/105021; Inoue M, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2247456; Kii T, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2180498; ltoh Y, 2014, ITOH Y, Patent No. 2014-127301; Nakamura T, 2011, J CRYO SOC JAPAN, V46, P139; Sakai N, 2011, J CRYO SOC JAPAN, V46, P131; Watanabe K, 2011, SUPERCOND CRYO, V13, P1	15	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	SEP	2015	28	9							095018	10.1088/0953-2048/28/9/095018		8	Physics, Applied; Physics, Condensed Matter	Physics	CQ9NU	WOS:000360942700025		
J	Kojima, T; Kuroiwa, K; Takahashi, T; Fujii, Y; Uzawa, Y; Asayama, S; Noguchi, T				Kojima, Takafumi; Kuroiwa, Koichi; Takahashi, Toshikazu; Fujii, Yumi; Uzawa, Yoshinori; Asayama, Shin'ichiro; Noguchi, Takashi			Design and performance of mass-produced sideband separating SIS mixers for ALMA band 4 receivers	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						superconductor-insulator-superconductor mixer; Atacama large millimeter/submillimeter array; low noise; sideband separating mixer	GHZ IF	We have designed and mass-produced low-noise sideband separating superconductor-insulator-superconductor (SIS) mixers for the Atacama Large Millimeter/submillimeter Array (ALMA) band 4 over the frequency range of 125-163 GHz. An integrated design was adopted for the band 4 sideband separating (2SB) mixer block because of the advantages it offers in terms of compactness, reduced testing time and lower cost. The mixer chip was designed to be robust for handling errors to avoid performance degradation caused by generation of the higher order mode in the mixer chip slot. Detailed analyses revealed its robustness and ability to ensure mass production of the 2SB mixers. Using the robust mixer design in addition to well-established waveguide technologies, all of the 2SB mixers met ALMA specifications for noise temperature and image rejection ratio.	[Kojima, Takafumi; Kuroiwa, Koichi; Takahashi, Toshikazu; Fujii, Yumi; Uzawa, Yoshinori; Noguchi, Takashi] Natl Inst Nat Sci, Natl Astron Observ Japan, Adv Technol Ctr, Mitaka, Tokyo 1818588, Japan; [Kuroiwa, Koichi] Osaka Prefecture Univ, Grad Sch Sci, Naka Ku, Sakai, Osaka 5998531, Japan; [Asayama, Shin'ichiro] Natl Astron Observ Japan, NAOJ Chile Observ, Mitaka, Tokyo 1818588, Japan	Kojima, T (reprint author), Natl Inst Nat Sci, Natl Astron Observ Japan, Adv Technol Ctr, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	t.kojima@nao.ac.jp					TUCKER JR, 1985, REV MOD PHYS, V57, P1055, DOI 10.1103/RevModPhys.57.1055; Shi SC, 1997, IEEE T APPL SUPERCON, V7, P3850; Asayama S, 2003, INT J INFRARED MILLI, V24, P1091, DOI 10.1023/A:1024733232384; Asayama S, 2004, INT J INFRARED MILLI, V25, P107, DOI 10.1023/B:IJIM.0000012766.63015.8c; Asayama S, 2014, PUBL ASTRON SOC JAPA, V66; Asayama S, 2008, 19 INT S SPAC TER TE; Claude S. M. X., 2003, P 14 INT S SPAC THZ, P22; Claude SMX, 316 ALMA; Gonzalez A, 2014, PROC SPIE, V9153, DOI 10.1117/12.2055598; Gonzalez A, 2012, P 37 INT C INFR MILL; Kerr AR, 1998, P 9 INT S SPAC TER T, P215; Satou N, 2008, PUBL ASTRON SOC JPN, V60, P1199; Tamura T, 2015, IEEE T APPL SUPERCON, V25; Gonzalez A, 2014, IEEE T THZ SCI TECHN, V4, P184, DOI 10.1109/TTHZ.2013.2294093; Uzawa Y, 2013, PHYSICA C, V494, P189, DOI 10.1016/j.physc.2013.04.008; Vassilev V, 2001, P 12 INT S SPAC TER, P373	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	SEP	2015	28	9							094001	10.1088/0953-2048/28/9/094001		11	Physics, Applied; Physics, Condensed Matter	Physics	CQ9NU	WOS:000360942700006		
J	Naito, T; Yoshida, T; Fujishiro, H				Naito, Tomoyuki; Yoshida, Takafumi; Fujishiro, Hiroyuki			Ti-doping effects on magnetic properties of dense MgB2 bulk superconductors	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						MgB2; superconducting bulk magnet; Ti-doping	CRITICAL CURRENTS; HIGH-PRESSURE; HARD SUPERCONDUCTORS; MAGNESIUM DIBORIDE; FIELD	We have studied the effects of Ti doping on the magnetic properties of MgB2 superconducting bulks. The trapped field, which was obtained by field-cooled magnetization, B-T(FC), was about 3.6 T at 13 K at the surface of the single Ti5-20% doped MgB2 bulks, which was about 1.3 times larger than that of the non-doped bulk. The B-T(FC) of 4.6 T was achieved at 14.1 K in the centre of the doubly stacked Ti-doped MgB2 bulks. The remanent magnetic flux density, which corresponds to the trapped field by zero-field cooled magnetization, B-T(ZFC), was comparable with the absolute value of coercive force with a very small vortex creep rate of about 2% over 40 h. These results suggested that the MgB2 bulk was an excellent 'quasipermanent' magnet. The critical current density, J(c), under magnetic field was also enhanced by Ti doping; under 3 T at 20 K, the J(c) of 4.0 x 10(3) A cm(-2) for the pristine sample was enhanced to that of 1.6-1.8 x 104 A cm(-2) for the Ti-doped samples. The irreversibility field exceeded 5 T at 20 K for the Ti-doped samples. The existence of nanometric unreacted B and strongly Mg-deficient Mg-B particles and TiB2 layers at the periphery of Ti precipitates was suggested in the Ti-doped bulks by microscopic observation. The improvement of the vortex pinning properties in Ti-doped MgB2 originated from the creation of the nanometric nonsuperconducting particles and TiB2 layers acting as strong vortex pinning centres.	[Naito, Tomoyuki; Yoshida, Takafumi; Fujishiro, Hiroyuki] Iwate Univ, Fac Engn, Morioka, Iwate 0208551, Japan	Naito, T (reprint author), Iwate Univ, Fac Engn, Morioka, Iwate 0208551, Japan.	tnaito@iwate-u.ac.jp			JST A-STEP [AS242Z02673L]; Hitachi Metals . Materials Science Foundation; JSPS KAKENHI [23560002, 15K04718, 15K04646]	We would like to acknowledge Dr H Teshima of Nippon Steel and Sumitomo Metal Corporation for his assistance in the production of the MgB2 bulks using the HIP furnace and Miss M Sasaki and Mr K Nonaka of the Faculty of Engineering, Iwate University, for their help in the microstructure analysis using FE-EPMA. The authors also would like to thank Dr M D Ainslie of the University of Cambridge for his critical reading of this paper. This work was partly supported by JST A-STEP (AS242Z02673L), Hitachi Metals . Materials Science Foundation, and JSPS KAKENHI Grant Numbers 23560002, 15K04718, and 15K04646.	Indrakanti SS, 2001, PHIL MAG LETT, V81, P849, DOI 10.1080/09500830110093236; JIN S, 1988, APPL PHYS LETT, V52, P2074, DOI 10.1063/1.99751; Yamamoto A, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890724; Prikhna TA, 2004, PHYSICA C, V402, P223, DOI 10.1016/j.physc.2003.10.021; GYORGY EM, 1989, APPL PHYS LETT, V55, P283, DOI 10.1063/1.102387; Eisterer M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.144524; Zou J, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/7/075009; Buzea C, 2001, SUPERCOND SCI TECH, V14, pR115, DOI 10.1088/0953-2048/14/11/201; BEAN CP, 1962, PHYS REV LETT, V8, P250, DOI 10.1103/PhysRevLett.8.250; Larbalestier DC, 2001, NATURE, V410, P186, DOI 10.1038/35065559; Durrell JH, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/8/082001; Fujishiro H, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/6/065019; Dou SX, 2002, APPL PHYS LETT, V81, P3419, DOI 10.1063/1.1517398; Takano Y, 2001, APPL PHYS LETT, V78, P2914, DOI 10.1063/1.1371239; Tomita M, 2003, NATURE, V421, P517, DOI 10.1038/nature01350; Kambara M, 2001, SUPERCOND SCI TECH, V14, pL5, DOI 10.1088/0953-2048/14/4/101; Viznichenko RV, 2003, APPL PHYS LETT, V83, P4360, DOI 10.1063/1.1629148; Nariki S, 2005, SUPERCOND SCI TECH, V18, pS126, DOI 10.1088/0953-2048/18/2/026; Naito T, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/9/095012; Fuchs G, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/12/122002; DEWHUGHE.D, 1974, PHILOS MAG, V30, P293, DOI 10.1080/14786439808206556; KRAMER EJ, 1973, J APPL PHYS, V44, P1360, DOI 10.1063/1.1662353; MURAKAMI M, 1989, JPN J APPL PHYS 1, V28, P1189, DOI 10.1143/JJAP.28.1189; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Ohsaki H, 2010, J PHYS CONF SER, V234, DOI 10.1088/1742-6596/234/3/032043; Sasaki T, 2013, PHYSCS PROC, V45, P93, DOI 10.1016/j.phpro.2013.04.060; Shields TC, 2002, SUPERCOND SCI TECH, V15, P202, DOI 10.1088/0953-2048/15/2/303; Yoshida T, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2381558; Zhao Y, 2001, APPL PHYS LETT, V79, P1154, DOI 10.1063/1.1396629; Zhao Y, 2002, APPL PHYS LETT, V80, P1640, DOI 10.1063/1.1456969	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	SEP	2015	28	9							095009	10.1088/0953-2048/28/9/095009		8	Physics, Applied; Physics, Condensed Matter	Physics	CQ9NU	WOS:000360942700016		
J	Posada, CM; Ade, PAR; Ahmed, Z; Arnold, K; Austermann, JE; Bender, AN; Bleem, LE; Benson, BA; Byrum, K; Carlstrom, JE; Chang, CL; Cho, HM; Ciocys, ST; Cliche, JF; Crawford, TM; Cukierman, A; Czaplewski, D; Ding, J; Divan, R; de Haan, T; Dobbs, MA; Dutcher, D; Everett, W; Gilbert, A; Halverson, NW; Harrington, NL; Hattori, K; Henning, JW; Hilton, GC; Holzapfel, WL; Hubmayr, J; Irwin, KD; Jeong, O; Keisler, R; Kubik, D; Kuo, CL; Lee, AT; Leitch, EM; Lendinez, S; Meyer, SS; Miller, CS; Montgomery, J; Myers, M; Nadolski, A; Natoli, T; Nguyen, H; Novosad, V; Padin, S; Pan, Z; Pearson, J; Ruhl, JE; Saliwanchik, BR; Smecher, G; Sayre, JT; Shirokoff, E; Stan, L; Stark, AA; Sobrin, J; Story, K; Suzuki, A; Thompson, KL; Tucker, C; Vanderlinde, K; Vieira, JD; Wang, G; Whitehorn, N; Yefremenko, V; Yoon, KW; Ziegler, KE				Posada, C. M.; Ade, P. A. R.; Ahmed, Z.; Arnold, K.; Austermann, J. E.; Bender, A. N.; Bleem, L. E.; Benson, B. A.; Byrum, K.; Carlstrom, J. E.; Chang, C. L.; Cho, H. M.; Ciocys, S. T.; Cliche, J. F.; Crawford, T. M.; Cukierman, A.; Czaplewski, D.; Ding, J.; Divan, R.; de Haan, T.; Dobbs, M. A.; Dutcher, D.; Everett, W.; Gilbert, A.; Halverson, N. W.; Harrington, N. L.; Hattori, K.; Henning, J. W.; Hilton, G. C.; Holzapfel, W. L.; Hubmayr, J.; Irwin, K. D.; Jeong, O.; Keisler, R.; Kubik, D.; Kuo, C. L.; Lee, A. T.; Leitch, E. M.; Lendinez, S.; Meyer, S. S.; Miller, C. S.; Montgomery, J.; Myers, M.; Nadolski, A.; Natoli, T.; Nguyen, H.; Novosad, V.; Padin, S.; Pan, Z.; Pearson, J.; Ruhl, J. E.; Saliwanchik, B. R.; Smecher, G.; Sayre, J. T.; Shirokoff, E.; Stan, L.; Stark, A. A.; Sobrin, J.; Story, K.; Suzuki, A.; Thompson, K. L.; Tucker, C.; Vanderlinde, K.; Vieira, J. D.; Wang, G.; Whitehorn, N.; Yefremenko, V.; Yoon, K. W.; Ziegler, K. E.			Fabrication of large dual-polarized multichroic TES bolometer arrays for CMB measurements with the SPT-3G camera	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						bolometers; TES detectors; multichroic sensors; CMB; polarimetry; microfabrication; low loss microstrip	ELECTROTHERMAL FEEDBACK	This work presents the procedures used at Argonne National Laboratory to fabricate large arrays of multichroic transition-edge sensor (TES) bolometers for cosmic microwave background (CMB) measurements. These detectors will be assembled into the focal plane for the SPT-3G camera, the third generation CMB camera to be installed in the South Pole Telescope. The complete SPT-3G camera will have approximately 2690 pixels, for a total of 16 140 TES bolometric detectors. Each pixel is comprised of a broad-band sinuous antenna coupled to a Nb microstrip line. In-line filters are used to define the different bands before the millimeter-wavelength signal is fed to the respective Ti/Au TES bolometers. There are six TES bolometer detectors per pixel, which allow for measurements of three band-passes (95, 150 and 220 GHz) and two polarizations. The steps involved in the monolithic fabrication of these detector arrays are presented here in detail. Patterns are defined using a combination of stepper and contact lithography. The misalignment between layers is kept below 200 nm. The overall fabrication involves a total of 16 processes, including reactive and magnetron sputtering, reactive ion etching, inductively coupled plasma etching and chemical etching.	[Posada, C. M.; Ding, J.; Lendinez, S.; Novosad, V.; Pearson, J.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Ade, P. A. R.; Tucker, C.] Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3YB, S Glam, Wales; [Ahmed, Z.; Irwin, K. D.; Keisler, R.; Kuo, C. L.; Thompson, K. L.; Yoon, K. W.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Ahmed, Z.; Irwin, K. D.; Keisler, R.; Kuo, C. L.; Thompson, K. L.; Yoon, K. W.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Ahmed, Z.; Cho, H. M.; Irwin, K. D.; Kuo, C. L.; Thompson, K. L.; Yoon, K. W.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Arnold, K.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Austermann, J. E.; Everett, W.; Halverson, N. W.; Sayre, J. T.] Univ Colorado, CASA, Dept Astrophys & Planetary Sci, Boulder, CO 80309 USA; [Bender, A. N.; Bleem, L. E.; Byrum, K.; Carlstrom, J. E.; Chang, C. L.; Ciocys, S. T.; Wang, G.; Yefremenko, V.] Argonne Natl Lab, Div High Energy Phys, Argonne, IL 60439 USA; [Bender, A. N.; Bleem, L. E.; Benson, B. A.; Carlstrom, J. E.; Chang, C. L.; Crawford, T. M.; Dutcher, D.; Henning, J. W.; Leitch, E. M.; Meyer, S. S.; Natoli, T.; Pan, Z.; Shirokoff, E.; Sobrin, J.; Story, K.; Ziegler, K. E.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Benson, B. A.; Kubik, D.; Nguyen, H.] Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA; [Benson, B. A.; Carlstrom, J. E.; Chang, C. L.; Crawford, T. M.; Leitch, E. M.; Meyer, S. S.; Shirokoff, E.; Ziegler, K. E.] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Carlstrom, J. E.; Meyer, S. S.] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; [Carlstrom, J. E.; Dutcher, D.; Meyer, S. S.; Natoli, T.; Pan, Z.; Sobrin, J.; Story, K.; Ziegler, K. E.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Cliche, J. F.; de Haan, T.; Dobbs, M. A.; Gilbert, A.; Montgomery, J.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Cukierman, A.; Harrington, N. L.; Holzapfel, W. L.; Jeong, O.; Lee, A. T.; Myers, M.; Suzuki, A.; Whitehorn, N.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Czaplewski, D.; Divan, R.; Miller, C. S.; Stan, L.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Dobbs, M. A.] CIFAR Program Cosmol & Grav, Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Halverson, N. W.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Hattori, K.] High Energy Accelerator Res Org KEK, Tsukuba, Ibaraki 3050801, Japan; [Austermann, J. E.; Hilton, G. C.; Hubmayr, J.] NIST Quantum Devices Grp, Boulder, CO 80305 USA; [Lee, A. T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Phys, Berkeley, CA 94720 USA; [Padin, S.] CALTECH, Pasadena, CA 91125 USA; [Ruhl, J. E.; Saliwanchik, B. R.] Case Western Reserve Univ, Dept Phys, Cleveland, OH 44106 USA; [Smecher, G.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Stark, A. A.] Three Speed Log Inc, Vancouver, BC V6A 2J8, Canada; [Vanderlinde, K.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Vanderlinde, K.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Nadolski, A.; Vieira, J. D.] Univ Illinois, Dept Astron, Urbana, IL 61801 USA; [Vieira, J. D.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Posada, CM (reprint author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.		DING, Junjia/K-2277-2013	DING, Junjia/0000-0002-9917-9156	Office of Science and the Office of Basic Energy Sciences of the US Department of Energy [DE-AC02- 06CH11357]; National Science Foundation (NSF) [ANT-0638937]; NSF Physics Frontiers Center [PHY-1125897]; Kavli Foundation; Gordon and Betty Moore Foundation; NSF [AST-0956135, AST-1402161]	This work was supported in part by the Office of Science and the Office of Basic Energy Sciences of the US Department of Energy under Contract DE-AC02- 06CH11357; by the National Science Foundation (NSF) under Grant ANT-0638937; by the NSF Physics Frontiers Center under Grant PHY-1125897; by The Kavli Foundation; by the Gordon and Betty Moore Foundation; and by the NSF under Grants AST-0956135 and AST-1402161. Technical support from the Nanofabrication Group at the Center for Nanoscale Materials, Argonne National Laboratory, is gratefully appreciated.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; MAXFIELD BW, 1965, PHYS REV, V139, P1515; Suzuki A, 2012, J LOW TEMP PHYS, V167, P852, DOI 10.1007/s10909-012-0602-y; Sadleir JE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.047003; O'Brient R, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4791692; IRWIN KD, 1995, APPL PHYS LETT, V66, P1998, DOI 10.1063/1.113674; PENZIAS AA, 1965, ASTROPHYS J, V142, P419, DOI 10.1086/148307; SMOOT GF, 1992, ASTROPHYS J, V396, pL1, DOI 10.1086/186504; Bender AN, 2014, PROC SPIE, V9153, DOI 10.1117/12.2054949; Benson BA, 2014, PROC SPIE, V9153, DOI 10.1117/12.2057305; Chang CL, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2369231; DICKE RH, 1965, ASTROPHYS J, V142, P414, DOI 10.1086/148306; Duhamel RH, 1987, US Patent Specification, Patent No. [US4658262 A, 4658262A]; Edwards JM, 2012, IEEE T ANTENN PROPAG, V60, P4082, DOI 10.1109/TAP.2012.2207048; Fujimoto R, 2000, NUCL INSTRUM METH A, V444, P180, DOI 10.1016/S0168-9002(99)01353-4; George EM, 2014, J LOW TEMP PHYS, V176, P383, DOI 10.1007/s10909-013-0994-3; Gottardi L, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4899065; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Kerr A, 1999, SURFACE IMPEDANCE SU; Kumar S, 2009, IEEE T APPL SUPERCON, V19, P924, DOI 10.1109/TASC.2009.2017884; Lee AT, 1996, APPL PHYS LETT, V69, P1801, DOI 10.1063/1.117491; Lueker M, 2009, IEEE T APPL SUPERCON, V19, P496, DOI 10.1109/TASC.2009.2018036; OBrient RC, 2010, THESIS U CALIFORNIA; PEEBLES PJE, 1991, NATURE, V352, P769, DOI 10.1038/352769a0; Sadleir JE, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.184502; Sievers JL, 2013, J COSMOL ASTROPART P, V1310, P060; Story, 2013, ASTROPHYS J, V779, P86; Suzuki, 2014, J LOW TEMP PHYS, V176, P650; Suzuki A, 2013, THESIS U CALIFORNIA; Wang G, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2251451; Yefremenko V, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2235892	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	SEP	2015	28	9							094002	10.1088/0953-2048/28/9/094002		12	Physics, Applied; Physics, Condensed Matter	Physics	CQ9NU	WOS:000360942700007		
J	Tamada, D; Nakamura, T; Kose, K				Tamada, D.; Nakamura, T.; Kose, K.			A gradient coil design for a high-temperature superconducting bulk magnet using the finite-difference method	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						magnetic resonance imaging; gradient coil; screening current; high-temperature superconducting bulk magnet	TARGET-FIELD METHOD	The screening current induced in a bulk superconductor presents a critical problem for gradient coil design because it gives rise to undesirable effects on the gradient field: namely, a decrease in the efficiency and a distortion of the field. In this paper, a new coil design method for the bulk magnet is proposed using the finite-difference method (FDM) and the target-field method. The calculation using the FDM was implemented with the boundary conditions of the bulk magnet. Transverse and longitudinal coils were designed and fabricated for a high-temperature superconducting bulk magnet. The calculated results of the efficiency and the nonlinearity distribution of the gradient field agreed well with the measured results.	[Tamada, D.; Nakamura, T.; Kose, K.] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Tamada, D.; Nakamura, T.] RIKEN, Wako, Saitama 3510198, Japan	Tamada, D (reprint author), Univ Tsukuba, Inst Appl Phys, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	tamada@mrlab.frsc.tsukuba.ac.jp					Ahn M, 2014, IEEE T APPL SUPERCON, V25; Wang DM, 2004, MAGN RESON IMAGING, V22, P529, DOI 10.1016/j.mri.2004.01.008; Terao Y, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2239342; Tamada D, 2013, PHYSICA C, V492, P174, DOI 10.1016/j.physc.2013.06.016; TURNER R, 1993, MAGN RESON IMAGING, V11, P903, DOI 10.1016/0730-725X(93)90209-V; Liu W, 2007, J PHYS D APPL PHYS, V40, P4418, DOI 10.1088/0022-3727/40/15/005; Nakamura T, 2007, CONCEPT MAGN RESON B, V31B, P65, DOI 10.1002/cmr.b.20083; MANSFIELD P, 1986, J MAGN RESON, V66, P573, DOI 10.1016/0022-2364(86)90205-2; Maeda H, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2287707; Ogawa K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3598440; Bernstein M. A., 2004, HDB MRI PULSE SEQUEN; Forbes LK, 2001, J PHYS D APPL PHYS, V34, P3447, DOI 10.1088/0022-3727/34/24/305; Hahn SY, 2009, IEEE T APPL SUPERCON, V19, P2285, DOI 10.1109/TASC.2009.2018809; Jin J.M., 1998, ELECTROMAGNETIC ANAL; KAWANAKA A, 1986, J PHYS E SCI INSTRUM, V19, P871, DOI 10.1088/0022-3735/19/10/022; Poole Jr Ch. P., 1988, COPPER OXIDE SUPERCO; Slade Robert A., 2014, IEEE Transactions on Applied Superconductivity, V24, DOI 10.1109/TASC.2013.2283660; Strikwerda JC, FINITE DIFFERENCE SC; Sudbo A, 2005, SUPERCONDUCTIVITY PH; TURNER R, 1988, J PHYS E SCI INSTRUM, V21, P948, DOI 10.1088/0022-3735/21/10/008; Turner R, 1986, J PHYS D, V19, P147; Yanagisawa Y, 2014, J MAGN RESON, V249, P38, DOI 10.1016/j.jmr.2014.10.006; Zhu MH, 2012, IEEE T BIO-MED ENG, V59, P2412, DOI 10.1109/TBME.2012.2188290	23	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	SEP	2015	28	9							095010	10.1088/0953-2048/28/9/095010		8	Physics, Applied; Physics, Condensed Matter	Physics	CQ9NU	WOS:000360942700017		
J	Kumazaki, H; Nakajima, R; Bessho, Y; Yokoshima, S; Fukuyama, T				Kumazaki, Hiroshi; Nakajima, Rie; Bessho, Yuka; Yokoshima, Satoshi; Fukuyama, Tohru			Synthetic Studies on Huperzine R: Construction of the 1-Azabicyclo[5.4.3]tetradec-6-ene Core	SYNLETT			English	Article						alkaloids; ammonium salts; lactams; asymmetric synthesis; polycycles	LYCOPODIUM ALKALOIDS	Synthetic studies on huperzine R are described. The 1-azabicyclo[5.4.3]tetradec-6-ene core was constructed by elimination of an ammonium salt formed at a position to a carbonyl group.	[Kumazaki, Hiroshi; Nakajima, Rie; Bessho, Yuka] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yokoshima, Satoshi; Fukuyama, Tohru] Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Fukuyama, T (reprint author), Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	fukuyama@ps.nagoya-u.ac.jp			JSPS KAKENHI [20002004, 25221301, 26713001]; Platform for Drug Discovery, Informatics, and Structural Life Science (MEXT)	This work was financially supported by JSPS KAKENHI (Grant Numbers 20002004, 25221301, and 26713001) and the Platform for Drug Discovery, Informatics, and Structural Life Science (MEXT).	Takayama H, 2002, TETRAHEDRON LETT, V43, P8307, DOI 10.1016/S0040-4039(02)02026-9; Siengalewicz P, 2013, ALKALOIDS-CHEM BIOL, V72, P1, DOI 10.1016/B978-0-12-407774-4.00001-7; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Ma XQ, 2004, NAT PROD REP, V21, P752, DOI 10.1039/b409720n; Schedler DJA, 1996, J ORG CHEM, V61, P4115, DOI 10.1021/jo960286j; [Anonymous], 1994, ALKALOIDS, DOI DOI 10.1016/S0099-9598(08)60278-3; Shibuya M, 2006, J AM CHEM SOC, V128, P8412, DOI 10.1021/ja0620336; Kitajima M, 2012, TOP CURR CHEM, V309, P1, DOI 10.1007/128_2011_126; Hirasawa Y, 2009, HETEROCYCLES, V77, P679, DOI 10.3987/REV-08-SF(R)6; Chiyoda K, 2012, ANGEW CHEM INT EDIT, V51, P2505, DOI 10.1002/anie.201109221; Kitaori K, 1998, SYNLETT, P499; Kobayashi Jun'ichi, 2005, Alkaloids Chem Biol, V61, P1, DOI 10.1016/S1099-4831(05)61001-2; Maclean D. B., 1985, ALKALOIDS, V26, P241, DOI 10.1016/S0099-9598(08)60196-0; MacLean D. B., 1968, ALKALOIDS, V10, P305, DOI 10.1016/S1876-0813(08)60256-0; MacLean D. B., 1973, ALKALOIDS SAN DIEGO, V14, P48; Murphy R. A., 2013, CHEM-EUR J, V20, P42; Nakayama A, 2009, ORG LETT, V11, P5554, DOI 10.1021/ol902437t; Ok T, 2007, J ORG CHEM, V72, P7390, DOI 10.1021/jo0709605; Tan CH, 2002, J NAT PROD, V65, P1021, DOI 10.1021/np0103564; Zeng C, 2015, TETRAHEDRON, V71, P64, DOI 10.1016/j.tet.2014.11.041	20	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	SEP	2015	26	15					2131	2134		10.1055/s-0034-1380425		4	Chemistry, Organic	Chemistry	CQ9OJ	WOS:000360944200011		
J	Sano, S; Matsumoto, T; Yano, T; Toguchi, M; Nakao, M				Sano, Shigeki; Matsumoto, Tomoya; Yano, Teppei; Toguchi, Munehisa; Nakao, Michiyasu			Synthesis of Allenyl Esters by Horner-Wadsworth-Emmons Reactions of Ketenes Mediated by Isopropylmagnesium Bromide	SYNLETT			English	Article						Horner-Wadsworth-Emmons reaction; allenes; ketenes; Grignard reagents; fluorine	Z-UNSATURATED ESTERS; ARYL ALKYL KETONES; ENANTIOSELECTIVE SYNTHESIS; WITTIG-REACTION; ETHYL (DIARYLPHOSPHONO)ACETATES; ALLENECARBOXYLIC ACIDS; OPTICAL RESOLUTION; NATURAL-PRODUCTS; YLIDE ROUTE; OLEFINATION	The synthesis of conjugated allenyl esters (tri-substituted allenes) was achieved by magnesium(II)-mediated Horner-Wadsworth-Emmons reaction of methyl bis(2,2,2-trifluoroethyl)phosphonoacetate with disubstituted ketenes. In addition, a novel access to -fluorinated allenyl carboxamides (tetrasubstituted allenes) is presented.	[Sano, Shigeki; Matsumoto, Tomoya; Yano, Teppei; Toguchi, Munehisa; Nakao, Michiyasu] Univ Tokushima, Grad Sch Pharmaceut Sci, Sho, Tokushima 7708505, Japan	Sano, S (reprint author), Univ Tokushima, Grad Sch Pharmaceut Sci, Sho, Tokushima 7708505, Japan.	ssano@tokushima-u.ac.jp			JSPS KAKENHI [2359007]; Grant for the Regional Innovation Cluster Program	This work was supported in part by a JSPS KAKENHI Grant (Number 2359007) and by a Grant for the Regional Innovation Cluster Program (Global Type) promoted by MEXT.	AKSNES G, 1968, ACTA CHEM SCAND, V22, P2347, DOI 10.3891/acta.chem.scand.22-2347; Ando K, 1999, J ORG CHEM, V64, P8406, DOI 10.1021/jo9907181; Ando K, 2001, SYNLETT, P1272; Bisceglia JA, 2012, CURR ORG CHEM, V16, P2206; Ando K, 2000, J ORG CHEM, V65, P4745, DOI 10.1021/jo000068x; Maitland P, 1935, NATURE, V135, P994, DOI 10.1038/135994a0; Burton DJ, 1996, CHEM REV, V96, P1641, DOI 10.1021/cr941140s; Melo TMVDPE, 2011, MONATSH CHEM, V142, P681, DOI 10.1007/s00706-011-0505-7; Yamazaki J, 2001, TETRAHEDRON-ASYMMETR, V12, P669, DOI 10.1016/S0957-4166(01)00114-8; Himbert G, 1997, J PRAK CHEM-CHEM ZTG, V339, P233, DOI 10.1002/prac.19973390142; Tanaka K, 1996, TETRAHEDRON LETT, V37, P3735, DOI 10.1016/0040-4039(96)00672-7; STILL WC, 1983, TETRAHEDRON LETT, V24, P4405, DOI 10.1016/S0040-4039(00)85909-2; Xu B, 2008, ANGEW CHEM INT EDIT, V47, P689, DOI 10.1002/anie.200704221; ANDO K, 1995, TETRAHEDRON LETT, V36, P4105, DOI 10.1016/0040-4039(95)00726-S; WADSWORTH W, 1961, J AM CHEM SOC, V83, P1733, DOI 10.1021/ja01468a042; Ando K, 1998, J ORG CHEM, V63, P8411, DOI 10.1021/jo981337a; Li CY, 2007, TETRAHEDRON, V63, P8046, DOI 10.1016/j.tet.2007.05.053; MARYANOFF BE, 1989, CHEM REV, V89, P863, DOI 10.1021/cr00094a007; Yu SC, 2011, CHEM COMMUN, V47, P5384, DOI 10.1039/c0cc05640e; Li CY, 2007, J AM CHEM SOC, V129, P1494, DOI 10.1021/ja068642v; Ando K, 1997, J ORG CHEM, V62, P1934, DOI 10.1021/jo970057c; Hoffmann-Roder A, 2004, ANGEW CHEM INT EDIT, V43, P1196, DOI 10.1002/anie.200300628; HORNER L, 1959, CHEM BER-RECL, V92, P2499, DOI 10.1002/cber.19590921017; Alcaide B, 2014, CHEM SOC REV, V43, P2886, DOI 10.1039/c4cs90020k; Yu SC, 2012, ANGEW CHEM INT EDIT, V51, P3074, DOI 10.1002/anie.201101460; BESTMANN HJ, 1966, CHEM BER-RECL, V99, P1198, DOI 10.1002/cber.19660990417; Boumendjel A, 1999, TETRAHEDRON LETT, V40, P9033, DOI 10.1016/S0040-4039(99)01921-8; Brummond KM, 2007, SYNTHESIS-STUTTGART, P795, DOI 10.1055/s-2007-965963; Burton B. S., 1887, BER DTSCH CHEM GES, V20, P145, DOI 10.1002/cber.18870200136; DeHoff B., 2012, E EROS ENCY REAGENTS; Al Jasem Y, 2014, J CHEM RES, P453, DOI 10.3184/174751914X14044684705710; Huang X, 2003, CHEM COMMUN, P1714, DOI 10.1039/b304527g; Inoue H, 2002, TETRAHEDRON, V58, P83, DOI 10.1016/S0040-4020(01)01089-4; Jiang J., 2006, E EROS ENCY REAGENTS; JONES ERH, 1954, J CHEM SOC, P3208, DOI 10.1039/jr9540003208; Kim H, 2008, CURR OPIN DRUG DISC, V11, P870; KRESZE G, 1972, LIEBIGS ANN CHEM, V756, P112, DOI 10.1002/jlac.19727560111; LANG RW, 1980, HELV CHIM ACTA, V63, P438, DOI 10.1002/hlca.19800630215; LANG RW, 1979, HELV CHIM ACTA, V62, P1025, DOI 10.1002/hlca.19790620413; Li CY, 2006, CHEM COMMUN, P2980, DOI 10.1039/b603659g; Liu WB, 2010, CHEM-EUR J, V16, P7376, DOI 10.1002/chem.201000316; MACHLEIDT H, 1964, LIEBIGS ANN CHEM, V674, P1; Nagao Y, 1996, TETRAHEDRON LETT, V37, P861, DOI 10.1016/0040-4039(95)02284-8; Nagao Y, 2000, TETRAHEDRON LETT, V41, P2419, DOI 10.1016/S0040-4039(00)00177-5; Nagaoka Y, 2002, PHOSPHORUS SULFUR, V177, P1843, DOI 10.1080/10426500290093432; Melo TMVDPE, 2004, EUR J ORG CHEM, P4830, DOI 10.1002/ejoc.200400413; Plunkett S, 2013, EUR J ORG CHEM, P1566, DOI 10.1002/ejoc.201201535; Roy M.-N., 2013, E EROS ENCY REAGENTS; RUNGE W, 1975, LIEBIGS ANN CHEM, P1361; Sano S, 2002, TETRAHEDRON LETT, V43, P9183, DOI 10.1016/S0040-4039(02)02269-4; Sano S, 2006, LETT ORG CHEM, V3, P798, DOI 10.2174/157017806779116969; Sano S, 2002, CHEM PHARM BULL, V50, P1300, DOI 10.1248/cpb.50.1300; Sano S, 2006, CHEM PHARM BULL, V54, P196, DOI 10.1248/cpb.54.196; Sano S, 2003, TETRAHEDRON LETT, V44, P8853, DOI 10.1016/j.tetlet.2003.09.185; Sano S, 2005, TETRAHEDRON LETT, V46, P2883, DOI 10.1016/j.tetlet.2005.02.138; Sano S, 2014, TETRAHEDRON LETT, V55, P6248, DOI 10.1016/j.tetlet.2014.09.077; Sano S, 2003, ARKIVOC, P93; Staudinger H, 1924, HELV CHIM ACTA, V7, P177, DOI 10.1002/hlca.19240070124; Takeuchi Y, 2008, BIOORG MED CHEM LETT, V18, P6202, DOI 10.1016/j.bmcl.2008.10.007; TAYLOR DR, 1967, CHEM REV, V67, P317, DOI 10.1021/cr60247a004	60	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	SEP	2015	26	15					2135	2138		10.1055/s-0034-1378803		4	Chemistry, Organic	Chemistry	CQ9OJ	WOS:000360944200012		
J	Yamaoka, Y; Taniguchi, M; Yamada, K; Takasu, K				Yamaoka, Yousuke; Taniguchi, Marie; Yamada, Ken-ichi; Takasu, Kiyosei			Asymmetric Total Synthesis of Tylophorine through a Formal [2+2] Cycloaddition Followed by Migrative Ring Opening of a Cyclobutane	SYNTHESIS-STUTTGART			English	Article						heterocycles; natural products; cycloaddition; asymmetric synthesis; anticancer agents	DOUBLE MICHAEL REACTION; TRANSFER HYDROGENATION; ENANTIOSELECTIVE SYNTHESIS; FUSED-CYCLOBUTANOLS; PHENANTHROINDOLIZIDINE; ALKALOIDS; (S)-(+)-TYLOPHORINE; (-)-TYLOPHORINE; (S)-TYLOPHORINE; CONTRACTION	The asymmetric total synthesis of phenanthroindolizidine alkaloid (-)-tylophorine was achieved by asymmetric transfer hydrogenation of a cyclic imine. The cyclic imine with a pendant phenanthrene core was synthesized by a TfOH-promoted domino ring-contraction/ring-opening sequence of a cyclobutanol bearing an azide group, which was constructed by a formal [2+2] cycloaddition of a 2-vinyl-1,1-biaryl-2-yl ketone enolate. Catalytic asymmetric hydrogenation of the cyclic imine intermediate allowed the late-stage construction of the asymmetric center.	[Yamaoka, Yousuke; Taniguchi, Marie; Yamada, Ken-ichi; Takasu, Kiyosei] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Yamaoka, Y (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	yyamaoka@pharm.kyoto-u.ac.jp; kay-t@pharm.kyoto-u.ac.jp			Japan Science Society; Kurata Memorial Hitachi Science and Technology Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by a Sasakawa Scientific Research Grant from The Japan Science Society (M.T.), the Kurata Memorial Hitachi Science and Technology Foundation, a Grant-in-Aid for Young Scientists (B), and 'Platform for Drug Design, Discovery and Development' from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Gao WL, 2004, CANCER RES, V64, P678, DOI 10.1158/0008-5472.CAN-03-1904; Wang KL, 2010, J AGR FOOD CHEM, V58, P2703, DOI 10.1021/jf902543r; Stoye A, 2010, ORG LETT, V12, P2140, DOI 10.1021/ol100652b; Uematsu N, 1996, J AM CHEM SOC, V118, P4916, DOI 10.1021/ja960364k; GOPALAKRISHNAN C, 1980, INDIAN J MED RES, V71, P940; Su B, 2014, ORG BIOMOL CHEM, V12, P3616, DOI 10.1039/c4ob00200h; Su B, 2013, J ORG CHEM, V78, P2775, DOI 10.1021/jo302725q; Niphakis MJ, 2011, ORG LETT, V13, P196, DOI [10.1021/ol1023954, 10.1021/011023954]; Arican D, 2013, ORG LETT, V15, P2582, DOI 10.1021/ol400510j; Cartigny D, 2010, ORG LETT, V12, P3788, DOI 10.1021/ol101451s; Williams GD, 2003, ORG LETT, V5, P4227, DOI 10.1021/ol035746r; Mai DN, 2010, J AM CHEM SOC, V132, P12157, DOI 10.1021/ja106989h; Cui MB, 2010, J ORG CHEM, V75, P7018, DOI 10.1021/jo101510x; Burtoloso ACB, 2014, CURR TOP MED CHEM, V14, P191, DOI 10.2174/1568026613666131213154633; Staerk D, 2000, J NAT PROD, V63, P1584; Yang CW, 2007, BIOCHEM BIOPH RES CO, V354, P942, DOI 10.1016/j.bbrc.2007.01.065; Yang XM, 2010, ORG LETT, V12, P1416, DOI 10.1021/ol902819j; Anton-Torrecillas C, 2014, ORG BIOMOL CHEM, V12, P7018, DOI 10.1039/c4ob01133c; Chemler S R, 2008, ORG CHEM, V73, P6045; Chemler S. R., 2009, CURR BIOACT COMPD, V5, P2, DOI DOI 10.2174/157340709787580928; Chen FZ, 2014, ORG CHEM FRONT, V1, P674, DOI 10.1039/c4qo00084f; COMINS DL, 1993, J ORG CHEM, V58, P4656, DOI 10.1021/jo00069a031; Comins DL, 1997, J ORG CHEM, V62, P7435, DOI 10.1021/jo9711495; DONALDSO.GR, 1968, BIOCHEM BIOPH RES CO, V31, P104, DOI 10.1016/0006-291X(68)90037-5; Gopalakrishnan C, 1979, J MED RES, V69, P513; IHARA M, 1990, J CHEM SOC PERK T 1, P2287, DOI 10.1039/p19900002287; IHARA M, 1988, TETRAHEDRON LETT, V29, P4135, DOI 10.1016/S0040-4039(00)80437-2; Kim S, 2003, ORG LETT, V5, P2703, DOI 10.1021/ol0349007; Kim S, 2004, ORG CHEM, V69, P3144; Li ZG, 2001, SYNTHESIS-STUTTGART, P2365; Lin QX, 2013, TETRAHEDRON, V69, P2996, DOI 10.1016/j.tet.2013.02.014; Lin Y. -D, 2012, ORG CHEM, V77, P9979; Nagamoto Y, 2013, SYNLETT, V24, P120, DOI 10.1055/s-0032-1317745; Nagamoto Y, 2014, ORG LETT, V16, P1008, DOI 10.1021/ol403757e; Nagamoto Y, 2013, CHEM COMMUN, V49, P2622, DOI 10.1039/c3cc39246e; NORDLANDER JE, 1987, J ORG CHEM, V52, P1627, DOI 10.1021/jo00384a053; Pansare SV, 2011, EUR J ORG CHEM, P2235, DOI 10.1002/ejoc.201100125; Pearson WH, 2000, J ORG CHEM, V65, P7158, DOI 10.1021/jo0011388; Ratnagiriswaran A, 1935, J MED RES, V22, P433; Stoye A, 2013, J NAT PROD, V76, P275, DOI 10.1021/np300838w; SUZUKI H, 1995, J ORG CHEM, V60, P6114, DOI 10.1021/jo00124a025; Takasu K, 2010, CHEM-EUR J, V16, P8427, DOI 10.1002/chem.201000930; Wen T, 2014, ACS MED CHEM LETT, V5, P1027, DOI 10.1021/ml500255j; Wendt JA, 1996, TETRAHEDRON LETT, V37, P1531, DOI 10.1016/0040-4039(96)00100-1; Wu CM, 2009, BIOCHEM BIOPH RES CO, V386, P140, DOI 10.1016/j.bbrc.2009.05.138; Yang CW, 2006, MOL PHARMACOL, V69, P749, DOI 10.1124/mol.105.017764; Zheng Y, 2014, ORG CHEM, V79, P3348	47	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	SEP	2015	47	18					2819	2825		10.1055/s-0034-1380430		7	Chemistry, Organic	Chemistry	CQ9NY	WOS:000360943100015		
J	Yano, S; Hara, S				Yano, Shohei; Hara, Shoji			Iodofluorination of Alkenes Using IF5-Pyridine-HF	SYNTHESIS-STUTTGART			English	Article						fluorine; addition; stereoselective synthesis; halogenation; alkenes	IONIC LIQUID EMIMF(HF)(2.3); DILUTE HYDROFLUORIC-ACID; ELEMENTAL FLUORINE; HYDROGEN-FLUORIDE; MILD METHOD; HALOFLUORINATION; REAGENT; OLEFINS; TETRAFLUOROBORATE; DIFLUORIDE	Iodofluorination of alkenes was performed by using IF5-pyridine-HF and a reductant such as potassium iodide or tin powder. The addition of IF to the double bond proceeded with stereo- and regioselectivity. In the reaction with internal alkenes, the trans-addition product was obtained selectively. With terminal alkenes, the addition took place regioselectively to give 1-iodo-2-fluoroalkanes.	[Yano, Shohei; Hara, Shoji] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan	Hara, S (reprint author), Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan.	shara@eng.hokudai.ac.jp					ALVERNHE G, 1987, SYNTHESIS-STUTTGART, P562; BARLUENGA J, 1985, ANGEW CHEM INT EDIT, V24, P319, DOI 10.1002/anie.198503191; Yoshino H, 2006, J FLUORINE CHEM, V127, P29, DOI 10.1016/j.jfluchem.2005.09.016; BARLUENGA J, 1991, J ORG CHEM, V56, P2234, DOI 10.1021/jo00006a050; Yoshino H, 2005, J FLUORINE CHEM, V126, P121, DOI 10.1016/j.fluchem.2004.10.023; Walkowiak J, 2012, J FLUORINE CHEM, V143, P287, DOI 10.1016/j.jfluchem.2012.07.012; OLAH GA, 1979, J ORG CHEM, V44, P3872, DOI 10.1021/jo01336a027; Hara S, 2012, TETRAHEDRON, V68, P10145, DOI 10.1016/j.tet.2012.09.104; ROZEN S, 1980, TETRAHEDRON LETT, V21, P4543, DOI 10.1016/S0040-4039(00)74546-1; Conte P, 2006, TETRAHEDRON LETT, V47, P273, DOI 10.1016/j.tetlet.2005.11.029; CAMPS F, 1989, J ORG CHEM, V54, P4294, DOI 10.1021/jo00279a013; Chambers RD, 2001, CHEM COMMUN, P2428, DOI 10.1039/b107565a; Crespo LTC, 2010, SYNTHESIS-STUTTGART, P2379, DOI 10.1055/s-0029-1220011; EVANS RD, 1987, SYNTHESIS-STUTTGART, P551; Hiyama T, 2000, ORGANOFLUORINE COMPO, P56; ICHIHARA J, 1990, TETRAHEDRON LETT, V31, P3167, DOI 10.1016/S0040-4039(00)94723-3; Kobayashi S, 2001, SYNLETT, P1938; Kunigami M, 2014, FLUORINE CHEM, V167, P101; KUROBOSHI M, 1995, B CHEM SOC JPN, V68, P1799, DOI 10.1246/bcsj.68.1799; KUROBOSHI M, 1991, TETRAHEDRON LETT, V32, P1215, DOI 10.1016/S0040-4039(00)92048-3; KUROBOSHI M, 1991, SYNLETT, P185; Nagura H, 2010, TETRAHEDRON, V66, P183, DOI 10.1016/j.tet.2009.11.005; Rozen S, 2007, FLUORINE CONTAINING, P336; ROZEN S, 1985, J ORG CHEM, V50, P3342, DOI 10.1021/jo00218a020; Shellhamer D F, 2006, ADV ORGANIC SYNTHESI, P43; Shellhamer DF, 1998, J FLUORINE CHEM, V88, P37, DOI 10.1016/S0022-1139(97)00133-4; SHIMIZU M, 1991, B CHEM SOC JPN, V64, P2596, DOI 10.1246/bcsj.64.2596; TAMURA M, 1995, SYNTHESIS-STUTTGART, P515; Yoshino H, 2004, J FLUORINE CHEM, V125, P455, DOI 10.1016/j.jfluchem.2003.11.015	29	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	SEP	2015	47	18					2839	2843		10.1055/s-0034-1381003		5	Chemistry, Organic	Chemistry	CQ9NY	WOS:000360943100018		
J	Koketsu, S; Sameshima, S; Okuyama, T; Yamagata, Y; Takeshita, E; Tagaya, N; Oya, M				Koketsu, S.; Sameshima, S.; Okuyama, T.; Yamagata, Y.; Takeshita, E.; Tagaya, N.; Oya, M.			An effective new method for the placement of an anti-adhesion barrier film using an introducer in laparoscopic surgery	TECHNIQUES IN COLOPROCTOLOGY			English	Article							SMALL-BOWEL OBSTRUCTION; RESECTION; MEMBRANE		[Koketsu, S.; Sameshima, S.; Okuyama, T.; Yamagata, Y.; Takeshita, E.; Tagaya, N.; Oya, M.] Dokkyo Med Univ, Koshigaya Hosp, Dept Surg, Koshigaya, Saitama 3438555, Japan	Koketsu, S (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Surg, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan.	koketsu-tky@umin.ac.jp					Chuang YC, 2008, FERTIL STERIL, V90, P1959, DOI 10.1016/j.fertnstert.2007.10.003; Duepree HJ, 2003, J AM COLL SURGEONS, V197, P177, DOI 10.1016/S1072-7515(03)00232-1; Fazio VW, 2006, DIS COLON RECTUM, V49, P1, DOI 10.1007/s10350-005-0268-5; Rosin D, 2007, J LAPAROENDOSC ADV S, V17, P604, DOI 10.1089/lap.2006.0002; Shinohara T, 2008, SURG LAPARO ENDO PER, V18, P188, DOI 10.1097/SLE.0b013e318166192f; Takeuchi H, 2006, J LAPAROENDOSC ADV S, V16, P497, DOI 10.1089/lap.2006.16.497	6	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1123-6337	1128-045X		TECH COLOPROCTOL	Tech. Coloproctology	SEP	2015	19	9					551	553		10.1007/s10151-015-1340-3		3	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CQ8WL	WOS:000360890700009		
J	Akimoto, M; Toyoda, T; Okuno, T; Hayase, S; Shen, Q				Akimoto, Masaya; Toyoda, Taro; Okuno, Tsuyoshi; Hayase, Shuji; Shen, Qing			Effect of defects in TiO2 nanotube thin film on the photovoltaic properties of quantum dot-sensitized solar cells	THIN SOLID FILMS			English	Article						TiO2 nanotube electrode; CdSe quantum dot; Quantum dot sensitized solar cells; Surface morphology; Defect; Recombination; Back electron transfer; Open circuit voltage decay; Electron lifetime	CONVERSION EFFICIENCY; ARRAY PHOTOELECTRODES; BAND-GAP; CDSE; ELECTRODES; NANOPARTICLES; ENERGY; NANOCRYSTALS; FABRICATION; ABSORPTION	In the liquid-phase-deposition (LPD) method, the deposition temperature is considered to be one of the most important factors in TiO2 nanotube crystal growth. We investigated the effects of the deposition temperature on the surface morphology and defects in TiO2 nanotube (NT-TiO2) thin film electrodes utilizing scanning-electron-microscopy (SEM), X-ray diffraction (XRD), and photoluminescence (PL), together with the effects of these on the photovoltaic characteristics of CdSe quantum dot (QD)-sensitized NT-TiO2 solar cells. In addition, we studied the effect of these defects on the physical properties, such as the carrier recombination and electron transport at the TiO2 and TiO2/QD interface. NT-TiO2 electrodes prepared at low temperatures have a more uniform surface and lower defects than those prepared at high temperatures. From the PL measurements and the photovoltaic characterization such as shunt resistance (R-sh) and open circuit voltage decay (OCVD), these defects can act as carrier recombination centers. The defect density increases with increasing deposition temperature, leading to an increase in carrier recombination. Series resistances (R-s) of the solar cells with NT-TiO2 electrodes prepared at high temperatures were larger than those of the solar cells with NT-TiO2 electrodes prepared at low temperatures, suggesting that the defects can also affect the carrier transport characteristics. Eventually, CdSe QD-sensitized NT-TiO2 solar cells employing NT-TiO2 prepared at low temperatures showed higher conversion efficiencies than those prepared at high temperatures. (C) 2015 Elsevier B.V. All rights reserved.	[Akimoto, Masaya; Toyoda, Taro; Okuno, Tsuyoshi; Shen, Qing] Univ Electrocommun, Fac Informat & Engn, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Hayase, Shuji] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan; [Toyoda, Taro; Hayase, Shuji; Shen, Qing] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Toyoda, T (reprint author), Univ Electrocommun, Fac Informat & Engn, Dept Engn Sci, Chofu, Tokyo 1828585, Japan.	toyoda@pc.uec.ac.jp; shen@pc.uec.ac.jp			Japan Science and Technology Agency (JST) CREST program, MEXT KAKENHI [26286013]; JSPS KAKENHI [26390016]	This research was supported by the Japan Science and Technology Agency (JST) CREST program, MEXT KAKENHI Grant Number 26286013 and JSPS KAKENHI Number 26390016.	Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374; Guijarro N, 2010, J PHYS CHEM C, V114, P22352, DOI 10.1021/jp108499h; Hoyer P, 1996, LANGMUIR, V12, P1411, DOI 10.1021/la9507803; Wang J, 2013, J AM CHEM SOC, V135, P15913, DOI 10.1021/ja4079804; Pan ZX, 2013, ACS NANO, V7, P5215, DOI 10.1021/nn400947e; Tachibana Y, 2007, CHEM LETT, V36, P88, DOI 10.1246/cl.2007.88; Yoo H, 2014, J PHYS CHEM C, V118, P9726, DOI 10.1021/jp4125588; Benkstein KD, 2003, J PHYS CHEM B, V107, P7759, DOI 10.1021/jp0226811; Pang YL, 2014, APPL CATAL A-GEN, V481, P127, DOI 10.1016/j.apcata.2014.05.007; Nozik AJ, 2005, INORG CHEM, V44, P6893, DOI 10.1021/ic0508425; Nozik AJ, 2002, PHYSICA E, V14, P115, DOI 10.1016/S1386-9477(02)00374-0; Li Z, 2014, ELECTROCHIM ACTA, V129, P379, DOI 10.1016/j.electacta.2014.02.145; BAWENDI MG, 1989, J CHEM PHYS, V91, P7282, DOI 10.1063/1.457295; Liu H, 2014, CHINESE J CATAL, V35, P66, DOI 10.1016/S1872-2067(12)60705-0; Niitsoo O, 2006, J PHOTOCH PHOTOBIO A, V181, P306, DOI 10.1016/j.jphotochem.2005.12.012; Nozik AJ, 2008, CHEM PHYS LETT, V457, P3, DOI 10.1016/j.cplett.2008.03.094; EKIMOV AI, 1985, SOLID STATE COMMUN, V56, P921, DOI 10.1016/S0038-1098(85)80025-9; Luo JS, 2012, J PHYS CHEM C, V116, P11956, DOI 10.1021/jp3031754; Seabold JA, 2008, CHEM MATER, V20, P5266, DOI 10.1021/cm8010666; Ahmed R, 2015, J PHYS CHEM C, V119, P2297, DOI 10.1021/jp510339z; Liu ZF, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3447356; Zaban A, 2003, CHEMPHYSCHEM, V4, P859, DOI 10.1002/cphc.200200615; Diguna LJ, 2006, JPN J APPL PHYS 1, V45, P5563, DOI 10.1143/JJAP.45.5563; Schaller RD, 2006, NANO LETT, V6, P424, DOI 10.1021/nl052276g; ROSENCWAIG A, 1976, J APPL PHYS, V47, P64, DOI 10.1063/1.322296; Chen SG, 2006, J PHOTOCH PHOTOBIO A, V177, P177, DOI 10.1016/j.jphotochem.2005.05.023; Shen Q, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3491245; Choudhury B, 2014, PHYSICA E, V56, P364, DOI 10.1016/j.physe.2013.10.014; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Baker DR, 2009, ADV FUNCT MATER, V19, P805, DOI 10.1002/adfm.200801173; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P12, DOI 10.1002/pip.2163; Sang LX, 2012, J PHYS CHEM C, V116, P18633, DOI 10.1021/jp305388c; Zhang J, 2012, ELECTROCHIM ACTA, V83, P59, DOI 10.1016/j.electacta.2012.07.120; Yang SM, 2002, J MATER CHEM, V12, P1459, DOI 10.1039/b105796k; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Klimov VI, 2006, J PHYS CHEM B, V110, P16827, DOI 10.1021/jp0615959; Shen Q, 2008, J APPL PHYS, V103, DOI 10.1063/1.2903059; GORER S, 1994, J PHYS CHEM-US, V98, P5338, DOI 10.1021/j100071a026; Tian JJ, 2013, J MATER CHEM A, V1, P6770, DOI 10.1039/c3ta11056g; Lee JH, 2005, J PHYS CHEM B, V109, P13056, DOI 10.1021/jp0522031; Zhang HZ, 2005, CHEM MATER, V17, P3421, DOI 10.1021/cm0508423; Toyoda T, 2012, J PHYS CHEM LETT, V3, P1885, DOI 10.1021/jz3004602; Chen C, 2014, MATER CHEM PHYS, V146, P531, DOI 10.1016/j.matchemphys.2014.04.011; Han L., 2006, Oyo Buturi, V75; NOMURA S, 1991, SOLID STATE COMMUN, V78, P677, DOI 10.1016/0038-1098(91)90843-K; Prias-Barragan JJ, 2006, J CRYST GROWTH, V286, P279, DOI 10.1016/j.jcrysgro.2005.09.022; ROSENCWAIG A, 1975, PHYS TODAY, V28, P23; Shen Q, 2004, JPN J APPL PHYS 1, V43, P2946, DOI 10.1143/JJAP.43.2946; Toyoda T., 2010, J APPL PHYS, V108; Toyoda T, 2009, J APPL PHYS, V105, DOI 10.1063/1.3074500; Underwood DF, 2001, EUR PHYS J D, V16, P241, DOI 10.1007/s100530170101; Yindeesuk W, 2013, AIP ADV, V3, DOI 10.1063/1.4825231; Zhao H, 2014, J SOL-GEL SCI TECHN, V71, P406, DOI 10.1007/s10971-014-3390-9	53	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	SEP 1	2015	590						90	97		10.1016/j.tsf.2015.07.038		8	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CR1BG	WOS:000361057100016		
J	Watanabe, R; Kawashima, M; Saito, Y				Watanabe, Ryosuke; Kawashima, Mizuho; Saito, Yoji			Film properties of alumina passivation layer for silicon solar cells prepared by spin-coating method	THIN SOLID FILMS			English	Article						Surface passivation; Solar cells; Sol-gel; Band bending passivation	TEMPERATURE SURFACE PASSIVATION; CHEMICAL-VAPOR-DEPOSITION; AL2O3 THIN-FILMS; CRYSTALLINE SILICON; SPRAY-PYROLYSIS; SI; INTERFACE; OXIDE; RECOMBINATION; CHEMISTRY	We prepared alumina passivation films deposited by a sol-gel wet process for silicon substrates. Aluminum acetylacetonate was used as a precursor, and the solution was spin-coated onto silicon substrates. Calcination temperature dependence of the passivation quality of the films was evaluated mainly by measuring effective lifetime using a photo conductance decay technique and capacitance-voltage measurements. Also, X-ray photoelectron spectroscopy and Fourier transform infrared spectroscopy were carried out to evaluate film properties. A large amount of negative fixed charge density (Q(f) = -3.1 x 10(12) cm(-2)) exists in the films calcined at 300 degrees C. On the other hand, a long effective lifetime of 400 mu s was obtained for the sample calcined at 600 degrees C, and the passivation films had a large amount of positive fixed charge density (Q(f) = 3.6 x 10(12) cm(-2)) with a low interface state density. (C) 2015 Elsevier B.V. All rights reserved.	[Watanabe, Ryosuke; Kawashima, Mizuho; Saito, Yoji] Seikei Univ, Dept Syst Design Engn, Tokyo 1808633, Japan	Watanabe, R (reprint author), Seikei Univ, Dept Syst Design Engn, Kichijoji Kitamachi, Tokyo 1808633, Japan.	rwatanabe@st.seikei.ac.jp					Hoex B, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2784168; BLAKERS AW, 1989, APPL PHYS LETT, V55, P1363, DOI 10.1063/1.101596; HEZEL R, 1989, J ELECTROCHEM SOC, V136, P518, DOI 10.1149/1.2096673; Hoex B, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2240736; Dingemans G, 2009, J APPL PHYS, V106, DOI 10.1063/1.3264572; Klein TM, 1999, APPL PHYS LETT, V75, P4001, DOI 10.1063/1.125519; Vitanov P, 2009, THIN SOLID FILMS, V517, P6327, DOI 10.1016/j.tsf.2009.02.085; HIMPSEL FJ, 1988, PHYS REV B, V38, P6084, DOI 10.1103/PhysRevB.38.6084; Dauwe S, 2002, PROG PHOTOVOLTAICS, V10, P271, DOI 10.1002/pip.420; Mackel H, 2002, J APPL PHYS, V92, P2602, DOI 10.1063/1.1495529; Schultz O, 2008, PROG PHOTOVOLTAICS, V16, P317, DOI 10.1002/pip.814; Leguijt C, 1996, SOL ENERG MAT SOL C, V40, P297, DOI 10.1016/0927-0248(95)00155-7; Hoex B, 2008, J APPL PHYS, V104, DOI 10.1063/1.2963707; Untila GG, 2013, SOL ENERGY, V98, P440, DOI 10.1016/j.solener.2013.08.041; Hwang YH, 2009, ELECTROCHEM SOLID ST, V12, pH336, DOI 10.1149/1.3156830; Zhao JH, 1999, PROG PHOTOVOLTAICS, V7, P471, DOI 10.1002/(SICI)1099-159X(199911/12)7:6<471::AID-PIP298>3.0.CO;2-7; Dingemans G, 2011, ELECTROCHEM SOLID ST, V14, pH1, DOI 10.1149/1.3501970; Miyajima S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.012301; Agostinelli G, 2006, SOL ENERG MAT SOL C, V90, P3438, DOI 10.1016/j.solmat.2006.04.014; Schmidt J, 2009, PHYS STATUS SOLIDI-R, V3, P287, DOI 10.1002/pssr.200903272; DILLON AC, 1995, SURF SCI, V322, P230, DOI 10.1016/0039-6028(95)90033-0; Untila GG, 2012, SEMICONDUCTORS+, V46, P832, DOI 10.1134/S1063782612060255; Werner F, 2011, J APPL PHYS, V109, DOI 10.1063/1.3587227; HEZEL R, 1981, J APPL PHYS, V52, P3076, DOI 10.1063/1.329058; Benick J, 2010, IEEE PHOT SPEC CONF, P891; Dingemans G, 2010, ELECTROCHEM SOLID ST, V13, pH76, DOI 10.1149/1.3276040; Dingemans G, 2012, J VAC SCI TECHNOL A, V30, DOI 10.1116/1.4728205; Dingemans G, 2012, J APPL PHYS, V111, DOI 10.1063/1.4709729; Dou YN, 2012, APPL PHYS A-MATER, V109, P673, DOI 10.1007/s00339-012-7097-x; Kuhnhold S, 2012, ENRGY PROCED, V27, P273, DOI 10.1016/j.egypro.2012.07.063; Li TT, 2009, PHYS STATUS SOLIDI-R, V3, P160, DOI 10.1002/pssr.200903140; MARUYAMA T, 1992, APPL PHYS LETT, V60, P322, DOI 10.1063/1.106699; Miyajima S., 2008, 23 EUR PHOT SOL EN C, P1029; Nicollian E., 2002, MOS METAL OXIDE SEMI; REED ML, 1988, J APPL PHYS, V63, P5776, DOI 10.1063/1.340317; Schroder D. K., 2006, SEMICONDUCTOR MAT DE; Sze S. M., 2002, SEMICONDUCTOR DEVICE; YABLONOVITCH E, 1992, SOLID STATE ELECTRON, V35, P261, DOI 10.1016/0038-1101(92)90230-A	38	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	SEP 1	2015	590						98	102		10.1016/j.tsf.2015.07.044		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CR1BG	WOS:000361057100017		
J	Mitsuhashi, T; Ito, Y; Takeuchi, Y; Harada, S; Ujihara, T				Mitsuhashi, Takato; Ito, Yasumasa; Takeuchi, Yukihisa; Harada, Shunta; Ujihara, Toru			Non-uniform electrodeposition of zinc on the (0001) plane	THIN SOLID FILMS			English	Article						Zinc anode; Crystallographic orientation; Morphology; Non-uniform electrodeposition	ELECTROCHEMICAL-BEHAVIOR; ALKALINE BATTERY; ELECTROLYTE; DEPOSITION; ADDITIVES; GROWTH; ALLOY	Transition of zinc morphology and crystallographic orientations with increasing charge capacity is examined to identify the origin of non-uniform electrodeposition. Galvanostatic charge experiments for zinc are carried out for both polycrystalline and oriented zinc substrates to investigate the effects of electrodeposited zinc on electrodepositing zinc. The results show that the crystallographic orientations of the zinc substrates strongly affect the morphology of the electrodeposited zinc. Non-uniformity appears in the (0001)-oriented case prior to the polycrystalline, (10 (1) over bar0)-and (2 (11) over bar0)-oriented cases. The (0001) plane initiates non-uniform zinc electrodeposition even in the polycrystalline case. It is attributed to the high density and low diffusivity of the ad-atom on the wide terrace structure. It is also indicated that porous structure appears from aggregated hexagonal hillocks with random orientations which initially are oriented hexagonal hillocks. (C) 2015 Elsevier B.V. All rights reserved.	[Mitsuhashi, Takato; Takeuchi, Yukihisa; Harada, Shunta; Ujihara, Toru] Nagoya Univ, Grad Sch Engn, Dept Mat Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ito, Yasumasa] Nagoya Univ, Grad Sch Engn, Dept Mech Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ito, Yasumasa; Ujihara, Toru] Nagoya Univ, Green Mobil Collaborat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Ito, Y (reprint author), Nagoya Univ, Grad Sch Engn, Dept Mech Sci & Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	yito@nagoya-u.jp			Adaptable & Seamless Technology Transfer Program through Target-driven RD (A-STEP); Japan Science and Technology Agency (JST) [AS242Z02637M]	Part of this study was supported by the Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) by the Japan Science and Technology Agency (JST) (No. AS242Z02637M).	ADZIC G, 1981, J ELECTROCHEM SOC, V128, P1691, DOI 10.1149/1.2127712; GREGORY TD, 1990, J ELECTROCHEM SOC, V137, P775, DOI 10.1149/1.2086553; SHIVKUMAR R, 1995, J POWER SOURCES, V55, P53, DOI 10.1016/0378-7753(94)02170-8; Ito Y, 2011, J POWER SOURCES, V196, P2340, DOI 10.1016/j.jpowsour.2010.09.065; MCLARNON FR, 1991, J ELECTROCHEM SOC, V138, P645, DOI 10.1149/1.2085653; Zhu JL, 1998, J POWER SOURCES, V72, P231, DOI 10.1016/S0378-7753(97)02705-5; Wen YH, 2012, ELECTROCHIM ACTA, V59, P64, DOI 10.1016/j.electacta.2011.10.042; Nishikawa K, 2011, J ELECTROANAL CHEM, V661, P84, DOI 10.1016/j.jelechem.2011.06.035; Liu S, 2011, J POWER SOURCES, V196, P7681, DOI 10.1016/j.jpowsour.2011.04.001; Zhang L, 2008, J POWER SOURCES, V179, P381, DOI 10.1016/j.jpowsour.2007.12.088; Desai D, 2014, J POWER SOURCES, V256, P145, DOI 10.1016/j.jpowsour.2014.01.026; Lee CW, 2006, J POWER SOURCES, V159, P1474, DOI 10.1016/j.jpowsour.2005.11.074; Guo L, 2010, ELECTROCHIM ACTA, V55, P4086, DOI 10.1016/j.electacta.2010.02.038; Turney DE, 2014, J POWER SOURCES, V264, P49, DOI 10.1016/j.jpowsour.2014.04.067; CHU MG, 1981, J ELECTROCHEM SOC, V128, P2281, DOI 10.1149/1.2127235; Haruyama S., 1963, J ELECTROCHEM SOC JP, V31, P478; Hirth J.P., 1963, SERIES PROGR MAT SCI, V2; Ito Y, 2012, J POWER SOURCES, V211, P119, DOI 10.1016/j.jpowsour.2012.03.056; Liu SS, 2011, ELECTROCHIM ACTA, V56, P8900, DOI 10.1016/j.electacta.2011.07.109; MCBREEN J, 1981, J ELECTROCHEM SOC, V128, P2287, DOI 10.1149/1.2127236; Oriani R.A., 1969, MODERN ASPECTS ELECT, V5; PANGAROV NA, 1965, J ELECTROANAL CHEM, V9, P70, DOI 10.1016/0022-0728(65)80066-3; SATO Y, 1983, J POWER SOURCES, V9, P147, DOI 10.1016/0378-7753(83)80029-9; Wang HQ, 2006, CHINESE J CHEM ENG, V14, P551, DOI 10.1016/S1004-9541(06)60113-4; Wen YH, 2009, J POWER SOURCES, V193, P890, DOI 10.1016/j.jpowsour.2009.04.047	25	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	SEP 1	2015	590						207	213		10.1016/j.tsf.2015.07.068		7	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CR1BG	WOS:000361057100032		
J	Tagami, T; Matsui, H; Fushimi, K; Yasunaga, H				Tagami, Takashi; Matsui, Hiroki; Fushimi, Kiyohide; Yasunaga, Hideo			Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis	THROMBOSIS AND HAEMOSTASIS			English	Article						Antithrombin; disseminated intravascular coagulation; sepsis; surgery	RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY-ILL PATIENTS; SEVERE PNEUMONIA PATIENTS; PROPENSITY SCORE METHODS; SEPTIC SHOCK; OBSERVATIONAL NATIONWIDE; DIAGNOSTIC-CRITERIA; CONTROLLED TRIAL; KYBERSEPT-TRIAL; BLEEDING RISK	The effectiveness of supplemental dose antithrombin administration (1,500 to 3,000 IU/ day) for patients with sepsis-associated disseminated intravascular coagulation (DIC), especially sepsis due to abdominal origin, remains uncertain. This was a retrospective cohort study of patients with mechanically ventilated septic shock and DIC after emergency surgery for perforation of the lower intestinal tract using a nationwide administrative database, Japanese Diagnosis Procedure Combination inpatient database. A total of 2,164 patients treated at 612 hospitals during the 33-month study period between 2010 and 2013 were divided into an antithrombin group (n=1,021) and a control group (n=1,143), from which 518 propensity score-matched pairs were generated. Although there was no significant 28-day mortality difference between the two groups in the unmatched groups (control vs antithrombin: 25.7 vs 22.9%; difference, 2.8%; 95% confidence interval [CI], -0.8-6.4), a significant difference existed between the two groups in propensity-score weighted groups (26.3 vs 21.7 A); difference, 4.6 %; 95% CI, 2.0-7.1) and propensity-score matched groups (27.6 vs 19.9%; difference, 7.7%; 95% CI, 2.5-12.9). Logistic regression analyses showed a significant association between antithrombin use and lower 28-day mortality in propensity-matched groups (odds ratio, 0.65; 95% CI, 0.49-0.87). Analysis using the hospital antithrombin-prescribing rate as an instrumental variable showed that receipt of antithrombin was associated with a 6.5% (95% CI, 0.05-13.0) reduction in 28-day mortality. Supplemental dose of antithrombin administration may be associated with reduced 28-day mortality in sepsis-associated DIC patients after emergency laparotomy for intestinal perforation.	[Tagami, Takashi; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1138555, Japan; [Tagami, Takashi] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Informat & Policy, Tokyo, Japan	Tagami, T (reprint author), Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138555, Japan.	t-tagami@nms.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare of Japan [H26-Policy-011]	This work was supported by the Ministry of Health, Labour and Welfare of Japan (Research on Policy Planning and Evaluation, grant H26-Policy-011 to Prof. Fushimi and Prof. Yasunaga.). The funders had no role in the execution of this study or interpretation of the results.	Afshari A, 2007, BRIT MED J, V335, P1248, DOI 10.1136/bmj.39398.682500.25; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI 10.1056/NEJMra1208623; Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI 10.1111/j.1365-2141.2009.07600.x; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Curtis LH, 2007, MED CARE, V45, pS103; Iba T, 2014, J THROMB HAEMOST, V12, P1010, DOI 10.1111/jth.12596; Tagami T, 2015, EUR RESPIR J, V45, P463, DOI 10.1183/09031936.00081514; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Dahabreh IJ, 2012, EUR HEART J, V33, P1893, DOI 10.1093/eurheartj/ehs114; Zhang ZH, 2014, J CLIN EPIDEMIOL, V67, P932, DOI 10.1016/j.jclinepi.2014.02.018; Iba T, 2012, THROMB RES, V130, pE129, DOI 10.1016/j.thromres.2012.03.021; Gando S, 2008, CRIT CARE MED, V36, P145, DOI 10.1097/01.CCM.0000295317.97245.2D; Wada H, 2010, THROMB RES, V125, P6, DOI 10.1016/j.thromres.2009.08.017; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Dhainaut JF, 2005, CRIT CARE MED, V33, P341, DOI 10.1097/01.CCM.0000153520.31562.48; Gando S, 2006, CRIT CARE MED, V34, P625, DOI 10.1097/01.CCM.0000202209.42491.38; Aota T, 2014, J THROMB HAEMOST; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; Di Nisio M, 2012, THROMB RES, V129, pE177, DOI 10.1016/j.thromres.2011.08.028; Egi M, 2009, THROMB HAEMOSTASIS, V101, P696, DOI 10.1160/TH08-07-0448; Eid A, 2008, ANESTH ANALG, V107, P1633, DOI 10.1213/ane.0b013e318184621d; FOURRIER F, 1993, CHEST, V104, P882, DOI 10.1378/chest.104.3.882; Fourrier F, 2012, CRIT CARE MED, V40, P2704, DOI 10.1097/CCM.0b013e318258ff30; Gando S, 2013, CRIT CARE, V17, DOI 10.1186/cc13163; Hunt BJ, 2014, NEW ENGL J MED, V370, P847, DOI 10.1056/NEJMra1208626; Iba T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0497-x; Kawano S, 2014, BLOOD COAGUL FIBRIN, V25, P795, DOI 10.1097/MBC.0000000000000115; Kushimoto S, 2008, THROMB HAEMOSTASIS, V100, P1099, DOI 10.1160/TH08-05-0306; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Oda Shigeto, 2014, J Intensive Care, V2, P55, DOI 10.1186/s40560-014-0055-2; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rublee D, 2002, CRIT CARE, V6, P349, DOI 10.1186/cc1529; Seam N, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0639-1; Tagami T, 2015, J THROMB HAEMOST, V13, P31, DOI 10.1111/jth.12786; Tagami T, 2014, J THROMB HAEMOST, V12, P1470, DOI 10.1111/jth.12643; Tagami T, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0027-7; Vincent JL, 2010, CRIT CARE MED, V38, pS534, DOI 10.1097/CCM.0b013e3181f208ac; Wada H, 2013, J THROMB HAEMOST, V11, P761, DOI DOI 10.1111/JTH.12155; Wiedermann CJ, 2006, CRIT CARE MED, V34, P285, DOI 10.1097/01.CCM.0000194731.08896.99; Wiedermann CJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4822; Wiedermann CJ, 2006, BLOOD COAGUL FIBRIN, V17, P521, DOI 10.1097/01.mbc.0000245302.18010.40; Zhang Z, 2014, J CRIT CARE, V29, p[886, e889]	48	0	0	SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN	STUTTGART	HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY	0340-6245			THROMB HAEMOSTASIS	Thromb. Haemost.	SEP	2015	114	3					537	545		10.1160/TH15-01-0053		9	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CQ7KR	WOS:000360783500011		
J	Abe, M; Maeda, M; Kanai, N; Hori, K; Kawahara, Y; Okada, H; Yamato, M				Abe, M.; Maeda, M.; Kanai, N.; Hori, K.; Kawahara, Y.; Okada, H.; Yamato, M.			The Development of a Novel Device for Transplantation of Cell Sheets in the Field of the Oropharynx and Hypopharynx	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Abe, M.; Hori, K.; Kawahara, Y.; Okada, H.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Maeda, M.; Kanai, N.; Yamato, M.] Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S186	S186				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201326		
J	Ajoudanian, M; Sudo, R				Ajoudanian, M.; Sudo, R.			Preparation and Culture of Collagen Microspheres as a Scaffold for Liver Tissue Engineering	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Ajoudanian, M.; Sudo, R.] Keio Univ, Syst Design Engn, Yokohama, Kanagawa 223, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S345	S345				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202444		
J	Akiyama, Y; Matsuyama, M; Takeda, N; Yamato, M; Okano, T				Akiyama, Y.; Matsuyama, M.; Takeda, N.; Yamato, M.; Okano, T.			Mechanical Stretch-Induced Alternation of Poly(N-isopropylacrylamide) Gel Modified PDMS Surface Properties	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Akiyama, Y.; Yamato, M.; Okano, T.] Tokyo Womens Med Univ, Tokyo, Japan; [Matsuyama, M.; Takeda, N.] Waseda Univ, Tokyo, Japan							Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f; Fukumori, 2010, MACROMOL BIOSCI, V10, P1117	2	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S291	S291				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202230		
J	Aoyama, T; Sawada, K; Fujisato, T				Aoyama, T.; Sawada, K.; Fujisato, T.			Keratin Nanofiber Scaffold for Vascular Graft	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Aoyama, T.; Fujisato, T.] Osaka Inst Technol, Biomed Engneering, Osaka 535, Japan; [Sawada, K.] Osaka Seikei Coll, Integrated Life, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S244	S244				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202046		
J	Aoyama, T; Tanaka, S; Okamoto, Y; Nakamichi, M; Sato, K; Sengoku, S				Aoyama, T.; Tanaka, S.; Okamoto, Y.; Nakamichi, M.; Sato, K.; Sengoku, S.			Development of a Transport Tool for Regenerative Medicine	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Aoyama, T.] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Tanaka, S.; Okamoto, Y.] JMS Co LTD, Hiroshima, Japan; [Nakamichi, M.; Sato, K.] TAMAIKASEI Co LTD, Otaru, Hokkaido, Japan; [Sengoku, S.] Tokyo Inst Technol, Tokyo 152, Japan							Akira I, J STEM CELL IN PRESS	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S175	S175				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201283		
J	Bongio, M; Arrigoni, C; Talo, G; Bersini, S; Enomoto, J; Fukuda, J; Moretti, M				Bongio, M.; Arrigoni, C.; Talo, G.; Bersini, S.; Enomoto, J.; Fukuda, J.; Moretti, M.			Geometrically Controlled Micro-Vascularized Constructs based on Electrochemical Transfer of Endothelial Monolayer	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Bongio, M.; Arrigoni, C.; Talo, G.; Bersini, S.; Moretti, M.] IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy; [Enomoto, J.; Fukuda, J.] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki, Japan; [Fukuda, J.] Brigham & Womens Hosp, Dept Med, Ctr Biomed Engn, Boston, MA 02115 USA								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S178	S178				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201295		
J	Chou, J; Hao, J; Ben-Nissan, B; Milthorpe, B; Otsuka, M				Chou, J.; Hao, J.; Ben-Nissan, B.; Milthorpe, B.; Otsuka, M.			Long-term Sustained Delivery of Zinc-doped Biomimetic System Improves Osteoporosis Condition	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Chou, J.; Ben-Nissan, B.] Univ Technol Sydney, Adv Tissue Regenerat & Drug Delivery Grp, Sydney, NSW 2007, Australia; [Hao, J.] Tokyo Med & Dent Univ, Oral Implantol & Regenerat Dent Med, Tokyo, Japan; [Milthorpe, B.] Univ Technol Sydney, Fac Sci, Sydney, NSW 2007, Australia; [Otsuka, M.] Musashino Univ, Pharmaceut Sci Res Inst, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S240	S240				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202032		
J	Du, D; Asaoka, T; Shinohara, M; Kageyama, T; Ushida, T; Furukawa, KS				Du, D.; Asaoka, T.; Shinohara, M.; Kageyama, T.; Ushida, T.; Furukawa, K. S.			Microstereolithography-based Fabrication of Anatomically Shaped beta-Tricalcium Phosphate Scaffolds for Bone Tissue Engineering	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Du, D.] Harbin Med Univ, Sino Russian Inst Hard Tissue Dev & Regenerat, Harbin, Peoples R China; [Du, D.; Shinohara, M.; Kageyama, T.; Furukawa, K. S.] Univ Tokyo, Sch Engn, Tokyo, Japan; [Asaoka, T.] Tokyo Denki Univ, Tokyo 101, Japan; [Ushida, T.] Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S346	S346				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202447		
J	Enomoto, J; Osaki, T; Kageyama, T; Fukuda, J				Enomoto, J.; Osaki, T.; Kageyama, T.; Fukuda, J.			Catch-and-release of Target Cells using Aptamer and Electrochemical Cell Detachment	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Enomoto, J.; Osaki, T.; Kageyama, T.; Fukuda, J.] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 240, Japan; [Osaki, T.] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S305	S306				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202286		
J	Escobedo-Lucea, C; Sanz-Garcia, A; Burks, DJ; Cerullo, V; Yliperttula, M				Escobedo-Lucea, C.; Sanz-Garcia, A.; Burks, D. J.; Cerullo, V.; Yliperttula, M.			Hasc and Nfc Membranes. New Promising Candidates for Wound Healing Treatment	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Escobedo-Lucea, C.] Univ Helsinki, Acad Finland, Pharmaceut Biosci, Helsinki, Finland; [Escobedo-Lucea, C.; Sanz-Garcia, A.] Tokyo Womens Med Univ TWINS, Inst Adv Biomed Engn, Tokyo, Japan; [Sanz-Garcia, A.] Univ Helsinki, Acad Finland, Pharmaceut Biosci CDR, Helsinki, Finland; [Burks, D. J.] Ciberer, Valencia, Spain; [Cerullo, V.] Univ Helsinki, Pharmaceut Biosci CDR, Helsinki, Finland; [Yliperttula, M.] Univ Helsinki, Pharmaceut Biosci, Helsinki, Finland								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S154	S154				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201203		
J	Fujihara, Y; Nitta, N; Misawa, M; Numano, T; Watanabe, Y; Sato, J; Otomo, K; Takato, T; Hoshi, K				Fujihara, Y.; Nitta, N.; Misawa, M.; Numano, T.; Watanabe, Y.; Sato, J.; Otomo, K.; Takato, T.; Hoshi, K.			T2 and ADC of MRI Reflect Maturation of Tissue-engineered Cartilage Subcutaneously Transplanted in Rats	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Fujihara, Y.; Watanabe, Y.; Sato, J.; Otomo, K.; Takato, T.; Hoshi, K.] Tokyo Univ Hosp, Tokyo 113, Japan; [Nitta, N.; Misawa, M.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Numano, T.] Tokyo Metropolitan Univ, Tokyo 158, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S376	S376				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202565		
J	Fujihara, Y; Hikita, A; Saijo, H; Kanno, Y; Takato, T; Hoshi, K				Fujihara, Y.; Hikita, A.; Saijo, H.; Kanno, Y.; Takato, T.; Hoshi, K.			Basic and Clinical Research on Custom-made Artificial Bone and Tissue-engineered Cartilage in Oral and Maxillofacial Region	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Fujihara, Y.; Hikita, A.; Saijo, H.; Kanno, Y.; Takato, T.; Hoshi, K.] Tokyo Univ Hosp, Tokyo 113, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S38	S38				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200144		
J	Fujita, I; Utho, R; Yamamoto, M; Shimizu, T; Okano, T				Fujita, I.; Utho, R.; Yamamoto, M.; Shimizu, T.; Okano, T.			Investigation of Proper Transplantation Site of Islet Cell Sheets for Treating Type 1 Diabetes Mellitus	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Fujita, I.; Utho, R.; Shimizu, T.; Okano, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Yamamoto, M.] Tokyo Womens Med Univ, Dept Surg, Inst Gastroenterol, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S183	S183				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201314		
J	Hara, T; Kakudo, N; Morimoto, N; Horio, O; Ogura, T; Kusumoto, K				Hara, T.; Kakudo, N.; Morimoto, N.; Horio, O.; Ogura, T.; Kusumoto, K.			Age-related Change in The Osteoinductive Activity of rhBMP-2	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Hara, T.; Kakudo, N.; Morimoto, N.; Horio, O.; Ogura, T.; Kusumoto, K.] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S369	S369				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202536		
J	Harimoto, K; Tsuda, Y; Ito, Y; Endo, H; Nakamura, S; Eto, K				Harimoto, K.; Tsuda, Y.; Ito, Y.; Endo, H.; Nakamura, S.; Eto, K.			Towards Industrialization: Development of Ips Cell-derived Platelet Production System	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Harimoto, K.; Tsuda, Y.; Ito, Y.; Endo, H.; Nakamura, S.; Eto, K.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S15	S15				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200050		
J	Higuchi, A; Alarfaj, AA; Munusamy, MA				Higuchi, A.; Alarfaj, A. A.; Munusamy, M. A.			Human Pluripotent Stem Cell Culture on Hydrogels Grafted with Nanosegments for Feeder-free Culture	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Higuchi, A.] Natl Cent Univ, Dept Chem & Mat Engn, Jhongli, Taiwan; [Higuchi, A.] RIKEN, Nano Med Engn Lab, Saitama, Japan; [Alarfaj, A. A.; Munusamy, M. A.] King Saud Univ, Dept Bot & Microbiol, Riyadh, Saudi Arabia								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S288	S289				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202220		
J	Homma, J; Sekine, H; Matsuura, K; Shimizu, T				Homma, J.; Sekine, H.; Matsuura, K.; Shimizu, T.			Cell Sheet Transplantation Ameliorates Cardiac Dysfunction of Infarcted Infant Hearts by Cardiomyocyte Proliferation and Angiogenesis	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Homma, J.; Sekine, H.; Matsuura, K.; Shimizu, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S192	S192				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201350		
J	Iseoka, H; Miyagawa, S; Fukushima, S; Masuda, S; Saito, A; Yajima, S; Ito, E; Lee, J; Sawa, Y				Iseoka, H.; Miyagawa, S.; Fukushima, S.; Masuda, S.; Saito, A.; Yajima, S.; Ito, E.; Lee, J.; Sawa, Y.			Development of Functional Tissue-engineered Artificial Cardiac Construct generated by Human Induced Pluripotent Stem Cells	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Iseoka, H.; Miyagawa, S.; Fukushima, S.; Masuda, S.; Saito, A.; Yajima, S.; Ito, E.; Sawa, Y.] Osaka Univ, Cardiovasc Surg, Osaka, Japan; [Lee, J.] Osaka Univ, Cardiovasc Regenerat Med, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S212	S213				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201431		
J	Itoh, M; Mukae, Y; Matsubayashi, K; Kawakatsu, M; Furukawa, K; Uchihashi, K; Toda, S; Oyama, J; Node, K; Nakayama, K; Morita, S				Itoh, M.; Mukae, Y.; Matsubayashi, K.; Kawakatsu, M.; Furukawa, K.; Uchihashi, K.; Toda, S.; Oyama, J.; Node, K.; Nakayama, K.; Morita, S.			The Effectiveness of using a Bio-3D Printer in the Development of a Scaffold-free Regenerative Vascular Graft	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Itoh, M.; Mukae, Y.; Furukawa, K.; Morita, S.] Saga Univ, Dept Thorac & Cardivasc Surg, Saga 840, Japan; [Matsubayashi, K.; Kawakatsu, M.; Nakayama, K.] Saga Univ, Fus Grad Sch Sci & Engineer, Biomed Engn Course Adv Technol, Saga 840, Japan; [Uchihashi, K.; Toda, S.] Saga Univ, Dept Pathol & Microbiol, Saga 840, Japan; [Oyama, J.; Node, K.] Saga Univ, Dept Cardiovasc Med, Saga 840, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S339	S339				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202419		
J	Kageyama, T; Osaki, T; Enomoto, J; Anada, T; Suzuki, O; Fukuda, J				Kageyama, T.; Osaki, T.; Enomoto, J.; Anada, T.; Suzuki, O.; Fukuda, J.			Vascularized Bone Engineering using Rapid Vascular Fabrication Technique	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kageyama, T.; Osaki, T.; Enomoto, J.; Fukuda, J.] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 240, Japan; [Anada, T.; Suzuki, O.] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S406	S406				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202687		
J	Kaji, H; Kondo, T; Mori, Y; Nagai, N; Abe, T				Kaji, H.; Kondo, T.; Mori, Y.; Nagai, N.; Abe, T.			Injectable Polymeric Nanosheets for Subretinal Cell Delivery	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kaji, H.; Kondo, T.; Mori, Y.] Tohoku Univ, Bioengn & Robot, Sendai, Miyagi 980, Japan; [Nagai, N.; Abe, T.] Tohoku Univ, United Ctr Adv Res & Translat Med, Sendai, Miyagi 980, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S276	S276				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202173		
J	Kajii, F; Iwai, A; Tanaka, H; Kamakura, S				Kajii, F.; Iwai, A.; Tanaka, H.; Kamakura, S.			Influence of Electron Beam Irradiation Dose on Bone Regeneration by Octacalcium Phosphate Collagen Composites	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kajii, F.; Iwai, A.; Tanaka, H.] TOYOBO Co Ltd, Res Inst, Otsu, Shiga, Japan; [Kamakura, S.] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan							Kamakura S, 2006, J BIOMED MATER RES B, V79B, P210, DOI 10.1002/jbm.b.30531	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S403	S403				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202675		
J	Kambe, Y; Yamaoka, T				Kambe, Y.; Yamaoka, T.			Development of Vascular Inducible Hydrogel with Functional Peptide Sequences for Angiogenic Therapy	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kambe, Y.; Yamaoka, T.] Natl Cerebral & Cardiovasc Ctr, Dept Biomed Engn, Res Inst, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S180	S180				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201302		
J	Kamei, S; Sakaguchi, K; Li, L; Shimizu, T; Umezu, M				Kamei, S.; Sakaguchi, K.; Li, L.; Shimizu, T.; Umezu, M.			Construction of Functional Liver Tissue Model by Cell Sheet Technology for Drug Test	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kamei, S.; Sakaguchi, K.; Li, L.; Umezu, M.] Waseda Univ, Sch Creat Sci & Engn, Tokyo, Japan; [Shimizu, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S264	S264				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202127		
J	Kamitori, S; Ozeki, Y; Kojima, N				Kamitori, S.; Ozeki, Y.; Kojima, N.			Role of Sugar Chain in the Self-organization of the Pancreatic Islet Structure In Vitro	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kamitori, S.; Ozeki, Y.; Kojima, N.] Yokohama City Univ, Yokohama, Kanagawa 232, Japan							Kojima N, 2014, TRANSPL P, V46, P1161, DOI 10.1016/j.transproceed.2013.11.147	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S134	S134				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201128		
J	Kanai, N; Maeda, M; Kobayashi, S; Okano, T; Yamato, M				Kanai, N.; Maeda, M.; Kobayashi, S.; Okano, T.; Yamato, M.			A Novel Endoscopic Device for Transplantation of Tissue-engineered Cell Sheets	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kanai, N.; Maeda, M.; Okano, T.; Yamato, M.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Kobayashi, S.] Nagasaki Univ, Dept Surg, Grad Sch Biomed Sci, Nagasaki 852, Japan							Ohki T, 2012, GASTROENTEROLOGY	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S239	S239				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202026		
J	Kawai, T; Matsui, K; Ezoe, Y; Kajii, F; Iwai, A; Tanaka, H; Takahashi, T; Kamakura, S				Kawai, T.; Matsui, K.; Ezoe, Y.; Kajii, F.; Iwai, A.; Tanaka, H.; Takahashi, T.; Kamakura, S.			Octacalcium Phosphate Collagen Composites Facilitates Bony Reconstruction after Canine Mandibular Amputation	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kawai, T.; Matsui, K.; Ezoe, Y.; Takahashi, T.] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan; [Kajii, F.; Iwai, A.; Tanaka, H.] TOYOBO Co Ltd, Res Inst, Otsu, Shiga, Japan; [Kamakura, S.] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan							Kamakura S, 2006, J BIOMED MATER RES B, V79B, P210, DOI 10.1002/jbm.b.30531	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S59	S59				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200227		
J	Kawasaki, T; Kirita, Y; Kami, D; Kitani, T; Ozaki, C; Itakura, Y; Toyoda, M; Gojo, S				Kawasaki, T.; Kirita, Y.; Kami, D.; Kitani, T.; Ozaki, C.; Itakura, Y.; Toyoda, M.; Gojo, S.			Novel Detergent for Whole Organ Tissue Engineering to Improve Implantability of Acellular Scaffold	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kawasaki, T.; Kitani, T.] Kyoto Prefectural Univ Med, Cardiol, Kyoto, Japan; [Kirita, Y.] Kyoto Prefectural Univ Med, Nephrol, Kyoto, Japan; [Kami, D.; Gojo, S.] Kyoto Prefectural Univ Med, Regenerat Med, Kyoto, Japan; [Ozaki, C.] Sanyo Chem Ind Ltd, Kyoto, Japan; [Itakura, Y.; Toyoda, M.] Tokyo Metropolitan Inst Gerontol, Vasc Med, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S135	S136				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201132		
J	Kiamehr, M; Yoshida, T; Takahashi, H; Washio, K; Iwata, T; Yamato, M; Okano, T; Yang, X				Kiamehr, M.; Yoshida, T.; Takahashi, H.; Washio, K.; Iwata, T.; Yamato, M.; Okano, T.; Yang, X.			Development of Bone-Like Tissue Graft in Vitro using Multilayer Cell Sheet Technology	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kiamehr, M.; Yang, X.] Univ Leeds, Dept Oral Biol, Leeds, W Yorkshire, England; [Yoshida, T.; Takahashi, H.; Washio, K.; Iwata, T.; Yamato, M.; Okano, T.] Tokyo Womens Med Univ, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S33	S33				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200122		
J	Kim, Y; Tabata, Y				Kim, Y.; Tabata, Y.			Synergistic Effect of Macrophage Recruitment Agent and Growth factors Release on Bone Regeneration	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kim, Y.; Tabata, Y.] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S122	S122				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201080		
J	Kimura, T; Morita, H; Wu, P; Nakamura, N; Nam, K; Fujisato, T; Kishida, A				Kimura, T.; Morita, H.; Wu, P.; Nakamura, N.; Nam, K.; Fujisato, T.; Kishida, A.			A Small-diameter Decellularized Vascular Graft Covered with Electrospun Fibers	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kimura, T.; Morita, H.; Wu, P.; Nakamura, N.; Nam, K.; Kishida, A.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan; [Fujisato, T.] Osaka Inst Technol, Fac Engn, Osaka 535, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S239	S239				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202025		
J	Kino-Oka, M; Kim, M				Kino-oka, M.; Kim, M.			Selective Removal of Cells Deviated from the Undifferentiated State in Hipsc Colonies by using Botulinum Hemagglutinin Proteins	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kino-oka, M.; Kim, M.] Osaka Univ, Biotechnol, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S273	S274				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202717		
J	Kishi, N				Kishi, N.			What Increases Firms' Dependence on External Organization in R&D? : The Case of the Regenerative Medicine Industry	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kishi, N.] Yokohama Natl Univ, Yokohama, Kanagawa 240, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S186	S186				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201329		
J	Kishida, A; Nakamura, N; Ito, A; Nam, K; Kimura, T; Fujisato, T; Tsuji, T				Kishida, A.; Nakamura, N.; Ito, A.; Nam, K.; Kimura, T.; Fujisato, T.; Tsuji, T.			Periodontal Reconstruction using Decellularized Periodontal Tissue Combined with Artificial Tooth	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kishida, A.; Nakamura, N.; Ito, A.; Nam, K.; Kimura, T.] Tokyo Med & Dent Univ, Tokyo, Japan; [Fujisato, T.] Osaka Inst Technol, Osaka 535, Japan; [Tsuji, T.] RIKEN, Kobe, Hyogo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S57	S57				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200220		
J	Kitai, M; Mahara, A; Masunaga, H; Hikima, T; Sasaki, S; Ohya, Y; Yamaoka, T				Kitai, M.; Mahara, A.; Masunaga, H.; Hikima, T.; Sasaki, S.; Ohya, Y.; Yamaoka, T.			Regulation of Inflammation and Degradation of Decellularized Vascular Grafts by Crosslinking with Branched Peg	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kitai, M.; Mahara, A.; Yamaoka, T.] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Suita, Osaka, Japan; [Kitai, M.; Ohya, Y.] Kansai Univ, Suita, Osaka, Japan; [Masunaga, H.; Hikima, T.] Japan Synchrotoron Radiat Res Inst, Registered Inst Facil Use Promot, Sayo, Hyogo, Japan; [Sasaki, S.] Kyoto Inst Technol, Sakyo Ku, Kyoto, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S168	S168				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201257		
J	Kitoh, H; Mishima, K; Matsushita, M; Ishiguro, N				Kitoh, H.; Mishima, K.; Matsushita, M.; Ishiguro, N.			Transplantation of Culture-expanded Bone Marrow Cells and Platelet Rich Plasma during Distraction Osteogenesis of the Long Bones	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kitoh, H.; Mishima, K.; Matsushita, M.; Ishiguro, N.] Nagoya Univ, Grad Sch Med, Orthopaed Surg, Nagoya, Aichi 4648601, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S37	S37				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200141		
J	Kobayashi, J; Arisaka, Y; Ohashi, K; Tatsumi, K; Kim, K; Akiyama, Y; Yamato, M; Okano, T				Kobayashi, J.; Arisaka, Y.; Ohashi, K.; Tatsumi, K.; Kim, K.; Akiyama, Y.; Yamato, M.; Okano, T.			Creation of Functional Hepatocyte Sheet Tissues by using Heparinized Thermoresponsive Surfaces	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kobayashi, J.; Arisaka, Y.; Ohashi, K.; Tatsumi, K.; Kim, K.; Akiyama, Y.; Yamato, M.; Okano, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S10	S11				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200033		
J	Komura, M; Komura, H; Satake, R; Moriwaki, T; Nakayama, Y				Komura, M.; Komura, H.; Satake, R.; Moriwaki, T.; Nakayama, Y.			Basic Research Toward a Cylinder-type Regenerative Airway (bio-air-tube)	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Komura, M.; Satake, R.] Saitama Med Univ, Moroyama, Saitama, Japan; [Komura, M.] Univ Tokyo, Dept Pediat Surg, Tokyo, Japan; [Komura, H.] Univ Tokyo, Tokyo, Japan; [Moriwaki, T.; Nakayama, Y.] Natl Cerebral & Cardiovasc Ctr, Div Med Engn & Mat, Res Inst, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S147	S147				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201174		
J	Koshino, K; Kanai, N; Takagi, R; Sugiyama, H; Yamato, M; Okano, T; Yamamoto, M				Koshino, K.; Kanai, N.; Takagi, R.; Sugiyama, H.; Yamato, M.; Okano, T.; Yamamoto, M.			Regenerative Therapy using Adipose tissue-derived Stem Cell Sheets Transplanted to the Intestinal Ulcer Lesion in Animal Models	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Koshino, K.; Kanai, N.; Takagi, R.; Sugiyama, H.; Yamato, M.; Okano, T.] Tokyo Womens Med Univ, Inst Adv BioMed Engn & Sci, Shinjuku Ku, Tokyo, Japan; [Koshino, K.; Yamamoto, M.] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Shinjuku Ku, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S98	S98				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200382		
J	Kunii, S; Yamamoto, E; Horiuchi, Y; Akahoshi, Y; Morimoto, K				Kunii, S.; Yamamoto, E.; Horiuchi, Y.; Akahoshi, Y.; Morimoto, K.			Low Adhesive Scaffold Collagen, Inducing Spheroid Formation, Promotes the Osteogenic Differentiation	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kunii, S.; Morimoto, K.] Kindai Univ, Genet Engn, Kinokawa, Japan; [Yamamoto, E.] Kindai Univ, Med Engn, Kinokawa, Japan; [Horiuchi, Y.; Akahoshi, Y.] Kindai Univ, Life Sci Res Ctr, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S197	S197				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201369		
J	Kunii, S; Horiuchi, Y; Morimoto, K				Kunii, S.; Horiuchi, Y.; Morimoto, K.			Low Adhesive Scaffold Collagen, Inducing Spheroid Formation, Promotes the Cell Crawling of Fibroblasts	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kunii, S.; Morimoto, K.] Kindai Univ, Genet Engn, Kinokawa, Japan; [Horiuchi, Y.] Kindai Univ, Life Sci Res Ctr, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S202	S202				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201390		
J	Kuramoto, G; Takagi, S; Ishitani, K; Shimizu, T; Yamato, M; Okano, T; Matsui, H				Kuramoto, G.; Takagi, S.; Ishitani, K.; Shimizu, T.; Yamato, M.; Okano, T.; Matsui, H.			Regeneration of Endometrium Tissue using Cell Sheet Engineering	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kuramoto, G.; Ishitani, K.; Matsui, H.] Tokyo Womens Med Univ, Dept Obstet & Gynecol, Tokyo, Japan; [Takagi, S.; Shimizu, T.; Yamato, M.; Okano, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S221	S221				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201465		
J	Kurimoto, R; Kanie, K; Idota, N; Uto, K; Tsukahara, T; Hara, M; Nagano, S; Narita, Y; Honda, H; Naito, M; Kato, R; Ebara, M				Kurimoto, R.; Kanie, K.; Idota, N.; Uto, K.; Tsukahara, T.; Hara, M.; Nagano, S.; Narita, Y.; Honda, H.; Naito, M.; Kato, R.; Ebara, M.			Property-tunable Polymer Platform for Optimizing Cell-adhesive Peptide Function	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Kurimoto, R.; Naito, M.] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Kurimoto, R.; Uto, K.; Naito, M.; Ebara, M.] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Kanie, K.; Hara, M.; Nagano, S.; Narita, Y.; Honda, H.; Kato, R.] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Idota, N.] Waseda Univ, Tokyo, Japan; [Tsukahara, T.] Tokyo Inst Technol, Tokyo 152, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S303	S303				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202277		
J	Mahara, A; Kitai, M; Otaka, A; Munisso, M; Ohya, Y; Yamaoka, T				Mahara, A.; Kitai, M.; Otaka, A.; Munisso, M.; Ohya, Y.; Yamaoka, T.			In Vivo Rapid Endotherialization of Small-diameter Decellularized Vascular Grafts with Bioactive Peptide Modifier	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Mahara, A.; Kitai, M.; Otaka, A.; Munisso, M.; Yamaoka, T.] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Suita, Osaka, Japan; [Kitai, M.; Ohya, Y.] Kansai Univ, Fac Chem Mat & Bioengn, Suita, Osaka, Japan							Fujisato T, 2005, CARDIOVASCULAR REGEN	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S82	S82				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200321		
J	Mahara, A; Morimoto, N; Jinno, C; Yamaoka, T				Mahara, A.; Morimoto, N.; Jinno, C.; Yamaoka, T.			Application of High Pressure Engineering to Maintain and Inactivation of Congenital Melanocytic Nevi Extirpation	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Mahara, A.; Yamaoka, T.] Natl Cerebral & Cardiovasc Ctr, Dept Biomed Engn, Res Inst, Suita, Osaka, Japan; [Morimoto, N.] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka, Japan; [Jinno, C.] Kyoto Univ, Dept Plast & Reconstruct Surg, Kyoto, Japan							Mahara A, 2014, BIOMED RES INT, DOI 10.1155/2014/379607; Morimoto N, 2015, BIOMED RES INT, DOI 10.1155/2015/587247	2	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S373	S374				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202555		
J	Makino, H; Ijiri, Y; Ogata, A; Shioyama, T; Kubo, H; Mizutani, M; Shimizu, T; Kino-oka, M; Yamamori, S				Makino, H.; Ijiri, Y.; Ogata, A.; Shioyama, T.; Kubo, H.; Mizutani, M.; Shimizu, T.; Kino-oka, M.; Yamamori, S.			Quantitative Evaluation of Human Culture Operation for the Design of Automated Cell Production System	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Makino, H.; Shioyama, T.; Kubo, H.; Yamamori, S.] Nihon Kohden Corp, Ogino Mem Lab, Tokyo, Japan; [Ijiri, Y.; Ogata, A.; Mizutani, M.; Kino-oka, M.] Osaka Univ, Dept Biotechnol, Osaka, Japan; [Shimizu, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S402	S402				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202673		
J	Maruya, Y; Kanai, N; Kobayashi, S; Hosoi, T; Maeda, M; Fukai, F; Eguchi, S; Yamato, M				Maruya, Y.; Kanai, N.; Kobayashi, S.; Hosoi, T.; Maeda, M.; Fukai, F.; Eguchi, S.; Yamato, M.			Transplantation Adipose-derived Stromal Cell Sheets for Prevention of Stricture after Esophageal Endoscopic Submucosal Dissection in Pig Models	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Maruya, Y.; Kobayashi, S.; Eguchi, S.] Nagasaki Univ, Dept Surg, Nagasaki 852, Japan; [Maruya, Y.; Kanai, N.; Hosoi, T.; Maeda, M.; Yamato, M.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Hosoi, T.; Fukai, F.] Tokyo Univ Sci, Dept Pharmaceut, Chiba, Japan							Maeda M, GASTROINTESTINAL END	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S222	S223				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201470		
J	Matsumoto, M; Fujitani, M; Sasaki, H; Kanie, K; Kiyota, Y; Honda, H; Kato, R				Matsumoto, M.; Fujitani, M.; Sasaki, H.; Kanie, K.; Kiyota, Y.; Honda, H.; Kato, R.			Image-based Profiling of Mesenchymal Stem Cells for Quality Assessment	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Matsumoto, M.; Honda, H.] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648601, Japan; [Fujitani, M.; Sasaki, H.; Kanie, K.; Kato, R.] Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4648601, Japan; [Kiyota, Y.] Nikon Inc, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S367	S367				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202528		
J	Matsusaki, M; Akashi, M				Matsusaki, M.; Akashi, M.			Development of Vascularized iPSC Derived 3D-Human Tissue Constructs for Regenerative Medicine	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Matsusaki, M.; Akashi, M.] Osaka Univ, Dept Appl Chem, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S48	S48				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200185		
J	Matsushite, N; Fujisato, T				Matsushite, N.; Fujisato, T.			Endometrium Tissue Culture for In Vitro Embryo Implantation	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Matsushite, N.; Fujisato, T.] Osaka Inst Technol, Osaka 535, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S131	S131				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201116		
J	Mishima, K; Ohkawara, B; Kitoh, H; Okabe, YT; Sugiura, H; Matsushita, M; Ishiguro, N; Ohno, K				Mishima, K.; Ohkawara, B.; Kitoh, H.; Okabe, Y. Tsukagoshi; Sugiura, H.; Matsushita, M.; Ishiguro, N.; Ohno, K.			Promoting Osteoblastogenesis using Lansoprazole	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Mishima, K.; Kitoh, H.; Sugiura, H.; Matsushita, M.; Ishiguro, N.] Nagoya Univ, Grad Sch Med, Orthopaed Surg, Nagoya, Aichi 4648601, Japan; [Ohkawara, B.; Ohno, K.] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan; [Okabe, Y. Tsukagoshi] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Nagoya, Aichi 4648601, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S246	S246				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202056		
J	Mizutani, M; Samejima, H; Terunuma, H; Kino-Oka, M				Mizutani, M.; Samejima, H.; Terunuma, H.; Kino-Oka, M.			An Aseptic Processing Assessment of Autologous Cell-based Manufacturing for Immunotherapy: Experiences of a Facility Operating under the Medical Practitioners Act in Japan	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Mizutani, M.; Kino-Oka, M.] Osaka Univ, Grad Sch Engn, Osaka, Japan; [Samejima, H.; Terunuma, H.] Biotherapy Inst Japan, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S395	S395				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202644		
J	Motoyama, W; Aoki, S; Kojima, N				Motoyama, W.; Aoki, S.; Kojima, N.			3D Microfabrication and Cell Polarity Formation in Multicellular Spheroids	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Motoyama, W.; Kojima, N.] Yokohama City Univ, Yokohama, Kanagawa 232, Japan; [Aoki, S.] Saga Univ, Saga 840, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S261	S261				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202114		
J	Murata, D; Tokunaga, S; Akieda, S; Fujiki, M; Nakayama, K; Misumi, K				Murata, D.; Tokunaga, S.; Akieda, S.; Fujiki, M.; Nakayama, K.; Misumi, K.			Osteochondral Regeneration using a Scaffold Free Three-Dimensional Construct of Swine Adipose Tissue-derived Mesenchymal Stem Cells	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Murata, D.; Tokunaga, S.; Fujiki, M.; Misumi, K.] Kagoshima Univ, Kagoshima 890, Japan; [Akieda, S.] Cyfuse Biomed KK, Fukuoka, Japan; [Nakayama, K.] Saga Univ, Saga 840, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S8	S8				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200023		
J	Myoui, A; Fujimoto, T; Tamai, N; Ezoe, S; Shimokawa, T; Yoshikawa, H				Myoui, A.; Fujimoto, T.; Tamai, N.; Ezoe, S.; Shimokawa, T.; Yoshikawa, H.			Clinical Research on Safety and Efficacy of Autologous MSC Integrated with Porous Ceramics for Bone Defect Repair after Benign Tumor Removal	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Myoui, A.; Ezoe, S.] Osaka Univ Hosp, Dept Med Innovat, Suita, Osaka, Japan; [Fujimoto, T.] Kawachi Gen Hosp, Dept Orthoped Surg, Higashiosaka, Osaka, Japan; [Tamai, N.] Tamai Hosp, Dept Orthoped Surg, Hannan, Japan; [Shimokawa, T.] Wakayama Med Univ Hosp, Clin Trial Ctr, Wakayama, Japan; [Yoshikawa, H.] Osaka Univ, Grad Sch Med, Dept Orthopaed, Suita, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S38	S38				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200143		
J	Nakamura, N; Kimura, T; Nam, K; Fujisato, T; Tsuji, T; Iwata, H; Kishida, A				Nakamura, N.; Kimura, T.; Nam, K.; Fujisato, T.; Tsuji, T.; Iwata, H.; Kishida, A.			Artificial Microenvironment of Decellularized Bone Marrow Induced Hematopoiesis	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Nakamura, N.; Kimura, T.; Nam, K.; Kishida, A.] Tokyo Med & Dent Univ, Tokyo, Japan; [Fujisato, T.] Osaka Inst Technol, Osaka 535, Japan; [Tsuji, T.] RIKEN, Kobe, Hyogo, Japan; [Iwata, H.] Kyoto Univ, Kyoto, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S171	S172				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201271		
J	Nakashima, K; Hasunuma, H; Satoh, O; Israsena, N; Wakitani, S				Nakashima, K.; Hasunuma, H.; Satoh, O.; Israsena, N.; Wakitani, S.			International Collaboration Research Between Thailand and Japan to Realize a Clinical Application of Regenerative Medicine using an Automatic Cell Processing Machine R-CPX	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Nakashima, K.; Hasunuma, H.; Satoh, O.] Kawasaki Heavy Ind Co Ltd, Syst Technol Dev Ctr, Kobe, Hyogo, Japan; [Israsena, N.] Chulalongkorn Univ, Bngkok, Thailand; [Wakitani, S.] Hiroshima Univ, Dept Artificial Joint & Biomat, Hiroshima, Japan							Nakashima K, 2012, TERMIS WC 2012	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S198	S198				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201374		
J	Nakayama, K				Nakayama, K.			A New Approach for 3D Tissue & Organ Fabrication Inspired From Orthopedic Surgery	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Nakayama, K.] Saga Univ, Dept Regenerat Med & Biomed Engn, Saga 840, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S295	S295				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202244		
J	Nakazawa, Y; Kameda, T; Tanaka, R; Nemoto, S; Shimada, R				Nakazawa, Y.; Kameda, T.; Tanaka, R.; Nemoto, S.; Shimada, R.			Development of Tissue-engineered Cardiac Patch based on Silk fibroin	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Nakazawa, Y.] Tokyo Univ Agr & Technol, Biotechnol & Life Sci, Tokyo, Japan; [Kameda, T.] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Tanaka, R.] Tokyo Univ Agr & Technol, Tokyo, Japan; [Nemoto, S.; Shimada, R.] Osaka Med Coll, Thorac & Cardiovasc Surg, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S386	S386				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202607		
J	Nozaki, T; Zhou, G; Nakajima, R; Nishimura, A; Kiyama, M; Nakamura, T; Sugaya, M; Terada, K; Suzuki, D; Igarashi, Y; Takeda, S; Takagi, R; Nagai, S; Takahara, T; Owaki, T; Okano, T; Yamato, M				Nozaki, T.; Zhou, G.; Nakajima, R.; Nishimura, A.; Kiyama, M.; Nakamura, T.; Sugaya, M.; Terada, K.; Suzuki, D.; Igarashi, Y.; Takeda, S.; Takagi, R.; Nagai, S.; Takahara, T.; Owaki, T.; Okano, T.; Yamato, M.			Automatic Closed Cell Culture Equipment for Cell Sheet-based Tissue Engineering	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Nozaki, T.; Zhou, G.; Nakajima, R.; Nishimura, A.; Kiyama, M.; Nakamura, T.; Sugaya, M.; Terada, K.; Suzuki, D.; Igarashi, Y.; Takeda, S.] Hitachi Ltd, Saitama, Japan; [Takagi, R.; Nagai, S.; Owaki, T.; Okano, T.; Yamato, M.] Tokyo Womens Med Univ, Tokyo, Japan; [Takahara, T.] CellSeed Inc, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S365	S366				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202523		
J	Ohki, T; Masayuki, Y; Kanai, N; Takagi, R; Okano, T; Yamamoto, M				Ohki, T.; Masayuki, Y.; Kanai, N.; Takagi, R.; Okano, T.; Yamamoto, M.			Long-term Outcomes of Endoscopic Transplantation of Oral Mucosal Epithelial Cell Sheets to Prevent of Esophageal Stricture After Endoscopic Submucosal Dissection	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Ohki, T.; Yamamoto, M.] Inst Gastroenterol, Dept Surg, Tokyo, Japan; [Masayuki, Y.; Kanai, N.; Takagi, R.; Okano, T.] Inst Adv Biomed Engn & Sci, Tokyo, Japan							Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S18	S18				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200062		
J	Okudaira, T; Naruo, Y; Mizumachi, H; Shirakigawa, N; Ijima, H; Mizumoto, H; Kajiwara, T				Okudaira, T.; Naruo, Y.; Mizumachi, H.; Shirakigawa, N.; Ijima, H.; Mizumoto, H.; Kajiwara, T.			Fabrication of Functionally Hepatic Tissue by Bottom-up Method using Spheroids Covered with an Endothelial Layer	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Okudaira, T.; Naruo, Y.; Mizumachi, H.; Shirakigawa, N.; Ijima, H.; Mizumoto, H.; Kajiwara, T.] Kyushu Univ, Fac Engn, Dept Chem Engn, Fukuoka 812, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S408	S408				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202697		
J	Omori, K				Omori, K.			Regenerative Medicine of the Larynx and Cervical Trachea	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Omori, K.] Fukushima Med Univ, Otolaryngol, Fukushima, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S19	S19				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200065		
J	Osada, A; Sekine, H; Sakurai, H; Shimizu, T				Osada, A.; Sekine, H.; Sakurai, H.; Shimizu, T.			Evaluation of Cultured Epithelial Cell Sheet's Basement Membrane using Temperature Responsive Dish, without Enzymatic Treatment	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Osada, A.; Sakurai, H.] Tokyo Womens Med Univ, Plast & Reconstruct Surg, Tokyo, Japan; [Sekine, H.; Shimizu, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S96	S96				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200376		
J	Otaka, A; Kitagawa, K; Mahara, A; Ishihara, K; Nakaoki, T; Yamaoka, T				Otaka, A.; Kitagawa, K.; Mahara, A.; Ishihara, K.; Nakaoki, T.; Yamaoka, T.			The Effect of Immobilized Antibody Density on iPS Cell Rolling Behavior in Cell Rolling Column	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Otaka, A.; Mahara, A.; Yamaoka, T.] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Osaka, Japan; [Kitagawa, K.; Nakaoki, T.] Ryukoku Univ, Dept Chem Mat, Otsu, Shiga, Japan; [Ishihara, K.] Univ Tokyo, Sch Engn, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S291	S292				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202232		
J	Owaki, T; Takagi, R; Kasai, Y; Hosoi, T; Yamato, M; Okano, T				Owaki, T.; Takagi, R.; Kasai, Y.; Hosoi, T.; Yamato, M.; Okano, T.			The Quality Stability of Human Epithelial Cell Sheet after Transportation by Air	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Owaki, T.; Takagi, R.; Kasai, Y.; Hosoi, T.; Yamato, M.; Okano, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S410	S410				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202706		
J	Pang, Y; Sutoko, SL; Horimoto, Y; Anzai, M; Niino, T; Sakai, Y				Pang, Y.; Sutoko, S. L.; Horimoto, Y.; Anzai, M.; Niino, T.; Sakai, Y.			Microfabrication and Perfusion Culture of New Tissue Elements Possessing Hollow Structures with High Mechanical Strength towards Scaling-up to Implantable Liver	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Pang, Y.] Tsinghua Univ, Dept Mech Engn, Tokyo, Japan; [Sutoko, S. L.; Niino, T.; Sakai, Y.] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Horimoto, Y.; Anzai, M.] Shibaura Inst Technol, Grad Sch Engn, Tokyo 108, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S3	S4				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200005		
J	Poudel, S; Mizuno, K; Shinohara, M; Ibuki, M; Watanabe, A; Michiue, T; Miyajima, A; Sakai, Y				Poudel, S.; Mizuno, K.; Shinohara, M.; Ibuki, M.; Watanabe, A.; Michiue, T.; Miyajima, A.; Sakai, Y.			Efficient Differentiation of human iPS cells to Pancreatic beta-cells by Optimizing Oxygen Supply through Silicone Membrane Plates	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Poudel, S.; Shinohara, M.; Ibuki, M.; Sakai, Y.] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Mizuno, K.; Michiue, T.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Ibuki, M.] Kaneka Corp, Tokyo, Japan; [Watanabe, A.; Miyajima, A.] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S169	S169				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201261		
J	Rahman, KA; Sathi, GA; Farahat, M; Taketa, H; Matsumoto, T				Rahman, K. A.; Sathi, G. A.; Farahat, M.; Taketa, H.; Matsumoto, T.			Critical Role of MCSF in Salivary Gland Branching Morphogenesis	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Rahman, K. A.; Sathi, G. A.; Farahat, M.; Taketa, H.; Matsumoto, T.] Okayama Univ, Dept Biomat, Okayama 7008530, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S209	S209				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201417		
J	Rana, D; Ramalingam, M				Rana, D.; Ramalingam, M.			Designer Cell-laden Polyacrylamide-alginate Gels for Stem Cell Delivery	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Rana, D.] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore, Tamil Nadu, India; [Ramalingam, M.] Ctr Stem Cell Res, Vellore, Tamil Nadu, India; [Ramalingam, M.] Tohoku Univ, Adv Inst Mat Res, Sendai, Miyagi 980, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S103	S103				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201006		
J	Sakaguchi, K; Shimizu, T; Matsuura, K; Umezu, M				Sakaguchi, K.; Shimizu, T.; Matsuura, K.; Umezu, M.			Engineering Vascularized Cardiac Tissue In Vitro	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Sakaguchi, K.; Umezu, M.] Waseda Univ, Fac Sci & Engn, Tokyo, Japan; [Shimizu, T.; Matsuura, K.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S139	S139				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201145		
J	Sanz-Garcia, A; Mertaniemi, H; Ikkala, O; Yliperttula, M; Escobedo-Lucea, C				Sanz-Garcia, A.; Mertaniemi, H.; Ikkala, O.; Yliperttula, M.; Escobedo-Lucea, C.			3D Printed Nanocellulose Threads for Delivering Human Stem Cell inside Wounds	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Sanz-Garcia, A.; Yliperttula, M.; Escobedo-Lucea, C.] Univ Helsinki, Fac Pharm, Helsinki, Finland; [Sanz-Garcia, A.; Escobedo-Lucea, C.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Mertaniemi, H.; Ikkala, O.] Aalto Univ, Helsinki, Finland								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S9	S9				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200027		
J	Sasaki, D; Seta, H; Haraguchi, Y; Matsuura, K; Okano, T; Shimizu, T				Sasaki, D.; Seta, H.; Haraguchi, Y.; Matsuura, K.; Okano, T.; Shimizu, T.			Contractile Force Measurement of Human iPS Cell-Derived Myocardial Sheet	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Sasaki, D.; Haraguchi, Y.; Matsuura, K.; Okano, T.; Shimizu, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Seta, H.] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S240	S240				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202030		
J	Sawada, K; Fujisato, T				Sawada, K.; Fujisato, T.			Preparation of Keratin Nanofibers for Biomedical Application	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Sawada, K.] Osaka Seikei Coll, Integrated Life, Osaka, Japan; [Fujisato, T.] Osaka Inst Technol, Osaka 535, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S391	S392				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202628		
J	Sayo, K; Aoki, S; Kojima, N				Sayo, K.; Aoki, S.; Kojima, N.			The Bone Marrow-Like Tissue In Vitro: Rapid Aggregation and Reconstraction of Dispersed Bone Marrow Cells	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Sayo, K.; Kojima, N.] Yokohama City Univ, Yokohama, Kanagawa 232, Japan; [Aoki, S.] Saga Univ, Saga 840, Japan							Kojima N, 2012, BIOMATERIALS, V33, P4508, DOI 10.1016/j.biomaterials.2012.02.065	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S168	S169				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201259		
J	Sekine, H; Shimizu, T				Sekine, H.; Shimizu, T.			The Model of Vascularized Three Dimensional Heart Tissue for Drug Evaluation	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Sekine, H.; Shimizu, T.] Tokyo Womens Med Univ, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S307	S307				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202293		
J	Sekine, W; Sekine, H; Dobashi, I; Fukushima, S; Shimizu, T				Sekine, W.; Sekine, H.; Dobashi, I.; Fukushima, S.; Shimizu, T.			Newly Developed Culture Method Providing Efficient Oxygen Supply to a Three-dimensional Artificial Tissue	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Sekine, W.; Sekine, H.; Dobashi, I.; Shimizu, T.] Tokyo Womens Med Univ, Tokyo, Japan; [Fukushima, S.] Kobe Gakuin Univ, Fac Pharmaceut Sci, Kobe, Hyogo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S292	S293				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202236		
J	Sekiya, S; Oka, M; Shimizu, T; Okano, T				Sekiya, S.; Oka, M.; Shimizu, T.; Okano, T.			Allopatric Renal Tissue Fabrication by 3-D Tissue Engineering	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Sekiya, S.; Shimizu, T.; Okano, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Scinece, Tokyo, Japan; [Oka, M.] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S247	S247				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202060		
J	Shinohara, M; Komori, K; Sakai, Y				Shinohara, M.; Komori, K.; Sakai, Y.			Efficient Formation of Size-regulated Hepatocyte Aggregates on Oxygen Permeable Microwell Sheets and the Size-dependency of Their Metabolic Capacities	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Shinohara, M.; Komori, K.; Sakai, Y.] Univ Tokyo, Inst Ind Sci, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S309	S309				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202300		
J	Shirakigawa, N; Sakamoto, H; Cho, J; Imai, D; Yamashita, Y; Shirabe, K; Maehara, Y; Ijima, H				Shirakigawa, N.; Sakamoto, H.; Cho, J.; Imai, D.; Yamashita, Y.; Shirabe, K.; Maehara, Y.; Ijima, H.			Fundamental Technology for the Creation of Whole Liver Engineering, and Functional Evaluation of Recellularized Liver	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Shirakigawa, N.; Sakamoto, H.; Cho, J.; Ijima, H.] Kyushu Univ, Chem Engn, Fukuoka 812, Japan; [Imai, D.; Yamashita, Y.; Shirabe, K.; Maehara, Y.] Kyushu Univ, Surg & Sci, Fukuoka 812, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S116	S117				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201058		
J	Sumi, S				Sumi, S.			Efficient and Simple Method to Prepare High Quality Cell Spheres -a Novel Culture Surface with Multiple Open Holes	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Sumi, S.] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S359	S359				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202497		
J	Takagi, S; Shimizu, T; Kuramoto, G; Ishitani, K; Matsui, H; Okano, T				Takagi, S.; Shimizu, T.; Kuramoto, G.; Ishitani, K.; Matsui, H.; Okano, T.			Ectopic Reconstruction of Endometrium-like Tissue using Cell Sheet Technology	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Takagi, S.; Shimizu, T.; Kuramoto, G.; Okano, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Kuramoto, G.; Ishitani, K.; Matsui, H.] Tokyo Womens Med Univ, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S190	S191				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201345		
J	Takeuchi, S				Takeuchi, S.			3d Tissue Fabrication Based on Cellular Building Blocks	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Takeuchi, S.] Univ Tokyo, IIS, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S40	S41				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200154		
J	Takeuchi, S				Takeuchi, S.			Cell Fibers for Cell Therapies	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Takeuchi, S.] UTokyo, IIS, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S48	S48				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200184		
J	Tanaka, N; Yanagimoto, S; Miyake, J				Tanaka, N.; Yanagimoto, S.; Miyake, J.			Inverted Scaffold: Rapid Cell-Molding with a Bubbled Medium	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Tanaka, N.] RIKEN, Suita, Osaka, Japan; [Tanaka, N.; Yanagimoto, S.; Miyake, J.] Osaka Univ, Toyonaka, Osaka 560, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S382	S382				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202589		
J	Tsuji, W; Bliley, JM; Marra, KG; Rubin, JP				Tsuji, W.; Bliley, J. M.; Marra, K. G.; Rubin, J. P.			Chemotherapeutic Drug-containing Microspheres for Tumor Suppressing Adipose Regeneration	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Tsuji, W.; Bliley, J. M.; Marra, K. G.; Rubin, J. P.] Univ Pittsburgh, Dept Plast Surg, Pittsburgh, PA USA; [Tsuji, W.] Shiga Med Ctr Adults, Dept Surg, Shiga, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S175	S175				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201284		
J	Tsurumachi, N; Shimizu, N; Tonogi, M; Isokawa, K; Honda, M				Tsurumachi, N.; Shimizu, N.; Tonogi, M.; Isokawa, K.; Honda, M.			Human Buccal Fat Pad as a New Cell Source for Dedifferentiated Fat Cells	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Tsurumachi, N.; Isokawa, K.] Nihon Univ, Sch Dent, Dept Anat, Tokyo 101, Japan; [Shimizu, N.] Nihon Univ, Sch Dent, Dept Orthodont, Tokyo 101, Japan; [Tonogi, M.] Nihon Univ, Sch Dent, Dept Oral Surg, Tokyo 101, Japan; [Honda, M.] Aichi Gakuin Univ, Sch Dent, Dept Oral Anat, Nagoya, Aichi 464, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S368	S368				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202532		
J	Wada, M; Matsuura, K; Ishikawa, Y; Shimizu, T				Wada, M.; Matsuura, K.; Ishikawa, Y.; Shimizu, T.			The Development of Large Scale and Medium Exchange System for Pluripotent Stem Cell Stirred Suspension Culture	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Wada, M.; Ishikawa, Y.] ABLE Corp, Tokyo, Japan; [Matsuura, K.; Shimizu, T.] Tokyo Womens Med Univ, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S390	S391				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202625		
J	Yamamoto, M; Arimoto, K; Tabata, Y				Yamamoto, M.; Arimoto, K.; Tabata, Y.			Design of a Sugar-responsive Hydrogel as a Sacrificial Template to Fabricate Collagen Scaffolds with a Vessel-like Structure	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Yamamoto, M.; Arimoto, K.; Tabata, Y.] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S41	S41				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205200157		
J	Yamamoto, M; Toda, H; Tabata, Y				Yamamoto, M.; Toda, H.; Tabata, Y.			Sandwich Culture with Bio-functional Hydrogels as a Three-dimensional Culture Technique to Induce Osteoblastic Differentiation of Mesenchymal Stem Cells	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Yamamoto, M.; Toda, H.; Tabata, Y.] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S295	S295				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202246		
J	Yamaoka, T; Mahara, A; Hirata, M				Yamaoka, T.; Mahara, A.; Hirata, M.			Effective ECM and Elasticity for iPS Differentitaion into Cardiac Marker Positive Cells or into Self Beating Cardiomyocytes	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Yamaoka, T.; Mahara, A.; Hirata, M.] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Suita, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S250	S250				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202071		
J	Yamawaki-ogata, A; Kosakai, M; Usui, A; Narita, Y				Yamawaki-ogata, A.; Kosakai, M.; Usui, A.; Narita, Y.			Exosomes Obtained from Mesenchymal Stem Cells as a Novel Therapeutic Tool for Aortic Aneurysm	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Yamawaki-ogata, A.; Kosakai, M.; Usui, A.; Narita, Y.] Nagoya Univ, Grad Sch Med, Cardiac Surg, Nagoya, Aichi 4648601, Japan			Usui, Akihiko/I-7251-2014					0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S211	S212				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201427		
J	Ye, J; Shirakigawa, N; Ijima, H				Ye, J.; Shirakigawa, N.; Ijima, H.			Hybrid Organoid Consisting of Extracellular Matrix Gel Particles and Cells for Functional Liver Tissue Construction	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Ye, J.; Shirakigawa, N.; Ijima, H.] Kyushu Univ, Chem Engn, Fukuoka 812, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S154	S155				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205201204		
J	Zhang, Y; Nam, K; Kimura, T; Kishida, A				Zhang, Y.; Nam, K.; Kimura, T.; Kishida, A.			Preparation of Gradient Decellullarized Dermis-polymer Complex for Tissue Interlinking Device	TISSUE ENGINEERING PART A			English	Meeting Abstract	4th TERMIS World Congress	SEP 08-11, 2015	Boston, MA	TERMIS					[Zhang, Y.; Nam, K.; Kimura, T.; Kishida, A.] Tokyo Med & Dent Univ, Dept Mat Based Med Engn, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	SEP 1	2015	21			1			S305	S305				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CP9HR	WOS:000360205202283		
J	Oka, H; Ahn, CJ; Omori, T; Hashimoto, K				Oka, Hikaru; Ahn, Chang-Jun; Omori, Tatsuya; Hashimoto, Ken-ya			IQ imbalance estimation and compensation schemes based on time-frequency interferometry for OFDM	TRANSACTIONS ON EMERGING TELECOMMUNICATIONS TECHNOLOGIES			English	Article								A direct-conversion receiver (DCR) can reduce the power consumption and cost. However, a DCR with orthogonal frequency-division multiplex (OFDM) suffers from IQ imbalance. Until this time, many algorithms have been proposed to compensate IQ imbalance in OFDM systems. However, the calculation complexity is still a considerable work to achieve the implementation of a DCR. Moreover, an accurate channel identification is also necessary for a DCR. Recently, time-frequency interferometry-OFDM (TFI-OFDM) system has been proposed to achieve an accurate channel identification property with small number of pilot symbols, and it has a periodicity of pilot amplitude. In this paper, we focus on the feature of TFI and propose a novel IQ imbalance estimation and compensation schemes using TFI-OFDM system. In the proposed system, by using the feature of the TFI pilot symbols, we can identify an IQ imbalance without high calculation complexity. Furthermore, by using subcarrier selection, the influence of the noise power can be reduced. From the simulation results, the proposed scheme can achieve the low complexity for IQ imbalance estimation and compensation without a degradation of the bit error rate performance. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Oka, Hikaru; Ahn, Chang-Jun; Omori, Tatsuya; Hashimoto, Ken-ya] Chiba Univ, Grad Engn, Inage Ku, Chiba 2630022, Japan	Oka, H (reprint author), Chiba Univ, Grad Engn, Inage Ku, 1-33 Yayoi, Chiba 2630022, Japan.	z9t0918@students.chiba-u.jp					Ahn C, 2007, P AIS PAC C COMM 200, P153; Ahn CJ, 2007, IEICE T FUND ELECTR, VE90A, P2641, DOI 10.1093/ietfec/e90-a.11.2641; [Anonymous], 1999, 80211A1999 IEEE; [Anonymous], 2004, 802162004 IEEE; Marey M, 2013, IEEE T VEH TECHNOL, V62, P2847, DOI 10.1109/TVT.2013.2242102; CIMINI LJ, 1985, IEEE T COMMUN, V33, P665, DOI 10.1109/TCOM.1985.1096357; Marey M, 2012, IEEE T BROADCAST, V58, P106, DOI 10.1109/TBC.2011.2179730; Haghbin S., 2010, P IEEE VEH POW PROP, P1; Horilin F, 2007, P IEEE ICC 2007 JUN, P2871; Inamori M, 2009, IEICE T FUND ELECTR, VE92A, P2688, DOI 10.1587/transfun.E92.A.2688; Kotera K, 2010, IEICE T FUND ELECTR, VJ93-B, P987; Mattera D, 2007, P WAV DIV DES JUN, P160; Miyasita H, 2012, P IEEE 71 VEH TECH C, P1; Tarighat A., 1997, IEEE T SIGNAL PROCES, V53, P428; Thomas T, 2006, P IEEE VTC2006 SEPT, P1; Yoshimura T, 2011, 2011 IEEE REGION 10 CONFERENCE TENCON 2011, P549	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2161-3915			T EMERG TELECOMMUN T	Trans. Emerg. Telecommun. Technol.	SEP	2015	26	9					1165	1172		10.1002/ett.2852		8	Telecommunications	Telecommunications	CQ9YB	WOS:000360971400004		
J	Herring, R; Norouzpour, M; Saitoh, K; Tanaka, N; Tanji, T				Herring, Rodney; Norouzpour, Mana; Saitoh, Koh; Tanaka, Nobuo; Tanji, Takayoshi			Determination of three-dimensional strain state in crystals using self-interfered split HOLZ lines	ULTRAMICROSCOPY			English	Article						Three-dimensional crystal strain; CBED; Split HOLZ line; Electron holography	BEAM ELECTRON-DIFFRACTION; DEVICES; SI	An experimental method to measure the strain through the thickness of a crystal is demonstrated. This enables the full three-dimensional stress-strain state of a crystal at the nanoscale to be determined taking the current practice from two-dimensional strain state determination. Knowing the 3D strain state is desired by crystal growers in order to improve their crystal's quality. This method involves combining electron diffraction with electron interferometry in a transmission electron microscope. The electron diffraction uses a split higher order Laue zone (HOLZ) line and the electron interferometiy uses an electron biprism. (C) 2015 Elsevier B.V. All rights reserved	[Herring, Rodney; Norouzpour, Mana] Univ Victoria, MENG, CAMTEC, Victoria, BC V8W 2Y2, Canada; [Saitoh, Koh; Tanaka, Nobuo; Tanji, Takayoshi] Nagoya Univ, EcoTopia, Nagoya, Aichi 4618603, Japan	Herring, R (reprint author), Univ Victoria, MENG, CAMTEC, Victoria, BC V8W 2Y2, Canada.	rherring@uvic.ca			Japan Society for the Promotion of Science; NSERC (Canada)	This work was supported by the Japan Society for the Promotion of Science and NSERC (Canada) grants.	BIERWOLF R, 1993, ULTRAMICROSCOPY, V49, P273, DOI 10.1016/0304-3991(93)90234-O; Schaffler F, 1997, SEMICOND SCI TECH, V12, P1515, DOI 10.1088/0268-1242/12/12/001; Hytch M, 2008, NATURE, V453, P1086, DOI 10.1038/nature07049; Usuda K, 2005, MAT SCI ENG B-SOLID, V124, P143, DOI 10.1016/j.mseb.2005.08.062; Armigliato A, 2003, APPL PHYS LETT, V82, P2172, DOI 10.1063/1.1565181; CHOU CT, 1994, ULTRAMICROSCOPY, V55, P334, DOI 10.1016/0304-3991(94)90070-1; Hirsch P. B., 1969, ELECT MICROSCOPY THI; Hutchings M. T., 2005, TORBENLORENTZEN INTR; Noyan C., 1987, SPRINGER SERIES MAT; Saitoh K., 2010, J ELECT MICROSC, V1; Tonnomura A., 1999, SPRINGER SERIES OPTI; Wolf I. D., 2003, MICROELECTRONIC ENG, V70, P425	12	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	SEP	2015	156						37	40		10.1016/j.ultramic.2015.04.013		4	Microscopy	Microscopy	CR0IL	WOS:000361001800007		
J	Kato, T; Mizutani, K; Kameyama, K; Kawakami, K; Fujita, Y; Nakane, K; Kanimoto, Y; Ehara, H; Ito, H; Seishima, M; Deguchi, T; Ito, M				Kato, Taku; Mizutani, Kosuke; Kameyama, Koji; Kawakami, Kyojiro; Fujita, Yasunori; Nakane, Keita; Kanimoto, Yusuke; Ehara, Hidetoshi; Ito, Hiroyasu; Seishima, Mitsuru; Deguchi, Takashi; Ito, Masafumi			Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer	UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS			English	Article						Castration-resistant prostate cancer; Docetaxel; Cabazitaxel; Exosomes; P-glycoprotein/P-gp; Multidrug protein 1/MDR1	ATTENUATES PACLITAXEL-RESISTANCE; MULTIDRUG-RESISTANCE; TRANSFERRIN RECEPTOR; MDR1 GENE; PC3 CELLS; EXPRESSION; CABAZITAXEL; RETICULOCYTES; MITOXANTRONE; PROGRESSION	Objectives: Docetaxel is used as the first-line chemotherapy for castration-resistant prostate cancer (CRPC), but docetaxel resistance occurs in part owing to induction of P-glycoprotein (P-gp) encoded by multidrug resistance protein 1 (MDR1) gene. A recently developed taxane-cabazitaxel-has poor affinity for P-gp and is thereby effective in docetaxel-resistant CRPC. It has been recently demonstrated that exosomes in the body fluids could serve as a diagnostic marker because they contain proteins and RNAs specific to the cells from which they are derived. In this study, we aimed to investigate if P-gp in blood exosomes could be a marker to diagnose docetaxel resistance and select a taxoid for patients with CRPC. Methods and materials: Exosomes were isolated by differential centrifugation from docetaxel-resistant prostate cancer (PC-3) cells (PC-3R) and their parental PC-3 cells and from the serum of patients. Silencing of P-gp was performed by small interfering RNA transfection. Protein expression was examined by Western blot analysis. Viability of cells treated with docetaxel or cabazitaxel was determined by water soluble tetrazolium salt (WST) assay. Results: The level of P-gp was higher in exosomes as well as cell lysates from PC-3R cells than in those from PC-3 cells. Cabazitaxel effectively killed PC-3R cells, and MDR1 knockdown improved the sensitivity of PC-3R cells to docetaxel but not to cabazitaxel. The P-gp level in blood exosomes was relatively higher in clinically docetaxel-resistant patients than in therapy-naive patients. Conclusions: Our results suggest that detection of P-gp in blood exosomes, which is involved in resistance to docetaxel but not to cabazitaxel, could be useful to diagnose docetaxel resistance and select an appropriate taxoid for patients with CRPC-docetaxel or cabazitaxel. (C) 2015 Elsevier Inc. All rights reserved.	[Kato, Taku; Ito, Hiroyasu; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu, Gifu, Japan; [Kato, Taku; Mizutani, Kosuke; Kameyama, Koji; Deguchi, Takashi] Gifu Univ, Grad Sch Med, Dept Urol, Gifu, Gifu, Japan; [Kawakami, Kyojiro; Fujita, Yasunori; Ito, Masafumi] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Itabashi Ku, Tokyo, Japan; [Nakane, Keita; Kanimoto, Yusuke] Chutoen Gen Med Ctr, Dept Urol, Shizuoka, Japan; [Ehara, Hidetoshi] Asahi Univ, Murakami Mem Hosp, Dept Urol, Gifu, Gifu, Japan	Ito, M (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Itabashi Ku, Tokyo, Japan.	mito@tmig.or.jp			Japan Society for the Promotion of Science, Japan [15K10582]	This work was supported in part by Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Japan (Grant no. 15K10582)	Abdulla A, 2011, CUAJ-CAN UROL ASSOC, V5, P120, DOI 10.5489/cuaj.10160; JOHNSTONE RM, 1989, BLOOD, V74, P1844; Takeda M, 2007, PROSTATE, V67, P955, DOI 10.1002/pros.20581; Vrignaud P, 2013, CLIN CANCER RES, V19, P2973, DOI 10.1158/1078-0432.CCR-12-3146; Paller CJ, 2011, DRUG DES DEV THER, V5, P117, DOI 10.2147/DDDT.S13029; Kato T, 2012, BIOCHEM BIOPH RES CO, V417, P966, DOI 10.1016/j.bbrc.2011.12.047; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Caffo O, 2012, UROLOGY, V79, P644, DOI 10.1016/j.urology.2011.11.043; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Loblaw DA, 2004, J CLIN ONCOL, V22, P2927, DOI 10.1200/jco.2004.04.579; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; van Zuylen L, 2000, CLIN CANCER RES, V6, P2598; Loriot Y, 2010, EUR J CANCER, V46, P1770, DOI 10.1016/j.ejca.2010.04.010; Ganju A, 2014, DRUG RESIST UPDATE, V17, P13, DOI 10.1016/j.drup.2014.04.001; Kojima K, 2010, PROSTATE, V70, P1501, DOI 10.1002/pros.21185; Marchetti S, 2007, ONCOLOGIST, V12, P927, DOI 10.1634/theoncologist.12-8-927; Mizutani K, 2014, ANTICANCER RES, V34, P3419; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; Xu H, 2012, CHINESE J CANCER RES, V24, P138, DOI 10.1007/s11670-012-0138-3; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Bhangal G, 2000, UROL ONCOL, V5, P118, DOI 10.1016/S1078-1439(99)00055-1; ARCECI RJ, 1988, P NATL ACAD SCI USA, V85, P4350, DOI 10.1073/pnas.85.12.4350; Corcoran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050999; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Heck MM, 2012, BJU INT, V110, pE635, DOI 10.1111/j.1464-410X.2012.11364.x; Hessvik Nina Pettersen, 2013, Frontiers in Genetics, V4, P36, DOI 10.3389/fgene.2013.00036; Hsing AW, 2006, FRONT BIOSCI, V11, P1388, DOI 10.2741/1891; Kharaziha P., 2015, ONCOTARGET IN PRESS; Xia ZS, 2009, MOL MED REP, V2, P579, DOI 10.3892/mmr_00000140	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1078-1439	1873-2496		UROL ONCOL-SEMIN ORI	Urol. Oncol.-Semin. Orig. Investig.	SEP	2015	33	9								10.1016/j.urolonc.2015.04.019		6	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CR0TV	WOS:000361037000010		
J	Niwa, N; Matsumoto, K; Hayakawa, N; Ito, Y; Maeda, T; Akatsuka, S; Masuda, T; Nakamura, S; Tanaka, N				Niwa, Naoya; Matsumoto, Kazuhiro; Hayakawa, Nozomi; Ito, Yujiro; Maeda, Takahiro; Akatsuka, Seiya; Masuda, Takeshi; Nakamura, So; Tanaka, Nobuyuki			Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers: A matched-pair analysis	UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS			English	Article						Bladder cancer; Surveillance; Follow-up; Cystoscopy; Ultrasonography; Recurrence	FLEXIBLE CYSTOSCOPY; STAGE-TA; TUMORS; MANAGEMENT; CARCINOMA; UPDATE	Purpose: To examine the clinical outcomes of regular use of ultrasonography when compared with those of cystoscopy in the follow-up of patients with TaG1-2 bladder tumors. Patients and methods: Between 1990 and 2012, 197 patients with TaG1-2 bladder tumors from a retrospective 2-institution cohort were included. We assessed clinical outcomes in 83 patients followed up by ultrasonography, matched for propensity score calculated from clinicopathological Variables including age, gender, tumor multiplicity, size, grade, postoperative immediate chemoinstillation, and adjuvant intravesical treatment. Results: Among the 166 patients identified using the one-to-one propensity score analysis, the 5- and 10-year recurrence-free survival rates were both 63.3% in the cystoscopy group and 69.1% and 58.4%, respectively, in the ultrasonography group (P = 0.762). A total of 54 patients experienced disease recurrence, and 18 patients acquired progressive disease such as tumor grade 3, pT1 tumors, and the appearance of concuirent carcinoma in situ. There were no significant differences in the characteristics of recurrent tumors between both the groups, whereas time to first recurrence in the cystoscopy group was significantly shorter than that in the ultrasonography group (P = 0.021). In a subgroup analysis using 111 patients without adjuvant intravesical treatments, the 5- and 10-year recurrence-free survival rates were both 56.9% in the cystoscopy group and 71.9% and 60.3%, respectively, in the ultrasonography group (P = 0.282). Conclusions: This retrospective study suggests that ultrasonography may be one of the follow-up substitutes when considering the management of low-risk bladder tumors such as TaG1-2 bladder tumors. (C) 2015 Elsevier Inc. All rights reserved.	[Niwa, Naoya; Ito, Yujiro; Masuda, Takeshi; Tanaka, Nobuyuki] Saitama City Hosp, Dept Urol, Saitama, Japan; [Matsumoto, Kazuhiro; Hayakawa, Nozomi; Maeda, Takahiro; Nakamura, So] Saiseikai Cent Hosp, Dept Urol, Tokyo, Japan; [Akatsuka, Seiya] Saitama City Hosp, Dept Clin Labs, Div Pathol, Saitama, Japan	Tanaka, N (reprint author), Saitama City Hosp, Dept Urol, Saitama, Japan.	urotanaka@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26462429, 15K20110]	This work was supported in part by Grants-in-Aid for Scientific Research (no.: 26462429 to N. Tanaka, no.: 15K20110 to N. Niwa) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	ABUYOUSEF MM, 1984, RADIOLOGY, V153, P223; Burke DM, 2002, BJU INT, V89, P347, DOI 10.1046/j.1464-4096.2001.01899.x; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Herr HW, 2007, J UROLOGY, V178, P1201, DOI 10.1016/j.juro.2007.05.148; Hollenbeck BK, 2010, CANCER-AM CANCER SOC, V116, P5235, DOI 10.1002/cncr.25310; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; CLARK KR, 1990, BRIT J UROL, V66, P503, DOI 10.1111/j.1464-410X.1990.tb14997.x; OLSEN PR, 1985, SCAND J UROL NEPHROL, V19, P105; Pavlica P, 2004, WORLD J UROL, V22, P328, DOI 10.1007/s00345-004-0415-y; Stamatiou K, 2011, MED ULTRASON, V13, P114; Sylvester RJ, 2006, EUR UROL, V49, P475, DOI DOI 10.1016/J.EURURO.2005.12.031	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1078-1439	1873-2496		UROL ONCOL-SEMIN ORI	Urol. Oncol.-Semin. Orig. Investig.	SEP	2015	33	9								10.1016/j.urolonc.2015.04.018		7	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CR0TV	WOS:000361037000012		
J	Shimada, S; Kunii, N; Kawai, K; Usami, K; Matsuo, T; Uno, T; Koizumi, T; Saito, N				Shimada, Seijiro; Kunii, Naoto; Kawai, Kensuke; Usami, Kenichi; Matsuo, Takeshi; Uno, Takeshi; Koizumi, Tomoyuki; Saito, Nobuhito			Spontaneous Temporal Pole Encephalocele Presenting with Epilepsy: Report of Two Cases	WORLD NEUROSURGERY			English	Article						Temporal lobe epilepsy; Temporal pole encephalocele; Temporopolar disconnection	LOBE EPILEPSY; REFRACTORY EPILEPSY; CLINICAL ARTICLE; TAILORED SURGERY; MIDDLE FOSSA; PRESERVATION; SEIZURES; MEMORY	BACKGROUND: Refractory temporal lobe epilepsy due to spontaneous temporal pole encephalocele is a rare but increasingly recognized condition. Optimal surgical management is complicated by the lack of knowledge regarding both the extent of the epileptogenic area and the need for repair of the encephalocele. CASE DESCRIPTION: We report two cases that add significant information to these issues. In Case 1, with a 5-year history of refractory seizures, implantation of diagnostic subdural electrodes into the anterior temporal base happened to abolish the seizures completely. No structural changes were evident on postoperative magnetic resonance imaging. In Case 2, with a large encephalocele and a 5-year history of refractory seizures, surgical disconnection of the temporal pole successfully abolished seizures without any need for encephalocele repair. CONCLUSIONS: These two cases support the view that the epileptogenic area is confined to within the temporal pole for spontaneous temporal pole encephalocele. Temporopolar disconnection represents one surgical option for this entity that achieves seizure cessation without requiring extra repair procedures.	[Shimada, Seijiro; Kunii, Naoto; Usami, Kenichi; Uno, Takeshi; Koizumi, Tomoyuki; Saito, Nobuhito] Tokyo Univ Hosp, Dept Neurosurg, Tokyo 113, Japan; [Kawai, Kensuke; Matsuo, Takeshi] NTT Med Ctr Tokyo, Dept Neurosurg, Tokyo, Japan	Kunii, N (reprint author), Tokyo Univ Hosp, Dept Neurosurg, Tokyo 113, Japan.	nkunii-tky@umin.ac.jp					Byrne RW, 2010, WORLD NEUROSURG, V73, P541, DOI 10.1016/j.wneu.2010.01.018; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; Carlson ML, 2013, J NEUROSURG, V119, P1314, DOI 10.3171/2013.6.JNS13322; ROSENBAUM TJ, 1985, NEUROLOGY, V35, P287; WHITING DM, 1990, SURG NEUROL, V34, P318, DOI 10.1016/0090-3019(90)90007-C; Shimizu H, 2006, J CLIN NEUROSCI, V13, P322, DOI 10.1016/j.jocn.2005.04.020; Aquilina K, 2010, J NEUROSURG-PEDIATR, V5, P360, DOI 10.3171/2009.11.PEDS09275; Abou-Hamden A, 2010, EPILEPSIA, V51, P2199, DOI 10.1111/j.1528-1167.2010.02572.x; Giulioni M, 2014, SEIZURE-EUR J EPILEP, V23, P164, DOI 10.1016/j.seizure.2013.10.005; LEBLANC R, 1991, J NEUROSURG, V74, P933, DOI 10.3171/jns.1991.74.6.0933; WILKINS RH, 1993, J NEUROSURG, V78, P492, DOI 10.3171/jns.1993.78.3.0492; Matsuo T, 2013, NEUROSURGERY, V73, P146, DOI 10.1227/01.neu.0000430327.48387.e1; HYSON M, 1984, NEUROLOGY, V34, P363; Faulkner HJ, 2010, EPILEPTIC DISORD, V12, P160, DOI 10.1684/epd.2010.0308; Gasparini S, 2014, SEIZURE-EUR J EPILEP, V23, P583, DOI 10.1016/j.seizure.2014.03.019; Giulioni M, 2013, J NEUROSURG, V119, P37, DOI 10.3171/2013.3.JNS122132; Koizumi S, 2011, NEUROL MED-CHIR, V51, P604; Kunii N, 2014, EPILEPSIA, V55, P1594, DOI 10.1111/epi.12764; Mulcahy MM, 1997, LARYNGOSCOPE, V107, P910, DOI 10.1097/00005537-199707000-00014; Ruiz Garcia F, 1971, REV ESP OTONEUROOFTA, V29, P216; Tabaee A, 2010, J NEUROSURG, V112, P1070, DOI 10.3171/2009.7.JNS0842; Yang E., 2004, SMJ Singapore Medical Journal, V45, P40	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2015	84	3							UNSP 867.e1	10.1016/j.wneu.2015.04.028		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CR0LR	WOS:000361010700055		
J	Takano, S; Yamamoto, T; Ishikawa, E; Akutsu, H; Nakai, K; Matsuda, M; Muroi, A; Shibata, Y; Mizumoto, M; Tsuboi, K; Matsumura, A				Takano, Shingo; Yamamoto, Tetsuya; Ishikawa, Eiichi; Akutsu, Hiroyoshi; Nakai, Kei; Matsuda, Masahide; Muroi, Ai; Shibata, Yasushi; Mizumoto, Masashi; Tsuboi, Koji; Matsumura, Akira			Improvement of Long-term Results with Neoadjuvant Chemotherapy and Radiotherapy for Central Nervous System Germinoma	WORLD NEUROSURGERY			English	Article						Chemoradiotherapy; Germinoma; Neuroendoscopy	GERM-CELL TUMORS; INTRACRANIAL GERMINOMA; FOLLOW-UP; CRANIOSPINAL IRRADIATION; 3RD VENTRICULOSTOMY; FIELD RADIOTHERAPY; OUTCOMES; FAILURE; TRIAL	OBJECTIVE: To evaluate the role of neoadjuvant chemotherapy and radiotherapy in the treatment of central nervous system germinomas in 38 patients who received definitive treatment and were followed-up >5 years between 1980 and 2009. METHODS: The median age at diagnosis and follow-up period were 16.5 years and 128.3 months, respectively. Treatment was irradiation alone or adjuvant platinum-based chemotherapy followed by reduced-dose local irradiation. Seven patients progressed at 12.9-133.9 months and 1 died of disease 89.3 months after therapy initiation. RESULTS: The treatment strategies were divided into 3 groups: group A (1980-1988, n=5), whole brain with local irradiation; group B (1989-2002, n=16), chemotherapy with or without reduced irradiation dose; and group C (2003-2009, n=17): neoadjuvant chemotherapy (3 courses) followed by 30.6 Gy of whole ventricle irradiation for patients with localized complete response, and additional local boost of 19.8 Gy for others. There were 7 recurrent cases, all in group B. The progression-free survival was significantly longer in groups A and C versus group B (P< 0.001). Decreased Karnofsky performance status was observed in 2 (40%), 6 (37.5%), and 0 cases in groups A-C, respectively. The main reasons for the good results in group C might be the neoadjuvant chemotherapy with whole ventricle radiotherapy and introduction of neuroendoscopy, especially for pineal lesions, resulting in a substantial reduction of time from the diagnosis to first treatment. CONCLUSIONS: Chemotherapy followed by whole ventricle radiotherapy, with or without local boost, and with use of neuroendoscopy results in good disease control without late complications in patients with germinomas.	[Takano, Shingo; Yamamoto, Tetsuya; Ishikawa, Eiichi; Akutsu, Hiroyoshi; Nakai, Kei; Matsuda, Masahide; Muroi, Ai; Shibata, Yasushi; Matsumura, Akira] Univ Tsukuba, Dept Neurosurg, Fac Med, Tsukuba, Ibaraki, Japan; [Mizumoto, Masashi; Tsuboi, Koji] Univ Tsukuba, Proton Med Res Ctr, Tsukuba, Ibaraki, Japan	Takano, S (reprint author), Univ Tsukuba, Dept Neurosurg, Fac Med, Tsukuba, Ibaraki, Japan.	shingo4@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24390339]; Japanese Foundation for Research and Promotion of Endoscopy	This work was supported in part by Grants-in-Aid for Scientific Research (to S.T., No. 24390339) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by the Japanese Foundation for Research and Promotion of Endoscopy (to S.T.).	Acharya S, 2015, NEURO-ONCOLOGY, V17, P741, DOI 10.1093/neuonc/nou311; Matsutani M, 2001, J NEURO-ONCOL, V54, P311, DOI 10.1023/A:1012743707883; Shono T, 2007, J NEUROSURG, V107, P193, DOI 10.3171/PED-07/09/193; Calaminus G, 2013, NEURO-ONCOLOGY, V15, P788, DOI 10.1093/neuonc/not019; Osuka S, 2007, CHILD NERV SYST, V23, P897, DOI 10.1007/s00381-007-0315-8; Wang LH, 2014, NATURE, V511, P241, DOI 10.1038/nature13296; Jensen AW, 2010, INT J RADIAT ONCOL, V77, P1449, DOI 10.1016/j.ijrobp.2009.06.077; Nguyen QN, 2006, CANCER, V107, P2228, DOI 10.1002/cncr.22246; Balmaceda C, 1996, J CLIN ONCOL, V14, P2908; Sato M, 2012, NEUROL MED-CHIR, V52, P832; Kanamori M, 2009, J NEUROS-PEDIATR, V4, P506, DOI 10.3171/2009.7.PEDS08288; Aoyama H, 2002, J CLIN ONCOL, V20, P857, DOI 10.1200/JCO.20.3.857; Chen YW, 2012, CANCER-AM CANCER SOC, V118, P2752, DOI 10.1002/cncr.26564; Kawabata Y, 2008, J NEURO-ONCOL, V88, P161, DOI 10.1007/s11060-008-9542-4; Kellie SJ, 2004, PEDIATR BLOOD CANCER, V43, P126, DOI 10.1002/pbc.20026; KERSH CR, 1988, CANCER, V61, P2148, DOI 10.1002/1097-0142(19880601)61:11<2148::AID-CNCR2820611103>3.0.CO;2-Q; Osuka S, 2007, J NEURO-ONCOL, V83, P71, DOI 10.1007/s11060-006-9305-z; Schoenfeld A, 2014, J NEURO-ONCOL, V120, P643, DOI 10.1007/s11060-014-1599-7; Shim KW, 2007, CHILD NERV SYST, V23, P1155, DOI 10.1007/s00381-007-0394-6; Shirato H, 1997, INT J RADIAT ONCOL, V37, P511, DOI 10.1016/S0360-3016(96)00607-4; Sonoda Y, 2008, J NEUROS-PEDIATR, V2, P118, DOI 10.3171/PED/2008/2/8/118; Ueba T, 2007, ACTA NEUROCHIR, V149, P897, DOI 10.1007/s00701-007-1268-0	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2015	84	3								10.1016/j.wneu.2015.06.029		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CR0LR	WOS:000361010700046		
J	Tsuji, A; Nozaki, K				Tsuji, Atsushi; Nozaki, Kazuhiko			Clinical Relevance of Racial Differences in Cerebrovascular Diseases	WORLD NEUROSURGERY			English	Editorial Material						Arteriovenous malformation; Hemorrhagic presentation; Intracranial hemorrhage; Race	CEREBRAL ARTERIOVENOUS-MALFORMATIONS; RACIAL/ETHNIC DIFFERENCES; INTRACRANIAL HEMORRHAGE; RISK; THERAPY		[Tsuji, Atsushi; Nozaki, Kazuhiko] Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga 52021, Japan	Nozaki, K (reprint author), Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga 52021, Japan.	noz@belle.shiga-med.ac.jp					van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Mehta RH, 2014, STROKE, V45, P2263, DOI 10.1161/STROKEAHA.114.005019; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Gross BA, 2013, J NEUROSURG, V118, P437, DOI 10.3171/2012.10.JNS121280; Kim H, 2014, NEUROLOGY, V83, P590, DOI 10.1212/WNL.0000000000000688; Kim H, 2007, STROKE, V38, P2430, DOI 10.1161/STROKEAHA.107.485573; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Hartmann Andreas, 2015, Curr Treat Options Neurol, V17, P346, DOI 10.1007/s11940-015-0346-5; Mouchtouris N, 2015, J CEREBR BLOOD F MET, V35, P167, DOI 10.1038/jcbfm.2014.179	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2015	84	3								10.1016/j.wneu.2015.04.062		2	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CR0LR	WOS:000361010700015		
J	Yamamoto, T; Shinojima, N; Todaka, T; Nishikawa, S; Yano, S; Kuratsu, J				Yamamoto, Takahiro; Shinojima, Naoki; Todaka, Tatemi; Nishikawa, Shigeyuki; Yano, Shigetoshi; Kuratsu, Jun-ichi			Meningioma in Down Syndrome	WORLD NEUROSURGERY			English	Article						Chromosome 21; Down syndrome; Intracranial tumor; Meningioma	YOLK-SAC TUMOR; PATIENT; CANCER; MEDULLOBLASTOMA; COUNTRIES; GROWTH; CHILD	BACKGROUND: Down syndrome comprises multiple malformations and is due to trisomy of chromosome 21. There is epidemiologic evidence that individuals with Down syndrome are at decreased risk for solid tumors including brain tumors. It has been suggested that some genes expressed on the extra copy of chromosome 21 act as tumor suppressor genes and contribute to protection against tumorigenesis. CASE DESCRIPTION: We report the first case to our knowledge of a patient with Down syndrome, an 8-year-old boy, with an intracranial meningioma, in which the status of chromosome 21 was examined. The diagnosis was based on histologic examination of the surgically resected tumor. Postoperatively, the patient's neurologic status improved, and there was no tumor regrowth in the next 2 years. Fluorescence in situ hybridization for chromosome 22 confirmed high allele loss involving the neurofibromin 2 gene locus, a finding typical in meningiomas. Fluorescence in situ hybridization also revealed chromosome 21 heterogeneity in tumor cells; not only cells with trisomy 21 but also cells with disomy and monosomy 21 were present. All blood cells from the patient manifested trisomy 21. CONCLUSIONS: Deletion of the chromosome 21 allele may be associated with tumorigenesis of meningioma in Down syndrome. This supports the hypothesis that some genes whose expression is increased on the extra copy of chromosome 21 function as tumor suppressor genes and that they contribute to the reduced tumor incidence in individuals with Down syndrome.	[Yamamoto, Takahiro; Todaka, Tatemi; Nishikawa, Shigeyuki] Nobeoka Hosp, Div Neurosurg, Miyazaki, Japan; [Yamamoto, Takahiro; Shinojima, Naoki; Yano, Shigetoshi; Kuratsu, Jun-ichi] Kumamoto Univ Hosp, Dept Neurosurg, Kumamoto, Japan	Shinojima, N (reprint author), Kumamoto Univ Hosp, Dept Neurosurg, Kumamoto, Japan.	nshinojima@fc.kuh.kumamoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [25462272]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 25462272). The authors declare no conflict of interest.	Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; Shinojima N, 2013, CANCER RES, V73, P2333, DOI 10.1158/0008-5472.CAN-12-3086; Nakamura H, 2011, J NEUROSURG-PEDIATR, V7, P431, DOI 10.3171/2011.1.PEDS10433; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Shinojima N, 2003, CANCER RES, V63, P6962; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Bakhtiar Yuriz, 2012, Surg Neurol Int, V3, P100, DOI 10.4103/2152-7806.100198; Benesch M, 2009, PEDIATR BLOOD CANCER, V53, P1150, DOI 10.1002/pbc.22109; Ehara H, 2011, PEDIATR INT, V53, P72, DOI 10.1111/j.1442-200X.2010.03189.x; Endo S, 2013, CLIN NEUROL NEUROSUR, V115, P811, DOI 10.1016/j.clineuro.2012.07.023; Ishiyama K, 2001, No To Shinkei, V53, P969; Maeda Y, 2011, J NEUROSURG-PEDIATR, V7, P604, DOI 10.3171/2011.3.PEDS10500; Makino K, 2010, CHILD NERV SYST, V26, P1029, DOI 10.1007/s00381-010-1126-x; MILLER RW, 1966, NEW ENGL J MED, V275, P87, DOI 10.1056/NEJM196607142750208; Murphy AM, 2006, CLIN DYSMORPHOL, V15, P149, DOI 10.1097/01.mcd.0000198933.16953.db; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, pii1, DOI [10.1093/neuonc/not151, DOI 10.1093/NEU0NC/N0T151]; Patja K, 2006, INT J CANCER, V118, P1769, DOI 10.1002/ijc.21518; Rickert CH, 2002, ACTA NEUROPATHOL, V103, P78; Satge D, 2001, CANCER, V91, P1458, DOI 10.1002/1097-0142(20010415)91:8<1458::AID-CNCR1153>3.0.CO;2-B; Satge D, 2013, J NEURO-ONCOL, V112, P107, DOI 10.1007/s11060-012-1041-y; Satge D, 1998, CANCER RES, V58, P448; Satoh Shunsuke, 2012, No Shinkei Geka, V40, P137; Shinojima N, 2014, J NEUROSURG-PEDIATR, V14, P615, DOI 10.3171/2014.8.PEDS13590; Sugimoto K, 2013, BRAIN TUMOR PATHOL, V30, P247, DOI 10.1007/s10014-012-0134-9; Tan HW, 2004, J CLIN PATHOL, V57, P882, DOI 10.1136/jcp.2004.016659	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2015	84	3							UNSP 866.e1	10.1016/j.wneu.2015.03.065		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CR0LR	WOS:000361010700052		
J	Wan, K; Kawara, H; Yamamoto, T; Kume, K; Yabuki, Y; Goshima, T; Kitamura, K; Ueno, M; Kanai, M; Hirata, D; Funato, K; Mizuta, K				Wan, Kun; Kawara, Haruka; Yamamoto, Tomoyuki; Kume, Kazunori; Yabuki, Yukari; Goshima, Tetsuya; Kitamura, Kenji; Ueno, Masaru; Kanai, Muneyoshi; Hirata, Dai; Funato, Kouichi; Mizuta, Keiko			The essential function of Rrs1 in ribosome biogenesis is conserved in budding and fission yeasts	YEAST			English	Article						ribosome biogenesis; fission yeast; budding yeast; Rrs1	PROTEIN L11-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; SUBUNIT; RNA; INTERACTS; HOMOLOG; EBP2P; GENE	The Rrs1 protein plays an essential role in the biogenesis of 60S ribosomal subunits in budding yeast (Saccharomyces cerevisiae). Here, we examined whether the fission yeast (Schizosaccharomyces pombe) homologue of Rrs1 also plays a role in ribosome biogenesis. To this end, we constructed two temperature-sensitive fission yeast strains, rrs1-D14/22G and rrs1-L51P, which had amino acid substitutions corresponding to those of the previously characterized budding yeast rrs1-84 (D22/30G) and rrs1-124 (L61P) strains, respectively. The fission yeast mutants exhibited severe defects in growth and 60S ribosomal subunit biogenesis at high temperatures. In addition, expression of the Rrs1 protein of fission yeast suppressed the growth defects of the budding yeast rrs1 mutants at high temperatures. Yeast two-hybrid analyses revealed that the interactions of Rrs1 with the Rfp2 and Ebp2 proteins were conserved in budding and fission yeasts. These results suggest that the essential function of Rrs1 in ribosome biogenesis may be conserved in budding and fission yeasts. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Wan, Kun; Kawara, Haruka; Yamamoto, Tomoyuki; Yabuki, Yukari; Funato, Kouichi; Mizuta, Keiko] Hiroshima Univ, Dept Biofunct Sci & Technol, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Kume, Kazunori; Goshima, Tetsuya; Kitamura, Kenji; Ueno, Masaru; Hirata, Dai] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398528, Japan; [Goshima, Tetsuya; Kanai, Muneyoshi] Natl Res Inst Brewing, Higashihiroshima, Japan; [Hirata, Dai] Asahi Shuzo Sake Brewing Co Ltd, Niigata, Japan	Mizuta, K (reprint author), Hiroshima Univ, Dept Biofunct Sci & Technol, Grad Sch Biosphere Sci, 1-4-4 Kagamiyama, Higashihiroshima 7398528, Japan.	kei7mizuta@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS; KAKENHI) [25450516]	We thank David Shore for the plasmid expressing the lexA-binding domain-Adh1 fusion protein. This study was supported by the Japan Society for the Promotion of Science (JSPS; KAKENHI Grant No. 25450516, to K.M.).	Tsujii R, 2000, GENES CELLS, V5, P543, DOI 10.1046/j.1365-2443.2000.00346.x; Fossale E, 2002, HUM MOL GENET, V11, P2233, DOI 10.1093/hmg/11.19.2233; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Gambe AE, 2009, FEBS LETT, V583, P1951, DOI 10.1016/j.febslet.2009.05.033; Horigome C, 2011, EMBO J, V30, P3799, DOI 10.1038/emboj.2011.267; Kaisers C, 1994, METHODS YEAST GENETI; Miyoshi K, 2004, FEBS LETT, V565, P106, DOI 10.1016/j.febslet.2004.03.087; Morenos S, 1991, METHODS ENZYMOL, V194, P795; Morita D, 2002, J BIOL CHEM, V277, P28780, DOI 10.1074/jbc.M203399200; Nariai M, 2005, NUCLEIC ACIDS RES, V33, P4553, DOI 10.1093/nar/gki772; Shimoji K, 2012, NUCLEIC ACIDS RES, V40, P4574, DOI 10.1093/nar/gks057; Shirai C, 2004, J BIOL CHEM, V279, P25353, DOI 10.1074/jbc.M403338200; Sipiczki M, 2000, GENOME BIOL, V1; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32	9					607	614		10.1002/yea.3083		8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR0AW	WOS:000360981300003		
J	Watanabe, K				Watanabe, Kazumi			Torsional waves produced by a semi-infinite needle-like torque source	ZAMM-ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND MECHANIK			English	Article						Torsional wave; torque source; closed form solution		A transient torsional response of an elastic solid is discussed. Introducing a semi-infinite needle-like torque source, exact closed form expressions for torsional displacement and stress are obtained. Due to the needle-like shape of the source, two waves are produced. One is a cylindrical wave centered at its symmetry axis and the other is a spherical one centered at the edge of the needle source. The cylindrical wave shows the inverse square root singularity at its front, but the spherical wave does a finite jump at the front. Some additional discussions for the static response to the torque source are also carried out. The proposed needle-like torque source might be used as a primary model for the bore drilling technology.		Watanabe, K (reprint author), Sakuragaoka Cyo 1-4, Shimonoseki, Yamaguchi 7500083, Japan.	kazy_watanabe_470921@hotmail.co.jp					Watanabe K, 2005, INT J ENG SCI, V43, P1283, DOI 10.1016/j.ijengsci.2005.05.005; Ryzhik I. M., 1980, TABLE INTEGRALS SERI; Sneddon I. N., 1951, FOURIER TRANSFORMS, P406; Watanabe K., 2014, INTEGRAL TRANSFORM T	4	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0044-2267	1521-4001		ZAMM-Z ANGEW MATH ME	ZAMM-Z. Angew. Math. Mech.	SEP	2015	95	9					888	896		10.1002/zamm.201400043		9	Mathematics, Applied; Mechanics	Mathematics; Mechanics	CR1AE	WOS:000361054200002		
J	Amano, Y; Namatame, I; Tateishi, Y; Honboh, K; Tanabe, E; Niimi, T; Sakashita, H				Amano, Yasushi; Namatame, Ichiji; Tateishi, Yukihiro; Honboh, Kazuya; Tanabe, Eiki; Niimi, Tatsuya; Sakashita, Hitoshi			Structural insights into the novel inhibition mechanism of Trypanosoma cruzi spermidine synthase	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						spermidine synthase; Trypanosoma cruzi; fragment-based drug discovery; Chagas disease; allosteric inhibition	TRYPANOTHIONE PATHWAY; CRYSTAL-STRUCTURE; LEAD GENERATION; DRUG DESIGN; GLUTATHIONE; EXPERIENCES; METABOLISM; DISCOVERY; TARGETS; POTENT	Trypanosoma cruzi causes Chagas disease, a severe disease affecting 8-10 million people in Latin America. While nifurtimox and benznidazole are used to treat this disease, their efficacy is limited and adverse effects are observed. New therapeutic targets and novel drugs are therefore urgently required. Enzymes in the polyamine-trypanothione pathway are promising targets for the treatment of Chagas disease. Spermidine synthase is a key enzyme in this pathway that catalyzes the transfer of an aminopropyl group from decarboxylated S-adenosylmethionine (dcSAM) to putrescine. Fragment-based drug discovery was therefore conducted to identify novel, potent inhibitors of spermidine synthase from T. cruzi (TcSpdSyn). Here, crystal structures of TcSpdSyn in complex with dcSAM, trans-4-methylcyclohexylamine and hit compounds from fragment screening are reported. The structure of dcSAM complexed with TcSpdSyn indicates that dcSAM stabilizes the conformation of the 'gatekeeping' loop to form the putrescine-binding pocket. The structures of fragments bound to TcSpdSyn revealed two fragment-binding sites: the putrescine-binding pocket and the dimer interface. The putrescine-binding pocket was extended by an induced-fit mechanism. The crystal structures indicate that the conformation of the dimer interface is required to stabilize the gatekeeping loop and that fragments binding to this interface inhibit TcSpdSyn by disrupting its conformation. These results suggest that utilizing the dynamic structural changes in TcSpdSyn that occur upon inhibitor binding will facilitate the development of more selective and potent inhibitors.	[Amano, Yasushi; Namatame, Ichiji; Tateishi, Yukihiro; Honboh, Kazuya; Tanabe, Eiki; Niimi, Tatsuya; Sakashita, Hitoshi] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan	Amano, Y (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	yasushi-amano@astellas.com					Abad MC, 2011, METHOD ENZYMOL, V493, P487, DOI 10.1016/B978-0-12-381274-2.00019-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murray CW, 2012, TRENDS PHARMACOL SCI, V33, P224, DOI 10.1016/j.tips.2012.02.006; Jacobsson M, 2008, J MED CHEM, V51, P2777, DOI 10.1021/jm7016144; Baker M, 2013, NAT REV DRUG DISCOV, V12, P5, DOI 10.1038/nrd3926; Hayakawa N, 1999, BIOCHEMISTRY-US, V38, P11501, DOI 10.1021/bi982829k; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Spurlino JC, 2011, METHOD ENZYMOL, V493, P321, DOI 10.1016/B978-0-12-381274-2.00013-3; Kranz JK, 2011, METHOD ENZYMOL, V493, P277, DOI 10.1016/B978-0-12-381274-2.00011-X; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Maya JD, 2014, CURR MED CHEM, V21, P1757; Manta B, 2013, BBA-GEN SUBJECTS, V1830, P3199, DOI 10.1016/j.bbagen.2013.01.013; Hubbard RE, 2011, METHOD ENZYMOL, V493, P509, DOI 10.1016/B978-0-12-381274-2.00020-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Trevillyan JM, 1999, ARCH BIOCHEM BIOPHYS, V364, P19, DOI 10.1006/abbi.1999.1099; Lepre CA, 2011, METHOD ENZYMOL, V493, P219, DOI 10.1016/B978-0-12-381274-2.00009-1; Centers for Disease Control and Prevention, 2011, NEGL TROP DIS; Centers for Disease Control and Prevention [CDC], 2013, PAR AM TRYP ALS KNOW; Colotti G, 2013, FUTURE MED CHEM, V5, P1861, DOI [10.4155/fmc.13.146, 10.4155/FMC.13.146]; COWARD JK, 1987, ADV ENZYME REGUL, V26, P107, DOI 10.1016/0065-2571(87)90008-2; Dufe VT, 2007, J MOL BIOL, V373, P167, DOI 10.1016/j.jmb.2007.07.053; Flohe L, 1999, FREE RADICAL BIO MED, V27, P966, DOI 10.1016/S0891-5849(99)00172-0; Hiraki M, 2008, J SYNCHROTRON RADIAT, V15, P300, DOI 10.1107/S0909049507064680; Hiraki M, 2013, J SYNCHROTRON RADIAT, V20, P890, DOI 10.1107/S0909049513021067; Ikeguchi Y, 2006, J BIOCHEM, V139, P1, DOI 10.1093/jb/mvj019; Orita M, 2011, METHOD ENZYMOL, V493, P383, DOI 10.1016/B978-0-12-381274-2.00015-7; PEGG AE, 1995, INT J BIOCHEM CELL B, V27, P425, DOI 10.1016/1357-2725(95)00007-C; SHIRAHATA A, 1988, CHEM PHARM BULL, V36, P3220; Sprenger J, 2015, ACTA CRYSTALLOGR D, V71, P484, DOI 10.1107/S1399004714027011; World Health Organization, 2015, CHAG DIS AM TRYP; World Health Organization, 2013, NEGL TROP DIS; Wu H, 2007, BIOCHEMISTRY-US, V46, P8331, DOI 10.1021/bi602498k; Yamada Y. H. M., 2009, AIP C P, V1234, P415; Zhu YQ, 2006, PROTEINS, V63, P1127, DOI 10.1002/prot.20965	36	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	SEP	2015	71		9				1879	1889		10.1107/S1399004715013048		11	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CQ5OH	WOS:000360654300010		
J	Kagawa, W; Arai, T; Ishikura, S; Kino, K; Kurumizaka, H				Kagawa, Wataru; Arai, Toshinobu; Ishikura, Shun; Kino, Kuniki; Kurumizaka, Hitoshi			Structure of RizA, an L-amino-acid ligase from Bacillus subtilis	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						L-amino-acid ligase; ATP-grasp fold; rhizocticin; dipeptide synthesis	ESCHERICHIA-COLI; PEPTIDE; MAD; LICHENIFORMIS; SYNTHETASES; DIPEPTIDES; MODE; ATP	RizA is an L-amino-acid ligase from Bacillus subtilis that participates in the biosynthesis of rhizocticin, an oligopeptide antibiotic. The substrate-free form of RizA has been crystallized and the structure was solved at 2.8 angstrom resolution. The amino-acid-binding site appears to be capable of accommodating multiple amino acids, consistent with previous biochemical studies.	[Kagawa, Wataru] Meisei Univ, Sch Sci & Engn, Program Chem & Life Sci, Dept Interdisciplinary Sci & Engn, Hino, Tokyo 1918506, Japan; [Arai, Toshinobu; Ishikura, Shun; Kino, Kuniki] Waseda Univ, Dept Appl Chem, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo 1628480, Japan	Kagawa, W (reprint author), Meisei Univ, Sch Sci & Engn, Program Chem & Life Sci, Dept Interdisciplinary Sci & Engn, 2-1-1 Hodokubo, Hino, Tokyo 1918506, Japan.	wataru.kagawa@meisei-u.ac.jp; kkino@waseda.jp			JSPS KAKENHI [24570138, 26289318]; MEXT KAKENHI [26116521, 25116002]; Waseda Research Institute for Science and Engineering	The synchrotron-radiation experiments were performed on the BL41XU beamline of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; Proposal Nos. 2010B1375, 2011A1528 and 2011B1133) and on the AR-NW12 and BL-17A beamlines of the Photon Factory (Proposal No. 2010G615). We are grateful to the beamline scientists for their assistance in data collection. This work was supported in part by JSPS KAKENHI Grant Nos. 24570138 (to WK) and 26289318 (to KK). This work was also supported in part by MEXT KAKENHI Grant Nos. 26116521 (to WK) and 25116002 (to HK). KK, TA and HK were also supported by the Waseda Research Institute for Science and Engineering.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Mills S, 2011, ANNU REV FOOD SCI T, V2, P299, DOI 10.1146/annurev-food-022510-133721; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Yagasaki M, 2008, APPL MICROBIOL BIOT, V81, P13, DOI 10.1007/s00253-008-1590-3; HENDRICKSON WA, 1990, EMBO J, V9, P1665; Shomura Y, 2012, PROTEIN SCI, V21, P707, DOI 10.1002/pro.2058; Santos S, 2012, BIOPOLYMERS, V98, P288, DOI 10.1002/bip.22067; Kino K, 2009, BIOSCI BIOTECH BIOCH, V73, P901, DOI 10.1271/bbb.80842; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Inaoka T, 2003, J BIOL CHEM, V278, P2169, DOI 10.1074/jbc.M208722200; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Galperin MY, 1997, PROTEIN SCI, V6, P2639; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Arai T, 2013, APPL ENVIRON MICROB, V79, P5023, DOI 10.1128/AEM.01003-13; Arai T, 2008, BIOSCI BIOTECH BIOCH, V72, P3048, DOI 10.1271/bbb.80439; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; Kino K, 2008, BIOCHEM BIOPH RES CO, V371, P536, DOI 10.1016/j.bbrc.2008.04.105; Kino K, 2008, J BIOSCI BIOENG, V106, P313, DOI 10.1263/jbb.106.313; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Suzuki M, 2012, ACTA CRYSTALLOGR D, V68, P1535, DOI 10.1107/S0907444912038103; Tabata K, 2005, J BACTERIOL, V187, P5195, DOI 10.1128/JB.187.15.5195-5202.2005; Tabata K, 2007, APPL ENVIRON MICROB, V73, P6378, DOI 10.1128/AEM.01249-07	26	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2053-230X			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	SEP	2015	71		9				1125	1130		10.1107/S2053230X15012698		6	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CQ5NS	WOS:000360652600003		
J	Aikawa, Y; Kida, H; Nishitani, Y; Miki, K				Aikawa, Yoshiki; Kida, Hiroshi; Nishitani, Yuichi; Miki, Kunio			Expression, purification, crystallization and X-ray diffraction studies of the molecular chaperone prefoldin from Homo sapiens	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						protein folding; molecular chaperone; prefoldin	EUKARYOTIC PREFOLDIN; CYTOSOLIC CHAPERONIN; UNFOLDED PROTEINS; NASCENT CHAIN; COMPLEXES; BINDING	Proper protein folding is an essential process for all organisms. Prefoldin (PFD) is a molecular chaperone that assists protein folding by delivering non-native proteins to group II chaperonin. A heterohexamer of eukaryotic PFD has been shown to specifically recognize and deliver non-native actin and tubulin to chaperonin-containing TCP-1 (CCT), but the mechanism of specific recognition is still unclear. To determine its crystal structure, recombinant human PFD was reconstituted, purified and crystallized. X-ray diffraction data were collected to 4.7 angstrom resolution. The crystals belonged to space group P2(1)2(1)2, with unit-cell parameters a = 123.2, b = 152.4, c = 105.9 angstrom.	[Aikawa, Yoshiki; Kida, Hiroshi; Nishitani, Yuichi; Miki, Kunio] Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	Miki, K (reprint author), Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	miki@kuchem.kyoto-u.ac.jp			National Project on Protein Structural and Functional Analyses; Global COE Program 'Integrated Material Science' of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [B-024]	The authors are grateful to the beamline staff at Photon Factory and SPring-8 for their assistance during data collection. The authors are also grateful to Dr Masafumi Yohda for providing purified PhPFD. The diffraction experiment was performed on beamlines BL1A at the Photon Factory with the approval of KEK (Proposal No. 2013G659) and BL41XU at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; Proposal Nos. 2007A1829, 2009B1694, 2011A1602, 2011B1672 and 2012A1704). This work was supported by a grant from the National Project on Protein Structural and Functional Analyses (to KM) and from the Global COE Program 'Integrated Material Science' (No. B-024) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to YA and HK).	Martin-Benito J, 2007, STRUCTURE, V15, P101, DOI 10.1016/j.str.2006.11.006; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Leroux MR, 1999, EMBO J, V18, P6730, DOI 10.1093/emboj/18.23.6730; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Kida H, 2008, J MOL BIOL, V383, P465, DOI 10.1016/j.jmb.2008.08.041; Ohtaki A, 2008, J MOL BIOL, V376, P1130, DOI 10.1016/j.jmb.2007.12.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X	11	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2053-230X			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	SEP	2015	71		9				1189	1193		10.1107/S2053230X15013990		5	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CQ5NS	WOS:000360652600013		
J	Godo, S; Saito, H; Tanaka, S; Ito, A; Ikumi, Y; Sato, S; Shimokawa, H				Godo, Shigeo; Saito, Hiroki; Tanaka, Shuhei; Ito, Akiyo; Ikumi, Yosuke; Sato, Saori; Shimokawa, Hiroaki			Excessive endothelium-derived nitric oxide impairs cardiovascular homeostasis by suppressing endothelium-dependent hyperpolarization-mediated relaxation in mice	ACTA PHYSIOLOGICA			English	Meeting Abstract									[Godo, Shigeo; Saito, Hiroki; Tanaka, Shuhei; Ito, Akiyo; Ikumi, Yosuke; Sato, Saori; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-1708	1748-1716		ACTA PHYSIOL	Acta Physiol.	SEP	2015	215			703	SI	17	8	8				1	Physiology	Physiology	CQ7UG	WOS:000360809600018		
J	Saito, H; Sato, S; Ikumi, Y; Tanaka, S; Godo, S; Shimokawa, H				Saito, Hiroki; Sato, Saori; Ikumi, Yousuke; Tanaka, Shuhei; Godo, Shigeo; Shimokawa, Hiroaki			Important roles of endothelial caveolin-1/eNOS complex in maintaining microvascular homeostasis through EDH-mediated mechanism	ACTA PHYSIOLOGICA			English	Meeting Abstract									[Saito, Hiroki; Sato, Saori; Ikumi, Yousuke; Tanaka, Shuhei; Godo, Shigeo; Shimokawa, Hiroaki] Tohoku Univ, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-1708	1748-1716		ACTA PHYSIOL	Acta Physiol.	SEP	2015	215			703	SI	35	15	15				1	Physiology	Physiology	CQ7UG	WOS:000360809600036		
J	Shimokawa, H				Shimokawa, Hiroaki			Endothelium-dependent hyperpolarizations in health and disease -crucial roles of endothelium-derived reactive oxygen species-endothelium-dependent hyperpolarization	ACTA PHYSIOLOGICA			English	Meeting Abstract									[Shimokawa, Hiroaki] Tohoku Univ, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-1708	1748-1716		ACTA PHYSIOL	Acta Physiol.	SEP	2015	215			703	SI	37	16	16				1	Physiology	Physiology	CQ7UG	WOS:000360809600038		
J	Yamashita, N; Mayekawa, S				Yamashita, Naoto; Mayekawa, Shin-ichi			A new biplot procedure with joint classification of objects and variables by fuzzy c-means clustering	ADVANCES IN DATA ANALYSIS AND CLASSIFICATION			English	Article						Biplot; Fuzzy c-means clustering; Principal component analysis; Singular value decomposition; Alternating least squares	COMPONENT ANALYSIS; REGRESSION; MODELS	Biplot is a technique for obtaining a low-dimensional configuration of the data matrix in which both the objects and the variables of the data matrix are jointly represented as points and vectors, respectively. However, biplots with a large number of objects and variables remain difficult to interpret. Therefore, in this research, we propose a new biplot procedure that allows us to interpret a large data matrix. In particular, the objects and variables are classified into a small number of clusters by using fuzzy -means clustering and the resulting clusters are simultaneously biplotted in lower-dimensional space. This procedure allows us to understand the configurations easily and to grasp the fuzzy memberships of the objects and variables to the clusters. A simulation study and real data example are also provided to demonstrate the effectiveness of the proposed procedure.	[Yamashita, Naoto; Mayekawa, Shin-ichi] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Dept Human Syst Sci, Meguro Ku, Tokyo 1528552, Japan	Yamashita, N (reprint author), Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Dept Human Syst Sci, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528552, Japan.	yamashita.ou.titech@gmail.com					Adachi K, 2011, ADV DATA ANAL CLASSI, V5, P23, DOI 10.1007/s11634-010-0081-4; Coppi R, 2006, COMPUT STAT DATA AN, V51, P1, DOI 10.1016/j.csda.2006.05.012; TENBERGE JMF, 1983, PSYCHOMETRIKA, V48, P519; Vichi M, 2001, COMPUT STAT DATA AN, V37, P49, DOI 10.1016/S0167-9473(00)00064-5; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.2307/2334381; Arabie P., 1994, ADV METHODS MARKETIN, P160; Bedzek JC, 1999, FUZZY MODELS ALGORIT; Benzecri J, 1973, ANAL DEX DONNES; Benzecri J, 1973, ANAL DEX DONNES; BEZDEK JC, 1981, SIAM J APPL MATH, V40, P339, DOI 10.1137/0140029; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; D'Urso P, 2010, INFORM SCIENCES, V180, P4737, DOI 10.1016/j.ins.2010.08.018; Eckart C, 1936, PSYCHOMETRIKA, V1, P200; Frank A., 2010, UCI MACHINE LEARNING; Gan G, 2007, ASA SIAM SER STAT AP, V20, P1, DOI 10.1137/1.9780898718348; Gifi A, 1990, NONLINEAR MULTIVARIA; Gower JC, 2011, UNDERSTANDING BIPLOT; Gower JC, 1996, BIPLOTS; Greenacre MJ, 2010, BIPLOTS IN PRACTICE; Harville D., 1997, MATRIX ALGEBRA STAT; Hathaway R. J., 1993, IEEE Transactions on Fuzzy Systems, V1, DOI 10.1109/91.236552; Hwang H, 2010, MULTIVAR BEHAV RES, V45, P186, DOI 10.1080/00273170903504893; Hwang H, 2010, BEHAVIORMETRIKA, V37, P111; Hwang HS, 2007, PSYCHOMETRIKA, V72, P181, DOI 10.1007/s11336-005-1314-x; Izenman AJ, 2008, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-78189-1_1; MacQueen J., 1967, P 5 BERK S MATH STAT, P281, DOI DOI 10.1234/12345678; Mori K, 1990, HDB NUMERICAL COMPUT, P589; Rocci R, 2005, PSYCHOMETRIKA, V70, P715, DOI 10.1007/s11336-001-0926-z; ROUBENS M, 1982, EUR J OPER RES, V10, P294, DOI 10.1016/0377-2217(82)90228-4; Spath, 1979, COMPUTING, V22, P367; Suk HW, 2010, ADV DATA ANAL CLASSI, V4, P35, DOI 10.1007/s11634-009-0056-5; ten Berge J. M. F., 1993, LEAST SQUARES OPTIMI; Tucker LR, 1951, 984 US DEP ARM; Vichi M, 2007, J CLASSIF, V24, P71, DOI 10.1007/s00357-007-0006-x; Wedel M., 1989, INT J RES MARK, V6, P241, DOI 10.1016/0167-8116(89)90052-9; Weisstein EW, 1998, CRC CONCISE ENCY MAT; Yamashita N, 2012, B DATA ANAL JPN CLAS, V2, P33; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	39	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1862-5347	1862-5355		ADV DATA ANAL CLASSI	Adv. Data Anal. Classif.	SEP	2015	9	3					243	266		10.1007/s11634-014-0184-4		24	Statistics & Probability	Mathematics	CQ4CM	WOS:000360551800002		
J	Kanawaku, Y; Takahashi, S; Kanetake, J; Funayama, M				Kanawaku, Yoshimasa; Takahashi, Shirushi; Kanetake, Jun; Funayama, Masato			An Autopsy Case of a Pregnant Woman With Severe Placental and Fetal Damage From Domestic Violence	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						maternal death; fetal death; domestic violence; placental avulsion	BLUNT ABDOMINAL-TRAUMA; NONPENETRATING TRAUMA; PARTNER VIOLENCE; DEATH SECONDARY; GRAVID UTERUS; OUTCOMES; LACERATION; INJURY; WOMEN	We present an autopsy case of a pregnant woman who was a victim of domestic violence. The deceased showed injuries mainly to her head and abdomen. Postmortem examination revealed 1400 mL of abdominal hemorrhage, ablation of the perimetrium, placental avulsion, and intracranial hematoma. The cause of death was diagnosed as hemorrhagic shock. The uterus contained a fetus of 7 months' gestational age. Fetal autopsy revealed laceration of the lungs, laceration and avulsion of the liver, and 15 mL of hemoperitoneum. Both placental and fetal injuries suggested repeated severe attacks to the abdomen, such as those expected to result from kicking or hitting.	[Kanawaku, Yoshimasa] Nippon Med Sch, Dept Legal Med, Bunkyo Ku, Tokyo 1138602, Japan; [Takahashi, Shirushi; Funayama, Masato] Tohoku Univ, Sch Med, Dept Publ Hlth & Forens Med, Div Forens Med, Sendai, Miyagi 980, Japan; [Kanetake, Jun] Natl Def Med Coll, Div Forens Med, Tokorozawa, Saitama 359, Japan	Kanawaku, Y (reprint author), Nippon Med Sch, Dept Legal Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	ykanawaku@nifty.com					Shah KH, 1998, J TRAUMA, V45, P83, DOI 10.1097/00005373-199807000-00018; Coker AL, 2004, PAEDIATR PERINAT EP, V18, P260, DOI 10.1111/j.1365-3016.2004.00569.x; Janssen PA, 2003, AM J OBSTET GYNECOL, V188, P1341, DOI 10.1067/mob.2003.274; Shadigian EM, 2005, OBSTET GYNECOL SURV, V60, P183, DOI 10.1097/01.ogx.0000155967.72418.6b; Poole GV, 1996, AM J OBSTET GYNECOL, V174, P1873, DOI 10.1016/S0002-9378(96)70223-5; DROST TF, 1990, J TRAUMA, V30, P574, DOI 10.1097/00005373-199005000-00008; Baegra-Varela Y, 2000, MAYO CLIN P, V75, P1243; Bewiey CA, 1991, MIDWIFERY, V7, P107; CIVIL ID, 1988, J TRAUMA, V28, P708, DOI 10.1097/00005373-198805000-00030; CONNOR E, 1976, AM J OBSTET GYNECOL, V125, P567; DAHMUS MA, 1993, AM J OBSTET GYNECOL, V169, P1054; ESPOSITO TJ, 1991, ARCH SURG-CHICAGO, V126, P1073; Horon IL, 2001, JAMA-J AM MED ASSOC, V285, P1455, DOI 10.1001/jama.285.11.1455; Kady D, 2005, OBSTET GYNECOL, V105, P357; NICHOLS MM, 1986, TEX MED, V82, P26; Parsons LH, 1999, OBSTET GYNECOL, V94, P990, DOI 10.1016/S0029-7844(99)00466-4; PEARLMAN MD, 1990, AM J OBSTET GYNECOL, V162, P1502; PEYSER MR, 1969, OBSTET GYNECOL, V34, P561; POULSON AM, 1973, AM J OBSTET GYNECOL, V116, P580; RANEY EH, 1970, AM J OBSTET GYNECOL, V106, P313; RIBE JK, 1993, J FORENSIC SCI, V38, P1092; SCORPIO RJ, 1992, J TRAUMA, V32, P213; Sheridan DJ, 1996, J NURSE-MIDWIFERY, V41, P467, DOI 10.1016/S0091-2182(96)00065-1; STUART GCE, 1980, CAN MED ASSOC J, V122, P901; Weiss HB, 2001, JAMA-J AM MED ASSOC, V286, P1863, DOI 10.1001/jama.286.15.1863	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2015	36	3					125	126		10.1097/PAF.0b013e318219c8bb		2	Medicine, Legal; Pathology	Legal Medicine; Pathology	CQ3UX	WOS:000360530200001		
J	Kakiuchi, Y; Idota, N; Nakamura, M; Ikegaya, H				Kakiuchi, Yasuhiro; Idota, Nozomi; Nakamura, Mami; Ikegaya, Hiroshi			A Fatal Case of Cervical Hemorrhage After Fine Needle Aspiration and Core Needle Biopsy of the Thyroid Gland	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						fine needle aspiration; core needle biopsy; massive cervical hemorrhage; postmortem computed tomography	AIRWAY-OBSTRUCTION; MANAGEMENT; DIAGNOSIS; NODULES; HEAD	Fine needle aspiration (FNA) and core needle biopsy (CNB) are recognized to be safe, useful, and inexpensive diagnostic tools for the evaluation of thyroid nodules. However, complications can arise during the procedure, albeit rarely and typically minor in nature. We report here an unusual fatal case of massive hematoma of the neck after FNA and CNB that may have caused airway obstruction. A 68-year-old Japanese woman underwent both procedures and was found dead at home later the same day. Although severe complications of FNA or CNB such as major bleeds or deaths are rarely reported, clinicians and forensic pathologists should be cognizant that complications can arise.	[Kakiuchi, Yasuhiro; Idota, Nozomi; Nakamura, Mami; Ikegaya, Hiroshi] Kyoto Prefectural Univ Med, Dept Forens Med, Grad Sch Med Sci, Kyoto 6028566, Japan	Kakiuchi, Y (reprint author), Kyoto Prefectural Univ Med, Dept Forens Med, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	kakiuchi@koto.kpu-m.ac.jp					Newkirk KA, 2000, OTOLARYNG HEAD NECK, V123, P700, DOI 10.1067/mhn.2000.110958; Roh JL, 2006, LARYNGOSCOPE, V116, P154, DOI 10.1097/01.mlg.0000187396.18016.d0; Polyzos SA, 2009, CLIN ENDOCRINOL, V71, P157, DOI 10.1111/j.1365-2265.2009.03522.x; Noordzij JP, 2005, AM J OTOLARYNG, V26, P398, DOI 10.1016/j.amjoto.2005.02.016; Screaton NJ, 2002, RADIOLOGY, V224, P75, DOI 10.1148/radiol.2241010602; Baloch Zubair W, 2004, Endocr Pract, V10, P234; Braga M, 2001, J CLIN ENDOCR METAB, V86, P4089, DOI 10.1210/jc.86.9.4089; Chen BT, 2014, ENDOCR PRACT, V8, P128; Hor T, 2008, THYROID, V18, P567, DOI 10.1089/thy.2007.0363; Novoa E, 2012, HEAD NECK-J SCI SPEC, V34, P1497, DOI 10.1002/hed.21821; RAMACCIOTTI CE, 1984, ARCH INTERN MED, V144, P1169, DOI 10.1001/archinte.144.6.1169; Ranta A, 1996, Duodecim, V112, P2024; SILVERMAN JF, 1986, CANCER, V57, P1164, DOI 10.1002/1097-0142(19860315)57:6<1164::AID-CNCR2820570617>3.0.CO;2-S	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2015	36	3					207	209		10.1097/PAF.0000000000000172		3	Medicine, Legal; Pathology	Legal Medicine; Pathology	CQ3UX	WOS:000360530200020		
J	Saito, Y; Yasuhara, H; Murakoshi, S; Komatsu, T; Fukatsu, K; Uetera, Y				Saito, Yuhei; Yasuhara, Hiroshi; Murakoshi, Satoshi; Komatsu, Takami; Fukatsu, Kazuhiko; Uetera, Yushi			Time-dependent influence on assessment of contaminated environmental surfaces in operating rooms	AMERICAN JOURNAL OF INFECTION CONTROL			English	Article						Environmental contamination; Time course; Health care-associated infection; Assessment method	DISINFECTION; REDUCTION; INFECTION; PATHOGENS; EFFICACY; CLOTHS; ATP	Background: There is no established method to assess the contamination of environmental surfaces because the results change with time. We evaluated current methods for assessment of contamination of environmental surfaces in the operating room (OR). Methods: Contamination of environmental surfaces in the OR was assessed using an adenosine triphosphate (ATP) test and bacterial culture. We collected 480 ATP test samples from 17 surfaces in 6 ORs to determine the influence of surface features, including frequency of touching and surface orientation on contamination, after completion of daily scheduled operations. Another 54 pairs of ATP and microbial samples were taken from 3 surfaces in each of the same OR except 1 to determine the time course of the results of ATP and microbial tests when ORs were not used. Results: Multivariate analysis demonstrated that the ATP results were strongly influenced by frequency of touching and orientation of environmental surfaces. The microbial counts declined over time, whereas the ATP results remained at a high level. Conclusion: The ATP test result could be used as a relatively stable trace of contamination of environmental surfaces; however, it is not a surrogate indicator of the number of viable microbes which declines over time. Copyright (C) 2015 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.	[Saito, Yuhei; Yasuhara, Hiroshi; Murakoshi, Satoshi; Komatsu, Takami; Fukatsu, Kazuhiko; Uetera, Yushi] Tokyo Univ Hosp, Surg Ctr, Tokyo 1138655, Japan	Saito, Y (reprint author), Tokyo Univ Hosp, Surg Ctr, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	saitoyu-ope@h.u-tokyo.ac.jp			Society for the Study of Infection Control (the Oiso Forum) - 3M Health Care Ltd	This study was partly supported by Society for the Study of Infection Control (the Oiso Forum) sponsored by 3M Health Care Ltd).	Moore G, 2013, INFECT CONT HOSP EP, V34, P500, DOI 10.1086/670219; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; [Anonymous], 2003, MMWR RECOMM REP, V52, P1; Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2; Schmidt MG, 2012, AM J INFECT CONTROL, V40, P559, DOI 10.1016/j.ajic.2011.07.013; Hubner NO, 2011, AM J NURS, V111, P30, DOI 10.1097/01.NAJ.0000408181.37017.82; Huslage K, 2013, INFECT CONT HOSP EP, V34, P211, DOI 10.1086/669092; Otter JA, 2013, J HOSP INFECT, V83, P1, DOI 10.1016/j.jhin.2012.10.002; Meakin NS, 2012, J HOSP INFECT, V80, P122, DOI 10.1016/j.jhin.2011.10.015; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Shama G, 2013, INT J HYG ENVIR HEAL, V216, P115, DOI 10.1016/j.ijheh.2012.03.009; Bergen LK, 2009, J HOSP INFECT, V71, P132, DOI 10.1016/j.jhin.2008.10.025; Diab-Elschahawi M, 2010, AM J INFECT CONTROL, V38, P289, DOI 10.1016/j.ajic.2009.09.006; Fajardo-Cavazos P, 2008, APPL ENVIRON MICROB, V74, P5159, DOI 10.1128/AEM.00891-08; Griffith CJ, 2007, J HOSP INFECT, V66, P352, DOI 10.1016/j.jhin.2007.05.016; Rutala WA, 2013, AM J INFECT CONTROL, V41, pS36, DOI 10.1016/j.ajic.2012.11.006; Sexton JD, 2011, AM J INFECT CONTROL, V39, P655, DOI 10.1016/j.ajic.2010.11.009; Smith DL, 2011, J HOSP INFECT, V78, P182, DOI 10.1016/j.jhin.2011.02.015	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-6553	1527-3296		AM J INFECT CONTROL	Am. J. Infect. Control	SEP 1	2015	43	9					951	955		10.1016/j.ajic.2015.04.196		5	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CQ4FQ	WOS:000360560200012		
J	Matsubara, T; Sato, T; Ohnishi, S; Yamasaki, M				Matsubara, Takumi; Sato, Takahiro; Ohnishi, Satoshi; Yamasaki, Masao			Pacemaker Dermatitis Induced by Backpack Strap Friction	AMERICAN JOURNAL OF MEDICINE			English	Letter									[Matsubara, Takumi] Univ Tokyo, Bunkyo Ku, Tokyo, Japan; [Sato, Takahiro; Ohnishi, Satoshi; Yamasaki, Masao] Nippon Telegraph & Tel Corp, Med Ctr Tokyo, Shinagawa, Tokyo, Japan	Matsubara, T (reprint author), Univ Tokyo, Bunkyo Ku, Hongo 7-3-1, Tokyo, Japan.	medical.natureboy@gmail.com					Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Raja Y, 2008, EUROPACE, V10, P1354, DOI 10.1093/europace/eun243; Sakakibara Y, 1997, PACE, V20, P370, DOI 10.1111/j.1540-8159.1997.tb06187.x	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	SEP	2015	128	9					E1	E2		10.1016/j.amjmed.2015.05.015		2	Medicine, General & Internal	General & Internal Medicine	CQ3GU	WOS:000360490900001		
J	Shikino, K; Suzuki, S; Noda, K; Ohira, Y; Ikusaka, M				Shikino, Kiyoshi; Suzuki, Shingo; Noda, Kazutaka; Ohira, Yoshiyuki; Ikusaka, Masatomi			Fever and Back Pain with Abdominal Aorta Tenderness: Takayasu Arteritis	AMERICAN JOURNAL OF MEDICINE			English	Letter									[Shikino, Kiyoshi; Suzuki, Shingo; Noda, Kazutaka; Ohira, Yoshiyuki; Ikusaka, Masatomi] Chiba Univ Hosp, Dept Gen Med, Chuo Ku, Chiba, Chiba 2608677, Japan	Shikino, K (reprint author), Chiba Univ Hosp, Dept Gen Med, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608677, Japan.	kshikino@gmail.com					KERR GS, 1994, ANN INTERN MED, V120, P919; Chatterjee S, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0499-y; Melamed E, 2010, ISR MED ASSOC J, V12, P507	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	SEP	2015	128	9					E17	E18		10.1016/j.amjmed.2015.04.010		2	Medicine, General & Internal	General & Internal Medicine	CQ3GU	WOS:000360490900007		
J	Takashima, S; Okubo, S; Ota, M				Takashima, Shota; Okubo, Shunichi; Ota, Mitsuhito			An Iatrogenic Metastasis	AMERICAN JOURNAL OF MEDICINE			English	Letter							CANCER; SITE		[Takashima, Shota; Ota, Mitsuhito] Chitose City Hosp, Dept Dermatol, Chitose 0660033, Japan; [Okubo, Shunichi] Chitose City Hosp, Dept Gastroenterol, Chitose 0660033, Japan	Ota, M (reprint author), Chitose City Hosp, Hokkou 2, Chitose 0660033, Japan.	ota@med.hokudai.ac.jp					Fiori E, 2003, J EXP CLIN CANC RES, V22, P151; Karayiannakis Anastasios J, 2010, Case Rep Oncol, V3, P495, DOI 10.1159/000323559; Morelli Umberto, 2009, J Med Case Rep, V3, P65, DOI 10.1186/1752-1947-3-65; Noro T, 2012, SURG TODAY, V42, P1248, DOI 10.1007/s00595-012-0340-4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	SEP	2015	128	9					E15	E16		10.1016/j.amjmed.2015.05.013		2	Medicine, General & Internal	General & Internal Medicine	CQ3GU	WOS:000360490900006		
J	Kadota, K; Nitadori, J; Rekhtman, N; Jones, DR; Adusumilli, PS; Travis, WD				Kadota, Kyuichi; Nitadori, Jun-ichi; Rekhtman, Natasha; Jones, David R.; Adusumilli, Prasad S.; Travis, William D.			Reevaluation and Reclassification of Resected Lung Carcinomas Originally Diagnosed as Squamous Cell Carcinoma Using Immunohistochemical Analysis	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						squamous cell carcinoma; lung; immunohistochemistry; classification	THYROID TRANSCRIPTION FACTOR-1; FACTOR-I EXPRESSION; CLINICAL-FEATURES; TISSUE MICROARRAY; PLUS CARBOPLATIN; ADENOCARCINOMA; CANCER; MUTATIONS; PULMONARY; GEFITINIB	Currently, non-small cell lung carcinomas are primarily classified by light microscopy. However, recent studies have shown that poorly differentiated tumors are more accurately classified by immunohistochemistry. In this study, we investigated the use of immunohistochemical analysis in reclassifying lung carcinomas that were originally diagnosed as squamous cell carcinoma. Tumor slides and blocks were available for histologic evaluation, and tissue microarrays were constructed from 480 patients with resected lung carcinomas originally diagnosed as squamous cell carcinoma between 1999 and 2009. Immunohistochemical analyses for p40, p63, thyroid transcription factor-1 (TTF-1; clones SPT24 and 8G7G3/1), napsin A, chromogranin A, synaptophysin, and CD56 were performed. Staining intensity (weak, moderate, or strong) and distribution (focal or diffuse) were also recorded. Of all, 449 (93.5%) patients were confirmed as having squamous cell carcinomas; the cases were mostly diffusely positive for p40 and negative for TTF-1 (8G7G3/1). Twenty cases (4.2%) were reclassified as adenocarcinoma, as they were positive for TTF-1 (8G7G3/1 or SPT24) with either no or focal p40 expression, and all of them were poorly differentiated with squamoid morphology. In addition, 1 case was reclassified as adenosquamous carcinoma, 4 cases as large cell carcinoma, 4 cases as large cell neuroendocrine carcinoma, and 2 cases as small cell carcinoma. In poorly differentiated non-small cell lung carcinomas, an accurate distinction between squamous cell carcinoma and adenocarcinoma cannot be reliably determined by morphology alone and requires immunohistochemical analysis, even in resected specimens. Our findings suggest that TTF-1 8G7G3/1 may be better suited as the primary antibody in differentiating adenocarcinoma from squamous cell carcinoma.	[Kadota, Kyuichi; Nitadori, Jun-ichi; Jones, David R.; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Thorac Serv, Dept Surg, New York, NY 10065 USA; [Kadota, Kyuichi; Rekhtman, Natasha; Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA; [Kadota, Kyuichi] Kagawa Univ, Dept Diagnost Pathol, Fac Med, Takamatsu, Kagawa 760, Japan; [Nitadori, Jun-ichi] Univ Tokyo, Grad Sch Med, Dept Thorac Surg, Tokyo, Japan	Travis, WD (reprint author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA.	travisw@mskcc.org			Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center; National Cancer Institute [R21 CA164568-01A1, R21 CA164585-01A1, R01 CA136705-06, U54 CA137788, P50 CA086438-13, U54 CA132378]; US Department of Defense [PR101053, LC110202]	Our laboratory work is supported in part by the William H. Goodwin and Alice Goodwin, the Commonwealth Foundation for Cancer Research and the Experimental Therapeutics Center; the National Cancer Institute (grants R21 CA164568-01A1, R21 CA164585-01A1, R01 CA136705-06, U54 CA137788, P50 CA086438-13, and U54 CA132378); and the US Department of Defense (grants PR101053 and LC110202). The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.	Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Rekhtman N, 2011, MODERN PATHOL, V24, P1348, DOI 10.1038/modpathol.2011.92; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Cohen MH, 2007, ONCOLOGIST, V12, P713, DOI 10.1634/theoncologist.12-6-713; Matoso A, 2010, APPL IMMUNOHISTO M M, V18, P142, DOI 10.1097/PAI.0b013e3181bdf4e7; Kadota K, 2013, CANCER-AM CANCER SOC, V119, P931, DOI 10.1002/cncr.27863; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Savci-Heijink CD, 2009, AM J PATHOL, V174, P1629, DOI 10.2353/ajpath.2009.080778; Nonaka D, 2012, AM J SURG PATHOL, V36, P895, DOI 10.1097/PAS.0b013e3182498f2b; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Rekhtman N, 2013, MODERN PATHOL, V26, P511, DOI 10.1038/modpathol.2012.195; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Whithaus K, 2012, ARCH PATHOL LAB MED, V136, P155, DOI 10.5858/arpa.2011-0232-OA; Sterlacci W, 2009, VIRCHOWS ARCH, V455, P125, DOI 10.1007/s00428-009-0812-0; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Turner BM, 2012, ARCH PATHOL LAB MED, V136, P163, DOI 10.5858/arpa.2011-0320-OA; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Kim MJ, 2013, ANN DIAGN PATHOL, V17, P85, DOI 10.1016/j.anndiagpath.2012.07.006; Barnes L, 2005, WHO CLASSIFICATION T; Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Comperat E, 2005, MODERN PATHOL, V18, P1371, DOI 10.1038/modpathol.3800422; Ionescu DN, 2007, AM J SURG PATHOL, V31, P26, DOI 10.1097/01.pas.0000213319.04919.97; Kadota K, 2014, J THORAC ONCOL, V9, P1126, DOI 10.1097/JTO.0000000000000253; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Moro-Sibilot D, 2008, EUR RESPIR J, V31, P854, DOI 10.1183/09031936.00058507; Travis WD, 2015, WHO CLASSIFICATION T; Travis WD, 2004, WHO CLASSIFICATION T	30	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	SEP	2015	39	9					1170	1180		10.1097/PAS.0000000000000439		11	Pathology; Surgery	Pathology; Surgery	CQ4QP	WOS:000360590000002		
J	Shah, RB; Li, JB; Cheng, L; Egevad, L; Deng, FM; Fine, SW; Kunju, LP; Melamed, J; Mehra, R; Osunkoya, AO; Paner, GP; Shen, SS; Tsuzuki, T; Trpkov, K; Tian, W; Yang, XMJ; Zhou, M				Shah, Rajal B.; Li, Jianbo; Cheng, Liang; Egevad, Lars; Deng, Fang-Ming; Fine, Samson W.; Kunju, Lakshmi P.; Melamed, Jonathan; Mehra, Rohit; Osunkoya, Adeboye O.; Paner, Gladell P.; Shen, Steve S.; Tsuzuki, Toyonori; Trpkov, Kiril; Tian, Wei; Yang, Ximing J.; Zhou, Ming			Diagnosis of Gleason Pattern 5 Prostate Adenocarcinoma on Core Needle Biopsy An Interobserver Reproducibility Study Among Urologic Pathologists	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						Gleason pattern 5; Gleason score; prostate cancer; prostate core needle biopsy; interobserver reproducibility	RADICAL PROSTATECTOMY; CANCER; FREQUENCY; PROGNOSIS; SYSTEM	Accurate recognition of Gleason pattern 5 (GP5) prostate adenocarcinoma on needle biopsy is critical as it is associated with disease progression and adverse clinical outcome. Despite important implications of this diagnosis, interobserver variation in the diagnosis of GP5 has not been adequately studied. Digital images of 66 prostate adenocarcinoma cases that potentially contained a GP5 component were distributed to 16 urologic pathologists who were asked to classify whether GP5 was present. Each image was initially classified into 1 of 4 morphologic subpatterns by 2 coauthors (R.B.S. and M.Z.): solid nests (15), comedocarcinoma (8), single cells and/or cords (35), and variant morphology (8). Additional features captured included: size (large: >20 cells, medium: 10 to 20 cells, and small: <10 cells) and distribution of nuclei (uniform vs. nonuniform) for nests pattern; intraluminal coagulative tumor necrosis, karyorrhectic debris, and amorphous material for comedocarcinoma pattern; and quantity (5, 6 to 10, and >10) and distribution (clustered vs. intermixed with adjacent well-formed glands) for single cells/cords pattern. Interobserver reproducibility of a diagnosis of GP5 was assessed and the morphologic subpatterns and features were correlated with the consensus diagnosis (defined as 75% agreement). Interobserver reproducibility for overall diagnostic agreement was fair (=0.376). Among subpatterns, comedocarcinoma had highest reproducibility (=0.499), followed by variant morphology (=0.443), single cells/cords (=0.369), and nests (=0.347). All cases with the following features achieved consensus for GP5: large nests regardless of nuclear distribution; coagulative necrosis with or without karyorrhectic debris; single cells/cords >10 or 6 to 10 in a cluster; and signet ring-like cells in single cells or within nests pattern. A majority of cases with the following features achieved consensus against GP5: medium-size nests; exclusive intraluminal amorphous material; single cells/cords 5; and Paneth cell change. Remaining morphologic features did not reach consensus for or against GP5. A majority (86%) of participants would diagnose a small focus of GP5 only when it is present in >1 level. The diagnostic reproducibility of GP5 within certain morphologies was only fair among urologic pathologists. However, the diagnosis of GP5 was more reproducible when certain restrictive morphologic and quantitative criteria were applied. These findings suggest that additional studies are needed to find highly reproducible features of GP5 associated with documented aggressive clinical outcome.	[Shah, Rajal B.; Tian, Wei] Miraca Life Sci, Miraca Life Sci Res Inst, Div Urol Pathol, Irving, TX 75039 USA; [Shen, Steve S.] Houston Methodist Hosp, Houston, TX USA; [Li, Jianbo] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Cheng, Liang] Indiana Univ, Indianapolis, IN 46204 USA; [Deng, Fang-Ming; Melamed, Jonathan; Zhou, Ming] NYU, Med Ctr, New York, NY 10016 USA; [Fine, Samson W.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Kunju, Lakshmi P.; Mehra, Rohit] Univ Michigan, Ann Arbor, MI 48109 USA; [Osunkoya, Adeboye O.] Emory Univ, Atlanta, GA 30322 USA; [Paner, Gladell P.] Univ Chicago, Chicago, IL 60637 USA; [Yang, Ximing J.] NW Mem Hosp, Chicago, IL 60611 USA; [Egevad, Lars] Karolinska Inst, Stockholm, Sweden; [Tsuzuki, Toyonori] Japanese Red Cross Nagoya Daini Hosp, Nagoya, Aichi, Japan; [Trpkov, Kiril] Univ Calgary, Calgary, AB, Canada; [Trpkov, Kiril] Calgary Lab Serv, Calgary, AB, Canada	Shah, RB (reprint author), Miraca Life Sci, Miraca Life Sci Res Inst, Div Urol Pathol, 6655 North MacArthur Blvd, Irving, TX 75039 USA.	rshah@Miracals.com		Melamed, Jonathan/0000-0003-2844-7990			Al-Hussain TO, 2012, UROLOGY, V79, P178, DOI 10.1016/j.urology.2011.08.060; GLEASON DF, 1974, J UROLOGY, V111, P58; Iczkowski KA, 2011, AM J CLIN PATHOL, V136, P98, DOI 10.1309/AJCPZ7WBU9YXSJPE; Bostwick DG, 2000, ARCH PATHOL LAB MED, V124, P995; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x; Pierorazio PM, 2010, UROLOGY, V76, P715, DOI 10.1016/j.urology.2009.11.085; Sabolch A, 2011, INT J RADIAT ONCOL, V81, pE351, DOI 10.1016/j.ijrobp.2011.01.063; Fajardo DA, 2011, AM J SURG PATHOL, V35, P1706, DOI 10.1097/PAS.0b013e318228571d; Shah RB, 2009, ARCH PATHOL LAB MED, V133, P1810, DOI 10.1043/1543-2165-133.11.1810; Gottipati S, 2012, AM J SURG PATHOL, V36, P900, DOI 10.1097/PAS.0b013e3182495dee; Brimo F, 2013, EUR UROL, V63, P892, DOI 10.1016/j.eururo.2012.10.015; Ellis CL, 2013, J UROLOGY, V190, P2068, DOI 10.1016/j.juro.2013.05.056; Mellinger GT, 1977, RECENT RESULTS CANC, V60, P61; Shah RB, 2014, HUM PATHOL, V45, P2263, DOI 10.1016/j.humpath.2014.07.012; Tamas EF, 2006, AM J SURG PATHOL, V30, P980, DOI 10.1097/00000478-200608000-00008; Trpkov K, 2009, AM J SURG PATHOL, V33, P233, DOI 10.1097/PAS.0b013e31817fb3bd	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	SEP	2015	39	9					1242	1249		10.1097/PAS.0000000000000442		8	Pathology; Surgery	Pathology; Surgery	CQ4QP	WOS:000360590000010		
J	Takata, K; Noujima-Harada, M; Miyata-Takata, T; Ichimura, K; Sato, Y; Miyata, T; Naruse, K; Iwamoto, T; Tari, A; Masunari, T; Sonobe, H; Okada, H; Iwamuro, M; Mizobuchi, K; Gion, Y; Yoshino, T				Takata, Katsuyoshi; Noujima-Harada, Mai; Miyata-Takata, Tomoko; Ichimura, Koichi; Sato, Yasuharu; Miyata, Takafumi; Naruse, Keishi; Iwamoto, Toshiyuki; Tari, Akira; Masunari, Taro; Sonobe, Hiroshi; Okada, Hiroyuki; Iwamuro, Masaya; Mizobuchi, Kohichi; Gion, Yuka; Yoshino, Tadashi			Clinicopathologic Analysis of 6 Lymphomatoid Gastropathy Cases Expanding the Disease Spectrum to CD4(-) CD8(+) Cases	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						lymphomatoid gastropathy; CD4; CD8; a benign mimic of lymphoma	T-CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; NASAL TYPE; PROLIFERATION; ENTEROPATHY	Lymphomatoid gastropathy, which was first reported in 2010, is a rare NK-cell proliferation of cyCD3(+), CD4(-), CD5(-), CD8(-), CD56(+) phenotypes with unknown etiology. The diagnosis is challenging, as there is histopathologic similarity to malignant lymphoma. In the 2010 report on 10 cases, all lesions were located in the stomach, and all regressed without any therapy. In the present study, we analyzed 6 cases of lymphomatoid gastropathy by investigating the clinicopathologic, immunohistochemical, and molecular findings. Endoscopic and morphologic appearances of all cases were consistent with previous reports, but 2 cases showed previously unreported unique immunophenotypes of CD4(-)CD8(+). Three of 6 patients underwent lower gastrointestinal examination (1 case underwent double-balloon endoscopic examination), but no patient had lesions in the lower gastrointestinal tract. No obvious difference of histology was found between the cases of CD4-CD8-typical phenotype and ones of CD4(-)CD8(+) phenotype. Both cases had similar clinical behavior as the other 4 cases, implying that the spectrum of the disease is broader than initially thought. Careful clinical and endoscopic follow-up is required for the diagnosis of lymphomatoid gastropathy, and additional case studies and molecular studies are warranted to further investigate the pathophysiology of this peculiar benign mimic of lymphoma.	[Takata, Katsuyoshi; Noujima-Harada, Mai; Miyata-Takata, Tomoko; Sato, Yasuharu; Gion, Yuka; Yoshino, Tadashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama, Okayama 7008558, Japan; [Okada, Hiroyuki; Iwamuro, Masaya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Okayama 7008558, Japan; [Ichimura, Koichi] Hiroshima City Hiroshima Citizens Hosp, Dept Pathol, Hiroshima, Japan; [Iwamoto, Toshiyuki] Chuden Hosp, Dept Pathol, Hiroshima, Japan; [Miyata, Takafumi] Nagoya Univ, Grad Sch Engn, Dept Computat Sci & Engn, Nagoya, Aichi 4648601, Japan; [Naruse, Keishi] Kochi Natl Hosp, Dept Pathol, Natl Hosp Org, Kochi, Japan; [Tari, Akira] Hiroshima Red Cross Hosp, Dept Gastroenterol, Hiroshima, Japan; [Tari, Akira] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Masunari, Taro] Chugoku Cent Hosp, Dept Hematol, Fukuyama, Hiroshima, Japan; [Okada, Hiroyuki] Chugoku Cent Hosp, Dept Lab Med & Pathol, Fukuyama, Hiroshima, Japan; [Mizobuchi, Kohichi] Kagawa Rosai Hosp, Dept Anat Pathol, Marugame, Japan	Takata, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	katsuyoshi.t@h5.dion.ne.jp			Japan Society for the Promotion Science (JSPS) [24790350]	Supported by a grant from the Japan Society for the Promotion Science (JSPS no. 24790350). The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.	Au WY, 2009, BLOOD, V113, P3931, DOI 10.1182/blood-2008-10-185256; Perry AM, 2013, BLOOD, V122, P3599, DOI 10.1182/blood-2013-07-512830; Hayashi E, 2013, HUM PATHOL, V44, P1927, DOI 10.1016/j.humpath.2013.03.002; Tse E, 2012, AM J HEMATOL, V87, P663, DOI 10.1002/ajh.23213; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Mansoor A, 2011, BLOOD, V117, P1447, DOI 10.1182/blood-2010-08-302737; Miyata-Takata T, 2014, LEUKEMIA LYMPHOMA, V55, P2161, DOI 10.3109/10428194.2013.871634; Swerdlow S, 2008, WHO CLASSIFICATION T; Takata K, 2015, AM J SURG PATHOL, V39, P1, DOI 10.1097/PAS.0000000000000312; Takeuchi K, 2010, BLOOD, V116, P5631, DOI 10.1182/blood-2010-06-290650; Tanaka T, 2011, PATHOL RES PRACT, V207, P786, DOI 10.1016/j.prp.2011.09.012; Terai T, 2012, WORLD J GASTROENTERO, V18, P2140, DOI 10.3748/wjg.v18.i17.2140; Win KT, 2015, APPL IMMUNOHISTO M M, DOI [10.1097/PAI.0000000000000162, DOI 10.1097/PAI.0000000000000162]; Yamamoto J, 2011, LEUKEMIA LYMPHOMA, V52, P1803, DOI 10.3109/10428194.2011.573030	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	SEP	2015	39	9					1259	1266		10.1097/PAS.0000000000000443		8	Pathology; Surgery	Pathology; Surgery	CQ4QP	WOS:000360590000012		
J	Harumi, T; Kobayashi, E; Naito, M				Harumi, Takashi; Kobayashi, Eiji; Naito, Mitsuru			Allele-specific polymerase chain reaction typing and sequencing of mitochondrial D-loop region in broiler chickens in Japan	ANIMAL SCIENCE JOURNAL			English	Article						broiler; meat discrimination; mtDNA; SNP haplotype	PRIMORDIAL GERM-CELLS; BLOOD; PCR	This study aimed to comprehend a feature of single nucleotide polymorphism (SNP) in mitochondrial DNA (mtDNA) mainly of general broiler chickens in Japan. We typed two SNP sites (199C/T and 792A/G) of the D-loop region in mtDNA by allele-specific PCR (AS-PCR) in 359 broiler (182 chunky and 177 cobb) and 506 layer (233 White Leghorn, 140 Barred Plymouth Rock and 133 Rhode Island Red) chickens. The SNP of 199C or 792A by AS-PCR was observed in the chunky and cobb chickens, and not in the layers. The haplotype 199T/792G was observed in a part of cobb and all layers. By the result of AS-PCR haplotyping and the broiler brands, the D-loop region was sequenced in 44 broiler chickens (20 chunky and 24 cobb) and compared with the layers' sequence data. Among the broiler and layer chickens, 21 SNP sites (including one insertion) and 11 sequence haplotypes were observed. Haplotype variation or correspondence was observed in and between the broiler brands. This study provides important information to establish a chicken meat traceability system by SNP haplotyping of mtDNA in Japan.	[Harumi, Takashi; Naito, Mitsuru] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Kobayashi, Eiji] NARO Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan	Harumi, T (reprint author), Natl Inst Agrobiol Sci, Anim Genome Res Unit, Ikenodai2, Tsukuba, Ibaraki 3058602, Japan.	haru90@affrc.go.jp			National Food Research Institute	The authors are grateful to Dr. M. Yamazaki, H. Ohtsu and H. Abe at NILGS for supplying samples and to the staff of the Poultry Management Section of NILGS for taking care of the chickens. This study forms a part of the Development of Evaluation and Management Methods for Supply of Safe, Reliable and Functional Food and Farm Produce. The funding was provided by the National Food Research Institute.	Choi JW, 2007, J EXP ZOOL PART A, V307A, P241, DOI 10.1002/jez.a.373; Guan X, 2007, J HERED, V98, P723, DOI 10.1093/jhered/esm094; Harumi T, 2011, ANIM SCI J, V82, P223, DOI 10.1111/j.1740-0929.2010.00831.x; Harumi Takashi, 2004, Animal Science Journal, V75, P503, DOI 10.1111/j.1740-0929.2004.00220.x; Naito M, 2007, REPRODUCTION, V134, P577, DOI 10.1530/REP-07-0134; Naito M, 2004, BRIT POULTRY SCI, V45, P762, DOI 10.1080/00071660400014325; Naito M, 2007, BRIT POULTRY SCI, V48, P121, DOI 10.1080/00071660701261294; Sano Akiko, 2005, Journal of Poultry Science, V42, P152, DOI 10.2141/jpsa.42.152	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	SEP	2015	86	9					815	817		10.1111/asj.12369		3	Agriculture, Dairy & Animal Science	Agriculture	CQ8EJ	WOS:000360839000001		
J	Hong, Y; Ardiyanti, A; Kikusato, M; Shimazu, T; Toyomizu, M; Suzuki, K				Hong, Yu; Ardiyanti, Astrid; Kikusato, Motoi; Shimazu, Tomoyuki; Toyomizu, Masaaki; Suzuki, Keiichi			Selection for high and low oxygen consumption altered hepatic mitochondrial energy efficiency in mice	ANIMAL SCIENCE JOURNAL			English	Article						mice; mitochondria; oxygen consumption; selection	FEED-INTAKE; HEAT-LOSS; CORRELATED RESPONSES; DIVERGENT SELECTION; METABOLIC-RATES; 15 GENERATIONS; LINES; SIZE; MASS	Selection for high (H) and low (L) oxygen consumption (OC) as an indirect estimation of maintenance energy requirement was determined. Feed intake and body weight were measured and feed conversion ratio (FCR) of 4-8-week-old mice was calculated. Respiratory activity of hepatic mitochondria was measured at 12 weeks. Total feed intake (H: 103.74g, L: 97.92g, P<0.01), daily feed intake (H: 3.70g/day, L: 3.50g/day, P<0.01) and FCR (H: 18.79, L: 15.50, P<0.01) were significantly different between lines. The line by sex interaction was significant for FCR. No line differences were observed in males; and the FCR of the H line was greater than in the L line in females. H line mice had the highest hepatic mitochondrial respiratory activity in state 2 (P<0.01), the highest uncoupled respiratory rate of mitochondria in the presence of an uncoupling agent (P<0.001), and the mitochondrial proton leak. The adenosine diphosphate/ O ratio was highest in the L line (P<0.05). This suggests that the selection for high and low OC induced differences in basal mitochondrial respiration and basal metabolism, resulting in difference in FCR between H and L lines.	[Hong, Yu; Ardiyanti, Astrid; Kikusato, Motoi; Shimazu, Tomoyuki; Toyomizu, Masaaki; Suzuki, Keiichi] Tohoku Univ, Grad Sch Agr Sci, Fac Agr, Sendai, Miyagi 9818555, Japan	Suzuki, K (reprint author), Tohoku Univ, Grad Sch Agr Sci, 1-1 Tsutsumidori Amemiyamachi, Sendai, Miyagi 9818555, Japan.	k1suzuki@bios.tohoku.ac.jp					Maciak S, 2014, J EVOLUTION BIOL, V27, P478, DOI 10.1111/jeb.12306; FERRELL CL, 1985, J ANIM SCI, V61, P725; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; Zhang GF, 2014, J ANIM SCI, V92, P2987, DOI 10.2527/jas.2013-7002; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Kikusato M, 2010, FEBS LETT, V584, P3143, DOI 10.1016/j.febslet.2010.05.057; Konarzewski M, 2005, INTEGR COMP BIOL, V45, P416, DOI 10.1093/icb/45.3.416; Rolfe DFS, 1997, PHYSIOL REV, V77, P731; Henderson ND, 1997, BEHAV GENET, V27, P145, DOI 10.1023/A:1025689425738; Hong Y, 2013, NIHON CHIKUSAN GAKKA, V84, P327; Japanese Ministry of Agriculture Forestry and Fisheries, 2014, PROD COST LIV PROD; Kawamoto T, 1993, NEUROSCIENCE, V19, P1; Mackay T. F. C., 1996, INTRO QUANTITATIVE G; McDonald JM, 2007, J ANIM SCI, V85, P658, DOI 10.2527/jas.2006-465; McDonald JM, 2009, J ANIM SCI, V87, P3105, DOI 10.2527/jas.2009-1935; Murphy TW, 2013, J ANIM SCI, V91, P2077, DOI 10.2527/jas.2012-5975; Newmaier A, 1998, GENET SEL EVOL, V30, P3; Nielsen MK, 1997, J ANIM SCI, V75, P1461; Nielsen MK, 1997, J ANIM SCI, V75, P1469; Satoh Masahiro, 2000, Japanese Journal of Swine Science, V37, P122	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	SEP	2015	86	9					818	825		10.1111/asj.12366		8	Agriculture, Dairy & Animal Science	Agriculture	CQ8EJ	WOS:000360839000002		
J	Win, KS; Ueda, K; Kondo, S				Win, Kyaw San; Ueda, Koichiro; Kondo, Seiji			Effects of grass hay proportion in a corn silage-based diet on rumen digesta kinetics and digestibility in dairy cows	ANIMAL SCIENCE JOURNAL			English	Article						corn silage; dairy cow; digestibility; grass hay; passage rate	SUPPLEMENTARY LONG HAY; FORAGE PARTICLE-SIZE; MILK-PRODUCTION; CHOP LENGTH; CHEWING ACTIVITY; FIBER DIGESTION; ALFALFA HAY; CATTLE; PASSAGE; SHEEP	In this study, we aimed to evaluate the effects of six levels of orchardgrass hay (GH) proportion (0%, 10%, 20%, 30%, 40% or 50% of dry matter) in finely chopped corn silage (CS)-based diets on digesta kinetics of CS and GH in the rumen. Six non-lactating, rumen-cannulated Holstein cows were used in a 6x6 Latin square design. Ruminal digesta kinetics was measured by ruminal dosing of feed particle markers (dysprosium for CS, erbium for GH) followed by fecal sampling. The increase of GH proportion had a quadratic effect (P<0.01) on total tract digestibility of neutral detergent fiber (NDF) and acid detergent fiber. The proportion of GH did not affect the particle size distribution of rumen digesta, total weight of dry matter or NDF in the rumen. The rates of large particle size reduction in the rumen for CS tended to increase linearly with increasing GH proportion (P=0.077). A quadratic effect (P<0.05) was found with increasing the GH proportion for the ruminal passage rate of small GH particles, but not for CS particles. The results suggested that associative effects between CS and GH could be generated on rumen digesta kinetics when cows were fed a CS-based diet with an increased proportion of GH.	[Win, Kyaw San; Ueda, Koichiro; Kondo, Seiji] Hokkaido Univ, Lab Anim Prod Syst, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan	Ueda, K (reprint author), Hokkaido Univ, Lab Anim Prod Syst, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan.	ueko@anim.agr.hokudai.ac.jp					ANDRIGHETTO I, 1993, J DAIRY SCI, V76, P2624; Johnson LM, 2003, J DAIRY SCI, V86, P208, DOI 10.3168/jds.S0022-0302(03)73601-7; VILES FJ, 1949, ANAL CHEM, V21, P950, DOI 10.1021/ac60032a019; Bal MA, 2000, J DAIRY SCI, V83, P1264; Couderc JJ, 2006, J DAIRY SCI, V89, P3599; SHAVER RD, 1986, J DAIRY SCI, V69, P1545; Beauchemin KA, 2003, J DAIRY SCI, V86, P630, DOI 10.3168/jds.S0022-0302(03)73641-8; ALLEN MS, 1988, J NUTR, V118, P261; AOAC, 1990, OFFICIAL METHODS ANA; BEAUCHEMIN KA, 1989, J DAIRY SCI, V72, P2288, DOI 10.3168/jds.S0022-0302(89)79360-7; BEAUCHEMIN KA, 1994, J DAIRY SCI, V77, P1326; Bhatti SA, 2008, J ANIM SCI, V86, P134, DOI 10.2527/jas.2006-693; Castro JJ, 2010, J DAIRY SCI, V93, P2143, DOI 10.3168/jds.2009-2891; FENNER H, 1966, J DAIRY SCI, V49, P1454; FISCHER JM, 1994, J DAIRY SCI, V77, P217; FLECK AT, 1988, J ANIM SCI, V66, P750; Goering HK, 1975, AGR HDB, V379; HEANEY D. P., 1963, JOUR ANIMAL SCI, V22, P752; Krause KM, 2002, J DAIRY SCI, V85, P1947, DOI 10.3168/jds.S0022-0302(02)74271-9; MADER TL, 1984, J ANIM SCI, V58, P208; MOSELEY G, 1979, BRIT J NUTR, V42, P139, DOI 10.1079/BJN19790098; Obitsu T, 2009, ANIM SCI J, V80, P546, DOI 10.1111/j.1740-0929.2009.00661.x; POND KR, 1988, BRIT J NUTR, V60, P571, DOI 10.1079/BJN19880129; Poppi DP, 2001, BRIT J NUTR, V85, P553, DOI 10.1079/BJN2001317; ROJASBOURRILLON A, 1987, J ANIM SCI, V64, P303; SAS Institute Inc, 2004, SAS STAT US GUID VER; Stone W, 2004, J DAIRY SCI, V87, P13, DOI DOI 10.3168/JDS.S0022-0302(04)70057-0; Sutherland TM, 1988, ASPECTS DIGESTIVE PH, P43; THEODOROU MK, 1994, ANIM FEED SCI TECH, V48, P185, DOI 10.1016/0377-8401(94)90171-6; Van Soest PJ, 1994, NUTR ECOLOGY RUMINAN; Varga GA, 1997, J NUTR, V127, pS819; Vranic M, 2008, LIVEST SCI, V114, P84, DOI 10.1016/j.livsci.2007.04.011; WATTIAUX MA, 1991, J DAIRY SCI, V74, P3872; West JW, 1997, J DAIRY SCI, V80, P1656; Wetherburn MW, 1967, ANAL CHEM, V36, P971; YEMM EW, 1954, BIOCHEM J, V57, P508; Wyburn RS, 1980, DIGESTIVE PHYSL META, P35	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	SEP	2015	86	9					833	841		10.1111/asj.12365		9	Agriculture, Dairy & Animal Science	Agriculture	CQ8EJ	WOS:000360839000004		
J	Napasirth, V; Napasirth, P; Sulinthone, T; Phommachanh, K; Cai, YM				Napasirth, Viengsakoun; Napasirth, Pattaya; Sulinthone, Tue; Phommachanh, Kham; Cai, Yimin			Microbial population, chemical composition and silage fermentation of cassava residues	ANIMAL SCIENCE JOURNAL			English	Article						cassava residues; fermentation quality; silage	LACTIC-ACID BACTERIA; MIXED RATION SILAGE; FORAGE CROPS; ALFALFA; DIGESTION; CORN	In order to effectively use the cassava (Manihot esculentaCrantz) residues, including cassava leaves, peel and pulp for livestock diets, the chemical and microbiological composition, silage preparation and the effects of lactic acid bacteria (LAB) inoculants on silage fermentation of cassava residues were studied. These residues contained 10(4) to 10(5) LAB and yeasts, 10(3) to 10(4) coliform bacteria and 10(4) aerobic bacteria in colony forming units (cfu) on a fresh matter (FM) basis. The molds were consistently at or below the detectable level (10(2) cfu of FM) in three kinds of cassava residues. Dry matter (DM), crude protein (CP) and neutral detergent fiber (NDF) content of cassava residues were 17.50-30.95%, 1.30-16.41% and 25.40-52.90% on a DM basis, respectively. The silage treatments were designed as control silage without additive (CO) or with LAB inoculants Chikuso-1 (CH, Lactobacillus plantarum) and Snow Lacto (SN, Lactobacillus rhamnosus) at a rate of 5mg/kg of FM basis. All silages were well preserved with a low pH (below 4.0) value and when cassava residues silage treated with inoculants CH and SN improved fermentation quality with a lower pH, butyric acid and higher lactic acid than control silage.	[Napasirth, Viengsakoun; Sulinthone, Tue; Phommachanh, Kham] Natl Univ Laos NUOL, Fac Agr FOA, Dept Livestock & Fisheries, Viangchan, Laos; [Napasirth, Pattaya] Udon Thani Rajabhat Univ, Fac Technol, Udon Thani, Thailand; [Cai, Yimin] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki, Japan; [Cai, Yimin] Japan Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan	Cai, YM (reprint author), Japan Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan.	cai@affrc.go.jp			project of Establishment of a Sustainable and Independent Farm Household Economy from in the Rural Areas of Indo-China from Japan International Research Center for Agricultural Sciences (JIRCAS)	This work was supported by the project of Establishment of a Sustainable and Independent Farm Household Economy from in the Rural Areas of Indo-China from Japan International Research Center for Agricultural Sciences (JIRCAS). We thank the Indo-China Group Co., Ltd, Lao PDR for providing the cassava residues samples, Hideyuki Ohmori (National Institute of Livestock and Grassland Science) and Yang Cao (Heilongjiang Bayi Agricultural University) for their advice in silage quality and statistical analysis.	Russell JB, 1996, J DAIRY SCI, V79, P1503; Cai YM, 1999, J DAIRY SCI, V82, P520; RODHE H, 1990, SCIENCE, V248, P1217, DOI 10.1126/science.248.4960.1217; AOAC, 1990, OFFICIAL METHODS ANA; Cai YM, 1998, APPL ENVIRON MICROB, V64, P2982; Cao Y, 2011, ANIM SCI J, V82, P259, DOI 10.1111/j.1740-0929.2010.00840.x; Cao Y, 2010, GRASSL SCI, V56, P19, DOI 10.1111/j.1744-697X.2009.00168.x; Champawadee S, 2009, PAKISTAN J NUTR, V8, P1380; Department of Agriculture (DOA), 2012, CROP STAT YEAR BOOK; Imai A, 2000, JAPANESE J GRASSLAND, V47, P307; LIN C, 1992, J DAIRY SCI, V75, P2484, DOI 10.3168/jds.S0022-0302(92)78010-2; LIN CJ, 1992, J APPL BACTERIOL, V73, P375, DOI 10.1111/j.1365-2672.1992.tb04992.x; MUCK RE, 1989, GRASS FORAGE SCI, V44, P19, DOI 10.1111/j.1365-2494.1989.tb01905.x; Pang HL, 2011, SYST APPL MICROBIOL, V34, P235, DOI 10.1016/j.syapm.2010.10.003; Phengsavanh P, 2010, TROP ANIM HEALTH PRO, V42, P1627, DOI 10.1007/s11250-010-9612-4; Phengvichith V, 2007, SMALL RUMINANT RES, V71, P109, DOI 10.1016/j.smallrumres.2006.05.009; Ruppert LD, 2003, J DAIRY SCI, V86, P593, DOI 10.3168/jds.S0022-0302(03)73638-8; Steel R.G., 1980, PRINCIPLES PROCEDURE; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583; Wanapat M, 1999, P FEED RUM TROP BAS, P191	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	SEP	2015	86	9					842	848		10.1111/asj.12362		7	Agriculture, Dairy & Animal Science	Agriculture	CQ8EJ	WOS:000360839000005		
J	Abrar, A; Tsukahara, T; Kondo, M; Ban-Tokuda, T; Chao, W; Matsui, H				Abrar, Arfan; Tsukahara, Takamitsu; Kondo, Makoto; Ban-Tokuda, Tomomi; Chao, Wang; Matsui, Hiroki			Effect of monensin withdrawal on rumen fermentation, methanogenesis and microbial populations in cattle	ANIMAL SCIENCE JOURNAL			English	Article						methanogenesis; methanogens; monensin; ruminal fermentation	NUTRIENT UTILIZATION; METHANE EMISSIONS; SUPPLEMENTATION; MITIGATION; RUMINANTS; DIVERSITY; DIETS; ACID; TERM	This study was designed to obtain information on the residual influence of dietary monensin on ruminant fermentation, methanogenesis and bacterial population. Three ruminally cannulated crossbreed heifers (14 months old, 363 +/- 11kg) were fed Italian ryegrass straw and concentrate supplemented with monensin for 21 days before sampling. Rumen fluid samples were collected for analysis of short chain fatty acid (SCFA) profiles, monensin concentration, methanogens and rumen bacterial density. Post-feeding rumen fluid was also collected to determine in vitro gas production. Monensin was eliminated from the rumen fluid within 3 days. The composition of SCFA varied after elimination of monensin, while total production of SCFA was 1.78 times higher than on the first day. Methane production increased 7 days after monensin administration ceased, whereas hydrogen production decreased. The methanogens and rumen bacterial copy numbers were unaffected by the withdrawal of monensin.	[Abrar, Arfan; Kondo, Makoto; Ban-Tokuda, Tomomi; Chao, Wang; Matsui, Hiroki] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Tsukahara, Takamitsu] Kyoto Inst Nutr & Pathol, Kyoto, Japan	Matsui, H (reprint author), Mie Univ, Grad Sch Bioresources, 1577 Kurimamachiya Cho, Tsu, Mie 5148507, Japan.	matsui@bio.mie-u.ac.jp			Japan Society for the Promotion of Science [25450393]	A part of this study was financially supported by Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science (25450393). Real-time PCR was carried out at The Life Science Research Center (Center for Molecular Biology and Genetics), Mie University (Tsu, Japan). The authors are grateful to Ms. Noriko Matsukawa at Kyoto Institute of Nutrition and Pathology for technical assistance with monensin detection by LC-MS/MS.	Aderinboye RY, 2012, TROP ANIM HEALTH PRO, V44, P1079, DOI 10.1007/s11250-011-0043-7; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; HUNGATE RE, 1967, ARCH MIKROBIOL, V59, P158, DOI 10.1007/BF00406327; Watanabe Y, 2010, J DAIRY SCI, V93, P5258, DOI 10.3168/jds.2009-2754; MCDOUGALL EI, 1948, BIOCHEM J, V43, P99; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; McGinn SM, 2004, J ANIM SCI, V82, P3346; Kobayashi Y, 2010, ASIAN AUSTRAL J ANIM, V23, P410; Guan H, 2006, J ANIM SCI, V84, P1896, DOI 10.2527/jas.2005-652; Takahashi J, 2005, ASIAN AUSTRAL J ANIM, V18, P1199; Russell JB, 2003, FEMS MICROBIOL REV, V27, P65, DOI 10.1016/S0168-6445(03)00019-6; Castro-Montoya J, 2012, ANIM FEED SCI TECH, V176, P47, DOI 10.1016/j.anifeedsci.2012.07.007; Cooprider EKL, 2011, J ANIM SCI, V89, P2643; Grainger C, 2010, J DAIRY SCI, V93, P5300, DOI 10.3168/jds.2010-3154; Hook SE, 2009, APPL ENVIRON MICROB, V75, P374, DOI 10.1128/AEM.01672-08; KOBAYASHI Y, 1988, NUTR REP INT, V38, P987; KONE P, 1989, J DAIRY SCI, V72, P2767, DOI 10.3168/jds.S0022-0302(89)79420-0; Lwin KO, 2012, ANIM SCI J, V83, P767, DOI 10.1111/j.1740-0929.2012.01031.x; Matsui H, 2013, GRASSL SCI, V59, P129, DOI 10.1111/grs.12023; Rogers M, 1997, ANIM FEED SCI TECH, V65, P113, DOI 10.1016/S0377-8401(96)01089-9; SCHELLING GT, 1984, J ANIM SCI, V58, P1518; Uddin MK, 2010, J FOOD AGRIC ENVIRON, V8, P282; WALLACE RJ, 1980, APPL ENVIRON MICROB, V40, P672; Weimer PJ, 2008, APPL MICROBIOL BIOT, V80, P135, DOI 10.1007/s00253-008-1528-9	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	SEP	2015	86	9					849	854		10.1111/asj.12368		6	Agriculture, Dairy & Animal Science	Agriculture	CQ8EJ	WOS:000360839000006		
J	Yamaguchi, S; Sato, E; Oda, Y; Nakamura, R; Oikawa, H; Yabuushi, T; Ariga, H; Ehara, S				Yamaguchi, Satoshi; Sato, Eiichi; Oda, Yasuyuki; Nakamura, Ryuji; Oikawa, Hiroburni; Yabuushi, Tomonori; Ariga, Hisanori; Ehara, Shigeru			Measurement of X-ray spectra using a Lu-2(SiO4)O-multipixel-photon detector with changes in the pixel number	APPLIED RADIATION AND ISOTOPES			English	Article						LSO-MPPC detector; 200-ns-width event pulse; X-ray spectra; Pre-Geiger mode; High-speed amplifier; Energy resolution	COMPUTED-TOMOGRAPHY SYSTEM	To measure X-ray spectra with high count rates, we developed a detector consisting of a Lu-2(SiO4)O [LSO] crystal with a decay time of 40 ns and a multipixel photon counter (MPPC). The photocurrents flowing through the MPPC are converted into voltages and amplified by a high-speed current-voltage amplifier, and event pulses from the amplifier are sent to a multichannel analyzer to measure spectra. We used three MPPCs of 100, 400 and 1600 pixels/mm(2), and the MPPCs were driven under pre-Geiger mode at a temperature of 20 degrees C. At a tube voltage of 100 kV and a tube current of 5.0 mu A, the maximum count rate was 12.8 kilo-counts per second. The event-pulse widths were 200 ns, and the energy resolution was 53% at 59.5 key using a 100-pixel MPPC. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamaguchi, Satoshi; Nakamura, Ryuji; Oikawa, Hiroburni; Yabuushi, Tomonori; Ariga, Hisanori; Ehara, Shigeru] Iwate Med Univ, Sch Med, Dept Radiol, Morioka, Iwate 0200023, Japan; [Sato, Eiichi; Oda, Yasuyuki] Iwate Med Univ, Dept Phys, Yahaba, Iwate 0283694, Japan	Yamaguchi, S (reprint author), Iwate Med Univ, Sch Med, Dept Radiol, 19-1 Uchimaru, Morioka, Iwate 0200023, Japan.	dresato@iwate-med.ac.jp			Keiryo Research Foundation; Promotion and Mutual Aid Corporation for Private Schools of Japan; Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT	This work was supported by Grants from Keiryo Research Foundation, Promotion and Mutual Aid Corporation for Private Schools of Japan, Japan Science and Technology Agency (JST), and Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). This was also supported by a Grant-in-Aid for Strategic Medical Science Research Center from MEXT, 2009-2013 and 2014-2018.	Sato E, 2012, APPL RADIAT ISOTOPES, V70, P831, DOI 10.1016/j.apradiso.2012.02.007; Sato E, 2012, APPL RADIAT ISOTOPES, V70, P336, DOI 10.1016/j.apradiso.2011.07.002; Feuerlein S, 2008, RADIOLOGY, V249, P1010, DOI 10.1148/radiol.2492080560; Oda Y, 2011, NUCL INSTRUM METH A, V643, P69, DOI 10.1016/j.nima.2011.04.001; Wang XL, 2011, MED PHYS, V38, P1534, DOI 10.1118/1.3553401; Matsukiyo H, 2011, NUCL INSTRUM METH A, V632, P142, DOI 10.1016/j.nima.2010.12.211; Hagiwara O., 2014, JPN J APPL PHYS, V53; Kami S, 2014, RADIAT PHYS CHEM, V100, P1, DOI 10.1016/j.radphyschem.2014.02.016; Maeda T., 2012, J MED IMAG RAD SCI, V43, P149; Shimamura A., 2014, MED IMAG INFORM SCI, V31, P35; Simpson PJ, 2003, NUCL INSTRUM METH A, V505, P82, DOI 10.1016/S0168-9002(03)01025-8; Sugimura S, 2011, NUCL INSTRUM METH A, V654, P314, DOI 10.1016/j.nima.2011.06.094	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-8043			APPL RADIAT ISOTOPES	Appl. Radiat. Isot.	SEP	2015	103						25	30		10.1016/j.apradiso.2015.05.012		6	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CQ3PE	WOS:000360513900004		
J	Kobuke, S; Suzuki, S; Hoshino, H; Haruyama, N; Nishimura, F; Shiba, H				Kobuke, Seiji; Suzuki, Shigeki; Hoshino, Hiroaki; Haruyama, Naoto; Nishimura, Fusanori; Shiba, Hideki			Relationship between length variations in Ser/Asp-rich repeats in phosphophoryn and in vitro precipitation of calcium phosphate	ARCHIVES OF ORAL BIOLOGY			English	Article						Phosphophoryn (PP); In vitro gel diffusion system; Serine/aspartic acid-rich repeats (SDrr); Recombinant protein preparation	DENTIN SIALOPHOSPHOPROTEIN DSPP; HYDROXYAPATITE FORMATION; PHOSPHOPROTEIN; MINERALIZATION; MUTATIONS; GEL; PHOSPHORYLATION; COLLAGEN; INVITRO; GROWTH	Objective: Phosphophoryn (PP) is generated from the proteolytic cleavage of dentin sialophosphoprotein (DSPP). PP which contains tandem serine/asparatic acid rich repeats (SDrr) is known to enhance dentin mineralization. The nucleotide sequences coding SDrr are identified in the DSPP genes of toothed animals and the length variations of SDrr between intra- and inter-species have been reported. However, it remains unknown about the relationship between the length variations in SDrr and the functions of PP in matrix mineralization. Design: By utilizing a mammalian expression system, we generated several recombinant PP proteins (rPP) containing SDrr of different lengths and analyzed their effects on the precipitation of calcium phosphate with an in vitro gel diffusion system. Results: rPP-Delta 37.6 SDrr and rPP-Delta 63.5 SDrr, which possessed shortened SDrr that accounted for 62.4 and 36.5% the length of SDrr in full-length rPP (rPP-full), respectively, induced the precipitation of calcium phosphate similar to that of rPP-full at the same molar concentration, whereas rPP-Delta SDrr, in which SDrr were flipped, did not. Furthermore, rPP-Delta 63.5 SDrr significantly increased the accumulation of calcium compared with rPP-full at adjusted concentrations so that the same amounts of SDrr were embedded. The results of an ELISA analysis indicated that the amounts of rPP-Delta 37.6 SDrr and rPP-Delta 63.5 SDrr secreted from transfected cells were 5.2- and 7.1-fold greater than that of rPP-full, respectively. Conclusions: The generated rPP-Delta 63.5 SDrr which can be substituted for rPP-full may be a candidate for a therapeutic molecule to facilitate hard tissue generation such as reparative dentin formation. (C) 2015 Elsevier Ltd. All rights reserved.	[Kobuke, Seiji; Suzuki, Shigeki; Hoshino, Hiroaki; Shiba, Hideki] Hiroshima Univ, Dept Biol Endodont, Integrated Hlth Sci, Inst Biomed & Hlth Sci, Hiroshima 7348553, Japan; [Haruyama, Naoto] Kyushu Univ, Fac Dent Sci, Sect Orthodont & Dentofacial Orthoped, Fukuoka 8125852, Japan; [Nishimura, Fusanori] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Periodontol, Fukuoka 8125852, Japan	Suzuki, S (reprint author), Hiroshima Univ, Dept Dent Sci Hlth Promot, Integrated Hlth Sci, Inst Biomed & Hlth Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	suzukis@hiroshima-u.ac.jp			JSPS [22792040, 23792176, 26861595]; JST [A-STEPAS231Z05041F]	We thank Dr. Yoshihiko Yamada for providing us with the pCEP4-Mul-PURD expression vector. This work was supported by JSPS KAKENHI 22792040, 23792176, and 26861595 and by JST A-STEPAS231Z05041F.	Hart PS, 2007, CELLS TISSUES ORGANS, V186, P70, DOI 10.1159/000102682; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Tsuchiya S, 2011, J BONE MINER RES, V26, P220, DOI 10.1002/jbmr.202; Suzuki S, 2010, BIOCHEM BIOPH RES CO, V398, P525, DOI 10.1016/j.bbrc.2010.06.112; Suzuki S, 2012, ARCH ORAL BIOL, V57, P1165, DOI 10.1016/j.archoralbio.2012.03.005; Verdelis K, 2008, BONE, V43, P983, DOI 10.1016/j.bone.2008.08.110; Kim JW, 2007, J DENT RES, V86, P392; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Fisher LW, 2011, CELLS TISSUES ORGANS, V194, P113, DOI 10.1159/000324254; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; BOSKEY AL, 1989, J PHYS CHEM-US, V93, P1628, DOI 10.1021/j100341a086; Dorvee JR, 2012, CRYSTENGCOMM, V14, P5681, DOI 10.1039/c2ce25289a; FUJISAWA R, 1987, CALCIFIED TISSUE INT, V41, P44, DOI 10.1007/BF02555130; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Jonsson M, 1978, J CHROMATOGR, V21, P234; McKnight DA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-299; McKnight DA, 2008, HUM MUTAT, V29, P1392, DOI 10.1002/humu.20783; Milan AM, 2006, EUR J ORAL SCI, V114, P223, DOI 10.1111/j.1600-0722.2006.00347.x; Nieminen P, 2011, J BONE MINER RES, V26, P873, DOI 10.1002/jbmr.276; STETLERSTEVENSON WG, 1987, CALCIFIED TISSUE INT, V40, P97, DOI 10.1007/BF02555712; Suzuki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112490; Villarreal-Ramirez E, 2014, CONNECT TISSUE RES, V55, P134, DOI 10.3109/03008207.2014.923870; Yamakoshi Y, 2008, J BIOL CHEM, V283, P14835, DOI 10.1074/jbc.M800633200; Yamakoshi Y, 2009, J ORAL BIOSCI, V51, P134; ZANETTI M, 1981, EUR J BIOCHEM, V113, P541, DOI 10.1111/j.1432-1033.1981.tb05096.x	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	SEP	2015	60	9					1263	1272		10.1016/j.archoralbio.2015.05.013		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ3OK	WOS:000360511700011		
J	Yamashita, Y; Ukai, T; Nakamura, H; Yoshinaga, Y; Kobayashi, H; Takamori, Y; Noguchi, S; Yoshimura, A; Hara, Y				Yamashita, Yasunori; Ukai, Takashi; Nakamura, Hirotaka; Yoshinaga, Yasunori; Kobayashi, Hiroki; Takamori, Yuzo; Noguchi, Satoshi; Yoshimura, Atsutoshi; Hara, Yoshitaka			RANKL pretreatment plays an important role in the differentiation of pit-forming osteoclasts induced by TNF-alpha on murine bone marrow macrophages	ARCHIVES OF ORAL BIOLOGY			English	Article						Receptor activator of NF-kappa B ligand; Tumour necrosis factor-alpha; Osteoclast; Resorbing activity	NECROSIS-FACTOR-ALPHA; CELL-CELL FUSION; RHEUMATOID-ARTHRITIS; TYPE-1 RECEPTOR; IN-VIVO; PRECURSORS; RESORPTION; IDENTIFICATION; ACTIVATION; LIPOPOLYSACCHARIDE	Background: Osteoclasts differentiated from bone marrow macrophages (BMMs) induced by TNF-alpha alone do not have resorbing activity. When BMMs are stimulated with receptor activator of NF-kappa B ligand (RANKL) before TNF-alpha stimulation, pit-forming osteoclasts are differentiated. However, the details of the effect of RANKL pretreatment on the pit-forming osteoclast differentiation by TNF-alpha have not been established. The aim of this study is to examine the condition of RANKL pretreatment for differentiation of pit-forming osteoclasts induced by TNF-alpha. Murine BMMs were stimulated with various concentrations of RANKL for 24 h in the presence of M-CSF, then the medium was changed and TNF-alpha was added. Osteoclasts and pits formation were examined. Osteoprotegerin (OPG), decoy receptor of RANKL, was added to the culture to examine the necessity of co-existing RANKL with TNF-alpha on the formation of pit-forming osteoclasts. To investigate the influence of RANKL of sufficient concentration as pretreatment for pit-forming osteoclast formation by TNF-alpha, dose- and time-dependent changes of osteoclast formation were checked. Results: The pit formation by osteoclasts in response to TNF-alpha required 10 ng/mL RANKL pretreatment. Stimulation with this concentration of RANKL led to the differentiation of mature osteoclasts in the 72 h culture. The pit formation was not inhibited by the OPG. Conclusion: These results suggested that the concentration of RANKL pretreatment, which also alone can differentiate BMMs into osteoclasts, may be important in the differentiation of pit-forming osteoclasts by TNF-alpha. In addition, the effects of TNF-alpha after RANKL treatment might be independent of RANKL. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamashita, Yasunori; Ukai, Takashi; Nakamura, Hirotaka; Yoshinaga, Yasunori; Kobayashi, Hiroki; Takamori, Yuzo; Noguchi, Satoshi; Yoshimura, Atsutoshi; Hara, Yoshitaka] Nagasaki Univ, Dept Periodontol, Grad Sch Biomed Sci, Nagasaki 8528588, Japan	Ukai, T (reprint author), Nagasaki Univ, Dept Periodontol, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	ukai@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [25463220]	This study was supported by Grants-in-Aid for Scientific Research (25463220) from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan.	Abbas S, 2003, CYTOKINE, V22, P33, DOI 10.1016/S1043-4666(03)00106-6; Ochi S, 2007, P NATL ACAD SCI USA, V104, P11394, DOI 10.1073/pnas.0701971104; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Miyasaka N, 2008, MOD RHEUMATOL, V18, P252, DOI 10.1007/s10165-008-0045-0; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Kanazawa K, 2003, J BONE MINER RES, V18, P443, DOI 10.1359/jbmr.2003.18.3.443; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Takami M, 2002, J IMMUNOL, V169, P1516; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Vaananen HK, 2000, J CELL SCI, V113, P377; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Ozaki Y, 2009, BONE, V44, P1169, DOI 10.1016/j.bone.2009.01.375; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Westhovens R, 2006, ARTHRITIS RHEUM, V54, P1075, DOI 10.1002/art.21734; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Hotokezaka H, 2007, J CELL BIOCHEM, V101, P122, DOI 10.1002/jcb.21167; Kitaura H, 2004, J IMMUNOL, V173, P4838; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101; Nilsson M, 2008, J PERIODONTOL, V79, P1689, DOI 10.1902/jop.2008.070599 ; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Jimi E, 1999, J IMMUNOL, V163, P434; Poblenz AT, 2007, BIOCHEM BIOPH RES CO, V359, P510, DOI 10.1016/j.bbrc.2007.05.151; Zhang YH, 2001, J BIOL CHEM, V276, P563; Mochizuki A, 2006, J IMMUNOL, V177, P4360; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Muto A, 2011, J BONE MINER RES, V26, P2978, DOI 10.1002/jbmr.490; Boyce Brendan F., 2005, Keio Journal of Medicine, V54, P127, DOI 10.2302/kjm.54.127; Hu MI, 2013, JNCI-J NATL CANCER I, V105, P1417, DOI 10.1093/jnci/djt225; Kadono Y, 2005, EMBO REP, V6, P171, DOI 10.1038/sj.embor.7400345; Kanazawa K, 2005, J BONE MINER RES, V20, P840, DOI 10.1359/JBMR.041225; Stolina M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2879; Yen ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038048	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	SEP	2015	60	9					1273	1282		10.1016/j.archoralbio.2015.06.002		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ3OK	WOS:000360511700012		
J	Yoshikawa, Y; Yoshizawa, T; Domae, E; Hieda, Y; Takeyama, A; Hirota, S; Kawamoto, A; Goda, S; Tamura, I; Kamada, A; Komasa, Y; Morita, S; Yamagata, K; Ikeo, T				Yoshikawa, Yoshihiro; Yoshizawa, Tatsuya; Domae, Eisuke; Hieda, Yohki; Takeyama, Akira; Hirota, Shuitsu; Kawamoto, Akiyo; Goda, Seiji; Tamura, Isao; Kamada, Aiko; Komasa, Yutaka; Morita, Shosuke; Yamagata, Kazuya; Ikeo, Takashi			RNA interference-mediated knockdown of Smad1 inhibits receptor activator of nuclear factor kappa B ligand expression induced by BMP-2 in primary osteoblasts	ARCHIVES OF ORAL BIOLOGY			English	Article						Osteoclast; Osteoblast; Bone morphogenetic protein-2; Receptor activator of nuclear factor kappa B ligand; Vitamin D receptor; Smad1	BONE MORPHOGENETIC PROTEIN-2; OSTEOCLAST DIFFERENTIATION FACTOR; 1,25-DIHYDROXYVITAMIN D-3; MICROENVIRONMENT; RESORPTION; CELLS	Objective: BMP-2 induces osteoblast differentiation and activates osteoclast formation. Here, we investigated the role of Smad1, a molecule that signals downstream of BMP-2, in mediating the effects of BMP-2 on osteoclast differentiation induced by 1,25-dihydroxyvitamin D3 (1,25(OH)(2)D-3) in osteoblasts. Design: The effects of 1,25(OH)(2)D-3 and BMP-2 in osteoclasts were examined using polymerase chain reaction and Western blotting to measure changes in target gene and protein expression. Immunostaining was carried out to investigate the localization of the vitamin D receptor (VDR) in the nucleus in response to BMP-2. Results: Stimulation with both 1,25(OH)(2)D-3 and BMP-2 resulted in significantly greater osteoclast formation and receptor activator of nuclear factor kappa B ligand (RANKL) mRNA expression compared to stimulation with 1,25(OH)(2)D-3 alone. In addition, expression of the VDR protein was increased, enhancing the activity of 1,25(OH)(2)D-3. Interestingly, knockdown of Smad1 resulted in reduced osteoclast formation, RANKL mRNA expression, and VDR protein expression compared with control cells. Costimulation with 1,25(OH)(2)D-3 and BMP-2 enhanced VDR localization in the nucleus. Conclusions: We found that BMP-2 induced Smad1 activation, thereby influencing the localization of VDR in the nucleus in the presence of 1,25(OH)(2)D-3 and resulting in increased RANKL mRNA expression. These effects ultimately resulted in enhanced osteoclast differentiation. (C) 2015 Elsevier Ltd. All rights reserved.	[Yoshikawa, Yoshihiro; Domae, Eisuke; Goda, Seiji; Tamura, Isao; Kamada, Aiko; Ikeo, Takashi] Osaka Dent Univ, Dept Biochem, Hirakata, Osaka 5731121, Japan; [Yoshizawa, Tatsuya; Yamagata, Kazuya] Kumamoto Univ, Dept Med Biochem, Fac Life Sci, Kumamoto 8608556, Japan; [Hieda, Yohki] SofSera, Osaka 5941157, Japan; [Takeyama, Akira; Morita, Shosuke] Osaka Dent Univ, Dept Oral & Maxillofacial Surg 1, Hirakata, Osaka 5731121, Japan; [Hirota, Shuitsu; Kawamoto, Akiyo; Komasa, Yutaka] Osaka Dent Univ, Dept Geriatr Dent, Hirakata, Osaka 5731121, Japan	Yoshikawa, Y (reprint author), Osaka Dent Univ, Dept Biochem, 8-1 Kuzuhahanazonocho, Hirakata, Osaka 5731121, Japan.	y-yoshi@cc.osaka-dent.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23792531]	This study was partially supported by a FY2011 Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant number: 23792531).	URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; KANATANI M, 1995, J BONE MINER RES, V10, P1681; Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656; Kim YJ, 2014, J ORAL MAXIL SURG, V72, P1281, DOI 10.1016/j.joms.2014.01.022; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Tsukii K, 1998, BIOCHEM BIOPH RES CO, V246, P337, DOI 10.1006/bbrc.1998.8610; Kim S, 2007, J STEROID BIOCHEM, V103, P430, DOI 10.1016/j.jsbmb.2006.12.020; Kitazawa R, 2002, BIOCHEM BIOPH RES CO, V290, P650, DOI 10.1006/bbrc.2001.6251; Lee SY, 2014, CELL TISSUE RES, V357, P119, DOI 10.1007/s00441-014-1831-y; Reddi A. Hari, 1997, Cytokine and Growth Factor Reviews, V8, P11, DOI 10.1016/S1359-6101(96)00049-4; Tachi K, 2010, CELL TISSUE RES, V342, P213, DOI 10.1007/s00441-010-1052-y; Wutzl A, 2010, J ORTHOP RES, V28, P1431, DOI 10.1002/jor.21144; Yang GB, 2014, J CELL PHYSIOL, V229, P943, DOI 10.1002/jcp.24525; Zanello LP, 2004, P NATL ACAD SCI USA, V101, P1589, DOI 10.1073/pnas.0305802101	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	SEP	2015	60	9					1319	1326		10.1016/j.archoralbio.2015.06.001		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ3OK	WOS:000360511700016		
J	Wignaraja, G; Morgan, P; Plummer, MG; Zhai, F				Wignaraja, Ganeshan; Morgan, Peter; Plummer, Michael G.; Zhai, Fan			Economic Implications of Deeper South Asian-Southeast Asian Integration: ACGE Approach	ASIAN ECONOMIC PAPERS			English	Article							EAST-ASIA	Using a computable general equilibrium model, this paper estimates the potential gains from deepening integration across South Asia and Southeast Asia. If the two regions succeed in dropping inter-regional tariffs, reducing non-tariff barriers by 50 percent, and decreasing inter-regional trade costs by 15 percent-which the paper suggests are ambitious but nevertheless attainable-welfare in South Asia and Southeast Asia would rise by 8.9 percent and 6.4 percent of GDP, respectively, by 2030. Hence, we conclude that deepening South Asian regional cooperation together with building links to Southeast Asia would pay off rich dividends.	[Wignaraja, Ganeshan] ADB, Econ Res & Reg Cooperat Dept, Mandaluyong City 1550, Metro Manila, Philippines; [Morgan, Peter] ADB Inst, Chiyoda Ku, Tokyo 1006008, Japan; [Plummer, Michael G.] Johns Hopkins Univ, SAIS, I-40126 Bologna, Italy; [Zhai, Fan] Chinese Investment Corp, Dept Asset Allocat & Strateg Res, Beijing 100010, Peoples R China	Wignaraja, G (reprint author), ADB, Econ Res & Reg Cooperat Dept, 6 ADB Ave, Mandaluyong City 1550, Metro Manila, Philippines.	mplummer@johnshopkins.it					ADB/ADBI, 2015, CONN S AS SE AS; Petri PA, 2012, ASIAN ECON J, V26, P93, DOI 10.1111/j.1467-8381.2012.02079.x; Athukorala PC, 2011, ASIAN ECON PAP, V10, P65, DOI 10.1162/ASEP_a_00045; Bandara JS, 2003, WORLD ECON, V26, P1293, DOI 10.1046/j.1467-9701.2003.00574.x; Chia Siow Yue, 2007, ASIAN ECON PAP, V6, P1, DOI 10.1162/asep.2007.6.3.1; Chia SY, 2013, ASIAN ECON PAP, V12, P1; De Dios Lorelei, 2006, 06001A REPSF; Economic Research Institute for ASEAN and East Asia (ERIA), 2010, 200971 ERIA; Frankel Jeffrey, 1997, REGIONAL TRADING BLO; Ghani Ejaz, 2010, PAKISTAN DEV REV, V49, P105; Kumagai S, 2013, ECON MODEL, V34, P145, DOI 10.1016/j.econmod.2013.03.021; Mohanty S. K., 2007, 26 RIS; Pitigala Nihal, 2012, EC REFORM PROCESSES, P23; Plummer M. G., 2009, REALIZING ASEAN EC C; Rana Pradumna, 2009, PAN ASIAN INTEGRATIO, P1; Shepherd Ben, 2008, 4615 WORLD BANK; Weerakoon D, 2010, WORLD ECON, V33, P916, DOI 10.1111/j.1467-9701.2009.01246.x; Wignaraja Ganeshan, 2008, GLOBAL EC J, V8, P1; Zhai Fan, 2008, Journal of Economic Integration, V23, P575	19	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	1535-3516	1536-0083		ASIAN ECON PAP	Asian Econ. Pap.	FAL	2015	14	3					63	81		10.1162/ASEP_a_00376		19	Economics	Business & Economics	CQ5RT	WOS:000360664000008		
J	Young, SAM; Aitken, J; Baker, MA				Young, Samantha A. M.; Aitken, John; Baker, Mark A.			Phosphorylation of Izumo1 and its role in male infertility	ASIAN JOURNAL OF ANDROLOGY			English	Review						epididymis; Izumo1; LC-MS; phosphorylation; proteomics	SUPERFAMILY PROTEIN IZUMO; SPERM-EGG FUSION; PHOSPHOPEPTIDE CHANGES; MOUSE SPERM; FERTILIZATION; CAPACITATION; SPERMATOZOA; IDENTIFICATION; JUNO; PKA	Izumo1 is a testis-specific gene product, whose function is essential for sperm-egg fusion. Throughout its lifespan, Izumo1 is posttranslationally modified, being both N-linked glycosylated on its extracellular domain and phosphorylated on the intracellular C-terminal tail. Within the caput regions of the rat epididymis, two phosphorylation events have been documented. However, as sperm pass through the epididymis, this cytoplasmic portion of Izumo1 has been shown to contain up to seven phosphorylation sites. Remarkably, in the rat, in correlation with these events, Izumo1 undergoes sub-cellular re-location, moving from the head/tail regions of the spermatozoa, to a predominantly equatorial segment location once they have reached the caudal end of the epididymis.	[Young, Samantha A. M.; Aitken, John; Baker, Mark A.] Univ Newcastle, Fac Sci & IT, Discipline Biol Sci, Prior Res Ctr Reprod Sci, Callaghan, NSW 2308, Australia; [Young, Samantha A. M.] Osaka Univ, Microbial Dis Res Inst, Anim Resource Ctr Infect Dis, Suita, Osaka 565, Japan	Baker, MA (reprint author), Univ Newcastle, Fac Sci & IT, Discipline Biol Sci, Prior Res Ctr Reprod Sci, Callaghan, NSW 2308, Australia.	mark.baker@newcastle.edu.au					Baker MA, 2005, PROTEOMICS, V5, P1003, DOI 10.1002/pmic.200401100; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Inoue N, 2008, BIOCHEM BIOPH RES CO, V377, P910, DOI 10.1016/j.bbrc.2008.10.073; Baker MA, 2012, J PROTEOME RES, V11, P5252, DOI 10.1021/pr300468m; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Inoue N, 2013, DEVELOPMENT, V140, P3221, DOI 10.1242/dev.094854; McLachlan RI, 2001, MED J AUSTRALIA, V174, P116; HULL MGR, 1985, BRIT MED J, V291, P1693; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Baker MA, 2010, J PROTEOME RES, V9, P718, DOI 10.1021/pr900513d; Bianchi E, 2014, CELL CYCLE, V13, P2019, DOI 10.4161/cc.29461; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Baker MA, 2009, DEV BIOL, V333, P57, DOI 10.1016/j.ydbio.2009.06.022; Baker MA, 2011, J PROTEOME RES, V10, P1004, DOI 10.1021/pr1007224; Hayasaka S, 2007, FERTIL STERIL, V88, P214, DOI 10.1016/j.fertnstert.2006.11.086; MULLER CH, 1992, J ANDROL, V13, P349; OKABE M, 1988, J REPROD IMMUNOL, V13, P211, DOI 10.1016/0165-0378(88)90002-2; Sosnik J, 2009, J CELL SCI, V122, P2741, DOI 10.1242/jcs.047225; Xing WJ, 2011, MOL BIOL REP, V38, P1995, DOI 10.1007/s11033-010-0322-9	23	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1008-682X	1745-7262		ASIAN J ANDROL	Asian J. Androl.	SEP-OCT	2015	17	5					708	710		10.4103/1008-682X.156119		3	Andrology; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	CQ5FN	WOS:000360628800005		
J	Murashima, A; Xu, BF; Hinton, BT				Murashima, Aki; Xu, Bingfang; Hinton, Barry T.			Understanding normal and abnormal development of the Wolffian/epididymal duct by using transgenic mice	ASIAN JOURNAL OF ANDROLOGY			English	Review						epididymis; mesonephros; transgenic mice; Wolffian duct	MALE REPRODUCTIVE-TRACT; CONGENITAL BILATERAL ABSENCE; TYROSINE KINASE RECEPTOR; FIBROBLAST-GROWTH-FACTOR; UROGENITAL DEVELOPMENT; RAT EPIDIDYMIS; WOLFFIAN DUCT; VAS-DEFERENS; CELL-PROLIFERATION; URINARY-TRACT	The development of the Wolffian/epididymal duct is crucial for proper function and, therefore, male fertility. The development of the epididymis is complex; the initial stages form as a transient embryonic kidney; then the mesonephros is formed, which in turn undergoes extensive morphogenesis under the influence of androgens and growth factors. Thus, understanding of its full development requires a wide and multidisciplinary view. This review focuses on mouse models that display abnormalities of the Wolffian duct and mesonephric development, the importance of these mouse models toward understanding male reproductive tract development, and how these models contribute to our understanding of clinical abnormalities in humans such as congenital anomalies of the kidney and urinary tract (CAKUT).	[Murashima, Aki] Wakayama Med Univ, Inst Adv Med, Dept Dev Genet, Wakayama 6418509, Japan; [Xu, Bingfang; Hinton, Barry T.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA	Hinton, BT (reprint author), Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA.	bth7c@virginia.edu			National Institutes of Health Eunice Kennedy Shriver NICHD Grants [HD069654, HD068365];  [25860771]	We would like to thank Prof. Gen Yamada and Dr. Mika Okazawa for the supportive discussion. This work is supported by Grant-in-Aid for Young Scientists B (25860771), and National Institutes of Health Eunice Kennedy Shriver NICHD Grants HD069654 and HD068365 (BTH).	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; ABOUHAILA A, 1984, ANAT REC, V209, P197, DOI 10.1002/ar.1092090207; ANGUIANO A, 1992, JAMA-J AM MED ASSOC, V267, P1794, DOI 10.1001/jama.267.13.1794; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Podlasek CA, 1999, DEV DYNAM, V214, P1, DOI 10.1002/(SICI)1097-0177(199901)214:1<1::AID-DVDY1>3.0.CO;2-2; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Ma WB, 2012, J BIOL CHEM, V287, P10189, DOI 10.1074/jbc.M111.303636; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Ma WB, 2013, J BIOL CHEM, V288, P29369, DOI 10.1074/jbc.M113.454066; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Staack A, 2003, DIFFERENTIATION, V71, P402, DOI 10.1046/j.1432-0436.2003.7107004.x; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; DeFalco T, 2009, ANNU REV CELL DEV BI, V25, P457, DOI 10.1146/annurev.cellbio.042308.13350; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; JOST A, 1953, RECENT PROG HORM RES, V8, P379; Warr N, 2009, DEV BIOL, V326, P273, DOI 10.1016/j.ydbio.2008.11.023; Snyder EM, 2010, DEV DYNAM, V239, P2479, DOI 10.1002/dvdy.22378; Evrard YA, 1998, NATURE, V394, P377; CUNHA GR, 1992, J ANDROL, V13, P465; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; Lupien M, 2006, DEV BIOL, V300, P497, DOI 10.1016/j.ydbio.2006.09.010; McCallum TJ, 2001, HUM REPROD, V16, P282, DOI 10.1093/humrep/16.2.282; Kochhar A, 2008, HUM MUTAT, V29, P565, DOI 10.1002/humu.20714; Wang QR, 2005, DEV BIOL, V288, P582, DOI 10.1016/j.ydbio.2005.09.024; SUN EL, 1979, AM J ANAT, V154, P27, DOI 10.1002/aja.1001540104; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Pole RJ, 2002, J UROLOGY, V167, P269, DOI 10.1016/S0022-5347(05)65446-8; Afzal AR, 2000, NAT GENET, V25, P419; Torres M, 1995, DEVELOPMENT, V121, P4057; Gupta C, 1996, ENDOCRINOLOGY, V137, P905, DOI 10.1210/en.137.3.905; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Pope JC, 1999, J AM SOC NEPHROL, V10, P2018; Xu BF, 2010, BIOL REPROD, V83, P807, DOI 10.1095/biolreprod.110.085613; Murashima A, 2011, ENDOCRINOLOGY, V152, P1640, DOI 10.1210/en.2010-1121; Shima Y, 2013, MOL ENDOCRINOL, V27, P63, DOI 10.1210/me.2012-1256; Xu BF, 2011, BIOL REPROD, V84, P1282, DOI 10.1095/biolreprod.110.090324; Shum WWC, 2008, CELL, V135, P1108, DOI 10.1016/j.cell.2008.10.020; Matsumoto T, 2003, J STEROID BIOCHEM, V85, P95, DOI 10.1016/S0960-0760(03)00231-0; Da Silva N, 2011, REPRODUCTION, V141, P653, DOI 10.1530/REP-10-0493; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Sainio K, 1997, DEVELOPMENT, V124, P1293; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Hahn KL, 2009, REPRODUCTION, V137, P79, DOI 10.1530/REP-08-0207; Xu BF, 2014, P NATL ACAD SCI USA, V111, P18643, DOI 10.1073/pnas.1413186112; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Lan ZJ, 1998, BIOL REPROD, V58, P197, DOI 10.1095/biolreprod58.1.197; Renfree MB, 2009, DEV BIOL, V334, P429, DOI 10.1016/j.ydbio.2009.07.040; Atsuta Y, 2013, DEV GROWTH DIFFER, V55, P579, DOI 10.1111/dgd.12047; AUGARTEN A, 1994, LANCET, V344, P1473, DOI 10.1016/S0140-6736(94)90292-5; Bjorkgren I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038457; Bomgardner D, 2001, J ANDROL, V22, P527; CHEN JM, 1994, ONCOGENE, V9, P773; Chia I, 2011, DEVELOPMENT, V138, P2089, DOI 10.1242/dev.056838; CUNHA GR, 1991, DEVELOPMENT, V111, P145; DEMARTIN.C, 1966, J ULTRA MOL STRUCT R, V16, P399; Donjacour AA, 2003, DEV BIOL, V261, P39, DOI 10.1016/S0012-1606(03)00250-1; GIRGIS SM, 1969, FERTIL STERIL, V20, P467; GUPTA C, 1991, DEV BIOL, V146, P106, DOI 10.1016/0012-1606(91)90451-8; GUTTROFF RF, 1992, ANAT REC, V232, P423, DOI 10.1002/ar.1092320311; Hirashima T, 2014, CELL REP, V9, P866, DOI 10.1016/j.celrep.2014.09.041; ILIO KY, 1994, MICROSC RES TECHNIQ, V29, P432, DOI 10.1002/jemt.1070290604; JEQUIER AM, 1985, J ANDROL, V6, P15; JOST A, 1947, ARCH ANAT MICROSC MO, V36, P151; Keilhack H, 2001, J CELL BIOL, V152, P325, DOI 10.1083/jcb.152.2.325; Kirby JL, 2003, BIOL REPROD, V68, P2314, DOI 10.1095/biolreprod.102.011270; Kitagaki J, 2011, DEVELOPMENT, V138, P5369, DOI 10.1242/dev.051888; Kobayashi A, 2004, DEVELOPMENT, V131, P539, DOI 10.1242/dev.00951; Kobayashi H, 2007, MECH DEVELOP, V124, P290, DOI 10.1016/j.mod.2007.01.002; Kroovand RL, 1981, PEDIAT ANDROLOGY, P173; Krutskikh A, 2011, ENDOCRINOLOGY, V152, P689, DOI 10.1210/en.2010-0768; Kume T, 2000, DEVELOPMENT, V127, P1387; Mattiske D, 2006, DEV BIOL, V290, P447, DOI 10.1016/j.ydbio.2005.12.007; Murashima A, 2014, DEV BIOL, V386, P216, DOI 10.1016/j.ydbio.2013.12.026; Nie XG, 2013, MECH DEVELOP, V130, P567, DOI 10.1016/j.mod.2013.07.006; Okazawa M, 2015, DEV BIOL, V400, P139, DOI 10.1016/j.ydbio.2015.01.023; ORNITZ DM, 2001, GENOME BIOL, V2, pS3005, DOI DOI 10.1186/GB-2001-2-3-REVIEWS3005; Pedersen A, 2005, DEV BIOL, V288, P571, DOI 10.1016/j.ydbio.2005.09.027; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Saxen L, 1987, ORGANOGENESIS KIDNEY; Simanainen U, 2008, ENDOCRINOLOGY, V149, P3330, DOI 10.1210/en.2007-1805; SMITH C, 1991, J ANAT, V174, P171; SONNENBERG E, 1991, EMBO J, V10, P3693; SonnenbergRiethmacher E, 1996, GENE DEV, V10, P1184, DOI 10.1101/gad.10.10.1184; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; TESSAROLLO L, 1992, DEVELOPMENT, V115, P11; TIEDEMANN K, 1984, CELL TISSUE RES, V238, P165; Tomaszewski J, 2007, P NATL ACAD SCI USA, V104, P11322, DOI 10.1073/pnas.0703445104; Tong SYC, 1996, J UROLOGY, V155, P2057, DOI 10.1016/S0022-5347(01)66107-X; TUREK PJ, 1994, J UROLOGY, V151, P726; Turner TT, 1999, MOL REPROD DEV, V53, P188, DOI 10.1002/(SICI)1098-2795(199906)53:2<188::AID-MRD8>3.0.CO;2-O; Welsh M, 2009, ENDOCRINOLOGY, V150, P2472, DOI 10.1210/en.2008-0529; Xu B, 2013, BIOL REPROD, V89, P1; YEUNG CH, 1991, AM J ANAT, V191, P261, DOI 10.1002/aja.1001910306; Yun KS, 2014, HUM MOL GENET, V23, P6807, DOI 10.1093/hmg/ddu397; Zvizdic Z, 2009, FOLIA MED, V44, P65	105	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1008-682X	1745-7262		ASIAN J ANDROL	Asian J. Androl.	SEP-OCT	2015	17	5					749	755		10.4103/1008-682X.155540		7	Andrology; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	CQ5FN	WOS:000360628800013		
J	Komeya, M; Ogawa, T				Komeya, Mitsuru; Ogawa, Takehiko			Spermatogonial stem cells: progress and prospects	ASIAN JOURNAL OF ANDROLOGY			English	Review						in vitro spermatogenesis; male infertility; organ culture	SPERMATOGENESIS IN-VITRO; SELF-RENEWAL; MALE GERMLINE; SEMINIFEROUS TUBULES; TERM CULTURE; MOUSE TESTES; RAT; DIFFERENTIATION; MICE; LINE	Twenty years ago, the transplantation of spermatogonial stem cells (SSCs) from a mouse to other recipient mice was shown to be feasible, which clearly demonstrated the functional identity of SSCs. Since then, several important new findings and other technical developments have followed, which included a new hypothesis on their cell kinetics and spermatogonial hierarchy in the testis, a culture method allowing their self-renewal and proliferation, a testis tissue organ culture method, which induced their complete differentiation up to sperm, and the in vitro induction of germ cells from embryonic stem cells and induced pluripotent stem cells. These advancements reinforced or advanced our understanding of this unique cell. Nonetheless, there are many unresolved questions in the study of spermatogonial stem cells and a long road remains until these cells can be used clinically in reproductive medicine.	[Komeya, Mitsuru; Ogawa, Takehiko] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan; [Ogawa, Takehiko] Yokohama City Univ, Assoc Med Sci, Inst Mol Med & Life Sci, Lab Prote, Yokohama, Kanagawa 2360004, Japan	Ogawa, T (reprint author), Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan.	ogawa@yokohama-cu.ac.jp					Takashima S, 2013, GENE DEV, V27, P1949, DOI 10.1101/gad.220194.113; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; RASSOULZADEGAN M, 1993, CELL, V75, P997, DOI 10.1016/0092-8674(93)90543-Y; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Kiger AA, 2000, NATURE, V407, P750; Oatley MJ, 2011, BIOL REPROD, V85, P347, DOI 10.1095/biolreprod.111.091330; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Ishii K, 2012, DEVELOPMENT, V139, P1734, DOI 10.1242/dev.076539; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; Clouthier DE, 1996, NATURE, V381, P418, DOI 10.1038/381418a0; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; Aloisio GM, 2014, J CLIN INVEST, V124, P3929, DOI 10.1172/JCI75943; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Kubota H, 2011, FASEB J, V25, P2604, DOI 10.1096/fj.10-175802; Parks JE, 2003, THERIOGENOLOGY, V59, P73, DOI 10.1016/S0093-691X(02)01275-X; La Salle S, 2009, METHODS MOL BIOL, V558, P279, DOI 10.1007/978-1-60761-103-5_17; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dobrinski I, 1999, MOL REPROD DEV, V53, P142, DOI 10.1002/(SICI)1098-2795(199906)53:2<142::AID-MRD3>3.3.CO;2-F; STEINBERGER A, 1964, EXP CELL RES, V36, P19, DOI 10.1016/0014-4827(64)90156-9; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Buganim Y, 2012, CELL STEM CELL, V11, P373, DOI 10.1016/j.stem.2012.07.019; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Champy C., 1920, Archives de Zoologie Experimentale Paris, V60; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Hara K, 2014, CELL STEM CELL, V14, P658, DOI 10.1016/j.stem.2014.01.019; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biloreprod.103.017012; Kita K, 2007, BIOL REPROD, V76, P211, DOI 10.1095/biolreprod.106.056895; Martinovitch P. N., 1937, Nature London, V139, P413, DOI 10.1038/139413a0; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Sato T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1478; Staub C, 2000, EXP CELL RES, V260, P85, DOI 10.1006/excr.2000.4998; Staub C, 2001, J ANDROL, V22, P911; Steinberger A., 1967, J REPROD FERTIL    S, V2, P117; Yokonishi T., 2013, BIOL REPROD, V89, P1	51	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1008-682X	1745-7262		ASIAN J ANDROL	Asian J. Androl.	SEP-OCT	2015	17	5					771	775		10.4103/1008-682X.154995		5	Andrology; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	CQ5FN	WOS:000360628800018		
J	Yamamoto, S; Zhong, JY; Yancey, PG; Zuo, YQ; Linton, MF; Fazio, S; Yang, HC; Narita, I; Kon, V				Yamamoto, Suguru; Zhong, Jiayong; Yancey, Patricia G.; Zuo, Yiqin; Linton, MacRae F.; Fazio, Sergio; Yang, Haichun; Narita, Ichiei; Kon, Valentina			Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype	ATHEROSCLEROSIS			English	Article						Pioglitazone; Losartan; PPAR gamma; Chronic kidney disease; Atherosclerosis; Macrophage phenotype	CHRONIC KIDNEY-DISEASE; TYPE-2 DIABETES-MELLITUS; ACTIVATED RECEPTOR-GAMMA; E-DEFICIENT MICE; CARDIOVASCULAR EVENTS; CHOLESTEROL EFFLUX; GLUCOSE-TOLERANCE; INHIBITORY FACTOR; PPAR-GAMMA; CALCIFICATION	Objective: Chronic kidney disease (CKD) amplifies atherosclerosis, which involves renin-angiotensin system (RAS) regulation of macrophages. RAS influences peroxisome proliferator-activated receptor-g (PPAR gamma), a modulator of atherogenic functions of macrophages, however, little is known about its effects in CKD. We examined the impact of combined therapy with a PPARg agonist and angiotensin receptor blocker on atherogenesis in a murine uninephrectomy model. Methods: Apolipoprotein E knockout mice underwent uninephrectomy (UNx) and treatment with pioglitazone (UNx + Pio), losartan (UNx + Los), or both (UNx + Pio/Los) for 10 weeks. Extent and characteristics of atherosclerotic lesions and macrophage phenotypes were assessed; RAW264.7 and primary peritoneal mouse cells were used to examine pioglitazone and losartan effects on macrophage phenotype and inflammatory response. Results: UNx significantly increased atherosclerosis. Pioglitazone and losartan each significantly reduced the atherosclerotic burden by 29.6% and 33.5%, respectively; although the benefit was dramatically augmented by combination treatment which lessened atherosclerosis by 55.7%. Assessment of plaques revealed significantly greater macrophage area in UNx + Pio/Los (80.7 +/- 11.4% vs. 50.3 +/- 4.2% in UNx + Pio and 57.2 +/- 6.5% in UNx + Los) with more apoptotic cells. The expanded macrophage-rich lesions of UNx + Pio/Los had more alternatively activated, Ym-1 and arginine 1-positive M2 phenotypes (Ym-1: 33.6 +/- 8.2%, p < 0.05 vs. 12.0 +/- 1.1% in UNx; arginase 1: 27.8 +/- 0.9%, p < 0.05 vs. 11.8 +/- 1.3% in UNx). In vitro, pioglitazone alone and together with losartan was more effective than losartan alone in dampening lipopolysaccharide-induced cytokine production, suppressing M1 phenotypic change while enhancing M2 phenotypic change. Conclusion: Combination of pioglitazone and losartan is more effective in reducing renal injury-induced atherosclerosis than either treatment alone. This benefit reflects mitigation in macrophage cytokine production, enhanced apoptosis, and a shift toward an anti-inflammatory phenotype. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Yamamoto, Suguru; Zhong, Jiayong; Kon, Valentina] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Yamamoto, Suguru; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Japan; [Yancey, Patricia G.; Linton, MacRae F.; Fazio, Sergio] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Zhong, Jiayong; Zuo, Yiqin; Fazio, Sergio; Yang, Haichun] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Linton, MacRae F.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Fazio, Sergio] Vanderbilt Univ, Med Ctr, Dept Immunol & Microbiol, Nashville, TN 37232 USA; [Fazio, Sergio] Oregon Hlth & Sci Univ, Ctr Prevent Cardiol, Knight Cardiovasc Inst, Portland, OR 97201 USA	Kon, V (reprint author), Vanderbilt Univ, Med Ctr, Dept Pediat, 1161 21st Ave South,C-4204 Med Ctr North, Nashville, TN 37232 USA.	valentina.kon@vanderbilt.edu			NIH [HL087061, DK44757, HL65709, HL57986]; Lipid, Lipoprotein and Atherosclerosis Core of the Vanderbilt Mouse Metabolic Phenotyping Center [NIH DK59637-01]	This work was supported in part by grants NIH HL087061, DK44757, HL65709 and HL57986 and the Lipid, Lipoprotein and Atherosclerosis Core of the Vanderbilt Mouse Metabolic Phenotyping Center (NIH DK59637-01).	Alexis JD, 2009, CIRC RES, V104, P69, DOI 10.1161/CIRCRESAHA.108.188409; Wong BLW, 2009, AM J PATHOL, V174, P1319, DOI 10.2353/ajpath.2009.080708; Mungrue IN, 2002, J CLIN INVEST, V109, P735, DOI 10.1172/JCI200213265; Westenfeld R, 2009, J AM SOC NEPHROL, V20, P1264, DOI 10.1681/ASN.2008060572; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Subramanian V, 2010, CIRC RES, V107, P953, DOI 10.1161/CIRCRESAHA.110.219089; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Wilcox R, 2008, AM HEART J, V155, P712, DOI 10.1016/j.ahj.2007.11.029; Ozasa H, 2011, ATHEROSCLEROSIS, V219, P141, DOI 10.1016/j.atherosclerosis.2011.07.113; Davidson M, 2008, CIRCULATION, V117, P2123, DOI 10.1161/CIRCULATIONAHA.107.746610; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Suganuma E, 2007, J AM SOC NEPHROL, V18, P2311, DOI 10.1681/ASN.2006090967; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Nicholls SJ, 2011, J AM COLL CARDIOL, V57, P153, DOI 10.1016/j.jacc.2010.06.055; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Zuo YQ, 2009, ARTERIOSCL THROM VAS, V29, P1277, DOI 10.1161/ATVBAHA.109.188995; Huang XR, 2008, J AM SOC NEPHROL, V19, P233, DOI 10.1681/ASN.2007040484; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Yamamoto S, 2011, NEPHROL DIAL TRANSPL, V26, P2491, DOI 10.1093/ndt/gfq759; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Guo L, 2000, J BIOL CHEM, V275, P8032, DOI 10.1074/jbc.275.11.8032; Teupser D, 2006, ARTERIOSCL THROM VAS, V26, P365, DOI 10.1161/01.ATV.0000195791.83380.4c; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Babaev V.R., 2005, THROMB VASC BIOL, V25, P1647; Babaev VR, 2008, CELL METAB, V8, P492, DOI 10.1016/j.cmet.2008.09.005; Boesten LSM, 2009, ATHEROSCLEROSIS, V207, P399, DOI 10.1016/j.atherosclerosis.2009.06.015; Feig J.E., P NATL ACAD SCI US, V108, P7166; Klausen KP, 2006, J INTERN MED, V260, P231, DOI 10.1111/j.1365-2796.2006.01679.x; Liu H, 2012, J NEPHROL, V25, P219, DOI 10.5301/JN.2011.8478; Liu J., 2005, THROMB VASC BIOL, V25, P174; Ma J, 2006, KIDNEY INT, V69, P1064, DOI 10.1038/sj.ki.5000201; Mahmoodi BK, 2013, LANCET, V381, P532, DOI 10.1016/S0140-6736(13)60273-1; Miyazaki Y, 2008, DIABETES OBES METAB, V10, P1204, DOI 10.1111/j.1463-1326.2008.00880.x; Nakaya H, 2009, AM J PATHOL, V174, P2007, DOI 10.2353/ajpath.2009.080611; Saremi A., 2013, THROMB VASC BIOL, V33, P393; Subramanian V., 2012, THROMB VASC BIOL, V32, P397; Suganuma E, 2006, J AM SOC NEPHROL, V17, P433, DOI 10.1681/ASN.2005080883; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094; Yamamoto S., 2011, THROMB VASC BIOL, V31, P2856; Yamamoto S, 2009, CURR OPIN NEPHROL HY, V18, P181, DOI 10.1097/MNH.0b013e328327b360; Yancey P.G., 2010, THROMB VASC BIOL, V30, P787	50	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	SEP	2015	242	1					56	64		10.1016/j.atherosclerosis.2015.06.055		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CP7WU	WOS:000360100900010		
J	Kotani, K; Sahebkar, A; Serban, C; Andrica, F; Toth, PP; Jones, SR; Kostner, K; Blaha, MJ; Martin, S; Rysz, J; Glasser, S; Ray, KK; Watts, GF; Mikhailidis, DP; Banach, M				Kotani, Kazuhiko; Sahebkar, Amirhossein; Serban, Corina; Andrica, Florina; Toth, Peter P.; Jones, Steven R.; Kostner, Karam; Blaha, Michael J.; Martin, Seth; Rysz, Jacek; Glasser, Stephen; Ray, Kausik K.; Watts, Gerald F.; Mikhailidis, Dimitri P.; Banach, Maciej		Lipid Blood Pressure Meta-analysis	Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients	ATHEROSCLEROSIS			English	Article						Cardiovascular disease; Cardiovascular risk; Lipoprotein(a); Tibolone	CARDIOVASCULAR-DISEASE RISK; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; CHOLESTEROL EFFLUX; HDL CHOLESTEROL; BLOOD-PRESSURE; THERAPY; INHIBITION; AGENTS; APOLIPOPROTEIN(A)	Introduction: Circulating lipoprotein (a) (Lp(a)) is a recognized risk factor for cardiovascular disease (CVD). Tibolone, a synthetic steroid, may lower Lp(a) levels; however, evidence of the effects of tibolone on Lp(a) still remain to be defined. Therefore, we investigated the effects of tibolone treatment on circulating Lp(a) levels in postmenopausal women. Methods: The search included PUBMED, Web of Science, Scopus, and Google Scholar (up to January 31st, 2015) to identify controlled clinical studies investigating the effects of oral tibolone treatment on Lp(a) levels in postmenopausal women. Random-effects meta-regression was performed using unrestricted maximum likelihood method for the association between calculated weighted mean difference (WMD) and potential moderators. Results: Meta-analysis of data from 12 trials (16 treatment arms) suggested a significant reduction of Lp(a) levels following tibolone treatment (WMD: -25.28%, 95% confidence interval [CI]: -36.50, -14.06; p < 0.001). This result was robust in the sensitivity analysis and its significance was not influenced after omitting each of the included studies from the meta-analysis. When the studies were categorized according to the tibolone dose, there were consistent significant reductions of Lp(a) in the subsets of studies with doses < 2.5 mg/day (WMD: -17.00%, 95% CI: -30.22, -3.77; p < 0.012) and 2.5 mg/day (WMD: -29.18%, 95% CI: -45.02, -13.33; p < 0.001). Likewise, there were similar reductions in the subsets of trials with follow-up either < 24 months (WMD: -26.79%, 95% CI: -38.40, -15.17; p < 0.001) or >= 24 months (WMD: -23.10%, 95% CI: -40.17, -6.03; p = 0.008). Conclusions: This meta-analysis shows that oral tibolone treatment significantly lowers circulating Lp(a) levels in postmenopausal women. Further studies are warranted to explore the mechanism of this effect and the potential value and place of tibolone or its analogues in the treatment of elevated Lp(a) in individuals at risk of CVD. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kotani, Kazuhiko] Jichi Med Univ, Dept Clin Lab Med, Shimotsuke, Tochigi, Japan; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Univ Western Australia, Metab Res Ctr, Sch Med & Pharmacol, Royal Perth Hosp, Perth, WA 6009, Australia; [Serban, Corina] Victor Babes Univ Med & Pharm, Dept Funct Sci, Discipline Pathophysiol, Timisoara, Romania; [Andrica, Florina] Victor Babes Univ Med & Pharm, Fac Pharm, Discipline Pharmaceut Chem, Timisoara, Romania; [Toth, Peter P.] CGH Med Ctr, Prevent Cardiol, Sterling, IL USA; [Toth, Peter P.; Jones, Steven R.; Blaha, Michael J.; Martin, Seth] Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA; [Kostner, Karam] Univ Queensland, Mater Hosp, St Lucia, Qld, Australia; [Rysz, Jacek] Med Univ Lodz, Chair Nephrol & Hypertens, PL-90549 Lodz, Poland; [Glasser, Stephen] Univ Alabama Birmingham, Dept Prevent Med, Birmingham, AL USA; [Ray, Kausik K.] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Watts, Gerald F.] Univ Western Australia, Lipid Disorders Clin, Sch Med & Pharmacol, Cardiovasc Med,Royal Perth Hosp, Perth, WA 6009, Australia; [Mikhailidis, Dimitri P.] UCL, Dept Clin Biochem, Sch Med, London, England; [Banach, Maciej] Med Univ Lodz, Dept Hypertens, Chair Nephrol & Hypertens, PL-90549 Lodz, Poland	Banach, M (reprint author), Med Univ Lodz, Dept Hypertens, WAM Univ Hosp Lodz, Zeromskiego 113, PL-90549 Lodz, Poland.	maciejbanach@aol.co.uk	Banach, Maciej/A-1271-2009	Banach, Maciej/0000-0001-6690-6874			Albertazzi P, 1998, MATURITAS, V30, P295, DOI 10.1016/S0378-5122(98)00059-0; Anedda F.M., 2003, HORM RES, V61, P47; Sahebkar A, 2014, PHYTOTHER RES, V28, P633, DOI 10.1002/ptr.5045; Kolski B, 2012, CURR OPIN LIPIDOL, V23, P560, DOI 10.1097/MOL.0b013e3283598d81; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; Kostner KM, 2013, EUR HEART J, V34, P3268, DOI 10.1093/eurheartj/eht053; Otocka-Kmiecik A, 2012, PROG LIPID RES, V51, P314, DOI 10.1016/j.plipres.2012.03.003; Ishikawa S, 2013, THROMB RES, V131, pE54, DOI 10.1016/j.thromres.2012.11.032; Jacobson TA, 2013, MAYO CLIN PROC, V88, P1294, DOI 10.1016/j.mayocp.2013.09.003; Bochem AE, 2013, CURR PHARM DESIGN, V19, P3143; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Cummings SR, 2008, NEW ENGL J MED, V359, P697, DOI 10.1056/NEJMoa0800743; Milner MH, 1996, OBSTET GYNECOL, V87, P593, DOI 10.1016/0029-7844(95)00468-8; Sahebkar A, 2013, DNA CELL BIOL, V32, P188, DOI 10.1089/dna.2012.1947; Sahebkar A, 2013, CARDIOVASC DRUG THER, V27, P559, DOI 10.1007/s10557-013-6479-4; Banach M, 2015, PHARMACOL RES, V95-96, P111, DOI 10.1016/j.phrs.2015.03.009; Angles-Cano E, 2001, ANN NY ACAD SCI, V936, P261; Dube JB, 2012, CURR OPIN LIPIDOL, V23, P133, DOI 10.1097/MOL.0b013e32835111d8; Norata GD, 2013, EUR HEART J, V34, P1783, DOI 10.1093/eurheartj/eht088; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Banach M, 2015, ARCH MED SCI, V11, P1, DOI 10.5114/aoms.2015.49807; Banach M, 2013, CURR PHARM DESIGN, V19, P3869; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Klezovitch O, 2001, J BIOL CHEM, V276, P46864, DOI 10.1074/jbc.M107943200; Ostberg JE, 2004, FERTIL STERIL, V81, P1624, DOI 10.1016/j.fertnstert.2003.11.033; Banach M., 2013, INT UROL NEPHROL, V46, P947; Biglia N, 2010, GYNECOL ENDOCRINOL, V26, P804, DOI 10.3109/09513590.2010.495437; Bjarnason NH, 1997, J CLIN ENDOCR METAB, V82, P1752, DOI 10.1210/jc.82.6.1752; Borenstein M, 2005, COMPREHENSIVE METAAN, P104; Bos S, 2014, CURR OPIN LIPIDOL, V25, P452, DOI 10.1097/MOL.0000000000000126; Collaboration C, 2011, COCHRANE HDB SYSTEMA; Demirol A, 2007, FERTIL STERIL, V87, P842, DOI 10.1016/j.fertnstert.2006.08.090; Dragan S, 2014, CURR MED CHEM, V21, P2927; Dragan S, 2015, J CARDIOVASC PHARM T, V20, P157, DOI 10.1177/1074248414539562; Enkhmaa B, 2011, METAB SYNDR RELAT D, V9, P411, DOI 10.1089/met.2011.0026; Gaeta G, 2011, EXPERT OPIN INV DRUG, V20, P221, DOI 10.1517/13543784.2011.548804; Gallagher JC, 2001, J CLIN ENDOCR METAB, V86, P4717, DOI 10.1210/jc.86.10.4717; HEGELE RA, 1992, CIRCULATION, V85, P2034; Higgins J., 2009, COCHRANE HDB SYSTEMA; Hong SJ, 2005, ANN CLIN BIOCHEM, V42, P285, DOI 10.1258/0004563054255560; Hoover-Plow J, 2013, METABOLISM, V62, P479, DOI 10.1016/j.metabol.2012.07.024; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hudita D, 2003, Eur Rev Med Pharmacol Sci, V7, P117; Kalogeropoulos S, 2004, GYNECOL ENDOCRINOL, V18, P227; Kamstrup PR, 2013, LANCET DIABETES ENDO, V1, P220, DOI 10.1016/S2213-8587(13)70064-0; Kotani Kazuhiko, 2012, J Clin Med Res, V4, P130, DOI 10.4021/jocmr849w; Kroiss R, 2005, BJOG-INT J OBSTET GY, V112, P228, DOI 10.1111/j.1471-0528.2004.00309.x; Kronenberg F, 1996, CRIT REV CL LAB SCI, V33, P495, DOI 10.3109/10408369609080056; Lloyd G, 2000, J HUM HYPERTENS, V14, P99, DOI 10.1038/sj.jhh.1000938; Lobentanz EM, 1997, ELECTROPHORESIS, V18, P2677, DOI 10.1002/elps.1150181424; MARKIEWICZ L, 1990, J STEROID BIOCHEM, V35, P535, DOI 10.1016/0022-4731(90)90196-Y; McCarty MF, 2003, MED HYPOTHESES, V61, P335, DOI 10.1016/s0306-9877(02)00215-3; Modelska K, 2002, J CLIN ENDOCR METAB, V87, P16, DOI 10.1210/jc.87.1.16; Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535; Maria MS, 2012, GYNECOL ENDOCRINOL, V28, P483, DOI 10.3109/09513590.2011.634937; NARUSZEWICZE M, 1994, CHEM PHYS LIPIDS, V67-8, P167, DOI 10.1016/0009-3084(94)90136-8; Parhofer KG, 2011, CURR PHARM DESIGN, V17, P871; Perrone G, 2009, GYNECOL OBSTET INVES, V68, P33, DOI 10.1159/000211676; Prelevic GM, 2002, FERTIL STERIL, V77, P945, DOI 10.1016/S0015-0282(02)03078-9; Ramharack R, 1998, ARTERIOSCL THROM VAS, V18, P984; Siegel G, 2014, ADV COLLOID INTERFAC, V205, P275, DOI 10.1016/j.cis.2014.01.009; Taub R, 2013, ATHEROSCLEROSIS, V230, P373, DOI 10.1016/j.atherosclerosis.2013.07.056; von Eckardstein A, 2003, CLIN ENDOCRINOL, V58, P49, DOI 10.1046/j.1365-2265.2003.01666.x; von Eckardstein A, 2001, ATHEROSCLEROSIS, V159, P433, DOI 10.1016/S0021-9150(01)00522-6; Zmuda JM, 1996, AM J CARDIOL, V77, P1244, DOI 10.1016/S0002-9149(96)00174-9	66	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	SEP	2015	242	1					87	96		10.1016/j.atherosclerosis.2015.06.056		10	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CP7WU	WOS:000360100900014		
J	Tanaka, A; Ishii, H; Oshima, H; Narita, Y; Kodama, A; Suzuki, S; Komori, K; Usui, A; Murohara, T				Tanaka, Akihito; Ishii, Hideki; Oshima, Hideki; Narita, Yuji; Kodama, Akio; Suzuki, Susumu; Komori, Kimihiro; Usui, Akihiko; Murohara, Toyoaki			Inverse association between diabetes and aortic dilatation in patients with advanced coronary artery disease	ATHEROSCLEROSIS			English	Article						Diabetes; Aortic dilatation; Advanced coronary artery disease	COMPUTED-TOMOGRAPHY; HIGH PREVALENCE; NORMAL LIMITS; ANEURYSM; AGE; GROWTH; GENDER; SIZE	Background: A negative association between diabetes and abdominal aortic aneurysm has recently been reported. The purpose of this study was to assess the relationship between diabetes and aortic diameter, including non-aneurysmal aortic diameter, in patients with advanced coronary artery disease. Methods: We identified 351 consecutive patients who had undergone coronary artery bypass graft surgery. The patients were divided into two groups: those with diabetes mellitus (DM) (DM + group; n = 180), and those without DM (DM - group; n = 171). Infrarenal and ascending aortic diameters were measured by preoperative computed tomography and corrected for body surface area. Results: Infrarenal and ascending aortic diameters were significantly shorter in the DM + group than in the DM - group (21.3 +/- 5.0 mm vs. 24.7 +/- 9.8 mm, p < 0.001 and 36.0 +/- 4.4 mm vs. 37.8 +/- 5.5 mm, p = 0.001, respectively). The rates of infrarenal aortic diameter >= 30 mm and ascending aortic diameter >= 40 mm were significantly lower in the DM + group than in the DM + group (3.5% vs. 13.3%, p = 0.003 and 14.2% vs. 24.1%, p = 0.025, respectively). Multivariate models demonstrated diabetes to be an independent predictor of both infrarenal and ascending aortic diameters even after correction for body surface area. Conclusion: Our findings indicated an inverse association between diabetes and aortic dilatation of both the infrarenal and ascending aorta in patients with advanced coronary artery disease. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Tanaka, Akihito; Ishii, Hideki; Suzuki, Susumu; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Oshima, Hideki; Narita, Yuji; Usui, Akihiko] Nagoya Univ, Dept Cardiac Surg, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Kodama, Akio; Komori, Kimihiro] Nagoya Univ, Dept Vasc Surg, Grad Sch Med, Nagoya, Aichi 4668550, Japan	Tanaka, A (reprint author), Nagoya Univ, Dept Cardiol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	akihito17491194@gmail.com	Murohara, Toyoaki/M-4958-2014; Usui, Akihiko/I-7251-2014		Astellas; Otsuka; Bayer; Daiichi Sankyo; Dainippon Sumitomo; Kowa; MSD; Mitsubishi Tanabe; Nippon Boehringer Ingelheim; Novartis; Pfizer Japan; Sanofi-Aventis; Takeda; Astellas (Tokyo, Japan); Daiichi Sankyo (Tokyo, Japan); Dainippon Sumitomo (Tokyo, Japan); Kowa (Nagoya, Japan); MSD (Tokyo, Japan); Mitsubishi Tanabe (Osaka, Japan); Nippon Boehringer Ingelheim (Tokyo, Japan); Novartis (Tokyo, Japan); Otsuka (Tokyo, Japan); Pfizer Japan (Tokyo, Japan); Sanofi-Aventis (Tokyo, Japan); Takeda (Tokyo, Japan); Teijin (Tokyo, Japan)	Dr. Ishii has received lecture fees from Astellas and Otsuka. Dr. Murohara has received lecture fees from Bayer, Daiichi Sankyo, Dainippon Sumitomo, Kowa, MSD, Mitsubishi Tanabe, Nippon Boehringer Ingelheim, Novartis, Pfizer Japan, Sanofi-Aventis, and Takeda. Dr. Murohara has received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine, from Astellas (Tokyo, Japan), Daiichi Sankyo (Tokyo, Japan), Dainippon Sumitomo (Tokyo, Japan), Kowa (Nagoya, Japan), MSD (Tokyo, Japan), Mitsubishi Tanabe (Osaka, Japan), Nippon Boehringer Ingelheim (Tokyo, Japan), Novartis (Tokyo, Japan), Otsuka (Tokyo, Japan), Pfizer Japan (Tokyo, Japan), Sanofi-Aventis (Tokyo, Japan), Takeda (Tokyo, Japan), and Teijin (Tokyo, Japan).	Miyama N, 2010, J VASC SURG, V52, P975, DOI 10.1016/j.jvs.2010.05.086; Dua MM, 2010, SURGERY, V148, P429, DOI 10.1016/j.surg.2010.05.014; Madaric J, 2005, AM J CARDIOL, V96, P1214, DOI 10.1016/j.amjcard.2005.06.058; Golledge J, 2008, EUR HEART J, V29, P665, DOI 10.1093/eurheartj/ehm557; Le MTQ, 2007, EUR J VASC ENDOVASC, V33, P599, DOI 10.1016/j.ejvs.2006.12.017; Wolak A, 2008, JACC-CARDIOVASC IMAG, V1, P200, DOI 10.1016/j.jcmg.2007.11.005; Rogers IS, 2013, AM J CARDIOL, V111, P1510, DOI 10.1016/j.amjcard.2013.01.306; Devereux RB, 2012, AM J CARDIOL, V110, P1189, DOI 10.1016/j.amjcard.2012.05.063; Vorp DA, 2007, J BIOMECH, V40, P1887, DOI 10.1016/j.jbiomech.2006.09.003; Dupont A, 2010, AM J CARDIOL, V105, P1545, DOI 10.1016/j.amjcard.2010.01.011; Astrand H, 2007, EUR J VASC ENDOVASC, V33, P592, DOI 10.1016/j.ejvs.2006.11.011; Monney P, 2004, EUR J CARDIO-THORAC, V25, P65, DOI 10.1016/S1010-7940(03)00674-2; Lederle FA, 2012, EUR J VASC ENDOVASC, V43, P254, DOI 10.1016/j.ejvs.2011.12.026; Long A, 2010, ANN VASC SURG, V24, P602, DOI 10.1016/j.avsg.2009.12.010; Evangelista A, 2010, EUR J ECHOCARDIOGR, V11, P645, DOI 10.1093/ejechocard/jeq056; Bergersen L, 1998, ANN VASC SURG, V12, P101, DOI 10.1007/s100169900124; Thompson A, 2010, J VASC SURG, V52, P55, DOI 10.1016/j.jvs.2010.02.012; HIROSE Y, 1992, RADIOLOGY, V185, P249; Baguet JP, 2012, J HYPERTENS, V30, P440, DOI 10.1097/HJH.0b013e32834f867a; De Rango P, 2014, EUR J VASC ENDOVASC, V47, P243, DOI 10.1016/j.ejvs.2013.12.007; Durieux R, 2014, EUR J VASC ENDOVASC, V47, P273, DOI 10.1016/j.ejvs.2013.12.011; Lederle FA, 1997, ANN INTERN MED, V126, P441; Prakash S.K., 2012, J AM HEART ASS, V1	23	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	SEP	2015	242	1					123	127		10.1016/j.atherosclerosis.2015.07.016		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CP7WU	WOS:000360100900019		
J	Ota, T; Ishii, H; Suzuki, S; Shibata, Y; Tatami, Y; Harata, S; Shimbo, Y; Takayama, Y; Tanaka, A; Kawamura, Y; Osugi, N; Maeda, K; Kondo, T; Murohara, T				Ota, Tomoyuki; Ishii, Hideki; Suzuki, Susumu; Shibata, Yohei; Tatami, Yosuke; Harata, Shingo; Shimbo, Yusaku; Takayama, Yohei; Tanaka, Akihito; Kawamura, Yoshihiro; Osugi, Naohiro; Maeda, Kengo; Kondo, Takahisa; Murohara, Toyoaki			Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS)	ATHEROSCLEROSIS			English	Article						Statin escape phenomenon; Clinical outcomes; Acute myocardial infarction	DENSITY-LIPOPROTEIN CHOLESTEROL; RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; LDL CHOLESTEROL; HDL CHOLESTEROL; RISK; PREVENTION; THERAPY; SMOKING	Background: Statins are reportedly effective in the primary and secondary prevention of cardiovascular disease, mainly due to their ability to aggressively reduce low-density lipoprotein cholesterol (LDL-C) levels. However, patients sometimes exhibit the so-called "statin escape" phenomenon. The purpose of our study was to investigate the impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction (AMI). Method: This was a subgroup analysis of 1144 patients from the Nagoya Acute Myocardial Infarction Study (NAMIS) treated between January 2004 and December 2012. We analyzed 660 patients who initiated statin treatment after AMI. Statin escape phenomenon was defined as an increase in the LDL-C levels during the 9-month treatment period by > 10% of the initial values after 4 weeks of initiating statin treatment. Patients were divided into two groups depending on whether they exhibited the statin escape phenomenon, with 474 patients in the non-escape group and 186 patients in the escape group. Result: Compared to the non-escape group, the escape group showed significantly lower LDL-C levels at 4 weeks after treatment initiation (81.3 +/- 20.1 mg/dL vs. 101.1 +/- 25.4 mg/dL, P < 0.01). By contrast, the escape group showed significantly higher LDL-C levels at 9 months after treatment initiation (105.8 +/- 28.3 mg/dL vs. 90.3 +/- 22.6 mg/dL, P < 0.01). Major adverse cardiac and cerebrovascular events (MACCE; a composite of all-cause death, MI, and stroke) were more frequent in the escape group than in the non-escape group (10.8% vs. 6.1%, P = 0.03). Multivariate analysis showed that statin escape phenomenon was an independent predictor of MACCE (hazard ratio: 2.02, 95% confidence interval: 1.11 -3.66, P = 0.02). Conclusion: Statin escape phenomenon may be an independent predictor of long-term clinical outcomes in AMI patients. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ota, Tomoyuki; Ishii, Hideki; Suzuki, Susumu; Shibata, Yohei; Tatami, Yosuke; Harata, Shingo; Shimbo, Yusaku; Takayama, Yohei; Tanaka, Akihito; Kawamura, Yoshihiro; Osugi, Naohiro; Maeda, Kengo; Kondo, Takahisa; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan	Ota, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan.	t-ota@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		Astellas Pharma Inc.; Astra Zeneca Co., Ltd.; Daiichi-Sankyo Pharma Inc.; Otsuka Pharma Inc.; Bayel Pharmaceutical Co., Ltd.; Daiichi Sankyo Co., Ltd.; Dainippon Sumitomo Pharma Co., Ltd.; Kowa Co., Ltd.; MSD K.K.; Mitsubishi Tanabe Pharma Co.; Nippon Boehringer Ingelheim Co., Ltd.; Novartis Pharma K.K.; Pfizer Japan Inc.; Sanofiaventis K.K.; Takeda Pharmaceutical Co., Ltd.; Astellas Pharma Inc; Otsuka Pharma Ltd.; Sanofi-aventis K.K.; Teijin Pharma Ltd.	H.I. received lecture fees from Astellas Pharma Inc., Astra Zeneca Co., Ltd., Daiichi-Sankyo Pharma Inc. and Otsuka Pharma Inc. T. M. received lecture fees from Bayel Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Pfizer Japan Inc., Sanofiaventis K.K., and Takeda Pharmaceutical Co., Ltd. T.M. received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc, Daiichi Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-aventis K.K., Takeda Pharmaceutical Co., Ltd., Teijin Pharma Ltd.	Akesson A, 2014, J AM COLL CARDIOL, V64, P1299, DOI 10.1016/j.jacc.2014.06.1190; Fernandez ML, 2008, J AM COLL NUTR, V27, P1; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Kivimaki M, 2013, CAN MED ASSOC J, V185, P763, DOI 10.1503/cmaj.121735; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Ota T, 2015, AM J CARDIOL, V115, P411, DOI 10.1016/j.amjcard.2014.11.043; RUBINSTEIN A, 1995, AM J CARDIOL, V76, P184, DOI 10.1016/S0002-9149(99)80057-5; Mora S, 2012, J AM COLL CARDIOL, V59, P1521, DOI 10.1016/j.jacc.2011.12.035; Morita Y, 2013, CIRC J, V77, P2778, DOI 10.1253/circj.CJ-13-0251; ROSENBERG L, 1985, NEW ENGL J MED, V313, P1511, DOI 10.1056/NEJM198512123132404; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Rea TD, 2002, ANN INTERN MED, V137, P494; BRADFORD RH, 1991, ARCH INTERN MED, V151, P43, DOI 10.1001/archinte.151.1.43; Assmann G, 2007, EUR J CLIN INVEST, V37, P925, DOI 10.1111/j.1365-2362.2007.01888.x; ROSENBERG L, 1990, NEW ENGL J MED, V322, P213, DOI 10.1056/NEJM199001253220401; Shalansky SJ, 2004, ANN PHARMACOTHER, V38, P1363, DOI 10.1345/aph.1E071; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Collins R, 2002, LANCET, V360, P7; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Matsudaira K, 2012, CIRC J, V76, P1509, DOI 10.1253/circj.CJ-11-1127; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Okayama Akira, 2004, Environ Health Prev Med, V9, P165, DOI [10.1007/BF02898096, 10.1265/ehpm.9.165]; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Suzuki S, 2013, CIRC J, V77, P2024, DOI 10.1253/circj.CJ-13-0017; Third report of the National Cholesterol Education Program (NCEP), 2002, CIRCULATION, V106, P3143; Ugawa T, 2002, BRIT J PHARMACOL, V135, P1572, DOI 10.1038/sj.bjp.0704595; Yeshurun D., 2005, EUR J INTERN MED, V16, P192, DOI 10.1016/j.ejim.2004.11.007	30	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	SEP	2015	242	1					155	160		10.1016/j.atherosclerosis.2015.07.012		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CP7WU	WOS:000360100900024		
J	Lim, ST; Min, SK; Kwon, YC; Park, SK; Park, H				Lim, Seung-Taek; Min, Seok-Ki; Kwon, Yoo-Chan; Park, Sang-Kab; Park, Hyuntae			Effects of intermittent exercise on biomarkers of cardiovascular risk in night shift workers	ATHEROSCLEROSIS			English	Article						Intermittent exercise; Night shift worker; Cathepsin S; Cathepsin L; Cathepsin K; Adhesion molecules	METABOLIC SYNDROME; BRISK WALKING; PLASMA-LEVELS; CATHEPSIN-S; DISEASE; CHILDREN; SELECTIN; PROGRAM; HEALTH; INJURY	Objective: Cathepsin L (CatL), cathepsin S (CatS), and arteriosclerosis adhesion molecules such as monocyte chemotactic protein-1 (MCP-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), and soluble E-selectin (sE-selectin) are potent elastases implicated in human arterial wall remodeling. In this study, we aimed to evaluate the effects of intermittent exercise on the plasma concentrations of these cathepsins and arteriosclerosis adhesion molecules in night shift workers. Methods: Thirty male participants who were night shift workers (experimental group, n = 15; control group, n = 15) were included in this study. The experimental group performed an intermittent exercise at 10-min bouts (30 min per day), three days a week during 10 weeks. Body composition, blood pressure, and cardiovascular disease risk factors were measured. Results: After intermittent exercise, significant group time interactions for body weight (p < .01) and body fat percentage (p < .01) were found. With regard to cardiovascular disease risk factors, group time interactions for CatL (p < .01), CatS (p < .01), MCP-1 (p < .05), sE-selectin (p < .01), and sVCAM-1 (p < .01) were significant. Conclusions: This study provides preliminary evidence to suggest that intermittent exercise may represent an effective intervention strategy for preventing atherosclerosis, thus leading to improved cardiovascular health in night shift workers. (C) 2015 Published by Elsevier Ireland Ltd.	[Lim, Seung-Taek; Kwon, Yoo-Chan; Park, Sang-Kab] Dong A Univ, Coll Sport Sci, Busan 604714, South Korea; [Min, Seok-Ki] KISS, Dept Sport Sci, Seoul 139242, South Korea; [Park, Hyuntae] Dong A Univ, Dept Hlth Care & Sci, Busan 604714, South Korea; [Park, Hyuntae] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Japan; [Park, Hyuntae] Dong A Univ, Inst Convergence Biohlth, Busan 604714, South Korea	Min, SK (reprint author), KISS, Dept Sport Sci, 727 Hwarang Ro, Seoul 139242, South Korea.	minseokki@kspo.or.kr; htpark@dau.ac.kr					Cheng XW, 2012, CIRCULATION, V125, P1551, DOI 10.1161/CIRCULATIONAHA.111.066712; Cheng XW, 2013, ATHEROSCLEROSIS, V228, P211, DOI 10.1016/j.atherosclerosis.2013.01.004; Eirin A, 2013, EUR HEART J, V34, P540, DOI 10.1093/eurheartj/ehs197; Costa G, 1996, APPL ERGON, V27, P9, DOI 10.1016/0003-6870(95)00047-X; [Anonymous], 2001, AM J CARDIOL, DOI 10.1016/S0002-9149(01)01924-5; Qin YW, 2011, PHARMACOL THERAPEUT, V131, P338, DOI 10.1016/j.pharmthera.2011.04.010; Lv BJ, 2013, ATHEROSCLEROSIS, V230, P100, DOI 10.1016/j.atherosclerosis.2013.05.018; Park H, 2010, EUR J APPL PHYSIOL, V109, P953, DOI 10.1007/s00421-010-1424-8; Jobs E, 2011, JAMA-J AM MED ASSOC, V306, P1113, DOI 10.1001/jama.2011.1246; Pimenta AM, 2012, REV ASSOC MED BRAS, V58, P168, DOI 10.1590/S0104-42302012000200012; Turk V, 2002, ADV ENZYME REGUL, V42, P285, DOI 10.1016/S0065-2571(01)00034-6; Marqueze EC, 2014, INT ARCH OCC ENV HEA, V87, P229, DOI 10.1007/s00420-013-0850-4; Ford PA, 2013, J SPORT SCI, V31, P114, DOI 10.1080/02640414.2012.723816; Murphy MH, 2009, SPORTS MED, V39, P29, DOI 10.2165/00007256-200939010-00003; Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323; ALBELDA SM, 1994, FASEB J, V8, P504; Danielsen K.K., 2013, J OBES, DOI DOI 10.1155/2013/325464; Fuentes Y, 2014, PEDIATR NEPHROL, V29, P1047, DOI 10.1007/s00467-013-2740-0; Harrington J. M., 1994, Annals Academy of Medicine Singapore, V23, P699; Karstoft K, 2012, DIABETES CARE, V36, P228; Laucella SA, 1999, CLIN EXP IMMUNOL, V118, P423; Li Xiang, 2012, Chonnam Med J, V48, P77, DOI 10.4068/cmj.2012.48.2.77; Liu YX, 2009, AM J CARDIOL, V103, P476, DOI 10.1016/j.amjcard.2008.10.011; Mosendane T, 2008, CARDIOVASC J AFR, V19, P210; Murphy MH, 1998, MED SCI SPORT EXER, V30, P152, DOI 10.1097/00005768-199801000-00021; Oh EG, 2013, BIOL RES NURS, V15, P48, DOI 10.1177/1099800411416637; Ota Tsuguhito, 2013, Diabetes Metab J, V37, P165, DOI 10.4093/dmj.2013.37.3.165; Pescatellos L.S., 2014, ACSMS GUIDELINES FOR, Vninth; Sun M., 2013, J AM HEART ASSOC, V2, P1; Taleb S, 2006, J CLIN ENDOCR METAB, V91, P1042, DOI 10.1210/jc.2005-1601; Troseid M, 2005, SCAND J CLIN LAB INV, V65, P283, DOI 10.1080/00365510510013811; Vyas MV, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4800; Waterhouse J., 1992, HSE CONTRACT RESEARC; Wehrens SM, 2012, SCAND J WORK ENV HEA, V38, P171, DOI 10.5271/sjweh.3197	34	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	SEP	2015	242	1					186	190		10.1016/j.atherosclerosis.2015.06.017		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CP7WU	WOS:000360100900029		
J	Gotoh, S; Hata, J; Ninomiya, T; Hirakawa, Y; Nagata, M; Mukai, N; Fukuhara, M; Ikeda, F; Ago, T; Kitazono, T; Kiyohara, Y				Gotoh, Seiji; Hata, Jun; Ninomiya, Toshiharu; Hirakawa, Yoichiro; Nagata, Masaharu; Mukai, Naoko; Fukuhara, Masayo; Ikeda, Fumie; Ago, Tetsuro; Kitazono, Takanari; Kiyohara, Yutaka			Hematocrit and the risk of cardiovascular disease in a Japanese community: The Hisayama Study	ATHEROSCLEROSIS			English	Article						Hematocrit; Stroke; Coronary heart disease; Epidemiology; General populations	CORONARY-HEART-DISEASE; RED-BLOOD-CELLS; THROMBIN GENERATION; INSULIN-RESISTANCE; ASSOCIATION; POPULATION; VISCOSITY; INFARCTION; PROGRAM; STROKE	Objectives: The association between hematocrit levels and the risk of cardiovascular disease (CVD) has been reported inconsistently. We aimed to investigate the association of hematocrit levels with the development of stroke and coronary heart disease (CHD) in a general Japanese population. Methods: A total of 2585 community-dwelling Japanese individuals aged 40 years or older in 1988 were followed up for 19 years. These subjects were divided into four groups according to the sex-specific quartiles of hematocrit at baseline. Results: During the follow-up, 301 subjects developed stroke (210 ischemic and 91 hemorrhagic) and 187 developed CHD. The risk of ischemic stroke was higher in both the lowest (Q1: men, <= 44.7%; women, <= 39.3%) and the highest (Q4: men, >= 49.7%; women, >= 43.8%) quartiles than in the third quartile (Q3: men, 47.1%-49.6%; women, 41.7%-43.7%) used as a reference (multivariable-adjusted hazard ratios [95% confidence intervals]: Q1, 1.55 [0.99-2.43]; Q2, 1.44 [0.93-2.23]; Q3, 1.00; and Q4, 1.62 [1.06-2.50]; P = 0.86 for trend). In contrast, hematocrit levels and the risk of hemorrhagic stroke showed a linear inverse association (Q1, 1.91 [1.03-3.54]; Q2, 1.26 [0.68-2.34]; Q3, 1.00; and Q4, 0.81 [0.41-1.61]; P = 0.009 for trend). The risk of CHD increased significantly in Q4 (Q1, 1.13 [0.71-1.80]; Q2, 1.08 [0.69 -1.71]; Q3, 1.00; and Q4, 1.60 [1.04-2.46]; P = 0.13 for trend). Conclusions: Our findings suggest that both elevated and decreased hematocrit levels are associated with an increased risk of CVD, but the influence of hematocrit is different among subtypes of CVD. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Gotoh, Seiji; Hata, Jun; Ninomiya, Toshiharu; Hirakawa, Yoichiro; Nagata, Masaharu; Mukai, Naoko; Fukuhara, Masayo; Ikeda, Fumie; Kiyohara, Yutaka] Kyushu Univ, Dept Environm Med, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Gotoh, Seiji; Hata, Jun; Ninomiya, Toshiharu; Hirakawa, Yoichiro; Nagata, Masaharu; Mukai, Naoko; Fukuhara, Masayo; Ikeda, Fumie; Ago, Tetsuro; Kitazono, Takanari] Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Hata, Jun; Ninomiya, Toshiharu; Mukai, Naoko; Ikeda, Fumie; Kitazono, Takanari; Kiyohara, Yutaka] Kyushu Univ, Ctr Cohort Studies, Grad Sch Med Sci, Fukuoka 8128582, Japan	Hata, J (reprint author), Kyushu Univ, Ctr Cohort Studies, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	junhata@cohort.med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22116010, 25253048, 22240073, 24590797, 24590796, 25460758, 26350895, 26460748]; Core Research for Evolutionary Science and Technology (CREST) from the Japan Science and Technology Agency [13417915]; Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan [H22-Junkankitou [Seishuu]-Ippan-005, H25-Junkankitou [Seishuu]-Ippan-005, H25-Junkankitou [Seishuu]-Ippan-009, H25-Junkankitou [Seishuu]-Sitei-022, H26-Junkankitou [Seisaku]-Ippan-001, H25-Ninchisho-Ippan-004]	This study was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas (22116010) and for Scientific Research (A) (25253048 and 22240073) and (C) (24590797, 24590796, 25460758, 26350895, and 26460748) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by a Core Research for Evolutionary Science and Technology (CREST) grant (13417915) from the Japan Science and Technology Agency, and by Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan (H22-Junkankitou [Seishuu]-Ippan-005, H25-Junkankitou [Seishuu]-Ippan-005, H25-Junkankitou [Seishuu]-Ippan-009, H25-Junkankitou [Seishuu]-Sitei-022, H26-Junkankitou [Seisaku]-Ippan-001, and H25-Ninchisho-Ippan-004).	ANAND A, 1994, SOUTHERN MED J, V87, P299; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nagata M, 2010, NEPHROL DIAL TRANSPL, V25, P2557, DOI 10.1093/ndt/gfq062; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Horne MK, 2006, BRIT J HAEMATOL, V133, P403, DOI 10.1111/j.1365-2141.2006.06047.x; Lowe GDO, 1997, BRIT J HAEMATOL, V96, P168, DOI 10.1046/j.1365-2141.1997.8532481.x; TURITTO VT, 1980, SCIENCE, V207, P541, DOI 10.1126/science.7352265; Danesh J, 2000, EUR HEART J, V21, P515, DOI 10.1053/euhj.1999.1699; GAGNON DR, 1994, AM HEART J, V127, P674, DOI 10.1016/0002-8703(94)90679-3; WANNAMETHEE G, 1994, J INTERN MED, V235, P163; Gotoh S, 2012, J ATHEROSCLER THROMB, V19, P977; DESIMONE G, 1990, CIRCULATION, V81, P107; Boneu B, 1987, Transfus Med Rev, V1, P182, DOI 10.1016/S0887-7963(87)70020-0; CARTER C, 1983, AM HEART J, V105, P674, DOI 10.1016/0002-8703(83)90493-3; KARINO T, 1984, BIORHEOLOGY, V21, P587; Katsuki S, 1966, Prog Brain Res, V21, P64; KIYOHARA Y, 1986, STROKE, V17, P687; KIYOHARA Y, 1985, STROKE, V16, P835; OHMURA T, 1994, DIABETOLOGIA, V37, P897, DOI 10.1007/BF00400945; Peyrou V, 1999, THROMB HAEMOSTASIS, V81, P400; SORLIE PD, 1981, AM HEART J, V101, P456, DOI 10.1016/0002-8703(81)90136-8; Toss F, 2013, INT J CARDIOL, V168, P3588, DOI 10.1016/j.ijcard.2013.05.065; WANNAMETHEE G, 1994, J EPIDEMIOL COMMUN H, V48, P112, DOI 10.1136/jech.48.2.112; WOOD JH, 1985, STROKE, V16, P765	24	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	SEP	2015	242	1					199	204		10.1016/j.atherosclerosis.2015.07.014		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CP7WU	WOS:000360100900031		
J	Ishikawa, T; Ayaori, M; Uto-Kondo, H; Nakajima, T; Mutoh, M; Ikewaki, K				Ishikawa, Tetsuya; Ayaori, Makoto; Uto-Kondo, Harumi; Nakajima, Takatomo; Mutoh, Makoto; Ikewaki, Katsunori			High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease	ATHEROSCLEROSIS			English	Article						Lipid disorder; Coronary artery disease; High-density lipoprotein cholesterol efflux capacity; Low-density lipoprotein cholesterol; Propensity score matching analysis	HDL-CHOLESTEROL; HEART-DISEASE; JAPANESE; SERUM; RISK	Background: We examined the clinical relevance of high-density lipoprotein cholesterol (HDL-C) efflux capacity from macrophage (cholesterol efflux capacity) as a predictor of atherosclerotic coronary artery disease (CAD) in comparison with that of conventional coronary and lipid risk variables in Japanese daily practice. Methods and Results: Fasting blood sampling, including 6 routinely measured dyslipidemia-related variables, was performed at the time of coronary angiography (CAG) or multi-slice coronary computed tomography (MSCT) between January 2011 and January 2013. CAD, defined as native coronary atherosclerosis stenosis >50% by CAG or MSCT, was identified in 182 patients (CAD group), but not in 72 patients (non-CAD group). Cholesterol efflux capacity, measured using a cell-based efflux system in (3)[H]cholesterol- labeled J774 macrophages in apolipoprotein B-depleted plasma, was significantly impaired in the CAD group compared with the non-CAD group (0.86 +/- 0.26 vs. 1.02 +/- 0.38; p = 0.001). After adjusting 15 patient and dyslipidemia-related variables using a propensity score matching analysis produced 55 patients in each arm, cholesterol efflux capacity in the CAD group remained to be significant compared with the non-CAD group (0.83 +/- 0.24 vs. 0.97 +/- 0.36; p = 0.019). Stepwise logistic regression analysis using a backward method after the baseline adjustment showed that cholesterol efflux capacity (odds ratio [OR]: 0.23; 95% confidence interval [CI]: 0.056-0.91; p = 0.037) was the single predictor of CAD, while other variables including HDL-C (p = 0.088) and apolipoprotein (apo) A-I (p = 0.681) were removed owing to those insignificance. The area under the receiver operating characteristic curve after the baseline adjustment was 0.67 (95% CI: 0.51-0.73, p = 0.048 by Hosmer-Lemeshow goodness-of-fit statistics). Conclusions: The present observational study conducted under daily clinical practice confirmed that cholesterol efflux capacity is a clinically relevant predictor of CAD among the conventional coronary risk factors and dyslipidemia-related variables. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ishikawa, Tetsuya; Nakajima, Takatomo; Mutoh, Makoto] Saitama Cardiovasc Resp Ctr, Div Cardiol, Kumagaya, Saitama, Japan; [Ayaori, Makoto; Uto-Kondo, Harumi; Ikewaki, Katsunori] Natl Def Med Coll, Dept Internal Med, Div Antiaging & Vasc Med, Tokorozawa, Saitama 359, Japan	Ishikawa, T (reprint author), Saitama Cardiovasc Resp Ctr, Div Cardiol, Kumagaya, Saitama, Japan.	tetsuya50ishikawa@gmail.com			Research Fund from Saitama Cardiovascular and Respiratory Center [10DR, 11DR, 12DR, 13DR]	This study was supported by a Research Fund from Saitama Cardiovascular and Respiratory Center under Grants 10DR, 11DR, 12DR, and 13DR.	Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; KITAMURA A, 1994, CIRCULATION, V89, P2533; Berrougui H, 2009, REJUV RES, V12, P117, DOI 10.1089/rej.2008.0840; Movva R, 2008, CLIN CHEM, V54, P788, DOI 10.1373/clinchem.2007.101923; Sarwar N, 2010, LANCET, V375, P1634; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Miyamoto-Sasaki M, 2013, J ATHEROSCLER THROMB, V20, P708; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Austen W G, 1975, Circulation, V51, P5; Cui RZ, 2007, ATHEROSCLEROSIS, V194, P415, DOI 10.1016/j.atherosclerosis.2006.08.022; Endo A, 2014, INTERNAL MED, V53, P819, DOI 10.2169/internalmedicine.53.1438; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Okamura T, 2010, ATHEROSCLEROSIS, V209, P290, DOI 10.1016/j.atherosclerosis.2009.09.012; Ralph B., 2007, CIRCULATION, V115, P2340; Yokoyama S, 2012, J ATHEROSCLER THROMB, V19, P207; Zhou HL, 2008, DIABETES-METAB RES, V24, P617, DOI 10.1002/dmrr.895	19	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	SEP	2015	242	1					318	322		10.1016/j.atherosclerosis.2015.06.028		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CP7WU	WOS:000360100900049		
J	Hsu, PW; Ai, M; Kanda, E; Yu, NC; Chen, HL; Chen, HW; Cheng, MH; Kohzuma, T; Schaefer, EJ; Yoshida, M				Hsu, Powen; Ai, Masumi; Kanda, Eiichiro; Yu, Neng-Chun; Chen, Hsiao-Lien; Chen, Huan-Wen; Cheng, Ming-Hui; Kohzuma, Takuji; Schaefer, Ernst J.; Yoshida, Masayuki			A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan	ATHEROSCLEROSIS			English	Article						Glycated albumin; Glycosylated hemoglobin; Glucose lowering medication; Taiwan; Reference range; Atherosclerosis; Prevention	DENSITY-LIPOPROTEIN CHOLESTEROL; BLOOD-GLUCOSE CONTROL; CARDIOVASCULAR-DISEASE; JAPANESE POPULATION; ALPHA-CYCLODEXTRIN; GLYCEMIC CONTROL; SERUM; COMPLICATIONS; ASSOCIATION; EXCURSION	Objective: Glycated albumin (GA) values reflect an average plasma glucose level over approximately 2-4 weeks, and the assay is stable and can be run on serum or plasma. The aim of this study was to determine the universality and the clinical utility of GA in screening for diabetes mellitus. Methods: Subjects consisted of 2192 male and female residents in Yi-lan County, Northern Taiwan (mean age 60.1 years), of whom 54.2% (n = 1188) had previously been diagnosed and treated for diabetes. Fasting blood samples were obtained to measure HbA1c, plasma glucose, serum GA, insulin, and measures of kidney and liver function. The reference values for these parameters were determined. Data from patients with diabetes and non-diabetic controls were also compared. Results: Mean GA values were 13.8% in controls and 18.1% in diabetic subjects (31.2% higher, p < 0.0001), while mean HbA1c values were 5.6% in controls and 7.2% in diabetic subjects (29.2% higher, p < 0.0001). The 95th percentile values for GA and HbA1c in controls were 16.1% and 6.2%, respectively. Our suggested GA and HbA1c cut-points for prediabetes at the 75th percentile of the normal population would be 14.6% and 5.8%, respectively. For both parameters, values greater than these cut-points provided a reasonable degree of specificity and sensitivity for risk of having diabetes, while a GA value of 16.5% corresponds to an HbA1c level of 6.5%, diagnostic of diabetes. Conclusion: These data indicate that GA values can be used as a surrogate parameter for HbA1c in screening for prediabetes and diabetes mellitus. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Hsu, Powen; Ai, Masumi; Kanda, Eiichiro; Yoshida, Masayuki] Tokyo Med & Dent Univ, Grad Sch Med, Dept Life Sci & Bioeth, Tokyo 1138519, Japan; [Hsu, Powen] Luodong Poh Ai Hosp, Dept Gen Internal Med, Luodong, Taiwan; [Ai, Masumi] Tokyo Med & Dent Univ, Grad Sch Med, Dept Insured Med Care Management, Tokyo 1138519, Japan; [Kanda, Eiichiro] Tokyo Kyosai Hosp, Dept Nephrol, Tokyo, Japan; [Yu, Neng-Chun] Neng Chun Diabet Clin, Yi Lan, Taiwan; [Chen, Hsiao-Lien; Chen, Huan-Wen] Luodong Poh Ai Hosp, Dept Endocrinol & Metab, Luodong, Taiwan; [Cheng, Ming-Hui] Luodong Poh Ai Hosp, Dept Lab Med, Luodong, Taiwan; [Kohzuma, Takuji] Asahi Kasei Pharma Corp, Diagnost Dept, Tokyo, Japan; [Schaefer, Ernst J.] Tufts Univ, Human Nutr Res Ctr Aging, Cardiovasc Nutr Lab, Boston, MA 02111 USA	Ai, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Insured Med Care Management, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	ai.vasc@tmd.ac.jp			Luodong Poh-ai Hospital, Luodong, Taiwan [1434020015]	This study was supported by the research funding of the Luodong Poh-ai Hospital (1434020015), Luodong, Taiwan.	Patel A, 2008, NEW ENGL J MED, V358, P2560; Ai M, 2009, CLIN CHIM ACTA, V406, P71, DOI 10.1016/j.cca.2009.05.015; American Diabetes Association, 2014, DIABETES CARE S1, V37, pS81, DOI DOI 10.2337/DC14-S081; American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; Furusyo N, 2013, BBA-GEN SUBJECTS, V1830, P5509, DOI 10.1016/j.bbagen.2013.05.010; Furusyo N, 2013, INT J CARDIOL, V167, P2066, DOI 10.1016/j.ijcard.2012.05.045; Takahashi S, 2007, ENDOCR J, V54, P139, DOI 10.1507/endocrj.K06-103; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; Kouzuma T, 2004, CLIN CHIM ACTA, V346, P135, DOI 10.1016/j.cccn.2004.02.019; Suwa T, 2010, ENDOCR J, V57, P135; Kawasaki R, 2011, DIABETOLOGIA, V54, P2288, DOI 10.1007/s00125-011-2199-0; Selvin E, 2011, DIABETES CARE, V34, P960, DOI 10.2337/dc10-1945; Yoshiuchi K, 2008, ENDOCR J, V55, P503, DOI 10.1507/endocrj.K07E-089; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; DELAHANTY LM, 1993, DIABETES CARE, V16, P1453, DOI 10.2337/diacare.16.11.1453; Sugiuchi H, 1998, CLIN CHEM, V44, P522; Furusyo N, 2011, DIABETOLOGIA, V54, P3028, DOI 10.1007/s00125-011-2310-6; Selvin E, 2004, ANN INTERN MED, V141, P421; Kouzuma T, 2002, CLIN CHIM ACTA, V324, P61, DOI 10.1016/S0009-8981(02)00207-3; Chiou S.T., 2001, CLIN PRACT, V54, P67; GUTHROW CE, 1979, P NATL ACAD SCI USA, V76, P4258, DOI 10.1073/pnas.76.9.4258; International Diabetes Federation, IDF DIABETES ATLAS; Kannel W.B., 1979, JAMA-J AM MED ASSOC, V241, P2053; Lu L, 2007, CLIN BIOCHEM, V40, P810, DOI 10.1016/j.clinbiochem.2007.03.022; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Nathan DM, 2011, CLIN CHEM, V57, P286, DOI 10.1373/clinchem.2010.150250; Preis SR, 2013, DIABETES CARE, V36, P1590, DOI 10.2337/dc12-1121; Taiwan Ministry of health and welfare, 2013, STATISTICS OF CAUSES; The Diabetes Association of the R.O.C, SUMMARY OF CLINICAL; The international Expert Committee, 2009, DIABETES CARE, V32, P1328; Tominaga Makoto, 2006, Journal of the Japan Diabetes Society, V49, P825; Tsai LY, 2001, CLIN CHEM, V47, P756; Turner RC, 1998, LANCET, V352, P837	33	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	SEP	2015	242	1					327	333		10.1016/j.atherosclerosis.2015.07.037		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CP7WU	WOS:000360100900051		
J	Tsushima, F; Sakurai, J; Harada, H				Tsushima, F.; Sakurai, J.; Harada, H.			A case of upper gingiva carcinoma with chronic graft-versus-host disease after allogenic bone marrow transplantation	AUSTRALIAN DENTAL JOURNAL			English	Article						Allogenic bone marrow transplantation; chronic graft-versus-host disease; oral cavity; squamous cell carcinoma	STEM-CELL TRANSPLANTATION; MALIGNANCIES; CANCERS	Oral squamous cell carcinoma (OSCC) is one of the most common solid tumours occurring after haematopoietic stem cell transplantation (HSCT), especially in patients with chronic graft-versus-host-disease (cGVHD). We describe a case of OSCC that developed in a 51-year-old male 22years after he had received allogeneic HSCT from his human leukocyte antigen-identical sister as a treatment for acute myelocytic leukaemia. The patient had presented with multiple white patchy lesions on the palatal gingiva and mucosa 16years after HSCT; these lesions were consistent with the clinical features of cGVHD. Six years later, oral examination and biopsy revealed upper gingival squamous cell carcinoma (SCC) in areas of cGVHD, and he underwent tumour excision. Follow-up examination at 2years and 4months after the operation revealed no evidence of recurrence of local SCC or metastasis of the cervical lymph node. The current case highlights the susceptibility of patients with cGVHD to the development of OSCC even two decades after HSCT. Therefore, we recommend careful long-term follow-up of the oral cavity for patients with cGVHD.	[Tsushima, F.; Sakurai, J.; Harada, H.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Oral & Maxillofacial Surg, Tokyo 1138549, Japan	Tsushima, F (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Oral & Maxillofacial Surg,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	ft.osur@tmd.ac.jp					Curtis RE, 1997, NEW ENGL J MED, V336, P897, DOI 10.1056/NEJM199703273361301; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Deeg HJ, 1998, BLOOD, V91, P1833; Curtis RE, 2005, BLOOD, V105, P3802, DOI 10.1182/blood-2004-09-3411; Yokota A, 2012, BONE MARROW TRANSPL, V47, P95, DOI 10.1038/bmt.2011.23; Demarosi F, 2005, ORAL ONCOL, V41, P865, DOI 10.1016/j.oralocology.2005.02.001; Mawardi H, 2011, BONE MARROW TRANSPL, V46, P884, DOI 10.1038/bmt.2011.77	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0421	1834-7819		AUST DENT J	Aust. Dent. J.	SEP	2015	60	3					404	407		10.1111/adj.12343		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ5DY	WOS:000360624700018		
J	Horie, N; Kawano, R; Kaneko, T; Shimoyama, T				Horie, N.; Kawano, R.; Kaneko, T.; Shimoyama, T.			Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis	AUSTRALIAN DENTAL JOURNAL			English	Article						Gingiva; lymphoproliferative disorder; methotrexate	EPSTEIN-BARR-VIRUS; DISEASE; REGRESSION; INFECTION	Methotrexate (MTX) is the primary drug used in the management of rheumatoid arthritis (RA) and other immune-mediated inflammatory diseases. MTX is a strong immunosuppressive agent and has been reported to cause iatrogenic immunodeficiency-associated lymphoproliferative disorders (LPDs). Stomatitis caused by MTX-related cytotoxicity may occur, but gingival MTX-related LPDs are rare. In this article we present a case of gingival MTX-related LPD in a 60-year-old male with RA. The local findings of the gingival ulceration and alveolar bone exposure were similar to those of bisphosphonate-related osteonecrosis of the jaw. However, he had never received bisphosphonate therapy. The biopsy specimen of the gingival lesion was diagnosed as diffuse large B-cell lymphoma with Epstein-Barr virus positivity. Immediate withdrawal of MTX resulted in marked remission of the LPD.	[Horie, N.; Kawano, R.; Kaneko, T.; Shimoyama, T.] Saitama Med Univ, Saitama Med Ctr, Dept Oral & Maxillofacial Surg, Saitama, Japan	Horie, N (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Oral & Maxillofacial Surg, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	horien@saitama-med.ac.jp					Rizzi R, 2009, MED ONCOL, V26, P1, DOI 10.1007/s12032-008-9069-8; Hoshida Y, 2007, J RHEUMATOL, V34, P322; Salloum E, 1996, J CLIN ONCOL, V14, P1943; Yamakawa N, 2014, J RHEUMATOL, V41, P293, DOI 10.3899/jrheum.130270; Kalantzis A, 2005, ORAL SURG ORAL MED O, V100, P52, DOI 10.1016/j.tripleo.2004.08.020; Kudoh M, 2014, OR SURG OR MED OR PA, V118, pE105, DOI 10.1016/j.oooo.2014.02.029; Mariette X, 2002, BLOOD, V99, P3909, DOI 10.1182/blood.V99.11.3909; Ichikawa A, 2013, EUR J HAEMATOL, V91, P20, DOI 10.1111/ejh.12116; Hoshida Y, 2004, INT J CANCER, V108, P443, DOI 10.1002/ijc.11582; Ishida M, 2013, INT J CLIN EXP PATHO, V6, P2237; Kikuchi Kentaro, 2010, Head Neck Pathol, V4, P305, DOI 10.1007/s12105-010-0202-6; Lescaille G, 2013, J RHEUMATOL, V40, P781, DOI 10.3899/jrheum.120810; RomAo VC, 2013, BMC MED, V23, P11; Sohlberg E, 2013, J IMMUNOL, V191, P5669, DOI 10.4049/jimmunol.1301343; Tanaka A, 2008, J ORAL MAXIL SURG, V66, P1492, DOI 10.1016/j.joms.2007.05.006; Uneda S, 2008, INTERNAL MED, V47, P1445, DOI 10.2169/internalmedicine.47.0989	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0421	1834-7819		AUST DENT J	Aust. Dent. J.	SEP	2015	60	3					408	411		10.1111/adj.12235		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ5DY	WOS:000360624700019		
J	Momota, Y; Kani, K; Takano, H; Azuma, M				Momota, Y.; Kani, K.; Takano, H.; Azuma, M.			Cerebellopontine angle mass mimicking lingual nerve injury after dental implant placement: a case report	AUSTRALIAN DENTAL JOURNAL			English	Article						Cerebellopontine angle mass; dental implant placement; lingual nerve injury	OF-THE-LITERATURE; TRIGEMINAL NEURALGIA; EPIDERMOID TUMOR; SURGERY; PAIN; DECOMPRESSION; DIAGNOSIS	This is a rare case report of a cerebellopontine angle (CPA) mass mimicking lingual nerve injury after a dental implant placement. Lingual nerve injury is a common complication following dental implant placement. CPA masses are likely to cause symptomatic trigeminal neuralgia, and thus can mimic and be easily confused with oral diseases. We experienced a case of CPA mass mimicking lingual nerve injury after dental implant placement. The patient was a 57-year-old Japanese female who complained of glossalgia. She underwent dental implant placement in the mandible before visiting our clinic. Panoramic x-ray radiography revealed no abnormalities; the salivary flow rate by gum test was 7.0 ml/10 min. She was diagnosed with lingual nerve injury and secondary burning mouth syndrome. Vitamin B12 and oral moisturizer did not provide relief; furthermore, numbness in the lower lip emerged. A Semmes Weinstein test demonstrated elevation of her sensitivity threshold. Finally, magnetic resonance imaging revealed a 20-mm diameter mass in the CPA. The patient is now being followed under conservative management. Our experience underscores the importance of including CPA mass in the differential diagnosis of dental diseases.	[Momota, Y.; Kani, K.; Takano, H.; Azuma, M.] Univ Tokushima, Grad Fac Dent, Inst Hlth Biosci, Dept Oral Med, Tokushima, Japan	Momota, Y (reprint author), Kuramoto 3-18-15, Tokushima 7708504, Japan.	momota@tokushima-u.ac.jp			Japan Society for the Promotion of the Science [25463247]	This work was supported by Japan Society for the Promotion of the Science KAKENHI, Grant No. 25463247.	AKSIK I, 1993, ACTA NEUROCHIR, V125, P64, DOI 10.1007/BF01401830; Alhassani AA, 2010, J ORAL IMPLANTOL, V36, P401, DOI 10.1563/AAID-JOI-D-09-00059; Chan HL, 2010, J PERIODONTOL, V81, P372, DOI 10.1902/jop.2009.090506; Rodriguez-Lozano FJ, 2010, ORAL SURG ORAL MED O, V109, pE8, DOI 10.1016/j.tripleo.2009.12.004; Robinson PP, 2000, BRIT J ORAL MAX SURG, V38, P255, DOI 10.1054/bjom.2000.0463; KIPP DP, 1980, J AM DENT ASSOC, V100, P185; BEDERSON JB, 1989, J NEUROSURG, V71, P359, DOI 10.3171/jns.1989.71.3.0359; Scala A, 2003, CRIT REV ORAL BIOL M, V14, P275; ELLIES LG, 1992, J PROSTHET DENT, V68, P664, DOI 10.1016/0022-3913(92)90384-M; Apfelbaum R I, 1983, Clin Neurosurg, V31, P351; BULLITT E, 1986, J NEUROSURG, V64, P865, DOI 10.3171/jns.1986.64.6.0865; CHENG TMW, 1993, NEUROLOGY, V43, P2298; Cirak Bayram, 2004, Pain Physician, V7, P129; Desai K, 2003, NEUROL INDIA, V51, P288; Ellies L G, 1993, Int J Oral Maxillofac Implants, V8, P674; Fujita N, 1998, AM J NEURORADIOL, V19, P333; Fukuda K, 2012, INT J DENT, V2012; Graff-Radford SB, 2003, HEADACHE, V43, P975, DOI 10.1046/j.1526-4610.2003.03189.x; Holzle FW, 2001, INT J ORAL MAX SURG, V30, P333, DOI 10.1054/ijom.2001.0064; International Headache Society, 2004, CEPHALALGIA, V24, P9; IWASAKI K, 1992, NEUROSURGERY, V30, P916; Khan J, 2010, CRANIO, V28, P205; Klieb HBE, 2008, J CAN DENT ASSOC, V74, P63; LaBanc JP, 1992, ORAL MAXILLOFAC SURG, V4, P285; Lewis MA, 2007, ORAL SURG ORAL M S32, V103, pe1; Momota Y, 2012, JPN J OROFAC PAIN, V5, P27; Nishiura I, 1989, Neurol Med Chir (Tokyo), V29, P600, DOI 10.2176/nmc.29.600; Pogrel M A, 1999, J Calif Dent Assoc, V27, P534; Pogrel M A, 1993, J Calif Dent Assoc, V21, P50; Rasmussen RV, 2004, PAIN, V110, P461; Scrivani SJ, 2005, ORAL SURG ORAL MED O, V100, P527, DOI 10.1016/j.tripleo.2005.06.004; TAYLOR JC, 1981, POSTGRAD MED J, V57, P16; Vickers E R, 2000, Aust Endod J, V26, P19; Zakrzewska JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g474; Zuniga JR, 1992, ORAL MAXILLOFAC SURG, V4, P353	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0421	1834-7819		AUST DENT J	Aust. Dent. J.	SEP	2015	60	3					412	415		10.1111/adj.12224		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ5DY	WOS:000360624700020		
J	Hosoya, S; Suetake, H; Suzuki, Y; Kikuchi, K				Hosoya, Sho; Suetake, Hiroaki; Suzuki, Yuzuru; Kikuchi, Kiyoshi			Genetic Basis Underlying Behavioral Correlation Between Fugu Takifugu rubripes and a Closely Related Species, Takifugu niphobles	BEHAVIOR GENETICS			English	Article						Temperament traits; Behavior syndrome; Fugu; Takifugu; QTL analysis	FALSE DISCOVERY RATE; PERSONALITY-TRAITS; ANIMAL PERSONALITY; DRD4 GENE; EVOLUTION; SELECTION; GENOME; TEMPERAMENT; ARCHITECTURE; EXPLORATION	Correlated suits of behaviors (behavioral syndrome) are commonly observed in both inter- and intraspecific studies. In order to understand the genetic basis of such a correlation between species, we compared ten behaviors classified into five categories (acclimation, feeding, normal swimming, reaction to a novel object and activity in a novel environment) between two pufferfish species, Takifugu rubripes and T. niphobles. The two species showed consistent differences in nine behaviors with a significant correlation among behaviors. Quantitative trait locus (QTL) analysis using second generation hybrids revealed that different sets of small effect QTL are associated with the observed interspecific behavioral disparity. This indicates that correlations in temperament traits between them are governed by many genes with small effects, and each behavior has been selected to form particular combination patterns. One of the QTL showing small pleiotropic effect includes the Drd4 gene known for its association with behavioral traits in some animal taxa including mammals.	[Hosoya, Sho; Suzuki, Yuzuru; Kikuchi, Kiyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Fisheries Lab, Hamamatsu, Shizuoka 4310214, Japan; [Suetake, Hiroaki] Fukui Prefectural Univ, Dept Marine Biosci, Obama, Fukui 9170003, Japan	Hosoya, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Fisheries Lab, 2971-4 Bentenjima, Hamamatsu, Shizuoka 4310214, Japan.	ahosoya@mail.ecc.u-tokyo.ac.jp			Japanese Society for the Promotion of Science	The authors thank Naoki Mizuno, Yuka Jo and Masashi Fujita (University of Tokyo) for technical support. This research was funded by Grants-in-Aid for Scientific Research, Japanese Society for the Promotion of Science (to S.H., H.S., Y.S. and K.K.).	Achiha Hideaki, 2006, Suisan Zoshoku, V54, P25; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; MANTEL N, 1967, CANCER RES, V27, P209; Kukekova AV, 2011, BEHAV GENET, V41, P593, DOI 10.1007/s10519-010-9418-1; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Kirkpatrick M, 2014, GENETICS, V197, P531, DOI 10.1534/genetics.113.156026; Bell AM, 2007, P R SOC B, V274, P755, DOI 10.1098/rspb.2006.0199; Pruitt JN, 2008, ANIM BEHAV, V76, P871, DOI 10.1016/j.anbehav.2008.05.009; Yamanoue Y, 2009, MOL BIOL EVOL, V26, P623, DOI 10.1093/molbev/msn283; Boehmler W, 2007, GENES BRAIN BEHAV, V6, P155, DOI 10.1111/j.1601-183X.2006.00243.x; Fidler AE, 2007, P R SOC B, V274, P1685, DOI 10.1098/rspb.2007.0337; Ingley SJ, 2014, TRENDS ECOL EVOL, V29, P369, DOI 10.1016/j.tree.2014.04.008; Solberg LC, 2004, MAMM GENOME, V15, P648, DOI 10.1007/s00335-004-2326-z; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Van Oers K, 2008, ANIM BEHAV, V76, P555, DOI 10.1016/j.anbehav.2008.03.011; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; Kobler A, 2011, BEHAVIOUR, V148, P603, DOI 10.1163/000579511X572035; Richardson JML, 2001, BEHAV ECOL, V12, P51; van Oers K, 2010, PHILOS T R SOC B, V365, P3991, DOI 10.1098/rstb.2010.0178; Poissant J, 2013, ECOL EVOL, V3, P474, DOI 10.1002/ece3.468; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Brodin T, 2004, ECOLOGY, V85, P2927, DOI 10.1890/03-3120; Yamahira K, 1996, ENVIRON BIOL FISH, V45, P311, DOI 10.1007/BF00003100; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Adriaenssens B, 2013, ECOL LETT, V16, P47, DOI 10.1111/ele.12011; Kai W, 2005, GENETICS, V171, P227, DOI 10.1534/genetics.105.042051; Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Carter AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042440; Gutierrez-Gil B, 2008, J HERED, V99, P629, DOI 10.1093/jhered/esn060; Hosoya S, 2013, INT J PARASITOL, V43, P909, DOI 10.1016/j.ijpara.2013.06.006; Hosoya S, 2013, EVOLUTION, V67, P590, DOI 10.1111/j.1558-5646.2012.01781.x; Ito H, 2004, J VET MED SCI, V66, P815, DOI 10.1292/jvms.66.815; Ito M, 1998, NIPPON SUISAN GAKK, V64, P435; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kirschner J, 2012, AGING CELL, V1, P252; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Laine VN, 2014, BEHAV GENET, V44, P77, DOI 10.1007/s10519-013-9624-8; Magnhagen D, 2008, ANIM BEHAV, V75, P509; Nehrenberg DL, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-113; Shimada MK, 2004, BIOCHEM BIOPH RES CO, V316, P1186, DOI 10.1016/j.bbrc.2004.03.006	53	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-8244	1573-3297		BEHAV GENET	Behav. Genet.	SEP	2015	45	5					560	572		10.1007/s10519-015-9728-4		13	Behavioral Sciences; Genetics & Heredity; Psychology, Multidisciplinary	Behavioral Sciences; Genetics & Heredity; Psychology	CQ8FB	WOS:000360840800007		
J	Morishige, Y; Fujimori, K; Amano, F				Morishige, Yuta; Fujimori, Ko; Amano, Fumio			Use of Flow Cytometry for Quantitative Analysis of Metabolism of Viable but Non-culturable (VBNC) Salmonella	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						viable but non-culturable (VBNC); Salmonella; flow cytometry	GLUCOSE-UPTAKE ACTIVITY; ESCHERICHIA-COLI-CELLS; NONCULTURABLE STATE; PROPIDIUM MONOAZIDE; UNITED-STATES; BACTERIA; ENTERICA; STRESS; PCR; DESICCATION	A simple and rapid assay method for analysis of the metabolic activity of viable but non-culturable (VBNC) Salmonella was established. An environmental isolate of Salmonella Enteritidis (SE), grown to the logarithmic phase, rapidly lost its culturability during incubation with 1-10 mm H2O2 in Luria-Bertani (LB) medium. To assess the viability of the bacteria, we measured 3 different metabolic activities: Respiratory activity by 5-cyano-2,3-ditolyl-tetrazolium chloride (CTC) reduction, glucose uptake assessed with 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose (2-NBDG), and DNA synthesis activity evaluated by 5-ethynyl-2'-deoxyuridine (EdU) incorporation. These activities were analyzed by both confocal laser-scanning microscopy and flow cytometry, together with colony-formation assays on LB-agar plates. The results showed that some of the H2O2-treated SE cells were in the VBNC state and that the extent of H2O2-induced decrease in each metabolic activity varied according to the activity. That is, glucose-uptake activity was not markedly changed, being kept at the highest level; whereas the respiratory activity was less than that of the glucose-uptake, and DNA synthesis activity was the lowest among them. These results suggest that the VBNC state might be characterized by different metabolic activities that vary and correspond to the kind and strength of the stress, threatening bacterial survival in an adverse environment.	[Morishige, Yuta; Fujimori, Ko; Amano, Fumio] Osaka Univ Pharmaceut Sci, Lab Biodefense & Regulat, Takatsuki, Osaka 5691094, Japan	Amano, F (reprint author), Osaka Univ Pharmaceut Sci, Lab Biodefense & Regulat, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	amano@gly.oups.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21590141]	This work was in a part supported by a Grant-in-Aid for the Promotion of Science (21590141) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alonso JL, 2002, APPL ENVIRON MICROB, V68, P5151, DOI 10.1128/AEM.68.10.5151-5154.2002; Natarajan A, 2000, J MICROBIOL METH, V42, P87, DOI 10.1016/S0167-7012(00)00180-9; Yoshioka K, 1996, BIOSCI BIOTECH BIOCH, V60, P1899; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; RODRIGUEZ GG, 1992, APPL ENVIRON MICROB, V58, P1801; Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069; KOGURE K, 1979, CAN J MICROBIOL, V25, P415; Morishige Y, 2013, MICROBES ENVIRON, V28, P180, DOI 10.1264/jsme2.ME12174; Ferullo DJ, 2009, METHODS, V48, P8, DOI 10.1016/j.ymeth.2009.02.010; Pedersen TB, 2008, AVIAN PATHOL, V37, P421, DOI 10.1080/03079450802216561; Vattakaven T, 2006, APPL ENVIRON MICROB, V72, P6508, DOI 10.1128/AEM.00798-06; Elgrably-Weiss M, 2002, J BACTERIOL, V184, P3774, DOI 10.1128/JB.184.14.3774-3784.2002; Hiramatsu R, 2005, APPL ENVIRON MICROB, V71, P6657, DOI 10.1128/AEM.71.11.6657-6663.2005; Xiao XL, 2013, CAN J MICROBIOL, V59, P157, DOI 10.1139/cjm-2012-0577; Braden CR, 2006, CLIN INFECT DIS, V43, P512, DOI 10.1086/505973; Conway T, 2003, MOL MICROBIOL, V47, P879, DOI 10.1046/j.1365-2958.2003.03338.x; Lleo MD, 2000, APPL ENVIRON MICROB, V66, P4564; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Berney M, 2006, MICROBIOL-SGM, V152, P1719, DOI 10.1099/mic.0.28617-0; Willenburg E, 2012, INT J FOOD MICROBIOL, V160, P131, DOI 10.1016/j.ijfoodmicro.2012.09.012; TAYLOR IW, 1980, J HISTOCHEM CYTOCHEM, V28, P1224; Asakura H, 2008, RES MICROBIOL, V159, P709, DOI 10.1016/j.resmic.2008.08.005; Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726; Cappelier JM, 1997, VET RES, V28, P547; Hedican E, 2009, JAMA-J AM MED ASSOC, V301, P818; Colwell R, 1985, NAT BIOTECHNOL, V3, P817, DOI [10.1038/nbt0985-817, DOI 10.1038/NBT0985-817]; Colwell R R, 2000, J Infect Chemother, V6, P121, DOI 10.1007/PL00012151; Dimitriadis G, 2005, CYTOM PART A, V64A, P27, DOI 10.1002/cyto.a.20108; Dinu LD, 2011, APPL ENVIRON MICROB, V77, P8295, DOI 10.1128/AEM.05020-11; Fakruddin M, 2013, ISRN MICROBIOL, V2013, P703; Imamura D, 2015, MICROBIOL IMMUNOL, V59, P305, DOI 10.1111/1348-0421.12246; Infectious Disease Surveillance Center, 2009, 308 IASR NAT I INF D; Kusumoto A, 2012, MICROBIOL IMMUNOL, V56, P228, DOI 10.1111/j.1348-0421.2012.00428.x; Little CL, 2008, J FOOD PROTECT, V71, P19; Wong HC, 2008, J FOOD PROTECT, V71, P416; Pawlowski DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017585; Terai S, 2005, BIOSCI MICROFLORA, V24, P113; van Frankenhuyzen JK, 2011, J MICROBIOL METH, V87, P263, DOI 10.1016/j.mimet.2011.09.007	39	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1255	1264				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300001		
J	Tsuji, Y; Iwanaga, N; Mizoguchi, A; Sonemoto, E; Hiraki, Y; Ota, Y; Kasai, H; Yukawa, E; Ueki, Y; To, H				Tsuji, Yasuhiro; Iwanaga, Nozomi; Mizoguchi, Akiko; Sonemoto, Emi; Hiraki, Yoichi; Ota, Yukio; Kasai, Hidefumi; Yukawa, Eiji; Ueki, Yukitaka; To, Hideto			Population Pharmacokinetic Approach to the Use of Low Dose Cyclosporine in Patients with Connective Tissue Diseases	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						cyclosporine; connective tissue disease; dosing strategy; nonlinear mixed effects modeling; population pharmacokinetics	SYSTEMIC-LUPUS-ERYTHEMATOSUS; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; IDIOPATHIC NEPHROTIC SYNDROME; PREDNISOLONE METABOLISM; THERAPY; MICROEMULSION; TRIAL; FORMULATION; NEPHRITIS; EFFICACY	This study describes the population pharmacokinetics and dose personalization of cyclosporine in 36 patients with connective tissue diseases. A one-compartment open model with absorption was adopted as a pharmacokinetic model, and a nonlinear mixed effects model was used to analyze the population pharmacokinetic models. In the final model, age (AGE) and total body weight (TBW) were influential covariates on clearance (CL/F), which was expressed as CL/F (L/h)=17.8x(AGE/60)(-0.269)x(TBW/46.9)(0.408), in addition to the volume of distribution (Vd/F), (L)=98.0 and absorption rate constant (K-a) (h(-1))=0.67 (fixed). The results of the present study provide novel insights into factors involved in determining the most suitable dose and dosing strategy for individual patients with connective tissue disease.	[Tsuji, Yasuhiro; Ota, Yukio; Kasai, Hidefumi; To, Hideto] Univ Toyama, Fac Pharmaceut Sci, Dept Med Pharmaceut, Sugitani, Toyama 9300194, Japan; [Iwanaga, Nozomi; Ueki, Yukitaka] Sasebo Chuo Hosp, Dept Rheumatol, Nagasaki 8571195, Japan; [Mizoguchi, Akiko; Sonemoto, Emi] Sasebo Chuo Hosp, Dept Pharm, Nagasaki 8571195, Japan; [Hiraki, Yoichi] Natl Hosp Org, Kumamoto Med Ctr, Dept Pharm, Kumamoto 8600008, Japan; [Kasai, Hidefumi] Certara GK, Minato Ku, Tokyo 1050001, Japan; [Yukawa, Eiji] Daiichi Univ Pharm, Lab Evidence Based Pharmacotherapy, Minami Ku, Fukuoka 8158511, Japan	Tsuji, Y (reprint author), Univ Toyama, Fac Pharmaceut Sci, Dept Med Pharmaceut, Sugitani, Toyama 9300194, Japan.	ytsuji@pha.u-toyama.ac.jp			Research Foundation for Pharmaceutical Sciences of Japan	This work was partially supported by a Grant-in-Aid from the Research Foundation for Pharmaceutical Sciences of Japan.	Nagai K, 2011, MOD RHEUMATOL, V21, P32, DOI 10.1007/s10165-010-0342-2; SAEKI T, 1993, J BIOL CHEM, V268, P6077; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; MASUDA K, 1989, LANCET, V1, P1093; Moroni G, 2006, CLIN J AM SOC NEPHRO, V1, P925, DOI 10.2215/CJN.02271205; Takeda A, 2007, NEPHROLOGY, V12, P197, DOI 10.1111/j.1440-1797.2007.00773.x; Parke J, 1999, COMPUT METH PROG BIO, V59, P19, DOI 10.1016/S0169-2607(98)00098-4; Lown KS, 1997, CLIN PHARMACOL THER, V62, P248, DOI 10.1016/S0009-9236(97)90027-8; Hooker AC, 2007, PHARM RES, V24, P2187, DOI 10.1007/s11095-007-9361-x; Cattran DC, 1999, KIDNEY INT, V56, P2220, DOI 10.1046/j.1523-1755.1999.00778.x; Beal SL, 1999, NONMEM USERS GUIDES; Callen JP, 2003, J AM ACAD DERMATOL, V49, P897, DOI 10.1067/S0190-9622(03)01870-X; Filler G, 2005, NEPHROL DIAL TRANSPL, V20, P1032, DOI 10.1093/ndt/gfh803; Fu LW, 1998, BRIT J RHEUMATOL, V37, P217; Johnson AE, 1996, LANCET, V347, P367, DOI 10.1016/S0140-6736(96)90539-5; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; LANGHOFF E, 1985, P EUR DIAL TRANS, V21, P963; LINDHOLM A, 1988, EUR J CLIN PHARMACOL, V34, P461, DOI 10.1007/BF01046702; Meyrier A, 1997, J NEPHROL, V10, P14; Morton SJ, 2000, ANN RHEUM DIS, V59, P487, DOI 10.1136/ard.59.6.487; MUELLER EA, 1994, PHARMACEUT RES, V11, P301, DOI 10.1023/A:1018923912135; Ogawa H, 2010, LUPUS, V19, P162, DOI 10.1177/0961203309350320; Ogawa Hiroe, 2007, Mod Rheumatol, V17, P92, DOI 10.1007/s10165-006-0545-8; OST L, 1987, TRANSPLANTATION, V44, P533; PTACHCINSKI RJ, 1986, CLIN PHARMACOKINET, V11, P107; Rinaldi S, 2005, PEDIATR NEPHROL, V20, P25, DOI 10.1007/s00467-004-1618-6; TOKUDA M, 1994, ARTHRITIS RHEUM, V37, P551, DOI 10.1002/art.1780370416; TUGWELL P, 1990, LANCET, V335, P1051, DOI 10.1016/0140-6736(90)92630-Z; Tune BM, 1997, J AM SOC NEPHROL, V8, P824; WALDO FB, 1987, PEDIATR NEPHROL, V1, P180; Xiaoli Du, 2009, J Clin Pharmacol, V49, P782, DOI 10.1177/0091270009337132; Yoshida K, 2001, TRANSPLANT P, V33, P3146, DOI 10.1016/S0041-1345(01)02340-5	32	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1265	1271				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300002		
J	Tanaka, S; Hosokawa, M; Ueda, K; Iwakawa, S				Tanaka, Shota; Hosokawa, Mika; Ueda, Kumiko; Iwakawa, Seigo			Effects of Decitabine on Invasion and Exosomal Expression of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						colorectal cancer (CRC); invasion; decitabine; exosome; microRNA; oxaliplatin resistance	EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; REPRESSORS ZEB1; TARGETING ZEB1; LINES; DEMETHYLATION; MIGRATION; FAMILY; INHIBITORS	The effects of decitabine (DAC), a DNA methyltransferase (DNMT) inhibitor, on metastasis and exosomal expression of microRNAs were examined in SW620/OxR cells, a human colorectal cancer (CRC) cell line (SW620) with acquired resistance to oxaliplatin. This cell line shows an invasive phenotype by epithelial-mesenchymal transition. Two CRC cell lines, SW480, derived from primary CRC, and SW620, derived from lymph node metastasis, which were obtained from the same patient, as well as SW620/OxR, were also used in the present study. Cytarabine (Ara-C), a non-DNMT-inhibiting cytidine analog, was used as negative control of DAC. No significant difference was observed in the invasion abilities of SW480 cells treated with DAC or Ara-C. On the other hand, invasion ability was suppressed by treatment with DAC in SW620 and SW620/OxR cells. Up-regulated expression of E-cadherin, microRNA-200c (miR-200c), and miR-141 following DAC treatment indicated the acquisition of epithelial cell-like characteristics in SW620 and SW620/OxR cells. Exosomal expression levels of miR-200c and miR-141 were also up-regulated by DAC treatment in SW620 and SW620/OxR but not in SW480 cells. This increase in exosomal miRNA expression negatively correlated with invasion ability. These results suggest that DNA demethylation treatment caused acquisition of epithelial cell-like characteristics in SW620 and SW620/OxR cells. Furthermore, the observed increased exosomal expression of miR-200c and miR-141 may be an indicator or biomarker candidate for mesenchymal epithelial transition of CRC cells.	[Tanaka, Shota; Hosokawa, Mika; Ueda, Kumiko; Iwakawa, Seigo] Kobe Pharmaceut Univ, Dept Pharmaceut, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Hosokawa, M (reprint author), Kobe Pharmaceut Univ, Dept Pharmaceut, Higashinada Ku, 4-19-1 Motoyamakita, Kobe, Hyogo 6588558, Japan.	ikehatam@kobepharma-u.ac.jp					Toiyama Y, 2014, ANN SURG, V259, P735, DOI 10.1097/SLA.0b013e3182a6909d; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Chen ML, 2012, CLIN EXP METASTAS, V29, P457, DOI 10.1007/s10585-012-9463-7; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Chik F, 2011, CARCINOGENESIS, V32, P224, DOI 10.1093/carcin/bgq221; Lin J, 2008, CANCER BIOL THER, V7, P1896, DOI 10.4161/cbt.7.12.6937; Cho CY, 2007, J CELL PHYSIOL, V213, P65, DOI 10.1002/jcp.21089; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Shin DY, 2012, ONCOL REP, V28, P1043, DOI 10.3892/or.2012.1858; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Soldevilla B, 2014, HUM MOL GENET, V23, P467, DOI 10.1093/hmg/ddt437; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Bathe E, 2000, NAT CELL BIOL, V2, P84; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Flis S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092305; Ikehata M, 2014, BIOL PHARM BULL, V37, P67; Kobayashi M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-4; Malentacchi F, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp383; Morelli MP, 2009, MOL CANCER THER, V8, P2546, DOI 10.1158/1535-7163.MCT-09-0380; Negrotto S, 2011, CANCER RES, V71, P1431, DOI 10.1158/0008-5472.CAN-10-2422; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Ren Jian-Zhen, 2010, Chin J Cancer, V29, P38; Tanaka S, 2015, BIOL PHARM BULL, V38, P435, DOI 10.1248/bpb.b14-00695; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Xiao WH, 2010, WORLD J GASTROENTERO, V16, P2371, DOI 10.3748/wjg.v16.i19.2371	33	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1272	1279				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300003		
J	Matsunaga, T; Kezuka, C; Morikawa, Y; Suzuki, A; Endo, S; Iguchi, K; Miura, T; Nishinaka, T; Terada, T; E-Kabbani, O; Hara, A; Ikari, A				Matsunaga, Toshiyuki; Kezuka, Chihiro; Morikawa, Yoshifumi; Suzuki, Ayaka; Endo, Satoshi; Iguchi, Kazuhiro; Miura, Takeshi; Nishinaka, Toru; Terada, Tomoyuki; E-Kabbani, Ossama; Hara, Akira; Ikari, Akira			Up-Regulation of Carbonyl Reductase 1 Renders Development of Doxorubicin Resistance in Human Gastrointestinal Cancers	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						carbonyl reductase 1; doxorubicin; drug resistance; gastrointestinal cancer cell; quercetin	ALDO-KETO REDUCTASES; KEAP1-NRF2 PATHWAY; OXIDATIVE STRESS; ANTHRACYCLINE ANTIBIOTICS; TISSUE DISTRIBUTION; GENE-EXPRESSION; MESSENGER-RNA; COLON-CANCER; MITOMYCIN-C; CELLS	Doxorubicin (DOX) is widely used for the treatment of a wide range of cancers such as breast and lung cancers, and malignant lymphomas, but is generally less efficacious in gastrointestinal cancers. The most accepted explanation for the DOX refractoriness is its resistance development. Here, we established DOX-resistant phenotypes of human gastric MKN45 and colon LoVo cells by continuous exposure to incremental concentrations of the drug. While the parental MKN45 and LoVo cells expressed carbonyl reductase 1 (CBR1) highly and moderately, respectively, the gain of DOX resistance further elevated the CBR1 expression. Additionally, the DOX-elicited cytotoxicity was lowered by overexpression of CBR1 and inversely strengthened by knockdown of the enzyme using small interfering RNA or pretreating with the specific inhibitor quercetin, which also reduced the DOX refractoriness of the two resistant cells. These suggest that CBR1 is a key enzyme responsible for the DOX resistance of gastrointestinal cancer cells and that its inhibitor is useful in the adjuvant therapy. Although CBR1 is known to metabolize DOX to a less toxic anticancer metabolite doxorubicinol, its overexpression in the parental cells hardly show significant reductase activity toward low concentration of DOX. In contrast, the overexpression of CBR1 increased the reductase activity toward an oxidative stress-derived cytotoxic aldehyde 4-oxo-2-nonenal. The sensitivity of the DOX-resistant cells to 4-oxo-2-nonenal was lower than that of the parental cells, and the resistance-elicited hyposensitivity was almost completely ameliorated by addition of the CBR1 inhibitor. Thus, CBR1 may promote development of DOX resistance through detoxification of cytotoxic aldehydes, rather than the drug's metabolism.	[Matsunaga, Toshiyuki; Kezuka, Chihiro; Morikawa, Yoshifumi; Suzuki, Ayaka; Endo, Satoshi; Ikari, Akira] Gifu Pharmaceut Univ, Biochem Lab, Gifu 5011196, Japan; [Iguchi, Kazuhiro] Gifu Pharmaceut Univ, Lab Community Pharm, Gifu 5011196, Japan; [Miura, Takeshi; Nishinaka, Toru; Terada, Tomoyuki] Osaka Ohtani Univ, Fac Pharm, Med Chem, Osaka 5848540, Japan; [E-Kabbani, Ossama] Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Hara, Akira] Gifu Univ, Fac Engn, Gifu 5011193, Japan	Matsunaga, T (reprint author), Gifu Pharmaceut Univ, Biochem Lab, Gifu 5011196, Japan.	matsunagat@gifu-pu.ac.jp			Japan Society for the Promotion of Science [25460068]	This work was supported in part by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grant number 25460068).	AKMAN SA, 1990, CANCER RES, V50, P1397; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Tak E, 2011, J HEPATOL, V54, P328, DOI 10.1016/j.jhep.2010.06.045; Endo S, 2009, ARCH BIOCHEM BIOPHYS, V487, P1, DOI 10.1016/j.abb.2009.05.009; Miura T, 2008, MOL CELL BIOCHEM, V315, P113, DOI 10.1007/s11010-008-9794-5; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Matsunaga T, 2013, CHEM-BIOL INTERACT, V202, P234, DOI 10.1016/j.cbi.2012.09.024; Oppermann U, 2007, ANNU REV PHARMACOL, V47, P293, DOI 10.1146/annurev.pharmtox.47.120505.105316; CUMMINGS J, 1991, EUR J CANCER, V27, P532, DOI 10.1016/0277-5379(91)90209-V; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Carlquist M, 2008, CHEM-BIOL INTERACT, V174, P98, DOI 10.1016/j.cbi.2008.05.021; Bains OS, 2010, J PHARMACOL EXP THER, V335, P533, DOI 10.1124/jpet.110.173179; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; FERRAZZI E, 1991, CANCER COMMUN, V3, P173; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x; SATTA T, 1992, CANCER, V69, P941, DOI 10.1002/1097-0142(19920215)69:4<941::AID-CNCR2820690418>3.0.CO;2-H; Hayes JD, 2000, BIOCHEM SOC T, V28, P33; Usami N, 2001, EUR J BIOCHEM, V268, P5755, DOI 10.1046/j.0014-2956.2001.02510.x; Matsuura K, 1998, J BIOCHEM-TOKYO, V124, P940; Kassner N, 2008, DRUG METAB DISPOS, V36, P2113, DOI 10.1124/dmd.108.022251; Xavier CPR, 2011, CANCER CHEMOTH PHARM, V68, P1449, DOI 10.1007/s00280-011-1641-9; van der Woude H, 2003, CANCER LETT, V200, P41, DOI 10.1016/S0304-3835(03)00412-9; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Zimmermann TJ, 2009, BIOORGAN MED CHEM, V17, P530, DOI 10.1016/j.bmc.2008.11.076; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; Mitani T, 2014, J NUTR SCI VITAMINOL, V60, P122, DOI 10.3177/jnsv.60.122; Fang J, 2007, J DRUG TARGET, V15, P475, DOI 10.1080/10611860701498286; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Kim HS, 2012, APOPTOSIS, V17, P938, DOI 10.1007/s10495-012-0719-0; Lakhman SS, 2007, MOL PHARMACOL, V72, P734, DOI 10.1124/mol.107.035550; Akhdar H, 2009, EUR J CANCER, V45, P2219, DOI 10.1016/j.ejca.2009.05.017; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; WERMUTH B, 1988, J BIOL CHEM, V263, P16185; Miura T, 2013, CHEM-BIOL INTERACT, V202, P126, DOI 10.1016/j.cbi.2012.11.023; Huang WX, 2010, HEPATOLOGY, V52, P703, DOI 10.1002/hep.23723; Forrest GL, 2000, CHEM-BIOL INTERACT, V129, P21, DOI 10.1016/S0009-2797(00)00196-4; OLSON RD, 1988, P NATL ACAD SCI USA, V85, P3585, DOI 10.1073/pnas.85.10.3585; BENJAMIN RS, 1977, CANCER RES, V37, P1416; KROOK M, 1993, P NATL ACAD SCI USA, V90, P502, DOI 10.1073/pnas.90.2.502; Doom JA, 2004, BIOCHEMISTRY-US, V43, P13106; Higaki Y, 2003, CHEM-BIOL INTERACT, V143, P503, DOI 10.1016/S0009-2797(02)00206-5; Hur GC, 2003, CLIN CANCER RES, V9, P5768; Ishikura S, 1998, BIOL PHARM BULL, V21, P879; Kang KA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.149; Kensler T W, 2000, Drug Metabol Drug Interact, V17, P3; KOMIYAMA T, 1982, BIOCHEM PHARMACOL, V31, P3651, DOI 10.1016/0006-2952(82)90590-1; Matsunaga T, 2013, MOL MECH TUMOR CELL, P109; Matsunaga T, 2011, ANTI-CANCER DRUG, V22, P402, DOI 10.1097/CAD.0b013e3283448df0; Matsuura K, 1998, BIOCHEM J, V336, P429; Mohan S, 1997, AM J PHYSIOL-CELL PH, V273, pC572; Nishinaka T, 2011, CHEM-BIOL INTERACT, V191, P185, DOI 10.1016/j.cbi.2011.01.026; PAN SS, 1980, MOL PHARMACOL, V17, P95; Shiraishi H, 1998, BIOCHEM J, V334, P399; Tanaka M, 2005, PLOS BIOL, V3, pel28; THAYER WS, 1977, CHEM-BIOL INTERACT, V19, P265, DOI 10.1016/0009-2797(77)90050-3; Usui S, 1997, BIOSCI BIOTECH BIOCH, V61, P1924	58	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1309	1319				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300007		
J	Shi, JF; Liu, N; Xiao, Y; Takei, Y; Yasue, M; Suzuki, Y; Hou, Z; Ohno, H; Yamada, M; Fuchi, N; Oshida, K; Miyamoto, Y; Tsujimoto, G; Hirasawa, A				Shi, Junfeng; Liu, Ning; Xiao, Ying; Takei, Yoshinori; Yasue, Misato; Suzuki, Yamato; Hou, Zengye; Ohno, Hiroaki; Yamada, Masateru; Fuchi, Nobuhiro; Oshida, Keiyu; Miyamoto, Yohei; Tsujimoto, Gozoh; Hirasawa, Akira			The Effects of a Selective CK2 Inhibitor on Anti-glomerular Basement Membrane Glomerulonephritis in Rats	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						protein kinase CK2; glomerulonephritis (GN); CK2 inhibitor; testicular toxicity	PROTEIN-KINASE CK2; IN-VIVO; EXPRESSION; POTENT; DEATH; CELLS	Protein kinase CK2 ("casein kinase II") is a protein serine/threonine kinase that plays critical roles in biological processes such as cell growth, cell cycle progression, and apoptosis. So far, we have identified that one catalytic isozyme of CK2, CK2 alpha, is over-expressed in the kidney during the progression of glomerulonephritis (GN). Moreover, we have shown that in vivo inhibition of CK2 by administration of CK2 inhibitors was effective in the treatment of experimental GN. Hence the development of potent CK2 inhibitors should be considered in therapeutic strategies for GN. In the present study we identified compound 13, a pyrazine derivative, as a potent CK2 inhibitor. By performing enzyme kinetics analysis in vitro, we characterized the inhibition of compound 13 toward each CK2 catalytic isozyme. Furthermore, in vivo, we demonstrated that compound 13 is effective in attenuating proteinuria, decreasing the enhanced level of blood urea nitrogen and serum creatinine, and ameliorating glomerular crescent formation in an experimental GN rat model. On the other hand, cellular apoptosis was detected in the rat testis following administration of compound 13. This study provides clues for new strategies for developing applicable compounds into CK2-targeted GN treatments.	[Shi, Junfeng; Liu, Ning; Xiao, Ying; Yasue, Misato; Tsujimoto, Gozoh; Hirasawa, Akira] Kyoto Univ, Dept Genom Drug Discovery Sci, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Takei, Yoshinori] Kyoto Univ, Dept Nanobio Drug Discovery, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Suzuki, Yamato; Hou, Zengye; Ohno, Hiroaki] Kyoto Univ, Dept Bioorgan Med Chem, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Yamada, Masateru; Fuchi, Nobuhiro; Oshida, Keiyu; Miyamoto, Yohei] Toray Industries Ltd, Pharmaceut Res Labs, Kanagawa 2488555, Japan; [Hirasawa, Akira] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan	Hirasawa, A (reprint author), Kyoto Univ, Dept Genom Drug Discovery Sci, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan.	akira.h@pharm.kyoto-u.ac.jp			Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Otsuka Toshimi Scholarship Foundation	This study was supported by Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO; to G.T.), Grants-in-Aid for Scientific Research and Targeted Protein Research Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (to G.T.), a research grant from the Scientific Fund of the (to A.H). J. S. is supported by the Otsuka Toshimi Scholarship Foundation. Thanks to Ms. Ayako Hirata for the manuscript preparation.	Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Johnston DS, 2008, P NATL ACAD SCI USA, V105, P8315, DOI 10.1073/pnas.0709854105; Yamada M, 2005, P NATL ACAD SCI USA, V102, P7736, DOI 10.1073/pnas.0409818102; Prudent R, 2009, CHEM BIOL, V16, P112, DOI 10.1016/j.chembiol.2009.01.004; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Yamada M, 2002, EUR J PHARMACOL, V449, P167, DOI 10.1016/S0014-2999(02)01988-X; Dominguez I, 2011, MOL CELL BIOCHEM, V356, P209, DOI 10.1007/s11010-011-0961-8; Xu X, 1999, NAT GENET, V23, P118; Fuchi N, 2012, BIOORG MED CHEM LETT, V22, P4358, DOI 10.1016/j.bmcl.2012.05.006; Cozza G, 2010, MED RES REV, V30, P419, DOI 10.1002/med.20164; Filhol O, 2009, CELL MOL LIFE SCI, V66, P1830, DOI 10.1007/s00018-009-9151-1; Bragdon B, 2011, BONE, V49, P944, DOI 10.1016/j.bone.2011.06.037; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Kinoshita T, 2011, MOL CELL BIOCHEM, V356, P97, DOI 10.1007/s11010-011-0960-9; Alvarado-Diaz CP, 2009, CELL TISSUE RES, V338, P139, DOI 10.1007/s00441-009-0847-1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hung MS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-135; Koch S, 2013, MUCOSAL IMMUNOL, V6, P136, DOI 10.1038/mi.2012.57; Liu N, 2004, AM J PHYSIOL-RENAL, V287, pF612, DOI 10.1152/ajprenal.00322.2003; Liu N, 2015, BIOL PHARM BULL, V38, P1175, DOI 10.1248/bpb.b15-00124; Nakaniwa T, 2009, ACTA CRYSTALLOGR F, V65, P75, DOI 10.1107/S1744309108043194; Ophascharoensuk V, 1998, KIDNEY INT, V54, P416, DOI 10.1046/j.1523-1755.1998.00003.x; Oshida K, 2011, J APPL TOXICOL, V31, P790, DOI 10.1002/jat.1637	24	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1345	1351				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300011		
J	Nakajima, S; Chi, Y; Gao, K; Kono, K; Yao, J				Nakajima, Shotaro; Chi, Yuan; Gao, Kun; Kono, Koji; Yao, Jian			eIF2 alpha-Independent Inhibition of TNF-alpha-Triggered NF-kappa B Activation by Salubrinal	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						salubrinal; nuclear factor-kappa B; eukaryotic translation initiation factor 2 alpha; protein phosphatase (PP) 1; guanabenz	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; SIGNALING PATHWAY; ER STRESS; PHOSPHORYLATION; EXPRESSION; KINASE; CELLS; IKK; CANCER	Salubrinal is a selective inhibitor of cellular complexes that dephosphorylate eukaryotic translation initiation factor 2 alpha (eIF2 alpha). In previous reports, salubrinal was shown to have the potential to inhibit the activation of nuclear factor-kappa B (NF-kappa B) by several stimuli. However, the effects of salubrinal on NF-kappa B signaling are largely unknown. In this study, we investigated whether and how salubrinal affects NF-KB activation induced by tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta. We found that salubrinal selectively blocked TNF-alpha- but not IL-1 beta-induced activation of NF-kappa B. This inhibitory effect occurred upstream of transforming growth factor (TGF)-beta-activated kinase 1 (TAK1). Further experiments revealed that salubrinal blocked TNF-alpha-triggered NF-kappa B activation independent of its action on eIF2 alpha because knockdown of eIF2 alpha by small interfering RNA (siRNA) did not reverse the inhibitory effect of salubrinal on NF-kappa B. Moreover, guanabenz, a selective inhibitor of the regulatory subunit of protein phosphatase (PP) 1, also preferentially inhibited TNF-alpha-triggered activation of NF-kappa B. These findings raise the possibility that salubrinal may selectively block TNF-alpha-triggered activation of the NF-kappa B pathway through inhibition of the PP1 complex.	[Nakajima, Shotaro; Chi, Yuan; Gao, Kun; Yao, Jian] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Yamanashi 4093898, Japan; [Kono, Koji] Fukushima Med Univ, Dept Organ Regulatory Surg, Fukushima 9601295, Japan; [Kono, Koji] Fukushima Med Univ, Dept Adv Canc Immunotherapy, Fukushima 9601295, Japan	Nakajima, S (reprint author), Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med, 14 Med Dr,MD6, Singapore 117599, Singapore.	csisn@nus.edu.sg			Japan Society for the Promotion of Science	We thank Dr. Karlhans Endlich, Dr. Keiji Miyazawa and Dr. Hiroaki Sakurai for providing us with experimental materials.. We are also grateful to Dr. Masanori Kitamura for helpful discussions and Mr. Tatsuya Yoshitomi for technical assistance. This work was supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (to S. Nakajima).	Tian T, 2011, BIOCHEM BIOPH RES CO, V410, P852, DOI 10.1016/j.bbrc.2011.06.078; Chang YL, 2013, J SURG RES, V181, P308, DOI 10.1016/j.jss.2012.07.017; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Hayakawa K, 2010, J AM SOC NEPHROL, V21, P73, DOI 10.1681/ASN.2009040432; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Gilbert SJ, 2002, BIOCHEM SOC T, V30, P886; HOLMES B, 1983, DRUGS, V26, P212; Ozes ON, 1999, NATURE, V401, P82; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Schiwek D, 2004, KIDNEY INT, V66, P91, DOI 10.1111/j.1523-1755.2004.00711.x; Hamamura K, 2013, OSTEOARTHR CARTILAGE, V21, P764, DOI 10.1016/j.joca.2013.02.657; Hayakawa K, 2006, AM J PHYSIOL-RENAL, V291, pF1169, DOI 10.1152/ajprenal.00513.2005; Huang X, 2012, NEUROBIOL AGING, V33, pe9; Kessel D, 2006, BIOCHEM BIOPH RES CO, V346, P1320, DOI 10.1016/j.bbrc.2006.06.056; Lee SK, 2013, INT J ONCOL, V42, P810, DOI 10.3892/ijo.2013.1792; Mitsuhashi S, 2008, INT J ONCOL, V33, P1027, DOI 10.3892/ijo_00000091; Nakajima S, 2013, J IMMUNOL, V190, P6559, DOI 10.4049/jimmunol.1300155; Niu MS, 2013, J PHARMACOL SCI, V121, P17, DOI 10.1254/jphs.12206FP; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Yokota H, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-197; Yu XH, 2014, J CELL MOL MED, V18, P263, DOI 10.1111/jcmm.12184	32	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1368	1374				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300014		
J	Kondo, N; Temma, T; Shimizu, Y; Ono, M; Saji, H				Kondo, Naoya; Temma, Takashi; Shimizu, Yoichi; Ono, Masahiro; Saji, Hideo			Radioiodinated Peptidic Imaging Probes for in Vivo Detection of Membrane Type-1 Matrix Metalloproteinase in Cancers	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						membrane type-1 matrix metalloproteinase (MT1-MMP); peptide; in vivo imaging	1-MATRIX METALLOPROTEINASE; ALPHA(V)BETA(3) INTEGRIN; GASTRIC-CANCER; BREAST-CANCER; RGD PEPTIDES; EXPRESSION; TUMORS; MT1-MMP; PROGELATINASE; METASTASIS	Membrane type-1 matrix metalloproteinase (MT1-MMP) plays pivotal roles in tumor progression and metastasis, and holds great promise as an early biomarker for malignant tumors. Therefore, the ability to evaluate MT1-MMP expression could be valuable for molecular biological and clinical studies. For this purpose, we aimed to develop short peptide-based nuclear probes because of their facile radiosynthesis, chemically uniform structures, and high specific activity, as compared to antibody-based probes, which could allow them to be more effective for in vivo MT1-MMP imaging. To the best of our knowledge, there have been no reports of radiolabeled peptide probes for the detection of MT1-MMP in cancer tissues. In this study, we designed and prepared four probes which consist of a MT1-MMP-specific binding peptide sequence (consisting of L or D amino acid isomers) and an additional cysteine (at the N or C-terminus) for conjugation with N-(m-[I-123/125]iodophenyl) maleimide. We investigated probe affinity, probe stability in mice plasma, and probe biodistribution in tumor-bearing mice. Finally, in vivo micro single photon emission computed tomography (SPECT) imaging and ex vivo autoradiography were performed. Consequentl y, [I-123] I-DC, a n-form peptide probe radioiodinated at the C-terminus, demonstrated greater than 1000-fold higher specific activity than previously reported antibody probes, and revealed comparably moderate binding affinity. [I-125]I-DC showed higher stability as expected, and [I-123]I-DC successfully identified MT1-MMP expressing tumor tissue by SPECT imaging. Furthermore, ex vivo autoradiographic analysis revealed that the radioactivity distribution profiles corresponded to MT1-MMP-positive areas. These findings suggest that [I-123]I-DC is a promising peptide probe for the in vivo detection of MT1-MMP in cancers.	[Kondo, Naoya; Temma, Takashi; Shimizu, Yoichi; Ono, Masahiro; Saji, Hideo] Kyoto Univ, Dept Patho Funct Bioanal, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Temma, Takashi] Res Inst, Dept Invest Radiol, Natl Cerebral & Cardiovasc Ctr, Suita, Osaka 5658565, Japan	Saji, H (reprint author), Kyoto Univ, Dept Patho Funct Bioanal, Grad Sch Pharmaceut Sci, Sakyo Ku, 46-29 Yoshida Shimoadachi Cho, Kyoto 6068501, Japan.	hsaji@pharmicyoto-u.ac.jp			JSPS KAKENHI [22791189]; MEXT KAKENHI [23113509]; New Energy and Industrial Technology Development Organization (NEDO), Japan; Extramural Collaborative Research Grant of the Cancer Research Institute, Kanazawa University	This study was supported in part by JSPS KAKENHI Grant Number 22791189 and MEXT KAKENHI Grant Number 23113509. Portions of this study were supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan and an Extramural Collaborative Research Grant of the Cancer Research Institute, Kanazawa University.	Zhu L, 2011, MOL PHARMACEUT, V8, P2331, DOI 10.1021/mp2002297; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Temma T, 2009, BIOL PHARM BULL, V32, P1272; Knauper V, 1996, J BIOL CHEM, V271, P17124; Zucker S, 2002, LAB INVEST, V82, P1673, DOI 10.1097/01.LAB.0000041713.74852.2A; Ohuchi E, 1997, J BIOL CHEM, V272, P2446; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jones JL, 1999, J PATHOL, V189, P161, DOI 10.1002/(SICI)1096-9896(199910)189:2<161::AID-PATH406>3.0.CO;2-2; Zhu L, 2011, J CONTROL RELEASE, V150, P248, DOI 10.1016/j.jconrel.2011.01.032; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Waldherr C, 2001, ANN ONCOL, V12, P941, DOI 10.1023/A:1011160913619; Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b; Ogura S, 2007, J SURG ONCOL, V96, P46, DOI 10.1002/jso.20805; He L, 2013, DIGEST DIS SCI, V58, P1264, DOI 10.1007/s10620-012-2513-9; Dijkgraaf I, 2007, EUR J NUCL MED MOL I, V34, P267, DOI 10.1007/s00259-006-0180-9; English WR, 2001, J BIOL CHEM, V276, P42018, DOI 10.1074/jbc.M107783200; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Dijkgraaf I, 2011, EUR J NUCL MED MOL I, V38, P128, DOI 10.1007/s00259-010-1615-x; Tolmachev V, 2011, EUR J NUCL MED MOL I, V38, P531, DOI 10.1007/s00259-010-1646-3; Kondo N, 2013, CANCER SCI, V104, P495, DOI 10.1111/cas.12102; Tolmachev V, 2012, J NUCL MED, V53, P953, DOI 10.2967/jnumed.111.101527; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Crispi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007016; Fani Melpomeni, 2012, Eur J Nucl Med Mol Imaging, V39 Suppl 1, pS11, DOI 10.1007/s00259-011-2001-z; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Fragogeorgi EA, 2009, BIOCONJUGATE CHEM, V20, P856, DOI 10.1021/bc800475k; Kenanova Vania, 2006, Expert Opin Drug Deliv, V3, P53, DOI 10.1517/17425247.3.1.53; KHAWLI LA, 1992, NUCL MED BIOL, V19, P289; Peng CW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-153; Schumacher FF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01525; Shimizu Y, 2011, CANCER SCI, V102, P1897, DOI 10.1111/j.1349-7006.2011.02020.x; Ueda M, 2014, BIOCHEM BIOPH RES CO, V445, P661, DOI 10.1016/j.bbrc.2014.02.086; Van Steenkiste M, 2010, CANCER BIOTHER RADIO, V25, P511, DOI 10.1089/cbr.2010.0789	34	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1375	1382				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300015		
J	Yokota, M; Tokudome, Y				Yokota, Mami; Tokudome, Yoshihiro			Permeation of Hydrophilic Molecules across Glycated Skin Is Differentially Regulated by the Stratum Corneum and Epidermis-Dermis	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						skin permeation; advanced glycation end product; stratum corneum	TRANSDERMAL DRUG-DELIVERY; DIABETES-MELLITUS; END-PRODUCTS; AGED SKIN; ACCUMULATION; PENETRATION; ALPHA	The effects of glycation on skin permeation and accumulation of compounds were evaluated using an in vitro glycated skin model. Glycation of the skin of hairless mice was induced using vertical diffusion cells and incubation with phosphate-buffered saline containing 50 mm glyoxal for 24 h. Flux and accumulation in the skin were determined by applying hydrophilic and lipophilic molecules (Sodium fluorescein; FL-Na and Nile red, respectively) to this in vitro glycated skin model. Furthermore, to investigate the effect of glycation on epidermal dermal barrier properties, we conducted diffusion experiments with FL-Na and fluorescein isothiocyanate-dextran using stratum corneum (SC)-stripped glycated skin. The in vitro glycated skin model demonstrated characteristic glycation alterations like a yellowish change in skin color and surface roughness. For low-molecular weight (MW) hydrophilic molecules, flux across glycated full-thickness skin was higher than that across normal skin, although there was no difference with lipophilic molecules. However, glycated epidermis dermis showed lower flux, and the difference increased with the MW of the compound. Furthermore, the amount of high-MW hydrophilic molecules accumulated in glycated epidermis dermis was decreased. These results suggest that glycated SC and epidermis dermis differentially regulate the permeability of hydrophilic molecules and highlight the importance of controlling drug delivery by modifying the formulation or method of application depending on skin condition.	[Yokota, Mami; Tokudome, Yoshihiro] Josai Univ, Fac Pharmaceut Sci, Lab Dermatol Physiol, Sakado, Saitama 3500295, Japan	Tokudome, Y (reprint author), Josai Univ, Fac Pharmaceut Sci, Lab Dermatol Physiol, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.	tolcudome@josai.ac.jp					Sakai S, 2005, BRIT J DERMATOL, V153, P319, DOI 10.1111/j.1365-2133.2005.06756.x; Zhu P, 2012, EXP DERMATOL, V21, P123, DOI 10.1111/j.1600-0625.2011.01408.x; Pageon H, 2007, EUR J DERMATOL, V17, P12; Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180; Chiang A, 2012, J APPL TOXICOL, V32, P537, DOI 10.1002/jat.1773; Mulder DJ, 2006, DIABETES TECHNOL THE, V8, P523, DOI 10.1089/dia.2006.8.523; Ogura Y, 2011, J DERMATOL SCI, V64, P45, DOI 10.1016/j.jdermsci.2011.06.015; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Jakasa I, 2007, J INVEST DERMATOL, V127, P129, DOI 10.1038/sj.jid.5700582; Hung CF, 2012, J DERMATOL SCI, V68, P135, DOI 10.1016/j.jdermsci.2012.09.005; Andrews SN, 2013, PHARM RES-DORDR, V30, P1099, DOI 10.1007/s11095-012-0946-7; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Yoshinaga E, 2012, J INVEST DERMATOL, V132, P315, DOI 10.1038/jid.2011.298; Kirschner N, 2010, EUR J CELL BIOL, V89, P839, DOI 10.1016/j.ejcb.2010.07.010; Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x; BARRY B W, 1987, Journal of Controlled Release, V6, P85, DOI 10.1016/0168-3659(87)90066-6; Crisan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075003; Gkogkolou Paraskevi, 2012, Dermatoendocrinol, V4, P259, DOI 10.4161/derm.22028; Ichihashi M., 2011, ANTI AGING MEDICINE, V8, P23, DOI [10.3793/jaam.8.23, DOI 10.3793/JAAM.8.23]; Kawabata K, 2011, BBA-PROTEINS PROTEOM, V1814, P1246, DOI 10.1016/j.bbapap.2011.06.006; Kielhorn J, 2004, 57 WHO CONC INT CHEM, V57; Leibold JS, 2013, J INVEST DERMATOL, V133, P2040; Lohwasser C, 2006, J INVEST DERMATOL, V126, P291, DOI 10.1038/sj.jid.5700070; MONNIER VM, 1986, NEW ENGL J MED, V314, P403, DOI 10.1056/NEJM198602133140702; Murthy SN, 2012, RRTD, V2012, P1; Sady C, 2000, BBA-PROTEIN STRUCT M, V1481, P255, DOI 10.1016/S0167-4838(00)00133-3; Schoellhammer CM, 2014, EXPERT OPIN DRUG DEL, V11, P393, DOI 10.1517/17425247.2014.875528	27	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1383	1388				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300016		
J	Xin, X; Akasaka-Manya, K; Manya, H; Furukawa, J; Kuwahara, N; Okada, K; Tsumoto, H; Higashi, N; Kato, R; Shinohara, Y; Irimura, T; Endo, T				Xin, Xin; Akasaka-Manya, Keiko; Manya, Hiroshi; Furukawa, Jun-ichi; Kuwahara, Naoyuki; Okada, Kazue; Tsumoto, Hiroki; Higashi, Nobuaki; Kato, Ryuichi; Shinohara, Yasuro; Irimura, Tatsuro; Endo, Tamao			POMGNT1 Is Glycosylated by Mucin-Type O-Glycans	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						O-glycosylation; mucin-type O-glycan; glycan structure; protein O-linked mannose beta 1,2-N-acetylglucosaminyltransferase 1	FIBRONECTIN; MUTATIONS; GALNT3	Protein O-linked mannose beta 1,2-N-acetylglucosaminyltransferase 1 (POMGNT1) is a Golgi glycosyltransferase that catalyzes the formation of the N-acetylglucosamine (GlcNAc) beta 1 -> 2Man linkage of O-mannosyl glycan. POMGNT1 is not modified by N-glycans because there are no potential N-glycosylation sites; however, it is not clear whether POMGNT1 is modified by O-glycans. To determine whether POMGNT1 is O-glycosylated, we prepared recombinant human POMGNT1 from HEK293T cells. The recombinant POMGNT1 was recognized by Sambucus sieboldiana lectin (SSA), and sialidase digestion of POMGNT1 decreased SSA reactivity and enhanced the reactivity of Arachis hypogaea lectin (PNA). These results suggest that POMGNT1 is modified by a sialylated core-1 O-glycan. Next, we analyzed the structures of the O-glycans on POMGNT1 by beta-elimination and pyrazolone-labeling methods in combination with mass spectrometry. We identified several mucin-type O-glycans containing (NeuAc)(1)(Hex)(1)(HexNAc)(1), (NeuAc)(2)(Hex)(1)(HexNAc)(1), and (NeuAc)(2)(Hex)(2)(HexNAc)(2). To examine whether the O-glycans affect the functions and properties of POMGNT1, we compared glycosylated and non-glycosylated forms of recombinant sPOMGNT1 for their activity and surface hydrophobicity using the hydrophobic probe 1-anilino-8-naphthalene sulfonate (ANS). POMGNT1 activity and surface hydrophobicity were not affected by the presence or absence of O-glycans.	[Xin, Xin; Akasaka-Manya, Keiko; Manya, Hiroshi; Endo, Tamao] Tokyo Metropolitan Geriatr Hosp, Res Team Mech Aging, Mol Glycobiol, Tokyo 1730015, Japan; [Xin, Xin; Akasaka-Manya, Keiko; Manya, Hiroshi; Tsumoto, Hiroki; Endo, Tamao] Inst Gerontol, Tokyo 1730015, Japan; [Xin, Xin; Higashi, Nobuaki] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo 1130033, Japan; [Furukawa, Jun-ichi; Okada, Kazue; Shinohara, Yasuro] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Med & Funct Glyc, Sapporo, Hokkaido 0010021, Japan; [Furukawa, Jun-ichi; Okada, Kazue; Shinohara, Yasuro] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 0010021, Japan; [Kuwahara, Naoyuki; Kato, Ryuichi] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Struct Biol Res Ctr, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; [Tsumoto, Hiroki] Tokyo Metropolitan Geriatr Hosp, Res Team Mech Aging, Proteome Res, Tokyo 1730015, Japan; [Irimura, Tatsuro] Juntendo Univ, Sch Med, Tokyo 1138421, Japan	Manya, H (reprint author), Tokyo Metropolitan Geriatr Hosp, Res Team Mech Aging, Mol Glycobiol, Tokyo 1730015, Japan.	manya@tmig.or.jp; endo@tmig.or.jp			Mizutani Foundation for Glycoscience [150171]; NCNP [26-8]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT; Iwaki Scholarship Foundation;  [25293016];  [26110727];  [6840029]	This research was partly supported by Grants-in-Aid for Scientific Research (B) 25293016 (to T.E), for Scientific Research on Innovative Areas 26110727 (to H.M.) and for Young Scientist (B) 6840029 (to N.K.), a Grant from the Mizutani Foundation for Glycoscience 150171 (to H.M), a Grant-in-Aid for Intramural Research Grant 26-8 (to T.E.) for Neurological and Psychiatric Disorders of NCNP, the Special Coordination Funds for Promoting Science and Technology (to Y.S) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and Student Grants from MEXT Scholarship for foreign students (to X.X) and Iwaki Scholarship Foundation (to X.X.).	Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V320, P39, DOI 10.1016/j.bbrc.2004.05.129; Furukawa J, 2011, ANAL CHEM, V83, P9060, DOI 10.1021/ac2019848; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; PEREIRA MEA, 1976, CARBOHYD RES, V51, P107; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Endo T, 2015, J BIOCHEM, V157, P1, DOI 10.1093/jb/mvu066; Manya H, 2003, BIOCHEM BIOPH RES CO, V306, P93, DOI 10.1016/S0006-291X(03)00924-0; MATSUURA H, 1989, J BIOL CHEM, V264, P10472; Mer G, 1996, NAT STRUCT BIOL, V3, P45, DOI 10.1038/nsb0196-45; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Takahashi S, 2001, GLYCOBIOLOGY, V11, P37, DOI 10.1093/glycob/11.1.37; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wasser CR, 2014, SCI SIGNAL, V7, pra113	20	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1389	1394				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300017		
J	Coulibaly, S; Minami, H; Abe, M; Hasei, T; Sera, N; Yamamoto, S; Funasaka, K; Asakawa, D; Watanabe, M; Honda, N; Wakabayashi, K; Watanabe, T				Coulibaly, Souleymane; Minami, Hiroki; Abe, Maho; Hasei, Tomohiro; Sera, Nobuyuki; Yamamoto, Shigekazu; Funasaka, Kunihiro; Asakawa, Daichi; Watanabe, Masanari; Honda, Naoko; Wakabayashi, Keiji; Watanabe, Tetsushi			Seasonal Fluctuations in Air Pollution in Dazaifu, Japan, and Effect of Long-Range Transport from Mainland East Asia	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						transboundary air pollution; airborne particle; Asian dust; China; Ames test; mutagenicity	POLYCYCLIC AROMATIC-HYDROCARBONS; SALMONELLA; CHINA; LEAD; PARTICLES; MORTALITY; RATIOS; DUST	To clarify the seasonal fluctuations in air pollution and the effect of long-range transport, we collected airborne particles (n=118) at Dazaifu in Fukuoka, Japan, from June 2012 to May 2013 and measured Pb and SO42-, which are indicators of the long-range transport of anthropogenic air pollutants, as well as their mutagenicity, and other factors. The levels of airborne particles, Pb, and SO42- were very high on March 4, 8, 9, and 19, and May 13, 21, and 22, 2013. The backward trajectories indicated that air masses had arrived from the Gobi Desert and northern China on those days. The mutagenicity of airborne particles was examined using the Ames test on Salmonella typhimurium YG1024. Highly mutagenic airborne particles were mostly collected in winter, and most of them showed high activity both with and without S9 mix. High levels of polycyclic aromatic hydrocarbons (PAHs) were found in many samples that showed high mutagenicity. For the samples collected on January 30, February 21, and March 4, the levels of Pb, SO42-, PAHs, and mutagenicity were high, and the backward trajectories indicated that air masses present on those days had passed through northern or central China. The Japan Meteorological Agency registered Asian dust events at Fukuoka on March 8, 9, and 19, 2013. The results of the present study suggest that high levels of anthropogenic air pollutants were transported with Asian dust. Similarly, long-range transport of air pollutants including mutagens occurred on days when Asian dust events were not registered.	[Coulibaly, Souleymane; Minami, Hiroki; Abe, Maho; Hasei, Tomohiro; Honda, Naoko; Wakabayashi, Keiji; Watanabe, Tetsushi] Kyoto Pharmaceut Univ, Dept Publ Hlth, Yamashina Ku, Kyoto 6078412, Japan; [Sera, Nobuyuki; Yamamoto, Shigekazu] Fukuoka Inst Hlth & Environm Sci, Dazaifu, Fukuoka 8180135, Japan; [Funasaka, Kunihiro; Asakawa, Daichi] Osaka City Inst Publ Hlth & Environm Sci, Tennoji Ku, Osaka 5430026, Japan; [Watanabe, Masanari] Tottori Univ, Fac Med, Dept Resp Med & Rheumatol, Yonago, Tottori 6838504, Japan; [Honda, Naoko] Sonoda Womens Univ, Fac Human Hlth, Dept Food & Nutr, Amagasaki, Hyogo 6618520, Japan; [Wakabayashi, Keiji] Univ Shizuoka, Grad Div Nutr & Environm Sci, Suruga Ku, Shizuoka 4228526, Japan	Watanabe, T (reprint author), Kyoto Pharmaceut Univ, Dept Publ Hlth, Yamashina Ku, 1 Misasagi Shichonocho, Kyoto 6078412, Japan.	watanabe@mblyoto-phu.ac.jp			Ministry of Health, Labour, and Welfare of Japan; Japanese Ministry of the Environment [C-1154]; Otsuka Toshimi Scholarship Foundation	This study was supported by the Health and Labour Sciences Research Grants for Research on global health issues, from the Ministry of Health, Labour, and Welfare of Japan and the Environment Research and Technology Development Fund (C-1154) of the Japanese Ministry of the Environment. Souleymane Coulibaly was granted scholarship assistance by Otsuka Toshimi Scholarship Foundation.	Air Resources Laboratory, HYSPLIT HYBR SINGL P; Aikawa M, 2010, ATMOS ENVIRON, V44, P381, DOI 10.1016/j.atmosenv.2009.10.025; YAHAGI T, 1977, MUTAT RES, V48, P121, DOI 10.1016/0027-5107(77)90151-8; Yang XY, 2007, ATMOS ENVIRON, V41, P2710, DOI 10.1016/j.atmosenv.2006.11.052; Kim HS, 2012, ENVIRON MONIT ASSESS, V184, P1973, DOI 10.1007/s10661-011-2092-9; Wang YS, 2014, SCI CHINA EARTH SCI, V57, P14, DOI 10.1007/s11430-013-4773-4; EINISTO P, 1991, MUTAT RES, V259, P95, DOI 10.1016/0165-1218(91)90113-Z; Mukai H, 2001, ENVIRON SCI TECHNOL, V35, P1064, DOI 10.1021/es001399u; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; WATANABE M, 1990, MUTAT RES, V234, P337, DOI 10.1016/0165-1161(90)90044-O; LYNCH AJ, 1980, JAPCA J AIR WASTE MA, V30, P257; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Funasaka K, 2003, ATMOS ENVIRON, V37, P4597, DOI 10.1016/j.atmosenv.2003.08.004; Kim HS, 2014, AIR QUAL ATMOS HLTH, V7, P309, DOI 10.1007/s11869-014-0238-y; Ravindra K, 2008, ATMOS ENVIRON, V42, P2895, DOI 10.1016/j.atmosenv.2007.12.010; ARCHER VE, 1990, ARCH ENVIRON HEALTH, V45, P325; Kong SF, 2010, J HAZARD MATER, V183, P70, DOI 10.1016/j.jhazmat.2010.06.107; Katanoda K, 2011, J EPIDEMIOL, V21, P132, DOI 10.2188/jea.JE20100098; Lin CY, 2007, ATMOS CHEM PHYS, V7, P423; Sato K, 2013, AEROSOL AIR QUAL RES, V13, P1263, DOI 10.4209/aaqr.2013.01.0006; ROGGE WF, 1993, ENVIRON SCI TECHNOL, V27, P636, DOI 10.1021/es00041a007; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Hioki T, 2006, J AEROSOL RES, V21, P160; International Agency for Research on Cancer, IARC OUTD AIR POLL L; Japan Meteorological Agency, DAT BANK GLOB ENV KO; Kaneyasu N, 2014, EAROZORU KENKYU, V29, P82; Mukai H, ENV SCI TECHNOL, V27, P1347; Ohara T, 2008, J JAPAN SOC ATMOS EN, V43, P198; Takami A, 2006, J AEROSOL RES, V21, P341; Tsuji A, 2013, J JPN SOC ATMOS ENV, V48, P82; Watanabe M, 2014, GENES ENV, V36, P120; Watanabe T, 2014, GENES ENV, V36, P120; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217; Yonemochi S, 2007, J JPN SOC ATMOS ENV, V42, P129, DOI DOI 10.11298/TAIKI1995A2.2_129	34	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1395	1403				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300018		
J	Morimoto, T; Katanasaka, Y; Sunagawa, Y; Hirano, S; Miyazaki, Y; Funamoto, M; Hojo, Y; Suzuki, H; Morimoto, E; Ueno, M; Shimatsu, A; Satoh-Asahara, N; Yamakage, H; Wada, H; Hasegawa, K				Morimoto, Tatsuya; Katanasaka, Yasufumi; Sunagawa, Yoichi; Hirano, Sae; Miyazaki, Yusuke; Funamoto, Masafumi; Hojo, Yuya; Suzuki, Hidetoshi; Morimoto, Eriko; Ueno, Morio; Shimatsu, Akira; Satoh-Asahara, Noriko; Yamakage, Hajime; Wada, Hiromichi; Hasegawa, Koji			Effects of Statins on Left Ventricular Diastolic Function in Patients with Dyslipidemia and Diastolic Dysfunction (Stat-LVDF Study)	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						lipophilic statin; hydrophilic statin; diastolic function; dyslipidemia	BRAIN NATRIURETIC PEPTIDE; CHRONIC HEART-FAILURE; A REDUCTASE INHIBITOR; CARDIOVASCULAR EVENTS; CARDIAC-HYPERTROPHY; AORTIC-STENOSIS; MORTALITY; THERAPY; CARDIOMYOPATHY; RISK	Statins, 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors, are potential drugs for chronic heart failure treatment in clinical studies. However, there may be differences in the effects on heart failure between lipophilic and hydrophilic statins. In this study, we investigated whether hydrophilic rosuvastatin (RSV) and lipophilic pitavastatin (PTV) exert different effects on the left ventricular diastolic function. Subjects were hypercholesterolemia patients with left ventricular diastolic dysfunction. This was an open-label, randomized, parallel, comparative, prospective study. The subjects received treatment with RSV or PTV for 24 weeks, and their low density lipoprotein (LDL)-cholesterol levels were controlled by these statins according to the guideline. The primary endpoint was defined as the change in left ventricle (LV) diastolic function (E/E') estimated by echocardiography, and the secondary endpoint was the plasma B-type natriuretic peptide (BNP) level. No serious adverse effects were observed during the entire study period in any patient, nor were there any significant differences in changes in the body mass index, blood pressure, or heart rate. Statin treatment did not significantly alter the primary endpoint, E/E'. The change ratio of BNP was not significantly different between PTV and RSV groups. However, BNP was significantly increased in the RSV (p=0.030) but not the PTV (p>0.999) group. This study revealed that although neither RSV nor PTV improved LV diastolic dysfunction, BNP, a biomarker of LV wall stress, was increased in the RSV but not the PTV group. Observation for a longer period is necessary to clarify the different effects of these statins on LV diastolic dysfunction. (UMIN-ID: UMIN000003571).	[Morimoto, Tatsuya; Katanasaka, Yasufumi; Sunagawa, Yoichi; Hirano, Sae; Miyazaki, Yusuke; Funamoto, Masafumi; Hojo, Yuya; Suzuki, Hidetoshi] Univ Shizuoka, Sch Pharmaceut Sci, Div Mol Med, Shizuoka 4228526, Japan; [Morimoto, Tatsuya; Katanasaka, Yasufumi; Sunagawa, Yoichi; Morimoto, Eriko] Shizuoka Prefectural Gen Hosp, Shizuoka 4208527, Japan; [Morimoto, Tatsuya; Katanasaka, Yasufumi; Sunagawa, Yoichi; Wada, Hiromichi; Hasegawa, Koji] Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Kyoto 6128555, Japan; [Hirano, Sae] Shizuoka Saiseikai Gen Hosp, Shizuoka 4228527, Japan; [Ueno, Morio] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto 6028566, Japan; [Shimatsu, Akira; Satoh-Asahara, Noriko; Yamakage, Hajime] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst, Kyoto 6128555, Japan	Morimoto, T (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Div Mol Med, Shizuoka 4228526, Japan.	morimoto@u-shizuoka-ken.ac.jp			Shizuoka Prefectural Hospital Organization	This study was supported by a Grant from the Medical Research Program of the Shizuoka Prefectural Hospital Organization.	Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Indolfi C, 2002, CIRCULATION, V106, P2118, DOI 10.1161/01.CIR.0000034047.70205.97; Bauersachs J, 2007, EUR J CLIN INVEST, V37, P852, DOI 10.1111/j.1365-2362.2007.01877.x; HO KKL, 1993, CIRCULATION, V88, P107; Arnold JMO, 2003, CIRCULATION, V107, P1284, DOI 10.1161/01.CIR.0000054165.93055.42; Krum H, 2007, INT J CARDIOL, V119, P48, DOI 10.1016/j.ijcard.2006.07.106; Node K, 2003, CIRCULATION, V108, P839, DOI 10.1161/01.CIR.0000084539.58092.DE; Booth RA, 2014, HEART FAIL REV, V19, P439, DOI 10.1007/s10741-014-9445-8; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Mozaffarian D, 2004, AM J CARDIOL, V93, P1124, DOI 10.1016/j.amjcard.2004.01.039; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Luo JD, 1999, CLIN EXP PHARMACOL P, V26, P903, DOI 10.1046/j.1440-1681.1999.03165.x; McKie PM, 2006, HYPERTENSION, V47, P874, DOI 10.1161/01.HYP.0000216794.24161.8c; Fong CW, 2014, EUR J MED CHEM, V85, P661, DOI 10.1016/j.ejmech.2014.08.037; Takano H, 2013, CIRC J, V77, P917, DOI 10.1253/circj.CJ-12-1062; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Xu Z, 2008, J CARDIOVASC PHARM, V51, P62, DOI 10.1097/FJC.0b013e31815bb629; Aoyagi T, 2008, INT HEART J, V49, P49, DOI 10.1536/ihj.49.49; Don-Wauchope AC, 2015, CLIN BIOCHEM, V48, P236, DOI 10.1016/j.clinbiochem.2014.11.002; Dormuth CR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f880; Gissi-HF Investigators, 2008, Lancet, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Ho KKL, 1993, J AM COLL CARDIOL  S, V22, P6; Jassal DS, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-5; Kjekshus J, 1997, J Card Fail, V3, P249, DOI 10.1016/S1071-9164(97)90022-1; Kohno M, 2000, METABOLISM, V49, P1356, DOI 10.1053/meta.2000.9508; Nakamura M, 2010, INT J CARDIOL, V143, P124, DOI 10.1016/j.ijcard.2009.01.076; Okura H, 2007, INTERNAL MED, V46, P1337, DOI 10.2169/internalmedicine.46.0021; Porter KE, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001931; Tang WHW, 2010, NAT REV CARDIOL, V7, P249, DOI 10.1038/nrcardio.2010.29; Tousoulis D, 2014, PHARMACOL THERAPEUT, V141, P79, DOI 10.1016/j.pharmthera.2013.09.001; Verma N, 2011, INT J CLIN PRACT, V65, P1156, DOI 10.1111/j.1742-1241.2011.02753.x; Wallen T, 1997, HEART, V77, P264, DOI 10.1136/hrt.77.3.264	35	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1404	1409				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300019		
J	Kuwahara, J; Yamada, T; Egashira, N; Ueda, M; Zukeyama, N; Ushio, S; Masuda, S				Kuwahara, Jun; Yamada, Takaaki; Egashira, Nobuaki; Ueda, Mitsuyo; Zukeyama, Nina; Ushio, Soichiro; Masuda, Satohiro			Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						selective serotonin reuptake inhibitor; anti-tumor effect; sertraline; serotonin and norepinephrine reuptake inhibitor; human hepatocellular carcinoma cell	ANTIDEPRESSANT SERTRALINE; INDUCED APOPTOSIS; PHASE-II; IN-VITRO; CANCER; EXPRESSION; PHARMACOKINETICS; CHEMOTHERAPY; TRANSPORTER; METABOLISM	The anti-tumor effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) on several types of cancer cells have been reported. However, comparison of the anti-tumor effects of these drugs on human hepatocellular carcinoma (HepG2) cells has not been studied. We compared the anti-tumor effects of four SSRIs and two SNRIs on HepG2 cells. SSRIs and duloxetine dose-dependently decreased cell viability. Milnacipran had no effect on cell viability. The half-maximal inhibitory concentration was lower in the order of: sertraline, paroxetine, duloxetine, fluvoxamine, escitalopram, and milnacipran. Exposure to sertraline (2 mu m) significantly increased caspase-3/7 activity. These results suggest that, of the agents tested here, sertraline had the highest sensitivity to HepG2 cells, and activation of the caspase pathway is involved in the anti-tumor effects of sertraline in HepG2 cells.	[Kuwahara, Jun; Egashira, Nobuaki; Ueda, Mitsuyo; Zukeyama, Nina; Ushio, Soichiro; Masuda, Satohiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Biopharmaceut, Higashi Ku, Fukuoka 8128582, Japan; [Yamada, Takaaki; Egashira, Nobuaki; Masuda, Satohiro] Kyushu Univ Hosp, Dept Pharm, Higashi Ku, Fukuoka 8128582, Japan	Egashira, N (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Biopharmaceut, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	n-egashi@pharm.med.kyushu-u.ac.jp					Abdel-Rahman Omar, 2013, J Egypt Natl Canc Inst, V25, P165, DOI 10.1016/j.jnci.2013.08.002; Abdul Mansoor, 1995, Journal of Urology, V154, P247, DOI 10.1016/S0022-5347(01)67288-4; Amit B, 2009, EUR NEUROPSYCHOPHARM, V19, P726, DOI 10.1016/j.euroneuro.2009.06.003; Andersen LT, 2013, BREAST CANCER RES TR, V141, P325, DOI 10.1007/s10549-013-2708-6; Fang YC, 2011, CHINESE J PHYSIOL, V54, P310, DOI 10.4077/CJP.2011.AMM046; Yasui-Furukori N, 2011, HUM PSYCHOPHARM CLIN, V26, P194, DOI 10.1002/hup.1192; Bai YS, 2001, FREE RADICAL BIO MED, V30, P555, DOI 10.1016/S0891-5849(00)00499-8; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Yeo W, 2005, J NATL CANCER I, V97, P1532, DOI 10.1093/jnci/dji315; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Kim Joo-Hyun, 2014, World J Hepatol, V6, P98, DOI 10.4254/wjh.v6.i2.98; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Boige V, 2006, EUR J CANCER, V42, P456, DOI 10.1016/j.ejca.2005.09.034; Gauthier A, 2013, HEPATOL RES, V43, P147, DOI 10.1111/j.1872-034X.2012.01113.x; Lantz RJ, 2003, DRUG METAB DISPOS, V31, P1142, DOI 10.1124/dmd.31.9.1142; Soll C, 2012, CLIN CANCER RES, V18, P5902, DOI 10.1158/1078-0432.CCR-11-1813; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Chou CT, 2007, TOXICOL APPL PHARM, V218, P265, DOI 10.1016/j.taap.2006.11.012; Chang AS, 1996, MOL BRAIN RES, V43, P185, DOI 10.1016/S0169-328X(96)00172-6; Chao Y, 1998, BRIT J CANCER, V78, P34, DOI 10.1038/bjc.1998.438; Chen S, 2014, TOXICOL SCI, V137, P404, DOI 10.1093/toxsci/kft254; Gil-Ad I, 2008, INT J ONCOL, V33, P277, DOI 10.3892/ijo_00000007; Huang JK, 2011, BASIC CLIN PHARMACOL, V109, P103, DOI 10.1111/j.1742-7843.2011.00690.x; Li FY, 2012, DRUG METAB DISPOS, V40, P1723, DOI 10.1124/dmd.112.045120; Liang C., 2013, MOL CANCER, V9, P12; Lin CJ, 2010, CANCER RES, V70, P3199, DOI 10.1158/0008-5472.CAN-09-4072; Mun AR, 2013, ANTICANCER RES, V33, P3691; Nilausen DO, 2011, CLIN THER, V33, P1492, DOI 10.1016/j.clinthera.2011.09.012; Spanova A, 1997, PHYSIOL RES, V46, P161; Torta R, 2011, HUM PSYCHOPHARM CLIN, V26, P291, DOI 10.1002/hup.1202; Unterecker S, 2013, J NEURAL TRANSM, V120, P1237, DOI 10.1007/s00702-012-0952-2; Yasui-Furukori N, 2005, J PHARMACEUT BIOMED, V37, P121, DOI 10.1016/j.jpba.2004.09.037	33	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1410	1414				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300020		
J	Miki, Y; Tachibana, Y; Ohminato, Y; Fujiwara, Y				Miki, Yuichi; Tachibana, Yoshihiro; Ohminato, Yukari; Fujiwara, Yasuyuki			Nucleolin Acts as a Scavenger Receptor for Acetylated Low-Density Lipoprotein on Macrophages	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						nucleolin; macrophage; acetylated low-density lipoprotein (AcLDL); scavenger receptor	SHUTTLING PROTEIN NUCLEOLIN; APOPTOTIC CELLS; CHOLESTEROL; LDL; RECOGNITION; FIBROBLASTS; METABOLISM; LEADS	Although macrophage phagocytoses modified low-density lipoprotein (LDL), excessive accumulation of modified LDL induces macrophage foam cell formation, which is a feature of atherosclerotic plaque. Thus, the identification of scavenger receptor for modified LDL will provide better understanding of an atherosclerotic event. We recently showed that nucleolin expressed on macrophages acts as a scavenger receptor for various endogenous discarded products. Here, we investigated whether or not nucleolin is involved in the uptake of acetylated LDL (AcLDL). In contrast to normal LDL, AcLDL directly bound to immobilized nucleolin. AcLDL exhibited a higher affinity for macrophages than normal LDL. This binding of AcLDL was inhibited by anti-nucleolin antibody and antineoplastic guanine-rich oligonucleotide (AGRO), a nucleolin-specific oligonucleotide aptamer. In addition, AcLDL exhibited a higher affinity for HEK cells transfected with nucleolin than those without. Further, intracellular accumulation of AcLDL was also inhibited by anti-nucleolin antibody. The results of this study suggest that nucleolin expressed on macrophages is a receptor for AcLDL.	[Miki, Yuichi; Tachibana, Yoshihiro; Ohminato, Yukari; Fujiwara, Yasuyuki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Environm Hlth, Hachioji, Tokyo 1920392, Japan	Fujiwara, Y (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Environm Hlth, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yasuyuki@toyaku.ac.jp					Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Sinclair JF, 2002, J BIOL CHEM, V277, P2876, DOI 10.1074/jbc.M110230200; Mongelard F, 2010, CURR OPIN MOL THER, V12, P107; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; VANREGENMORTEL MHV, 1994, DEV BIOL STAND, V83, P143; Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004; Ginisty H, 1999, J CELL SCI, V112, P761; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Wang Y, 2011, CELL BIOL INT, V35, P677, DOI 10.1042/CBI20100625; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177; Song N, 2012, ANGIOGENESIS, V15, P697, DOI 10.1007/s10456-012-9284-y; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Lougheed M, 1999, ARTERIOSCL THROM VAS, V19, P1881; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Miki Y, 2015, BIOL PHARM BULL, V38, P116, DOI 10.1248/bpb.b14-00624; Miki Y, 2014, BIOL PHARM BULL, V37, P588; Ozawa D, 2013, BIOL PHARM BULL, V36, P1587; Wang M, 2007, J LIPID RES, V48, P633, DOI 10.1194/jlr.M600470-JLR200; Zha XH, 1997, ARTERIOSCL THROM VAS, V17, P1421	23	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1420	1424				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300022		
J	Shimokawa, Y; Yoda, N; Kondo, S; Yamamura, Y; Takiguchi, Y; Umehara, K				Shimokawa, Yoshihiko; Yoda, Noriaki; Kondo, Satoshi; Yamamura, Yoshiya; Takiguchi, Yoshiharu; Umehara, Ken			Inhibitory Potential of Twenty Five Anti-tuberculosis Drugs on CYP Activities in Human Liver Microsomes	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						anti-tuberculosis drug; human liver microsome; CYP inhibition; drug-drug interaction	RESISTANT TUBERCULOSIS; UPDATE; PREDICTION; MANAGEMENT; METABOLISM; OXIDATION; UTILITY; AGENTS	The direct inhibitory potential of twenty five anti-tuberculosis drugs on eight CYP-specific reactions in human liver microsomes was investigated to predict in vivo drug drug interactions (DDIs) from in vitro data. Rifampicin, rifabutin, and thioacetazone inhibited one CYP reaction. Isoniazid and clofazimine had inhibitory effects on four CYP reactions, and rifapentine, ethionamide, and prothionamide widely inhibited CYP reactions. Based on the inhibition constant (Kr) and the therapeutic total inhibitor concentrations [I](max) of eight drugs in human plasma, [I](max)/K-i values were calculated to evaluate clinical DDIs. The [I](max)/K-i values were 0.20 or less for rifampicin, rifabutin, and thioacetazone; 0.15-2.0 for isoniazid; 0.14-1.5 for rifapentine; 0.29-1.4 for ethionamide; 0.41-2.2 for prothionamide; and 0.12-6.3 for clofazimine. The highest [I](max)/K-i values were 2.0 for isoniazid on CYP3A4 [testosterone (T)]; 1.5 for rifapentine on CYP3A4 [midazolam (M)]; 1.4 for ethionamide on CYP2C8; 2.2, 1.8, and 1.3 for prothionamide on CYP2B6, CYP2C19, and CYP2C8, respectively; and 6.3 and 5.7 for clofazimine on CYP3A4 (M) and CYP3A4 (T), respectively. These drugs with high [I](max)/K-i values lead to clinical DDIs. Considering the drug regimens for tuberculosis (TB) and co-infection with TB and human immunodeficiency virus, the inhibitory potential for CYP3A4 and CYP2B6 is particularly important. These results suggest that clofazimine and prothionamide are likely to cause clinically relevant DDIs when co-administered with products metabolized by CYP3A4 and CYP2B6, respectively. Isoniazid and rifapentine may cause DDIs with drugs metabolized by CYP3A4.	[Shimokawa, Yoshihiko; Yoda, Noriaki; Kondo, Satoshi; Yamamura, Yoshiya; Umehara, Ken] Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Dept Drug Metab, Tokushima 7710192, Japan; [Shimokawa, Yoshihiko; Takiguchi, Yoshiharu] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Clin Pharmacol, Tokushima 7708505, Japan	Shimokawa, Y (reprint author), Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Dept Drug Metab, 463-10 Kagasuno,Kawauchi Cho, Tokushima 7710192, Japan.	Shimokawa.Yoshihiko@otsuka.jp					Barry M, 1999, CLIN PHARMACOKINET, V36, P289, DOI 10.2165/00003088-199936040-00004; Guengerich FP, 2010, CURR DRUG METAB, V11, P1; Kenworthy KE, 1999, BRIT J CLIN PHARMACO, V48, P716; Lakshminarayana SB, 2015, J ANTIMICROB CHEMOTH, V70, P857, DOI 10.1093/jac/dku457; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Ito K, 2004, BRIT J CLIN PHARMACO, V57, P473, DOI 10.1111/j.1365-2125.2003.02041.x; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Chang KC, 2013, RESPIROLOGY, V18, P8, DOI 10.1111/j.1440-1843.2012.02257.x; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Dooley KE, 2012, AIDS RES TREAT, V2012; European Medicines Agency, 2012, CPMPEWP56095REV1 COR; Global Alliance for Drug Development TB, 2008, TUBERCULOSIS, V88, P85; [Guidance for Industry U.S. Food and Drug Administration (FDA)], GUID IND DRUG INT ST; Horita Y, 2014, ANTIMICROB AGENTS CH, V58, P3168, DOI 10.1128/AAC.02278-13; LESCA P, 1978, BIOCHEM PHARMACOL, V27, P1203, DOI 10.1016/0006-2952(78)90453-7; OCHS HR, 1983, BRIT J CLIN PHARMACO, V16, P743; Peloquin CA, 1996, PHARMACOTHERAPY, V16, P735; World Health Organization, WHOHTMTB201408; World Health Organization, WHOHTMTB20116	21	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1425	1429				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300023		
J	Yamada, T; Ishiguro, N; Oku, K; Higuchi, I; Nakagawa, I; Noguchi, A; Yasuda, S; Fukumoto, T; Iwasaki, S; Akizawa, K; Furugen, A; Yamaguchi, H; Iseki, K				Yamada, Takehiro; Ishiguro, Nobuhisa; Oku, Kenji; Higuchi, Issei; Nakagawa, Ikuma; Noguchi, Atsushi; Yasuda, Shinsuke; Fukumoto, Tatsuya; Iwasaki, Sumio; Akizawa, Kouji; Furugen, Ayako; Yamaguchi, Hiroaki; Iseki, Ken			Successful Colistin Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection Using a Rapid Method for Determination of Colistin in Plasma: Usefulness of Therapeutic Drug Monitoring	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						colistin; drug monitoring; multidrug-resistant Pseudomonas aeruginosa	NEGATIVE BACTERIAL-INFECTIONS; INTRAVENOUS COLISTIN; METHANESULFONATE; PHARMACOKINETICS; SODIUM	A 56-year-old woman with systemic lupus erythematosus had bacteremia due to multidrug-resistant Pseudomonas aeruginosa (MDRP). She was initially treated with imipenem cilastatin, tobramycin, and aztreonam; however, MDRP was still detected intermittently in her plasma. Multidrug-susceptibility tests demonstrated that MDRP was susceptible only to colistin. Therefore, in addition to these antibiotics, the administration of intravenous colistin methanesulfonate, a prodrug formula of colistin, was started at a daily dose of 2.5 mg/kg (as colistin base activity). The initial dose setting was based on the patient's renal function (baseline creatinine clearance=32.7mL/min). After initiating colistin, the patient's C-reactive protein levels gradually decreased. Blood cultures showed no evidence of MDRP on days 8, 14, and 22 after colistin initiation. However, the patient's renal function went from bad to worse owing to septic shock induced by methicillin-resistant Staphylococcus aureus (MRSA) infection. A few days later, the trough plasma levels of colistin were 7.88 mg/L, which appeared to be higher than expected. After decreasing the colistin dose, the patient's renal function gradually improved. On the final day of colistin treatment, the plasma levels decreased to 0.60 mg/L. MDRP could not be detected in blood culture after colistin treatment. Therefore, we successfully treated a case of bloodstream infection due to MDRP by therapeutic drug monitoring (TDM) of colistin. It is suggested that the monitoring of blood colistin levels by liquid chromatography-tandem mass spectrometry can contribute to safer, more effective antimicrobial therapy of MDRP because TDM facilitates quick decisions on dose adjustments.	[Yamada, Takehiro; Higuchi, Issei; Akizawa, Kouji; Furugen, Ayako; Yamaguchi, Hiroaki; Iseki, Ken] Hokkaido Univ Hosp, Dept Pharm, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Yamada, Takehiro; Ishiguro, Nobuhisa; Fukumoto, Tatsuya; Iwasaki, Sumio] Hokkaido Univ, Infect Control Team, Sapporo, Hokkaido 0608648, Japan; [Oku, Kenji; Nakagawa, Ikuma; Noguchi, Atsushi; Yasuda, Shinsuke] Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido 0608638, Japan; [Iseki, Ken] Hokkaido Univ, Fac Pharmaceut Sci, Div Pharmasci, Lab Clin Pharmaceut & Therapeut, Sapporo, Hokkaido 0600812, Japan	Iseki, K (reprint author), Hokkaido Univ Hosp, Dept Pharm, Kita Ku, Kita 14,Nishi 5, Sapporo, Hokkaido 0608648, Japan.	ken-i@pharm.hokudai.ac.jp					Yaita K, 2013, INTERNAL MED, V52, P1407, DOI 10.2169/internalmedicine.52.9296; Bode-Boger SM, 2013, INT J ANTIMICROB AG, V42, P357, DOI 10.1016/j.ijantimicag.2013.06.009; Mizuyachi K, 2011, CURR MED RES OPIN, V27, P2261, DOI 10.1185/03007995.2011.626557; Couet W, 2011, CLIN PHARMACOL THER, V89, P875, DOI 10.1038/clpt.2011.48; Li J, 2003, J ANTIMICROB CHEMOTH, V52, P987, DOI 10.1093/jac/dkg468; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; Montero M, 2009, INFECTION, V37, P461, DOI 10.1007/s15010-009-8342-x; Li J, 2002, ANTIMICROB AGENTS CH, V46, P3304, DOI 10.1128/AAC.46.10.3304-3304.2002; Martis N, 2014, J INFECTION, V69, P1, DOI 10.1016/j.jinf.2014.03.001; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Garonzik SM, 2011, ANTIMICROB AGENTS CH, V55, P3284, DOI 10.1128/AAC.01733-10; Jansson B, 2009, J PHARMACEUT BIOMED, V49, P760, DOI 10.1016/j.jpba.2008.12.016; Sorli L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-380	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1430	1433				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300024		
J	Okuda, K; Ito, A; Uehara, T				Okuda, Kosaku; Ito, Akihiro; Uehara, Takashi			Regulation of Histone Deacetylase 6 Activity via S-Nitrosylation	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						S-nitrosylation; histone deacetylase 6; nitric oxide; acetylated alpha-tubulin	INDUCIBLE NITRIC-OXIDE; HDAC6; SIGNAL; CELLS	Nitric oxide (NO) is a gaseous regulatory factor produced by NO synthases (NOS) and it plays several critical roles via S-nitrosylation of protein cysteine residues. Histone deacetylase (HDAC) functions in the maintenance/balance of chromatin acetylation and contributes to transcriptional supression. It has been reported that S-nitrosylation of HDAC2 is involved in the regulation of deacetylase activity. However, it remains unknown whether other subtypes of the HDAC family are S-nitrosylated. In the present study, we found that HDAC6 is a target of NO. A biotin-switch assay revealed that endogenous HDAC6 is S-nitrosylated by both NO donors and NO derived from the inducible type of NOS in cells treated with cytokines. NO led to suppressed deacetylase activity in vitro and increased acetylated alpha-tubulin, a major substrate for HDAC6, in A549 cells. These findings suggest that S-nitrosylation of HDAC6 plays a pivotal role in the regulation of protein acetylation.	[Okuda, Kosaku; Uehara, Takashi] Okayama Univ, Dept Med Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Ito, Akihiro] RIKEN, Chem Genet Lab, Wako, Saitama 3510198, Japan	Uehara, T (reprint author), Okayama Univ, Dept Med Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	uehara@pharm.okayama-u.ac.jp			Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [15H04649, 15K14952]; Takeda Science Foundation; Uehara Memorial Foundation; Smoking Research Foundation	We thank Yoko Okamoto for technical assistance. This work was supported in part by the Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan Grants-in-Aid for Scientific Research (B) 15H04649, Challenging Exploratory Research 15K14952; Takeda Science Foundation, the Uehara Memorial Foundation, and the Smoking Research Foundation.	Chittezhath M, 2008, MOL CANCER THER, V7, P1817, DOI 10.1158/1535-7163.MCT-08-0256; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Bhuiyan MPI, 2006, BIOORGAN MED CHEM, V14, P3438, DOI 10.1016/j.bmc.2005.12.063; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Numajiri N, 2011, P NATL ACAD SCI USA, V108, P10349, DOI 10.1073/pnas.1103503108; ROBBINS RA, 1994, BIOCHEM BIOPH RES CO, V203, P209, DOI 10.1006/bbrc.1994.2169; Rodriguez-Ortigosa CM, 2014, GASTROENTEROLOGY, V147, P1084, DOI 10.1053/j.gastro.2014.07.030; STEINBERG HO, 1994, J CLIN INVEST, V94, P1172, DOI 10.1172/JCI117433; Wang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052095; Williams KA, 2013, J BIOL CHEM, V288, P33156, DOI 10.1074/jbc.M113.472506	22	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	SEP	2015	38	9					1434	1437				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4UE	WOS:000360599300025		
J	Yamada, H; Kikuchi, T; Masumoto, T; Wei, FY; Abe, T; Takeda, T; Nishiki, T; Tomizawa, K; Watanabe, M; Matsui, H; Takei, K				Yamada, Hiroshi; Kikuchi, Tatsuya; Masumoto, Toshio; Wei, Fan-Yan; Abe, Tadashi; Takeda, Tetsuya; Nishiki, Teiichi; Tomizawa, Kazuhito; Watanabe, Masami; Matsui, Hideki; Takei, Kohji			Possible role of cortactin phosphorylation by protein kinase C in actin-bundle formation at growth cone	BIOLOGY OF THE CELL			English	Article						Actin bundle; Cortactin; Growth cone; Protein kinase C	HUMAN NEUROBLASTOMA-CELLS; CYTOSKELETAL DYNAMICS; BINDING PROTEIN; AXON GUIDANCE; ALPHA; ADHESION; NEURONS; COMPLEX; SITES; AMPHIPHYSIN-1	Background Information. Cortactin contributes to growth cone morphogenesis by forming with dynamin, ring-shaped complexes that mechanically bundle and stabilise F-actin. However, the regulatory mechanism of cortactin action is poorly understood. Results. Immunofluorescence microscopy revealed that protein kinase C (PKC) colocalises with cortactin at growth cone filopodia in SH-SY5Y neuroblastoma cells. PKC activation by phorbol 12-myristate 13-acetate causes cortactin phosphorylation, filopodial retraction and F-actin-bundle loss. Moreover, PKC directly phosphorylates cortactin in vitro at S135/T145/S172, mitigating both cortactin's actin-binding and actin-crosslinking activity, whereas cellular expression of a phosphorylation-mimetic cortactin mutant hinders filopodial formation with a significant decrease of actin bundles. Conclusions. Our results indicate that PKC-mediated cortactin phosphorylation might be implicated in the maintenance of growth cone.	[Yamada, Hiroshi; Kikuchi, Tatsuya; Abe, Tadashi; Takeda, Tetsuya; Takei, Kohji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, Kita Ku, Okayama 7008558, Japan; [Yamada, Hiroshi; Abe, Tadashi; Takeda, Tetsuya; Takei, Kohji] Japan Sci & Technol Agcy, CREST, Kita Ku, Okayama 7008558, Japan; [Masumoto, Toshio; Nishiki, Teiichi; Matsui, Hideki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Physiol, Kita Ku, Okayama 7008558, Japan; [Wei, Fan-Yan; Tomizawa, Kazuhito] Kumamoto Univ, Fac Life Sci, Dept Mol Physiol, Kumamoto 8608556, Japan; [Watanabe, Masami] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Kita Ku, Okayama 7008558, Japan	Yamada, H (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, Kita Ku, Okayama 7008558, Japan.	hiroyama@md.okayama-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [26670201]; Astellas Foundation for Research on Metabolic Disorders; Intractable Infectious Diseases Research Project Okayama; Japan Foundation for Applied Enzymology	This work was supported in part by grants from the Ministry of Education, Science, Sports, and Culture of Japan (Grant No. 26670201); by the Astellas Foundation for Research on Metabolic Disorders; by the Intractable Infectious Diseases Research Project Okayama; and by the Japan Foundation for Applied Enzymology (all to H.Y.).	Anilkumar N, 2003, EMBO J, V22, P5390, DOI 10.1093/emboj/cdg521; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Hayashi M, 2008, P NATL ACAD SCI USA, V105, P2175, DOI 10.1073/pnas.0712171105; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Jones ML, 2004, J BIOL CHEM, V279, P40475, DOI 10.1074/jbc.M402970200; Kurklinsky S, 2011, J NEUROCHEM, V117, P48, DOI 10.1111/j.1471-4159.2011.07169.x; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Hur EM, 2012, TRENDS NEUROSCI, V35, P164, DOI 10.1016/j.tins.2011.11.002; Tigges U, 2003, J BIOL CHEM, V278, P23561, DOI 10.1074/jbc.M302302200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Guo DR, 2012, MOL CELL NEUROSCI, V50, P82, DOI 10.1016/j.mcn.2012.03.008; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Du YR, 1998, MOL CELL BIOL, V18, P5838; Chitaley K, 2004, FEBS LETT, V556, P211, DOI 10.1016/S0014-5793(03)01435-2; Decourt B, 2009, J NEUROSCI RES, V87, P1057, DOI 10.1002/jnr.21937; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Bonsall J, 1999, BRAIN RES, V839, P120, DOI 10.1016/S0006-8993(99)01725-4; Cheng S, 2000, CELL MOTIL CYTOSKEL, V47, P337, DOI 10.1002/1097-0169(200012)47:4<337::AID-CM7>3.0.CO;2-B; Fagerstrom S, 1996, CELL GROWTH DIFFER, V7, P775; Fogh BS, 2014, J HISTOCHEM CYTOCHEM, V62, P172, DOI 10.1369/0022155413517701; JALAVA A, 1993, J CELL PHYSIOL, V155, P301, DOI 10.1002/jcp.1041550211; Kostan J, 2014, EMBO REP, V15, P1154, DOI 10.15252/embr.201439267; Liang S, 2007, J NEUROCHEM, V102, P1466, DOI 10.1111/j.1471-4159.2007.04507.x; LITCHFIELD DW, 1986, BIOCHEM BIOPH RES CO, V134, P1276, DOI 10.1016/0006-291X(86)90388-8; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; OKAJIMA S, 1995, NEUROSCIENCE, V66, P645, DOI 10.1016/0306-4522(94)00591-R; PARROW V, 1995, J NEUROSCI RES, V41, P782, DOI 10.1002/jnr.490410609; Yamada H, 2007, MOL BIOL CELL, V18, P4669, DOI 10.1091/mbc.E07-04-0296; Zhou FQ, 2001, J CELL BIOL, V153, P1071, DOI 10.1083/jcb.153.5.1071; Ziegler WH, 2002, J BIOL CHEM, V277, P7396, DOI 10.1074/jbc.M110008200	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0248-4900	1768-322X		BIOL CELL	Biol. Cell	SEP	2015	107	9					319	330		10.1111/boc.201500032		12	Cell Biology	Cell Biology	CQ7YR	WOS:000360823300003		
J	Sawamura, R; Sakurai, H; Wada, N; Nishiya, Y; Honda, T; Kazui, M; Kurihara, A; Shinagawa, A; Izumi, T				Sawamura, Ryoko; Sakurai, Hidetaka; Wada, Naoya; Nishiya, Yumi; Honda, Tomoyo; Kazui, Miho; Kurihara, Atsushi; Shinagawa, Akira; Izumi, Takashi			Bioactivation of loxoprofen to a pharmacologically active metabolite and its disposition kinetics in human skin	BIOPHARMACEUTICS & DRUG DISPOSITION			English	Article						human skin; NSAID; active metabolite; carbonyl reductase 1	HUMAN CARBONYL REDUCTASE; DRUG; BIOTRANSFORMATION; PERMEATION; SODIUM; LIVER	Loxoprofen (LX) is a prodrug-type non-steroidal anti-inflammatory drug which is used not only as an oral drug but also as a transdermal formulation. As a pharmacologically active metabolite, the trans-alcohol form of LX (trans-OH form) is generated after oral administration to humans. The objectives of this study were to evaluate the generation of the trans-OH form in human in vitro skin and to identify the predominant enzyme for its generation. In the permeation and metabolism study using human in vitro skin, both the permeation of LX and the formation of the trans-OH form increased in a time- and dose-dependent manner after the application of LX gel to the skin. In addition, the characteristics of permeation and metabolism of both LX and the trans-OH form were examined by a mathematical pharmacokinetic model. The K-m value was calculated to be 10.3mm in the human in vitro skin. The predominant enzyme which generates the trans-OH form in human whole skin was identified to be carbonyl reductase 1 (CBR1) by immunodepletion using the anti-human CBR1 antibody. The results of the enzyme kinetic study using the recombinant human CBR1 protein demonstrated that the K-m and V-max values were 7.30mm and 402nmol/min/mg protein, respectively. In addition, it was found that no unknown metabolites were generated in the human in vitro skin. This is the first report in which LX is bioactivated to the trans-OH form in human skin by CBR1. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Sawamura, Ryoko; Nishiya, Yumi; Honda, Tomoyo; Kazui, Miho; Kurihara, Atsushi; Izumi, Takashi] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Tokyo 1408710, Japan; [Sakurai, Hidetaka; Wada, Naoya; Shinagawa, Akira] Daiichi Sankyo RD Novare Co Ltd, Discovery Sci & Technol Dept, Tokyo, Japan	Sawamura, R (reprint author), Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	sawamura.ryoko.yi@daiichisankyo.co.jp					Andronis V, 1995, Pharm Acta Helv, V70, P301, DOI 10.1016/0031-6865(95)00035-6; Malatkova P, 2010, CURR DRUG METAB, V11, P639, DOI 10.2174/138920010794233530; Heyneman CA, 2000, DRUGS, V60, P555, DOI 10.2165/00003495-200060030-00004; Miura T, 2008, MOL CELL BIOCHEM, V315, P113, DOI 10.1007/s11010-008-9794-5; Trommer H, 2006, SKIN PHARMACOL PHYS, V19, P106, DOI 10.1159/000091978; Rostami-Hodjegan A, 2012, CLIN PHARMACOL THER, V92, P50, DOI 10.1038/clpt.2012.65; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; Bains OS, 2009, DRUG METAB DISPOS, V37, P1107, DOI 10.1124/dmd.108.024711; Svensson CK, 2009, DRUG METAB DISPOS, V37, P247, DOI 10.1124/dmd.108.024794; OHARA H, 1995, BIOCHEM PHARMACOL, V50, P221, DOI 10.1016/0006-2952(95)00124-I; Endo S, 2008, BIOCHEM BIOPH RES CO, V377, P1326, DOI 10.1016/j.bbrc.2008.11.003; Chen Y, 2012, BIOPHARM DRUG DISPOS, V33, P85, DOI 10.1002/bdd.1769; Katritzky AR, 2006, J MED CHEM, V49, P3305, DOI 10.1021/jm051031d; Colombe L, 2007, EXP DERMATOL, V16, P762, DOI 10.1111/j.1600-0625.2007.00586.x; Daiichi Sankyo Co. Ltd, INV BROCH LOX GEL 1; DEJONG J, 1993, J PHARMACOL EXP THER, V266, P1312; Gonzalez-Covarrubias V, 2007, DRUG METAB DISPOS, V35, P973, DOI 10.1124/dmd.107.014779; Honma M., 1994, J CLIN THER MED, V10, P2107; Hotchkiss SAM, 1998, DRUGS PHARM SCI, V91, P43; Kajita Y, 2012, J NEW REM CLIN, V61, P2039; Knaak B, 1991, PREDICTION PERCUTANE, P1; Lakhman SS, 2005, DRUG METAB DISPOS, V33, P254, DOI 10.1124/dmd.104.002006; Matsubara T, 2011, PAIN CLINIC, V32, P715; MATSUDA K, 1984, BIOCHEM PHARMACOL, V33, P2473, DOI 10.1016/0006-2952(84)90720-2; OSBORNE R, 1994, FOOD CHEM TOXICOL, V32, P133, DOI 10.1016/0278-6915(94)90174-0; Sawamura R, 2014, XENOBIOTICA, V11, P1; Shibayama H, 2008, SKIN PHARMACOL PHYS, V21, P235, DOI 10.1159/000139128; TANAKA Y, 1984, CHEM PHARM BULL, V32, P1040; Zhang JP, 2009, PHARM RES-DORD, V26, P2209, DOI 10.1007/s11095-009-9936-9	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2782	1099-081X		BIOPHARM DRUG DISPOS	Biopharm. Drug Dispos.	SEP	2015	36	6					352	363		10.1002/bdd.1945		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ7DG	WOS:000360762500002		
J	Konuma, R; Umezawa, K; Mizukoshi, A; Kawarada, K; Yoshida, M				Konuma, Rumi; Umezawa, Kiwamu; Mizukoshi, Atsushi; Kawarada, Kensuke; Yoshida, Makoto			Analysis of microbial volatile organic compounds produced by wood-decay fungi	BIOTECHNOLOGY LETTERS			English	Article						Brown-rot fungus; Fomitopsis palustris; Trametes versicolor; Volatile organic compound; White-rot fungus; Wood decay	STACHYBOTRYS-CHARTARUM; CONIOPHORA-PUTEANA; SERPULA-LACRYMANS; SYNTHETIC MEDIA; INDOOR MOLDS; GROWTH; METABOLITES; IDENTIFICATION; BACTERIA	Microbial volatile organic compounds (MVOCs) produced by the brown-rot fungus Fomitopsis palustris and white-rot fungus Trametes versicolor grown on wood chip and potato dextrose agar were analyzed by GC-MS. In total, 110 organic compounds were identified as MVOCs. Among them, only 23 were MVOCs commonly observed in both types of fungi, indicating that the fungi have differential MVOC expression profiles. In addition, F. palustris and T. versicolor produced 38 and 22 MVOCs, respectively, which were detected only after cultivation on wood chip. This suggests that the fungi specifically released these MVOCs when degrading the cell-wall structure of the wood. Time course analysis of MVOC emission showed that both types of fungi produced the majority of MVOCs during the active phase of wood degradation. As both fungi produced specific MVOCs in the course of wood degradation indicates the possibility of the application of MVOCs as detection markers for wood-decay fungus existing in woody materials.	[Konuma, Rumi; Umezawa, Kiwamu; Yoshida, Makoto] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 1838509, Japan; [Konuma, Rumi; Kawarada, Kensuke] Tokyo Metropolitan Ind Technol Res Inst, Koto Ku, Tokyo 1350064, Japan; [Mizukoshi, Atsushi] Kinki Univ, Fac Med, Osakasayama, Osaka 5898511, Japan	Yoshida, M (reprint author), Tokyo Univ Agr & Technol, Fac Agr, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	konuma.rumi@iri-tokyo.jp; 50014953002@st.tuat.ac.jp; mizukoshi@med.kindai.ac.jp; kawarada.kensuke@iri-tokyo.jp; ymakoto@cc.tuat.ac.jp			Japan Society for the Promotion of Science (JSPS) [25850126]	This study was supported financially by a Grant-in-Aid for Young Scientists (B) to R.K. (no. 25850126) from the Japan Society for the Promotion of Science (JSPS).	Kim JL, 2007, INDOOR AIR, V17, P153, DOI 10.1111/j.1600-0668.2006.00466.x; Agger S, 2009, MOL MICROBIOL, V72, P1181, DOI 10.1111/j.1365-2958.2009.06717.x; Wilkins K, 2000, CHEMOSPHERE, V41, P437, DOI 10.1016/S0045-6535(99)00273-8; Walinder R, 2008, TOXICOL LETT, V181, P141, DOI 10.1016/j.toxlet.2008.07.013; Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5; Polizzi V, 2012, FUNGAL BIOL-UK, V116, P941, DOI 10.1016/j.funbio.2012.06.001; Polizzi V, 2012, SCI TOTAL ENVIRON, V414, P277, DOI 10.1016/j.scitotenv.2011.10.035; Araki A, 2010, SCI TOTAL ENVIRON, V408, P2208, DOI 10.1016/j.scitotenv.2010.02.012; Araki A, 2012, SCI TOTAL ENVIRON, V423, P18, DOI 10.1016/j.scitotenv.2012.02.026; Betancourt DA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-283; Ewen RJ, 2004, MYCOL RES, V108, P806, DOI 10.1017/S095375620400022X; Fiedler K, 2001, INT J HYG ENVIR HEAL, V204, P111, DOI 10.1078/1438-4639-00094; Korpi A, 1999, BUILD ENVIRON, V34, P205; Matysik S, 2008, J MICROBIOL METH, V75, P182, DOI 10.1016/j.mimet.2008.05.027; Schleibinger H, 2005, INDOOR AIR, V15, P98, DOI 10.1111/j.1600-0668.2005.00349.x; Schleibinger H, 2008, INDOOR AIR, V18, P113, DOI 10.1111/j.1600-0668.2007.00513.x; Schuchardt S, 2013, J BASIC MICROB, V53, P532, DOI 10.1002/jobm.201200056; Schwarze F. W. M. R., 2000, FUNGAL STRATEGIES WO	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	SEP	2015	37	9					1845	1852		10.1007/s10529-015-1870-9		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CQ2LO	WOS:000360432100015		
J	Morita, Y; Yamamoto, S; Ju, Y				Morita, Yasuyuki; Yamamoto, Shuhei; Ju, Yang			Development of a new co-culture system, the "separable-close co-culture system," to enhance stem-cell-to-chondrocyte differentiation	BIOTECHNOLOGY LETTERS			English	Article						Anode aluminum oxide (AAO); Co-culture; Differentiation; Human articular chondrocyte (hAC-kn); Human bone marrow mesenchymal stem cell (hBMSC); Nanoporous	CHONDROGENIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; ARTICULAR CHONDROCYTES; PROLIFERATION; PROTEIN; REGENERATION; ALUMINA	To develop a new co-culture system, the separable-close co-culture system, to replace the indirect co-culture system which analyzes cellular interactions between two groups of cells with each type being cultured separately and also the direct co-culture system where the two cell types are cultured together. The new system not only achieved effective cellular interactions but also allowed the effect that one group of cells has on another group of cells to be evaluated. We performed co-culturing of human bone marrow mesenchymal stem cells and human articular chondrocytes using the new system. The new system made it possible to assess separately the effects of one group of cells on the other cell type, as in the indirect co-culture system. Furthermore, the new system rivaled or surpassed other co-culture systems in terms of the chondrogenic gene expression. The new co-culture system is effective in terms of assessing gene expression in two cell types.	[Morita, Yasuyuki; Yamamoto, Shuhei; Ju, Yang] Nagoya Univ, Grad Sch Engn, Dept Mech Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Ju, Y (reprint author), Nagoya Univ, Grad Sch Engn, Dept Mech Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	ju@mech.nagoya-u.ac.jp					Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565; Chiang HS, 2011, TISSUE ENG PT A, V17, P2919, DOI 10.1089/ten.tea.2010.0732; Aung A, 2011, ARTHRITIS RHEUM-US, V63, P148, DOI 10.1002/art.30086; Lin YF, 2006, MOL CELL BIOCHEM, V291, P1, DOI 10.1007/s11010-006-9188-5; Xu L, 2013, STEM CELLS DEV, V22, P1657, DOI 10.1089/scd.2012.0605; Morita Y, 2013, ACTA BIOENG BIOMECH, V15, P71, DOI 10.5277/abb130309; Kang SW, 2008, BIOTECHNOL LETT, V30, P1163, DOI 10.1007/s10529-008-9675-8; Song YH, 2013, J BIOSCI BIOENG, V116, P509, DOI 10.1016/j.jbiosc.2013.04.007; Wu L, 2011, TISSUE ENG PT A, V17, P1425, DOI [10.1089/ten.TEA.2010.0517, 10.1089/ten.tea.2010.0517]; Sun LY, 2009, BIOELECTROMAGNETICS, V30, P251, DOI 10.1002/bem.20472; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; Song YH, 2013, INT J NANOMED, V8, P2745, DOI 10.2147/IJN.S44885; Meretoja VV, 2012, BIOMATERIALS, V33, P6362, DOI 10.1016/j.biomaterials.2012.05.042; Brammer KS, 2010, MAT SCI ENG C-MATER, V30, P518, DOI 10.1016/j.msec.2010.01.013; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Jeong JY, 2012, J MATER SCI-MATER M, V23, P2773, DOI 10.1007/s10856-012-4718-z; Lai JH, 2015, TISSUE ENG PT A, V21, P992, DOI [10.1089/ten.TEA.2014.0244, 10.1089/ten.tea.2014.0244]; Levorson EJ, 2014, ACTA BIOMATER, V10, P1824, DOI 10.1016/j.actbio.2013.12.026; Liu YQ, 2015, BIOTECHNOL LETT, V37, P219, DOI 10.1007/s10529-014-1661-8; Maxson S, 2010, J BIOMAT SCI-POLYM E, V21, P1441, DOI 10.1163/092050609X12518804794703; Morita Y, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414500250	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	SEP	2015	37	9					1911	1918		10.1007/s10529-015-1858-5		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CQ2LO	WOS:000360432100023		
J	Nakamura, R; Komatsu, N; Murao, T; Okamoto, Y; Nakamura, S; Fujita, K; Nishimura, H; Katsuki, Y				Nakamura, R.; Komatsu, N.; Murao, T.; Okamoto, Y.; Nakamura, S.; Fujita, K.; Nishimura, H.; Katsuki, Y.			The validity of the classification for lateral hinge fractures in open wedge high tibial osteotomy	BONE & JOINT JOURNAL			English	Article							PLATE FIXATION; WEIGHT-BEARING; OSTEOARTHRITIS; COMPLICATIONS	The objective of this study was to validate the efficacy of Takeuchi classification for lateral hinge fractures (LHFs) in open wedge high tibial osteotomy (OWHTO). In all 74 osteoarthritic knees (58 females, 16 males; mean age 62.9 years, standard deviation 7.5, 42 to 77) were treated with OWHTO using a TomoFix plate. The knees were divided into non-fracture (59 knees) and LHF (15 knees) groups, and the LHF group was further divided into Takeuchi types I, II, and III (seven, two, and six knees, respectively). The outcomes were assessed preoperatively and one year after OWHTO. Pre-operative characteristics (age, gender and body mass index) showed no significant difference between the two groups. The mean Japanese Orthopaedic Association score was significantly improved one year after operation regardless of the presence or absence of LHF (p = 0.0015, p < 0.001, respectively). However, six of seven type I cases had no LHF-related complications; both type II cases had delayed union; and of six type III cases, two had delayed union with correction loss and one had overcorrection. These results suggest that Takeuchi type II and III LHFs are structurally unstable compared with type I.	[Nakamura, R.; Murao, T.; Okamoto, Y.; Nakamura, S.; Fujita, K.; Katsuki, Y.] Yawata Med Ctr, Dept Orthopaed Surg, Komatsu 9238551, Japan; [Komatsu, N.] Yawata Med Ctr, Dept Dermatol, Komatsu 9238551, Japan; [Nishimura, H.] Yawata Med Ctr, Rehabil Dept, Komatsu 9238551, Japan	Nakamura, R (reprint author), Yawata Med Ctr, Dept Orthopaed Surg, Komatsu 9238551, Japan.	ryu-nakamura@msj.biglobe.ne.jp					Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Nelissen EM, 2010, INT ORTHOP, V34, P217, DOI 10.1007/s00264-009-0723-3; van Raaij TM, 2008, ACTA ORTHOP, V79, P508, DOI 10.1080/17453670710015508; COVENTRY MB, 1993, J BONE JOINT SURG AM, V75A, P196; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Chae DJ, 2011, KNEE, V18, P278, DOI 10.1016/j.knee.2010.05.009; Brosset T, 2011, ORTHOP TRAUMATOL-SUR, V97, P705, DOI 10.1016/j.otsr.2011.06.011; SINGH M, 1970, J BONE JOINT SURG AM, VA 52, P457; FUJISAWA Y, 1979, ORTHOP CLIN N AM, V10, P585; Staubli AE, 2010, INT ORTHOP, V34, P167, DOI 10.1007/s00264-009-0902-2; Miller BS, 2009, ARTHROSCOPY, V25, P639, DOI 10.1016/j.arthro.2008.12.020; Lobenhoffer P, 2003, KNEE SURG SPORT TR A, V11, P132, DOI 10.1007/s00167-002-0334-7; Takeuchi R, 2012, ARTHROSCOPY, V28, P85, DOI 10.1016/j.arthro.2011.06.034; Tsumaki N, 2004, J BONE JOINT SURG AM, V86A, P2399; HERNIGOU P, 1987, J BONE JOINT SURG AM, V69A, P332; Takeuchi R, 2009, ARTHROSCOPY, V25, P46, DOI 10.1016/j.arthro.2008.08.015; Staubli AE, 2003, INJURY, V34, P55, DOI 10.1016/j.injury.2003.09.025; OGATA K, 1991, J BONE JOINT SURG BR, V73, P927; Okuda M, 2012, J ORTHOP SCI, V17, P750, DOI 10.1007/s00776-012-0274-0; Paley D, 1994, CLIN N AM, V25, P425; Spahn Gunter, 2004, Arch Orthop Trauma Surg, V124, P649, DOI 10.1007/s00402-003-0588-7; TAKEBE K, 1984, CLIN ORTHOP RELAT R, P289	22	0	0	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	2049-4394			BONE JOINT J	Bone Joint J.	SEP	2015	97B	9					1226	1231		10.1302/0301-620X.97B9.34949		6	Orthopedics; Surgery	Orthopedics; Surgery	CQ7GC	WOS:000360770000012		
J	Ogi, H; Itoh, K; Ikegaya, H; Fushiki, S				Ogi, Hiroshi; Itoh, Kyoko; Ikegaya, Hiroshi; Fushiki, Shinji			Alterations of neurotransmitter norepinephrine and gamma-aminobutyric acid correlate with murine behavioral perturbations related to bisphenol A exposure	BRAIN & DEVELOPMENT			English	Article						Bisphenol A; IntelliCage; Behavior; Neurotransmitter; Development	ANXIETY-LIKE BEHAVIOR; PERINATAL EXPOSURE; INCREASES ANXIETY; PUBERTAL EXPOSURE; BRAIN-DEVELOPMENT; SOCIAL-BEHAVIOR; MICE; RATS; DISRUPTS; SYSTEM	Aim: Humans are commonly exposed to endocrine-disrupting chemical bisphenol A (BPA), giving rise to concern over the psychobehavioral effects of BPA. The aim of this study was to investigate the effects of prenatal and lactational BPA exposure on neurotransmitters, including norepinephrine (NE), gamma-aminobutyric acid (GABA) and glutamate (Glu), and to assess the association with behavioral phenotypes. Methods: C57BL/6J mice were orally administered with BPA (500 mu g/bw kg/day) or vehicle daily from embryonic day 0 to postnatal week 3 (P3W), through their darns. The IntelliCage behavioral experiments were conducted from P11W to P15W. At around P14-16W, NE, GABA and Glu levels in nine brain regions were measured by high performance liquid chromatography. Furthermore, the associations between the neurotransmitter levels and the behavioral indices were statistically analyzed. Results: In females exposed to BPA, the GABA and Glu levels in almost all regions, and the NE levels in the cortex, hypothalamus and thalamus were higher than those in the controls. In males exposed to BPA, the GABA levels in the amygdala and hippocampus showed lower values, while Gin levels were higher in some regions, compared with the controls. In regard to the associations, the number of "diurnal corner visits without drinking" was correlated with the NE levels in the cortex and thalamus in females. The "nocturnal corner visit duration without drinking" was correlated with the GABA level in the hippocampus in males. Conclusion: These results suggest that prenatal and lactational exposure to low doses of BPA might modulate the NE, GABA and Glu systems, resulting in behavioral alterations. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Ogi, Hiroshi; Itoh, Kyoko; Fushiki, Shinji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kyoto 6028566, Japan; [Ikegaya, Hiroshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Forens Med, Kyoto 6028566, Japan	Itoh, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kamigyo Ku, 465 Kajii Cho,Kawaramachi Hirokoji, Kyoto 6028566, Japan.	kxi14@koto.kpu-m.ac.jp			JSPS-KAKENHI [20310036]; Environment Research and Technology Development Fund of the Ministry of the Environment Japan, Japanese National Government [5S2-12]	This work was supported by JSPS-KAKENHI, Grants-in-Aid for Scientific Research (20310036 to S.F.) and the Environment Research and Technology Development Fund of the Ministry of the Environment Japan (5S2-12 to S.F.), Japanese National Government. The authors have no conflict of interest to declare.	Agster KL, 2013, J COMP NEUROL, V521, P2195, DOI 10.1002/cne.23270; Masuo Y, 2011, J TOXICOL ENV HEAL B, V14, P346, DOI 10.1080/10937404.2011.578557; WESTLUND KN, 1993, BRAIN RES, V612, P221, DOI 10.1016/0006-8993(93)91664-E; Wolstenholme JT, 2012, ENDOCRINOLOGY, V153, P3828, DOI 10.1210/en.2012-1195; Nakamura K, 2012, BRAIN DEV-JPN, V34, P57, DOI 10.1016/j.braindev.2010.12.011; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Luo J, 2011, J ANESTH, V25, P657, DOI 10.1007/s00540-011-1199-z; Kubo K, 2003, NEUROSCI RES, V45, P345, DOI 10.1016/S0168-0102(02)00251-1; Nakamura K, 2006, J NEUROSCI RES, V84, P1197, DOI 10.1002/jnr.21020; Tanaka M, 1999, IND HEALTH, V37, P143, DOI 10.2486/indhealth.37.143; Blatt GJ, 2011, ANAT REC, V294, P1646, DOI 10.1002/ar.21252; Nussbaum D, 2011, J GAMBL STUD, V27, P523, DOI 10.1007/s10899-010-9219-8; Adriani W, 2003, ENVIRON HEALTH PERSP, V111, P395, DOI 10.1289/ehp.5856; Matsuda S, 2012, PROG NEURO-PSYCHOPH, V39, P273, DOI 10.1016/j.pnpbp.2012.06.016; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Ishido M, 2007, TOXICOL LETT, V173, P66, DOI 10.1016/j.toxlet.2007.06.014; Matsuda S, 2013, HORM BEHAV, V63, P709, DOI 10.1016/j.yhbeh.2013.03.016; Cabaton NJ, 2013, ENVIRON HEALTH PERSP, V121, P586, DOI 10.1289/ehp.1205588; Harada M, 2011, J AUTISM DEV DISORD, V41, P447, DOI 10.1007/s10803-010-1065-0; Vega-Flores G, 2014, CEREB CORTEX, V24, P2093, DOI 10.1093/cercor/bht060; Gaetz W, 2014, NEUROIMAGE, V86, P1, DOI 10.1016/j.neuroimage.2013.05.068; Hong SB, 2013, J CHILD PSYCHOL PSYC, V54, P890, DOI 10.1111/jcpp.12050; Sandhu KV, 2014, GENES BRAIN BEHAV, V13, P439, DOI 10.1111/gbb.12131; Nakamura K, 2010, NEUROSCI LETT, V484, P66, DOI 10.1016/j.neulet.2010.08.021; Matsuda S, 2010, CHEMOSPHERE, V78, P894, DOI 10.1016/j.chemosphere.2009.11.010; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Weinstein SD, 2013, BRAIN RES, V1529, P56, DOI 10.1016/j.brainres.2013.07.018; Perera F, 2012, ENVIRON HEALTH PERSP, V120, P1190, DOI 10.1289/ehp.1104492; Luo GY, 2013, FOOD CHEM TOXICOL, V60, P177, DOI 10.1016/j.fct.2013.07.037; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Yu CJ, 2011, ENVIRON TOXICOL PHAR, V31, P88, DOI 10.1016/j.etap.2010.09.009; Car H, 1998, Rocz Akad Med Bialymst, V43, P5; DESCARRI.L, 1970, J CELL BIOL, V44, P385, DOI 10.1083/jcb.44.2.385; Devilbiss DM, 2012, NEUROPSYCHOPHARMACOL, V37, P2020, DOI 10.1038/npp.2012.50; GRZANNA R, 1991, PROG BRAIN RES, V88, P89; Sustkova-Fiserova M, 2009, NEUROENDOCRINOL LETT, V30, P79; Ogi H, 2013, BRAIN BEHAV, V3, P223, DOI 10.1002/brb3.130; SAFAEI R, 1985, J NEUROCHEM, V45, P1405, DOI 10.1111/j.1471-4159.1985.tb07206.x; Shelby MD, 2008, NTP CERHR MON, V22, P1; Tando S, 2007, BRAIN DEV-JPN, V29, P352, DOI 10.1016/j.braindev.2006.10.003; Tando S, 2014, NEUROPATHOLOGY, V34, P527, DOI 10.1111/neup.12137; Wolstenholme JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025448; Zhou R, 2013, J PSYCHIATR RES, V47, P1535, DOI 10.1016/j.jpsychires.2013.05.013	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					739	746		10.1016/j.braindev.2014.12.008		8	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800001		
J	Morioka, I; Nakamura, H; Koda, T; Sakai, H; Kurokawa, D; Yonetani, M; Morisawa, T; Katayama, Y; Wada, H; Funato, M; Takatera, A; Okumura, A; Sato, I; Kawano, S; Iijima, K				Morioka, Ichiro; Nakamura, Hajime; Koda, Tsubasa; Sakai, Hitomi; Kurokawa, Daisuke; Yonetani, Masahiko; Morisawa, Takeshi; Katayama, Yoshinori; Wada, Hiroshi; Funato, Masahisa; Takatera, Akihiro; Okumura, Akihisa; Sato, Itsuko; Kawano, Seiji; Iijima, Kazumoto			Serum unbound bilirubin as a predictor for clinical kernicterus in extremely low birth weight infants at a late age in the neonatal intensive care unit	BRAIN & DEVELOPMENT			English	Article						Athetosis; Brainstem auditory evoked potentials; Jaundice; Magnetic resonance imaging; Motor impairment	BRAIN-STEM RESPONSES; PREMATURE-INFANTS; NEURODEVELOPMENTAL OUTCOMES; NEWBORN-INFANTS; HYPERBILIRUBINEMIA; ASSOCIATION; PHOTOTHERAPY; CHILDREN; PLASMA	Background: This study aimed to evaluate peak serum total bilirubin (TB) and unbound bilirubin (UB) levels in preterm infants with clinical kernicterus (KI) who were diagnosed by clinical findings during infancy. Design/subjects. For this multicenter retrospective study, 18 Japanese extremely low birth weight (ELBW) infants with clinical KI were included. Clinical KI was diagnosed based on the presence of motor developmental impairment with/without athetosis, and abnormal magnetic resonance imaging or brainstem auditory evoked potential findings during infancy. High and low TB or UB levels were defined as serum TB levels >= and <15 mg/dL or serum UB levels >= and <0.8 mu g/dL, respectively. The clinical characteristics of KI preterm infants were analyzed. The proportion of infants with high or low serum TB levels and with high or low serum UB levels was then investigated. Sensitivity and specificity were calculated. Results: In 18 KI infants, the median age when serum TB levels peaked was 28 days after birth. In eight KI infants with low serum TB levels, 88% of them had high serum UB levels. For comparison of the number of infants who had high or low serum TB and UB levels, the sensitivity was 90% and specificity was 13%. Conclusions: Serum TB and UB levels peak at a later age than expected. Chronic serum UB monitoring may be helpful for identifying ELBW infants at risk for developing KI, even when they do not have high serum TB levels. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Morioka, Ichiro; Nakamura, Hajime; Koda, Tsubasa; Kurokawa, Daisuke; Iijima, Kazumoto] Kobe Univ Hosp, Dept Pediat, Kobe, Hyogo 6500017, Japan; [Sato, Itsuko; Kawano, Seiji] Kobe Univ Hosp, Clin Lab, Kobe, Hyogo 6500017, Japan; [Sakai, Hitomi] Kobe Childrens Hosp, Dept Neonatol, Kobe, Hyogo, Japan; [Yonetani, Masahiko; Morisawa, Takeshi] Kakogawa West Municipal Hosp, Dept Pediat, Kakogawa, Hyogo, Japan; [Katayama, Yoshinori] Takatsuki Gen Hosp, Dept Pediat, Takatsuki, Osaka, Japan; [Wada, Hiroshi; Funato, Masahisa] Yodogawa Christians Hosp, Dept Pediat, Osaka, Japan; [Takatera, Akihiro] Chibune Gen Hosp, Dept Pediat, Osaka, Japan; [Okumura, Akihisa] Juntendo Univ Hosp, Dept Pediat, Tokyo, Japan	Morioka, I (reprint author), Kobe Univ Hosp, Dept Pediat, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ichim@med.kobe-u.ac.jp			JSPS KAKENHI [26461632, 26461633]	This work was supported by Grant-in-Aid for Scientific Research (C) of JSPS KAKENHI Grant Number 26461632 and 26461633.	Shapiro SM, 2010, SEMIN FETAL NEONAT M, V15, P157, DOI 10.1016/j.siny.2009.12.004; Morris BH, 2008, NEW ENGL J MED, V359, P1885, DOI 10.1056/NEJMoa0803024; FUNATO M, 1994, PEDIATRICS, V93, P50; Oh W, 2003, PEDIATRICS, V112, P773, DOI 10.1542/peds.112.4.773; Oh W, 2010, ACTA PAEDIATR, V99, P673, DOI 10.1111/j.1651-2227.2010.01688.x; Maruo Y, 1999, PEDIATRICS, V103, P1224, DOI 10.1542/peds.103.6.1224; Ahlfors CE, 2008, PEDIATRICS, V121, P976, DOI 10.1542/peds.2007-2297; CASHORE WJ, 1982, PEDIATRICS, V69, P481; DEVRIES LS, 1985, PEDIATRICS, V76, P351; GARTNER LM, 1970, PEDIATRICS, V45, P906; HARRIS RC, 1958, PEDIATRICS, V21, P875; Maruo Y, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.5.e59; Merhar SL, 2005, PEDIATRICS, V116, P1226, DOI 10.1542/peds.2004-2468; Miwa A, 2011, NEONATOLOGY, V99, P202, DOI 10.1159/000314893; Miwa A, 2012, CLIN LAB, V58, P507; Moll M, 2011, NEONATOLOGY, V99, P90, DOI 10.1159/000302719; NAKAMURA H, 1985, PEDIATRICS, V75, P703; Nakamura Hajime, 1992, Acta Paediatrica Japonica, V34, P642; Okumura A, 2009, PEDIATRICS, V123, pE1052, DOI 10.1542/peds.2008-2791; Sato Y, 2012, PEDIATR INT, V54, P81, DOI 10.1111/j.1442-200X.2011.03457.x; STERN L, 1965, PEDIATRICS, V35, P483; Sugama S, 2001, PEDIATR NEUROL, V25, P328, DOI 10.1016/S0887-8994(01)00306-X; Yokota T, 2013, PEDIATR INT, V55, P54, DOI 10.1111/j.1442-200X.2012.03726.x	23	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					753	757		10.1016/j.braindev.2015.01.001		5	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800003		
J	Kitai, Y; Hirai, S; Ohmura, K; Ogura, K; Arai, H				Kitai, Yukihiro; Hirai, Satori; Ohmura, Kayo; Ogura, Kaeko; Arai, Hiroshi			Cerebellar injury in preterm children with cerebral palsy after intraventricular hemorrhage: Prevalence and relationship to functional outcomes	BRAIN & DEVELOPMENT			English	Article						Cerebral palsy; Preterm; Cerebellar injury; Intraventricular hemorrhage; Hydrocephalus; Outcome	COGNITIVE-AFFECTIVE SYNDROME; VISUAL IMPAIRMENT; NEONATAL BRAIN; INFANTS; BIRTH; MALFORMATIONS; US	Objectives: To elucidate the prevalence of cerebellar injury and its relationship to functional outcomes in preterm children with cerebral palsy (CP) after intraventricular hemorrhage (IVH). Participants: We selected 69 children (40 males and 29 females, aged between 6 and 13 years) out of 2049 with cerebral palsy who visited Morinomiya Hospital, the regional center hospital for CP in West Japan. The inclusion criteria were (1) gestational age under 36 weeks at birth, (2) clear history of postnatal intraventricular hemorrhage, and (3) age at investigation over 6 years old. Those without sufficient imaging study or functional evaluation were excluded. Methods: The participants were divided into four groups according to the presence of post-hemorrhagic hydrocephalus (PH) and cerebellar injury (CI): PH+/CI+, PH+/CI-, PH-/CI+, and PH-/CI-. Type of CP, ability to walk, verbal function, the incidence of severe visual impairment, and the complication of epilepsy were investigated and compared among the groups. Results: The gestational ages of the participants were between 22 and 34 weeks, and their birth weight was between 412 and 1788 g. PH and CI were found in 39 (57%) and 40 (58%) children, respectively. Both the PH+/CI+ group (n = 31) and the PH-/CI+ group (n = 9) showed significantly lower walking and verbal abilities and a higher incidence of epilepsy than the PH-/CI- group (n = 21), while the PH+/CI- group showed no significant difference from the PH-/CI- group. Severe visual impairment was found only in the PH+/CI+ group and the PH-/CI+ group. Conclusions: The prevalence of CI in preterm children with CP after IVH (58%) was almost the same as that of PH. CI is one of the most significant complications in preterm infants, affecting motor and verbal functions and being associated with epilepsy more than PH. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Kitai, Yukihiro; Hirai, Satori; Ohmura, Kayo; Ogura, Kaeko; Arai, Hiroshi] Morinomiya Hosp, Dept Pediat Neurol, Osaka, Osaka 5360025, Japan	Kitai, Y (reprint author), Morinomiya Hosp, Dept Pediat Neurol, Joto Ku, 2-1-88 Morinomiya, Osaka, Osaka 5360025, Japan.	kitai@omichikai.or.jp					Bolduc ME, 2012, CEREBELLUM, V11, P531, DOI 10.1007/s12311-011-0312-z; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Messerschmidt A, 2008, EUR J PEDIATR, V167, P1141, DOI 10.1007/s00431-007-0647-0; Tavano A, 2007, BRAIN, V130, P2646, DOI 10.1093/brain/awm201; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Correa F, 2004, AM J NEURORADIOL, V25, P1274; Limperopoulos C, 2005, PEDIATRICS, V115, P688, DOI 10.1542/peds.2004-1169; Steggerda SJ, 2009, RADIOLOGY, V252, P190, DOI 10.1148/radiol.2521081525; Castano G, 2000, J AAPOS, V4, P175, DOI 10.1016/S1091-8531(00)70009-7; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Di Salvo DN, 2001, RADIOGRAPHICS, V21, P943; Limperopoulos C, 2005, PEDIATRICS, V116, P844, DOI 10.1542/peds.2004-2282; Tam EWY, 2011, J PEDIATR-US, V158, P366, DOI 10.1016/j.jpeds.2010.09.005; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; Merrill JD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.6.e62; Limperopoulos C, 2005, PEDIATRICS, V116, P717, DOI 10.1542/peds.2005-0556; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; Bodensteiner JB, 2006, J CHILD NEUROL, V21, P743, DOI 10.2310/7010.2006.00179; Bosch DGM, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-59; Tam EWY, 2011, J PEDIATR-US, V158, P245, DOI 10.1016/j.jpeds.2010.07.049; Towbin R, 1998, PEDIATR RADIOL, V28, P995, DOI 10.1007/s002470050518	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					758	763		10.1016/j.braindev.2014.12.009		6	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800004		
J	Tamura, K; Karube, C; Mizuba, T; Matsufuji, M; Takashima, S; Iramina, K				Tamura, Kaori; Karube, Chihiro; Mizuba, Takaaki; Matsufuji, Mayumi; Takashima, Sachio; Iramina, Keiji			Phase-locked theta activity evoked in patients with severe motor and intellectual disabilities upon hearing own names	BRAIN & DEVELOPMENT			English	Article						Severe motor and intellectual disability; Theta phase-locked activity; Subject's own name; Inter-trial coherence	FREQUENCY-ANALYSIS; COMATOSE PATIENTS; RESPONSES; EEG; CONSCIOUSNESS; DYNAMICS; PROGNOSIS; STIMULUS; PET	Background: Severe motor and intellectual disability (SMID) patients cannot express their feelings with language. Understanding what they are thinking about or how they feel is thus difficult. This study focused on brain responses to hearing their own names to clarify the situation in these patients. Methods: We performed and analyzed electroencephalography (EEG) for six patients with SMID and eleven healthy subjects. All subjects were presented with auditory stimuli including calling the subject's own name (SON) and reading words. EEG was analyzed by time frequency analysis, event-related spectral perturbation (ERSP) to detect EEG power changes caused by EEG amplitude, and inter-trial coherence (ITC) to investigate phase-locked changes. Results: ERSP results from healthy subjects showed significant theta power increases as a specific response to SON. While we could not identify a similar pattern in the responses of patients with SMID, analysis of ITC revealed that theta phase-locked activity increased in response to SON not only in all healthy subjects, but also in four patients. Discussion: These results indicate that theta phase-locked activity in some patients with SMID was strongly associated with SON, as in healthy subjects. Our study suggests the existence of specific neural markers that signal an attentional shift in patients upon hearing SON. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Tamura, Kaori; Karube, Chihiro; Mizuba, Takaaki; Iramina, Keiji] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8128582, Japan; [Matsufuji, Mayumi; Takashima, Sachio] Int Univ Hlth & Welf, Grad Sch, Yanagawa Inst Dev Disabil, Fukuoka, Japan	Tamura, K (reprint author), Kyushu Univ, Grad Sch Syst Life Sci, Higashi Ku, 1-1-3 Maidashi, Fukuoka 8128582, Japan.	tamura@bie.inf.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23650267, 25560287]; Japan Society for the Promotion of Science (JSPS) [264908]	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Nos. 23650267, 25560287) and a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows (No. 264908).	Lehembre R, 2012, FUNCT NEUROL, V27, P41; Holeckova I, 2006, BRAIN RES, V1082, P142, DOI 10.1016/j.brainres.2006.01.089; Tateuchi T, 2012, PSYCHOPHYSIOLOGY, V49, P786, DOI 10.1111/j.1469-8986.2012.01363.x; Bak TH, 2004, BRAIN LANG, V89, P354, DOI 10.1016/S0093-934X(03)00357-2; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Fischer C, 2008, CLIN NEUROPHYSIOL, V119, P2224, DOI 10.1016/j.clinph.2008.03.035; Cavinato M, 2011, CLIN NEUROPHYSIOL, V122, P719, DOI 10.1016/j.clinph.2010.08.024; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Mouraux A, 2008, MAGN RESON IMAGING, V26, P1041, DOI 10.1016/j.mri.2008.01.011; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Muller HM, 1996, NEUROREPORT, V8, P221; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; BERLAD I, 1995, EVOKED POTENTIAL, V96, P472, DOI 10.1016/0168-5597(95)00116-A; D'Argembeau A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00372; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Fellinger R, 2011, CLIN NEUROPHYSIOL, V122, P2177, DOI 10.1016/j.clinph.2011.03.004; Perrin F, 2005, NEUROPSYCHOLOGIA, V43, P12, DOI 10.1016/j.neuropsychologia.2004.07.002; Berens P., 2009, J STAT SOFTW, V31; Fisher N. I., 1995, STAT ANAL CIRCULAR D; Hanaoka T, 2010, J EPIDEMIOL, V20, P77, DOI 10.2188/jea.JE20090024; Holeckova I, 2008, BRAIN RES, V1189, P152, DOI 10.1016/j.brainres.2007.10.091; Holler Y, 2011, CLIN NEUROPHYSIOL, V122, P99, DOI 10.1016/j.clinph.2010.05.029; Holler Y, 2011, INT J PSYCHOPHYSIOL, V80, P227, DOI 10.1016/j.ijpsycho.2011.03.012; Kurihara M, 1998, BRAIN DEV-JPN, V20, P519, DOI 10.1016/S0387-7604(98)00038-2; Laureys S, 2007, CONSCIOUS COGN, V16, P742; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Folmer RL, 1997, BRAIN LANG, V56, P306, DOI 10.1006/brln.1997.1828	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					764	772		10.1016/j.braindev.2014.11.009		9	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800005		
J	Iwasaki, T; Toki, T; Nonoda, Y; Ishii, M				Iwasaki, Toshiyuki; Toki, Taira; Nonoda, Yutaka; Ishii, Masahiro			The efficacy of levetiracetam for focal seizures and its blood levels in children	BRAIN & DEVELOPMENT			English	Article						Antiepileptic drug; Maintenance dosage; Optimal range; Seizure reduction rate; Side effect	DOUBLE-BLIND; ANTIEPILEPTIC DRUGS; REFRACTORY EPILEPSY; CHILDHOOD EPILEPSY; PROFILE; ONSET; PHARMACOKINETICS; TRIAL	Aim: To evaluate the efficacy of levetiracetam (LEV) and the usefulness of measurement of its blood levels during the follow-up of patients with focal seizures. Methods: Twenty-four patients (13 cases without impairment of consciousness or awareness and 11 cases with them or evolving to a bilateral, convulsive seizure) treated with LEV had their peak blood levels measured. The blood concentrations were measured at 2 weeks, 1 year and 2 years after reaching the LEV maintenance dosage. The efficacy of LEV was evaluated with repeated blood sampling to determine the seizure reduction rate. The patients were classified as effective cases (seizure reduction rate > 50%) and ineffective cases (<= 50%). Results: In Japanese children treated with LEV, the dosage and blood level showed positive correlations. The blood levels were higher in effective cases than in ineffective cases at all time points (p < 0.05). In effective cases, the blood concentration was 23.26 +/- 6.88 mu g/mL (mean +/- SD) 2 weeks later, 23.59 +/- 8.23 mu m/mL 1 year later, and 24.46 +/- 7.57 mu g/mL 2 years later. However, the blood levels and efficacies showed positive correlations only at 2 weeks and 1 year later. No patients had any side effects. Conclusions: No precise definition of the therapeutic range was possible because of the incomplete correlation between the blood level and seizure frequency. Instead of a therapeutic range, we recommend an optimal range for LEV of 20-30 mu g/mL as a therapeutic target without any side effects. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Iwasaki, Toshiyuki; Toki, Taira; Nonoda, Yutaka; Ishii, Masahiro] Kitasato Univ, Sch Med, Dept Pediat, Sagamihara, Kanagawa 2520374, Japan	Iwasaki, T (reprint author), Kitasato Univ, Sch Med, Dept Pediat, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	tiwasaki@kitasato-u.ac.jp					Perucca E, 2001, FUND CLIN PHARMACOL, V15, P405, DOI 10.1046/j.1472-8206.2001.00055.x; Pellock JM, 2001, EPILEPSIA, V42, P1574, DOI 10.1046/j.1528-1157.2001.41300.x; Ben-Menachem E, 2000, EPILEPSIA, V41, P1276, DOI 10.1111/j.1528-1157.2000.tb04605.x; Perucca E, 2006, BRIT J CLIN PHARMACO, V61, P246, DOI 10.1111/j.1365-2125.2005.02529.x; Glauser TA, 2007, EPILEPSIA, V48, P1117, DOI 10.1111/j.1528-1167.2007.01090.x; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Cereghino JJ, 2000, NEUROLOGY, V55, P236; Patsalos PN, 2000, PHARMACOL THERAPEUT, V85, P77, DOI 10.1016/S0163-7258(99)00052-2; Glauser TA, 2006, NEUROLOGY, V66, P1654, DOI 10.1212/01.wnl.0000217916.00225.3a; Boon P, 2002, EPILEPSY RES, V48, P77, DOI 10.1016/S0920-1211(01)00323-0; Fountain NB, 2007, EPILEPSY RES, V74, P60, DOI 10.1016/j.eplepsyres.2006.12.005; French J, 2005, EPILEPSIA, V46, P324, DOI 10.1111/j.0013-9580.2005.31504.x; Giroux PC, 2009, SEIZURE-EUR J EPILEP, V18, P559, DOI 10.1016/j.seizure.2009.05.007; GOWER AJ, 1992, EUR J PHARMACOL, V222, P193, DOI 10.1016/0014-2999(92)90855-X; Kanemura H, 2013, BRAIN DEV-JPN, V35, P386, DOI 10.1016/j.braindev.2012.07.005; Klitgaard H, 2001, EPILEPSIA, V42, P13, DOI 10.1046/j.1528-1157.2001.0420s4013.x; Lancelin F, 2007, THER DRUG MONIT, V29, P576; May TW, 2003, THER DRUG MONIT, V25, P690, DOI 10.1097/00007691-200312000-00007; Meencke HJ, 2006, EUR J NEUROL, V13, P942, DOI 10.1111/j.1468-1331.2006.01381.x; Nonoda Y, 2014, BRAIN DEV-JPN, V36, P194, DOI 10.1016/j.braindev.2013.04.006; Tomson T, 2004, J NEUROL, V251, P1043, DOI 10.1007/s00415-004-0344-0; Verrotti Alberto, 2010, Paediatr Drugs, V12, P177, DOI 10.2165/11316250-000000000-00000; von Stuelpnagel C, 2007, EUR J PAEDIATR NEURO, V11, P341, DOI 10.1016/j.ejpn.2007.02.016; Welty TE, 2002, ANN PHARMACOTHER, V36, P296; Wheless James W, 2007, Neuropsychiatr Dis Treat, V3, P409	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					773	779		10.1016/j.braindev.2014.11.008		7	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800006		
J	Ito, Y; Takahashi, S; Kagitani-Shimono, K; Natsume, J; Yanagihara, K; Fujii, T; Oguni, H				Ito, Yasushi; Takahashi, Satoru; Kagitani-Shimono, Kuriko; Natsume, Jun; Yanagihara, Keiko; Fujii, Tatsuya; Oguni, Hirokazu			Nationwide survey of glucose transporter-1 deficiency syndrome (GLUT-1DS) in Japan	BRAIN & DEVELOPMENT			English	Article						Glucose transporter type-1; Hypoglycorrhachia; Epilepsy; Movement disorders; Ketogenic diet	TRANSPORTER TYPE-1 DEFICIENCY; BLOOD-BRAIN-BARRIER; GLUT1 DEFICIENCY; GLUCOSE-TRANSPORT; KETOGENIC DIET; SLC2A1 GENE; EPILEPSY; MUTATIONS; SEIZURES; HAPLOINSUFFICIENCY	Objectives: We conducted a nationwide survey of glucose transporter type-1 deficiency syndrome (GLUT-1DS) in Japan in order to clarify its incidence as well as clinical and laboratory information. Subjects and methods: A questionnaire to survey the number of genetically and clinically confirmed cases of GLUT-1DS was sent to 1018 board-certified pediatric neurologists, which resulted in 57 patients being reported. We obtained the clinical and laboratory data of 33 patients through a secondary questionnaire. Results: The age of the 33 patients (male: 15, female: 18) at the time of the study ranged between 3 and 35 years (mean: 13.5 years). The age of these patients at the onset of initial neurological symptoms ranged between the neonatal period and 48 months (mean: 9.4 months). GLUT-1DS was diagnosed at a mean age of 8.4 years (range: 1 year to 33 years). The initial symptom was convulsive seizures, which occurred in 15 cases, and was followed by abnormal eye movements in 7 cases and apneic or cyanotic attacks in 4 cases. The latter two symptoms most frequently occurred early in infancy. Thirty-two patients (97%) exhibited some type of epileptic seizure. Neurological findings revealed that most patients had muscle hypotonia, cerebellar ataxia, dystonia, and spastic paralysis. Mild to severe mental retardation was detected in all 33 cases. Furthermore, paroxysmal episodes of ataxia, dystonia/dyskinesia, and motor paralysis were described in approximately 1/3 of all patients. The factors that frequently aggravated these events were hunger, exercise, fever, and fatigue, in that order. The mean CSF/blood glucose ratio was 0.36 (0.28-0.48). Pathological mutations in the SLC2A1 gene were identified in 28 out of 32 cases (87.5%). Conclusion: The results described herein provided an insight into the early diagnosis of GLUT1-DS, including unexplained paroxysmal abnormal eye movements, apneic/cyanotic attacks, and convulsive seizures in infancy, as well as uncommon paroxysmal events (ataxia, atonia, and motor paralysis) in childhood. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Ito, Yasushi; Oguni, Hirokazu] Tokyo Womens Med Univ, Dept Pediat, Tokyo 1628666, Japan; [Takahashi, Satoru] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido, Japan; [Kagitani-Shimono, Kuriko] Osaka Univ, Grad Sch Med, United Grad Sch Child Dev, Suita, Osaka 565, Japan; [Natsume, Jun] Nagoya Univ, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Yanagihara, Keiko] Osaka Med Ctr, Sect Pediat Neurol, Osaka, Japan; [Yanagihara, Keiko] Res Inst Maternal & Child Hlth, Osaka, Japan; [Fujii, Tatsuya] Shiga Med Ctr Children, Shiga, Japan	Oguni, H (reprint author), Tokyo Womens Med Univ, Dept Pediat, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	hoguni@ped.twmu.ac.jp			Ministry of Health, Labor, and Welfare [059]	We are grateful to Naoko Ishihara MD, Yoshiteru Azuma MD, and Ikuko Kato MD and all of the doctors who collaborated and sent valuable information on their patients for this study. This study was funded in part by Research Grants (059) for the Specified Disease Treatment Research Program from the Ministry of Health, Labor, and Welfare. We certify that we have read the Journal's position regarding issues pertaining to ethical publications, and affirm that this report is consistent with those guidelines.	DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; Klepper J, 2002, EUR J PEDIATR, V161, P295, DOI 10.1007/s00431-002-0939-3; Ito Y, 2011, DEV MED CHILD NEUROL, V53, P658, DOI 10.1111/j.1469-8749.2011.03961.x; Anand G, 2011, DEV MED CHILD NEUROL, V53, P664, DOI 10.1111/j.1469-8749.2011.03949.x; Klepper J, 2008, EPILEPSIA, V49, P46, DOI 10.1111/j.1528-1167.2008.01833.x; Arsov T, 2012, ANN NEUROL, V72, P807, DOI 10.1002/ana.23702; Suls A, 2008, BRAIN, V131, P1831, DOI 10.1093/brain/awn113; Klepper J, 2007, DEV MED CHILD NEUROL, V49, P707; Roubergue A, 2011, J INHERIT METAB DIS, V34, P483, DOI 10.1007/s10545-010-9264-6; Perez-Duenas B, 2009, ARCH NEUROL-CHICAGO, V66, P1410, DOI 10.1001/archneurol.2009.236; Gokben S, 2011, EPILEPSY BEHAV, V21, P200, DOI 10.1016/j.yebeh.2011.03.027; Klepper J, 2012, EPILEPSY RES, V100, P272, DOI 10.1016/j.eplepsyres.2011.02.007; Klepper J, 2009, NEUROPEDIATRICS, V40, P207, DOI 10.1055/s-0030-1248264; Rotstein M, 2010, ANN NEUROL, V68, P955, DOI 10.1002/ana.22088; Leen WG, 2010, BRAIN, V133, P655, DOI 10.1093/brain/awp336; Pong AW, 2012, EPILEPSIA, V53, P1503, DOI 10.1111/j.1528-1167.2012.03592.x; Takahashi S, 2008, EPILEPSY RES, V80, P18, DOI 10.1016/j.eplepsyres.2008.03.010; Schneider SA, 2009, MOVEMENT DISORD, V24, P1684, DOI 10.1002/mds.22507; Hashimoto N, 2011, J HUM GENET, V56, P846, DOI 10.1038/jhg.2011.115; Klepper J, 2007, PEDIATR NEUROL, V37, P130, DOI 10.1016/j.pediatrneurol.2007.03.009; Akman CI, 2010, ANN NEUROL, V67, P31, DOI 10.1002/ana.21797; Mullen SA, 2011, ARCH NEUROL-CHICAGO, V68, P1152, DOI 10.1001/archneurol.2011.102; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Pascual JM, 2002, ANN NEUROL, V52, P458, DOI 10.1002/ana.10311; Arsov T, 2012, EPILEPSIA, V53, pe204, DOI 10.1111/epi.12007; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Fujii T, 2011, BRAIN DEV-JPN, V33, P316, DOI 10.1016/j.braindev.2010.06.012; Hirano Y, 2009, EPILEPSIA, V50, P1525, DOI 10.1111/j.1528-1167.2008.01859.x; Ito Y, 2005, BRAIN DEV-JPN, V27, P311, DOI 10.1016/j.braindev.2004.09.010; Klepper J, 2013, NEUROPEDIATRICS, V44, P235, DOI 10.1055/s-0033-1336015; Koy A, 2011, DEV MED CHILD NEUROL, V53, P1154, DOI 10.1111/j.1469-8749.2011.04082.x; Leen WG, 2013, JAMA NEUROL, V70, P1440, DOI 10.1001/jamaneurol.2013.3090; Striano P, 2012, NEUROLOGY, V78, P557, DOI 10.1212/WNL.0b013e318247ff54; Verrotti A, 2012, EUR J PAEDIATR NEURO, V16, P3, DOI 10.1016/j.ejpn.2011.09.005; Wang D, 2008, PEDIATR RES, V64, P538, DOI 10.1203/PDR.0b013e318184d2b5; Wang D, 1993, GLUCOSE TRANSPORTER	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					780	789		10.1016/j.braindev.2014.11.006		10	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800007		
